SNP	REF	ALT	HOM REF CLM	HET CLM	HOM ALT CLM	HOM REF CHO	HET CHO	HOM ALT CHO	Ref Freq CLM	Ref Freq CHO	Alt Freq CLM	Alt Freq CHO	Risk	OR	Fst	Trait	HigherLevel
rs2814778	T	C	81	12	1	4	27	63	0.93	0.19	0.07	0.81	A	1.35	0.553562731	White blood cell count	Immune diseases and disorders
rs343092	T	G	7	0	56	65	25	4	0.11	0.82	0.89	0.18	T	1.16	0.510998838	Type 2 diabetes	Diabetes
rs2518564	G	A	5	23	66	69	23	2	0.18	0.86	0.82	0.14	A	0.1905	0.464030815	White blood cell count	Immune diseases and disorders
rs2340727	A	G	67	25	2	3	37	54	0.85	0.23	0.15	0.77	A	0.0229	0.382838284	Hematology traits	Heart health and disorders
rs187200046	C	T	68	23	3	4	36	54	0.85	0.23	0.15	0.77	T	0.2366	0.376576782	Metabolite levels HVA	General health
rs12074934	T	G	84	9	1	16	35	43	0.94	0.36	0.06	0.64	C	15.23	0.37568306	Diisocyanate-induced asthma	Pulmonology
rs16891982	C	G	15	38	41	82	12	0	0.36	0.94	0.64	0.06	C	0.31	0.362146051	Skin sensitivity to sun	Appearance
rs11894081	G	T	3	32	59	61	28	5	0.20	0.80	0.80	0.20	T	1.22	0.354911725	Crohn's disease	Digestive system and its disorders
rs2484990	T	C	1	10	83	40	37	17	0.06	0.62	0.94	0.38	C	0.68	0.346012617	Disc degeneration lumbar	Aging
rs2484992	T	C	1	10	83	40	37	17	0.06	0.62	0.94	0.38	C	0.68	0.346012617	Disc degeneration lumbar	Aging
rs1250307	G	A	1	9	84	37	39	18	0.06	0.60	0.94	0.40	A	0.68	0.332949309	Disc degeneration lumbar	Aging
rs11814448	A	C	77	16	1	7	51	36	0.90	0.35	0.10	0.65	C	1.26	0.332729742	Breast cancer	Cancer
rs11868441	A	G	5	34	55	63	26	5	0.23	0.81	0.77	0.19	G	0.0059	0.330612245	Renal function-related traits BUN	General health
rs10231619	C	T	65	26	3	11	27	56	0.83	0.26	0.17	0.74	T	1.13	0.326601055	Type 2 diabetes	Diabetes
rs11104870	C	T	3	38	53	62	27	5	0.23	0.80	0.77	0.20	C	0.013	0.324380224	Red blood cell traits	Immune diseases and disorders
rs10836945	T	C	0	13	81	31	52	11	0.07	0.61	0.93	0.39	G	2.1739	0.322581665	Bronchopulmonary dysplasia	Pulmonology
rs1399090	C	T	75	17	2	13	37	44	0.89	0.34	0.11	0.66	T	0.216	0.322096486	Economic and political preferences	Mental aptitude and behavioural traits
rs802571	A	G	73	21	0.001	11	41	42	0.89	0.34	0.11	0.66	T	1.923077	0.32208405	Alzheimer's disease late onset	Brain health and disorders
rs7144018	T	C	70	23	1	6	46	42	0.87	0.31	0.13	0.69	G	1.85	0.321850825	Multiple myeloma IgH translocation	Cancer
rs10007810	G	A	59	26	9	4	30	60	0.77	0.20	0.23	0.80	A	1.2	0.318228164	Longevity 90 years and older	Aging
rs4690909	G	C	2	35	57	55	35	4	0.21	0.77	0.79	0.23	C	0.056	0.318048007	Blood metabolite ratios	Heart health and disorders
rs2358944	G	A	5	35	54	62	26	6	0.24	0.80	0.76	0.20	G	1.33	0.312367191	Type 2 diabetes nephropathy	Diabetes
rs509360	A	G	6	33	55	65	20	9	0.24	0.80	0.76	0.20	A	0.0031	0.312367191	Trans fatty acid levels	General health
rs223116	A	G	14	32	48	69	23	2	0.32	0.86	0.68	0.14	A	7.4	0.297795942	Resting heart rate	General health
rs7951870	T	C	64	26	4	9	34	51	0.82	0.28	0.18	0.72	C	1.098901	0.297087379	Schizophrenia	Brain health and disorders
rs1834640	A	G	58	31	5	8	29	57	0.78	0.24	0.22	0.76	G	12.5	0.294497283	Skin pigmentation	Appearance
rs12959570	G	A	6	29	59	58	27	9	0.22	0.76	0.78	0.24	G	1.2	0.294497283	Tourette's syndrome or obsessive-compulsive disorder	Brain health and disorders
rs11651885	G	A	8	36	50	64	25	5	0.28	0.81	0.72	0.19	G	0.022	0.290999857	Optic cup area	Misc
rs9623117	T	C	69	22	3	13	35	46	0.85	0.32	0.15	0.68	C	1.18	0.286118815	Prostate cancer	Cancer
rs1137	T	C	0.001	49	45	63	23	8	0.26	0.79	0.74	0.21	C	0.12	0.283728086	Myopia pathological	General health
rs4474514	G	A	3	25	66	46	38	10	0.16	0.69	0.84	0.31	A	3.07	0.283143146	Testicular cancer	Cancer
rs10828735	C	T	81	13	0.001	14	54	26	0.93	0.44	0.07	0.56	A	6.76	0.282790474	Diisocyanate-induced asthma	Pulmonology
rs1298637	C	T	44	47	3	2	32	60	0.72	0.19	0.28	0.81	A	5.972	0.279589217	Nicotine use	General health
rs705117	C	T	4	34	56	55	31	8	0.22	0.75	0.78	0.25	C	2026.78	0.277499363	Serum vitamin D-binding protein levels	General health
rs3753841	G	A	6	35	53	53	40	1	0.25	0.78	0.75	0.22	G	1.2	0.277499363	Glaucoma primary angle closure	General health
rs28777	C	A	13	39	42	69	23	2	0.35	0.86	0.65	0.14	C	0.46	0.271858407	Black vs. blond hair color	Appearance
rs2472649	A	G	4	38	52	52	40	2	0.24	0.77	0.76	0.23	G	1.095	0.271760045	Inflammatory bowel disease	Immune diseases and disorders
rs7769089	A	T	77	16	1	14	49	31	0.90	0.41	0.10	0.59	T	0.16	0.271443367	Lipoprotein a levels	Heart health and disorders
rs7582701	G	C	71	21	2	13	42	39	0.87	0.36	0.13	0.64	C	0.4547	0.2694432	IgG glycosylation	Immune diseases and disorders
rs995030	A	G	3	24	67	44	38	12	0.16	0.67	0.84	0.33	G	2.69	0.268531469	Testicular germ cell tumor	Cancer
rs261532	G	T	45	44	5	3	31	60	0.71	0.20	0.29	0.80	A	1	0.268406789	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs11845134	C	T	60	28	6	6	39	49	0.79	0.27	0.21	0.73	A	0.03	0.267126593	Obesity-related traits	Obesity
rs8068952	G	C	8	35	51	61	26	7	0.27	0.79	0.73	0.21	G	0.01	0.267126593	Vertical cup-disc ratio	Misc
rs2303565	T	C	40	38	16	1	22	71	0.63	0.13	0.37	0.87	C	1.17	0.265920308	Amyotrophic lateral sclerosis	Brain health and disorders
rs11627546	A	C	4	27	63	48	35	11	0.19	0.70	0.81	0.30	C	0.162	0.264371773	Red blood cell traits	Immune diseases and disorders
rs1426654	A	G	50	35	9	4	31	59	0.72	0.21	0.28	0.79	A	0.484	0.262205531	Body mass index	Obesity
rs9368849	T	G	8	45	41	64	28	2	0.32	0.83	0.68	0.17	T	0.044	0.261571458	Airway responsiveness in chronic obstructive pulmonary disease	Pulmonology
rs11729931	T	C	5	37	52	52	39	3	0.25	0.76	0.75	0.24	C	0.014849857	0.260780985	Urate levels BMI interaction	Obesity
rs7310309	T	C	6	21	67	41	46	7	0.18	0.68	0.82	0.32	T	1.83	0.260725119	Classic bladder exstrophy	Misc
rs12940030	T	C	46	36	12	3	27	64	0.68	0.18	0.32	0.82	T	0.08	0.260725119	Corneal structure	General health
rs11532322	A	G	6	47	41	65	24	5	0.31	0.82	0.69	0.18	A	1.094	0.259944123	Schizophrenia	Brain health and disorders
rs12050794	G	A	14	46	34	74	18	2	0.39	0.88	0.61	0.12	G	0.2996	0.259313725	Metabolite levels HVA_MHPG ratio	Brain health and disorders
rs861318	A	G	2	16	76	34	43	17	0.11	0.59	0.89	0.41	A	0.04	0.258015267	Obesity-related traits	Obesity
rs4898878	A	G	50	36	8	6	29	59	0.72	0.22	0.28	0.78	A	0.006	0.256224626	Height	General health
rs16957091	T	G	54	37	3	9	32	53	0.77	0.27	0.23	0.73	G	1.7	0.255701941	MGMT methylation in smokers	General health
rs670523	A	G	17	37	40	73	17	4	0.38	0.87	0.62	0.13	A	1.0770509	0.254724931	Crohn's disease	Digestive system and its disorders
rs2102949	G	A	6	47	41	64	25	5	0.31	0.81	0.69	0.19	G	1.098901	0.25414174	Schizophrenia	Brain health and disorders
rs2851447	G	C	6	47	41	64	25	5	0.31	0.81	0.69	0.19	G	1.0928961	0.25414174	Schizophrenia	Brain health and disorders
rs4427170	A	T	40	43	11	4	22	68	0.65	0.16	0.35	0.84	T	1.629	0.25349512	Methamphetamine dependence	General health
rs10242455	A	G	63	26	5	10	38	46	0.81	0.31	0.19	0.69	A	0.221	0.253471027	Blood metabolite levels	Heart health and disorders
rs3790567	A	G	7	39	48	57	33	4	0.28	0.78	0.72	0.22	A	1.51	0.251022727	Primary biliary cirrhosis	Immune diseases and disorders
rs2589113	T	G	0	10	84	23	48	23	0.05	0.50	0.95	0.50	T	0.044	0.249434389	Height	General health
rs10483727	T	C	15	41	38	70	22	2	0.38	0.86	0.62	0.14	T	0.026	0.248536871	Optic cup area	Misc
rs4948317	C	T	9	41	44	61	30	3	0.31	0.81	0.69	0.19	C	1.1	0.248427402	Colorectal cancer	Cancer
rs3733631	G	C	60	32	2	13	33	48	0.81	0.31	0.19	0.69	C	0.05	0.248427402	Menarche age at onset	Reproductive health
rs10885122	T	G	2	28	64	42	40	12	0.17	0.66	0.83	0.34	G	1	0.246620047	Fasting glucose-related traits	General health
rs1790100	G	T	4	40	50	54	33	7	0.26	0.75	0.74	0.25	G	1.11	0.244716068	Multiple sclerosis	Brain health and disorders
rs2270788	T	C	69	24	1	13	46	35	0.86	0.38	0.14	0.62	C	0.2364	0.243770314	IgG glycosylation	Immune diseases and disorders
rs2093210	C	T	15	42	37	70	22	2	0.38	0.86	0.62	0.14	T	0.039	0.243770314	Height	General health
rs9868873	G	A	66	28	0	13	44	37	0.85	0.37	0.15	0.63	G	1.19	0.241215009	Esophageal cancer	Cancer
rs311904	T	C	0	15	79	27	46	21	0.08	0.53	0.92	0.47	A	0.03	0.240712977	Obesity-related traits	Obesity
rs602633	T	G	5	34	55	48	40	6	0.23	0.72	0.77	0.28	T	1.1111	0.239909297	Coronary artery disease	Heart health and disorders
rs2153960	G	A	8	46	40	62	29	3	0.33	0.81	0.67	0.19	A	1	0.239231547	Insulin-like growth factors	General health
rs2908004	G	A	37	41	16	4	18	72	0.61	0.14	0.39	0.86	G	0.16	0.239052362	Bone mineral density	General health
rs1056513	G	A	18	37	39	68	26	0	0.39	0.86	0.61	0.14	A	0.04	0.239052362	Obesity-related traits	Obesity
rs2545801	T	C	9	39	46	57	34	3	0.30	0.79	0.70	0.21	C	1.68	0.236228783	Activated partial thromboplastin time	Heart health and disorders
rs5769765	G	A	4	33	57	47	38	9	0.22	0.70	0.78	0.30	G	1.0638298	0.235798286	Schizophrenia	Brain health and disorders
rs13025652	C	T	11	34	49	61	25	8	0.30	0.78	0.70	0.22	C	0.0913	0.235798286	Verbal declarative memory	Brain health and disorders
rs906175	C	T	18	41	35	74	16	4	0.41	0.87	0.59	0.13	T	1.58	0.23264177	Frontotemporal dementia	Brain health and disorders
rs55661361	G	A	59	32	3	9	42	43	0.80	0.32	0.20	0.68	G	1.0869565	0.232358003	Schizophrenia	Brain health and disorders
rs7951911	A	G	78	15	1	20	47	27	0.91	0.46	0.09	0.54	G	0.2689	0.231769807	IgG glycosylation	Immune diseases and disorders
rs1667394	C	T	17	46	31	73	20	1	0.43	0.88	0.57	0.12	A	4.94	0.231269543	Blond vs. brown hair color	Appearance
rs10838634	A	G	1	14	79	28	43	23	0.09	0.53	0.91	0.47	A	1.1	0.229518574	Schizophrenia	Brain health and disorders
rs599839	G	A	7	32	55	48	40	6	0.24	0.72	0.76	0.28	G	5.2254	0.229409765	Metabolite levels	General health
rs10275044	A	T	3	41	50	50	37	7	0.25	0.73	0.75	0.27	T	0.0069	0.229279891	Renal function-related traits BUN	General health
rs61826828	A	G	55	29	10	7	35	52	0.74	0.26	0.26	0.74	A	1.07	0.229176098	Schizophrenia	Brain health and disorders
rs13390159	G	A	66	25	3	14	41	39	0.84	0.37	0.16	0.63	A	1	0.228436578	Response to statin therapy	General health
rs227584	A	C	38	38	18	1	25	68	0.61	0.14	0.39	0.86	A	0.06	0.228429153	Bone mineral density	General health
rs7965364	C	T	3	26	65	40	40	14	0.17	0.64	0.83	0.36	T	3.79	0.227443609	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs2908007	A	G	35	45	14	5	18	71	0.61	0.15	0.39	0.85	G	0.15	0.227167682	Bone properties heel	General health
rs6899976	G	A	6	47	41	59	30	5	0.31	0.79	0.69	0.21	G	3.8	0.226424263	Height	General health
rs2707466	C	T	38	40	16	5	19	70	0.62	0.15	0.38	0.85	C	0.11	0.225974026	Cortical thickness	Heart health and disorders
rs2238151	T	C	28	45	21	2	14	78	0.54	0.10	0.46	0.90	T	1.13	0.225255861	Stroke ischemic	Brain health and disorders
rs10838798	T	G	6	43	45	58	28	8	0.29	0.77	0.71	0.23	T	1.16	0.224881469	Height	General health
rs183671	T	G	13	39	42	62	29	3	0.35	0.81	0.65	0.19	T	0.020743314	0.224828707	Skin colour saturation	Appearance
rs234709	C	T	39	46	9	6	24	64	0.66	0.19	0.34	0.81	T	0.0718	0.224074074	Homocysteine levels	Misc
rs7623430	G	C	39	41	14	5	22	67	0.63	0.17	0.37	0.83	G	3.03	0.222781457	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs5750250	G	A	1	10	83	25	41	28	0.06	0.48	0.94	0.52	G	1.27	0.221949571	Diabetic kidney disease	Diabetes
rs224333	G	A	44	40	10	6	28	60	0.68	0.21	0.32	0.79	G	0.0363	0.221611722	Waist-to-hip ratio adjusted for body mass index	Obesity
rs2842895	G	C	19	56	19	82	10	2	0.50	0.93	0.50	0.07	C	1	0.221116639	Visceral adipose tissue adjusted for BMI	Obesity
rs896543	G	A	61	32	1	11	45	38	0.82	0.36	0.18	0.64	G	1.54	0.220960444	Alcohol dependence age at onset	General health
rs6427419	C	A	15	47	32	71	20	3	0.41	0.86	0.59	0.14	C	0.03	0.220657851	Obesity-related traits	Obesity
rs6999631	G	C	0	7	87	17	48	29	0.04	0.44	0.96	0.56	C	0.09	0.220216889	Bulimia nervosa	Brain health and disorders
rs2032224	C	A	11	34	49	57	30	7	0.30	0.77	0.70	0.23	A	2.16	0.22	Adverse response to chemotherapy in breast cancer alopecia anti-microtubule	General health
rs138880	A	C	55	34	5	9	38	47	0.77	0.30	0.23	0.70	C	1.1	0.22	Schizophrenia	Brain health and disorders
rs1205863	T	G	58	28	8	8	40	46	0.77	0.30	0.23	0.70	G	0.21	0.22	Disc degeneration lumbar	Aging
rs11784536	A	G	11	29	54	54	31	9	0.27	0.74	0.73	0.26	A	1.06	0.219128466	Schizophrenia	Brain health and disorders
rs2737229	A	C	34	40	20	2	20	72	0.57	0.13	0.43	0.87	C	1.11	0.219076006	Cholesterol, total	General health
rs1826508	C	T	1	15	78	24	50	20	0.09	0.52	0.91	0.48	C	0.08	0.218590705	Metabolite levels Dihydroxy docosatrienoic acid	General health
rs6047116	A	G	41	44	9	8	23	63	0.67	0.21	0.33	0.79	G	3.7872	0.21740629	Cognitive function	Brain health and disorders
rs2854437	T	G	3	27	64	39	41	14	0.18	0.63	0.82	0.37	G	1.2345679	0.217222744	Alzheimer's disease in APOE e4+ carriers	Brain health and disorders
rs9870146	C	T	14	46	34	67	25	2	0.39	0.85	0.61	0.15	G	0.03	0.216843243	Obesity-related traits	Obesity
rs7607369	A	G	13	42	39	62	30	2	0.36	0.82	0.64	0.18	A	1.15	0.216333216	Amyotrophic lateral sclerosis	Brain health and disorders
rs929354	C	T	15	38	41	63	28	3	0.36	0.82	0.64	0.18	T	0.023	0.216333216	Body mass index	Obesity
rs6679356	C	T	1	19	74	24	55	15	0.11	0.55	0.89	0.45	C	1.52	0.215181772	Primary biliary cirrhosis	Immune diseases and disorders
rs10166942	T	C	47	37	10	4	36	54	0.70	0.23	0.30	0.77	T	1.18	0.215181237	Migraine	Brain health and disorders
rs6846071	T	G	81	13	0	24	49	21	0.93	0.52	0.07	0.48	G	0.224	0.215073529	C-reactive protein and white blood cell count	Immune diseases and disorders
rs11038871	T	C	49	34	11	7	31	56	0.70	0.24	0.30	0.76	C	1.36	0.214887999	Immunoglobulin A	Immune diseases and disorders
rs1172294	A	G	37	48	9	5	26	63	0.65	0.19	0.35	0.81	G	0.08	0.214725351	Pubertal anthropometrics	Appearance
rs9386463	A	G	17	32	45	59	34	1	0.35	0.81	0.65	0.19	G	0.38	0.214725351	Primary tooth development time to first tooth eruption	Misc
rs4665736	C	T	9	48	37	63	26	5	0.35	0.81	0.65	0.19	T	0.037	0.214725351	Height	General health
rs5756506	G	C	53	36	5	11	33	50	0.76	0.29	0.24	0.71	C	0.14	0.214644245	Hematological parameters	Heart health and disorders
rs2267739	C	G	62	32	0	14	43	37	0.83	0.38	0.17	0.62	G	0.241	0.213612039	Vitamin B levels in ischemic stroke	General health
rs4770049	C	T	0	12	82	21	47	26	0.06	0.47	0.94	0.53	G	0.03	0.213465347	Obesity-related traits	Obesity
rs2066808	A	G	72	22	0	16	52	26	0.88	0.45	0.12	0.55	A	0.067	0.213460317	Height	General health
rs1823913	T	C	10	44	40	59	32	3	0.34	0.80	0.66	0.20	A	0.03	0.213337949	Obesity-related traits	Obesity
rs9366309	C	T	36	41	17	2	25	67	0.60	0.15	0.40	0.85	T	0.024	0.212351029	Pulmonary function in asthmatics	Pulmonology
rs1830074	T	C	40	46	8	5	30	59	0.67	0.21	0.33	0.79	C	0.025	0.212162937	Body mass index	Obesity
rs714515	G	A	15	39	40	65	24	5	0.37	0.82	0.63	0.18	G	0.029	0.211758844	Waist-to-hip ratio adjusted for body mass index	Obesity
rs542631	T	G	1	4	89	22	34	38	0.03	0.41	0.97	0.59	A	1	0.211350294	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs13126513	T	C	35	40	19	1	25	68	0.59	0.14	0.41	0.86	C	0.285	0.210396115	Metabolite levels MHPG	General health
rs2159292	C	T	1	22	71	28	50	16	0.13	0.56	0.87	0.44	C	1.098901	0.21025641	Schizophrenia	Brain health and disorders
rs10849689	A	G	66	25	3	17	39	38	0.84	0.39	0.16	0.61	A	1.07	0.210125074	Schizophrenia	Brain health and disorders
rs1923775	C	T	7	40	47	53	34	7	0.29	0.74	0.71	0.26	T	1.6	0.209470941	Alzheimer's disease	Brain health and disorders
rs10838801	G	A	6	42	46	54	32	8	0.29	0.74	0.71	0.26	A	0.027	0.209470941	Height	General health
rs7916663	G	A	75	16	3	23	39	32	0.88	0.45	0.12	0.55	A	0.04	0.209115538	Obesity-related traits	Obesity
rs2897442	C	T	16	49	29	71	21	2	0.43	0.87	0.57	0.13	C	1.11	0.208768008	Atopic dermatitis	Immune diseases and disorders
rs824931	C	T	6	53	35	59	32	3	0.35	0.80	0.65	0.20	G	0.07	0.208724541	Body mass index	Obesity
rs7209435	T	C	60	26	8	14	33	47	0.78	0.32	0.22	0.68	C	4.8	0.206528885	Height	General health
rs1919128	A	G	22	46	26	76	17	1	0.48	0.90	0.52	0.10	A	0.18	0.205953206	Waist Circumference - Triglycerides WC-TG	General health
rs7577851	C	T	56	30	8	12	33	49	0.76	0.30	0.24	0.70	T	6.85	0.205121653	Parkinson's disease age of onset	Brain health and disorders
rs1512777	T	G	59	33	2	8	51	35	0.80	0.36	0.20	0.64	T	1.92	0.204854256	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs7586879	C	T	47	39	8	5	38	51	0.71	0.26	0.29	0.74	T	0.047	0.204703216	Body mass index	Obesity
rs3108919	T	C	36	43	15	3	26	65	0.61	0.17	0.39	0.83	C	2.13	0.204646051	AIDS	Immune diseases and disorders
rs930847	G	T	3	26	65	37	41	16	0.17	0.61	0.83	0.39	T	0.11	0.204646051	Corneal structure	General health
rs927485	G	A	5	41	48	48	40	6	0.27	0.72	0.73	0.28	C	1.33	0.204425204	Ossification of the posterior longitudinal ligament of the spine	Misc
rs9586179	T	C	71	21	2	17	48	29	0.87	0.44	0.13	0.56	T	0.05	0.204424365	Phospholipid levels plasma	General health
rs707824	T	C	1	31	62	36	44	14	0.18	0.62	0.82	0.38	T	1.33	0.203677971	Lymphoma	Cancer
rs7607316	C	A	67	25	2	14	49	31	0.85	0.41	0.15	0.59	A	1.29	0.203510896	Airflow obstruction	Pulmonology
rs10944	T	G	17	43	34	66	27	1	0.41	0.85	0.59	0.15	T	1	0.203510896	Blood and toenail selenium levels	Heart health and disorders
rs11658329	G	C	60	26	8	15	32	47	0.78	0.33	0.22	0.67	G	0.049	0.201923077	Height	General health
rs3001167	A	G	61	31	2	16	38	40	0.81	0.37	0.19	0.63	G	0.03	0.201910959	Obesity-related traits	Obesity
rs6051520	T	G	67	23	4	22	31	41	0.84	0.40	0.16	0.60	T	0.18	0.201269157	Information processing speed	Mental aptitude and behavioural traits
rs9328321	G	A	64	24	6	11	47	36	0.81	0.37	0.19	0.63	A	1.22	0.201109327	Obesity early onset extreme	Obesity
rs1011731	G	A	15	39	40	63	26	5	0.37	0.81	0.63	0.19	G	0.03	0.201109327	Waist-hip ratio	General health
rs1787200	G	A	3	26	65	36	42	16	0.17	0.61	0.83	0.39	T	0.044	0.200238237	Height	General health
rs62209	G	T	56	29	9	11	35	48	0.75	0.30	0.25	0.70	C	2.04	0.20020429	Alzheimer's disease late onset	Brain health and disorders
rs6517656	G	A	51	38	5	7	42	45	0.74	0.30	0.26	0.70	G	0.0402	0.2	Glycemic traits pregnancy	Reproductive health
rs8034004	C	T	23	44	27	76	16	2	0.48	0.89	0.52	0.11	C	0.0611	0.199842333	Self-reported allergy	General health
rs6599175	T	C	59	31	4	15	36	43	0.79	0.35	0.21	0.65	G	1.48	0.199017767	Multiple myeloma hyperdiploidy	Cancer
rs947612	G	A	11	43	40	61	26	7	0.35	0.79	0.65	0.21	A	0.3459	0.198421614	HIV-1 viral setpoint	Immune diseases and disorders
rs11259403	C	T	11	50	33	63	28	3	0.38	0.82	0.62	0.18	C	1	0.198348083	Body mass index in asthmatics	Obesity
rs12969657	C	T	16	45	33	65	28	1	0.41	0.84	0.59	0.16	T	0.007	0.198008148	Mean platelet volume	Heart health and disorders
rs3227	G	C	19	33	42	61	31	2	0.38	0.81	0.62	0.19	C	1.037	0.197485902	Educational attainment	Mental aptitude and behavioural traits
rs9556711	G	A	77	17	0	21	53	20	0.91	0.51	0.09	0.49	G	0.163	0.197402597	Alcoholism alcohol use disorder factor score	General health
rs7086803	G	A	72	20	2	18	49	27	0.87	0.45	0.13	0.55	A	1.28	0.197356355	Lung cancer	Cancer
rs334147	T	G	73	20	1	21	46	27	0.88	0.47	0.12	0.53	T	0.046	0.196334065	Educational attainment	Mental aptitude and behavioural traits
rs240993	T	C	14	41	39	58	35	1	0.37	0.80	0.63	0.20	T	1.2	0.195920746	Psoriasis	Immune diseases and disorders
rs2243803	T	A	37	39	18	1	30	63	0.60	0.17	0.40	0.83	A	2	0.195879982	Menarche age at onset	Reproductive health
rs1451488	A	G	25	55	14	83	11	0	0.56	0.94	0.44	0.06	G	1.0638298	0.195563603	Schizophrenia	Brain health and disorders
rs1951082	T	A	17	34	43	60	30	4	0.36	0.80	0.64	0.20	T	1	0.195215422	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs2514895	C	T	63	24	7	13	42	39	0.80	0.36	0.20	0.64	C	0.1858	0.195215422	IgG glycosylation	Immune diseases and disorders
rs757278	G	T	45	42	7	10	29	55	0.70	0.26	0.30	0.74	T	1.32	0.195183454	Response to methotrexate in juvenile idiopathic arthritis	General health
rs1957894	T	G	5	23	66	32	50	12	0.18	0.61	0.82	0.39	T	1.5	0.194902415	Obesity early onset extreme	Obesity
rs1957895	G	T	5	23	66	33	48	13	0.18	0.61	0.82	0.39	G	1.09	0.194902415	Rheumatoid arthritis	Immune diseases and disorders
rs1053593	G	T	19	41	34	68	23	3	0.42	0.85	0.58	0.15	T	0.0215	0.194860553	Waist-to-hip ratio adjusted for body mass index	Obesity
rs2317230	G	T	29	47	18	4	18	72	0.56	0.14	0.44	0.86	T	1.07	0.194453965	Rheumatoid arthritis	Immune diseases and disorders
rs143384	A	G	41	40	13	6	28	60	0.65	0.21	0.35	0.79	G	0.058	0.193954079	Infant length	Misc
rs7129229	A	T	72	20	2	21	44	29	0.87	0.46	0.13	0.54	T	1	0.193142857	Homeostasis model assessment of beta-cell function interaction	Misc
rs375092	A	C	56	34	4	11	42	41	0.78	0.34	0.22	0.66	C	0.02	0.192885829	Personality dimensions	Brain health and disorders
rs2272007	T	C	4	34	56	44	36	14	0.22	0.66	0.78	0.34	A	1.47	0.192885829	Multiple myeloma hyperdiploidy	Cancer
rs17514846	C	A	38	48	8	6	30	58	0.66	0.22	0.34	0.78	A	1.05	0.192885829	Coronary artery disease	Heart health and disorders
rs7041	A	C	16	45	33	66	25	3	0.41	0.84	0.59	0.16	T	2109.34	0.192608643	Serum vitamin D-binding protein levels	General health
rs2148710	C	T	60	24	10	10	42	42	0.77	0.33	0.23	0.67	T	0.22	0.192004569	Anger	General health
rs3799296	T	A	20	45	29	71	21	2	0.45	0.87	0.55	0.13	T	1.09	0.191658266	Psoriasis	Immune diseases and disorders
rs8002688	C	T	89	5	0	36	45	13	0.97	0.62	0.03	0.38	T	2.04	0.191052632	Blood pressure measurement low sodium intervention	Heart health and disorders
rs6780569	G	A	76	15	3	22	47	25	0.89	0.48	0.11	0.52	G	1.17	0.189725397	Type 2 diabetes	Diabetes
rs11910494	A	G	59	30	5	12	43	39	0.79	0.36	0.21	0.64	G	0.1483	0.189542106	IgG glycosylation	Immune diseases and disorders
rs13148252	G	A	27	46	21	80	13	1	0.53	0.92	0.47	0.08	G	0.171	0.189515986	IgG glycosylation	Immune diseases and disorders
rs12566888	G	T	68	22	4	14	51	29	0.84	0.42	0.16	0.58	A	1	0.189448441	Platelet aggregation	Heart health and disorders
rs2080501	G	A	32	45	17	6	18	70	0.58	0.16	0.42	0.84	G	0.1421	0.189448441	IgG glycosylation	Immune diseases and disorders
rs1717027	T	C	4	33	57	42	38	14	0.22	0.65	0.78	0.35	T	0.49	0.188974337	Blood pressure	Heart health and disorders
rs3902354	C	A	12	41	41	55	36	3	0.35	0.78	0.65	0.22	A	0.15	0.188453253	Cholesterol, total	General health
rs12098973	A	G	64	29	1	18	42	34	0.84	0.41	0.16	0.59	G	2.17	0.188350687	Cardiac Troponin-T levels	Heart health and disorders
rs2730260	G	T	1	20	73	25	48	21	0.12	0.52	0.88	0.48	C	1.33	0.188020833	Myopia pathological	General health
rs974379	C	A	0	22	72	25	48	21	0.12	0.52	0.88	0.48	C	1.2872	0.188020833	Major depressive disorder	Brain health and disorders
rs478607	G	A	1	20	73	29	40	25	0.12	0.52	0.88	0.48	A	0.047	0.188020833	Urate levels	General health
rs9471075	A	C	87	7	0	34	46	14	0.96	0.61	0.04	0.39	A	5.25	0.18786357	Smooth-surface caries	Appearance
rs9636252	T	C	14	43	37	62	27	5	0.38	0.80	0.62	0.20	C	0.1514	0.187200187	IgG glycosylation	Immune diseases and disorders
rs2966	C	T	19	33	42	59	33	2	0.38	0.80	0.62	0.20	T	0.022	0.187200187	Educational attainment	Mental aptitude and behavioural traits
rs9949526	C	T	90	4	0	32	56	6	0.98	0.64	0.02	0.36	A	34.03	0.187134503	Diisocyanate-induced asthma	Pulmonology
rs12220488	G	A	21	47	26	72	21	1	0.47	0.88	0.53	0.12	A	1	0.186394733	Mammographic density non-dense area	Reproductive health
rs3784099	G	A	44	43	7	6	38	50	0.70	0.27	0.30	0.73	A	1.49	0.185890353	Breast cancer survival	Cancer
rs1895302	C	T	10	37	47	53	32	9	0.30	0.73	0.70	0.27	C	1.34	0.185890353	Adverse response to chemotherapy neutropenia_leucopenia all platinum-based drugs	Drug response
rs1979541	T	G	59	31	4	10	49	35	0.79	0.37	0.21	0.63	G	0.18	0.185808849	Lipoprotein a levels	Heart health and disorders
rs1473500	C	T	76	15	3	24	44	26	0.89	0.49	0.11	0.51	A	1	0.185625186	Immune reponse to smallpox secreted IL-2	Immune diseases and disorders
rs6519955	G	T	35	43	16	3	28	63	0.60	0.18	0.40	0.82	A	1.54	0.185396429	Dupuytren's disease	Skin related disease
rs210937	G	A	29	50	15	2	26	66	0.57	0.16	0.43	0.84	A	0.04	0.185239313	Obesity-related traits	Obesity
rs9525916	T	A	20	48	26	72	20	2	0.47	0.87	0.53	0.13	T	1	0.18484383	Fasting insulin interaction	General health
rs10175798	G	A	10	46	38	56	34	4	0.35	0.78	0.65	0.22	A	1.09	0.184077312	Rheumatoid arthritis	Immune diseases and disorders
rs163818	T	C	42	39	13	6	31	57	0.65	0.23	0.35	0.77	C	11.5	0.183591509	Adverse response to chemotherapy in breast cancer alopecia paclitaxel	General health
rs1432364	T	G	15	48	31	63	30	1	0.41	0.83	0.59	0.17	T	1	0.183098592	Response to methylphenidate treatment in attention-deficit_hyperactivity disorder blood pressure	Drug response
rs2266928	C	A	73	19	2	21	48	25	0.88	0.48	0.12	0.52	A	0.1178	0.182304327	Mean corpuscular hemoglobin concentration	Heart health and disorders
rs4987595	T	C	68	23	3	20	42	32	0.85	0.44	0.15	0.56	T	0.044	0.182234517	Neuroticism	Brain health and disorders
rs8083786	A	G	70	22	2	21	44	29	0.86	0.46	0.14	0.54	G	1.18	0.181955645	Rheumatoid arthritis	Immune diseases and disorders
rs2011962	A	C	53	33	8	8	43	43	0.74	0.31	0.26	0.69	A	0.046	0.181591193	Height	General health
rs2235544	C	A	12	46	36	60	29	5	0.37	0.79	0.63	0.21	A	1.3	0.18151412	Multiple myeloma hyperdiploidy	Cancer
rs1395	G	A	10	50	34	61	27	6	0.37	0.79	0.63	0.21	A	0.017	0.18151412	Blood metabolite levels	Heart health and disorders
rs10260824	A	C	79	15	0	27	48	19	0.92	0.54	0.08	0.46	C	1.749	0.181494149	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Immune diseases and disorders
rs10846744	G	C	49	40	5	8	42	44	0.73	0.31	0.27	0.69	C	4.6	0.181405896	Lipoprotein-associated phospholipase A2 activity and mass	General health
rs911263	C	T	7	44	43	50	38	6	0.31	0.73	0.69	0.27	T	1.29	0.181405896	Primary biliary cirrhosis	Immune diseases and disorders
rs6494537	C	T	33	46	15	3	28	63	0.60	0.18	0.40	0.82	C	0.078	0.181179273	Mean corpuscular hemoglobin	Heart health and disorders
rs725344	T	C	2	15	77	21	50	23	0.10	0.49	0.90	0.51	T	1.32	0.181166072	Serum VEGFR2 concentration	General health
rs342958	A	G	89	5	0	38	44	12	0.97	0.64	0.03	0.36	G	34.08	0.179438492	Diisocyanate-induced asthma	Pulmonology
rs11605924	A	C	25	45	24	76	16	2	0.51	0.89	0.49	0.11	A	1	0.179312897	Fasting glucose-related traits	General health
rs11054731	A	G	24	40	30	71	21	2	0.47	0.87	0.53	0.13	A	0.21	0.179282869	Coronary artery calcification	Heart health and disorders
rs6749331	T	C	69	25	0	21	46	27	0.87	0.47	0.13	0.53	G	0.03	0.179282869	Obesity-related traits	Obesity
rs7688014	T	C	16	50	28	1	11	82	0.44	0.07	0.56	0.93	C	1.0526316	0.178348005	Schizophrenia	Brain health and disorders
rs11077773	T	C	66	27	1	18	47	29	0.85	0.44	0.15	0.56	T	0.24	0.178117676	Information processing speed	Mental aptitude and behavioural traits
rs9394152	C	T	14	44	36	59	32	3	0.38	0.80	0.62	0.20	T	0.045	0.177957178	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs549433	T	C	59	32	3	13	46	35	0.80	0.38	0.20	0.62	G	0.03	0.177957178	Obesity-related traits	Obesity
rs9400239	T	C	8	46	40	53	35	6	0.33	0.75	0.67	0.25	C	0.023	0.177710071	Body mass index	Obesity
rs3744061	G	A	29	45	20	79	15	0	0.55	0.92	0.45	0.08	G	0.86	0.177536232	Retinal arteriolar caliber	General health
rs13407913	A	G	34	49	11	4	31	59	0.62	0.21	0.38	0.79	G	1.1213214	0.177272727	Crohn's disease	Digestive system and its disorders
rs10878577	A	C	11	28	55	45	39	10	0.27	0.69	0.73	0.31	A	1.06	0.176984375	Schizophrenia	Brain health and disorders
rs892295	A	G	0	8	86	15	43	36	0.04	0.39	0.96	0.61	A	0.03	0.176815233	Obesity-related traits	Obesity
rs10261878	A	C	1	22	71	28	42	24	0.13	0.52	0.87	0.48	C	0.032	0.176713567	Body mass index	Obesity
rs4240748	C	G	9	39	46	49	38	7	0.30	0.72	0.70	0.28	G	1.0638298	0.176703757	Schizophrenia	Brain health and disorders
rs9677476	A	G	49	35	10	5	44	45	0.71	0.29	0.29	0.71	G	0.21	0.176583765	Food antigen IgG levels	Immune diseases and disorders
rs8055236	G	T	70	21	3	18	50	26	0.86	0.46	0.14	0.54	G	1.91	0.176537049	Coronary heart disease	Heart health and disorders
rs713586	T	C	35	49	10	6	29	59	0.63	0.22	0.37	0.78	C	0.14	0.176041667	Body mass index	Obesity
rs1378942	C	A	35	40	19	85	7	2	0.59	0.94	0.41	0.06	C	0.613	0.175742865	Systolic blood pressure	Heart health and disorders
rs16872248	C	T	89	5	0	39	43	12	0.97	0.64	0.03	0.36	A	0.03	0.175621345	Obesity-related traits	Obesity
rs1150668	T	G	26	40	28	0	20	74	0.49	0.11	0.51	0.89	G	0.06	0.175324675	Pubertal anthropometrics	Appearance
rs4657616	A	G	28	40	26	75	18	1	0.51	0.89	0.49	0.11	G	0.0612	0.175324675	Hematology traits	Heart health and disorders
rs4432842	T	C	37	39	18	3	30	61	0.60	0.19	0.40	0.81	C	0.034	0.175294918	Birth weight	Misc
rs10779751	A	G	1	34	59	35	43	16	0.19	0.60	0.81	0.40	A	0.016	0.175294918	Body mass index	Obesity
rs12622534	T	C	18	44	32	62	32	0	0.43	0.83	0.57	0.17	A	2.26	0.174818402	Diisocyanate-induced asthma	Pulmonology
rs4846914	G	A	18	43	33	64	27	3	0.42	0.82	0.58	0.18	G	0.61	0.173829301	HDL cholesterol	General health
rs2144300	C	T	18	43	33	64	27	3	0.42	0.82	0.58	0.18	C	0.05	0.173829301	Circulating myeloperoxidase levels serum	Immune diseases and disorders
rs7594192	A	G	6	26	62	31	53	10	0.20	0.61	0.80	0.39	A	0.026	0.173774143	Educational attainment	Mental aptitude and behavioural traits
rs1027643	C	T	79	15	0	32	40	22	0.92	0.55	0.08	0.45	T	1.43	0.17361339	Wilms tumor	Cancer
rs2251844	T	C	59	31	4	15	42	37	0.79	0.38	0.21	0.62	C	0.087	0.173084221	Tumor biomarkers	Cancer
rs786425	G	A	18	47	29	67	24	3	0.44	0.84	0.56	0.16	G	0.06	0.172890733	Pubertal anthropometrics	Appearance
rs10208940	T	C	72	20	2	22	47	25	0.87	0.48	0.13	0.52	C	0.083	0.172711068	Urate levels in lean individuals	Obesity
rs4292676	T	C	25	47	22	0	24	70	0.52	0.13	0.48	0.87	T	0.2708	0.172711068	Verbal declarative memory	Brain health and disorders
rs7528684	A	G	27	47	20	3	21	70	0.54	0.14	0.46	0.86	T	1.52	0.17250504	Type 1 diabetes autoantibodies	Diabetes
rs6000762	T	C	59	30	5	15	41	38	0.79	0.38	0.21	0.62	C	0.059	0.172439869	Optic disc area	Misc
rs1950897	C	T	7	44	43	48	40	6	0.31	0.72	0.69	0.28	T	1.1	0.172312224	Rheumatoid arthritis	Immune diseases and disorders
rs4357530	G	A	9	39	46	45	45	4	0.30	0.72	0.70	0.28	G	0.019	0.172214674	Body mass index	Obesity
rs12149074	C	G	10	34	50	45	42	7	0.29	0.70	0.71	0.30	G	1.7857143	0.172156197	Bipolar disorder and eating disorder	Brain health and disorders
rs2373000	C	T	28	38	28	0	22	72	0.50	0.12	0.50	0.88	T	1.087	0.171883289	Schizophrenia	Brain health and disorders
rs6918152	A	G	18	46	30	65	27	2	0.44	0.84	0.56	0.16	A	0.11	0.171792444	Black vs. blond hair color	Appearance
rs3024667	T	C	2	16	76	19	53	22	0.11	0.48	0.89	0.52	T	0.28	0.171375149	Serum IgE levels	General health
rs10182181	A	G	36	47	11	5	32	57	0.63	0.22	0.37	0.78	G	0.037	0.171284125	Body mass index	Obesity
rs2161300	G	T	67	26	1	21	44	29	0.85	0.46	0.15	0.54	T	1.07	0.17123202	Schizophrenia	Brain health and disorders
rs8042680	C	A	24	40	30	2	14	78	0.47	0.10	0.53	0.90	A	1.07	0.171208945	Type 2 diabetes	Diabetes
rs1425902	G	A	12	44	38	57	31	6	0.36	0.77	0.64	0.23	G	2.14	0.170771048	IgE levels in asthmatics D.p. specific	Immune diseases and disorders
rs11755724	A	G	15	51	28	65	26	3	0.43	0.83	0.57	0.17	G	1.15	0.170749476	Age-related macular degeneration	Aging
rs10741243	C	G	0	13	81	16	48	30	0.07	0.43	0.93	0.57	G	1.75	0.170561192	Type 2 diabetes	Diabetes
rs11951068	G	A	81	13	0	32	44	18	0.93	0.57	0.07	0.43	A	1	0.170561192	Blood and toenail selenium levels	Heart health and disorders
rs2672886	T	C	38	45	11	2	40	52	0.64	0.23	0.36	0.77	C	0.051	0.170300158	Airway responsiveness in chronic obstructive pulmonary disease	Pulmonology
rs11651483	A	G	1	21	72	20	55	19	0.12	0.51	0.88	0.49	C	1.357	0.170279858	Adverse response to chemotherapy neutropenia_leucopenia all antimicrotubule drugs	Drug response
rs1161463	A	G	7	31	56	36	50	8	0.24	0.65	0.76	0.35	C	1.72	0.169870785	Attention deficit hyperactivity disorder symptoms interaction	Brain health and disorders
rs7694118	G	A	65	25	4	19	42	33	0.82	0.43	0.18	0.57	C	1.3	0.169760072	Yu-Zhi constitution type in type 2 diabetes	Diabetes
rs6805251	T	C	18	44	32	64	27	3	0.43	0.82	0.57	0.18	T	0.02	0.169760072	HDL cholesterol	General health
rs9322428	T	A	35	38	21	1	31	62	0.57	0.18	0.43	0.82	A	0.19	0.169760072	Lipoprotein a levels	Heart health and disorders
rs1956529	C	T	17	40	37	59	32	3	0.39	0.80	0.61	0.20	T	0.51	0.169642857	Primary tooth development number of teeth	Misc
rs1362153	T	C	73	21	0	23	50	21	0.89	0.51	0.11	0.49	C	1.47	0.169622127	Alcohol dependence age at onset	General health
rs958617	A	G	10	43	41	50	40	4	0.34	0.74	0.66	0.26	G	6.6667	0.168825992	Tuberculosis	Immune diseases and disorders
rs10761659	A	G	22	48	24	74	16	4	0.49	0.87	0.51	0.13	G	1.28	0.16875	Crohn's disease	Digestive system and its disorders
rs7224438	T	C	87	7	0	37	45	12	0.96	0.63	0.04	0.37	G	1	0.168596491	Immune reponse to smallpox secreted IL-2	Immune diseases and disorders
rs9398171	C	T	8	46	40	52	35	7	0.33	0.74	0.67	0.26	C	1.0638298	0.168557214	Schizophrenia	Brain health and disorders
rs2929278	C	T	40	46	8	8	33	53	0.67	0.26	0.33	0.74	C	1.0638298	0.168557214	Schizophrenia	Brain health and disorders
rs7182209	T	C	88	6	0	32	57	5	0.97	0.64	0.03	0.36	C	0.5	0.168226412	Carotid plaque burden smoking interaction	Heart health and disorders
rs9543325	C	T	19	45	30	67	23	4	0.44	0.84	0.56	0.16	C	1.26	0.167769608	Pancreatic cancer	Cancer
rs9296092	A	G	12	47	35	56	35	3	0.38	0.78	0.62	0.22	G	0.044	0.167692486	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs7531118	T	C	29	40	25	74	20	0	0.52	0.89	0.48	0.11	C	1.08	0.167464115	Obesity	Obesity
rs2253612	C	T	1	16	77	20	47	27	0.10	0.46	0.90	0.54	C	1.4285715	0.167316816	Alcohol dependence	General health
rs1052501	C	T	4	34	56	39	40	15	0.22	0.63	0.78	0.37	G	1.32	0.16712963	Multiple myeloma	Cancer
rs355810	G	A	15	49	30	1	11	82	0.42	0.07	0.58	0.93	A	0.015	0.166717697	Body mass index	Obesity
rs713587	C	T	35	49	10	6	31	57	0.63	0.23	0.37	0.77	T	1	0.166608977	Body mass index in non-asthmatics	Obesity
rs11165643	C	T	9	51	34	56	33	5	0.37	0.77	0.63	0.23	T	0.023	0.166608977	Body mass index	Obesity
rs9573163	C	G	15	46	33	63	25	6	0.40	0.80	0.60	0.20	G	1.26	0.166306951	Pancreatic cancer	Cancer
rs1801133	G	A	21	44	29	67	25	2	0.46	0.85	0.54	0.15	A	0.1583	0.166038324	Homocysteine levels	Misc
rs1462872	A	G	3	20	71	21	56	17	0.14	0.52	0.86	0.48	A	0.16	0.165898618	Coronary artery calcification	Heart health and disorders
rs4733724	A	G	34	39	21	3	27	64	0.57	0.18	0.43	0.82	A	0.05	0.165738499	Height	General health
rs2060070	G	A	53	36	5	16	34	44	0.76	0.35	0.24	0.65	G	0.1789	0.16529304	IgG glycosylation	Immune diseases and disorders
rs13003464	A	G	40	43	11	3	41	50	0.65	0.25	0.35	0.75	G	1.15	0.164934323	Celiac disease	Immune diseases and disorders
rs10277115	A	T	12	41	41	52	37	5	0.35	0.75	0.65	0.25	T	0.0052	0.164934323	Renal function-related traits sCR	General health
rs9296736	T	C	22	41	31	67	24	3	0.45	0.84	0.55	0.16	T	3	0.164887527	Liver enzyme levels gamma-glutamyl transferase	General health
rs2072910	T	C	61	32	1	15	50	29	0.82	0.43	0.18	0.57	C	0.11	0.16480077	Neutrophil count	Immune diseases and disorders
rs1917861	A	G	7	49	38	50	39	5	0.34	0.74	0.66	0.26	G	0.010929617	0.164333675	Urate levels BMI interaction	Obesity
rs10048897	T	C	89	5	0	39	46	9	0.97	0.66	0.03	0.34	G	34.08	0.164329887	Diisocyanate-induced asthma	Pulmonology
rs263156	T	G	14	45	35	59	30	5	0.39	0.79	0.61	0.21	C	1	0.164209604	Ear morphology	Appearance
rs10012307	T	C	73	20	1	26	44	24	0.88	0.51	0.12	0.49	T	1	0.164055176	DNA methylation parent-of-origin	Misc
rs10032216	T	C	60	33	1	17	45	32	0.81	0.42	0.19	0.58	T	0.106	0.163912835	Thyroid hormone levels	General health
rs2995271	C	T	8	36	50	47	34	13	0.28	0.68	0.72	0.32	T	1.27	0.163718821	Pancreatitis	General health
rs7477	A	C	30	45	19	78	16	0	0.56	0.91	0.44	0.09	T	1.3	0.163694709	Amyotrophic lateral sclerosis	Brain health and disorders
rs800292	G	A	39	38	17	5	31	58	0.62	0.22	0.38	0.78	A	0.15	0.16359829	Circulating myeloperoxidase levels serum	Immune diseases and disorders
rs354225	G	A	46	42	6	4	50	40	0.71	0.31	0.29	0.69	G	1.0526316	0.163496377	Schizophrenia	Brain health and disorders
rs589691	C	T	7	40	47	42	46	6	0.29	0.69	0.71	0.31	T	0.15	0.163496377	Urate levels	General health
rs11918654	T	C	47	37	10	11	33	50	0.70	0.29	0.30	0.71	C	0.11	0.16344086	Disc degeneration lumbar	Aging
rs10486715	G	A	84	10	0	37	41	16	0.95	0.61	0.05	0.39	A	0.44	0.163205724	Quantitative traits	Misc
rs6435999	A	G	84	10	0	32	51	11	0.95	0.61	0.05	0.39	A	0.041	0.163205724	Height	General health
rs3731896	C	T	62	28	4	13	52	29	0.81	0.41	0.19	0.59	T	0.029	0.163073258	Educational attainment	Mental aptitude and behavioural traits
rs11676272	A	G	35	47	12	5	32	57	0.62	0.22	0.38	0.78	G	0.2	0.163029302	Height adjusted BMI	Obesity
rs9888739	C	T	64	28	2	21	41	32	0.83	0.44	0.17	0.56	T	1.8	0.162752344	Systemic lupus erythematosus	Immune diseases and disorders
rs2284219	A	G	16	51	27	67	22	5	0.44	0.83	0.56	0.17	T	1.05	0.162752344	Type 2 diabetes	Diabetes
rs10995356	G	A	19	45	30	69	18	7	0.44	0.83	0.56	0.17	A	0.11	0.162752344	Temperament	Mental aptitude and behavioural traits
rs251130	G	A	39	40	15	5	33	56	0.63	0.23	0.37	0.77	G	0.04	0.162501806	Menarche age at onset	Reproductive health
rs46522	C	T	28	51	15	80	13	1	0.57	0.92	0.43	0.08	T	1.06	0.162053571	Coronary heart disease	Heart health and disorders
rs16829840	C	T	86	8	0	37	45	12	0.96	0.63	0.04	0.37	T	0.46	0.161620988	Plasma omega-6 polyunsaturated fatty acid levels arachidonic acid	General health
rs4083242	G	A	26	49	19	75	19	0	0.54	0.90	0.46	0.10	A	0.03	0.161565339	Obesity-related traits	Obesity
rs138777	A	G	17	42	35	61	28	5	0.40	0.80	0.60	0.20	A	0.021	0.161533923	Cholesterol, total	General health
rs13035304	A	G	6	26	62	29	54	11	0.20	0.60	0.80	0.40	G	0.063	0.161533923	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs10890920	G	A	12	43	39	59	24	11	0.36	0.76	0.64	0.24	A	1	0.161160932	QT interval interaction	Heart health and disorders
rs735854	T	C	13	41	40	55	32	7	0.36	0.76	0.64	0.24	C	0.156	0.161160932	Optic nerve measurement rim area	Misc
rs7916697	A	G	10	47	37	54	34	6	0.36	0.76	0.64	0.24	A	0.0938	0.161160932	Optic disc area	Misc
rs2224391	A	C	40	41	13	5	36	53	0.64	0.24	0.36	0.76	A	0.049	0.161160932	Height	General health
rs975752	G	A	65	28	1	21	44	29	0.84	0.46	0.16	0.54	A	1.09	0.1609538	Schizophrenia	Brain health and disorders
rs3736757	G	A	34	45	15	5	29	60	0.60	0.21	0.40	0.79	A	0.03	0.160831767	Obesity-related traits	Obesity
rs7226371	A	G	64	26	4	16	49	29	0.82	0.43	0.18	0.57	G	0.026	0.16082692	Body mass index	Obesity
rs1791780	G	A	22	46	26	69	23	2	0.48	0.86	0.52	0.14	G	1	0.160669323	Visceral adipose tissue adjusted for BMI	Obesity
rs2472304	G	A	37	40	17	85	7	2	0.61	0.94	0.39	0.06	A	0.08	0.160460885	Caffeine consumption	General health
rs10928927	C	T	3	34	57	29	56	9	0.21	0.61	0.79	0.39	T	0.057	0.16017316	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs7932354	T	C	14	46	34	58	32	4	0.39	0.79	0.61	0.21	T	0.05	0.16017316	Bone mineral density	General health
rs994014	T	C	53	33	8	10	44	40	0.74	0.34	0.26	0.66	T	0.054	0.160169709	Height	General health
rs10830962	C	G	33	42	19	2	31	61	0.57	0.19	0.43	0.81	C	0.191	0.159938774	Glycemic traits	General health
rs2217560	G	A	1	18	75	19	50	25	0.11	0.47	0.89	0.53	G	1.97	0.159756772	Pulmonary arterial hypertension without BMPR2 mutations	Heart health and disorders
rs1051920	C	T	52	33	9	11	40	43	0.73	0.33	0.27	0.67	T	1.143	0.159696789	Hypothyroidism	Immune diseases and disorders
rs4662986	A	G	4	33	57	29	57	8	0.22	0.61	0.78	0.39	G	0.058	0.15955711	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs4662984	G	A	4	33	57	29	57	8	0.22	0.61	0.78	0.39	A	0.057	0.15955711	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs12767760	G	A	14	33	47	50	36	8	0.32	0.72	0.68	0.28	G	0.02	0.15951564	Obesity-related traits	Obesity
rs11210892	G	A	20	49	25	68	24	2	0.47	0.85	0.53	0.15	A	1.0706638	0.159409291	Schizophrenia	Brain health and disorders
rs1502172	A	G	9	36	49	46	37	11	0.29	0.69	0.71	0.31	A	1	0.15926272	Visceral adipose tissue adjusted for BMI	Obesity
rs7844647	T	C	44	42	8	9	37	48	0.69	0.29	0.31	0.71	T	0.017	0.159190604	Body mass index	Obesity
rs10748180	A	G	32	45	17	4	28	62	0.58	0.19	0.42	0.81	G	0.123	0.159098373	Economic and political preferences time	Mental aptitude and behavioural traits
rs1371737	A	C	37	43	14	4	35	55	0.62	0.23	0.38	0.77	C	0.04	0.158449074	Obesity-related traits	Obesity
rs4605213	G	C	35	47	12	4	35	55	0.62	0.23	0.38	0.77	C	0.021	0.158449074	Height	General health
rs7760535	G	C	23	42	29	66	27	1	0.47	0.85	0.53	0.15	G	0.035	0.15820858	Metabolic traits	Misc
rs12949451	A	C	83	10	1	33	47	14	0.94	0.60	0.06	0.40	A	0.439	0.157857058	Postprandial triglyceride response to high fat diet meal	General health
rs11102001	G	A	78	15	1	27	51	16	0.91	0.56	0.09	0.44	A	0.057	0.157826087	Fibrinogen levels smoking status, alcohol consumption or body mass index interaction	General health
rs138740	C	T	17	43	34	60	30	4	0.41	0.80	0.59	0.20	C	1.16	0.15755551	Multiple myeloma and monoclonal gammopathy	Cancer
rs16954776	A	G	88	5	1	38	46	10	0.96	0.65	0.04	0.35	A	5.1206	0.157376012	Smooth-surface caries	Appearance
rs13210693	G	A	28	37	29	0	24	70	0.49	0.13	0.51	0.87	A	1.15	0.157113157	Ankylosing spondylitis	Immune diseases and disorders
rs139371	T	C	35	50	9	4	38	52	0.64	0.24	0.36	0.76	A	1.37	0.157085485	Multiple myeloma hyperdiploidy	Cancer
rs1533317	T	C	16	50	28	65	24	5	0.44	0.82	0.56	0.18	A	0.14	0.156900726	QT interval	Heart health and disorders
rs12103	T	C	24	43	27	68	25	1	0.48	0.86	0.52	0.14	A	1.082054	0.156810036	Crohn's disease	Digestive system and its disorders
rs12101726	A	C	70	21	3	15	61	18	0.86	0.48	0.14	0.52	C	0.101	0.156810036	Overweight status	Obesity
rs13329835	A	G	52	37	5	15	37	42	0.75	0.36	0.25	0.64	G	1.08	0.156707875	Breast cancer	Cancer
rs2553026	G	A	17	52	25	66	25	3	0.46	0.84	0.54	0.16	A	0.056	0.155976361	Height	General health
rs7212798	T	C	49	40	5	11	42	41	0.73	0.34	0.27	0.66	C	1.07	0.155798338	Myocardial infarction	Heart health and disorders
rs6987702	T	C	39	46	9	9	32	53	0.66	0.27	0.34	0.73	G	0.07	0.155798338	Cholesterol, total	General health
rs6504909	A	G	47	42	5	13	36	45	0.72	0.33	0.28	0.67	G	0.05	0.155373964	Obesity-related traits	Obesity
rs11242704	A	G	48	39	7	8	45	41	0.72	0.32	0.28	0.68	G	0.257	0.15521542	Response to hepatitis C treatment	General health
rs7931342	T	G	36	36	22	3	30	61	0.57	0.19	0.43	0.81	G	1.3	0.155172414	Prostate cancer early onset	Cancer
rs7901794	T	C	72	21	1	22	53	19	0.88	0.52	0.12	0.48	C	1.1235955	0.154814517	Schizophrenia	Brain health and disorders
rs284737	T	C	21	49	24	2	19	73	0.48	0.12	0.52	0.88	C	0.2134	0.154814517	Metabolite levels HVA_5-HIAA ratio	Brain health and disorders
rs13026414	C	T	31	47	16	79	15	0	0.58	0.92	0.42	0.08	C	1.23	0.15451939	Epilepsy generalized	Brain health and disorders
rs2462021	C	T	15	49	30	61	29	4	0.42	0.80	0.58	0.20	C	1.1755	0.154377606	Suicide risk	General health
rs11877878	A	G	62	27	5	14	51	29	0.80	0.42	0.20	0.58	A	0.0906	0.154377606	Periodontitis Mean PAL	Misc
rs8040009	T	C	69	24	1	25	43	26	0.86	0.49	0.14	0.51	C	1.4	0.154302382	Bipolar I disorder	Brain health and disorders
rs9367895	T	C	79	13	2	25	56	13	0.91	0.56	0.09	0.44	G	34.08	0.154067753	Diisocyanate-induced asthma	Pulmonology
rs1881681	C	A	77	15	2	28	47	19	0.90	0.55	0.10	0.45	C	0.363	0.153987557	Current cigarettes per day in chronic obstructive pulmonary disease	General health
rs6901152	T	C	10	39	45	0	4	90	0.31	0.02	0.69	0.98	T	1	0.153405345	Acute lymphoblastic leukemia childhood	Cancer
rs504915	T	A	23	50	21	71	22	1	0.51	0.87	0.49	0.13	T	0.2251	0.15331565	Renal function-related traits urea	General health
rs9589866	G	A	89	5	0	45	37	12	0.97	0.68	0.03	0.32	A	34.08	0.153274682	Diisocyanate-induced asthma	Pulmonology
rs2239785	G	A	4	26	64	26	53	15	0.18	0.56	0.82	0.44	G	1	0.153021886	Glomerulosclerosis	Misc
rs4730779	G	A	22	52	20	3	21	70	0.51	0.14	0.49	0.86	A	0.1	0.152993348	Waist circumference	General health
rs2249694	A	G	4	31	59	32	47	15	0.21	0.59	0.79	0.41	A	0.03	0.152920354	Obesity-related traits	Obesity
rs616488	A	G	27	48	19	76	16	2	0.54	0.89	0.46	0.11	A	1.1	0.152201258	Breast cancer	Cancer
rs1549519	T	C	31	39	24	3	25	66	0.54	0.16	0.46	0.84	T	0.048	0.152136115	Height	General health
rs514341	C	T	70	23	1	21	53	20	0.87	0.51	0.13	0.49	T	1.5	0.151885429	Alcohol dependence age at onset	General health
rs6448799	T	C	24	45	25	3	19	72	0.49	0.13	0.51	0.87	T	1.08	0.151885429	Alzheimer's disease late onset	Brain health and disorders
rs16949516	T	C	81	13	0	35	43	16	0.93	0.60	0.07	0.40	T	0.2015	0.15167298	Stearic acid 18:0 plasma levels	General health
rs6703183	T	C	39	35	20	6	29	59	0.60	0.22	0.40	0.78	A	1.312	0.151632152	Amyotrophic lateral sclerosis	Brain health and disorders
rs2055729	G	A	7	37	50	38	48	8	0.27	0.66	0.73	0.34	G	1.3	0.151499645	Multiple myeloma hyperdiploidy	Cancer
rs2540552	C	T	28	46	20	2	28	64	0.54	0.17	0.46	0.83	C	0.1381	0.151103984	IgG glycosylation	Immune diseases and disorders
rs11148252	C	T	13	48	33	56	34	4	0.39	0.78	0.61	0.22	C	0.2351	0.151048951	Lewy body disease	Brain health and disorders
rs3112530	A	G	2	19	73	20	50	24	0.12	0.48	0.88	0.52	G	1.18	0.151048151	Aging time to event	Aging
rs9384488	G	A	45	37	12	9	36	49	0.68	0.29	0.32	0.71	A	1	0.150984559	Alzheimer's disease biomarkers	Brain health and disorders
rs7574070	A	C	5	50	39	50	33	11	0.32	0.71	0.68	0.29	A	1.27	0.150881962	Behcet's disease	Immune diseases and disorders
rs10509091	T	G	9	41	44	44	44	6	0.31	0.70	0.69	0.30	T	0.074	0.150813641	Height	General health
rs7748513	A	G	80	13	1	32	46	16	0.92	0.59	0.08	0.41	G	1	0.150803602	C-reactive protein	Immune diseases and disorders
rs6470764	C	T	35	38	21	5	27	62	0.57	0.20	0.43	0.80	T	0.054	0.150500075	Infant length	Misc
rs2659005	C	T	26	49	19	76	15	3	0.54	0.89	0.46	0.11	C	0.1653	0.150497512	IgG glycosylation	Immune diseases and disorders
rs2237457	C	T	38	39	17	82	12	0	0.61	0.94	0.39	0.06	T	1.74	0.150434607	Schizophrenia treatment resistant	Brain health and disorders
rs926657	C	T	77	17	0	29	49	16	0.91	0.57	0.09	0.43	T	0.14	0.15034503	Lipoprotein a levels	Heart health and disorders
rs2122554	T	G	1	15	78	14	53	27	0.09	0.43	0.91	0.57	A	0.1	0.15034503	Conduct disorder symptom count	Brain health and disorders
rs9378357	G	T	76	17	1	24	56	14	0.90	0.55	0.10	0.45	A	0.03	0.150254276	Obesity-related traits	Obesity
rs12960119	A	G	61	28	5	15	49	30	0.80	0.42	0.20	0.58	G	1.26	0.149748983	Rhegmatogenous retinal detachment	General health
rs3749147	G	A	41	46	7	89	5	0	0.68	0.97	0.32	0.03	C	0.18	0.149641355	Waist Circumference - Triglycerides WC-TG	General health
rs2033654	C	A	34	49	11	4	37	53	0.62	0.24	0.38	0.76	A	1	0.14953271	Body mass index in non-asthmatics	Obesity
rs10849033	G	A	3	21	70	26	43	25	0.14	0.51	0.86	0.49	G	2.55	0.149219053	Acute lymphoblastic leukemia childhood	Cancer
rs2168784	C	T	68	25	1	25	43	26	0.86	0.49	0.14	0.51	T	1.46	0.149219053	Alcohol dependence age at onset	General health
rs1042058	T	C	25	34	35	64	26	4	0.45	0.82	0.55	0.18	A	1.0776412	0.149190111	Crohn's disease	Digestive system and its disorders
rs6468852	A	G	62	30	2	21	42	31	0.82	0.45	0.18	0.55	G	1	0.149190111	Alzheimer's disease late onset	Brain health and disorders
rs1256531	A	G	63	28	3	19	46	29	0.82	0.45	0.18	0.55	G	0.09	0.149190111	Conduct disorder symptom count	Brain health and disorders
rs7638995	C	A	61	27	6	15	48	31	0.79	0.41	0.21	0.59	A	1	0.149040594	Alzheimer's disease late onset	Brain health and disorders
rs2623384	A	G	39	41	14	7	33	54	0.63	0.25	0.37	0.75	G	724	0.148709122	Superior frontal gyrus grey matter volume	Misc
rs433598	C	T	40	39	15	5	37	52	0.63	0.25	0.37	0.75	T	1.13	0.148709122	Schizophrenia	Brain health and disorders
rs7904519	A	G	36	47	11	8	31	55	0.63	0.25	0.37	0.75	G	1.06	0.148709122	Breast cancer	Cancer
rs267567	G	A	18	47	29	64	25	5	0.44	0.81	0.56	0.19	A	2.73	0.148305085	PR interval	Heart health and disorders
rs7432375	G	A	20	43	31	62	29	3	0.44	0.81	0.56	0.19	G	1.0718113	0.148305085	Schizophrenia	Brain health and disorders
rs11809524	C	T	2	21	71	21	50	23	0.13	0.49	0.87	0.51	T	0.03	0.148137148	Bone mineral density	General health
rs6546847	A	G	38	45	11	8	33	53	0.64	0.26	0.36	0.74	A	0.91	0.148029697	Urinary metabolites H-NMR features	General health
rs215738	G	A	0	13	81	15	44	35	0.07	0.39	0.93	0.61	A	3.778	0.147993477	Smooth-surface caries	Appearance
rs6031252	C	A	83	9	2	38	38	18	0.93	0.61	0.07	0.39	A	0.11	0.147993477	Conduct disorder symptom count	Brain health and disorders
rs7845056	C	T	18	40	36	59	29	6	0.40	0.78	0.60	0.22	C	0.1776	0.147747589	IgG glycosylation	Immune diseases and disorders
rs5756504	C	T	57	33	4	15	46	33	0.78	0.40	0.22	0.60	T	0.076	0.147747589	Hematological and biochemical traits	Heart health and disorders
rs3091307	A	G	60	32	2	17	48	29	0.81	0.44	0.19	0.56	A	1.24	0.147465993	Atopic dermatitis	Immune diseases and disorders
rs2117032	C	T	20	47	27	66	24	4	0.46	0.83	0.54	0.17	C	0.13	0.147312726	Bilirubin levels	General health
rs1318772	A	G	87	6	1	40	43	11	0.96	0.65	0.04	0.35	G	0.91	0.146887291	F-cell distribution	Immune diseases and disorders
rs56364076	C	T	11	33	50	44	39	11	0.29	0.68	0.71	0.32	C	1.16	0.14682225	Psoriasis	Immune diseases and disorders
rs9443189	A	G	67	25	2	20	51	23	0.85	0.48	0.15	0.52	G	1.08	0.146793651	Prostate cancer	Cancer
rs199347	A	G	23	51	20	4	21	69	0.52	0.15	0.48	0.85	A	1.11	0.146793651	Parkinson's disease	Brain health and disorders
rs1619249	A	G	74	19	1	31	40	23	0.89	0.54	0.11	0.46	A	1	0.146788035	Ear morphology	Appearance
rs9947954	A	C	44	40	10	3	50	41	0.68	0.30	0.32	0.70	C	0.1398	0.14673913	IgG glycosylation	Immune diseases and disorders
rs7186852	A	G	46	40	8	11	38	45	0.70	0.32	0.30	0.68	A	1.29	0.14673913	Systemic lupus erythematosus	Immune diseases and disorders
rs12457997	C	T	11	38	45	46	40	8	0.32	0.70	0.68	0.30	T	0.1663	0.14673913	Periodontitis DPAL	Misc
rs10180663	T	C	44	43	7	8	43	43	0.70	0.31	0.30	0.69	A	1.64	0.146689304	Multiple myeloma IgH translocation	Cancer
rs3845905	T	C	5	33	56	33	48	13	0.23	0.61	0.77	0.39	G	2.433	0.146613152	Adverse response to chemotherapy neutropenia_leucopenia carboplatin	Drug response
rs902464	T	C	0	3	91	7	41	46	0.02	0.29	0.98	0.71	A	1	0.146605942	Immune reponse to smallpox secreted IL-1beta	Immune diseases and disorders
rs2636061	A	G	0	4	90	0	57	37	0.02	0.30	0.98	0.70	A	0.02	0.146187874	Obesity-related traits	Obesity
rs1042602	C	A	43	41	10	89	4	1	0.68	0.97	0.32	0.03	C	4.36	0.14611409	Skin pigmentation	Appearance
rs16924133	A	T	88	6	0	43	41	10	0.97	0.68	0.03	0.32	A	0.38	0.14611409	Anger	General health
rs2046315	A	G	8	28	58	32	51	11	0.23	0.61	0.77	0.39	T	1.871	0.146103237	Pit-and-Fissure caries	Misc
rs174468	G	A	41	47	6	89	5	0	0.69	0.97	0.31	0.03	A	0.05	0.146033654	Phospholipid levels plasma	General health
rs7602441	G	A	61	28	5	20	40	34	0.80	0.43	0.20	0.57	G	1	0.145920191	Visceral adipose tissue adjusted for BMI	Obesity
rs4315565	A	G	30	48	16	3	32	59	0.57	0.20	0.43	0.80	A	0.059	0.145920191	Height	General health
rs12882718	C	T	27	44	23	71	22	1	0.52	0.87	0.48	0.13	T	1.555	0.145841703	Adverse response to chemotherapy neutropenia_leucopenia all antimicrotubule drugs	Drug response
rs1517352	A	C	29	40	25	72	20	2	0.52	0.87	0.48	0.13	A	1.0832976	0.145841703	Crohn's disease	Digestive system and its disorders
rs4970988	G	A	26	46	22	71	22	1	0.52	0.87	0.48	0.13	A	0.028	0.145841703	Urate levels	General health
rs2187642	A	C	15	42	37	50	43	1	0.38	0.76	0.62	0.24	A	4.6	0.145630507	Height	General health
rs1876449	G	A	29	49	16	77	16	1	0.57	0.90	0.43	0.10	A	4.438	0.144732524	Very long-chain saturated fatty acid levels fatty acid 22:0	General health
rs11724635	C	A	23	43	28	66	25	3	0.47	0.84	0.53	0.16	A	1.15	0.144590369	Parkinson's disease	Brain health and disorders
rs4698412	G	A	23	43	28	66	25	3	0.47	0.84	0.53	0.16	A	1.14	0.144590369	Parkinson's disease	Brain health and disorders
rs1035275	T	C	21	47	26	69	19	6	0.47	0.84	0.53	0.16	C	0.1416	0.144590369	IgG glycosylation	Immune diseases and disorders
rs589249	A	G	29	46	19	5	25	64	0.55	0.19	0.45	0.81	G	1.2	0.144522357	Schizophrenia	Brain health and disorders
rs4387287	A	C	7	21	66	27	50	17	0.19	0.55	0.81	0.45	A	0.1	0.144522357	Telomere length	Aging
rs1900005	A	C	10	48	36	52	35	7	0.36	0.74	0.64	0.26	A	0.018	0.144098562	Vertical cup-disc ratio	Misc
rs2069036	T	C	8	34	52	40	41	13	0.27	0.64	0.73	0.36	T	1	0.143802596	Plasma omega-6 polyunsaturated fatty acid levels gamma-linolenic acid	General health
rs6586977	T	C	92	2	0	46	44	4	0.99	0.72	0.01	0.28	G	15.23	0.143777318	Diisocyanate-induced asthma	Pulmonology
rs4471226	C	T	1	13	80	13	50	31	0.08	0.40	0.92	0.60	C	0.097	0.14347407	Fractional exhaled nitric oxide childhood	Pulmonology
rs2274316	C	A	12	41	41	50	36	8	0.35	0.72	0.65	0.28	C	1.14	0.143312011	Migraine - clinic-based	Brain health and disorders
rs9290065	C	T	14	43	37	0	12	82	0.38	0.06	0.62	0.94	G	2.119	0.143139109	Kawasaki disease	Misc
rs3790455	C	T	11	42	41	49	37	8	0.34	0.72	0.66	0.28	C	1.2	0.143116714	Migraine	Brain health and disorders
rs3806624	A	G	24	37	33	0	21	73	0.45	0.11	0.55	0.89	G	1.26	0.143116702	Hodgkin's lymphoma	Cancer
rs2138852	C	T	19	47	28	1	19	74	0.45	0.11	0.55	0.89	T	0.02	0.143116702	Mean platelet volume	Heart health and disorders
rs8076739	C	T	19	47	28	1	19	74	0.45	0.11	0.55	0.89	T	0.013	0.143116702	Mean platelet volume	Heart health and disorders
rs7263077	A	G	71	20	3	26	44	24	0.86	0.51	0.14	0.49	G	0.09	0.143082381	Urate levels in obese individuals	Obesity
rs16867579	A	C	91	3	0	48	38	8	0.98	0.71	0.02	0.29	A	8.4163	0.143045702	Smooth-surface caries	Appearance
rs335810	C	A	0	3	91	6	42	46	0.02	0.29	0.98	0.71	A	1.1	0.143045702	Type 2 diabetes	Diabetes
rs872071	A	G	29	51	14	80	11	3	0.58	0.91	0.42	0.09	G	1.54	0.143005952	Chronic lymphocytic leukemia	Cancer
rs874426	C	A	6	25	63	29	48	17	0.20	0.56	0.80	0.44	C	1	0.142891443	Attention deficit hyperactivity disorder time to onset	Brain health and disorders
rs897200	T	C	5	52	37	50	33	11	0.33	0.71	0.67	0.29	A	1.45	0.142824763	Behcet's disease	Immune diseases and disorders
rs6055685	G	A	56	33	5	16	43	35	0.77	0.40	0.23	0.60	A	3.568	0.142773893	Suicide ideation score in major depressive disorder	Brain health and disorders
rs7197475	C	T	46	40	8	11	39	44	0.70	0.32	0.30	0.68	A	1.31	0.14272771	Systemic lupus erythematosus	Immune diseases and disorders
rs13389219	C	T	46	39	9	7	46	41	0.70	0.32	0.30	0.68	C	1.13	0.142663082	Waist-hip ratio	General health
rs12519062	T	C	71	22	1	25	49	20	0.87	0.53	0.13	0.47	C	1.0869565	0.142164945	Schizophrenia	Brain health and disorders
rs10943703	A	G	26	47	21	72	20	2	0.53	0.87	0.47	0.13	A	0.055	0.142164945	Sitting height ratio	Appearance
rs2194437	G	C	80	14	0	34	46	14	0.93	0.61	0.07	0.39	C	4.92	0.142045455	Fractional exhaled nitric oxide levels	Pulmonology
rs11641184	C	A	24	47	23	68	25	1	0.51	0.86	0.49	0.14	A	1.0798526	0.141796875	Crohn's disease	Digestive system and its disorders
rs10796051	T	C	25	45	24	70	21	3	0.51	0.86	0.49	0.14	C	0.0532	0.141796875	Self-reported allergy	General health
rs45490496	A	T	23	49	22	70	21	3	0.51	0.86	0.49	0.14	A	0.038	0.141796875	HDL cholesterol	General health
rs4705952	G	A	4	37	53	35	45	14	0.24	0.61	0.76	0.39	G	0.042	0.141782407	C-reactive protein levels	Immune diseases and disorders
rs994988	C	T	11	51	32	53	37	4	0.39	0.76	0.61	0.24	T	0.1395	0.141782407	Palmitic acid 16:0 plasma levels	General health
rs10893845	T	G	28	46	20	73	20	1	0.54	0.88	0.46	0.12	T	0.059	0.141514649	Self-reported allergy	General health
rs2118674	A	T	1	14	79	9	59	26	0.09	0.41	0.91	0.59	A	0.0498	0.141380752	Palmitoleic acid 16:1n-7 plasma levels	General health
rs7433306	C	G	20	43	31	3	14	77	0.44	0.11	0.56	0.89	C	4.33	0.141150112	PR interval	Heart health and disorders
rs6800541	C	T	20	43	31	3	14	77	0.44	0.11	0.56	0.89	C	2.6	0.141150112	Atrioventricular conduction	Heart health and disorders
rs16901979	C	A	84	10	0	41	39	14	0.95	0.64	0.05	0.36	A	1.8	0.14111975	Prostate cancer	Cancer
rs10505483	C	T	84	10	0	41	39	14	0.95	0.64	0.05	0.36	T	1.73	0.14111975	Prostate cancer	Cancer
rs318095	T	C	28	52	14	77	16	1	0.57	0.90	0.43	0.10	T	0.024	0.141095287	Height	General health
rs6570507	G	A	25	48	21	4	23	67	0.52	0.16	0.48	0.84	G	0.08	0.140884411	Height	General health
rs655601	A	C	62	29	3	27	31	36	0.81	0.45	0.19	0.55	A	0.23	0.140786749	Quantitative traits	Misc
rs6859974	C	T	52	36	6	13	44	37	0.74	0.37	0.26	0.63	T	3.67	0.140562249	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs4886670	G	T	52	36	6	11	48	35	0.74	0.37	0.26	0.63	A	1.835	0.140562249	Adverse response to chemotherapy neutropenia_leucopenia paclitaxel	Drug response
rs10892583	G	A	55	30	9	9	52	33	0.74	0.37	0.26	0.63	A	0.2	0.140562249	Intraocular pressure	General health
rs205262	A	G	52	36	6	10	50	34	0.74	0.37	0.26	0.63	G	0.027	0.140562249	Body mass index	Obesity
rs6545800	C	T	35	48	11	5	38	51	0.63	0.26	0.37	0.74	T	1.109	0.140562249	Inflammatory bowel disease	Immune diseases and disorders
rs9943753	A	G	13	39	42	0	9	85	0.35	0.05	0.65	0.95	G	0.02	0.140325756	HDL cholesterol	General health
rs9321659	G	A	73	19	2	28	45	21	0.88	0.54	0.12	0.46	A	0.06	0.139986329	Menarche age at onset	Reproductive health
rs2201728	G	A	19	46	29	62	28	4	0.45	0.81	0.55	0.19	G	3.13	0.139951574	Cardiac Troponin-T levels	Heart health and disorders
rs7311660	A	G	36	48	10	5	40	49	0.64	0.27	0.36	0.73	G	0.03	0.139920046	Obesity-related traits	Obesity
rs5767992	T	C	0	15	79	17	41	36	0.08	0.40	0.92	0.60	A	0.03	0.13986014	Obesity-related traits	Obesity
rs10469266	A	T	82	9	3	37	39	18	0.92	0.60	0.08	0.40	A	0.007	0.13986014	Trans fatty acid levels	General health
rs10876864	G	A	9	49	36	50	37	7	0.36	0.73	0.64	0.27	G	1.18	0.139648883	Vitiligo	Immune diseases and disorders
rs2041073	T	C	17	50	27	1	19	74	0.45	0.11	0.55	0.89	T	0.018	0.139483395	Blood metabolite levels	Heart health and disorders
rs11171739	C	T	9	48	37	51	34	9	0.35	0.72	0.65	0.28	C	1.34	0.139410493	Type 1 diabetes	Diabetes
rs9985399	T	C	79	13	2	35	40	19	0.91	0.59	0.09	0.41	T	0.26	0.139389399	Information processing speed	Mental aptitude and behavioural traits
rs2056417	G	A	32	46	16	78	15	1	0.59	0.91	0.41	0.09	A	0.0658	0.139389399	Self-reported allergy	General health
rs7702057	G	T	87	7	0	42	43	9	0.96	0.68	0.04	0.32	A	2.05	0.139228419	Amyotrophic lateral sclerosis	Brain health and disorders
rs11212617	C	A	10	44	40	48	38	8	0.34	0.71	0.66	0.29	A	1	0.139030757	Response to metformin	General health
rs11850957	C	T	67	21	6	20	48	26	0.82	0.47	0.18	0.53	T	1	0.138896624	Subcutaneous adipose tissue	Obesity
rs12808199	G	A	19	50	25	65	25	4	0.47	0.82	0.53	0.18	G	0.21	0.138896624	Osteoporosis-related phenotypes	Immune diseases and disorders
rs2162440	A	G	1	31	62	28	44	22	0.18	0.53	0.82	0.47	G	106	0.138896624	Telomere length	Aging
rs1032757	G	A	89	5	0	47	37	10	0.97	0.70	0.03	0.30	T	1.96	0.138894596	Eosinophilic esophagitis pediatric	Digestive system and its disorders
rs9937837	T	G	45	42	7	12	38	44	0.70	0.33	0.30	0.67	G	1.86	0.138778747	Systemic lupus erythematosus	Immune diseases and disorders
rs10824026	G	A	8	40	46	45	36	13	0.30	0.67	0.70	0.33	A	1.15	0.138778747	Atrial fibrillation	Heart health and disorders
rs6717858	T	C	47	38	9	9	44	41	0.70	0.33	0.30	0.67	T	1	0.138778747	Sexual dimorphism in anthropometric traits	Misc
rs1128249	G	T	46	39	9	8	45	41	0.70	0.32	0.30	0.68	G	0.0526	0.138700181	Waist-to-hip ratio adjusted for body mass index	Obesity
rs441810	A	G	43	44	7	8	44	42	0.69	0.32	0.31	0.68	G	0.069	0.138653084	Tumor biomarkers	Cancer
rs559389	C	T	10	40	44	44	42	8	0.32	0.69	0.68	0.31	C	0.023	0.138653084	Pulmonary function in asthmatics	Pulmonology
rs5756931	T	C	24	52	18	74	16	4	0.53	0.87	0.47	0.13	C	1.54	0.138528139	Triglycerides	General health
rs2378870	T	C	17	41	36	57	30	7	0.40	0.77	0.60	0.23	T	0.02	0.138469593	Height	General health
rs11231629	C	T	23	46	25	69	20	5	0.49	0.84	0.51	0.16	C	1.0526316	0.138285714	Schizophrenia	Brain health and disorders
rs4129267	C	T	23	50	21	69	23	2	0.51	0.86	0.49	0.14	T	1.09	0.138148645	Asthma	Immune diseases and disorders
rs10069690	C	T	55	33	6	14	46	34	0.76	0.39	0.24	0.61	A	1.24	0.137988001	Breast cancer estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative	Cancer
rs10143866	T	C	65	24	5	22	43	29	0.82	0.46	0.18	0.54	T	1.472	0.137974489	Smooth-surface caries	Appearance
rs10519005	C	T	20	47	27	65	24	5	0.46	0.82	0.54	0.18	T	1.26	0.137974489	Alcohol dependence age at onset	General health
rs10865924	C	G	30	43	21	73	20	1	0.55	0.88	0.45	0.12	G	1.84	0.137893896	Clozapine-induced agranulocytosis	General health
rs7512221	C	T	1	14	79	17	42	35	0.09	0.40	0.91	0.60	G	1	0.137783221	Fat distribution HIV	General health
rs2900174	A	G	76	18	0	29	51	14	0.90	0.58	0.10	0.42	G	3.3	0.137493995	Response to gemcitabine in pancreatic cancer	General health
rs12699477	T	C	31	47	16	79	12	3	0.58	0.90	0.42	0.10	C	1.21	0.137493995	Testicular germ cell tumor	Cancer
rs16850864	C	T	82	11	1	37	43	14	0.93	0.62	0.07	0.38	A	1	0.13714938	Immune reponse to smallpox secreted IL-1beta	Immune diseases and disorders
rs11241936	T	C	50	41	3	15	42	37	0.75	0.38	0.25	0.62	C	0.08	0.137129526	Plasma amyloid beta peptide concentrations ABx-42	Brain health and disorders
rs253959	T	C	18	44	32	59	30	5	0.43	0.79	0.57	0.21	T	1.21	0.137031769	Bipolar disorder and schizophrenia	Brain health and disorders
rs3805663	A	G	23	47	24	1	26	67	0.49	0.15	0.51	0.85	T	1.25	0.136930805	Testicular germ cell tumor	Cancer
rs702543	C	T	19	57	18	67	26	1	0.51	0.85	0.49	0.15	A	1.27	0.136930805	Neuroticism	Brain health and disorders
rs28453840	G	A	24	47	23	66	28	0	0.51	0.85	0.49	0.15	G	0.046	0.136930805	Cholesterol, total	General health
rs4757144	G	A	30	42	22	73	19	2	0.54	0.88	0.46	0.12	G	1.154	0.136377693	Schizophrenia	Brain health and disorders
rs1475591	T	C	2	11	81	17	40	37	0.08	0.39	0.92	0.61	T	1.18	0.136279998	Hypertension	Heart health and disorders
rs7527939	C	T	59	34	1	21	43	30	0.81	0.45	0.19	0.55	C	2.63	0.136265671	Schizophrenia	Brain health and disorders
rs2244012	A	G	60	32	2	18	49	27	0.81	0.45	0.19	0.55	C	1.64	0.136265671	Asthma	Immune diseases and disorders
rs2045084	C	T	19	52	23	65	26	3	0.48	0.83	0.52	0.17	G	1.16	0.136210131	Rhegmatogenous retinal detachment	General health
rs11260603	T	C	64	28	2	12	66	16	0.83	0.48	0.17	0.52	C	0.2608	0.136210131	IgG glycosylation	Immune diseases and disorders
rs2433610	C	T	82	12	0	37	45	12	0.94	0.63	0.06	0.37	T	0.09	0.135969868	Serum metabolite levels	General health
rs6823268	A	G	40	39	15	82	12	0	0.63	0.94	0.37	0.06	A	0.038	0.135969868	Height	General health
rs2454206	A	G	40	39	15	82	12	0	0.63	0.94	0.37	0.06	A	0.027	0.135969868	Height	General health
rs74157220	G	T	94	0	0	50	43	1	1.00	0.76	0.00	0.24	T	0.267	0.135951662	Serum dimethylarginine levels asymmetric_symetric ratio	General health
rs11150589	T	C	13	42	39	50	37	7	0.36	0.73	0.64	0.27	T	1.09	0.135815148	Ulcerative colitis	Immune diseases and disorders
rs340630	G	A	24	46	24	67	25	2	0.50	0.85	0.50	0.15	A	1.21	0.135769144	Systemic lupus erythematosus	Immune diseases and disorders
rs7773324	G	A	21	52	21	68	23	3	0.50	0.85	0.50	0.15	G	1.0819273	0.135769144	Crohn's disease	Digestive system and its disorders
rs1470579	A	C	36	49	9	10	32	52	0.64	0.28	0.36	0.72	C	1.332	0.135567641	Diabetes gestational	Diabetes
rs6769511	T	C	36	49	9	10	32	52	0.64	0.28	0.36	0.72	C	1.23	0.135567641	Type 2 diabetes	Diabetes
rs10172965	C	T	61	29	4	20	44	30	0.80	0.45	0.20	0.55	T	0.3	0.135476083	Temperament	Mental aptitude and behavioural traits
rs6788895	G	T	70	24	0	29	43	22	0.87	0.54	0.13	0.46	G	1.22	0.134931158	Breast cancer	Cancer
rs1055129	A	G	46	33	15	6	44	44	0.66	0.30	0.34	0.70	G	1	0.134891628	White matter hyperintensity burden	Brain health and disorders
rs2274910	T	C	13	32	49	43	41	10	0.31	0.68	0.69	0.32	C	1.14	0.134738927	Crohn's disease	Digestive system and its disorders
rs6440003	G	A	35	43	16	8	29	57	0.60	0.24	0.40	0.76	A	0.07	0.134246894	Height	General health
rs6763931	G	A	35	43	16	8	29	57	0.60	0.24	0.40	0.76	A	0.024	0.134246894	Pulmonary function in asthmatics	Pulmonology
rs6430538	C	T	19	37	38	0	16	78	0.40	0.09	0.60	0.91	C	1.1429	0.134220166	Parkinson's disease	Brain health and disorders
rs5742915	T	C	40	33	21	80	12	2	0.60	0.91	0.40	0.09	T	0.035	0.134220166	Height	General health
rs1351592	C	G	58	33	3	19	44	31	0.79	0.44	0.21	0.56	G	1.18	0.134020003	Polycystic ovary syndrome	Reproductive health
rs12173570	C	T	75	18	1	34	39	21	0.89	0.57	0.11	0.43	T	0.171	0.133969397	Breast size	General health
rs12470505	T	G	76	16	2	32	43	19	0.89	0.57	0.11	0.43	T	0.041	0.133969397	Height	General health
rs9933712	G	A	78	14	2	23	64	7	0.90	0.59	0.10	0.41	A	5.2	0.133928571	Emphysema imaging phenotypes	Pulmonology
rs11132733	T	C	5	36	53	38	38	18	0.24	0.61	0.76	0.39	T	0.225	0.133796296	Testosterone levels	Reproductive health
rs1658442	G	A	13	48	33	54	34	6	0.39	0.76	0.61	0.24	A	0.055	0.133796296	Corneal astigmatism	General health
rs10783050	T	C	37	44	13	81	13	0	0.63	0.93	0.37	0.07	C	2.6	0.133599243	Body mass index	Obesity
rs876983	T	C	24	52	18	72	19	3	0.53	0.87	0.47	0.13	T	1.06	0.133550927	Schizophrenia	Brain health and disorders
rs6600365	C	T	26	49	19	4	27	63	0.54	0.19	0.46	0.81	T	0.027	0.133455882	Height	General health
rs1662853	C	G	54	33	7	14	45	35	0.75	0.39	0.25	0.61	C	0.08	0.133379485	Pubertal anthropometrics	Appearance
rs7615568	T	G	56	36	2	15	51	28	0.79	0.43	0.21	0.57	G	0.11	0.133351157	Age-related nuclear cataracts	Aging
rs3846662	A	G	24	44	26	4	20	70	0.49	0.15	0.51	0.85	G	0.09	0.133333333	Cholesterol, total	General health
rs641525	T	G	72	21	1	29	45	20	0.88	0.55	0.12	0.45	T	2.19	0.132808181	Emphysema-related traits	Pulmonology
rs6469804	G	A	18	49	27	3	17	74	0.45	0.12	0.55	0.88	A	0.12	0.132808181	Bone mineral density spine	General health
rs4840097	C	T	6	29	59	27	54	13	0.22	0.57	0.78	0.43	G	1	0.132720338	Age-related macular degeneration smoking status interaction	Aging
rs218238	A	T	35	47	12	9	31	54	0.62	0.26	0.38	0.74	A	0.033	0.132644865	Red blood cell traits	Immune diseases and disorders
rs907499	C	T	0	3	91	5	41	48	0.02	0.27	0.98	0.73	G	0.05	0.132505176	Obesity-related traits	Obesity
rs59294057	T	G	91	3	0	45	47	2	0.98	0.73	0.02	0.27	C	34.08	0.132505176	Diisocyanate-induced asthma	Pulmonology
rs6931262	C	T	91	3	0	54	29	11	0.98	0.73	0.02	0.27	T	0.06	0.132505176	Waist-hip ratio	General health
rs6797178	G	A	33	52	9	8	34	52	0.63	0.27	0.37	0.73	A	1	0.132326007	Glucocorticoid-induced osteonecrosis	Drug response
rs11241130	G	A	5	16	73	22	45	27	0.14	0.47	0.86	0.53	G	0.04	0.132233883	Obesity-related traits	Obesity
rs7447927	C	G	28	43	23	70	22	2	0.53	0.86	0.47	0.14	C	1.18	0.132233883	Esophageal squamous cell carcinoma	Cancer
rs1497406	A	G	26	43	25	65	29	0	0.51	0.85	0.49	0.15	G	3.8	0.132180199	Liver enzyme levels gamma-glutamyl transferase	General health
rs628751	C	A	21	53	20	68	23	3	0.51	0.85	0.49	0.15	C	1	0.132180199	Mean corpuscular hemoglobin	Heart health and disorders
rs2478333	C	A	47	41	6	90	4	0	0.72	0.98	0.28	0.02	A	0.17	0.132046417	QT interval	Heart health and disorders
rs724568	C	A	5	41	48	37	45	12	0.27	0.63	0.73	0.37	C	1.17	0.132038835	Major depressive disorder broad	Brain health and disorders
rs2302729	T	C	7	37	50	34	51	9	0.27	0.63	0.73	0.37	T	0.17	0.132038835	Sleep quality	General health
rs1043274	C	T	88	6	0	43	45	6	0.97	0.70	0.03	0.30	A	0.03	0.131903241	Obesity-related traits	Obesity
rs2790232	C	T	88	6	0	47	37	10	0.97	0.70	0.03	0.30	A	0.01	0.131903241	Obesity-related traits	Obesity
rs1199103	A	G	49	38	7	9	50	35	0.72	0.36	0.28	0.64	G	1.1072454	0.131782946	Crohn's disease	Digestive system and its disorders
rs4821544	T	C	57	31	6	16	46	32	0.77	0.41	0.23	0.59	C	1.09	0.131568921	Atopic dermatitis	Immune diseases and disorders
rs807624	G	T	41	39	14	10	33	51	0.64	0.28	0.36	0.72	A	1.33	0.131557983	Wilms tumor	Cancer
rs9341835	T	C	28	46	20	71	22	1	0.54	0.87	0.46	0.13	C	1.0526316	0.131373889	Schizophrenia	Brain health and disorders
rs12198220	G	T	12	42	40	48	38	8	0.35	0.71	0.65	0.29	T	1.12	0.131363636	Prostate cancer	Cancer
rs2495478	G	A	81	12	1	38	41	15	0.93	0.62	0.07	0.38	T	1.4	0.131352335	Wilms tumor	Cancer
rs6035126	C	T	81	12	1	37	43	14	0.93	0.62	0.07	0.38	A	0.176	0.131352335	Liver enzyme levels alanine transaminase	General health
rs4767364	G	A	28	48	18	4	30	60	0.55	0.20	0.45	0.80	A	1.13	0.131094258	Upper aerodigestive tract cancers	Cancer
rs2802728	C	T	0	30	64	21	52	21	0.16	0.50	0.84	0.50	T	0.026	0.131080389	Toenail selenium levels	Misc
rs10206899	T	C	47	38	9	0	64	30	0.70	0.34	0.30	0.66	G	1	0.13106576	Creatinine levels	Immune diseases and disorders
rs7149242	T	G	4	36	54	30	51	13	0.23	0.59	0.77	0.41	G	2.142	0.131046563	Platelet count	Heart health and disorders
rs10195252	T	C	45	39	10	8	45	41	0.69	0.32	0.31	0.68	T	0.0524	0.130843237	Waist-to-hip ratio adjusted for body mass index	Obesity
rs2981578	C	T	21	47	26	62	30	2	0.47	0.82	0.53	0.18	C	1.225	0.130728055	Breast cancer	Cancer
rs6832720	A	G	79	14	1	34	46	14	0.91	0.61	0.09	0.39	A	0.0585	0.130691531	Cotinine glucuronidation	General health
rs10934853	C	A	35	42	17	6	33	55	0.60	0.24	0.40	0.76	A	1.12	0.130558706	Prostate cancer	Cancer
rs881858	G	A	7	31	56	33	46	15	0.24	0.60	0.76	0.40	G	1.08	0.130558706	Chronic kidney disease	Immune diseases and disorders
rs6479891	T	C	12	40	42	0	10	84	0.34	0.05	0.66	0.95	T	1.19	0.130481475	Arthritis juvenile idiopathic	Immune diseases and disorders
rs12914626	C	T	17	41	36	54	34	6	0.40	0.76	0.60	0.24	C	1.0526316	0.130104629	Schizophrenia	Brain health and disorders
rs8049603	T	G	18	33	43	0	13	81	0.37	0.07	0.63	0.93	T	1.19	0.130081301	Multiple sclerosis	Brain health and disorders
rs7576600	C	G	81	13	0	39	41	14	0.93	0.63	0.07	0.37	G	5.26	0.130081301	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs10508459	A	T	18	57	19	66	25	3	0.49	0.84	0.51	0.16	T	0.1446	0.130031746	IgG glycosylation	Immune diseases and disorders
rs4285401	A	G	24	53	17	72	19	3	0.54	0.87	0.46	0.13	A	5.599	0.130005411	Nicotine use	General health
rs61310603	T	C	68	24	2	23	51	20	0.85	0.52	0.15	0.48	T	1.1904762	0.129777981	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs1697421	C	T	27	43	24	69	22	3	0.52	0.85	0.48	0.15	T	0.056	0.129777981	Blood metabolite ratios	Heart health and disorders
rs500492	T	C	62	24	8	20	42	32	0.79	0.44	0.21	0.56	A	1.32	0.129720071	Polycystic ovary syndrome	Reproductive health
rs13122250	C	T	15	52	27	55	38	1	0.44	0.79	0.56	0.21	T	0.006	0.129720071	Blood metabolite levels	Heart health and disorders
rs12034383	G	A	15	43	36	51	38	5	0.39	0.74	0.61	0.26	G	0.13	0.129295199	Erythrocyte sedimentation rate	Immune diseases and disorders
rs4331426	G	A	0	15	79	17	38	39	0.08	0.38	0.92	0.62	G	1.19	0.129220857	Tuberculosis	Immune diseases and disorders
rs11034653	C	T	86	8	0	43	42	9	0.96	0.68	0.04	0.32	A	1	0.129106188	Immune reponse to smallpox secreted IL-12p40	Immune diseases and disorders
rs8140172	C	T	86	8	0	45	38	11	0.96	0.68	0.04	0.32	C	0.8795	0.129106188	IgG glycosylation	Immune diseases and disorders
rs12079745	G	A	65	26	3	0	92	2	0.83	0.49	0.17	0.51	A	1.34	0.129032258	QT interval	Heart health and disorders
rs7094131	C	T	14	44	36	50	39	5	0.38	0.74	0.62	0.26	G	0.03	0.128938676	Obesity-related traits	Obesity
rs10946808	A	G	39	43	12	82	12	0	0.64	0.94	0.36	0.06	G	0.36	0.128926395	Height	General health
rs3845624	A	C	17	47	30	2	17	75	0.43	0.11	0.57	0.89	C	1	0.128810648	Inflammatory biomarkers	Immune diseases and disorders
rs11259474	T	C	74	19	1	29	49	16	0.89	0.57	0.11	0.43	G	0.03	0.128810648	Obesity-related traits	Obesity
rs12075	G	A	23	29	42	1	15	78	0.40	0.09	0.60	0.91	A	0.022	0.128750765	Educational attainment	Mental aptitude and behavioural traits
rs9947295	C	T	69	24	1	25	50	19	0.86	0.53	0.14	0.47	T	1	0.128699612	QT interval interaction	Heart health and disorders
rs61812598	G	A	23	50	21	67	25	2	0.51	0.85	0.49	0.15	G	1	0.128633933	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Brain health and disorders
rs12141041	T	C	24	48	22	67	25	2	0.51	0.85	0.49	0.15	T	0.025	0.128633933	Blood metabolite levels	Heart health and disorders
rs9394931	C	T	31	48	15	75	19	0	0.59	0.90	0.41	0.10	T	0.15	0.128625799	Plasma omega-6 polyunsaturated fatty acid levels arachidonic acid	General health
rs730570	G	A	15	41	38	52	34	8	0.38	0.73	0.62	0.27	G	1.14	0.128613586	Type 2 diabetes	Diabetes
rs3950186	C	T	34	40	20	6	30	58	0.57	0.22	0.43	0.78	T	1.319	0.128495575	Anxiety and major depressive disorder	Brain health and disorders
rs76569837	G	A	89	5	0	45	44	5	0.97	0.71	0.03	0.29	G	2.7	0.128375127	Schizophrenia	Brain health and disorders
rs606458	C	T	5	41	48	37	44	13	0.27	0.63	0.73	0.37	T	0.18	0.128319469	Urate levels	General health
rs2790216	G	A	49	38	7	10	49	35	0.72	0.37	0.28	0.63	G	1.066	0.128055912	Inflammatory bowel disease	Immune diseases and disorders
rs867529	G	C	42	39	13	85	7	2	0.65	0.94	0.35	0.06	C	0.04	0.127894737	Height	General health
rs3935740	G	A	71	22	1	28	47	19	0.87	0.55	0.13	0.45	T	1	0.127856235	Parkinson's disease	Brain health and disorders
rs16867576	A	G	80	14	0	35	48	11	0.93	0.63	0.07	0.37	A	1.101	0.127853881	Schizophrenia	Brain health and disorders
rs2013441	G	A	41	36	17	81	12	1	0.63	0.93	0.37	0.07	A	0.03	0.127853881	Obesity-related traits	Obesity
rs3803800	A	G	9	35	50	45	30	19	0.28	0.64	0.72	0.36	A	1.21	0.127822546	IgA nephropathy	Immune diseases and disorders
rs9314308	C	G	14	39	41	43	48	3	0.36	0.71	0.64	0.29	C	1.55	0.127619048	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs643381	C	A	21	53	20	67	24	3	0.51	0.84	0.49	0.16	A	1	0.127542659	Mean corpuscular volume	Heart health and disorders
rs37439	C	A	3	24	67	24	45	25	0.16	0.49	0.84	0.51	A	1	0.127542659	Response to angiotensin II receptor blocker therapy	General health
rs1472147	T	C	54	36	4	20	38	36	0.77	0.41	0.23	0.59	A	0.0488	0.127413127	Calcium levels	General health
rs6736587	A	C	46	40	8	13	39	42	0.70	0.35	0.30	0.65	C	1.38	0.12730057	Orthostatic hypotension	Heart health and disorders
rs13538	A	G	47	38	9	0	65	29	0.70	0.35	0.30	0.65	G	0.01	0.12730057	Chronic kidney disease	Immune diseases and disorders
rs10852344	C	T	31	44	19	73	20	1	0.56	0.88	0.44	0.12	T	0.158	0.127262443	Menopause age at onset	Reproductive health
rs2186903	G	A	35	45	14	79	14	1	0.61	0.91	0.39	0.09	A	1.07	0.127197275	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs1054052	T	A	11	42	41	47	37	10	0.34	0.70	0.66	0.30	T	0.1727	0.127185154	IgG glycosylation	Immune diseases and disorders
rs11742741	A	T	31	47	16	75	18	1	0.58	0.89	0.42	0.11	A	0.022	0.126937242	Educational attainment	Mental aptitude and behavioural traits
rs831574	A	G	31	50	13	77	16	1	0.60	0.90	0.40	0.10	A	0.16	0.126905085	Metabolite levels Dihydroxy docosatrienoic acid	General health
rs314280	A	G	18	48	28	56	37	1	0.45	0.79	0.55	0.21	T	1.2	0.126804526	Menarche age at onset	Reproductive health
rs13376709	T	C	22	40	32	57	35	2	0.45	0.79	0.55	0.21	C	1.0638298	0.126804526	Schizophrenia	Brain health and disorders
rs2285714	C	T	42	36	16	81	13	0	0.64	0.93	0.36	0.07	T	1.31	0.126595522	Age-related macular degeneration	Aging
rs4955124	T	C	3	19	72	13	60	21	0.13	0.46	0.87	0.54	T	1.08	0.126500085	Schizophrenia	Brain health and disorders
rs11902236	C	T	56	30	8	18	40	36	0.76	0.40	0.24	0.60	A	1.07	0.126466148	Prostate cancer	Cancer
rs10834691	G	T	17	42	35	55	32	7	0.40	0.76	0.60	0.24	G	0.1479	0.126466148	IgG glycosylation	Immune diseases and disorders
rs27855	A	G	17	42	35	55	32	7	0.40	0.76	0.60	0.24	A	0.047	0.126466148	Height	General health
rs1669539	T	C	92	2	0	52	37	5	0.99	0.75	0.01	0.25	T	1.52	0.126380828	Systolic blood pressure in sickle cell anemia	Heart health and disorders
rs11627056	G	A	47	33	14	86	7	1	0.68	0.95	0.32	0.05	A	0.04	0.126237162	Obesity-related traits	Obesity
rs2663905	G	A	19	45	30	1	21	72	0.44	0.12	0.56	0.88	A	1	0.125786164	QT interval interaction	Heart health and disorders
rs6931421	T	G	27	51	16	73	19	2	0.56	0.88	0.44	0.12	T	0.059	0.125786164	Sitting height ratio	Appearance
rs12692737	C	A	53	34	7	13	48	33	0.74	0.39	0.26	0.61	A	0.0319	0.125649013	Waist-to-hip ratio adjusted for body mass index	Obesity
rs4895808	C	T	15	44	35	53	34	7	0.39	0.74	0.61	0.26	C	0.03	0.125649013	Menarche age at onset	Reproductive health
rs10237103	C	T	86	8	0	43	43	8	0.96	0.69	0.04	0.31	A	34.08	0.125633966	Diisocyanate-induced asthma	Pulmonology
rs4492324	A	G	45	39	10	86	8	0	0.69	0.96	0.31	0.04	G	0.04	0.125633966	Obesity-related traits	Obesity
rs10144321	A	G	24	45	25	66	24	4	0.49	0.83	0.51	0.17	A	0.04	0.125509914	Menarche age at onset	Reproductive health
rs7155454	G	A	21	53	20	2	28	64	0.51	0.17	0.49	0.83	A	0.002	0.125509914	Red blood cell traits	Immune diseases and disorders
rs3942852	C	T	6	29	59	31	44	19	0.22	0.56	0.78	0.44	T	1.2987013	0.125508719	Acute lymphoblastic leukemia childhood	Cancer
rs1155866	T	G	21	40	33	56	35	3	0.44	0.78	0.56	0.22	G	0.013509792	0.125508719	Urate levels BMI interaction	Obesity
rs314272	G	A	20	48	26	60	32	2	0.47	0.81	0.53	0.19	G	1.0526316	0.125490196	Schizophrenia	Brain health and disorders
rs7819412	G	A	28	44	22	2	32	60	0.53	0.19	0.47	0.81	G	0.04	0.125490196	Triglycerides	General health
rs6983561	A	C	83	10	1	43	36	15	0.94	0.65	0.06	0.35	C	1.87	0.125451729	Prostate cancer	Cancer
rs4557020	T	C	18	44	32	1	19	74	0.43	0.11	0.57	0.89	T	0.12	0.125328533	Myopia pathological	General health
rs12052359	C	A	31	46	17	74	19	1	0.57	0.89	0.43	0.11	A	0.224	0.125328533	Bilirubin levels	General health
rs12993006	C	T	72	18	4	28	45	21	0.86	0.54	0.14	0.46	T	1.45	0.125206097	Systemic lupus erythematosus	Immune diseases and disorders
rs2178146	T	C	37	37	20	77	15	2	0.59	0.90	0.41	0.10	A	1.1364	0.12514881	Digestive system disease Barrett's esophagus and esophageal adenocarcinoma combined	Digestive system and its disorders
rs1129038	C	T	49	39	6	90	4	0	0.73	0.98	0.27	0.02	C	1.22	0.125120363	Vitiligo	Immune diseases and disorders
rs2219937	G	A	90	4	0	48	41	5	0.98	0.73	0.02	0.27	G	0.7496	0.125120363	IgG glycosylation	Immune diseases and disorders
rs13072512	A	G	15	42	37	52	34	8	0.38	0.73	0.62	0.27	G	0.1484	0.124956971	IgG glycosylation	Immune diseases and disorders
rs4307059	T	C	46	41	7	88	6	0	0.71	0.97	0.29	0.03	T	1.19	0.124954463	Autism	Brain health and disorders
rs2664299	T	C	49	37	8	89	5	0	0.72	0.97	0.28	0.03	C	0.1673	0.124918673	IgG glycosylation	Immune diseases and disorders
rs7584330	A	G	39	39	16	3	45	46	0.62	0.27	0.38	0.73	C	1.06	0.124656593	Prostate cancer	Cancer
rs11621145	G	A	17	58	19	62	31	1	0.49	0.82	0.51	0.18	G	0.23	0.124564542	Immunoglobulin G index levels in multiple sclerosis	Immune diseases and disorders
rs4946260	C	T	20	56	18	5	23	66	0.51	0.18	0.49	0.82	T	1.08	0.124564542	Colorectal cancer	Cancer
rs6701713	A	G	0	14	80	15	39	40	0.07	0.37	0.93	0.63	A	1.16	0.124388338	Alzheimer's disease late onset	Brain health and disorders
rs67478160	T	C	11	47	36	0	14	80	0.37	0.07	0.63	0.93	C	1.0526316	0.124388338	Schizophrenia	Brain health and disorders
rs9313296	G	C	83	8	3	35	49	10	0.93	0.63	0.07	0.37	C	10	0.124388338	Weight	Appearance
rs4555772	A	G	37	44	13	7	38	49	0.63	0.28	0.37	0.72	A	0.0888	0.124386065	Stearic acid 18:0 plasma levels	General health
rs12190287	C	G	27	50	17	72	20	2	0.55	0.87	0.45	0.13	G	1.1111	0.124378109	Coronary artery disease	Heart health and disorders
rs10752212	G	A	19	46	29	0	24	70	0.45	0.13	0.55	0.87	G	0.034	0.124378109	Motion sickness	Misc
rs2298632	C	T	19	42	33	55	35	4	0.43	0.77	0.57	0.23	T	0.7	0.124356144	QT interval	Heart health and disorders
rs440837	A	G	38	43	13	11	31	52	0.63	0.28	0.37	0.72	A	0.042	0.124145007	Sex hormone-binding globulin levels	Reproductive health
rs13336428	G	A	36	47	11	8	37	49	0.63	0.28	0.37	0.72	A	0.04	0.124145007	Bone mineral density	General health
rs1865760	C	T	26	44	24	67	24	3	0.51	0.84	0.49	0.16	T	0.033	0.124048019	Height	General health
rs10158481	T	A	59	32	3	18	50	26	0.80	0.46	0.20	0.54	T	0.113	0.123970944	Urate levels in obese individuals	Obesity
rs3105491	G	T	9	36	49	37	46	11	0.29	0.64	0.71	0.36	T	1.52	0.123933083	Systolic blood pressure in sickle cell anemia	Heart health and disorders
rs3739998	C	G	28	51	15	73	20	1	0.57	0.88	0.43	0.12	C	1.15	0.123795299	Coronary heart disease	Heart health and disorders
rs10128711	T	C	14	39	41	47	39	8	0.36	0.71	0.64	0.29	T	1.06	0.12375	Cholesterol, total	General health
rs2898261	G	T	38	45	11	9	37	48	0.64	0.29	0.36	0.71	C	1.35	0.12375	Eosinophilic esophagitis	Digestive system and its disorders
rs7692808	A	G	18	55	21	64	26	4	0.48	0.82	0.52	0.18	A	2.01	0.123664122	PR interval	Heart health and disorders
rs1385890	G	A	5	46	43	38	46	10	0.30	0.65	0.70	0.35	G	0.02	0.123595506	Obesity-related traits	Obesity
rs4491175	T	C	11	44	39	46	40	8	0.35	0.70	0.65	0.30	T	1.1	0.123595506	Response to angiotensin II receptor blocker therapy	General health
rs3129109	T	C	32	46	16	74	20	0	0.59	0.89	0.41	0.11	T	0.032	0.123476729	Height	General health
rs1748195	C	G	46	37	11	4	55	35	0.69	0.34	0.31	0.66	G	1.0702562	0.12330163	Crohn's disease	Digestive system and its disorders
rs2131925	G	T	11	37	46	35	55	4	0.31	0.66	0.69	0.34	G	4.94	0.12330163	Triglycerides	General health
rs477895	C	T	3	33	58	32	39	23	0.21	0.55	0.79	0.45	T	4.19	0.123269532	Mean platelet volume	Heart health and disorders
rs2098713	C	T	28	47	19	5	29	60	0.55	0.21	0.45	0.79	T	0.25	0.123269532	Telomere length	Aging
rs1801275	A	G	42	42	10	11	38	45	0.67	0.32	0.33	0.68	G	0.05	0.123259762	IgE levels	Immune diseases and disorders
rs4796995	A	G	27	41	26	66	25	3	0.51	0.84	0.49	0.16	A	0.03	0.123015873	Bone mineral density	General health
rs2206030	T	C	5	36	53	28	55	11	0.24	0.59	0.76	0.41	T	1	0.122880493	Pulmonary function interaction	Pulmonology
rs11995824	C	G	24	50	20	5	25	64	0.52	0.19	0.48	0.81	G	0.07	0.122807018	Bone mineral density hip	General health
rs6693036	T	C	85	9	0	34	60	0	0.95	0.68	0.05	0.32	G	0.04	0.122787141	Obesity-related traits	Obesity
rs11967485	G	A	85	9	0	41	46	7	0.95	0.68	0.05	0.32	A	0.026	0.122787141	Calcium levels	General health
rs12692738	T	C	59	30	5	20	44	30	0.79	0.45	0.21	0.55	T	0.0527	0.122605364	Waist-to-hip ratio adjusted for body mass index	Obesity
rs1735151	T	C	3	41	50	33	46	15	0.25	0.60	0.75	0.40	T	1.16	0.12245312	Hypertension	Heart health and disorders
rs7929962	C	T	37	38	19	3	41	50	0.60	0.25	0.40	0.75	T	1.15	0.12245312	Prostate cancer	Cancer
rs10778560	A	C	76	15	3	31	47	16	0.89	0.58	0.11	0.42	C	2.11	0.121884058	Diabetic kidney disease	Diabetes
rs7151302	C	T	2	17	75	17	45	32	0.11	0.42	0.89	0.58	C	0.14	0.121884058	Plasma amyloid beta peptide concentrations ABx-40	Brain health and disorders
rs12230170	T	G	87	7	0	44	44	6	0.96	0.70	0.04	0.30	T	0.5482	0.121760738	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs356150	C	A	0	7	87	6	44	44	0.04	0.30	0.96	0.70	C	34.08	0.121760738	Diisocyanate-induced asthma	Pulmonology
rs728478	G	A	24	38	32	0	26	68	0.46	0.14	0.54	0.86	G	0.4	0.121753247	QT interval	Heart health and disorders
rs6822297	A	G	30	42	22	73	16	5	0.54	0.86	0.46	0.14	G	0.02	0.121753247	Obesity-related traits	Obesity
rs3791950	C	A	17	42	35	1	17	76	0.40	0.10	0.60	0.90	A	0.061	0.121708185	Height	General health
rs4145130	A	T	90	4	0	47	44	3	0.98	0.73	0.02	0.27	A	1	0.121693122	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs12913832	A	G	50	38	6	90	4	0	0.73	0.98	0.27	0.02	G	0.14	0.121693122	Tanning	Appearance
rs4932217	A	C	38	38	18	9	31	54	0.61	0.26	0.39	0.74	A	0.66	0.121691293	Height	General health
rs1490388	C	T	15	44	35	52	35	7	0.39	0.74	0.61	0.26	T	4.8	0.121691293	Height	General health
rs763361	T	C	17	40	37	49	41	4	0.39	0.74	0.61	0.26	A	1.16	0.121691293	Type 1 diabetes	Diabetes
rs4418209	T	G	15	44	35	52	35	7	0.39	0.74	0.61	0.26	T	0.07	0.121691293	Bone mineral density paediatric, skull	General health
rs7076156	A	G	7	40	47	0	6	88	0.29	0.03	0.71	0.97	G	1.19	0.121518987	Crohn's disease	Digestive system and its disorders
rs4778138	A	G	52	34	8	14	45	35	0.73	0.39	0.27	0.61	G	0.17	0.121355737	Cutaneous malignant melanoma	Cancer
rs2853694	G	T	27	46	21	1	35	58	0.53	0.20	0.47	0.80	G	1.25	0.121216749	Psoriasis	Immune diseases and disorders
rs10783615	G	A	5	27	62	23	54	17	0.20	0.53	0.80	0.47	G	0.0455	0.121216749	Waist-to-hip ratio adjusted for body mass index	Obesity
rs1011108	C	T	22	49	23	64	27	3	0.49	0.82	0.51	0.18	T	1.79	0.12109375	Periodontal microbiota	Misc
rs1540771	C	T	24	45	25	64	27	3	0.49	0.82	0.51	0.18	A	1.4	0.12109375	Freckles	Appearance
rs3770752	A	G	45	35	14	83	11	0	0.66	0.94	0.34	0.06	A	1.05	0.120995167	Schizophrenia	Brain health and disorders
rs16857178	G	A	84	9	1	41	43	10	0.94	0.66	0.06	0.34	A	0.04	0.120995167	Obesity-related traits	Obesity
rs7179575	T	C	10	43	41	0	11	83	0.34	0.06	0.66	0.94	C	1.2	0.120995167	Gene methylation in lung tissue	Misc
rs2106139	G	A	81	12	1	37	46	11	0.93	0.64	0.07	0.36	G	0.4353	0.120955699	IgG glycosylation	Immune diseases and disorders
rs3782724	A	G	72	20	2	31	43	20	0.87	0.56	0.13	0.44	G	1.47	0.120939443	Obesity early onset extreme	Obesity
rs37369	C	T	55	35	4	14	53	27	0.77	0.43	0.23	0.57	C	0.77	0.120825959	Urinary metabolites H-NMR features	General health
rs1808478	C	T	50	36	8	12	47	35	0.72	0.38	0.28	0.62	T	0.59	0.120772947	Seasonality	Mental aptitude and behavioural traits
rs9385399	G	T	14	43	37	49	38	7	0.38	0.72	0.62	0.28	T	0.055	0.120772947	Infant length	Misc
rs6545814	A	G	35	48	11	8	37	49	0.63	0.28	0.37	0.72	G	3.26	0.120524889	Body mass index	Obesity
rs7660345	A	T	39	40	15	5	43	46	0.63	0.28	0.37	0.72	T	1.19	0.120524889	Acne severe	Misc
rs11709498	A	C	13	44	37	50	35	9	0.37	0.72	0.63	0.28	C	0.1549	0.120524889	Periodontitis DPAL	Misc
rs38055	A	G	18	35	41	0	16	78	0.38	0.09	0.62	0.91	A	1.18	0.120311816	Acne severe	Misc
rs1295686	T	C	12	44	38	51	31	12	0.36	0.71	0.64	0.29	T	1.15	0.120113717	Asthma	Immune diseases and disorders
rs9398652	C	A	75	18	1	31	49	14	0.89	0.59	0.11	0.41	A	12.6	0.120053209	Resting heart rate	General health
rs11043007	G	T	31	49	14	74	20	0	0.59	0.89	0.41	0.11	G	1.19	0.120053209	Type 2 diabetes	Diabetes
rs2819332	G	A	35	41	18	77	14	3	0.59	0.89	0.41	0.11	A	1	0.120053209	Amyotrophic lateral sclerosis age of onset	Brain health and disorders
rs1015451	T	C	75	18	1	31	49	14	0.89	0.59	0.11	0.41	C	0.713	0.120053209	Heart rate	General health
rs3923113	A	C	47	38	9	9	49	36	0.70	0.36	0.30	0.64	A	1.09	0.119950033	Type 2 diabetes	Diabetes
rs137699	A	G	8	40	46	41	39	14	0.30	0.64	0.70	0.36	G	0.1564	0.119950033	IgG glycosylation	Immune diseases and disorders
rs10490919	T	G	15	37	42	42	48	4	0.36	0.70	0.64	0.30	T	0.12	0.119950033	Information processing speed	Mental aptitude and behavioural traits
rs483610	C	T	12	43	39	48	36	10	0.36	0.70	0.64	0.30	G	0.03	0.119950033	Obesity-related traits	Obesity
rs4006531	G	A	7	31	56	35	39	20	0.24	0.58	0.76	0.42	A	0.11	0.11980812	Metabolite levels Dihydroxy docosatrienoic acid	General health
rs301901	A	G	10	46	38	1	11	82	0.35	0.07	0.65	0.93	A	0.024	0.119720411	Height	General health
rs9272535	G	A	83	9	2	39	44	11	0.93	0.65	0.07	0.35	A	1.61	0.119720411	Chronic lymphocytic leukemia	Cancer
rs805297	C	A	43	36	15	81	13	0	0.65	0.93	0.35	0.07	A	1.56	0.119720411	Rheumatoid arthritis	Immune diseases and disorders
rs6119285	C	T	81	13	0	45	32	17	0.93	0.65	0.07	0.35	T	1	0.119720411	Attention deficit hyperactivity disorder combined symptoms	Brain health and disorders
rs1741309	A	G	10	38	46	36	51	7	0.31	0.65	0.69	0.35	A	0.3232	0.119705341	Dementia and core Alzheimer's disease neuropathologic changes	Brain health and disorders
rs1681630	T	C	13	39	42	46	38	10	0.35	0.69	0.65	0.31	T	0.029	0.119705341	Height	General health
rs7919006	C	T	69	25	0	33	38	23	0.87	0.55	0.13	0.45	G	4	0.119609662	Weight	Appearance
rs2720508	C	T	0	2	92	5	35	54	0.01	0.24	0.99	0.76	C	1.61	0.119575761	Conduct disorder	Brain health and disorders
rs1158867	C	T	10	43	41	39	50	5	0.34	0.68	0.66	0.32	C	0.12	0.119569832	Protein C levels	General health
rs1996720	C	T	42	44	8	8	47	39	0.68	0.34	0.32	0.66	T	0.11	0.119569832	Temperament	Mental aptitude and behavioural traits
rs9923856	T	C	43	39	12	7	46	41	0.66	0.32	0.34	0.68	A	1.17	0.119569832	Atopic dermatitis	Immune diseases and disorders
rs2466067	G	A	8	45	41	41	44	9	0.32	0.67	0.68	0.33	C	0.05	0.119542767	Serum thyroid-stimulating hormone levels	General health
rs10090896	G	A	68	24	2	21	58	15	0.85	0.53	0.15	0.47	A	0.04	0.119363395	Metabolite levels  X-11787	General health
rs2239633	G	A	25	35	34	61	26	7	0.45	0.79	0.55	0.21	G	1.34	0.119121222	Acute lymphoblastic leukemia childhood	Cancer
rs11156429	T	G	19	47	28	55	38	1	0.45	0.79	0.55	0.21	G	0.11	0.119121222	Pubertal anthropometrics	Appearance
rs4788439	C	T	58	32	4	19	47	28	0.79	0.45	0.21	0.55	T	0.027	0.119121222	Blood metabolite levels	Heart health and disorders
rs10509373	T	C	33	41	20	72	21	1	0.57	0.88	0.43	0.12	C	4.51	0.118919683	Response to tamoxifen in breast cancer	General health
rs1151008	G	T	6	35	53	30	51	13	0.25	0.59	0.75	0.41	G	0.144	0.118917663	Corneal astigmatism	General health
rs7626795	A	G	65	26	3	32	31	31	0.83	0.51	0.17	0.49	G	1.16	0.11859761	Lung cancer	Cancer
rs6683977	G	C	41	42	11	82	12	0	0.66	0.94	0.34	0.06	C	1.41	0.118596491	Acute lymphoblastic leukemia childhood	Cancer
rs13036722	T	C	83	10	1	44	36	14	0.94	0.66	0.06	0.34	G	0.04	0.118596491	Obesity-related traits	Obesity
rs2166775	G	A	29	40	25	4	28	62	0.52	0.19	0.48	0.81	G	0.99	0.118539534	Response to angiotensin II receptor blocker therapy	General health
rs603424	G	A	54	32	8	17	42	35	0.74	0.40	0.26	0.60	A	0.054	0.118518519	Blood metabolite ratios	Heart health and disorders
rs10896449	A	G	37	38	19	3	42	49	0.60	0.26	0.40	0.74	G	1.21	0.118518519	Prostate cancer	Cancer
rs17206779	C	T	19	46	29	60	27	7	0.45	0.78	0.55	0.22	G	1.33	0.118495298	Osteosarcoma	Cancer
rs6694545	A	G	14	56	24	56	35	3	0.45	0.78	0.55	0.22	A	1.07	0.118495298	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs314580	G	A	7	27	60	30	44	20	0.22	0.55	0.78	0.45	G	2.41	0.118495298	Bipolar disorder and eating disorder	Brain health and disorders
rs11761441	G	A	32	46	16	76	15	3	0.59	0.89	0.41	0.11	G	1.12	0.118477191	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs2489260	G	A	75	17	2	31	48	15	0.89	0.59	0.11	0.41	A	0.04	0.118477191	Obesity-related traits	Obesity
rs4776997	A	G	0	21	73	15	48	31	0.11	0.41	0.89	0.59	G	1	0.118477191	Verbal declarative memory	Brain health and disorders
rs4712972	A	G	0	26	68	16	53	25	0.14	0.45	0.86	0.55	A	0.0099	0.118340982	Carotid intima media thickness	Heart health and disorders
rs8028689	T	C	76	17	1	27	59	8	0.90	0.60	0.10	0.40	G	1.65	0.118303908	Multiple myeloma IgH translocation	Cancer
rs6493206	G	T	90	4	0	53	33	8	0.98	0.74	0.02	0.26	T	1	0.11828962	Response to methylphenidate treatment in attention-deficit_hyperactivity disorder blood pressure	Drug response
rs10463833	G	A	68	23	3	23	53	18	0.85	0.53	0.15	0.47	A	1	0.118249901	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs7722425	T	C	68	23	3	23	53	18	0.85	0.53	0.15	0.47	T	1	0.118249901	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs9388489	A	G	15	44	35	52	34	8	0.39	0.73	0.61	0.27	G	1.17	0.11780948	Type 1 diabetes	Diabetes
rs4246511	T	C	15	44	35	50	38	6	0.39	0.73	0.61	0.27	T	0.24	0.11780948	Menopause age at onset	Reproductive health
rs1373004	T	G	2	33	59	25	49	20	0.20	0.53	0.80	0.47	T	0.06	0.117769608	Bone mineral density	General health
rs2053302	T	C	3	27	64	25	44	25	0.18	0.50	0.82	0.50	T	1	0.11766752	Response to statin therapy	General health
rs7358151	A	G	81	12	1	37	47	10	0.93	0.64	0.07	0.36	G	15.23	0.117555974	Diisocyanate-induced asthma	Pulmonology
rs9420907	C	A	3	18	73	19	44	31	0.13	0.44	0.87	0.56	A	0.069	0.117540182	Telomere length	Aging
rs4451621	C	T	27	52	15	73	18	3	0.56	0.87	0.44	0.13	T	0.023	0.117540182	Educational attainment	Mental aptitude and behavioural traits
rs3764419	C	A	38	39	17	7	37	50	0.61	0.27	0.39	0.73	C	1.16	0.117498566	Height	General health
rs1469170	A	G	14	45	35	50	37	7	0.39	0.73	0.61	0.27	A	1.2	0.117498566	Malaria	Immune diseases and disorders
rs4735738	A	G	52	33	9	15	43	36	0.73	0.39	0.27	0.61	A	0.0728	0.117498566	Menarche age at onset	Reproductive health
rs8042238	C	T	20	42	32	55	35	4	0.44	0.77	0.56	0.23	T	1.26	0.117346185	Chronic obstructive pulmonary disease	Immune diseases and disorders
rs838880	C	T	11	50	33	51	34	9	0.38	0.72	0.62	0.28	C	0.61	0.117216117	HDL cholesterol	General health
rs6462411	T	C	50	36	8	17	38	39	0.72	0.38	0.28	0.62	C	0.36	0.117216117	Quantitative traits	Misc
rs9969524	A	T	49	38	7	10	52	32	0.72	0.38	0.28	0.62	T	0.03	0.117216117	Optic disc area	Misc
rs157640	T	G	26	46	22	68	22	4	0.52	0.84	0.48	0.16	G	1	0.1171875	Celiac disease	Immune diseases and disorders
rs9902453	G	A	22	42	30	3	21	70	0.46	0.14	0.54	0.86	A	0.03	0.117130455	Coffee consumption cups per day	Misc
rs9406316	T	C	57	36	1	20	48	26	0.80	0.47	0.20	0.53	C	0.17	0.11703812	Lipoprotein a levels	Heart health and disorders
rs1161397	G	A	72	22	0	29	51	14	0.88	0.58	0.12	0.42	A	0.127	0.116975698	Overweight status	Obesity
rs6939340	A	G	17	45	32	0	22	72	0.42	0.12	0.58	0.88	G	1.37	0.116975698	Neuroblastoma	Cancer
rs7965445	G	A	78	16	0	35	48	11	0.91	0.63	0.09	0.37	A	1.3	0.116920609	Mortality in heart failure	Heart health and disorders
rs600231	A	G	28	51	15	6	32	56	0.57	0.23	0.43	0.77	A	0.02	0.116821192	Bone mineral density	General health
rs9465871	T	C	56	32	6	22	37	35	0.77	0.43	0.23	0.57	C	1.18	0.116821192	Type 2 diabetes	Diabetes
rs34912216	G	A	57	30	7	16	49	29	0.77	0.43	0.23	0.57	G	0.035	0.116821192	Motion sickness	Misc
rs7143963	C	T	49	36	9	16	38	40	0.71	0.37	0.29	0.63	T	0.026	0.116735066	Body mass index	Obesity
rs6141	C	T	17	42	35	0	20	74	0.40	0.11	0.60	0.89	T	2.467	0.116666667	Platelet count	Heart health and disorders
rs4702	G	A	16	44	34	3	14	77	0.40	0.11	0.60	0.89	G	1.0845987	0.116666667	Schizophrenia	Brain health and disorders
rs6795970	A	G	17	42	35	3	14	77	0.40	0.11	0.60	0.89	A	0.7476	0.116666667	Electrocardiographic conduction measures	Heart health and disorders
rs9378805	A	C	32	48	14	77	14	3	0.60	0.89	0.40	0.11	C	1.38	0.116666667	Chronic lymphocytic leukemia	Cancer
rs12110693	G	A	75	18	1	32	48	14	0.89	0.60	0.11	0.40	A	0.66	0.116666667	Biomedical quantitative traits	General health
rs11635191	A	C	12	45	37	46	41	7	0.37	0.71	0.63	0.29	A	2.32	0.116535792	Diisocyanate-induced asthma	Pulmonology
rs9309711	T	C	45	42	7	11	46	37	0.70	0.36	0.30	0.64	C	0.2055	0.116363636	Neurofibrillary tangles	Brain health and disorders
rs28620942	A	G	26	49	19	4	31	59	0.54	0.21	0.46	0.79	A	10.25	0.116343826	Heschl's gyrus morphology	Brain health and disorders
rs11209718	C	T	19	49	26	60	29	5	0.46	0.79	0.54	0.21	T	1.12	0.116343826	Height	General health
rs6686842	T	C	26	49	19	5	29	60	0.54	0.21	0.46	0.79	C	0.05	0.116343826	Height	General health
rs11022157	C	A	42	39	13	81	13	0	0.65	0.93	0.35	0.07	A	1.22	0.116331096	Chronic lymphocytic leukemia	Cancer
rs73394838	A	G	81	13	0	40	43	11	0.93	0.65	0.07	0.35	G	1	0.116331096	Telomere length	Aging
rs1417205	A	G	81	13	0	35	53	6	0.93	0.65	0.07	0.35	A	0.064	0.116331096	Cannabis use initiation	General health
rs10448044	T	C	57	29	8	11	58	25	0.76	0.43	0.24	0.57	C	4.685	0.116328146	Suicide in bipolar disorder	Brain health and disorders
rs8022296	G	A	65	27	2	22	53	19	0.84	0.52	0.16	0.48	G	1.269	0.116174003	Adverse response to chemotherapy neutropenia_leucopenia all antimicrotubule drugs	Drug response
rs2982712	T	C	20	51	23	3	25	66	0.48	0.16	0.52	0.84	C	1.17	0.116174003	Height	General health
rs846271	C	T	40	44	10	9	42	43	0.66	0.32	0.34	0.68	C	0.1538	0.115942029	IgG glycosylation	Immune diseases and disorders
rs1567127	A	G	62	29	3	23	46	25	0.81	0.49	0.19	0.51	G	1	0.115937062	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs7529251	C	T	61	31	2	22	48	24	0.81	0.49	0.19	0.51	C	0.2765	0.115937062	IgG glycosylation	Immune diseases and disorders
rs4953911	T	A	11	40	43	39	48	7	0.33	0.67	0.67	0.33	T	1	0.115889543	Multiple sclerosis severity	Brain health and disorders
rs4792909	G	T	28	53	13	8	30	56	0.58	0.24	0.42	0.76	T	0.04	0.115866297	Bone mineral density	General health
rs12048904	T	C	21	44	29	60	28	6	0.46	0.79	0.54	0.21	A	1.09	0.115685566	Multiple sclerosis	Brain health and disorders
rs710841	C	T	54	33	7	15	48	31	0.75	0.41	0.25	0.59	A	5	0.115434953	Height	General health
rs1631486	G	A	35	40	19	5	37	52	0.59	0.25	0.41	0.75	A	1.18	0.115434953	Obesity early onset extreme	Obesity
rs2238355	T	C	30	50	14	4	39	51	0.59	0.25	0.41	0.75	A	0.03	0.115434953	Obesity-related traits	Obesity
rs2430457	G	A	0	3	91	3	40	51	0.02	0.24	0.98	0.76	G	2.6041	0.115396617	IgG glycosylation	Immune diseases and disorders
rs10841530	A	G	44	37	13	82	12	0	0.66	0.94	0.34	0.06	G	0.155	0.115215947	Systolic blood pressure alcohol consumption interaction	General health
rs9461856	G	A	26	44	24	64	28	2	0.51	0.83	0.49	0.17	A	1.08	0.115207373	Schizophrenia	Brain health and disorders
rs7678436	G	A	64	28	2	23	50	21	0.83	0.51	0.17	0.49	A	0.09	0.115207373	Height	General health
rs1530016	C	T	20	51	23	63	26	5	0.48	0.81	0.52	0.19	T	1	0.115133513	Body mass index in non-asthmatics	Obesity
rs7118412	A	G	22	47	25	62	28	4	0.48	0.81	0.52	0.19	A	0.09	0.115133513	Disc degeneration lumbar	Aging
rs476828	T	C	75	17	2	34	43	17	0.89	0.59	0.11	0.41	C	1.33	0.115107914	Obesity early onset extreme	Obesity
rs6764388	T	C	34	43	17	74	19	1	0.59	0.89	0.41	0.11	T	0.046	0.115107914	Corneal astigmatism	General health
rs2784505	A	G	77	17	0	35	47	12	0.91	0.62	0.09	0.38	G	1.15	0.115056818	Longevity 90 years and older	Aging
rs62164511	A	G	28	48	18	71	20	3	0.55	0.86	0.45	0.14	A	84.664	0.114969241	Forced vital capacity	Pulmonology
rs2067615	A	T	17	50	27	2	22	70	0.45	0.14	0.55	0.86	A	0.278	0.114969241	Heart rate	General health
rs4664308	A	G	46	42	6	87	7	0	0.71	0.96	0.29	0.04	A	2.28	0.114962269	Idiopathic membranous nephropathy	Brain health and disorders
rs7715172	C	G	87	7	0	49	36	9	0.96	0.71	0.04	0.29	G	1	0.114962269	Response to citalopram treatment	General health
rs7209847	A	G	87	7	0	50	34	10	0.96	0.71	0.04	0.29	G	0.273	0.114962269	Economic and political preferences	Mental aptitude and behavioural traits
rs7098785	A	G	24	40	30	3	23	68	0.47	0.15	0.53	0.85	T	0.9	0.114873115	Orthostatic hypotension	Heart health and disorders
rs7576072	T	C	88	6	0	48	40	6	0.97	0.72	0.03	0.28	G	34.08	0.114725656	Diisocyanate-induced asthma	Pulmonology
rs198426	C	T	51	34	9	88	6	0	0.72	0.97	0.28	0.03	T	0.02	0.114725656	Phospholipid levels plasma	General health
rs1435547	T	C	0	6	88	8	36	50	0.03	0.28	0.97	0.72	A	34.08	0.114725656	Diisocyanate-induced asthma	Pulmonology
rs6474359	T	C	89	5	0	50	38	6	0.97	0.73	0.03	0.27	T	0.06	0.114698386	Glycated hemoglobin levels	Diabetes
rs2837857	C	T	51	37	6	10	56	28	0.74	0.40	0.26	0.60	T	3.3333	0.114661274	Tuberculosis	Immune diseases and disorders
rs727088	G	A	18	40	36	49	41	4	0.40	0.74	0.60	0.26	G	1.0637558	0.114661274	Ulcerative colitis	Immune diseases and disorders
rs6066084	G	A	20	44	30	55	36	3	0.45	0.78	0.55	0.22	A	0.85	0.114472901	Quantitative traits	Misc
rs4871611	G	A	21	48	25	60	31	3	0.48	0.80	0.52	0.20	A	1.17	0.114369141	Crohn's disease	Digestive system and its disorders
rs921720	A	G	21	48	25	60	31	3	0.48	0.80	0.52	0.20	A	1.1255294	0.114369141	Crohn's disease	Digestive system and its disorders
rs1551398	G	A	21	48	25	60	31	3	0.48	0.80	0.52	0.20	A	1.08	0.114369141	Crohn's disease	Digestive system and its disorders
rs1490384	C	T	16	43	35	51	36	7	0.40	0.73	0.60	0.27	T	1.18	0.114317809	Height	General health
rs199307	A	G	50	38	6	11	53	30	0.73	0.40	0.27	0.60	G	0.03	0.114317809	Obesity-related traits	Obesity
rs8026898	G	A	64	27	3	20	55	19	0.82	0.51	0.18	0.49	A	1.15	0.114285714	Rheumatoid arthritis	Immune diseases and disorders
rs6575793	T	C	25	43	26	0	33	61	0.49	0.18	0.51	0.82	C	2.3	0.114285714	Menarche age at onset	Reproductive health
rs9595066	T	C	4	25	65	22	49	23	0.18	0.49	0.82	0.51	T	1.07	0.114285714	Schizophrenia	Brain health and disorders
rs4599440	T	C	2	29	63	24	45	25	0.18	0.49	0.82	0.51	A	0.2	0.114285714	Biochemical measures	General health
rs2172873	G	A	83	11	0	42	43	9	0.94	0.68	0.06	0.32	A	1.18	0.114217836	Uterine fibroids	Cancer
rs7147996	T	A	39	44	11	80	14	0	0.65	0.93	0.35	0.07	A	28.09	0.114189189	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs2487928	G	A	28	51	15	71	22	1	0.57	0.87	0.43	0.13	A	1.06	0.114180285	Coronary artery disease	Heart health and disorders
rs9419958	T	C	3	18	73	19	43	32	0.13	0.43	0.87	0.57	T	0.0829	0.114180285	Telomere length	Aging
rs66691851	C	T	20	43	31	54	37	3	0.44	0.77	0.56	0.23	C	1.0752687	0.113916548	Schizophrenia	Brain health and disorders
rs1429411	A	G	31	37	26	65	28	1	0.53	0.84	0.47	0.16	C	1.55	0.113821404	Interferon alpha levels in systemic lupus erythematosus	Immune diseases and disorders
rs13314993	G	T	30	39	25	68	22	4	0.53	0.84	0.47	0.16	C	1.13	0.113821404	Celiac disease	Immune diseases and disorders
rs13022873	A	C	22	45	27	62	26	6	0.47	0.80	0.53	0.20	A	0.17	0.113642611	Waist Circumference - Triglycerides WC-TG	General health
rs228836	G	A	14	44	36	53	29	12	0.38	0.72	0.62	0.28	G	0.061	0.113455107	Sitting height ratio	Appearance
rs2554152	G	T	64	26	4	24	46	24	0.82	0.50	0.18	0.50	G	1	0.113407258	Visceral adipose tissue adjusted for BMI	Obesity
rs10841287	T	C	57	30	7	15	52	27	0.77	0.44	0.23	0.56	G	0.03	0.11339233	Obesity-related traits	Obesity
rs2820443	T	C	35	43	16	75	18	1	0.60	0.89	0.40	0.11	T	0.0616	0.113317101	Waist-to-hip ratio adjusted for body mass index	Obesity
rs2877649	T	C	0	18	76	17	38	39	0.10	0.38	0.90	0.62	T	0.1877	0.113286713	Smooth-surface caries	Appearance
rs9537938	G	A	12	47	35	45	44	5	0.38	0.71	0.62	0.29	A	0.023	0.11322208	Educational attainment	Mental aptitude and behavioural traits
rs131654	G	T	12	40	42	1	11	82	0.34	0.07	0.66	0.93	A	1.28	0.112973983	Systemic lupus erythematosus	Immune diseases and disorders
rs6442708	C	A	81	13	0	38	48	8	0.93	0.66	0.07	0.34	A	3.35	0.112973983	Diisocyanate-induced asthma	Pulmonology
rs170183	G	A	30	46	18	73	17	4	0.56	0.87	0.44	0.13	G	1	0.11287913	Bone mineral density	General health
rs2856321	G	A	13	43	38	39	54	1	0.37	0.70	0.63	0.30	G	1.14	0.112835821	Height	General health
rs2529049	G	A	39	42	13	11	35	48	0.64	0.30	0.36	0.70	G	0.119	0.112682054	Urate levels in obese individuals	Obesity
rs4654748	C	T	30	42	22	69	22	3	0.54	0.85	0.46	0.15	C	1.45	0.1126289	Folate pathway vitamin levels	General health
rs11175194	G	A	87	5	2	45	41	8	0.95	0.70	0.05	0.30	G	1.19	0.112609971	Epithelial ovarian cancer	Cancer
rs4646404	G	A	45	41	8	85	9	0	0.70	0.95	0.30	0.05	G	0.0337	0.112609971	Waist-to-hip ratio adjusted for body mass index	Obesity
rs12666280	T	C	26	41	27	64	25	5	0.49	0.81	0.51	0.19	C	8.93	0.112570356	QT interval	Heart health and disorders
rs10804591	C	A	7	44	43	39	43	12	0.31	0.64	0.69	0.36	A	0.0401	0.112554235	Waist-to-hip ratio adjusted for body mass index	Obesity
rs2455601	A	G	7	32	55	29	50	15	0.24	0.57	0.76	0.43	A	1.34	0.112437112	Schizophrenia	Brain health and disorders
rs10923038	C	A	14	52	28	55	32	7	0.43	0.76	0.57	0.24	C	1	0.112437112	Serum protein levels sST2	General health
rs1520333	A	G	45	36	13	13	37	44	0.67	0.34	0.33	0.66	G	1.1	0.112299465	Multiple sclerosis	Brain health and disorders
rs6800435	C	A	60	28	6	18	51	25	0.79	0.46	0.21	0.54	A	1.08	0.112298174	Schizophrenia	Brain health and disorders
rs993648	C	T	29	43	22	6	28	60	0.54	0.21	0.46	0.79	T	1	0.112298174	Response to iloperidone treatment QT prolongation	General health
rs3853444	T	C	34	41	19	74	17	3	0.58	0.88	0.42	0.12	G	7.69	0.112208387	Coronary heart disease	Heart health and disorders
rs669446	A	G	21	37	36	4	15	75	0.42	0.12	0.58	0.88	T	1	0.112208387	Amyotrophic lateral sclerosis age of onset	Brain health and disorders
rs11249433	A	G	36	49	9	79	15	0	0.64	0.92	0.36	0.08	G	1.09	0.112161938	Breast cancer	Cancer
rs6686423	G	A	41	39	14	80	13	1	0.64	0.92	0.36	0.08	A	0.194	0.112161938	Renal sinus fat	General health
rs1690789	C	T	42	37	15	79	15	0	0.64	0.92	0.36	0.08	C	0.03	0.112161938	Local histogram emphysema pattern	Pulmonology
rs2737618	G	A	56	31	7	92	1	1	0.76	0.98	0.24	0.02	A	0.311	0.112042683	Uric acid levels	General health
rs917727	C	T	56	29	9	15	49	30	0.75	0.42	0.25	0.58	T	0.154	0.112004662	Bone mineral density	General health
rs4669297	T	C	1	10	83	2	58	34	0.06	0.33	0.94	0.67	T	1.17	0.111866834	Schizophrenia	Brain health and disorders
rs1558902	T	A	45	36	13	83	10	1	0.67	0.94	0.33	0.06	A	0.21	0.111866834	Height adjusted BMI	Obesity
rs1421085	T	C	45	36	13	83	10	1	0.67	0.94	0.33	0.06	C	0.1	0.111866834	Dietary macronutrient intake	General health
rs17372114	T	C	34	44	16	73	21	0	0.60	0.89	0.40	0.11	T	0.04	0.111776226	Resistin levels	Immune diseases and disorders
rs2240919	C	G	33	46	15	73	21	0	0.60	0.89	0.40	0.11	C	0.027	0.111776226	Height	General health
rs7558233	A	T	78	15	1	40	38	16	0.91	0.63	0.09	0.37	T	0.48	0.111720956	Cannabis use initiation	General health
rs9257616	G	A	36	46	12	77	17	0	0.63	0.91	0.37	0.09	G	0.093	0.111720956	Social communication problems	Brain health and disorders
rs1561296	T	C	19	48	27	56	35	3	0.46	0.78	0.54	0.22	T	1.05	0.111678022	Schizophrenia	Brain health and disorders
rs7359397	C	T	32	41	21	69	24	1	0.56	0.86	0.44	0.14	T	0.15	0.111637975	Body mass index	Obesity
rs4748185	T	C	0	7	87	3	47	44	0.04	0.28	0.96	0.72	A	33.99	0.111603376	Diisocyanate-induced asthma	Pulmonology
rs1941027	C	T	1	5	88	8	37	49	0.04	0.28	0.96	0.72	C	0.04	0.111603376	Metabolite levels  X-11787	General health
rs17028615	A	G	87	7	0	50	35	9	0.96	0.72	0.04	0.28	A	0.19	0.111603376	Serum metabolite levels	General health
rs365132	G	T	34	42	18	8	32	54	0.59	0.26	0.41	0.74	T	0.39	0.11160144	Menarche and menopause age at onset	Reproductive health
rs788867	T	G	53	34	7	15	48	31	0.74	0.41	0.26	0.59	T	0.043	0.11160144	Height	General health
rs4901977	C	T	52	36	6	16	46	32	0.74	0.41	0.26	0.59	T	0.011	0.11160144	Vertical cup-disc ratio	Misc
rs6689858	T	C	48	43	3	19	39	36	0.74	0.41	0.26	0.59	C	1	0.111226852	Pediatric autoimmune diseases	Immune diseases and disorders
rs9914578	C	G	53	33	8	16	45	33	0.74	0.41	0.26	0.59	G	0.026	0.111226852	Body mass index	Obesity
rs4593108	C	G	58	30	6	21	43	30	0.78	0.45	0.22	0.55	C	1.07	0.111091208	Myocardial infarction	Heart health and disorders
rs364663	T	A	21	49	24	58	35	1	0.48	0.80	0.52	0.20	A	0.089	0.111015172	Menarche age at onset	Reproductive health
rs6459467	G	A	25	47	22	4	29	61	0.52	0.20	0.48	0.80	A	0.02	0.111015172	Blood metabolite levels	Heart health and disorders
rs214782	G	A	2	29	63	22	48	24	0.18	0.49	0.82	0.51	G	1.29	0.110948207	Basal cell carcinoma	Cancer
rs762421	G	A	22	48	24	5	23	66	0.49	0.18	0.51	0.82	G	1.13	0.110948207	Crohn's disease	Digestive system and its disorders
rs2500488	C	T	10	30	54	25	62	7	0.27	0.60	0.73	0.40	C	1.472	0.110880351	Epithelial ovarian cancer	Cancer
rs1155939	C	A	16	44	34	51	36	7	0.40	0.73	0.60	0.27	A	0.042	0.110880351	Height	General health
rs9581943	G	A	43	42	9	83	11	0	0.68	0.94	0.32	0.06	A	1.15	0.110875087	Pancreatic cancer	Cancer
rs9849248	C	T	1	22	71	23	34	37	0.13	0.43	0.87	0.57	C	0.04	0.110859729	Menarche age at onset	Reproductive health
rs79252495	G	A	81	12	1	39	45	10	0.93	0.65	0.07	0.35	A	4.25	0.110855389	Diisocyanate-induced asthma	Pulmonology
rs4478147	G	A	31	38	25	66	26	2	0.53	0.84	0.47	0.16	G	1.12	0.110497963	Migraine - clinic-based	Brain health and disorders
rs6465657	C	T	38	44	12	79	14	1	0.64	0.91	0.36	0.09	C	1.12	0.110241357	Prostate cancer	Cancer
rs548987	G	C	78	16	0	39	42	13	0.91	0.64	0.09	0.36	C	0.0597	0.110241357	Homocysteine levels	Misc
rs10897518	C	T	22	51	21	64	26	4	0.51	0.82	0.49	0.18	C	0.06	0.110078108	Urate levels in lean individuals	Obesity
rs9364687	G	T	44	42	8	84	10	0	0.69	0.95	0.31	0.05	G	0.02	0.110007639	Body mass index	Obesity
rs4988235	G	A	49	32	13	84	10	0	0.69	0.95	0.31	0.05	A	0.016	0.110007639	Body mass index	Obesity
rs2290854	A	G	13	47	34	49	37	8	0.39	0.72	0.61	0.28	A	1.13	0.110004579	Breast Cancer in BRCA1 mutation carriers	Cancer
rs11693094	C	T	35	44	15	75	18	1	0.61	0.89	0.39	0.11	C	1.0764263	0.110004527	Schizophrenia	Brain health and disorders
rs6715284	C	G	78	14	2	38	41	15	0.90	0.62	0.10	0.38	G	1.15	0.109971421	Rheumatoid arthritis	Immune diseases and disorders
rs4850410	C	T	6	27	61	25	49	20	0.21	0.53	0.79	0.47		1.56	0.109609061	Interferon alpha levels in systemic lupus erythematosus	Immune diseases and disorders
rs9314614	C	G	26	47	21	4	31	59	0.53	0.21	0.47	0.79	C	1.135	0.109609061	IgA nephropathy	Immune diseases and disorders
rs9388451	T	C	31	45	18	70	23	1	0.57	0.87	0.43	0.13	C	1.58	0.109573725	Brugada syndrome	Heart health and disorders
rs174536	A	C	32	43	19	75	13	6	0.57	0.87	0.43	0.13	A	0.02	0.109573725	Phospholipid levels plasma	General health
rs2239815	T	C	38	41	15	9	37	48	0.62	0.29	0.38	0.71	T	1.16	0.109553124	Esophageal squamous cell carcinoma	Cancer
rs6474412	C	T	9	37	48	35	47	12	0.29	0.62	0.71	0.38	T	0.29	0.109553124	Smoking behavior	General health
rs3889237	G	T	23	43	28	4	23	67	0.47	0.16	0.53	0.84	C	0.056	0.109505208	Height	General health
rs4391122	A	G	19	47	28	3	22	69	0.45	0.15	0.55	0.85	G	1.0869565	0.109324001	Schizophrenia	Brain health and disorders
rs1858037	T	A	29	45	20	67	26	1	0.55	0.85	0.45	0.15	T	1.19	0.109324001	Rheumatoid arthritis	Immune diseases and disorders
rs1535500	G	T	19	56	19	3	29	62	0.50	0.19	0.50	0.81	T	1.13	0.109248972	Type 2 diabetes	Diabetes
rs752092	A	G	44	43	7	12	45	37	0.70	0.37	0.30	0.63	A	0.08	0.109204545	Corneal structure	General health
rs11989868	A	C	38	43	13	8	41	45	0.63	0.30	0.37	0.70	C	0.03	0.109204545	Obesity-related traits	Obesity
rs8020095	G	A	29	49	16	5	36	53	0.57	0.24	0.43	0.76	A	1	0.109059468	Depression quantitative trait	Brain health and disorders
rs9502570	C	T	51	40	3	13	55	26	0.76	0.43	0.24	0.57	A	1.06	0.109059468	Type 2 diabetes	Diabetes
rs140174	A	G	24	52	18	5	30	59	0.53	0.21	0.47	0.79	G	1.08	0.108958838	Migraine	Brain health and disorders
rs3765535	A	G	73	19	2	32	46	16	0.88	0.59	0.12	0.41	G	0.065	0.108910891	Airway responsiveness in chronic obstructive pulmonary disease	Pulmonology
rs1167998	C	A	11	38	45	34	54	6	0.32	0.65	0.68	0.35	C	0.09	0.108870511	Triglycerides	General health
rs988712	G	T	38	46	10	80	13	1	0.65	0.92	0.35	0.08	G	1.36	0.108851224	Obesity	Obesity
rs6484218	G	A	80	13	1	38	46	10	0.92	0.65	0.08	0.35	A	1	0.108851224	Schizophrenia, bipolar disorder and depression combined	Brain health and disorders
rs2828478	A	G	12	42	40	0	15	79	0.35	0.08	0.65	0.92	A	1.06	0.108851224	Schizophrenia	Brain health and disorders
rs62531686	T	C	11	42	41	39	48	7	0.34	0.67	0.66	0.33	C	0.83	0.10877193	PCA3 expression level	Cancer
rs744166	A	G	44	36	14	11	40	43	0.66	0.33	0.34	0.67	A	1.18	0.10877193	Crohn's disease	Digestive system and its disorders
rs1296720	A	C	54	36	4	92	1	1	0.77	0.98	0.23	0.02	C	0.83	0.108711117	QT interval	Heart health and disorders
rs11890081	T	C	91	3	0	53	38	3	0.98	0.77	0.02	0.23	C	0.6811	0.108711117	IgG glycosylation	Immune diseases and disorders
rs4750211	C	T	49	36	9	87	6	1	0.71	0.96	0.29	0.04	A	0.05	0.108691186	Obesity-related traits	Obesity
rs3198697	C	T	52	30	12	86	8	0	0.71	0.96	0.29	0.04	T	0.02	0.108691186	Triglycerides	General health
rs2579330	C	T	1	6	87	7	40	47	0.04	0.29	0.96	0.71	C	1.36	0.108691186	QT interval	Heart health and disorders
rs494558	C	T	0	8	86	5	44	45	0.04	0.29	0.96	0.71	G	0.05	0.108691186	Obesity-related traits	Obesity
rs7839488	G	A	24	50	20	65	26	3	0.52	0.83	0.48	0.17	A	1.32	0.108558152	Myopia pathological	General health
rs1341320	G	A	3	26	65	22	46	26	0.17	0.48	0.83	0.52	G	0.18	0.108558152	Plasma amyloid beta peptide concentrations ABx-40	Brain health and disorders
rs6721654	C	T	83	10	1	37	53	4	0.94	0.68	0.06	0.32	T	1.26	0.108549211	Age-related macular degeneration	Aging
rs11630316	T	C	35	43	16	75	17	2	0.60	0.89	0.40	0.11	C	2.2705	0.108482143	Cognitive function	Brain health and disorders
rs7072216	T	C	23	49	22	7	22	65	0.51	0.19	0.49	0.81	C	1.19	0.108459262	Metabolite levels	General health
rs7189020	A	T	21	53	20	4	28	62	0.51	0.19	0.49	0.81	T	1	0.108459262	Mean corpuscular volume	Heart health and disorders
rs2147896	A	G	23	49	22	7	22	65	0.51	0.19	0.49	0.81	A	0.85	0.108459262	Urinary metabolites H-NMR features	General health
rs4539242	T	C	23	49	22	7	22	65	0.51	0.19	0.49	0.81	T	0.35	0.108459262	Urinary metabolites H-NMR features	General health
rs4488133	A	T	23	49	22	6	24	64	0.51	0.19	0.49	0.81	A	0.282	0.108459262	Blood metabolite levels	Heart health and disorders
rs12386622	G	A	60	32	2	26	41	27	0.81	0.49	0.19	0.51	A	1	0.108459262	Homeostasis model assessment of beta-cell function interaction	Misc
rs3128935	T	C	79	13	2	38	43	13	0.91	0.63	0.09	0.37	T	2.28	0.108420209	Periodontitis CDC_AAP	Misc
rs4840086	A	G	30	46	18	72	18	4	0.56	0.86	0.44	0.14	G	2.1	0.108347153	Menarche age at onset	Reproductive health
rs174541	T	C	32	42	20	74	14	6	0.56	0.86	0.44	0.14	T	0.28	0.108347153	Metabolite levels	General health
rs4246215	G	T	32	42	20	74	14	6	0.56	0.86	0.44	0.14	T	0.08	0.108347153	Phospholipid levels plasma	General health
rs1077989	A	C	24	39	31	56	35	3	0.46	0.78	0.54	0.22	A	0.0653	0.108342362	Glycerophospholipid levels	Diabetes
rs17221829	C	A	51	36	7	88	6	0	0.73	0.97	0.27	0.03	A	0.4408	0.108035714	Anxiety in major depressive disorder	Brain health and disorders
rs3020418	G	A	52	35	7	19	40	35	0.74	0.41	0.26	0.59	A	0.032	0.107845695	Height	General health
rs3019885	T	G	23	46	25	64	23	7	0.49	0.80	0.51	0.20	G	1.34	0.10770754	Asthma	Immune diseases and disorders
rs7666129	C	T	25	47	22	64	27	3	0.52	0.82	0.48	0.18	A	1.59	0.10765489	Polycystic ovary syndrome	Reproductive health
rs12568266	G	A	81	12	1	43	38	13	0.93	0.66	0.07	0.34	A	5.02	0.107554638	Diisocyanate-induced asthma	Pulmonology
rs7756992	A	G	50	38	6	20	37	37	0.73	0.41	0.27	0.59	G	1.2	0.10749675	Type 2 diabetes	Diabetes
rs13093086	G	A	22	41	31	55	35	4	0.45	0.77	0.55	0.23	A	0.57	0.107206671	Intraocular pressure	General health
rs963837	T	C	30	45	19	71	19	4	0.56	0.86	0.44	0.14	T	0.0037	0.107177033	Renal function-related traits sCR	General health
rs16961543	T	G	51	35	8	12	52	30	0.73	0.40	0.27	0.60	C	0.03	0.107174746	Obesity-related traits	Obesity
rs9647379	G	C	35	42	17	73	20	1	0.60	0.88	0.40	0.12	C	0.206	0.107032741	Heart rate	General health
rs3805236	A	G	15	46	33	2	18	74	0.40	0.12	0.60	0.88	G	1.12	0.107032741	Asthma	Immune diseases and disorders
rs6983267	G	T	21	49	24	61	28	5	0.48	0.80	0.52	0.20	G	1.36	0.10699247	Prostate cancer early onset	Cancer
rs1697137	G	A	24	43	27	61	28	5	0.48	0.80	0.52	0.20	C	1	0.10699247	Carotid atherosclerosis in HIV infection	Heart health and disorders
rs1263173	G	A	17	57	20	60	30	4	0.48	0.80	0.52	0.20	A	0.0873	0.10699247	HDL cholesterol	General health
rs1877644	G	A	61	28	5	27	37	30	0.80	0.48	0.20	0.52	A	0.03	0.10699247	Obesity-related traits	Obesity
rs7924176	A	G	39	43	12	79	14	1	0.64	0.91	0.36	0.09	A	0.167	0.106953411	Primary tooth development time to first tooth eruption	Misc
rs1995138	G	A	78	16	0	38	45	11	0.91	0.64	0.09	0.36	A	0.0957	0.106953411	Periodontitis Mean PAL	Misc
rs12455580	T	C	14	47	33	47	42	5	0.40	0.72	0.60	0.28	C	0.1716	0.106879219	IgG glycosylation	Immune diseases and disorders
rs4336470	C	T	35	43	16	6	40	48	0.60	0.28	0.40	0.72	C	1.26	0.106879219	Neuroblastoma	Cancer
rs4846567	G	T	37	41	16	75	18	1	0.61	0.89	0.39	0.11	G	0.03	0.106728979	Waist-hip ratio	General health
rs35343117	C	G	44	43	7	84	10	0	0.70	0.95	0.30	0.05	G	1.1	0.106699512	Psoriasis	Immune diseases and disorders
rs10176755	A	G	84	10	0	43	45	6	0.95	0.70	0.05	0.30	G	1	0.106699512	Visceral fat	Obesity
rs2657879	A	G	44	43	7	84	10	0	0.70	0.95	0.30	0.05	A	0.024	0.106699512	Blood metabolite levels	Heart health and disorders
rs2086512	A	G	0	18	76	10	50	34	0.10	0.37	0.90	0.63	A	0.324	0.106691919	Cytomegalovirus antibody response	Immune diseases and disorders
rs11242111	A	G	1	16	77	12	46	36	0.10	0.37	0.90	0.63	A	0.023	0.106691919	Fibrinogen	General health
rs7739264	C	T	26	52	16	5	34	55	0.55	0.23	0.45	0.77	T	1.17	0.106685633	Endometriosis	General health
rs1386809	A	C	32	40	22	3	38	53	0.55	0.23	0.45	0.77	C	0.1576	0.106685633	IgG glycosylation	Immune diseases and disorders
rs1501357	T	C	49	36	9	12	49	33	0.71	0.39	0.29	0.61	C	1.0799136	0.106365949	Schizophrenia	Brain health and disorders
rs1277203	C	T	8	38	48	36	43	15	0.29	0.61	0.71	0.39	A	1.615	0.106365949	Adverse response to chemotherapy neutropenia_leucopenia carboplatin	Drug response
rs12068753	T	A	81	13	0	43	40	11	0.93	0.67	0.07	0.33	A	3.97	0.106356589	Inflammatory biomarkers in Kawasaki disease	Immune diseases and disorders
rs11847697	C	T	82	11	1	38	50	6	0.93	0.67	0.07	0.33	T	0.17	0.106356589	Body mass index	Obesity
rs1498232	T	C	18	54	22	60	29	5	0.48	0.79	0.52	0.21	T	1.07	0.1063128	Schizophrenia	Brain health and disorders
rs11820502	G	C	27	44	23	5	29	60	0.52	0.21	0.48	0.79	C	0.1836	0.1063128	IgG glycosylation	Immune diseases and disorders
rs174537	G	T	32	44	18	75	13	6	0.57	0.87	0.43	0.13	A	1.0922968	0.106308206	Crohn's disease	Digestive system and its disorders
rs174547	T	C	33	42	19	75	13	6	0.57	0.87	0.43	0.13	C	1	0.106308206	Comprehensive strength and appendicular lean mass	General health
rs174546	C	T	33	42	19	75	13	6	0.57	0.87	0.43	0.13	T	0.73	0.106308206	HDL cholesterol	General health
rs174550	T	C	33	42	19	75	13	6	0.57	0.87	0.43	0.13	T	0.08	0.106308206	Phospholipid levels plasma	General health
rs174551	T	C	33	42	19	75	13	6	0.57	0.87	0.43	0.13	T	0.067	0.106308206	LDL cholesterol	General health
rs174554	A	G	33	42	19	75	13	6	0.57	0.87	0.43	0.13	A	0.062	0.106308206	Cholesterol, total	General health
rs174545	C	G	33	42	19	75	13	6	0.57	0.87	0.43	0.13	C	0.0031	0.106308206	Trans fatty acid levels	General health
rs1641537	T	C	1	29	64	21	46	27	0.16	0.47	0.84	0.53	T	0.064	0.10623549	Sex hormone-binding globulin levels	Reproductive health
rs4711751	T	C	26	48	20	66	25	3	0.53	0.84	0.47	0.16	T	1.15	0.10623549	Age-related macular degeneration	Aging
rs11995572	G	T	66	25	3	25	50	19	0.84	0.53	0.16	0.47	T	1.12	0.10623549	Schizophrenia	Brain health and disorders
rs17515225	T	C	27	46	21	65	27	2	0.53	0.84	0.47	0.16	T	0.032	0.10623549	Motion sickness	Misc
rs16995986	G	A	0	2	92	3	35	56	0.01	0.22	0.99	0.78	G	34.08	0.106222502	Diisocyanate-induced asthma	Pulmonology
rs12294076	T	C	92	2	0	57	33	4	0.99	0.78	0.01	0.22	T	6.25	0.106222502	Tuberculosis	Immune diseases and disorders
rs2371767	G	C	48	37	9	13	46	35	0.71	0.38	0.29	0.62	G	0.057	0.106147483	Waist-to-hip ratio adjusted for body mass index	Obesity
rs12303914	A	G	9	37	48	37	42	15	0.29	0.62	0.71	0.38	A	20.39	0.106147483	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs2080454	C	A	6	43	45	38	40	16	0.29	0.62	0.71	0.38	C	0.017	0.106147483	Body mass index	Obesity
rs3825932	T	C	33	38	23	67	26	1	0.55	0.85	0.45	0.15	T	1.16	0.106060606	Type 1 diabetes	Diabetes
rs7523455	A	G	70	20	4	26	52	16	0.85	0.55	0.15	0.45	A	1	0.106060606	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs246234	C	G	6	23	65	23	47	24	0.19	0.49	0.81	0.51	C	0.02	0.105972782	Blood metabolite levels	Heart health and disorders
rs10774625	A	G	8	39	47	2	5	87	0.29	0.05	0.71	0.95	A	1.5	0.105969551	Retinal vascular caliber	General health
rs4766578	T	A	8	39	47	2	5	87	0.29	0.05	0.71	0.95	T	1.32	0.105969551	Vitiligo	Immune diseases and disorders
rs10774624	G	A	8	39	47	2	5	87	0.29	0.05	0.71	0.95	G	1.09	0.105969551	Rheumatoid arthritis	Immune diseases and disorders
rs261342	G	C	10	37	47	38	42	14	0.30	0.63	0.70	0.37	C	1	0.105785359	Metabolite levels	General health
rs9660180	G	A	21	47	26	55	38	1	0.47	0.79	0.53	0.21	A	0.017	0.105667365	Body mass index	Obesity
rs9474614	A	G	73	19	2	26	59	9	0.88	0.59	0.12	0.41	G	0.03	0.105652174	Obesity-related traits	Obesity
rs6490294	C	A	42	37	15	9	42	43	0.64	0.32	0.36	0.68	A	4.38	0.105425698	Mean platelet volume	Heart health and disorders
rs4452212	G	A	50	35	9	86	8	0	0.72	0.96	0.28	0.04	A	0.05	0.105386417	Telomere length	Aging
rs3096644	G	T	39	44	11	6	49	39	0.65	0.32	0.35	0.68	G	0.08	0.105354059	Metabolite levels Dihydroxy docosatrienoic acid	General health
rs918629	G	A	43	41	10	11	44	39	0.68	0.35	0.32	0.65	G	0.1737	0.105354059	IgG glycosylation	Immune diseases and disorders
rs10789285	T	G	66	24	4	30	39	25	0.83	0.53	0.17	0.47	G	1.12	0.105298979	Psoriasis	Immune diseases and disorders
rs10831284	G	A	3	26	65	19	51	24	0.17	0.47	0.83	0.53	G	1	0.105298979	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs10745841	G	C	11	41	42	41	42	11	0.34	0.66	0.66	0.34	C	1.05	0.105282517	Schizophrenia	Brain health and disorders
rs1413885	C	T	11	38	45	0	12	82	0.32	0.06	0.68	0.94	C	0.428	0.105263158	Anticoagulant levels	Immune diseases and disorders
rs2505083	T	C	30	54	10	74	19	1	0.61	0.89	0.39	0.11	C	1.06	0.105225698	Myocardial infarction	Heart health and disorders
rs2885805	C	A	33	48	13	73	21	0	0.61	0.89	0.39	0.11	A	0.207	0.105225698	Cytomegalovirus antibody response	Immune diseases and disorders
rs2728124	T	A	34	46	14	74	19	1	0.61	0.89	0.39	0.11	A	0.044	0.105225698	Sitting height ratio	Appearance
rs1077514	C	T	1	34	59	22	50	22	0.19	0.50	0.81	0.50	C	0.03	0.105190744	Cholesterol, total	General health
rs10943724	C	A	41	38	15	77	17	0	0.64	0.91	0.36	0.09	A	19.77	0.105154639	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs735396	T	C	29	49	16	71	20	3	0.57	0.86	0.43	0.14	G	0.17	0.105096759	N-glycan levels	General health
rs2259816	G	T	29	49	16	71	20	3	0.57	0.86	0.43	0.14	T	0.141	0.105096759	C-reactive protein	Immune diseases and disorders
rs1169310	G	A	29	49	16	71	20	3	0.57	0.86	0.43	0.14	A	0.13	0.105096759	C-reactive protein	Immune diseases and disorders
rs10048158	T	C	12	47	35	0	19	75	0.38	0.10	0.62	0.90	C	0.41	0.105050505	&beta;2-Glycoprotein I &beta;2-GPI plasma levels	Immune diseases and disorders
rs7905537	A	C	32	53	9	77	15	2	0.62	0.90	0.38	0.10	A	1.85	0.105050505	Emphysema-related traits	Pulmonology
rs10519302	A	G	77	15	2	35	47	12	0.90	0.62	0.10	0.38	A	0.069	0.105050505	Height	General health
rs2116324	T	C	75	19	0	36	45	13	0.90	0.62	0.10	0.38	T	0.0066	0.105050505	Trans fatty acid levels	General health
rs7185923	T	C	29	45	20	70	19	5	0.55	0.85	0.45	0.15	C	1.89	0.104995313	Weight loss gastric bypass surgery	Obesity
rs9896052	A	C	29	45	20	66	27	1	0.55	0.85	0.45	0.15	A	1.67	0.104995313	Sight-threatening diabetic retinopathy in type 2 diabetes	Diabetes
rs4896582	G	A	19	47	28	3	23	68	0.45	0.15	0.55	0.85	A	0.38	0.104995313	Height	General health
rs3811321	A	C	90	4	0	49	45	0	0.98	0.76	0.02	0.24	C	0.481	0.104911689	Renal transplant outcome	Misc
rs12229918	G	C	52	35	7	88	6	0	0.74	0.97	0.26	0.03	C	0.218	0.104729538	Primary tooth development time to first tooth eruption	Misc
rs2949837	A	T	54	33	7	89	5	0	0.75	0.97	0.25	0.03	A	0.056	0.104700855	Sitting height ratio	Appearance
rs7758616	G	A	89	5	0	49	43	2	0.97	0.75	0.03	0.25	A	0.03	0.104700855	Obesity-related traits	Obesity
rs2405522	A	G	6	37	51	31	47	16	0.26	0.58	0.74	0.42	A	0.126	0.104517478	Blood metabolite levels	Heart health and disorders
rs6893782	C	A	6	37	51	31	47	16	0.26	0.58	0.74	0.42	A	0.0449	0.104517478	Acylcarnitine levels	General health
rs1473247	T	C	35	39	20	7	35	52	0.58	0.26	0.42	0.74	C	0.01	0.104517478	Mean platelet volume	Heart health and disorders
rs3755132	T	G	63	25	6	27	39	28	0.80	0.49	0.20	0.51	G	1.45	0.1044461	Wilms tumor	Cancer
rs1010304	A	G	59	33	2	22	49	23	0.80	0.49	0.20	0.51	A	1	0.1044461	Verbal declarative memory	Brain health and disorders
rs791595	A	G	1	22	71	16	46	32	0.13	0.41	0.87	0.59	A	1.17	0.104336625	Type 2 diabetes	Diabetes
rs1299926	T	A	0	14	80	7	49	38	0.07	0.34	0.93	0.66	T	0.26	0.104287017	Anger	General health
rs11766496	G	C	80	14	0	37	51	6	0.93	0.66	0.07	0.34	C	1.3	0.104287017	Airflow obstruction	Pulmonology
rs6982751	C	G	80	14	0	35	55	4	0.93	0.66	0.07	0.34	G	1.1878	0.104287017	Asthma and hay fever	Immune diseases and disorders
rs7979673	C	T	81	12	1	39	47	8	0.93	0.66	0.07	0.34	T	0.058	0.104287017	Height	General health
rs4360309	C	T	8	42	44	1	9	84	0.31	0.06	0.69	0.94	T	1.35	0.104281735	Triglycerides	General health
rs7570971	C	A	12	34	48	0	11	83	0.31	0.06	0.69	0.94	C	0.017	0.104281735	Body mass index	Obesity
rs4737547	A	G	31	48	15	5	40	49	0.59	0.27	0.41	0.73	G	1.3	0.104166667	Multiple myeloma IgH translocation	Cancer
rs2391518	T	C	4	42	48	26	58	10	0.27	0.59	0.73	0.41	T	0.022	0.104166667	Body mass index	Obesity
rs13392177	T	C	28	46	20	67	24	3	0.54	0.84	0.46	0.16	C	2.3	0.10397878	Pyoderma gangrenosum in inflammatory bowel disease	Immune diseases and disorders
rs913678	T	C	19	48	27	2	26	66	0.46	0.16	0.54	0.84	A	1.0787014	0.10397878	Ulcerative colitis	Immune diseases and disorders
rs1260326	T	C	17	48	29	3	21	70	0.44	0.14	0.56	0.86	T	0.074	0.103941174	Urate levels	General health
rs4767631	G	A	28	46	20	3	37	54	0.54	0.23	0.46	0.77	A	0.12	0.103925959	Biochemical measures	General health
rs12961799	T	C	35	43	16	73	20	1	0.60	0.88	0.40	0.12	C	0.017	0.103794849	Body mass index	Obesity
rs10030601	T	C	60	30	4	22	48	24	0.80	0.49	0.20	0.51	C	1.58	0.103737511	Epilepsy generalized	Brain health and disorders
rs4693646	A	G	24	44	26	60	30	4	0.49	0.80	0.51	0.20	A	0.03	0.103737511	Obesity-related traits	Obesity
rs700651	G	A	12	42	40	1	14	79	0.35	0.09	0.65	0.91	G	1.24	0.103700017	Intracranial aneurysm	Misc
rs11888559	T	C	2	12	80	12	42	40	0.09	0.35	0.91	0.65	T	1.05	0.103700017	Height	General health
rs7700895	T	A	49	38	7	15	46	33	0.72	0.40	0.28	0.60	T	0.1776	0.103543488	IgG glycosylation	Immune diseases and disorders
rs1038304	A	G	34	44	16	10	32	52	0.60	0.28	0.40	0.72	G	0.1	0.103543488	Bone mineral density spine	General health
rs8066384	T	C	13	46	35	2	16	76	0.38	0.11	0.62	0.89	C	1.0526316	0.103490508	Schizophrenia	Brain health and disorders
rs2836823	C	T	40	39	15	77	16	1	0.63	0.90	0.37	0.10	T	1.46	0.103448276	Nicotine dependence	General health
rs6855629	G	A	40	39	15	76	18	0	0.63	0.90	0.37	0.10	G	1.14	0.103448276	Height	General health
rs6915443	C	T	84	10	0	46	40	8	0.95	0.70	0.05	0.30	T	1	0.10342131	Sexual dimorphism in anthropometric traits	Misc
rs3943077	A	G	22	41	31	56	32	6	0.45	0.77	0.55	0.23	A	0.07	0.103407302	Adiponectin levels	Obesity
rs7923837	G	A	34	41	19	74	15	5	0.58	0.87	0.42	0.13	G	1.1	0.103082579	Multiple sclerosis	Brain health and disorders
rs1476442	A	C	69	25	0	29	51	14	0.87	0.58	0.13	0.42	C	0.02	0.103082579	Obesity-related traits	Obesity
rs7765828	C	G	25	47	22	4	31	59	0.52	0.21	0.48	0.79	G	0.55	0.103063725	QT interval	Heart health and disorders
rs1539893	G	A	6	27	61	21	55	18	0.21	0.52	0.79	0.48	G	0.06	0.103063725	Liver enzyme levels alanine transaminase	General health
rs1962636	A	C	19	49	26	1	29	64	0.46	0.16	0.54	0.84	C	1.0526316	0.103008803	Schizophrenia	Brain health and disorders
rs790116	G	C	44	45	5	0	73	21	0.71	0.39	0.29	0.61	G	1	0.102798401	Response to angiotensin II receptor blocker therapy opposite direction w_ diuretic therapy	Drug response
rs3184504	T	C	8	38	48	2	5	87	0.29	0.05	0.71	0.95	C	1.09	0.102692834	Colorectal cancer	Cancer
rs894177	G	A	8	38	48	0	9	85	0.29	0.05	0.71	0.95	G	0.28	0.102692834	Non-alcoholic fatty liver disease histology other	Obesity
rs653178	C	T	8	38	48	2	5	87	0.29	0.05	0.71	0.95	C	0.0147	0.102692834	Thyroid peroxidase antibody levels	Immune diseases and disorders
rs17465637	A	C	14	44	36	46	40	8	0.38	0.70	0.62	0.30	C	1.14	0.102599179	Myocardial infarction early onset	Heart health and disorders
rs67180937	T	G	14	44	36	46	40	8	0.38	0.70	0.62	0.30	G	1.08	0.102599179	Coronary artery disease	Heart health and disorders
rs12472911	C	T	6	34	54	28	49	17	0.24	0.56	0.76	0.44	C	2.5	0.102457689	Menarche age at onset	Reproductive health
rs2076054	C	T	4	38	52	31	43	20	0.24	0.56	0.76	0.44	C	1.12	0.102457689	Migraine with aura	Brain health and disorders
rs8014204	G	A	12	52	30	4	15	75	0.40	0.12	0.60	0.88	A	0.065	0.102432265	Caffeine consumption	General health
rs13708	G	A	13	45	36	47	37	10	0.38	0.70	0.62	0.30	G	1.55	0.102424036	Psoriasis	Immune diseases and disorders
rs10782001	G	A	13	45	36	47	37	10	0.38	0.70	0.62	0.30	G	1.16	0.102424036	Psoriasis	Immune diseases and disorders
rs4714699	T	C	21	48	25	57	34	3	0.48	0.79	0.52	0.21	C	0.0241	0.102423578	Waist-to-hip ratio adjusted for body mass index	Obesity
rs16930685	T	C	79	15	0	41	42	11	0.92	0.66	0.08	0.34	C	0.1	0.10233133	Cutaneous nevi	Cancer
rs35320439	T	C	37	44	13	5	48	41	0.63	0.31	0.37	0.69	G	1.0876893	0.102272727	Crohn's disease	Digestive system and its disorders
rs9922678	G	A	45	40	9	13	44	37	0.69	0.37	0.31	0.63	A	1.07	0.102272727	Schizophrenia	Brain health and disorders
rs2280018	A	C	13	44	37	44	42	8	0.37	0.69	0.63	0.31	A	0.38	0.102272727	Plasma omega-6 polyunsaturated fatty acid levels linoleic acid	General health
rs9356744	T	C	42	45	7	15	39	40	0.69	0.37	0.31	0.63	T	3.39	0.102145046	Body mass index	Obesity
rs12456874	A	G	57	32	5	91	3	0	0.78	0.98	0.22	0.02	G	1.38	0.102114804	Pancreatic cancer	Cancer
rs4634985	T	C	11	46	37	43	42	9	0.36	0.68	0.64	0.32	A	1.54	0.102040816	Bronchopulmonary dysplasia	Pulmonology
rs12053903	T	C	31	44	19	8	31	55	0.56	0.25	0.44	0.75	T	6.59	0.102025265	Electrocardiographic traits	Heart health and disorders
rs1004689	T	G	31	44	19	6	35	53	0.56	0.25	0.44	0.75	G	1	0.102025265	DNA methylation variation	Misc
rs2820446	C	G	37	41	16	75	17	2	0.61	0.89	0.39	0.11	C	1.05	0.102006941	Type 2 diabetes	Diabetes
rs56232506	G	A	25	45	24	62	28	4	0.51	0.81	0.49	0.19	A	1.07	0.1019678	Prostate cancer	Cancer
rs506338	T	C	22	51	21	62	28	4	0.51	0.81	0.49	0.19	C	0.229	0.1019678	Urate levels	General health
rs7147705	T	C	10	41	43	37	47	10	0.32	0.64	0.68	0.36	T	1	0.101959896	Amyotrophic lateral sclerosis age of onset	Brain health and disorders
rs11677592	C	T	41	39	14	78	15	1	0.64	0.91	0.36	0.09	T	0.13	0.101924331	Glomerular filtration rate in chronic kidney disease	General health
rs838886	T	G	8	50	36	40	46	8	0.35	0.67	0.65	0.33	T	0.058	0.101902174	HDL cholesterol	General health
rs11825064	G	C	70	22	2	30	48	16	0.86	0.57	0.14	0.43	C	0.64	0.101886792	Seasonality	Mental aptitude and behavioural traits
rs10772939	T	C	33	42	19	71	20	3	0.57	0.86	0.43	0.14	T	0.112	0.101886792	Economic and political preferences	Mental aptitude and behavioural traits
rs174534	A	G	32	44	18	74	14	6	0.57	0.86	0.43	0.14	A	0.0029	0.101886792	Trans fatty acid levels	General health
rs10802346	G	C	76	17	1	38	42	14	0.90	0.63	0.10	0.37	C	0.076	0.10182829	Fractional exhaled nitric oxide childhood	Pulmonology
rs2036225	C	T	18	45	31	51	38	5	0.43	0.74	0.57	0.26	T	1	0.101620201	Amyotrophic lateral sclerosis age of onset	Brain health and disorders
rs544434	T	C	88	6	0	49	42	3	0.97	0.74	0.03	0.26	C	1	0.101449275	Response to methylphenidate treatment in attention-deficit_hyperactivity disorder blood pressure	Drug response
rs12281359	G	C	89	5	0	51	40	3	0.97	0.76	0.03	0.24	C	0.247	0.101417798	Urate levels in obese individuals	Obesity
rs174549	G	A	35	41	18	75	14	5	0.59	0.87	0.41	0.13	A	1	0.101134113	Comprehensive strength and appendicular lean mass	General health
rs174555	T	C	35	41	18	75	14	5	0.59	0.87	0.41	0.13	T	0.39	0.101134113	Plasma omega-6 polyunsaturated fatty acid levels dihomo-gamma-linolenic acid	General health
rs174556	C	T	35	41	18	75	14	5	0.59	0.87	0.41	0.13	T	0.036	0.101134113	Blood metabolite levels	Heart health and disorders
rs10278040	G	A	81	12	1	45	36	13	0.93	0.67	0.07	0.33	A	0.361	0.101052632	Blood metabolite levels	Heart health and disorders
rs801112	T	C	85	7	2	42	47	5	0.94	0.70	0.06	0.30	C	1.65	0.101031322	Endometriosis	General health
rs9389316	C	A	83	11	0	48	35	11	0.94	0.70	0.06	0.30	A	1	0.101031322	Immune reponse to smallpox secreted IL-2	Immune diseases and disorders
rs10205487	A	G	31	47	16	5	40	49	0.58	0.27	0.42	0.73	A	0.38	0.100889778	Carotid plaque burden smoking interaction	Heart health and disorders
rs10076782	G	A	35	39	20	8	34	52	0.58	0.27	0.42	0.73	A	0.007	0.100889778	Mean platelet volume	Heart health and disorders
rs11071559	C	T	66	26	2	29	45	20	0.84	0.55	0.16	0.45	C	1.18	0.100782942	Asthma	Immune diseases and disorders
rs4704397	G	A	21	43	30	4	22	68	0.45	0.16	0.55	0.84	A	0.25	0.100782942	Thyroid stimulating hormone	General health
rs1382879	T	C	21	43	30	4	22	68	0.45	0.16	0.55	0.84	G	0.09	0.100782942	Serum thyroid-stimulating hormone levels	General health
rs10188217	T	C	29	43	22	3	37	54	0.54	0.23	0.46	0.77	C	1	0.100694444	Crohn's disease and celiac disease	Digestive system and its disorders
rs898549	C	T	40	34	20	73	20	1	0.61	0.88	0.39	0.12	A	0.06	0.100595238	Obesity-related traits	Obesity
rs7134221	C	A	26	41	27	58	34	2	0.49	0.80	0.51	0.20	C	0.038	0.100529101	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs1335688	T	C	43	37	14	78	16	0	0.65	0.91	0.35	0.09	C	0.14	0.100481272	Plasma amyloid beta peptide concentrations ABx-40	Brain health and disorders
rs4936894	G	A	35	53	6	79	14	1	0.65	0.91	0.35	0.09	A	0.09	0.100481272	Aging time to death	Aging
rs11021504	T	A	37	46	11	76	18	0	0.64	0.90	0.36	0.10	A	0.083	0.100240577	Height	General health
rs17172185	T	C	84	10	0	48	37	9	0.95	0.71	0.05	0.29	T	1.4706	0.100173139	Esophageal adenocarcinoma	Cancer
rs983392	A	G	44	45	5	85	8	1	0.71	0.95	0.29	0.05	A	1.1111	0.100173139	Alzheimer's disease late onset	Brain health and disorders
rs4664304	A	G	44	45	5	84	10	0	0.71	0.95	0.29	0.05	A	1.0610188	0.100173139	Crohn's disease	Digestive system and its disorders
rs4675374	T	C	4	45	45	31	50	13	0.28	0.60	0.72	0.40	A	1.14	0.099985638	Celiac disease	Immune diseases and disorders
rs3774937	T	C	31	48	15	71	21	2	0.59	0.87	0.41	0.13	G	1.1043711	0.099896867	Ulcerative colitis	Immune diseases and disorders
rs2929282	A	T	82	11	1	44	40	10	0.93	0.68	0.07	0.32	T	5.13	0.099868891	Triglycerides	General health
rs4788985	A	G	26	40	28	58	33	3	0.49	0.79	0.51	0.21	G	8.347	0.099861687	Illicit drug use	General health
rs11650106	C	T	32	38	24	66	25	3	0.54	0.84	0.46	0.16	C	0.0092	0.0998251	Lipoprotein-associated phospholipase A2 activity and mass	General health
rs823156	G	A	3	39	52	27	49	18	0.24	0.55	0.76	0.45	A	1.21	0.099691797	Parkinson's disease	Brain health and disorders
rs2847281	A	G	29	48	17	69	22	3	0.56	0.85	0.44	0.15	A	0.031	0.099658237	C-reactive protein levels	Immune diseases and disorders
rs451390	G	C	86	7	1	45	45	4	0.95	0.72	0.05	0.28	G	4.5455	0.099445243	Tuberculosis	Immune diseases and disorders
rs9642880	G	T	33	49	12	9	38	47	0.61	0.30	0.39	0.70	T	1.22	0.099301098	Urinary bladder cancer	Cancer
rs4649203	G	A	9	38	47	31	53	10	0.30	0.61	0.70	0.39	A	1.13	0.099301098	Psoriasis	Immune diseases and disorders
rs6867265	A	G	72	21	1	35	43	16	0.88	0.60	0.12	0.40	A	1.11	0.099251211	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs131408	T	C	27	50	17	8	30	56	0.55	0.24	0.45	0.76	C	1.211	0.099233038	Peripheral artery disease	Heart health and disorders
rs1167827	A	G	22	60	12	7	32	55	0.55	0.24	0.45	0.76	G	0.023	0.099233038	Body mass index	Obesity
rs11067228	A	G	18	48	28	53	36	5	0.45	0.76	0.55	0.24	A	8.3	0.099233038	Serum prostate-specific antigen levels	General health
rs12431204	T	A	18	48	28	53	36	5	0.45	0.76	0.55	0.24	A	1.05	0.099233038	Schizophrenia	Brain health and disorders
rs854572	C	G	22	40	32	52	38	4	0.45	0.76	0.55	0.24	C	1	0.099233038	Paraoxonase activity	Diabetes
rs17014760	G	A	56	30	8	22	40	32	0.76	0.45	0.24	0.55	A	0.3262	0.099233038	Cerebral amyloid angiopathy	Brain health and disorders
rs956237	G	A	18	55	21	58	32	4	0.48	0.79	0.52	0.21	A	1.18	0.099227316	Systemic lupus erythematosus	Immune diseases and disorders
rs4917014	T	G	19	53	22	60	28	6	0.48	0.79	0.52	0.21	G	0.022	0.099227316	HDL cholesterol	General health
rs3856261	G	A	44	37	13	79	15	0	0.66	0.92	0.34	0.08	G	1.0526316	0.099122354	Schizophrenia	Brain health and disorders
rs12940887	C	T	42	41	11	79	15	0	0.66	0.92	0.34	0.08	T	0.252	0.099122354	Blood pressure	Heart health and disorders
rs164368	C	T	14	44	36	45	41	8	0.38	0.70	0.62	0.30	T	1.12	0.099120134	Yu-Zhi constitution type in type 2 diabetes	Diabetes
rs10875943	T	C	48	35	11	16	40	38	0.70	0.38	0.30	0.62	C	1.12	0.099120134	Prostate cancer	Cancer
rs6064045	C	T	15	42	37	46	39	9	0.38	0.70	0.62	0.30	C	0.137	0.099120134	IgG glycosylation	Immune diseases and disorders
rs2373011	C	G	36	44	14	9	39	46	0.62	0.30	0.38	0.70	C	0.03	0.099120134	Body mass index	Obesity
rs10862688	A	G	49	32	13	14	43	37	0.69	0.38	0.31	0.62	G	0.008	0.098962331	Vertical cup-disc ratio	Misc
rs7651039	T	C	22	43	29	3	26	65	0.46	0.17	0.54	0.83	C	1.06	0.09891116	Coronary heart disease	Heart health and disorders
rs7732320	C	T	66	24	4	31	39	24	0.83	0.54	0.17	0.46	T	1.64	0.09891116	Glioblastoma	Cancer
rs17266097	C	T	48	41	5	86	8	0	0.73	0.96	0.27	0.04	T	0.04	0.098861145	Menarche age at onset	Reproductive health
rs2586731	G	T	0	8	86	6	39	49	0.04	0.27	0.96	0.73	C	6.67	0.098861145	Diisocyanate-induced asthma	Pulmonology
rs11229030	C	T	6	47	41	40	38	16	0.31	0.63	0.69	0.37	C	1.15	0.098827471	Crohn's disease	Digestive system and its disorders
rs1168013	C	G	11	37	46	30	58	6	0.31	0.63	0.69	0.37	G	0.04	0.098827471	Triglycerides	General health
rs11970475	G	A	75	17	2	31	54	9	0.89	0.62	0.11	0.38	A	0.07	0.098825943	Height	General health
rs1105881	C	G	34	48	12	74	19	1	0.62	0.89	0.38	0.11	C	0.02	0.098825943	Educational attainment	Mental aptitude and behavioural traits
rs753955	A	G	14	55	25	50	41	3	0.44	0.75	0.56	0.25	G	1.18	0.098801692	Lung cancer	Cancer
rs9860340	A	G	50	41	3	19	45	30	0.75	0.44	0.25	0.56	A	0.122	0.098801692	Electroencephalographic traits in alcoholism	Heart health and disorders
rs11857176	T	C	31	43	20	5	37	52	0.56	0.25	0.44	0.75	A	1.8	0.098801692	Adverse response to chemotherapy neutropenia_leucopenia doxorubicin	Drug response
rs922106	C	A	22	52	20	62	28	4	0.51	0.81	0.49	0.19	T	1.679	0.098790323	Adverse response to chemotherapy neutropenia_leucopenia paclitaxel	Drug response
rs1552244	A	G	61	30	3	27	42	25	0.81	0.51	0.19	0.49	A	1.32	0.098790323	Alzheimer's disease	Brain health and disorders
rs10777288	G	A	5	26	63	22	48	24	0.19	0.49	0.81	0.51	A	1	0.098790323	Pulmonary function interaction	Pulmonology
rs285575	G	A	25	42	27	3	30	61	0.49	0.19	0.51	0.81	A	0.019	0.098790323	Body mass index	Obesity
rs62033400	A	G	47	36	11	83	10	1	0.69	0.94	0.31	0.06	G	0.08	0.098786181	Body mass index	Obesity
rs11649653	C	G	30	49	15	73	16	5	0.58	0.86	0.42	0.14	G	2.13	0.098717273	Triglycerides	General health
rs7194676	C	T	13	43	38	40	48	6	0.37	0.68	0.63	0.32	C	1.0638298	0.098715367	Schizophrenia	Brain health and disorders
rs2027760	G	A	77	15	2	35	49	10	0.90	0.63	0.10	0.37	A	1	0.098642677	Pulmonary function interaction	Pulmonology
rs10842707	C	T	38	43	13	77	15	2	0.63	0.90	0.37	0.10	T	0.0413	0.098642677	Waist-to-hip ratio adjusted for body mass index	Obesity
rs35123781	A	G	41	45	8	11	46	37	0.68	0.36	0.32	0.64	G	1.0526316	0.098625868	Schizophrenia	Brain health and disorders
rs4076555	T	C	45	37	12	14	40	40	0.68	0.36	0.32	0.64	C	0.1591	0.098625868	IgG glycosylation	Immune diseases and disorders
rs1746048	C	T	58	31	5	16	58	20	0.78	0.48	0.22	0.52	C	1.17	0.098624898	Myocardial infarction early onset	Heart health and disorders
rs17024218	T	C	87	7	0	51	37	6	0.96	0.74	0.04	0.26	G	0.03	0.0984375	Obesity-related traits	Obesity
rs12099085	C	T	90	4	0	55	35	4	0.98	0.77	0.02	0.23	A	1	0.098363836	Response to methylphenidate treatment in attention-deficit_hyperactivity disorder blood pressure	Drug response
rs8016620	C	T	0	6	88	5	37	52	0.03	0.25	0.97	0.75	G	0.03	0.098194988	Obesity-related traits	Obesity
rs560887	T	C	6	33	55	1	3	90	0.24	0.03	0.76	0.97	T	1.29	0.098159509	Fasting plasma glucose	General health
rs3842770	G	A	89	5	0	54	35	5	0.97	0.76	0.03	0.24	A	1.14	0.098159509	Type 2 diabetes	Diabetes
rs12622686	T	C	23	49	22	63	25	6	0.51	0.80	0.49	0.20	G	1	0.098061288	Diisocyanate-induced asthma	Pulmonology
rs2741200	T	C	56	34	4	25	39	30	0.78	0.47	0.22	0.53	T	0.32	0.098053418	Temperament	Mental aptitude and behavioural traits
rs2034650	G	A	16	49	29	51	37	6	0.43	0.74	0.57	0.26	A	1.3	0.098018648	Interstitial lung disease	Pulmonology
rs981782	A	C	32	48	14	71	22	1	0.60	0.87	0.40	0.13	C	1.04	0.097971014	Breast cancer	Cancer
rs6546043	C	A	9	43	42	0	14	80	0.32	0.07	0.68	0.93	A	2.079	0.097851606	Clozapine-induced agranulocytosis	General health
rs10058074	G	A	44	39	11	81	12	1	0.68	0.93	0.32	0.07	A	1.15	0.097851606	Height	General health
rs7086888	A	G	83	11	0	41	50	3	0.94	0.70	0.06	0.30	G	1.87	0.097811911	Multiple myeloma IgH translocation	Cancer
rs1243180	T	A	46	40	8	83	11	0	0.70	0.94	0.30	0.06	A	1.1	0.097811911	Epithelial ovarian cancer	Cancer
rs8042988	A	G	50	38	6	13	54	27	0.73	0.43	0.27	0.57	A	0.006	0.097665776	Height	General health
rs9631085	G	A	66	26	2	21	62	11	0.84	0.55	0.16	0.45	A	1.13	0.09762957	Schizophrenia	Brain health and disorders
rs6943555	T	A	57	31	6	21	46	27	0.77	0.47	0.23	0.53	A	0.013	0.09751193	Alcohol consumption	General health
rs584438	C	A	39	37	18	75	16	3	0.61	0.88	0.39	0.12	C	1.18	0.097433976	Height	General health
rs117799466	G	C	37	41	16	72	22	0	0.61	0.88	0.39	0.12	C	1.06	0.097433976	Schizophrenia	Brain health and disorders
rs4750316	C	G	0	22	72	13	47	34	0.12	0.39	0.88	0.61	G	1.15	0.097433976	Rheumatoid arthritis	Immune diseases and disorders
rs4875857	T	C	59	32	3	24	46	24	0.80	0.50	0.20	0.50	C	0.1846	0.097367114	IgG glycosylation	Immune diseases and disorders
rs310008	C	G	63	24	7	20	54	20	0.80	0.50	0.20	0.50	G	0.1076	0.097367114	Menarche age at onset	Reproductive health
rs11599315	C	T	9	33	52	32	45	17	0.27	0.58	0.73	0.42	T	3.88	0.097337963	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs610604	G	T	14	51	29	49	39	6	0.42	0.73	0.58	0.27	G	1.19	0.097337963	Psoriasis	Immune diseases and disorders
rs206626	A	G	23	41	30	55	34	5	0.46	0.77	0.54	0.23	A	0.13	0.096999552	Metabolite levels Pyroglutamine	General health
rs17530068	T	C	49	36	9	85	8	1	0.71	0.95	0.29	0.05	G	1.05	0.096955128	Breast cancer	Cancer
rs1152591	A	G	18	41	35	3	19	72	0.41	0.13	0.59	0.87	A	1.13	0.096751109	Atrial fibrillation	Heart health and disorders
rs174538	G	A	34	43	17	75	13	6	0.59	0.87	0.41	0.13	A	0.08	0.096751109	Phospholipid levels plasma	General health
rs17271305	A	G	35	41	18	70	23	1	0.59	0.87	0.41	0.13	G	0.06	0.096751109	Two-hour glucose challenge	Diabetes
rs10941710	A	T	36	39	19	70	23	1	0.59	0.87	0.41	0.13	A	0.032	0.096751109	Neuroticism	Brain health and disorders
rs35767	A	G	4	31	59	20	55	19	0.21	0.51	0.79	0.49	G	1	0.09670655	Fasting insulin-related traits	General health
rs6776003	G	A	20	55	19	7	25	62	0.51	0.21	0.49	0.79	A	0.138	0.09670655	Red blood cell traits	Immune diseases and disorders
rs2403254	C	T	24	55	15	65	27	2	0.55	0.84	0.45	0.16	T	0.041	0.09668435	Blood metabolite levels	Heart health and disorders
rs2857693	G	T	34	35	25	64	29	1	0.55	0.84	0.45	0.16	T	0.034	0.09668435	Height	General health
rs6705628	C	T	81	13	0	41	47	6	0.93	0.69	0.07	0.31	C	1.3333	0.096673977	Systemic lupus erythematosus	Immune diseases and disorders
rs6789327	G	A	92	2	0	58	34	2	0.99	0.80	0.01	0.20	A	3.7647	0.096428571	Axial length	Misc
rs16871289	C	T	92	2	0	62	26	6	0.99	0.80	0.01	0.20	A	0.03	0.096428571	Obesity-related traits	Obesity
rs7578361	G	T	7	41	46	36	41	17	0.29	0.60	0.71	0.40	C	1.4	0.096268315	Acute lymphoblastic leukemia childhood	Cancer
rs12058524	C	T	94	0	0	64	27	3	1.00	0.82	0.00	0.18	T	0.223	0.096209913	Uric acid levels	General health
rs7589998	A	G	94	0	0	64	27	3	1.00	0.82	0.00	0.18	G	0.03	0.096209913	Obesity-related traits	Obesity
rs6733160	T	C	16	42	36	2	19	73	0.39	0.12	0.61	0.88	C	9.276	0.096109079	Allergic dermatitis nickel	Immune diseases and disorders
rs3903072	G	T	34	46	14	73	19	2	0.61	0.88	0.39	0.12	G	1.05	0.096109079	Breast cancer	Cancer
rs6554809	C	T	56	36	2	25	42	27	0.79	0.49	0.21	0.51	C	1.29	0.096078431	IgE grass sensitization	Immune diseases and disorders
rs10790382	T	C	48	36	10	14	46	34	0.70	0.39	0.30	0.61	T	0.16	0.096059395	Intraocular pressure	General health
rs1561927	C	T	7	32	55	31	41	22	0.24	0.55	0.76	0.45	C	1.06	0.096058895	Type 2 diabetes	Diabetes
rs10795668	G	A	44	38	12	82	9	3	0.67	0.92	0.33	0.08	G	1.15	0.095947531	Colorectal cancer	Cancer
rs1802295	C	T	39	48	7	81	11	2	0.67	0.92	0.33	0.08	A	1.08	0.095947531	Type 2 diabetes	Diabetes
rs857721	T	A	42	42	10	79	15	0	0.67	0.92	0.33	0.08	A	1	0.095947531	Other erythrocyte phenotypes	Immune diseases and disorders
rs8123881	A	G	79	15	0	42	42	10	0.92	0.67	0.08	0.33	G	0.023	0.095947531	Body mass index	Obesity
rs6669543	T	C	8	41	45	31	53	10	0.30	0.61	0.70	0.39	T	1.46	0.095873233	QT interval	Heart health and disorders
rs2785197	A	G	15	43	36	45	41	8	0.39	0.70	0.61	0.30	C	1.2346	0.095873233	Systemic lupus erythematosus	Immune diseases and disorders
rs3763048	C	T	43	45	6	15	43	36	0.70	0.39	0.30	0.61	C	0.1425	0.095873233	IgG glycosylation	Immune diseases and disorders
rs2247341	G	A	26	50	18	63	30	1	0.54	0.83	0.46	0.17	A	0.025	0.09578242	Height	General health
rs6868223	G	A	14	44	36	43	44	7	0.38	0.69	0.62	0.31	A	1.58	0.095709571	Mortality in heart failure	Heart health and disorders
rs35700460	A	G	14	44	36	44	42	8	0.38	0.69	0.62	0.31	G	1.09	0.095709571	Myocardial infarction	Heart health and disorders
rs3729639	C	T	74	19	1	33	51	10	0.89	0.62	0.11	0.38	T	0.09	0.095682792	HDL cholesterol	General health
rs3757247	C	T	27	43	24	59	34	1	0.52	0.81	0.48	0.19	A	1.13	0.095658223	Type 1 diabetes	Diabetes
rs28498503	C	T	61	30	3	21	55	18	0.81	0.52	0.19	0.48	T	1.03	0.095658223	Attention function in attention deficit hyperactive disorder	Brain health and disorders
rs2125000	C	T	49	40	5	86	8	0	0.73	0.96	0.27	0.04	T	1.425	0.095640859	Major depressive disorder	Brain health and disorders
rs857160	C	T	4	32	58	0	3	91	0.21	0.02	0.79	0.98	T	100.41	0.095607235	Hippocampal volume	Brain health and disorders
rs7658486	C	T	91	3	0	60	28	6	0.98	0.79	0.02	0.21	A	1	0.095607235	Immune reponse to smallpox secreted IL-12p40	Immune diseases and disorders
rs58605417	G	C	0	12	82	3	51	40	0.06	0.30	0.94	0.70	G	1.0638298	0.095595525	Schizophrenia	Brain health and disorders
rs7184597	T	C	19	40	35	1	24	69	0.41	0.14	0.59	0.86	T	1.1	0.095588235	Obesity	Obesity
rs2048327	T	C	29	52	13	71	20	3	0.59	0.86	0.41	0.14	C	1.07	0.095588235	Coronary artery disease	Heart health and disorders
rs56693116	G	T	71	20	3	29	52	13	0.86	0.59	0.14	0.41	T	0.24	0.095588235	Intraocular pressure	General health
rs108499	C	T	34	42	18	74	14	6	0.59	0.86	0.41	0.14	T	0.0029	0.095588235	Trans fatty acid levels	General health
rs7578465	T	C	45	33	16	77	17	0	0.65	0.91	0.35	0.09	T	0.023	0.095569935	Body mass index	Obesity
rs7747216	C	T	12	47	35	44	41	9	0.38	0.69	0.62	0.31	T	0.044	0.095568182	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs8073783	C	T	30	46	18	68	23	3	0.56	0.85	0.44	0.15	C	1.76	0.095495495	Conduct disorder interaction	Brain health and disorders
rs597800	G	C	69	21	4	23	60	11	0.85	0.56	0.15	0.44	C	0.148	0.095495495	Estradiol levels	General health
rs1425053	A	T	31	44	19	68	23	3	0.56	0.85	0.44	0.15	A	0.037	0.095495495	Osteoprotegerin levels	Immune diseases and disorders
rs6830724	T	C	75	19	0	37	46	11	0.90	0.64	0.10	0.36	T	0.0067	0.095493776	Trans fatty acid levels	General health
rs7224610	C	A	11	46	37	0	19	75	0.36	0.10	0.64	0.90	A	0.042	0.095493776	Urate levels	General health
rs13137008	G	T	18	55	21	59	29	6	0.48	0.78	0.52	0.22	T	1.764	0.095481671	PR segment	Heart health and disorders
rs6870983	C	T	56	35	3	25	41	28	0.78	0.48	0.22	0.52	C	0.018	0.095481671	Body mass index	Obesity
rs2365389	C	T	23	51	20	5	31	58	0.52	0.22	0.48	0.78	C	0.02	0.095481671	Body mass index	Obesity
rs12499371	G	A	12	46	36	46	36	12	0.37	0.68	0.63	0.32	A	703.9	0.095448871	Superior frontal gyrus grey matter volume	Misc
rs3913363	C	T	42	36	16	13	36	45	0.64	0.33	0.36	0.67	T	1.3	0.095275858	Response to angiotensin II receptor blocker therapy	General health
rs2165738	C	G	10	48	36	46	34	14	0.36	0.67	0.64	0.33	C	1.07	0.095275858	Type 1 diabetes	Diabetes
rs3136202	G	A	42	42	10	8	52	34	0.67	0.36	0.33	0.64	A	0.07	0.095275858	Conduct disorder symptom count	Brain health and disorders
rs3853750	T	C	54	32	8	18	47	29	0.74	0.44	0.26	0.56	C	1.1533	0.095225534	Asthma and hay fever	Immune diseases and disorders
rs11922372	T	C	43	39	12	14	39	41	0.66	0.36	0.34	0.64	C	1.14	0.09522192	Psoriasis	Immune diseases and disorders
rs9975691	T	G	44	37	13	9	49	36	0.66	0.36	0.34	0.64	G	0.2307	0.09522192	Neurofibrillary tangles	Brain health and disorders
rs12419342	C	T	14	39	41	38	49	7	0.36	0.66	0.64	0.34	C	0.153	0.09522192	Intraocular pressure	General health
rs6723108	G	T	9	30	55	0	7	87	0.26	0.04	0.74	0.96	T	1.27	0.09521382	Type 2 diabetes	Diabetes
rs17020489	C	A	87	7	0	52	36	6	0.96	0.74	0.04	0.26	A	1	0.09521382	Hemoglobin A2 levels in sickle cell anemia	Heart health and disorders
rs3812111	T	A	42	38	14	14	36	44	0.65	0.34	0.35	0.66	T	1.1	0.095189587	Age-related macular degeneration	Aging
rs11653144	C	T	37	48	9	11	42	41	0.65	0.34	0.35	0.66	T	0.13	0.095189587	Mean platelet volume	Heart health and disorders
rs3731714	C	T	57	32	5	90	4	0	0.78	0.98	0.22	0.02	T	0.0022	0.095125165	Trans fatty acid levels	General health
rs57126985	G	C	89	4	1	49	44	1	0.97	0.76	0.03	0.24	C	1.754386	0.094966762	Alcohol dependence	General health
rs7350721	A	G	54	34	6	88	6	0	0.76	0.97	0.24	0.03	C	0.41	0.094966762	Body mass index interaction	Obesity
rs2770228	G	A	0	6	88	5	36	53	0.03	0.24	0.97	0.76	A	0.08	0.094966762	Metabolite levels Dihydroxy docosatrienoic acid	General health
rs1906953	C	T	60	31	3	22	52	20	0.80	0.51	0.20	0.49	A	1.57	0.094937702	Osteosarcoma	Cancer
rs8017161	G	A	24	48	22	58	35	1	0.51	0.80	0.49	0.20	A	1.22	0.094937702	Primary biliary cirrhosis	Immune diseases and disorders
rs1539808	C	T	89	5	0	52	40	2	0.97	0.77	0.03	0.23	T	44.44	0.094926044	Sleep time	General health
rs11877305	G	A	89	5	0	58	28	8	0.97	0.77	0.03	0.23	A	34.08	0.094926044	Diisocyanate-induced asthma	Pulmonology
rs17017235	T	C	89	5	0	56	32	6	0.97	0.77	0.03	0.23	T	4.473	0.094926044	Very long-chain saturated fatty acid levels fatty acid 20:0	General health
rs12122440	A	C	57	30	7	89	5	0	0.77	0.97	0.23	0.03	C	0.08	0.094926044	Pubertal anthropometrics	Appearance
rs1395479	C	A	56	32	6	89	5	0	0.77	0.97	0.23	0.03	A	0.043	0.094926044	Serum selenium levels	General health
rs1421084	A	G	84	9	1	48	37	9	0.94	0.71	0.06	0.29	A	1	0.094623656	Subcutaneous adipose tissue	Obesity
rs9783698	G	A	67	24	3	30	45	19	0.84	0.56	0.16	0.44	A	0.04	0.094518658	Obesity-related traits	Obesity
rs1864774	C	T	32	43	19	3	44	47	0.57	0.27	0.43	0.73	C	1.0526316	0.094494372	Schizophrenia	Brain health and disorders
rs9923231	C	T	33	43	18	72	17	5	0.58	0.86	0.42	0.14	T	0.97	0.094479385	Warfarin maintenance dose	General health
rs694739	A	G	34	48	12	75	16	3	0.62	0.88	0.38	0.12	A	1.1	0.094311151	Crohn's disease	Digestive system and its disorders
rs1933182	A	C	8	22	64	23	47	24	0.20	0.49	0.80	0.51	A	0.01	0.094251441	Chronic kidney disease	Immune diseases and disorders
rs11580078	C	G	24	47	23	58	34	2	0.51	0.80	0.49	0.20	G	1	0.094251441	Pediatric autoimmune diseases	Immune diseases and disorders
rs7831697	T	G	50	37	7	16	48	30	0.73	0.43	0.27	0.57	G	1	0.094165725	Pediatric autoimmune diseases	Immune diseases and disorders
rs4873403	A	C	80	12	2	45	35	14	0.91	0.66	0.09	0.34	C	1048	0.094148233	Superior frontal gyrus grey matter volume	Misc
rs4481233	C	T	46	33	15	79	14	1	0.66	0.91	0.34	0.09	T	0.074	0.094148233	Metabolic traits	Misc
rs6120141	T	C	78	14	2	39	44	11	0.90	0.65	0.10	0.35	T	5.0772	0.093933464	Smooth-surface caries	Appearance
rs12150665	T	C	39	44	11	77	16	1	0.65	0.90	0.35	0.10	T	0.016	0.093933464	Body mass index	Obesity
rs1961102	T	C	15	36	43	3	12	79	0.35	0.10	0.65	0.90	T	0.57	0.093933464	QT interval	Heart health and disorders
rs3077	A	G	44	48	2	18	43	33	0.72	0.42	0.28	0.58	C	1.82	0.093861043	Hepatitis B viral clearance	Immune diseases and disorders
rs6141600	T	C	50	36	8	18	43	33	0.72	0.42	0.28	0.58	C	1.21	0.093861043	Height	General health
rs2270968	T	G	15	49	30	52	32	10	0.42	0.72	0.58	0.28	T	0.031	0.093861043	Blood metabolite levels	Heart health and disorders
rs640090	G	C	0	10	84	4	45	45	0.05	0.28	0.95	0.72	C	0.55	0.093767432	Preschool internalizing problems	Mental aptitude and behavioural traits
rs3785574	T	C	33	46	15	73	17	4	0.60	0.87	0.40	0.13	T	0.036	0.093645365	Height	General health
rs13233308	C	T	33	38	23	66	25	3	0.55	0.84	0.45	0.16	C	1.0526316	0.09358654	Schizophrenia	Brain health and disorders
rs10438978	T	C	2	27	65	17	50	27	0.16	0.45	0.84	0.55	C	0.095	0.09358654	HDL cholesterol	General health
rs13315591	T	C	81	13	0	43	44	7	0.93	0.69	0.07	0.31	C	1.29	0.093511891	Rheumatoid arthritis	Immune diseases and disorders
rs10866682	C	T	2	24	68	17	46	31	0.15	0.43	0.85	0.57	C	0.4356	0.09342178	Postprandial triglyceride response to high fat diet meal	General health
rs4434872	T	C	1	26	67	20	40	34	0.15	0.43	0.85	0.57	T	0.08	0.09342178	Conduct disorder symptom count	Brain health and disorders
rs9475752	C	T	67	26	1	30	48	16	0.85	0.57	0.15	0.43	C	0.04	0.09342178	Menarche age at onset	Reproductive health
rs9387478	C	A	17	55	22	4	27	63	0.47	0.19	0.53	0.81	C	1.18	0.093317972	Lung cancer	Cancer
rs11047543	G	A	64	23	7	92	2	0	0.80	0.99	0.20	0.01	A	2.09	0.093205509	PR interval	Heart health and disorders
rs13107740	C	G	63	25	6	93	0	1	0.80	0.99	0.20	0.01	G	1.51	0.093205509	Response to angiotensin II receptor blocker therapy	General health
rs11065987	A	G	51	35	8	87	5	2	0.73	0.95	0.27	0.05	A	0.06	0.093037975	Hemoglobin	Heart health and disorders
rs8179646	C	T	21	51	22	60	28	6	0.49	0.79	0.51	0.21	T	1.17	0.092976794	Ulcerative colitis	Immune diseases and disorders
rs4533267	A	G	5	36	53	27	48	19	0.24	0.54	0.76	0.46	A	5.6	0.09293504	Height	General health
rs1881797	C	T	2	42	50	19	64	11	0.24	0.54	0.76	0.46	C	1.52	0.09293504	Acute lymphoblastic leukemia childhood	Cancer
rs16841832	G	A	47	33	14	79	15	0	0.68	0.92	0.32	0.08	G	2	0.092807018	Bipolar disorder and eating disorder	Brain health and disorders
rs1251350	A	C	43	41	10	81	11	2	0.68	0.92	0.32	0.08	C	1.0526316	0.092807018	Schizophrenia	Brain health and disorders
rs3026968	C	T	47	33	14	79	15	0	0.68	0.92	0.32	0.08	T	1	0.092807018	Inflammatory biomarkers	Immune diseases and disorders
rs7947981	A	G	79	15	0	39	49	6	0.92	0.68	0.08	0.32	G	1	0.092807018	Electrocardiographic traits	Heart health and disorders
rs9295536	C	A	19	47	28	2	28	64	0.45	0.17	0.55	0.83	A	1.357	0.092697093	Neuroblastoma	Cancer
rs4150581	A	G	23	57	14	65	26	3	0.55	0.83	0.45	0.17	A	0.043	0.092697093	Blood metabolite ratios	Heart health and disorders
rs835154	G	A	20	45	29	3	26	65	0.45	0.17	0.55	0.83	A	0.012	0.092697093	Blood metabolite levels	Heart health and disorders
rs7604827	C	T	1	19	74	7	56	31	0.11	0.37	0.89	0.63	C	6.54	0.092577598	PR interval	Heart health and disorders
rs626657	C	A	62	28	4	25	48	21	0.81	0.52	0.19	0.48	C	0.2321	0.092571429	IgG glycosylation	Immune diseases and disorders
rs2071518	C	T	52	37	5	18	49	27	0.75	0.45	0.25	0.55	T	0.312	0.092507375	Blood pressure	Heart health and disorders
rs9366816	T	C	30	51	13	70	22	2	0.59	0.86	0.41	0.14	C	1.43	0.092499733	Chronic hepatitis B infection	Immune diseases and disorders
rs1144403	A	T	31	49	14	69	24	1	0.59	0.86	0.41	0.14	A	1.05	0.092499733	Schizophrenia	Brain health and disorders
rs11645002	G	A	69	24	1	32	47	15	0.86	0.59	0.14	0.41	A	0.1312	0.092499733	Urinary metabolites	General health
rs16858164	A	G	87	6	1	53	33	8	0.96	0.74	0.04	0.26	G	0.253	0.092448991	Urate levels in obese individuals	Obesity
rs5029939	C	G	77	17	0	42	40	12	0.91	0.66	0.09	0.34	G	1.67	0.092446118	Sjogren's syndrome	Immune diseases and disorders
rs2230926	T	G	77	17	0	42	40	12	0.91	0.66	0.09	0.34	C	1.31	0.092446118	Rheumatoid arthritis	Immune diseases and disorders
rs1756650	C	T	2	13	79	10	44	40	0.09	0.34	0.91	0.66	G	1.386	0.092446118	Adverse response to chemotherapy neutropenia_leucopenia docetaxel	Drug response
rs13072552	G	T	76	17	1	39	43	12	0.90	0.64	0.10	0.36	T	1.5	0.092381716	Serum ceruloplasmin levels	General health
rs2201862	T	C	10	47	37	0	19	75	0.36	0.10	0.64	0.90	C	1.22	0.092381716	Myeloproliferative neoplasms	Cancer
rs7138951	G	A	1	17	76	12	43	39	0.10	0.36	0.90	0.64	G	0.12	0.092381716	Plasma amyloid beta peptide concentrations ABx-42	Brain health and disorders
rs6584202	G	A	44	39	11	10	50	34	0.68	0.37	0.32	0.63	A	0.04	0.092136233	Obesity-related traits	Obesity
rs4376071	C	T	8	46	40	35	49	10	0.33	0.63	0.67	0.37	C	0.1605	0.092052699	IgG glycosylation	Immune diseases and disorders
rs2479808	C	T	87	7	0	53	35	6	0.96	0.75	0.04	0.25	A	34.08	0.092017483	Diisocyanate-induced asthma	Pulmonology
rs12900463	T	C	55	31	8	87	7	0	0.75	0.96	0.25	0.04	C	2.154	0.092017483	Adverse response to chemotherapy neutropenia_leucopenia gemcitabine	Drug response
rs11743851	T	C	52	37	5	87	7	0	0.75	0.96	0.25	0.04	G	1.1548939	0.092017483	Crohn's disease	Digestive system and its disorders
rs4462262	T	C	8	52	34	43	39	12	0.36	0.66	0.64	0.34	C	1	0.091990147	Diabetic retinopathy	Diabetes
rs12447690	C	T	14	39	41	43	38	13	0.36	0.66	0.64	0.34	G	0.16	0.091948493	Central corneal thickness	General health
rs2670321	A	C	42	40	12	13	41	40	0.66	0.36	0.34	0.64	C	0.16	0.091948493	RR interval heart rate	Heart health and disorders
rs10147992	A	G	41	40	13	11	43	40	0.65	0.35	0.35	0.65	G	0.061	0.09192768	White blood cell types	Immune diseases and disorders
rs6912405	A	G	43	36	15	11	43	40	0.65	0.35	0.35	0.65	G	0.02	0.09192768	Obesity-related traits	Obesity
rs1175550	A	G	62	27	5	26	45	23	0.80	0.52	0.20	0.48	A	0.198	0.091859879	Blood trace element Cu levels	Heart health and disorders
rs10428132	T	G	23	45	26	6	25	63	0.48	0.20	0.52	0.80	T	2.55	0.091859879	Brugada syndrome	Heart health and disorders
rs4377469	G	T	5	27	62	22	47	25	0.20	0.48	0.80	0.52	T	0.039	0.091859879	Body mass index	Obesity
rs2973155	T	C	25	36	33	4	25	65	0.46	0.18	0.54	0.82	C	1.0638298	0.091848413	Schizophrenia	Brain health and disorders
rs10831496	A	G	17	52	25	3	27	64	0.46	0.18	0.54	0.82	G	0.14	0.091848413	Tanning	Appearance
rs12656502	G	A	64	27	3	24	54	16	0.82	0.54	0.18	0.46	A	0.08	0.091848413	Plasma amyloid beta peptide concentrations ABx-42	Brain health and disorders
rs10253216	G	A	54	38	2	19	53	22	0.78	0.48	0.22	0.52	T	1.478	0.091825274	Adverse response to chemotherapy neutropenia_leucopenia cisplatin	Drug response
rs3011225	G	A	21	49	24	57	32	5	0.48	0.78	0.52	0.22	G	1	0.091825274	Amyotrophic lateral sclerosis age of onset	Brain health and disorders
rs4554859	G	T	22	47	25	58	30	6	0.48	0.78	0.52	0.22	G	0.09	0.091825274	Disc degeneration lumbar	Aging
rs7103004	C	T	22	47	25	58	30	6	0.48	0.78	0.52	0.22	C	0.09	0.091825274	Disc degeneration lumbar	Aging
rs12805875	A	G	22	47	25	58	30	6	0.48	0.78	0.52	0.22	A	0.09	0.091825274	Disc degeneration lumbar	Aging
rs4141885	A	T	50	43	1	88	6	0	0.76	0.97	0.24	0.03	A	0.073	0.091764706	Height	General health
rs61501627	T	C	71	22	1	29	56	9	0.87	0.61	0.13	0.39	C	4.35	0.091763324	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs11168618	C	T	34	46	14	70	24	0	0.61	0.87	0.39	0.13	T	0.06	0.091763324	Adiponectin levels	Obesity
rs1814175	T	C	20	43	31	51	37	6	0.44	0.74	0.56	0.26	T	0.022	0.091728092	Height	General health
rs10027628	T	C	89	5	0	53	39	2	0.97	0.77	0.03	0.23	C	1.81	0.09171748	QT interval	Heart health and disorders
rs3811444	C	T	49	31	14	80	14	0	0.69	0.93	0.31	0.07	C	3.346	0.091550251	Platelet count	Heart health and disorders
rs11018874	G	A	41	47	6	80	14	0	0.69	0.93	0.31	0.07	G	0.077	0.091550251	White blood cell types	Immune diseases and disorders
rs9290877	T	C	46	42	6	83	11	0	0.71	0.94	0.29	0.06	C	0.04	0.091466733	IgE levels	Immune diseases and disorders
rs556621	T	G	21	36	37	4	19	71	0.41	0.14	0.59	0.86	A	1.21	0.091407486	Stroke ischemic	Brain health and disorders
rs4947339	C	T	18	42	34	1	25	68	0.41	0.14	0.59	0.86	T	1	0.091407486	Platelet aggregation	Heart health and disorders
rs1941184	A	C	51	36	7	16	50	28	0.73	0.44	0.27	0.56	C	2.28	0.091375291	Parkinson's disease age of onset	Brain health and disorders
rs4077468	A	G	18	46	30	51	36	7	0.44	0.73	0.56	0.27	A	1.39	0.091375291	Cystic fibrosis-related diabetes	Diabetes
rs2046210	G	A	53	32	9	20	42	32	0.73	0.44	0.27	0.56	C	1.28	0.091375291	Breast Cancer in BRCA1 mutation carriers	Cancer
rs1973993	T	C	17	56	21	55	35	4	0.48	0.77	0.52	0.23	C	2.71	0.091293195	Weight	Appearance
rs11037575	T	C	20	50	24	59	27	8	0.48	0.77	0.52	0.23	C	1.231	0.091293195	Neuroblastoma	Cancer
rs78975256	T	C	93	1	0	64	26	4	0.99	0.82	0.01	0.18	G	2.439	0.09124424	Bronchopulmonary dysplasia	Pulmonology
rs2936519	G	A	74	18	2	35	47	12	0.88	0.62	0.12	0.38	A	1.8867927	0.09122687	Progression free survival in metastatic colorectal cancer CAPOX-B vs CAPOX-B plus cetuximab	Cancer
rs12991836	A	C	35	47	12	73	20	1	0.62	0.88	0.38	0.12	C	1.08	0.09122687	Schizophrenia	Brain health and disorders
rs1390401	A	G	72	22	0	38	41	15	0.88	0.62	0.12	0.38	A	0.04	0.09122687	Height	General health
rs2336030	C	T	45	36	13	78	16	0	0.67	0.91	0.33	0.09	C	1	0.091034245	Visceral adipose tissue adjusted for BMI	Obesity
rs2279590	T	C	14	40	40	0	20	74	0.36	0.11	0.64	0.89	C	1.1235955	0.090909091	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs6795735	C	T	13	42	39	0	20	74	0.36	0.11	0.64	0.89	T	1.1	0.090909091	Age-related macular degeneration	Aging
rs470490	G	T	12	41	41	0	18	76	0.35	0.10	0.65	0.90	G	2.45	0.090834327	Atrioventricular conduction	Heart health and disorders
rs2736428	C	T	43	37	14	76	18	0	0.65	0.90	0.35	0.10	T	0.05	0.090834327	Telomere length	Aging
rs11150911	A	C	20	40	34	46	44	4	0.43	0.72	0.57	0.28	A	0.015	0.090740741	Body mass index	Obesity
rs17616434	T	C	32	44	18	3	46	45	0.57	0.28	0.43	0.72	T	1.23	0.090740741	Allergic sensitization	Immune diseases and disorders
rs275456	G	T	48	40	6	84	10	0	0.72	0.95	0.28	0.05	A	2.26	0.090610232	Paclitaxel-induced neuropathy	Brain health and disorders
rs10932194	A	G	50	36	8	84	10	0	0.72	0.95	0.28	0.05	G	1.0526316	0.090610232	Schizophrenia	Brain health and disorders
rs10890032	T	C	25	43	26	5	29	60	0.49	0.21	0.51	0.79	T	1.07	0.090536513	Schizophrenia	Brain health and disorders
rs9652490	A	G	58	33	3	25	45	24	0.79	0.51	0.21	0.49	G	1.55	0.090536513	Essential tremor	General health
rs10825269	C	T	59	31	4	21	53	20	0.79	0.51	0.21	0.49	T	1.55	0.090536513	Irritable bowel syndrome	General health
rs12129573	C	A	26	43	25	60	29	5	0.51	0.79	0.49	0.21	A	1.078	0.090536513	Schizophrenia	Brain health and disorders
rs4939883	T	C	1	29	64	20	43	31	0.16	0.44	0.84	0.56	T	0.14	0.090531673	HDL cholesterol	General health
rs437943	T	C	33	43	18	10	33	51	0.58	0.28	0.42	0.72	G	1	0.090458059	Response to TNF antagonist treatment	General health
rs2413450	T	C	30	49	15	7	39	48	0.58	0.28	0.42	0.72	T	0.17	0.090458059	Hematocrit	General health
rs7920721	A	G	32	45	17	68	24	2	0.58	0.85	0.42	0.15	G	1.12	0.090365841	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs10455657	T	G	68	24	2	31	47	16	0.85	0.58	0.15	0.42	T	0.032	0.090365841	Cannabis use initiation	General health
rs8030672	T	A	92	2	0	59	34	1	0.99	0.81	0.01	0.19	A	1.56	0.090003114	Esophageal cancer	Cancer
rs4487103	G	C	14	49	31	49	35	10	0.41	0.71	0.59	0.29	C	0.08	0.089959839	Glomerular filtration rate in chronic kidney disease	General health
rs7909670	C	T	35	41	18	7	41	46	0.59	0.29	0.41	0.71	T	0.021	0.089959839	Height	General health
rs1994016	C	T	38	40	16	71	23	0	0.62	0.88	0.38	0.12	C	1.19	0.089941937	Coronary artery disease	Heart health and disorders
rs62378245	C	T	71	23	0	33	50	11	0.88	0.62	0.12	0.38	C	1.0752687	0.089941937	Schizophrenia	Brain health and disorders
rs295137	C	T	54	34	6	20	47	27	0.76	0.46	0.24	0.54	T	1	0.089861272	Asthma bronchodilator response	Immune diseases and disorders
rs164009	A	G	26	49	19	4	38	52	0.54	0.24	0.46	0.76	A	0.028	0.089861272	Urate levels	General health
rs1959947	A	G	17	42	35	45	42	7	0.40	0.70	0.60	0.30	A	4.76	0.08974359	Hemostatic factors and hematological phenotypes	Heart health and disorders
rs4949718	T	C	13	30	51	35	42	17	0.30	0.60	0.70	0.40	A	0.053	0.08974359	Liver enzyme levels alanine transaminase	General health
rs4703855	C	T	42	44	8	79	15	0	0.68	0.92	0.32	0.08	A	1.0760114	0.089700997	Crohn's disease	Digestive system and its disorders
rs12149832	G	A	45	38	11	81	11	2	0.68	0.92	0.32	0.08	A	0.073	0.089700997	Body mass index	Obesity
rs138641402	A	T	43	42	9	79	15	0	0.68	0.92	0.32	0.08	A	0.03	0.089700997	Local histogram emphysema pattern	Pulmonology
rs6427528	A	G	3	26	65	22	40	32	0.17	0.45	0.83	0.55	A	1	0.089655172	Response to anti-TNF treatment in rheumatoid arthritis	General health
rs6060373	A	G	45	41	8	13	49	32	0.70	0.40	0.30	0.60	C	0.79	0.089548829	Spine bone size	Misc
rs6060369	T	C	45	41	8	13	49	32	0.70	0.40	0.30	0.60	T	0.064	0.089548829	Height	General health
rs7224668	T	C	18	53	23	4	28	62	0.47	0.19	0.53	0.81	C	0.1729	0.08952988	IgG glycosylation	Immune diseases and disorders
rs6988229	C	T	61	30	3	27	45	22	0.81	0.53	0.19	0.47	T	1	0.08952988	Asthma bronchodilator response	Immune diseases and disorders
rs11869286	G	C	25	49	20	62	28	4	0.53	0.81	0.47	0.19	G	0.032	0.08952988	HDL cholesterol	General health
rs10493773	A	G	39	41	14	73	21	0	0.63	0.89	0.37	0.11	G	0.082	0.08951049	Urate levels in overweight individuals	Obesity
rs4749884	A	C	13	50	31	2	22	70	0.40	0.14	0.60	0.86	C	1.12	0.089451839	Prostate cancer	Cancer
rs6462018	G	A	18	40	36	1	24	69	0.40	0.14	0.60	0.86	G	0.084	0.089451839	Lead levels in blood	General health
rs9460635	T	C	52	37	5	18	50	26	0.75	0.46	0.25	0.54	C	0.2238	0.089436182	Metabolite levels HVA-5-HIAA Factor score	General health
rs7234864	C	T	66	27	1	28	52	14	0.85	0.57	0.15	0.43	T	0.081	0.08937223	Body mass index	Obesity
rs3925584	T	C	31	46	17	70	19	5	0.57	0.85	0.43	0.15	C	0.01	0.08937223	Magnesium levels	General health
rs9590614	G	C	30	48	16	68	23	3	0.57	0.85	0.43	0.15	G	0.002	0.08937223	Local histogram emphysema pattern	Pulmonology
rs1960445	C	T	5	19	70	16	48	30	0.15	0.43	0.85	0.57	C	0.114	0.08937223	Refractive error	General health
rs17401966	A	G	41	43	10	77	17	0	0.66	0.91	0.34	0.09	A	1.64	0.089358108	Hepatocellular carcinoma	Cancer
rs6750486	C	T	86	8	0	53	34	7	0.96	0.74	0.04	0.26	T	0.1	0.089285714	Conduct disorder symptom count	Brain health and disorders
rs2338104	C	G	31	41	22	8	32	54	0.55	0.26	0.45	0.74	G	0.48	0.089036056	HDL cholesterol	General health
rs365302	T	C	41	44	9	15	40	39	0.67	0.37	0.33	0.63	C	1.11	0.088888889	Coronary heart disease	Heart health and disorders
rs6753473	T	G	87	7	0	55	32	7	0.96	0.76	0.04	0.24	G	1	0.088848648	Non-small cell lung cancer	Cancer
rs10879490	T	A	54	34	6	87	7	0	0.76	0.96	0.24	0.04	A	0.14	0.088848648	Metabolite levels Dihydroxy docosatrienoic acid	General health
rs1604897	C	T	64	23	7	24	50	20	0.80	0.52	0.20	0.48	C	0.1864	0.088827752	IgG glycosylation	Immune diseases and disorders
rs559972	C	T	28	47	19	64	27	3	0.55	0.82	0.45	0.18	T	3.264	0.088818815	Platelet count	Heart health and disorders
rs7929679	A	G	37	45	12	9	45	40	0.63	0.34	0.37	0.66	G	1	0.088818398	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs2460882	T	C	38	43	13	7	49	38	0.63	0.34	0.37	0.66	T	0.11	0.088818398	Percentage gas trapping	Misc
rs6087685	G	C	44	37	13	11	47	36	0.66	0.37	0.34	0.63	C	1.15	0.088818398	Venous thromboembolism	Heart health and disorders
rs1361108	C	T	14	41	39	42	41	11	0.37	0.66	0.63	0.34	T	0.038	0.088818398	Height	General health
rs1570854	C	T	26	40	28	55	36	3	0.49	0.78	0.51	0.22	T	0.079	0.088783339	Economic and political preferences environmentalism	Mental aptitude and behavioural traits
rs62402013	A	G	9	46	39	37	46	11	0.34	0.64	0.66	0.36	G	1.0752687	0.088768116	Schizophrenia	Brain health and disorders
rs452036	G	A	37	48	9	11	44	39	0.65	0.35	0.35	0.65	G	9.6	0.088727931	Resting heart rate	General health
rs4784054	G	A	72	20	2	35	45	14	0.87	0.61	0.13	0.39	A	0.035	0.088718915	Blood metabolite levels	Heart health and disorders
rs11158559	C	T	70	24	0	34	47	13	0.87	0.61	0.13	0.39	A	0.03	0.088718915	Obesity-related traits	Obesity
rs17684571	C	T	56	36	2	90	4	0	0.79	0.98	0.21	0.02	C	1.0638298	0.08871851	Schizophrenia	Brain health and disorders
rs2646928	T	C	89	4	1	54	36	4	0.97	0.77	0.03	0.23	G	34.08	0.088588957	Diisocyanate-induced asthma	Pulmonology
rs2228638	C	T	57	30	7	88	6	0	0.77	0.97	0.23	0.03	A	1.447	0.088588957	Tetralogy of Fallot	Heart health and disorders
rs16963349	T	C	88	6	0	55	34	5	0.97	0.77	0.03	0.23	C	1.178	0.088588957	Systolic blood pressure alcohol consumption interaction	General health
rs73989024	A	G	88	6	0	51	42	1	0.97	0.77	0.03	0.23	A	0.977	0.088588957	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs16831047	G	A	58	30	6	89	5	0	0.78	0.97	0.22	0.03	A	1.07	0.08853392	Schizophrenia	Brain health and disorders
rs2722769	C	G	43	44	7	80	14	0	0.69	0.93	0.31	0.07	C	1.35	0.088450292	Type 2 diabetes	Diabetes
rs9862730	G	A	80	14	0	44	42	8	0.93	0.69	0.07	0.31	A	1	0.088450292	Fasting insulin interaction	General health
rs17817964	C	T	47	36	11	82	10	2	0.69	0.93	0.31	0.07	T	0.073	0.088450292	Body mass index	Obesity
rs3767627	T	C	49	32	13	80	14	0	0.69	0.93	0.31	0.07	T	0.036	0.088450292	Height	General health
rs11681884	C	T	68	22	4	32	43	19	0.84	0.57	0.16	0.43	T	0.24	0.088424273	Stroke	Brain health and disorders
rs2468186	C	T	19	43	32	3	24	67	0.43	0.16	0.57	0.84	T	0.04	0.088424273	Osteoprotegerin levels	Immune diseases and disorders
rs749671	G	A	34	43	17	72	17	5	0.59	0.86	0.41	0.14	G	20.4	0.088376697	Warfarin maintenance dose	General health
rs9430161	G	T	69	23	2	32	47	15	0.86	0.59	0.14	0.41	G	2.2	0.088376697	Ewing sarcoma	Cancer
rs11638815	A	C	51	33	10	83	11	0	0.72	0.94	0.28	0.06	C	4.1	0.088341346	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	General health
rs2845885	C	T	1	9	84	7	39	48	0.06	0.28	0.94	0.72	T	0.028	0.088341346	Body mass index	Obesity
rs4684854	G	C	37	44	13	72	22	0	0.63	0.88	0.37	0.12	C	1	0.088181261	Sexual dimorphism in anthropometric traits	Misc
rs12761450	G	T	35	48	11	73	20	1	0.63	0.88	0.37	0.12	T	0.07	0.088181261	Plasma amyloid beta peptide concentrations ABx-42	Brain health and disorders
rs2114646	C	T	35	48	11	73	20	1	0.63	0.88	0.37	0.12	G	0.03	0.088181261	Obesity-related traits	Obesity
rs4626214	A	G	12	46	36	0	22	72	0.37	0.12	0.63	0.88	G	1.0526316	0.088181261	Schizophrenia	Brain health and disorders
rs10475598	T	C	30	46	18	6	39	49	0.56	0.27	0.44	0.73	T	0.15	0.087979525	Information processing speed	Mental aptitude and behavioural traits
rs12449157	A	G	51	35	8	23	36	35	0.73	0.44	0.27	0.56	G	0.02	0.087979525	HDL cholesterol	General health
rs181394970	C	T	79	14	1	48	31	15	0.91	0.68	0.09	0.32	T	0.19	0.087955523	Glomerular filtration rate in chronic kidney disease	General health
rs344081	T	C	74	20	0	39	43	12	0.89	0.64	0.11	0.36	T	0.06	0.087857455	Bone mineral density	General health
rs2360969	C	T	37	50	7	76	18	0	0.66	0.90	0.34	0.10	T	0.21	0.087771694	Food antigen IgG levels	Immune diseases and disorders
rs1987778	C	T	10	44	40	1	16	77	0.34	0.10	0.66	0.90	T	1.06	0.087771694	Schizophrenia	Brain health and disorders
rs6449586	C	T	26	46	22	4	36	54	0.52	0.23	0.48	0.77	A	1.1628	0.087757313	Barrett's esophagus	Digestive system and its disorders
rs2869967	T	C	29	49	16	9	34	51	0.57	0.28	0.43	0.72	C	1.38	0.087673536	Chronic bronchitis and chronic obstructive pulmonary disease	Pulmonology
rs2564921	T	C	16	49	29	48	40	6	0.43	0.72	0.57	0.28	T	1.15	0.087673536	Height	General health
rs2336725	C	T	16	49	29	48	40	6	0.43	0.72	0.57	0.28	T	0.027	0.087673536	Height	General health
rs13247936	C	G	37	40	17	70	23	1	0.61	0.87	0.39	0.13	G	1.0526316	0.087554243	Schizophrenia	Brain health and disorders
rs17158930	A	G	71	21	2	35	44	15	0.87	0.61	0.13	0.39	G	0.3082	0.087554243	Pharmacokinetics of antidepressant drugs in severe mental disorder concentration dose ratio	General health
rs743777	A	G	59	31	4	24	48	22	0.79	0.51	0.21	0.49	G	1.09	0.087521421	Rheumatoid arthritis	Immune diseases and disorders
rs6718520	A	G	18	46	30	3	25	66	0.44	0.16	0.56	0.84	A	1.17	0.087519768	Multiple sclerosis	Brain health and disorders
rs548234	C	T	8	35	51	0	10	84	0.27	0.05	0.73	0.95	G	1.25	0.087483737	Systemic lupus erythematosus	Immune diseases and disorders
rs259991	G	A	85	8	1	46	45	3	0.95	0.73	0.05	0.27	G	1.78	0.087483737	Attention function in attention deficit hyperactive disorder	Brain health and disorders
rs10018288	G	A	4	45	45	29	50	15	0.28	0.57	0.72	0.43	G	1.16	0.08738986	Alzheimer's disease in APOE e4+ carriers	Brain health and disorders
rs9881798	A	C	35	38	21	7	39	48	0.57	0.28	0.43	0.72	C	1.0526316	0.08738986	Schizophrenia	Brain health and disorders
rs6024938	C	T	17	44	33	3	22	69	0.41	0.15	0.59	0.85	A	0.04	0.087351502	Obesity-related traits	Obesity
rs7714584	A	G	69	22	3	31	48	15	0.85	0.59	0.15	0.41	G	1.37	0.087351502	Crohn's disease	Digestive system and its disorders
rs11747270	A	G	69	22	3	31	48	15	0.85	0.59	0.15	0.41	G	1.33	0.087351502	Crohn's disease	Digestive system and its disorders
rs3825807	A	G	34	42	18	66	28	0	0.59	0.85	0.41	0.15	A	0.363	0.087351502	Coronary artery calcification	Heart health and disorders
rs1261117	T	C	81	13	0	43	46	5	0.93	0.70	0.07	0.30	T	1.6	0.087286975	Schizophrenia	Brain health and disorders
rs421490	A	G	82	11	1	44	44	6	0.93	0.70	0.07	0.30	A	0.01	0.087286975	Plasma omega-6 polyunsaturated fatty acid levels gamma-linolenic acid	General health
rs1042151	A	G	61	31	2	26	49	19	0.81	0.54	0.19	0.46	G	2.4	0.087259584	Aspirin exacerbated respiratory disease in asthmatics	General health
rs10504554	T	C	63	27	4	23	55	16	0.81	0.54	0.19	0.46	A	1.82	0.087259584	Postoperative atrial fibrillation in coronary artery bypass grafting surgery	Heart health and disorders
rs11264341	C	T	17	45	32	48	38	8	0.42	0.71	0.58	0.29	T	0.05	0.087128085	Urate levels	General health
rs7335631	C	A	1	21	72	14	43	37	0.12	0.38	0.88	0.62	C	1	0.086917157	Fat distribution HIV	General health
rs7649739	G	A	18	35	41	1	21	72	0.38	0.12	0.62	0.88	G	0.1501	0.086917157	IgG glycosylation	Immune diseases and disorders
rs10894804	A	T	17	44	33	47	39	8	0.41	0.71	0.59	0.29	A	0.2826	0.086887836	Verbal declarative memory	Brain health and disorders
rs2007044	A	G	24	52	18	6	34	54	0.53	0.24	0.47	0.76	G	1.098901	0.086837403	Schizophrenia	Brain health and disorders
rs11066301	A	G	53	33	8	87	5	2	0.74	0.95	0.26	0.05	G	4.65	0.086749078	Hematological parameters	Heart health and disorders
rs2297067	C	T	52	35	7	85	9	0	0.74	0.95	0.26	0.05	T	3.538	0.086749078	Platelet count	Heart health and disorders
rs17696736	A	G	53	33	8	87	5	2	0.74	0.95	0.26	0.05	G	1	0.086749078	Type 1 diabetes	Diabetes
rs12145743	T	G	53	33	8	85	9	0	0.74	0.95	0.26	0.05	G	0.02	0.086749078	HDL cholesterol	General health
rs17630235	G	A	53	33	8	87	5	2	0.74	0.95	0.26	0.05	G	0.016	0.086749078	Body mass index	Obesity
rs7517537	C	T	94	0	0	67	24	3	1.00	0.84	0.00	0.16	T	0.227	0.086705202	Uric acid levels	General health
rs2137920	T	A	7	42	45	33	45	16	0.30	0.59	0.70	0.41	T	1.15	0.086668768	Migraine with aura	Brain health and disorders
rs978152	C	G	30	51	13	9	38	47	0.59	0.30	0.41	0.70	C	0.19	0.086668768	Coronary artery calcification	Heart health and disorders
rs3132613	C	G	22	39	33	2	28	64	0.44	0.17	0.56	0.83	C	1.43	0.086656672	Graves' disease	Immune diseases and disorders
rs6504340	A	G	0	32	62	23	37	34	0.17	0.44	0.83	0.56	G	0.44	0.086656672	Primary tooth development number of teeth	Misc
rs361171	C	T	25	55	14	63	30	1	0.56	0.83	0.44	0.17	T	0.0014	0.086656672	Trans fatty acid levels	General health
rs330071	G	A	43	43	8	79	15	0	0.69	0.92	0.31	0.08	G	1.23	0.086629676	Acne severe	Misc
rs2257011	G	T	8	43	43	0	15	79	0.31	0.08	0.69	0.92	T	0.044	0.086629676	Height	General health
rs945270	C	G	26	36	32	6	24	64	0.47	0.19	0.53	0.81	C	48.89	0.086533538	Subcortical brain region volumes	Brain health and disorders
rs663743	G	A	37	46	11	75	17	2	0.64	0.89	0.36	0.11	A	1.24	0.086481619	Leprosy	Immune diseases and disorders
rs538656	G	T	75	17	2	37	46	11	0.89	0.64	0.11	0.36	T	1.15	0.086481619	Obesity	Obesity
rs1394678	C	T	46	39	9	13	50	31	0.70	0.40	0.30	0.60	T	0.035	0.086470571	Blood metabolite levels	Heart health and disorders
rs303084	G	A	10	37	47	28	56	10	0.30	0.60	0.70	0.40	A	0.0288	0.086470571	Waist-to-hip ratio adjusted for body mass index	Obesity
rs6945541	C	T	13	49	32	2	22	70	0.40	0.14	0.60	0.86	C	1.27	0.086444644	Male-pattern baldness	Appearance
rs331463	A	T	1	24	69	14	47	33	0.14	0.40	0.86	0.60	T	1.12	0.086444644	Rheumatoid arthritis	Immune diseases and disorders
rs2070615	A	G	16	43	35	2	22	70	0.40	0.14	0.60	0.86	G	1.1	0.086444644	Bipolar disorder	Brain health and disorders
rs12912233	C	T	35	43	16	69	24	1	0.60	0.86	0.40	0.14	T	0.15	0.086444644	Depression quantitative trait	Brain health and disorders
rs10443196	T	C	29	55	10	70	22	2	0.60	0.86	0.40	0.14	G	0.04	0.086444644	Obesity-related traits	Obesity
rs562338	A	G	9	29	56	30	41	23	0.25	0.54	0.75	0.46	T	0.04	0.086415363	LDL cholesterol	General health
rs9277555	G	A	51	39	4	24	39	31	0.75	0.46	0.25	0.54	G	0.0199	0.086415363	Thyroid peroxidase antibody levels	Immune diseases and disorders
rs4308128	A	C	32	45	17	68	23	3	0.58	0.85	0.42	0.15	A	1.795	0.086373687	Suicide attempts in major depressive disorder	Brain health and disorders
rs6494849	C	A	67	25	2	26	57	11	0.85	0.58	0.15	0.42	A	1.23	0.086373687	Bipolar disorder	Brain health and disorders
rs7412746	C	T	33	43	18	65	29	0	0.58	0.85	0.42	0.15	T	1.15	0.086373687	Melanoma	Cancer
rs7165170	A	C	67	25	2	31	47	16	0.85	0.58	0.15	0.42	C	1.0798767	0.086373687	Crohn's disease	Digestive system and its disorders
rs4907240	G	A	28	53	13	66	27	1	0.58	0.85	0.42	0.15	A	0.254	0.086373687	Event-related brain oscillations	Brain health and disorders
rs10146615	T	C	65	29	0	30	49	15	0.85	0.58	0.15	0.42	T	0.138	0.086373687	Economic and political preferences immigration_crime	Mental aptitude and behavioural traits
rs202072	A	G	5	31	58	19	56	19	0.22	0.50	0.78	0.50	A	0.4038	0.08633779	HIV-1 viral setpoint	Immune diseases and disorders
rs11072566	A	G	25	44	25	55	37	2	0.50	0.78	0.50	0.22	A	0.028	0.08633779	Red blood cell traits	Immune diseases and disorders
rs2267193	G	C	40	46	8	78	15	1	0.67	0.91	0.33	0.09	C	1	0.086306099	Visceral fat	Obesity
rs11118316	G	A	44	38	12	77	17	0	0.67	0.91	0.33	0.09	A	1	0.086306099	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs11249215	G	A	12	51	31	45	40	9	0.40	0.69	0.60	0.31	A	1	0.086292968	Ankylosing spondylitis	Immune diseases and disorders
rs1524480	G	T	49	36	9	83	10	1	0.71	0.94	0.29	0.06	G	1.0638298	0.086217009	Schizophrenia	Brain health and disorders
rs9862857	A	G	82	12	0	42	50	2	0.94	0.71	0.06	0.29	C	0.7386	0.086217009	Pharmacokinetics of olanzapine in severe mental disorder concentration dose ratio	General health
rs7517847	T	G	21	44	29	50	40	4	0.46	0.74	0.54	0.26	C	1.3990791	0.086017699	Crohn's disease	Digestive system and its disorders
rs17287293	A	G	64	23	7	91	3	0	0.80	0.98	0.20	0.02	G	8.6	0.086011905	Resting heart rate	General health
rs12322695	G	T	91	3	0	57	37	0	0.98	0.80	0.02	0.20	A	0.03	0.086011905	Obesity-related traits	Obesity
rs604381	G	T	43	42	9	12	49	33	0.68	0.39	0.32	0.61	A	1.26	0.085998579	Conduct disorder interaction	Brain health and disorders
rs724016	A	G	37	41	16	10	40	44	0.61	0.32	0.39	0.68	G	1.0572861	0.085998579	Crohn's disease	Digestive system and its disorders
rs4868126	T	G	9	43	42	39	38	17	0.32	0.62	0.68	0.38	T	0.036	0.085881384	Height	General health
rs669607	A	C	24	51	19	63	25	6	0.53	0.80	0.47	0.20	C	1.13	0.08584127	Multiple sclerosis	Brain health and disorders
rs11732231	G	C	27	50	17	65	25	4	0.55	0.82	0.45	0.18	C	2.28	0.085833086	PR interval	Heart health and disorders
rs4724100	T	C	28	48	18	66	23	5	0.55	0.82	0.45	0.18	C	1.14	0.085833086	Allergic rhinitis	Immune diseases and disorders
rs747782	T	C	63	29	2	27	50	17	0.82	0.55	0.18	0.45	C	0.203	0.085833086	Intraocular pressure	General health
rs6818288	A	C	62	31	1	26	52	16	0.82	0.55	0.18	0.45	C	0.04	0.085833086	Obesity-related traits	Obesity
rs4622329	G	A	41	44	9	9	53	32	0.67	0.38	0.33	0.62	A	1.1905	0.085783966	Systemic lupus erythematosus	Immune diseases and disorders
rs3819340	A	G	71	22	1	35	46	13	0.87	0.62	0.13	0.38	G	0.07	0.085714286	LDL peak particle diameter total fat intake interaction	General health
rs13108904	G	T	39	38	17	71	22	1	0.62	0.87	0.38	0.13	A	0.04	0.085714286	Obesity-related traits	Obesity
rs26868	T	A	35	46	13	72	20	2	0.62	0.87	0.38	0.13	A	0.034	0.085714286	Height	General health
rs4265793	T	C	0	7	87	5	35	54	0.04	0.24	0.96	0.76	T	1.22	0.085707502	Response to angiotensin II receptor blocker therapy	General health
rs370409	C	A	5	35	54	0	7	87	0.24	0.04	0.76	0.96	T	1.15	0.085707502	Graves' disease	Immune diseases and disorders
rs10954668	G	A	55	33	6	87	7	0	0.76	0.96	0.24	0.04	A	0.32	0.085707502	Non-alcoholic fatty liver disease histology lobular	Obesity
rs8017304	G	A	15	40	39	41	43	10	0.37	0.66	0.63	0.34	A	1.11	0.085706191	Age-related macular degeneration	Aging
rs684232	T	C	37	44	13	11	41	42	0.63	0.34	0.37	0.66	G	1.1	0.085706191	Prostate cancer	Cancer
rs136161	G	C	10	44	40	33	53	8	0.34	0.63	0.66	0.37	G	1.36	0.085647952	Diabetic kidney disease	Diabetes
rs6679002	G	T	16	37	41	36	52	6	0.37	0.66	0.63	0.34	T	0.014	0.085647952	Blood metabolite levels	Heart health and disorders
rs9947276	A	T	5	39	50	29	45	20	0.26	0.55	0.74	0.45	T	1.39	0.085643797	Alcohol dependence age at onset	General health
rs1430193	A	T	40	40	14	7	51	36	0.64	0.35	0.36	0.65	T	21.125	0.085609169	Forced vital capacity	Pulmonology
rs4779031	C	A	14	40	40	39	45	10	0.36	0.65	0.64	0.35	C	0.1832	0.085609169	IgG glycosylation	Immune diseases and disorders
rs7744392	A	G	90	4	0	60	29	5	0.98	0.79	0.02	0.21	G	1	0.085550667	Cataracts in type 2 diabetes	Diabetes
rs9860547	G	A	29	50	15	68	22	4	0.57	0.84	0.43	0.16	A	0.0741	0.085440875	Self-reported allergy	General health
rs10767873	C	T	31	46	17	70	18	6	0.57	0.84	0.43	0.16	C	0.0068	0.085440875	Renal function-related traits BUN	General health
rs13403179	G	C	88	6	0	57	31	6	0.97	0.77	0.03	0.23	C	2.947	0.08543968	Recalcitrant atopic dermatitis	Immune diseases and disorders
rs4698775	G	T	13	31	50	0	14	80	0.30	0.07	0.70	0.93	G	1.14	0.085384438	Age-related macular degeneration	Aging
rs7578597	T	C	80	14	0	49	33	12	0.93	0.70	0.07	0.30	T	1.15	0.085384438	Type 2 diabetes	Diabetes
rs840016	C	T	46	39	9	80	14	0	0.70	0.93	0.30	0.07	C	1.11	0.085384438	Rheumatoid arthritis	Immune diseases and disorders
rs3790515	C	T	82	10	2	44	43	7	0.93	0.70	0.07	0.30	T	0.79	0.085384438	Depressive symptoms SSRI exposure interaction	Brain health and disorders
rs7499271	T	A	81	12	1	41	49	4	0.93	0.70	0.07	0.30	A	0.25	0.085384438	Serum metabolite levels	General health
rs11004008	G	A	28	42	24	58	34	2	0.52	0.80	0.48	0.20	G	1.0526316	0.085181452	Schizophrenia	Brain health and disorders
rs798338	C	A	24	42	28	4	30	60	0.48	0.20	0.52	0.80	A	0.111	0.085181452	Lead levels in blood	General health
rs7294919	T	C	74	18	2	36	47	11	0.88	0.63	0.12	0.37	C	47.58	0.085174475	Brain structure	Brain health and disorders
rs11563251	C	T	74	18	2	39	41	14	0.88	0.63	0.12	0.37	T	0.037	0.085174475	Cholesterol, total	General health
rs1488864	T	G	0	22	72	10	49	35	0.12	0.37	0.88	0.63	A	1.295	0.085174475	Smooth-surface caries	Appearance
rs11865121	C	A	49	39	6	22	39	33	0.73	0.44	0.27	0.56	C	1.15	0.084965035	Multiple sclerosis	Brain health and disorders
rs2241208	G	C	32	41	21	8	35	51	0.56	0.27	0.44	0.73	C	0.036	0.084965035	HDL cholesterol	General health
rs4578395	C	T	9	42	43	0	16	78	0.32	0.09	0.68	0.91	C	1.19	0.084912281	Gastric cancer	Cancer
rs820430	A	G	40	48	6	80	12	2	0.68	0.91	0.32	0.09	A	0.76	0.084912281	Systolic blood pressure	Heart health and disorders
rs1980057	C	T	43	42	9	78	16	0	0.68	0.91	0.32	0.09	T	0.52	0.084912281	Pulmonary function	Pulmonology
rs950169	C	T	64	28	2	93	1	0	0.83	0.99	0.17	0.01	C	1.0869565	0.084901493	Schizophrenia	Brain health and disorders
rs1502337	C	T	28	41	25	5	34	55	0.52	0.23	0.48	0.77	T	0.014	0.084774408	Body mass index	Obesity
rs948426	A	G	46	33	15	77	16	1	0.66	0.90	0.34	0.10	A	1.14	0.084745763	Hypothyroidism	Immune diseases and disorders
rs12533251	G	A	77	16	1	44	37	13	0.90	0.66	0.10	0.34	A	0.057	0.084745763	Blood metabolite levels	Heart health and disorders
rs1380181	A	G	14	45	35	1	23	70	0.39	0.13	0.61	0.87	A	1.97	0.084569079	QT interval	Heart health and disorders
rs10745954	A	G	19	43	32	2	27	65	0.43	0.16	0.57	0.84	A	0.039	0.084550866	C-reactive protein levels	Immune diseases and disorders
rs2280655	C	T	84	10	0	49	40	5	0.95	0.73	0.05	0.27	C	0.6294	0.084388186	IgG glycosylation	Immune diseases and disorders
rs2293152	G	C	30	38	26	0	45	49	0.52	0.24	0.48	0.76	C	1.22	0.084306252	Multiple sclerosis	Brain health and disorders
rs3783006	G	C	22	46	26	51	41	2	0.48	0.76	0.52	0.24	C	0.088	0.084306252	Educational attainment	Mental aptitude and behavioural traits
rs1487141	G	C	61	31	2	27	48	19	0.81	0.54	0.19	0.46	C	0.04	0.084297521	Metabolite levels  X-11787	General health
rs28671666	G	A	22	42	30	2	31	61	0.46	0.19	0.54	0.81	A	0.5396	0.084297521	Hippocampal sclerosis	Brain health and disorders
rs2062377	T	A	18	50	26	4	27	63	0.46	0.19	0.54	0.81	A	0.08	0.084297521	Bone mineral density	General health
rs10925507	G	A	81	13	0	46	41	7	0.93	0.71	0.07	0.29	A	0.27	0.084224599	Cannabis use age at onset	General health
rs9292394	G	T	8	38	48	33	42	19	0.29	0.57	0.71	0.43	T	1.83	0.08411215	Emphysema-related traits	Pulmonology
rs11830103	A	G	58	32	4	27	42	25	0.79	0.51	0.21	0.49	A	0.035	0.083954297	Height	General health
rs35349669	C	T	37	44	13	71	23	0	0.63	0.88	0.37	0.12	T	1.08	0.08393176	Alzheimer's disease late onset	Brain health and disorders
rs7837045	A	C	7	41	46	29	51	14	0.29	0.58	0.71	0.42	A	0.092	0.083870225	Breast size	General health
rs4262906	T	C	29	41	24	6	34	54	0.53	0.24	0.47	0.76	C	4.36	0.083863263	Adverse response to chemotherapy in breast cancer alopecia docetaxel	General health
rs4888262	C	T	27	45	22	4	38	52	0.53	0.24	0.47	0.76	C	1.26	0.083863263	Testicular germ cell tumor	Cancer
rs780093	T	C	17	48	29	6	20	68	0.44	0.17	0.56	0.83	A	0.19	0.08370162	Waist Circumference - Triglycerides WC-TG	General health
rs12753569	G	T	29	48	17	66	24	4	0.56	0.83	0.44	0.17	G	0.1	0.08370162	Personality dimensions	Brain health and disorders
rs7539892	G	T	64	28	2	29	48	17	0.83	0.56	0.17	0.44	G	0.096	0.08370162	Urate levels in overweight individuals	Obesity
rs7068966	C	T	29	48	17	65	26	3	0.56	0.83	0.44	0.17	T	0.033	0.08370162	Pulmonary function	Pulmonology
rs11078884	T	C	66	22	6	92	2	0	0.82	0.99	0.18	0.01	C	0.2234	0.083660131	Metabolite levels 5-HIAA	General health
rs1903595	A	G	49	42	3	85	9	0	0.74	0.95	0.26	0.05	G	1	0.083649563	Platelet aggregation	Heart health and disorders
rs11920719	A	C	85	9	0	53	34	7	0.95	0.74	0.05	0.26	A	0.0973	0.083649563	LDL cholesterol	General health
rs1371867	A	C	35	40	19	7	42	45	0.59	0.30	0.41	0.70	C	2.32	0.083648881	Atrioventricular conduction	Heart health and disorders
rs10892576	C	T	48	36	10	15	48	31	0.70	0.41	0.30	0.59	T	0.17	0.083648881	Intraocular pressure	General health
rs7118391	C	T	48	36	10	15	48	31	0.70	0.41	0.30	0.59	T	0.16	0.083648881	Intraocular pressure	General health
rs10888073	T	C	49	34	11	14	50	30	0.70	0.41	0.30	0.59	T	0.0365	0.083648881	Magnesium levels	General health
rs7324845	G	A	2	11	81	4	50	40	0.08	0.31	0.92	0.69	A	3.29	0.083593291	Non-alcoholic fatty liver disease histology other	Obesity
rs4815191	T	C	10	38	46	0	15	79	0.31	0.08	0.69	0.92	A	0.03	0.083593291	Obesity-related traits	Obesity
rs7003257	T	C	81	11	2	44	42	8	0.92	0.69	0.08	0.31	T	1.1	0.083593291	Type 2 diabetes	Diabetes
rs2310173	T	G	21	45	28	5	26	63	0.46	0.19	0.54	0.81	A	1.18	0.083582377	Ankylosing spondylitis	Immune diseases and disorders
rs10490823	C	T	34	46	14	70	22	2	0.61	0.86	0.39	0.14	G	0.06	0.083478261	Bone mineral density hip	General health
rs11625793	G	A	22	44	28	51	39	4	0.47	0.75	0.53	0.25	G	1.0526316	0.083444732	Schizophrenia	Brain health and disorders
rs1501550	G	A	54	33	7	20	48	26	0.75	0.47	0.25	0.53	A	0.011	0.083444732	Circulating vasoactive peptide levels	Immune diseases and disorders
rs7544372	C	T	2	25	67	14	50	30	0.15	0.41	0.85	0.59	G	0.03	0.083417295	Obesity-related traits	Obesity
rs4589502	C	T	68	23	3	34	42	18	0.85	0.59	0.15	0.41	T	1.55	0.083417295	Lung cancer smoking interaction	Cancer
rs3824999	T	G	33	44	17	66	27	1	0.59	0.85	0.41	0.15	G	1.0752687	0.083417295	Colorectal cancer	Cancer
rs6710518	C	T	36	38	20	67	25	2	0.59	0.85	0.41	0.15	T	0.064	0.083417295	Bone mineral density	General health
rs1555804	A	G	77	17	0	45	37	12	0.91	0.68	0.09	0.32	G	15.23	0.083290311	Diisocyanate-induced asthma	Pulmonology
rs12022722	C	T	44	39	11	77	17	0	0.68	0.91	0.32	0.09	T	1	0.083290311	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs10838738	A	G	41	42	11	76	17	1	0.66	0.90	0.34	0.10	G	0.07	0.083268226	Body mass index	Obesity
rs6854292	A	G	75	19	0	40	44	10	0.90	0.66	0.10	0.34	A	0.0067	0.083268226	Trans fatty acid levels	General health
rs2911132	G	A	46	43	5	82	12	0	0.72	0.94	0.28	0.06	G	0.013958143	0.083156072	Urate levels BMI interaction	Obesity
rs1867631	C	A	44	41	9	14	47	33	0.69	0.40	0.31	0.60	A	0.1071	0.083105335	Menopause age at onset	Reproductive health
rs213032	T	C	44	41	9	12	51	31	0.69	0.40	0.31	0.60	G	0.03	0.083105335	Obesity-related traits	Obesity
rs6092354	G	T	86	8	0	52	38	4	0.96	0.76	0.04	0.24	G	0.6324	0.083045779	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs8072843	G	A	86	8	0	54	34	6	0.96	0.76	0.04	0.24	A	0.511	0.083045779	Airway responsiveness in chronic obstructive pulmonary disease	Pulmonology
rs7156510	G	T	7	46	41	37	40	17	0.32	0.61	0.68	0.39	T	0.21	0.082963469	Stroke	Brain health and disorders
rs1561570	T	C	12	50	32	40	48	6	0.39	0.68	0.61	0.32	T	1.67	0.082963469	Paget's disease	General health
rs734999	C	T	22	44	28	3	31	60	0.47	0.20	0.53	0.80	C	1.05	0.082900398	Ulcerative colitis	Immune diseases and disorders
rs501120	T	C	61	29	4	22	56	16	0.80	0.53	0.20	0.47	C	1.087	0.082900398	Coronary artery disease	Heart health and disorders
rs6817170	T	C	62	31	1	27	51	16	0.82	0.56	0.18	0.44	G	1.517	0.082891247	Adverse response to chemotherapy neutropenia_leucopenia all antimicrotubule drugs	Drug response
rs11755527	C	G	31	43	20	62	31	1	0.56	0.82	0.44	0.18	G	1.13	0.082891247	Type 1 diabetes	Diabetes
rs3812831	T	C	31	43	20	65	25	4	0.56	0.82	0.44	0.18	C	1.0526316	0.082891247	Schizophrenia	Brain health and disorders
rs7188697	G	A	23	37	34	2	29	63	0.44	0.18	0.56	0.82	A	1.66	0.082891247	QT interval	Heart health and disorders
rs11014306	T	C	72	20	2	40	37	17	0.87	0.62	0.13	0.38	C	0.1	0.082749579	Metabolite levels Pyroglutamine	General health
rs365990	A	G	33	50	11	11	40	43	0.62	0.33	0.38	0.67	G	5.25	0.082737487	Electrocardiographic traits	Heart health and disorders
rs2114039	T	C	45	36	13	16	40	38	0.67	0.38	0.33	0.62	C	0.129	0.082737487	Corneal curvature	General health
rs10088262	A	G	24	38	32	52	35	7	0.46	0.74	0.54	0.26	A	1.4	0.08267844	Pancreatic cancer	Cancer
rs6929568	T	G	48	43	3	17	52	25	0.74	0.46	0.26	0.54	T	0.17	0.08267844	Coronary artery calcification	Heart health and disorders
rs893363	G	A	9	45	40	36	45	13	0.34	0.62	0.66	0.38	A	0.0513	0.082653061	Axial length	Misc
rs4812712	C	A	37	51	6	16	39	39	0.66	0.38	0.34	0.62	A	0.18	0.082653061	Antibody level in response to infection	Immune diseases and disorders
rs4263408	T	C	14	43	37	40	45	9	0.38	0.66	0.62	0.34	T	0.09	0.082653061	Plasma amyloid beta peptide concentrations ABx-40	Brain health and disorders
rs8007661	C	T	40	44	10	13	44	37	0.66	0.37	0.34	0.63	T	0.42	0.082587516	Height	General health
rs1445898	C	T	11	47	36	41	41	12	0.37	0.65	0.63	0.35	G	1.12	0.082540761	Type 1 diabetes	Diabetes
rs1990760	C	T	33	43	18	67	24	3	0.58	0.84	0.42	0.16	A	1.18	0.082500086	Type 1 diabetes	Diabetes
rs9787796	C	T	65	28	1	35	39	20	0.84	0.58	0.16	0.42	T	1	0.082500086	Middle childhood and early adolescence aggressive behavior	Brain health and disorders
rs2086824	A	C	36	41	17	69	23	2	0.60	0.86	0.40	0.14	A	1.58	0.082438815	Multiple myeloma IgH translocation	Cancer
rs7940646	T	C	2	34	58	0	4	90	0.20	0.02	0.80	0.98	T	1	0.082406615	Platelet aggregation	Heart health and disorders
rs1075309	C	T	60	30	4	90	4	0	0.80	0.98	0.20	0.02	T	2.8571	0.082406615	Tuberculosis	Immune diseases and disorders
rs10998035	C	T	81	12	1	44	44	6	0.93	0.70	0.07	0.30	C	0.151	0.082352941	Eating disorders purging via substances	Brain health and disorders
rs1728918	A	G	8	40	46	1	12	81	0.30	0.07	0.70	0.93	A	1.123	0.082352941	Crohn's disease	Digestive system and its disorders
rs1747924	C	A	6	31	57	19	57	18	0.23	0.51	0.77	0.49	A	1.1111112	0.082328584	Pancreatic cancer	Cancer
rs643507	C	T	0	6	88	4	34	56	0.03	0.22	0.97	0.78	C	1	0.082317073	Body mass index in asthmatics	Obesity
rs7567851	G	C	88	6	0	58	30	6	0.97	0.78	0.03	0.22	C	0.037	0.082317073	Height	General health
rs13012266	T	C	60	30	4	21	57	16	0.80	0.53	0.20	0.47	C	0.2833	0.082250261	Metabolite levels HVA_MHPG ratio	Brain health and disorders
rs294777	A	G	0	5	89	2	36	56	0.03	0.21	0.97	0.79	A	0.1905	0.082242363	Cotinine glucuronidation	General health
rs7551641	A	C	89	5	0	56	36	2	0.97	0.79	0.03	0.21	C	34.08	0.082242363	Diisocyanate-induced asthma	Pulmonology
rs11863065	G	A	89	5	0	55	38	1	0.97	0.79	0.03	0.21	A	0.04	0.082242363	Obesity-related traits	Obesity
rs225675	A	G	35	50	9	73	20	1	0.64	0.88	0.36	0.12	G	5.29	0.082206682	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs41268896	G	A	40	40	14	72	22	0	0.64	0.88	0.36	0.12	A	1.298	0.082206682	Atopic dermatitis	Immune diseases and disorders
rs488400	G	T	36	48	10	73	20	1	0.64	0.88	0.36	0.12	T	0.0019	0.082206682	Trans fatty acid levels	General health
rs10511052	G	A	83	11	0	51	35	8	0.94	0.73	0.06	0.27	G	0.3598	0.082186152	IgG glycosylation	Immune diseases and disorders
rs7765175	C	T	25	54	15	63	28	3	0.55	0.82	0.45	0.18	T	0.21	0.082117987	Coronary artery calcification	Heart health and disorders
rs17490056	T	C	29	46	19	5	41	48	0.55	0.27	0.45	0.73	T	133.8	0.082002627	Forced expiratory volume in 1 second environmental interaction	Pulmonology
rs17747401	C	T	45	39	10	79	14	1	0.69	0.91	0.31	0.09	T	1.2	0.081904762	Hypospadias	Misc
rs1344706	A	C	46	37	11	79	14	1	0.69	0.91	0.31	0.09	T	1.12	0.081904762	Schizophrenia	Brain health and disorders
rs2298948	T	C	44	41	9	79	14	1	0.69	0.91	0.31	0.09	C	1	0.081904762	Hippocampal atrophy	Brain health and disorders
rs7711186	T	C	78	16	0	45	39	10	0.91	0.69	0.09	0.31	C	0.215	0.081904762	Urate levels in obese individuals	Obesity
rs735860	T	C	8	49	37	1	18	75	0.35	0.11	0.65	0.89	C	1.69	0.081867799	Glaucoma	General health
rs342275	C	T	38	47	9	75	18	1	0.65	0.89	0.35	0.11	C	3.742	0.081867799	Platelet count	Heart health and disorders
rs2034588	T	C	93	1	0	63	31	0	0.99	0.84	0.01	0.16	G	1	0.081758721	Response to anti-depressant treatment in major depressive disorder	General health
rs12583882	A	G	41	44	9	76	18	0	0.67	0.90	0.33	0.10	G	1	0.081756757	Subcutaneous adipose tissue	Obesity
rs470763	G	A	15	53	26	51	34	9	0.44	0.72	0.56	0.28	G	0.113	0.08169735	Economic and political preferences fairness	Mental aptitude and behavioural traits
rs2806731	C	T	7	25	62	20	50	24	0.21	0.48	0.79	0.52	G	0.04	0.081630732	Obesity-related traits	Obesity
rs13271465	T	C	3	33	58	22	46	26	0.21	0.48	0.79	0.52	A	0.03	0.081630732	Obesity-related traits	Obesity
rs4142041	A	G	30	48	16	65	27	2	0.57	0.84	0.43	0.16	G	1.14	0.081625021	Nicotine dependence	General health
rs9865818	A	G	30	48	16	66	25	3	0.57	0.84	0.43	0.16	G	1.12	0.081625021	Allergic sensitization	Immune diseases and disorders
rs12368653	G	A	33	42	19	64	29	1	0.57	0.84	0.43	0.16	A	1.1	0.081625021	Multiple sclerosis	Brain health and disorders
rs2837253	G	A	33	42	19	64	29	1	0.57	0.84	0.43	0.16	A	0.182	0.081625021	Systolic blood pressure alcohol consumption interaction	General health
rs9324268	C	T	65	27	2	30	48	16	0.84	0.57	0.16	0.43	A	0.1738	0.081625021	Renal transplant outcome	Misc
rs4712653	T	C	18	44	32	2	27	65	0.43	0.16	0.57	0.84	C	1.4	0.081625021	Neuroblastoma	Cancer
rs2467853	T	G	16	48	30	1	29	64	0.43	0.16	0.57	0.84	G	0.01	0.081625021	Renal function and chronic kidney disease	General health
rs12073837	C	T	37	42	15	73	17	4	0.62	0.87	0.38	0.13	T	1.39	0.081624358	F-cell distribution	Immune diseases and disorders
rs1531343	G	C	69	25	0	36	44	14	0.87	0.62	0.13	0.38	C	1.1	0.081624358	Type 2 diabetes	Diabetes
rs704010	T	C	14	44	36	3	19	72	0.38	0.13	0.62	0.87	T	1.08	0.081624358	Breast cancer	Cancer
rs10002492	A	G	72	19	3	40	36	18	0.87	0.62	0.13	0.38	G	0.1837	0.081624358	IgG glycosylation	Immune diseases and disorders
rs4852324	T	C	67	26	1	31	50	13	0.85	0.60	0.15	0.40	T	1.2658	0.081447964	Systemic lupus erythematosus	Immune diseases and disorders
rs7581224	G	T	32	48	14	67	26	1	0.60	0.85	0.40	0.15	T	0.2	0.081447964	Coronary artery calcification	Heart health and disorders
rs6825268	A	G	19	44	31	47	41	6	0.44	0.72	0.56	0.28	G	1.0526316	0.08141321	Schizophrenia	Brain health and disorders
rs7319358	C	T	23	57	14	63	27	4	0.55	0.81	0.45	0.19	A	1	0.081380208	Ulcerative colitis	Immune diseases and disorders
rs990871	C	T	5	35	54	22	53	19	0.24	0.52	0.76	0.48	T	1	0.081377152	Subcutaneous adipose tissue	Obesity
rs9977253	C	T	10	29	55	0	10	84	0.26	0.05	0.74	0.95	G	0.76	0.081323852	Non-alcoholic fatty liver disease histology other	Obesity
rs7830341	G	A	84	10	0	48	43	3	0.95	0.74	0.05	0.26	G	0.068	0.081323852	Body mass index	Obesity
rs6532197	A	G	82	11	1	50	34	10	0.93	0.71	0.07	0.29	G	1.32	0.081195962	Parkinson's disease	Brain health and disorders
rs10513432	T	C	81	13	0	45	44	5	0.93	0.71	0.07	0.29	G	1	0.081195962	Immune reponse to smallpox secreted IL-2	Immune diseases and disorders
rs17045031	G	A	81	13	0	46	42	6	0.93	0.71	0.07	0.29	A	0.2986	0.081195962	Carotid intima media thickness	Heart health and disorders
rs2847297	A	G	50	34	10	15	51	28	0.71	0.43	0.29	0.57	G	1.1	0.081149791	Rheumatoid arthritis	Immune diseases and disorders
rs12499086	G	A	18	45	31	48	38	8	0.43	0.71	0.57	0.29	G	0.129	0.081149791	Economic and political preferences time	Mental aptitude and behavioural traits
rs17824620	C	A	36	47	11	71	23	0	0.63	0.88	0.37	0.12	C	2.457	0.080985915	Platelet count	Heart health and disorders
rs4143832	T	G	2	19	73	15	39	40	0.12	0.37	0.88	0.63	C	7.1	0.080985915	Eosinophil counts	General health
rs7002619	T	G	4	15	75	12	45	37	0.12	0.37	0.88	0.63	T	1.1	0.080985915	Schizophrenia	Brain health and disorders
rs10148671	T	C	20	50	24	57	28	9	0.48	0.76	0.52	0.24	C	1.0526316	0.080938697	Schizophrenia	Brain health and disorders
rs825937	C	A	54	34	6	21	48	25	0.76	0.48	0.24	0.52	C	0.83	0.080938697	Blood pressure	Heart health and disorders
rs12611820	T	G	54	34	6	20	50	24	0.76	0.48	0.24	0.52	C	0.169	0.080938697	Vitamin B levels in ischemic stroke	General health
rs896854	T	C	19	42	33	49	35	10	0.43	0.71	0.57	0.29	T	1.06	0.080906708	Type 2 diabetes	Diabetes
rs8032939	T	C	32	44	18	5	45	44	0.57	0.29	0.43	0.71	C	1.13	0.080906708	Rheumatoid arthritis	Immune diseases and disorders
rs6568401	C	T	0	32	62	11	59	24	0.17	0.43	0.83	0.57	C	0.19	0.080790067	Primary tooth development time to first tooth eruption	Misc
rs17742757	C	T	16	47	31	44	44	6	0.42	0.70	0.58	0.30	C	1.64	0.080683613	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs7674369	G	A	31	47	16	9	38	47	0.58	0.30	0.42	0.70	A	1.29	0.080683613	Chronic obstructive pulmonary disease	Immune diseases and disorders
rs6717918	T	C	32	45	17	6	44	44	0.58	0.30	0.42	0.70	T	0.44	0.080683613	Height	General health
rs10750173	T	C	48	36	10	15	49	30	0.70	0.42	0.30	0.58	T	0.16	0.080683613	Intraocular pressure	General health
rs10838708	G	A	31	40	23	60	32	2	0.54	0.81	0.46	0.19	G	1.15	0.080676391	Height	General health
rs11170624	G	T	63	26	5	30	42	22	0.81	0.54	0.19	0.46	T	0.037	0.080676391	Height	General health
rs980000	C	T	79	15	0	45	41	8	0.92	0.70	0.08	0.30	T	4.69	0.080592105	Menarche age at onset	Reproductive health
rs73388146	G	A	85	9	0	49	43	2	0.95	0.75	0.05	0.25	G	1.1494253	0.080580357	Schizophrenia	Brain health and disorders
rs1584468	G	A	85	9	0	55	31	8	0.95	0.75	0.05	0.25	A	1	0.080580357	Immune reponse to smallpox secreted IL-12p40	Immune diseases and disorders
rs10514758	T	G	85	9	0	52	37	5	0.95	0.75	0.05	0.25	G	0.321	0.080580357	Urate levels in obese individuals	Obesity
rs4380187	A	C	42	38	14	75	17	2	0.65	0.89	0.35	0.11	A	1.078	0.080539315	Schizophrenia	Brain health and disorders
rs13173682	T	C	8	50	36	3	15	76	0.35	0.11	0.65	0.89	A	0.03	0.080539315	Obesity-related traits	Obesity
rs11682175	T	C	22	45	27	55	31	8	0.47	0.75	0.53	0.25	C	1.0752687	0.080524122	Schizophrenia	Brain health and disorders
rs1879637	C	T	5	37	52	30	39	25	0.25	0.53	0.75	0.47	C	0.1	0.080524122	Personality dimensions	Brain health and disorders
rs17631303	A	G	61	33	0	92	2	0	0.82	0.99	0.18	0.01	G	1.27	0.080519481	Ovarian cancer in BRCA1 mutation carriers	Cancer
rs1442808	T	C	0	2	92	2	29	63	0.01	0.18	0.99	0.82	A	34.08	0.080519481	Diisocyanate-induced asthma	Pulmonology
rs3951439	C	T	0	2	92	5	23	66	0.01	0.18	0.99	0.82	G	0.03	0.080519481	Obesity-related traits	Obesity
rs11211480	A	G	34	43	17	67	25	2	0.59	0.85	0.41	0.15	G	1.9278966	0.080503145	Clozapine-induced agranulocytosis	General health
rs13437751	C	T	66	27	1	34	43	17	0.85	0.59	0.15	0.41	T	1	0.080503145	QT interval interaction	Heart health and disorders
rs17721822	G	A	32	47	15	67	25	2	0.59	0.85	0.41	0.15	A	0.035	0.080503145	Height	General health
rs17518584	C	T	17	44	33	43	45	6	0.41	0.70	0.59	0.30	T	5.92	0.080480188	Information processing speed	Mental aptitude and behavioural traits
rs7937612	T	C	47	37	10	15	48	31	0.70	0.41	0.30	0.59	T	0.16	0.080480188	Intraocular pressure	General health
rs6589812	T	C	47	37	10	15	48	31	0.70	0.41	0.30	0.59	T	0.16	0.080480188	Intraocular pressure	General health
rs6466479	T	G	58	31	5	25	46	23	0.78	0.51	0.22	0.49	G	0.2414	0.080478975	IgG glycosylation	Immune diseases and disorders
rs3793039	A	G	58	31	5	15	66	13	0.78	0.51	0.22	0.49	G	0.2388	0.080478975	IgG glycosylation	Immune diseases and disorders
rs4792814	T	C	20	52	22	3	35	56	0.49	0.22	0.51	0.78	G	1.08	0.080478975	Multiple sclerosis	Brain health and disorders
rs12450323	G	T	42	44	8	77	17	0	0.68	0.91	0.32	0.09	T	1.16	0.080310993	Asthma and hay fever	Immune diseases and disorders
rs10860964	T	C	42	44	8	78	15	1	0.68	0.91	0.32	0.09	T	1.06	0.080310993	Schizophrenia	Brain health and disorders
rs8048207	C	T	78	15	1	42	44	8	0.91	0.68	0.09	0.32	T	1	0.080310993	Non-small cell lung cancer	Cancer
rs11987678	T	C	77	17	0	44	40	10	0.91	0.68	0.09	0.32	C	0.32	0.080310993	Sleep duration	General health
rs13147758	A	G	43	42	9	77	17	0	0.68	0.91	0.32	0.09	G	0.1	0.080310993	Pulmonary function	Pulmonology
rs1512281	A	G	43	42	9	77	17	0	0.68	0.91	0.32	0.09	A	0.08	0.080310993	Percentage gas trapping	Misc
rs2503875	G	A	44	37	13	77	15	2	0.66	0.90	0.34	0.10	A	1.66	0.080305293	Multiple sclerosis	Brain health and disorders
rs12118362	G	A	41	43	10	75	19	0	0.66	0.90	0.34	0.10	A	0.172	0.080305293	Vitamin B levels in ischemic stroke	General health
rs7702276	C	T	32	48	14	7	45	42	0.60	0.31	0.40	0.69	T	1	0.080131222	Alzheimer's disease biomarkers	Brain health and disorders
rs6835174	C	T	82	12	0	48	40	6	0.94	0.72	0.06	0.28	T	0.34	0.080128205	Cannabis use initiation	General health
rs11099098	G	T	49	38	7	83	10	1	0.72	0.94	0.28	0.06	T	0.029	0.080128205	Urate levels	General health
rs6665019	G	A	61	29	4	24	53	17	0.80	0.54	0.20	0.46	A	0.5008	0.08000512	Dementia and core Alzheimer's disease neuropathologic changes	Brain health and disorders
rs702485	A	G	19	49	26	6	25	63	0.46	0.20	0.54	0.80	G	0.024	0.08000512	HDL cholesterol	General health
rs37062	A	G	35	36	23	63	29	2	0.56	0.82	0.44	0.18	A	6.09	0.079993337	Electrocardiographic traits	Heart health and disorders
rs246196	T	C	35	36	23	63	29	2	0.56	0.82	0.44	0.18	C	1.73	0.079993337	QT interval	Heart health and disorders
rs13209747	C	T	30	46	18	65	25	4	0.56	0.82	0.44	0.18	T	0.85	0.079993337	Blood pressure	Heart health and disorders
rs12035879	G	A	32	42	20	64	27	3	0.56	0.82	0.44	0.18	A	0.048	0.079993337	Liver enzyme levels alanine transaminase	General health
rs11826937	A	T	86	8	0	51	41	2	0.96	0.76	0.04	0.24	A	0.6	0.079969624	Retinopathy in non-diabetics	General health
rs10509168	T	C	26	43	25	56	34	4	0.51	0.78	0.49	0.22	T	1	0.079944675	Percent mammographic density	General health
rs4799915	C	T	12	37	45	31	52	11	0.32	0.61	0.68	0.39	T	1	0.079857854	Response to iloperidone treatment QT prolongation	General health
rs1077835	A	G	45	37	12	17	40	37	0.68	0.39	0.32	0.61	A	0.17	0.079857854	HDL cholesterol	General health
rs1077834	T	C	45	37	12	17	40	37	0.68	0.39	0.32	0.61	T	0.14	0.079857854	Hematological and biochemical traits	Heart health and disorders
rs7301826	C	T	13	48	33	44	39	11	0.39	0.68	0.61	0.32	C	0.027	0.079857854	Plasma plasminogen activator levels	General health
rs11039571	G	A	70	24	0	36	46	12	0.87	0.63	0.13	0.37	G	0.039	0.079824959	D-dimer levels	Heart health and disorders
rs11158026	C	T	25	51	18	5	39	50	0.54	0.26	0.46	0.74	C	1.11	0.079764012	Parkinson's disease	Brain health and disorders
rs9487094	G	A	40	35	19	9	44	41	0.61	0.33	0.39	0.67	G	4.7	0.079749028	Height	General health
rs1558324	G	A	33	49	12	6	50	38	0.61	0.33	0.39	0.67	A	0.01	0.079749028	Mean platelet volume	Heart health and disorders
rs12185268	A	G	60	33	1	91	3	0	0.81	0.98	0.19	0.02	A	1.3	0.079725942	Parkinson's disease	Brain health and disorders
rs13430864	T	G	91	3	0	61	31	2	0.98	0.81	0.02	0.19	G	1	0.079725942	Response to citalopram treatment	General health
rs76513344	C	A	91	3	0	62	29	3	0.98	0.81	0.02	0.19	C	0.0995	0.079725942	Cotinine glucuronidation	General health
rs4619890	G	A	30	50	14	68	22	4	0.59	0.84	0.41	0.16	G	1.2	0.07960199	Glaucoma primary open-angle	General health
rs6496667	C	A	68	22	4	32	46	16	0.84	0.59	0.16	0.41	A	1.09	0.07960199	Rheumatoid arthritis	Immune diseases and disorders
rs227731	T	G	36	45	13	11	42	41	0.62	0.34	0.38	0.66	C	1.38	0.079586344	Orofacial clefts	Misc
rs11165354	C	A	17	36	41	42	39	13	0.37	0.65	0.63	0.35	A	1.17	0.079532263	Type 2 diabetes	Diabetes
rs533123	G	A	1	25	68	13	48	33	0.14	0.39	0.86	0.61	A	1.08	0.079531953	Schizophrenia	Brain health and disorders
rs6658356	G	A	87	7	0	55	35	4	0.96	0.77	0.04	0.23	A	1	0.079509202	Response to statin therapy	General health
rs1793257	C	T	87	7	0	53	39	2	0.96	0.77	0.04	0.23	A	0.83	0.079509202	Alcohol dependence	General health
rs7624766	A	G	39	41	14	9	48	37	0.63	0.35	0.37	0.65	G	2.28	0.07949625	Response to methotrexate in rheumatoid arthritis	General health
rs1900004	C	T	36	49	9	12	44	38	0.64	0.36	0.36	0.64	T	0.102	0.079478256	Optic disc area	Misc
rs966423	C	T	27	40	27	56	33	5	0.50	0.77	0.50	0.23	C	1.34	0.079436826	Thyroid cancer	Cancer
rs4979906	A	G	56	33	5	26	42	26	0.77	0.50	0.23	0.50	G	1.23	0.079436826	Mortality in heart failure	Heart health and disorders
rs1355023	T	C	58	29	7	21	52	21	0.77	0.50	0.23	0.50	T	1.13	0.079436826	Age-related macular degeneration	Aging
rs10032549	A	G	15	56	23	49	40	5	0.46	0.73	0.54	0.27	A	0.93	0.079417293	Glomerular filtration rate	General health
rs7134594	C	T	31	40	23	8	34	52	0.54	0.27	0.46	0.73	C	0.44	0.079417293	HDL cholesterol	General health
rs87938	A	G	24	54	16	5	40	49	0.54	0.27	0.46	0.73	A	0.07	0.079417293	Bone mineral density hip	General health
rs9861887	C	T	2	34	58	22	44	28	0.20	0.47	0.80	0.53	T	1	0.079365079	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs525455	G	A	21	46	27	1	36	57	0.47	0.20	0.53	0.80	G	1	0.079365079	Platelet aggregation	Heart health and disorders
rs10736877	G	A	4	30	60	24	40	30	0.20	0.47	0.80	0.53	A	0.131	0.079365079	Sitting height ratio	Appearance
rs11071657	A	G	26	48	20	58	34	2	0.53	0.80	0.47	0.20	A	1	0.079365079	Fasting glucose-related traits	General health
rs13255292	C	T	46	41	7	81	12	1	0.71	0.93	0.29	0.07	T	1.22	0.079356087	Diffuse large B cell lymphoma	Cancer
rs12500579	C	G	81	12	1	47	39	8	0.93	0.71	0.07	0.29	G	0.42	0.079356087	Fractional exhaled nitric oxide childhood	Pulmonology
rs11864909	C	T	47	39	8	80	14	0	0.71	0.93	0.29	0.07	C	0.0052	0.079356087	Renal function-related traits sCR	General health
rs7120489	A	G	1	12	81	5	45	44	0.07	0.29	0.93	0.71	A	1.35	0.079356087	Mortality in heart failure	Heart health and disorders
rs12550729	C	T	1	12	81	5	45	44	0.07	0.29	0.93	0.71	T	0.064	0.079356087	Blood metabolite levels	Heart health and disorders
rs7344105	A	G	90	4	0	60	31	3	0.98	0.80	0.02	0.20	G	15.21	0.079286494	Diisocyanate-induced asthma	Pulmonology
rs7735563	T	C	90	4	0	61	29	4	0.98	0.80	0.02	0.20	G	6.67	0.079286494	Diisocyanate-induced asthma	Pulmonology
rs11211309	A	T	62	27	5	90	4	0	0.80	0.98	0.20	0.02	A	1.41	0.079286494	Schizophrenia	Brain health and disorders
rs2857009	G	C	41	39	14	72	22	0	0.64	0.88	0.36	0.12	G	0.08	0.07927808	Complement C3 and C4 levels	Immune diseases and disorders
rs567754	C	T	35	51	8	73	20	1	0.64	0.88	0.36	0.12	T	0.018	0.07927808	Toenail selenium levels	Misc
rs12623288	G	A	62	30	2	24	57	13	0.82	0.56	0.18	0.44	A	1	0.079233079	Hair morphology	Appearance
rs4811971	G	A	1	32	61	14	55	25	0.18	0.44	0.82	0.56	C	0.7	0.079233079	Height	General health
rs2115200	T	G	59	29	6	88	6	0	0.78	0.97	0.22	0.03	T	0.098	0.079221367	Eating disorders	Brain health and disorders
rs1323292	G	A	4	33	57	0	6	88	0.22	0.03	0.78	0.97	A	1.12	0.079221367	Multiple sclerosis	Brain health and disorders
rs1805081	T	C	53	32	9	83	11	0	0.73	0.94	0.27	0.06	A	1	0.079156909	Obesity	Obesity
rs7307889	C	T	83	11	0	50	38	6	0.94	0.73	0.06	0.27	A	0.04	0.079156909	Obesity-related traits	Obesity
rs10036748	C	T	24	47	23	7	30	57	0.51	0.23	0.49	0.77	T	1.25	0.078954558	Systemic lupus erythematosus	Immune diseases and disorders
rs8058295	C	A	56	32	6	22	49	23	0.77	0.49	0.23	0.51	A	1.06	0.078954558	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs1386478	A	G	45	40	9	78	16	0	0.69	0.91	0.31	0.09	A	1.12	0.078933238	Crohn's disease and psoriasis	Digestive system and its disorders
rs2858942	A	C	9	46	39	0	20	74	0.34	0.11	0.66	0.89	A	0.069	0.078930202	Mean corpuscular hemoglobin	Heart health and disorders
rs4308051	T	G	11	42	41	1	18	75	0.34	0.11	0.66	0.89	G	0.055	0.078930202	Sitting height ratio	Appearance
rs56728521	A	C	76	18	0	41	45	8	0.90	0.68	0.10	0.32	A	8.65	0.078804927	Heschl's gyrus morphology	Brain health and disorders
rs4833095	T	C	29	46	19	8	36	50	0.55	0.28	0.45	0.72	T	1.2	0.078787879	Asthma and hay fever	Immune diseases and disorders
rs10206020	T	C	59	31	4	21	57	16	0.79	0.53	0.21	0.47	C	0.1805	0.07875504	IgG glycosylation	Immune diseases and disorders
rs4886755	A	G	28	43	23	57	35	2	0.53	0.79	0.47	0.21	G	0.094	0.07875504	Urate levels in obese individuals	Obesity
rs194151	C	T	27	45	22	58	33	3	0.53	0.79	0.47	0.21	A	0.03	0.07875504	Obesity-related traits	Obesity
rs178585	T	C	23	43	28	4	31	59	0.47	0.21	0.53	0.79	C	1.13	0.07875504	Alzheimer's disease in APOE e4+ carriers	Brain health and disorders
rs6029526	T	A	22	45	27	3	33	58	0.47	0.21	0.53	0.79	A	0.04	0.07875504	Cholesterol, total	General health
rs750338	A	G	66	25	3	27	55	12	0.84	0.58	0.16	0.42	C	1	0.07874231	Alcohol dependence	General health
rs2660753	T	C	3	22	69	17	41	36	0.15	0.40	0.85	0.60	T	1.1904762	0.078558981	Prostate cancer	Cancer
rs13394619	G	A	15	45	34	2	24	68	0.40	0.15	0.60	0.85	G	1.15	0.078558981	Endometriosis	General health
rs7680126	G	A	17	41	36	1	26	67	0.40	0.15	0.60	0.85	G	0.341	0.078558981	Urate levels in lean individuals	Obesity
rs226444	A	G	11	53	30	1	26	67	0.40	0.15	0.60	0.85	A	0.0534	0.078558981	Trans fatty acid levels	General health
rs2284932	G	A	35	43	16	68	24	2	0.60	0.85	0.40	0.15	C	4.35	0.078558981	Lachrymal_Salivary gland lesion in type 1 autoimmune pancreatitis	Immune diseases and disorders
rs4813802	T	G	32	49	13	68	24	2	0.60	0.85	0.40	0.15	G	1.1	0.078558981	Colorectal cancer	Cancer
rs7122181	A	T	18	48	28	2	31	61	0.45	0.19	0.55	0.81	T	1.0526316	0.078507668	Schizophrenia	Brain health and disorders
rs9310709	T	C	17	49	28	50	35	9	0.44	0.72	0.56	0.28	C	1.15	0.078504239	Chronic kidney disease and serum creatinine levels	Immune diseases and disorders
rs12474906	A	C	46	43	5	14	55	25	0.72	0.44	0.28	0.56	A	1.07	0.078504239	Schizophrenia	Brain health and disorders
rs4971100	G	A	19	44	31	48	38	8	0.44	0.71	0.56	0.29	A	0.02982	0.078240741	Magnesium levels	General health
rs563694	C	A	8	37	49	1	11	82	0.28	0.07	0.72	0.93	C	1	0.078201369	Fasting plasma glucose	General health
rs7232775	C	T	7	39	48	1	11	82	0.28	0.07	0.72	0.93	C	0.0148	0.078201369	Metabolite levels	General health
rs9373124	T	C	58	32	4	25	48	21	0.79	0.52	0.21	0.48	C	1	0.078173859	Other erythrocyte phenotypes	Immune diseases and disorders
rs4984499	T	A	12	44	38	0	23	71	0.36	0.12	0.64	0.88	T	1.06	0.078079815	Migraine	Brain health and disorders
rs11039131	C	T	39	42	13	74	17	3	0.64	0.88	0.36	0.12	C	1.0526316	0.078079815	Schizophrenia	Brain health and disorders
rs2651899	T	C	30	37	27	5	36	53	0.52	0.24	0.48	0.76	C	1.11	0.078063567	Migraine	Brain health and disorders
rs12903146	G	A	20	51	23	51	40	3	0.48	0.76	0.52	0.24	A	1.07	0.078063567	Schizophrenia	Brain health and disorders
rs4686760	G	A	23	45	26	55	32	7	0.48	0.76	0.52	0.24	G	0.15	0.078063567	vWF and FVIII levels	Heart health and disorders
rs7191820	A	G	23	45	26	56	30	8	0.48	0.76	0.52	0.24	A	0.03	0.078063567	Obesity-related traits	Obesity
rs7173419	T	C	18	45	31	45	43	6	0.43	0.71	0.57	0.29	T	0.33	0.077997	Eye color	Appearance
rs11675251	A	G	18	45	31	49	35	10	0.43	0.71	0.57	0.29	A	0.15	0.077997	Butyrylcholinesterase levels	Cancer
rs10799701	A	G	19	43	32	48	37	9	0.43	0.71	0.57	0.29	A	0.131	0.077997	Metabolic traits	Misc
rs6001832	A	G	26	56	12	67	22	5	0.57	0.83	0.43	0.17	G	1.089	0.077922078	Hand grip strength	Appearance
rs921943	C	T	66	24	4	27	54	13	0.83	0.57	0.17	0.43	T	0.246	0.077922078	Blood trace element Se levels	Heart health and disorders
rs1346987	C	A	64	28	2	30	48	16	0.83	0.57	0.17	0.43	C	0.18	0.077922078	Economic and political preferences immigration_crime	Mental aptitude and behavioural traits
rs6726821	T	G	34	40	20	65	26	3	0.57	0.83	0.43	0.17	T	0.091	0.077922078	Bone mineral density paediatric, total body less head	General health
rs1346004	G	A	34	40	20	65	26	3	0.57	0.83	0.43	0.17	A	0.06	0.077922078	Bone mineral density	General health
rs2970992	C	A	14	57	23	5	26	63	0.45	0.19	0.55	0.81	A	0.02	0.077815589	Educational attainment	Mental aptitude and behavioural traits
rs8035957	T	C	32	44	18	7	42	45	0.57	0.30	0.43	0.70	C	1.14	0.077772665	Type 1 diabetes	Diabetes
rs7818382	C	T	19	42	33	45	42	7	0.43	0.70	0.57	0.30	T	1.07	0.077772665	Alzheimer's disease late onset	Brain health and disorders
rs12326088	T	G	20	40	34	42	48	4	0.43	0.70	0.57	0.30	C	0.04	0.077772665	Obesity-related traits	Obesity
rs6445797	C	G	34	48	12	70	22	2	0.62	0.86	0.38	0.14	C	1.402	0.077668477	Gastritis	Cancer
rs59979824	C	A	36	44	14	70	22	2	0.62	0.86	0.38	0.14	C	1.0672358	0.077668477	Schizophrenia	Brain health and disorders
rs586688	G	A	69	24	1	36	44	14	0.86	0.62	0.14	0.38	A	0.03	0.077668477	Obesity-related traits	Obesity
rs7729356	C	A	36	44	14	69	24	1	0.62	0.86	0.38	0.14	A	0.021	0.077668477	Educational attainment	Mental aptitude and behavioural traits
rs10218712	T	G	53	35	6	19	52	23	0.75	0.48	0.25	0.52	T	1.06	0.077653381	Schizophrenia	Brain health and disorders
rs10853575	T	C	52	37	5	21	48	25	0.75	0.48	0.25	0.52	T	1.05	0.077653381	Schizophrenia	Brain health and disorders
rs13252298	A	G	29	54	11	66	27	1	0.60	0.85	0.40	0.15	A	1.12	0.077631348	Prostate cancer	Cancer
rs154657	G	A	33	46	15	67	25	2	0.60	0.85	0.40	0.15	A	0.0963	0.077631348	Homocysteine levels	Misc
rs13259853	T	A	46	40	8	79	15	0	0.70	0.92	0.30	0.08	A	0.088	0.077626414	Percentage gas trapping	Misc
rs2283873	G	A	73	21	0	37	49	8	0.89	0.65	0.11	0.35	A	2.05	0.077626303	Wilms tumor	Cancer
rs2294239	A	G	26	45	23	60	27	7	0.52	0.78	0.48	0.22	A	0.0284	0.077620467	Waist-to-hip ratio adjusted for body mass index	Obesity
rs6499255	A	G	46	39	9	17	45	32	0.70	0.42	0.30	0.58	A	0.11	0.077567413	IgE levels	Immune diseases and disorders
rs13105210	C	T	52	38	4	85	9	0	0.76	0.95	0.24	0.05	C	1.27	0.077541773	Chronic obstructive pulmonary disease	Immune diseases and disorders
rs7137521	G	T	92	2	0	65	26	3	0.99	0.83	0.01	0.17	A	34.08	0.077399381	Diisocyanate-induced asthma	Pulmonology
rs10255329	G	C	92	2	0	64	28	2	0.99	0.83	0.01	0.17	C	0.06	0.077399381	Metabolite levels  X-11787	General health
rs1061955	G	A	92	2	0	63	30	1	0.99	0.83	0.01	0.17	A	0.03	0.077399381	Obesity-related traits	Obesity
rs2352028	C	T	43	44	7	19	40	35	0.69	0.41	0.31	0.59	A	1.46	0.077380952	Lung cancer	Cancer
rs17496827	A	C	17	44	33	47	36	11	0.41	0.69	0.59	0.31	C	0.042	0.077380952	Anorexia nervosa	Brain health and disorders
rs498872	A	G	13	36	45	2	15	77	0.33	0.10	0.67	0.90	T	1.18	0.077380205	Glioma	Cancer
rs7495694	A	G	0	0	94	0	27	67	0.00	0.14	1.00	0.86	G	7.6	0.077363897	Epilepsy and lamotrigine-induced maculopapular eruptions	Brain health and disorders
rs193153567	C	T	94	0	0	67	27	0	1.00	0.86	0.00	0.14	T	0.017	0.077363897	Magnesium levels	General health
rs9951150	A	G	29	41	24	3	42	49	0.53	0.26	0.47	0.74	A	1.06	0.077265841	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs2247419	A	G	6	36	52	24	51	19	0.26	0.53	0.74	0.47	G	1.0526316	0.077265841	Schizophrenia	Brain health and disorders
rs6549915	T	C	25	49	20	1	46	47	0.53	0.26	0.47	0.74	T	0.078	0.077265841	Breast size	General health
rs987525	C	A	50	40	4	24	41	29	0.74	0.47	0.26	0.53	A	1.78	0.077265841	Cleft lip	Misc
rs16863064	G	C	53	34	7	19	51	24	0.74	0.47	0.26	0.53	G	1.0638298	0.077265841	Schizophrenia	Brain health and disorders
rs6469937	G	A	26	50	18	62	27	5	0.54	0.80	0.46	0.20	A	1.27	0.077155436	Myopia severe	General health
rs4650994	G	A	25	52	17	62	27	5	0.54	0.80	0.46	0.20	G	0.021	0.077155436	HDL cholesterol	General health
rs3132565	A	G	18	50	26	4	29	61	0.46	0.20	0.54	0.80	A	1.07	0.077155436	Schizophrenia	Brain health and disorders
rs10037512	T	C	19	43	32	3	27	64	0.43	0.18	0.57	0.82	T	0.041	0.077139413	Height	General health
rs4240326	A	G	17	47	30	3	27	64	0.43	0.18	0.57	0.82	A	0.04	0.077139413	Height	General health
rs13068101	G	A	51	35	8	82	12	0	0.73	0.94	0.27	0.06	A	8.5	0.077133729	Sleep time	General health
rs7007970	C	G	82	12	0	53	31	10	0.94	0.73	0.06	0.27	C	0.041	0.077133729	Height	General health
rs433406	A	G	32	48	14	6	48	40	0.60	0.32	0.40	0.68	G	1	0.077063383	Male fertility	Reproductive health
rs12679556	T	G	32	48	14	9	42	43	0.60	0.32	0.40	0.68	G	0.0329	0.077063383	Waist-to-hip ratio adjusted for body mass index	Obesity
rs10838725	T	C	59	26	9	86	8	0	0.77	0.96	0.23	0.04	C	1.08	0.076923077	Alzheimer's disease late onset	Brain health and disorders
rs6840361	C	G	86	8	0	54	36	4	0.96	0.77	0.04	0.23	C	1	0.076923077	Hair morphology	Appearance
rs9303521	T	G	22	56	16	2	45	47	0.53	0.26	0.47	0.74	T	0.07	0.076900334	Bone mineral density spine	General health
rs3771166	G	A	35	45	14	5	53	36	0.61	0.34	0.39	0.66	G	1.15	0.076722279	Asthma	Immune diseases and disorders
rs2219089	T	A	36	43	15	10	43	41	0.61	0.34	0.39	0.66	T	1.0526316	0.076722279	Schizophrenia	Brain health and disorders
rs634010	T	C	20	33	41	0	27	67	0.39	0.14	0.61	0.86	T	1.04	0.076666667	Body mass index change over time	Obesity
rs1714746	G	A	14	44	36	40	44	10	0.38	0.66	0.62	0.34	G	1.61	0.076643991	Adverse response to chemotherapy neutropenia_leucopenia carboplatin	Drug response
rs2876189	A	G	42	40	12	19	34	41	0.66	0.38	0.34	0.62	G	1.14	0.076643991	Alzheimer's disease in APOE e4+ carriers	Brain health and disorders
rs17689882	G	A	61	32	1	91	3	0	0.82	0.98	0.18	0.02	A	13460.47	0.076616439	Subcortical brain region volumes	Brain health and disorders
rs487836	A	G	91	3	0	61	32	1	0.98	0.82	0.02	0.18	G	34.03	0.076616439	Diisocyanate-induced asthma	Pulmonology
rs1981997	G	A	61	32	1	91	3	0	0.82	0.98	0.18	0.02	G	1.41	0.076616439	Interstitial lung disease	Pulmonology
rs12373124	T	C	61	32	1	91	3	0	0.82	0.98	0.18	0.02	T	1.33	0.076616439	Male-pattern baldness	Appearance
rs17649553	C	T	61	32	1	91	3	0	0.82	0.98	0.18	0.02	C	1.3	0.076616439	Parkinson's disease	Brain health and disorders
rs2942168	G	A	61	32	1	91	3	0	0.82	0.98	0.18	0.02	G	1.27	0.076616439	Parkinson's disease	Brain health and disorders
rs13395546	A	G	91	3	0	62	30	2	0.98	0.82	0.02	0.18	A	0.16	0.076616439	Metabolite levels Dihydroxy docosatrienoic acid	General health
rs1864325	C	T	61	32	1	91	3	0	0.82	0.98	0.18	0.02	T	0.04	0.076616439	Bone mineral density	General health
rs12718597	C	A	26	43	25	58	29	7	0.51	0.77	0.49	0.23	A	1	0.076593137	Mean corpuscular volume	Heart health and disorders
rs1912816	A	G	39	39	16	9	47	38	0.62	0.35	0.38	0.65	A	1.2821	0.076583211	Bronchopulmonary dysplasia	Pulmonology
rs2605393	T	G	40	42	12	16	38	40	0.65	0.37	0.35	0.63	G	1	0.076539855	Celiac disease	Immune diseases and disorders
rs1013063	T	C	13	44	37	41	40	13	0.37	0.65	0.63	0.35	T	0.08	0.076539855	Body mass index interaction	Obesity
rs4652795	C	T	16	38	40	38	46	10	0.37	0.65	0.63	0.35	G	0.03	0.076539855	Obesity-related traits	Obesity
rs35214987	G	C	28	45	21	59	32	3	0.54	0.80	0.46	0.20	G	3.3262	0.076525896	Cognitive function	Brain health and disorders
rs1032355	T	C	61	28	5	29	43	22	0.80	0.54	0.20	0.46	C	1	0.076525896	Celiac disease	Immune diseases and disorders
rs2292884	A	G	40	39	15	11	45	38	0.63	0.36	0.37	0.64	G	1.14	0.076513865	Prostate cancer	Cancer
rs9513627	G	A	0	7	87	3	36	55	0.04	0.22	0.96	0.78	G	0.03	0.076452599	Obesity-related traits	Obesity
rs61550741	A	G	87	7	0	52	42	0	0.96	0.78	0.04	0.22	G	2.27	0.076452599	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs10514550	T	C	60	26	8	87	7	0	0.78	0.96	0.22	0.04	T	0.0018	0.076452599	Trans fatty acid levels	General health
rs11543198	G	A	47	40	7	80	14	0	0.71	0.93	0.29	0.07	G	1.41	0.076394194	Bladder cancer	Cancer
rs6558295	C	G	81	12	1	45	44	5	0.93	0.71	0.07	0.29	G	0.121	0.076394194	Metabolic traits	Misc
rs7822232	A	C	81	12	1	45	44	5	0.93	0.71	0.07	0.29	A	0.03	0.076394194	Blood metabolite levels	Heart health and disorders
rs17388568	G	A	63	26	5	90	4	0	0.81	0.98	0.19	0.02	A	1.26	0.076190476	Type 1 diabetes	Diabetes
rs12908161	A	G	61	30	3	90	4	0	0.81	0.98	0.19	0.02	A	1.08	0.076190476	Schizophrenia	Brain health and disorders
rs17112190	G	A	83	11	0	53	33	8	0.94	0.74	0.06	0.26	A	1.8	0.076160338	Multiple myeloma IgH translocation	Cancer
rs17142067	A	C	58	32	4	88	6	0	0.79	0.97	0.21	0.03	A	0.299	0.076152833	End-stage coagulation	General health
rs3795958	A	G	59	30	5	88	6	0	0.79	0.97	0.21	0.03	G	0.2394	0.076152833	Metabolite levels HVA	General health
rs7617937	A	G	26	42	26	4	36	54	0.50	0.23	0.50	0.77	A	1.05	0.076117403	Schizophrenia	Brain health and disorders
rs1335532	A	G	55	34	5	15	64	15	0.77	0.50	0.23	0.50	A	1.28	0.076117403	Multiple sclerosis	Brain health and disorders
rs2315885	C	T	58	34	2	89	5	0	0.80	0.97	0.20	0.03	T	1.41	0.076052797	Blood pressure	Heart health and disorders
rs2819742	A	G	10	43	41	4	12	78	0.34	0.11	0.66	0.89	G	2.08	0.076031087	Cerivastatin-induced rhabdomyolysis	Immune diseases and disorders
rs886126	C	T	53	30	11	14	57	23	0.72	0.45	0.28	0.55	T	1.14	0.075930521	Coronary heart disease	Heart health and disorders
rs110419	A	G	29	42	23	60	29	5	0.53	0.79	0.47	0.21	A	1.34	0.07592575	Neuroblastoma	Cancer
rs6747972	A	G	20	48	26	1	37	56	0.47	0.21	0.53	0.79	A	1.23	0.07592575	Restless legs syndrome	Mental aptitude and behavioural traits
rs72932726	G	A	67	23	4	33	44	17	0.84	0.59	0.16	0.41	A	13.74	0.075902828	Heschl's gyrus morphology	Brain health and disorders
rs12564445	G	A	66	25	3	30	50	14	0.84	0.59	0.16	0.41	A	2.33	0.075902828	Cardiac Troponin-T levels	Heart health and disorders
rs9349379	A	G	38	42	14	71	21	2	0.63	0.87	0.37	0.13	A	1.3	0.075856902	Cervical artery dissection	Reproductive health
rs2014300	A	G	4	27	63	20	43	31	0.19	0.44	0.81	0.56	G	1.43	0.075679937	Esophageal cancer	Cancer
rs2022068	A	G	21	53	20	5	35	54	0.51	0.24	0.49	0.76	A	1.1831	0.07566586	Pit-and-Fissure caries	Misc
rs1549318	C	T	4	37	53	24	47	23	0.24	0.51	0.76	0.49	T	1	0.07566586	Proinsulin levels	Diabetes
rs38855	A	G	22	49	23	52	39	3	0.49	0.76	0.51	0.24	G	0.019	0.07566586	Triglycerides	General health
rs503662	T	C	10	33	51	28	48	18	0.28	0.55	0.72	0.45	T	0.11	0.075647849	LDL cholesterol	General health
rs9997524	A	C	93	1	0	66	27	1	0.99	0.85	0.01	0.15	C	0.02	0.075529865	Obesity-related traits	Obesity
rs8060686	T	C	48	38	8	25	33	36	0.71	0.44	0.29	0.56	T	0.0715	0.075384749	HDL cholesterol	General health
rs943080	C	T	20	49	25	5	30	59	0.47	0.21	0.53	0.79	T	1.15	0.075353859	Age-related macular degeneration	Aging
rs10193430	T	A	85	8	1	55	31	8	0.95	0.75	0.05	0.25	A	1	0.075290106	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs3093059	A	G	84	10	0	54	33	7	0.95	0.75	0.05	0.25	G	0.161	0.075290106	C-reactive protein	Immune diseases and disorders
rs9358749	T	G	0	13	81	7	38	49	0.07	0.28	0.93	0.72	T	3.27	0.075241158	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs9391988	G	A	49	38	7	81	13	0	0.72	0.93	0.28	0.07	A	1	0.075241158	Fasting insulin interaction	General health
rs2526932	A	G	28	40	26	6	34	54	0.51	0.24	0.49	0.76	G	0.275	0.075237751	C-reactive protein and white blood cell count	Immune diseases and disorders
rs6768930	T	C	19	54	21	55	32	7	0.49	0.76	0.51	0.24	G	0.05	0.075237751	Obesity-related traits	Obesity
rs1051730	G	A	41	39	14	72	21	1	0.64	0.88	0.36	0.12	A	1.35	0.075213675	Lung cancer	Cancer
rs538147	G	A	36	49	9	74	17	3	0.64	0.88	0.36	0.12	G	1.23	0.075213675	Primary biliary cirrhosis	Immune diseases and disorders
rs3847794	A	G	39	43	12	73	19	2	0.64	0.88	0.36	0.12	G	1	0.075213675	Behavioural disinhibition generation interaction	Brain health and disorders
rs4859682	C	A	37	47	10	72	21	1	0.64	0.88	0.36	0.12	A	0.96	0.075213675	Glomerular filtration rate	General health
rs329648	T	C	19	44	31	49	35	10	0.44	0.71	0.56	0.29	T	1.105	0.075140835	Parkinson's disease	Brain health and disorders
rs2786189	G	T	15	54	25	2	32	60	0.45	0.19	0.55	0.81	C	1.4706	0.075	Bronchopulmonary dysplasia	Pulmonology
rs11730243	C	T	18	45	31	46	40	8	0.43	0.70	0.57	0.30	T	0.129	0.074915752	Economic and political preferences time	Mental aptitude and behavioural traits
rs3002271	A	C	36	45	13	71	20	3	0.62	0.86	0.38	0.14	A	0.019	0.074825407	Body mass index	Obesity
rs12543592	A	G	18	54	22	5	31	58	0.48	0.22	0.52	0.78	G	1.43	0.07480916	Autism spectrum disorder	Brain health and disorders
rs998731	C	T	12	40	42	2	17	75	0.34	0.11	0.66	0.89	T	1.09	0.074752375	Rheumatoid arthritis	Immune diseases and disorders
rs5747035	T	C	75	17	2	44	36	14	0.89	0.66	0.11	0.34	T	0.6585	0.074752375	Verbal declarative memory	Brain health and disorders
rs174570	C	T	40	44	10	77	13	4	0.66	0.89	0.34	0.11	G	0.06	0.074752375	HDL cholesterol	General health
rs7747960	C	A	80	13	1	48	37	9	0.92	0.71	0.08	0.29	A	1.23	0.074696545	Bipolar disorder	Brain health and disorders
rs12302103	G	A	50	33	11	79	15	0	0.71	0.92	0.29	0.08	A	1	0.074696545	Homeostasis model assessment of beta-cell function interaction	Misc
rs6969802	A	G	79	15	0	46	41	7	0.92	0.71	0.08	0.29	G	0.2669	0.074696545	IgG glycosylation	Immune diseases and disorders
rs9557635	A	G	11	33	50	0	15	79	0.29	0.08	0.71	0.92	A	1	0.074696545	Non-small cell lung cancer	Cancer
rs7314056	T	C	8	29	57	1	7	86	0.24	0.05	0.76	0.95	C	0.44	0.074534161	Urinary metabolites H-NMR features	General health
rs12580240	A	G	85	9	0	53	37	4	0.95	0.76	0.05	0.24	G	0.895	0.074534161	IgG glycosylation	Immune diseases and disorders
rs4944571	A	G	55	33	6	86	7	1	0.76	0.95	0.24	0.05	G	0.072	0.074534161	Urate levels in obese individuals	Obesity
rs2062078	G	T	36	37	21	11	36	47	0.58	0.31	0.42	0.69	T	0.032	0.074520815	Height	General health
rs12696304	C	G	45	40	9	10	59	25	0.69	0.42	0.31	0.58	G	0.11	0.074520815	Telomere length	Aging
rs1893767	A	G	75	19	0	39	49	6	0.90	0.68	0.10	0.32	G	0.04	0.074493243	Obesity-related traits	Obesity
rs12447804	C	T	42	43	9	75	19	0	0.68	0.90	0.32	0.10	T	0.038	0.074493243	Pulmonary function	Pulmonology
rs7233332	G	A	42	43	9	76	17	1	0.68	0.90	0.32	0.10	G	0.0232	0.074493243	Blood pressure age interaction	Heart health and disorders
rs13254990	C	T	45	40	9	78	15	1	0.69	0.91	0.31	0.09	T	1.18	0.074462901	Follicular lymphoma	Cancer
rs2273669	A	G	78	15	1	47	36	11	0.91	0.69	0.09	0.31	G	1.07	0.074462901	Prostate cancer	Cancer
rs41458646	A	G	47	36	11	79	13	2	0.69	0.91	0.31	0.09	G	1	0.074462901	Alzheimer's disease late onset	Brain health and disorders
rs2844775	G	A	46	38	10	77	17	0	0.69	0.91	0.31	0.09	A	0.15	0.074462901	Anger	General health
rs8008270	T	C	1	15	78	11	36	47	0.09	0.31	0.91	0.69	G	1.12	0.074462901	Prostate cancer	Cancer
rs1529093	T	C	23	44	27	54	32	8	0.48	0.74	0.52	0.26	A	4.13	0.074449077	Non-alcoholic fatty liver disease histology other	Obesity
rs6596075	G	C	5	38	51	26	46	22	0.26	0.52	0.74	0.48	C	1.55	0.074449077	Crohn's disease	Digestive system and its disorders
rs11763147	A	G	26	38	30	51	38	5	0.48	0.74	0.52	0.26	A	0.07	0.074449077	Corneal structure	General health
rs2307111	T	C	17	51	26	5	27	62	0.45	0.20	0.55	0.80	T	1.07	0.074351362	Obesity	Obesity
rs2062375	G	C	19	47	28	5	27	62	0.45	0.20	0.55	0.80	G	0.14	0.074351362	Osteoporosis-related phenotypes	Immune diseases and disorders
rs2153904	T	G	4	29	61	17	51	26	0.20	0.45	0.80	0.55	C	0.13	0.074351362	Prostate-specific antigen levels	Cancer
rs16904316	C	T	92	2	0	64	29	1	0.99	0.84	0.01	0.16	C	1	0.07429985	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs12239436	G	A	92	2	0	63	31	0	0.99	0.84	0.01	0.16	A	0.0928	0.07429985	HDL cholesterol	General health
rs1521470	A	G	1	29	64	0	2	92	0.16	0.01	0.84	0.99	A	1.07	0.07429985	Schizophrenia	Brain health and disorders
rs1549733	C	T	54	38	2	23	51	20	0.78	0.52	0.22	0.48	T	0.033	0.074290665	Optic disc area	Misc
rs9383951	G	C	94	0	0	70	22	2	1.00	0.86	0.00	0.14	G	1.14	0.074285714	Breast cancer	Cancer
rs17056274	A	G	94	0	0	69	24	1	1.00	0.86	0.00	0.14	G	0.658	0.074285714	Estradiol levels	General health
rs12092053	T	G	94	0	0	69	24	1	1.00	0.86	0.00	0.14	C	0.02	0.074285714	Obesity-related traits	Obesity
rs4389526	T	A	11	38	45	31	49	14	0.32	0.59	0.68	0.41	A	1	0.074197689	Ankylosing spondylitis	Immune diseases and disorders
rs3757037	A	G	33	45	16	8	44	42	0.59	0.32	0.41	0.68	G	0.2	0.074197689	Lipoprotein a levels	Heart health and disorders
rs6534441	C	T	12	36	46	30	51	13	0.32	0.59	0.68	0.41	C	0.1801	0.074197689	Major depressive disorder	Brain health and disorders
rs3777193	G	A	43	42	9	16	45	33	0.68	0.41	0.32	0.59	G	0.1592	0.074197689	IgG glycosylation	Immune diseases and disorders
rs10069748	T	C	43	42	9	16	45	33	0.68	0.41	0.32	0.59	C	0.1539	0.074197689	IgG glycosylation	Immune diseases and disorders
rs7709377	A	G	44	40	10	15	47	32	0.68	0.41	0.32	0.59	A	0.04	0.074197689	Metabolite levels  X-11787	General health
rs1054627	G	A	53	32	9	82	12	0	0.73	0.94	0.27	0.06	G	0.05	0.074173002	Bone mineral density	General health
rs35832626	C	T	18	53	23	47	45	2	0.47	0.74	0.53	0.26	T	0.09	0.074087245	Sitting height ratio	Appearance
rs4938534	G	A	12	37	45	32	48	14	0.32	0.60	0.68	0.40	A	1.39	0.074062473	Primary biliary cirrhosis	Immune diseases and disorders
rs793834	A	G	10	41	43	32	48	14	0.32	0.60	0.68	0.40	A	0.15	0.074062473	Information processing speed	Mental aptitude and behavioural traits
rs1800588	C	T	45	37	12	17	42	35	0.68	0.40	0.32	0.60	T	0.14	0.074062473	HDL cholesterol	General health
rs2070895	G	A	45	37	12	17	42	35	0.68	0.40	0.32	0.60	A	0.03	0.074062473	Blood metabolite levels	Heart health and disorders
rs10520163	T	C	14	47	33	39	48	7	0.40	0.67	0.60	0.33	T	1.065	0.073944563	Schizophrenia	Brain health and disorders
rs7178424	C	T	17	41	36	44	38	12	0.40	0.67	0.60	0.33	T	0.021	0.073944563	Height	General health
rs2290720	C	T	30	52	12	67	24	3	0.60	0.84	0.40	0.16	G	148.1	0.073934312	Brain structure hippocampal volume	Brain health and disorders
rs11556924	C	T	56	33	5	86	8	0	0.77	0.96	0.23	0.04	C	1.07	0.073906486	Myocardial infarction	Heart health and disorders
rs10237735	C	T	87	6	1	57	31	6	0.96	0.77	0.04	0.23	T	0.7138	0.073906486	Palmitic acid 16:0 plasma levels	General health
rs35751268	C	T	56	33	5	86	8	0	0.77	0.96	0.23	0.04	T	0.23	0.073906486	Cannabis use initiation	General health
rs17094222	T	C	54	37	3	86	8	0	0.77	0.96	0.23	0.04	C	0.031	0.073906486	Body mass index	Obesity
rs3751972	C	A	7	29	58	0	8	86	0.23	0.04	0.77	0.96	C	0.095	0.073906486	Fractional exhaled nitric oxide childhood	Pulmonology
rs4776059	C	T	19	36	39	42	41	11	0.39	0.66	0.61	0.34	T	1.06	0.073843795	Schizophrenia	Brain health and disorders
rs6845999	C	T	32	52	10	69	23	2	0.62	0.86	0.38	0.14	T	0.037	0.073843124	Height	General health
rs1298908	C	T	23	40	31	2	34	58	0.46	0.20	0.54	0.80	G	1.36	0.073732719	Diabetic kidney disease	Diabetes
rs11020821	C	A	59	32	3	28	46	20	0.80	0.54	0.20	0.46	C	1	0.073732719	Response to angiotensin II receptor blocker therapy opposite direction w_ diuretic therapy	Drug response
rs210648	A	G	22	42	30	7	24	63	0.46	0.20	0.54	0.80	G	0.122	0.073732719	Economic and political preferences	Mental aptitude and behavioural traits
rs2307449	T	G	43	37	14	14	44	36	0.65	0.38	0.35	0.62	G	0.184	0.073693158	Menopause age at onset	Reproductive health
rs2764208	A	G	35	47	12	14	38	42	0.62	0.35	0.38	0.65	G	1.28	0.073643082	Systemic lupus erythematosus	Immune diseases and disorders
rs9277554	C	T	34	53	7	17	36	41	0.64	0.37	0.36	0.63	C	4.17	0.073609735	Wegener's granulomatosis	General health
rs9447700	C	T	35	48	11	12	43	39	0.63	0.36	0.37	0.64	C	0.03	0.073609735	Menarche age at onset	Reproductive health
rs2305707	A	G	65	24	5	30	47	17	0.82	0.57	0.18	0.43	G	0.06	0.073596535	Height	General health
rs1355767	A	G	15	39	40	34	52	8	0.37	0.64	0.63	0.36	A	0.25	0.073593074	Cannabis use initiation	General health
rs11634397	A	G	10	48	36	33	53	8	0.36	0.63	0.64	0.37	G	1.06	0.073593074	Type 2 diabetes	Diabetes
rs11712165	T	G	39	45	10	72	22	0	0.65	0.88	0.35	0.12	C	1.13	0.073539355	Celiac disease	Immune diseases and disorders
rs199533	G	A	62	31	1	91	3	0	0.82	0.98	0.18	0.02	C	1.35	0.073529412	Parkinson's disease	Brain health and disorders
rs9662633	G	A	91	3	0	63	29	2	0.98	0.82	0.02	0.18	A	1	0.073529412	Visceral adipose tissue adjusted for BMI	Obesity
rs9856151	G	A	47	41	6	80	14	0	0.72	0.93	0.28	0.07	A	0.017	0.073467613	Body mass index	Obesity
rs2816062	G	A	17	53	24	51	35	8	0.46	0.73	0.54	0.27	G	0.091	0.073425752	Urate levels in lean individuals	Obesity
rs11196174	A	G	58	31	5	87	7	0	0.78	0.96	0.22	0.04	G	1.13	0.073424797	Breast Cancer in BRCA1 mutation carriers	Cancer
rs7910620	C	G	87	7	0	55	37	2	0.96	0.78	0.04	0.22	G	0.17	0.073424797	Cardiac structure and function	Heart health and disorders
rs10170236	G	A	4	36	54	23	47	24	0.23	0.49	0.77	0.51	C	1.45	0.07332865	Acute lymphoblastic leukemia childhood	Cancer
rs12289961	C	T	56	32	6	27	41	26	0.77	0.51	0.23	0.49	T	1.29	0.07332865	Lymphoma	Cancer
rs76329678	A	G	26	43	25	51	42	1	0.51	0.77	0.49	0.23	A	1.05	0.07332865	Schizophrenia	Brain health and disorders
rs4074961	C	T	24	47	23	54	36	4	0.51	0.77	0.49	0.23	T	0.0728	0.07332865	Axial length	Misc
rs1358980	C	T	28	39	27	54	36	4	0.51	0.77	0.49	0.23	T	0.0595	0.07332865	Waist-to-hip ratio adjusted for body mass index	Obesity
rs59753639	T	G	83	11	0	50	40	4	0.94	0.74	0.06	0.26	C	6.77	0.073196813	Diisocyanate-induced asthma	Pulmonology
rs7534016	A	G	52	36	6	83	11	0	0.74	0.94	0.26	0.06	G	0.03	0.073196813	Obesity-related traits	Obesity
rs559928	T	C	0	20	74	9	44	41	0.11	0.33	0.89	0.67	A	1.1042032	0.073170732	Crohn's disease	Digestive system and its disorders
rs12832485	A	C	42	42	10	75	18	1	0.67	0.89	0.33	0.11	C	0.003	0.073170732	Calcium levels	General health
rs11126630	T	C	25	51	18	58	33	3	0.54	0.79	0.46	0.21	T	1	0.073142857	Middle childhood and early adolescence aggressive behavior	Brain health and disorders
rs12321906	T	C	90	4	0	61	31	2	0.98	0.81	0.02	0.19	T	0.052	0.07311877	Height	General health
rs882632	C	T	59	31	4	88	6	0	0.79	0.97	0.21	0.03	T	1.34	0.073111782	Major depressive disorder	Brain health and disorders
rs12204127	C	T	60	29	5	88	6	0	0.79	0.97	0.21	0.03	T	1	0.073111782	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs12282107	T	C	88	6	0	63	23	8	0.97	0.79	0.03	0.21	C	0.29	0.073111782	Serum metabolite levels	General health
rs17776563	G	A	57	35	2	88	6	0	0.79	0.97	0.21	0.03	A	0.069	0.073111782	Thyroid hormone levels	General health
rs430	G	A	88	6	0	59	31	4	0.97	0.79	0.03	0.21	A	0.03	0.073111782	Obesity-related traits	Obesity
rs4665058	A	C	0	6	88	6	27	61	0.03	0.21	0.97	0.79	A	1.92	0.073111782	Sudden cardiac arrest	Heart health and disorders
rs10932688	C	G	31	49	14	66	25	3	0.59	0.84	0.41	0.16	G	0.143	0.073106689	Primary tooth development number of teeth	Misc
rs655167	A	G	5	21	68	14	49	31	0.16	0.41	0.84	0.59	A	1.259	0.073106689	Hypothyroidism	Immune diseases and disorders
rs9446777	A	G	79	14	1	47	38	9	0.91	0.70	0.09	0.30	G	1.22	0.073099415	Periodontitis	Misc
rs11642841	C	A	48	36	10	80	12	2	0.70	0.91	0.30	0.09	A	1.13	0.073099415	Type 2 diabetes	Diabetes
rs784420	A	G	38	43	13	71	21	2	0.63	0.87	0.37	0.13	G	0.12	0.073034556	Economic and political preferences	Mental aptitude and behavioural traits
rs3791679	A	G	44	41	9	77	16	1	0.69	0.90	0.31	0.10	T	5.8	0.073013943	Height	General health
rs11889338	G	A	79	12	3	45	39	10	0.90	0.69	0.10	0.31	A	1.55	0.073013943	Alzheimer's disease	Brain health and disorders
rs8000124	G	A	9	41	44	2	14	78	0.31	0.10	0.69	0.90	A	0.0026	0.073013943	Trans fatty acid levels	General health
rs75002042	T	A	89	5	0	59	33	2	0.97	0.80	0.03	0.20	T	1.59	0.072996863	Alzheimer's disease late onset	Brain health and disorders
rs679087	C	A	61	29	4	89	5	0	0.80	0.97	0.20	0.03	C	1.0638298	0.072996863	Schizophrenia	Brain health and disorders
rs8115222	A	G	89	5	0	59	33	2	0.97	0.80	0.03	0.20	G	0.04	0.072996863	Obesity-related traits	Obesity
rs10046456	G	T	89	5	0	59	33	2	0.97	0.80	0.03	0.20	A	0.03	0.072996863	Obesity-related traits	Obesity
rs11684404	T	C	37	41	16	69	22	3	0.61	0.85	0.39	0.15	T	0.032	0.072907291	Height	General health
rs7691216	T	G	60	33	1	31	44	19	0.81	0.56	0.19	0.44	G	0.1881	0.072897073	IgG glycosylation	Immune diseases and disorders
rs1405108	C	A	4	37	53	25	44	25	0.24	0.50	0.76	0.50	C	1.0854406	0.072883465	Ulcerative colitis	Immune diseases and disorders
rs10230207	G	T	16	53	25	47	41	6	0.45	0.72	0.55	0.28	T	1.21	0.072843823	Intracranial aneurysm	Misc
rs417096	G	A	19	46	29	47	40	7	0.45	0.71	0.55	0.29	G	1.43	0.072581582	Hypospadias	Misc
rs4452313	A	T	45	44	5	18	48	28	0.71	0.45	0.29	0.55	T	1.11	0.072581582	Rheumatoid arthritis	Immune diseases and disorders
rs228769	G	C	7	40	47	29	46	19	0.29	0.55	0.71	0.45	G	0.07	0.072581582	Bone mineral density spine	General health
rs853308	C	T	28	44	22	59	30	5	0.53	0.79	0.47	0.21	G	1.2	0.072580645	Vitiligo	Immune diseases and disorders
rs16896068	G	A	61	26	7	24	52	18	0.79	0.53	0.21	0.47	A	0.07	0.072580645	Height	General health
rs2306029	T	C	27	46	21	58	32	4	0.53	0.79	0.47	0.21	C	0.0269	0.072580645	D-dimer levels	Heart health and disorders
rs297755	G	A	5	36	53	20	55	19	0.24	0.51	0.76	0.49	G	0.291	0.072461144	Current cigarettes per day in chronic obstructive pulmonary disease	General health
rs2676917	T	G	26	41	27	53	36	5	0.49	0.76	0.51	0.24	G	0.12	0.072461144	Metabolite levels Pyroglutamine	General health
rs11070098	T	C	54	34	6	24	45	25	0.76	0.49	0.24	0.51	G	0.04	0.072461144	Obesity-related traits	Obesity
rs6795349	A	G	93	1	0	67	26	1	0.99	0.85	0.01	0.15	G	1	0.072443605	Response to anti-depressant treatment in major depressive disorder	General health
rs364585	A	G	14	38	42	1	21	72	0.35	0.12	0.65	0.88	A	0.025	0.072387738	LDL cholesterol	General health
rs12682344	T	G	84	10	0	50	42	2	0.95	0.76	0.05	0.24	G	0.67	0.072321429	Prostate cancer	Cancer
rs2650951	C	T	85	8	1	53	36	5	0.95	0.76	0.05	0.24	A	0.29	0.072321429	QT interval	Heart health and disorders
rs1409005	C	T	84	10	0	51	40	3	0.95	0.76	0.05	0.24	T	0.25	0.072321429	Serum thyroid-stimulating hormone levels	General health
rs4820792	C	T	52	38	4	84	10	0	0.76	0.95	0.24	0.05	T	0.105	0.072321429	Breast size	General health
rs6503905	A	G	17	44	33	4	24	66	0.41	0.17	0.59	0.83	A	0.06	0.072317157	Circulating myeloperoxidase levels plasma	Immune diseases and disorders
rs113731670	C	T	82	11	1	48	41	5	0.93	0.73	0.07	0.27	C	1.1627907	0.072315705	Schizophrenia	Brain health and disorders
rs2277425	A	G	82	11	1	51	35	8	0.93	0.73	0.07	0.27	G	0.075	0.072315705	Sitting height ratio	Appearance
rs6894139	T	G	20	43	31	4	28	62	0.44	0.19	0.56	0.81	T	0.03	0.07222967	Height	General health
rs9810857	A	G	25	55	14	60	32	2	0.56	0.81	0.44	0.19	T	1.41	0.07222967	Attention deficit hyperactivity disorder	Brain health and disorders
rs10235789	T	C	35	35	24	61	30	3	0.56	0.81	0.44	0.19	C	0.12	0.07222967	Iris characteristics	Misc
rs2871865	C	G	61	30	3	26	53	15	0.81	0.56	0.19	0.44	C	0.085	0.07222967	Height	General health
rs693	G	A	40	38	16	70	22	2	0.63	0.86	0.37	0.14	A	1	0.07202381	Triglycerides	General health
rs1041968	G	A	40	38	16	70	22	2	0.63	0.86	0.37	0.14	A	0.095	0.07202381	Cholesterol, total	General health
rs8012283	A	G	68	23	3	37	40	17	0.85	0.61	0.15	0.39	G	1.64	0.072015363	Lupus nephritis in systemic lupus erythematosus	Immune diseases and disorders
rs10155981	C	T	67	25	2	40	34	20	0.85	0.61	0.15	0.39	T	0.126	0.072015363	Bilirubin levels	General health
rs969088	G	C	74	19	1	38	49	7	0.89	0.66	0.11	0.34	C	1.43	0.071917808	Response to platinum-based chemotherapy in non-small-cell lung cancer	General health
rs842828	C	T	74	19	1	41	43	10	0.89	0.66	0.11	0.34	C	0.166	0.071917808	Urate levels in lean individuals	Obesity
rs12821008	C	T	39	47	8	73	21	0	0.66	0.89	0.34	0.11	T	0.05	0.071917808	Bone mineral density	General health
rs6563943	G	A	28	41	25	7	34	53	0.52	0.26	0.48	0.74	A	0.05	0.071682341	Height	General health
rs13424740	T	C	26	45	23	7	34	53	0.52	0.26	0.48	0.74	T	0.018	0.071682341	Body mass index	Obesity
rs2954038	C	A	6	48	40	0	19	75	0.32	0.10	0.68	0.90	C	1	0.071644717	Response to statin therapy	General health
rs139909	C	T	4	52	38	0	19	75	0.32	0.10	0.68	0.90	T	0.25	0.071644717	Height	General health
rs12504628	T	C	43	42	9	75	19	0	0.68	0.90	0.32	0.10	T	0.077	0.071644717	Pulmonary function	Pulmonology
rs61280460	A	T	48	35	11	78	15	1	0.70	0.91	0.30	0.09	T	0.095	0.071594774	Breast size	General health
rs34638952	A	T	45	41	8	79	13	2	0.70	0.91	0.30	0.09	A	0.091	0.071594774	Sitting height ratio	Appearance
rs11621792	C	T	48	35	11	77	17	0	0.70	0.91	0.30	0.09	T	0.037	0.071594774	LDL cholesterol	General health
rs654950	G	C	46	39	9	79	13	2	0.70	0.91	0.30	0.09	C	0.011	0.071594774	Airway imaging phenotypes	Pulmonology
rs2954033	A	G	5	47	42	0	17	77	0.30	0.09	0.70	0.91	A	0.17	0.071594774	Triglycerides-Blood Pressure TG-BP	General health
rs2954026	T	G	5	47	42	0	17	77	0.30	0.09	0.70	0.91	G	0.16	0.071594774	HDL Cholesterol - Triglycerides HDLC-TG	General health
rs2493168	A	G	6	45	43	1	15	78	0.30	0.09	0.70	0.91	A	0.0653	0.071594774	Cerebrospinal AB1-42 levels	Brain health and disorders
rs12993904	C	G	30	44	20	59	33	2	0.55	0.80	0.45	0.20	G	1.93	0.071592935	Clozapine-induced agranulocytosis	General health
rs34777351	C	T	27	50	17	59	33	2	0.55	0.80	0.45	0.20	C	1.0526316	0.071592935	Schizophrenia	Brain health and disorders
rs12680842	A	G	33	43	18	62	31	1	0.58	0.82	0.42	0.18	A	0.015	0.071563853	Body mass index	Obesity
rs11898505	A	G	6	32	56	0	9	85	0.23	0.05	0.77	0.95	G	0.06	0.071557918	Bone properties heel	General health
rs12566232	A	C	56	32	6	85	9	0	0.77	0.95	0.23	0.05	A	0.045	0.071557918	Blood metabolite levels	Heart health and disorders
rs13387042	A	G	20	38	36	44	40	10	0.41	0.68	0.59	0.32	A	1.25	0.071387778	Breast cancer	Cancer
rs4800353	A	G	47	34	13	19	40	35	0.68	0.41	0.32	0.59	T	1.22	0.071387778	Digestive system disease Barrett's esophagus and esophageal adenocarcinoma combined	Digestive system and its disorders
rs2110267	C	G	52	35	7	21	48	25	0.74	0.48	0.26	0.52	C	1	0.0713246	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs6733938	A	G	71	22	1	36	49	9	0.87	0.64	0.13	0.36	G	2.38	0.071293619	Mammographic density	Reproductive health
rs1446468	T	C	38	45	11	71	22	1	0.64	0.87	0.36	0.13	T	0.336	0.071293619	Blood pressure	Heart health and disorders
rs6028	T	C	39	43	12	74	16	4	0.64	0.87	0.36	0.13	C	0.226	0.071293619	Activated partial thromboplastin time	Heart health and disorders
rs13146355	G	A	37	47	10	71	22	1	0.64	0.87	0.36	0.13	A	0.0047	0.071293619	Renal function-related traits sCR	General health
rs1550532	C	G	15	37	42	1	22	71	0.36	0.13	0.64	0.87	C	0.018	0.071293619	Calcium levels	General health
rs2279913	A	C	45	37	12	17	43	34	0.68	0.41	0.32	0.59	C	0.1579	0.07124943	IgG glycosylation	Immune diseases and disorders
rs4948418	C	T	52	35	7	83	10	1	0.74	0.94	0.26	0.06	T	1	0.071246422	Bipolar disorder	Brain health and disorders
rs596406	T	C	84	8	2	50	39	5	0.94	0.74	0.06	0.26	G	0.11	0.071246422	Liver enzyme levels alanine transaminase	General health
rs16906714	T	C	92	2	0	67	24	3	0.99	0.84	0.01	0.16	T	1.257	0.07122093	Airway responsiveness in chronic obstructive pulmonary disease	Pulmonology
rs62064224	G	A	34	45	15	70	18	6	0.60	0.84	0.40	0.16	G	1.0526316	0.071164997	Schizophrenia	Brain health and disorders
rs2573652	T	C	16	43	35	4	22	68	0.40	0.16	0.60	0.84	T	0.036	0.071164997	Height	General health
rs255049	T	C	42	42	10	19	38	37	0.67	0.40	0.33	0.60	G	0.05	0.071127802	HDL cholesterol	General health
rs13424309	C	T	32	48	14	6	50	38	0.60	0.33	0.40	0.67	T	1.05	0.071127802	Schizophrenia	Brain health and disorders
rs1421746	A	G	32	48	14	6	50	38	0.60	0.33	0.40	0.67	C	1	0.071127802	Amyotrophic lateral sclerosis age of onset	Brain health and disorders
rs2099077	C	A	70	21	3	33	51	10	0.86	0.62	0.14	0.38	A	16.53	0.071061518	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs12270397	C	T	71	19	4	37	43	14	0.86	0.62	0.14	0.38	T	0.24	0.071061518	Intraocular pressure	General health
rs4076764	T	C	36	45	13	69	23	2	0.62	0.86	0.38	0.14	T	0.033	0.071061518	Motion sickness	Misc
rs4820408	T	G	8	55	31	1	25	68	0.38	0.14	0.62	0.86	T	0.019	0.071061518	Body mass index	Obesity
rs11601239	C	G	13	49	32	41	43	10	0.40	0.66	0.60	0.34	C	0.095	0.071022727	Refractive error	General health
rs7282490	G	A	26	47	21	5	40	49	0.53	0.27	0.47	0.73	G	1.1274672	0.070987198	Crohn's disease	Digestive system and its disorders
rs13278062	G	T	22	45	27	47	44	3	0.47	0.73	0.53	0.27	T	1.37	0.070987198	Age-related macular degeneration	Aging
rs9934948	C	T	61	28	5	28	47	19	0.80	0.55	0.20	0.45	C	1.29	0.070985572	Breast cancer survival	Cancer
rs12580035	C	T	57	32	5	86	8	0	0.78	0.96	0.22	0.04	C	0.087	0.070920245	Urate levels in lean individuals	Obesity
rs621636	C	T	57	32	5	86	8	0	0.78	0.96	0.22	0.04	A	0.03	0.070920245	Obesity-related traits	Obesity
rs161645	A	G	1	40	53	0	8	86	0.22	0.04	0.78	0.96	A	1	0.070920245	Depression quantitative trait	Brain health and disorders
rs7459527	A	C	1	6	87	7	28	59	0.04	0.22	0.96	0.78	A	0.03	0.070920245	Obesity-related traits	Obesity
rs6499100	T	C	11	43	40	35	45	14	0.35	0.61	0.65	0.39	A	1.26	0.070861678	Tetralogy of Fallot	Heart health and disorders
rs7970350	C	T	9	47	38	36	43	15	0.35	0.61	0.65	0.39	T	0.047	0.070861678	Infant length	Misc
rs991964	T	C	20	40	34	3	28	63	0.43	0.18	0.57	0.82	A	1.15	0.070845052	Uterine fibroids	Cancer
rs2425163	A	G	63	28	3	31	46	17	0.82	0.57	0.18	0.43	A	0.058	0.070845052	Height	General health
rs10192369	G	A	13	46	35	43	36	15	0.38	0.65	0.62	0.35	T	1.17	0.070805483	Amyotrophic lateral sclerosis	Brain health and disorders
rs17318866	G	A	43	38	13	73	20	1	0.66	0.88	0.34	0.12	G	7.559	0.070729751	Adverse response to chemotherapy neutropenia_leucopenia camptothecin	Drug response
rs7769051	C	A	73	20	1	37	50	7	0.88	0.66	0.12	0.34	A	1.28	0.070729751	Type 2 diabetes nephropathy	Diabetes
rs12527818	T	C	38	48	8	74	18	2	0.66	0.88	0.34	0.12	T	0.274	0.070729751	Response to hepatitis C treatment	General health
rs2315504	C	A	9	46	39	1	20	73	0.34	0.12	0.66	0.88	C	1.9	0.070729751	Height	General health
rs3818802	G	A	24	40	30	47	43	4	0.47	0.73	0.53	0.27	A	1.06	0.07066961	Schizophrenia	Brain health and disorders
rs11583200	C	T	22	44	28	51	35	8	0.47	0.73	0.53	0.27	C	0.018	0.07066961	Body mass index	Obesity
rs1354034	T	C	24	48	22	54	36	4	0.51	0.77	0.49	0.23	T	10.4352	0.070588235	Platelet count	Heart health and disorders
rs4669418	A	C	24	48	22	56	32	6	0.51	0.77	0.49	0.23	A	1.86	0.070588235	Mammographic density	Reproductive health
rs4075958	G	A	50	36	8	81	12	1	0.72	0.93	0.28	0.07	A	1.09	0.070576735	Multiple sclerosis	Brain health and disorders
rs2213169	G	A	91	3	0	64	28	2	0.98	0.83	0.02	0.17	T	0.2227	0.070465019	Mean corpuscular hemoglobin concentration	Heart health and disorders
rs2173063	G	A	87	7	0	59	30	5	0.96	0.79	0.04	0.21	A	1	0.070426179	Subcutaneous adipose tissue	Obesity
rs4656784	A	G	60	28	6	87	7	0	0.79	0.96	0.21	0.04	G	0.08	0.070426179	IgE levels	Immune diseases and disorders
rs7231412	T	C	65	27	2	33	46	15	0.84	0.60	0.16	0.40	T	0.17	0.070354028	Economic and political preferences immigration_crime	Mental aptitude and behavioural traits
rs632728	T	C	11	39	44	1	18	75	0.32	0.11	0.68	0.89	T	1.19	0.070349445	Large artery stroke	Heart health and disorders
rs571312	C	A	75	18	1	41	45	8	0.89	0.68	0.11	0.32	A	1	0.070349445	Body mass index	Obesity
rs6910741	T	C	41	45	8	76	16	2	0.68	0.89	0.32	0.11	T	0.61	0.070349445	Blood pressure	Heart health and disorders
rs4839516	C	A	52	37	5	83	11	0	0.75	0.94	0.25	0.06	A	0.079	0.070266753	Word reading	Mental aptitude and behavioural traits
rs2264750	C	T	39	42	13	72	19	3	0.64	0.87	0.36	0.13	T	0.042	0.070253429	Cholesterol, total	General health
rs6573416	C	G	69	25	0	35	50	9	0.87	0.64	0.13	0.36	G	0.03	0.070253429	Self-rated health	General health
rs4711171	C	T	12	44	38	2	21	71	0.36	0.13	0.64	0.87	T	0.012	0.070253429	Phospholipid levels plasma	General health
rs7620363	C	T	48	37	9	80	12	2	0.71	0.91	0.29	0.09	A	1.662	0.07023782	Non-substance related behavioral disinhibition	Brain health and disorders
rs11962089	A	G	79	14	1	46	41	7	0.91	0.71	0.09	0.29	G	0.69	0.07023782	Multiple sclerosis	Brain health and disorders
rs3753394	C	T	42	49	3	79	14	1	0.71	0.91	0.29	0.09	C	0.05	0.07023782	Complement C3 and C4 levels	Immune diseases and disorders
rs7687921	A	T	77	16	1	46	38	10	0.90	0.69	0.10	0.31	T	1.77	0.070175439	Mortality in heart failure	Heart health and disorders
rs4784227	C	T	44	42	8	76	18	0	0.69	0.90	0.31	0.10	T	1.38	0.070175439	Breast cancer	Cancer
rs3791675	C	T	44	42	8	77	16	1	0.69	0.90	0.31	0.10	T	0.065	0.070175439	Height	General health
rs7124676	G	A	43	44	7	76	18	0	0.69	0.90	0.31	0.10	A	0.04	0.070175439	Obesity-related traits	Obesity
rs3217901	A	G	30	47	17	60	33	1	0.57	0.81	0.43	0.19	G	1.1	0.070159151	Colorectal cancer	Cancer
rs6998277	T	C	62	29	3	30	47	17	0.81	0.57	0.19	0.43	C	1.07	0.070159151	Migraine	Brain health and disorders
rs2360111	C	T	29	49	16	64	25	5	0.57	0.81	0.43	0.19	T	0.113	0.070159151	Economic and political preferences	Mental aptitude and behavioural traits
rs1535	A	G	32	43	19	67	19	8	0.57	0.81	0.43	0.19	A	0.07	0.070159151	Phospholipid levels plasma	General health
rs7652177	C	G	19	43	32	1	33	60	0.43	0.19	0.57	0.81	C	0.038	0.070159151	Height	General health
rs8097348	G	A	7	31	56	20	53	21	0.24	0.49	0.76	0.51	G	1.36	0.070149799	Exercise leisure time	Mental aptitude and behavioural traits
rs1053051	T	C	16	40	38	3	22	69	0.38	0.15	0.62	0.85	T	0.03	0.070144928	Bone mineral density	General health
rs12413624	T	A	39	38	17	66	28	0	0.62	0.85	0.38	0.15	T	1.23	0.070144928	Pancreatic cancer	Cancer
rs11243081	C	T	60	30	4	88	6	0	0.80	0.97	0.20	0.03	C	0.299	0.070098576	End-stage coagulation	General health
rs2174866	A	T	90	4	0	62	30	2	0.98	0.82	0.02	0.18	T	1.19	0.070071629	Hepatitis	Immune diseases and disorders
rs1325765	A	C	0	4	90	3	28	63	0.02	0.18	0.98	0.82	T	0.83	0.070071629	Seasonality	Mental aptitude and behavioural traits
rs11787111	G	A	90	4	0	60	34	0	0.98	0.82	0.02	0.18	G	0.053	0.070071629	Body mass index	Obesity
rs2069772	T	C	63	26	5	89	5	0	0.81	0.97	0.19	0.03	C	1.19	0.069967237	IgE grass sensitization	Immune diseases and disorders
rs3000140	G	T	89	5	0	61	30	3	0.97	0.81	0.03	0.19	A	0.03	0.069967237	Obesity-related traits	Obesity
rs7713917	A	G	22	43	29	3	34	57	0.46	0.21	0.54	0.79	G	1.33	0.06985422	Major depressive disorder	Brain health and disorders
rs680379	A	G	14	37	43	1	21	72	0.35	0.12	0.65	0.88	A	7.205	0.069602273	Very long-chain saturated fatty acid levels fatty acid 20:0	General health
rs2268667	G	A	45	33	16	72	21	1	0.65	0.88	0.35	0.12	A	0.022	0.069602273	Asymmetrical dimethylarginine levels	General health
rs2736990	G	A	23	38	33	48	37	9	0.45	0.71	0.55	0.29	C	1.23	0.069588152	Parkinson's disease	Brain health and disorders
rs12597458	G	T	17	50	27	48	37	9	0.45	0.71	0.55	0.29	G	1.11	0.069588152	Prostate cancer	Cancer
rs6430491	G	A	48	37	9	12	60	22	0.71	0.45	0.29	0.55	G	1.0638298	0.069588152	Schizophrenia	Brain health and disorders
rs4869739	A	T	30	44	20	10	35	49	0.55	0.29	0.45	0.71	T	0.07	0.069588152	Bone properties heel	General health
rs479844	A	G	33	45	16	65	26	3	0.59	0.83	0.41	0.17	G	1.14	0.069580456	Atopic dermatitis	Immune diseases and disorders
rs1367858	C	T	34	43	17	63	30	1	0.59	0.83	0.41	0.17	T	1.06	0.069580456	Schizophrenia	Brain health and disorders
rs2485376	G	A	31	49	14	65	26	3	0.59	0.83	0.41	0.17	A	0.56	0.069580456	QT interval	Heart health and disorders
rs7499892	C	T	66	24	4	34	43	17	0.83	0.59	0.17	0.41	A	0.24	0.069580456	Biochemical measures	General health
rs2531995	C	T	35	41	18	64	28	2	0.59	0.83	0.41	0.17	T	0.0315	0.069580456	Body mass index	Obesity
rs878860	C	T	27	52	15	63	26	5	0.56	0.81	0.44	0.19	G	1.31	0.069504664	Atopic dermatitis	Immune diseases and disorders
rs2572207	C	T	62	28	4	28	50	16	0.81	0.56	0.19	0.44	C	0.153	0.069504664	Red blood cell traits	Immune diseases and disorders
rs10994415	T	C	51	36	7	82	11	1	0.73	0.93	0.27	0.07	C	1.27	0.069425427	Bipolar disorder	Brain health and disorders
rs1569723	C	A	5	35	54	0	10	84	0.24	0.05	0.76	0.95	A	1.415	0.069385443	Kawasaki disease	Misc
rs1916333	C	G	8	29	57	1	8	85	0.24	0.05	0.76	0.95	C	0.1691	0.069385443	Urinary metabolites	General health
rs12510916	C	T	52	39	3	84	10	0	0.76	0.95	0.24	0.05	C	1.27	0.069385443	Chronic obstructive pulmonary disease	Immune diseases and disorders
rs16898904	C	T	84	10	0	54	35	5	0.95	0.76	0.05	0.24	T	0.6617	0.069385443	Dementia and core Alzheimer's disease neuropathologic changes	Brain health and disorders
rs11981919	G	A	93	1	0	68	25	1	0.99	0.86	0.01	0.14	A	0.02	0.069376026	Obesity-related traits	Obesity
rs4925386	T	C	12	59	23	46	40	8	0.44	0.70	0.56	0.30	C	1.08	0.069362993	Colorectal cancer	Cancer
rs230014	G	A	20	55	19	4	39	51	0.51	0.25	0.49	0.75	A	1	0.069339112	QT interval interaction	Heart health and disorders
rs3750817	C	T	34	47	13	66	27	1	0.61	0.85	0.39	0.15	T	1.22	0.069271504	Breast cancer	Cancer
rs2008905	C	T	36	43	15	66	27	1	0.61	0.85	0.39	0.15	T	1.05	0.069271504	Schizophrenia	Brain health and disorders
rs1052536	C	T	33	49	12	68	23	3	0.61	0.85	0.39	0.15	C	0.98	0.069271504	QT interval	Heart health and disorders
rs1038094	A	G	2	22	70	11	47	36	0.14	0.37	0.86	0.63	G	1.27	0.069263907	Bipolar disorder	Brain health and disorders
rs1374313	T	C	30	46	18	6	45	43	0.56	0.30	0.44	0.70	G	0.03	0.069155218	Obesity-related traits	Obesity
rs1878874	A	T	47	32	15	74	19	1	0.67	0.89	0.33	0.11	T	1.0638298	0.069122908	Schizophrenia	Brain health and disorders
rs11174478	G	A	42	42	10	74	19	1	0.67	0.89	0.33	0.11	A	0.1	0.069122908	Insomnia	General health
rs16833934	A	G	51	38	5	20	52	22	0.74	0.49	0.26	0.51	G	1.63	0.068965517	Blood pressure	Heart health and disorders
rs2108225	G	A	25	46	23	8	32	54	0.51	0.26	0.49	0.74	A	1.32	0.068965517	Ulcerative colitis	Immune diseases and disorders
rs6704641	G	A	5	38	51	21	54	19	0.26	0.51	0.74	0.49	A	1.081	0.068965517	Schizophrenia	Brain health and disorders
rs2905627	C	T	50	40	4	21	50	23	0.74	0.49	0.26	0.51	T	1.06	0.068965517	Schizophrenia	Brain health and disorders
rs7610761	T	A	23	46	25	50	40	4	0.49	0.74	0.51	0.26	A	1.05	0.068965517	Schizophrenia	Brain health and disorders
rs1046943	A	G	26	44	24	4	40	50	0.51	0.26	0.49	0.74	A	0.02	0.068965517	Height	General health
rs2041278	T	G	16	49	29	44	42	8	0.43	0.69	0.57	0.31	A	0.03	0.068964527	Obesity-related traits	Obesity
rs153734	C	T	1	35	58	18	47	29	0.20	0.44	0.80	0.56	T	0.29	0.068880208	Folate pathway vitamin levels	General health
rs3138144	G	C	33	39	22	62	27	5	0.56	0.80	0.44	0.20	C	0.119	0.068880208	Refractive error	General health
rs10951138	G	A	63	29	2	32	46	16	0.82	0.59	0.18	0.41	A	1	0.068842427	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs6789987	C	T	64	27	3	33	44	17	0.82	0.59	0.18	0.41	C	1	0.068842427	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs6025590	A	G	9	41	44	0	19	75	0.31	0.10	0.69	0.90	A	0.04	0.068834968	Obesity-related traits	Obesity
rs2084637	T	C	43	43	8	76	17	1	0.69	0.90	0.31	0.10	T	0.32	0.068834968	Stroke	Brain health and disorders
rs4146922	T	A	43	43	8	76	17	1	0.69	0.90	0.31	0.10	A	0.056	0.068834968	Height	General health
rs6696239	G	A	75	19	0	45	39	10	0.90	0.69	0.10	0.31	A	0.038	0.068834968	Height	General health
rs2078454	C	A	57	32	5	20	59	15	0.78	0.53	0.22	0.47	A	3.603	0.06882692	Smooth-surface caries	Appearance
rs2735413	A	T	13	33	48	32	44	18	0.31	0.57	0.69	0.43	A	0.158	0.068790648	Systolic blood pressure alcohol consumption interaction	General health
rs12269901	G	C	31	46	17	14	31	49	0.57	0.31	0.43	0.69	C	0.069	0.068790648	HDL cholesterol	General health
rs11170631	T	C	31	46	17	14	31	49	0.57	0.31	0.43	0.69	C	0.05	0.068790648	Height	General health
rs11071720	T	C	6	47	41	26	56	12	0.31	0.57	0.69	0.43	T	0.01	0.068790648	Mean platelet volume	Heart health and disorders
rs13141641	T	C	47	38	9	77	17	0	0.70	0.91	0.30	0.09	T	2.2	0.068764411	Emphysema imaging phenotypes	Pulmonology
rs7836436	A	G	78	15	1	48	36	10	0.91	0.70	0.09	0.30	G	1.401	0.068764411	HIV-1 viral setpoint	Immune diseases and disorders
rs73976923	C	T	86	7	1	56	33	5	0.95	0.77	0.05	0.23	A	34.03	0.068613485	Diisocyanate-induced asthma	Pulmonology
rs2679084	T	C	70	24	0	38	46	10	0.87	0.65	0.13	0.35	T	1.86	0.068531469	Febrile seizures MMR vaccine-related	General health
rs3934834	C	T	71	22	1	37	48	9	0.87	0.65	0.13	0.35	G	0.11	0.068531469	Body mass index	Obesity
rs16871023	G	A	71	22	1	39	44	11	0.87	0.65	0.13	0.35	G	0.0761	0.068531469	D-dimer levels	Heart health and disorders
rs12652777	T	C	20	38	36	42	43	9	0.41	0.68	0.59	0.32	T	1.05	0.068492369	Schizophrenia	Brain health and disorders
rs17229285	C	T	38	38	18	66	26	2	0.61	0.84	0.39	0.16	G	1.1000017	0.068438914	Ulcerative colitis	Immune diseases and disorders
rs10796849	C	G	17	43	34	39	48	7	0.41	0.67	0.59	0.33	C	0.6132	0.06836755	IgG glycosylation	Immune diseases and disorders
rs9297994	G	A	5	38	51	0	12	82	0.26	0.06	0.74	0.94	G	0.042	0.06835443	LDL cholesterol	General health
rs4738684	A	G	5	38	51	0	12	82	0.26	0.06	0.74	0.94	A	0.041	0.06835443	Cholesterol, total	General health
rs4735677	A	T	54	32	8	83	10	1	0.74	0.94	0.26	0.06	A	0.037	0.06835443	Height	General health
rs199950	C	T	6	31	57	20	50	24	0.23	0.48	0.77	0.52	G	1	0.068349887	Body mass index change over time	Obesity
rs7289126	C	A	22	46	26	5	33	56	0.48	0.23	0.52	0.77	A	0.1	0.068349887	Percent mammographic density	General health
rs6836899	C	T	67	27	0	38	42	14	0.86	0.63	0.14	0.37	T	0.0022	0.068322063	Trans fatty acid levels	General health
rs6836750	C	A	67	27	0	38	42	14	0.86	0.63	0.14	0.37	A	0.0022	0.068322063	Trans fatty acid levels	General health
rs2376264	C	G	67	27	0	38	42	14	0.86	0.63	0.14	0.37	C	0.0022	0.068322063	Trans fatty acid levels	General health
rs10030764	C	T	67	27	0	38	42	14	0.86	0.63	0.14	0.37	T	0.0021	0.068322063	Trans fatty acid levels	General health
rs6836250	G	A	67	27	0	38	42	14	0.86	0.63	0.14	0.37	A	0.0021	0.068322063	Trans fatty acid levels	General health
rs10031224	C	T	67	27	0	38	42	14	0.86	0.63	0.14	0.37	T	0.0021	0.068322063	Trans fatty acid levels	General health
rs2174496	A	G	67	27	0	38	42	14	0.86	0.63	0.14	0.37	A	0.0021	0.068322063	Trans fatty acid levels	General health
rs11648785	C	T	30	44	20	58	34	2	0.55	0.80	0.45	0.20	T	0.14	0.068284497	Tanning	Appearance
rs6952407	A	G	29	40	25	9	32	53	0.52	0.27	0.48	0.73	A	0.033	0.068278805	Cotinine glucuronidation	General health
rs2326017	C	T	51	36	7	24	42	28	0.73	0.48	0.27	0.52	T	1	0.068278805	Body mass index in non-asthmatics	Obesity
rs1641549	C	T	51	36	7	18	54	22	0.73	0.48	0.27	0.52	T	0.127	0.068278805	Sex hormone levels	Reproductive health
rs10266483	A	G	11	41	42	30	52	12	0.34	0.60	0.66	0.40	A	1	0.068258706	Response to statin therapy	General health
rs13339636	A	G	94	0	0	70	24	0	1.00	0.87	0.00	0.13	G	0.6847	0.068181818	Red blood cell traits	Immune diseases and disorders
rs12251332	G	C	94	0	0	71	22	1	1.00	0.87	0.00	0.13	C	0.17	0.068181818	Metabolite levels Pyroglutamine	General health
rs295140	T	C	34	45	15	11	42	41	0.60	0.34	0.40	0.66	T	0.61	0.068165687	QT interval	Heart health and disorders
rs2142672	G	A	35	43	16	14	36	44	0.60	0.34	0.40	0.66	C	0.01	0.068165687	LDL cholesterol	General health
rs2745851	G	A	41	42	11	17	41	36	0.66	0.40	0.34	0.60	G	0.1618	0.068165687	IgG glycosylation	Immune diseases and disorders
rs11225569	G	A	68	23	3	92	2	0	0.85	0.99	0.15	0.01	A	3.06	0.068162693	Diisocyanate-induced asthma	Pulmonology
rs878962	G	T	11	43	40	33	48	13	0.35	0.61	0.65	0.39	C	1.89	0.068088365	Temporomandibular joint disorders	Immune diseases and disorders
rs1447537	G	A	33	48	13	14	37	43	0.61	0.35	0.39	0.65	A	0.15	0.068088365	RR interval heart rate	Heart health and disorders
rs17807185	A	G	39	45	10	14	46	34	0.65	0.39	0.35	0.61	A	0.022	0.068088365	Height	General health
rs6035684	T	C	39	44	11	10	53	31	0.65	0.39	0.35	0.61	C	1.0638298	0.068026633	Schizophrenia	Brain health and disorders
rs1042725	C	T	9	48	37	36	43	15	0.35	0.61	0.65	0.39	T	0.047	0.068026633	Birth weight	Misc
rs2709736	C	T	37	42	15	17	33	44	0.62	0.36	0.38	0.64	G	1.44	0.067980407	Bipolar I disorder	Brain health and disorders
rs6732426	C	T	35	51	8	13	46	35	0.64	0.38	0.36	0.62	T	1	0.067980407	Hair morphology	Appearance
rs248381	G	A	15	42	37	38	45	11	0.38	0.64	0.62	0.36	A	0.025	0.067980407	Toenail selenium levels	Misc
rs485499	T	C	56	35	3	86	8	0	0.78	0.96	0.22	0.04	T	1.4084507	0.067964801	Primary biliary cirrhosis	Immune diseases and disorders
rs16983214	G	A	86	8	0	58	31	5	0.96	0.78	0.04	0.22	A	0.378	0.067964801	Cognitive function	Brain health and disorders
rs724210	C	T	8	25	61	0	8	86	0.22	0.04	0.78	0.96	C	1	0.067964801	DNA methylation variation	Misc
rs9590974	C	A	8	35	51	24	51	19	0.27	0.53	0.73	0.47	A	1.193	0.067964602	PR segment	Heart health and disorders
rs13391552	G	A	49	39	6	22	45	27	0.73	0.47	0.27	0.53	A	0.371	0.067964602	Metabolic traits	Misc
rs1183910	G	A	43	39	12	75	16	3	0.66	0.88	0.34	0.12	T	13.8	0.06796038	C-reactive protein	Immune diseases and disorders
rs801114	T	G	21	49	24	4	36	54	0.48	0.23	0.52	0.77	G	1.28	0.067896112	Basal cell carcinoma	Cancer
rs4770394	G	A	0	14	80	8	35	51	0.07	0.27	0.93	0.73	A	1.59	0.067721989	Bipolar disorder	Brain health and disorders
rs10927094	A	C	52	33	9	81	12	1	0.73	0.93	0.27	0.07	C	0.06	0.067721989	Urate levels in lean individuals	Obesity
rs10847980	T	G	80	14	0	53	31	10	0.93	0.73	0.07	0.27	T	0.06	0.067721989	Adiponectin levels	Obesity
rs10784496	A	G	19	47	28	3	33	58	0.45	0.21	0.55	0.79	G	1	0.067716334	Cerebrospinal AB1-42 levels	Brain health and disorders
rs7115714	G	A	59	31	4	27	49	18	0.79	0.55	0.21	0.45	A	0.16	0.067716334	Intraocular pressure	General health
rs11715566	C	T	29	45	20	58	33	3	0.55	0.79	0.45	0.21	T	0.05	0.067716334	Menarche age at onset	Reproductive health
rs11247230	G	A	33	37	24	58	33	3	0.55	0.79	0.45	0.21	G	0.014	0.067716334	Optic cup area	Misc
rs4875053	C	G	26	48	20	4	44	46	0.53	0.28	0.47	0.72	G	0.03	0.067669173	Menarche age at onset	Reproductive health
rs7097397	G	A	30	53	11	65	27	2	0.60	0.84	0.40	0.16	G	1.3	0.067645003	Systemic lupus erythematosus	Immune diseases and disorders
rs10789181	A	G	11	38	45	1	18	75	0.32	0.11	0.68	0.89	A	0.03	0.067567568	Menarche age at onset	Reproductive health
rs10788251	T	C	71	21	2	38	45	11	0.87	0.64	0.13	0.36	C	1.0869565	0.067513778	Schizophrenia	Brain health and disorders
rs6798015	C	T	17	46	31	5	25	64	0.43	0.19	0.57	0.81	C	4.98	0.067466267	PR interval	Heart health and disorders
rs314277	A	C	4	27	63	17	46	31	0.19	0.43	0.81	0.57	A	0.41	0.067466267	Height	General health
rs4710191	A	G	28	52	14	63	27	4	0.57	0.81	0.43	0.19	G	0.0854	0.067466267	Response to simvastatin treatment PCSK9 protein level change	General health
rs6435957	T	C	24	44	26	8	29	57	0.49	0.24	0.51	0.76	T	0.37	0.067464802	Primary tooth development number of teeth	Misc
rs10448080	T	C	52	39	3	26	44	24	0.76	0.51	0.24	0.49	T	0.023	0.067464802	Height	General health
rs7328278	A	C	87	7	0	60	29	5	0.96	0.79	0.04	0.21	C	0.13	0.067457181	Asthma childhood onset	Immune diseases and disorders
rs2216405	A	G	58	33	3	87	7	0	0.79	0.96	0.21	0.04	G	0.117	0.067457181	Metabolic traits	Misc
rs7352944	T	C	36	45	13	71	18	5	0.62	0.85	0.38	0.15	T	1.19	0.067425154	Psoriasis	Immune diseases and disorders
rs3916765	G	A	66	25	3	91	3	0	0.84	0.98	0.16	0.02	A	1.21	0.067423461	Type 2 diabetes	Diabetes
rs16965962	C	A	91	3	0	66	25	3	0.98	0.84	0.02	0.16	T	1	0.067423461	Response to citalopram treatment	General health
rs17612678	T	C	49	36	9	78	16	0	0.71	0.91	0.29	0.09	G	0.03	0.067413632	Obesity-related traits	Obesity
rs6137287	C	T	48	38	8	79	14	1	0.71	0.91	0.29	0.09	T	0.02	0.067413632	Height	General health
rs6730148	T	C	79	14	1	45	44	5	0.91	0.71	0.09	0.29	G	0.02	0.067413632	Obesity-related traits	Obesity
rs10954361	G	A	9	35	50	30	41	23	0.28	0.54	0.72	0.46	G	3.6994	0.067392067	Cognitive function	Brain health and disorders
rs10495537	C	T	43	45	6	76	18	0	0.70	0.90	0.30	0.10	T	1	0.067375415	Visceral adipose tissue adjusted for BMI	Obesity
rs2624265	T	C	47	37	10	77	16	1	0.70	0.90	0.30	0.10	G	0.07	0.067375415	Metabolic traits	Misc
rs72634501	T	C	49	44	1	83	11	0	0.76	0.94	0.24	0.06	T	0.044	0.067370621	HDL cholesterol	General health
rs2410182	A	G	5	36	53	0	11	83	0.24	0.06	0.76	0.94	A	0.452	0.067370621	Systolic blood pressure alcohol consumption interaction	General health
rs4822024	G	A	27	48	19	60	28	6	0.54	0.79	0.46	0.21	G	1.28	0.067174603	Vitiligo	Immune diseases and disorders
rs10456100	C	T	61	29	4	88	6	0	0.80	0.97	0.20	0.03	T	1.07	0.067113625	Migraine	Brain health and disorders
rs11169838	C	T	61	29	4	88	6	0	0.80	0.97	0.20	0.03	C	0.1764	0.067113625	IgG glycosylation	Immune diseases and disorders
rs7775698	C	T	88	6	0	60	31	3	0.97	0.80	0.03	0.20	T	0.085	0.067113625	Mean corpuscular hemoglobin concentration	Heart health and disorders
rs7733624	C	A	90	4	0	62	31	1	0.98	0.82	0.02	0.18	A	34.08	0.06704935	Diisocyanate-induced asthma	Pulmonology
rs10488023	A	G	64	27	3	90	4	0	0.82	0.98	0.18	0.02	G	0.099	0.06704935	Breast size	General health
rs10065203	C	T	61	31	2	90	3	1	0.81	0.97	0.19	0.03	A	2.51	0.066964286	Paclitaxel-induced neuropathy	Brain health and disorders
rs12411988	G	C	64	25	5	89	5	0	0.81	0.97	0.19	0.03	C	1.18	0.066964286	Arthritis juvenile idiopathic	Immune diseases and disorders
rs12468226	A	G	63	27	4	89	5	0	0.81	0.97	0.19	0.03	A	0.039	0.066964286	Urate levels	General health
rs8012941	A	G	28	47	19	9	37	48	0.55	0.29	0.45	0.71	G	1.5387	0.066891186	Major depressive disorder	Brain health and disorders
rs239713	T	C	10	35	49	33	37	24	0.29	0.55	0.71	0.45	T	1	0.066891186	Cerebrospinal AB1-42 levels	Brain health and disorders
rs156299	T	G	28	47	19	7	41	46	0.55	0.29	0.45	0.71	G	0.95	0.066891186	Vitamin D levels	General health
rs2302612	T	C	48	37	9	19	47	28	0.71	0.45	0.29	0.55	C	0.08	0.066891186	Serum protein levels sST2	General health
rs9287719	C	T	15	46	33	4	24	66	0.40	0.17	0.60	0.83	C	1.07	0.066887783	Prostate cancer	Cancer
rs2299587	T	G	31	50	13	64	28	2	0.60	0.83	0.40	0.17	T	0.125	0.066887783	Economic and political preferences	Mental aptitude and behavioural traits
rs3130340	T	C	65	26	3	34	44	16	0.83	0.60	0.17	0.40	T	0.1	0.066887783	Bone mineral density spine	General health
rs9315702	C	A	42	40	12	73	19	2	0.66	0.88	0.34	0.12	A	1	0.066857575	Hippocampal atrophy	Brain health and disorders
rs4343	G	A	21	39	34	4	28	62	0.43	0.19	0.57	0.81	A	0.059	0.066825067	Blood metabolite ratios	Heart health and disorders
rs6498169	G	A	24	46	24	5	37	52	0.50	0.25	0.50	0.75	G	1.14	0.066666667	Multiple sclerosis	Brain health and disorders
rs2025345	A	G	29	43	22	58	31	5	0.54	0.78	0.46	0.22	G	0.0572	0.066658266	Self-reported allergy	General health
rs2001846	T	C	18	51	25	6	29	59	0.46	0.22	0.54	0.78	T	1.05	0.066658266	Myocardial infarction	Heart health and disorders
rs7551318	G	T	4	33	57	20	47	27	0.22	0.46	0.78	0.54	T	0.062	0.066658266	Body mass index	Obesity
rs2056626	T	G	52	35	7	82	11	1	0.74	0.93	0.26	0.07	T	1.2	0.066570783	Systemic sclerosis	Brain health and disorders
rs8050896	A	T	82	11	1	54	31	9	0.93	0.74	0.07	0.26	T	1	0.066570783	Response to antipsychotic treatment	General health
rs170149	G	A	81	13	0	49	41	4	0.93	0.74	0.07	0.26	A	0.026	0.066570783	Blood metabolite levels	Heart health and disorders
rs10957961	A	G	10	52	32	3	23	68	0.38	0.15	0.62	0.85	A	0.153	0.066570657	Metabolite levels Pyroglutamine	General health
rs6842241	C	A	70	22	2	38	44	12	0.86	0.64	0.14	0.36	C	1.249	0.066545948	Intracranial aneurysm	Misc
rs1169314	A	G	39	42	13	71	20	3	0.64	0.86	0.36	0.14	G	0.037	0.066545948	LDL cholesterol	General health
rs1883832	T	C	5	34	55	0	10	84	0.23	0.05	0.77	0.95	T	1.19	0.066482632	Chronic hepatitis B infection	Immune diseases and disorders
rs6074022	C	T	5	34	55	0	10	84	0.23	0.05	0.77	0.95	G	1.1011126	0.066482632	Crohn's disease	Digestive system and its disorders
rs499697	G	A	9	26	59	0	10	84	0.23	0.05	0.77	0.95	G	0.13	0.066482632	Common traits Other	Misc
rs933769	C	T	4	36	54	0	10	84	0.23	0.05	0.77	0.95	T	0.097	0.066482632	Alcoholism alcohol dependence factor score	General health
rs10919071	A	G	55	34	5	84	10	0	0.77	0.95	0.23	0.05	A	2.05	0.066482632	QT interval	Heart health and disorders
rs10919070	A	C	55	34	5	84	10	0	0.77	0.95	0.23	0.05	C	1.68	0.066482632	QT interval	Heart health and disorders
rs1036736	T	C	85	8	1	58	28	8	0.95	0.77	0.05	0.23	T	1	0.066482632	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs2076751	C	A	54	36	4	84	10	0	0.77	0.95	0.23	0.05	A	0.087	0.066482632	Menarche age at onset	Reproductive health
rs17470137	G	A	54	36	4	84	10	0	0.77	0.95	0.23	0.05	A	0.03	0.066482632	Aortic root size	Heart health and disorders
rs10454142	T	C	57	30	7	84	10	0	0.77	0.95	0.23	0.05	T	0.023	0.066482632	Sex hormone-binding globulin levels	Reproductive health
rs1436958	G	T	20	43	31	42	47	5	0.44	0.70	0.56	0.30	G	0.1389	0.066458982	IgG glycosylation	Immune diseases and disorders
rs2255141	A	G	12	37	45	1	19	74	0.32	0.11	0.68	0.89	A	1.14	0.066368011	Cholesterol, total	General health
rs557933	A	C	13	35	46	4	13	77	0.32	0.11	0.68	0.89	C	0.049	0.066368011	Cholesterol, total	General health
rs268786	C	A	0	1	93	3	20	71	0.01	0.14	0.99	0.86	C	0.02	0.066327072	Obesity-related traits	Obesity
rs2916733	G	A	55	30	9	25	43	26	0.74	0.49	0.26	0.51	C	2.74	0.066298508	Epirubicin-induced leukopenia	Drug response
rs2687201	A	C	15	28	51	29	48	17	0.31	0.56	0.69	0.44	T	1.18	0.066267832	Digestive system disease Barrett's esophagus and esophageal adenocarcinoma combined	Digestive system and its disorders
rs2725220	G	C	29	48	17	9	40	45	0.56	0.31	0.44	0.69	C	0.135	0.066267832	Renal function-related traits urea	General health
rs6110969	C	T	64	27	3	32	47	15	0.82	0.59	0.18	0.41	T	1.2	0.066165414	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs12429545	G	A	50	36	8	79	15	0	0.72	0.92	0.28	0.08	A	1	0.066125682	Body mass index	Obesity
rs3902035	T	C	48	40	6	79	15	0	0.72	0.92	0.28	0.08	C	0.85	0.066125682	QT interval	Heart health and disorders
rs9568867	G	A	50	36	8	79	15	0	0.72	0.92	0.28	0.08	A	0.031	0.066125682	Body mass index	Obesity
rs11168249	T	C	42	45	7	16	49	29	0.69	0.43	0.31	0.57	G	1.0644168	0.066092943	Ulcerative colitis	Immune diseases and disorders
rs1780324	A	G	19	43	32	46	37	11	0.43	0.69	0.57	0.31	T	0.03	0.066092943	Liver enzyme levels	General health
rs4687717	T	C	16	49	29	46	37	11	0.43	0.69	0.57	0.31	T	0.018	0.066092943	Blood metabolite ratios	Heart health and disorders
rs6808835	G	T	75	19	0	46	38	10	0.90	0.69	0.10	0.31	G	1	0.06606437	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Brain health and disorders
rs12290811	T	A	78	15	1	49	35	10	0.91	0.71	0.09	0.29	A	1.2	0.065972222	Bipolar disorder	Brain health and disorders
rs12750249	T	C	47	39	8	78	15	1	0.71	0.91	0.29	0.09	C	0.165	0.065972222	IgG glycosylation	Immune diseases and disorders
rs9647570	T	G	43	47	4	77	17	0	0.71	0.91	0.29	0.09	G	0.05	0.065972222	Menarche age at onset	Reproductive health
rs3743104	A	G	24	44	26	49	41	4	0.49	0.74	0.51	0.26	G	1.24	0.065950142	Hypospadias	Misc
rs1153858	C	T	24	48	22	6	37	51	0.51	0.26	0.49	0.74	C	0.271	0.065950142	Homoarginine levels	Misc
rs8049607	T	C	45	38	11	16	48	30	0.68	0.43	0.32	0.57	T	1.25	0.065934066	QT interval	Heart health and disorders
rs4290173	C	T	70	24	0	36	51	7	0.87	0.65	0.13	0.35	C	1.8	0.065810594	Narcolepsy with cataplexy	Brain health and disorders
rs6751349	C	A	70	24	0	37	49	8	0.87	0.65	0.13	0.35	A	1.22	0.065810594	QT interval	Heart health and disorders
rs2641348	A	G	71	22	1	37	49	8	0.87	0.65	0.13	0.35	G	1.1290045	0.065810594	Crohn's disease	Digestive system and its disorders
rs1483242	G	A	45	33	16	72	20	2	0.65	0.87	0.35	0.13	G	1.0638298	0.065810594	Schizophrenia	Brain health and disorders
rs17050272	G	A	40	43	11	74	16	4	0.65	0.87	0.35	0.13	A	0.035	0.065810594	Urate levels	General health
rs235770	T	C	12	41	41	1	22	71	0.35	0.13	0.65	0.87	T	0.089	0.065810594	Refractive error	General health
rs7807441	C	T	10	41	43	30	49	15	0.32	0.58	0.68	0.42	T	4.02	0.065790977	Menarche age at onset	Reproductive health
rs7568069	G	A	17	45	32	42	43	9	0.42	0.68	0.58	0.32	A	0.022	0.065790977	Height	General health
rs17381664	T	C	34	47	13	66	26	2	0.61	0.84	0.39	0.16	C	1.09	0.06575625	Obesity	Obesity
rs11745512	A	G	58	30	6	85	9	0	0.78	0.95	0.22	0.05	A	4.516	0.065701357	Very long-chain saturated fatty acid levels fatty acid 22:0	General health
rs7215286	C	G	85	9	0	55	36	3	0.95	0.78	0.05	0.22	C	0.4016	0.065701357	IgG glycosylation	Immune diseases and disorders
rs12287212	C	A	28	43	23	56	33	5	0.53	0.77	0.47	0.23	A	0.94	0.065697963	Vitamin D levels	General health
rs3125734	T	C	8	46	40	30	50	14	0.33	0.59	0.67	0.41	T	1.2	0.065663475	Rheumatoid arthritis	Immune diseases and disorders
rs1457614	C	A	2	23	69	15	39	40	0.14	0.37	0.86	0.63	C	1.4652	0.065625	Major depressive disorder	Brain health and disorders
rs6751439	G	A	69	23	2	39	41	14	0.86	0.63	0.14	0.37	A	170.8	0.065625	Forced expiratory volume in 1 second environmental interaction	Pulmonology
rs2376265	G	A	67	27	0	38	43	13	0.86	0.63	0.14	0.37	A	0.0023	0.065625	Trans fatty acid levels	General health
rs12827476	T	C	25	41	28	49	40	5	0.48	0.73	0.52	0.27	A	0.03	0.065621008	Obesity-related traits	Obesity
rs10946940	A	G	19	39	36	42	41	11	0.41	0.66	0.59	0.34	A	1.45	0.065551383	Systemic lupus erythematosus	Immune diseases and disorders
rs9512637	T	C	11	41	42	33	45	16	0.34	0.59	0.66	0.41	C	0.105	0.065551383	Alcoholism heaviness of drinking	General health
rs2785173	G	A	82	12	0	54	33	7	0.94	0.75	0.06	0.25	T	1.94	0.065497514	Response to Vitamin E supplementation	General health
rs11263654	C	T	82	12	0	49	43	2	0.94	0.75	0.06	0.25	C	1.53	0.065497514	Renal cell carcinoma	Cancer
rs10994336	C	T	54	33	7	83	10	1	0.75	0.94	0.25	0.06	T	1.45	0.065497514	Bipolar disorder	Brain health and disorders
rs495524	A	T	33	44	17	65	24	5	0.59	0.82	0.41	0.18	T	1	0.06547619	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs58938945	A	G	33	44	17	62	30	2	0.59	0.82	0.41	0.18	A	0.2848	0.06547619	Metabolite levels MHPG	General health
rs2049186	T	A	14	50	30	4	26	64	0.41	0.18	0.59	0.82	T	0.075	0.06547619	Urate levels in overweight individuals	Obesity
rs1629212	A	T	30	50	14	60	34	0	0.59	0.82	0.41	0.18	A	0.0493	0.06547619	Glycerophospholipid levels	Diabetes
rs6580083	A	G	34	44	16	8	48	38	0.60	0.34	0.40	0.66	G	0.85	0.065454545	QRS duration	Heart health and disorders
rs12964056	A	G	18	39	37	39	45	10	0.40	0.65	0.60	0.35	A	4.98	0.065372829	Body mass index	Obesity
rs479336	T	G	42	39	13	15	45	34	0.65	0.40	0.35	0.60	T	0.04	0.065372829	Bone mineral density	General health
rs2116483	C	T	24	50	20	4	43	47	0.52	0.27	0.48	0.73	A	0.02	0.065310587	Obesity-related traits	Obesity
rs12640626	G	A	16	41	37	35	51	8	0.39	0.64	0.61	0.36	A	1.034	0.065254333	Educational attainment	Mental aptitude and behavioural traits
rs10067427	A	G	38	45	11	9	55	30	0.64	0.39	0.36	0.61	G	0.75	0.065254333	Non-alcoholic fatty liver disease histology lobular	Obesity
rs2166706	T	C	36	43	15	10	47	37	0.61	0.36	0.39	0.64	G	0.07	0.065254333	Fasting plasma glucose	General health
rs10789336	G	A	5	34	55	18	54	22	0.23	0.48	0.77	0.52	A	0.042	0.065252251	Body mass index	Obesity
rs4465599	G	A	6	32	56	17	56	21	0.23	0.48	0.77	0.52	A	0.0276	0.065252251	Palmitoleic acid 16:1n-7 plasma levels	General health
rs6438424	A	C	24	50	20	54	36	4	0.52	0.77	0.48	0.23	A	2.7	0.065252251	Menarche age at onset	Reproductive health
rs10798069	G	T	41	44	9	74	18	2	0.67	0.88	0.33	0.12	A	1.0729233	0.065231572	Crohn's disease	Digestive system and its disorders
rs508970	A	G	9	44	41	1	20	73	0.33	0.12	0.67	0.88	A	1.07	0.065231572	Rheumatoid arthritis	Immune diseases and disorders
rs3905706	C	T	38	40	16	11	46	37	0.62	0.36	0.38	0.64	T	0.05	0.065217391	Bone mineral density	General health
rs2268361	C	T	11	47	36	31	55	8	0.37	0.62	0.63	0.38	C	1.15	0.065195246	Polycystic ovary syndrome	Reproductive health
rs6445754	C	T	10	49	35	35	47	12	0.37	0.62	0.63	0.38	C	1	0.065195246	Acute lymphoblastic leukemia childhood	Cancer
rs1991431	G	A	39	40	15	12	46	36	0.63	0.37	0.37	0.63	A	1.33	0.065187868	Height	General health
rs13414205	C	T	94	0	0	75	15	4	1.00	0.88	0.00	0.12	A	1	0.065155807	Immune reponse to smallpox secreted TNF-alpha	Immune diseases and disorders
rs10018902	G	A	92	2	0	68	24	2	0.99	0.85	0.01	0.15	A	0.04	0.065125241	Obesity-related traits	Obesity
rs73004856	G	A	92	2	0	66	28	0	0.99	0.85	0.01	0.15	A	0.02	0.065125241	Obesity-related traits	Obesity
rs13409348	G	C	58	33	3	26	52	16	0.79	0.55	0.21	0.45	G	1.2	0.065072785	Bipolar disorder	Brain health and disorders
rs17690703	C	T	57	34	3	86	8	0	0.79	0.96	0.21	0.04	C	1.43	0.06504065	Idiopathic pulmonary fibrosis	Pulmonology
rs56336142	T	C	57	34	3	86	8	0	0.79	0.96	0.21	0.04	T	1.07	0.06504065	Coronary artery disease	Heart health and disorders
rs17111652	C	T	86	8	0	59	30	5	0.96	0.79	0.04	0.21	T	0.234	0.06504065	Airway responsiveness in chronic obstructive pulmonary disease	Pulmonology
rs6563199	T	C	13	48	33	1	29	64	0.39	0.16	0.61	0.84	T	0.018	0.064979793	Height	General health
rs4780141	T	C	1	12	81	4	42	48	0.07	0.27	0.93	0.73	T	0.0028	0.064903846	Trans fatty acid levels	General health
rs7181696	T	C	1	12	81	4	42	48	0.07	0.27	0.93	0.73	T	0.0028	0.064903846	Trans fatty acid levels	General health
rs1229741	G	A	51	36	7	80	14	0	0.73	0.93	0.27	0.07	A	1.67	0.064903846	HIV-1 susceptibility	Immune diseases and disorders
rs7463166	A	G	49	40	5	80	14	0	0.73	0.93	0.27	0.07	A	0.03	0.064903846	Menarche age at onset	Reproductive health
rs10500871	C	T	53	32	9	82	10	2	0.73	0.93	0.27	0.07	T	0.022	0.064903846	Educational attainment	Mental aptitude and behavioural traits
rs10774740	G	T	20	51	23	2	41	51	0.48	0.24	0.52	0.76	G	1.14	0.064828431	Prostate cancer	Cancer
rs967417	G	A	22	53	19	56	31	7	0.52	0.76	0.48	0.24	C	4.3	0.064828431	Height	General health
rs2937550	C	T	24	49	21	55	33	6	0.52	0.76	0.48	0.24	T	0.045	0.064828431	Height	General health
rs1046896	C	T	23	51	20	54	35	5	0.52	0.76	0.48	0.24	T	0.04	0.064828431	Glycated hemoglobin levels	Diabetes
rs12922061	C	T	43	43	8	74	20	0	0.69	0.89	0.31	0.11	T	1.231	0.06482547	Breast cancer	Cancer
rs5753037	C	T	43	43	8	74	20	0	0.69	0.89	0.31	0.11	T	1.1	0.06482547	Type 1 diabetes	Diabetes
rs1847472	C	A	46	37	11	74	20	0	0.69	0.89	0.31	0.11	G	1.07	0.06482547	Crohn's disease	Digestive system and its disorders
rs1335882	A	T	6	47	41	0	20	74	0.31	0.11	0.69	0.89	T	1.0526316	0.06482547	Schizophrenia	Brain health and disorders
rs10877839	T	C	46	37	11	75	18	1	0.69	0.89	0.31	0.11	C	0.1459	0.06482547	IgG glycosylation	Immune diseases and disorders
rs1420103	A	C	13	33	48	2	16	76	0.31	0.11	0.69	0.89	A	0.13	0.06482547	Serum protein levels sST2	General health
rs2046180	G	T	8	43	43	1	18	75	0.31	0.11	0.69	0.89	G	0.124	0.06482547	Urate levels in obese individuals	Obesity
rs34330	T	C	1	33	60	18	43	33	0.19	0.42	0.81	0.58	C	1.1905	0.064818535	Systemic lupus erythematosus	Immune diseases and disorders
rs4143094	T	G	2	31	61	14	51	29	0.19	0.42	0.81	0.58	T	1.17	0.064818535	Colorectal cancer diet interaction	Cancer
rs1366594	A	C	18	43	33	3	29	62	0.42	0.19	0.58	0.81	C	0.35	0.064818535	Bone mineral density	General health
rs1473307	C	T	19	41	34	1	33	60	0.42	0.19	0.58	0.81	T	0.1441	0.064818535	Menopause age at onset	Reproductive health
rs55951657	G	A	69	25	0	44	34	16	0.87	0.65	0.13	0.35	A	158.61	0.064815886	Hippocampal volume	Brain health and disorders
rs3897478	T	C	70	23	1	36	50	8	0.87	0.65	0.13	0.35	T	1.161	0.064815886	Crohn's disease	Digestive system and its disorders
rs10096633	C	T	71	21	2	41	40	13	0.87	0.65	0.13	0.35	T	0.101	0.064815886	HDL cholesterol	General health
rs1035050	T	C	41	36	17	70	20	4	0.63	0.85	0.37	0.15	T	1.17	0.064748201	Bipolar disorder	Brain health and disorders
rs12755164	A	G	1	26	67	9	52	33	0.15	0.37	0.85	0.63	A	1.06	0.064748201	Schizophrenia	Brain health and disorders
rs4575	T	C	25	50	19	4	45	45	0.53	0.28	0.47	0.72	G	1.492	0.064743984	Suicide behavior	Brain health and disorders
rs7586898	G	C	10	33	51	27	46	21	0.28	0.53	0.72	0.47	C	1	0.064743984	Hair morphology	Appearance
rs59072263	G	T	79	14	1	44	47	3	0.91	0.72	0.09	0.28	G	0.45	0.064627295	Intraocular pressure	General health
rs16890640	T	A	48	39	7	78	16	0	0.72	0.91	0.28	0.09	T	0.092	0.064627295	Urate levels in overweight individuals	Obesity
rs1670533	G	A	5	43	46	0	16	78	0.28	0.09	0.72	0.91	C	88.2	0.064627295	Recombination rate females	Misc
rs1440372	T	C	5	43	46	0	16	78	0.28	0.09	0.72	0.91	C	0.0277	0.064627295	Waist-to-hip ratio adjusted for body mass index	Obesity
rs1928168	T	C	45	42	7	77	16	1	0.70	0.90	0.30	0.10	T	1	0.064614283	Pulmonary function interaction	Pulmonology
rs3738934	T	C	48	36	10	76	18	0	0.70	0.90	0.30	0.10	T	0.106	0.064614283	Blood metabolite levels	Heart health and disorders
rs9393903	G	A	43	46	5	77	16	1	0.70	0.90	0.30	0.10	A	0.06	0.064614283	Metabolic traits	Misc
rs17023457	T	C	48	36	10	77	16	1	0.70	0.90	0.30	0.10	C	0.06	0.064614283	Antitragus size	Misc
rs38664	T	C	5	46	43	0	18	76	0.30	0.10	0.70	0.90	T	0.05	0.064614283	Bone properties heel	General health
rs939317	A	G	7	42	45	1	16	77	0.30	0.10	0.70	0.90	G	0.04	0.064614283	Menarche age at onset	Reproductive health
rs793108	C	T	27	49	18	58	32	4	0.55	0.79	0.45	0.21	T	1.08	0.064541833	Rheumatoid arthritis	Immune diseases and disorders
rs17156371	C	A	87	7	0	56	38	0	0.96	0.80	0.04	0.20	A	2.1463	0.064518295	Clozapine-induced agranulocytosis	General health
rs2271893	G	A	63	24	7	87	7	0	0.80	0.96	0.20	0.04	G	1	0.064518295	Bipolar disorder	Brain health and disorders
rs472926	C	T	4	30	60	0	7	87	0.20	0.04	0.80	0.96	C	1	0.064518295	Alzheimer's disease late onset	Brain health and disorders
rs11903187	G	A	84	9	1	55	33	6	0.94	0.76	0.06	0.24	A	1	0.064508929	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs17389644	G	A	68	22	4	91	3	0	0.84	0.98	0.16	0.02	A	1.208	0.064404983	Atopic dermatitis	Immune diseases and disorders
rs17454584	A	G	68	22	4	91	3	0	0.84	0.98	0.16	0.02	G	1.15	0.064404983	Allergic sensitization	Immune diseases and disorders
rs2483058	C	G	22	42	30	48	37	9	0.46	0.71	0.54	0.29	C	0.203	0.064246866	Cholesterol and Triglycerides	General health
rs2179367	A	G	27	48	19	7	41	46	0.54	0.29	0.46	0.71	G	1.23	0.064246866	Dupuytren's disease	Skin related disease
rs4870044	C	T	28	46	20	10	35	49	0.54	0.29	0.46	0.71	T	0.11	0.064246866	Bone mineral density spine	General health
rs207954	T	C	3	26	65	8	59	27	0.17	0.40	0.83	0.60	C	1.25	0.064239308	Acute lymphoblastic leukemia childhood	Cancer
rs12120588	T	A	33	42	19	64	24	6	0.57	0.81	0.43	0.19	T	0.077	0.064190981	Urate levels in overweight individuals	Obesity
rs2360806	A	C	62	28	4	32	44	18	0.81	0.57	0.19	0.43	C	0.047	0.064190981	Motion sickness	Misc
rs12210538	A	G	60	32	2	88	6	0	0.81	0.97	0.19	0.03	A	0.086	0.064157399	Acylcarnitine levels	General health
rs1435703	G	T	73	19	2	44	37	13	0.88	0.66	0.12	0.34	T	1.66	0.06415397	Obesity extreme	Obesity
rs10768122	A	G	40	45	9	72	21	1	0.66	0.88	0.34	0.12	G	1.22	0.06415397	Vitiligo	Immune diseases and disorders
rs1424609	C	T	9	45	40	3	17	74	0.34	0.12	0.66	0.88	G	1.72	0.06415397	Diabetic kidney disease	Diabetes
rs66714249	G	T	90	4	0	63	30	1	0.98	0.83	0.02	0.17	A	8.66	0.064052288	Diisocyanate-induced asthma	Pulmonology
rs2333163	T	C	90	4	0	62	32	0	0.98	0.83	0.02	0.17	G	0.03	0.064052288	Obesity-related traits	Obesity
rs816475	T	C	51	39	4	28	39	27	0.75	0.51	0.25	0.49	T	3.69	0.064043584	Heart rate	General health
rs6801957	T	C	21	44	29	6	29	59	0.46	0.22	0.54	0.78	T	1.436	0.06403567	P wave duration	Heart health and disorders
rs4936891	G	C	21	44	29	3	35	56	0.46	0.22	0.54	0.78	C	1	0.06403567	Male fertility	Reproductive health
rs2648875	G	A	50	32	12	24	37	33	0.70	0.45	0.30	0.55	A	2.97	0.064023418	End-stage renal disease	General health
rs9993613	T	G	23	39	32	42	48	4	0.45	0.70	0.55	0.30	T	0.03	0.064023418	Height	General health
rs7697556	T	C	23	39	32	42	48	4	0.45	0.70	0.55	0.30	T	0.028	0.064023418	Height	General health
rs11848070	G	A	2	30	62	1	3	90	0.18	0.03	0.82	0.97	C	1	0.063988435	Alzheimer's disease late onset	Brain health and disorders
rs7944584	A	T	67	20	7	89	5	0	0.82	0.97	0.18	0.03	A	1	0.063988435	Fasting glucose-related traits	General health
rs17038828	C	T	89	5	0	62	30	2	0.97	0.82	0.03	0.18	C	0.56	0.063988435	IgG glycosylation	Immune diseases and disorders
rs12477314	C	T	63	28	3	89	5	0	0.82	0.97	0.18	0.03	T	0.041	0.063988435	Pulmonary function	Pulmonology
rs1528149	C	T	39	39	16	67	25	2	0.62	0.85	0.38	0.15	C	0.047	0.063913043	Sitting height ratio	Appearance
rs7584262	C	T	69	24	1	37	47	10	0.86	0.64	0.14	0.36	T	0.04	0.063870208	Bone mineral density	General health
rs7617400	C	T	70	22	2	42	37	15	0.86	0.64	0.14	0.36	A	0.034	0.063870208	Liver enzyme levels aspartate transaminase	General health
rs2710642	G	A	13	41	40	3	20	71	0.36	0.14	0.64	0.86	G	0.024	0.063870208	LDL cholesterol	General health
rs10400694	G	C	6	45	43	29	46	19	0.30	0.55	0.70	0.45	C	0.24	0.063816265	Ischemic stroke	Brain health and disorders
rs6738028	G	C	32	40	22	8	41	45	0.55	0.30	0.45	0.70	G	0.04	0.063816265	Dehydroepiandrosterone sulphate levels	Immune diseases and disorders
rs11644424	C	A	18	48	28	47	37	10	0.45	0.70	0.55	0.30	T	3.32	0.063816265	Adverse response to chemotherapy in breast cancer alopecia cyclophosphamide+doxorubicin+_-5FU	Drug response
rs7754840	G	C	43	45	6	23	38	33	0.70	0.45	0.30	0.55	C	1.518	0.063816265	Diabetes gestational	Diabetes
rs4712524	A	G	43	45	6	23	38	33	0.70	0.45	0.30	0.55	G	1.22	0.063816265	Type 2 diabetes	Diabetes
rs10946398	A	C	43	45	6	23	38	33	0.70	0.45	0.30	0.55	C	1.16	0.063816265	Type 2 diabetes	Diabetes
rs7772603	T	C	43	45	6	23	38	33	0.70	0.45	0.30	0.55	C	0.06	0.063816265	Glycated hemoglobin levels	Diabetes
rs2200578	C	T	53	34	7	81	13	0	0.74	0.93	0.26	0.07	C	0.1902	0.063752277	IgG glycosylation	Immune diseases and disorders
rs1007392	A	G	25	44	25	52	36	6	0.50	0.74	0.50	0.26	A	1.06	0.063681233	Vitamin D levels	General health
rs6547115	A	G	23	48	23	7	34	53	0.50	0.26	0.50	0.74	G	0.1432	0.063681233	IgG glycosylation	Immune diseases and disorders
rs1169288	A	C	43	42	9	74	19	1	0.68	0.89	0.32	0.11	C	1.45	0.063653484	Cholesterol, total	General health
rs4712523	A	G	42	46	6	22	39	33	0.69	0.44	0.31	0.56	G	1.27	0.063625104	Type 2 diabetes	Diabetes
rs10950821	C	G	43	44	7	19	45	30	0.69	0.44	0.31	0.56	G	1	0.063625104	Response to statin therapy	General health
rs6504663	A	G	47	36	11	16	51	27	0.69	0.44	0.31	0.56	A	1	0.063625104	Visceral fat	Obesity
rs2421649	A	G	20	43	31	42	46	6	0.44	0.69	0.56	0.31	G	0.048	0.063625104	Sitting height ratio	Appearance
rs2421650	A	G	20	43	31	42	46	6	0.44	0.69	0.56	0.31	A	0.047	0.063625104	Sitting height ratio	Appearance
rs7679673	C	A	31	43	20	11	36	47	0.56	0.31	0.44	0.69	C	1.12	0.063625104	Prostate cancer	Cancer
rs2425752	T	C	7	29	58	0	10	84	0.23	0.05	0.77	0.95	A	1.11	0.063613529	Multiple sclerosis	Brain health and disorders
rs16982689	C	T	84	10	0	56	33	5	0.95	0.77	0.05	0.23	T	2.67	0.063613529	Attention function in attention deficit hyperactive disorder	Brain health and disorders
rs13132184	A	G	55	35	4	85	8	1	0.77	0.95	0.23	0.05	A	1	0.063613529	Verbal declarative memory	Brain health and disorders
rs12613775	C	T	85	8	1	58	29	7	0.95	0.77	0.05	0.23	T	1	0.063613529	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs6099847	T	C	65	21	8	29	49	16	0.80	0.57	0.20	0.43	G	0.03	0.063592169	Obesity-related traits	Obesity
rs4297946	G	C	21	45	28	5	32	57	0.46	0.22	0.54	0.78	C	1.52	0.063553338	Cholesterol, total	General health
rs3096702	A	G	16	44	34	1	31	62	0.40	0.18	0.60	0.82	A	1.07	0.063532969	Prostate cancer	Cancer
rs6445975	G	T	11	37	46	30	46	18	0.31	0.56	0.69	0.44	C	1.25	0.063449663	Systemic lupus erythematosus	Immune diseases and disorders
rs855791	A	G	29	48	17	10	39	45	0.56	0.31	0.44	0.69	T	0.0875	0.063449663	Mean corpuscular hemoglobin concentration	Heart health and disorders
rs2227564	T	C	6	39	49	1	13	80	0.27	0.08	0.73	0.92	C	1.082	0.063343109	Inflammatory bowel disease	Immune diseases and disorders
rs1458038	C	T	50	37	7	80	13	1	0.73	0.92	0.27	0.08	T	0.706	0.063343109	Systolic blood pressure	Heart health and disorders
rs662138	C	G	50	37	7	81	11	2	0.73	0.92	0.27	0.08	C	0.077	0.063343109	Blood metabolite levels	Heart health and disorders
rs2286503	C	T	26	43	25	7	35	52	0.51	0.26	0.49	0.74	T	0.006	0.063338123	Fibrinogen	General health
rs2120019	T	C	55	29	10	21	51	22	0.74	0.49	0.26	0.51	C	0.287	0.063338123	Blood trace element Zn levels	Heart health and disorders
rs7651778	C	T	23	47	24	54	31	9	0.49	0.74	0.51	0.26	C	0.126	0.063338123	Corneal astigmatism	General health
rs663129	G	A	76	17	1	44	43	7	0.90	0.70	0.10	0.30	A	1.06	0.063333333	Coronary artery disease	Heart health and disorders
rs17001868	A	C	46	39	9	76	17	1	0.70	0.90	0.30	0.10	A	0.18	0.063333333	Mammographic density dense area	Reproductive health
rs7142143	T	C	93	1	0	73	17	4	0.99	0.87	0.01	0.13	C	3.61	0.063296703	Acute lymphoblastic leukemia childhood	Cancer
rs1496766	T	C	93	1	0	73	17	4	0.99	0.87	0.01	0.13	C	2.84	0.063296703	Acute lymphoblastic leukemia childhood	Cancer
rs16923647	C	T	72	19	3	93	1	0	0.87	0.99	0.13	0.01	T	1	0.063296703	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs17885785	C	T	72	19	3	93	1	0	0.87	0.99	0.13	0.01	T	1	0.063296703	Pediatric autoimmune diseases	Immune diseases and disorders
rs16862426	C	T	93	1	0	69	25	0	0.99	0.87	0.01	0.13	C	1	0.063296703	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs10464059	G	A	77	17	0	50	34	10	0.91	0.71	0.09	0.29	A	1.33	0.063218656	Parkinson's disease	Brain health and disorders
rs9596905	G	A	77	17	0	49	36	9	0.91	0.71	0.09	0.29	A	1	0.063218656	DNA methylation variation	Misc
rs2370983	G	A	8	38	48	0	17	77	0.29	0.09	0.71	0.91	A	1.04	0.063218656	Obesity	Obesity
rs591166	T	A	32	44	18	10	41	43	0.57	0.32	0.43	0.68	A	0.0464	0.063144956	Body mass index	Obesity
rs4713693	T	C	44	39	11	13	54	27	0.68	0.43	0.32	0.57	T	1.4	0.063144956	Graves' disease	Immune diseases and disorders
rs2449215	A	G	46	35	13	6	68	20	0.68	0.43	0.32	0.57	G	0.04	0.063144956	Obesity-related traits	Obesity
rs11231017	G	A	41	42	11	74	16	4	0.66	0.87	0.34	0.13	A	0.7189	0.063131313	HIV-1 viral setpoint	Immune diseases and disorders
rs3824662	C	A	35	46	13	67	24	3	0.62	0.84	0.38	0.16	T	1.31	0.063117218	Acute lymphoblastic leukemia B-cell precursor	Cancer
rs10262537	C	T	55	35	4	28	44	22	0.77	0.53	0.23	0.47	C	0.08	0.06309394	Metabolite levels Dihydroxy docosatrienoic acid	General health
rs4143912	A	G	17	45	32	41	44	9	0.42	0.67	0.58	0.33	G	0.1434	0.063015262	IgG glycosylation	Immune diseases and disorders
rs1873386	A	G	41	44	9	18	43	33	0.67	0.42	0.33	0.58	A	0.03	0.063015262	Personality dimensions	Brain health and disorders
rs12059546	A	G	50	38	6	25	42	27	0.73	0.49	0.27	0.51	G	1.42	0.063013699	Epilepsy generalized	Brain health and disorders
rs267939	C	T	19	54	21	50	38	6	0.49	0.73	0.51	0.27	C	1.1	0.063013699	Ulcerative colitis	Immune diseases and disorders
rs7155279	G	T	50	38	6	21	50	23	0.73	0.49	0.27	0.51	T	0.024	0.063013699	Height	General health
rs8038465	C	T	36	48	10	69	23	2	0.64	0.86	0.36	0.14	T	2.4	0.062970594	Liver enzyme levels gamma-glutamyl transferase	General health
rs6864049	A	G	15	38	41	2	23	69	0.36	0.14	0.64	0.86	G	0.016	0.062970594	Body mass index	Obesity
rs10273775	A	G	17	44	33	41	43	10	0.41	0.66	0.59	0.34	G	1.52	0.062900424	Alzheimer's disease	Brain health and disorders
rs6083	A	G	33	44	17	5	53	36	0.59	0.34	0.41	0.66	A	1.29	0.062900424	Schizophrenia	Brain health and disorders
rs10914967	G	A	48	29	17	11	56	27	0.66	0.41	0.34	0.59	A	1	0.062900424	Visceral adipose tissue adjusted for BMI	Obesity
rs979976	A	C	14	35	45	34	42	18	0.34	0.59	0.66	0.41	A	0.134	0.062900424	Corneal astigmatism	General health
rs1480380	C	T	85	9	0	59	29	6	0.95	0.78	0.05	0.22	T	3.05	0.062822086	Idiopathic membranous nephropathy	Brain health and disorders
rs4749080	A	G	58	31	5	85	9	0	0.78	0.95	0.22	0.05	G	0.04	0.062822086	Obesity-related traits	Obesity
rs10105606	C	A	38	48	8	11	55	28	0.66	0.41	0.34	0.59	C	0.07	0.062800284	Triglycerides	General health
rs10994359	T	C	55	32	7	83	10	1	0.76	0.94	0.24	0.06	C	1.081	0.062676209	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs664154	C	T	54	36	4	23	53	18	0.77	0.53	0.23	0.47	A	5.03	0.062656642	Information processing speed	Mental aptitude and behavioural traits
rs10089517	C	A	28	43	23	54	36	4	0.53	0.77	0.47	0.23	C	1	0.062656642	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs6496932	C	A	54	36	4	31	37	26	0.77	0.53	0.23	0.47	A	0.11	0.062656642	Corneal structure	General health
rs682331	A	G	34	46	14	9	49	36	0.61	0.36	0.39	0.64	G	0.02	0.062586769	Obesity-related traits	Obesity
rs678741	G	A	16	41	37	43	34	17	0.39	0.64	0.61	0.36	A	1.44	0.06254424	Adolescent idiopathic scoliosis	Obesity
rs10512597	T	C	11	46	37	34	47	13	0.36	0.61	0.64	0.39	T	0.008	0.06254424	Fibrinogen	General health
rs9967417	G	C	9	43	42	3	16	75	0.32	0.12	0.68	0.88	G	1.13	0.06254369	Height	General health
rs6142618	A	G	9	43	42	2	18	74	0.32	0.12	0.68	0.88	G	1.072	0.06254369	Inflammatory bowel disease	Immune diseases and disorders
rs924607	C	T	40	47	7	74	18	2	0.68	0.88	0.32	0.12	T	2.43	0.06254369	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	Cancer
rs3790672	T	C	41	45	8	73	20	1	0.68	0.88	0.32	0.12	C	1.23	0.06254369	Testicular germ cell tumor	Cancer
rs6589964	A	C	38	40	16	12	45	37	0.62	0.37	0.38	0.63	A	2.7	0.062515919	Menarche age at onset	Reproductive health
rs1541777	A	G	40	39	15	14	44	36	0.63	0.38	0.37	0.62	A	0.036	0.062515919	Height	General health
rs10446497	T	G	36	46	12	16	39	39	0.63	0.38	0.37	0.62	G	1.0526316	0.062501768	Schizophrenia	Brain health and disorders
rs3820201	A	G	24	35	35	3	33	58	0.44	0.21	0.56	0.79	A	1	0.062475797	Hippocampal atrophy	Brain health and disorders
rs11177	G	A	28	49	17	59	31	4	0.56	0.79	0.44	0.21	A	1.09	0.062475797	Osteoarthritis	Immune diseases and disorders
rs10505477	A	G	19	52	23	49	38	7	0.48	0.72	0.52	0.28	A	1.39	0.062418879	Prostate cancer early onset	Cancer
rs932764	A	G	23	44	27	52	32	10	0.48	0.72	0.52	0.28	G	0.484	0.062418879	Systolic blood pressure	Heart health and disorders
rs17711722	C	T	30	38	26	7	38	49	0.52	0.28	0.48	0.72	T	0.015	0.062418879	Calcium levels	General health
rs6923462	T	C	65	27	2	39	37	18	0.84	0.61	0.16	0.39	T	30.883	0.062358597	Forced vital capacity	Pulmonology
rs7182385	G	A	34	47	13	64	29	1	0.61	0.84	0.39	0.16	G	0.094	0.062358597	Urate levels in lean individuals	Obesity
rs420017	C	T	41	33	20	66	25	3	0.61	0.84	0.39	0.16	T	0.043	0.062358597	Height	General health
rs10873876	T	C	2	27	65	12	49	33	0.16	0.39	0.84	0.61	T	1.55	0.062358597	Acute lymphoblastic leukemia childhood	Cancer
rs11755164	T	C	5	35	54	20	50	24	0.24	0.48	0.76	0.52	T	0.04	0.062240664	Bone mineral density	General health
rs6845865	T	C	53	37	4	24	50	20	0.76	0.52	0.24	0.48	G	0.19	0.062240664	QT interval	Heart health and disorders
rs1902859	T	C	42	39	13	70	23	1	0.65	0.87	0.35	0.13	C	1.34	0.062160062	Systolic blood pressure	Heart health and disorders
rs4075154	A	G	70	23	1	37	49	8	0.87	0.65	0.13	0.35	A	1.29	0.062160062	Height	General health
rs11129176	G	A	39	45	10	70	23	1	0.65	0.87	0.35	0.13	A	0.028	0.062160062	Optic disc area	Misc
rs11783655	T	A	41	41	12	70	23	1	0.65	0.87	0.35	0.13	A	0.018	0.062160062	Height	General health
rs3783938	C	T	86	8	0	60	29	5	0.96	0.79	0.04	0.21	T	1	0.062148354	Visceral fat	Obesity
rs2244067	A	T	49	37	8	20	49	25	0.72	0.47	0.28	0.53	T	0.2142	0.062147556	Metabolite levels 5-HIAA	General health
rs7747752	G	C	49	37	8	25	39	30	0.72	0.47	0.28	0.53	C	0.046	0.062147556	Glycated hemoglobin levels	Diabetes
rs6457730	G	A	94	0	0	73	20	1	1.00	0.88	0.00	0.12	A	0.275	0.062146893	Self-reported allergy	General health
rs9469457	G	A	94	0	0	73	20	1	1.00	0.88	0.00	0.12	A	0.03	0.062146893	Obesity-related traits	Obesity
rs1358075	T	C	94	0	0	73	20	1	1.00	0.88	0.00	0.12	G	0.03	0.062146893	Obesity-related traits	Obesity
rs31872	G	A	7	44	43	1	18	75	0.31	0.11	0.69	0.89	G	1	0.062123559	Visceral adipose tissue adjusted for BMI	Obesity
rs11206801	C	A	76	16	2	44	42	8	0.89	0.69	0.11	0.31	A	1	0.062123559	Cerebrospinal AB1-42 levels	Brain health and disorders
rs6885116	A	G	80	14	0	51	37	6	0.93	0.74	0.07	0.26	G	2.57	0.062122826	Periodontal microbiota	Misc
rs12632235	C	T	81	12	1	51	37	6	0.93	0.74	0.07	0.26	T	2.173913	0.062122826	Alcohol dependence	General health
rs2188962	C	T	50	39	5	81	12	1	0.74	0.93	0.26	0.07	T	1.25	0.062122826	Crohn's disease	Digestive system and its disorders
rs12521868	G	T	50	39	5	81	12	1	0.74	0.93	0.26	0.07	T	1.23	0.062122826	Crohn's disease	Digestive system and its disorders
rs17622378	A	G	50	39	5	81	12	1	0.74	0.93	0.26	0.07	G	1.2094882	0.062122826	Crohn's disease	Digestive system and its disorders
rs1109501	G	A	52	35	7	81	12	1	0.74	0.93	0.26	0.07	G	0.1	0.062122826	Alcoholism heaviness of drinking	General health
rs2274465	C	G	51	37	6	81	12	1	0.74	0.93	0.26	0.07	C	0.03	0.062122826	Menarche age at onset	Reproductive health
rs4409785	T	C	69	23	2	92	2	0	0.86	0.99	0.14	0.01	C	1.12	0.062108715	Rheumatoid arthritis	Immune diseases and disorders
rs6943090	C	T	92	2	0	69	23	2	0.99	0.86	0.01	0.14	A	1	0.062108715	Immune reponse to smallpox secreted IL-12p40	Immune diseases and disorders
rs6546857	A	G	46	42	6	21	46	27	0.71	0.47	0.29	0.53	A	0.09	0.061893062	Metabolite levels  X-11787	General health
rs10747502	A	G	0	18	76	11	33	50	0.10	0.29	0.90	0.71	A	0.04	0.061892491	Obesity-related traits	Obesity
rs61935443	G	C	47	39	8	78	14	2	0.71	0.90	0.29	0.10	C	1.06	0.061892491	Schizophrenia	Brain health and disorders
rs5751902	C	T	45	43	6	77	16	1	0.71	0.90	0.29	0.10	T	0.172	0.061892491	Hematological and biochemical traits	Heart health and disorders
rs1178977	A	G	77	16	1	45	43	6	0.90	0.71	0.10	0.29	A	0.047	0.061892491	Urate levels	General health
rs11867479	C	T	48	37	9	77	16	1	0.71	0.90	0.29	0.10	T	0.025	0.061892491	Height	General health
rs10846617	G	C	46	41	7	77	16	1	0.71	0.90	0.29	0.10	C	0.014	0.061892491	Optic cup area	Misc
rs13226763	C	T	46	44	4	80	12	2	0.72	0.91	0.28	0.09	C	0.095	0.061879297	Urate levels in obese individuals	Obesity
rs10097669	T	C	52	32	10	80	12	2	0.72	0.91	0.28	0.09	T	0.0461	0.061879297	Trans fatty acid levels	General health
rs4796793	G	C	6	34	54	24	43	27	0.24	0.48	0.76	0.52	C	1.08	0.06184528	Atopic dermatitis	Immune diseases and disorders
rs4889240	T	C	24	49	21	53	36	5	0.52	0.76	0.48	0.24	T	1	0.06184528	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs493519	T	C	7	30	57	1	9	84	0.23	0.06	0.77	0.94	T	0.036	0.061682243	Blood metabolite levels	Heart health and disorders
rs17088439	T	G	83	11	0	52	40	2	0.94	0.77	0.06	0.23	T	2.2772	0.061682243	Smooth-surface caries	Appearance
rs12188164	C	A	53	38	3	84	9	1	0.77	0.94	0.23	0.06	A	1	0.061682243	Cystic fibrosis severity	Immune diseases and disorders
rs2774920	A	G	83	11	0	55	34	5	0.94	0.77	0.06	0.23	G	0.0513	0.061682243	D-dimer levels	Heart health and disorders
rs5751614	G	A	28	45	21	10	35	49	0.54	0.29	0.46	0.71	A	4.3	0.061655012	Height	General health
rs6592362	A	G	24	53	17	5	45	44	0.54	0.29	0.46	0.71	A	1.083	0.061655012	Inflammatory bowel disease	Immune diseases and disorders
rs10744304	G	A	19	49	26	45	43	6	0.46	0.71	0.54	0.29	A	0.15	0.061655012	Depression quantitative trait	Brain health and disorders
rs4470825	G	A	30	54	10	64	28	2	0.61	0.83	0.39	0.17	G	1.0526316	0.06163522	Schizophrenia	Brain health and disorders
rs1878526	G	A	69	18	7	31	52	11	0.83	0.61	0.17	0.39	A	0.04	0.06163522	Bone mineral density	General health
rs2601828	T	C	12	50	32	2	28	64	0.39	0.17	0.61	0.83	A	1.12	0.06163522	Partial epilepsies	Brain health and disorders
rs189897	T	A	58	35	1	87	7	0	0.80	0.96	0.20	0.04	A	3.18	0.061610077	Nasopharyngeal carcinoma	Cancer
rs544368	T	C	4	29	61	0	7	87	0.20	0.04	0.80	0.96	T	1.22	0.061610077	Bipolar disorder	Brain health and disorders
rs13393173	G	A	62	27	5	87	7	0	0.80	0.96	0.20	0.04	A	1	0.061610077	Response to TNF antagonist treatment	General health
rs12153048	C	G	87	7	0	61	29	4	0.96	0.80	0.04	0.20	G	0.3459	0.061610077	Periodontitis DPAL	Misc
rs1401999	C	G	18	43	33	6	24	64	0.42	0.19	0.58	0.81	C	0.045	0.061602532	Anterior chamber depth	Heart health and disorders
rs2074193	T	G	43	40	11	73	19	2	0.67	0.88	0.33	0.12	C	1.15	0.061491813	Migraine with aura	Brain health and disorders
rs4698036	T	G	47	32	15	73	19	2	0.67	0.88	0.33	0.12	G	0.257	0.061491813	Cardiovascular disease risk factors	Heart health and disorders
rs4848780	C	T	55	31	8	26	44	24	0.75	0.51	0.25	0.49	T	0.21	0.061469811	Food antigen IgG levels	Immune diseases and disorders
rs2250417	T	C	25	46	23	55	31	8	0.51	0.75	0.49	0.25	T	0.1	0.061469811	Inflammatory biomarkers	Immune diseases and disorders
rs974819	T	C	8	31	55	18	56	20	0.25	0.49	0.75	0.51	T	1.07	0.061469811	Coronary heart disease	Heart health and disorders
rs2074409	G	T	57	33	4	29	45	20	0.78	0.55	0.22	0.45	T	1.2	0.061460317	Response to angiotensin II receptor blocker therapy	General health
rs7828089	T	G	17	51	26	3	35	56	0.45	0.22	0.55	0.78	G	1	0.061460317	Verbal declarative memory	Brain health and disorders
rs10928195	C	G	4	33	57	21	43	30	0.22	0.45	0.78	0.55	C	0.36	0.061460317	Quantitative traits	Misc
rs6449353	T	C	61	25	8	25	53	16	0.78	0.55	0.22	0.45	T	0.065	0.061460317	Birth length	Misc
rs1558744	G	A	47	38	9	18	50	26	0.70	0.46	0.30	0.54	A	1.35	0.061433051	Ulcerative colitis	Immune diseases and disorders
rs1000778	A	G	22	42	30	43	46	5	0.46	0.70	0.54	0.30	A	0.62	0.061433051	Sphingolipid levels	Misc
rs4750535	C	T	1	1	92	2	25	67	0.02	0.15	0.98	0.85	C	0.0999	0.061409884	Cotinine glucuronidation	General health
rs4915863	A	G	0	3	91	3	23	68	0.02	0.15	0.98	0.85	A	0.00275	0.061409884	Calcium levels	General health
rs6688613	C	T	70	22	2	43	36	15	0.86	0.65	0.14	0.35	T	1.309	0.061236987	Refractive astigmatism	General health
rs8013477	G	C	40	42	12	69	24	1	0.65	0.86	0.35	0.14	C	1	0.061236987	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs2075230	A	G	68	26	0	40	42	12	0.86	0.65	0.14	0.35	G	0.28	0.061236987	Hormone measurements	General health
rs747685	T	A	88	6	0	60	33	1	0.97	0.81	0.03	0.19	T	1.5	0.061230433	Blood pressure	Heart health and disorders
rs747687	G	C	88	6	0	60	33	1	0.97	0.81	0.03	0.19	G	1.37	0.061230433	Blood pressure	Heart health and disorders
rs55914911	A	G	88	6	0	60	33	1	0.97	0.81	0.03	0.19	G	0.23	0.061230433	Age-related nuclear cataracts	Aging
rs7550918	C	T	3	51	40	19	65	10	0.30	0.55	0.70	0.45	T	3.133	0.061226852	Platelet count	Heart health and disorders
rs2619566	G	A	8	32	54	22	49	23	0.26	0.49	0.74	0.51	G	3.03	0.061113626	Amyotrophic lateral sclerosis	Brain health and disorders
rs7524258	T	C	26	43	25	50	40	4	0.51	0.74	0.49	0.26	T	1.16	0.061113626	Tourette's syndrome or obsessive-compulsive disorder	Brain health and disorders
rs12471454	T	C	21	53	20	53	34	7	0.51	0.74	0.49	0.26	T	0.1	0.061113626	Insomnia	General health
rs16840760	T	C	89	5	0	66	23	5	0.97	0.82	0.03	0.18	G	0.03	0.061040174	Obesity-related traits	Obesity
rs12144094	C	G	63	29	2	89	5	0	0.82	0.97	0.18	0.03	C	0.025	0.061040174	Height	General health
rs2450083	T	C	29	46	19	9	40	45	0.55	0.31	0.45	0.69	T	0.102	0.061036114	Bone mineral density paediatric, skull	General health
rs247929	G	C	9	40	45	26	52	16	0.31	0.55	0.69	0.45	C	0.02	0.061036114	Educational attainment	Mental aptitude and behavioural traits
rs7845219	T	C	19	46	29	47	36	11	0.45	0.69	0.55	0.31	T	1.08	0.061036114	Type 2 diabetes	Diabetes
rs7738636	A	C	61	29	4	32	44	18	0.80	0.57	0.20	0.43	A	1.2658228	0.061017061	Acute lymphoblastic leukemia childhood	Cancer
rs7085142	T	C	29	44	21	55	36	3	0.54	0.78	0.46	0.22	T	1	0.060987903	Visceral fat	Obesity
rs1167796	A	G	8	43	43	3	15	76	0.31	0.11	0.69	0.89	G	1.2	0.06097973	Systemic lupus erythematosus	Immune diseases and disorders
rs2579103	C	A	4	51	39	1	19	74	0.31	0.11	0.69	0.89	C	0.024	0.06097973	Body mass index	Obesity
rs1975974	A	G	56	29	9	82	11	1	0.75	0.93	0.25	0.07	G	1.17	0.060970464	Psoriasis	Immune diseases and disorders
rs7815944	A	G	81	13	0	52	37	5	0.93	0.75	0.07	0.25	A	1.16	0.060970464	Atopic dermatitis	Immune diseases and disorders
rs6924906	T	C	81	13	0	54	33	7	0.93	0.75	0.07	0.25	T	0.51	0.060970464	Blood pressure	Heart health and disorders
rs7514705	T	C	34	45	15	62	31	1	0.60	0.82	0.40	0.18	C	0.04	0.060945274	Menarche age at onset	Reproductive health
rs294958	A	G	16	43	35	2	29	63	0.40	0.18	0.60	0.82	A	1.29	0.060945274	Periodontitis PAL4Q3	Misc
rs40457	A	G	28	49	17	13	33	48	0.56	0.31	0.44	0.69	A	1.3	0.060860561	Leprosy	Immune diseases and disorders
rs7200786	A	G	31	43	20	11	37	46	0.56	0.31	0.44	0.69	A	1.15	0.060860561	Multiple sclerosis	Brain health and disorders
rs17294280	A	G	59	28	7	85	8	1	0.78	0.95	0.22	0.05	G	1.18	0.060778727	Asthma and hay fever	Immune diseases and disorders
rs4698433	G	T	26	42	26	52	35	7	0.50	0.74	0.50	0.26	T	7.23	0.060776134	QT interval	Heart health and disorders
rs3919627	G	A	25	44	25	51	37	6	0.50	0.74	0.50	0.26	G	0.03	0.060776134	Obesity-related traits	Obesity
rs13405728	A	G	75	19	0	46	40	8	0.90	0.70	0.10	0.30	A	1.41	0.060642303	Polycystic ovary syndrome	Reproductive health
rs962528	C	T	43	46	5	75	19	0	0.70	0.90	0.30	0.10	T	1	0.060642303	Visceral fat	Obesity
rs4675874	G	A	6	44	44	1	17	76	0.30	0.10	0.70	0.90	A	0.024	0.060642303	Blood metabolite levels	Heart health and disorders
rs12075079	A	G	52	34	8	79	15	0	0.73	0.92	0.27	0.08	G	1.2	0.060598565	Height	General health
rs2278729	G	A	50	38	6	79	15	0	0.73	0.92	0.27	0.08	A	0.19	0.060598565	Osteoporosis-related phenotypes	Immune diseases and disorders
rs11203649	T	C	7	36	51	1	13	80	0.27	0.08	0.73	0.92	A	0.05	0.060598565	Obesity-related traits	Obesity
rs7174989	G	A	1	13	80	4	42	48	0.08	0.27	0.92	0.73	A	0.0028	0.060598565	Trans fatty acid levels	General health
rs9989419	A	G	7	47	40	30	47	17	0.32	0.57	0.68	0.43	G	1.72	0.060554029	HDL cholesterol	General health
rs2393911	C	T	57	31	6	27	47	20	0.77	0.54	0.23	0.46	T	0.039	0.060537836	Neuroticism	Brain health and disorders
rs4736192	A	T	38	41	15	66	26	2	0.62	0.84	0.38	0.16	A	0.073	0.060522052	Anxiety disorder	Brain health and disorders
rs12025126	T	C	35	47	12	66	26	2	0.62	0.84	0.38	0.16	C	0.01	0.060522052	Vertical cup-disc ratio	Misc
rs6599234	A	T	16	39	39	2	26	66	0.38	0.16	0.62	0.84	A	0.7	0.060522052	QT interval	Heart health and disorders
rs1438673	C	T	11	49	34	2	26	66	0.38	0.16	0.62	0.84	C	0.1104	0.060522052	Self-reported allergy	General health
rs2630772	C	T	47	41	6	78	15	1	0.72	0.91	0.28	0.09	T	110.21	0.060504202	Hippocampal volume	Brain health and disorders
rs11074779	T	C	47	41	6	77	17	0	0.72	0.91	0.28	0.09	T	0.4033	0.060504202	Verbal declarative memory	Brain health and disorders
rs56051278	A	G	48	39	7	78	15	1	0.72	0.91	0.28	0.09	G	0.066	0.060504202	Motion sickness	Misc
rs12045440	T	G	41	43	10	71	22	1	0.66	0.87	0.34	0.13	T	1.38	0.060493974	Thyroid volume	General health
rs72925918	G	A	42	41	11	70	24	0	0.66	0.87	0.34	0.13	G	1.0752687	0.060493974	Schizophrenia	Brain health and disorders
rs2530545	C	T	71	22	1	38	49	7	0.87	0.66	0.13	0.34	C	0.1859	0.060493974	IgG glycosylation	Immune diseases and disorders
rs11654699	C	T	29	49	16	60	30	4	0.57	0.80	0.43	0.20	C	0.2055	0.060458425	Neurofibrillary tangles	Brain health and disorders
rs10800309	A	G	24	47	23	10	30	54	0.51	0.27	0.49	0.73	A	1.23	0.060456785	Ulcerative colitis	Immune diseases and disorders
rs708224	A	G	18	44	32	42	42	10	0.43	0.67	0.57	0.33	A	1.32	0.060422616	Pancreatic cancer	Cancer
rs6088765	T	G	30	48	16	10	42	42	0.57	0.33	0.43	0.67	G	1.079	0.060422616	Ulcerative colitis	Immune diseases and disorders
rs10752881	A	G	20	40	34	47	32	15	0.43	0.67	0.57	0.33	A	1.07	0.060422616	Colorectal cancer	Cancer
rs2153157	G	A	29	50	15	11	40	43	0.57	0.33	0.43	0.67	T	0.29	0.060422616	Menarche and menopause age at onset	Reproductive health
rs11154801	C	A	39	43	12	69	23	2	0.64	0.86	0.36	0.14	A	1.13	0.060359137	Multiple sclerosis	Brain health and disorders
rs425277	C	T	39	43	12	69	23	2	0.64	0.86	0.36	0.14	T	0.022	0.060359137	Height	General health
rs2869966	C	T	31	47	16	13	37	44	0.58	0.34	0.42	0.66	T	1.29	0.060305518	Chronic obstructive pulmonary disease	Immune diseases and disorders
rs10861032	T	C	62	30	2	34	44	16	0.82	0.60	0.18	0.40	C	1	0.060287081	Coronary restenosis	Heart health and disorders
rs13273891	G	A	62	30	2	34	44	16	0.82	0.60	0.18	0.40	A	0.953	0.060287081	Pit-and-Fissure caries	Misc
rs405460	G	T	33	46	15	65	24	5	0.60	0.82	0.40	0.18	A	0.03	0.060287081	Obesity-related traits	Obesity
rs607987	G	A	14	48	32	3	28	63	0.40	0.18	0.60	0.82	G	0.024	0.060287081	Body mass index	Obesity
rs61741390	A	G	93	1	0	71	22	1	0.99	0.87	0.01	0.13	G	34.03	0.0602849	Diisocyanate-induced asthma	Pulmonology
rs727957	G	T	72	20	2	93	1	0	0.87	0.99	0.13	0.01	T	11.7	0.0602849	Electrocardiographic traits	Heart health and disorders
rs6570465	C	T	93	1	0	70	24	0	0.99	0.87	0.01	0.13	C	1	0.0602849	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs7742587	C	T	93	1	0	70	24	0	0.99	0.87	0.01	0.13	C	1	0.0602849	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs7203560	T	G	93	1	0	70	24	0	0.99	0.87	0.01	0.13	G	0.5311	0.0602849	Mean corpuscular hemoglobin concentration	Heart health and disorders
rs41279633	G	T	71	22	1	93	1	0	0.87	0.99	0.13	0.01	T	0.054	0.0602849	LDL cholesterol	General health
rs6046346	C	T	93	1	0	72	20	2	0.99	0.87	0.01	0.13	A	0.04	0.0602849	Obesity-related traits	Obesity
rs310405	G	A	22	48	24	50	37	7	0.49	0.73	0.51	0.27	A	1.14	0.060155066	Height	General health
rs144223816	G	A	24	44	26	48	41	5	0.49	0.73	0.51	0.27	G	1.0526316	0.060155066	Schizophrenia	Brain health and disorders
rs310421	G	T	22	48	24	50	37	7	0.49	0.73	0.51	0.27	T	0.032	0.060155066	Height	General health
rs10505648	A	G	26	48	20	58	28	8	0.53	0.77	0.47	0.23	A	1.92	0.06010929	Polycystic ovary syndrome	Reproductive health
rs12593813	A	G	25	50	19	57	30	7	0.53	0.77	0.47	0.23	G	1.5	0.06010929	Restless legs syndrome	Mental aptitude and behavioural traits
rs1678618	A	G	27	46	21	56	32	6	0.53	0.77	0.47	0.23	A	0.06	0.06010929	Smoking behavior	General health
rs13174348	G	A	32	48	14	10	46	38	0.60	0.35	0.40	0.65	G	0.1823	0.060038588	IgG glycosylation	Immune diseases and disorders
rs6576443	C	T	41	39	14	15	45	34	0.64	0.40	0.36	0.60	A	1	0.059977324	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs2603127	G	A	61	26	7	85	9	0	0.79	0.95	0.21	0.05	A	2.79	0.059976284	Hemostatic factors and hematological phenotypes	Heart health and disorders
rs749141	T	C	85	9	0	56	36	2	0.95	0.79	0.05	0.21	C	0.196	0.059976284	Symmetrical dimethylarginine levels	General health
rs12292796	A	C	85	9	0	57	34	3	0.95	0.79	0.05	0.21	C	0.003	0.059976284	Pulse pressure alcohol consumption interaction	General health
rs505404	T	G	59	31	4	32	42	20	0.79	0.56	0.21	0.44	G	4.662	0.059925458	Platelet count	Heart health and disorders
rs12403795	C	T	47	34	13	72	22	0	0.68	0.88	0.32	0.12	A	12.28	0.05989713	Illicit drug use	General health
rs7336332	A	G	73	20	1	45	38	11	0.88	0.68	0.12	0.32	G	4.01	0.05989713	Weight	Appearance
rs603894	C	T	73	20	1	42	44	8	0.88	0.68	0.12	0.32	A	0.03641	0.05989713	Magnesium levels	General health
rs11623713	G	A	82	12	0	55	33	6	0.94	0.76	0.06	0.24	A	0.03	0.059891107	Obesity-related traits	Obesity
rs2293889	T	G	8	29	57	0	12	82	0.24	0.06	0.76	0.94	T	0.44	0.059891107	HDL cholesterol	General health
rs220299	C	T	14	44	36	39	40	15	0.38	0.63	0.62	0.37	G	0.05	0.059875495	Obesity-related traits	Obesity
rs2197089	G	A	23	51	20	2	48	44	0.52	0.28	0.48	0.72	C	0.18	0.059870502	Metabolic syndrome bivariate traits	Immune diseases and disorders
rs14235	G	A	37	42	15	66	25	3	0.62	0.84	0.38	0.16	A	1.103	0.059781642	Parkinson's disease	Brain health and disorders
rs4980079	T	C	14	44	36	4	23	67	0.38	0.16	0.62	0.84	T	1.46	0.059781642	Frontotemporal dementia	Brain health and disorders
rs2479724	T	C	24	41	29	4	37	53	0.47	0.24	0.53	0.76	T	0.03	0.059701493	Menarche age at onset	Reproductive health
rs11082304	G	T	35	41	18	62	29	3	0.59	0.81	0.41	0.19	T	3.49	0.059659091	Platelet count	Heart health and disorders
rs7953508	C	T	52	31	11	21	48	25	0.72	0.48	0.28	0.52	C	0.07	0.059602649	Pubertal anthropometrics	Appearance
rs10923931	G	T	70	23	1	38	48	8	0.87	0.66	0.13	0.34	T	1.13	0.059546647	Type 2 diabetes	Diabetes
rs1565411	G	A	0	28	66	18	32	44	0.15	0.36	0.85	0.64	G	1.0752687	0.05952381	Schizophrenia	Brain health and disorders
rs77502336	G	C	44	43	7	76	16	2	0.70	0.89	0.30	0.11	C	1.07	0.059462277	Schizophrenia	Brain health and disorders
rs2078267	C	T	43	45	6	75	18	1	0.70	0.89	0.30	0.11	C	0.078	0.059462277	Urate levels in lean individuals	Obesity
rs476141	G	T	32	41	21	58	32	4	0.56	0.79	0.44	0.21	A	1.37	0.059417076	Diabetic retinopathy	Diabetes
rs1291183	A	C	7	26	61	13	57	24	0.21	0.44	0.79	0.56	T	0.18	0.059417076	Pulmonary function in asthmatics	Pulmonology
rs2323397	A	T	81	12	1	49	42	3	0.93	0.74	0.07	0.26	A	0.0357	0.059379495	Palmitoleic acid 16:1n-7 plasma levels	General health
rs2124499	G	C	51	38	5	81	12	1	0.74	0.93	0.26	0.07	G	0.014	0.059379495	Body mass index	Obesity
rs7980799	A	C	6	36	52	1	12	81	0.26	0.07	0.74	0.93	A	0.377	0.059379495	Heart rate	General health
rs2235852	G	T	22	45	27	50	34	10	0.47	0.71	0.53	0.29	T	0.0577	0.059351095	Self-reported allergy	General health
rs7184046	G	C	48	38	8	23	43	28	0.71	0.47	0.29	0.53	C	0.03	0.059351095	Height	General health
rs7612581	T	G	22	46	26	8	30	56	0.48	0.24	0.52	0.76	T	0.088	0.059313725	Economic and political preferences environmentalism	Mental aptitude and behavioural traits
rs6687262	T	C	28	42	24	52	38	4	0.52	0.76	0.48	0.24	C	0.1576	0.059313725	IgG glycosylation	Immune diseases and disorders
rs11575088	C	A	60	30	4	86	8	0	0.80	0.96	0.20	0.04	A	1.62	0.059288538	Social autistic-like traits	Brain health and disorders
rs1335515	T	C	62	26	6	86	8	0	0.80	0.96	0.20	0.04	C	1	0.059288538	Attention deficit hyperactivity disorder time to onset	Brain health and disorders
rs17145713	C	T	77	16	1	45	44	5	0.90	0.71	0.10	0.29	T	0.06	0.059210526	Protein C levels	General health
rs1178979	T	C	77	16	1	46	42	6	0.90	0.71	0.10	0.29	A	0.05	0.059210526	Triglycerides	General health
rs6984305	A	T	2	14	78	8	38	48	0.10	0.29	0.90	0.71	A	2.7	0.059210526	Liver enzyme levels alkaline phosphatase	General health
rs9641123	G	C	52	33	9	80	12	2	0.73	0.91	0.27	0.09	C	0.025	0.059170169	Body mass index	Obesity
rs10428959	C	T	94	0	0	73	21	0	1.00	0.89	0.00	0.11	T	6	0.05915493	Response to fenofibrate	General health
rs17006206	A	G	94	0	0	73	21	0	1.00	0.89	0.00	0.11	G	2.05	0.05915493	Alzheimer's disease	Brain health and disorders
rs80332023	C	T	94	0	0	73	21	0	1.00	0.89	0.00	0.11	C	0.12	0.05915493	Cotinine glucuronidation	General health
rs7659604	C	T	47	39	8	22	44	28	0.71	0.47	0.29	0.53	T	1.35	0.059115458	Type 2 diabetes	Diabetes
rs245880	A	G	29	42	23	6	43	45	0.53	0.29	0.47	0.71	A	4.6948357	0.059115458	Warfarin maintenance dose	General health
rs2048672	C	A	29	42	23	6	43	45	0.53	0.29	0.47	0.71	C	1.11	0.059115458	Breast cancer	Cancer
rs8179116	C	T	92	2	0	68	26	0	0.99	0.86	0.01	0.14	A	0.23	0.0591133	Conduct disorder symptom count	Brain health and disorders
rs12037222	G	A	71	20	3	92	2	0	0.86	0.99	0.14	0.01	A	0.045	0.0591133	C-reactive protein levels	Immune diseases and disorders
rs10500856	A	G	92	2	0	68	26	0	0.99	0.86	0.01	0.14	G	0.03	0.0591133	Obesity-related traits	Obesity
rs6670062	C	T	92	2	0	68	26	0	0.99	0.86	0.01	0.14	T	0.0046	0.0591133	Trans fatty acid levels	General health
rs9313808	A	G	4	18	72	0	2	92	0.14	0.01	0.86	0.99	G	1.1528302	0.0591133	Inflammatory bowel disease	Immune diseases and disorders
rs4287304	C	T	0	2	92	1	24	69	0.01	0.14	0.99	0.86	C	0.1028	0.0591133	Cotinine glucuronidation	General health
rs1383808	C	T	0	2	92	1	24	69	0.01	0.14	0.99	0.86	G	0.03	0.0591133	Obesity-related traits	Obesity
rs12476047	T	C	36	43	15	65	26	3	0.61	0.83	0.39	0.17	C	3.21	0.059075734	Response to antipsychotic treatment	General health
rs1995809	A	G	63	30	1	33	49	12	0.83	0.61	0.17	0.39	G	0.22	0.059075734	Plasma amyloid beta peptide concentrations ABx-40	Brain health and disorders
rs7951105	T	G	4	28	62	19	40	35	0.19	0.41	0.81	0.59	T	0.161	0.059059863	Free thyroxine concentration	General health
rs1015563	C	T	29	52	13	61	30	3	0.59	0.81	0.41	0.19	T	1.12	0.059059863	Colorectal cancer	Cancer
rs17765344	A	G	21	49	24	7	33	54	0.48	0.25	0.52	0.75	A	1.19	0.058945317	Prostate cancer	Cancer
rs8071558	C	G	21	49	24	7	33	54	0.48	0.25	0.52	0.75	C	1.14	0.058945317	Prostate cancer	Cancer
rs2176528	C	G	25	47	22	51	39	4	0.52	0.75	0.48	0.25	C	1.12	0.058945317	Bipolar disorder	Brain health and disorders
rs672413	A	G	4	39	51	23	45	26	0.25	0.48	0.75	0.52	A	1	0.058945317	Blood and toenail selenium levels	Heart health and disorders
rs1046875	A	G	20	51	23	5	37	52	0.48	0.25	0.52	0.75	A	0.08	0.058945317	Glycated hemoglobin levels	Diabetes
rs6920372	G	A	24	43	27	4	39	51	0.48	0.25	0.52	0.75	A	0.025	0.058945317	Height	General health
rs6468049	T	C	18	48	28	2	37	55	0.45	0.22	0.55	0.78	T	1.05	0.058932271	Schizophrenia	Brain health and disorders
rs2046045	T	G	21	42	31	9	23	62	0.45	0.22	0.55	0.78	T	0.115	0.058932271	Thyroid function	Immune diseases and disorders
rs4713266	C	T	19	49	26	47	38	9	0.46	0.70	0.54	0.30	C	1.07	0.058895384	Prostate cancer	Cancer
rs13272568	C	A	47	38	9	21	45	28	0.70	0.46	0.30	0.54	A	0.03	0.058895384	Bone mineral density	General health
rs7141276	A	G	28	45	21	9	38	47	0.54	0.30	0.46	0.70	A	0.37	0.058895384	Response to anti-TNF treatment in rheumatoid arthritis	General health
rs6782299	G	T	7	29	58	0	11	83	0.23	0.06	0.77	0.94	T	1.1	0.058891189	Schizophrenia	Brain health and disorders
rs6990255	C	T	83	11	0	55	35	4	0.94	0.77	0.06	0.23	T	1.146	0.058891189	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs886774	G	A	7	47	40	1	21	72	0.32	0.12	0.68	0.88	G	1.11	0.058871494	Ulcerative colitis	Immune diseases and disorders
rs1556929	C	G	8	45	41	1	21	72	0.32	0.12	0.68	0.88	C	0.014684178	0.058871494	Urate levels BMI interaction	Obesity
rs11233413	T	C	39	49	6	72	21	1	0.68	0.88	0.32	0.12	T	0.108	0.058871494	Economic and political preferences feminism_equality	Mental aptitude and behavioural traits
rs6503659	A	T	2	32	60	0	7	87	0.19	0.04	0.81	0.96	A	1.27	0.058733152	Esophageal cancer squamous cell	Cancer
rs3798220	T	C	62	28	4	87	7	0	0.81	0.96	0.19	0.04	C	1.51	0.058733152	Coronary heart disease	Heart health and disorders
rs999737	C	T	62	28	4	87	7	0	0.81	0.96	0.19	0.04	C	1.09	0.058733152	Breast cancer	Cancer
rs908366	C	T	42	35	17	68	23	3	0.63	0.85	0.37	0.15	A	2.199	0.058728527	Adverse response to chemotherapy neutropenia_leucopenia epirubicin	Drug response
rs13259109	G	C	41	37	16	71	17	6	0.63	0.85	0.37	0.15	G	1.19	0.058728527	Diabetic kidney disease	Diabetes
rs9650315	G	T	67	25	2	34	51	9	0.85	0.63	0.15	0.37	T	0.43	0.058728527	Height	General health
rs1390943	T	G	31	40	23	7	43	44	0.54	0.30	0.46	0.70	G	0.05	0.058690549	Circulating myeloperoxidase levels serum	Immune diseases and disorders
rs2334880	A	G	0	26	68	15	35	44	0.14	0.35	0.86	0.65	C	1.19	0.058646617	Malaria	Immune diseases and disorders
rs2284553	A	G	12	41	41	1	24	69	0.35	0.14	0.65	0.86	G	1.123	0.058646617	Crohn's disease	Digestive system and its disorders
rs12513663	C	T	40	43	11	70	22	2	0.65	0.86	0.35	0.14	T	1.184	0.058646617	Major depressive disorder	Brain health and disorders
rs13017997	T	A	44	35	15	70	22	2	0.65	0.86	0.35	0.14	T	1.0526316	0.058646617	Schizophrenia	Brain health and disorders
rs347412	A	G	26	51	17	9	40	45	0.55	0.31	0.45	0.69	A	0.026	0.05850065	Pulmonary function in asthmatics	Pulmonology
rs9504361	A	G	21	43	30	48	34	12	0.45	0.69	0.55	0.31	G	1.156	0.05850065	Pit-and-Fissure caries	Misc
rs10830228	A	G	22	41	31	45	40	9	0.45	0.69	0.55	0.31	A	1.12	0.05850065	Age-related macular degeneration	Aging
rs2544390	C	T	46	38	10	17	51	26	0.69	0.45	0.31	0.55	C	0.082	0.05850065	Urate levels	General health
rs842625	G	A	35	39	20	62	27	5	0.58	0.80	0.42	0.20	G	1.2	0.058488064	Psoriasis	Immune diseases and disorders
rs151181	T	C	34	41	19	58	35	1	0.58	0.80	0.42	0.20	G	1.07	0.058488064	Crohn's disease	Digestive system and its disorders
rs718314	A	G	31	47	16	61	29	4	0.58	0.80	0.42	0.20	G	0.03	0.058488064	Waist-hip ratio	General health
rs1012307	A	C	91	3	0	68	24	2	0.98	0.85	0.02	0.15	C	1.44	0.058438523	Asthma sex interaction	Immune diseases and disorders
rs17265703	A	G	67	26	1	91	3	0	0.85	0.98	0.15	0.02	G	0.04	0.058438523	Phosphorus levels	General health
rs13361160	T	C	32	50	12	65	25	4	0.61	0.82	0.39	0.18	C	1.17	0.058402529	Pain	Brain health and disorders
rs9616064	T	C	16	42	36	3	27	64	0.39	0.18	0.61	0.82	C	0.104	0.058402529	Urate levels in obese individuals	Obesity
rs427230	C	T	75	17	2	41	48	5	0.89	0.69	0.11	0.31	T	1.12	0.058347185	Schizophrenia	Brain health and disorders
rs9850225	G	C	45	40	9	74	19	1	0.69	0.89	0.31	0.11	A	1	0.058347185	Erectile dysfunction in type 1 diabetes	Diabetes
rs3213545	G	A	46	38	10	74	19	1	0.69	0.89	0.31	0.11	A	0.121	0.058347185	Cardiovascular disease risk factors	Heart health and disorders
rs339978	C	T	89	4	1	64	26	4	0.97	0.82	0.03	0.18	T	5.31	0.058333333	Menarche age at onset	Reproductive health
rs10995251	C	T	61	32	1	88	6	0	0.82	0.97	0.18	0.03	C	1.28	0.058333333	Atopic dermatitis	Immune diseases and disorders
rs17104630	A	G	61	32	1	88	6	0	0.82	0.97	0.18	0.03	G	0.42	0.058333333	Height	General health
rs11076221	A	G	0	6	88	3	28	63	0.03	0.18	0.97	0.82	G	1.57	0.058333333	Alcohol dependence	General health
rs8002180	T	C	42	45	7	16	52	26	0.69	0.45	0.31	0.55	T	0.024	0.058325413	Blood metabolite levels	Heart health and disorders
rs2627282	G	A	55	32	7	81	13	0	0.76	0.93	0.24	0.07	A	2.33	0.058225953	Blood pressure measurement high sodium intervention	Heart health and disorders
rs12926503	A	G	82	11	1	52	38	4	0.93	0.76	0.07	0.24	A	1.23	0.058225953	Body mass index change over time	Obesity
rs1250563	G	C	53	36	5	81	13	0	0.76	0.93	0.24	0.07	C	1	0.058225953	Pediatric autoimmune diseases	Immune diseases and disorders
rs6497441	G	T	67	24	3	90	4	0	0.84	0.98	0.16	0.02	T	1.44	0.058135535	Chronic kidney disease	Immune diseases and disorders
rs12447542	G	A	68	22	4	90	4	0	0.84	0.98	0.16	0.02	A	1.08	0.058135535	Schizophrenia	Brain health and disorders
rs12651106	C	A	66	26	2	90	4	0	0.84	0.98	0.16	0.02	A	0.14	0.058135535	Fibrinogen	General health
rs10026364	C	T	89	5	0	64	28	2	0.97	0.83	0.03	0.17	T	1.28	0.058120067	Hypertension	Heart health and disorders
rs10502575	A	G	89	5	0	64	28	2	0.97	0.83	0.03	0.17	A	0.22	0.058120067	Coronary artery calcification	Heart health and disorders
rs790123	T	C	40	47	7	18	46	30	0.68	0.44	0.32	0.56	T	1.07	0.058017935	Response to angiotensin II receptor blocker therapy	General health
rs1367117	G	A	48	37	9	75	19	0	0.71	0.90	0.29	0.10	A	4.16	0.057991767	Cholesterol, total	General health
rs11021499	G	A	36	46	12	65	28	1	0.63	0.84	0.37	0.16	A	0.39	0.057971014	Waist-to-hip circumference ratio interaction	General health
rs11023332	G	C	25	44	25	50	38	6	0.50	0.73	0.50	0.27	C	0.94	0.057950192	Vitamin D levels	General health
rs4938806	C	A	51	36	7	23	48	23	0.73	0.50	0.27	0.50	A	0.16	0.057950192	Intraocular pressure	General health
rs7565158	G	T	22	50	22	51	36	7	0.50	0.73	0.50	0.27	A	0.136	0.057950192	Body mass index change over time	Obesity
rs10946292	A	G	51	36	7	20	54	20	0.73	0.50	0.27	0.50	G	0.03	0.057950192	Obesity-related traits	Obesity
rs2111485	A	G	33	42	19	62	26	6	0.57	0.80	0.43	0.20	A	1.0891383	0.057942452	Ulcerative colitis	Immune diseases and disorders
rs17042140	T	C	21	38	35	5	28	61	0.43	0.20	0.57	0.80	T	0.105	0.057942452	Plasma thyroid-stimulating hormone levels	Immune diseases and disorders
rs27387	A	G	0	15	79	7	35	52	0.08	0.26	0.92	0.74	A	4.44	0.057892628	Diisocyanate-induced asthma	Pulmonology
rs11741255	G	A	50	39	5	80	13	1	0.74	0.92	0.26	0.08	A	1	0.057892628	Pediatric autoimmune diseases	Immune diseases and disorders
rs1439523	T	C	0	15	79	7	35	52	0.08	0.26	0.92	0.74	C	0.6089	0.057892628	IgG glycosylation	Immune diseases and disorders
rs11205303	T	C	53	33	8	80	13	1	0.74	0.92	0.26	0.08	C	0.087	0.057892628	Infant length	Misc
rs11694172	A	G	49	41	4	80	13	1	0.74	0.92	0.26	0.08	G	0.028	0.057892628	Cholesterol, total	General health
rs10041935	A	C	50	36	8	78	15	1	0.72	0.91	0.28	0.09	C	2.5	0.057829391	Lupus nephritis in systemic lupus erythematosus	Immune diseases and disorders
rs10503672	C	T	48	40	6	78	15	1	0.72	0.91	0.28	0.09	T	1	0.057829391	Amyotrophic lateral sclerosis age of onset	Brain health and disorders
rs12157904	A	C	78	15	1	53	30	11	0.91	0.72	0.09	0.28	G	1	0.057829391	Response to anti-depressant treatment in major depressive disorder	General health
rs11165924	A	G	48	40	6	77	17	0	0.72	0.91	0.28	0.09	A	0.03	0.057829391	Menarche age at onset	Reproductive health
rs1892700	G	A	54	28	12	78	15	1	0.72	0.91	0.28	0.09	A	0.023	0.057829391	Educational attainment	Mental aptitude and behavioural traits
rs1819084	C	A	41	40	13	70	21	3	0.65	0.86	0.35	0.14	C	6.25	0.05779095	Tuberculosis	Immune diseases and disorders
rs7696430	G	A	70	21	3	43	36	15	0.86	0.65	0.14	0.35	A	0.014	0.05779095	Response to statins LDL cholesterol change	General health
rs6533014	A	G	29	50	15	8	47	39	0.57	0.34	0.43	0.66	A	1	0.057766367	Homeostasis model assessment of beta-cell function interaction	Misc
rs12871532	T	C	15	49	30	43	38	13	0.42	0.66	0.58	0.34	T	1.06	0.057661095	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs3734398	T	C	16	47	31	39	46	9	0.42	0.66	0.58	0.34	T	0.04	0.057661095	Phospholipid levels plasma	General health
rs10871290	C	T	6	39	49	21	53	20	0.27	0.51	0.73	0.49	SNP haplotype 1	1	0.057653365	Breast cancer	Cancer
rs2943650	C	T	10	45	39	34	42	18	0.35	0.59	0.65	0.41	T	0.03	0.057569296	Adiposity	Obesity
rs11228583	G	T	36	39	19	6	54	34	0.59	0.35	0.41	0.65	T	1.33	0.057490844	Prostate cancer early onset	Cancer
rs9308433	T	C	40	42	12	18	41	35	0.65	0.41	0.35	0.59	C	0.1494	0.057490844	IgG glycosylation	Immune diseases and disorders
rs1901440	C	A	12	52	30	39	43	12	0.40	0.64	0.60	0.36	C	34	0.05742563	Response to gemcitabine in pancreatic cancer	General health
rs11603151	G	A	33	54	7	16	43	35	0.64	0.40	0.36	0.60	A	1.05	0.057373566	Schizophrenia	Brain health and disorders
rs3922844	T	C	11	46	37	34	45	15	0.36	0.60	0.64	0.40	T	4.54	0.057373566	PR interval	Heart health and disorders
rs1475010	C	A	25	46	23	7	38	49	0.51	0.28	0.49	0.72	C	0.06	0.057373163	Overweight status	Obesity
rs805303	G	A	37	40	17	15	39	40	0.61	0.37	0.39	0.63	G	0.376	0.057334579	Systolic blood pressure	Heart health and disorders
rs4900384	A	G	38	43	13	15	44	35	0.63	0.39	0.37	0.61	G	1.09	0.057334579	Type 1 diabetes	Diabetes
rs356220	T	C	16	40	38	37	43	14	0.38	0.62	0.62	0.38	T	1.38	0.057295646	Parkinson's disease	Brain health and disorders
rs7978454	A	G	33	50	11	14	43	37	0.62	0.38	0.38	0.62	G	0.1473	0.057295646	IgG glycosylation	Immune diseases and disorders
rs11674248	A	C	16	39	39	32	52	10	0.38	0.62	0.62	0.38	A	0.03	0.057295646	Obesity-related traits	Obesity
rs1572050	G	A	72	22	0	40	49	5	0.88	0.69	0.12	0.31	A	0.313	0.057292321	Renal sinus fat	General health
rs2244608	A	G	46	37	11	74	18	2	0.69	0.88	0.31	0.12	A	0.036	0.057292321	Urate levels	General health
rs6919534	G	A	3	16	75	10	39	45	0.12	0.31	0.88	0.69	A	0.05	0.057292321	Height	General health
rs4502542	T	C	0	1	93	3	17	74	0.01	0.12	0.99	0.88	T	1	0.057291667	Response to citalopram treatment	General health
rs12291066	G	A	93	1	0	71	23	0	0.99	0.88	0.01	0.12	A	1.45	0.057291667	Stroke	Brain health and disorders
rs72951640	C	T	93	1	0	71	23	0	0.99	0.88	0.01	0.12	T	0.408	0.057291667	Asymmetrical dimethylarginine levels	General health
rs11060180	A	G	38	41	15	66	25	3	0.62	0.84	0.38	0.16	A	1.105	0.057249177	Parkinson's disease	Brain health and disorders
rs10849004	C	T	64	29	1	36	45	13	0.84	0.62	0.16	0.38	C	1	0.057249177	Glucocorticoid-induced osteonecrosis	Drug response
rs2361701	G	A	66	25	3	38	41	15	0.84	0.62	0.16	0.38	G	0.1856	0.057249177	IgG glycosylation	Immune diseases and disorders
rs541041	G	A	9	27	58	25	38	31	0.24	0.47	0.76	0.53	G	1	0.057210929	Response to statin therapy	General health
rs1844437	C	G	5	29	60	1	7	86	0.21	0.05	0.79	0.95	C	0.62	0.057164634	Hoarding	Misc
rs11749327	C	A	56	37	1	85	9	0	0.79	0.95	0.21	0.05	C	1.25	0.057164634	Hypospadias	Misc
rs9510787	A	G	59	31	4	86	7	1	0.79	0.95	0.21	0.05	G	1.2	0.057164634	Nasopharyngeal carcinoma	Cancer
rs4073054	C	A	13	50	31	4	27	63	0.40	0.19	0.60	0.81	A	0.016	0.057147714	Blood metabolite levels	Heart health and disorders
rs6910071	A	G	59	26	9	83	10	1	0.77	0.94	0.23	0.06	G	2.88	0.057142857	Rheumatoid arthritis	Immune diseases and disorders
rs1949829	C	T	82	12	0	55	34	5	0.94	0.77	0.06	0.23	T	1.78	0.057142857	Wegener's granulomatosis	General health
rs715170	C	T	53	38	3	83	10	1	0.77	0.94	0.23	0.06	C	1.0752687	0.057142857	Schizophrenia	Brain health and disorders
rs2902940	A	G	49	37	8	25	41	28	0.72	0.48	0.28	0.52	G	1.38	0.057109145	Cholesterol, total	General health
rs1898111	G	A	11	31	52	27	43	24	0.28	0.52	0.72	0.48	A	1.15	0.057109145	Eating disorders	Brain health and disorders
rs2880058	A	G	25	47	22	7	39	48	0.52	0.28	0.48	0.72	G	0.19	0.057109145	QT interval	Heart health and disorders
rs163030	A	C	13	41	40	2	24	68	0.36	0.15	0.64	0.85	A	117.5	0.056976962	Caudate nucleus volume	Brain health and disorders
rs2035647	A	G	17	33	44	2	24	68	0.36	0.15	0.64	0.85	A	0.029	0.056976962	Blood metabolite levels	Heart health and disorders
rs6595551	C	T	67	26	1	40	41	13	0.85	0.64	0.15	0.36	G	2.63	0.056976962	Type 2 diabetes young onset and obesity	Diabetes
rs5745568	G	T	43	39	12	69	25	0	0.66	0.87	0.34	0.13	T	0.09	0.05697601	Platelet count	Heart health and disorders
rs12422552	G	C	57	34	3	28	50	16	0.79	0.56	0.21	0.44	C	1.05	0.056925261	Breast cancer	Cancer
rs4908760	G	A	19	44	31	3	34	57	0.44	0.21	0.56	0.79	G	1.36	0.056925261	Vitiligo	Immune diseases and disorders
rs780094	T	C	17	48	29	6	28	60	0.44	0.21	0.56	0.79	T	0.05	0.056925261	Uric acid levels	General health
rs7126328	C	T	49	36	9	21	48	25	0.71	0.48	0.29	0.52	T	0.17	0.056860902	Intraocular pressure	General health
rs1483012	G	A	23	52	19	7	40	47	0.52	0.29	0.48	0.71	G	6.02	0.056860902	QT interval	Heart health and disorders
rs258401	T	G	11	34	49	2	16	76	0.30	0.11	0.70	0.89	T	0.24	0.056842105	Retinopathy in non-diabetics	General health
rs4869266	A	G	23	43	28	6	34	54	0.47	0.24	0.53	0.76	G	0.1519	0.056831105	IgG glycosylation	Immune diseases and disorders
rs331079	G	C	53	35	6	82	10	2	0.75	0.93	0.25	0.07	C	0.0658	0.056674473	Heschl's gyrus morphology	Brain health and disorders
rs1509091	C	T	1	12	81	0	47	47	0.07	0.25	0.93	0.75	C	0.11	0.056674473	Metabolite levels Pyroglutamine	General health
rs73206853	A	C	78	14	2	50	35	9	0.90	0.72	0.10	0.28	A	1.88	0.056568922	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs17731	G	A	52	31	11	77	16	1	0.72	0.90	0.28	0.10	A	1.05	0.056568922	Schizophrenia	Brain health and disorders
rs1558648	T	G	76	18	0	46	43	5	0.90	0.72	0.10	0.28	G	0.13	0.056568922	Serum protein levels sST2	General health
rs4243400	A	G	17	43	34	1	34	59	0.41	0.19	0.59	0.81	A	0.048	0.056563141	Height	General health
rs17531088	C	T	30	51	13	61	30	3	0.59	0.81	0.41	0.19	T	1.43	0.056563141	Kawasaki disease	Misc
rs768048	C	T	64	28	2	30	56	8	0.83	0.62	0.17	0.38	C	0.11	0.056561086	Alcoholism alcohol use disorder factor score	General health
rs1443512	A	C	5	37	52	21	48	25	0.25	0.48	0.75	0.52	A	0.0408	0.056470085	Waist-to-hip ratio adjusted for body mass index	Obesity
rs8034595	A	C	6	35	53	16	58	20	0.25	0.48	0.75	0.52	A	0.026	0.056470085	Optic disc area	Misc
rs170934	C	T	22	54	18	54	33	7	0.52	0.75	0.48	0.25	T	1.17	0.056470085	Multiple sclerosis	Brain health and disorders
rs6495122	A	C	25	48	21	52	37	5	0.52	0.75	0.48	0.25	A	0.05	0.056470085	Coffee consumption	Misc
rs10490193	C	A	60	31	3	86	8	0	0.80	0.96	0.20	0.04	A	4.494	0.0564619	Very long-chain saturated fatty acid levels fatty acid 20:0	General health
rs563507	G	A	87	6	1	62	27	5	0.96	0.80	0.04	0.20	A	2	0.0564619	Acute lymphoblastic leukemia childhood	Cancer
rs2968864	T	C	60	31	3	86	8	0	0.80	0.96	0.20	0.04	C	1.4	0.0564619	QT interval	Heart health and disorders
rs2968863	C	T	60	31	3	86	8	0	0.80	0.96	0.20	0.04	T	1.35	0.0564619	QT interval	Heart health and disorders
rs17695092	T	G	62	27	5	86	8	0	0.80	0.96	0.20	0.04	T	1.095	0.0564619	Crohn's disease	Digestive system and its disorders
rs72810983	A	G	62	27	5	86	8	0	0.80	0.96	0.20	0.04	A	1.0646069	0.0564619	Inflammatory bowel disease	Immune diseases and disorders
rs12580533	T	C	86	8	0	60	31	3	0.96	0.80	0.04	0.20	C	0.8247	0.0564619	IgG glycosylation	Immune diseases and disorders
rs1878007	G	A	61	29	4	86	8	0	0.80	0.96	0.20	0.04	A	0.12	0.0564619	Preschool internalizing problems	Mental aptitude and behavioural traits
rs1388551	G	A	87	6	1	59	33	2	0.96	0.80	0.04	0.20	A	0.07	0.0564619	Waist-to-hip circumference ratio interaction	General health
rs7705502	G	A	62	27	5	86	8	0	0.80	0.96	0.20	0.04	A	0.0271	0.0564619	Waist-to-hip ratio adjusted for body mass index	Obesity
rs6861681	G	A	62	27	5	86	8	0	0.80	0.96	0.20	0.04	A	0.02	0.0564619	Waist-hip ratio	General health
rs495337	G	A	26	53	15	62	23	9	0.56	0.78	0.44	0.22	G	1.21	0.056451613	Psoriasis	Immune diseases and disorders
rs9533962	C	T	31	43	20	56	35	3	0.56	0.78	0.44	0.22	C	1.14	0.056451613	Psoriasis	Immune diseases and disorders
rs10911251	A	C	33	39	22	61	25	8	0.56	0.78	0.44	0.22	A	1.09	0.056451613	Colorectal cancer	Cancer
rs147897924	T	C	45	42	7	16	56	22	0.70	0.47	0.30	0.53	C	1.0638298	0.056410256	Schizophrenia	Brain health and disorders
rs2655898	T	C	48	36	10	17	54	23	0.70	0.47	0.30	0.53	G	0.03	0.056410256	Obesity-related traits	Obesity
rs13401104	G	A	72	21	1	38	52	4	0.88	0.68	0.12	0.32	A	0.032	0.056293433	Educational attainment	Mental aptitude and behavioural traits
rs3807375	C	T	25	51	18	10	37	47	0.54	0.30	0.46	0.70	T	11.95	0.056207177	Electrocardiographic traits	Heart health and disorders
rs894734	A	G	6	45	43	23	55	16	0.30	0.54	0.70	0.46	G	1.619	0.056207177	Adverse response to chemotherapy neutropenia_leucopenia all antimetabolite drugs	Drug response
rs2271920	G	A	45	41	8	16	55	23	0.70	0.46	0.30	0.54	A	1.11	0.056207177	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs9296404	T	C	26	49	19	7	43	44	0.54	0.30	0.46	0.70	T	0.356	0.056207177	Plasma homocysteine levels post-methionine load test	Heart health and disorders
rs10445033	G	A	19	49	26	40	51	3	0.46	0.70	0.54	0.30	G	0.02	0.056207177	Red blood cell traits	Immune diseases and disorders
rs4791051	A	T	13	42	39	1	27	66	0.36	0.15	0.64	0.85	A	4.04	0.056202195	Heschl's gyrus morphology	Brain health and disorders
rs4681767	C	T	12	44	38	2	25	67	0.36	0.15	0.64	0.85	T	0.18	0.056202195	Attention function in attention deficit hyperactive disorder	Brain health and disorders
rs7947821	T	C	92	2	0	70	23	1	0.99	0.87	0.01	0.13	T	7.1429	0.056139234	Tuberculosis	Immune diseases and disorders
rs12283022	A	G	92	2	0	70	23	1	0.99	0.87	0.01	0.13	G	7.1429	0.056139234	Tuberculosis	Immune diseases and disorders
rs11680810	C	T	70	23	1	92	2	0	0.87	0.99	0.13	0.01	T	0.099	0.056139234	Sitting height ratio	Appearance
rs1801725	G	T	70	23	1	92	2	0	0.87	0.99	0.13	0.01	T	0.071	0.056139234	Calcium levels	General health
rs17251221	A	G	70	23	1	92	2	0	0.87	0.99	0.13	0.01	G	0.06	0.056139234	Calcium levels	General health
rs4629710	G	A	58	30	6	83	11	0	0.78	0.94	0.22	0.06	A	1.6	0.056136457	Multiple myeloma IgH translocation	Cancer
rs11753937	C	T	55	36	3	83	11	0	0.78	0.94	0.22	0.06	T	1.12	0.056136457	Response to angiotensin II receptor blocker therapy	General health
rs10998624	G	A	84	9	1	57	32	5	0.94	0.78	0.06	0.22	A	1	0.056136457	Immune reponse to smallpox secreted IL-1beta	Immune diseases and disorders
rs4933824	T	G	1	9	84	4	34	56	0.06	0.22	0.94	0.78	T	1	0.056136457	Response to iloperidone treatment QT prolongation	General health
rs10506328	A	C	6	30	58	0	11	83	0.22	0.06	0.78	0.94	C	0.09	0.056136457	Mean platelet volume	Heart health and disorders
rs7153648	C	G	1	24	69	8	48	38	0.14	0.34	0.86	0.66	C	1.11	0.056099456	Prostate cancer	Cancer
rs9506942	C	G	41	42	11	70	22	2	0.66	0.86	0.34	0.14	C	1.29	0.056099456	Smoking cessation in chronic obstructive pulmonary disease	Heart health and disorders
rs4646312	T	C	39	46	9	70	22	2	0.66	0.86	0.34	0.14	C	1.25	0.056099456	Schizophrenia	Brain health and disorders
rs3132440	T	C	45	34	15	71	20	3	0.66	0.86	0.34	0.14	C	0.0752	0.056099456	Urinary metabolites	General health
rs1978633	T	G	32	38	24	10	38	46	0.54	0.31	0.46	0.69	T	0.09	0.056018519	Economic and political preferences feminism_equality	Mental aptitude and behavioural traits
rs17030795	A	G	31	48	15	63	25	6	0.59	0.80	0.41	0.20	G	1.149	0.056005331	Anorexia nervosa	Brain health and disorders
rs1494961	C	T	15	48	31	6	25	63	0.41	0.20	0.59	0.80	C	1.12	0.056005331	Upper aerodigestive tract cancers	Cancer
rs4693089	A	G	15	48	31	6	25	63	0.41	0.20	0.59	0.80	G	0.228	0.056005331	Menopause age at onset	Reproductive health
rs652520	T	C	18	48	28	6	30	58	0.45	0.22	0.55	0.78	C	1	0.056	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs7181486	T	C	38	39	17	65	25	4	0.61	0.82	0.39	0.18	C	1.32	0.055904962	Pulmonary artery enlargement in chronic obstructive pulmonary disease	Heart health and disorders
rs7195386	T	C	14	45	35	3	27	64	0.39	0.18	0.61	0.82	A	0.03	0.055904962	Obesity-related traits	Obesity
rs79392787	C	T	88	5	1	60	33	1	0.96	0.81	0.04	0.19	A	34.08	0.055888224	Diisocyanate-induced asthma	Pulmonology
rs10825036	T	G	63	27	4	87	7	0	0.81	0.96	0.19	0.04	G	2.26	0.055888224	Disease-free survival in breast cancer	Cancer
rs7746082	G	C	60	33	1	87	7	0	0.81	0.96	0.19	0.04	C	1.17	0.055888224	Crohn's disease	Digestive system and its disorders
rs13078807	A	G	62	29	3	87	7	0	0.81	0.96	0.19	0.04	G	0.1	0.055888224	Body mass index	Obesity
rs13204965	A	C	64	25	5	87	7	0	0.81	0.96	0.19	0.04	A	0.09	0.055888224	Bone mineral density paediatric, total body less head	General health
rs1995082	T	G	61	31	2	88	5	1	0.81	0.96	0.19	0.04	T	0.029	0.055888224	Educational attainment	Mental aptitude and behavioural traits
rs6838440	C	T	41	47	6	16	53	25	0.69	0.45	0.31	0.55	C	2.1	0.055844006	Epirubicin-induced leukopenia	Drug response
rs12209128	T	G	5	49	40	30	43	21	0.31	0.55	0.69	0.45	T	0.15	0.055844006	Plasma omega-6 polyunsaturated fatty acid levels arachidonic acid	General health
rs2009314	A	G	44	41	9	21	43	30	0.69	0.45	0.31	0.55	G	0.03	0.055844006	Obesity-related traits	Obesity
rs1878528	A	G	53	33	8	24	48	22	0.74	0.51	0.26	0.49	G	1.2	0.055802022	Height	General health
rs1582763	G	A	43	45	6	76	15	3	0.70	0.89	0.30	0.11	G	1.1494253	0.055756324	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs7132746	T	C	76	15	3	43	45	6	0.89	0.70	0.11	0.30	C	0.3623	0.055756324	Lewy body disease	Brain health and disorders
rs4869742	C	T	30	44	20	11	38	45	0.55	0.32	0.45	0.68	T	1.67	0.055683387	Chronic myeloid leukemia	Cancer
rs10792665	G	T	15	54	25	44	40	10	0.45	0.68	0.55	0.32	C	0.03	0.055683387	Obesity-related traits	Obesity
rs9990174	G	T	28	47	19	55	35	4	0.55	0.77	0.45	0.23	T	2.52	0.055569556	Conduct disorder interaction	Brain health and disorders
rs520865	G	A	45	37	12	18	47	29	0.68	0.44	0.32	0.56	A	770.6	0.055536431	Superior frontal gyrus grey matter volume	Misc
rs2057178	G	A	82	11	1	53	37	4	0.93	0.76	0.07	0.24	A	1.6129	0.05551941	Tuberculosis	Immune diseases and disorders
rs254893	G	A	55	33	6	82	11	1	0.76	0.93	0.24	0.07	A	0.58	0.05551941	Quantitative traits	Misc
rs13207034	G	A	54	35	5	81	13	0	0.76	0.93	0.24	0.07	A	0.2275	0.05551941	Metabolite levels HVA	General health
rs12817488	G	A	26	43	25	51	36	7	0.51	0.73	0.49	0.27	T	1.14	0.055493862	Parkinson's disease	Brain health and disorders
rs2479768	A	G	0	3	91	3	21	70	0.02	0.14	0.98	0.86	G	1	0.055491329	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs11712066	A	G	69	23	2	91	3	0	0.86	0.98	0.14	0.02	A	1.61	0.055491329	Infantile hypertrophic pyloric stenosis	Misc
rs199499	C	T	68	25	1	91	3	0	0.86	0.98	0.14	0.02	C	1.1627907	0.055491329	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs1552224	A	C	69	23	2	91	3	0	0.86	0.98	0.14	0.02	A	1.14	0.055491329	Type 2 diabetes	Diabetes
rs702873	C	T	35	39	20	61	28	5	0.58	0.80	0.42	0.20	T	1.216545	0.055473055	Psoriasis	Immune diseases and disorders
rs2010809	C	T	88	6	0	65	25	4	0.97	0.82	0.03	0.18	C	14.0668	0.055466788	Smooth-surface caries	Appearance
rs6021191	A	T	88	6	0	64	27	3	0.97	0.82	0.03	0.18	T	3.109	0.055466788	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Immune diseases and disorders
rs73060317	T	G	63	29	2	88	6	0	0.82	0.97	0.18	0.03	T	1.06	0.055466788	Schizophrenia	Brain health and disorders
rs7078012	C	T	66	26	2	36	47	11	0.84	0.63	0.16	0.37	T	1	0.055464391	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs11587438	C	T	1	28	65	13	43	38	0.16	0.37	0.84	0.63	T	0.075	0.055464391	White blood cell types	Immune diseases and disorders
rs4523957	G	T	18	46	30	41	44	9	0.44	0.67	0.56	0.33	T	1.083	0.05540293	Schizophrenia	Brain health and disorders
rs2910032	C	T	14	34	46	29	48	17	0.33	0.56	0.67	0.44	C	1.08	0.05540293	Schizophrenia	Brain health and disorders
rs2014355	T	C	45	44	5	76	17	1	0.71	0.90	0.29	0.10	T	21.5	0.055382251	Metabolite levels	General health
rs4587207	A	G	51	32	11	75	19	0	0.71	0.90	0.29	0.10	G	3.14	0.055382251	Sleep duration	General health
rs12896399	G	T	48	38	8	77	15	2	0.71	0.90	0.29	0.10	T	2.56	0.055382251	Blond vs. brown hair color	Appearance
rs4151657	T	C	48	38	8	75	19	0	0.71	0.90	0.29	0.10	G	1.54	0.055382251	Ulcerative colitis	Immune diseases and disorders
rs3916	G	C	45	44	5	76	17	1	0.71	0.90	0.29	0.10	G	0.4	0.055382251	Urinary metabolites H-NMR features	General health
rs4900109	G	T	48	38	8	77	15	2	0.71	0.90	0.29	0.10	G	0.17	0.055382251	Iris characteristics	Misc
rs2717068	A	C	13	35	46	0	24	70	0.32	0.13	0.68	0.87	T	1.27	0.055346675	Epilepsy generalized	Brain health and disorders
rs4253399	T	G	44	39	11	72	20	2	0.68	0.87	0.32	0.13	G	1.24	0.055346675	Venous thromboembolism	Heart health and disorders
rs1875714	T	C	29	49	16	7	49	38	0.57	0.34	0.43	0.66	T	0.022	0.055282696	Educational attainment	Mental aptitude and behavioural traits
rs2074518	C	T	33	48	13	63	28	3	0.61	0.82	0.39	0.18	T	1.05	0.05527916	QT interval	Heart health and disorders
rs7552722	T	C	11	43	40	1	25	68	0.35	0.14	0.65	0.86	A	1.27	0.055266381	Non-alcoholic fatty liver disease	Obesity
rs1270884	A	G	9	47	38	2	23	69	0.35	0.14	0.65	0.86	A	1.07	0.055266381	Prostate cancer	Cancer
rs989507	T	C	2	23	69	12	41	41	0.14	0.35	0.86	0.65	A	0.03	0.055266381	Obesity-related traits	Obesity
rs11208659	T	C	70	21	3	38	47	9	0.86	0.65	0.14	0.35	C	1.42	0.055266381	Obesity early onset extreme	Obesity
rs2058710	A	G	40	43	11	68	25	1	0.65	0.86	0.35	0.14	A	1.24	0.055266381	Bipolar disorder and schizophrenia	Brain health and disorders
rs16870629	C	T	39	45	10	70	21	3	0.65	0.86	0.35	0.14	T	0.45	0.055266381	QT interval	Heart health and disorders
rs10845606	C	A	65	27	2	89	5	0	0.84	0.97	0.16	0.03	C	1.2658	0.055228758	Systemic lupus erythematosus	Immune diseases and disorders
rs61765555	C	T	66	25	3	89	5	0	0.84	0.97	0.16	0.03	C	1.0638298	0.055228758	Schizophrenia	Brain health and disorders
rs10501320	G	C	69	19	6	89	5	0	0.84	0.97	0.16	0.03	G	1	0.055228758	Proinsulin levels	Diabetes
rs12600635	A	G	66	25	3	89	5	0	0.84	0.97	0.16	0.03	G	0.2272	0.055228758	IgG glycosylation	Immune diseases and disorders
rs2286963	T	G	55	30	9	79	15	0	0.74	0.92	0.26	0.08	T	13.8	0.055225924	Metabolite levels	General health
rs705702	A	G	49	42	3	80	13	1	0.74	0.92	0.26	0.08	G	1.27	0.055225924	Polycystic ovary syndrome	Reproductive health
rs17086954	A	G	49	42	3	79	15	0	0.74	0.92	0.26	0.08	A	1	0.055225924	Early childhood aggressive behavior	Mental aptitude and behavioural traits
rs3764913	T	C	55	30	9	79	15	0	0.74	0.92	0.26	0.08	T	1	0.055225924	Metabolite levels	General health
rs16864968	A	G	80	13	1	53	34	7	0.92	0.74	0.08	0.26	G	0.826	0.055225924	Response to hepatitis C treatment	General health
rs822531	C	T	3	42	49	1	13	80	0.26	0.08	0.74	0.92	T	0.036	0.055225924	Height	General health
rs28405582	T	C	91	2	1	67	25	2	0.98	0.85	0.02	0.15	C	11.67	0.055216892	Acne severe	Misc
rs1222043	G	C	90	4	0	65	29	0	0.98	0.85	0.02	0.15	C	3.41	0.055216892	Classic bladder exstrophy	Misc
rs11989782	C	A	68	23	3	90	4	0	0.85	0.98	0.15	0.02	A	1.53	0.055216892	Eosinophilic esophagitis pediatric	Digestive system and its disorders
rs16849553	T	C	90	4	0	69	21	4	0.98	0.85	0.02	0.15	C	1.452	0.055216892	Mean arterial pressure alcohol consumption interaction	General health
rs10484389	C	T	90	4	0	68	23	3	0.98	0.85	0.02	0.15	T	1.18	0.055216892	Hepatitis	Immune diseases and disorders
rs16998084	A	G	90	4	0	67	25	2	0.98	0.85	0.02	0.15	G	0.4	0.055216892	Economic and political preferences immigration_crime	Mental aptitude and behavioural traits
rs57440971	C	T	90	4	0	65	29	0	0.98	0.85	0.02	0.15	T	0.1413	0.055216892	Periodontitis Mean PAL	Misc
rs2597167	T	C	0	4	90	0	29	65	0.02	0.15	0.98	0.85	C	0.14	0.055216892	Metabolite levels Pyroglutamine	General health
rs7495132	C	T	84	10	0	59	30	5	0.95	0.79	0.05	0.21	C	1.134	0.055214724	Inflammatory bowel disease	Immune diseases and disorders
rs1062177	C	T	57	34	3	84	10	0	0.79	0.95	0.21	0.05	T	0.16	0.055214724	Preschool internalizing problems	Mental aptitude and behavioural traits
rs6956675	A	G	9	22	63	0	10	84	0.21	0.05	0.79	0.95	A	0.03	0.055214724	Obesity-related traits	Obesity
rs12478601	C	T	26	42	26	7	37	50	0.50	0.27	0.50	0.73	C	1.39	0.055202269	Polycystic ovary syndrome	Reproductive health
rs2930047	T	C	20	54	20	8	35	51	0.50	0.27	0.50	0.73	G	1.0912733	0.055202269	Crohn's disease	Digestive system and its disorders
rs7536700	C	T	77	17	0	54	29	11	0.91	0.73	0.09	0.27	A	1.86	0.055194805	Multiple myeloma IgH translocation	Cancer
rs17779747	G	T	53	31	10	78	15	1	0.73	0.91	0.27	0.09	T	1.02	0.055194805	QT interval	Heart health and disorders
rs12410416	T	C	52	33	9	77	17	0	0.73	0.91	0.27	0.09	T	0.028	0.055194805	Height	General health
rs4731742	G	C	13	38	43	25	58	11	0.34	0.57	0.66	0.43	G	0.12	0.055175559	Cutaneous malignant melanoma	Cancer
rs7964407	G	A	55	34	5	31	40	23	0.77	0.54	0.23	0.46	G	0.2061	0.055159475	IgG glycosylation	Immune diseases and disorders
rs174529	T	C	31	40	23	58	28	8	0.54	0.77	0.46	0.23	T	0.041	0.055159475	HDL cholesterol	General health
rs721146	A	C	15	49	30	37	49	8	0.42	0.65	0.58	0.35	A	1.17	0.05508137	Alzheimer's disease in APOE e4+ carriers	Brain health and disorders
rs806276	A	G	41	40	13	16	46	32	0.65	0.41	0.35	0.59	A	1	0.055	Attention deficit hyperactivity disorder time to onset	Brain health and disorders
rs1805126	A	G	41	40	13	16	46	32	0.65	0.41	0.35	0.59	A	0.6568	0.055	Electrocardiographic conduction measures	Heart health and disorders
rs9783347	A	G	8	50	36	33	44	17	0.35	0.59	0.65	0.41	A	1.36	0.055	Pancreatic cancer	Cancer
rs10142119	G	A	14	39	41	34	43	17	0.36	0.59	0.64	0.41	G	1.96	0.054931336	IgE levels in asthmatics D.f. specific	Immune diseases and disorders
rs2505059	A	G	38	43	13	13	49	32	0.63	0.40	0.37	0.60	G	1.765	0.054831766	Adverse response to chemotherapy neutropenia_leucopenia all anthracycline-based drugs	Drug response
rs2941484	C	T	34	45	15	11	47	36	0.60	0.37	0.40	0.63	T	0.044	0.054831766	Urate levels	General health
rs356219	G	A	16	38	40	36	42	16	0.37	0.61	0.63	0.39	G	1.29	0.054800725	Parkinson's disease	Brain health and disorders
rs11648796	A	G	41	36	17	8	58	28	0.63	0.39	0.37	0.61	A	0.043	0.054800725	Height	General health
rs2616978	T	C	33	50	11	15	42	37	0.62	0.38	0.38	0.62	T	2.004	0.054775917	Post-traumatic stress disorder	Brain health and disorders
rs4440177	G	A	33	50	11	13	46	35	0.62	0.38	0.38	0.62	A	0.347	0.054775917	Alcohol dependence	General health
rs2029213	C	T	37	44	13	65	27	2	0.63	0.84	0.37	0.16	C	1	0.054761476	Heart rate	General health
rs1467979	C	T	66	25	3	38	42	14	0.84	0.63	0.16	0.37	C	0.1923	0.054761476	IgG glycosylation	Immune diseases and disorders
rs9835332	G	C	7	44	43	1	20	73	0.31	0.12	0.69	0.88	C	0.028	0.05472973	Height	General health
rs7221059	C	A	62	29	3	24	65	5	0.81	0.60	0.19	0.40	C	0.328	0.05468216	Pulmonary emphysema	Pulmonology
rs12153327	C	T	30	53	11	61	31	2	0.60	0.81	0.40	0.19	C	0.064	0.05468216	Anxiety disorder	Brain health and disorders
rs9558942	T	C	33	47	14	62	29	3	0.60	0.81	0.40	0.19	G	0.03	0.05468216	Obesity-related traits	Obesity
rs12702595	C	A	26	44	24	8	37	49	0.51	0.28	0.49	0.72	A	0.099	0.054666943	Symmetrical dimethylarginine levels	General health
rs9545740	G	A	31	34	29	7	39	48	0.51	0.28	0.49	0.72	A	0.03	0.054666943	Obesity-related traits	Obesity
rs4377367	C	T	4	20	70	12	42	40	0.15	0.35	0.85	0.65	C	1.5873016	0.054474121	Progression free survival in metastatic colorectal cancer CAPOX-B vs CAPOX-B plus cetuximab	Cancer
rs6054512	C	T	12	42	40	1	26	67	0.35	0.15	0.65	0.85	T	0.0589	0.054474121	Axial length	Misc
rs1160351	A	C	41	40	13	70	20	4	0.65	0.85	0.35	0.15	T	2.92	0.054474121	Sexual dysfunction SSRI_SNRI-related	General health
rs16928705	G	A	66	28	0	41	40	13	0.85	0.65	0.15	0.35	A	2.67	0.054474121	Diisocyanate-induced asthma	Pulmonology
rs11679592	C	T	43	36	15	68	24	2	0.65	0.85	0.35	0.15	C	1.16	0.054474121	Ulcerative colitis	Immune diseases and disorders
rs11852372	A	C	44	38	12	73	17	4	0.67	0.87	0.33	0.13	A	0.003	0.054448554	Local histogram emphysema pattern	Pulmonology
rs12318506	G	T	82	12	0	53	39	2	0.94	0.77	0.06	0.23	T	0.21	0.054432172	Coronary artery calcification	Heart health and disorders
rs10750172	A	G	49	36	9	22	47	25	0.71	0.48	0.29	0.52	A	0.16	0.054422369	Intraocular pressure	General health
rs998584	C	A	30	40	24	54	34	6	0.53	0.76	0.47	0.24	A	0.0631	0.054397434	Waist-to-hip ratio adjusted for body mass index	Obesity
rs10517025	C	T	60	30	4	86	7	1	0.80	0.95	0.20	0.05	A	1	0.054387894	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs17767225	C	T	74	18	2	93	1	0	0.88	0.99	0.12	0.01	T	1	0.054317034	Alzheimer's disease late onset	Brain health and disorders
rs11620399	G	T	93	1	0	83	0	11	0.99	0.88	0.01	0.12	T	1	0.054317034	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs1443170	T	C	93	1	0	74	18	2	0.99	0.88	0.01	0.12	G	0.03	0.054317034	Obesity-related traits	Obesity
rs17551536	A	G	76	16	2	41	51	2	0.89	0.71	0.11	0.29	G	1.4706	0.054263566	Bronchopulmonary dysplasia	Pulmonology
rs3091338	C	T	47	39	8	75	18	1	0.71	0.89	0.29	0.11	T	1.23	0.054263566	Crohn's disease	Digestive system and its disorders
rs12421382	C	T	49	35	10	75	18	1	0.71	0.89	0.29	0.11	C	1.0638298	0.054263566	Schizophrenia	Brain health and disorders
rs2614463	A	T	48	37	9	74	20	0	0.71	0.89	0.29	0.11	T	0.1731	0.054263566	IgG glycosylation	Immune diseases and disorders
rs723794	G	T	6	43	45	28	42	24	0.29	0.52	0.71	0.48	G	3.645	0.054192679	Smooth-surface caries	Appearance
rs11765845	A	G	9	37	48	23	52	19	0.29	0.52	0.71	0.48	A	1.02	0.054192679	Diabetic retinopathy	Diabetes
rs674313	C	T	63	26	5	31	50	13	0.81	0.60	0.19	0.40	T	1.69	0.054112554	Chronic lymphocytic leukemia	Cancer
rs255414	G	A	3	26	65	12	47	35	0.17	0.38	0.83	0.62	A	1	0.05409154	Body mass index	Obesity
rs4304924	G	A	23	53	18	52	37	5	0.53	0.75	0.47	0.25	G	1.1765	0.054044118	Large artery stroke	Heart health and disorders
rs12449568	C	T	27	45	22	53	35	6	0.53	0.75	0.47	0.25	C	0.25	0.054044118	Height	General health
rs7126629	C	A	4	33	57	21	40	33	0.22	0.44	0.78	0.56	C	1.44	0.054018445	Prostate cancer early onset	Cancer
rs3801387	A	G	60	27	7	34	38	22	0.78	0.56	0.22	0.44	A	0.09	0.054018445	Bone mineral density	General health
rs4965593	C	G	7	32	55	0	14	80	0.24	0.07	0.76	0.93	C	1.15	0.054008439	Height	General health
rs12213468	G	A	52	38	4	80	14	0	0.76	0.93	0.24	0.07	G	0.1455	0.054008439	IgG glycosylation	Immune diseases and disorders
rs4972489	A	C	49	38	7	76	18	0	0.72	0.90	0.28	0.10	C	0.03	0.053968254	Obesity-related traits	Obesity
rs13017599	G	A	53	33	8	80	12	2	0.74	0.91	0.26	0.09	A	1.21	0.053870888	Rheumatoid arthritis	Immune diseases and disorders
rs13031237	G	T	52	35	7	80	12	2	0.74	0.91	0.26	0.09	T	1.13	0.053870888	Rheumatoid arthritis	Immune diseases and disorders
rs240768	T	C	80	12	2	51	37	6	0.91	0.74	0.09	0.26	T	0.267	0.053870888	Economic and political preferences immigration_crime	Mental aptitude and behavioural traits
rs13019803	C	T	79	14	1	52	35	7	0.91	0.74	0.09	0.26	T	0.14	0.053870888	Serum protein levels sST2	General health
rs16989979	G	T	45	41	8	20	48	26	0.70	0.47	0.30	0.53	T	0.3325	0.053776576	Cerebral amyloid angiopathy	Brain health and disorders
rs9988450	C	T	48	35	11	17	54	23	0.70	0.47	0.30	0.53	C	0.077	0.053776576	Triglycerides	General health
rs2629046	T	C	24	52	18	8	41	45	0.53	0.30	0.47	0.70	T	0.024	0.053776576	Height	General health
rs6828523	C	A	71	23	0	47	35	12	0.88	0.69	0.12	0.31	C	1.11	0.053758089	Breast cancer	Cancer
rs254560	G	A	44	41	9	72	21	1	0.69	0.88	0.31	0.12	A	1.0823938	0.053758089	Ulcerative colitis	Immune diseases and disorders
rs6095357	A	C	6	47	41	1	21	72	0.31	0.12	0.69	0.88	C	1.0526316	0.053758089	Schizophrenia	Brain health and disorders
rs480409	C	T	34	53	7	69	21	4	0.64	0.85	0.36	0.15	G	1.842	0.053720238	Adverse response to chemotherapy neutropenia_leucopenia all topoisomerase inhibitors	Drug response
rs3914502	T	A	16	35	43	1	27	66	0.36	0.15	0.64	0.85	A	1.4	0.053720238	Autism spectrum disorder	Brain health and disorders
rs2507838	C	A	86	8	0	62	28	4	0.96	0.81	0.04	0.19	A	1	0.053669222	Body mass lean	Obesity
rs11188352	T	G	87	6	1	62	28	4	0.96	0.81	0.04	0.19	G	0.4377	0.053669222	IgG glycosylation	Immune diseases and disorders
rs17228058	A	G	64	24	6	86	8	0	0.81	0.96	0.19	0.04	G	0.0789	0.053669222	Self-reported allergy	General health
rs7987251	C	T	86	8	0	61	30	3	0.96	0.81	0.04	0.19	T	0.0051	0.053669222	Trans fatty acid levels	General health
rs4938807	C	A	71	20	3	43	39	12	0.86	0.66	0.14	0.34	A	0.24	0.053595897	Intraocular pressure	General health
rs10892565	T	C	71	20	3	43	39	12	0.86	0.66	0.14	0.34	T	0.23	0.053595897	Intraocular pressure	General health
rs2018683	G	T	17	53	24	42	46	6	0.46	0.69	0.54	0.31	T	7.8	0.053589543	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	General health
rs10844154	A	C	11	36	47	27	47	20	0.31	0.54	0.69	0.46	C	1.46	0.053589543	Emphysema-related traits	Pulmonology
rs12051443	G	A	32	41	21	55	36	3	0.56	0.78	0.44	0.22	A	1.06	0.053577689	Prostate cancer	Cancer
rs2863171	A	C	61	29	4	30	51	13	0.80	0.59	0.20	0.41	C	23.924	0.053569037	Forced vital capacity	Pulmonology
rs9925964	A	G	37	42	15	65	25	4	0.62	0.82	0.38	0.18	A	0.02	0.05345282	Body mass index	Obesity
rs2120461	C	T	3	27	64	13	46	35	0.18	0.38	0.82	0.62	T	0.03	0.05345282	Bone mineral density	General health
rs16986825	C	T	60	27	7	83	11	0	0.78	0.94	0.22	0.06	T	1.18	0.053418803	Pancreatic cancer	Cancer
rs2888674	G	A	32	38	24	13	33	48	0.54	0.31	0.46	0.69	A	123.5	0.053416149	Forced expiratory volume in 1 second environmental interaction	Pulmonology
rs4580814	G	T	24	49	21	45	49	0	0.52	0.74	0.48	0.26	T	0.083	0.053389831	Mean corpuscular hemoglobin concentration	Heart health and disorders
rs2236212	G	C	18	49	27	43	42	9	0.45	0.68	0.55	0.32	C	0.11	0.053256142	Phospholipid levels plasma	General health
rs941764	A	G	26	51	17	8	44	42	0.55	0.32	0.45	0.68	G	1.06	0.053256142	Breast cancer	Cancer
rs8018967	T	C	28	47	19	9	42	43	0.55	0.32	0.45	0.68	T	0.033	0.053256142	Blood metabolite ratios	Heart health and disorders
rs9924561	G	T	94	0	0	75	19	0	1.00	0.90	0.00	0.10	T	3.57	0.053221289	Red blood cell traits	Immune diseases and disorders
rs10263087	G	C	1	19	74	9	38	47	0.11	0.30	0.89	0.70	C	1.547	0.053207662	Formal thought disorder in schizophrenia	Brain health and disorders
rs57104699	C	A	46	40	8	73	21	0	0.70	0.89	0.30	0.11	C	0.19	0.053207662	Multiple myeloma and monoclonal gammopathy	Cancer
rs2366858	C	A	0	2	92	0	24	70	0.01	0.13	0.99	0.87	C	0.0325	0.053186813	HDL cholesterol	General health
rs13257518	T	A	70	24	0	92	2	0	0.87	0.99	0.13	0.01	A	1.37	0.053186813	Refractive astigmatism	General health
rs17767392	C	T	72	20	2	92	2	0	0.87	0.99	0.13	0.01	T	1.23	0.053186813	Mitral valve prolapse	Heart health and disorders
rs4660293	A	G	73	18	3	92	2	0	0.87	0.99	0.13	0.01	G	0.48	0.053186813	HDL cholesterol	General health
rs8028579	G	T	92	2	0	71	22	1	0.99	0.87	0.01	0.13	T	0.3	0.053186813	Coronary artery calcification	Heart health and disorders
rs12261589	C	T	92	2	0	70	24	0	0.99	0.87	0.01	0.13	A	0.04	0.053186813	Obesity-related traits	Obesity
rs4522865	G	A	24	44	26	4	42	48	0.49	0.27	0.51	0.73	A	1.3514	0.053087757	Systemic lupus erythematosus	Immune diseases and disorders
rs2854160	T	C	22	48	24	9	32	53	0.49	0.27	0.51	0.73	T	0.053	0.053087757	Height	General health
rs2068888	G	A	30	36	28	55	28	11	0.51	0.73	0.49	0.27	A	2.28	0.053087757	Triglycerides	General health
rs17133858	G	T	87	7	0	62	30	2	0.96	0.82	0.04	0.18	T	20.99	0.053076083	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs4968361	A	G	65	24	5	87	7	0	0.82	0.96	0.18	0.04	A	1.08	0.053076083	Schizophrenia	Brain health and disorders
rs9966832	A	G	88	5	1	63	28	3	0.96	0.82	0.04	0.18	A	0.1502	0.053076083	Periodontitis Mean PAL	Misc
rs6951258	T	C	87	7	0	63	28	3	0.96	0.82	0.04	0.18	G	0.03	0.053076083	Obesity-related traits	Obesity
rs9320913	C	A	30	50	14	58	34	2	0.59	0.80	0.41	0.20	A	0.101	0.053050398	Educational attainment	Mental aptitude and behavioural traits
rs12251307	C	T	67	24	3	36	48	10	0.84	0.64	0.16	0.36	T	1	0.053002496	Type 1 diabetes	Diabetes
rs10028213	C	G	64	30	0	38	44	12	0.84	0.64	0.16	0.36	C	0.084	0.053002496	Thyroid function	Immune diseases and disorders
rs796127	T	C	18	47	29	42	42	10	0.44	0.67	0.56	0.33	T	0.093	0.052975389	C-reactive protein levels	Immune diseases and disorders
rs12465515	C	G	9	26	59	1	11	82	0.23	0.07	0.77	0.93	C	1.25	0.052851565	Mitral valve prolapse	Heart health and disorders
rs13188771	C	A	53	38	3	82	11	1	0.77	0.93	0.23	0.07	A	4.24	0.052851565	Conduct disorder interaction	Brain health and disorders
rs991427	C	T	81	13	0	56	32	6	0.93	0.77	0.07	0.23	T	0.412	0.052851565	Systolic blood pressure alcohol consumption interaction	General health
rs12151790	G	A	81	13	0	56	32	6	0.93	0.77	0.07	0.23	A	0.4	0.052851565	Osteoporosis-related phenotypes	Immune diseases and disorders
rs4494364	G	A	81	13	0	56	32	6	0.93	0.77	0.07	0.23	A	0.142	0.052851565	Systolic blood pressure alcohol consumption interaction	General health
rs2798641	C	T	56	32	6	82	11	1	0.77	0.93	0.23	0.07	T	0.041	0.052851565	Pulmonary function	Pulmonology
rs6980334	G	A	20	33	41	2	30	62	0.39	0.18	0.61	0.82	A	0.038	0.052843692	Blood metabolite ratios	Heart health and disorders
rs1165151	T	G	11	38	45	0	24	70	0.32	0.13	0.68	0.87	T	0.091	0.052837573	Urate levels	General health
rs2251468	C	A	11	38	45	2	20	72	0.32	0.13	0.68	0.87	A	0.0512	0.052837573	Homocysteine levels	Misc
rs2522056	G	A	73	18	3	47	34	13	0.87	0.68	0.13	0.32	A	0.06	0.052837573	Fibrinogen	General health
rs12324805	C	A	7	39	48	2	15	77	0.28	0.10	0.72	0.90	C	1	0.052814327	Body mass index	Obesity
rs1039443	T	C	75	19	0	48	39	7	0.90	0.72	0.10	0.28	C	0.2223	0.052814327	IgG glycosylation	Immune diseases and disorders
rs2066955	C	A	51	33	10	75	19	0	0.72	0.90	0.28	0.10	A	0.023	0.052814327	Educational attainment	Mental aptitude and behavioural traits
rs12705981	A	C	45	45	4	77	15	2	0.72	0.90	0.28	0.10	C	0.021	0.052814327	Body mass index	Obesity
rs9674544	G	A	25	43	26	6	39	49	0.49	0.27	0.51	0.73	G	0.25	0.052801724	Primary tooth development time to first tooth eruption	Misc
rs12623976	G	A	69	23	2	36	52	6	0.86	0.66	0.14	0.34	A	4.469	0.052785811	Very long-chain saturated fatty acid levels fatty acid 22:0	General health
rs2900333	C	T	36	52	6	69	23	2	0.66	0.86	0.34	0.14	C	1.32	0.052785811	Testicular germ cell tumor	Cancer
rs6577641	C	T	10	44	40	1	25	68	0.34	0.14	0.66	0.86	G	1.17	0.052785811	Chronic mucus hypersecretion	Immune diseases and disorders
rs12568930	T	C	69	23	2	39	46	9	0.86	0.66	0.14	0.34	A	1.1360025	0.052785811	Ulcerative colitis	Immune diseases and disorders
rs2165953	G	A	8	28	58	11	63	20	0.23	0.45	0.77	0.55	G	0.02	0.052757116	Obesity-related traits	Obesity
rs12565727	A	G	59	26	9	23	57	14	0.77	0.55	0.23	0.45	A	1.33	0.052757116	Male-pattern baldness	Appearance
rs4320486	C	T	18	44	32	38	47	9	0.43	0.65	0.57	0.35	C	1.69	0.052649563	Pneumoconiosis in silica exposure	Pulmonology
rs10231759	T	C	40	43	11	19	42	33	0.65	0.43	0.35	0.57	C	1.15	0.052649563	Height	General health
rs186749	A	G	15	50	29	38	47	9	0.43	0.65	0.57	0.35	A	0.1	0.052649563	Percent mammographic density	General health
rs11568377	G	A	88	6	0	65	26	3	0.97	0.83	0.03	0.17	A	1.64	0.052631579	Systolic blood pressure in sickle cell anemia	Heart health and disorders
rs62296447	T	A	64	28	2	89	4	1	0.83	0.97	0.17	0.03	T	1.0752687	0.052631579	Schizophrenia	Brain health and disorders
rs7594645	A	G	88	6	0	64	28	2	0.97	0.83	0.03	0.17	G	0.072	0.052631579	Episodic memory	Brain health and disorders
rs9987289	A	G	2	13	79	7	36	51	0.09	0.27	0.91	0.73	A	1.21	0.052601072	HDL cholesterol	General health
rs4240624	G	A	2	13	79	7	36	51	0.09	0.27	0.91	0.73	G	1.0869565	0.052601072	Schizophrenia	Brain health and disorders
rs13831	A	G	6	38	50	0	17	77	0.27	0.09	0.73	0.91	T	0.21	0.052601072	Event-related brain oscillations	Brain health and disorders
rs7846385	T	C	52	34	8	78	15	1	0.73	0.91	0.27	0.09	C	5	0.052601072	Height	General health
rs6602217	T	C	77	17	0	54	30	10	0.91	0.73	0.09	0.27	T	1.12	0.052601072	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs2540917	T	C	49	40	5	78	15	1	0.73	0.91	0.27	0.09	C	1	0.052601072	Mean corpuscular volume	Heart health and disorders
rs6473015	A	C	52	34	8	78	15	1	0.73	0.91	0.27	0.09	A	0.045	0.052601072	Infant length	Misc
rs11622475	C	T	52	37	5	80	13	1	0.75	0.92	0.25	0.08	C	1.13	0.052599137	Bipolar disorder	Brain health and disorders
rs72689147	G	T	53	35	6	79	15	0	0.75	0.92	0.25	0.08	G	1.08	0.052599137	Myocardial infarction	Heart health and disorders
rs10267337	A	C	0	15	79	3	41	50	0.08	0.25	0.92	0.75	A	0.03	0.052599137	Obesity-related traits	Obesity
rs11653989	A	T	72	18	4	91	3	0	0.86	0.98	0.14	0.02	T	1.61	0.052568816	Cardiac repolarization	Heart health and disorders
rs16948200	G	A	91	3	0	73	16	5	0.98	0.86	0.02	0.14	A	1	0.052568816	Immune reponse to smallpox secreted IL-2	Immune diseases and disorders
rs10004839	C	T	91	3	0	68	26	0	0.98	0.86	0.02	0.14	T	0.57	0.052568816	Retinopathy in non-diabetics	General health
rs4342585	C	G	91	3	0	70	22	2	0.98	0.86	0.02	0.14	C	0.2559	0.052568816	Axial length	Misc
rs2073963	T	G	40	42	12	16	47	31	0.65	0.42	0.35	0.58	G	1.29	0.052565743	Male-pattern baldness	Appearance
rs6027506	A	G	42	38	14	13	53	28	0.65	0.42	0.35	0.58	A	1.22	0.052565743	Type 1 diabetes nephropathy	Diabetes
rs7217932	A	G	16	47	31	40	42	12	0.42	0.65	0.58	0.35	A	0.03	0.052565743	Bone mineral density	General health
rs1223245	A	G	33	43	18	58	33	3	0.58	0.79	0.42	0.21	A	0.11	0.052555512	Preschool internalizing problems	Mental aptitude and behavioural traits
rs636291	G	A	27	40	27	46	44	4	0.50	0.72	0.50	0.28	A	1.18	0.052531269	Prostate cancer	Cancer
rs2688325	T	C	10	32	52	21	52	21	0.28	0.50	0.72	0.50	T	0.03	0.052531269	Menarche age at onset	Reproductive health
rs9543976	G	A	14	39	41	34	42	18	0.36	0.59	0.64	0.41	G	1.6	0.052494109	Diabetic retinopathy	Diabetes
rs2322633	T	C	11	45	38	29	52	13	0.36	0.59	0.64	0.41	T	1.12	0.052494109	Height	General health
rs735665	G	A	62	25	7	86	6	2	0.79	0.95	0.21	0.05	T	1.81	0.05248705	Follicular lymphoma	Cancer
rs4073582	G	A	57	35	2	84	10	0	0.79	0.95	0.21	0.05	G	1.66	0.05248705	Gout	General health
rs12424086	T	C	58	33	3	84	10	0	0.79	0.95	0.21	0.05	C	0.29	0.05248705	Primary tooth development time to first tooth eruption	Misc
rs9296335	G	A	84	10	0	60	29	5	0.95	0.79	0.05	0.21	A	0.03	0.05248705	Obesity-related traits	Obesity
rs6479800	G	C	53	37	4	27	48	19	0.76	0.54	0.24	0.46	C	1.19	0.052375759	Rheumatoid arthritis	Immune diseases and disorders
rs74013184	A	C	89	5	0	64	30	0	0.97	0.84	0.03	0.16	C	7.73	0.052366988	Diisocyanate-induced asthma	Pulmonology
rs17071124	A	G	89	5	0	68	22	4	0.97	0.84	0.03	0.16	G	0.75	0.052366988	Sleep quality	General health
rs346221	G	A	8	54	32	36	41	17	0.37	0.60	0.63	0.40	A	1.31	0.052351426	Periodontitis PAL4Q3	Misc
rs9369640	C	A	17	36	41	32	49	13	0.37	0.60	0.63	0.40	C	1.0989	0.052351426	Coronary artery disease	Heart health and disorders
rs987360	C	T	36	46	12	17	41	36	0.63	0.40	0.37	0.60	T	0.27	0.052351426	Temperament	Mental aptitude and behavioural traits
rs6004862	A	T	36	46	12	6	63	25	0.63	0.40	0.37	0.60	T	0.097	0.052351426	Urate levels in lean individuals	Obesity
rs8017423	T	C	17	37	40	37	40	17	0.38	0.61	0.62	0.39	T	1.64	0.05232772	Mortality in heart failure	Heart health and disorders
rs4698790	T	G	18	38	38	37	43	14	0.39	0.62	0.61	0.38	T	1	0.05232772	Fasting insulin interaction	General health
rs268067	G	A	3	22	69	0	4	90	0.15	0.02	0.85	0.98	A	0.04	0.052325581	Menarche age at onset	Reproductive health
rs7912575	A	G	90	4	0	69	22	3	0.98	0.85	0.02	0.15	G	4.52	0.052325581	Bipolar disorder and eating disorder	Brain health and disorders
rs111547017	A	G	69	22	3	90	4	0	0.85	0.98	0.15	0.02	A	1.1	0.052325581	Schizophrenia	Brain health and disorders
rs1799945	C	G	69	22	3	90	4	0	0.85	0.98	0.15	0.02	G	0.627	0.052325581	Systolic blood pressure	Heart health and disorders
rs9470004	C	T	90	4	0	69	22	3	0.98	0.85	0.02	0.15	T	0.081	0.052325581	Height	General health
rs17181956	C	T	70	20	4	90	4	0	0.85	0.98	0.15	0.02	T	0.028	0.052325581	Height	General health
rs9349205	G	A	69	22	3	90	4	0	0.85	0.98	0.15	0.02	A	0.01	0.052325581	Mean corpuscular hemoglobin	Heart health and disorders
rs13124827	C	T	41	37	16	64	29	1	0.63	0.84	0.37	0.16	C	1.23	0.052318841	Hypospadias	Misc
rs2675724	A	C	37	41	16	11	50	33	0.61	0.38	0.39	0.62	A	1.44	0.052315876	Asthma sex interaction	Immune diseases and disorders
rs832187	C	T	14	44	36	34	47	13	0.38	0.61	0.62	0.39	C	1.0626993	0.052315876	Schizophrenia	Brain health and disorders
rs944289	C	T	37	40	17	63	27	4	0.61	0.81	0.39	0.19	T	1.37	0.052262653	Thyroid cancer	Cancer
rs4285028	A	C	33	48	13	61	31	2	0.61	0.81	0.39	0.19	A	1.1	0.052262653	Multiple sclerosis	Brain health and disorders
rs11638450	C	T	30	54	10	61	31	2	0.61	0.81	0.39	0.19	T	0.012	0.052262653	Response to statins LDL cholesterol change	General health
rs10023113	A	G	73	20	1	45	41	8	0.88	0.70	0.12	0.30	A	2.3	0.052209862	Non-small cell lung cancer survival	Cancer
rs4656940	A	G	59	30	5	29	50	15	0.79	0.57	0.21	0.43	A	1.15	0.052083333	Crohn's disease	Digestive system and its disorders
rs6914598	T	C	49	36	9	19	54	21	0.71	0.49	0.29	0.51	C	0.1	0.052035398	Cutaneous malignant melanoma	Cancer
rs10106540	A	G	48	38	8	15	62	17	0.71	0.49	0.29	0.51	G	0.04	0.052035398	Personality dimensions	Brain health and disorders
rs917997	T	C	15	35	44	2	24	68	0.35	0.15	0.65	0.85	A	1.19	0.052015654	Celiac disease	Immune diseases and disorders
rs2058660	G	A	15	35	44	2	24	68	0.35	0.15	0.65	0.85	G	1.19	0.052015654	Crohn's disease	Digestive system and its disorders
rs6708413	G	A	15	35	44	2	24	68	0.35	0.15	0.65	0.85	G	1.1225724	0.052015654	Crohn's disease	Digestive system and its disorders
rs2075184	T	C	15	35	44	2	24	68	0.35	0.15	0.65	0.85	T	1	0.052015654	Pediatric autoimmune diseases	Immune diseases and disorders
rs8034191	T	C	44	39	11	73	17	4	0.68	0.87	0.32	0.13	C	1.4	0.051964715	Chronic obstructive pulmonary disease	Immune diseases and disorders
rs4988462	C	T	41	45	8	70	23	1	0.68	0.87	0.32	0.13	T	1.18	0.051964715	Tourette's syndrome or obsessive-compulsive disorder	Brain health and disorders
rs4268748	T	C	73	17	4	43	41	10	0.87	0.68	0.13	0.32	C	0.008637669	0.051964715	Skin colour saturation	Appearance
rs224329	C	T	46	41	7	25	41	28	0.71	0.48	0.29	0.52	T	0.064	0.051809211	Height	General health
rs10174165	G	T	82	12	0	56	34	4	0.94	0.78	0.06	0.22	A	2.89	0.051759834	Diisocyanate-induced asthma	Pulmonology
rs10250997	C	A	82	12	0	57	32	5	0.94	0.78	0.06	0.22	C	1.03	0.051759834	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs10502739	C	T	82	12	0	56	34	4	0.94	0.78	0.06	0.22	C	0.04	0.051759834	Metabolite levels  X-11787	General health
rs12446289	T	C	50	34	10	76	16	2	0.71	0.89	0.29	0.11	C	0.2893	0.051727224	Metabolite levels MHPG	General health
rs6471393	A	G	14	47	33	3	30	61	0.40	0.19	0.60	0.81	A	1.57	0.051708312	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs3103267	A	C	19	37	38	2	32	60	0.40	0.19	0.60	0.81	C	1.16	0.051708312	Height	General health
rs2123536	T	C	4	28	62	13	49	32	0.19	0.40	0.81	0.60	T	1.12	0.051708312	Coronary heart disease	Heart health and disorders
rs12635698	T	C	59	34	1	35	43	16	0.81	0.60	0.19	0.40	C	1.41	0.051708312	Obesity extreme	Obesity
rs2820464	G	A	36	41	17	63	26	5	0.60	0.81	0.40	0.19	G	1.16	0.051708312	Waist-hip ratio	General health
rs73013527	C	T	37	39	18	61	30	3	0.60	0.81	0.40	0.19	C	1.14	0.051708312	Rheumatoid arthritis	Immune diseases and disorders
rs12700667	G	A	3	41	50	21	46	27	0.25	0.47	0.75	0.53	A	1.2	0.051667435	Endometriosis	General health
rs11168048	T	C	31	38	25	49	43	2	0.53	0.75	0.47	0.25	T	0.4	0.051667435	Pulmonary function	Pulmonology
rs2184180	T	G	26	48	20	52	37	5	0.53	0.75	0.47	0.25	G	0.1637	0.051667435	IgG glycosylation	Immune diseases and disorders
rs2687481	G	T	65	26	3	37	44	13	0.83	0.63	0.17	0.37	G	1	0.051667382	Hearing function	General health
rs1472631	A	G	37	44	13	62	32	0	0.63	0.83	0.37	0.17	A	0.037	0.051667382	Blood metabolite levels	Heart health and disorders
rs12474201	G	A	38	42	14	63	30	1	0.63	0.83	0.37	0.17	A	0.028	0.051667382	Height	General health
rs3177928	G	A	60	31	3	85	9	0	0.80	0.95	0.20	0.05	A	2.31	0.051646904	Cholesterol, total	General health
rs17246404	C	T	60	31	3	85	9	0	0.80	0.95	0.20	0.05	C	1.22	0.051646904	Chronic lymphocytic leukemia	Cancer
rs9268839	A	G	19	52	23	47	38	9	0.48	0.70	0.52	0.30	G	2.47	0.051597052	Rheumatoid arthritis	Immune diseases and disorders
rs758747	C	T	48	36	10	24	42	28	0.70	0.48	0.30	0.52	T	0.026	0.051597052	Body mass index	Obesity
rs34695944	T	C	52	33	9	78	14	2	0.73	0.90	0.27	0.10	C	1.13	0.051409149	Rheumatoid arthritis	Immune diseases and disorders
rs11067763	A	G	77	16	1	49	39	6	0.90	0.73	0.10	0.27	A	0.81	0.051409149	Systolic blood pressure	Heart health and disorders
rs11754288	G	A	50	37	7	76	18	0	0.73	0.90	0.27	0.10	A	0.084	0.051409149	Cardiovascular disease risk factors	Heart health and disorders
rs1550582	G	A	52	33	9	78	14	2	0.73	0.90	0.27	0.10	A	0.022	0.051409149	Educational attainment	Mental aptitude and behavioural traits
rs4238010	G	A	1	16	77	5	41	48	0.10	0.27	0.90	0.73	G	1.72	0.051409149	Major depressive disorder	Brain health and disorders
rs11628318	T	A	8	41	45	23	53	18	0.30	0.53	0.70	0.47	A	2.572	0.051398601	Platelet count	Heart health and disorders
rs9905704	G	T	8	29	57	0	14	80	0.24	0.07	0.76	0.93	T	1.27	0.051382131	Testicular germ cell tumor	Cancer
rs4810485	T	G	6	33	55	2	10	82	0.24	0.07	0.76	0.93	T	1.18	0.051382131	Rheumatoid arthritis	Immune diseases and disorders
rs4965598	C	T	6	33	55	0	14	80	0.24	0.07	0.76	0.93	T	0.028	0.051382131	Height	General health
rs17111530	T	C	80	14	0	52	39	3	0.93	0.76	0.07	0.24	T	2.529	0.051382131	Smooth-surface caries	Appearance
rs846111	G	C	55	33	6	80	14	0	0.76	0.93	0.24	0.07	C	1.75	0.051382131	QT interval	Heart health and disorders
rs3742130	G	A	55	33	6	81	12	1	0.76	0.93	0.24	0.07	A	1.0992312	0.051382131	Crohn's disease	Digestive system and its disorders
rs41322152	G	C	93	1	0	73	21	0	0.99	0.89	0.01	0.11	C	2.52	0.051361068	Acute lymphoblastic leukemia childhood	Cancer
rs11021169	G	T	73	21	0	93	1	0	0.89	0.99	0.11	0.01	G	1.3	0.051361068	Tourette's syndrome or obsessive-compulsive disorder	Brain health and disorders
rs13335629	G	A	93	1	0	73	21	0	0.99	0.89	0.01	0.11	A	0.648	0.051361068	Red blood cell traits	Immune diseases and disorders
rs17002342	T	A	93	1	0	75	17	2	0.99	0.89	0.01	0.11	T	0.61	0.051361068	Waist-to-hip circumference ratio interaction	General health
rs2647264	A	G	74	19	1	93	1	0	0.89	0.99	0.11	0.01	G	0.165	0.051361068	Immune response to anthrax vaccine	Immune diseases and disorders
rs384627	C	T	93	1	0	75	17	2	0.99	0.89	0.01	0.11	A	0.03	0.051361068	Obesity-related traits	Obesity
rs8056742	T	C	67	25	2	38	46	10	0.85	0.65	0.15	0.35	C	1.27	0.051283012	Amyotrophic lateral sclerosis	Brain health and disorders
rs8128234	C	T	68	23	3	39	44	11	0.85	0.65	0.15	0.35	T	1.17	0.051283012	Psoriasis	Immune diseases and disorders
rs55676755	C	G	41	40	13	70	19	5	0.65	0.85	0.35	0.15	C	0.11	0.051283012	Emphysema imaging phenotypes	Pulmonology
rs4246076	G	A	41	40	13	66	27	1	0.65	0.85	0.35	0.15	G	0.051	0.051283012	Urate levels in overweight individuals	Obesity
rs1765142	C	A	9	48	37	2	25	67	0.35	0.15	0.65	0.85	A	1.05	0.051283012	Schizophrenia	Brain health and disorders
rs2000260	A	G	33	40	21	54	38	2	0.56	0.78	0.44	0.22	A	1.32	0.051203277	Eosinophilic esophagitis	Digestive system and its disorders
rs823118	C	T	27	52	15	57	32	5	0.56	0.78	0.44	0.22	T	1.122	0.051203277	Parkinson's disease	Brain health and disorders
rs9375225	G	T	27	52	15	56	34	4	0.56	0.78	0.44	0.22	T	1	0.051203277	QT interval interaction	Heart health and disorders
rs10778213	T	C	22	38	34	3	36	55	0.44	0.22	0.56	0.78	G	0.12	0.051203277	C-reactive protein	Immune diseases and disorders
rs7481584	G	A	30	46	18	56	34	4	0.56	0.78	0.44	0.22	A	0.018	0.051203277	Calcium levels	General health
rs2358740	G	T	43	40	11	69	24	1	0.67	0.86	0.33	0.14	G	1.0526316	0.051136364	Schizophrenia	Brain health and disorders
rs346923	G	A	73	16	5	39	48	7	0.86	0.67	0.14	0.33	A	0.28	0.051136364	Biochemical measures	General health
rs9359762	G	T	42	42	10	69	24	1	0.67	0.86	0.33	0.14	T	0.265	0.051136364	Left superior temporal gyrus thickness schizophrenia interaction	Brain health and disorders
rs11217857	A	G	71	20	3	44	38	12	0.86	0.67	0.14	0.33	A	0.24	0.051136364	Intraocular pressure	General health
rs9886428	G	A	43	40	11	71	20	3	0.67	0.86	0.33	0.14	G	0.1476	0.051136364	IgG glycosylation	Immune diseases and disorders
rs11684202	A	G	43	40	11	69	24	1	0.67	0.86	0.33	0.14	A	0.0938	0.051136364	LDL cholesterol	General health
rs1316453	T	C	44	38	12	69	24	1	0.67	0.86	0.33	0.14	C	0.0624	0.051136364	Self-reported allergy	General health
rs7314326	A	C	6	47	41	21	59	14	0.31	0.54	0.69	0.46	A	1.06	0.051041667	Schizophrenia	Brain health and disorders
rs4820599	A	G	29	43	22	6	47	41	0.54	0.31	0.46	0.69	G	0.0088	0.051041667	Gamma glutamyl transpeptidase	Immune diseases and disorders
rs28643277	C	A	43	43	8	17	53	24	0.69	0.46	0.31	0.54	A	1.32	0.051041667	Periodontitis CDC_AAP	Misc
rs11655550	T	C	62	29	3	86	8	0	0.81	0.96	0.19	0.04	C	1.475	0.050911376	Systemic lupus erythematosus	Immune diseases and disorders
rs16850885	G	A	86	8	0	65	23	6	0.96	0.81	0.04	0.19	A	1	0.050911376	Immune reponse to smallpox secreted IL-1beta	Immune diseases and disorders
rs17064136	G	A	86	8	0	63	27	4	0.96	0.81	0.04	0.19	A	0.04	0.050911376	Obesity-related traits	Obesity
rs13078960	T	G	62	29	3	86	8	0	0.81	0.96	0.19	0.04	G	0.034	0.050911376	Body mass index	Obesity
rs1733724	A	G	3	29	62	0	8	86	0.19	0.04	0.81	0.96	A	0.49	0.050911376	QRS duration	Heart health and disorders
rs7089814	C	T	24	38	32	47	34	13	0.46	0.68	0.54	0.32	C	0.096	0.050882658	Breast size	General health
rs6804368	A	G	47	34	13	21	44	29	0.68	0.46	0.32	0.54	A	0.022	0.050882658	Blood metabolite levels	Heart health and disorders
rs174535	T	C	31	43	20	59	27	8	0.56	0.77	0.44	0.23	T	0.08	0.050793651	Phospholipid levels plasma	General health
rs538174	T	C	61	26	7	84	9	1	0.79	0.94	0.21	0.06	C	2.44	0.050739065	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs504008	A	C	8	45	41	26	51	17	0.32	0.55	0.68	0.45	C	2.7	0.050736309	QRS duration	Heart health and disorders
rs391023	C	T	24	55	15	10	41	43	0.55	0.32	0.45	0.68	G	1.33	0.050736309	Chronic lymphocytic leukemia	Cancer
rs7626019	C	T	42	43	9	20	45	29	0.68	0.45	0.32	0.55	T	0.2353	0.050736309	Neurofibrillary tangles	Brain health and disorders
rs2361763	C	T	20	51	23	9	32	53	0.48	0.27	0.52	0.73	C	1.72	0.050731855	Classic bladder exstrophy	Misc
rs1533087	T	C	24	49	21	54	30	10	0.52	0.73	0.48	0.27	T	1.06	0.050731855	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs7801375	A	G	5	28	61	14	49	31	0.20	0.41	0.80	0.59	G	1.0869565	0.050674663	Schizophrenia	Brain health and disorders
rs744972	A	C	59	32	3	33	45	16	0.80	0.59	0.20	0.41	C	1	0.050674663	Homeostasis model assessment of beta-cell function interaction	Misc
rs4986172	C	T	28	48	18	7	48	39	0.55	0.33	0.45	0.67	T	0.034	0.05060241	Height	General health
rs7636293	C	T	12	38	44	30	44	20	0.33	0.55	0.67	0.45	T	0.029	0.05060241	Height	General health
rs1840440	T	C	22	40	32	41	44	9	0.45	0.67	0.55	0.33	G	2.16	0.05060241	Weight	Appearance
rs3181157	C	T	67	24	3	40	41	13	0.84	0.64	0.16	0.36	A	3.22	0.05058567	Paclitaxel-induced neuropathy	Brain health and disorders
rs1949733	A	G	11	45	38	3	24	67	0.36	0.16	0.64	0.84	A	2.36	0.05058567	Response to antineoplastic agents	General health
rs438895	G	A	2	26	66	16	35	43	0.16	0.36	0.84	0.64	G	0.384	0.05058567	Economic and political preferences	Mental aptitude and behavioural traits
rs2371030	G	A	10	43	41	30	45	19	0.34	0.56	0.66	0.44	G	1	0.050480769	Non-small cell lung cancer	Cancer
rs2140418	T	C	12	39	43	30	45	19	0.34	0.56	0.66	0.44	C	0.101	0.050480769	Alcoholism alcohol use disorder factor score	General health
rs7945071	G	T	62	30	2	35	46	13	0.82	0.62	0.18	0.38	T	3.012	0.050454228	Cognitive function	Brain health and disorders
rs1992269	C	T	65	24	5	39	38	17	0.82	0.62	0.18	0.38	A	1.66	0.050454228	Alzheimer's disease late onset	Brain health and disorders
rs12145418	G	T	40	36	18	64	26	4	0.62	0.82	0.38	0.18	T	1.331	0.050454228	Adverse response to chemotherapy neutropenia_leucopenia all antimicrotubule drugs	Drug response
rs2268241	G	A	65	24	5	36	44	14	0.82	0.62	0.18	0.38	A	0.03	0.050454228	Obesity-related traits	Obesity
rs9851724	C	T	16	40	38	4	26	64	0.38	0.18	0.62	0.82	C	0.66	0.050454228	QRS duration	Heart health and disorders
rs2297374	C	T	50	37	7	23	50	21	0.73	0.51	0.27	0.49	C	0.029	0.050451694	LDL cholesterol	General health
rs2275215	T	C	53	38	3	30	44	20	0.77	0.55	0.23	0.45	T	0.09	0.050403226	Body mass index	Obesity
rs6885099	A	G	21	42	31	9	26	59	0.45	0.23	0.55	0.77	A	0.168	0.050403226	Thyroid hormone levels	General health
rs2120335	G	A	16	52	26	3	38	53	0.45	0.23	0.55	0.77	A	0.019	0.050403226	Height	General health
rs2716816	C	T	1	22	71	10	39	45	0.13	0.31	0.87	0.69	C	0.098	0.050372137	Breast size	General health
rs8035452	T	C	34	56	4	15	52	27	0.66	0.44	0.34	0.56	T	1.0753	0.050371216	Alzheimer's disease late onset	Brain health and disorders
rs10162002	G	A	69	23	2	42	41	11	0.86	0.66	0.14	0.34	A	1.233	0.05034965	Hypothyroidism	Immune diseases and disorders
rs7811528	A	G	68	25	1	36	53	5	0.86	0.66	0.14	0.34	G	1.0752687	0.05034965	Schizophrenia	Brain health and disorders
rs742108	G	A	65	25	4	87	7	0	0.82	0.96	0.18	0.04	T	1.24	0.050297619	Systemic lupus erythematosus	Immune diseases and disorders
rs4886088	A	G	66	23	5	88	5	1	0.82	0.96	0.18	0.04	A	1	0.050297619	Subcutaneous adipose tissue	Obesity
rs17750321	C	A	87	7	0	64	27	3	0.96	0.82	0.04	0.18	A	0.3	0.050297619	Social communication problems	Brain health and disorders
rs10518224	G	A	64	27	3	88	5	1	0.82	0.96	0.18	0.04	A	0.19	0.050297619	Quantitative traits	Misc
rs2222656	A	G	87	7	0	64	27	3	0.96	0.82	0.04	0.18	A	0.12	0.050297619	Metabolite levels Pyroglutamine	General health
rs28810	A	G	67	21	6	87	7	0	0.82	0.96	0.18	0.04	A	0.0624	0.050297619	Cerebral amyloid deposition PET imaging	Brain health and disorders
rs11624164	C	T	64	27	3	87	7	0	0.82	0.96	0.18	0.04	A	0.03	0.050297619	Obesity-related traits	Obesity
rs11784833	T	C	50	36	8	75	19	0	0.72	0.90	0.28	0.10	C	0.042	0.050288617	LDL cholesterol	General health
rs34698933	A	T	52	32	10	75	19	0	0.72	0.90	0.28	0.10	A	0.0328	0.050288617	Heschl's gyrus morphology	Brain health and disorders
rs4835265	C	A	46	44	4	76	17	1	0.72	0.90	0.28	0.10	T	0.0043	0.050288617	Gamma glutamyl transpeptidase	Immune diseases and disorders
rs74935252	A	T	94	0	0	77	16	1	1.00	0.90	0.00	0.10	A	34.03	0.05027933	Diisocyanate-induced asthma	Pulmonology
rs17015535	A	T	94	0	0	78	14	2	1.00	0.90	0.00	0.10	A	0.38	0.05027933	Coronary artery calcification	Heart health and disorders
rs6796026	C	T	94	0	0	76	18	0	1.00	0.90	0.00	0.10	A	0.03	0.05027933	Obesity-related traits	Obesity
rs2380205	C	T	43	37	14	15	51	28	0.65	0.43	0.35	0.57	C	1.06	0.050273598	Breast cancer	Cancer
rs1436351	G	T	11	43	40	30	47	17	0.35	0.57	0.65	0.43	T	0.016	0.050273598	Body mass index	Obesity
rs11968814	G	A	92	2	0	71	23	0	0.99	0.88	0.01	0.12	A	1.17	0.05025641	F-cell distribution	Immune diseases and disorders
rs17396122	G	A	73	19	2	92	2	0	0.88	0.99	0.12	0.01	G	1.0869565	0.05025641	Schizophrenia	Brain health and disorders
rs7795747	G	A	92	2	0	71	23	0	0.99	0.88	0.01	0.12	A	0.242	0.05025641	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs909674	C	A	5	33	56	0	13	81	0.23	0.07	0.77	0.93	C	0.3447	0.050223214	IgG glycosylation	Immune diseases and disorders
rs6499165	A	C	4	35	55	0	13	81	0.23	0.07	0.77	0.93	A	0.11	0.050223214	Metabolic traits	Misc
rs2863979	G	A	4	35	55	0	13	81	0.23	0.07	0.77	0.93	A	0.014	0.050223214	Blood metabolite levels	Heart health and disorders
rs8124695	C	A	83	9	2	57	31	6	0.93	0.77	0.07	0.23	A	1.48	0.050223214	Dupuytren's disease	Skin related disease
rs3002288	G	A	57	31	6	84	7	3	0.77	0.93	0.23	0.07	A	0.22	0.050223214	Eye color	Appearance
rs1362756	C	G	4	31	59	14	50	30	0.21	0.41	0.79	0.59	C	0.037	0.05019305	Optic disc area	Misc
rs12744221	C	T	30	50	14	56	37	1	0.59	0.79	0.41	0.21	C	1.66	0.05019305	Epilepsy remission after treatment	Brain health and disorders
rs7017914	A	G	36	38	20	59	31	4	0.59	0.79	0.41	0.21	A	0.03	0.05019305	Bone mineral density	General health
rs10807828	T	C	30	48	16	12	42	40	0.57	0.35	0.43	0.65	C	1.098901	0.050187777	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs1747683	A	G	38	46	10	17	46	31	0.65	0.43	0.35	0.57	G	0.1694	0.050187777	IgG glycosylation	Immune diseases and disorders
rs41350144	A	T	25	45	24	46	44	4	0.51	0.72	0.49	0.28	T	2.269	0.050186595	Bipolar disorder	Brain health and disorders
rs10484761	T	C	48	40	6	23	49	22	0.72	0.51	0.28	0.49	G	1.33	0.050186595	Esophageal cancer	Cancer
rs2731672	T	C	8	36	50	19	55	20	0.28	0.49	0.72	0.51	T	4.61	0.050186595	Circulating vasoactive peptide levels	Immune diseases and disorders
rs4949316	G	C	5	42	47	19	55	20	0.28	0.49	0.72	0.51	G	0.2127	0.050186595	Metabolite levels 5-HIAA	General health
rs10098647	T	C	38	45	11	16	47	31	0.64	0.42	0.36	0.58	G	0.03	0.050113636	Obesity-related traits	Obesity
rs73371737	C	A	78	15	1	48	43	3	0.91	0.74	0.09	0.26	A	1.35	0.050048876	Gene methylation in lung tissue	Misc
rs2293052	G	A	51	37	6	78	15	1	0.74	0.91	0.26	0.09	G	1.0526316	0.050048876	Schizophrenia	Brain health and disorders
rs2106595	G	A	51	37	6	79	13	2	0.74	0.91	0.26	0.09	G	0.88	0.050048876	Smoking behavior	General health
rs13073838	T	C	51	37	6	77	17	0	0.74	0.91	0.26	0.09	T	0.116	0.050048876	Economic and political preferences	Mental aptitude and behavioural traits
rs2249625	A	G	22	41	31	5	35	54	0.45	0.24	0.55	0.76	C	2.24	0.05003127	Acute urticaria and angioedema non-steroidal anti-inflammatory drug-induced	Immune diseases and disorders
rs10937705	T	G	5	35	54	24	37	33	0.24	0.45	0.76	0.55	G	0.1717	0.05003127	IgG glycosylation	Immune diseases and disorders
rs12917712	C	T	56	31	7	27	49	18	0.76	0.55	0.24	0.45	T	1.07	0.05003127	Systemic lupus erythematosus	Immune diseases and disorders
rs17013524	T	G	80	13	1	55	32	7	0.92	0.76	0.08	0.24	T	1.833	0.050013011	Pit-and-Fissure caries	Misc
rs57244888	T	C	79	15	0	50	42	2	0.92	0.76	0.08	0.24	T	1.32	0.050013011	Basal cell carcinoma	Cancer
rs10994397	C	T	55	32	7	81	11	2	0.76	0.92	0.24	0.08	T	1.22	0.050013011	Bipolar disorder	Brain health and disorders
rs2072590	A	C	6	34	54	0	15	79	0.24	0.08	0.76	0.92	A	1.14	0.050013011	Epithelial ovarian cancer	Cancer
rs4820268	G	A	31	49	14	12	45	37	0.59	0.37	0.41	0.63	A	4.39	0.05	Iron levels	General health
rs12285276	G	C	31	49	14	12	45	37	0.59	0.37	0.41	0.63	G	1	0.05	Visceral fat	Obesity
rs2294008	C	T	13	50	31	37	44	13	0.40	0.63	0.60	0.37	T	1.21	0.049960349	Gastric adenocarcinoma histologically verified	Cancer
rs10276619	G	A	9	35	50	23	48	23	0.28	0.50	0.72	0.50	G	1.1765	0.049936132	Systemic lupus erythematosus	Immune diseases and disorders
rs2072499	A	G	34	49	11	22	31	41	0.62	0.40	0.38	0.60	G	1.22	0.049932065	Testicular germ cell tumor	Cancer
rs7742369	A	G	38	40	16	14	46	34	0.62	0.39	0.38	0.61	G	0.11	0.04991511	Height	General health
rs1320561	G	A	14	46	34	38	40	16	0.39	0.62	0.61	0.38	G	0.03	0.04991511	Obesity-related traits	Obesity
rs4549631	T	C	14	44	36	34	46	14	0.38	0.61	0.62	0.39	C	0.06	0.04991511	Height	General health
rs2248359	C	T	37	41	16	14	45	35	0.61	0.39	0.39	0.61	G	1.12	0.049909461	Multiple sclerosis	Brain health and disorders
rs11006747	A	C	13	47	34	33	49	12	0.39	0.61	0.61	0.39	A	0.02	0.049909461	Obesity-related traits	Obesity
rs6454764	T	C	4	27	63	14	45	35	0.19	0.39	0.81	0.61	T	0.31	0.049889442	vWF and FVIII levels	Heart health and disorders
rs7105056	T	C	0	6	88	2	27	65	0.03	0.16	0.97	0.84	A	1	0.04982859	Immune reponse to smallpox secreted IL-12p40	Immune diseases and disorders
rs5757676	T	C	1	29	64	0	6	88	0.16	0.03	0.84	0.97	C	0.1968	0.04982859	IgG glycosylation	Immune diseases and disorders
rs10279826	C	A	88	6	0	63	31	0	0.97	0.84	0.03	0.16	C	0.284	0.04982859	Urate levels in obese individuals	Obesity
rs466639	T	C	1	8	85	1	36	57	0.05	0.20	0.95	0.80	T	4.2	0.049796748	Menarche age at onset	Reproductive health
rs2544527	T	C	2	34	58	2	6	86	0.20	0.05	0.80	0.95	T	1	0.049796748	Pulmonary function interaction	Pulmonology
rs788076	G	A	0	10	84	6	26	62	0.05	0.20	0.95	0.80	A	0.0439	0.049796748	Palmitoleic acid 16:1n-7 plasma levels	General health
rs11780156	C	T	59	32	3	84	10	0	0.80	0.95	0.20	0.05	T	1.07	0.049796748	Breast cancer	Cancer
rs1335587	C	T	17	45	32	4	32	58	0.42	0.21	0.58	0.79	G	0.03	0.049733512	Obesity-related traits	Obesity
rs2685295	A	G	30	49	15	56	36	2	0.58	0.79	0.42	0.21	A	1.724138	0.049733512	Bipolar disorder and eating disorder	Brain health and disorders
rs2839627	C	T	72	22	0	47	38	9	0.88	0.70	0.12	0.30	T	0.27	0.049733264	Information processing speed	Mental aptitude and behavioural traits
rs17137734	C	T	75	16	3	46	40	8	0.88	0.70	0.12	0.30	T	0.0893	0.049733264	Corneal curvature	General health
rs11205277	A	G	47	38	9	74	18	2	0.70	0.88	0.30	0.12	A	0.041	0.049733264	Birth length	Misc
rs9304270	C	T	72	22	0	46	40	8	0.88	0.70	0.12	0.30	A	0.03	0.049733264	Obesity-related traits	Obesity
rs17074636	T	G	91	3	0	70	23	1	0.98	0.87	0.02	0.13	T	0.7091	0.049671593	Gout	General health
rs12059860	T	C	91	3	0	70	23	1	0.98	0.87	0.02	0.13	C	0.619	0.049671593	Testosterone levels	Reproductive health
rs73114594	G	A	72	19	3	91	3	0	0.87	0.98	0.13	0.02	A	0.272	0.049671593	Metabolite levels 5-HIAA_ MHPG Ratio	Brain health and disorders
rs7569328	C	T	91	3	0	70	23	1	0.98	0.87	0.02	0.13	T	0.0995	0.049671593	LDL cholesterol	General health
rs1190596	A	G	3	22	69	9	46	39	0.15	0.34	0.85	0.66	A	1	0.04960196	Behavioural disinhibition generation interaction	Brain health and disorders
rs2692194	T	G	13	38	43	5	18	71	0.34	0.15	0.66	0.85	G	0.1502	0.04960196	IgG glycosylation	Immune diseases and disorders
rs4273712	A	G	41	42	11	68	24	2	0.66	0.85	0.34	0.15	G	12.5	0.04960196	Intracranial volume	Misc
rs4585146	G	A	39	46	9	68	24	2	0.66	0.85	0.34	0.15	G	1.1643	0.04960196	Major depressive disorder	Brain health and disorders
rs1417066	G	A	44	36	14	68	24	2	0.66	0.85	0.34	0.15	G	1.07	0.04960196	Osteoarthritis	Immune diseases and disorders
rs10904887	T	C	43	38	13	70	20	4	0.66	0.85	0.34	0.15	T	1	0.04960196	Telomere length	Aging
rs11646917	G	T	38	48	8	66	28	0	0.66	0.85	0.34	0.15	T	0.018	0.04960196	Optic cup area	Misc
rs3024493	C	A	68	23	3	89	5	0	0.85	0.97	0.15	0.03	T	1.35	0.049535604	Ulcerative colitis	Immune diseases and disorders
rs11594258	A	T	67	25	2	89	5	0	0.85	0.97	0.15	0.03	A	1	0.049535604	Glucocorticoid-induced osteonecrosis	Drug response
rs10203166	C	T	89	5	0	65	29	0	0.97	0.85	0.03	0.15	C	0.7988	0.049535604	IgG glycosylation	Immune diseases and disorders
rs13053505	G	T	66	27	1	89	5	0	0.85	0.97	0.15	0.03	G	0.04	0.049535604	Menarche age at onset	Reproductive health
rs571411	G	A	0	5	89	2	25	67	0.03	0.15	0.97	0.85	G	0.02	0.049535604	Obesity-related traits	Obesity
rs746265	A	C	70	23	1	41	46	7	0.87	0.68	0.13	0.32	C	6.27	0.049524965	PR interval	Heart health and disorders
rs7006527	A	C	69	25	0	43	42	9	0.87	0.68	0.13	0.32	A	1.32	0.049524965	Basal cell carcinoma	Cancer
rs6871536	T	C	71	21	2	43	42	9	0.87	0.68	0.13	0.32	C	1.17	0.049524965	Asthma childhood onset	Immune diseases and disorders
rs11077614	G	A	20	52	22	44	45	5	0.49	0.71	0.51	0.29	G	3.25	0.049477557	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs1493354	A	G	19	54	21	46	41	7	0.49	0.71	0.51	0.29	T	2.37	0.049477557	Adverse response to chemotherapy in breast cancer alopecia anti-microtubule	General health
rs11089637	T	C	51	31	12	25	42	27	0.71	0.49	0.29	0.51	C	1.1	0.049477557	Rheumatoid arthritis	Immune diseases and disorders
rs12612420	G	A	68	25	1	90	4	0	0.86	0.98	0.14	0.02	A	1.43	0.049462366	Exercise leisure time	Mental aptitude and behavioural traits
rs16830122	G	A	69	23	2	90	4	0	0.86	0.98	0.14	0.02	A	1.17	0.049462366	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs35855737	T	C	68	25	1	90	4	0	0.86	0.98	0.14	0.02	C	0.04	0.049462366	Neuroticism	Brain health and disorders
rs58603829	C	T	90	4	0	68	25	1	0.98	0.86	0.02	0.14	A	0.03	0.049462366	Obesity-related traits	Obesity
rs11603334	G	A	69	23	2	90	4	0	0.86	0.98	0.14	0.02	A	0.018	0.049462366	Body mass index	Obesity
rs10948197	T	C	32	50	12	63	26	5	0.61	0.81	0.39	0.19	C	0.51	0.049350649	Height	General health
rs7692995	T	C	64	24	6	33	48	13	0.81	0.61	0.19	0.39	T	0.074	0.049350649	Height	General health
rs234714	T	C	14	46	34	4	28	62	0.39	0.19	0.61	0.81	T	0.404	0.049350649	Plasma homocysteine levels post-methionine load test	Heart health and disorders
rs9607782	T	A	34	40	20	58	31	5	0.57	0.78	0.43	0.22	A	1.09	0.04929509	Schizophrenia	Brain health and disorders
rs12129719	G	A	33	42	19	57	33	4	0.57	0.78	0.43	0.22	A	1.05	0.04929509	Schizophrenia	Brain health and disorders
rs8067165	C	G	30	48	16	57	33	4	0.57	0.78	0.43	0.22	C	0.023	0.04929509	Height	General health
rs3002142	C	T	5	22	67	13	43	38	0.17	0.37	0.83	0.63	G	0.050391905	0.049288929	LDL peak particle diameter total fat intake interaction	General health
rs7463256	T	C	35	49	10	63	30	1	0.63	0.83	0.37	0.17	T	1	0.049288929	Attention deficit hyperactivity disorder	Brain health and disorders
rs1033962	C	T	44	44	6	23	45	26	0.70	0.48	0.30	0.52	A	1.43	0.049268736	Post-traumatic stress disorder	Brain health and disorders
rs12438353	C	T	45	42	7	17	57	20	0.70	0.48	0.30	0.52	T	1.39	0.049268736	Ischemic stroke	Brain health and disorders
rs12907866	A	G	47	41	6	74	20	0	0.72	0.89	0.28	0.11	A	6.06	0.04923369	Menarche age at onset	Reproductive health
rs34626435	G	A	75	18	1	50	35	9	0.89	0.72	0.11	0.28	A	1.1	0.04923369	Schizophrenia	Brain health and disorders
rs1339227	C	T	50	35	9	76	16	2	0.72	0.89	0.28	0.11	C	1.0638298	0.04923369	Schizophrenia	Brain health and disorders
rs7550636	T	C	47	41	6	74	20	0	0.72	0.89	0.28	0.11	T	0.25	0.04923369	Coronary artery calcification	Heart health and disorders
rs12138061	C	A	58	31	5	82	12	0	0.78	0.94	0.22	0.06	A	1.06	0.049126701	Schizophrenia	Brain health and disorders
rs17157266	T	C	60	27	7	82	12	0	0.78	0.94	0.22	0.06	C	1	0.049126701	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs17625845	T	C	58	31	5	82	12	0	0.78	0.94	0.22	0.06	C	0.125	0.049126701	Breast size	General health
rs5758511	G	A	58	31	5	82	12	0	0.78	0.94	0.22	0.06	A	0.027	0.049126701	Birth weight	Misc
rs10955971	G	A	51	38	5	28	44	22	0.74	0.53	0.26	0.47	T	1.319	0.049019608	Gastritis	Cancer
rs6858365	C	T	85	9	0	63	26	5	0.95	0.81	0.05	0.19	A	5.21	0.048942598	Diisocyanate-induced asthma	Pulmonology
rs17166082	G	A	85	9	0	60	32	2	0.95	0.81	0.05	0.19	A	1	0.048942598	Self-employment	Mental aptitude and behavioural traits
rs10858946	A	C	63	26	5	85	9	0	0.81	0.95	0.19	0.05	A	0.179	0.048942598	Optic nerve measurement cup-to-disc ratio	Misc
rs11106179	G	A	60	32	2	86	7	1	0.81	0.95	0.19	0.05	A	0.087	0.048942598	Expressive vocabulary in infants	Mental aptitude and behavioural traits
rs11030104	A	G	61	30	3	85	9	0	0.81	0.95	0.19	0.05	A	0.0478	0.048942598	Body mass index	Obesity
rs2868985	G	A	3	30	61	0	9	85	0.19	0.05	0.81	0.95	A	1.07	0.048942598	Schizophrenia	Brain health and disorders
rs2274788	T	C	48	42	4	76	18	0	0.73	0.90	0.27	0.10	C	23.07	0.048892284	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs4481887	A	G	7	36	51	2	14	78	0.27	0.10	0.73	0.90	G	1.67	0.048892284	Common traits Other	Misc
rs2523722	C	T	66	27	1	40	43	11	0.85	0.65	0.15	0.35	G	1.25	0.048890901	Schizophrenia	Brain health and disorders
rs16928297	T	G	42	46	6	20	49	25	0.69	0.47	0.31	0.53	G	1.25	0.04889044	QT interval	Heart health and disorders
rs8051149	G	A	43	44	7	19	51	24	0.69	0.47	0.31	0.53	A	0.026	0.04889044	Blood metabolite levels	Heart health and disorders
rs1623879	A	G	55	36	3	26	55	13	0.78	0.57	0.22	0.43	G	1.669	0.048876892	Adverse response to chemotherapy neutropenia_leucopenia carboplatin	Drug response
rs12360997	A	G	31	45	18	55	36	3	0.57	0.78	0.43	0.22	G	1.0638298	0.048876892	Schizophrenia	Brain health and disorders
rs10070303	C	T	57	32	5	32	43	19	0.78	0.57	0.22	0.43	A	0.03	0.048876892	Obesity-related traits	Obesity
rs757608	A	G	17	41	36	4	29	61	0.40	0.20	0.60	0.80	T	4.4	0.04883658	Height	General health
rs7700970	C	T	58	35	1	26	61	7	0.80	0.60	0.20	0.40	T	0.03	0.04883658	Toenail selenium levels	Misc
rs56322409	T	C	36	41	17	60	31	3	0.60	0.80	0.40	0.20	T	0.011	0.04883658	Blood metabolite levels	Heart health and disorders
rs9290663	A	T	71	23	0	49	33	12	0.88	0.70	0.12	0.30	T	1.58	0.048817568	Acute lymphoblastic leukemia childhood	Cancer
rs2380220	T	C	14	29	51	2	19	73	0.30	0.12	0.70	0.88	A	1	0.048817568	Behavioural disinhibition generation interaction	Brain health and disorders
rs1867982	A	G	7	30	57	1	12	81	0.23	0.07	0.77	0.93	A	0.058	0.048796357	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs11613092	C	T	56	32	6	80	14	0	0.77	0.93	0.23	0.07	G	1.64	0.048796357	Alzheimer's disease late onset	Brain health and disorders
rs9258260	C	T	80	14	0	53	38	3	0.93	0.77	0.07	0.23	T	1.45	0.048796357	Crohn's disease	Digestive system and its disorders
rs1452787	A	G	53	35	6	78	16	0	0.75	0.91	0.25	0.09	A	1.33	0.048734723	Sclerosing cholangitis and ulcerative colitis combined	Cancer
rs10496992	A	G	51	39	4	79	14	1	0.75	0.91	0.25	0.09	G	0.05	0.048734723	Serum thyroid-stimulating hormone levels	General health
rs2605100	A	G	11	39	44	2	22	70	0.32	0.14	0.68	0.86	G	0.04	0.048721314	Adiposity	Obesity
rs11217874	G	A	71	20	3	44	39	11	0.86	0.68	0.14	0.32	A	0.27	0.048721314	Intraocular pressure	General health
rs12794618	T	C	71	20	3	45	37	12	0.86	0.68	0.14	0.32	T	0.25	0.048721314	Intraocular pressure	General health
rs17123861	T	C	71	20	3	45	37	12	0.86	0.68	0.14	0.32	T	0.25	0.048721314	Intraocular pressure	General health
rs11217875	C	A	71	20	3	44	39	11	0.86	0.68	0.14	0.32	A	0.24	0.048721314	Intraocular pressure	General health
rs1812974	C	T	71	20	3	43	41	10	0.86	0.68	0.14	0.32	T	0.23	0.048721314	Intraocular pressure	General health
rs494562	A	G	69	24	1	38	51	5	0.86	0.68	0.14	0.32	A	0.118	0.048721314	Blood metabolite levels	Heart health and disorders
rs10995245	G	A	20	49	25	4	41	49	0.47	0.26	0.53	0.74	A	1.23	0.048715138	Narcolepsy	Brain health and disorders
rs6981992	G	T	15	40	39	1	31	62	0.37	0.18	0.63	0.82	A	0.02	0.048685942	Obesity-related traits	Obesity
rs1799810	A	T	42	44	8	14	59	21	0.68	0.46	0.32	0.54	T	0.02	0.048562762	Self-rated health	General health
rs10500715	T	G	29	48	17	55	35	4	0.56	0.77	0.44	0.23	T	1.32	0.048478088	Pancreatic cancer	Cancer
rs7015630	T	C	56	33	5	25	56	13	0.77	0.56	0.23	0.44	T	1.075	0.048478088	Crohn's disease	Digestive system and its disorders
rs4466877	G	A	56	33	5	25	56	13	0.77	0.56	0.23	0.44	G	0.2413	0.048478088	IgG glycosylation	Immune diseases and disorders
rs7580658	G	A	33	40	21	53	39	2	0.56	0.77	0.44	0.23	A	0.15	0.048478088	Protein C levels	General health
rs11161851	T	C	24	50	20	51	36	7	0.52	0.73	0.48	0.27	T	1	0.04842615	Visceral fat	Obesity
rs6589813	A	G	51	36	7	26	46	22	0.73	0.52	0.27	0.48	A	0.16	0.04842615	Intraocular pressure	General health
rs79143957	G	T	93	1	0	74	20	0	0.99	0.89	0.01	0.11	A	5.54	0.048423877	Diisocyanate-induced asthma	Pulmonology
rs7428297	C	T	75	18	1	93	1	0	0.89	0.99	0.11	0.01	T	2.0602	0.048423877	Clozapine-induced agranulocytosis	General health
rs11825259	A	G	93	1	0	75	18	1	0.99	0.89	0.01	0.11	A	0.21	0.048423877	Coronary artery calcification	Heart health and disorders
rs16976587	G	A	93	1	0	76	16	2	0.99	0.89	0.01	0.11	A	0.02	0.048423877	Obesity-related traits	Obesity
rs1034200	C	A	42	43	9	23	40	31	0.68	0.46	0.32	0.54	A	0.1	0.048417293	Corneal structure	General health
rs2357266	A	G	17	42	35	1	36	57	0.40	0.20	0.60	0.80	G	0.02	0.048346056	Self-rated health	General health
rs11892454	A	G	59	32	3	29	54	11	0.80	0.60	0.20	0.40	A	13.16	0.048346056	Heschl's gyrus morphology	Brain health and disorders
rs1364063	T	C	32	48	14	59	32	3	0.60	0.80	0.40	0.20	C	2.1	0.048346056	Menarche age at onset	Reproductive health
rs13014235	C	G	31	41	22	7	48	39	0.55	0.33	0.45	0.67	C	1.15	0.048283786	Basal cell carcinoma	Cancer
rs1913633	C	A	50	34	10	75	17	2	0.71	0.89	0.29	0.11	A	3.84	0.048239203	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs4972593	T	A	76	15	3	47	40	7	0.89	0.71	0.11	0.29	A	1.81	0.048239203	End-stage renal disease in Type 1 diabetics	Diabetes
rs2221433	T	G	12	42	40	2	26	66	0.35	0.16	0.65	0.84	G	0.087	0.048214286	Eating disorders	Brain health and disorders
rs11753077	T	G	41	40	13	66	26	2	0.65	0.84	0.35	0.16	T	1.17	0.048214286	Longevity 90 years and older	Aging
rs3773506	G	C	86	8	0	64	26	4	0.96	0.82	0.04	0.18	C	1.81	0.048189336	Type 2 diabetes	Diabetes
rs6871087	A	G	86	8	0	64	26	4	0.96	0.82	0.04	0.18	G	1.4	0.048189336	Response to angiotensin II receptor blocker therapy	General health
rs17293632	C	T	65	24	5	86	8	0	0.82	0.96	0.18	0.04	T	1.12	0.048189336	Crohn's disease	Digestive system and its disorders
rs1342371	C	T	62	30	2	86	8	0	0.82	0.96	0.18	0.04	A	0.03	0.048189336	Obesity-related traits	Obesity
rs4141404	A	C	5	24	65	0	8	86	0.18	0.04	0.82	0.96	A	2.41	0.048189336	Paclitaxel-induced neuropathy	Brain health and disorders
rs2106294	C	T	5	24	65	0	8	86	0.18	0.04	0.82	0.96	T	1.75	0.048189336	Type 2 diabetes nephropathy	Diabetes
rs2823357	G	A	28	48	18	13	37	44	0.55	0.34	0.45	0.66	A	1.15	0.048162049	Parkinson's disease	Brain health and disorders
rs10183486	C	T	44	37	13	18	48	28	0.66	0.45	0.34	0.55	T	0.196	0.048162049	Menopause age at onset	Reproductive health
rs4026608	C	T	29	46	19	10	43	41	0.55	0.34	0.45	0.66	C	0.03	0.048162049	Aortic root size	Heart health and disorders
rs382216	C	T	26	45	23	47	43	4	0.52	0.73	0.48	0.27	C	1.1494253	0.048152161	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs4689642	A	G	53	31	10	27	43	24	0.73	0.52	0.27	0.48	G	1.01	0.048152161	Attention function in attention deficit hyperactive disorder	Brain health and disorders
rs1254319	G	A	50	37	7	25	47	22	0.73	0.52	0.27	0.48	A	0.088	0.048152161	Refractive error	General health
rs1254337	A	T	50	37	7	25	47	22	0.73	0.52	0.27	0.48	T	0.04	0.048152161	Menarche age at onset	Reproductive health
rs1004368	A	G	63	28	3	33	51	10	0.82	0.62	0.18	0.38	G	0.03	0.048111053	Obesity-related traits	Obesity
rs16938437	C	T	83	11	0	58	33	3	0.94	0.79	0.06	0.21	T	3.7	0.04809816	Menarche age at onset	Reproductive health
rs1015213	C	T	83	11	0	60	29	5	0.94	0.79	0.06	0.21	A	1.5	0.04809816	Glaucoma primary angle closure	General health
rs2156107	C	T	1	9	84	3	33	58	0.06	0.21	0.94	0.79	C	0.203	0.04809816	Fractional exhaled nitric oxide childhood	Pulmonology
rs4659996	G	A	18	47	29	8	28	58	0.44	0.23	0.56	0.77	A	0.004	0.048097903	Ankle-brachial index	Heart health and disorders
rs6922269	G	A	41	42	11	18	47	29	0.66	0.44	0.34	0.56	A	1.23	0.048051911	Coronary heart disease	Heart health and disorders
rs6907340	C	T	39	46	9	17	49	28	0.66	0.44	0.34	0.56	A	1.2	0.048051911	Endometriosis	General health
rs218361	G	A	14	55	25	38	48	8	0.44	0.66	0.56	0.34	G	1.061	0.048051911	Eating disorders	Brain health and disorders
rs7524102	A	G	69	23	2	41	44	9	0.86	0.67	0.14	0.33	G	0.44	0.047958345	Bone mineral density	General health
rs11237982	T	C	68	25	1	44	38	12	0.86	0.67	0.14	0.33	T	0.3923	0.047958345	Verbal declarative memory	Brain health and disorders
rs6773931	C	A	9	44	41	1	25	68	0.33	0.14	0.67	0.86	A	0.053	0.047958345	Height	General health
rs9880192	G	C	42	42	10	69	23	2	0.67	0.86	0.33	0.14	C	0.028	0.047958345	White blood cell count	Immune diseases and disorders
rs1422438	G	T	11	43	40	25	56	13	0.35	0.56	0.65	0.44	G	1	0.047953216	Alzheimer's disease biomarkers	Brain health and disorders
rs10021303	G	A	40	43	11	14	54	26	0.65	0.44	0.35	0.56	A	1	0.047953216	Hypertension	Heart health and disorders
rs7240382	A	G	11	43	40	35	36	23	0.35	0.56	0.65	0.44	A	0.0931	0.047953216	Verbal declarative memory	Brain health and disorders
rs6984449	G	A	13	39	42	28	50	16	0.35	0.56	0.65	0.44	A	0.022	0.047953216	Educational attainment	Mental aptitude and behavioural traits
rs6493487	G	A	10	38	46	4	16	74	0.31	0.13	0.69	0.87	G	5.96	0.047950888	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs11122895	C	T	43	44	7	72	20	2	0.69	0.87	0.31	0.13	T	1.09	0.047950888	Allergic sensitization	Immune diseases and disorders
rs12458596	A	G	47	36	11	71	22	1	0.69	0.87	0.31	0.13	A	0.045	0.047950888	Sitting height ratio	Appearance
rs1020410	T	C	48	40	6	20	56	18	0.72	0.51	0.28	0.49	G	0.04	0.04789272	Obesity-related traits	Obesity
rs4779584	T	C	8	36	50	22	48	24	0.28	0.49	0.72	0.51	T	1.12	0.04789272	Colorectal cancer	Cancer
rs2675662	A	G	14	49	31	4	31	59	0.41	0.21	0.59	0.79	A	1.12	0.047877984	Psoriasis	Immune diseases and disorders
rs738409	C	G	29	53	12	57	35	2	0.59	0.79	0.41	0.21	G	6	0.047877984	Liver enzyme levels alanine transaminase	General health
rs4459386	A	G	5	41	48	1	17	76	0.27	0.10	0.73	0.90	A	1.05	0.047805789	Schizophrenia	Brain health and disorders
rs7523050	C	A	77	15	2	50	37	7	0.90	0.73	0.10	0.27	A	1	0.047805789	Fat distribution HIV	General health
rs1799922	T	G	48	41	5	76	17	1	0.73	0.90	0.27	0.10	T	0.14	0.047805789	Primary tooth development time to first tooth eruption	Misc
rs2230061	G	A	28	48	18	57	29	8	0.55	0.76	0.45	0.24	A	0.06	0.047735618	Fat body mass	Obesity
rs2351491	C	T	29	46	19	58	27	9	0.55	0.76	0.45	0.24	T	0.057	0.047735618	Height	General health
rs7127399	G	A	38	44	12	23	33	38	0.64	0.42	0.36	0.58	G	1.0526316	0.047724498	Schizophrenia	Brain health and disorders
rs1759645	C	T	14	41	39	31	48	15	0.37	0.59	0.63	0.41	C	1.29	0.047670363	Height	General health
rs13068298	T	C	49	37	8	24	47	23	0.72	0.51	0.28	0.49	T	0.102	0.047647409	Economic and political preferences feminism_equality	Mental aptitude and behavioural traits
rs12411277	G	A	47	41	6	24	47	23	0.72	0.51	0.28	0.49	A	0.022	0.047647409	Height	General health
rs6703865	G	A	82	11	1	57	32	5	0.93	0.78	0.07	0.22	A	1	0.047635231	Hippocampal atrophy	Brain health and disorders
rs11954519	A	T	55	36	3	81	13	0	0.78	0.93	0.22	0.07	A	0.033	0.047635231	Urate levels	General health
rs11776767	G	C	40	38	16	15	47	32	0.63	0.41	0.37	0.59	C	2.01	0.047627143	Triglycerides	General health
rs445114	T	C	39	40	15	14	49	31	0.63	0.41	0.37	0.59	T	1.22	0.047627143	Prostate cancer	Cancer
rs4817775	A	C	37	44	13	14	49	31	0.63	0.41	0.37	0.59	A	0.03	0.047627143	Bone mineral density	General health
rs1570669	A	G	39	40	15	18	41	35	0.63	0.41	0.37	0.59	A	0.018	0.047627143	Calcium levels	General health
rs6585827	G	A	18	40	36	35	47	12	0.40	0.62	0.60	0.38	G	0.05	0.047594779	Height	General health
rs9834970	T	C	17	41	36	36	44	14	0.40	0.62	0.60	0.38	C	1.051	0.047573228	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs1907926	T	C	69	19	6	43	35	16	0.84	0.64	0.16	0.36	G	9.793	0.047570107	Nicotine use	General health
rs823123	C	T	0	31	63	12	43	39	0.16	0.36	0.84	0.64	G	0.19	0.047570107	Prostate-specific antigen levels	Cancer
rs7567389	A	T	6	23	65	11	50	33	0.19	0.38	0.81	0.62	A	0.03	0.047562797	Self-rated health	General health
rs7780883	G	A	64	25	5	32	52	10	0.81	0.62	0.19	0.38	A	3.28	0.047562797	Cervical cancer	Cancer
rs343064	C	T	38	40	16	65	23	6	0.62	0.81	0.38	0.19	A	1.31	0.047562797	Non-alcoholic fatty liver disease histology other	Obesity
rs4899260	C	T	62	29	3	34	48	12	0.81	0.62	0.19	0.38	A	1.12	0.047562797	Celiac disease	Immune diseases and disorders
rs12793173	T	C	63	30	1	87	7	0	0.83	0.96	0.17	0.04	C	1	0.047553831	Cystic fibrosis severity	Immune diseases and disorders
rs7986704	C	T	87	7	0	64	28	2	0.96	0.83	0.04	0.17	T	0.0051	0.047553831	Trans fatty acid levels	General health
rs2554380	C	T	2	28	64	0	7	87	0.17	0.04	0.83	0.96	T	4.5	0.047553831	Height	General health
rs1012036	C	T	51	38	5	79	13	2	0.74	0.91	0.26	0.09	C	1.47	0.047538956	Emphysema-related traits	Pulmonology
rs13385191	A	G	51	38	5	77	17	0	0.74	0.91	0.26	0.09	G	1.17	0.047538956	Prostate cancer	Cancer
rs2561477	G	A	51	38	5	77	17	0	0.74	0.91	0.26	0.09	G	1.11	0.047538956	Rheumatoid arthritis	Immune diseases and disorders
rs2764743	T	A	77	17	0	53	34	7	0.91	0.74	0.09	0.26	T	0.346	0.047538956	IgG glycosylation	Immune diseases and disorders
rs12479213	C	A	55	30	9	77	17	0	0.74	0.91	0.26	0.09	A	0.03	0.047538956	Obesity-related traits	Obesity
rs2551802	C	G	6	33	55	0	15	79	0.24	0.08	0.76	0.92	G	0.04	0.047468354	Motion sickness	Misc
rs971768	G	A	56	31	7	80	13	1	0.76	0.92	0.24	0.08	A	13.91	0.047468354	Heschl's gyrus morphology	Brain health and disorders
rs17221417	C	G	51	41	2	80	13	1	0.76	0.92	0.24	0.08	G	1.29	0.047468354	Crohn's disease	Digestive system and its disorders
rs2788032	A	C	79	15	0	55	33	6	0.92	0.76	0.08	0.24	C	0.15	0.047468354	Body mass index interaction	Obesity
rs16964211	G	A	80	13	1	54	35	5	0.92	0.76	0.08	0.24	A	0.057	0.047468354	Height	General health
rs3934285	G	A	53	37	4	80	13	1	0.76	0.92	0.24	0.08	A	0.03	0.047468354	Obesity-related traits	Obesity
rs10821936	C	T	15	48	31	5	30	59	0.41	0.21	0.59	0.79	C	1.91	0.047431349	Acute lymphoblastic leukemia childhood	Cancer
rs4245595	C	T	15	48	31	4	32	58	0.41	0.21	0.59	0.79	C	1.63	0.047431349	Acute lymphoblastic leukemia childhood	Cancer
rs3812762	G	C	31	48	15	60	28	6	0.59	0.79	0.41	0.21	G	1.1965	0.047431349	Hypospadias	Misc
rs12202969	G	A	30	50	14	56	36	2	0.59	0.79	0.41	0.21	A	1.12	0.047431349	Bipolar disorder	Brain health and disorders
rs12431702	C	A	33	44	17	59	30	5	0.59	0.79	0.41	0.21	C	0.1459	0.047431349	IgG glycosylation	Immune diseases and disorders
rs10892567	A	G	49	36	9	24	46	24	0.71	0.50	0.29	0.50	A	0.16	0.047415837	Intraocular pressure	General health
rs9660992	A	G	45	44	5	20	54	20	0.71	0.50	0.29	0.50	A	0.11	0.047415837	Mean platelet volume	Heart health and disorders
rs1436904	T	G	27	49	18	53	36	5	0.55	0.76	0.45	0.24	T	1.04	0.047390559	Breast cancer	Cancer
rs11843309	C	T	94	0	0	79	13	2	1.00	0.91	0.00	0.09	T	0.212	0.04735376	Bilirubin levels	General health
rs17879755	G	A	92	2	0	73	20	1	0.99	0.88	0.01	0.12	C	5.64	0.047348485	QT interval	Heart health and disorders
rs349423	C	T	92	2	0	73	20	1	0.99	0.88	0.01	0.12	A	2.52	0.047348485	Bronchopulmonary dysplasia	Pulmonology
rs5754638	A	T	74	18	2	92	2	0	0.88	0.99	0.12	0.01	T	1.44	0.047348485	Alcohol dependence age at onset	General health
rs11594111	A	G	74	18	2	92	2	0	0.88	0.99	0.12	0.01	G	1.09	0.047348485	Migraine	Brain health and disorders
rs648425	T	C	0	2	92	2	18	74	0.01	0.12	0.99	0.88	T	0.317	0.047348485	Systolic blood pressure alcohol consumption interaction	General health
rs1970671	C	G	47	39	8	73	20	1	0.71	0.88	0.29	0.12	G	1.37	0.047300526	Diabetic retinopathy	Diabetes
rs7844537	T	G	0	22	72	9	37	48	0.12	0.29	0.88	0.71	G	0.05	0.047300526	Metabolite levels  X-11787	General health
rs7552186	C	T	44	45	5	22	49	23	0.71	0.49	0.29	0.51	C	1.12	0.04719764	Height	General health
rs1501908	G	C	6	43	45	21	53	20	0.29	0.51	0.71	0.49	G	0.07	0.04719764	LDL cholesterol	General health
rs6882076	T	C	6	43	45	20	55	19	0.29	0.51	0.71	0.49	T	0.029	0.04719764	Triglycerides	General health
rs659580	T	C	4	29	61	1	8	85	0.20	0.05	0.80	0.95	T	1.28	0.047144797	Response to angiotensin II receptor blocker therapy	General health
rs4957048	G	A	58	35	1	84	10	0	0.80	0.95	0.20	0.05	C	1.11	0.047144797	Ulcerative colitis	Immune diseases and disorders
rs6679073	C	A	62	27	5	84	10	0	0.80	0.95	0.20	0.05	C	0.15	0.047144797	Prostate-specific antigen levels	Cancer
rs11647936	A	T	48	33	13	70	23	1	0.69	0.87	0.31	0.13	A	2.29	0.047129811	Waist circumference	General health
rs7195486	G	C	70	23	1	40	49	5	0.87	0.69	0.13	0.31	C	0.55	0.047129811	QT interval	Heart health and disorders
rs10835187	C	T	42	45	7	69	25	0	0.69	0.87	0.31	0.13	T	0.03	0.047129811	Bone mineral density	General health
rs4389974	A	C	45	39	10	70	23	1	0.69	0.87	0.31	0.13	C	0.014	0.047129811	Body mass index	Obesity
rs2073398	C	G	24	54	16	49	43	2	0.54	0.75	0.46	0.25	G	12.3	0.0470621	Liver enzyme levels gamma-glutamyl transferase	General health
rs59448276	G	A	88	6	0	65	28	1	0.97	0.84	0.03	0.16	A	34.08	0.047058824	Diisocyanate-induced asthma	Pulmonology
rs2826659	A	C	67	24	3	88	6	0	0.84	0.97	0.16	0.03	A	1.35	0.047058824	Alcohol dependence age at onset	General health
rs13015955	G	A	65	28	1	88	6	0	0.84	0.97	0.16	0.03	A	0.179	0.047058824	LDL cholesterol	General health
rs16942341	C	T	88	6	0	67	24	3	0.97	0.84	0.03	0.16	T	0.13	0.047058824	Height	General health
rs34479159	T	C	71	16	7	88	6	0	0.84	0.97	0.16	0.03	C	0.089	0.047058824	Breast size	General health
rs6746082	A	C	61	30	3	37	41	16	0.81	0.61	0.19	0.39	A	1.29	0.047039824	Multiple myeloma	Cancer
rs1858740	T	C	37	41	16	65	22	7	0.61	0.81	0.39	0.19	C	1.0526316	0.047039824	Schizophrenia	Brain health and disorders
rs2383876	A	T	16	41	37	1	34	59	0.39	0.19	0.61	0.81	A	0.0508	0.047039824	Corneal curvature	General health
rs4586057	T	G	65	26	3	34	52	8	0.83	0.64	0.17	0.36	T	0.141	0.046956522	Economic and political preferences time	Mental aptitude and behavioural traits
rs11717368	G	C	12	44	38	2	28	64	0.36	0.17	0.64	0.83	C	0.008	0.046956522	Red blood cell traits	Immune diseases and disorders
rs12498806	T	C	91	3	0	73	18	3	0.98	0.87	0.02	0.13	C	1.2967	0.046800382	Hippocampal sclerosis	Brain health and disorders
rs705415	C	T	73	18	3	91	3	0	0.87	0.98	0.13	0.02	T	1	0.046800382	Blood and toenail selenium levels	Heart health and disorders
rs16984718	G	A	91	3	0	70	24	0	0.98	0.87	0.02	0.13	G	0.246	0.046800382	Urate levels in obese individuals	Obesity
rs1809845	G	T	91	3	0	71	22	1	0.98	0.87	0.02	0.13	G	0.124588	0.046800382	LDL peak particle diameter total fat intake interaction	General health
rs12296050	C	T	43	45	6	23	45	26	0.70	0.48	0.30	0.52	T	13.16	0.046800047	Electrocardiographic traits	Heart health and disorders
rs12883884	T	G	44	43	7	24	43	27	0.70	0.48	0.30	0.52	T	1	0.046800047	Cystic fibrosis severity	Immune diseases and disorders
rs134871	T	C	22	47	25	51	29	14	0.48	0.70	0.52	0.30	C	0.013	0.046800047	Body mass index	Obesity
rs4242382	A	G	2	16	76	11	30	53	0.11	0.28	0.89	0.72	A	1.66	0.046783626	Prostate cancer	Cancer
rs526231	C	T	48	40	6	75	18	1	0.72	0.89	0.28	0.11	C	1.1494253	0.046783626	Primary biliary cirrhosis	Immune diseases and disorders
rs3758785	A	G	46	44	4	75	18	1	0.72	0.89	0.28	0.11	G	1	0.046783626	Response to angiotensin II receptor blocker therapy opposite direction w_ diuretic therapy	Drug response
rs10934011	A	G	5	38	51	21	45	28	0.26	0.46	0.74	0.54	G	1	0.046749654	DNA methylation parent-of-origin	Misc
rs113740863	A	G	89	5	0	67	26	1	0.97	0.85	0.03	0.15	G	4.82	0.046735577	Diisocyanate-induced asthma	Pulmonology
rs1125355	T	A	69	22	3	89	5	0	0.85	0.97	0.15	0.03	A	1.16	0.046735577	Alzheimer's disease in APOE e4+ carriers	Brain health and disorders
rs9984896	A	C	70	22	2	90	4	0	0.86	0.98	0.14	0.02	A	2.85	0.046628131	QT interval	Heart health and disorders
rs563538	C	T	90	4	0	68	26	0	0.98	0.86	0.02	0.14	T	2.05	0.046628131	Spontaneous preterm birth preterm birth	Reproductive health
rs3116602	T	G	70	22	2	90	4	0	0.86	0.98	0.14	0.02	G	0.04	0.046628131	Height	General health
rs12543318	C	A	14	52	28	6	30	58	0.43	0.22	0.57	0.78	C	1.272	0.046598683	Orofacial clefts	Misc
rs2021722	C	T	66	27	1	40	44	10	0.85	0.66	0.15	0.34	C	1.15	0.046544322	Schizophrenia	Brain health and disorders
rs3761168	C	A	66	27	1	39	46	9	0.85	0.66	0.15	0.34	A	0.32	0.046544322	Social communication problems	Brain health and disorders
rs705145	C	A	39	46	9	67	25	2	0.66	0.85	0.34	0.15	C	0.051	0.046544322	Motion sickness	Misc
rs876793	T	C	45	34	15	66	27	1	0.66	0.85	0.34	0.15	C	0.009	0.046544322	Lipid traits	Misc
rs4256922	T	C	0	29	65	11	42	41	0.15	0.34	0.85	0.66	C	0.08	0.046544322	Urate levels in lean individuals	Obesity
rs17594362	C	T	58	32	4	82	12	0	0.79	0.94	0.21	0.06	A	1.11	0.046533713	Multiple sclerosis	Brain health and disorders
rs975334	G	A	16	56	22	7	35	52	0.47	0.26	0.53	0.74	C	8.3	0.046452677	Gallbladder cancer	Cancer
rs2130392	G	A	29	42	23	52	35	7	0.53	0.74	0.47	0.26	A	1.42	0.046452677	Kawasaki disease	Misc
rs62324212	C	A	20	49	25	45	39	10	0.47	0.69	0.53	0.31	A	1	0.046452212	Pediatric autoimmune diseases	Immune diseases and disorders
rs4711350	A	G	1	16	77	8	33	53	0.10	0.26	0.90	0.74	G	1.0869565	0.046418393	Schizophrenia	Brain health and disorders
rs6590330	G	A	78	14	2	54	31	9	0.90	0.74	0.10	0.26	A	1.51	0.046418393	Systemic lupus erythematosus	Immune diseases and disorders
rs11552449	C	T	53	33	8	77	16	1	0.74	0.90	0.26	0.10	T	1.07	0.046418393	Breast cancer	Cancer
rs9545047	A	C	51	37	6	78	14	2	0.74	0.90	0.26	0.10	A	1.05	0.046418393	Schizophrenia	Brain health and disorders
rs7950726	C	A	77	16	1	51	37	6	0.90	0.74	0.10	0.26	A	1	0.046418393	HbA2 levels	Immune diseases and disorders
rs8042543	C	T	51	37	6	79	12	3	0.74	0.90	0.26	0.10	C	0.0309	0.046418393	Waist-to-hip ratio adjusted for body mass index	Obesity
rs2115763	A	T	46	40	8	73	19	2	0.70	0.88	0.30	0.12	T	1	0.046413502	Interleukin-18 levels	Immune diseases and disorders
rs10922162	C	T	47	38	9	71	23	0	0.70	0.88	0.30	0.12	C	0.521	0.046413502	End-stage coagulation	General health
rs11776272	A	G	47	38	9	74	17	3	0.70	0.88	0.30	0.12	G	0.05	0.046413502	Obesity-related traits	Obesity
rs2036707	G	A	73	19	2	43	46	5	0.88	0.70	0.12	0.30	A	0.02	0.046413502	Obesity-related traits	Obesity
rs2947349	C	A	13	30	51	0	23	71	0.30	0.12	0.70	0.88	C	1.23	0.046413502	Epilepsy	Brain health and disorders
rs344235	A	G	5	46	43	1	21	72	0.30	0.12	0.70	0.88	G	0.08	0.046413502	Urate levels in overweight individuals	Obesity
rs3093023	G	A	38	43	13	65	25	4	0.63	0.82	0.37	0.18	A	1.146	0.046371833	Rheumatoid arthritis	Immune diseases and disorders
rs10497394	C	T	42	44	8	69	24	1	0.68	0.86	0.32	0.14	G	1.51	0.046351243	Otitis media chronic_recurrent	General health
rs4768903	A	G	45	38	11	70	22	2	0.68	0.86	0.32	0.14	A	1.1	0.046351243	Colorectal cancer	Cancer
rs1109114	C	T	45	38	11	71	20	3	0.68	0.86	0.32	0.14	C	0.021	0.046351243	Body mass index	Obesity
rs9921222	C	T	27	46	21	9	42	43	0.53	0.32	0.47	0.68	T	0.04	0.046296296	Bone mineral density	General health
rs17436410	G	A	62	29	3	85	9	0	0.81	0.95	0.19	0.05	G	2	0.046276013	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs10911628	C	A	86	7	1	60	33	1	0.95	0.81	0.05	0.19	A	1.954	0.046276013	Systemic lupus erythematosus	Immune diseases and disorders
rs28455997	T	C	62	29	3	85	9	0	0.81	0.95	0.19	0.05	T	1.48	0.046276013	Periodontitis CDC_AAP	Misc
rs891835	T	G	65	23	6	85	9	0	0.81	0.95	0.19	0.05	G	1.24	0.046276013	Glioma	Cancer
rs6062314	C	T	0	9	85	1	33	60	0.05	0.19	0.95	0.81	A	1.16	0.046276013	Multiple sclerosis	Brain health and disorders
rs941898	G	T	4	27	63	1	7	86	0.19	0.05	0.81	0.95	G	1	0.046276013	White matter hyperintensity burden	Brain health and disorders
rs2610739	G	A	5	25	64	1	7	86	0.19	0.05	0.81	0.95	G	0.1852	0.046276013	IgG glycosylation	Immune diseases and disorders
rs2169387	A	G	2	12	80	6	34	54	0.09	0.24	0.91	0.76	G	0.083	0.04622971	LDL cholesterol	General health
rs3734266	T	C	79	14	1	54	34	6	0.91	0.76	0.09	0.24	G	1.56	0.04622971	Systemic lupus erythematosus	Immune diseases and disorders
rs12634229	T	C	78	16	0	58	26	10	0.91	0.76	0.09	0.24	G	1.29	0.04622971	Atopic dermatitis	Immune diseases and disorders
rs2120771	A	G	53	36	5	79	14	1	0.76	0.91	0.24	0.09	G	0.107	0.04622971	Economic and political preferences feminism_equality	Mental aptitude and behavioural traits
rs56219066	T	C	55	35	4	30	47	17	0.77	0.57	0.23	0.43	T	1.24	0.046210958	Multiple myeloma and monoclonal gammopathy	Cancer
rs9693444	A	C	5	33	56	17	47	30	0.23	0.43	0.77	0.57	A	1.07	0.046210958	Breast cancer	Cancer
rs3777200	C	T	55	35	4	28	51	15	0.77	0.57	0.23	0.43	T	0.0204	0.046210958	Serum total protein level	General health
rs4245213	G	A	51	36	7	27	45	22	0.73	0.53	0.27	0.47	A	0.17	0.046170658	Intraocular pressure	General health
rs4466998	C	A	24	53	17	8	45	41	0.54	0.32	0.46	0.68	A	1	0.046152071	Mean corpuscular volume	Heart health and disorders
rs2802493	T	C	30	41	23	8	45	41	0.54	0.32	0.46	0.68	C	0.275	0.046152071	Left superior temporal gyrus thickness schizophrenia interaction	Brain health and disorders
rs9447004	A	G	27	47	20	11	39	44	0.54	0.32	0.46	0.68	A	0.012	0.046152071	Calcium levels	General health
rs559356	T	C	37	49	8	67	24	3	0.65	0.84	0.35	0.16	C	2.0925	0.045888743	Cognitive function	Brain health and disorders
rs7551345	C	A	66	26	2	41	41	12	0.84	0.65	0.16	0.35	A	1.07	0.045888743	Schizophrenia	Brain health and disorders
rs6009824	G	A	68	22	4	40	43	11	0.84	0.65	0.16	0.35	A	0.13	0.045888743	Natriuretic peptide levels	General health
rs608194	C	T	67	24	3	40	43	11	0.84	0.65	0.16	0.35	T	0.05	0.045888743	Emphysema imaging phenotypes	Pulmonology
rs7814749	A	G	13	39	42	3	24	67	0.35	0.16	0.65	0.84	A	0.0913	0.045888743	Response to simvastatin treatment PCSK9 protein level change	General health
rs9489510	A	G	53	38	3	26	54	14	0.77	0.56	0.23	0.44	G	0.61	0.04584127	QT interval	Heart health and disorders
rs12144344	C	T	48	39	7	74	19	1	0.72	0.89	0.28	0.11	T	396.39	0.045820655	Serum vitamin D-binding protein levels	General health
rs2943640	A	C	8	37	49	1	19	74	0.28	0.11	0.72	0.89	C	1	0.045820655	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs1475911	A	C	51	33	10	74	19	1	0.72	0.89	0.28	0.11	C	0.2012	0.045820655	IgG glycosylation	Immune diseases and disorders
rs1834180	G	A	8	37	49	1	19	74	0.28	0.11	0.72	0.89	A	0.097	0.045820655	Social communication problems	Brain health and disorders
rs127430	A	G	3	28	63	3	64	27	0.18	0.37	0.82	0.63	G	0.19	0.04581448	Cardiovascular disease risk factors	Heart health and disorders
rs10176176	A	T	30	45	19	10	45	39	0.56	0.35	0.44	0.65	T	1.07	0.045688178	Myocardial infarction	Heart health and disorders
rs2523864	C	T	38	47	9	20	43	31	0.65	0.44	0.35	0.56	T	1	0.045688178	Change in intraocular pressure in response to steroid treatment triamcinolone acetonide	General health
rs2251830	C	A	38	47	9	20	43	31	0.65	0.44	0.35	0.56	A	0.053	0.045688178	Height	General health
rs4793529	T	C	21	49	24	7	38	49	0.48	0.28	0.52	0.72	T	0.28	0.045649629	Prostate cancer	Cancer
rs1351696	A	G	0	27	67	8	45	41	0.14	0.32	0.86	0.68	G	0.0382	0.045612374	D-dimer levels	Heart health and disorders
rs2920503	C	T	42	43	9	70	21	3	0.68	0.86	0.32	0.14	T	0.041	0.045612374	LDL cholesterol	General health
rs12270115	G	A	58	33	3	31	50	13	0.79	0.60	0.21	0.40	A	0.15	0.045610528	Preschool internalizing problems	Mental aptitude and behavioural traits
rs7157785	G	T	57	35	2	34	44	16	0.79	0.60	0.21	0.40	T	0.065	0.045610528	Blood metabolite ratios	Heart health and disorders
rs4085613	T	G	8	50	36	29	48	17	0.35	0.56	0.65	0.44	A	1.32	0.045599635	Psoriasis	Immune diseases and disorders
rs2071449	C	A	45	41	8	72	20	2	0.70	0.87	0.30	0.13	A	0.0287	0.045574388	Waist-to-hip ratio adjusted for body mass index	Obesity
rs6110278	C	T	44	43	7	72	20	2	0.70	0.87	0.30	0.13	T	0.01	0.045574388	Mean platelet volume	Heart health and disorders
rs566767	T	G	0	1	93	1	17	76	0.01	0.10	0.99	0.90	A	34.08	0.045505618	Diisocyanate-induced asthma	Pulmonology
rs9445732	G	T	93	1	0	76	17	1	0.99	0.90	0.01	0.10	G	1.284	0.045505618	Corneal astigmatism	General health
rs11564024	T	G	93	1	0	76	17	1	0.99	0.90	0.01	0.10	C	1	0.045505618	Immune reponse to smallpox secreted IL-1beta	Immune diseases and disorders
rs10998466	A	G	93	1	0	75	19	0	0.99	0.90	0.01	0.10	A	0.53	0.045505618	Disc degeneration lumbar	Aging
rs16993221	A	T	93	1	0	75	19	0	0.99	0.90	0.01	0.10	A	0.455	0.045505618	C-reactive protein and white blood cell count	Immune diseases and disorders
rs16961557	A	G	93	1	0	76	17	1	0.99	0.90	0.01	0.10	G	0.03	0.045505618	Obesity-related traits	Obesity
rs7190458	G	A	83	11	0	60	30	4	0.94	0.80	0.06	0.20	A	1.46	0.045497098	Pancreatic cancer	Cancer
rs9372149	T	A	59	32	3	83	11	0	0.80	0.94	0.20	0.06	A	1	0.045497098	Childhood and early adolescence aggressive behavior	Brain health and disorders
rs9469578	C	T	84	9	1	63	24	7	0.94	0.80	0.06	0.20	T	0.06	0.045497098	Phosphorus levels	General health
rs212388	C	T	32	41	21	55	33	6	0.56	0.76	0.44	0.24	C	1	0.045488911	Crohn's disease and celiac disease	Digestive system and its disorders
rs2050190	A	G	55	33	6	29	47	18	0.76	0.56	0.24	0.44	A	0.2528	0.045488911	Activated partial thromboplastin time	Heart health and disorders
rs8088832	T	C	16	48	30	38	44	12	0.43	0.64	0.57	0.36	C	1.94	0.045454545	Cervical cancer	Cancer
rs10774214	T	C	21	38	35	37	46	11	0.43	0.64	0.57	0.36	T	1.17	0.045454545	Colorectal cancer	Cancer
rs2681424	T	C	21	38	35	36	48	10	0.43	0.64	0.57	0.36	T	1.16	0.045454545	Multiple sclerosis	Brain health and disorders
rs591044	T	C	31	47	16	13	43	38	0.58	0.37	0.42	0.63	A	9	0.045397798	Insulin resistance_response	Drug response
rs4618210	A	G	27	55	12	13	43	38	0.58	0.37	0.42	0.63	G	1.1	0.045397798	Myocardial infarction	Heart health and disorders
rs9371601	G	T	40	39	15	19	41	34	0.63	0.42	0.37	0.58	T	1.1	0.045397798	Bipolar disorder	Brain health and disorders
rs708886	T	G	37	45	12	21	37	36	0.63	0.42	0.37	0.58	T	0.0504	0.045397798	Cerebral amyloid deposition PET imaging	Brain health and disorders
rs1429107	A	G	1	17	76	7	36	51	0.10	0.27	0.90	0.73	A	0.02	0.045366568	Obesity-related traits	Obesity
rs7169523	G	A	48	42	4	75	19	0	0.73	0.90	0.27	0.10	G	1.4	0.045366568	Myasthenia gravis	Brain health and disorders
rs62024995	C	T	50	38	6	77	15	2	0.73	0.90	0.27	0.10	C	1	0.045366568	White matter hyperintensity burden	Brain health and disorders
rs8052123	T	C	76	17	1	54	30	10	0.90	0.73	0.10	0.27	C	1	0.045366568	Cataracts in type 2 diabetes	Diabetes
rs16998073	A	T	50	38	6	76	17	1	0.73	0.90	0.27	0.10	T	0.5	0.045366568	Diastolic blood pressure	Heart health and disorders
rs6577655	C	T	35	48	11	15	48	31	0.63	0.41	0.37	0.59	T	1	0.045351474	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs6953837	G	A	39	39	16	6	65	23	0.62	0.41	0.38	0.59	A	1.06	0.045315509	Schizophrenia	Brain health and disorders
rs1267813	G	C	34	49	11	20	37	37	0.62	0.41	0.38	0.59	G	1.0526316	0.045315509	Schizophrenia	Brain health and disorders
rs59950280	G	A	35	47	12	17	43	34	0.62	0.41	0.38	0.59	A	0.044	0.045315509	Triglycerides	General health
rs2551043	A	G	37	43	14	63	27	4	0.62	0.81	0.38	0.19	G	0.03	0.045283019	Obesity-related traits	Obesity
rs11174436	T	A	68	21	5	42	38	14	0.84	0.65	0.16	0.35	A	2.3	0.045264753	Pyoderma gangrenosum in inflammatory bowel disease	Immune diseases and disorders
rs17761864	C	A	42	38	14	67	23	4	0.65	0.84	0.35	0.16	A	1.21	0.045264753	Esophageal cancer squamous cell	Cancer
rs2302190	T	C	67	23	4	38	46	10	0.84	0.65	0.16	0.35	C	0.94	0.045264753	Vitamin D levels	General health
rs7061710	G	C	68	21	5	40	42	12	0.84	0.65	0.16	0.35	C	0.045	0.045264753	Blood metabolite levels	Heart health and disorders
rs1892894	C	T	49	36	9	25	45	24	0.71	0.51	0.29	0.49	T	0.15	0.045183139	Intraocular pressure	General health
rs984300	G	A	24	47	23	47	40	7	0.51	0.71	0.49	0.29	G	0.02	0.045183139	Obesity-related traits	Obesity
rs2414739	G	A	5	44	45	21	51	22	0.29	0.49	0.71	0.51	A	1.113	0.045183139	Parkinson's disease	Brain health and disorders
rs515135	T	C	5	30	59	17	43	34	0.21	0.41	0.79	0.59	T	0.16	0.045177045	LDL cholesterol	General health
rs6720763	T	C	51	40	3	26	52	16	0.76	0.55	0.24	0.45	C	1.29	0.045153221	Atopic dermatitis	Immune diseases and disorders
rs2019090	A	T	7	32	55	16	52	26	0.24	0.45	0.76	0.55	A	1.07	0.045153221	Myocardial infarction	Heart health and disorders
rs7498403	C	T	0	13	81	3	35	56	0.07	0.22	0.93	0.78	C	1	0.045088567	Height	General health
rs188610	G	A	82	11	1	59	29	6	0.93	0.78	0.07	0.22	A	11.49	0.045088567	Diisocyanate-induced asthma	Pulmonology
rs2069408	A	G	55	37	2	81	13	0	0.78	0.93	0.22	0.07	C	1.15	0.045088567	Asthma	Immune diseases and disorders
rs10438933	A	G	79	13	2	53	35	6	0.91	0.75	0.09	0.25	G	1.3	0.045072115	Amyotrophic lateral sclerosis	Brain health and disorders
rs17082664	A	G	80	11	3	52	37	5	0.91	0.75	0.09	0.25	G	1.22	0.045072115	Bipolar disorder	Brain health and disorders
rs9512900	T	C	53	35	6	78	15	1	0.75	0.91	0.25	0.09	C	1	0.045072115	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs10956483	G	C	53	35	6	77	17	0	0.75	0.91	0.25	0.09	C	0.071	0.045072115	White blood cell types	Immune diseases and disorders
rs11242496	G	A	50	41	3	78	15	1	0.75	0.91	0.25	0.09	A	0.043	0.045072115	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs12741973	C	T	25	44	25	46	41	7	0.50	0.71	0.50	0.29	C	0.167	0.0449694	Optic nerve measurement rim area	Misc
rs3785859	A	C	21	52	21	43	47	4	0.50	0.71	0.50	0.29	T	0.029	0.0449694	Airway responsiveness in chronic obstructive pulmonary disease	Pulmonology
rs9825379	G	A	79	15	0	58	28	8	0.92	0.77	0.08	0.23	A	0.07	0.044966048	Height	General health
rs9546434	C	T	57	30	7	79	15	0	0.77	0.92	0.23	0.08	T	0.022	0.044966048	Optic cup area	Misc
rs4074995	G	A	49	36	9	73	20	1	0.71	0.88	0.29	0.12	A	0.013	0.044912281	Calcium levels	General health
rs2032314	T	C	2	18	74	8	38	48	0.12	0.29	0.88	0.71	T	0.154	0.044912281	Red blood cell traits	Immune diseases and disorders
rs1928007	G	A	1	20	73	6	42	46	0.12	0.29	0.88	0.71	A	0.108	0.044912281	Word reading	Mental aptitude and behavioural traits
rs4780144	C	T	2	18	74	5	44	45	0.12	0.29	0.88	0.71	T	0.0027	0.044912281	Trans fatty acid levels	General health
rs78894156	T	C	87	7	0	63	31	0	0.96	0.84	0.04	0.16	G	34.03	0.044845842	Diisocyanate-induced asthma	Pulmonology
rs12252129	A	G	88	5	1	64	29	1	0.96	0.84	0.04	0.16	G	1.186	0.044845842	Airway responsiveness in chronic obstructive pulmonary disease	Pulmonology
rs11694842	A	G	66	25	3	88	5	1	0.84	0.96	0.16	0.04	A	0.062	0.044845842	Height	General health
rs17346452	T	C	64	29	1	87	7	0	0.84	0.96	0.16	0.04	T	0.04	0.044845842	Height	General health
rs6757720	C	G	88	5	1	64	29	1	0.96	0.84	0.04	0.16	C	0.0082	0.044845842	Trans fatty acid levels	General health
rs7566684	A	G	88	5	1	64	29	1	0.96	0.84	0.04	0.16	A	0.0082	0.044845842	Trans fatty acid levels	General health
rs6707470	A	G	88	5	1	64	29	1	0.96	0.84	0.04	0.16	A	0.008	0.044845842	Trans fatty acid levels	General health
rs6136813	G	T	52	37	5	25	53	16	0.75	0.55	0.25	0.45	T	0.043	0.044833582	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs1570155	G	A	17	51	26	8	31	55	0.45	0.25	0.55	0.75	A	0.04	0.044833582	Obesity-related traits	Obesity
rs9557704	A	T	45	40	9	70	23	1	0.69	0.87	0.31	0.13	A	0.04	0.044779802	Waist-to-hip circumference ratio interaction	General health
rs12780845	A	G	49	34	11	20	53	21	0.70	0.49	0.30	0.51	A	0.0529	0.044768212	Homocysteine levels	Misc
rs1487441	G	A	30	50	14	57	33	4	0.59	0.78	0.41	0.22	A	0.026	0.044763431	Educational attainment	Mental aptitude and behavioural traits
rs13090836	T	C	46	39	9	22	48	24	0.70	0.49	0.30	0.51	T	3.58	0.044579267	Heart rate	General health
rs181362	C	T	49	33	12	25	42	27	0.70	0.49	0.30	0.51	T	0.46	0.044579267	HDL cholesterol	General health
rs5754217	G	T	49	33	12	25	42	27	0.70	0.49	0.30	0.51	G	0.194	0.044579267	Red blood cell traits	Immune diseases and disorders
rs1677894	C	T	3	30	61	0	10	84	0.19	0.05	0.81	0.95	G	1.44	0.044532279	Diabetic kidney disease	Diabetes
rs11785622	C	T	61	30	3	84	10	0	0.81	0.95	0.19	0.05	T	7.21	0.044532279	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs12791447	A	G	63	26	5	84	10	0	0.81	0.95	0.19	0.05	C	1.23	0.044532279	Prostate cancer	Cancer
rs56062135	C	T	64	24	6	84	10	0	0.81	0.95	0.19	0.05	C	1.07	0.044532279	Coronary artery disease	Heart health and disorders
rs10865864	A	G	59	34	1	84	10	0	0.81	0.95	0.19	0.05	G	1	0.044532279	Callous-unemotional behaviour	Brain health and disorders
rs2284746	C	G	30	42	22	50	40	4	0.54	0.74	0.46	0.26	G	0.04	0.044529419	Pulmonary function	Pulmonology
rs7120391	T	C	92	2	0	73	21	0	0.99	0.89	0.01	0.11	C	0.3	0.044463604	Red blood cell traits	Immune diseases and disorders
rs1000791	T	A	73	21	0	92	2	0	0.89	0.99	0.11	0.01	T	0.209	0.044463604	Urate levels in obese individuals	Obesity
rs60283548	C	T	94	0	0	80	12	2	1.00	0.91	0.00	0.09	C	0.1327	0.044444444	Cotinine glucuronidation	General health
rs1239954	C	T	94	0	0	79	14	1	1.00	0.91	0.00	0.09	A	0.02	0.044444444	Obesity-related traits	Obesity
rs7666831	C	T	94	0	0	78	16	0	1.00	0.91	0.00	0.09	A	0.02	0.044444444	Obesity-related traits	Obesity
rs10443215	C	T	11	36	47	26	45	23	0.31	0.52	0.69	0.48	C	9.39	0.044402277	Adverse response to chemotherapy in breast cancer alopecia docetaxel	General health
rs3894194	G	A	20	51	23	45	40	9	0.48	0.69	0.52	0.31	A	1.17	0.044402277	Asthma	Immune diseases and disorders
rs1939012	T	C	24	49	21	11	36	47	0.52	0.31	0.48	0.69	T	1.12	0.044402277	Epilepsy	Brain health and disorders
rs6565681	A	G	2	47	45	1	18	75	0.27	0.11	0.73	0.89	A	4.82	0.044377742	Moyamoya disease	Brain health and disorders
rs11759769	G	A	52	33	9	75	18	1	0.73	0.89	0.27	0.11	A	1.16	0.044377742	Migraine - clinic-based	Brain health and disorders
rs1357978	C	A	50	37	7	75	18	1	0.73	0.89	0.27	0.11	A	0.07	0.044377742	Word reading	Mental aptitude and behavioural traits
rs4670779	C	T	51	35	8	75	18	1	0.73	0.89	0.27	0.11	T	0.07	0.044377742	Bone mineral density spine	General health
rs10876432	G	A	4	34	56	15	49	30	0.22	0.42	0.78	0.58	A	0.08	0.044368822	Bone mineral density spine	General health
rs56868568	A	G	88	6	0	67	25	2	0.97	0.85	0.03	0.15	G	34.03	0.044323419	Diisocyanate-induced asthma	Pulmonology
rs17136627	C	T	88	6	0	66	27	1	0.97	0.85	0.03	0.15	A	12.6	0.044323419	Coronary arterial lesions in patients with Kawasaki disease	Heart health and disorders
rs62184315	T	C	66	27	1	89	4	1	0.85	0.97	0.15	0.03	T	1.47	0.044323419	Alcohol dependence age at onset	General health
rs12517906	C	T	65	29	0	88	6	0	0.85	0.97	0.15	0.03	G	0.16	0.044323419	Body mass index	Obesity
rs3736228	C	T	69	21	4	88	6	0	0.85	0.97	0.15	0.03	T	0.13	0.044323419	Bone mineral density	General health
rs3027234	C	T	68	23	3	88	6	0	0.85	0.97	0.15	0.03	T	0.0573	0.044323419	Telomere length	Aging
rs11049611	C	T	66	27	1	89	4	1	0.85	0.97	0.15	0.03	T	0.038	0.044323419	Height	General health
rs1986655	A	G	68	23	3	88	6	0	0.85	0.97	0.15	0.03	A	0.02	0.044323419	Bilirubin levels	General health
rs11918665	A	G	4	21	69	0	6	88	0.15	0.03	0.85	0.97	G	2.7	0.044323419	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs7355746	T	C	1	4	89	4	21	69	0.03	0.15	0.97	0.85	A	0.04	0.044323419	Obesity-related traits	Obesity
rs6898653	A	G	59	33	2	42	31	21	0.80	0.61	0.20	0.39	G	1.23	0.04429255	Allergic rhinitis	Immune diseases and disorders
rs1980946	C	G	66	27	1	38	49	7	0.85	0.66	0.15	0.34	C	0.298	0.044243723	Palmitic acid 16:0 plasma levels	General health
rs4936518	A	T	68	23	3	43	39	12	0.85	0.66	0.15	0.34	A	0.27	0.044243723	Intraocular pressure	General health
rs13110633	G	C	5	19	70	12	39	43	0.15	0.34	0.85	0.66	C	1.06	0.044243723	Schizophrenia	Brain health and disorders
rs2001945	G	C	18	51	25	9	31	54	0.46	0.26	0.54	0.74	C	0.0405	0.044240196	Triglycerides	General health
rs6107853	G	A	23	55	16	54	31	9	0.54	0.74	0.46	0.26	A	0.04	0.044240196	Body mass index	Obesity
rs13135934	G	C	29	43	22	49	41	4	0.54	0.74	0.46	0.26	C	0.03	0.044240196	Menarche age at onset	Reproductive health
rs12046278	T	C	22	46	26	47	35	12	0.48	0.69	0.52	0.31	T	0.53	0.044236978	Systolic blood pressure	Heart health and disorders
rs12541335	A	G	35	50	9	66	23	5	0.64	0.82	0.36	0.18	G	1.23	0.04410441	Hypertriglyceridemia	General health
rs7577894	T	C	29	41	24	10	40	44	0.53	0.32	0.47	0.68	T	1.41	0.044083123	Amyotrophic lateral sclerosis	Brain health and disorders
rs6499766	A	T	26	47	21	7	46	41	0.53	0.32	0.47	0.68	A	0.099	0.044083123	Thyroid hormone levels	General health
rs11126185	G	A	10	40	44	25	49	20	0.32	0.53	0.68	0.47	G	0.03	0.044083123	Obesity-related traits	Obesity
rs6576878	A	G	42	44	8	21	47	26	0.68	0.47	0.32	0.53	G	0.053	0.044083123	White blood cell types	Immune diseases and disorders
rs55716084	G	A	72	21	1	48	37	9	0.88	0.71	0.12	0.29	A	1.59	0.04405438	Bronchopulmonary dysplasia	Pulmonology
rs11169552	C	T	46	41	7	72	21	1	0.71	0.88	0.29	0.12	C	1.09	0.04405438	Colorectal cancer	Cancer
rs9810233	A	G	48	37	9	74	17	3	0.71	0.88	0.29	0.12	G	1	0.04405438	Erectile dysfunction in type 1 diabetes	Diabetes
rs9789347	G	T	42	49	3	73	19	2	0.71	0.88	0.29	0.12	A	0.03	0.04405438	Obesity-related traits	Obesity
rs2642660	G	A	3	20	71	9	41	44	0.14	0.31	0.86	0.69	C	0.05	0.044026683	Airway responsiveness in chronic obstructive pulmonary disease	Pulmonology
rs9635759	G	A	42	45	7	71	20	3	0.69	0.86	0.31	0.14	A	3	0.044026683	Menarche age at onset	Reproductive health
rs10937273	G	A	47	35	12	69	24	1	0.69	0.86	0.31	0.14	A	0.12	0.044026683	Adiponectin levels	Obesity
rs7750345	A	G	58	29	7	30	48	16	0.77	0.57	0.23	0.43	A	1.16	0.043992416	Age-related macular degeneration	Aging
rs10806425	C	A	31	46	17	53	39	2	0.57	0.77	0.43	0.23	A	1.13	0.043992416	Celiac disease	Immune diseases and disorders
rs7235528	T	C	55	35	4	32	44	18	0.77	0.57	0.23	0.43	T	0.167	0.043992416	Economic and political preferences immigration_crime	Mental aptitude and behavioural traits
rs13182402	A	G	77	16	1	52	36	6	0.90	0.74	0.10	0.26	G	2.25	0.04398827	Osteoporosis	Immune diseases and disorders
rs2358994	G	A	54	32	8	77	16	1	0.74	0.90	0.26	0.10	A	1.8688	0.04398827	Type 1 diabetes and autoimmune thyroid diseases	Diabetes
rs6707387	G	A	58	33	3	82	12	0	0.79	0.94	0.21	0.06	A	1	0.0439819	Fasting insulin interaction	General health
rs12629805	T	C	82	12	0	62	25	7	0.94	0.79	0.06	0.21	C	1	0.0439819	Subcutaneous adipose tissue	Obesity
rs3136441	T	C	60	29	5	84	8	2	0.79	0.94	0.21	0.06	C	0.78	0.0439819	HDL cholesterol	General health
rs1539809	C	T	82	12	0	58	33	3	0.94	0.79	0.06	0.21	T	0.33	0.0439819	Social communication problems	Brain health and disorders
rs12676965	T	C	59	31	4	83	10	1	0.79	0.94	0.21	0.06	T	0.062	0.0439819	Axial length	Misc
rs586446	C	T	2	35	57	2	8	84	0.21	0.06	0.79	0.94	C	0.2296	0.0439819	IgG glycosylation	Immune diseases and disorders
rs7651446	G	T	89	5	0	69	23	2	0.97	0.86	0.03	0.14	A	1.59	0.043968023	Epithelial ovarian cancer	Cancer
rs16839553	G	A	89	5	0	68	25	1	0.97	0.86	0.03	0.14	G	1.1375	0.043968023	IgG glycosylation	Immune diseases and disorders
rs13201877	A	G	69	23	2	90	3	1	0.86	0.97	0.14	0.03	G	0.028	0.043968023	Body mass index	Obesity
rs3131513	G	A	23	42	29	5	40	49	0.47	0.27	0.53	0.73	G	0.353	0.043965412	Alcohol dependence	General health
rs12053868	A	G	72	21	1	91	3	0	0.88	0.98	0.12	0.02	G	0.84	0.043956044	Longitudinal change in brain amyloid plaque burden	Brain health and disorders
rs12530	T	C	72	21	1	91	3	0	0.88	0.98	0.12	0.02	C	0.1828	0.043956044	IgG glycosylation	Immune diseases and disorders
rs17129289	T	C	91	3	0	71	23	0	0.98	0.88	0.02	0.12	G	0.02	0.043956044	Obesity-related traits	Obesity
rs11656696	C	A	37	40	17	59	32	3	0.61	0.80	0.39	0.20	A	0.19	0.043831169	Intraocular pressure	General health
rs12566985	G	A	35	44	15	58	34	2	0.61	0.80	0.39	0.20	G	0.027	0.043831169	Body mass index	Obesity
rs3134353	A	T	15	44	35	3	32	59	0.39	0.20	0.61	0.80	T	0.018	0.043831169	Body mass index	Obesity
rs7297018	A	G	1	23	70	0	4	90	0.13	0.02	0.87	0.98	A	1	0.043823909	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs17444745	G	A	69	25	0	90	4	0	0.87	0.98	0.13	0.02	A	6.4	0.043823909	QRS duration	Heart health and disorders
rs12527253	A	G	70	23	1	90	4	0	0.87	0.98	0.13	0.02	G	1	0.043823909	Response to statin therapy	General health
rs1027730	G	A	70	23	1	90	4	0	0.87	0.98	0.13	0.02	A	1	0.043823909	Attention deficit hyperactivity disorder	Brain health and disorders
rs1048497	G	A	72	19	3	90	4	0	0.87	0.98	0.13	0.02	G	1	0.043823909	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs1151200	T	C	29	43	22	7	48	39	0.54	0.33	0.46	0.67	G	0.06	0.043808865	Obesity-related traits	Obesity
rs4409675	A	T	11	40	43	32	37	25	0.33	0.54	0.67	0.46	T	0.058	0.043808865	Corneal astigmatism	General health
rs6485978	T	C	31	39	24	5	52	37	0.54	0.33	0.46	0.67	T	0.023	0.043808865	Height	General health
rs7604693	C	A	9	27	58	2	12	80	0.24	0.09	0.76	0.91	G	2.7	0.04376789	Kawasaki disease	Misc
rs271170	T	C	6	33	55	0	16	78	0.24	0.09	0.76	0.91	T	0.11	0.04376789	Bone mineral density	General health
rs11819199	A	G	78	16	0	53	37	4	0.91	0.76	0.09	0.24	G	1.62	0.04376789	Eosinophilic esophagitis	Digestive system and its disorders
rs6450922	C	G	53	37	4	78	16	0	0.76	0.91	0.24	0.09	C	1.2	0.04376789	Height	General health
rs10519201	G	T	54	35	5	79	14	1	0.76	0.91	0.24	0.09	T	1.158	0.04376789	Eating disorders	Brain health and disorders
rs1012583	G	A	57	29	8	78	16	0	0.76	0.91	0.24	0.09	G	0.1552	0.04376789	IgG glycosylation	Immune diseases and disorders
rs11914070	C	T	53	37	4	78	16	0	0.76	0.91	0.24	0.09	T	0.136	0.04376789	Gait variability	Appearance
rs3740540	G	A	56	31	7	78	16	0	0.76	0.91	0.24	0.09	A	0.03	0.04376789	Obesity-related traits	Obesity
rs502514	T	C	55	36	3	81	12	1	0.78	0.93	0.22	0.07	G	1	0.04375	Fat distribution HIV	General health
rs4982029	G	A	81	12	1	60	26	8	0.93	0.78	0.07	0.22	A	1	0.04375	Schizophrenia, bipolar disorder and depression combined	Brain health and disorders
rs9961113	T	C	50	37	7	16	67	11	0.73	0.53	0.27	0.47	C	2.473	0.0437046	Adverse response to chemotherapy neutropenia_leucopenia gemcitabine	Drug response
rs10499694	A	G	28	43	23	51	35	8	0.53	0.73	0.47	0.27	A	0.015	0.0437046	Body mass index	Obesity
rs359457	C	T	25	52	17	11	41	42	0.54	0.34	0.46	0.66	T	1.08	0.043688065	Crohn's disease	Digestive system and its disorders
rs7539624	G	A	9	45	40	23	56	15	0.34	0.54	0.66	0.46	A	1.06	0.043688065	Schizophrenia	Brain health and disorders
rs6544311	A	C	11	41	42	23	56	15	0.34	0.54	0.66	0.46	A	0.65	0.043688065	QT interval	Heart health and disorders
rs1537424	C	T	23	40	31	44	37	13	0.46	0.66	0.54	0.34	T	0.052	0.043688065	Thyroid hormone levels	General health
rs10788160	G	A	60	34	0	85	9	0	0.82	0.95	0.18	0.05	A	10.2	0.043648299	Serum prostate-specific antigen levels	General health
rs13006237	G	A	62	30	2	86	7	1	0.82	0.95	0.18	0.05	A	1	0.043648299	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs11603160	C	T	65	24	5	86	7	1	0.82	0.95	0.18	0.05	T	1	0.043648299	Body mass index in asthmatics	Obesity
rs72743477	A	G	65	24	5	85	9	0	0.82	0.95	0.18	0.05	G	1	0.043648299	Pediatric autoimmune diseases	Immune diseases and disorders
rs11231693	G	A	86	7	1	63	28	3	0.95	0.82	0.05	0.18	A	0.0684	0.043648299	Waist-to-hip ratio adjusted for body mass index	Obesity
rs4149056	T	C	63	28	3	86	7	1	0.82	0.95	0.18	0.05	T	0.029	0.043648299	Sex hormone-binding globulin levels	Reproductive health
rs2568958	G	A	5	34	55	14	53	27	0.23	0.43	0.77	0.57	A	3.77	0.043633466	Body mass index	Obesity
rs2815752	G	A	5	34	55	14	53	27	0.23	0.43	0.77	0.57	A	0.13	0.043633466	Body mass index	Obesity
rs3101336	T	C	5	34	55	14	53	27	0.23	0.43	0.77	0.57	C	0.035	0.043633466	Body mass index	Obesity
rs4788084	C	T	32	43	19	57	30	7	0.57	0.77	0.43	0.23	G	1.09	0.043633466	Type 1 diabetes	Diabetes
rs2030114	G	A	66	26	2	41	42	11	0.84	0.66	0.16	0.34	A	4.12	0.043609476	Blood pressure measurement high sodium and potassium intervention	Heart health and disorders
rs2419374	C	T	66	26	2	40	44	10	0.84	0.66	0.16	0.34	A	3.456	0.043609476	Suicide ideation score in major depressive disorder	Brain health and disorders
rs2823819	A	G	66	26	2	35	54	5	0.84	0.66	0.16	0.34	C	1.65	0.043609476	Attention deficit hyperactivity disorder	Brain health and disorders
rs4915559	T	C	45	34	15	67	24	3	0.66	0.84	0.34	0.16	T	0.339	0.043609476	End-stage coagulation	General health
rs7975752	G	A	9	46	39	4	22	68	0.34	0.16	0.66	0.84	G	1.76	0.043609476	Diabetic kidney disease	Diabetes
rs2412475	G	A	40	44	10	16	53	25	0.66	0.45	0.34	0.55	A	0.03	0.043577916	Obesity-related traits	Obesity
rs7617219	A	G	15	39	40	4	26	64	0.37	0.18	0.63	0.82	A	1	0.043564849	Subcutaneous adipose tissue	Obesity
rs7895244	T	A	64	26	4	37	45	12	0.82	0.63	0.18	0.37	T	0.2836	0.043564849	IgG glycosylation	Immune diseases and disorders
rs1299548	G	A	31	42	21	16	33	45	0.55	0.35	0.45	0.65	A	1	0.043478261	Visceral adipose tissue adjusted for BMI	Obesity
rs1994318	C	A	27	44	23	47	42	5	0.52	0.72	0.48	0.28	A	6.79	0.043457325	PR interval	Heart health and disorders
rs2235682	G	A	49	38	7	75	17	2	0.72	0.89	0.28	0.11	A	1.28	0.04344681	Airway responsiveness in chronic obstructive pulmonary disease	Pulmonology
rs2293579	G	A	54	28	12	73	21	0	0.72	0.89	0.28	0.11	A	0.0093	0.04344681	Serum albumin level	General health
rs6733011	A	G	13	49	32	3	33	58	0.40	0.21	0.60	0.79	G	1.17	0.04339092	Bipolar disorder	Brain health and disorders
rs1012068	T	G	37	48	9	17	49	28	0.65	0.44	0.35	0.56	G	1.75	0.04338896	Chronic hepatitis C infection	Immune diseases and disorders
rs1046089	G	A	42	38	14	17	49	28	0.65	0.44	0.35	0.56	G	1.3	0.04338896	Schizophrenia	Brain health and disorders
rs4384209	A	G	12	42	40	30	45	19	0.35	0.56	0.65	0.44	G	0.126	0.04338896	Economic and political preferences feminism_equality	Mental aptitude and behavioural traits
rs2302777	A	G	41	46	7	67	27	0	0.68	0.86	0.32	0.14	A	1.31	0.043312254	Multiple myeloma hyperdiploidy	Cancer
rs1183201	A	T	11	38	45	2	23	69	0.32	0.14	0.68	0.86	A	0.06	0.043312254	Uric acid levels	General health
rs10742752	T	C	9	42	43	4	19	71	0.32	0.14	0.68	0.86	C	0.014	0.043312254	Body mass index	Obesity
rs7170668	T	C	32	42	20	13	41	40	0.56	0.36	0.44	0.64	T	0.035	0.043309889	Motion sickness	Misc
rs2857595	G	A	56	31	7	29	48	17	0.76	0.56	0.24	0.44	G	0.037	0.043291275	Pulmonary function	Pulmonology
rs10889677	C	A	43	46	5	72	20	2	0.70	0.87	0.30	0.13	A	1.29	0.043243243	Ulcerative colitis	Immune diseases and disorders
rs11685299	C	A	46	40	8	71	22	1	0.70	0.87	0.30	0.13	C	1.0649627	0.043243243	Schizophrenia	Brain health and disorders
rs12401738	G	A	46	40	8	71	22	1	0.70	0.87	0.30	0.13	A	0.026	0.043243243	Body mass index	Obesity
rs10993994	T	C	18	45	31	38	44	12	0.43	0.64	0.57	0.36	T	1.32	0.043240938	Prostate cancer early onset	Cancer
rs644435	A	G	29	49	16	10	48	36	0.57	0.36	0.43	0.64	G	0.03	0.043240938	Obesity-related traits	Obesity
rs10859567	T	G	24	49	21	47	41	6	0.52	0.72	0.48	0.28	T	0.035	0.04322318	Height	General health
rs11773845	C	A	14	52	28	37	45	12	0.43	0.63	0.57	0.37	C	3.21	0.043182012	PR interval	Heart health and disorders
rs3807989	A	G	14	52	28	37	45	12	0.43	0.63	0.57	0.37	G	1.11	0.043182012	Atrial fibrillation	Heart health and disorders
rs1354492	T	C	17	46	31	41	37	16	0.43	0.63	0.57	0.37	A	0.16	0.043182012	vWF and FVIII levels	Heart health and disorders
rs668459	C	T	13	53	28	36	46	12	0.42	0.63	0.58	0.37	T	0.139	0.043133029	Mean corpuscular hemoglobin	Heart health and disorders
rs17585887	T	C	13	53	28	36	46	12	0.42	0.63	0.58	0.37	T	0.039	0.043133029	Triglycerides	General health
rs1393902	A	G	32	46	16	11	49	34	0.59	0.38	0.41	0.62	G	1	0.043093923	Hearing function	General health
rs975739	G	T	15	42	37	30	51	13	0.38	0.59	0.62	0.41	G	0.08	0.043064639	Hair color	Appearance
rs1005224	T	A	14	49	31	34	48	12	0.41	0.62	0.59	0.38	T	1.2048	0.043064639	Large artery stroke	Heart health and disorders
rs9479482	T	C	33	52	9	62	29	3	0.63	0.81	0.37	0.19	A	1.65	0.043050431	Alopecia areata	Immune diseases and disorders
rs974417	C	T	62	29	3	37	44	13	0.81	0.63	0.19	0.37	C	0.0049	0.043050431	Body mass index	Obesity
rs2865531	T	A	17	41	36	35	44	15	0.40	0.61	0.60	0.39	T	0.031	0.043035396	Pulmonary function	Pulmonology
rs8001641	G	A	41	41	12	66	25	3	0.65	0.84	0.35	0.16	A	1.354	0.043005952	Orofacial clefts	Misc
rs1426063	A	G	64	29	1	40	43	11	0.84	0.65	0.16	0.35	A	1.18	0.043005952	QT interval	Heart health and disorders
rs17639207	T	C	40	43	11	65	27	2	0.65	0.84	0.35	0.16	T	1	0.043005952	Sexual dimorphism in anthropometric traits	Misc
rs11712655	T	G	43	37	14	67	23	4	0.65	0.84	0.35	0.16	T	1	0.043005952	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs7207400	T	C	46	42	6	24	48	22	0.71	0.51	0.29	0.49	T	1.1363636	0.043001787	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs170020	G	A	20	52	22	5	44	45	0.49	0.29	0.51	0.71	C	2.96	0.043001787	Interstitial lung disease	Pulmonology
rs4786816	A	G	5	39	50	1	17	76	0.26	0.10	0.74	0.90	A	0.03	0.042971734	Obesity-related traits	Obesity
rs1701704	T	G	48	43	3	75	19	0	0.74	0.90	0.26	0.10	C	1.25	0.042971734	Type 1 diabetes	Diabetes
rs1689510	G	C	48	43	3	75	19	0	0.74	0.90	0.26	0.10	C	1	0.042971734	Pediatric autoimmune diseases	Immune diseases and disorders
rs7188801	G	A	77	15	2	54	31	9	0.90	0.74	0.10	0.26	G	0.05	0.042971734	Bone properties heel	General health
rs3817334	C	T	34	44	16	56	36	2	0.60	0.79	0.40	0.21	T	0.06	0.042970822	Body mass index	Obesity
rs340029	C	T	16	44	34	2	36	56	0.40	0.21	0.60	0.79	T	0.032	0.042970822	C-reactive protein levels	Immune diseases and disorders
rs10782529	C	T	20	43	31	5	36	53	0.44	0.24	0.56	0.76	C	1.7	0.042965195	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	General health
rs271738	G	A	23	37	34	6	34	54	0.44	0.24	0.56	0.76	A	1.32	0.042965195	Bipolar disorder	Brain health and disorders
rs6586513	C	A	1	44	49	6	71	17	0.24	0.44	0.76	0.56	C	1.24	0.042965195	Allergic rhinitis	Immune diseases and disorders
rs2120991	C	A	62	27	5	83	11	0	0.80	0.94	0.20	0.06	A	2.14	0.042936992	Biliary atresia	Digestive system and its disorders
rs12950363	G	T	83	11	0	57	37	0	0.94	0.80	0.06	0.20	T	0.9201	0.042936992	Hippocampal sclerosis	Brain health and disorders
rs17376026	C	T	62	27	5	83	11	0	0.80	0.94	0.20	0.06	T	0.121	0.042936992	Economic and political preferences immigration_crime	Mental aptitude and behavioural traits
rs17049741	G	A	59	33	2	84	9	1	0.80	0.94	0.20	0.06	A	0.05	0.042936992	Obesity-related traits	Obesity
rs10911390	C	T	86	8	0	65	26	3	0.96	0.83	0.04	0.17	T	1.13	0.042857143	Systemic lupus erythematosus	Immune diseases and disorders
rs11216126	A	C	63	30	1	86	8	0	0.83	0.96	0.17	0.04	C	0.0322	0.042857143	HDL cholesterol	General health
rs320320	A	G	49	35	10	25	45	24	0.71	0.51	0.29	0.49	A	4.03	0.042792793	Menarche age at onset	Reproductive health
rs1007738	G	A	8	39	47	22	49	23	0.29	0.49	0.71	0.51	A	0.08	0.042792793	Bone mineral density hip	General health
rs10132280	C	A	46	41	7	24	47	23	0.71	0.51	0.29	0.49	C	0.029	0.042792793	Body mass index	Obesity
rs1511589	G	A	31	42	21	52	37	5	0.55	0.75	0.45	0.25	A	0.012	0.042654619	Optic cup area	Misc
rs10941694	G	A	53	36	5	77	17	0	0.76	0.91	0.24	0.09	A	1.35	0.042649222	Chronic kidney disease and serum creatinine levels	Immune diseases and disorders
rs2235529	C	T	56	30	8	78	15	1	0.76	0.91	0.24	0.09	A	1.3	0.042649222	Endometriosis	General health
rs11650494	G	A	78	15	1	51	40	3	0.91	0.76	0.09	0.24	A	1.15	0.042649222	Prostate cancer	Cancer
rs6778436	T	A	77	17	0	54	34	6	0.91	0.76	0.09	0.24	A	1	0.042649222	Response to methylphenidate treatment in attention-deficit_hyperactivity disorder blood pressure	Drug response
rs3924426	T	C	78	15	1	53	36	5	0.91	0.76	0.09	0.24	T	1	0.042649222	Response to iloperidone treatment QT prolongation	General health
rs2011077	C	T	51	40	3	77	17	0	0.76	0.91	0.24	0.09	T	0.062	0.042649222	Sitting height ratio	Appearance
rs225717	C	T	6	34	54	1	15	78	0.24	0.09	0.76	0.91	C	1.9	0.042649222	Retinal vascular caliber	General health
rs1305088	T	C	1	15	78	8	30	56	0.09	0.24	0.91	0.76	A	0.58	0.042649222	Non-alcoholic fatty liver disease histology other	Obesity
rs9941349	C	T	44	39	11	70	20	4	0.68	0.85	0.32	0.15	T	1.48	0.04263399	Obesity extreme	Obesity
rs7116456	T	C	0	1	93	1	16	77	0.01	0.10	0.99	0.90	T	0.929	0.042606516	Systolic blood pressure alcohol consumption interaction	General health
rs55816310	G	A	93	1	0	76	18	0	0.99	0.90	0.01	0.10	A	33.91	0.042606516	Diisocyanate-induced asthma	Pulmonology
rs16861531	G	C	93	1	0	76	18	0	0.99	0.90	0.01	0.10	G	1	0.042606516	Response to anti-depressant treatment in major depressive disorder	General health
rs3135758	C	T	77	16	1	93	1	0	0.90	0.99	0.10	0.01	A	0.05774	0.042606516	Magnesium levels	General health
rs7772697	T	C	48	36	10	24	46	24	0.70	0.50	0.30	0.50	T	1.35	0.04259587	Diabetic retinopathy	Diabetes
rs732765	A	G	46	40	8	23	48	23	0.70	0.50	0.30	0.50	G	1	0.04259587	Non-small cell lung cancer	Cancer
rs6573333	T	G	0	13	81	2	36	56	0.07	0.21	0.93	0.79	A	1	0.042584263	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs6536413	C	A	57	34	3	81	13	0	0.79	0.93	0.21	0.07	A	0.075	0.042584263	Intelligence childhood	Mental aptitude and behavioural traits
rs17134585	T	C	56	36	2	82	11	1	0.79	0.93	0.21	0.07	T	0.043	0.042584263	Blood metabolite ratios	Heart health and disorders
rs1832007	A	G	56	36	2	82	11	1	0.79	0.93	0.21	0.07	G	0.033	0.042584263	Triglycerides	General health
rs7633988	T	A	16	39	39	4	28	62	0.38	0.19	0.62	0.81	T	0.86	0.042559844	QRS duration	Heart health and disorders
rs2441727	A	G	60	32	2	36	45	13	0.81	0.62	0.19	0.38	G	1.35	0.042559844	Interstitial lung disease	Pulmonology
rs8083346	T	G	56	33	5	79	15	0	0.77	0.92	0.23	0.08	G	0.0278	0.042507048	D-dimer levels	Heart health and disorders
rs9321637	T	C	72	19	3	49	33	12	0.87	0.70	0.13	0.30	C	2.17	0.042475527	Cardiac Troponin-T levels	Heart health and disorders
rs2205960	G	T	46	39	9	69	25	0	0.70	0.87	0.30	0.13	T	1.36	0.042475527	Systemic lupus erythematosus	Immune diseases and disorders
rs2398162	A	G	46	39	9	71	21	2	0.70	0.87	0.30	0.13	A	1.31	0.042475527	Hypertension	Heart health and disorders
rs1486134	G	T	12	33	49	1	23	70	0.30	0.13	0.70	0.87	G	1.14	0.042475527	Pancreatic cancer	Cancer
rs6432832	A	C	8	41	45	1	23	70	0.30	0.13	0.70	0.87	A	1.06	0.042475527	Longevity 85 years and older	Aging
rs11616188	G	A	45	41	8	69	25	0	0.70	0.87	0.30	0.13	A	1	0.042475527	Ankylosing spondylitis	Immune diseases and disorders
rs10517287	G	T	70	23	1	46	39	9	0.87	0.70	0.13	0.30	T	1	0.042475527	Response to anti-depressant treatment in major depressive disorder	General health
rs501344	G	A	45	41	8	71	21	2	0.70	0.87	0.30	0.13	A	0.03	0.042475527	LDL peak particle diameter total fat intake interaction	General health
rs546784	T	C	39	44	11	63	30	1	0.65	0.83	0.35	0.17	A	1.4	0.042431361	Acute lymphoblastic leukemia childhood	Cancer
rs13075436	C	T	40	42	12	65	26	3	0.65	0.83	0.35	0.17	C	1.3	0.042431361	Response to angiotensin II receptor blocker therapy	General health
rs2016444	C	G	65	26	3	38	46	10	0.83	0.65	0.17	0.35	G	0.292	0.042431361	Fractional exhaled nitric oxide childhood	Pulmonology
rs2530544	G	T	65	26	3	35	52	7	0.83	0.65	0.17	0.35	G	0.1982	0.042431361	IgG glycosylation	Immune diseases and disorders
rs962856	C	T	14	38	42	4	24	66	0.35	0.17	0.65	0.83	C	1.12	0.042431361	Pancreatic cancer	Cancer
rs2342371	G	A	8	50	36	4	24	66	0.35	0.17	0.65	0.83	G	1	0.042431361	Fat distribution HIV	General health
rs2330809	C	T	25	45	24	3	51	40	0.51	0.30	0.49	0.70	T	0.055	0.042410714	Blood metabolite levels	Heart health and disorders
rs2075726	G	A	27	49	18	52	36	6	0.55	0.74	0.45	0.26	G	1.14	0.042358984	Ankylosing spondylitis	Immune diseases and disorders
rs16971384	A	G	53	34	7	26	51	17	0.74	0.55	0.26	0.45	A	0.0715	0.042358984	LDL cholesterol	General health
rs6825911	C	T	14	30	50	20	56	18	0.31	0.51	0.69	0.49	C	0.6	0.042237042	Blood pressure	Heart health and disorders
rs10850409	G	A	35	40	19	56	34	4	0.59	0.78	0.41	0.22	A	1.651	0.0421875	PR segment	Heart health and disorders
rs10886471	C	T	31	48	15	57	32	5	0.59	0.78	0.41	0.22	C	1.12	0.0421875	Type 2 diabetes	Diabetes
rs11242417	T	G	66	26	2	87	7	0	0.84	0.96	0.16	0.04	C	1	0.042174918	Immune reponse to smallpox secreted IL-12p40	Immune diseases and disorders
rs13383928	T	G	87	7	0	65	28	1	0.96	0.84	0.04	0.16	C	1	0.042174918	Lung cancer asbestos exposure interaction	Cancer
rs11644988	G	A	87	7	0	64	30	0	0.96	0.84	0.04	0.16	G	0.128	0.042174918	Corneal astigmatism	General health
rs6694089	G	A	64	30	0	87	7	0	0.84	0.96	0.16	0.04	A	0.039	0.042174918	Height	General health
rs12193070	G	A	59	33	2	36	44	14	0.80	0.62	0.20	0.38	A	1.06	0.042091881	Schizophrenia	Brain health and disorders
rs10150332	T	C	59	33	2	33	50	11	0.80	0.62	0.20	0.38	C	0.13	0.042091881	Body mass index	Obesity
rs10212419	G	A	29	44	21	49	41	4	0.54	0.74	0.46	0.26	A	1	0.042077762	Ear morphology	Appearance
rs3744028	T	C	54	31	9	24	54	16	0.74	0.54	0.26	0.46	C	1	0.042077762	White matter hyperintensity burden	Brain health and disorders
rs2273017	G	A	22	47	25	43	43	8	0.48	0.69	0.52	0.31	A	1.53	0.042074592	Graves' disease	Immune diseases and disorders
rs920915	C	G	28	41	25	9	41	44	0.52	0.31	0.48	0.69	C	1.13	0.042074592	Age-related macular degeneration	Aging
rs444881	G	C	26	39	29	46	37	11	0.48	0.69	0.52	0.31	C	0.1441	0.042074592	IgG glycosylation	Immune diseases and disorders
rs190982	G	A	6	38	50	0	20	74	0.27	0.11	0.73	0.89	A	1.0753	0.042016807	Alzheimer's disease late onset	Brain health and disorders
rs537930	G	T	49	40	5	76	16	2	0.73	0.89	0.27	0.11	T	0.035	0.042016807	Height	General health
rs75968099	C	T	44	38	12	67	25	2	0.67	0.85	0.33	0.15	T	1.085	0.041989589	Schizophrenia	Brain health and disorders
rs11624776	A	C	42	42	10	66	27	1	0.67	0.85	0.33	0.15	A	0.069	0.041989589	Thyroid hormone levels	General health
rs6662617	A	G	42	42	10	67	25	2	0.67	0.85	0.33	0.15	G	0.02	0.041989589	Obesity-related traits	Obesity
rs6733301	G	A	85	8	1	62	29	3	0.95	0.81	0.05	0.19	G	7.5	0.041960389	Height	General health
rs4688011	G	A	60	33	1	84	10	0	0.81	0.95	0.19	0.05	T	1.23	0.041960389	Arthritis juvenile idiopathic	Immune diseases and disorders
rs244731	G	A	62	29	3	84	10	0	0.81	0.95	0.19	0.05	G	0.102	0.041960389	Urate levels in lean individuals	Obesity
rs10858583	C	T	2	31	61	0	10	84	0.19	0.05	0.81	0.95	C	1.84	0.041960389	Bipolar disorder and eating disorder	Brain health and disorders
rs2565065	A	G	2	31	61	0	10	84	0.19	0.05	0.81	0.95	A	1.06	0.041960389	Schizophrenia	Brain health and disorders
rs6517329	G	A	45	38	11	19	52	23	0.68	0.48	0.32	0.52	A	1.05	0.041923122	Schizophrenia	Brain health and disorders
rs10903129	A	G	26	46	22	9	42	43	0.52	0.32	0.48	0.68	G	0.06	0.041923122	Cholesterol, total	General health
rs7326068	G	A	38	45	11	65	25	4	0.64	0.82	0.36	0.18	A	1	0.041884058	Schizophrenia, bipolar disorder and depression combined	Brain health and disorders
rs6441961	T	C	14	39	41	5	23	66	0.36	0.18	0.64	0.82	A	1.21	0.041884058	Celiac disease	Immune diseases and disorders
rs7632500	A	G	56	33	5	36	37	21	0.77	0.58	0.23	0.42	C	1.37	0.041822641	Digestive system disease Barrett's esophagus and esophageal adenocarcinoma combined	Digestive system and its disorders
rs11739663	T	C	55	35	4	27	55	12	0.77	0.58	0.23	0.42	T	1.15	0.041822641	Ulcerative colitis	Immune diseases and disorders
rs10746514	G	A	33	43	18	59	27	8	0.58	0.77	0.42	0.23	A	1	0.041822641	Response to statin therapy	General health
rs6738181	G	A	55	35	4	31	47	16	0.77	0.58	0.23	0.42	A	1	0.041822641	Alzheimer's disease late onset	Brain health and disorders
rs9309473	A	G	50	38	6	27	47	20	0.73	0.54	0.27	0.46	G	1.1	0.041810463	Metabolite levels	General health
rs13178541	A	C	9	43	42	28	43	23	0.32	0.53	0.68	0.47	C	0.1833	0.041782407	IgG glycosylation	Immune diseases and disorders
rs1516971	T	C	70	22	2	48	34	12	0.86	0.69	0.14	0.31	T	1.16	0.041748206	Rheumatoid arthritis	Immune diseases and disorders
rs12676170	A	G	46	38	10	69	24	1	0.69	0.86	0.31	0.14	A	0.054	0.041748206	Corneal astigmatism	General health
rs11661542	C	A	46	42	6	72	21	1	0.71	0.88	0.29	0.12	C	1.22	0.041740868	Intracranial aneurysm	Misc
rs11889341	C	T	49	36	9	74	17	3	0.71	0.88	0.29	0.12	T	1.16	0.041740868	Rheumatoid arthritis	Immune diseases and disorders
rs4129767	G	A	20	48	26	42	42	10	0.47	0.67	0.53	0.33	G	0.4	0.041652244	HDL cholesterol	General health
rs2410601	G	C	11	40	43	23	54	17	0.33	0.53	0.67	0.47	G	0.08	0.041652244	Urinary albumin excretion rate in type 1 diabetes	Diabetes
rs2207790	G	A	38	39	17	61	28	5	0.61	0.80	0.39	0.20	A	0.5956	0.041645419	Electrocardiographic conduction measures	Heart health and disorders
rs699371	T	C	8	57	29	2	34	58	0.39	0.20	0.61	0.80	T	0.043	0.041645419	Height	General health
rs10509328	T	C	88	6	0	67	26	1	0.97	0.85	0.03	0.15	G	1.86	0.041623667	Multiple myeloma IgH translocation	Cancer
rs1223271	G	A	68	24	2	88	6	0	0.85	0.97	0.15	0.03	G	1.18	0.041623667	Parkinson's disease	Brain health and disorders
rs7136572	A	G	88	6	0	67	26	1	0.97	0.85	0.03	0.15	G	1	0.041623667	Response to anti-depressant treatment in major depressive disorder	General health
rs2071288	C	T	88	6	0	69	22	3	0.97	0.85	0.03	0.15	T	0.56	0.041623667	Advanced glycation end-product levels	General health
rs11213935	G	A	88	6	0	68	24	2	0.97	0.85	0.03	0.15	A	0.03	0.041623667	Obesity-related traits	Obesity
rs7620457	G	A	1	26	67	0	6	88	0.15	0.03	0.85	0.97	G	0.019	0.041623667	Body mass index	Obesity
rs111294930	A	G	54	33	7	77	16	1	0.75	0.90	0.25	0.10	A	1.094	0.04160277	Schizophrenia	Brain health and disorders
rs55705316	T	G	76	16	2	92	2	0	0.89	0.99	0.11	0.01	G	1	0.041602465	Pediatric autoimmune diseases	Immune diseases and disorders
rs10189050	C	A	2	16	76	0	2	92	0.11	0.01	0.89	0.99	C	0.03	0.041602465	Obesity-related traits	Obesity
rs319564	C	T	30	40	24	49	39	6	0.53	0.73	0.47	0.27	C	0.0238	0.041556628	Waist-to-hip ratio adjusted for body mass index	Obesity
rs16842994	C	G	94	0	0	79	15	0	1.00	0.92	0.00	0.08	C	1	0.041551247	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs6793245	G	A	43	39	12	16	55	23	0.66	0.46	0.34	0.54	A	1.12	0.041532444	QT interval	Heart health and disorders
rs8044769	T	C	26	49	19	14	35	45	0.54	0.34	0.46	0.66	C	1.07	0.041532444	Osteoarthritis	Immune diseases and disorders
rs4959677	G	C	20	47	27	37	51	6	0.46	0.66	0.54	0.34	C	0.83	0.041532444	Orthostatic hypotension	Heart health and disorders
rs745580	G	A	25	51	18	10	43	41	0.54	0.34	0.46	0.66	A	0.04	0.041532444	Obesity-related traits	Obesity
rs2404602	A	G	22	43	29	39	47	8	0.46	0.66	0.54	0.34	A	0.026	0.041532444	Blood metabolite levels	Heart health and disorders
rs6576132	C	A	41	43	10	16	55	23	0.66	0.46	0.34	0.54	A	0.004	0.041532444	Resting oxygen saturation in chronic osbtructive pulmonary disease pulse oxymetry	Pulmonology
rs9326244	C	T	56	32	6	27	54	13	0.77	0.57	0.23	0.43	C	0.237	0.041474654	IgG glycosylation	Immune diseases and disorders
rs16879552	C	T	83	10	1	61	28	5	0.94	0.80	0.06	0.20	G	1.68	0.041472393	Hirschsprung disease	Brain health and disorders
rs12938078	G	A	61	28	5	83	10	1	0.80	0.94	0.20	0.06	A	1.07	0.041472393	Schizophrenia	Brain health and disorders
rs430086	A	G	82	12	0	57	36	1	0.94	0.80	0.06	0.20	A	0.16	0.041472393	Percentage gas trapping	Misc
rs4402960	G	T	39	46	9	23	40	31	0.66	0.46	0.34	0.54	T	1.17	0.041422834	Type 2 diabetes	Diabetes
rs623323	T	C	3	24	67	7	49	38	0.16	0.34	0.84	0.66	T	1.28	0.041376952	Type 2 diabetes	Diabetes
rs9894429	C	T	12	39	43	2	26	66	0.34	0.16	0.66	0.84	T	0.12	0.041376952	Eye color traits	Appearance
rs2802369	C	A	43	34	17	62	30	2	0.64	0.82	0.36	0.18	C	9.37	0.04136253	Response to methotrexate in juvenile idiopathic arthritis	General health
rs12824981	C	T	37	46	11	63	28	3	0.64	0.82	0.36	0.18	T	4.56	0.04136253	Heart rate	General health
rs906628	A	C	80	12	2	56	32	6	0.91	0.77	0.09	0.23	G	4.35	0.041350211	Tooth agenesis mandibular third molar	Misc
rs74338693	C	G	78	16	0	55	34	5	0.91	0.77	0.09	0.23	G	1.0638298	0.041350211	Schizophrenia	Brain health and disorders
rs6517368	T	C	35	53	6	19	47	28	0.65	0.45	0.35	0.55	C	1.1201	0.04132326	Asthma and hay fever	Immune diseases and disorders
rs138229	A	G	26	47	21	47	42	5	0.53	0.72	0.47	0.28	G	1	0.041315829	Behavioural disinhibition generation interaction	Brain health and disorders
rs11742977	C	G	29	41	24	50	36	8	0.53	0.72	0.47	0.28	C	0.065	0.041315829	Expressive vocabulary in infants	Mental aptitude and behavioural traits
rs9267972	A	G	9	34	51	21	47	26	0.28	0.47	0.72	0.53	A	1.85	0.041315829	Lupus nephritis in systemic lupus erythematosus	Immune diseases and disorders
rs2483280	G	A	57	33	4	80	14	0	0.78	0.93	0.22	0.07	A	0.75	0.041291419	QRS duration	Heart health and disorders
rs6711016	C	A	57	33	4	80	14	0	0.78	0.93	0.22	0.07	C	0.08	0.041291419	Metabolic syndrome	Immune diseases and disorders
rs16921914	G	A	57	33	4	80	14	0	0.78	0.93	0.22	0.07	A	0.08	0.041291419	Bone mineral density spine	General health
rs4563609	G	A	6	29	59	1	12	81	0.22	0.07	0.78	0.93	A	1.2	0.041291419	Hypospadias	Misc
rs1476679	C	T	4	33	57	0	14	80	0.22	0.07	0.78	0.93	T	1.0989	0.041291419	Alzheimer's disease late onset	Brain health and disorders
rs76917448	C	T	89	5	0	68	26	0	0.97	0.86	0.03	0.14	A	3.65	0.041234222	Diisocyanate-induced asthma	Pulmonology
rs17625382	G	A	70	22	2	89	5	0	0.86	0.97	0.14	0.03	G	1.41	0.041234222	Alcohol dependence age at onset	General health
rs3821396	G	A	70	22	2	89	5	0	0.86	0.97	0.14	0.03	A	1.23	0.041234222	Bipolar disorder	Brain health and disorders
rs12586317	T	C	70	22	2	89	5	0	0.86	0.97	0.14	0.03	T	1.1904762	0.041234222	Psoriasis	Immune diseases and disorders
rs17221323	T	C	68	26	0	89	5	0	0.86	0.97	0.14	0.03	G	1	0.041234222	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs17647114	G	A	89	5	0	70	22	2	0.97	0.86	0.03	0.14	T	1	0.041234222	Response to anti-depressant treatment in major depressive disorder	General health
rs9301951	T	C	89	5	0	70	22	2	0.97	0.86	0.03	0.14	C	0.26	0.041234222	Disc degeneration lumbar	Aging
rs13962	G	A	71	20	3	89	5	0	0.86	0.97	0.14	0.03	A	0.09	0.041234222	IgE levels	Immune diseases and disorders
rs12143789	G	C	71	20	3	89	5	0	0.86	0.97	0.14	0.03	C	0.0274	0.041234222	Waist-to-hip ratio adjusted for body mass index	Obesity
rs2377360	G	A	13	40	41	28	48	18	0.35	0.55	0.65	0.45	G	1.6	0.041233581	Major depressive disorder	Brain health and disorders
rs10764775	T	C	38	46	10	18	48	28	0.65	0.45	0.35	0.55	C	0.1435	0.041233581	IgG glycosylation	Immune diseases and disorders
rs10852932	G	T	29	46	19	12	42	40	0.55	0.35	0.45	0.65	T	0.03	0.041233581	Aortic root size	Heart health and disorders
rs2638953	G	C	5	29	60	14	46	34	0.21	0.39	0.79	0.61	C	0.032	0.041219422	Height	General health
rs17760268	C	T	72	22	0	91	3	0	0.88	0.98	0.12	0.02	C	1	0.041139601	Celiac disease	Immune diseases and disorders
rs11725509	A	C	91	3	0	75	16	3	0.98	0.88	0.02	0.12	A	1	0.041139601	Subcutaneous adipose tissue	Obesity
rs3764796	T	G	73	20	1	91	3	0	0.88	0.98	0.12	0.02	G	0.06534	0.041139601	Calcium levels	General health
rs10039217	A	G	91	3	0	72	22	0	0.98	0.88	0.02	0.12	G	0.04	0.041139601	Obesity-related traits	Obesity
rs1567482	T	C	2	17	75	6	39	49	0.11	0.27	0.89	0.73	G	2.846	0.041118421	Adverse response to chemotherapy neutropenia_leucopenia 5-fluorouracil	Drug response
rs9611177	C	T	51	35	8	75	17	2	0.73	0.89	0.27	0.11	C	1.0638298	0.041118421	Schizophrenia	Brain health and disorders
rs9637454	G	A	50	37	7	75	17	2	0.73	0.89	0.27	0.11	A	0.5006	0.041118421	Hippocampal sclerosis	Brain health and disorders
rs2481665	T	C	54	29	11	74	19	1	0.73	0.89	0.27	0.11	T	0.019	0.041118421	Body mass index	Obesity
rs12134040	A	G	49	39	6	74	19	1	0.73	0.89	0.27	0.11	G	0.00955155	0.041118421	Urate levels BMI interaction	Obesity
rs4140885	G	A	48	39	7	26	46	22	0.72	0.52	0.28	0.48	A	0.217	0.041087668	Heart rate	General health
rs11649743	G	A	62	31	1	86	7	1	0.82	0.95	0.18	0.05	G	1.15	0.041060736	Prostate cancer	Cancer
rs17025426	C	T	86	7	1	65	25	4	0.95	0.82	0.05	0.18	C	1	0.041060736	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs28479400	A	G	85	9	0	62	31	1	0.95	0.82	0.05	0.18	G	0.7864	0.041060736	Neuritic plaque	Brain health and disorders
rs1747593	G	T	85	9	0	65	25	4	0.95	0.82	0.05	0.18	T	0.118	0.041060736	Sitting height ratio	Appearance
rs17404153	G	T	63	29	2	85	9	0	0.82	0.95	0.18	0.05	T	0.028	0.041060736	HDL cholesterol	General health
rs12284594	A	G	71	19	4	43	43	8	0.86	0.69	0.14	0.31	G	1.77	0.04105854	Substance dependence	General health
rs7819570	G	T	70	21	3	42	45	7	0.86	0.69	0.14	0.31	T	1.08	0.04105854	Schizophrenia	Brain health and disorders
rs1490453	G	A	69	23	2	46	37	11	0.86	0.69	0.14	0.31	A	0.25	0.04105854	Biochemical measures	General health
rs10248351	T	C	90	4	0	71	22	1	0.98	0.87	0.02	0.13	C	1.843	0.041050903	Hypothyroidism	Immune diseases and disorders
rs267738	T	G	70	24	0	90	4	0	0.87	0.98	0.13	0.02	A	1.23	0.041050903	Rhegmatogenous retinal detachment	General health
rs267734	T	C	70	24	0	90	4	0	0.87	0.98	0.13	0.02	C	0.01	0.041050903	Chronic kidney disease	Immune diseases and disorders
rs613872	G	T	1	22	71	1	2	91	0.13	0.02	0.87	0.98	G	5.47	0.041050903	Fuchs's corneal dystrophy	General health
rs383592	C	T	27	53	14	13	43	38	0.57	0.37	0.43	0.63	G	1.32	0.041022727	Leprosy	Immune diseases and disorders
rs7240777	G	A	15	39	40	38	31	25	0.37	0.57	0.63	0.43	A	0.083	0.041022727	Thyroid hormone levels	General health
rs12668848	G	A	16	48	30	37	44	13	0.43	0.63	0.57	0.37	G	1.0869565	0.040971513	Schizophrenia	Brain health and disorders
rs6136489	T	G	32	44	18	11	48	35	0.57	0.37	0.43	0.63	T	0.01	0.040971513	Mean platelet volume	Heart health and disorders
rs347272	A	G	4	16	74	9	37	48	0.13	0.29	0.87	0.71	A	1.8	0.040958104	QT interval	Heart health and disorders
rs2130604	T	G	2	20	72	7	41	46	0.13	0.29	0.87	0.71	T	0.1291	0.040958104	Bone mineral density paediatric, skull	General health
rs13307587	A	G	47	39	8	72	20	2	0.71	0.87	0.29	0.13	A	0.088	0.040958104	Reading and spelling	Brain health and disorders
rs3743832	A	C	20	39	35	34	49	11	0.42	0.62	0.58	0.38	A	1.724	0.040929705	Non-substance related behavioral disinhibition	Brain health and disorders
rs7583877	C	T	12	47	35	31	47	16	0.38	0.58	0.62	0.42	C	1.29	0.040929705	Type 1 diabetes nephropathy	Diabetes
rs2466035	T	C	32	45	17	14	43	37	0.58	0.38	0.42	0.62	C	1.21	0.040929705	Chronic lymphocytic leukemia	Cancer
rs2043085	T	C	13	45	36	31	47	16	0.38	0.58	0.62	0.42	A	0.17	0.040929705	Metabolic syndrome bivariate traits	Immune diseases and disorders
rs7759938	C	T	15	41	38	28	53	13	0.38	0.58	0.62	0.42	T	0.045	0.040929705	Height	General health
rs9940536	C	T	35	46	13	17	44	33	0.62	0.41	0.38	0.59	T	0.022	0.040897247	Educational attainment	Mental aptitude and behavioural traits
rs1809889	T	C	12	48	34	32	46	16	0.38	0.59	0.62	0.41	T	0.032	0.040897247	Height	General health
rs507506	A	G	12	48	34	31	48	15	0.38	0.59	0.62	0.41	G	0.022	0.040897247	Adiponectin levels	Obesity
rs2048656	G	A	38	39	17	15	47	32	0.61	0.41	0.39	0.59	A	1.06	0.040874094	Schizophrenia	Brain health and disorders
rs6918981	G	A	14	45	35	34	43	17	0.39	0.59	0.61	0.41	G	0.55	0.040874094	Height	General health
rs2016266	G	A	12	49	33	31	49	14	0.39	0.59	0.61	0.41	A	0.05	0.040874094	Bone mineral density	General health
rs1864982	G	T	61	31	2	38	43	13	0.81	0.63	0.19	0.37	A	1.36	0.040865385	Alcohol dependence	General health
rs17319721	G	A	31	57	6	62	29	3	0.63	0.81	0.37	0.19	A	0.01	0.040865385	Renal function and chronic kidney disease	General health
rs220519	C	T	14	41	39	6	23	65	0.37	0.19	0.63	0.81	T	1.05	0.040865385	Schizophrenia	Brain health and disorders
rs10751226	C	T	6	23	65	14	41	39	0.19	0.37	0.81	0.63	T	1	0.040865385	Pulmonary function interaction	Pulmonology
rs4795519	A	C	34	44	16	17	40	37	0.60	0.39	0.40	0.61	C	1.85	0.040860215	Chronic myeloid leukemia	Cancer
rs6750795	T	C	16	44	34	33	48	13	0.40	0.61	0.60	0.39	T	1.12	0.040860215	Height	General health
rs4953318	A	C	36	42	16	13	50	31	0.61	0.40	0.39	0.60	A	0.152	0.040860215	Red blood cell traits	Immune diseases and disorders
rs2087017	G	A	15	46	33	30	54	10	0.40	0.61	0.60	0.39	A	0.05	0.040860215	Personality dimensions	Brain health and disorders
rs1551678	C	G	16	43	35	33	47	14	0.40	0.60	0.60	0.40	C	2.65	0.040855591	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs34792	C	G	30	46	18	55	32	7	0.56	0.76	0.44	0.24	C	0.21	0.040826613	Plasma omega-6 polyunsaturated fatty acid levels linoleic acid	General health
rs11158345	T	C	30	46	18	56	30	8	0.56	0.76	0.44	0.24	T	0.084	0.040826613	Word reading	Mental aptitude and behavioural traits
rs2275565	G	T	54	34	6	29	48	17	0.76	0.56	0.24	0.44	T	0.0542	0.040826613	Homocysteine levels	Misc
rs9635324	A	G	31	44	19	53	36	5	0.56	0.76	0.44	0.24	A	0.036	0.040826613	Blood metabolite ratios	Heart health and disorders
rs174548	C	G	33	40	21	56	30	8	0.56	0.76	0.44	0.24	G	0.01	0.040826613	HDL cholesterol	General health
rs10185424	T	G	17	48	29	2	42	50	0.44	0.24	0.56	0.76	A	1.0748146	0.040826613	Crohn's disease	Digestive system and its disorders
rs3825942	G	A	59	30	5	35	43	16	0.79	0.60	0.21	0.40	G	20.1	0.040812927	Glaucoma exfoliation	General health
rs10830956	C	T	58	32	4	31	51	12	0.79	0.60	0.21	0.40	C	0.2	0.040812927	Metabolic syndrome bivariate traits	Immune diseases and disorders
rs648831	C	T	32	49	13	58	32	4	0.60	0.79	0.40	0.21	T	0.031	0.040812927	Height	General health
rs12454712	T	C	43	38	13	65	27	2	0.66	0.84	0.34	0.16	T	0.0347	0.040794156	Waist-to-hip ratio adjusted for body mass index	Obesity
rs11933540	T	C	49	35	10	19	58	17	0.71	0.51	0.29	0.49	C	1.15	0.040667796	Rheumatoid arthritis	Immune diseases and disorders
rs4676049	C	T	76	17	1	53	34	7	0.90	0.74	0.10	0.26	A	1.76	0.040622132	Alzheimer's disease late onset	Brain health and disorders
rs11006253	G	A	52	36	6	75	19	0	0.74	0.90	0.26	0.10	A	1.06	0.040622132	Schizophrenia	Brain health and disorders
rs4236644	A	G	5	37	52	15	53	26	0.25	0.44	0.75	0.56	A	0.02	0.040525328	Bilirubin levels	General health
rs821931	G	C	7	27	60	19	38	37	0.22	0.40	0.78	0.60	G	1.587	0.04042504	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Immune diseases and disorders
rs1539143	G	A	6	29	59	16	44	34	0.22	0.40	0.78	0.60	G	0.04	0.04042504	Obesity-related traits	Obesity
rs6893858	C	G	84	9	1	59	34	1	0.94	0.81	0.06	0.19	C	0.0143	0.040419065	Trans fatty acid levels	General health
rs11680328	T	A	2	24	68	10	40	44	0.15	0.32	0.85	0.68	T	1.0752687	0.04040404	Schizophrenia	Brain health and disorders
rs17655948	T	A	46	36	12	67	26	1	0.68	0.85	0.32	0.15	T	0.1638	0.04040404	Periodontitis DPAL	Misc
rs1005956	T	C	43	42	9	67	26	1	0.68	0.85	0.32	0.15	C	0.13	0.04040404	Sleep quality	General health
rs6942756	T	G	36	46	12	61	30	3	0.63	0.81	0.37	0.19	G	1	0.040391335	White matter hyperintensity burden	Brain health and disorders
rs6863418	T	C	8	41	45	22	50	22	0.30	0.50	0.70	0.50	A	3.623	0.040294334	Adverse response to chemotherapy neutropenia_leucopenia gemcitabine	Drug response
rs7734985	G	A	26	42	26	9	39	46	0.50	0.30	0.50	0.70	G	0.1571	0.040294334	IgG glycosylation	Immune diseases and disorders
rs7203193	A	G	23	48	23	6	45	43	0.50	0.30	0.50	0.70	A	0.08	0.040294334	LDL cholesterol	General health
rs4951011	A	G	49	38	7	74	18	2	0.72	0.88	0.28	0.12	G	1.09	0.04027206	Breast cancer	Cancer
rs12478234	G	A	72	22	0	49	38	7	0.88	0.72	0.12	0.28	A	1.09	0.04027206	Schizophrenia	Brain health and disorders
rs6907728	A	C	74	18	2	47	42	5	0.88	0.72	0.12	0.28	C	0.04	0.04027206	Obesity-related traits	Obesity
rs1978648	T	C	3	39	52	0	17	77	0.24	0.09	0.76	0.91		0.2	0.040271214	Glucose homeostasis traits	General health
rs13317787	C	A	86	8	0	67	23	4	0.96	0.84	0.04	0.16	A	21.66	0.040249563	Acute kidney injury in coronary artery bypass surgery creatinine rise	General health
rs4685500	C	T	66	25	3	87	6	1	0.84	0.96	0.16	0.04	T	1	0.040249563	Middle childhood and early adolescence aggressive behavior	Brain health and disorders
rs3736638	C	A	86	8	0	66	25	3	0.96	0.84	0.04	0.16	A	1	0.040249563	Immune reponse to smallpox secreted IL-12p40	Immune diseases and disorders
rs6598266	G	A	65	26	3	36	51	7	0.83	0.65	0.17	0.35	A	0.2543	0.040239441	Major depressive disorder	Brain health and disorders
rs393152	A	G	48	44	2	31	42	21	0.74	0.55	0.26	0.45	A	1.3	0.04023845	Parkinson's disease	Brain health and disorders
rs1994969	G	T	21	42	31	6	36	52	0.45	0.26	0.55	0.74	T	0.027	0.04023845	Primary tooth development time to first tooth eruption	Misc
rs12595668	A	G	70	23	1	44	44	6	0.87	0.70	0.13	0.30	G	6.26	0.040217619	PR interval	Heart health and disorders
rs860413	A	C	45	42	7	72	19	3	0.70	0.87	0.30	0.13	A	1.3	0.040217619	Primary biliary cirrhosis	Immune diseases and disorders
rs2201841	A	G	43	46	5	71	21	2	0.70	0.87	0.30	0.13	C	1.16	0.040217619	Ulcerative colitis	Immune diseases and disorders
rs7004633	A	G	44	42	8	21	51	22	0.69	0.49	0.31	0.51	A	1.11	0.040124271	Schizophrenia	Brain health and disorders
rs1564060	A	G	6	46	42	19	57	18	0.31	0.51	0.69	0.49	A	0.24	0.040124271	Stroke	Brain health and disorders
rs2077147	T	C	45	40	9	22	49	23	0.69	0.49	0.31	0.51	C	0.1568	0.040124271	IgG glycosylation	Immune diseases and disorders
rs2087160	G	T	14	30	50	20	55	19	0.31	0.51	0.69	0.49	G	0.124	0.040124271	Metabolic traits	Misc
rs1564892	A	G	45	40	9	23	47	24	0.69	0.49	0.31	0.51	A	0.08	0.040124271	Corneal structure	General health
rs4766646	T	A	7	25	62	1	11	82	0.21	0.07	0.79	0.93	T	0.3211	0.040123457	Metabolite levels MHPG	General health
rs2943559	A	G	82	11	1	62	25	7	0.93	0.79	0.07	0.21	G	1.13	0.040123457	Breast cancer	Cancer
rs78901727	A	G	62	25	7	81	13	0	0.79	0.93	0.21	0.07	A	1.11	0.040123457	Schizophrenia	Brain health and disorders
rs4711279	C	G	59	31	4	81	13	0	0.79	0.93	0.21	0.07	C	0.1964	0.040123457	IgG glycosylation	Immune diseases and disorders
rs746630	G	C	63	23	8	81	13	0	0.79	0.93	0.21	0.07	G	0.04	0.040123457	Obesity-related traits	Obesity
rs11995252	T	C	82	11	1	58	33	3	0.93	0.79	0.07	0.21	G	0.03	0.040123457	Obesity-related traits	Obesity
rs16849225	C	T	56	34	4	79	15	0	0.78	0.92	0.22	0.08	C	0.75	0.040092394	Blood pressure	Heart health and disorders
rs2393967	A	C	58	30	6	79	15	0	0.78	0.92	0.22	0.08	A	0.01	0.040092394	Mean platelet volume	Heart health and disorders
rs526934	G	A	5	32	57	1	13	80	0.22	0.08	0.78	0.92	A	27.62	0.040092394	Folate pathway vitamin levels	General health
rs1482853	C	A	30	43	21	53	33	8	0.55	0.74	0.45	0.26	C	43.2	0.039965462	Anthropometric traits in newborns	Misc
rs10049088	C	T	30	43	21	53	33	8	0.55	0.74	0.45	0.26	T	0.522	0.039965462	Anthropometric traits in newborns	Misc
rs900400	T	C	30	43	21	53	33	8	0.55	0.74	0.45	0.26	C	0.09	0.039965462	Birth weight	Misc
rs9303542	A	G	44	41	9	23	46	25	0.69	0.49	0.31	0.51	G	1.14	0.039964969	Epithelial ovarian cancer	Cancer
rs783147	G	A	21	50	23	46	37	11	0.49	0.69	0.51	0.31	A	0.3	0.039964969	Lp a levels	General health
rs4714261	C	T	61	29	4	37	43	14	0.80	0.62	0.20	0.38	T	0.95	0.039939193	Attention deficit hyperactivity disorder symptoms interaction	Brain health and disorders
rs2153127	T	C	36	45	13	58	35	1	0.62	0.80	0.38	0.20	T	0.08	0.039939193	Menarche age at onset	Reproductive health
rs145379083	G	A	36	45	13	60	31	3	0.62	0.80	0.38	0.20	G	0.037	0.039939193	Bulimia nervosa	Brain health and disorders
rs1330	C	T	42	43	9	67	25	2	0.68	0.85	0.32	0.15	T	0.022	0.03978244	Height	General health
rs6543610	G	C	0	1	93	1	15	78	0.01	0.09	0.99	0.91	C	1	0.039726878	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs4900022	G	A	0	1	93	1	15	78	0.01	0.09	0.99	0.91	A	0.45	0.039726878	Coronary artery calcification	Heart health and disorders
rs1513859	G	A	0	1	93	0	17	77	0.01	0.09	0.99	0.91	G	0.03	0.039726878	Obesity-related traits	Obesity
rs11838918	T	C	93	1	0	77	17	0	0.99	0.91	0.01	0.09	C	2.26	0.039726878	Conduct disorder	Brain health and disorders
rs908327	A	C	93	1	0	77	17	0	0.99	0.91	0.01	0.09	C	1	0.039726878	Immune reponse to smallpox secreted IL-2	Immune diseases and disorders
rs11899928	T	C	93	1	0	77	17	0	0.99	0.91	0.01	0.09	C	0.7169	0.039726878	IgG glycosylation	Immune diseases and disorders
rs898534	G	A	77	17	0	93	1	0	0.91	0.99	0.09	0.01	G	0.016758949	0.039726878	Urate levels BMI interaction	Obesity
rs6739392	A	T	14	38	42	4	25	65	0.35	0.18	0.65	0.82	A	0.06	0.039711191	Waist-hip ratio	General health
rs12720541	G	T	27	48	19	52	34	8	0.54	0.73	0.46	0.27	T	1.21	0.039705882	Epilepsy generalized	Brain health and disorders
rs2236176	C	T	52	34	8	31	40	23	0.73	0.54	0.27	0.46	T	0.02	0.039705882	Body mass index	Obesity
rs72662233	G	A	32	46	16	54	37	3	0.59	0.77	0.41	0.23	G	0.0761	0.039701831	Cerebral amyloid deposition in APOEe4 non-carriers PET imaging	Brain health and disorders
rs954820	G	A	5	39	50	1	18	75	0.26	0.11	0.74	0.89	C	1	0.039701648	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs4775041	G	C	52	35	7	74	20	0	0.74	0.89	0.26	0.11	C	1.38	0.039701648	HDL cholesterol	General health
rs8017455	T	C	76	16	2	49	41	4	0.89	0.74	0.11	0.26	T	1	0.039701648	Hair morphology	Appearance
rs9305556	A	G	26	46	22	8	45	41	0.52	0.32	0.48	0.68	A	1.1	0.039677709	Psoriasis	Immune diseases and disorders
rs6759808	G	A	10	42	42	24	51	19	0.33	0.53	0.67	0.47	G	0.03	0.039549328	Obesity-related traits	Obesity
rs1494508	A	G	19	51	24	47	32	15	0.47	0.67	0.53	0.33	A	0.2	0.039549328	Temperament	Mental aptitude and behavioural traits
rs9380516	T	C	0	29	65	0	7	87	0.15	0.04	0.85	0.96	T	1	0.039542484	Hepatitis C induced liver fibrosis	Immune diseases and disorders
rs77421486	C	A	66	27	1	87	7	0	0.85	0.96	0.15	0.04	C	1.1235955	0.039542484	Schizophrenia	Brain health and disorders
rs12931939	C	T	66	27	1	87	7	0	0.85	0.96	0.15	0.04	T	1	0.039542484	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs17669622	G	A	66	27	1	87	7	0	0.85	0.96	0.15	0.04	A	0.094	0.039542484	Mean arterial pressure alcohol consumption interaction	General health
rs16918253	G	T	87	7	0	65	29	0	0.96	0.85	0.04	0.15	A	0.03	0.039542484	Obesity-related traits	Obesity
rs11069062	G	A	70	22	2	44	43	7	0.86	0.70	0.14	0.30	A	0.03	0.039516427	Obesity-related traits	Obesity
rs1321311	C	A	59	32	3	34	48	12	0.80	0.62	0.20	0.38	T	6.52	0.039507861	Electrocardiographic traits	Heart health and disorders
rs7127900	A	G	4	30	60	15	42	37	0.20	0.38	0.80	0.62	A	1.4	0.039507861	Prostate cancer early onset	Cancer
rs7998202	A	G	72	21	1	46	43	5	0.88	0.72	0.12	0.28	G	0.03	0.039473684	Glycated hemoglobin levels	Diabetes
rs6469488	G	A	2	30	62	0	10	84	0.18	0.05	0.82	0.95	G	1	0.039430449	Bronchodilator response in asthma inhaled corticosteroid treatment interaction	Pulmonology
rs72975629	T	C	84	10	0	62	30	2	0.95	0.82	0.05	0.18	C	1.0869565	0.039430449	Schizophrenia	Brain health and disorders
rs72743461	C	A	65	24	5	84	10	0	0.82	0.95	0.18	0.05	C	1.07	0.039430449	Myocardial infarction	Heart health and disorders
rs35148638	A	C	61	32	1	84	10	0	0.82	0.95	0.18	0.05	C	0.088	0.039430449	Prostate cancer aggressiveness	Cancer
rs2444217	G	A	32	45	17	54	36	4	0.58	0.77	0.42	0.23	A	1	0.039365018	Body mass index	Obesity
rs3796619	A	G	19	49	26	40	44	10	0.46	0.66	0.54	0.34	T	70.7	0.039322131	Recombination rate males	Misc
rs62097986	C	A	54	34	6	78	14	2	0.76	0.90	0.24	0.10	A	30.28	0.039262821	Subcortical brain region volumes	Brain health and disorders
rs13045180	C	T	56	30	8	77	16	1	0.76	0.90	0.24	0.10	T	1.28	0.039262821	Type 1 diabetes nephropathy	Diabetes
rs5757949	T	C	50	42	2	76	18	0	0.76	0.90	0.24	0.10	T	1	0.039262821	Height	General health
rs891684	G	A	77	16	1	53	36	5	0.90	0.76	0.10	0.24	A	0.093	0.039262821	Serum selenium levels	General health
rs10174949	G	A	56	30	8	76	18	0	0.76	0.90	0.24	0.10	A	0.0703	0.039262821	Self-reported allergy	General health
rs1625579	G	T	0	18	76	2	42	50	0.10	0.24	0.90	0.76	T	1.12	0.039262821	Schizophrenia	Brain health and disorders
rs10465746	T	G	21	58	15	51	34	9	0.53	0.72	0.47	0.28	A	0.03	0.039225182	Obesity-related traits	Obesity
rs2838923	A	G	25	52	17	9	47	38	0.54	0.35	0.46	0.65	A	1	0.039222989	Hippocampal atrophy	Brain health and disorders
rs2499604	C	T	28	46	20	11	43	40	0.54	0.35	0.46	0.65	A	0.39	0.039222989	Non-alcoholic fatty liver disease histology AST	Obesity
rs7122488	T	C	12	41	41	25	52	17	0.35	0.54	0.65	0.46	T	0.2	0.039222989	Attention function in attention deficit hyperactive disorder	Brain health and disorders
rs2822687	C	T	60	34	0	33	55	6	0.82	0.64	0.18	0.36	T	4.964	0.039207921	Very long-chain saturated fatty acid levels fatty acid 20:0	General health
rs2798269	C	T	38	45	11	63	28	3	0.64	0.82	0.36	0.18	T	1.382	0.039207921	PR segment	Heart health and disorders
rs12050412	T	G	43	40	11	66	26	2	0.67	0.84	0.33	0.16	T	0.077	0.039191672	Word reading	Mental aptitude and behavioural traits
rs3826538	T	C	2	26	66	4	54	36	0.16	0.33	0.84	0.67	T	0.35	0.039191672	Airway imaging phenotypes	Pulmonology
rs10929956	C	T	19	47	28	37	48	9	0.45	0.65	0.55	0.35	C	1.85	0.039133293	Crohn's disease-related phenotypes	Digestive system and its disorders
rs7410943	A	G	22	41	31	42	38	14	0.45	0.65	0.55	0.35	A	0.301	0.039133293	End-stage coagulation	General health
rs138597	G	A	17	51	26	39	44	11	0.45	0.65	0.55	0.35	G	0.123	0.039133293	Economic and political preferences time	Mental aptitude and behavioural traits
rs3858526	A	C	59	31	4	36	43	15	0.79	0.61	0.21	0.39	C	1	0.03909632	DNA methylation variation	Misc
rs6046393	T	C	61	27	6	31	53	10	0.79	0.61	0.21	0.39	T	0.2954	0.03909632	Verbal declarative memory	Brain health and disorders
rs6448317	C	T	59	31	4	33	49	12	0.79	0.61	0.21	0.39	T	0.0583	0.03909632	Heschl's gyrus morphology	Brain health and disorders
rs7741741	T	A	29	46	19	10	47	37	0.55	0.36	0.45	0.64	T	1.24	0.039052917	Height	General health
rs826838	C	T	12	43	39	26	52	16	0.36	0.55	0.64	0.45	C	0.234	0.039052917	Heart rate	General health
rs1601935	G	T	13	41	40	27	50	17	0.36	0.55	0.64	0.45	G	0.059	0.039052917	Cholesterol, total	General health
rs6946969	G	A	14	52	28	4	37	53	0.43	0.24	0.57	0.76	G	0.033	0.039043825	Motion sickness	Misc
rs6917824	A	G	55	33	6	27	54	13	0.76	0.57	0.24	0.43	G	1.3	0.039043825	Schizophrenia	Brain health and disorders
rs12311304	T	C	52	39	3	29	50	15	0.76	0.57	0.24	0.43	G	1	0.039043825	Behavioural disinhibition generation interaction	Brain health and disorders
rs241436	A	G	34	40	20	56	31	7	0.57	0.76	0.43	0.24	G	0.089	0.039043825	Urate levels in lean individuals	Obesity
rs2084898	G	A	60	31	3	82	12	0	0.80	0.94	0.20	0.06	A	3.04	0.039006428	Stroke pediatric	Brain health and disorders
rs17746001	C	T	59	33	2	82	12	0	0.80	0.94	0.20	0.06	T	1.75	0.039006428	Bipolar disorder and schizophrenia	Brain health and disorders
rs2727270	C	T	60	31	3	84	8	2	0.80	0.94	0.20	0.06	T	0.69	0.039006428	Plasma omega-6 polyunsaturated fatty acid levels linoleic acid	General health
rs12098564	A	G	82	12	0	60	31	3	0.94	0.80	0.06	0.20	A	0.435	0.039006428	Stearic acid 18:0 plasma levels	General health
rs2727271	A	T	60	31	3	84	8	2	0.80	0.94	0.20	0.06	A	0.055	0.039006428	Blood metabolite levels	Heart health and disorders
rs2296342	G	A	11	46	37	30	45	19	0.36	0.56	0.64	0.44	A	1.05	0.038981748	Schizophrenia	Brain health and disorders
rs1893592	A	C	56	33	5	80	12	2	0.77	0.91	0.23	0.09	A	1.11	0.038977704	Rheumatoid arthritis	Immune diseases and disorders
rs13196614	G	T	70	21	3	88	6	0	0.86	0.97	0.14	0.03	T	1.08	0.038961039	Migraine	Brain health and disorders
rs11777747	C	T	70	21	3	88	6	0	0.86	0.97	0.14	0.03	T	0.68	0.038961039	Coronary artery calcification	Heart health and disorders
rs8050907	G	A	88	6	0	67	27	0	0.97	0.86	0.03	0.14	A	0.03	0.038961039	Obesity-related traits	Obesity
rs268073	C	G	3	21	70	0	6	88	0.14	0.03	0.86	0.97	C	0.027	0.038961039	Body mass index	Obesity
rs6819013	A	G	37	45	12	19	44	31	0.63	0.44	0.37	0.56	A	6.06	0.038919687	QT interval	Heart health and disorders
rs7120820	C	T	14	54	26	33	53	8	0.44	0.63	0.56	0.37	T	0.004	0.038919687	Fibrinogen levels smoking status, alcohol consumption or body mass index interaction	General health
rs16971465	C	G	80	14	0	56	36	2	0.93	0.79	0.07	0.21	C	1.08	0.038877387	Schizophrenia	Brain health and disorders
rs4931594	A	C	62	24	8	80	14	0	0.79	0.93	0.21	0.07	C	0.03	0.038877387	Obesity-related traits	Obesity
rs4973768	C	T	17	47	30	37	44	13	0.43	0.63	0.57	0.37	T	1.16	0.03886665	Breast cancer	Cancer
rs4380874	T	C	8	42	44	1	25	68	0.31	0.14	0.69	0.86	T	1.137	0.038851829	Ulcerative colitis	Immune diseases and disorders
rs13149971	T	C	67	27	0	45	40	9	0.86	0.69	0.14	0.31	T	0.0021	0.038851829	Trans fatty acid levels	General health
rs1394866	G	A	67	27	0	46	38	10	0.86	0.69	0.14	0.31	A	0.002	0.038851829	Trans fatty acid levels	General health
rs1728785	A	C	7	36	51	2	17	75	0.27	0.11	0.73	0.89	G	1.17	0.038836296	Ulcerative colitis	Immune diseases and disorders
rs7594321	T	C	2	46	46	1	19	74	0.27	0.11	0.73	0.89	T	0.015	0.038836296	Pulmonary function interaction	Pulmonology
rs10871777	A	G	75	17	2	48	42	4	0.89	0.73	0.11	0.27	G	1.1	0.038836296	Obesity	Obesity
rs962888	G	A	49	36	9	26	46	22	0.71	0.52	0.29	0.48	G	1	0.038793103	White matter hyperintensity burden	Brain health and disorders
rs2764209	T	A	46	42	6	19	60	15	0.71	0.52	0.29	0.48	T	0.044	0.038793103	HDL cholesterol	General health
rs7617877	A	G	9	36	49	19	52	23	0.29	0.48	0.71	0.52	A	1.23	0.038793103	Parkinson's disease	Brain health and disorders
rs79014439	T	C	92	2	0	76	17	1	0.99	0.90	0.01	0.10	G	34.08	0.038765929	Diisocyanate-induced asthma	Pulmonology
rs17299841	A	C	76	17	1	92	2	0	0.90	0.99	0.10	0.01	C	1	0.038765929	Immune response to smallpox vaccine IL-6	Immune diseases and disorders
rs2163287	G	A	92	2	0	75	19	0	0.99	0.90	0.01	0.10	A	1	0.038765929	Response to anti-depressant treatment in major depressive disorder	General health
rs17362588	G	A	77	15	2	92	2	0	0.90	0.99	0.10	0.01	A	0.736	0.038765929	Heart rate	General health
rs11726248	G	A	75	19	0	92	2	0	0.90	0.99	0.10	0.01	A	0.123	0.038765929	Thyroid hormone levels	General health
rs7004587	G	A	92	2	0	75	19	0	0.99	0.90	0.01	0.10	A	0.02	0.038765929	Obesity-related traits	Obesity
rs1512268	T	C	16	46	32	34	47	13	0.41	0.61	0.59	0.39	T	1.35	0.038761007	Prostate cancer	Cancer
rs4923705	G	A	11	51	32	29	52	13	0.39	0.59	0.61	0.41	C	1.51	0.038761007	Attention deficit hyperactivity disorder	Brain health and disorders
rs4416442	T	C	32	46	16	18	37	39	0.59	0.39	0.41	0.61	C	1.28	0.038761007	Chronic obstructive pulmonary disease moderate to severe	Immune diseases and disorders
rs4811340	G	C	31	48	15	13	47	34	0.59	0.39	0.41	0.61	G	1.13	0.038761007	Thyroid peroxidase antibody positivity	Immune diseases and disorders
rs61712019	C	T	29	49	16	54	34	6	0.57	0.76	0.43	0.24	T	1.06	0.038737628	Schizophrenia	Brain health and disorders
rs2412971	G	A	20	41	33	5	36	53	0.43	0.24	0.57	0.76	G	1.35	0.038737628	IgA nephropathy	Immune diseases and disorders
rs225190	C	T	19	43	32	1	44	49	0.43	0.24	0.57	0.76	G	1.26	0.038737628	Pancreatic cancer	Cancer
rs12677663	G	T	20	41	33	5	36	53	0.43	0.24	0.57	0.76	T	1.15	0.038737628	Crohn's disease	Digestive system and its disorders
rs5763767	G	A	20	41	33	5	36	53	0.43	0.24	0.57	0.76	A	1.0924478	0.038737628	Crohn's disease	Digestive system and its disorders
rs2412970	A	G	20	41	33	5	36	53	0.43	0.24	0.57	0.76	G	0.024	0.038737628	Optic disc area	Misc
rs7748270	C	T	12	51	31	31	50	13	0.40	0.60	0.60	0.40	T	2.01	0.038734686	Rheumatoid arthritis	Immune diseases and disorders
rs9386485	C	T	35	42	17	14	47	33	0.60	0.40	0.40	0.60	T	1.821	0.038734686	Adverse response to chemotherapy neutropenia_leucopenia paclitaxel	Drug response
rs1633360	C	T	16	43	35	33	46	15	0.40	0.60	0.60	0.40	T	1.08	0.038734686	Rheumatoid arthritis	Immune diseases and disorders
rs590856	G	A	12	51	31	33	46	15	0.40	0.60	0.60	0.40	G	0.313	0.038734686	Red blood cell traits	Immune diseases and disorders
rs711245	G	A	33	46	15	16	43	35	0.60	0.40	0.40	0.60	A	0.024	0.038734686	Height	General health
rs2039964	G	A	63	27	4	34	52	8	0.81	0.64	0.19	0.36	A	0.2877	0.038728262	Metabolite levels MHPG	General health
rs9393366	G	A	50	34	10	72	20	2	0.71	0.87	0.29	0.13	A	1.27	0.03871967	Tourette syndrome	Brain health and disorders
rs10995439	G	A	51	32	11	73	18	3	0.71	0.87	0.29	0.13	G	0.1635	0.03871967	IgG glycosylation	Immune diseases and disorders
rs7902708	G	C	71	22	1	48	38	8	0.87	0.71	0.13	0.29	G	0.09	0.03871967	Bone properties heel	General health
rs10952362	T	C	57	34	3	31	52	11	0.79	0.61	0.21	0.39	C	1.42	0.038703629	Diabetic kidney disease	Diabetes
rs7323893	T	C	94	0	0	80	14	0	1.00	0.93	0.00	0.07	T	0.136	0.038674033	HDL cholesterol	General health
rs2973662	A	G	0	0	94	1	12	81	0.00	0.07	1.00	0.93	A	1	0.038674033	Immune response to smallpox vaccine IL-6	Immune diseases and disorders
rs10058728	A	T	9	45	40	2	27	65	0.34	0.16	0.66	0.84	T	2.04	0.038629848	Esophageal cancer	Cancer
rs1858800	C	T	46	33	15	63	31	0	0.66	0.84	0.34	0.16	T	1.36	0.038629848	Hypospadias	Misc
rs9922619	G	T	42	41	11	67	23	4	0.66	0.84	0.34	0.16	T	1	0.038629848	Subcutaneous adipose tissue	Obesity
rs523516	A	T	66	25	3	38	49	7	0.84	0.66	0.16	0.34	T	0.1916	0.038629848	IgG glycosylation	Immune diseases and disorders
rs396045	G	A	43	39	12	65	27	2	0.66	0.84	0.34	0.16	A	0.03	0.038629848	Obesity-related traits	Obesity
rs73208120	T	G	71	21	2	89	5	0	0.87	0.97	0.13	0.03	G	1.16	0.038535645	Colorectal cancer	Cancer
rs4273100	T	C	69	25	0	89	5	0	0.87	0.97	0.13	0.03	T	1.1	0.038535645	Schizophrenia	Brain health and disorders
rs1346220	A	G	85	9	0	62	32	0	0.95	0.83	0.05	0.17	G	15.45	0.038514743	Diisocyanate-induced asthma	Pulmonology
rs5763662	C	T	65	26	3	85	9	0	0.83	0.95	0.17	0.05	T	0.077	0.038514743	LDL cholesterol	General health
rs798489	C	T	66	24	4	85	9	0	0.83	0.95	0.17	0.05	T	0.048	0.038514743	Height	General health
rs390966	C	G	51	39	4	21	64	9	0.75	0.56	0.25	0.44	G	2.17	0.038445846	Erythema nodosum in inflammatory bowel disease	Digestive system and its disorders
rs2420903	G	A	29	48	17	52	37	5	0.56	0.75	0.44	0.25	A	0.4386	0.038445846	HIV-1 viral setpoint	Immune diseases and disorders
rs735951	G	A	48	36	10	18	60	16	0.70	0.51	0.30	0.49	A	1.15	0.038406828	QT interval	Heart health and disorders
rs6494964	G	A	50	32	12	23	50	21	0.70	0.51	0.30	0.49	G	0.1846	0.038406828	IgG glycosylation	Immune diseases and disorders
rs16841200	A	G	91	3	0	75	17	2	0.98	0.89	0.02	0.11	G	34.08	0.038352273	Diisocyanate-induced asthma	Pulmonology
rs12248541	A	G	92	1	1	73	21	0	0.98	0.89	0.02	0.11	G	34.08	0.038352273	Diisocyanate-induced asthma	Pulmonology
rs17666963	C	T	73	21	0	91	3	0	0.89	0.98	0.11	0.02	T	2.28	0.038352273	Cardiac Troponin-T levels	Heart health and disorders
rs78606339	T	A	91	3	0	73	21	0	0.98	0.89	0.02	0.11	T	0.4614	0.038352273	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs7301016	A	G	74	19	1	91	3	0	0.89	0.98	0.11	0.02	G	0.1687	0.038352273	IgG glycosylation	Immune diseases and disorders
rs6830062	T	C	60	27	7	34	45	15	0.78	0.60	0.22	0.40	T	6.3	0.038328912	Height	General health
rs402219	A	G	37	39	18	60	27	7	0.60	0.78	0.40	0.22	G	0.19	0.038328912	Monocyte early outgrowth colony forming units	Immune diseases and disorders
rs1380294	C	T	61	25	8	34	45	15	0.78	0.60	0.22	0.40	T	0.108	0.038328912	Infant length	Misc
rs59374417	A	C	75	19	0	52	37	5	0.90	0.75	0.10	0.25	C	1.34	0.038318671	Vitiligo	Immune diseases and disorders
rs2069762	A	C	52	37	5	78	13	3	0.75	0.90	0.25	0.10	A	1.12	0.038318671	Type 1 diabetes autoantibodies	Diabetes
rs17737465	A	G	53	35	6	75	19	0	0.75	0.90	0.25	0.10	G	0.14	0.038318671	Sleep duration	General health
rs12596210	T	C	52	37	5	76	17	1	0.75	0.90	0.25	0.10	C	0.12	0.038318671	Sex hormone-binding globulin levels	Reproductive health
rs55714927	C	T	53	35	6	75	19	0	0.75	0.90	0.25	0.10	C	0.057	0.038318671	Cholesterol, total	General health
rs7112383	C	T	90	4	0	71	23	0	0.98	0.88	0.02	0.12	A	34.08	0.038310517	Diisocyanate-induced asthma	Pulmonology
rs75608493	C	G	73	19	2	90	4	0	0.88	0.98	0.12	0.02	C	1.09	0.038310517	Schizophrenia	Brain health and disorders
rs60945108	C	T	90	4	0	71	23	0	0.98	0.88	0.02	0.12	A	0.03	0.038310517	Obesity-related traits	Obesity
rs1198575	T	C	2	19	73	0	4	90	0.12	0.02	0.88	0.98	T	0.026	0.038310517	Educational attainment	Mental aptitude and behavioural traits
rs10128264	T	C	17	35	42	3	30	61	0.37	0.19	0.63	0.81	C	1.18	0.038270954	Response to methotrexate in juvenile idiopathic arthritis	General health
rs7305618	C	T	62	28	4	36	47	11	0.81	0.63	0.19	0.37	T	0.267	0.038270954	C-reactive protein	Immune diseases and disorders
rs34894639	C	T	63	26	5	38	43	13	0.81	0.63	0.19	0.37	C	0.042	0.038270954	Triglycerides	General health
rs556493	A	G	21	51	22	6	45	43	0.49	0.30	0.51	0.70	A	1.3514	0.038230088	Bronchopulmonary dysplasia	Pulmonology
rs13168506	A	G	24	45	25	8	41	45	0.49	0.30	0.51	0.70	A	1.33	0.038230088	Stroke	Brain health and disorders
rs7677751	C	T	67	26	1	44	41	9	0.85	0.69	0.15	0.31	T	1.26	0.038221374	Corneal astigmatism	General health
rs8017377	G	A	45	39	10	67	26	1	0.69	0.85	0.31	0.15	T	1.17	0.038221374	LDL cholesterol	General health
rs2650000	A	C	11	37	46	2	24	68	0.31	0.15	0.69	0.85	A	0.4	0.038221374	Metabolic traits	Misc
rs10999409	T	C	25	55	14	55	30	9	0.56	0.74	0.44	0.26	T	1.3	0.038167939	Obesity extreme	Obesity
rs3788567	G	T	41	42	11	64	28	2	0.66	0.83	0.34	0.17	T	1.08	0.038095238	Schizophrenia	Brain health and disorders
rs6893807	A	G	64	28	2	43	38	13	0.83	0.66	0.17	0.34	G	0.024	0.038095238	Body mass index	Obesity
rs2858884	A	C	74	18	2	50	37	7	0.88	0.73	0.12	0.27	A	1.79	0.03802161	Narcolepsy	Brain health and disorders
rs17066096	A	G	48	41	5	73	20	1	0.73	0.88	0.27	0.12	G	1.14	0.03802161	Multiple sclerosis	Brain health and disorders
rs2256609	A	G	52	33	9	75	16	3	0.73	0.88	0.27	0.12	G	1.1082332	0.03802161	Crohn's disease	Digestive system and its disorders
rs2266959	G	T	52	33	9	75	16	3	0.73	0.88	0.27	0.12	T	1.105	0.03802161	Inflammatory bowel disease	Immune diseases and disorders
rs12153160	A	C	52	33	9	75	16	3	0.73	0.88	0.27	0.12	A	1	0.03802161	Middle childhood and early adolescence aggressive behavior	Brain health and disorders
rs5754344	A	G	52	33	9	75	16	3	0.73	0.88	0.27	0.12	A	0.045	0.03802161	HDL cholesterol	General health
rs12140439	C	A	49	35	10	70	23	1	0.71	0.87	0.29	0.13	C	1.3	0.038006757	Schizophrenia	Brain health and disorders
rs11775199	A	G	33	46	15	55	36	3	0.60	0.78	0.40	0.22	A	0.11	0.037971357	Metabolite levels Dihydroxy docosatrienoic acid	General health
rs16948098	G	A	84	9	1	64	25	5	0.94	0.81	0.06	0.19	A	0.0229	0.037944664	Serum albumin level	General health
rs1596370	G	A	64	25	5	84	9	1	0.81	0.94	0.19	0.06	A	0.021	0.037944664	Toenail selenium levels	Misc
rs8056893	C	A	4	36	54	1	15	78	0.23	0.09	0.77	0.91	A	0.044	0.03793911	Blood metabolite ratios	Heart health and disorders
rs2140930	A	G	19	46	29	8	33	53	0.45	0.26	0.55	0.74	G	0.1678	0.0379034	IgG glycosylation	Immune diseases and disorders
rs6065945	C	G	16	52	26	7	35	52	0.45	0.26	0.55	0.74	C	0.141	0.0379034	IgG glycosylation	Immune diseases and disorders
rs2236164	T	C	53	33	8	28	48	18	0.74	0.55	0.26	0.45	T	0.053	0.0379034	Height	General health
rs4718428	T	G	31	42	21	54	31	9	0.55	0.74	0.45	0.26	T	0.05	0.0379034	Corneal structure	General health
rs1439620	A	G	5	39	50	16	52	26	0.26	0.45	0.74	0.55	A	0.016	0.0379034	Body mass index	Obesity
rs4766428	C	T	42	34	18	60	31	3	0.63	0.80	0.37	0.20	T	1.07	0.037834833	Schizophrenia	Brain health and disorders
rs921231	T	C	62	27	5	40	38	16	0.80	0.63	0.20	0.37	G	1	0.037834833	Fat distribution HIV	General health
rs246185	T	C	61	29	4	29	60	5	0.80	0.63	0.20	0.37	C	0.72	0.037834833	QT interval	Heart health and disorders
rs13272623	T	G	61	29	4	35	48	11	0.80	0.63	0.20	0.37	G	0.218	0.037834833	IgG glycosylation	Immune diseases and disorders
rs4243849	A	G	37	44	13	61	29	4	0.63	0.80	0.37	0.20	G	0.14	0.037834833	Non-alcoholic fatty liver disease histology other	Obesity
rs2011013	A	T	60	31	3	39	40	15	0.80	0.63	0.20	0.37	A	0.051	0.037834833	Sitting height ratio	Appearance
rs1867082	A	G	29	38	27	5	50	39	0.51	0.32	0.49	0.68	A	2.82	0.037762238	QRS duration	Heart health and disorders
rs4869931	A	G	45	38	11	21	50	23	0.68	0.49	0.32	0.51	A	1.21	0.037762238	Systolic blood pressure in sickle cell anemia	Heart health and disorders
rs12316703	A	G	42	44	8	18	56	20	0.68	0.49	0.32	0.51	G	0.6574	0.037762238	Hippocampal sclerosis	Brain health and disorders
rs423674	G	T	80	13	1	54	39	1	0.92	0.78	0.08	0.22	A	1.1317871	0.037723214	Crohn's disease	Digestive system and its disorders
rs529866	C	T	80	13	1	54	39	1	0.92	0.78	0.08	0.22	C	1.124	0.037723214	Inflammatory bowel disease	Immune diseases and disorders
rs12044963	G	T	59	29	6	79	15	0	0.78	0.92	0.22	0.08	A	1	0.037723214	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs42039	C	T	58	31	5	79	15	0	0.78	0.92	0.22	0.08	T	0.068	0.037723214	Height	General health
rs10511378	T	C	80	13	1	57	33	4	0.92	0.78	0.08	0.22	G	0.04	0.037723214	Obesity-related traits	Obesity
rs1191551	T	G	7	27	60	0	15	79	0.22	0.08	0.78	0.92	T	1.07	0.037723214	Schizophrenia	Brain health and disorders
rs11107116	G	T	62	26	6	82	11	1	0.80	0.93	0.20	0.07	T	0.052	0.037707391	Height	General health
rs6265	C	T	65	28	1	86	8	0	0.84	0.96	0.16	0.04	G	4.58	0.037682965	Body mass index	Obesity
rs10179686	C	T	86	8	0	67	24	3	0.96	0.84	0.04	0.16	T	1.69	0.037682965	Large artery stroke	Heart health and disorders
rs1902813	G	C	65	28	1	86	8	0	0.84	0.96	0.16	0.04	C	1	0.037682965	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs12926725	C	T	65	28	1	86	8	0	0.84	0.96	0.16	0.04	T	1	0.037682965	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs12596252	G	A	65	28	1	86	8	0	0.84	0.96	0.16	0.04	A	1	0.037682965	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs9403856	C	T	65	28	1	86	8	0	0.84	0.96	0.16	0.04	C	0.3492	0.037682965	IgG glycosylation	Immune diseases and disorders
rs6909229	C	G	2	26	66	0	8	86	0.16	0.04	0.84	0.96	C	0.27	0.037682965	Lipoprotein a levels	Heart health and disorders
rs11884776	C	T	50	38	6	28	47	19	0.73	0.55	0.27	0.45	C	0.35	0.03765176	Urinary metabolites H-NMR features	General health
rs10865035	A	G	29	53	12	56	33	5	0.59	0.77	0.41	0.23	A	1.12	0.037630208	Rheumatoid arthritis	Immune diseases and disorders
rs1722636	C	T	58	29	7	34	43	17	0.77	0.59	0.23	0.41	T	1	0.037630208	Subcutaneous adipose tissue	Obesity
rs10519980	C	T	65	29	0	45	38	11	0.85	0.68	0.15	0.32	C	1.16	0.037622832	Hypothyroidism	Immune diseases and disorders
rs3936060	C	G	68	23	3	41	46	7	0.85	0.68	0.15	0.32	C	0.049	0.037622832	Body mass index	Obesity
rs10934753	G	A	40	43	11	64	27	3	0.65	0.82	0.35	0.18	A	0.193	0.037586258	Plasma homocysteine levels post-methionine load test	Heart health and disorders
rs7464572	C	G	43	37	14	62	31	1	0.65	0.82	0.35	0.18	C	0.007	0.037586258	Fibrinogen	General health
rs736408	C	T	22	54	18	10	42	42	0.52	0.33	0.48	0.67	C	1.1	0.0375	Bipolar disorder	Brain health and disorders
rs2806561	A	G	22	54	18	12	38	44	0.52	0.33	0.48	0.67	A	0.027	0.0375	Height	General health
rs7112365	C	T	75	18	1	53	34	7	0.89	0.74	0.11	0.26	A	0.03	0.037433155	Obesity-related traits	Obesity
rs11616416	G	A	36	45	13	59	32	3	0.62	0.80	0.38	0.20	A	1.06	0.037418823	Schizophrenia	Brain health and disorders
rs3096490	G	A	22	42	30	6	39	49	0.46	0.27	0.54	0.73	G	0.317	0.037412577	Body mass index	Obesity
rs11071033	T	C	29	44	21	51	35	8	0.54	0.73	0.46	0.27	T	4.49	0.037412577	Menarche age at onset	Reproductive health
rs224278	C	T	29	44	21	53	31	10	0.54	0.73	0.46	0.27	C	1.66	0.037412577	Ewing sarcoma	Cancer
rs34311235	C	T	28	46	20	47	43	4	0.54	0.73	0.46	0.27	T	0.032	0.037412577	Motion sickness	Misc
rs2820292	A	C	28	46	20	51	35	8	0.54	0.73	0.46	0.27	C	0.023	0.037412577	Body mass index	Obesity
rs2686586	T	C	43	39	12	21	47	26	0.66	0.47	0.34	0.53	T	18.93	0.037383178	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs654723	C	A	21	47	26	41	43	10	0.47	0.66	0.53	0.34	A	0.025	0.037383178	Height	General health
rs492400	C	T	14	35	45	28	43	23	0.34	0.53	0.66	0.47	C	0.024	0.037383178	Body mass index	Obesity
rs2721173	C	T	31	27	36	40	45	9	0.47	0.66	0.53	0.34	T	0.02	0.037383178	Educational attainment	Mental aptitude and behavioural traits
rs7896691	C	T	1	24	69	8	40	46	0.14	0.30	0.86	0.70	C	0.17	0.037332006	Disc degeneration lumbar	Aging
rs8396	T	C	69	24	1	45	42	7	0.86	0.70	0.14	0.30	T	5.6	0.037332006	Metabolite levels	General health
rs4557101	T	C	46	40	8	70	22	2	0.70	0.86	0.30	0.14	C	1.72	0.037332006	QT interval	Heart health and disorders
rs2276035	G	A	71	20	3	48	36	10	0.86	0.70	0.14	0.30	A	1.18	0.037332006	Glaucoma primary open-angle	General health
rs11217878	G	A	71	20	3	48	36	10	0.86	0.70	0.14	0.30	A	0.24	0.037332006	Intraocular pressure	General health
rs11823264	G	A	71	20	3	47	38	9	0.86	0.70	0.14	0.30	A	0.24	0.037332006	Intraocular pressure	General health
rs10892575	C	G	71	20	3	46	40	8	0.86	0.70	0.14	0.30	C	0.24	0.037332006	Intraocular pressure	General health
rs6911965	T	C	68	26	0	45	42	7	0.86	0.70	0.14	0.30	C	0.235	0.037332006	Hematological and biochemical traits	Heart health and disorders
rs10492972	T	C	34	42	18	56	32	6	0.59	0.77	0.41	0.23	C	1.34	0.037304763	Multiple sclerosis	Brain health and disorders
rs1330225	T	C	42	40	12	19	50	25	0.66	0.47	0.34	0.53	C	5.48	0.037275656	Blood pressure measurement low sodium intervention	Heart health and disorders
rs11109072	C	A	74	17	3	43	50	1	0.88	0.72	0.12	0.28	A	1.67	0.037253599	Obesity early onset extreme	Obesity
rs4821116	C	T	51	34	9	74	17	3	0.72	0.88	0.28	0.12	G	1.2195	0.037253599	Hepatitis B	Immune diseases and disorders
rs7619427	G	A	73	19	2	52	32	10	0.88	0.72	0.12	0.28	G	1.0869565	0.037253599	Schizophrenia	Brain health and disorders
rs2280470	A	G	22	43	29	8	36	50	0.46	0.28	0.54	0.72	A	0.053	0.037185442	Infant length	Misc
rs649729	T	A	10	32	52	13	61	20	0.28	0.46	0.72	0.54	T	0.008	0.037185442	Mean platelet volume	Heart health and disorders
rs1329650	G	T	38	46	10	64	26	4	0.65	0.82	0.35	0.18	T	0.37	0.037101449	Smoking behavior	General health
rs9275595	T	C	38	46	10	61	32	1	0.65	0.82	0.35	0.18	T	0.016	0.037101449	Body mass index	Obesity
rs10874746	T	C	12	42	40	27	48	19	0.35	0.54	0.65	0.46	T	0.024	0.037087912	Height	General health
rs2844036	A	C	39	49	6	64	30	0	0.68	0.84	0.32	0.16	A	0.11	0.037054174	Percentage gas trapping	Misc
rs7227401	T	G	8	45	41	2	26	66	0.32	0.16	0.68	0.84	T	0.17	0.037054174	Osteoporosis-related phenotypes	Immune diseases and disorders
rs1843834	A	G	18	36	40	5	29	60	0.38	0.21	0.62	0.79	A	2.14	0.037021928	IgE levels in asthmatics D.p. specific	Immune diseases and disorders
rs11760485	C	T	38	40	16	60	29	5	0.62	0.79	0.38	0.21	T	1	0.037021928	Early childhood aggressive behavior	Mental aptitude and behavioural traits
rs6556301	G	T	31	54	9	60	29	5	0.62	0.79	0.38	0.21	T	0.0286	0.037021928	Waist-to-hip ratio adjusted for body mass index	Obesity
rs6428370	A	G	39	43	12	17	51	26	0.64	0.45	0.36	0.55	G	1.43	0.037007424	Acute lymphoblastic leukemia childhood	Cancer
rs670292	C	G	26	57	11	52	39	3	0.58	0.76	0.42	0.24	C	0.13	0.036994368	Anger	General health
rs6942458	A	G	53	37	4	28	53	13	0.76	0.58	0.24	0.42	G	0.05	0.036994368	Obesity-related traits	Obesity
rs1390096	G	A	59	25	10	77	16	1	0.76	0.90	0.24	0.10	A	1.44	0.03696942	Nonalcoholic fatty liver disease	Obesity
rs688034	C	T	54	35	5	76	18	0	0.76	0.90	0.24	0.10	T	1.11	0.03696942	Coronary heart disease	Heart health and disorders
rs236114	T	C	9	27	58	0	18	76	0.24	0.10	0.76	0.90	A	0.5	0.03696942	Menopause age at onset	Reproductive health
rs16826005	A	G	87	7	0	68	24	2	0.96	0.85	0.04	0.15	G	3.52	0.036950147	Hypersomnia HLA-DQB1*06:02 negative	Misc
rs496300	C	T	4	25	65	0	10	84	0.18	0.05	0.82	0.95	G	0.03	0.036943921	Metabolic syndrome	Immune diseases and disorders
rs13096657	C	T	84	10	0	63	29	2	0.95	0.82	0.05	0.18	C	0.3713	0.036943921	Postprandial triglyceride response to high fat diet meal	General health
rs13077017	C	T	65	25	4	84	10	0	0.82	0.95	0.18	0.05	C	0.073	0.036943921	Eating disorders purging via substances	Brain health and disorders
rs4298948	C	G	84	10	0	64	27	3	0.95	0.82	0.05	0.18	G	0.04	0.036943921	Obesity-related traits	Obesity
rs7219669	G	T	19	46	29	38	44	12	0.45	0.64	0.55	0.36	T	1.7	0.036935705	Cardiac repolarization	Heart health and disorders
rs1478693	T	G	39	41	14	14	55	25	0.63	0.44	0.37	0.56	G	8.82	0.036872653	Sleep time	General health
rs61463699	T	A	15	53	26	34	51	9	0.44	0.63	0.56	0.37	A	0.077	0.036872653	Sitting height ratio	Appearance
rs6764050	G	A	0	1	93	2	12	80	0.01	0.09	0.99	0.91	G	1	0.036867115	Response to citalopram treatment	General health
rs4470583	A	G	0	1	93	0	16	78	0.01	0.09	0.99	0.91	A	1	0.036867115	Diabetic retinopathy	Diabetes
rs9906595	T	C	1	14	79	0	1	93	0.09	0.01	0.91	0.99	A	0.03	0.036867115	Obesity-related traits	Obesity
rs17431357	C	T	79	14	1	93	1	0	0.91	0.99	0.09	0.01	C	34	0.036867115	Insulin resistance_response	Drug response
rs79079833	T	C	93	1	0	78	16	0	0.99	0.91	0.01	0.09	G	0.03	0.036867115	Obesity-related traits	Obesity
rs7088969	T	C	12	46	36	30	46	18	0.37	0.56	0.63	0.44	T	1	0.036818182	Homeostasis model assessment of beta-cell function interaction	Misc
rs9275698	A	G	48	38	8	23	53	18	0.71	0.53	0.29	0.47	T	1.18	0.036765809	Asthma	Immune diseases and disorders
rs2576037	C	T	15	50	29	32	52	10	0.43	0.62	0.57	0.38	T	0.41	0.036734694	Personality dimensions	Brain health and disorders
rs427943	A	C	31	46	17	16	40	38	0.57	0.38	0.43	0.62	C	0.025	0.036734694	Body mass index	Obesity
rs13278849	G	A	18	44	32	43	30	21	0.43	0.62	0.57	0.38	A	0.013	0.036734694	Blood metabolite levels	Heart health and disorders
rs2764980	A	G	15	49	30	33	49	12	0.42	0.61	0.58	0.39	A	1	0.036705562	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs679830	T	C	0	27	67	2	53	39	0.14	0.30	0.86	0.70	A	0.03	0.036692759	Obesity-related traits	Obesity
rs1585440	G	T	43	45	6	68	25	1	0.70	0.86	0.30	0.14	C	1.3	0.036692759	Pancreatic cancer	Cancer
rs9714717	G	A	67	27	0	46	39	9	0.86	0.70	0.14	0.30	A	0.0021	0.036692759	Trans fatty acid levels	General health
rs7672520	T	G	67	27	0	46	39	9	0.86	0.70	0.14	0.30	T	0.002	0.036692759	Trans fatty acid levels	General health
rs10034852	C	T	67	27	0	46	39	9	0.86	0.70	0.14	0.30	T	0.002	0.036692759	Trans fatty acid levels	General health
rs9992966	C	T	67	27	0	46	39	9	0.86	0.70	0.14	0.30	T	0.002	0.036692759	Trans fatty acid levels	General health
rs10012750	A	G	67	27	0	46	39	9	0.86	0.70	0.14	0.30	A	0.002	0.036692759	Trans fatty acid levels	General health
rs7694110	A	G	67	27	0	46	39	9	0.86	0.70	0.14	0.30	A	0.002	0.036692759	Trans fatty acid levels	General health
rs10034736	C	T	67	27	0	46	39	9	0.86	0.70	0.14	0.30	T	0.002	0.036692759	Trans fatty acid levels	General health
rs9303277	C	T	33	48	13	14	50	30	0.61	0.41	0.39	0.59	T	1.44	0.036684783	Primary biliary cirrhosis	Immune diseases and disorders
rs9276370	G	T	18	38	38	32	46	16	0.39	0.59	0.61	0.41	T	1.95	0.036684783	Chronic hepatitis B infection	Immune diseases and disorders
rs2981579	A	G	14	46	34	30	50	14	0.39	0.59	0.61	0.41	T	1.17	0.036684783	Breast cancer	Cancer
rs1665050	A	G	14	47	33	35	41	18	0.40	0.59	0.60	0.41	A	1.25	0.036672326	Atopic dermatitis	Immune diseases and disorders
rs2063714	C	G	30	51	13	17	41	36	0.59	0.40	0.41	0.60	G	0.052	0.036672326	Sitting height ratio	Appearance
rs647316	A	G	7	28	59	0	16	78	0.22	0.09	0.78	0.91	A	0.01	0.036651486	Mean platelet volume	Heart health and disorders
rs10830963	C	G	57	32	5	80	12	2	0.78	0.91	0.22	0.09	G	1.38	0.036651486	Fasting plasma glucose	General health
rs76049629	T	G	56	34	4	78	16	0	0.78	0.91	0.22	0.09	G	1.0869565	0.036651486	Schizophrenia	Brain health and disorders
rs2555603	A	C	58	30	6	78	16	0	0.78	0.91	0.22	0.09	C	1	0.036651486	Body mass index in asthmatics	Obesity
rs17407594	G	A	57	32	5	79	14	1	0.78	0.91	0.22	0.09	A	0.157	0.036651486	Fasting plasma glucose childhood	General health
rs16844839	C	T	56	34	4	78	16	0	0.78	0.91	0.22	0.09	T	0.1212	0.036651486	Amino acid levels	Misc
rs2562519	C	T	4	32	58	16	41	37	0.21	0.39	0.79	0.61	A	1	0.036643225	Nevirapine-induced rash	General health
rs1011397	C	T	4	32	58	15	43	36	0.21	0.39	0.79	0.61	G	0.04	0.036643225	Obesity-related traits	Obesity
rs9364220	G	A	34	47	13	56	36	2	0.61	0.79	0.39	0.21	A	1	0.036643225	Attention deficit hyperactivity disorder combined symptoms	Brain health and disorders
rs1039302	C	T	57	34	3	39	37	18	0.79	0.61	0.21	0.39	T	0.21	0.036643225	Quantitative traits	Misc
rs11118346	C	T	36	43	15	61	26	7	0.61	0.79	0.39	0.21	T	0.025	0.036643225	Height	General health
rs9319321	A	T	12	43	39	2	31	61	0.36	0.19	0.64	0.81	T	5.2	0.036639473	Asthma toluene diisocyanate-induced	Immune diseases and disorders
rs1979679	T	C	42	37	15	63	27	4	0.64	0.81	0.36	0.19	T	1.3	0.036639473	Ossification of the posterior longitudinal ligament of the spine	Misc
rs2567426	A	G	13	41	40	5	25	64	0.36	0.19	0.64	0.81	A	0.13	0.036639473	Information processing speed	Mental aptitude and behavioural traits
rs2538958	C	T	8	33	53	3	15	76	0.26	0.11	0.74	0.89	C	0.1388	0.036601307	IgG glycosylation	Immune diseases and disorders
rs2814982	C	T	73	21	0	51	37	6	0.89	0.74	0.11	0.26	T	1.86	0.036601307	Cholesterol, total	General health
rs10513137	G	A	73	21	0	55	29	10	0.89	0.74	0.11	0.26	A	0.49	0.036601307	Height	General health
rs7783529	C	T	53	33	8	74	19	1	0.74	0.89	0.26	0.11	C	0.107	0.036601307	Urate levels in obese individuals	Obesity
rs17483466	A	G	60	32	2	82	12	0	0.81	0.94	0.19	0.06	G	1.39	0.036585366	Chronic lymphocytic leukemia	Cancer
rs71508903	C	T	60	32	2	82	12	0	0.81	0.94	0.19	0.06	T	1.18	0.036585366	Rheumatoid arthritis	Immune diseases and disorders
rs17674580	C	T	63	26	5	83	10	1	0.81	0.94	0.19	0.06	T	1.17	0.036585366	Bladder cancer	Cancer
rs7142881	G	A	26	46	22	46	41	7	0.52	0.71	0.48	0.29	A	1	0.036572623	Response to iloperidone treatment QT prolongation	General health
rs11123170	C	G	25	48	21	47	39	8	0.52	0.71	0.48	0.29	G	0.0051	0.036572623	Renal function-related traits BUN	General health
rs12659144	T	C	72	20	2	49	37	8	0.87	0.72	0.13	0.28	G	1.67	0.036528689	Multiple myeloma hyperdiploidy	Cancer
rs9554197	C	T	41	44	9	63	31	0	0.67	0.84	0.33	0.16	T	1.14	0.036513545	Pancreatic cancer	Cancer
rs2401171	T	G	7	48	39	3	25	66	0.33	0.16	0.67	0.84	T	0.052	0.036513545	Height	General health
rs729761	T	G	3	33	58	0	14	80	0.21	0.07	0.79	0.93	T	0.047	0.036509142	Urate levels	General health
rs28727938	C	G	80	14	0	60	29	5	0.93	0.79	0.07	0.21	C	1.43	0.036509142	Basal cell carcinoma	Cancer
rs1218282	T	C	80	14	0	61	27	6	0.93	0.79	0.07	0.21	C	1	0.036509142	Response to statin therapy	General health
rs17556750	C	A	60	29	5	81	12	1	0.79	0.93	0.21	0.07	A	0.046	0.036509142	Height	General health
rs13393800	G	A	61	27	6	80	14	0	0.79	0.93	0.21	0.07	A	0.027	0.036509142	Height	General health
rs7122937	C	T	43	46	5	23	51	20	0.70	0.52	0.30	0.48	T	1.93	0.036390102	QT interval	Heart health and disorders
rs2836754	T	C	24	49	21	49	34	11	0.52	0.70	0.48	0.30	C	0.019	0.036390102	Body mass index	Obesity
rs7097577	G	T	0	6	88	4	18	72	0.03	0.14	0.97	0.86	C	0.04	0.036337209	Obesity-related traits	Obesity
rs80221072	G	A	88	6	0	68	26	0	0.97	0.86	0.03	0.14	A	15.23	0.036337209	Diisocyanate-induced asthma	Pulmonology
rs11617058	T	G	68	26	0	88	6	0	0.86	0.97	0.14	0.03	T	1.07	0.036337209	Schizophrenia	Brain health and disorders
rs61747867	G	T	72	18	4	88	6	0	0.86	0.97	0.14	0.03	T	1.07	0.036337209	Schizophrenia	Brain health and disorders
rs8123073	A	G	88	6	0	72	18	4	0.97	0.86	0.03	0.14	A	1	0.036337209	Attention deficit hyperactivity disorder combined symptoms	Brain health and disorders
rs7270085	G	A	88	6	0	72	18	4	0.97	0.86	0.03	0.14	A	1	0.036337209	Attention deficit hyperactivity disorder combined symptoms	Brain health and disorders
rs1567865	C	T	70	22	2	89	4	1	0.86	0.97	0.14	0.03	T	0.063	0.036337209	Infant length	Misc
rs1967017	T	C	23	50	21	42	47	5	0.51	0.70	0.49	0.30	T	3.33	0.036217958	Urate levels	General health
rs12914385	C	T	39	42	13	64	24	6	0.64	0.81	0.36	0.19	T	1.28	0.036199095	Chronic obstructive pulmonary disease moderate to severe	Immune diseases and disorders
rs8005161	C	T	61	30	3	42	36	16	0.81	0.64	0.19	0.36	T	1.23	0.036199095	Crohn's disease	Digestive system and its disorders
rs13408379	G	A	62	28	4	35	50	9	0.81	0.64	0.19	0.36	G	0.059	0.036199095	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs2149085	T	C	19	44	31	4	40	50	0.44	0.26	0.56	0.74	T	1.34	0.036147592	Crohn's disease	Digestive system and its disorders
rs7726839	A	G	50	40	4	24	58	12	0.74	0.56	0.26	0.44	G	0.03	0.036147592	Obesity-related traits	Obesity
rs7544736	A	G	68	24	2	44	42	8	0.85	0.69	0.15	0.31	G	1.25	0.036086608	Schizophrenia	Brain health and disorders
rs12232497	T	C	42	46	6	70	20	4	0.69	0.85	0.31	0.15	C	1	0.036086608	Pediatric autoimmune diseases	Immune diseases and disorders
rs1532624	C	A	46	38	10	66	28	0	0.69	0.85	0.31	0.15	C	0.21	0.036086608	HDL cholesterol	General health
rs11891	G	A	75	19	0	54	34	6	0.90	0.76	0.10	0.24	T	0.0322	0.03606233	Magnesium levels	General health
rs11612228	C	T	55	32	7	75	19	0	0.76	0.90	0.24	0.10	T	0.02	0.03606233	Height	General health
rs4886707	C	T	46	38	10	23	49	22	0.69	0.51	0.31	0.49	T	0.06	0.036055923	Height	General health
rs3114018	A	C	23	49	22	45	40	9	0.51	0.69	0.49	0.31	T	0.029	0.036055923	Serum uric acid levels	General health
rs3788556	T	C	26	41	27	6	46	42	0.49	0.31	0.51	0.69	C	0.1799	0.036055923	IgG glycosylation	Immune diseases and disorders
rs74976893	C	T	85	9	0	67	23	4	0.95	0.84	0.05	0.16	T	4.18	0.036011905	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs6893207	G	A	85	9	0	64	29	1	0.95	0.84	0.05	0.16	G	2.88	0.036011905	Attention function in attention deficit hyperactive disorder	Brain health and disorders
rs10491334	C	T	67	23	4	85	9	0	0.84	0.95	0.16	0.05	C	1.82	0.036011905	Longevity	Aging
rs11041530	G	C	85	9	0	63	31	0	0.95	0.84	0.05	0.16	C	1.35	0.036011905	Blood pressure	Heart health and disorders
rs17639215	G	A	66	25	3	85	9	0	0.84	0.95	0.16	0.05	A	0.15	0.036011905	Serum protein levels sST2	General health
rs470093	T	G	4	23	67	0	9	85	0.16	0.05	0.84	0.95	T	1.63	0.036011905	Staphylococcus aureus infection	Immune diseases and disorders
rs972283	A	G	11	41	42	3	26	65	0.34	0.17	0.66	0.83	G	1.07	0.035999251	Type 2 diabetes	Diabetes
rs1736135	T	C	42	41	11	64	28	2	0.66	0.83	0.34	0.17	T	1.18	0.035999251	Crohn's disease	Digestive system and its disorders
rs10769945	C	T	42	41	11	67	22	5	0.66	0.83	0.34	0.17	T	1	0.035999251	DNA methylation variation	Misc
rs1458095	C	T	66	24	4	44	37	13	0.83	0.66	0.17	0.34	G	0.19	0.035999251	Body mass index	Obesity
rs1955873	A	G	0	2	92	0	18	76	0.01	0.10	0.99	0.90	A	0.5923	0.035955056	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs7921536	A	G	92	2	0	76	18	0	0.99	0.90	0.01	0.10	G	34.03	0.035955056	Diisocyanate-induced asthma	Pulmonology
rs79946301	C	T	92	2	0	76	18	0	0.99	0.90	0.01	0.10	A	7.81	0.035955056	Diisocyanate-induced asthma	Pulmonology
rs17331151	C	T	77	16	1	92	2	0	0.90	0.99	0.10	0.01	A	1	0.035955056	Immune reponse to smallpox secreted IL-2	Immune diseases and disorders
rs13088281	C	A	78	14	2	92	2	0	0.90	0.99	0.10	0.01	A	1	0.035955056	Immune reponse to smallpox secreted IL-2	Immune diseases and disorders
rs10508503	C	T	78	14	2	92	2	0	0.90	0.99	0.10	0.01	C	1	0.035955056	Obesity	Obesity
rs6733051	C	T	92	2	0	77	16	1	0.99	0.90	0.01	0.10	A	0.04	0.035955056	Obesity-related traits	Obesity
rs12134600	C	A	77	16	1	92	2	0	0.90	0.99	0.10	0.01	A	0.038	0.035955056	Educational attainment	Mental aptitude and behavioural traits
rs1061147	A	C	4	34	56	16	43	35	0.22	0.40	0.78	0.60	A	1.4	0.035937036	Age-related macular degeneration	Aging
rs12261843	T	G	46	37	11	21	52	21	0.69	0.50	0.31	0.50	G	1.07	0.035903749	Ulcerative colitis	Immune diseases and disorders
rs2823743	T	C	43	43	8	23	48	23	0.69	0.50	0.31	0.50	C	1	0.035903749	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs4961252	A	G	22	50	22	3	53	38	0.50	0.31	0.50	0.69	G	0.23	0.035903749	Response to interferon beta therapy	General health
rs4596632	G	A	13	33	48	23	48	23	0.31	0.50	0.69	0.50	C	0.167	0.035903749	Eye color	Appearance
rs2295359	G	A	31	43	20	50	39	5	0.56	0.74	0.44	0.26	A	1.15	0.035891704	Psoriasis	Immune diseases and disorders
rs1051424	A	G	72	20	2	89	5	0	0.87	0.97	0.13	0.03	G	0.03	0.035873994	Obesity-related traits	Obesity
rs6911490	T	C	1	22	71	0	5	89	0.13	0.03	0.87	0.97	T	1.08	0.035873994	Ulcerative colitis	Immune diseases and disorders
rs7511006	T	C	52	30	12	70	23	1	0.71	0.87	0.29	0.13	G	0.04	0.035843669	Obesity-related traits	Obesity
rs2675163	C	T	9	36	49	1	23	70	0.29	0.13	0.71	0.87	C	0.68	0.035843669	Response to Vitamin E supplementation	General health
rs1663189	T	C	7	36	51	0	22	72	0.27	0.12	0.73	0.88	T	1.79	0.035818713	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs12436436	T	C	72	22	0	49	40	5	0.88	0.73	0.12	0.27	C	1.3	0.035818713	Bipolar disorder	Brain health and disorders
rs16832011	A	G	94	0	0	81	13	0	1.00	0.93	0.00	0.07	A	0.02	0.035812672	Phospholipid levels plasma	General health
rs13156607	T	C	4	29	61	14	41	39	0.20	0.37	0.80	0.63	T	3.91	0.035779175	Waist circumference	General health
rs9913911	A	G	38	43	13	60	31	3	0.63	0.80	0.37	0.20	G	0.179	0.035779175	Intraocular pressure	General health
rs6137473	G	A	28	39	27	9	42	43	0.51	0.32	0.49	0.68	G	1.3	0.035761203	Adolescent idiopathic scoliosis	Obesity
rs4271390	T	C	13	34	47	22	51	21	0.32	0.51	0.68	0.49	T	1.2	0.035761203	Tourette's syndrome or obsessive-compulsive disorder	Brain health and disorders
rs887304	T	C	5	33	56	1	15	78	0.23	0.09	0.77	0.91	A	0.36	0.035654008	Non-alcoholic fatty liver disease histology lobular	Obesity
rs17418283	T	C	58	29	7	79	13	2	0.77	0.91	0.23	0.09	C	1.21	0.035654008	Bipolar disorder	Brain health and disorders
rs11602337	C	T	55	35	4	77	17	0	0.77	0.91	0.23	0.09	T	0.2943	0.035654008	Vascular brain injury	Brain health and disorders
rs10770612	A	G	54	37	3	77	17	0	0.77	0.91	0.23	0.09	G	0.03	0.035654008	Aortic root size	Heart health and disorders
rs10265216	T	A	31	42	21	53	32	9	0.55	0.73	0.45	0.27	A	1.19	0.035648205	Major depressive disorder broad	Brain health and disorders
rs4899329	C	A	19	46	29	9	32	53	0.45	0.27	0.55	0.73	C	0.142	0.035648205	IgG glycosylation	Immune diseases and disorders
rs880315	T	C	23	46	25	44	39	11	0.49	0.68	0.51	0.32	C	0.97	0.035628072	Systolic blood pressure	Heart health and disorders
rs7832552	C	T	22	48	24	43	41	10	0.49	0.68	0.51	0.32	T	0.1	0.035628072	Body mass lean	Obesity
rs2789047	C	A	18	40	36	3	37	54	0.40	0.23	0.60	0.77	A	0.053	0.035608018	Peak creatinine levels in vancomycin therapy	General health
rs17669535	C	G	73	20	1	90	4	0	0.88	0.98	0.12	0.02	C	14.5	0.035604396	Menarche age at onset	Reproductive health
rs2047076	C	T	74	18	2	90	4	0	0.88	0.98	0.12	0.02	C	2.678	0.035604396	Monocyte count	Immune diseases and disorders
rs7120173	T	G	73	20	1	91	2	1	0.88	0.98	0.12	0.02	G	1	0.035604396	Visceral adipose tissue adjusted for BMI	Obesity
rs7912580	G	A	73	20	1	90	4	0	0.88	0.98	0.12	0.02	A	1	0.035604396	Response to haloperidol in psychosis	General health
rs1834481	C	G	73	20	1	90	4	0	0.88	0.98	0.12	0.02	G	1	0.035604396	Interleukin-18 levels	Immune diseases and disorders
rs17054392	T	C	90	4	0	74	18	2	0.98	0.88	0.02	0.12	C	1	0.035604396	Response to iloperidone treatment QT prolongation	General health
rs6108038	G	A	90	4	0	73	20	1	0.98	0.88	0.02	0.12	A	0.03	0.035604396	Obesity-related traits	Obesity
rs1372791	T	C	0	4	90	2	18	74	0.02	0.12	0.98	0.88	A	1	0.035604396	Immune reponse to smallpox secreted IL-2	Immune diseases and disorders
rs276000	T	C	0	3	91	0	20	74	0.02	0.11	0.98	0.89	C	1	0.035595517	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs4731120	A	C	74	20	0	91	3	0	0.89	0.98	0.11	0.02	C	4.14	0.035595517	Platelet count	Heart health and disorders
rs2168303	A	G	91	3	0	75	18	1	0.98	0.89	0.02	0.11	A	1.9403	0.035595517	Gout	General health
rs17000918	C	A	91	3	0	74	20	0	0.98	0.89	0.02	0.11	A	1	0.035595517	Immune reponse to smallpox secreted IL-1beta	Immune diseases and disorders
rs13184316	G	A	76	16	2	91	3	0	0.89	0.98	0.11	0.02	A	0.07	0.035595517	Emphysema imaging phenotypes	Pulmonology
rs939207	C	T	75	18	1	91	3	0	0.89	0.98	0.11	0.02	A	0.03	0.035595517	Obesity-related traits	Obesity
rs11006263	A	G	91	3	0	75	18	1	0.98	0.89	0.02	0.11	G	0.03	0.035595517	Obesity-related traits	Obesity
rs73912949	T	C	83	11	0	62	30	2	0.94	0.82	0.06	0.18	G	6.97	0.035515274	Diisocyanate-induced asthma	Pulmonology
rs12194062	C	T	60	34	0	84	9	1	0.82	0.94	0.18	0.06	T	5.16	0.035515274	QRS duration	Heart health and disorders
rs11012	C	T	60	34	0	84	9	1	0.82	0.94	0.18	0.06	T	1.43	0.035515274	Parkinson's disease	Brain health and disorders
rs17043947	C	T	83	11	0	65	24	5	0.94	0.82	0.06	0.18	T	0.07	0.035515274	Self-rated health	General health
rs2272306	G	A	62	30	2	83	11	0	0.82	0.94	0.18	0.06	A	0.04	0.035515274	Obesity-related traits	Obesity
rs10540	G	A	62	30	2	83	11	0	0.82	0.94	0.18	0.06	G	0.028	0.035515274	Body mass index	Obesity
rs10065906	C	A	13	33	48	1	27	66	0.31	0.15	0.69	0.85	C	1.5298	0.035511364	Major depressive disorder	Brain health and disorders
rs780151	G	A	44	41	9	68	23	3	0.69	0.85	0.31	0.15	G	1.13	0.035511364	Height	General health
rs2307121	C	T	42	45	7	67	25	2	0.69	0.85	0.31	0.15	T	0.09	0.035511364	Corneal structure	General health
rs10199768	G	T	44	36	14	65	25	4	0.66	0.82	0.34	0.18	T	0.11	0.035509737	Cardiovascular disease risk factors	Heart health and disorders
rs7335046	G	C	5	23	66	6	52	36	0.18	0.34	0.82	0.66	G	1.26	0.035509737	Basal cell carcinoma	Cancer
rs899967	C	G	10	42	42	23	51	20	0.33	0.52	0.67	0.48	C	0.04	0.035504159	Cardiac Troponin-T levels	Heart health and disorders
rs41464348	G	A	20	45	29	7	37	50	0.45	0.27	0.55	0.73	T	0.37	0.035416667	Height	General health
rs7359257	A	C	26	51	17	48	41	5	0.55	0.73	0.45	0.27	A	1.7	0.035416667	Menarche age at onset	Reproductive health
rs1819658	C	T	51	35	8	23	57	14	0.73	0.55	0.27	0.45	C	1.19	0.035416667	Crohn's disease	Digestive system and its disorders
rs11082762	A	G	30	43	21	51	35	8	0.55	0.73	0.45	0.27	A	1.16	0.035416667	Amyotrophic lateral sclerosis	Brain health and disorders
rs10885531	C	T	33	37	24	52	33	9	0.55	0.73	0.45	0.27	T	0.02	0.035416667	Adiponectin levels	Obesity
rs1487630	C	T	79	15	0	58	32	4	0.92	0.79	0.08	0.21	T	1.33	0.035400736	Crohn's disease	Digestive system and its disorders
rs1898671	C	T	59	30	5	79	15	0	0.79	0.92	0.21	0.08	T	1.15	0.035400736	Allergic rhinitis	Immune diseases and disorders
rs6765687	C	T	59	30	5	80	13	1	0.79	0.92	0.21	0.08	T	1.07	0.035400736	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs12636148	T	C	60	28	6	79	15	0	0.79	0.92	0.21	0.08	C	1	0.035400736	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs12946454	A	T	56	36	2	80	13	1	0.79	0.92	0.21	0.08	T	0.57	0.035400736	Systolic blood pressure	Heart health and disorders
rs2032794	T	C	56	36	2	79	15	0	0.79	0.92	0.21	0.08	C	0.48	0.035400736	Personality dimensions	Brain health and disorders
rs12760731	C	T	79	15	0	56	36	2	0.92	0.79	0.08	0.21	A	0.03	0.035400736	Obesity-related traits	Obesity
rs2854207	C	G	60	30	4	36	46	12	0.80	0.63	0.20	0.37	C	0.046	0.035378662	Height	General health
rs2518049	A	G	1	35	58	1	11	82	0.20	0.07	0.80	0.93	A	0.07	0.035337423	Metabolic traits	Misc
rs11822667	G	A	81	13	0	59	33	2	0.93	0.80	0.07	0.20	A	1.6601	0.035337423	Pit-and-Fissure caries	Misc
rs8133932	C	T	57	37	0	81	13	0	0.80	0.93	0.20	0.07	C	1.0638298	0.035337423	Schizophrenia	Brain health and disorders
rs10918196	T	C	18	53	23	43	38	13	0.47	0.66	0.53	0.34	C	93.94	0.035283274	Lentiform nucleus volume	Misc
rs7219014	A	G	9	46	39	31	37	26	0.34	0.53	0.66	0.47	A	0.156	0.035283274	Urinary metabolites	General health
rs1447295	A	C	0	20	74	6	35	53	0.11	0.25	0.89	0.75	A	1.6	0.035212288	Prostate cancer	Cancer
rs6010620	A	G	5	37	52	1	18	75	0.25	0.11	0.75	0.89	G	1.56	0.035212288	Glioma high-grade	Cancer
rs334809	A	T	7	33	54	0	20	74	0.25	0.11	0.75	0.89	A	0.3286	0.035212288	Oleic acid 18:1n-9 plasma levels	General health
rs3012465	A	G	6	35	53	1	18	75	0.25	0.11	0.75	0.89	G	0.127	0.035212288	Bone mineral density paediatric, skull	General health
rs6714546	A	G	7	33	54	0	20	74	0.25	0.11	0.75	0.89	A	0.03	0.035212288	Height	General health
rs16862964	T	C	47	42	5	23	56	15	0.72	0.54	0.28	0.46	G	2.59	0.035196687	Type 2 diabetes young onset and obesity	Diabetes
rs611203	G	A	10	32	52	23	40	31	0.28	0.46	0.72	0.54	A	0.037	0.035196687	Height	General health
rs12823424	A	G	47	39	8	69	24	1	0.71	0.86	0.29	0.14	A	1.07	0.035195648	Schizophrenia	Brain health and disorders
rs600626	A	G	68	26	0	46	41	7	0.86	0.71	0.14	0.29	A	0.07	0.035195648	Plasma omega-6 polyunsaturated fatty acid levels dihomo-gamma-linolenic acid	General health
rs812481	C	G	11	33	50	0	26	68	0.29	0.14	0.71	0.86	G	1.09	0.035195648	Colorectal cancer	Cancer
rs442309	C	T	23	42	29	39	45	10	0.47	0.65	0.53	0.35	T	1.37	0.035185983	Vogt-Koyanagi-Harada syndrome	Heart health and disorders
rs7438704	A	G	10	45	39	26	48	20	0.35	0.53	0.65	0.47	A	1.0875221	0.035185983	Crohn's disease	Digestive system and its disorders
rs6837335	A	G	10	45	39	26	48	20	0.35	0.53	0.65	0.47	G	1.086	0.035185983	Crohn's disease	Digestive system and its disorders
rs9488363	A	G	29	42	23	12	41	41	0.53	0.35	0.47	0.65	G	0.147	0.035185983	Optic nerve measurement rim area	Misc
rs7777593	T	G	21	46	27	33	57	4	0.47	0.65	0.53	0.35	A	0.04	0.035185983	Obesity-related traits	Obesity
rs4823006	A	G	20	48	26	41	41	12	0.47	0.65	0.53	0.35	A	0.02	0.035185983	Waist-hip ratio	General health
rs17609940	G	C	68	23	3	86	8	0	0.85	0.96	0.15	0.04	G	1.07	0.035159053	Coronary heart disease	Heart health and disorders
rs2271293	G	A	67	25	2	86	8	0	0.85	0.96	0.15	0.04	G	0.13	0.035159053	HDL cholesterol	General health
rs12587252	C	T	86	8	0	65	29	0	0.96	0.85	0.04	0.15	T	0.0785	0.035159053	Palmitoleic acid 16:1n-7 plasma levels	General health
rs7968324	T	G	86	8	0	68	23	3	0.96	0.85	0.04	0.15	T	0.01	0.035159053	Plasma omega-6 polyunsaturated fatty acid levels gamma-linolenic acid	General health
rs438034	A	G	13	40	41	27	47	20	0.35	0.54	0.65	0.46	T	1.88	0.03509727	Response to antineoplastic agents	General health
rs4345897	A	G	26	49	19	11	44	39	0.54	0.35	0.46	0.65	A	0.34	0.03509727	Urinary metabolites H-NMR features	General health
rs11071200	C	A	73	19	2	53	31	10	0.88	0.73	0.12	0.27	T	8.241	0.035081439	Adverse response to chemotherapy neutropenia_leucopenia carboplatin	Drug response
rs2298428	C	T	52	33	9	74	17	3	0.73	0.88	0.27	0.12	A	1.13	0.035081439	Celiac disease	Immune diseases and disorders
rs10897449	C	T	50	37	7	72	21	1	0.73	0.88	0.27	0.12	T	0.099	0.035081439	Electroencephalographic traits in alcoholism	Heart health and disorders
rs17194666	A	C	52	33	9	72	21	1	0.73	0.88	0.27	0.12	C	0.04	0.035081439	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs6497031	G	A	64	26	4	36	51	7	0.82	0.65	0.18	0.35	A	1.84	0.035043577	Periodontitis CDC_AAP	Misc
rs9552733	G	A	41	41	12	62	30	2	0.65	0.82	0.35	0.18	G	1.29	0.035043577	Smoking cessation in chronic obstructive pulmonary disease	Heart health and disorders
rs9268301	G	A	41	41	12	62	30	2	0.65	0.82	0.35	0.18	A	0.03	0.035043577	Obesity-related traits	Obesity
rs6984242	G	A	8	49	37	2	30	62	0.35	0.18	0.65	0.82	G	1.0638298	0.035043577	Schizophrenia	Brain health and disorders
rs13025833	A	G	37	47	10	22	42	30	0.64	0.46	0.36	0.54	A	1.2	0.035017008	Breast cancer	Cancer
rs282544	C	T	13	60	21	40	41	13	0.46	0.64	0.54	0.36	C	0.1	0.035017008	Myopia pathological	General health
rs7244261	C	T	59	31	4	32	53	9	0.79	0.62	0.21	0.38	T	4.606	0.034996582	Suicide in bipolar disorder	Brain health and disorders
rs16825455	A	G	59	31	4	32	53	9	0.79	0.62	0.21	0.38	T	1.425	0.034996582	Adverse response to chemotherapy neutropenia_leucopenia all platinum-based drugs	Drug response
rs17648524	G	C	37	43	14	60	29	5	0.62	0.79	0.38	0.21	C	0.118	0.034996582	Refractive error	General health
rs171408	G	A	5	35	54	11	56	27	0.24	0.41	0.76	0.59	G	1.32	0.034994698	Mitral valve prolapse	Heart health and disorders
rs2250245	A	G	55	33	6	37	36	21	0.76	0.59	0.24	0.41	G	0.112	0.034994698	Economic and political preferences feminism_equality	Mental aptitude and behavioural traits
rs6929137	G	A	57	29	8	33	44	17	0.76	0.59	0.24	0.41	A	0.1	0.034994698	Bone mineral density spine	General health
rs7591996	A	C	22	43	29	7	39	48	0.46	0.28	0.54	0.72	C	1.39	0.034987893	Osteosarcoma	Cancer
rs781542	A	G	20	47	27	9	35	50	0.46	0.28	0.54	0.72	A	1.35	0.034987893	Stroke	Brain health and disorders
rs4521954	A	G	4	45	45	18	51	25	0.28	0.46	0.72	0.54	A	0.0476	0.034987893	Trans fatty acid levels	General health
rs11874712	C	A	42	44	8	67	24	3	0.68	0.84	0.32	0.16	A	1.15	0.034965035	Migraine - clinic-based	Brain health and disorders
rs17338034	A	G	67	24	3	41	46	7	0.84	0.68	0.16	0.32	A	0.351	0.034965035	Left superior temporal gyrus thickness schizophrenia interaction	Brain health and disorders
rs1564981	G	A	7	46	41	2	26	66	0.32	0.16	0.68	0.84	A	0.04	0.034965035	Bone mineral density	General health
rs9600079	G	T	34	52	8	14	57	23	0.64	0.45	0.36	0.55	T	1.1904762	0.034945086	Prostate cancer	Cancer
rs758569	C	A	11	47	36	29	46	19	0.37	0.55	0.63	0.45	A	0.8017	0.034881403	Pit-and-Fissure caries	Misc
rs1667255	A	C	32	40	22	13	43	38	0.55	0.37	0.45	0.63	C	0.03	0.034881403	Retinol levels	Aging
rs3892715	C	T	27	51	16	3	64	27	0.56	0.37	0.44	0.63	C	1	0.034825871	Attention deficit hyperactivity disorder time to onset	Brain health and disorders
rs10822013	C	T	28	44	22	45	44	5	0.53	0.71	0.47	0.29	T	1.12	0.034789936	Breast cancer	Cancer
rs7745098	C	T	23	42	29	5	44	45	0.47	0.29	0.53	0.71	G	1.21	0.034789936	Hodgkin's lymphoma	Cancer
rs10859871	A	C	37	43	14	17	48	29	0.62	0.44	0.38	0.56	C	1.2	0.034778412	Endometriosis	General health
rs4467099	C	T	19	44	31	38	41	15	0.44	0.62	0.56	0.38	A	1.09	0.034778412	Hepatitis	Immune diseases and disorders
rs8016982	C	T	13	45	36	29	48	17	0.38	0.56	0.62	0.44	C	1.0526316	0.034778412	Schizophrenia	Brain health and disorders
rs10007186	C	T	12	47	35	28	50	16	0.38	0.56	0.62	0.44	C	0.085	0.034778412	Non-albumin protein levels	General health
rs11771145	G	A	37	42	15	14	53	27	0.62	0.43	0.38	0.57	G	1.1111	0.034738962	Alzheimer's disease late onset	Brain health and disorders
rs4581712	C	A	57	30	7	77	16	1	0.77	0.90	0.23	0.10	A	3.2	0.034723649	Liver enzyme levels gamma-glutamyl transferase	General health
rs2196122	G	C	58	28	8	77	16	1	0.77	0.90	0.23	0.10	G	1.91	0.034723649	Blood pressure	Heart health and disorders
rs9557195	T	C	56	32	6	77	16	1	0.77	0.90	0.23	0.10	T	1.112	0.034723649	Inflammatory bowel disease	Immune diseases and disorders
rs2035403	A	G	31	47	16	51	40	3	0.58	0.76	0.42	0.24	G	0.039	0.034709163	Triglycerides	General health
rs3902751	G	A	52	38	4	31	47	16	0.76	0.58	0.24	0.42	A	0.0386	0.034709163	Waist-to-hip ratio adjusted for body mass index	Obesity
rs12599402	T	C	32	44	18	16	41	37	0.57	0.39	0.43	0.61	A	1.2821	0.034707466	Systemic lupus erythematosus	Immune diseases and disorders
rs889472	C	A	20	40	34	37	41	16	0.43	0.61	0.57	0.39	C	0.0711	0.034707466	Renal function-related traits urea	General health
rs7528859	T	A	38	38	18	19	41	34	0.61	0.42	0.39	0.58	A	1.12	0.034683881	Migraine with aura	Brain health and disorders
rs2662776	A	G	30	49	15	15	44	35	0.58	0.39	0.42	0.61	A	0.066	0.034683881	Lead levels in blood	General health
rs206936	A	G	31	48	15	16	43	35	0.59	0.40	0.41	0.60	G	0.06	0.034668176	Body mass index	Obesity
rs1077773	G	A	19	39	36	33	46	15	0.41	0.60	0.59	0.40	A	1.0747931	0.034660329	Ulcerative colitis	Immune diseases and disorders
rs13083990	T	C	37	42	15	59	30	5	0.62	0.79	0.38	0.21	T	2.66	0.034632035	Cardiac Troponin-T levels	Heart health and disorders
rs16851055	G	A	61	26	7	31	54	9	0.79	0.62	0.21	0.38	G	1.12	0.034632035	Stroke ischemic	Brain health and disorders
rs6675828	G	A	49	35	10	24	51	19	0.71	0.53	0.29	0.47	A	5.457	0.03460249	Warfarin maintenance dose	General health
rs9352866	T	C	18	53	23	8	39	47	0.47	0.29	0.53	0.71	T	0.17	0.03460249	Antibody level in response to infection	Immune diseases and disorders
rs6013355	A	G	62	29	3	40	42	12	0.81	0.65	0.19	0.35	A	1	0.03459946	Subcutaneous adipose tissue	Obesity
rs12887734	G	T	45	42	7	68	25	1	0.70	0.86	0.30	0.14	T	1.09	0.034582014	Schizophrenia	Brain health and disorders
rs7717823	C	T	43	46	5	70	21	3	0.70	0.86	0.30	0.14	C	0.44	0.034582014	Urinary metabolites H-NMR features	General health
rs6436285	C	T	0	10	84	3	26	65	0.05	0.17	0.95	0.83	G	3.9	0.034502424	Diisocyanate-induced asthma	Pulmonology
rs9275326	C	T	65	26	3	84	10	0	0.83	0.95	0.17	0.05	C	1.21	0.034502424	Parkinson's disease	Brain health and disorders
rs11767400	C	A	63	30	1	84	10	0	0.83	0.95	0.17	0.05	A	0.04	0.034502424	Menarche age at onset	Reproductive health
rs11662748	G	A	63	30	1	84	10	0	0.83	0.95	0.17	0.05	A	0.03	0.034502424	Obesity-related traits	Obesity
rs1723838	C	T	84	10	0	66	24	4	0.95	0.83	0.05	0.17	A	0.02	0.034502424	Obesity-related traits	Obesity
rs715	T	C	40	47	7	64	29	1	0.68	0.84	0.32	0.16	C	0.022	0.034445805	Body mass index	Obesity
rs11654749	G	T	42	43	9	67	23	4	0.68	0.84	0.32	0.16	T	0.017	0.034445805	Pulmonary function interaction	Pulmonology
rs4687552	T	C	28	52	14	54	33	7	0.57	0.75	0.43	0.25	T	1.086	0.03443696	Schizophrenia	Brain health and disorders
rs11079764	A	G	31	46	17	51	39	4	0.57	0.75	0.43	0.25	G	0.1833	0.03443696	IgG glycosylation	Immune diseases and disorders
rs6013509	G	A	55	31	8	28	52	14	0.75	0.57	0.25	0.43	A	0.06	0.03443696	Hemoglobin	Heart health and disorders
rs300489	G	A	55	31	8	30	48	16	0.75	0.57	0.25	0.43	A	0.03	0.03443696	Self-rated health	General health
rs171748	A	G	21	48	25	11	34	49	0.48	0.30	0.52	0.70	A	1.078	0.034425253	Schizophrenia	Brain health and disorders
rs7322916	G	A	27	44	23	43	46	5	0.52	0.70	0.48	0.30	G	0.089	0.034425253	Eating disorders	Brain health and disorders
rs12967135	G	A	75	17	2	49	42	3	0.89	0.74	0.11	0.26	A	0.42	0.034414389	HDL cholesterol	General health
rs17782313	T	C	75	17	2	50	40	4	0.89	0.74	0.11	0.26	C	0.2	0.034414389	Body mass index	Obesity
rs75562159	C	A	87	7	0	68	25	1	0.96	0.86	0.04	0.14	A	2.7027025	0.034399725	Alcohol dependence	General health
rs34975555	G	C	69	23	2	87	7	0	0.86	0.96	0.14	0.04	C	2.08	0.034399725	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs17221259	T	C	69	23	2	87	7	0	0.86	0.96	0.14	0.04	G	1.252	0.034399725	Breast cancer	Cancer
rs72634030	C	A	67	27	0	87	7	0	0.86	0.96	0.14	0.04	A	1.12	0.034399725	Rheumatoid arthritis	Immune diseases and disorders
rs3851357	G	A	70	21	3	87	7	0	0.86	0.96	0.14	0.04	G	0.1814	0.034399725	IgG glycosylation	Immune diseases and disorders
rs11225148	A	G	69	23	2	87	7	0	0.86	0.96	0.14	0.04	G	0.1	0.034399725	Pubertal anthropometrics	Appearance
rs34065801	T	C	69	23	2	87	7	0	0.86	0.96	0.14	0.04	C	0.096	0.034399725	Breast size	General health
rs892877	A	G	5	17	72	0	7	87	0.14	0.04	0.86	0.96	A	0.032	0.034399725	Liver enzyme levels aspartate transaminase	General health
rs16923476	G	A	72	20	2	50	36	8	0.87	0.72	0.13	0.28	A	1.78	0.034385965	Obesity early onset extreme	Obesity
rs6922632	C	A	71	22	1	47	42	5	0.87	0.72	0.13	0.28	A	0.19	0.034385965	Information processing speed	Mental aptitude and behavioural traits
rs11154022	A	G	7	38	49	1	22	71	0.28	0.13	0.72	0.87	A	5.8	0.034385965	Resting heart rate	General health
rs16949825	C	G	78	16	0	55	37	2	0.91	0.78	0.09	0.22	C	0.2547	0.034372766	IgG glycosylation	Immune diseases and disorders
rs2228213	G	A	60	27	7	78	16	0	0.78	0.91	0.22	0.09	G	0.019	0.034372766	Body mass index	Obesity
rs540425	A	T	13	47	34	2	37	55	0.39	0.22	0.61	0.78	T	1.0638298	0.034284184	Schizophrenia	Brain health and disorders
rs7283316	G	A	21	49	24	11	35	48	0.48	0.30	0.52	0.70	A	0.37	0.034257942	Information processing speed	Mental aptitude and behavioural traits
rs6470120	G	A	48	35	11	23	51	20	0.70	0.52	0.30	0.48	A	6.251	0.034257942	Nicotine use	General health
rs1900442	T	C	46	39	9	25	47	22	0.70	0.52	0.30	0.48	T	2.7027	0.034257942	Tuberculosis	Immune diseases and disorders
rs636523	A	G	47	37	10	19	59	16	0.70	0.52	0.30	0.48	G	0.021	0.034257942	Lipid traits	Misc
rs3748682	T	C	63	27	4	82	12	0	0.81	0.94	0.19	0.06	T	1.19	0.034210697	Hypothyroidism	Immune diseases and disorders
rs4789693	A	C	51	38	5	30	47	17	0.74	0.57	0.26	0.43	C	1	0.034177573	Glucocorticoid-induced osteonecrosis	Drug response
rs10518693	C	T	31	45	18	51	38	5	0.57	0.74	0.43	0.26	T	0.092	0.034177573	Metabolic traits	Misc
rs2813746	C	A	27	42	25	46	38	10	0.51	0.69	0.49	0.31	C	148.1	0.034100295	Brain structure hippocampal volume	Brain health and disorders
rs378108	A	G	24	48	22	43	44	7	0.51	0.69	0.49	0.31	G	1	0.034100295	Ankylosing spondylitis	Immune diseases and disorders
rs7336109	C	T	47	36	11	24	48	22	0.69	0.51	0.31	0.49	T	1	0.034100295	Visceral fat	Obesity
rs2677247	A	C	22	52	20	46	38	10	0.51	0.69	0.49	0.31	C	0.1417	0.034100295	IgG glycosylation	Immune diseases and disorders
rs4471613	G	A	79	15	0	93	1	0	0.92	0.99	0.08	0.01	A	2.26	0.034027778	Stroke	Brain health and disorders
rs1564282	C	T	79	15	0	93	1	0	0.92	0.99	0.08	0.01	T	1.7	0.034027778	Parkinson's disease familial	Brain health and disorders
rs3918226	C	T	79	15	0	93	1	0	0.92	0.99	0.08	0.01	T	1.14	0.034027778	Coronary artery disease	Heart health and disorders
rs7931462	G	A	93	1	0	80	13	1	0.99	0.92	0.01	0.08	G	1	0.034027778	DNA methylation parent-of-origin	Misc
rs17168526	T	C	93	1	0	79	15	0	0.99	0.92	0.01	0.08	G	1	0.034027778	Immune reponse to smallpox secreted IL-1beta	Immune diseases and disorders
rs17150687	A	G	93	1	0	79	15	0	0.99	0.92	0.01	0.08	C	1	0.034027778	Response to anti-depressant treatment in major depressive disorder	General health
rs724743	A	G	93	1	0	79	15	0	0.99	0.92	0.01	0.08	A	0.101	0.034027778	Height	General health
rs11907106	G	A	93	1	0	79	15	0	0.99	0.92	0.01	0.08	A	0.01	0.034027778	Obesity-related traits	Obesity
rs3101457	G	A	2	24	68	10	37	47	0.15	0.30	0.85	0.70	A	0.041	0.034000404	Smoking behavior	General health
rs11022131	C	G	45	41	8	69	22	3	0.70	0.85	0.30	0.15	C	6.535948	0.034000404	Warfarin maintenance dose	General health
rs4751058	G	A	47	37	10	68	24	2	0.70	0.85	0.30	0.15	A	1.06	0.034000404	Vitamin D levels	General health
rs3828309	A	G	39	36	19	59	28	7	0.61	0.78	0.39	0.22	G	1.25	0.033952255	Crohn's disease	Digestive system and its disorders
rs4502156	T	C	13	48	33	3	36	55	0.39	0.22	0.61	0.78	T	1	0.033952255	Proinsulin levels	Diabetes
rs784288	A	G	21	51	22	12	35	47	0.49	0.31	0.51	0.69	A	1.39	0.033952068	Osteoporosis	Immune diseases and disorders
rs13015714	G	T	13	36	45	3	26	65	0.33	0.17	0.67	0.83	C	1.28	0.033952014	Celiac disease	Immune diseases and disorders
rs9501030	T	A	43	40	11	64	28	2	0.67	0.83	0.33	0.17	A	1	0.033952014	Ulcerative colitis	Immune diseases and disorders
rs10429371	C	T	9	31	54	16	50	28	0.26	0.44	0.74	0.56	C	3.8	0.033930519	Smooth-surface caries	Appearance
rs415890	G	C	31	44	19	50	39	5	0.56	0.74	0.44	0.26	C	1.17	0.033930519	Crohn's disease	Digestive system and its disorders
rs10838687	T	G	55	29	10	29	48	17	0.74	0.56	0.26	0.44	T	1	0.033930519	Proinsulin levels	Diabetes
rs830124	A	G	8	29	57	2	15	77	0.24	0.10	0.76	0.90	A	1	0.033854167	Urinary metabolites	General health
rs17688601	C	A	57	29	8	76	17	1	0.76	0.90	0.24	0.10	C	1.1363636	0.033854167	Pancreatic cancer	Cancer
rs2745967	G	A	8	44	42	23	48	23	0.32	0.50	0.68	0.50	G	5.4	0.033813034	Resting heart rate	General health
rs10400419	T	C	10	40	44	23	48	23	0.32	0.50	0.68	0.50	T	0.0562	0.033813034	Axial length	Misc
rs727563	C	T	25	44	25	43	42	9	0.50	0.68	0.50	0.32	G	1.0965022	0.033813034	Crohn's disease	Digestive system and its disorders
rs915286	G	A	23	48	23	45	38	11	0.50	0.68	0.50	0.32	G	1.068916	0.033813034	Crohn's disease	Digestive system and its disorders
rs2291738	T	C	37	46	11	63	25	6	0.64	0.80	0.36	0.20	T	0.0518	0.033772623	Axial length	Misc
rs938036	T	C	0	6	88	1	23	70	0.03	0.13	0.97	0.87	T	2.88	0.033754091	Tooth agenesis mandibular third molar	Misc
rs4016429	C	G	88	6	0	69	25	0	0.97	0.87	0.03	0.13	C	4.564	0.033754091	Smooth-surface caries	Appearance
rs10486201	C	T	71	21	2	88	6	0	0.87	0.97	0.13	0.03	A	0.03	0.033754091	Obesity-related traits	Obesity
rs1165209	G	A	9	35	50	2	21	71	0.28	0.13	0.72	0.87	G	0.096	0.033729134	Urate levels in lean individuals	Obesity
rs1165196	G	A	9	35	50	2	21	71	0.28	0.13	0.72	0.87	A	0.05	0.033729134	Serum uric acid levels	General health
rs2762353	A	G	9	35	50	2	21	71	0.28	0.13	0.72	0.87	A	0.03	0.033729134	Blood metabolite levels	Heart health and disorders
rs1419607	A	G	28	49	17	49	40	5	0.56	0.73	0.44	0.27	G	0.03	0.033695349	Obesity-related traits	Obesity
rs7172432	A	G	22	51	21	8	45	41	0.51	0.32	0.49	0.68	A	1.11	0.033682984	Type 2 diabetes	Diabetes
rs3806933	C	T	22	49	23	42	43	9	0.49	0.68	0.51	0.32	G	1.37	0.033682984	Eosinophilic esophagitis	Digestive system and its disorders
rs4796827	A	G	22	49	23	40	47	7	0.49	0.68	0.51	0.32	A	1.326	0.033682984	Anxiety and major depressive disorder	Brain health and disorders
rs6062509	G	T	5	39	50	2	18	74	0.26	0.12	0.74	0.88	A	1.12	0.033664281	Prostate cancer	Cancer
rs8025470	G	A	74	18	2	45	49	0	0.88	0.74	0.12	0.26	A	1.1	0.033664281	Schizophrenia	Brain health and disorders
rs6741949	G	C	35	43	16	56	33	5	0.60	0.77	0.40	0.23	G	52.8	0.033635528	Hippocampal volume	Brain health and disorders
rs10513686	G	A	56	33	5	37	39	18	0.77	0.60	0.23	0.40	A	4.9	0.033635528	Liver enzyme levels gamma-glutamyl transferase	General health
rs3792109	G	A	38	37	19	59	27	8	0.60	0.77	0.40	0.23	A	1.38	0.033635528	Crohn's disease	Digestive system and its disorders
rs8060598	T	C	35	43	16	56	33	5	0.60	0.77	0.40	0.23	C	1.14	0.033635528	Leprosy	Immune diseases and disorders
rs10932600	A	C	36	41	17	54	37	3	0.60	0.77	0.40	0.23	A	0.32	0.033635528	Airway imaging phenotypes	Pulmonology
rs10911021	C	T	38	50	6	24	44	26	0.67	0.49	0.33	0.51	C	1.36	0.033561723	Cardiovascular heart disease in diabetics	Heart health and disorders
rs11230563	C	T	40	46	8	25	42	27	0.67	0.49	0.33	0.51	A	1.0883777	0.033561723	Crohn's disease	Digestive system and its disorders
rs3924048	G	A	24	44	26	37	52	5	0.49	0.67	0.51	0.33	G	0.016	0.033561723	Optic cup area	Misc
rs7940866	T	A	24	48	22	10	42	42	0.51	0.33	0.49	0.67	T	1.09	0.033561723	Schizophrenia	Brain health and disorders
rs12727642	C	A	68	22	4	86	7	1	0.84	0.95	0.16	0.05	A	1.14	0.033553983	Celiac disease	Immune diseases and disorders
rs3768644	G	A	86	7	1	66	26	2	0.95	0.84	0.05	0.16	G	1.1061947	0.033553983	Schizophrenia	Brain health and disorders
rs9510661	A	C	85	9	0	66	26	2	0.95	0.84	0.05	0.16	C	0.39	0.033553983	Cannabis use initiation	General health
rs2944755	A	G	4	22	68	0	9	85	0.16	0.05	0.84	0.95	A	9.45	0.033553983	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs17065898	T	C	63	29	2	39	47	8	0.82	0.66	0.18	0.34	T	4.914	0.033482143	Very long-chain saturated fatty acid levels fatty acid 24:0	General health
rs1736020	C	A	42	41	11	63	29	2	0.66	0.82	0.34	0.18	C	1.16	0.033482143	Crohn's disease	Digestive system and its disorders
rs12637047	C	T	43	39	12	61	33	0	0.66	0.82	0.34	0.18	T	0.06	0.033482143	Plasma omega-6 polyunsaturated fatty acid levels dihomo-gamma-linolenic acid	General health
rs2036527	G	A	43	39	12	65	25	4	0.66	0.82	0.34	0.18	G	0.026	0.033482143	Pulmonary function	Pulmonology
rs7189501	T	C	44	37	13	65	25	4	0.66	0.82	0.34	0.18	C	0.014	0.033482143	Body mass index	Obesity
rs12483959	G	A	40	45	9	63	29	2	0.66	0.82	0.34	0.18	A	0.0039	0.033482143	Metabolite levels	General health
rs10461617	A	G	6	39	49	19	46	29	0.27	0.45	0.73	0.55	A	1.17	0.033471646	Type 2 diabetes	Diabetes
rs4380028	C	T	30	44	20	48	41	5	0.55	0.73	0.45	0.27	C	1.07	0.033471646	Coronary heart disease	Heart health and disorders
rs59227481	A	G	42	41	11	25	41	28	0.66	0.48	0.34	0.52	G	0.08	0.033449074	Age-related nuclear cataracts	Aging
rs11255841	T	A	46	38	10	70	19	5	0.69	0.85	0.31	0.15	T	1.19	0.033448674	Colorectal cancer	Cancer
rs7775861	C	T	43	44	7	68	23	3	0.69	0.85	0.31	0.15	T	1	0.033448674	Body mass index in non-asthmatics	Obesity
rs4939827	T	C	11	47	36	3	32	59	0.37	0.20	0.63	0.80	T	1.2	0.033387764	Colorectal cancer	Cancer
rs10146997	A	G	58	34	2	34	51	9	0.80	0.63	0.20	0.37	G	0.65	0.033387764	Waist circumference	General health
rs1000940	A	G	36	47	11	60	30	4	0.63	0.80	0.37	0.20	G	0.02	0.033387764	Body mass index	Obesity
rs1884537	C	T	34	44	16	54	36	4	0.60	0.77	0.40	0.23	C	0.134	0.033333333	Optic nerve measurement disc area	Misc
rs12507634	A	G	27	49	18	48	40	6	0.55	0.72	0.45	0.28	G	4.84	0.033259017	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs7661864	G	A	46	44	4	25	53	16	0.72	0.55	0.28	0.45	G	0.3307	0.033259017	IgG glycosylation	Immune diseases and disorders
rs6117615	A	G	89	5	0	71	23	0	0.97	0.88	0.03	0.12	C	3.89	0.033251232	Adverse response to chemotherapy in breast cancer alopecia docetaxel	General health
rs1879352	T	C	73	19	2	89	5	0	0.88	0.97	0.12	0.03	C	1.53	0.033251232	Acute lymphoblastic leukemia childhood	Cancer
rs180803	G	T	89	5	0	71	23	0	0.97	0.88	0.03	0.12	G	1.21	0.033251232	Myocardial infarction	Heart health and disorders
rs2470893	C	T	74	17	3	89	5	0	0.88	0.97	0.12	0.03	T	0.2	0.033251232	Coffee consumption	Misc
rs16858228	A	G	72	21	1	89	5	0	0.88	0.97	0.12	0.03	G	0.04	0.033251232	Obesity-related traits	Obesity
rs780179	T	C	27	45	22	12	41	41	0.53	0.35	0.47	0.65	G	1.59	0.033248965	Multiple myeloma IgH translocation	Cancer
rs669408	A	C	24	51	19	12	41	41	0.53	0.35	0.47	0.65	C	1.33	0.033248965	Immunoglobulin A	Immune diseases and disorders
rs11204538	C	T	30	39	25	9	47	38	0.53	0.35	0.47	0.65	C	0.091	0.033248965	Mean corpuscular volume	Heart health and disorders
rs6731443	T	G	22	45	27	38	47	9	0.47	0.65	0.53	0.35	G	0.022	0.033248965	Airway hyperresponsiveness	Pulmonology
rs4821261	T	C	0	17	77	0	2	92	0.09	0.01	0.91	0.99	A	1	0.033171163	Behavioural disinhibition generation interaction	Brain health and disorders
rs17111684	C	T	92	2	0	77	17	0	0.99	0.91	0.01	0.09	A	9.01	0.033171163	LDL cholesterol	General health
rs2838519	G	A	27	46	21	9	48	37	0.53	0.35	0.47	0.65	G	1.18	0.033161216	Crohn's disease	Digestive system and its disorders
rs62026376	C	T	64	27	3	83	11	0	0.82	0.94	0.18	0.06	C	1.17	0.03313253	Asthma and hay fever	Immune diseases and disorders
rs17423910	A	G	62	31	1	83	11	0	0.82	0.94	0.18	0.06	G	1	0.03313253	Acute lymphoblastic leukemia childhood	Cancer
rs11121382	G	C	64	27	3	83	11	0	0.82	0.94	0.18	0.06	C	0.099	0.03313253	Immune response to anthrax vaccine	Immune diseases and disorders
rs2163950	C	A	83	11	0	62	31	1	0.94	0.82	0.06	0.18	A	0.021	0.03313253	White blood cell count	Immune diseases and disorders
rs7809799	G	A	2	7	85	5	23	66	0.06	0.18	0.94	0.82	G	1.56	0.03313253	Ulcerative colitis	Immune diseases and disorders
rs2180233	C	T	4	25	65	1	9	84	0.18	0.06	0.82	0.94	C	1	0.03313253	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs334699	A	G	0	11	83	3	27	64	0.06	0.18	0.94	0.82	A	0.149	0.03313253	Thyroid hormone levels	General health
rs6740462	C	A	5	29	60	0	15	79	0.21	0.08	0.79	0.92	C	1.1048803	0.033126294	Crohn's disease	Digestive system and its disorders
rs4613763	T	C	80	13	1	57	35	2	0.92	0.79	0.08	0.21	C	1.32	0.033126294	Crohn's disease	Digestive system and its disorders
rs7130881	A	G	81	11	2	60	29	5	0.92	0.79	0.08	0.21	G	1.31	0.033126294	Prostate cancer	Cancer
rs858249	A	G	81	11	2	60	29	5	0.92	0.79	0.08	0.21	A	1.1	0.033126294	Chronic obstructive pulmonary disease	Immune diseases and disorders
rs654600	A	C	70	22	2	47	40	7	0.86	0.71	0.14	0.29	A	1.7	0.033108108	Emphysema imaging phenotypes	Pulmonology
rs10168266	C	T	48	38	8	71	20	3	0.71	0.86	0.29	0.14	T	1.44	0.033108108	Sjogren's syndrome	Immune diseases and disorders
rs73058713	C	A	70	22	2	46	42	6	0.86	0.71	0.14	0.29	A	1.19	0.033108108	Leprosy	Immune diseases and disorders
rs17309827	T	G	51	32	11	69	24	1	0.71	0.86	0.29	0.14	T	1.1	0.033108108	Crohn's disease	Digestive system and its disorders
rs626750	G	A	70	22	2	46	42	6	0.86	0.71	0.14	0.29	G	1	0.033108108	Emphysema imaging phenotypes	Pulmonology
rs10790381	A	G	71	20	3	49	36	9	0.86	0.71	0.14	0.29	A	0.25	0.033108108	Intraocular pressure	General health
rs4938803	A	G	71	20	3	49	36	9	0.86	0.71	0.14	0.29	A	0.25	0.033108108	Intraocular pressure	General health
rs11217866	T	A	71	20	3	49	36	9	0.86	0.71	0.14	0.29	A	0.24	0.033108108	Intraocular pressure	General health
rs11217843	A	G	71	20	3	49	36	9	0.86	0.71	0.14	0.29	A	0.24	0.033108108	Intraocular pressure	General health
rs7129944	T	C	71	20	3	49	36	9	0.86	0.71	0.14	0.29	T	0.24	0.033108108	Intraocular pressure	General health
rs195204	T	C	46	42	6	68	26	0	0.71	0.86	0.29	0.14	T	0.1	0.033108108	Alcoholism heaviness of drinking	General health
rs1699337	G	A	46	42	6	69	24	1	0.71	0.86	0.29	0.14	G	0.043	0.033108108	Cholesterol, total	General health
rs7574865	T	G	9	36	49	4	18	72	0.29	0.14	0.71	0.86	T	1.38	0.033108108	Systemic sclerosis	Brain health and disorders
rs309064	C	A	3	48	43	1	24	69	0.29	0.14	0.71	0.86	C	0.19	0.033108108	Blood pressure anthropometric measures interaction	Heart health and disorders
rs9900280	G	A	20	46	28	9	35	50	0.46	0.28	0.54	0.72	G	0.1	0.033057099	Mean platelet volume	Heart health and disorders
rs197273	A	G	16	45	33	6	33	55	0.41	0.24	0.59	0.76	A	0.23	0.03304505	Dietary macronutrient intake	General health
rs4343996	G	A	14	49	31	5	35	54	0.41	0.24	0.59	0.76	G	0.034	0.03304505	Motion sickness	Misc
rs313426	A	G	6	33	55	17	43	34	0.24	0.41	0.76	0.59	A	0.018	0.03304505	Toenail selenium levels	Misc
rs7433808	A	T	53	37	4	34	43	17	0.76	0.59	0.24	0.41	A	1	0.03304505	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs11150612	G	A	52	38	4	74	20	0	0.76	0.89	0.24	0.11	A	1.19	0.033040078	IgA nephropathy	Immune diseases and disorders
rs9930506	A	G	41	42	11	64	26	4	0.66	0.82	0.34	0.18	A	0.16	0.033034797	Obesity-related traits	Obesity
rs7776725	T	C	61	27	6	36	46	12	0.79	0.63	0.21	0.37	C	0.159	0.033020651	Bone mineral density paediatric, total body less head	General health
rs4819143	G	A	58	36	0	81	13	0	0.81	0.93	0.19	0.07	C	17	0.033015041	Insulin resistance_response	Drug response
rs1385374	C	T	61	30	3	81	13	0	0.81	0.93	0.19	0.07	A	1.41	0.033015041	Systemic lupus erythematosus	Immune diseases and disorders
rs42490	G	A	22	58	14	13	42	39	0.54	0.36	0.46	0.64	G	1.32	0.033009709	Leprosy	Immune diseases and disorders
rs76939711	G	A	94	0	0	82	12	0	1.00	0.94	0.00	0.06	A	1.2	0.032967033	Schizophrenia	Brain health and disorders
rs1445021	A	G	94	0	0	82	12	0	1.00	0.94	0.00	0.06	A	0.1365	0.032967033	HDL cholesterol	General health
rs6457821	C	A	94	0	0	82	12	0	1.00	0.94	0.00	0.06	A	0.104	0.032967033	Height	General health
rs17064002	C	T	94	0	0	82	12	0	1.00	0.94	0.00	0.06	A	0.06	0.032967033	Obesity-related traits	Obesity
rs7650621	A	C	94	0	0	82	12	0	1.00	0.94	0.00	0.06	C	0.04	0.032967033	Obesity-related traits	Obesity
rs12455924	C	T	73	19	2	52	34	8	0.88	0.73	0.12	0.27	T	17.88	0.03295809	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs17030613	A	C	50	38	6	74	17	3	0.73	0.88	0.27	0.12	C	0.49	0.03295809	Blood pressure	Heart health and disorders
rs12529314	C	T	71	23	0	46	46	2	0.88	0.73	0.12	0.27	T	0.2433	0.03295809	Neurofibrillary tangles	Brain health and disorders
rs1560104	C	T	27	49	18	13	43	38	0.55	0.37	0.45	0.63	G	0.03	0.032945736	Obesity-related traits	Obesity
rs4142995	G	T	27	49	18	12	45	37	0.55	0.37	0.45	0.63	T	0.026	0.032945736	HDL cholesterol	General health
rs7084402	A	G	35	49	10	19	47	28	0.63	0.45	0.37	0.55	G	0.108	0.032945736	Refractive error	General health
rs7974425	C	T	0	4	90	0	21	73	0.02	0.11	0.98	0.89	G	0.03	0.032934473	Obesity-related traits	Obesity
rs12296937	T	G	90	4	0	73	21	0	0.98	0.89	0.02	0.11	G	1.08	0.032934473	Age-related cataracts age at onset	Aging
rs34660913	C	T	75	17	2	90	4	0	0.89	0.98	0.11	0.02	T	0.6319	0.032934473	Vascular brain injury	Brain health and disorders
rs1380131	C	T	74	19	1	90	4	0	0.89	0.98	0.11	0.02	C	0.147	0.032934473	Alcoholism heaviness of drinking	General health
rs11693697	T	C	74	19	1	90	4	0	0.89	0.98	0.11	0.02	C	0.08	0.032934473	Serum protein levels sST2	General health
rs12279250	T	C	44	41	9	65	28	1	0.69	0.84	0.31	0.16	C	28.2	0.032924872	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs17428041	T	C	46	37	11	66	26	2	0.69	0.84	0.31	0.16	T	1.49	0.032924872	Neuropathic pain in type 2 diabetes	Diabetes
rs2814944	G	A	67	24	3	42	45	7	0.84	0.69	0.16	0.31	A	0.49	0.032924872	HDL cholesterol	General health
rs8015138	A	C	48	33	13	65	28	1	0.69	0.84	0.31	0.16	C	0.11	0.032924872	Non-melanoma skin cancer	Cancer
rs3792366	G	A	14	42	38	29	46	19	0.37	0.55	0.63	0.45	G	2.153	0.032889496	Platelet count	Heart health and disorders
rs2015599	G	A	35	48	11	18	48	28	0.63	0.45	0.37	0.55	A	0.008	0.032889496	Mean platelet volume	Heart health and disorders
rs9469099	G	A	91	3	0	77	15	2	0.98	0.90	0.02	0.10	G	1.61	0.032871084	Atopic dermatitis	Immune diseases and disorders
rs9918807	T	C	76	17	1	91	3	0	0.90	0.98	0.10	0.02	T	0.47	0.032871084	Retinopathy in non-diabetics	General health
rs1393350	G	A	75	19	0	91	3	0	0.90	0.98	0.10	0.02	A	0.19	0.032871084	Tanning	Appearance
rs7642482	A	G	75	19	0	91	3	0	0.90	0.98	0.10	0.02	G	0.11	0.032871084	Expressive vocabulary in infants	Mental aptitude and behavioural traits
rs12659622	G	A	76	17	1	91	3	0	0.90	0.98	0.10	0.02	A	0.03	0.032871084	Obesity-related traits	Obesity
rs573332	C	T	0	3	91	0	19	75	0.02	0.10	0.98	0.90	G	1	0.032871084	Response to anti-depressant treatment in major depressive disorder	General health
rs491376	G	C	0	3	91	0	19	75	0.02	0.10	0.98	0.90	C	1	0.032871084	Response to anti-depressant treatment in major depressive disorder	General health
rs7153027	A	C	47	40	7	27	47	20	0.71	0.54	0.29	0.46	A	5.7	0.03286555	Height	General health
rs4602861	A	G	45	44	5	23	55	16	0.71	0.54	0.29	0.46	A	1.2	0.03286555	Venous thromboembolism	Heart health and disorders
rs4673553	T	G	29	43	22	48	38	8	0.54	0.71	0.46	0.29	G	0.099	0.03286555	Urate levels in obese individuals	Obesity
rs6507022	G	C	9	36	49	21	45	28	0.29	0.46	0.71	0.54	C	0.04	0.03286555	Metabolite levels  X-11787	General health
rs7154721	T	C	47	40	7	27	47	20	0.71	0.54	0.29	0.46	T	0.027	0.03286555	Height	General health
rs12940622	G	A	36	45	13	12	59	23	0.62	0.44	0.38	0.56	G	0.021	0.032840909	Body mass index	Obesity
rs586178	G	C	30	45	19	0	71	23	0.56	0.38	0.44	0.62	C	0.037	0.032840909	Cholesterol, total	General health
rs3781913	T	G	31	44	19	15	42	37	0.56	0.38	0.44	0.62	T	1.12	0.032799909	Rheumatoid arthritis	Immune diseases and disorders
rs1992950	A	G	35	46	13	22	38	34	0.62	0.44	0.38	0.56	A	1.25	0.032799909	Ulcerative colitis	Immune diseases and disorders
rs241257	C	T	16	49	29	35	45	14	0.43	0.61	0.57	0.39	A	0.17	0.03276644	Anxiety disorder	Brain health and disorders
rs10175070	G	A	15	51	28	33	49	12	0.43	0.61	0.57	0.39	A	0.124	0.03276644	Eating disorders purging via substances	Brain health and disorders
rs12475512	G	A	37	33	24	11	51	32	0.57	0.39	0.43	0.61	G	0.108	0.03276644	Eating disorders purging via substances	Brain health and disorders
rs7616006	A	G	29	50	15	16	42	36	0.57	0.39	0.43	0.61	A	1.997	0.032740455	Platelet count	Heart health and disorders
rs2600959	A	G	13	54	27	34	46	14	0.43	0.61	0.57	0.39	A	0.04	0.032740455	Menarche age at onset	Reproductive health
rs835367	A	G	29	50	15	13	48	33	0.57	0.39	0.43	0.61	G	0.03	0.032740455	Obesity-related traits	Obesity
rs55670112	A	C	14	51	29	34	45	15	0.42	0.60	0.58	0.40	C	1.18	0.03272192	Epilepsy	Brain health and disorders
rs259964	A	G	16	47	31	37	39	18	0.42	0.60	0.58	0.40	A	1.07394	0.03272192	Crohn's disease	Digestive system and its disorders
rs1521365	T	C	86	8	0	68	24	2	0.96	0.85	0.04	0.15	T	41.3	0.032679739	Attention function in attention deficit hyperactive disorder	Brain health and disorders
rs2119507	C	T	86	8	0	68	24	2	0.96	0.85	0.04	0.15	T	1	0.032679739	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs7953528	T	A	67	26	1	86	8	0	0.85	0.96	0.15	0.04	A	0.05	0.032679739	Bone mineral density	General health
rs6569648	C	T	2	24	68	1	6	87	0.15	0.04	0.85	0.96	C	0.022	0.032679739	Body mass index	Obesity
rs7779057	C	T	62	29	3	43	37	14	0.81	0.65	0.19	0.35	C	17.16	0.032608696	Serum tamsulosin hydrochloride concentration	General health
rs2124379	C	T	12	41	41	5	25	64	0.35	0.19	0.65	0.81	T	0.2774	0.032608696	Lewy body disease	Brain health and disorders
rs1923367	G	C	15	35	44	4	27	63	0.35	0.19	0.65	0.81	C	0.03	0.032608696	Height	General health
rs7223966	G	A	64	25	5	40	43	11	0.81	0.65	0.19	0.35	G	0.017	0.032608696	Body mass index	Obesity
rs74874915	A	T	77	16	1	52	41	1	0.90	0.77	0.10	0.23	A	2.55	0.032526672	Diisocyanate-induced asthma	Pulmonology
rs6897932	C	T	56	33	5	77	16	1	0.77	0.90	0.23	0.10	G	1.12	0.032526672	Type 1 diabetes	Diabetes
rs10197862	A	G	68	25	1	46	41	7	0.86	0.71	0.14	0.29	A	1.24	0.032520325	Asthma and hay fever	Immune diseases and disorders
rs13408661	G	A	68	25	1	46	41	7	0.86	0.71	0.14	0.29	G	1.23	0.032520325	Asthma	Immune diseases and disorders
rs3771175	T	A	68	25	1	46	41	7	0.86	0.71	0.14	0.29	T	1.2	0.032520325	Allergic sensitization	Immune diseases and disorders
rs12541491	C	T	46	41	7	67	27	0	0.71	0.86	0.29	0.14	T	1.06	0.032520325	Schizophrenia	Brain health and disorders
rs17216035	C	A	47	39	8	68	25	1	0.71	0.86	0.29	0.14	A	1	0.032520325	Visceral adipose tissue adjusted for BMI	Obesity
rs8000245	C	T	67	27	0	45	43	6	0.86	0.71	0.14	0.29	C	0.212	0.032520325	Optic nerve measurement rim area	Misc
rs1555399	T	A	25	49	20	42	48	4	0.53	0.70	0.47	0.30	T	1.1148	0.032512315	Parkinson's disease	Brain health and disorders
rs493733	T	G	44	44	6	23	53	18	0.70	0.53	0.30	0.47	G	0.013144915	0.032512315	Urate levels BMI interaction	Obesity
rs2082412	G	A	55	31	8	33	43	18	0.75	0.58	0.25	0.42	G	1.44	0.032507937	Psoriasis	Immune diseases and disorders
rs11574637	T	C	65	27	2	44	40	10	0.84	0.68	0.16	0.32	T	1.32	0.032427222	IgA nephropathy	Immune diseases and disorders
rs1432295	G	A	11	38	45	1	29	64	0.32	0.16	0.68	0.84	G	1.24	0.032427222	Hodgkin's lymphoma	Cancer
rs7518687	A	T	64	29	1	39	50	5	0.84	0.68	0.16	0.32	A	1.19	0.032427222	Hepatitis	Immune diseases and disorders
rs6688363	C	T	42	44	8	66	25	3	0.68	0.84	0.32	0.16	T	1	0.032427222	Response to antipsychotic treatment	General health
rs11083271	C	T	45	38	11	67	23	4	0.68	0.84	0.32	0.16	A	0.61	0.032427222	Non-alcoholic fatty liver disease histology lobular	Obesity
rs9609565	G	A	44	40	10	65	27	2	0.68	0.84	0.32	0.16	G	0.37	0.032427222	Hematological parameters	Heart health and disorders
rs2910124	C	T	64	29	1	44	40	10	0.84	0.68	0.16	0.32	C	0.059	0.032427222	Bulimia nervosa	Brain health and disorders
rs857684	C	T	42	44	8	64	29	1	0.68	0.84	0.32	0.16	C	0.006	0.032427222	Red blood cell traits	Immune diseases and disorders
rs6869388	T	C	58	31	5	39	38	17	0.78	0.62	0.22	0.38	C	72.7	0.032336216	Gallbladder cancer	Cancer
rs17057640	T	C	71	22	1	49	39	6	0.87	0.73	0.13	0.27	C	3.0069	0.032292359	Cognitive function	Brain health and disorders
rs9573194	T	C	56	29	9	73	21	0	0.75	0.89	0.25	0.11	T	2.52	0.032276547	Heschl's gyrus morphology	Brain health and disorders
rs1789924	C	T	55	31	8	75	17	2	0.75	0.89	0.25	0.11	C	1.12	0.032276547	Upper aerodigestive tract cancers	Cancer
rs1262476	A	G	9	29	56	0	21	73	0.25	0.11	0.75	0.89	G	0.1045	0.032276547	Bone mineral density paediatric, upper limb	General health
rs12494658	T	C	53	35	6	75	17	2	0.75	0.89	0.25	0.11	T	0.078	0.032276547	Temperament	Mental aptitude and behavioural traits
rs206548	C	T	29	50	15	53	34	7	0.57	0.74	0.43	0.26	T	1	0.032258065	Serum protein levels sST2	General health
rs6090583	A	G	33	42	19	51	38	5	0.57	0.74	0.43	0.26	A	0.0286	0.032258065	Waist-to-hip ratio adjusted for body mass index	Obesity
rs1974942	A	G	7	34	53	14	52	28	0.26	0.43	0.74	0.57	A	5.29	0.032258065	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs6087990	T	C	19	42	33	9	30	55	0.43	0.26	0.57	0.74	G	1.0586283	0.032258065	Ulcerative colitis	Immune diseases and disorders
rs1863824	G	A	12	42	40	3	30	61	0.35	0.19	0.65	0.81	G	1.0526316	0.032202662	Schizophrenia	Brain health and disorders
rs6503319	C	T	61	30	3	41	40	13	0.81	0.65	0.19	0.35	T	1.21	0.032202662	Malaria	Immune diseases and disorders
rs7638909	T	G	45	40	9	25	47	22	0.69	0.52	0.31	0.48	G	4.8	0.032197026	Electrocardiographic conduction measures	Heart health and disorders
rs2362965	T	A	27	43	24	45	40	9	0.52	0.69	0.48	0.31	T	1.12	0.032197026	Height	General health
rs643608	C	T	19	53	22	13	32	49	0.48	0.31	0.52	0.69	G	0.74	0.032197026	Non-alcoholic fatty liver disease histology other	Obesity
rs7239679	T	C	27	43	24	41	48	5	0.52	0.69	0.48	0.31	T	0.2971	0.032197026	Dementia and core Alzheimer's disease neuropathologic changes	Brain health and disorders
rs12538407	A	G	49	32	13	22	53	19	0.69	0.52	0.31	0.48	A	0.032	0.032197026	Height	General health
rs1544935	T	G	57	34	3	78	16	0	0.79	0.91	0.21	0.09	T	1.08	0.032142857	Myocardial infarction	Heart health and disorders
rs10466239	C	T	78	16	0	54	40	0	0.91	0.79	0.09	0.21	T	1	0.032142857	Telomere length	Aging
rs11857380	T	G	59	30	5	78	16	0	0.79	0.91	0.21	0.09	C	0.03	0.032142857	Obesity-related traits	Obesity
rs112511621	C	T	66	25	3	84	10	0	0.84	0.95	0.16	0.05	T	2.4087	0.032107754	Clozapine-induced agranulocytosis	General health
rs4915077	T	C	66	25	3	84	10	0	0.84	0.95	0.16	0.05	C	1.302	0.032107754	Hypothyroidism	Immune diseases and disorders
rs7225151	G	A	84	10	0	66	25	3	0.95	0.84	0.05	0.16	A	1.1	0.032107754	Alzheimer's disease late onset	Brain health and disorders
rs964611	C	A	68	21	5	84	10	0	0.84	0.95	0.16	0.05	A	0.15	0.032107754	Metabolite levels Pyroglutamine	General health
rs1471633	A	C	23	50	21	42	45	7	0.51	0.69	0.49	0.31	A	0.059	0.03205298	Urate levels	General health
rs9515201	A	C	13	33	48	26	40	28	0.31	0.49	0.69	0.51	A	1	0.03205298	White matter hyperintensity burden	Brain health and disorders
rs7901695	T	C	50	39	5	31	45	18	0.74	0.57	0.26	0.43	C	1.37	0.032020013	Type 2 diabetes	Diabetes
rs7561966	A	G	58	30	6	35	45	14	0.78	0.61	0.22	0.39	A	0.6809	0.032017325	Palmitic acid 16:0 plasma levels	General health
rs4620914	T	A	3	36	55	13	47	34	0.22	0.39	0.78	0.61	T	0.095	0.032017325	Urate levels in overweight individuals	Obesity
rs11864146	A	G	71	18	5	48	36	10	0.85	0.70	0.15	0.30	A	3.14	0.03196347	Non-alcoholic fatty liver disease histology other	Obesity
rs10795130	T	G	68	24	2	46	40	8	0.85	0.70	0.15	0.30	G	0.103	0.03196347	Sex hormone-binding globulin levels	Reproductive health
rs1775154	T	A	39	49	6	65	26	3	0.68	0.83	0.32	0.17	A	0.45	0.031954102	QT interval	Heart health and disorders
rs112875651	G	A	41	45	8	66	24	4	0.68	0.83	0.32	0.17	G	0.08	0.031954102	Cholesterol, total	General health
rs11259933	G	A	8	45	41	4	24	66	0.32	0.17	0.68	0.83	A	1.19	0.031954102	Height	General health
rs10906982	T	A	8	45	41	4	24	66	0.32	0.17	0.68	0.83	A	0.07	0.031954102	Height	General health
rs7183263	T	G	8	45	41	4	24	66	0.32	0.17	0.68	0.83	G	0.07	0.031954102	Height	General health
rs4842838	G	T	8	45	41	4	24	66	0.32	0.17	0.68	0.83	G	0.06	0.031954102	Height	General health
rs11259936	A	C	8	45	41	4	24	66	0.32	0.17	0.68	0.83	A	0.044	0.031954102	Height	General health
rs7531806	G	A	23	47	24	10	40	44	0.49	0.32	0.51	0.68	A	1.22	0.0319177	Acne severe	Misc
rs102275	T	C	27	39	28	8	44	42	0.49	0.32	0.51	0.68	C	1.08	0.0319177	Crohn's disease	Digestive system and its disorders
rs159788	A	G	0	14	80	2	33	59	0.07	0.20	0.93	0.80	G	1.012	0.031915535	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs73201717	A	T	71	20	3	88	5	1	0.86	0.96	0.14	0.04	T	2.08	0.031893277	Clozapine-induced agranulocytosis	General health
rs2104286	T	C	71	20	3	87	7	0	0.86	0.96	0.14	0.04	T	1.15	0.031893277	Multiple sclerosis	Brain health and disorders
rs12205331	C	T	70	22	2	87	7	0	0.86	0.96	0.14	0.04	T	1.0753	0.031893277	Coronary artery disease	Heart health and disorders
rs11839053	T	C	87	7	0	69	24	1	0.96	0.86	0.04	0.14	C	1	0.031893277	Pediatric autoimmune diseases	Immune diseases and disorders
rs2292303	G	C	70	22	2	87	7	0	0.86	0.96	0.14	0.04	C	0.51	0.031893277	Height	General health
rs11766519	T	C	70	22	2	87	7	0	0.86	0.96	0.14	0.04	C	0.102	0.031893277	Pulse pressure alcohol consumption interaction	General health
rs2271266	T	C	70	22	2	87	7	0	0.86	0.96	0.14	0.04	T	0.077	0.031893277	Height	General health
rs4854912	C	T	66	22	6	82	12	0	0.82	0.94	0.18	0.06	T	1.91	0.031884058	Bipolar disorder and eating disorder	Brain health and disorders
rs10134944	C	T	84	8	2	64	26	4	0.94	0.82	0.06	0.18	T	1.45	0.031884058	Bipolar disorder	Brain health and disorders
rs721048	G	A	61	32	1	82	12	0	0.82	0.94	0.18	0.06	A	1.15	0.031884058	Prostate cancer	Cancer
rs11645366	C	T	63	28	3	82	12	0	0.82	0.94	0.18	0.06	C	1	0.031884058	Cystic fibrosis severity	Immune diseases and disorders
rs9375813	C	A	83	10	1	62	30	2	0.94	0.82	0.06	0.18	A	0.167	0.031884058	C-reactive protein levels	Immune diseases and disorders
rs12150284	C	T	40	41	13	60	31	3	0.64	0.80	0.36	0.20	A	0.62	0.031815611	Intraocular pressure	General health
rs11675841	C	T	36	49	9	59	33	2	0.64	0.80	0.36	0.20	C	0.1458	0.031815611	IgG glycosylation	Immune diseases and disorders
rs1819333	T	G	19	44	31	5	40	49	0.44	0.27	0.56	0.73	C	1.1177828	0.031793343	Crohn's disease	Digestive system and its disorders
rs10788819	C	T	31	44	19	49	40	5	0.56	0.73	0.44	0.27	T	1	0.031793343	Hair morphology	Appearance
rs11191865	G	A	29	36	29	46	35	13	0.50	0.68	0.50	0.32	A	1.25	0.031790979	Interstitial lung disease	Pulmonology
rs10887741	T	C	38	38	18	53	39	2	0.61	0.77	0.39	0.23	T	1.32	0.031713032	Exercise leisure time	Mental aptitude and behavioural traits
rs3852186	G	T	76	17	1	56	32	6	0.90	0.77	0.10	0.23	A	3.17	0.031695319	Diisocyanate-induced asthma	Pulmonology
rs112537273	T	C	55	34	5	76	17	1	0.77	0.90	0.23	0.10	T	1.07	0.031695319	Schizophrenia	Brain health and disorders
rs1566045	T	C	55	34	5	75	19	0	0.77	0.90	0.23	0.10	T	0.06	0.031695319	Bone mineral density	General health
rs12571664	T	C	53	38	3	76	17	1	0.77	0.90	0.23	0.10	T	0.04	0.031695319	Menarche age at onset	Reproductive health
rs10045431	A	C	10	24	60	0	19	75	0.23	0.10	0.77	0.90	C	1.11	0.031695319	Crohn's disease	Digestive system and its disorders
rs6749447	T	G	43	40	11	25	43	26	0.67	0.49	0.33	0.51	G	1.9	0.031672629	Blood pressure	Heart health and disorders
rs1934951	C	T	69	25	0	51	34	9	0.87	0.72	0.13	0.28	T	12.75	0.031663988	Osteonecrosis of the jaw	Immune diseases and disorders
rs12718598	T	C	7	37	50	17	49	28	0.27	0.44	0.73	0.56	T	0.204	0.031577649	Red blood cell traits	Immune diseases and disorders
rs555044	C	A	51	35	8	29	47	18	0.73	0.56	0.27	0.44	A	0.07	0.031577649	Serum metabolite levels	General health
rs13358908	C	T	23	46	25	37	51	6	0.49	0.66	0.51	0.34	C	1.0526316	0.031562473	Schizophrenia	Brain health and disorders
rs1073203	C	G	72	22	0	50	40	4	0.88	0.74	0.12	0.26	G	1.54	0.03155929	Diabetic retinopathy	Diabetes
rs7909235	G	T	54	32	8	76	14	4	0.74	0.88	0.26	0.12	A	0.03	0.03155929	Obesity-related traits	Obesity
rs4809330	A	G	5	38	51	2	18	74	0.26	0.12	0.74	0.88	G	1.12	0.03155929	Crohn's disease	Digestive system and its disorders
rs9290936	G	T	67	21	6	36	54	4	0.82	0.67	0.18	0.33	G	1.79	0.031504027	Waist circumference	General health
rs17029069	C	T	40	46	8	62	31	1	0.67	0.82	0.33	0.18	T	1.29	0.031504027	Cardiac repolarization	Heart health and disorders
rs11245052	T	A	43	40	11	64	27	3	0.67	0.82	0.33	0.18	A	0.3034	0.031504027	Metabolite levels MHPG	General health
rs17157663	G	A	42	42	10	63	29	2	0.67	0.82	0.33	0.18	A	0.18	0.031504027	Quantitative traits	Misc
rs10445672	T	C	63	29	2	38	50	6	0.82	0.67	0.18	0.33	G	0.03	0.031504027	Obesity-related traits	Obesity
rs216026	T	G	2	29	63	5	52	37	0.18	0.33	0.82	0.67	T	0.067	0.031504027	Fractional exhaled nitric oxide childhood	Pulmonology
rs6466055	A	C	9	46	39	28	41	25	0.34	0.52	0.66	0.48	A	1.07	0.03146035	Schizophrenia	Brain health and disorders
rs8066857	C	T	61	28	5	34	52	8	0.80	0.64	0.20	0.36	C	1.48	0.031446541	Amyotrophic lateral sclerosis	Brain health and disorders
rs163184	T	G	38	44	12	59	32	3	0.64	0.80	0.36	0.20	G	1.09	0.031446541	Type 2 diabetes	Diabetes
rs2514218	C	T	41	38	15	57	36	1	0.64	0.80	0.36	0.20	C	1.0787487	0.031446541	Schizophrenia	Brain health and disorders
rs434943	G	A	39	42	13	56	38	0	0.64	0.80	0.36	0.20	A	0.007	0.031446541	Fibrinogen	General health
rs6762477	G	A	15	38	41	2	34	58	0.36	0.20	0.64	0.80	G	2.5	0.031446541	Menarche age at onset	Reproductive health
rs10906466	A	G	13	42	39	2	34	58	0.36	0.20	0.64	0.80	A	1.06	0.031446541	Migraine	Brain health and disorders
rs11979158	A	G	69	21	4	46	39	9	0.85	0.70	0.15	0.30	A	1.23	0.031435445	Glioma	Cancer
rs2305480	G	A	43	45	6	69	21	4	0.70	0.85	0.30	0.15	G	1.18	0.031435445	Asthma	Immune diseases and disorders
rs11845867	C	G	11	22	61	13	49	32	0.23	0.40	0.77	0.60	C	0.0626	0.031422686	Self-reported allergy	General health
rs6909279	G	C	34	45	15	57	30	7	0.60	0.77	0.40	0.23	G	0.09	0.031422686	Bone mineral density	General health
rs56145559	C	T	48	40	6	20	64	10	0.72	0.55	0.28	0.45	T	1.07	0.031372549	Schizophrenia	Brain health and disorders
rs7608623	G	T	12	41	41	23	52	19	0.35	0.52	0.65	0.48	C	0.03	0.031366111	Obesity-related traits	Obesity
rs7009110	T	C	23	43	28	44	34	16	0.47	0.65	0.53	0.35	T	1.14	0.031279621	Asthma and hay fever	Immune diseases and disorders
rs11054935	A	G	59	29	6	79	13	2	0.78	0.91	0.22	0.09	G	1.0779562	0.031229668	Ulcerative colitis	Immune diseases and disorders
rs630923	C	A	59	29	6	79	13	2	0.78	0.91	0.22	0.09	C	1.074	0.031229668	Inflammatory bowel disease	Immune diseases and disorders
rs12571093	G	A	55	37	2	79	13	2	0.78	0.91	0.22	0.09	G	0.313	0.031229668	Optic nerve measurement disc area	Misc
rs6537825	A	G	4	33	57	0	17	77	0.22	0.09	0.78	0.91	A	1.4	0.031229668	Autism	Brain health and disorders
rs560713	A	C	4	33	57	0	17	77	0.22	0.09	0.78	0.91	A	0.53	0.031229668	Intraocular pressure	General health
rs16933829	T	C	89	4	1	72	20	2	0.97	0.87	0.03	0.13	C	4.76	0.031213873	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs7474896	C	T	71	22	1	88	6	0	0.87	0.97	0.13	0.03	T	1.46	0.031213873	Obesity extreme	Obesity
rs11117432	G	A	74	16	4	89	4	1	0.87	0.97	0.13	0.03	G	1.31	0.031213873	Primary biliary cirrhosis	Immune diseases and disorders
rs11044946	C	T	88	6	0	72	20	2	0.97	0.87	0.03	0.13	T	1.1	0.031213873	Schizophrenia	Brain health and disorders
rs17142462	C	T	88	6	0	72	20	2	0.97	0.87	0.03	0.13	A	1	0.031213873	Immune reponse to smallpox secreted IL-12p40	Immune diseases and disorders
rs7534537	T	C	88	6	0	73	18	3	0.97	0.87	0.03	0.13	T	0.0587	0.031213873	Palmitoleic acid 16:1n-7 plasma levels	General health
rs7788657	C	T	89	4	1	73	18	3	0.97	0.87	0.03	0.13	T	0.056	0.031213873	Educational attainment	Mental aptitude and behavioural traits
rs604708	T	C	0	6	88	3	18	73	0.03	0.13	0.97	0.87	C	0.4114	0.031213873	IgG glycosylation	Immune diseases and disorders
rs17589516	A	G	80	14	0	93	1	0	0.93	0.99	0.07	0.01	C	45	0.031209603	Insulin resistance_response	Drug response
rs16950650	C	T	93	1	0	80	14	0	0.99	0.93	0.01	0.07	T	30.2	0.031209603	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	General health
rs7700191	G	A	81	12	1	93	1	0	0.93	0.99	0.07	0.01	A	1.12	0.031209603	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs41314284	C	T	82	10	2	93	1	0	0.93	0.99	0.07	0.01	T	1.09	0.031209603	Schizophrenia	Brain health and disorders
rs114886597	A	G	81	12	1	93	1	0	0.93	0.99	0.07	0.01	A	0.2219	0.031209603	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs1801689	A	C	81	12	1	93	1	0	0.93	0.99	0.07	0.01	C	0.103	0.031209603	LDL cholesterol	General health
rs17668738	T	C	81	12	1	93	1	0	0.93	0.99	0.07	0.01	T	0.07	0.031209603	LDL peak particle diameter total fat intake interaction	General health
rs35694355	G	A	93	1	0	80	14	0	0.99	0.93	0.01	0.07	A	0.03	0.031209603	Obesity-related traits	Obesity
rs8038108	C	A	93	1	0	80	14	0	0.99	0.93	0.01	0.07	C	0.009	0.031209603	Resting oxygen saturation in chronic osbtructive pulmonary disease pulse oxymetry	Pulmonology
rs6022786	A	G	13	41	40	29	42	23	0.36	0.53	0.64	0.47	A	1.13	0.031200756	Polycystic ovary syndrome	Reproductive health
rs4930103	G	A	21	46	27	38	45	11	0.47	0.64	0.53	0.36	A	1	0.031200756	DNA methylation parent-of-origin	Misc
rs568617	C	T	49	37	8	28	47	19	0.72	0.55	0.28	0.45	A	1.0888312	0.031177688	Crohn's disease	Digestive system and its disorders
rs3213764	A	G	28	47	19	47	41	6	0.55	0.72	0.45	0.28	G	0.049	0.031177688	Prostate-specific antigen levels	Cancer
rs1160312	A	G	18	40	36	8	29	57	0.40	0.24	0.60	0.76	A	1.6	0.031145681	Male-pattern baldness	Appearance
rs564343	A	G	30	52	12	53	37	4	0.60	0.76	0.40	0.24	A	1.22	0.031145681	Obesity early onset extreme	Obesity
rs11615866	C	T	85	9	0	68	23	3	0.95	0.85	0.05	0.15	T	2.26	0.031142946	Neuropathic pain in type 2 diabetes	Diabetes
rs4710520	T	C	67	25	2	85	9	0	0.85	0.95	0.15	0.05	C	2.1675	0.031142946	IgG glycosylation	Immune diseases and disorders
rs10065637	C	T	66	27	1	85	9	0	0.85	0.95	0.15	0.05	C	1.123	0.031142946	Crohn's disease	Digestive system and its disorders
rs1506297	T	C	67	25	2	85	9	0	0.85	0.95	0.15	0.05	T	1.06	0.031142946	Schizophrenia	Brain health and disorders
rs2075671	G	A	66	27	1	85	9	0	0.85	0.95	0.15	0.05	A	1	0.031142946	Other erythrocyte phenotypes	Immune diseases and disorders
rs11681792	C	T	70	19	5	86	7	1	0.85	0.95	0.15	0.05	A	1	0.031142946	Behavioural disinhibition generation interaction	Brain health and disorders
rs10826334	C	G	86	7	1	69	21	4	0.95	0.85	0.05	0.15	G	0.529	0.031142946	Mean arterial pressure alcohol consumption interaction	General health
rs16950303	A	G	85	9	0	67	25	2	0.95	0.85	0.05	0.15	A	0.042	0.031142946	Height	General health
rs17766217	T	C	36	48	10	15	57	22	0.64	0.46	0.36	0.54	A	1	0.031129406	Response to anti-depressant treatment in major depressive disorder	General health
rs764255	C	T	14	40	40	28	45	21	0.36	0.54	0.64	0.46	T	0.077	0.031129406	Word reading	Mental aptitude and behavioural traits
rs12545912	G	T	5	29	60	16	37	41	0.21	0.37	0.79	0.63	C	1.3	0.031094527	Multiple myeloma hyperdiploidy	Cancer
rs4958881	T	C	63	28	3	43	39	12	0.82	0.66	0.18	0.34	G	1.73	0.031075638	Myasthenia gravis	Brain health and disorders
rs1028166	G	A	9	45	40	3	28	63	0.34	0.18	0.66	0.82	G	1.49	0.031075638	Colorectal cancer calcium intake interaction	Cancer
rs7203315	G	T	69	24	1	49	37	8	0.86	0.72	0.14	0.28	T	15.83	0.031070196	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs6651252	T	C	70	22	2	55	25	14	0.86	0.72	0.14	0.28	T	1.23	0.031070196	Crohn's disease	Digestive system and its disorders
rs10892569	A	G	71	20	3	50	35	9	0.86	0.72	0.14	0.28	A	0.25	0.031070196	Intraocular pressure	General health
rs12807097	G	A	71	20	3	50	35	9	0.86	0.72	0.14	0.28	A	0.25	0.031070196	Intraocular pressure	General health
rs11824032	G	A	71	20	3	50	35	9	0.86	0.72	0.14	0.28	A	0.24	0.031070196	Intraocular pressure	General health
rs4243830	C	T	2	22	70	4	45	45	0.14	0.28	0.86	0.72	C	0.03	0.031070196	Body mass index	Obesity
rs13181561	G	A	21	44	29	36	47	11	0.46	0.63	0.54	0.37	G	1	0.031065469	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs7325564	T	C	14	41	39	29	44	21	0.37	0.54	0.63	0.46	C	0.2463	0.031065469	IgG glycosylation	Immune diseases and disorders
rs60490158	G	A	17	52	25	34	51	9	0.46	0.63	0.54	0.37	A	0.077	0.031065469	Sitting height ratio	Appearance
rs614092	T	A	13	44	37	26	51	17	0.37	0.55	0.63	0.45	A	0.03570385	0.031008856	LDL peak particle diameter total fat intake interaction	General health
rs4132568	A	C	20	45	29	39	40	15	0.45	0.63	0.55	0.37	A	0.0343	0.031008856	Nicotine glucouronidation	Brain health and disorders
rs6441286	T	G	31	40	23	47	40	7	0.54	0.71	0.46	0.29	G	1.54	0.030992736	Primary biliary cirrhosis	Immune diseases and disorders
rs10997979	A	G	32	38	24	46	42	6	0.54	0.71	0.46	0.29	A	0.021	0.030992736	Height	General health
rs58667	C	T	19	48	27	9	36	49	0.46	0.29	0.54	0.71	A	0.18	0.030992736	Pulmonary function in asthmatics	Pulmonology
rs2548145	G	A	20	46	28	9	36	49	0.46	0.29	0.54	0.71	G	0.081	0.030992736	Alcoholism alcohol use disorder factor score	General health
rs1478897	T	A	17	50	27	35	47	12	0.45	0.62	0.55	0.38	T	1.56	0.030959488	Systemic lupus erythematosus	Immune diseases and disorders
rs28498976	G	A	36	45	13	16	52	26	0.62	0.45	0.38	0.55	A	1.11	0.030959488	Epilepsy	Brain health and disorders
rs11886999	T	C	46	38	10	66	26	2	0.69	0.84	0.31	0.16	T	0.04	0.030934343	Cardiac Troponin-T levels	Heart health and disorders
rs2296743	C	T	45	40	9	68	22	4	0.69	0.84	0.31	0.16	A	0.03	0.030934343	Obesity-related traits	Obesity
rs2312147	T	C	11	36	47	1	28	65	0.31	0.16	0.69	0.84	C	1.09	0.030934343	Schizophrenia	Brain health and disorders
rs908922	G	A	9	27	58	1	18	75	0.24	0.11	0.76	0.89	A	1	0.030917635	Hair morphology	Appearance
rs3827760	A	G	54	35	5	76	16	2	0.76	0.89	0.24	0.11	G	1	0.030917635	Ear morphology	Appearance
rs742004	G	A	54	35	5	75	18	1	0.76	0.89	0.24	0.11	A	0.2973	0.030917635	Metabolite levels HVA_MHPG ratio	Brain health and disorders
rs6009583	C	T	58	27	9	77	14	3	0.76	0.89	0.24	0.11	C	0.03	0.030917635	Menarche age at onset	Reproductive health
rs11152213	A	C	76	16	2	53	37	4	0.89	0.76	0.11	0.24	A	0.025	0.030917635	Height	General health
rs4964469	G	A	38	40	16	16	51	27	0.62	0.44	0.38	0.56	A	1.16	0.030917298	Parkinson's disease	Brain health and disorders
rs17234657	T	G	80	13	1	58	34	2	0.92	0.80	0.08	0.20	G	1.54	0.030901338	Crohn's disease	Digestive system and its disorders
rs8041227	G	A	63	24	7	79	15	0	0.80	0.92	0.20	0.08	G	1.52	0.030901338	Eosinophilic esophagitis	Digestive system and its disorders
rs139014	T	C	80	13	1	56	38	0	0.92	0.80	0.08	0.20	C	0.1994	0.030901338	IgG glycosylation	Immune diseases and disorders
rs12150660	G	T	59	32	3	82	9	3	0.80	0.92	0.20	0.08	T	0.11	0.030901338	Sex hormone-binding globulin levels	Reproductive health
rs1422110	A	G	5	28	61	2	11	81	0.20	0.08	0.80	0.92	G	0.19	0.030901338	Attention function in attention deficit hyperactive disorder	Brain health and disorders
rs12280753	C	T	73	19	2	52	35	7	0.88	0.74	0.12	0.26	T	0.69	0.030884503	Cardiovascular disease risk factors	Heart health and disorders
rs1364477	A	G	54	31	9	71	23	0	0.74	0.88	0.26	0.12	G	0.1816	0.030884503	IgG glycosylation	Immune diseases and disorders
rs9548119	T	A	52	35	7	74	17	3	0.74	0.88	0.26	0.12	A	0.03	0.030884503	Self-rated health	General health
rs877819	A	G	31	44	19	13	47	34	0.56	0.39	0.44	0.61	A	1.46	0.030882228	Systemic lupus erythematosus	Immune diseases and disorders
rs6906021	T	C	35	45	14	17	48	29	0.61	0.44	0.39	0.56	C	0.0945	0.030882228	Self-reported allergy	General health
rs362987	A	C	31	44	19	15	43	36	0.56	0.39	0.44	0.61	A	0.02	0.030882228	Educational attainment	Mental aptitude and behavioural traits
rs347313	A	G	32	47	15	52	38	4	0.59	0.76	0.41	0.24	G	0.249	0.030881455	Body mass index change over time	Obesity
rs1532423	A	G	16	45	33	6	34	54	0.41	0.24	0.59	0.76	A	0.178	0.030881455	Blood trace element Zn levels	Heart health and disorders
rs6954895	T	C	53	36	5	32	47	15	0.76	0.59	0.24	0.41	G	0.16	0.030881455	Anger	General health
rs2057681	A	G	27	54	13	13	49	32	0.57	0.40	0.43	0.60	G	1	0.030833263	Paraoxonase activity	Diabetes
rs1541364	G	A	22	36	36	30	53	11	0.43	0.60	0.57	0.40	G	1.24	0.030833263	Bronchopulmonary dysplasia	Pulmonology
rs376592364	A	T	34	41	19	10	56	28	0.58	0.40	0.42	0.60	T	1.2	0.030819301	Prostate cancer	Cancer
rs12118721	T	C	17	45	32	32	48	14	0.42	0.60	0.58	0.40	T	1.06	0.030819301	Myocardial infarction	Heart health and disorders
rs11775334	A	G	17	45	32	34	44	16	0.42	0.60	0.58	0.40	A	0.08	0.030819301	Hypertension	Heart health and disorders
rs6591182	T	G	25	51	18	44	45	5	0.54	0.71	0.46	0.29	A	0.54	0.030817383	Non-alcoholic fatty liver disease histology lobular	Obesity
rs6465825	T	C	45	43	6	25	51	18	0.71	0.54	0.29	0.46	C	0.01	0.030817383	Chronic kidney disease	Immune diseases and disorders
rs11785400	C	T	33	45	16	17	44	33	0.59	0.41	0.41	0.59	T	1.06	0.030812325	Schizophrenia	Brain health and disorders
rs2859113	C	G	19	39	36	32	46	16	0.41	0.59	0.59	0.41	C	0.1817	0.030812325	IgG glycosylation	Immune diseases and disorders
rs340874	T	C	36	46	12	58	32	4	0.63	0.79	0.37	0.21	C	1	0.030758715	Fasting glucose-related traits	General health
rs16982515	C	G	81	13	0	60	33	1	0.93	0.81	0.07	0.19	C	0.3117	0.03074187	IgG glycosylation	Immune diseases and disorders
rs10065350	C	T	76	14	4	89	5	0	0.88	0.97	0.12	0.03	C	0.2004	0.030669638	IgG glycosylation	Immune diseases and disorders
rs13191362	A	G	73	20	1	89	5	0	0.88	0.97	0.12	0.03	A	0.03	0.030669638	Body mass index	Obesity
rs11065706	T	C	42	40	12	63	27	4	0.66	0.81	0.34	0.19	T	1	0.030667688	Heart rate	General health
rs11158198	A	C	41	42	11	62	29	3	0.66	0.81	0.34	0.19	C	0.286	0.030667688	Dementia and core Alzheimer's disease neuropathologic changes	Brain health and disorders
rs7980687	G	A	62	29	3	42	40	12	0.81	0.66	0.19	0.34	A	0.029	0.030667688	Educational attainment	Mental aptitude and behavioural traits
rs2244020	A	G	10	44	40	2	31	61	0.34	0.19	0.66	0.81	G	1.11	0.030667688	Type 2 diabetes	Diabetes
rs2571445	A	G	7	50	37	3	29	62	0.34	0.19	0.66	0.81	G	0.035	0.030667688	Pulmonary function	Pulmonology
rs499974	C	A	67	27	0	47	40	7	0.86	0.71	0.14	0.29	A	0.026	0.030508475	HDL cholesterol	General health
rs13217239	T	C	47	37	10	24	51	19	0.70	0.53	0.30	0.47	T	1.09	0.030494342	Schizophrenia	Brain health and disorders
rs9574565	T	C	10	37	47	18	53	23	0.30	0.47	0.70	0.53	C	1.31	0.030494342	Orofacial clefts	Misc
rs2909457	G	A	23	43	28	9	39	46	0.47	0.30	0.53	0.70	G	1.0638298	0.030494342	Schizophrenia	Brain health and disorders
rs2581794	G	A	46	37	11	66	25	3	0.69	0.84	0.31	0.16	A	1.06	0.03045843	Schizophrenia	Brain health and disorders
rs6504950	G	A	66	25	3	46	37	11	0.84	0.69	0.16	0.31	G	1.06	0.03045843	Breast cancer	Cancer
rs2070488	G	A	39	39	16	62	23	9	0.62	0.78	0.38	0.22	A	5	0.030438312	Electrocardiographic conduction measures	Heart health and disorders
rs12435940	A	G	0	2	92	0	16	78	0.01	0.09	0.99	0.91	A	0.485	0.030415891	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs61921502	T	G	78	16	0	92	2	0	0.91	0.99	0.09	0.01	T	39.9	0.030415891	Subcortical brain region volumes	Brain health and disorders
rs6772209	G	A	92	2	0	79	14	1	0.99	0.91	0.01	0.09	G	1.49	0.030415891	Esophageal cancer	Cancer
rs17700144	G	A	79	14	1	92	2	0	0.91	0.99	0.09	0.01	A	1.22	0.030415891	Obesity early onset extreme	Obesity
rs13204742	G	T	79	14	1	92	2	0	0.91	0.99	0.09	0.01	T	1.173	0.030415891	Crohn's disease	Digestive system and its disorders
rs2277912	T	G	78	16	0	92	2	0	0.91	0.99	0.09	0.01	G	1.07	0.030415891	Height	General health
rs3796352	C	T	80	12	2	92	2	0	0.91	0.99	0.09	0.01	A	1	0.030415891	Immune reponse to smallpox secreted IL-2	Immune diseases and disorders
rs508487	C	T	81	10	3	92	2	0	0.91	0.99	0.09	0.01	T	0.235	0.030415891	Cardiovascular disease risk factors	Heart health and disorders
rs2193071	G	A	92	2	0	79	14	1	0.99	0.91	0.01	0.09	A	0.03	0.030415891	Obesity-related traits	Obesity
rs7952106	G	T	16	47	31	7	34	53	0.42	0.26	0.58	0.74	G	1.54	0.030389274	Systolic blood pressure in sickle cell anemia	Heart health and disorders
rs1034566	C	T	58	30	6	76	18	0	0.78	0.90	0.22	0.10	T	2.128	0.030379747	Platelet count	Heart health and disorders
rs968451	G	T	57	32	5	78	14	2	0.78	0.90	0.22	0.10	T	1.27	0.030379747	Primary biliary cirrhosis	Immune diseases and disorders
rs12643440	C	T	58	30	6	76	18	0	0.78	0.90	0.22	0.10	C	0.17	0.030379747	Metabolite levels Pyroglutamine	General health
rs312274	T	A	55	36	3	77	16	1	0.78	0.90	0.22	0.10	A	0.05	0.030379747	Metabolite levels  X-11787	General health
rs5415	T	C	4	34	56	1	16	77	0.22	0.10	0.78	0.90	T	0.034	0.030379747	Birth weight	Misc
rs419132	A	G	45	40	9	28	42	24	0.69	0.52	0.31	0.48	G	0.056	0.030346136	Triglycerides	General health
rs12211360	A	G	75	18	1	90	4	0	0.89	0.98	0.11	0.02	A	0.16	0.03030303	Adiponectin levels	Obesity
rs2043090	A	G	77	14	3	90	4	0	0.89	0.98	0.11	0.02	A	0.119	0.03030303	Anorexia nervosa	Brain health and disorders
rs17143586	C	A	90	4	0	76	16	2	0.98	0.89	0.02	0.11	A	0.03	0.03030303	Obesity-related traits	Obesity
rs7734448	G	A	90	4	0	74	20	0	0.98	0.89	0.02	0.11	A	0.03	0.03030303	Obesity-related traits	Obesity
rs6708166	G	A	38	47	9	60	32	2	0.65	0.81	0.35	0.19	A	0.17	0.030279028	vWF and FVIII levels	Heart health and disorders
rs2762051	C	T	54	30	10	72	20	2	0.73	0.87	0.27	0.13	A	1.13	0.030248792	Celiac disease	Immune diseases and disorders
rs11203203	G	A	57	24	13	70	24	0	0.73	0.87	0.27	0.13	A	1.11	0.030248792	Rheumatoid arthritis	Immune diseases and disorders
rs2185077	T	C	2	20	72	6	38	50	0.13	0.27	0.87	0.73	T	1.07	0.030248792	Schizophrenia	Brain health and disorders
rs12120956	G	A	50	38	6	73	18	3	0.73	0.87	0.27	0.13	A	0.025	0.030248792	Height	General health
rs75718479	C	A	69	23	2	86	8	0	0.86	0.96	0.14	0.04	C	1.22	0.030247172	Prostate cancer	Cancer
rs8067912	T	C	87	6	1	67	27	0	0.96	0.86	0.04	0.14	C	0.4565	0.030247172	IgG glycosylation	Immune diseases and disorders
rs1408282	G	A	69	23	2	86	8	0	0.86	0.96	0.14	0.04	A	0.412	0.030247172	C-reactive protein	Immune diseases and disorders
rs17183295	C	T	69	23	2	86	8	0	0.86	0.96	0.14	0.04	T	0.131	0.030247172	Refractive error	General health
rs2513900	G	C	24	43	27	7	45	42	0.48	0.31	0.52	0.69	C	0.23	0.03020649	Airway imaging phenotypes	Pulmonology
rs2075292	G	T	9	28	57	3	15	76	0.24	0.11	0.76	0.89	G	8.7	0.030188862	Triglycerides	General health
rs6972204	T	C	73	21	0	49	44	1	0.89	0.76	0.11	0.24	G	0.03	0.030188862	Obesity-related traits	Obesity
rs2019872	C	T	2	14	78	0	3	91	0.10	0.02	0.90	0.98	C	1.0752687	0.030181087	Schizophrenia	Brain health and disorders
rs1339738	C	T	0	18	76	0	3	91	0.10	0.02	0.90	0.98	C	0.2911	0.030181087	IgG glycosylation	Immune diseases and disorders
rs14271	C	T	91	3	0	77	16	1	0.98	0.90	0.02	0.10	A	34.08	0.030181087	Diisocyanate-induced asthma	Pulmonology
rs2274459	G	A	79	12	3	91	3	0	0.90	0.98	0.10	0.02	A	1.38	0.030181087	Obesity extreme	Obesity
rs12812736	T	C	76	18	0	91	3	0	0.90	0.98	0.10	0.02	T	0.55	0.030181087	Depressive symptoms SSRI exposure interaction	Brain health and disorders
rs8014194	T	A	52	35	7	30	48	16	0.74	0.57	0.26	0.43	A	1	0.030160374	Response to statin therapy	General health
rs16962638	A	G	94	0	0	83	11	0	1.00	0.94	0.00	0.06	C	15	0.030136986	Insulin resistance_response	Drug response
rs13375391	G	A	94	0	0	83	11	0	1.00	0.94	0.00	0.06	A	5.82	0.030136986	QRS duration	Heart health and disorders
rs7122209	T	C	94	0	0	83	11	0	1.00	0.94	0.00	0.06	C	1.98	0.030136986	Antibody level in response to infection	Immune diseases and disorders
rs12245299	T	C	94	0	0	83	11	0	1.00	0.94	0.00	0.06	T	1.392	0.030136986	Airway responsiveness in chronic obstructive pulmonary disease	Pulmonology
rs76280858	C	T	94	0	0	83	11	0	1.00	0.94	0.00	0.06	T	0.21	0.030136986	Cannabis use age at onset	General health
rs627871	C	A	94	0	0	83	11	0	1.00	0.94	0.00	0.06	A	0.03	0.030136986	Obesity-related traits	Obesity
rs12073504	C	G	94	0	0	83	11	0	1.00	0.94	0.00	0.06	G	0.03	0.030136986	Obesity-related traits	Obesity
rs1665650	T	C	10	22	62	14	44	36	0.22	0.38	0.78	0.62	T	1.13	0.030132583	Colorectal cancer	Cancer
rs2128739	A	C	7	28	59	14	44	36	0.22	0.38	0.78	0.62	A	1.07	0.030132583	Coronary artery disease	Heart health and disorders
rs822354	A	G	16	40	38	8	26	60	0.38	0.22	0.62	0.78	A	1	0.030132583	Adiponectin levels	Obesity
rs17691453	T	C	37	42	15	55	36	3	0.62	0.78	0.38	0.22	C	0.1	0.030132583	Metabolite levels Dihydroxy docosatrienoic acid	General health
rs7158359	A	G	42	44	8	19	58	17	0.68	0.51	0.32	0.49	G	2.27	0.030075188	Weight loss gastric bypass surgery	Obesity
rs2336384	G	T	23	46	25	10	40	44	0.49	0.32	0.51	0.68	G	2.172	0.030075188	Platelet count	Heart health and disorders
rs12692432	C	T	24	48	22	46	36	12	0.51	0.68	0.49	0.32	C	0.2855	0.030075188	Metabolite levels HVA_MHPG ratio	Brain health and disorders
rs2458413	C	T	45	38	11	64	28	2	0.68	0.83	0.32	0.17	A	1.4	0.030006124	Paget's disease	General health
rs12642133	G	A	45	38	11	64	28	2	0.68	0.83	0.32	0.17	A	1	0.030006124	Mammographic density dense area	Reproductive health
rs6758290	T	C	44	40	10	64	28	2	0.68	0.83	0.32	0.17	T	0.04	0.030006124	Menarche age at onset	Reproductive health
rs301801	T	C	65	26	3	44	40	10	0.83	0.68	0.17	0.32	C	0.016	0.030006124	Optic cup area	Misc
rs2763339	T	G	9	42	43	1	30	63	0.32	0.17	0.68	0.83	T	1	0.030006124	Early childhood aggressive behavior	Mental aptitude and behavioural traits
rs11611246	G	T	48	37	9	67	26	1	0.71	0.85	0.29	0.15	T	0.024	0.029976562	Body mass index	Obesity
rs8015959	C	T	80	12	2	61	27	6	0.91	0.79	0.09	0.21	T	1.59	0.029963183	Bipolar disorder	Brain health and disorders
rs1024889	A	G	59	31	4	79	14	1	0.79	0.91	0.21	0.09	G	0.12	0.029963183	Body mass index	Obesity
rs266717	T	C	22	49	23	8	45	41	0.49	0.32	0.51	0.68	C	1.07	0.02995203	Adiponectin levels	Obesity
rs9859260	C	T	22	51	21	41	45	8	0.51	0.68	0.49	0.32	C	1	0.02995203	Mean corpuscular volume	Heart health and disorders
rs172166	C	G	50	38	6	32	43	19	0.73	0.57	0.27	0.43	C	0.04	0.029942359	Cardiac Troponin-T levels	Heart health and disorders
rs4510766	A	G	37	48	9	60	31	3	0.65	0.80	0.35	0.20	A	1.2	0.029908603	Ulcerative colitis	Immune diseases and disorders
rs11047526	C	G	39	44	11	58	35	1	0.65	0.80	0.35	0.20	G	0.0031	0.029908603	Calcium levels	General health
rs1495377	G	C	13	40	41	5	27	62	0.35	0.20	0.65	0.80	G	1.28	0.029908603	Type 2 diabetes	Diabetes
rs1557305	C	T	34	47	13	58	29	7	0.61	0.77	0.39	0.23	C	1.11	0.029840849	Eating disorders	Brain health and disorders
rs12882679	G	A	33	49	12	55	35	4	0.61	0.77	0.39	0.23	G	0.057	0.029840849	Underweight status	General health
rs2469434	T	C	43	40	11	24	46	24	0.67	0.50	0.33	0.50	C	1.11	0.02983683	Rheumatoid arthritis	Immune diseases and disorders
rs7163757	C	T	22	50	22	8	46	40	0.50	0.33	0.50	0.67	C	1.06	0.02983683	Type 2 diabetes	Diabetes
rs2957613	C	T	84	10	0	67	24	3	0.95	0.84	0.05	0.16	T	1.09	0.029761905	Schizophrenia	Brain health and disorders
rs9821630	A	G	66	26	2	84	10	0	0.84	0.95	0.16	0.05	G	1.08	0.029761905	Multiple sclerosis	Brain health and disorders
rs12664111	A	G	69	20	5	84	10	0	0.84	0.95	0.16	0.05	G	0.2425	0.029761905	IgG glycosylation	Immune diseases and disorders
rs4325129	A	G	68	22	4	85	8	1	0.84	0.95	0.16	0.05	G	0.03	0.029761905	Obesity-related traits	Obesity
rs745962	T	C	4	22	68	0	10	84	0.16	0.05	0.84	0.95	T	1	0.029761905	Hormone measurements	General health
rs9274477	A	G	51	35	8	27	52	15	0.73	0.56	0.27	0.44	G	1.82	0.029734831	Narcolepsy age of onset	Brain health and disorders
rs2121875	C	A	32	42	20	50	37	7	0.56	0.73	0.44	0.27	G	1.05	0.029734831	Prostate cancer	Cancer
rs12680109	T	C	31	44	19	51	35	8	0.56	0.73	0.44	0.27	T	1	0.029734831	Attention deficit hyperactivity disorder	Brain health and disorders
rs4737009	G	A	53	31	10	30	46	18	0.73	0.56	0.27	0.44	A	0.08	0.029734831	Glycated hemoglobin levels	Diabetes
rs3771512	C	A	61	30	3	81	12	1	0.81	0.93	0.19	0.07	A	740.3	0.029693252	Superior frontal gyrus grey matter volume	Misc
rs2820651	C	A	80	14	0	60	32	2	0.93	0.81	0.07	0.19	A	1.22	0.029693252	Migraine with aura	Brain health and disorders
rs698813	A	G	5	26	63	1	12	81	0.19	0.07	0.81	0.93	C	4.27	0.029693252	Adverse response to chemotherapy in breast cancer alopecia paclitaxel	General health
rs6671200	A	C	1	12	81	3	30	61	0.07	0.19	0.93	0.81	A	0.2461	0.029693252	Stearic acid 18:0 plasma levels	General health
rs4780805	A	G	2	32	60	0	14	80	0.19	0.07	0.81	0.93	A	0.19	0.029693252	Sleep duration	General health
rs7613051	G	A	72	19	3	51	35	8	0.87	0.73	0.13	0.27	A	1.29	0.029649123	Atopic dermatitis	Immune diseases and disorders
rs11829119	T	C	71	21	2	51	35	8	0.87	0.73	0.13	0.27	C	0.4991	0.029649123	Pharmacokinetics of antiepileptic drugs in severe mental disorder concentration drug ratio	General health
rs10952132	C	T	70	23	1	49	39	6	0.87	0.73	0.13	0.27	T	0.31	0.029649123	Response to fenofibrate	General health
rs10784502	C	T	8	48	38	27	42	25	0.34	0.51	0.66	0.49	C	9006.71	0.02962963	Brain structure	Brain health and disorders
rs2145270	C	T	11	42	41	25	46	23	0.34	0.51	0.66	0.49	T	1	0.02962963	Body mass index	Obesity
rs11236809	T	G	64	27	3	82	12	0	0.82	0.94	0.18	0.06	G	1.24	0.029607251	Atopic dermatitis	Immune diseases and disorders
rs12926729	G	A	64	27	3	82	12	0	0.82	0.94	0.18	0.06	A	1	0.029607251	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs10050311	C	T	54	37	3	76	17	1	0.77	0.90	0.23	0.10	T	0.25	0.029587015	Insulin-related traits	Diabetes
rs3817198	T	C	58	29	7	76	17	1	0.77	0.90	0.23	0.10	C	0.14	0.029587015	Mammographic density dense area	Reproductive health
rs13266634	C	T	55	35	4	76	17	1	0.77	0.90	0.23	0.10	A	0.05	0.029587015	Glycated hemoglobin levels	Diabetes
rs12885454	C	A	53	39	2	76	17	1	0.77	0.90	0.23	0.10	C	0.023	0.029587015	Body mass index	Obesity
rs7336933	G	A	76	17	1	55	35	4	0.90	0.77	0.10	0.23	A	0.022	0.029587015	Calcium levels	General health
rs7657746	A	G	62	31	1	41	45	8	0.82	0.68	0.18	0.32	G	1.0890222	0.029575977	Crohn's disease	Digestive system and its disorders
rs1525293	C	T	31	52	11	53	38	3	0.61	0.77	0.39	0.23	C	1.7041	0.029562475	Major depressive disorder	Brain health and disorders
rs2280630	C	T	52	40	2	31	52	11	0.77	0.61	0.23	0.39	T	1	0.029562475	Verbal declarative memory	Brain health and disorders
rs2497306	A	C	40	34	20	53	38	3	0.61	0.77	0.39	0.23	C	0.04	0.029562475	Dehydroepiandrosterone sulphate levels	Immune diseases and disorders
rs8093763	G	A	59	32	3	36	49	9	0.80	0.64	0.20	0.36	A	0.18	0.029555438	Response to bleomycin chromatid breaks	General health
rs12429252	A	G	62	26	6	35	51	8	0.80	0.64	0.20	0.36	G	0.117	0.029555438	Fractional exhaled nitric oxide childhood	Pulmonology
rs2489279	C	G	40	41	13	59	32	3	0.64	0.80	0.36	0.20	C	0.038	0.029555438	HDL cholesterol	General health
rs1345467	G	A	3	32	59	14	39	41	0.20	0.36	0.80	0.64	G	0.01	0.029555438	Vertical cup-disc ratio	Misc
rs61201007	C	T	52	32	10	29	47	18	0.72	0.56	0.28	0.44	T	1.54	0.029537421	Proteinuria in chronic kidney disease	General health
rs1043515	A	G	31	43	20	47	42	5	0.56	0.72	0.44	0.28	A	0.023	0.029537421	Height	General health
rs11761231	T	C	18	47	29	5	42	47	0.44	0.28	0.56	0.72	G	1.44	0.029537421	Rheumatoid arthritis	Immune diseases and disorders
rs4712652	G	A	19	45	30	6	40	48	0.44	0.28	0.56	0.72	A	1.2	0.029537421	Obesity	Obesity
rs10776612	C	T	40	43	11	21	49	24	0.65	0.48	0.35	0.52	T	1.33	0.029537325	Conduct disorder	Brain health and disorders
rs6885224	C	T	28	41	25	11	43	40	0.52	0.35	0.48	0.65	C	1.24	0.029537325	Myopia pathological	General health
rs1014246	C	T	39	45	10	26	39	29	0.65	0.48	0.35	0.52	T	0.04	0.029537325	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs4129585	A	C	5	37	52	1	20	73	0.25	0.12	0.75	0.88	A	1.091	0.029504792	Schizophrenia	Brain health and disorders
rs1209950	C	T	48	36	10	68	23	3	0.70	0.85	0.30	0.15	T	4.96	0.029472408	Non-small cell lung cancer survival	Cancer
rs9594293	G	A	66	27	1	47	38	9	0.85	0.70	0.15	0.30	A	0.229	0.029472408	Cytomegalovirus antibody response	Immune diseases and disorders
rs6708331	G	A	68	23	3	49	34	11	0.85	0.70	0.15	0.30	A	0.04	0.029472408	Obesity-related traits	Obesity
rs231906	G	A	25	48	21	10	46	38	0.52	0.35	0.48	0.65	A	1.51	0.02945237	QT interval	Heart health and disorders
rs9611198	A	C	29	40	25	12	42	40	0.52	0.35	0.48	0.65	C	1.22	0.02945237	Schizophrenia	Brain health and disorders
rs6084946	G	C	40	42	12	10	70	14	0.65	0.48	0.35	0.52	C	0.2176	0.02945237	IgG glycosylation	Immune diseases and disorders
rs2693676	A	G	41	40	13	23	44	27	0.65	0.48	0.35	0.52	A	0.0435	0.02945237	Corneal curvature	General health
rs1484642	G	C	0	7	87	1	23	70	0.04	0.13	0.96	0.87	C	1.43	0.02943314	Bipolar disorder and schizophrenia	Brain health and disorders
rs10790162	A	G	2	21	71	0	7	87	0.13	0.04	0.87	0.96	A	0.39	0.02943314	Waist Circumference - Triglycerides WC-TG	General health
rs2482109	G	A	3	19	72	1	5	88	0.13	0.04	0.87	0.96	G	0.2978	0.02943314	Metabolite levels HVA_MHPG ratio	Brain health and disorders
rs12529935	C	T	72	19	3	87	7	0	0.87	0.96	0.13	0.04	C	1.3514	0.02943314	Systemic lupus erythematosus	Immune diseases and disorders
rs11636768	G	A	69	25	0	87	7	0	0.87	0.96	0.13	0.04	A	1.248	0.02943314	Migraine	Brain health and disorders
rs17826816	A	G	70	23	1	87	7	0	0.87	0.96	0.13	0.04	G	1.14	0.02943314	Bipolar disorder	Brain health and disorders
rs116237496	T	C	87	7	0	70	23	1	0.96	0.87	0.04	0.13	T	1.0422	0.02943314	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs7483296	A	T	70	23	1	87	7	0	0.87	0.96	0.13	0.04	T	0.3152	0.02943314	Metabolite levels HVA_MHPG ratio	Brain health and disorders
rs6904416	T	C	72	19	3	87	7	0	0.87	0.96	0.13	0.04	C	0.183	0.02943314	C-reactive protein and white blood cell count	Immune diseases and disorders
rs675209	T	C	10	47	37	28	43	23	0.36	0.53	0.64	0.47	T	4.39	0.029374641	Urate levels	General health
rs929351	T	G	24	56	14	49	37	8	0.55	0.72	0.45	0.28	C	1	0.029349785	Ulcerative colitis	Immune diseases and disorders
rs3846663	C	T	30	44	20	50	35	9	0.55	0.72	0.45	0.28	T	0.21	0.029349785	Quantitative traits	Misc
rs936229	A	G	7	39	48	18	48	28	0.28	0.45	0.72	0.55	G	1.685	0.029349785	Adverse response to chemotherapy neutropenia_leucopenia carboplatin	Drug response
rs1629826	G	A	8	37	49	17	50	27	0.28	0.45	0.72	0.55	G	0.04	0.029349785	Obesity-related traits	Obesity
rs2062541	G	A	13	42	39	27	46	21	0.36	0.53	0.64	0.47	A	0.018	0.029304029	Blood metabolite ratios	Heart health and disorders
rs2273601	G	A	53	37	4	35	43	16	0.76	0.60	0.24	0.40	A	1	0.029296875	QT interval interaction	Heart health and disorders
rs2224538	T	C	32	49	13	57	29	8	0.60	0.76	0.40	0.24	T	0.017	0.029296875	Height	General health
rs7178572	A	G	12	45	37	27	47	20	0.37	0.54	0.63	0.46	G	1.11	0.029240434	Type 2 diabetes	Diabetes
rs6564851	T	G	20	47	27	37	45	12	0.46	0.63	0.54	0.37	G	0.15	0.029240434	Carotenoid and tocopherol levels	General health
rs1983474	A	C	7	25	62	13	42	39	0.21	0.36	0.79	0.64	C	0.13	0.029218636	Osteoarthritis biomarkers	General health
rs7226408	C	T	58	33	3	35	50	9	0.79	0.64	0.21	0.36	A	0.03	0.029218636	Obesity-related traits	Obesity
rs470119	T	C	19	48	27	38	42	14	0.46	0.63	0.54	0.37	T	0.074	0.029183767	Mean corpuscular hemoglobin	Heart health and disorders
rs6752828	C	T	20	46	28	36	46	12	0.46	0.63	0.54	0.37	C	0.021	0.029183767	Body mass index	Obesity
rs3824789	G	A	52	30	12	32	39	23	0.71	0.55	0.29	0.45	A	0.03	0.029171599	Obesity-related traits	Obesity
rs1046934	A	C	40	46	8	61	32	1	0.67	0.82	0.33	0.18	A	0.044	0.029166667	Height	General health
rs4144743	T	C	65	24	5	42	42	10	0.82	0.67	0.18	0.33	C	0.023	0.029166667	Body mass index	Obesity
rs6431393	A	G	28	47	19	10	51	33	0.55	0.38	0.45	0.62	A	0.0776	0.029133948	Menarche age at onset	Reproductive health
rs11612508	A	G	59	30	5	79	13	2	0.79	0.91	0.21	0.09	G	1.058	0.029093109	Inflammatory bowel disease	Immune diseases and disorders
rs1006899	A	G	77	17	0	54	40	0	0.91	0.79	0.09	0.21	A	0.09	0.029093109	Bone mineral density spine	General health
rs11254160	G	A	80	11	3	60	28	6	0.91	0.79	0.09	0.21	A	0.04	0.029093109	Obesity-related traits	Obesity
rs16958148	T	G	61	26	7	77	17	0	0.79	0.91	0.21	0.09	T	0.002	0.029093109	Trans fatty acid levels	General health
rs266719	T	C	6	28	60	1	15	78	0.21	0.09	0.79	0.91	T	0.13	0.029093109	Adiponectin levels	Obesity
rs3126085	G	A	32	52	10	16	52	26	0.62	0.45	0.38	0.55	A	1.22	0.029090909	Atopic dermatitis	Immune diseases and disorders
rs10207392	A	G	36	44	14	13	58	23	0.62	0.45	0.38	0.55	G	0.132	0.029090909	Red blood cell traits	Immune diseases and disorders
rs35158985	A	G	35	46	13	17	50	27	0.62	0.45	0.38	0.55	G	0.095	0.029090909	Cutaneous malignant melanoma	Cancer
rs7403856	A	G	3	46	45	0	26	68	0.28	0.14	0.72	0.86	A	0.03	0.029082774	Obesity-related traits	Obesity
rs1943816	A	G	70	22	2	53	30	11	0.86	0.72	0.14	0.28	C	1	0.029082774	Cerebrospinal P-tau181p levels	Brain health and disorders
rs11066587	C	G	71	20	3	48	40	6	0.86	0.72	0.14	0.28	G	0.26	0.029082774	Quantitative traits	Misc
rs4938802	A	G	71	20	3	51	34	9	0.86	0.72	0.14	0.28	A	0.24	0.029082774	Intraocular pressure	General health
rs11223731	G	A	48	40	6	73	16	5	0.72	0.86	0.28	0.14	A	0.1101	0.029082774	Verbal declarative memory	Brain health and disorders
rs1616122	C	T	27	51	16	16	41	37	0.56	0.39	0.44	0.61	T	1.85	0.029054591	Periodontal microbiota	Misc
rs1414896	G	A	16	51	27	34	47	13	0.44	0.61	0.56	0.39	G	0.26	0.029054591	Non-alcoholic fatty liver disease histology AST	Obesity
rs2101521	G	A	35	45	14	13	57	24	0.61	0.44	0.39	0.56	A	0.1374	0.029054591	Self-reported allergy	General health
rs2839619	G	A	13	47	34	29	47	18	0.39	0.56	0.61	0.44	G	0.13	0.029054591	Biochemical measures	General health
rs9540493	A	G	18	47	29	35	45	14	0.44	0.61	0.56	0.39	A	0.018	0.029054591	Body mass index	Obesity
rs3087243	G	A	29	54	11	52	38	4	0.60	0.76	0.40	0.24	A	1	0.029043501	Type 1 diabetes	Diabetes
rs10903027	C	T	34	44	16	52	38	4	0.60	0.76	0.40	0.24	C	0.1594	0.029043501	IgG glycosylation	Immune diseases and disorders
rs6549358	G	A	38	38	18	18	46	30	0.61	0.44	0.39	0.56	G	1.0526316	0.029024943	Schizophrenia	Brain health and disorders
rs12916	T	C	29	44	21	48	37	9	0.54	0.71	0.46	0.29	C	2.84	0.029002565	Cholesterol, total	General health
rs701157	T	C	33	41	20	13	49	32	0.57	0.40	0.43	0.60	C	1	0.029001926	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs7620503	C	T	35	37	22	16	43	35	0.57	0.40	0.43	0.60	T	0.06	0.029001926	Corneal structure	General health
rs1932040	A	G	19	43	32	36	41	17	0.43	0.60	0.57	0.40	G	2.47	0.029001926	Periodontal microbiota	Misc
rs13149020	C	A	47	37	10	66	26	2	0.70	0.84	0.30	0.16	A	10.69	0.028994153	QT interval	Heart health and disorders
rs8064100	A	G	46	39	9	67	24	3	0.70	0.84	0.30	0.16	A	0.148	0.028994153	Gambling	General health
rs9469890	C	T	67	24	3	47	37	10	0.84	0.70	0.16	0.30	C	0.12	0.028994153	Pubertal anthropometrics	Appearance
rs9312517	A	G	64	30	0	44	43	7	0.84	0.70	0.16	0.30	G	0.03	0.028994153	Obesity-related traits	Obesity
rs7173064	G	C	17	46	31	32	48	14	0.43	0.60	0.57	0.40	C	1	0.028985507	White matter hyperintensity burden	Brain health and disorders
rs9271588	T	C	14	51	29	29	53	12	0.42	0.59	0.58	0.41	T	1.75	0.028975665	Sjogren's syndrome	Immune diseases and disorders
rs9268402	G	A	13	53	28	29	53	12	0.42	0.59	0.58	0.41	G	1.16	0.028975665	Coronary heart disease	Heart health and disorders
rs4676406	G	T	14	49	31	29	51	14	0.41	0.58	0.59	0.42	T	1.14	0.028975665	Ulcerative colitis	Immune diseases and disorders
rs4986044	C	T	30	50	14	14	50	30	0.59	0.41	0.41	0.59	C	0.016	0.028972386	Body mass index	Obesity
rs12414342	G	A	34	51	9	57	34	3	0.63	0.79	0.37	0.21	A	1.79	0.028897365	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs8192917	C	T	6	28	60	14	41	39	0.21	0.37	0.79	0.63	G	1.28	0.028897365	Vitiligo	Immune diseases and disorders
rs10891354	T	C	1	38	55	14	41	39	0.21	0.37	0.79	0.63	C	1.0526316	0.028897365	Schizophrenia	Brain health and disorders
rs947474	G	A	0	23	71	4	40	50	0.12	0.26	0.88	0.74	G	1.1	0.028861695	Type 1 diabetes	Diabetes
rs10876550	G	A	9	30	55	1	21	72	0.26	0.12	0.74	0.88	G	0.008	0.028861695	Mean platelet volume	Heart health and disorders
rs12360000	G	A	52	36	6	72	21	1	0.74	0.88	0.26	0.12	A	0.14	0.028861695	Metabolite levels Dihydroxy docosatrienoic acid	General health
rs12023396	A	G	53	34	7	72	21	1	0.74	0.88	0.26	0.12	G	0.03	0.028861695	Obesity-related traits	Obesity
rs10047462	G	T	9	26	59	2	16	76	0.23	0.11	0.77	0.89	T	0.041	0.028846154	Iron status biomarkers	General health
rs6763048	A	G	74	20	0	55	34	5	0.89	0.77	0.11	0.23	A	2.62	0.028846154	PR interval	Heart health and disorders
rs10507349	G	A	52	40	2	75	18	1	0.77	0.89	0.23	0.11	G	1.06	0.028846154	Type 2 diabetes	Diabetes
rs11164530	C	G	57	30	7	74	20	0	0.77	0.89	0.23	0.11	C	0.014369881	0.028846154	Urate levels BMI interaction	Obesity
rs7984869	G	T	19	49	26	11	34	49	0.46	0.30	0.54	0.70	T	0.115	0.028842402	Economic and political preferences fairness	Mental aptitude and behavioural traits
rs10935120	A	G	7	42	45	18	51	25	0.30	0.46	0.70	0.54	A	0.06	0.028842402	Height	General health
rs4733601	A	G	29	53	12	50	41	3	0.59	0.75	0.41	0.25	A	1.19	0.028801843	Diffuse large B cell lymphoma	Cancer
rs410285	A	G	86	7	1	68	24	2	0.95	0.85	0.05	0.15	G	6.45	0.028780993	Classic bladder exstrophy	Misc
rs16940202	T	C	66	28	0	85	9	0	0.85	0.95	0.15	0.05	C	1.52	0.028780993	Ulcerative colitis	Immune diseases and disorders
rs859267	A	C	85	9	0	69	22	3	0.95	0.85	0.05	0.15	C	1	0.028780993	Immune reponse to smallpox secreted IL-12p40	Immune diseases and disorders
rs11046430	C	T	85	9	0	68	24	2	0.95	0.85	0.05	0.15	T	0.21	0.028780993	Coronary artery calcification	Heart health and disorders
rs13326165	A	G	4	27	63	10	43	41	0.19	0.34	0.81	0.66	A	0.029	0.028776978	HDL cholesterol	General health
rs3790844	A	G	46	33	15	59	35	0	0.66	0.81	0.34	0.19	T	1.3	0.028776978	Pancreatic cancer	Cancer
rs4253417	T	C	43	39	12	62	29	3	0.66	0.81	0.34	0.19	C	1.27	0.028776978	Venous thromboembolism	Heart health and disorders
rs2073016	T	C	60	31	3	79	15	0	0.80	0.92	0.20	0.08	T	1.62	0.028727445	Progression free survival in metastatic colorectal cancer CAPOX-B vs CAPOX-B plus cetuximab	Cancer
rs11648003	A	G	58	35	1	80	13	1	0.80	0.92	0.20	0.08	G	0.07	0.028727445	Cholesterol, total	General health
rs7560163	C	G	88	6	0	71	23	0	0.97	0.88	0.03	0.12	C	1.33	0.02871907	Type 2 diabetes	Diabetes
rs12522290	C	G	73	19	2	88	6	0	0.88	0.97	0.12	0.03	C	1.08	0.02871907	Schizophrenia	Brain health and disorders
rs13358260	T	C	74	17	3	88	6	0	0.88	0.97	0.12	0.03	C	1	0.02871907	Adiponectin levels	Obesity
rs7199896	T	A	1	4	89	1	21	72	0.03	0.12	0.97	0.88	T	1.5873016	0.02871907	Alcohol dependence	General health
rs699363	G	A	0	6	88	0	23	71	0.03	0.12	0.97	0.88	G	1	0.02871907	Obesity extreme	Obesity
rs5767218	C	A	9	39	46	24	40	30	0.30	0.47	0.70	0.53	C	1.71	0.028690849	Classic bladder exstrophy	Misc
rs2093746	C	G	8	41	45	11	66	17	0.30	0.47	0.70	0.53	C	0.2917	0.028690849	IgG glycosylation	Immune diseases and disorders
rs2851391	T	C	18	52	24	11	35	48	0.47	0.30	0.53	0.70	T	0.056	0.028690849	Homocysteine levels	Misc
rs2461751	G	A	57	33	4	43	32	19	0.78	0.63	0.22	0.37	G	4.54	0.028590855	Electrocardiographic conduction measures	Heart health and disorders
rs10185142	C	T	57	33	4	34	50	10	0.78	0.63	0.22	0.37	A	0.03	0.028590855	Obesity-related traits	Obesity
rs1896312	C	T	17	44	33	5	38	51	0.41	0.26	0.59	0.74	C	1.95	0.028571429	PR interval	Heart health and disorders
rs7979367	G	T	26	47	21	43	44	7	0.53	0.69	0.47	0.31	C	1	0.028547664	Behavioural disinhibition generation interaction	Brain health and disorders
rs1993976	G	A	45	40	9	27	45	22	0.69	0.53	0.31	0.47	A	1	0.028547664	Fat distribution HIV	General health
rs3995090	A	C	29	41	24	42	46	6	0.53	0.69	0.47	0.31	C	0.038	0.028547664	Pulmonary function	Pulmonology
rs1165152	A	G	9	35	50	2	23	69	0.28	0.14	0.72	0.86	G	0.088	0.028547297	Urate levels in overweight individuals	Obesity
rs6446315	G	A	1	25	68	4	45	45	0.14	0.28	0.86	0.72	A	0.028	0.028547297	Height	General health
rs1185567	A	G	9	35	50	2	23	69	0.28	0.14	0.72	0.86	A	0.028	0.028547297	Blood metabolite ratios	Heart health and disorders
rs7171171	A	G	66	25	3	43	44	7	0.84	0.69	0.16	0.31	C	1	0.028540109	Type 1 diabetes autoantibodies	Diabetes
rs2294369	G	A	60	34	0	81	13	0	0.82	0.93	0.18	0.07	A	2.77	0.028519692	Response to methotrexate in juvenile idiopathic arthritis	General health
rs7423615	C	T	62	30	2	81	13	0	0.82	0.93	0.18	0.07	T	1.12	0.028519692	Crohn's disease	Digestive system and its disorders
rs17736589	A	G	65	24	5	82	11	1	0.82	0.93	0.18	0.07	G	1.0858142	0.028519692	Ulcerative colitis	Immune diseases and disorders
rs12877581	G	C	65	24	5	82	11	1	0.82	0.93	0.18	0.07	C	1.07	0.028519692	Schizophrenia	Brain health and disorders
rs17793829	C	T	64	26	4	81	13	0	0.82	0.93	0.18	0.07	A	0.201	0.028519692	Cytomegalovirus antibody response	Immune diseases and disorders
rs2845573	A	G	62	30	2	83	9	2	0.82	0.93	0.18	0.07	A	0.0044	0.028519692	Trans fatty acid levels	General health
rs10769691	C	T	84	9	1	64	29	1	0.94	0.84	0.06	0.16	A	3.13	0.0285144	Diisocyanate-induced asthma	Pulmonology
rs10843164	T	C	65	27	2	84	9	1	0.84	0.94	0.16	0.06	T	1.16	0.0285144	Height	General health
rs28581422	T	C	83	11	0	64	29	1	0.94	0.84	0.06	0.16	C	0.65	0.0285144	Cannabis use initiation	General health
rs9483788	T	C	65	27	2	83	11	0	0.84	0.94	0.16	0.06	C	0.22	0.0285144	Hematocrit	General health
rs12148769	G	A	68	21	5	83	11	0	0.84	0.94	0.16	0.06	G	0.05	0.0285144	Menarche age at onset	Reproductive health
rs1230666	A	G	0	13	81	0	1	93	0.07	0.01	0.93	0.99	A	0.0269	0.028413575	Thyroid peroxidase antibody levels	Immune diseases and disorders
rs112973353	C	T	81	13	0	93	1	0	0.93	0.99	0.07	0.01	T	1.11	0.028413575	Schizophrenia	Brain health and disorders
rs8096445	C	T	93	1	0	81	13	0	0.99	0.93	0.01	0.07	A	1	0.028413575	Immune response to smallpox vaccine IL-6	Immune diseases and disorders
rs62256378	G	A	81	13	0	93	1	0	0.93	0.99	0.07	0.01	A	0.71	0.028413575	Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	Brain health and disorders
rs718545	A	G	81	13	0	93	1	0	0.93	0.99	0.07	0.01	G	0.03	0.028413575	Obesity-related traits	Obesity
rs2734839	C	T	25	48	21	47	35	12	0.52	0.69	0.48	0.31	T	4.91	0.028412619	Information processing speed	Mental aptitude and behavioural traits
rs6598955	C	T	41	47	6	26	46	22	0.69	0.52	0.31	0.48	A	0.03	0.028412619	Obesity-related traits	Obesity
rs9939224	T	G	4	28	62	11	42	41	0.19	0.34	0.81	0.66	G	0.31	0.028405797	Metabolic syndrome bivariate traits	Immune diseases and disorders
rs12614	C	T	61	30	3	42	40	12	0.81	0.66	0.19	0.34	T	1.89	0.028405797	Chronic hepatitis B infection	Immune diseases and disorders
rs4622507	T	C	40	44	10	62	28	4	0.66	0.81	0.34	0.19	C	0.15	0.028405797	Social communication problems	Brain health and disorders
rs2844479	A	C	34	41	19	51	37	6	0.58	0.74	0.42	0.26	A	1.14	0.028351815	Height	General health
rs876537	C	T	34	41	19	55	29	10	0.58	0.74	0.42	0.26	C	0.288	0.028351815	C-reactive protein	Immune diseases and disorders
rs3899697	T	A	34	49	11	56	34	4	0.62	0.78	0.38	0.22	A	1.949	0.028298395	Cervical cancer	Cancer
rs3756008	A	T	37	43	14	58	30	6	0.62	0.78	0.38	0.22	T	1.4	0.028298395	Venous thromboembolism	Heart health and disorders
rs8042271	G	A	43	42	9	20	57	17	0.68	0.52	0.32	0.48	G	1.1	0.028285504	Coronary artery disease	Heart health and disorders
rs1823874	T	C	42	44	8	28	41	25	0.68	0.52	0.32	0.48	C	0.1478	0.028285504	IgG glycosylation	Immune diseases and disorders
rs17007695	T	C	55	37	2	76	18	0	0.78	0.90	0.22	0.10	C	2.67	0.028284232	Response to treatment for acute lymphoblastic leukemia	General health
rs7758229	G	T	58	31	5	76	18	0	0.78	0.90	0.22	0.10	T	1.28	0.028284232	Colorectal cancer	Cancer
rs9790517	C	T	60	27	7	77	16	1	0.78	0.90	0.22	0.10	T	1.05	0.028284232	Breast cancer	Cancer
rs28631020	G	A	77	16	1	55	37	2	0.90	0.78	0.10	0.22	G	0.08	0.028284232	Bulimia nervosa	Brain health and disorders
rs2456973	A	C	48	43	3	71	22	1	0.74	0.87	0.26	0.13	C	1.29	0.02825625	Vitiligo	Immune diseases and disorders
rs1250550	C	A	50	39	5	71	22	1	0.74	0.87	0.26	0.13	G	1.19	0.02825625	Crohn's disease	Digestive system and its disorders
rs7307902	T	C	55	29	10	72	20	2	0.74	0.87	0.26	0.13	G	0.05	0.02825625	Obesity-related traits	Obesity
rs154659	T	C	44	39	11	23	50	21	0.68	0.51	0.32	0.49	C	0.14	0.028166124	Tanning	Appearance
rs12431307	G	A	26	44	24	43	41	10	0.51	0.68	0.49	0.32	G	0.03	0.028166124	Obesity-related traits	Obesity
rs2523590	T	C	54	35	5	73	21	0	0.76	0.89	0.24	0.11	C	2.4	0.028152493	HIV-1 control	Immune diseases and disorders
rs7936247	G	T	49	40	5	28	52	14	0.73	0.57	0.27	0.43	T	0.222	0.028142589	Glycemic traits pregnancy	Reproductive health
rs608114	A	T	1	19	74	0	5	89	0.11	0.03	0.89	0.97	A	4.84	0.028131868	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs17194490	G	T	74	19	1	89	5	0	0.89	0.97	0.11	0.03	T	1.101	0.028131868	Schizophrenia	Brain health and disorders
rs17444059	T	C	77	13	4	89	5	0	0.89	0.97	0.11	0.03	G	1	0.028131868	Immune response to smallpox vaccine IL-6	Immune diseases and disorders
rs16859517	C	T	75	17	2	89	5	0	0.89	0.97	0.11	0.03	T	0.067	0.028131868	Height	General health
rs17095355	C	T	66	24	4	49	31	14	0.83	0.69	0.17	0.31	T	1.77	0.028108733	Biliary atresia	Digestive system and its disorders
rs907092	G	A	44	41	9	66	24	4	0.69	0.83	0.31	0.17	A	1.29	0.028108733	Primary biliary cirrhosis	Immune diseases and disorders
rs9990395	G	A	44	41	9	66	24	4	0.69	0.83	0.31	0.17	G	1.0526316	0.028108733	Schizophrenia	Brain health and disorders
rs587847	C	A	9	41	44	3	26	65	0.31	0.17	0.69	0.83	C	0.69	0.028108733	Intraocular pressure	General health
rs1106529	G	A	8	43	43	2	28	64	0.31	0.17	0.69	0.83	A	0.0377	0.028108733	Waist-to-hip ratio adjusted for body mass index	Obesity
rs9877502	G	A	43	40	11	23	49	22	0.67	0.51	0.33	0.49	A	0.052	0.028054299	Alzheimer's disease biomarkers	Brain health and disorders
rs9321453	T	C	2	33	59	11	43	40	0.20	0.35	0.80	0.65	T	0.14	0.028052097	Urate levels	General health
rs7286472	A	G	68	24	2	48	38	8	0.85	0.71	0.15	0.29	G	2.25	0.028040484	Blood pressure measurement cold pressor test	Heart health and disorders
rs1927745	G	A	67	26	1	49	36	9	0.85	0.71	0.15	0.29	A	0.16	0.028040484	Depression quantitative trait	Brain health and disorders
rs4667682	C	T	48	38	8	69	22	3	0.71	0.85	0.29	0.15	T	0.018	0.028040484	Body mass index	Obesity
rs4506565	A	T	48	41	5	31	45	18	0.73	0.57	0.27	0.43	T	1.36	0.027943368	Type 2 diabetes	Diabetes
rs11045818	G	A	73	16	5	86	8	0	0.86	0.96	0.14	0.04	G	9.3	0.027863777	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs72899866	T	A	69	24	1	87	6	1	0.86	0.96	0.14	0.04	A	1.39	0.027863777	Periodontitis CDC_AAP	Misc
rs17662626	A	G	71	20	3	86	8	0	0.86	0.96	0.14	0.04	A	1.2	0.027863777	Schizophrenia	Brain health and disorders
rs17599629	A	G	68	26	0	86	8	0	0.86	0.96	0.14	0.04	G	1.14	0.027863777	Prostate cancer	Cancer
rs7395555	G	C	69	24	1	86	8	0	0.86	0.96	0.14	0.04	C	1	0.027863777	Response to antipsychotic treatment	General health
rs10198552	T	C	87	6	1	70	22	2	0.96	0.86	0.04	0.14	G	0.04	0.027863777	Obesity-related traits	Obesity
rs13116011	T	A	70	22	2	86	8	0	0.86	0.96	0.14	0.04	T	0.019576594	0.027863777	Urate levels BMI interaction	Obesity
rs7537052	T	G	24	45	25	39	46	9	0.49	0.66	0.51	0.34	G	1.0638298	0.02785265	Schizophrenia	Brain health and disorders
rs1789001	G	A	15	34	45	22	51	21	0.34	0.51	0.66	0.49	A	0.079	0.02785265	Percentage gas trapping	Misc
rs1150781	C	G	10	44	40	21	53	20	0.34	0.51	0.66	0.49	C	0.048	0.02785265	Height	General health
rs3094228	T	C	79	14	1	60	30	4	0.91	0.80	0.09	0.20	C	1.23	0.027835289	Thyroid peroxidase antibody positivity	Immune diseases and disorders
rs12288512	G	A	61	28	5	78	16	0	0.80	0.91	0.20	0.09	A	0.04	0.027835289	Coffee consumption cups per day	Misc
rs2739330	T	C	26	40	28	35	53	6	0.49	0.65	0.51	0.35	T	3.7	0.027762531	Liver enzyme levels gamma-glutamyl transferase	General health
rs31490	G	A	41	41	12	20	52	22	0.65	0.49	0.35	0.51	A	1.18	0.027762531	Chronic lymphocytic leukemia	Cancer
rs2830487	G	A	23	46	25	42	39	13	0.49	0.65	0.51	0.35	A	0.2543	0.027762531	Metabolite levels HVA	General health
rs2071748	G	A	39	45	10	24	44	26	0.65	0.49	0.35	0.51	A	0.05	0.027762531	Obesity-related traits	Obesity
rs4656958	A	G	9	34	51	16	50	28	0.28	0.44	0.72	0.56	A	1.0694069	0.027753793	Crohn's disease	Digestive system and its disorders
rs11830157	T	G	36	43	15	54	36	4	0.61	0.77	0.39	0.23	G	1.12	0.027753028	Coronary artery disease	Heart health and disorders
rs11915082	G	A	33	49	12	54	36	4	0.61	0.77	0.39	0.23	A	1	0.027753028	Mean corpuscular hemoglobin	Heart health and disorders
rs16926523	G	A	90	4	0	78	13	3	0.98	0.90	0.02	0.10	A	9.55	0.027712773	PR interval	Heart health and disorders
rs73954691	G	C	90	4	0	75	19	0	0.98	0.90	0.02	0.10	G	2.6	0.027712773	Type 2 diabetes	Diabetes
rs2822388	A	G	75	19	0	90	4	0	0.90	0.98	0.10	0.02	G	2.3809524	0.027712773	Stroke	Brain health and disorders
rs2679073	A	G	75	19	0	90	4	0	0.90	0.98	0.10	0.02	A	1.5	0.027712773	Coronary artery calcification	Heart health and disorders
rs10226930	T	C	90	4	0	76	17	1	0.98	0.90	0.02	0.10	C	1.375	0.027712773	Corneal astigmatism	General health
rs17810546	A	G	75	19	0	90	4	0	0.90	0.98	0.10	0.02	G	1.36	0.027712773	Celiac disease	Immune diseases and disorders
rs6721345	G	A	90	4	0	76	17	1	0.98	0.90	0.02	0.10	A	1.13	0.027712773	Sex hormone-binding globulin levels	Reproductive health
rs12643654	A	G	77	15	2	91	2	1	0.90	0.98	0.10	0.02	G	1	0.027712773	Cerebrospinal P-tau181p levels	Brain health and disorders
rs741013	A	T	76	17	1	90	4	0	0.90	0.98	0.10	0.02	A	0.97	0.027712773	Coronary artery calcification	Heart health and disorders
rs17623382	T	G	76	17	1	90	4	0	0.90	0.98	0.10	0.02	G	0.78	0.027712773	Response to Vitamin E supplementation	General health
rs17236969	C	T	77	15	2	90	4	0	0.90	0.98	0.10	0.02	T	0.05	0.027712773	Menarche age at onset	Reproductive health
rs2399233	C	T	0	4	90	0	19	75	0.02	0.10	0.98	0.90	T	0.057	0.027712773	Airway responsiveness in chronic obstructive pulmonary disease	Pulmonology
rs73376930	A	G	63	29	2	43	42	9	0.82	0.68	0.18	0.32	G	1.246	0.027698621	Colorectal cancer	Cancer
rs12077769	G	A	92	2	0	79	15	0	0.99	0.92	0.01	0.08	A	4.631	0.027691299	Very long-chain saturated fatty acid levels fatty acid 22:0	General health
rs114333818	G	A	79	15	0	92	2	0	0.92	0.99	0.08	0.01	A	1.3513513	0.027691299	Schizophrenia	Brain health and disorders
rs76043829	G	A	79	15	0	92	2	0	0.92	0.99	0.08	0.01	A	1.2133	0.027691299	Asthma and hay fever	Immune diseases and disorders
rs17828380	G	C	79	15	0	92	2	0	0.92	0.99	0.08	0.01	C	0.18	0.027691299	Social communication problems	Brain health and disorders
rs1801239	T	C	80	13	1	92	2	0	0.92	0.99	0.08	0.01	T	0.0835	0.027691299	Urinary albumin excretion	General health
rs17368659	G	T	80	13	1	92	2	0	0.92	0.99	0.08	0.01	G	0.04	0.027691299	Local histogram emphysema pattern	Pulmonology
rs7117404	A	G	80	13	1	92	2	0	0.92	0.99	0.08	0.01	G	0.0398	0.027691299	D-dimer levels	Heart health and disorders
rs6560749	T	G	1	23	70	4	42	48	0.13	0.27	0.87	0.73	T	0.34	0.027685493	Quantitative traits	Misc
rs4789580	T	G	54	30	10	72	19	3	0.73	0.87	0.27	0.13	G	0.2275	0.027685493	IgG glycosylation	Immune diseases and disorders
rs10937329	T	A	54	30	10	69	25	0	0.73	0.87	0.27	0.13	T	0.01	0.027685493	Renal function-related traits BUN	General health
rs6759952	T	C	23	45	26	41	40	13	0.48	0.65	0.52	0.35	T	1.25	0.027679369	Thyroid cancer	Cancer
rs10882272	T	C	37	48	9	20	51	23	0.65	0.48	0.35	0.52	C	0.03	0.027679369	Retinol levels	Aging
rs13046373	A	G	11	44	39	26	45	23	0.35	0.52	0.65	0.48	C	0.0226	0.027679369	HDL cholesterol	General health
rs2546890	A	G	28	42	24	15	37	42	0.52	0.36	0.48	0.64	A	1.1494253	0.027603045	Primary biliary cirrhosis	Immune diseases and disorders
rs10893268	C	T	40	41	13	19	52	23	0.64	0.48	0.36	0.52	T	0.069	0.027603045	Anxiety disorder	Brain health and disorders
rs12621643	T	G	9	35	50	15	53	26	0.28	0.44	0.72	0.56	T	1.48	0.027573529	Acute lymphoblastic leukemia childhood	Cancer
rs12788764	T	C	25	55	14	48	39	7	0.56	0.72	0.44	0.28	C	0.07	0.027573529	Age-related nuclear cataracts	Aging
rs7741021	A	C	29	47	18	50	35	9	0.56	0.72	0.44	0.28	C	0.06	0.027573529	Bone properties heel	General health
rs1353545	G	C	20	49	25	39	42	13	0.47	0.64	0.53	0.36	C	1.06	0.02753345	Schizophrenia	Brain health and disorders
rs924135	A	T	13	42	39	26	47	21	0.36	0.53	0.64	0.47	A	0.017	0.02753345	Blood metabolite levels	Heart health and disorders
rs1973985	G	A	76	17	1	57	32	5	0.90	0.78	0.10	0.22	A	0.443	0.027530575	Left superior temporal gyrus thickness schizophrenia interaction	Brain health and disorders
rs1530440	C	T	57	32	5	76	17	1	0.78	0.90	0.22	0.10	T	0.39	0.027530575	Diastolic blood pressure	Heart health and disorders
rs12915708	G	C	54	38	2	75	19	0	0.78	0.90	0.22	0.10	C	0.007	0.027530575	Fibrinogen	General health
rs1520339	T	C	5	32	57	1	17	76	0.22	0.10	0.78	0.90	C	1.724138	0.027530575	Crohn's disease-related phenotypes	Digestive system and its disorders
rs6576507	T	C	91	3	0	78	15	1	0.98	0.91	0.02	0.09	A	14	0.02752809	Insulin resistance_response	Drug response
rs17155315	G	A	91	3	0	78	15	1	0.98	0.91	0.02	0.09	G	4.73	0.02752809	QT interval	Heart health and disorders
rs644695	A	G	77	17	0	91	3	0	0.91	0.98	0.09	0.02	A	1.35	0.02752809	Major depressive disorder broad	Brain health and disorders
rs78707713	T	C	78	15	1	91	3	0	0.91	0.98	0.09	0.02	T	1.31	0.02752809	Venous thromboembolism	Heart health and disorders
rs80130819	A	C	78	15	1	91	3	0	0.91	0.98	0.09	0.02	A	1.14	0.02752809	Prostate cancer	Cancer
rs11009175	G	A	78	15	1	92	1	1	0.91	0.98	0.09	0.02	A	0.16	0.02752809	Depression quantitative trait	Brain health and disorders
rs10833583	G	A	78	15	1	91	3	0	0.91	0.98	0.09	0.02	A	0.03	0.02752809	Obesity-related traits	Obesity
rs2000999	G	A	59	35	0	81	12	1	0.81	0.93	0.19	0.07	A	0.138	0.027522936	Haptoglobin levels	Immune diseases and disorders
rs2851682	A	G	61	31	2	83	8	3	0.81	0.93	0.19	0.07	A	0.0039	0.027522936	Trans fatty acid levels	General health
rs12143842	C	T	55	32	7	73	20	1	0.76	0.88	0.24	0.12	T	3.888	0.02750191	Electrocardiographic traits	Heart health and disorders
rs4714888	G	T	73	20	1	56	30	8	0.88	0.76	0.12	0.24	T	1.3	0.02750191	Age-related macular degeneration	Aging
rs10826566	G	A	73	20	1	55	32	7	0.88	0.76	0.12	0.24	A	1.16	0.02750191	Migraine with aura	Brain health and disorders
rs6696981	G	T	73	20	1	54	34	6	0.88	0.76	0.12	0.24	G	0.12	0.02750191	Bone mineral density spine	General health
rs3800569	C	T	6	34	54	0	22	72	0.24	0.12	0.76	0.88	C	1.2	0.02750191	F-cell distribution	Immune diseases and disorders
rs1364989	T	C	4	37	53	15	44	35	0.24	0.39	0.76	0.61	T	3.41	0.027498937	Lupus nephritis in systemic lupus erythematosus	Immune diseases and disorders
rs9728717	T	C	58	27	9	33	48	13	0.76	0.61	0.24	0.39	T	0.14	0.027498937	Economic and political preferences time	Mental aptitude and behavioural traits
rs12122337	A	G	84	10	0	68	23	3	0.95	0.85	0.05	0.15	G	2.2	0.027467093	Crohn's disease-related phenotypes	Digestive system and its disorders
rs3024505	G	A	68	23	3	84	10	0	0.85	0.95	0.15	0.05	T	1.12	0.027467093	Crohn's disease	Digestive system and its disorders
rs7236492	C	T	68	23	3	84	10	0	0.85	0.95	0.15	0.05	A	1.1047964	0.027467093	Crohn's disease	Digestive system and its disorders
rs75059851	A	G	67	25	2	85	8	1	0.85	0.95	0.15	0.05	A	1.1	0.027467093	Schizophrenia	Brain health and disorders
rs7404928	T	C	66	27	1	85	8	1	0.85	0.95	0.15	0.05	T	1.08	0.027467093	Rheumatoid arthritis	Immune diseases and disorders
rs903614	A	C	84	10	0	69	21	4	0.95	0.85	0.05	0.15	C	1	0.027467093	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs13161895	C	T	68	23	3	85	8	1	0.85	0.95	0.15	0.05	T	0.147	0.027467093	LDL cholesterol	General health
rs1439283	C	T	28	45	21	10	50	34	0.54	0.37	0.46	0.63	A	0.04	0.027414064	Obesity-related traits	Obesity
rs1738475	C	G	24	53	17	14	42	38	0.54	0.37	0.46	0.63	C	0.025	0.027414064	Height	General health
rs10472076	T	C	31	42	21	48	38	8	0.55	0.71	0.45	0.29	C	1.05	0.027402265	Breast cancer	Cancer
rs9908552	T	C	20	44	30	9	36	49	0.45	0.29	0.55	0.71	T	1.05	0.027402265	Schizophrenia	Brain health and disorders
rs9663362	G	C	21	42	31	6	42	46	0.45	0.29	0.55	0.71	G	0.271	0.027402265	Blood pressure	Heart health and disorders
rs912988	C	T	38	45	11	59	31	4	0.64	0.79	0.36	0.21	T	0.1825	0.027393431	Major depressive disorder	Brain health and disorders
rs11630290	C	T	60	29	5	36	49	9	0.79	0.64	0.21	0.36	C	0.09	0.027393431	Iris characteristics	Misc
rs9596219	C	T	66	24	4	83	10	1	0.83	0.94	0.17	0.06	T	1.16	0.027382256	Height	General health
rs3771570	C	T	64	28	2	82	12	0	0.83	0.94	0.17	0.06	A	1.12	0.027382256	Prostate cancer	Cancer
rs2544523	T	C	1	30	63	2	8	84	0.17	0.06	0.83	0.94	T	1.07	0.027382256	Asthma or chronic obstructive pulmonary disease	Immune diseases and disorders
rs7006821	T	C	83	10	1	66	24	4	0.94	0.83	0.06	0.17	C	1	0.027382256	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs12300553	G	A	63	30	1	82	12	0	0.83	0.94	0.17	0.06	G	0.08	0.027382256	Urate levels in overweight individuals	Obesity
rs8030605	G	A	66	24	4	82	12	0	0.83	0.94	0.17	0.06	A	0.0313	0.027382256	Waist-to-hip ratio adjusted for body mass index	Obesity
rs4722404	T	C	22	42	30	35	47	12	0.46	0.62	0.54	0.38	G	1.18	0.027364105	Atopic dermatitis	Immune diseases and disorders
rs701428	A	G	22	42	30	40	37	17	0.46	0.62	0.54	0.38	G	0.04	0.027364105	Obesity-related traits	Obesity
rs6820368	T	C	94	0	0	84	10	0	1.00	0.95	0.00	0.05	C	9.9	0.027322404	QRS duration	Heart health and disorders
rs151326733	G	C	94	0	0	84	10	0	1.00	0.95	0.00	0.05	C	2.2	0.027322404	Glaucoma	General health
rs16955379	C	T	94	0	0	84	10	0	1.00	0.95	0.00	0.05	C	1.08	0.027322404	Type 2 diabetes	Diabetes
rs17159991	A	G	94	0	0	84	10	0	1.00	0.95	0.00	0.05	A	0.329	0.027322404	Uric acid levels	General health
rs73175262	G	A	94	0	0	84	10	0	1.00	0.95	0.00	0.05	A	0.05	0.027322404	Obesity-related traits	Obesity
rs77443149	G	A	94	0	0	85	8	1	1.00	0.95	0.00	0.05	A	0.04	0.027322404	Obesity-related traits	Obesity
rs857228	A	C	27	49	18	10	52	32	0.55	0.38	0.45	0.62	T	2.56	0.02732054	Sexual dysfunction SSRI_SNRI-related	General health
rs11676348	C	T	30	43	21	18	36	40	0.55	0.38	0.45	0.62	T	1.07	0.02732054	Ulcerative colitis	Immune diseases and disorders
rs7613875	C	A	29	45	20	15	42	37	0.55	0.38	0.45	0.62	A	0.021	0.02732054	Body mass index	Obesity
rs885389	A	G	24	56	14	13	47	34	0.55	0.39	0.45	0.61	A	0.17	0.027283309	RR interval heart rate	Heart health and disorders
rs16937456	A	G	55	32	7	28	57	9	0.76	0.60	0.24	0.40	G	1.4	0.027256522	Hypospadias	Misc
rs6445055	G	A	51	40	3	29	55	10	0.76	0.60	0.24	0.40	A	0.177	0.027256522	Intraocular pressure	General health
rs348495	G	A	30	45	19	15	44	35	0.56	0.39	0.44	0.61	G	0.051	0.027252361	Body mass index	Obesity
rs2459210	A	C	9	37	48	13	59	22	0.29	0.45	0.71	0.55	T	4.35	0.027239709	Hemostatic factors and hematological phenotypes	Heart health and disorders
rs1495741	G	A	12	31	51	20	45	29	0.29	0.45	0.71	0.55	G	2.97	0.027239709	Triglycerides	General health
rs35246381	C	T	12	31	51	20	45	29	0.29	0.45	0.71	0.55	C	1.1291	0.027239709	Urinary metabolites	General health
rs4921914	C	T	12	31	51	20	45	29	0.29	0.45	0.71	0.55	T	0.51	0.027239709	Urinary metabolites H-NMR features	General health
rs4921915	G	A	12	31	51	20	45	29	0.29	0.45	0.71	0.55	A	0.079	0.027239709	Iron status biomarkers transferrin levels	General health
rs4921913	C	T	12	31	51	20	45	29	0.29	0.45	0.71	0.55	T	0.036	0.027239709	Blood metabolite ratios	Heart health and disorders
rs11647589	A	G	48	37	9	26	51	17	0.71	0.55	0.29	0.45	A	0.03	0.027239709	Blood metabolite levels	Heart health and disorders
rs12699125	A	G	18	46	30	29	55	10	0.44	0.60	0.56	0.40	A	0.072	0.027227653	Lifetime average cigarettes per day in chronic obstructive pulmonary disease	General health
rs401681	C	T	30	46	18	15	45	34	0.56	0.40	0.44	0.60	A	1.2	0.027227653	Melanoma	Cancer
rs11717383	G	T	30	47	17	18	40	36	0.57	0.40	0.43	0.60	G	1.0638298	0.027209151	Schizophrenia	Brain health and disorders
rs11070747	G	C	27	53	14	15	46	33	0.57	0.40	0.43	0.60	C	1	0.027209151	Verbal declarative memory	Brain health and disorders
rs2923084	A	G	36	37	21	19	40	35	0.58	0.41	0.42	0.59	G	0.41	0.027190674	HDL cholesterol	General health
rs9500927	G	A	70	22	2	51	35	8	0.86	0.73	0.14	0.27	T	1.13	0.027146766	Asthma	Immune diseases and disorders
rs10502235	A	G	71	20	3	52	33	9	0.86	0.73	0.14	0.27	A	0.23	0.027146766	Intraocular pressure	General health
rs12792526	A	G	52	33	9	68	26	0	0.73	0.86	0.27	0.14	A	0.2189	0.027146766	Periodontitis Mean PAL	Misc
rs672561	T	C	68	22	4	46	40	8	0.84	0.70	0.16	0.30	C	0.1677	0.027105052	IgG glycosylation	Immune diseases and disorders
rs10152811	A	C	57	34	3	39	42	13	0.79	0.64	0.21	0.36	A	18.81	0.027086788	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs8135665	C	T	57	34	3	40	40	14	0.79	0.64	0.21	0.36	T	1.15	0.027086788	Age-related macular degeneration	Aging
rs1316952	T	C	55	38	1	40	40	14	0.79	0.64	0.21	0.36	T	1	0.027086788	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs7498665	A	G	31	40	23	46	40	8	0.54	0.70	0.46	0.30	G	3.63	0.02708559	Body mass index	Obesity
rs1800871	A	G	10	36	48	21	44	29	0.30	0.46	0.70	0.54	T	1.45	0.02708559	Behcet's disease	Immune diseases and disorders
rs806321	C	T	30	42	22	44	44	6	0.54	0.70	0.46	0.30	A	1.08	0.02708559	Multiple sclerosis	Brain health and disorders
rs10865355	A	G	3	41	50	18	40	36	0.25	0.40	0.75	0.60	A	2.89	0.02702529	PR interval	Heart health and disorders
rs1558861	C	T	1	22	71	0	7	87	0.13	0.04	0.87	0.96	C	17	0.027021973	Triglycerides	General health
rs9326246	C	G	1	22	71	0	7	87	0.13	0.04	0.87	0.96	C	1.15	0.027021973	Coronary artery disease	Heart health and disorders
rs980952	T	G	0	7	87	0	24	70	0.04	0.13	0.96	0.87	G	0.4489	0.027021973	IgG glycosylation	Immune diseases and disorders
rs2862035	C	G	0	7	87	0	24	70	0.04	0.13	0.96	0.87	C	0.4382	0.027021973	IgG glycosylation	Immune diseases and disorders
rs2266788	G	A	2	20	72	0	7	87	0.13	0.04	0.87	0.96	A	0.41	0.027021973	Waist Circumference - Triglycerides WC-TG	General health
rs6589566	G	A	2	20	72	0	7	87	0.13	0.04	0.87	0.96	C	0.2066	0.027021973	Triglycerides	General health
rs1035147	A	C	73	18	3	87	7	0	0.87	0.96	0.13	0.04	T	7.294	0.027021973	Adverse response to chemotherapy neutropenia_leucopenia all topoisomerase inhibitors	Drug response
rs17445836	G	A	74	16	4	88	5	1	0.87	0.96	0.13	0.04	G	1.25	0.027021973	Multiple sclerosis	Brain health and disorders
rs71277158	T	G	72	20	2	87	7	0	0.87	0.96	0.13	0.04	T	1.22	0.027021973	Prostate cancer	Cancer
rs4074373	A	G	71	22	1	87	7	0	0.87	0.96	0.13	0.04	G	1	0.027021973	Homeostasis model assessment of beta-cell function interaction	Misc
rs3757057	A	T	74	16	4	88	5	1	0.87	0.96	0.13	0.04	T	1	0.027021973	Response to statin therapy	General health
rs981844	A	G	72	20	2	88	5	1	0.87	0.96	0.13	0.04	A	0.009	0.027021973	Response to statins LDL cholesterol change	General health
rs67072384	C	T	77	17	0	62	25	7	0.91	0.79	0.09	0.21	T	6.22	0.027008929	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Immune diseases and disorders
rs13405366	G	A	77	17	0	61	27	6	0.91	0.79	0.09	0.21	A	4.3	0.027008929	Diisocyanate-induced asthma	Pulmonology
rs10896794	T	C	58	33	3	77	17	0	0.79	0.91	0.21	0.09	T	1.08	0.027008929	Inflammatory bowel disease	Immune diseases and disorders
rs705162	G	A	60	29	5	77	17	0	0.79	0.91	0.21	0.09	A	1.06	0.027008929	Migraine	Brain health and disorders
rs12153391	C	A	60	29	5	79	13	2	0.79	0.91	0.21	0.09	A	0.03	0.027008929	Height	General health
rs10238623	A	G	8	41	45	22	43	29	0.30	0.46	0.70	0.54	A	1.545	0.026939655	Anxiety in major depressive disorder	Brain health and disorders
rs6937795	A	C	25	51	18	47	37	10	0.54	0.70	0.46	0.30	A	1.04	0.026939655	Type 2 diabetes	Diabetes
rs2274432	G	A	40	46	8	60	33	1	0.67	0.81	0.33	0.19	T	5.3	0.026937147	Height	General health
rs514230	A	T	12	38	44	2	31	61	0.33	0.19	0.67	0.81	A	1.36	0.026937147	Cholesterol, total	General health
rs1926872	T	C	40	46	8	60	33	1	0.67	0.81	0.33	0.19	T	0.043	0.026937147	Height	General health
rs17632159	G	C	42	42	10	60	33	1	0.67	0.81	0.33	0.19	C	0.039	0.026937147	Urate levels	General health
rs74380195	A	G	71	23	0	51	39	4	0.88	0.75	0.12	0.25	G	4.02	0.026890756	Diisocyanate-induced asthma	Pulmonology
rs12807809	T	C	72	21	1	53	35	6	0.88	0.75	0.12	0.25	T	1.15	0.026890756	Schizophrenia	Brain health and disorders
rs8033165	C	T	52	37	5	73	19	2	0.75	0.88	0.25	0.12	T	0.12	0.026890756	Black vs. blond hair color	Appearance
rs742134	A	G	2	19	73	3	41	50	0.12	0.25	0.88	0.75	G	1.16	0.026890756	Prostate cancer	Cancer
rs55675132	C	T	55	35	4	75	18	1	0.77	0.89	0.23	0.11	C	1.0638298	0.026826918	Schizophrenia	Brain health and disorders
rs10892151	C	T	74	20	0	57	31	6	0.89	0.77	0.11	0.23	A	1	0.026826918	Triglycerides	General health
rs1668873	G	A	54	37	3	76	16	2	0.77	0.89	0.23	0.11	G	0.01	0.026826918	Mean platelet volume	Heart health and disorders
rs339969	C	A	17	43	34	5	38	51	0.41	0.26	0.59	0.74	A	4.5	0.026804781	Liver enzyme levels gamma-glutamyl transferase	General health
rs8078723	T	C	33	45	16	51	38	5	0.59	0.74	0.41	0.26	C	0.043	0.026804781	Neutrophil count	Immune diseases and disorders
rs2111836	G	A	18	52	24	11	36	47	0.47	0.31	0.53	0.69	G	1.32	0.026801668	Breast cancer	Cancer
rs1867485	G	A	22	44	28	7	44	43	0.47	0.31	0.53	0.69	G	0.04	0.026801668	Obesity-related traits	Obesity
rs17007017	A	G	42	46	6	26	48	20	0.69	0.53	0.31	0.47	G	1.34	0.026801668	Conduct disorder	Brain health and disorders
rs1392635	G	A	59	29	6	38	43	13	0.78	0.63	0.22	0.37	A	1.7	0.026794258	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	General health
rs7682241	G	T	36	47	11	59	29	6	0.63	0.78	0.37	0.22	A	1.34	0.026794258	Alopecia areata	Immune diseases and disorders
rs638893	G	A	0	31	63	9	39	46	0.16	0.30	0.84	0.70	C	1.22	0.02667298	Vitiligo	Immune diseases and disorders
rs2836882	G	A	45	41	8	66	25	3	0.70	0.84	0.30	0.16	A	1	0.02667298	Pediatric autoimmune diseases	Immune diseases and disorders
rs2972146	G	T	9	39	46	3	25	66	0.30	0.16	0.70	0.84	G	0.032	0.02667298	HDL cholesterol	General health
rs7744020	G	A	46	37	11	26	47	21	0.69	0.53	0.31	0.47	A	1.9	0.026671408	Narcolepsy age of onset	Brain health and disorders
rs3859192	C	T	24	51	19	45	39	10	0.53	0.69	0.47	0.31	A	0.14	0.026671408	White blood cell count	Immune diseases and disorders
rs13259289	T	C	47	42	5	68	25	1	0.72	0.86	0.28	0.14	G	8.675	0.026637685	Illicit drug use	General health
rs1553091	A	G	53	30	11	67	27	0	0.72	0.86	0.28	0.14	G	1.48	0.026637685	Adverse response to chemotherapy neutropenia_leucopenia epirubicin	Drug response
rs9273363	C	A	51	34	9	70	21	3	0.72	0.86	0.28	0.14	A	1.24	0.026637685	Chronic lymphocytic leukemia	Cancer
rs16966142	C	T	48	40	6	71	19	4	0.72	0.86	0.28	0.14	T	0.118	0.026637685	Caffeine consumption	General health
rs13396424	T	G	53	30	11	69	23	2	0.72	0.86	0.28	0.14	G	0.08	0.026637685	Metabolite levels  X-11787	General health
rs3820706	T	C	79	15	0	63	26	5	0.92	0.81	0.08	0.19	G	2.38	0.026606335	Adverse response to chemotherapy in breast cancer alopecia	General health
rs243070	T	A	59	34	1	80	13	1	0.81	0.92	0.19	0.08	T	0.181	0.026606335	Red blood cell traits	Immune diseases and disorders
rs11945798	T	C	79	15	0	61	30	3	0.92	0.81	0.08	0.19	T	0.175	0.026606335	Word reading	Mental aptitude and behavioural traits
rs10514310	A	G	59	34	1	79	15	0	0.81	0.92	0.19	0.08	G	0.03	0.026606335	Obesity-related traits	Obesity
rs28305	C	G	5	26	63	0	15	79	0.19	0.08	0.81	0.92	C	0.031	0.026606335	Symmetrical dimethylarginine levels	General health
rs7216389	C	T	7	49	38	5	26	63	0.34	0.19	0.66	0.81	T	1.45	0.026583525	Asthma	Immune diseases and disorders
rs6091540	C	T	39	47	8	62	28	4	0.66	0.81	0.34	0.19	C	0.03	0.026583525	Body mass index	Obesity
rs7266699	T	C	43	42	9	27	44	23	0.68	0.52	0.32	0.48	C	1.0638298	0.026548673	Schizophrenia	Brain health and disorders
rs2236267	C	T	21	48	25	10	40	44	0.48	0.32	0.52	0.68	C	0.2	0.026548673	Food antigen IgG levels	Immune diseases and disorders
rs2803904	T	C	33	52	9	58	30	6	0.63	0.78	0.37	0.22	C	0.2574	0.026515152	Lewy body disease	Brain health and disorders
rs7599312	G	A	60	26	8	34	50	10	0.78	0.63	0.22	0.37	G	0.026	0.026515152	Body mass index	Obesity
rs7930295	A	G	70	21	3	85	9	0	0.86	0.95	0.14	0.05	G	1.3	0.026470588	Schizophrenia	Brain health and disorders
rs9554348	T	A	71	19	4	86	7	1	0.86	0.95	0.14	0.05	T	1.0752687	0.026470588	Schizophrenia	Brain health and disorders
rs1347155	C	T	86	7	1	68	25	1	0.95	0.86	0.05	0.14	T	0.559	0.026470588	Body mass index change over time	Obesity
rs1739654	G	A	85	9	0	69	23	2	0.95	0.86	0.05	0.14	G	0.4461	0.026470588	IgG glycosylation	Immune diseases and disorders
rs17616316	C	G	86	7	1	67	27	0	0.95	0.86	0.05	0.14	G	0.014	0.026470588	Red blood cell traits	Immune diseases and disorders
rs988913	C	T	26	45	23	45	37	12	0.52	0.68	0.48	0.32	C	0.04	0.026433271	Menarche age at onset	Reproductive health
rs2860223	A	G	36	37	21	54	30	10	0.58	0.73	0.42	0.27	C	1.26	0.02639425	Schizophrenia negative symptoms	Brain health and disorders
rs4809324	T	C	63	29	2	81	13	0	0.82	0.93	0.18	0.07	C	1.6	0.026350461	Glioma high-grade	Cancer
rs4899554	C	T	65	25	4	81	13	0	0.82	0.93	0.18	0.07	C	1.083	0.026350461	Inflammatory bowel disease	Immune diseases and disorders
rs11706018	C	T	81	13	0	63	29	2	0.93	0.82	0.07	0.18	C	0.2799	0.026350461	IgG glycosylation	Immune diseases and disorders
rs13179411	G	T	68	19	7	83	9	2	0.82	0.93	0.18	0.07	T	0.06	0.026350461	Menarche age at onset	Reproductive health
rs11136341	A	G	41	44	9	22	52	20	0.67	0.51	0.33	0.49	G	1.34	0.026325026	Cholesterol, total	General health
rs4911642	C	T	2	20	72	6	36	52	0.13	0.26	0.87	0.74	C	1	0.026315789	Celiac disease	Immune diseases and disorders
rs6498068	C	A	7	34	53	1	22	71	0.26	0.13	0.74	0.87	C	0.2897	0.026315789	Metabolite levels MHPG	General health
rs11683197	T	C	50	40	4	71	22	1	0.74	0.87	0.26	0.13	T	1	0.026315789	Visceral fat	Obesity
rs4686914	C	T	56	28	10	70	24	0	0.74	0.87	0.26	0.13	T	0.0242	0.026315789	Metabolite levels	General health
rs13178964	A	G	64	30	0	83	11	0	0.84	0.94	0.16	0.06	G	3.42	0.026283218	Blood pressure measurement low sodium intervention	Heart health and disorders
rs11225247	A	C	83	11	0	68	22	4	0.94	0.84	0.06	0.16	C	1	0.026283218	Vein graft stenosis in coronary artery bypass grafting	Heart health and disorders
rs17455577	C	T	65	28	1	83	11	0	0.84	0.94	0.16	0.06	C	0.45	0.026283218	Urinary metabolites H-NMR features	General health
rs9267663	C	T	83	11	0	66	26	2	0.94	0.84	0.06	0.16	T	0.29	0.026283218	Economic and political preferences environmentalism	Mental aptitude and behavioural traits
rs4074793	A	G	73	20	1	88	6	0	0.88	0.97	0.12	0.03	G	5.5	0.026272578	Liver enzyme levels gamma-glutamyl transferase	General health
rs13096210	C	T	73	20	1	88	6	0	0.88	0.97	0.12	0.03	C	1.1363636	0.026272578	Schizophrenia	Brain health and disorders
rs6134479	G	C	73	20	1	88	6	0	0.88	0.97	0.12	0.03	G	1	0.026272578	Hearing function	General health
rs11819364	A	C	88	6	0	73	20	1	0.97	0.88	0.03	0.12	C	0.32	0.026272578	Social communication problems	Brain health and disorders
rs9376090	T	C	72	22	0	88	6	0	0.88	0.97	0.12	0.03	C	0.025	0.026272578	Cholesterol, total	General health
rs6870564	A	G	0	32	62	7	44	43	0.17	0.31	0.83	0.69	A	3.84	0.026262626	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs17819328	T	G	38	41	15	55	35	4	0.62	0.77	0.38	0.23	G	0.0352	0.026248828	Waist-to-hip ratio adjusted for body mass index	Obesity
rs4235898	G	A	11	42	41	3	31	60	0.34	0.20	0.66	0.80	A	1.718	0.026246625	Adverse response to chemotherapy neutropenia_leucopenia all antimicrotubule drugs	Drug response
rs2281135	G	A	39	46	9	59	33	2	0.66	0.80	0.34	0.20	T	0.06	0.026246625	Liver enzyme levels	General health
rs2079742	T	C	42	40	12	63	25	6	0.66	0.80	0.34	0.20	T	0.043	0.026246625	Urate levels	General health
rs791888	G	T	40	44	10	60	31	3	0.66	0.80	0.34	0.20	T	0.02742	0.026246625	Magnesium levels	General health
rs6864869	G	C	55	38	1	76	18	0	0.79	0.90	0.21	0.10	C	2.7468	0.026241596	Cognitive function	Brain health and disorders
rs2299116	C	A	56	36	2	76	18	0	0.79	0.90	0.21	0.10	A	0.25	0.026241596	Serum thyroid-stimulating hormone levels	General health
rs1650123	C	T	28	39	27	41	43	10	0.51	0.66	0.49	0.34	C	0.1628	0.026223776	IgG glycosylation	Immune diseases and disorders
rs2143571	G	A	48	41	5	30	48	16	0.73	0.57	0.27	0.43	A	1.47	0.026203458	Nonalcoholic fatty liver disease	Obesity
rs3824660	C	T	32	44	18	50	37	7	0.57	0.73	0.43	0.27	C	1.1	0.026203458	Rheumatoid arthritis	Immune diseases and disorders
rs977747	T	G	33	42	19	48	41	5	0.57	0.73	0.43	0.27	T	0.017	0.026203458	Body mass index	Obesity
rs4245791	C	T	5	34	55	1	19	74	0.23	0.11	0.77	0.89	C	12	0.026168687	Phytosterol levels	General health
rs11757063	G	A	57	30	7	74	19	1	0.77	0.89	0.23	0.11	A	1.2	0.026168687	Migraine	Brain health and disorders
rs11558471	A	G	55	34	5	74	19	1	0.77	0.89	0.23	0.11	A	1	0.026168687	Proinsulin levels	Diabetes
rs3763558	C	A	73	21	0	55	34	5	0.89	0.77	0.11	0.23	A	1	0.026168687	DNA methylation variation	Misc
rs2570467	A	G	53	38	3	74	19	1	0.77	0.89	0.23	0.11	A	0.1	0.026168687	Waist circumference	General health
rs11088226	C	G	46	43	5	67	26	1	0.72	0.85	0.28	0.15	G	1.3	0.0261561	Gastritis	Cancer
rs10776733	A	G	13	38	43	27	40	27	0.34	0.50	0.66	0.50	A	0.03	0.026129369	Obesity-related traits	Obesity
rs3775948	G	C	29	37	28	13	39	42	0.51	0.35	0.49	0.65	C	0.1786	0.026041667	Renal function-related traits urea	General health
rs524023	C	T	22	51	21	12	41	41	0.51	0.35	0.49	0.65	C	0.093	0.026041667	Urate levels in obese individuals	Obesity
rs505802	T	C	22	51	21	12	41	41	0.51	0.35	0.49	0.65	T	0.06	0.026041667	Uric acid levels	General health
rs2070755	G	C	28	37	29	38	47	9	0.49	0.65	0.51	0.35	C	2.5	0.026041667	Emphysema imaging phenotypes	Pulmonology
rs2002842	C	A	22	49	23	40	43	11	0.49	0.65	0.51	0.35	A	1.61	0.026041667	Rheumatoid arthritis	Immune diseases and disorders
rs402710	C	T	38	47	9	21	51	22	0.65	0.49	0.35	0.51	C	1.18	0.026041667	Lung cancer	Cancer
rs12130212	T	A	29	49	16	48	40	6	0.57	0.72	0.43	0.28	T	1	0.026021845	Obesity extreme	Obesity
rs6039763	A	G	13	46	35	8	28	58	0.38	0.23	0.62	0.77	A	5.966	0.025994695	Adverse response to chemotherapy neutropenia_leucopenia etoposide	Drug response
rs9924758	G	C	7	30	57	15	42	37	0.23	0.38	0.77	0.62	C	1.06	0.025994695	Schizophrenia	Brain health and disorders
rs9832461	A	G	52	40	2	41	34	19	0.77	0.62	0.23	0.38	A	3785.6	0.025994695	Brain structure temporal lobe volume	Brain health and disorders
rs999943	A	G	36	44	14	55	34	5	0.62	0.77	0.38	0.23	T	1.37	0.025994695	Obesity extreme	Obesity
rs12412391	A	G	37	42	15	54	36	4	0.62	0.77	0.38	0.23	G	1.08	0.025994695	Colorectal cancer	Cancer
rs7214628	A	G	58	28	8	34	48	12	0.77	0.62	0.23	0.38	G	1	0.025994695	White matter hyperintensity burden	Brain health and disorders
rs2237895	A	C	39	45	10	59	32	3	0.65	0.80	0.35	0.20	C	1.29	0.025925531	Type 2 diabetes	Diabetes
rs12310399	T	C	39	43	12	23	45	26	0.64	0.48	0.36	0.52	A	1.852	0.025885872	Adverse response to chemotherapy neutropenia_leucopenia paclitaxel + carboplatin	Drug response
rs832190	C	T	12	43	39	24	49	21	0.36	0.52	0.64	0.48	C	1.0638298	0.025885872	Schizophrenia	Brain health and disorders
rs1107592	A	G	22	47	25	37	47	10	0.48	0.64	0.52	0.36	A	1.06	0.025885872	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs7708584	A	G	23	51	20	12	43	39	0.52	0.36	0.48	0.64	A	0.021	0.025885872	Body mass index	Obesity
rs2076529	T	C	21	49	24	37	47	10	0.48	0.64	0.52	0.36	C	0.02	0.025885872	Waist-hip ratio	General health
rs60580184	G	A	63	29	2	40	49	5	0.82	0.69	0.18	0.31	A	0.34	0.025872627	Lead levels in blood	General health
rs9491697	A	G	29	48	17	50	35	9	0.56	0.72	0.44	0.28	G	1.077	0.025849086	Crohn's disease	Digestive system and its disorders
rs2581624	G	C	49	37	8	31	44	19	0.72	0.56	0.28	0.44	C	0.125	0.025849086	Red blood cell fatty acid levels	Immune diseases and disorders
rs32576	A	G	50	35	9	29	48	17	0.72	0.56	0.28	0.44	G	0.03	0.025849086	Obesity-related traits	Obesity
rs3741208	A	G	28	42	24	15	38	41	0.52	0.36	0.48	0.64	T	1.25	0.025817556	Type 1 diabetes	Diabetes
rs374748	G	A	0	25	69	9	31	54	0.13	0.26	0.87	0.74	G	1.47	0.025774118	Obesity extreme	Obesity
rs13021401	C	T	50	39	5	72	19	3	0.74	0.87	0.26	0.13	T	1.21	0.025774118	Systemic sclerosis	Brain health and disorders
rs3850370	G	T	14	41	39	19	61	14	0.37	0.53	0.63	0.47	C	1.31	0.025755495	Response to platinum-based chemotherapy in non-small-cell lung cancer	General health
rs9490860	A	C	33	53	8	14	61	19	0.63	0.47	0.37	0.53	C	0.17	0.025755495	IgG glycosylation	Immune diseases and disorders
rs2648708	T	C	5	35	54	15	43	36	0.24	0.39	0.76	0.61	T	0.0696	0.025752201	Calcium levels	General health
rs3100127	C	A	34	47	13	54	35	5	0.61	0.76	0.39	0.24	A	4.31	0.025752201	Post-traumatic stress disorder	Brain health and disorders
rs7069733	C	G	53	37	4	32	51	11	0.76	0.61	0.24	0.39	C	1.08	0.025752201	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs5754891	A	G	37	41	16	52	39	3	0.61	0.76	0.39	0.24	A	0.16	0.025752201	Coronary artery calcification	Heart health and disorders
rs16967103	T	C	67	25	2	44	46	4	0.85	0.71	0.15	0.29	C	1.088	0.02570007	Crohn's disease	Digestive system and its disorders
rs7902627	A	C	69	21	4	46	42	6	0.85	0.71	0.15	0.29	C	0.1989	0.02570007	IgG glycosylation	Immune diseases and disorders
rs11149178	G	A	51	32	11	67	25	2	0.71	0.85	0.29	0.15	A	0.1777	0.02570007	Major depressive disorder	Brain health and disorders
rs11829373	G	C	67	25	2	44	46	4	0.85	0.71	0.15	0.29	C	0.08	0.02570007	Periodontitis Mean PAL	Misc
rs836589	A	G	2	25	67	5	44	45	0.15	0.29	0.85	0.71	A	1	0.02570007	Erectile dysfunction in type 1 diabetes	Diabetes
rs251925	T	C	12	30	52	0	29	65	0.29	0.15	0.71	0.85	A	0.03	0.02570007	Obesity-related traits	Obesity
rs13142500	T	C	17	54	23	34	50	10	0.47	0.63	0.53	0.37	C	1.1	0.0256996	Rheumatoid arthritis	Immune diseases and disorders
rs11987235	G	A	17	54	23	37	44	13	0.47	0.63	0.53	0.37	A	0.0384	0.0256996	Corneal curvature	General health
rs2791553	A	G	41	36	17	22	44	28	0.63	0.47	0.37	0.53	G	0.02	0.0256996	Adiponectin levels	Obesity
rs11885103	T	A	13	44	37	27	46	21	0.37	0.53	0.63	0.47	A	9.74	0.0256996	Heschl's gyrus morphology	Brain health and disorders
rs4794665	A	G	11	48	35	28	44	22	0.37	0.53	0.63	0.47	A	3.6	0.0256996	Height	General health
rs335206	T	C	28	44	22	9	52	33	0.53	0.37	0.47	0.63	T	0.66	0.0256996	QRS duration	Heart health and disorders
rs7976059	G	T	30	45	19	47	40	7	0.56	0.71	0.44	0.29	T	0.032	0.025684879	Urate levels	General health
rs11803731	A	T	74	20	0	89	5	0	0.89	0.97	0.11	0.03	A	6.11	0.025641026	Hair morphology	Appearance
rs16948876	G	A	74	20	0	89	5	0	0.89	0.97	0.11	0.03	A	1.56	0.025641026	Leprosy	Immune diseases and disorders
rs72749142	G	A	74	20	0	89	5	0	0.89	0.97	0.11	0.03	G	1.0752687	0.025641026	Schizophrenia	Brain health and disorders
rs2287654	T	G	75	18	1	89	5	0	0.89	0.97	0.11	0.03	T	1	0.025641026	Visceral adipose tissue adjusted for BMI	Obesity
rs7164923	C	T	89	5	0	75	18	1	0.97	0.89	0.03	0.11	T	1	0.025641026	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs11708304	C	T	75	18	1	89	5	0	0.89	0.97	0.11	0.03	C	0.059	0.025641026	Bulimia nervosa	Brain health and disorders
rs62495153	G	T	82	12	0	93	1	0	0.94	0.99	0.06	0.01	T	254.89	0.025641026	Hippocampal volume	Brain health and disorders
rs76506302	A	G	93	1	0	82	12	0	0.99	0.94	0.01	0.06	G	34.08	0.025641026	Diisocyanate-induced asthma	Pulmonology
rs74377925	T	C	93	1	0	82	12	0	0.99	0.94	0.01	0.06	G	5.34	0.025641026	Diisocyanate-induced asthma	Pulmonology
rs11754661	G	A	82	12	0	93	1	0	0.94	0.99	0.06	0.01	A	2.1	0.025641026	Alzheimer's disease late onset	Brain health and disorders
rs11957368	C	T	93	1	0	82	12	0	0.99	0.94	0.01	0.06	C	0.15	0.025641026	Metabolite levels Dihydroxy docosatrienoic acid	General health
rs7647305	T	C	5	29	60	7	52	35	0.21	0.35	0.79	0.65	C	4.42	0.025619399	Body mass index	Obesity
rs13333226	A	G	60	29	5	43	36	15	0.79	0.65	0.21	0.35	A	1.15	0.025619399	Hypertension	Heart health and disorders
rs1541010	C	T	59	31	4	39	44	11	0.79	0.65	0.21	0.35	A	0.15	0.025619399	RR interval heart rate	Heart health and disorders
rs6903823	A	G	61	27	6	47	28	19	0.79	0.65	0.21	0.35	G	0.037	0.025619399	Pulmonary function	Pulmonology
rs1775715	A	G	20	46	28	37	42	15	0.46	0.62	0.54	0.38	G	1.18	0.025606009	Bipolar disorder with mood-incongruent psychosis	Brain health and disorders
rs11782824	C	A	26	50	18	9	54	31	0.54	0.38	0.46	0.62	A	0.027	0.025606009	Neuroticism	Brain health and disorders
rs4533720	A	G	29	45	20	13	47	34	0.55	0.39	0.45	0.61	A	0.07	0.025568182	Urinary uromodulin levels	General health
rs11155133	A	G	72	22	0	55	33	6	0.88	0.76	0.12	0.24	G	3.62	0.025551852	Acute lymphoblastic leukemia childhood	Cancer
rs11810217	C	T	53	37	4	75	16	3	0.76	0.88	0.24	0.12	A	1.15	0.025551852	Multiple sclerosis	Brain health and disorders
rs28587833	C	G	75	16	3	53	37	4	0.88	0.76	0.12	0.24	G	1.0638298	0.025551852	Schizophrenia	Brain health and disorders
rs1472189	C	T	54	35	5	75	16	3	0.76	0.88	0.24	0.12	C	0.11	0.025551852	Metabolite levels Dihydroxy docosatrienoic acid	General health
rs2086452	G	A	19	46	29	32	50	12	0.45	0.61	0.55	0.39	C	1.35	0.025536261	Osteosarcoma	Cancer
rs3798713	G	C	18	48	28	37	40	17	0.45	0.61	0.55	0.39	C	0.04	0.025536261	Phospholipid levels plasma	General health
rs6828740	T	C	87	6	1	72	19	3	0.96	0.87	0.04	0.13	C	4.14	0.025532291	Erythema nodosum in inflammatory bowel disease	Digestive system and its disorders
rs17034687	C	G	86	8	0	69	25	0	0.96	0.87	0.04	0.13	C	0.23	0.025532291	Disc degeneration lumbar	Aging
rs2275906	A	G	71	21	2	86	8	0	0.87	0.96	0.13	0.04	G	0.125	0.025532291	Urate levels in lean individuals	Obesity
rs4148155	A	G	69	25	0	86	8	0	0.87	0.96	0.13	0.04	G	0.121	0.025532291	Urate levels	General health
rs2650492	G	A	71	21	2	86	8	0	0.87	0.96	0.13	0.04	A	0.021	0.025532291	Body mass index	Obesity
rs9291768	C	T	46	41	7	30	44	20	0.71	0.55	0.29	0.45	T	2.18	0.025528944	Classic bladder exstrophy	Misc
rs174583	C	T	32	40	22	49	35	10	0.55	0.71	0.45	0.29	T	0.57	0.025528944	QT interval	Heart health and disorders
rs174576	C	A	32	40	22	49	35	10	0.55	0.71	0.45	0.29	A	0.0032	0.025528944	Trans fatty acid levels	General health
rs2014791	T	C	19	46	29	7	41	46	0.45	0.29	0.55	0.71	A	2.15	0.025528944	Diisocyanate-induced asthma	Pulmonology
rs2617170	T	C	5	45	44	18	48	28	0.29	0.45	0.71	0.55	T	1.28	0.025528944	Behcet's disease	Immune diseases and disorders
rs6933660	C	A	18	48	28	10	35	49	0.45	0.29	0.55	0.71	C	0.03	0.025528944	Menarche age at onset	Reproductive health
rs11128271	T	C	1	17	76	3	35	56	0.10	0.22	0.90	0.78	C	0.338	0.025527426	IgG glycosylation	Immune diseases and disorders
rs2738774	G	A	57	33	4	76	17	1	0.78	0.90	0.22	0.10	A	1	0.025527426	Pediatric autoimmune diseases	Immune diseases and disorders
rs12130333	C	T	58	31	5	76	17	1	0.78	0.90	0.22	0.10	T	0.11	0.025527426	Triglycerides	General health
rs1741344	C	T	9	28	57	11	52	31	0.24	0.39	0.76	0.61	T	0.023	0.025520833	Height	General health
rs17151904	G	A	63	28	3	42	44	8	0.82	0.68	0.18	0.32	A	1	0.025501735	Carotid atherosclerosis in HIV infection	Heart health and disorders
rs424950	G	C	42	44	8	61	32	1	0.68	0.82	0.32	0.18	C	0.076	0.025501735	Sex hormone-binding globulin levels	Reproductive health
rs3127447	C	A	9	42	43	1	32	61	0.32	0.18	0.68	0.82	A	0.02	0.025501735	Educational attainment	Mental aptitude and behavioural traits
rs12539316	A	G	63	28	3	37	54	3	0.82	0.68	0.18	0.32	C	0.0051	0.025501735	Gamma glutamyl transpeptidase	Immune diseases and disorders
rs1492820	G	A	16	44	34	31	44	19	0.40	0.56	0.60	0.44	G	0.29	0.025489974	Height	General health
rs652889	C	A	32	42	20	11	54	29	0.56	0.40	0.44	0.60	A	0.15	0.025489974	QT interval	Heart health and disorders
rs8002779	G	A	13	50	31	29	48	17	0.40	0.56	0.60	0.44	A	0.05	0.025489974	Height	General health
rs1963569	A	C	17	42	35	26	54	14	0.40	0.56	0.60	0.44	A	0.03	0.025489974	Obesity-related traits	Obesity
rs7568458	T	A	34	44	16	22	38	34	0.60	0.44	0.40	0.56	A	1.06	0.025489974	Coronary artery disease	Heart health and disorders
rs1023008	A	T	33	46	15	14	54	26	0.60	0.44	0.40	0.56	T	0.03	0.025489974	Obesity-related traits	Obesity
rs4478858	T	C	32	47	15	14	53	27	0.59	0.43	0.41	0.57	G	1.26	0.025475543	Alcohol dependence	General health
rs854555	A	C	15	51	28	32	47	15	0.43	0.59	0.57	0.41	A	1	0.025475543	Response to TNF antagonist treatment	General health
rs9908102	C	T	14	50	30	29	50	15	0.41	0.57	0.59	0.43	T	1.05	0.025466893	Schizophrenia	Brain health and disorders
rs10929925	C	A	32	44	18	16	46	32	0.57	0.41	0.43	0.59	C	0.016	0.025466893	Body mass index	Obesity
rs17560407	A	G	64	26	4	80	14	0	0.82	0.93	0.18	0.07	G	23.23	0.025406504	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs7801534	A	G	81	12	1	63	28	3	0.93	0.82	0.07	0.18	G	4.96	0.025406504	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs17030845	C	T	80	14	0	63	28	3	0.93	0.82	0.07	0.18	C	3.577	0.025406504	Platelet count	Heart health and disorders
rs3115663	T	C	80	14	0	64	26	4	0.93	0.82	0.07	0.18	G	3.04	0.025406504	Idiopathic membranous nephropathy	Brain health and disorders
rs3130618	C	A	80	14	0	63	28	3	0.93	0.82	0.07	0.18	A	3.03	0.025406504	Idiopathic membranous nephropathy	Brain health and disorders
rs17467825	A	G	62	30	2	81	12	1	0.82	0.93	0.18	0.07	A	1.07	0.025406504	Vitamin D levels	General health
rs2282679	T	G	62	30	2	81	12	1	0.82	0.93	0.18	0.07	C	0.38	0.025406504	Vitamin D levels	General health
rs4815868	A	G	64	26	4	82	10	2	0.82	0.93	0.18	0.07	A	0.16	0.025406504	Information processing speed	Mental aptitude and behavioural traits
rs631844	C	T	29	45	20	44	44	6	0.55	0.70	0.45	0.30	T	4.9	0.025381017	Epilepsy and lamotrigine-induced maculopapular eruptions	Brain health and disorders
rs510372	C	T	37	47	10	59	30	5	0.64	0.79	0.36	0.21	C	1.2345679	0.02532745	Primary biliary cirrhosis	Immune diseases and disorders
rs4253238	C	T	16	35	43	5	30	59	0.36	0.21	0.64	0.79	C	5.136	0.02532745	Circulating vasoactive peptide levels	Immune diseases and disorders
rs1795240	A	G	14	47	33	3	41	50	0.40	0.25	0.60	0.75	A	112.27	0.025300116	Lentiform nucleus volume	Misc
rs9921338	T	C	3	41	50	13	49	32	0.25	0.40	0.75	0.60	A	1	0.025300116	Vein graft stenosis in coronary artery bypass grafting	Heart health and disorders
rs36068923	A	G	66	26	2	50	33	11	0.84	0.71	0.16	0.29	G	1.0881393	0.025267839	Schizophrenia	Brain health and disorders
rs2206734	C	T	67	24	3	46	41	7	0.84	0.71	0.16	0.29	C	0.039	0.025267839	Body mass index	Obesity
rs823128	G	A	0	30	64	8	39	47	0.16	0.29	0.84	0.71	A	1.52	0.025267839	Parkinson's disease	Brain health and disorders
rs4239702	T	C	6	38	50	3	20	71	0.27	0.14	0.73	0.86	C	1.14	0.025263158	Rheumatoid arthritis	Immune diseases and disorders
rs4846835	G	A	52	34	8	69	24	1	0.73	0.86	0.27	0.14	A	0.4595	0.025263158	Dementia and core Alzheimer's disease neuropathologic changes	Brain health and disorders
rs12785387	C	T	71	20	3	52	34	8	0.86	0.73	0.14	0.27	T	0.28	0.025263158	Intraocular pressure	General health
rs11827818	A	G	71	20	3	51	36	7	0.86	0.73	0.14	0.27	A	0.23	0.025263158	Intraocular pressure	General health
rs3888190	C	A	31	40	23	45	41	8	0.54	0.70	0.46	0.30	A	0.035	0.025240854	Body mass index	Obesity
rs3181077	C	T	2	24	68	0	10	84	0.15	0.05	0.85	0.95	T	1.63	0.025225786	Narcolepsy with cataplexy	Brain health and disorders
rs10508343	C	A	69	22	3	84	10	0	0.85	0.95	0.15	0.05	A	3.81	0.025225786	Response to treatment for acute lymphoblastic leukemia	General health
rs17007761	C	A	70	20	4	85	8	1	0.85	0.95	0.15	0.05	A	1	0.025225786	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs10237118	C	A	84	10	0	67	26	1	0.95	0.85	0.05	0.15	C	0.313	0.025225786	Optic nerve measurement cup area	Misc
rs16976171	G	T	84	10	0	68	24	2	0.95	0.85	0.05	0.15	T	0.2	0.025225786	Coronary artery calcification	Heart health and disorders
rs8135828	G	A	67	26	1	84	10	0	0.85	0.95	0.15	0.05	A	0.11	0.025225786	Lipid traits	Misc
rs12355688	C	T	83	10	1	64	29	1	0.94	0.84	0.06	0.16	T	1.24	0.025211258	Breast cancer	Cancer
rs14403	C	T	65	27	2	82	12	0	0.84	0.94	0.16	0.06	C	1.1	0.025211258	Schizophrenia	Brain health and disorders
rs2295888	A	G	82	12	0	65	27	2	0.94	0.84	0.06	0.16	A	0.02	0.025211258	Prothrombin time	Immune diseases and disorders
rs7161179	G	A	90	4	0	77	16	1	0.98	0.90	0.02	0.10	A	34.08	0.025166923	Diisocyanate-induced asthma	Pulmonology
rs1476029	C	T	76	18	0	90	4	0	0.90	0.98	0.10	0.02	A	6.426	0.025166923	Adverse response to chemotherapy neutropenia_leucopenia paclitaxel + carboplatin	Drug response
rs10483776	A	G	77	16	1	90	4	0	0.90	0.98	0.10	0.02	G	0.22	0.025166923	N-glycan levels	General health
rs2278491	C	T	76	18	0	90	4	0	0.90	0.98	0.10	0.02	C	0.028	0.025166923	Body mass index	Obesity
rs588517	T	C	0	18	76	0	4	90	0.10	0.02	0.90	0.98	A	1	0.025166923	Carotid atherosclerosis in HIV infection	Heart health and disorders
rs4716055	G	T	1	16	77	0	4	90	0.10	0.02	0.90	0.98	T	0.031	0.025166923	Adiponectin levels	Obesity
rs4760636	T	C	13	35	46	3	29	62	0.32	0.19	0.68	0.81	T	0.027	0.02514881	Urate levels	General health
rs12773846	G	A	61	31	2	48	31	15	0.81	0.68	0.19	0.32	G	1	0.02514881	Subcutaneous adipose tissue	Obesity
rs709400	A	G	40	47	7	63	27	4	0.68	0.81	0.32	0.19	A	0.019	0.02514881	Body mass index	Obesity
rs588136	C	T	13	32	49	19	49	26	0.31	0.46	0.69	0.54	T	0.029	0.025108225	Blood metabolite levels	Heart health and disorders
rs3891585	A	G	3	42	49	18	40	36	0.26	0.40	0.74	0.60	A	2.13	0.025089606	PR interval	Heart health and disorders
rs2474937	A	G	56	35	3	34	52	8	0.78	0.64	0.22	0.36	C	1.4	0.025048964	Congenital heart malformation	Heart health and disorders
rs10936632	C	A	40	40	14	57	33	4	0.64	0.78	0.36	0.22	A	1.11	0.025048964	Prostate cancer	Cancer
rs7094308	C	T	44	32	18	55	37	2	0.64	0.78	0.36	0.22	T	0.095	0.025048964	Serum dimethylarginine levels asymmetric_symetric ratio	General health
rs10447248	A	G	12	44	38	5	31	58	0.36	0.22	0.64	0.78	A	1	0.025048964	Adiponectin levels	Obesity
rs4987855	C	T	82	10	2	92	2	0	0.93	0.99	0.07	0.01	G	1.47	0.025	Chronic lymphocytic leukemia	Cancer
rs76355118	A	G	80	14	0	92	2	0	0.93	0.99	0.07	0.01	G	1.1627907	0.025	Schizophrenia	Brain health and disorders
rs9317639	C	T	80	14	0	92	2	0	0.93	0.99	0.07	0.01	C	1.098901	0.025	Schizophrenia	Brain health and disorders
rs10508196	G	A	80	14	0	92	2	0	0.93	0.99	0.07	0.01	A	1.08	0.025	Vitamin D levels	General health
rs4129601	A	G	92	2	0	82	10	2	0.99	0.93	0.01	0.07	G	1	0.025	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs191555775	A	T	80	14	0	92	2	0	0.93	0.99	0.07	0.01	A	0.057	0.025	HDL cholesterol	General health
rs17368582	T	C	81	12	1	92	2	0	0.93	0.99	0.07	0.01	G	0.02	0.025	Local histogram emphysema pattern	Pulmonology
rs9395066	A	C	27	46	21	44	41	9	0.53	0.69	0.47	0.31	C	3.5	0.024982919	Height	General health
rs166881	T	C	80	11	3	61	28	5	0.91	0.80	0.09	0.20	C	22.26	0.02497876	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs3118906	G	A	60	30	4	77	17	0	0.80	0.91	0.20	0.09	G	1.26	0.02497876	Height	General health
rs11185790	G	A	59	32	3	79	13	2	0.80	0.91	0.20	0.09	A	0.31	0.02497876	Metabolic traits	Misc
rs3118905	G	A	60	30	4	77	17	0	0.80	0.91	0.20	0.09	A	0.1	0.02497876	Height	General health
rs2300603	T	C	52	38	4	73	19	2	0.76	0.88	0.24	0.12	A	1.11	0.024972856	Multiple sclerosis	Brain health and disorders
rs2277339	T	G	71	23	0	53	36	5	0.88	0.76	0.12	0.24	G	0.38	0.024972856	Menopause age at onset	Reproductive health
rs950880	C	A	55	32	7	71	23	0	0.76	0.88	0.24	0.12	A	0.18	0.024972856	Serum protein levels sST2	General health
rs681383	T	A	1	21	72	2	42	50	0.12	0.24	0.88	0.76	T	0.099	0.024972856	Sitting height ratio	Appearance
rs10268774	T	C	91	3	0	79	14	1	0.98	0.91	0.02	0.09	G	34.08	0.024915229	Diisocyanate-induced asthma	Pulmonology
rs12446956	T	C	78	16	0	91	3	0	0.91	0.98	0.09	0.02	C	1.22	0.024915229	Major depressive disorder	Brain health and disorders
rs7318913	C	G	79	14	1	91	3	0	0.91	0.98	0.09	0.02	G	0.242	0.024915229	Symmetrical dimethylarginine levels	General health
rs17723576	A	G	81	10	3	91	3	0	0.91	0.98	0.09	0.02	G	0.108	0.024915229	Urate levels in obese individuals	Obesity
rs1997243	A	G	80	12	2	91	3	0	0.91	0.98	0.09	0.02	G	0.033	0.024915229	Cholesterol, total	General health
rs2991396	G	A	2	45	47	20	37	37	0.26	0.41	0.74	0.59	G	1	0.024888889	Male fertility	Reproductive health
rs734597	G	A	54	38	2	75	18	1	0.78	0.89	0.22	0.11	A	1	0.024861311	Obesity extreme	Obesity
rs12713280	C	T	55	36	3	75	18	1	0.78	0.89	0.22	0.11	T	0.123	0.024861311	Economic and political preferences	Mental aptitude and behavioural traits
rs2207139	A	G	54	38	2	75	18	1	0.78	0.89	0.22	0.11	G	0.047	0.024861311	Body mass index	Obesity
rs11133665	G	A	48	36	10	64	29	1	0.70	0.84	0.30	0.16	A	0.1569	0.024857813	Urinary metabolites	General health
rs11215400	A	C	46	40	8	66	25	3	0.70	0.84	0.30	0.16	C	0.04	0.024857813	Menarche age at onset	Reproductive health
rs12660691	A	C	61	30	3	40	46	8	0.81	0.67	0.19	0.33	A	3.199	0.024812803	Adverse response to chemotherapy neutropenia_leucopenia docetaxel	Drug response
rs9584154	A	G	42	42	10	61	30	3	0.67	0.81	0.33	0.19	A	1.06	0.024812803	Schizophrenia	Brain health and disorders
rs17776120	C	A	39	48	7	62	28	4	0.67	0.81	0.33	0.19	C	0.1654	0.024812803	IgG glycosylation	Immune diseases and disorders
rs7819937	G	A	37	45	12	56	34	4	0.63	0.78	0.37	0.22	A	1	0.024783274	Diisocyanate-induced asthma	Pulmonology
rs1056053	C	T	12	45	37	3	36	55	0.37	0.22	0.63	0.78	T	1	0.024783274	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs9584805	A	G	55	36	3	38	43	13	0.78	0.63	0.22	0.37	G	0.44	0.024783274	Non-alcoholic fatty liver disease histology lobular	Obesity
rs824192	C	T	28	42	24	45	37	12	0.52	0.68	0.48	0.32	T	0.43	0.024753495	Depressive symptoms SSRI exposure interaction	Brain health and disorders
rs11646213	A	T	31	48	15	54	30	10	0.59	0.73	0.41	0.27	T	1.28	0.024697581	Hypertension	Heart health and disorders
rs9285640	G	A	87	7	0	73	19	2	0.96	0.88	0.04	0.12	G	29.95	0.024662813	Response to fenofibrate	General health
rs10431397	C	T	87	7	0	73	19	2	0.96	0.88	0.04	0.12	A	1.73	0.024662813	Endometriosis	General health
rs10496964	C	T	72	21	1	88	5	1	0.88	0.96	0.12	0.04	C	1.47	0.024662813	Epilepsy generalized	Brain health and disorders
rs7800668	G	C	89	3	2	73	19	2	0.96	0.88	0.04	0.12	C	1.34	0.024662813	Response to methotrexate in juvenile idiopathic arthritis	General health
rs17653722	G	T	73	19	2	87	7	0	0.88	0.96	0.12	0.04	T	0.1223	0.024662813	Telomere length	Aging
rs2185570	T	C	71	23	0	87	7	0	0.88	0.96	0.12	0.04	C	0.06	0.024662813	Dehydroepiandrosterone sulphate levels	Immune diseases and disorders
rs8099121	A	G	8	46	40	26	39	29	0.33	0.48	0.67	0.52	A	1.06	0.024649023	Schizophrenia	Brain health and disorders
rs2713536	C	T	8	46	40	22	47	25	0.33	0.48	0.67	0.52	C	0.038	0.024649023	HDL cholesterol	General health
rs4065321	C	T	22	48	24	9	45	40	0.49	0.34	0.51	0.66	T	0.094	0.02455116	White blood cell count	Immune diseases and disorders
rs7164569	A	G	42	41	11	25	46	23	0.66	0.51	0.34	0.49	A	1.15	0.02455116	Venous thromboembolism	Heart health and disorders
rs9535020	A	G	62	29	3	79	15	0	0.81	0.92	0.19	0.08	G	1.69	0.024539877	Chronic kidney disease	Immune diseases and disorders
rs13393577	T	C	79	15	0	63	27	4	0.92	0.81	0.08	0.19	T	1.53	0.024539877	Breast cancer	Cancer
rs11024102	T	C	65	23	6	80	13	1	0.81	0.92	0.19	0.08	G	1.22	0.024539877	Glaucoma primary angle closure	General health
rs11190164	A	G	61	31	2	79	15	0	0.81	0.92	0.19	0.08	G	1.13	0.024539877	Colorectal cancer	Cancer
rs16883019	T	C	79	15	0	63	27	4	0.92	0.81	0.08	0.19	C	1	0.024539877	Response to statin therapy	General health
rs13226650	A	G	80	13	1	61	31	2	0.92	0.81	0.08	0.19	A	0.12	0.024539877	Metabolic syndrome	Immune diseases and disorders
rs2051457	G	T	79	15	0	64	25	5	0.92	0.81	0.08	0.19	A	0.03	0.024539877	Obesity-related traits	Obesity
rs17478107	T	C	60	33	1	80	13	1	0.81	0.92	0.19	0.08	C	0.02	0.024539877	Self-rated health	General health
rs887912	T	C	4	27	63	1	13	80	0.19	0.08	0.81	0.92	T	0.1	0.024539877	Body mass index	Obesity
rs2341459	T	C	7	29	58	11	48	35	0.23	0.37	0.77	0.63	T	0.025	0.024529762	Height	General health
rs2255327	C	T	94	0	0	85	9	0	1.00	0.95	0.00	0.05	A	1	0.024523161	Immune response to smallpox vaccine IL-6	Immune diseases and disorders
rs115848955	C	T	94	0	0	85	9	0	1.00	0.95	0.00	0.05	T	0.79	0.024523161	Lipoprotein a levels	Heart health and disorders
rs10266254	A	G	94	0	0	85	9	0	1.00	0.95	0.00	0.05	A	0.61	0.024523161	Coronary artery calcification	Heart health and disorders
rs76547188	C	T	94	0	0	86	7	1	1.00	0.95	0.00	0.05	A	0.03	0.024523161	Obesity-related traits	Obesity
rs372091	A	G	0	0	94	0	9	85	0.00	0.05	1.00	0.95	C	2.17	0.024523161	Malaria	Immune diseases and disorders
rs13041126	T	C	39	47	8	61	29	4	0.66	0.80	0.34	0.20	T	1.06	0.024492754	Obesity	Obesity
rs954123	T	A	41	43	10	59	33	2	0.66	0.80	0.34	0.20	A	0.52	0.024492754	Depressive symptoms SSRI exposure interaction	Brain health and disorders
rs17536328	C	T	40	45	9	61	29	4	0.66	0.80	0.34	0.20	T	0.0866	0.024492754	Bone mineral density paediatric, total body less head	General health
rs11866815	C	T	58	35	1	37	51	6	0.80	0.66	0.20	0.34	C	0.024	0.024492754	Body mass index	Obesity
rs16897978	C	A	2	28	64	7	43	44	0.17	0.30	0.83	0.70	C	1.53	0.024468543	Alcohol dependence age at onset	General health
rs199498	T	C	47	37	10	63	30	1	0.70	0.83	0.30	0.17	T	1.69	0.024468543	Parkinson's disease	Brain health and disorders
rs1587409	G	T	67	22	5	46	39	9	0.83	0.70	0.17	0.30	T	0.572	0.024468543	Left superior temporal gyrus thickness schizophrenia interaction	Brain health and disorders
rs7089227	G	T	12	40	42	23	47	24	0.34	0.49	0.66	0.51	G	1.99	0.024459762	Adverse response to chemotherapy in breast cancer alopecia cyclophosphamide+epirubicin+_-5FU	Drug response
rs6563569	C	T	9	46	39	22	49	23	0.34	0.49	0.66	0.51	C	1.16	0.024459762	Tourette's syndrome or obsessive-compulsive disorder	Brain health and disorders
rs4380275	C	T	7	33	54	3	18	73	0.25	0.13	0.75	0.87	G	3.604	0.024428538	Adverse response to chemotherapy neutropenia_leucopenia doxorubicin	Drug response
rs73329476	C	T	73	18	3	49	43	2	0.87	0.75	0.13	0.25	T	2.17	0.024428538	Pneumoconiosis in silica exposure	Pulmonology
rs2457996	C	T	1	22	71	6	35	53	0.13	0.25	0.87	0.75	A	1.1094414	0.024428538	Ulcerative colitis	Immune diseases and disorders
rs12468557	C	T	53	35	6	72	20	2	0.75	0.87	0.25	0.13	T	1	0.024428538	Body mass index in asthmatics	Obesity
rs2445284	C	T	25	44	25	7	51	36	0.50	0.35	0.50	0.65	G	0.82	0.024374692	Sickle cell anemia haemolysis	Heart health and disorders
rs1581057	A	C	13	39	42	20	54	20	0.35	0.50	0.65	0.50	C	0.13	0.024374692	Social communication problems	Brain health and disorders
rs6887276	C	G	22	36	36	7	38	49	0.43	0.28	0.57	0.72	C	0.018	0.024341778	Height	General health
rs10762738	A	G	50	36	8	67	26	1	0.72	0.85	0.28	0.15	G	1.24	0.024324324	Hypospadias	Misc
rs2022309	G	T	50	36	8	70	20	4	0.72	0.85	0.28	0.15	G	0.244	0.024324324	End-stage coagulation	General health
rs7702331	A	G	40	42	12	21	51	22	0.65	0.49	0.35	0.51	A	1.12	0.024295826	Crohn's disease	Digestive system and its disorders
rs9303525	A	G	52	40	2	37	43	14	0.77	0.62	0.23	0.38	G	14.9	0.024287856	Intracranial volume	Misc
rs8008961	C	T	56	32	6	41	35	18	0.77	0.62	0.23	0.38	A	2.44	0.024287856	Acute urticaria and angioedema non-steroidal anti-inflammatory drug-induced	Immune diseases and disorders
rs6047844	T	C	16	39	39	7	30	57	0.38	0.23	0.62	0.77	T	1.6	0.024287856	Male-pattern baldness	Appearance
rs1257344	A	G	10	51	33	8	28	58	0.38	0.23	0.62	0.77	G	1	0.024287856	Diisocyanate-induced asthma	Pulmonology
rs6799788	A	G	57	35	2	76	18	0	0.79	0.90	0.21	0.10	G	1.6268	0.024253424	Major depressive disorder	Brain health and disorders
rs1001021	G	A	58	33	3	76	18	0	0.79	0.90	0.21	0.10	A	1	0.024253424	Schizophrenia, bipolar disorder and depression combined	Brain health and disorders
rs11966072	A	G	61	27	6	77	16	1	0.79	0.90	0.21	0.10	G	0.114	0.024253424	Red blood cell count	Immune diseases and disorders
rs7965584	A	G	60	29	5	76	18	0	0.79	0.90	0.21	0.10	G	0.07	0.024253424	Magnesium levels	General health
rs1763500	G	A	1	16	77	4	31	59	0.10	0.21	0.90	0.79	C	0.26	0.024253424	Body mass index interaction	Obesity
rs10740609	T	A	6	31	57	3	15	76	0.23	0.11	0.77	0.89	T	3.41	0.024238782	Weight	Appearance
rs3802177	G	A	55	35	4	74	19	1	0.77	0.89	0.23	0.11	G	1.23	0.024238782	Type 2 diabetes	Diabetes
rs987237	A	G	54	37	3	74	19	1	0.77	0.89	0.23	0.11	G	1.2	0.024238782	Body mass index	Obesity
rs36059107	T	A	58	29	7	76	15	3	0.77	0.89	0.23	0.11	A	1.06	0.024238782	Schizophrenia	Brain health and disorders
rs1789953	C	T	55	35	4	73	21	0	0.77	0.89	0.23	0.11	T	1	0.024238782	Blood and toenail selenium levels	Heart health and disorders
rs17482078	C	T	64	28	2	81	13	0	0.83	0.93	0.17	0.07	T	4.56	0.024236321	Behcet's disease	Immune diseases and disorders
rs941207	C	G	64	28	2	81	13	0	0.83	0.93	0.17	0.07	G	2.751	0.024236321	Platelet count	Heart health and disorders
rs9470794	T	C	81	13	0	63	30	1	0.93	0.83	0.07	0.17	C	1.12	0.024236321	Type 2 diabetes	Diabetes
rs10842994	C	T	66	24	4	82	11	1	0.83	0.93	0.17	0.07	C	1.09	0.024236321	Type 2 diabetes	Diabetes
rs304172	G	A	81	13	0	64	28	2	0.93	0.83	0.07	0.17	G	0.3337	0.024236321	IgG glycosylation	Immune diseases and disorders
rs2687950	C	T	66	24	4	82	11	1	0.83	0.93	0.17	0.07	T	0.036	0.024236321	Height	General health
rs10904180	T	G	66	24	4	81	13	0	0.83	0.93	0.17	0.07	T	0.026	0.024236321	Educational attainment	Mental aptitude and behavioural traits
rs7072776	A	G	10	47	37	26	44	24	0.36	0.51	0.64	0.49	A	1.07	0.024223048	Breast cancer	Cancer
rs6993813	T	C	25	46	23	14	39	41	0.51	0.36	0.49	0.64	C	0.09	0.024223048	Bone mineral density hip	General health
rs1950832	T	C	2	22	70	0	9	85	0.14	0.05	0.86	0.95	C	0.121	0.024214495	Urate levels in obese individuals	Obesity
rs10958476	T	C	72	18	4	86	7	1	0.86	0.95	0.14	0.05	T	0.051	0.024214495	Height	General health
rs116139393	C	G	60	30	4	40	44	10	0.80	0.66	0.20	0.34	C	1.098901	0.024187777	Alzheimer's disease APOE e4 interaction	Brain health and disorders
rs1432723	G	A	43	38	13	61	28	5	0.66	0.80	0.34	0.20	G	0.03	0.024187777	Obesity-related traits	Obesity
rs6458016	T	C	46	43	5	32	43	19	0.72	0.57	0.28	0.43	T	0.062	0.024176637	Sitting height ratio	Appearance
rs633185	G	C	20	41	33	3	47	44	0.43	0.28	0.57	0.72	G	0.565	0.024176637	Systolic blood pressure	Heart health and disorders
rs3761944	G	C	19	43	32	6	41	47	0.43	0.28	0.57	0.72	C	0.016	0.024176637	Hematology traits	Heart health and disorders
rs352889	G	A	39	42	13	23	45	26	0.64	0.48	0.36	0.52	A	0.016	0.024156254	Toenail selenium levels	Misc
rs35766269	A	T	68	23	3	83	11	0	0.85	0.94	0.15	0.06	A	1.946	0.024107143	Recalcitrant atopic dermatitis	Immune diseases and disorders
rs17710780	T	C	66	27	1	83	11	0	0.85	0.94	0.15	0.06	T	1.662	0.024107143	Major depressive disorder	Brain health and disorders
rs67682613	G	A	84	9	1	66	27	1	0.94	0.85	0.06	0.15	G	1.1494253	0.024107143	Schizophrenia	Brain health and disorders
rs6974491	G	A	68	23	3	83	11	0	0.85	0.94	0.15	0.06	A	1.14	0.024107143	Celiac disease	Immune diseases and disorders
rs2899472	C	A	67	25	2	83	11	0	0.85	0.94	0.15	0.06	A	1	0.024107143	Cerebrospinal AB1-42 levels	Brain health and disorders
rs738968	T	G	83	11	0	65	29	0	0.94	0.85	0.06	0.15	C	1	0.024107143	Immune reponse to smallpox secreted TNF-alpha	Immune diseases and disorders
rs4867766	G	A	68	23	3	83	11	0	0.85	0.94	0.15	0.06	A	0.41	0.024107143	Stroke	Brain health and disorders
rs17635075	A	G	83	11	0	68	23	3	0.94	0.85	0.06	0.15	G	0.05	0.024107143	Obesity-related traits	Obesity
rs884205	A	C	3	23	68	1	9	84	0.15	0.06	0.85	0.94	A	0.05	0.024107143	Bone mineral density	General health
rs419291	T	C	13	32	49	0	33	61	0.31	0.18	0.69	0.82	T	0.008	0.024098708	Blood metabolite levels	Heart health and disorders
rs3118470	T	C	50	30	14	63	29	2	0.69	0.82	0.31	0.18	G	1.41	0.024098708	Alopecia areata	Immune diseases and disorders
rs10489202	G	T	47	36	11	62	31	1	0.69	0.82	0.31	0.18	A	1.23	0.024098708	Schizophrenia	Brain health and disorders
rs7164883	A	G	67	21	6	43	44	7	0.82	0.69	0.18	0.31	G	1.19	0.024098708	Atrial fibrillation	Heart health and disorders
rs4489968	T	G	67	21	6	43	44	7	0.82	0.69	0.18	0.31	T	0.513	0.024098708	Heart rate	General health
rs10510181	G	A	37	42	15	56	31	7	0.62	0.76	0.38	0.24	A	1.37	0.024057024	Adolescent idiopathic scoliosis	Obesity
rs6127471	C	T	35	46	13	55	33	6	0.62	0.76	0.38	0.24	C	0.429	0.024057024	Heart rate	General health
rs13113518	T	C	38	40	16	55	33	6	0.62	0.76	0.38	0.24	T	0.018	0.024057024	Height	General health
rs2740	A	G	33	40	21	48	38	8	0.56	0.71	0.44	0.29	A	0.022	0.024019608	Blood metabolite ratios	Heart health and disorders
rs11870935	G	A	11	49	34	25	50	19	0.38	0.53	0.62	0.47	G	0.015	0.023990871	Optic cup area	Misc
rs4148008	C	G	34	48	12	19	49	26	0.62	0.46	0.38	0.54	G	0.42	0.023947151	HDL cholesterol	General health
rs32579	C	T	35	46	13	17	53	24	0.62	0.46	0.38	0.54	A	0.11	0.023947151	Tanning	Appearance
rs7427021	A	G	24	53	17	15	42	37	0.54	0.38	0.46	0.62	G	1.16	0.023947151	Bipolar disorder	Brain health and disorders
rs569805	A	T	7	34	53	1	23	70	0.26	0.13	0.74	0.87	A	0.16	0.02391609	Metabolic syndrome bivariate traits	Immune diseases and disorders
rs4272	A	G	53	34	7	70	23	1	0.74	0.87	0.26	0.13	G	1.1	0.02391609	Rheumatoid arthritis	Immune diseases and disorders
rs7597593	T	C	19	48	27	34	47	13	0.46	0.61	0.54	0.39	T	1.055	0.023909026	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs4845812	C	T	34	47	13	23	40	31	0.61	0.46	0.39	0.54	T	0.2917	0.023909026	Metabolite levels MHPG	General health
rs3735025	T	C	50	35	9	67	25	2	0.72	0.85	0.28	0.15	T	1.07	0.023892484	Schizophrenia	Brain health and disorders
rs80021942	C	T	49	37	8	69	21	4	0.72	0.85	0.28	0.15	C	1.0638298	0.023892484	Schizophrenia	Brain health and disorders
rs6139030	T	C	88	6	0	73	21	0	0.97	0.89	0.03	0.11	T	25	0.023877746	Response to hepatitis C treatment	General health
rs17641524	C	T	74	19	1	88	6	0	0.89	0.97	0.11	0.03	T	1.2987013	0.023877746	Primary biliary cirrhosis	Immune diseases and disorders
rs12487279	C	G	75	17	2	88	6	0	0.89	0.97	0.11	0.03	C	1.11	0.023877746	Schizophrenia	Brain health and disorders
rs12682527	C	T	75	17	2	88	6	0	0.89	0.97	0.11	0.03	C	1.0869565	0.023877746	Schizophrenia	Brain health and disorders
rs17658378	A	G	74	19	1	88	6	0	0.89	0.97	0.11	0.03	A	1	0.023877746	Attention deficit hyperactivity disorder time to onset	Brain health and disorders
rs2038823	G	T	75	17	2	88	6	0	0.89	0.97	0.11	0.03	C	1	0.023877746	Diabetic retinopathy	Diabetes
rs9907236	G	A	89	4	1	74	19	1	0.97	0.89	0.03	0.11	A	0.51	0.023877746	Coronary artery calcification	Heart health and disorders
rs900145	C	T	22	41	31	37	40	17	0.45	0.61	0.55	0.39	C	2.3	0.023876444	Menarche age at onset	Reproductive health
rs4654438	T	C	15	44	35	27	49	18	0.39	0.55	0.61	0.45	T	1.6269	0.023876444	Smooth-surface caries	Appearance
rs372883	T	C	19	45	30	8	39	47	0.44	0.29	0.56	0.71	T	1.27	0.023870418	Pancreatic cancer	Cancer
rs12915189	A	G	18	39	37	28	48	18	0.40	0.55	0.60	0.45	A	0.14	0.023849361	Information processing speed	Mental aptitude and behavioural traits
rs7141210	T	C	17	41	36	28	48	18	0.40	0.55	0.60	0.45	T	0.03	0.023849361	Menarche age at onset	Reproductive health
rs2359952	A	G	34	45	15	17	50	27	0.60	0.45	0.40	0.55	A	1.31	0.023849361	Ulcerative colitis	Immune diseases and disorders
rs1389724	C	T	32	49	13	17	50	27	0.60	0.45	0.40	0.55	T	1.05	0.023849361	Schizophrenia	Brain health and disorders
rs907121	C	T	32	48	14	14	55	25	0.60	0.44	0.40	0.56	C	1.83	0.023827738	Weight	Appearance
rs1187415	G	C	22	32	40	30	45	19	0.40	0.56	0.60	0.44	C	0.11	0.023827738	Adiponectin levels	Obesity
rs12987465	G	A	32	42	20	16	45	33	0.56	0.41	0.44	0.59	A	2.597	0.023811546	Adverse response to chemotherapy neutropenia_leucopenia etoposide	Drug response
rs7774434	T	C	13	52	29	27	53	14	0.41	0.57	0.59	0.43	C	1.75	0.023800764	Primary biliary cirrhosis	Immune diseases and disorders
rs6918586	T	C	34	39	21	18	42	34	0.57	0.41	0.43	0.59	T	1.07	0.023800764	Schizophrenia	Brain health and disorders
rs7220048	T	C	31	45	18	14	50	30	0.57	0.41	0.43	0.59	G	0.04	0.023800764	Obesity-related traits	Obesity
rs1870634	T	G	21	39	34	30	50	14	0.43	0.59	0.57	0.41	G	1.07	0.023800764	Myocardial infarction	Heart health and disorders
rs954108	C	T	18	45	31	32	46	16	0.43	0.59	0.57	0.41	A	0.02	0.023800764	Obesity-related traits	Obesity
rs4976646	T	C	29	51	14	19	42	33	0.58	0.43	0.42	0.57	G	1.0721266	0.023795377	Crohn's disease	Digestive system and its disorders
rs2237436	C	G	13	53	28	28	52	14	0.42	0.57	0.58	0.43	C	1.06	0.023795377	Schizophrenia	Brain health and disorders
rs4571457	C	T	16	47	31	29	50	15	0.42	0.57	0.58	0.43	G	1	0.023795377	Ulcerative colitis	Immune diseases and disorders
rs6838021	T	C	19	42	33	37	35	22	0.43	0.58	0.57	0.42	A	0.043	0.023795377	Blood metabolite ratios	Heart health and disorders
rs1976403	A	C	47	35	12	62	30	2	0.69	0.82	0.31	0.18	C	3.6	0.023747103	Liver enzyme levels alkaline phosphatase	General health
rs12484776	A	G	40	49	5	62	30	2	0.69	0.82	0.31	0.18	G	1.23	0.023747103	Uterine fibroids	Cancer
rs7827290	T	G	47	35	12	62	30	2	0.69	0.82	0.31	0.18	G	1.1	0.023747103	Bipolar disorder	Brain health and disorders
rs5006884	C	T	63	28	3	46	37	11	0.82	0.69	0.18	0.31	A	0.16	0.023747103	Fetal hemoglobin levels	General health
rs7121446	G	A	63	28	3	46	37	11	0.82	0.69	0.18	0.31	G	0.15	0.023747103	Cardiovascular disease risk factors	Heart health and disorders
rs2286276	C	T	63	28	3	39	51	4	0.82	0.69	0.18	0.31	T	0.0652	0.023747103	Triglycerides	General health
rs10090117	T	C	78	16	0	61	30	3	0.91	0.81	0.09	0.19	G	2.38	0.02374169	Paclitaxel-induced neuropathy	Brain health and disorders
rs6066043	G	A	62	28	4	80	12	2	0.81	0.91	0.19	0.09	G	2.13	0.02374169	Chronic kidney disease	Immune diseases and disorders
rs11226613	T	A	62	28	4	78	16	0	0.81	0.91	0.19	0.09	T	1.4286	0.02374169	Bronchopulmonary dysplasia	Pulmonology
rs13114435	T	C	59	34	1	79	14	1	0.81	0.91	0.19	0.09	G	0.03	0.02374169	Obesity-related traits	Obesity
rs4535251	T	C	31	42	21	45	42	7	0.55	0.70	0.45	0.30	T	1.18	0.023728814	Height	General health
rs2055011	G	A	8	40	46	17	50	27	0.30	0.45	0.70	0.55	C	1.347	0.023728814	Adverse response to chemotherapy neutropenia_leucopenia all antimetabolite drugs	Drug response
rs9297145	C	A	8	40	46	20	44	30	0.30	0.45	0.70	0.55	C	1.0761806	0.023728814	Crohn's disease	Digestive system and its disorders
rs17217757	G	C	55	34	5	74	18	2	0.77	0.88	0.23	0.12	G	2.3256	0.023655914	Tuberculosis	Immune diseases and disorders
rs2251396	G	A	72	22	0	55	34	5	0.88	0.77	0.12	0.23	T	2.2132	0.023655914	Type 1 diabetes and autoimmune thyroid diseases	Diabetes
rs12493607	G	C	52	40	2	74	18	2	0.77	0.88	0.23	0.12	C	1.06	0.023655914	Breast cancer	Cancer
rs11889798	C	T	73	20	1	57	30	7	0.88	0.77	0.12	0.23	A	1	0.023655914	Immune reponse to smallpox secreted TNF-alpha	Immune diseases and disorders
rs10160399	C	T	72	22	0	55	34	5	0.88	0.77	0.12	0.23	A	0.03	0.023655914	Obesity-related traits	Obesity
rs17405819	T	C	57	30	7	73	20	1	0.77	0.88	0.23	0.12	T	0.024	0.023655914	Body mass index	Obesity
rs10097215	C	T	56	32	6	73	20	1	0.77	0.88	0.23	0.12	T	0.01	0.023655914	Plasma omega-6 polyunsaturated fatty acid levels gamma-linolenic acid	General health
rs513349	A	G	19	36	39	6	35	53	0.39	0.25	0.61	0.75	A	7.7549	0.023626641	Platelet count	Heart health and disorders
rs4234284	G	A	40	42	12	59	30	5	0.65	0.79	0.35	0.21	T	3.01	0.023619846	Adverse response to chemotherapy in breast cancer alopecia docetaxel	General health
rs10176705	C	T	43	36	15	57	34	3	0.65	0.79	0.35	0.21	T	0.1	0.023619846	Personality dimensions	Brain health and disorders
rs6735786	C	T	41	40	13	60	28	6	0.65	0.79	0.35	0.21	C	0.07	0.023619846	Bone mineral density hip	General health
rs1239947	C	T	5	30	59	14	38	42	0.21	0.35	0.79	0.65	G	3.8	0.023619846	Height	General health
rs2954029	A	T	26	51	17	45	41	8	0.55	0.70	0.45	0.30	T	0.61	0.023594559	HDL cholesterol	General health
rs11208446	G	A	76	17	1	58	32	4	0.90	0.79	0.10	0.21	A	0.12	0.023579105	Bilirubin levels	General health
rs1506203	G	T	55	38	1	76	17	1	0.79	0.90	0.21	0.10	G	0.083	0.023579105	Eating disorders purging via substances	Brain health and disorders
rs10488226	G	T	48	38	8	68	22	4	0.71	0.84	0.29	0.16	A	2.026	0.023483366	Adverse response to chemotherapy neutropenia_leucopenia 5-fluorouracil	Drug response
rs300774	A	C	12	30	52	1	28	65	0.29	0.16	0.71	0.84	A	1.22	0.023483366	Suicide attempts in bipolar disorder	Brain health and disorders
rs9363918	T	G	28	46	20	48	34	12	0.54	0.69	0.46	0.31	A	1.27	0.023467433	Pancreatic cancer	Cancer
rs15285	C	T	43	44	7	25	52	17	0.69	0.54	0.31	0.46	A	0.27	0.023467433	Triglycerides-Blood Pressure TG-BP	General health
rs16902947	A	G	71	20	3	50	39	5	0.86	0.74	0.14	0.26	A	19.48	0.023433001	Serum tamsulosin hydrochloride concentration	General health
rs2100290	A	G	38	37	19	53	34	7	0.60	0.74	0.40	0.26	G	3.443	0.023426203	Alcohol consumption	General health
rs2294693	T	C	49	42	3	32	49	13	0.74	0.60	0.26	0.40	C	1.18	0.023426203	Non-cardia gastric cancer	Cancer
rs2947411	A	G	2	31	61	9	42	43	0.19	0.32	0.81	0.68	A	2.8	0.023412624	Menarche age at onset	Reproductive health
rs2040406	A	G	61	31	2	42	44	8	0.81	0.68	0.19	0.32	G	2.05	0.023412624	Multiple sclerosis	Brain health and disorders
rs9315204	C	T	42	44	8	63	27	4	0.68	0.81	0.32	0.19	T	1.2	0.023412624	Intracranial aneurysm	Misc
rs1027841	G	A	40	48	6	64	25	5	0.68	0.81	0.32	0.19	A	1	0.023412624	Behavioural disinhibition generation interaction	Brain health and disorders
rs16863118	C	T	62	29	3	46	36	12	0.81	0.68	0.19	0.32	C	0.2044	0.023412624	IgG glycosylation	Immune diseases and disorders
rs1387153	C	T	58	31	5	36	49	9	0.78	0.64	0.22	0.36	T	0.07	0.023355445	Fasting plasma glucose	General health
rs798766	T	C	5	31	58	13	41	40	0.22	0.36	0.78	0.64	T	1.24	0.023355445	Urinary bladder cancer	Cancer
rs319598	T	C	12	43	39	7	27	60	0.36	0.22	0.64	0.78	C	1.05	0.023355445	Type 2 diabetes	Diabetes
rs3733402	G	A	16	35	43	5	31	58	0.36	0.22	0.64	0.78	G	0.2	0.023355445	B-type natriuretic peptide	Heart health and disorders
rs10948222	T	C	27	47	20	44	41	9	0.54	0.69	0.46	0.31	T	0.031	0.02334723	Height	General health
rs13328933	C	T	80	14	0	64	27	3	0.93	0.82	0.07	0.18	C	0.3116	0.023346052	IgG glycosylation	Immune diseases and disorders
rs16851771	A	G	81	12	1	61	33	0	0.93	0.82	0.07	0.18	G	0.04	0.023346052	Obesity-related traits	Obesity
rs227932	A	G	4	25	65	1	12	81	0.18	0.07	0.82	0.93	G	1.0869565	0.023346052	Schizophrenia	Brain health and disorders
rs17690232	C	G	73	18	3	86	8	0	0.87	0.96	0.13	0.04	C	0.86	0.023255814	Height	General health
rs1122979	G	A	70	24	0	86	8	0	0.87	0.96	0.13	0.04	G	0.3134	0.023255814	IgG glycosylation	Immune diseases and disorders
rs2870137	C	T	71	22	1	86	8	0	0.87	0.96	0.13	0.04	A	0.256	0.023255814	Cytomegalovirus antibody response	Immune diseases and disorders
rs7812088	G	A	70	24	0	86	8	0	0.87	0.96	0.13	0.04	A	0.05	0.023255814	Bone mineral density	General health
rs1351356	T	C	50	39	5	31	50	13	0.74	0.60	0.26	0.40	T	1.06	0.02323506	Schizophrenia	Brain health and disorders
rs10516173	C	T	20	48	26	13	34	47	0.47	0.32	0.53	0.68	T	2.85	0.02323376	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs35951	G	T	8	44	42	18	52	24	0.32	0.47	0.68	0.53	G	1.43	0.02323376	Alcohol dependence age at onset	General health
rs31489	C	A	44	40	10	24	52	18	0.68	0.53	0.32	0.47	C	1.12	0.02323376	Lung adenocarcinoma	Cancer
rs10930597	C	T	76	17	1	89	5	0	0.90	0.97	0.10	0.03	T	3.72	0.023200758	Blood pressure measurement low sodium intervention	Heart health and disorders
rs35264875	A	T	75	19	0	89	5	0	0.90	0.97	0.10	0.03	T	2.49	0.023200758	Blond vs. brown hair color	Appearance
rs10944479	G	A	76	17	1	89	5	0	0.90	0.97	0.10	0.03	A	1.25	0.023200758	Thyroid peroxidase antibody positivity	Immune diseases and disorders
rs35360328	T	A	76	17	1	89	5	0	0.90	0.97	0.10	0.03	A	1.14	0.023200758	Colorectal cancer	Cancer
rs16985437	G	A	89	5	0	76	17	1	0.97	0.90	0.03	0.10	A	0.4569	0.023200758	Axial length	Misc
rs2023634	A	G	89	5	0	75	19	0	0.97	0.90	0.03	0.10	G	0.113	0.023200758	Metabolic traits	Misc
rs267733	A	G	76	17	1	89	5	0	0.90	0.97	0.10	0.03	G	0.033	0.023200758	LDL cholesterol	General health
rs1368882	G	A	23	53	18	45	37	12	0.53	0.68	0.47	0.32	A	1.752	0.023126844	Non-substance related behavioral disinhibition	Brain health and disorders
rs2833693	T	C	26	47	21	46	35	13	0.53	0.68	0.47	0.32	T	0.17	0.023126844	Temperament	Mental aptitude and behavioural traits
rs599083	T	G	46	35	13	27	45	22	0.68	0.53	0.32	0.47	G	0.07	0.023126844	Bone mineral density spine	General health
rs340839	G	A	27	45	22	43	41	10	0.53	0.68	0.47	0.32	A	0.039	0.023126844	Triglycerides	General health
rs2780226	C	T	11	39	44	16	57	21	0.32	0.47	0.68	0.53	T	0.076	0.023126844	Height	General health
rs4072286	T	G	25	39	30	7	47	40	0.47	0.32	0.53	0.68	C	0.03	0.023126844	Obesity-related traits	Obesity
rs12437854	T	G	71	23	0	52	39	3	0.88	0.76	0.12	0.24	G	1.8	0.023109244	Type 1 diabetes nephropathy	Diabetes
rs10936599	C	T	55	33	6	71	23	0	0.76	0.88	0.24	0.12	A	1.12	0.023109244	Celiac disease	Immune diseases and disorders
rs1317082	A	G	55	33	6	71	23	0	0.76	0.88	0.24	0.12	G	0.0679	0.023109244	Telomere length	Aging
rs7396835	T	C	10	25	59	1	21	72	0.24	0.12	0.76	0.88	T	0.23	0.023109244	Quantitative traits	Misc
rs7731626	G	A	38	44	12	54	38	2	0.64	0.78	0.36	0.22	G	1.21	0.023103213	Rheumatoid arthritis	Immune diseases and disorders
rs11920090	T	A	57	32	5	42	36	16	0.78	0.64	0.22	0.36	T	1	0.023103213	Fasting glucose-related traits	General health
rs10511400	C	T	55	36	3	39	42	13	0.78	0.64	0.22	0.36	T	0.157	0.023103213	Economic and political preferences feminism_equality	Mental aptitude and behavioural traits
rs11895026	C	A	65	28	1	82	12	0	0.84	0.94	0.16	0.06	A	1.19	0.023096664	Height	General health
rs7068341	C	T	65	28	1	82	12	0	0.84	0.94	0.16	0.06	T	1.09	0.023096664	Migraine	Brain health and disorders
rs17854409	T	C	82	12	0	66	26	2	0.94	0.84	0.06	0.16	G	0.02	0.023096664	Obesity-related traits	Obesity
rs9554752	C	T	48	37	9	69	19	6	0.71	0.84	0.29	0.16	T	1.65	0.023095429	Bipolar disorder and eating disorder	Brain health and disorders
rs332034	T	C	66	25	3	47	39	8	0.84	0.71	0.16	0.29	A	1.05	0.023095429	Conduct disorder interaction	Brain health and disorders
rs7090871	T	C	49	35	10	67	23	4	0.71	0.84	0.29	0.16	T	0.06	0.023095429	Corneal structure	General health
rs333960	C	T	3	25	66	8	39	47	0.16	0.29	0.84	0.71	G	0.04	0.023095429	Obesity-related traits	Obesity
rs1986116	T	C	3	30	61	14	33	47	0.19	0.32	0.81	0.68	T	0.16	0.023094262	Sleep quality	General health
rs16886165	T	G	63	26	5	44	39	11	0.81	0.68	0.19	0.32	G	1.23	0.023094262	Breast cancer	Cancer
rs4733781	A	C	45	37	12	61	30	3	0.68	0.81	0.32	0.19	A	1	0.023094262	Tuberculosis	Immune diseases and disorders
rs17730281	G	A	44	39	11	61	30	3	0.68	0.81	0.32	0.19	G	0.0051	0.023094262	Renal function-related traits BUN	General health
rs8074700	A	C	5	40	49	17	43	34	0.27	0.41	0.73	0.59	A	1	0.023052841	Body mass index in non-asthmatics	Obesity
rs17102423	G	T	51	36	7	28	55	11	0.73	0.59	0.27	0.41	A	0.03	0.023052841	Obesity-related traits	Obesity
rs17161791	T	C	52	34	8	35	41	18	0.73	0.59	0.27	0.41	C	0.002	0.023052841	Pulmonary function in asthmatics	Pulmonology
rs1362931	A	C	2	23	69	0	10	84	0.14	0.05	0.86	0.95	A	0.0231	0.02304074	Lipoprotein-associated phospholipase A2 activity and mass	General health
rs17095830	A	G	84	10	0	69	23	2	0.95	0.86	0.05	0.14	G	1.29	0.02304074	Ankylosing spondylitis	Immune diseases and disorders
rs3813009	G	C	71	19	4	84	10	0	0.86	0.95	0.14	0.05	C	0.2122	0.02304074	IgG glycosylation	Immune diseases and disorders
rs2154319	T	C	69	23	2	85	8	1	0.86	0.95	0.14	0.05	T	0.03	0.02304074	Height	General health
rs13174863	A	G	70	21	3	84	10	0	0.86	0.95	0.14	0.05	G	0.026	0.02304074	Body mass index	Obesity
rs7640424	C	T	70	21	3	84	10	0	0.86	0.95	0.14	0.05	C	0.015	0.02304074	Body mass index	Obesity
rs204247	G	A	20	50	24	12	38	44	0.48	0.33	0.52	0.67	G	1.05	0.023026316	Breast cancer	Cancer
rs326	A	G	40	46	8	23	52	19	0.67	0.52	0.33	0.48	T	0.0221	0.023026316	HDL cholesterol	General health
rs1165640	C	T	2	13	79	4	29	61	0.09	0.20	0.91	0.80	C	1.56	0.023004371	Smoking cessation in chronic obstructive pulmonary disease	Heart health and disorders
rs12731740	C	T	59	33	2	77	17	0	0.80	0.91	0.20	0.09	T	1.09	0.023004371	Biomedical quantitative traits	General health
rs4635969	G	A	68	25	1	50	38	6	0.86	0.73	0.14	0.27	T	1.39	0.022977023	Testicular germ cell tumor	Cancer
rs642858	G	A	51	36	7	68	25	1	0.73	0.86	0.27	0.14	A	1.35	0.022977023	Type 2 diabetes	Diabetes
rs988958	G	A	69	23	2	52	34	8	0.86	0.73	0.14	0.27	G	1.3	0.022977023	Hypospadias	Misc
rs61847307	C	T	51	36	7	68	25	1	0.73	0.86	0.27	0.14	C	1.0638298	0.022977023	Schizophrenia	Brain health and disorders
rs10830265	G	A	48	42	4	70	21	3	0.73	0.86	0.27	0.14	A	0.02	0.022977023	Obesity-related traits	Obesity
rs4234853	G	A	58	31	5	76	16	2	0.78	0.89	0.22	0.11	A	4.88	0.02295082	Hemostatic factors and hematological phenotypes	Heart health and disorders
rs13160562	G	A	57	33	4	74	20	0	0.78	0.89	0.22	0.11	G	1.27	0.02295082	Alcohol dependence	General health
rs4615179	C	T	74	20	0	56	35	3	0.89	0.78	0.11	0.22	A	0.02	0.02295082	Obesity-related traits	Obesity
rs694424	A	G	1	18	75	6	29	59	0.11	0.22	0.89	0.78	G	5.01	0.02295082	Longitudinal alcohol consumption	General health
rs4972806	C	T	26	39	29	11	41	42	0.48	0.34	0.52	0.66	C	0.1425	0.022932023	IgG glycosylation	Immune diseases and disorders
rs1449672	T	C	23	45	26	9	45	40	0.48	0.34	0.52	0.66	T	0.002	0.022932023	Trans fatty acid levels	General health
rs1517484	C	T	43	39	12	21	55	18	0.66	0.52	0.34	0.48	C	1	0.022932023	Attention deficit hyperactivity disorder time to onset	Brain health and disorders
rs11216831	G	A	84	9	1	93	1	0	0.94	0.99	0.06	0.01	A	42.47	0.022893773	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs75430906	G	A	93	1	0	83	11	0	0.99	0.94	0.01	0.06	A	3.46	0.022893773	Acne severe	Misc
rs17570583	G	A	83	11	0	93	1	0	0.94	0.99	0.06	0.01	A	1.23	0.022893773	Migraine - clinic-based	Brain health and disorders
rs10521318	C	T	84	9	1	93	1	0	0.94	0.99	0.06	0.01	C	1.155	0.022893773	Inflammatory bowel disease	Immune diseases and disorders
rs17391694	C	T	83	11	0	93	1	0	0.94	0.99	0.06	0.01	C	1.134	0.022893773	Crohn's disease	Digestive system and its disorders
rs80353807	G	A	83	11	0	93	1	0	0.94	0.99	0.06	0.01	G	1.0869565	0.022893773	Schizophrenia	Brain health and disorders
rs11171846	C	T	83	11	0	93	1	0	0.94	0.99	0.06	0.01	A	1	0.022893773	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs13231718	T	G	84	9	1	93	1	0	0.94	0.99	0.06	0.01	C	1	0.022893773	Immune reponse to smallpox secreted IL-10	Immune diseases and disorders
rs17608766	T	C	83	11	0	93	1	0	0.94	0.99	0.06	0.01	T	0.556	0.022893773	Systolic blood pressure	Heart health and disorders
rs6549373	C	T	93	1	0	83	11	0	0.99	0.94	0.01	0.06	T	0.349	0.022893773	Uric acid levels	General health
rs17348299	C	A	83	11	0	93	1	0	0.94	0.99	0.06	0.01	C	0.2916	0.022893773	IgG glycosylation	Immune diseases and disorders
rs17801127	C	T	84	9	1	93	1	0	0.94	0.99	0.06	0.01	A	0.154	0.022893773	Liver enzyme levels alanine transaminase	General health
rs1741439	C	T	93	1	0	83	11	0	0.99	0.94	0.01	0.06	A	0.04	0.022893773	Obesity-related traits	Obesity
rs6151429	T	C	83	11	0	93	1	0	0.94	0.99	0.06	0.01	T	0.029	0.022893773	Blood metabolite levels	Heart health and disorders
rs333119	C	T	93	1	0	83	11	0	0.99	0.94	0.01	0.06	A	0.02	0.022893773	Obesity-related traits	Obesity
rs4345115	T	C	33	44	17	46	45	3	0.59	0.73	0.41	0.27	T	4.4	0.022879202	Height	General health
rs151997	T	C	16	37	41	4	35	55	0.37	0.23	0.63	0.77	T	1	0.022862554	Callous-unemotional behaviour	Brain health and disorders
rs7617456	G	A	29	38	27	39	46	9	0.51	0.66	0.49	0.34	G	1.18	0.022843823	IgE grass sensitization	Immune diseases and disorders
rs2982552	G	A	24	48	22	39	46	9	0.51	0.66	0.49	0.34	G	0.05	0.022843823	Bone properties heel	General health
rs212524	T	C	13	36	45	5	27	62	0.33	0.20	0.67	0.80	T	0.021	0.022791088	Height	General health
rs2549003	G	A	14	37	43	23	47	24	0.35	0.49	0.65	0.51	G	1.33	0.022761584	Asthma sex interaction	Immune diseases and disorders
rs4768236	C	A	13	39	42	20	53	21	0.35	0.49	0.65	0.51	C	1.1238824	0.022761584	Crohn's disease	Digestive system and its disorders
rs424971	T	C	20	53	21	11	43	40	0.49	0.35	0.51	0.65	G	0.22	0.022761584	Monocyte count	Immune diseases and disorders
rs9458975	C	T	40	43	11	22	51	21	0.65	0.51	0.35	0.49	T	0.026	0.022761584	Cannabis use initiation	General health
rs7435	A	G	40	43	11	22	51	21	0.65	0.51	0.35	0.49	A	0.02	0.022761584	Phospholipid levels plasma	General health
rs11681930	G	A	66	24	4	47	38	9	0.83	0.70	0.17	0.30	A	1	0.022727273	Attention deficit hyperactivity disorder combined symptoms	Brain health and disorders
rs6764623	A	C	46	44	4	36	37	21	0.72	0.58	0.28	0.42	C	1.18	0.022713818	Venous thromboembolism	Heart health and disorders
rs10794648	T	C	9	34	51	13	53	28	0.28	0.42	0.72	0.58	C	1.2	0.022713818	Psoriasis	Immune diseases and disorders
rs13064773	G	A	29	36	29	39	44	11	0.50	0.65	0.50	0.35	A	2.26	0.022685185	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs9577729	T	C	90	4	0	80	11	3	0.98	0.91	0.02	0.09	G	5.91	0.022669349	Diisocyanate-induced asthma	Pulmonology
rs76247873	G	A	78	15	1	91	2	1	0.91	0.98	0.09	0.02	A	3.37	0.022669349	Diisocyanate-induced asthma	Pulmonology
rs7811653	C	A	78	15	1	90	4	0	0.91	0.98	0.09	0.02	A	1.57	0.022669349	Hypospadias	Misc
rs17716942	T	C	78	15	1	90	4	0	0.91	0.98	0.09	0.02	T	1.309	0.022669349	Psoriasis	Immune diseases and disorders
rs7948661	T	C	90	4	0	77	17	0	0.98	0.91	0.02	0.09	C	1.05	0.022669349	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs9920	T	C	78	15	1	90	4	0	0.91	0.98	0.09	0.02	C	0.79	0.022669349	QT interval	Heart health and disorders
rs12207601	A	G	78	15	1	90	4	0	0.91	0.98	0.09	0.02	G	0.26	0.022669349	Biochemical measures	General health
rs17515642	C	A	79	13	2	90	4	0	0.91	0.98	0.09	0.02	C	0.2258	0.022669349	IgG glycosylation	Immune diseases and disorders
rs7588550	G	A	1	15	78	0	4	90	0.09	0.02	0.91	0.98	A	1.52	0.022669349	Type 1 diabetes nephropathy	Diabetes
rs8127571	A	G	1	15	78	0	4	90	0.09	0.02	0.91	0.98	A	1	0.022669349	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs7644516	G	A	2	13	79	0	4	90	0.09	0.02	0.91	0.98	G	1	0.022669349	DNA methylation variation	Misc
rs1115363	A	T	0	4	90	1	15	78	0.02	0.09	0.98	0.91	A	0.0974	0.022669349	Cotinine glucuronidation	General health
rs9883949	T	C	55	34	5	40	38	16	0.77	0.63	0.23	0.37	C	1.0869565	0.022632918	Schizophrenia	Brain health and disorders
rs7312770	C	T	9	49	36	24	47	23	0.36	0.51	0.64	0.49	C	1.1	0.022614515	Polycystic ovary syndrome	Reproductive health
rs12607903	C	T	11	45	38	18	59	17	0.36	0.51	0.64	0.49	C	0.04	0.022614515	Menarche age at onset	Reproductive health
rs491567	A	C	40	41	13	22	49	23	0.64	0.49	0.36	0.51	C	0.01	0.022614515	Chronic kidney disease	Immune diseases and disorders
rs17796783	T	C	55	32	7	72	20	2	0.76	0.87	0.24	0.13	T	0.334	0.022595705	Heart rate	General health
rs17077154	T	C	73	18	3	50	42	2	0.87	0.76	0.13	0.24	G	0.302	0.022595705	Cytomegalovirus antibody response	Immune diseases and disorders
rs9863067	C	G	72	20	2	53	36	5	0.87	0.76	0.13	0.24	C	0.194	0.022595705	Lead levels in blood	General health
rs6678639	A	G	73	18	3	53	36	5	0.87	0.76	0.13	0.24	A	0.085	0.022595705	Blood metabolite ratios	Heart health and disorders
rs6799682	G	A	48	39	7	28	52	14	0.72	0.57	0.28	0.43	A	1.79	0.022556391	Anxiety disorder	Brain health and disorders
rs10045497	C	A	32	44	18	50	35	9	0.57	0.72	0.43	0.28	C	0.1	0.022556391	Lipid traits	Misc
rs108961	C	T	48	39	7	28	52	14	0.72	0.57	0.28	0.43	T	0.09	0.022556391	Plasma amyloid beta peptide concentrations ABx-40	Brain health and disorders
rs3843482	T	G	32	44	18	50	35	9	0.57	0.72	0.43	0.28	G	0.087	0.022556391	LDL cholesterol	General health
rs10494366	G	T	21	50	23	36	48	10	0.49	0.64	0.51	0.36	G	12.2	0.022549471	Electrocardiographic traits	Heart health and disorders
rs1415259	C	T	21	50	23	36	48	10	0.49	0.64	0.51	0.36	A	2.53	0.022549471	Electrocardiographic traits	Heart health and disorders
rs10226084	T	C	22	48	24	38	44	12	0.49	0.64	0.51	0.36	T	0.007	0.022549471	Fibrinogen	General health
rs266590	A	G	16	36	42	20	56	18	0.36	0.51	0.64	0.49	G	0.05	0.022549471	Obesity-related traits	Obesity
rs11074889	A	G	2	24	68	7	37	50	0.15	0.27	0.85	0.73	A	1.68	0.022546136	Attention deficit hyperactivity disorder	Brain health and disorders
rs2820037	A	T	69	22	3	48	41	5	0.85	0.73	0.15	0.27	T	1.54	0.022546136	Hypertension	Heart health and disorders
rs2488856	C	A	1	13	80	4	26	64	0.08	0.18	0.92	0.82	A	0.044	0.022530113	Osteoprotegerin levels	Immune diseases and disorders
rs13023239	A	C	66	22	6	79	15	0	0.82	0.92	0.18	0.08	A	112.73	0.022530113	Hippocampal volume	Brain health and disorders
rs12701220	T	C	63	28	3	79	15	0	0.82	0.92	0.18	0.08	G	1.5385	0.022530113	Bronchopulmonary dysplasia	Pulmonology
rs3768716	T	C	64	26	4	79	15	0	0.82	0.92	0.18	0.08	C	1.386	0.022530113	Neuroblastoma	Cancer
rs16847609	G	A	80	13	1	63	28	3	0.92	0.82	0.08	0.18	A	1.19	0.022530113	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs4293630	A	G	79	15	0	65	24	5	0.92	0.82	0.08	0.18	A	0.108	0.022530113	Alcoholism alcohol dependence factor score	General health
rs60464047	T	A	64	26	4	79	15	0	0.82	0.92	0.18	0.08	T	0.043	0.022530113	Motion sickness	Misc
rs3931020	T	C	8	47	39	0	38	56	0.34	0.20	0.66	0.80	C	0.05	0.02250225	Resistin levels	Immune diseases and disorders
rs634552	T	G	6	26	62	6	51	37	0.20	0.34	0.80	0.66	T	0.039	0.02250225	Height	General health
rs4699052	C	T	41	37	16	19	53	22	0.63	0.48	0.37	0.52	C	1.21	0.02248996	Testicular germ cell tumor	Cancer
rs8114671	C	A	21	49	24	36	47	11	0.48	0.63	0.52	0.37	C	1.17	0.02248996	Height	General health
rs2945412	G	A	13	45	36	4	37	53	0.38	0.24	0.62	0.76	G	1.1196703	0.022413793	Crohn's disease	Digestive system and its disorders
rs842636	G	A	32	43	19	46	42	6	0.57	0.71	0.43	0.29	G	1.15	0.022406639	Psoriasis	Immune diseases and disorders
rs3774959	G	A	29	49	16	48	38	8	0.57	0.71	0.43	0.29	A	1.118	0.022406639	Ulcerative colitis	Immune diseases and disorders
rs1424233	T	C	31	45	18	48	38	8	0.57	0.71	0.43	0.29	A	1	0.022406639	Obesity	Obesity
rs2640806	C	A	45	44	5	30	47	17	0.71	0.57	0.29	0.43	A	0.03	0.022406639	Obesity-related traits	Obesity
rs140522	T	C	13	45	36	26	47	21	0.38	0.53	0.62	0.47	C	0.287	0.022387207	Red blood cell traits	Immune diseases and disorders
rs1401795	A	G	11	49	34	26	47	21	0.38	0.53	0.62	0.47	A	0.03	0.022387207	Height	General health
rs17079247	C	T	66	23	5	47	37	10	0.82	0.70	0.18	0.30	T	1.75	0.022377622	Bipolar disorder mania	Brain health and disorders
rs4601790	A	G	46	39	9	63	29	2	0.70	0.82	0.30	0.18	G	0.022	0.022377622	Blood pressure age interaction	Heart health and disorders
rs6434928	G	A	8	41	45	2	29	63	0.30	0.18	0.70	0.82	G	1.0764263	0.022377622	Schizophrenia	Brain health and disorders
rs286905	A	G	3	27	64	9	39	46	0.18	0.30	0.82	0.70	A	0.03	0.022377622	Obesity-related traits	Obesity
rs6678275	G	C	76	15	3	55	36	3	0.89	0.78	0.11	0.22	C	1.09	0.022364217	Alzheimer's disease late onset	Brain health and disorders
rs4760790	A	G	6	30	58	2	17	75	0.22	0.11	0.78	0.89	A	1.11	0.022364217	Type 2 diabetes	Diabetes
rs14165	A	G	6	30	58	0	21	73	0.22	0.11	0.78	0.89	A	0.096	0.022364217	Refractive error	General health
rs9378688	G	A	74	18	2	87	7	0	0.88	0.96	0.12	0.04	A	154.2	0.022359137	Caudate nucleus volume	Brain health and disorders
rs62055045	G	A	72	22	0	87	7	0	0.88	0.96	0.12	0.04	G	1.0752687	0.022359137	Schizophrenia	Brain health and disorders
rs13104971	A	G	73	20	1	87	7	0	0.88	0.96	0.12	0.04	G	0.113	0.022359137	Lifetime average cigarettes per day in chronic obstructive pulmonary disease	General health
rs17203016	A	G	74	18	2	87	7	0	0.88	0.96	0.12	0.04	G	0.023	0.022359137	Body mass index	Obesity
rs7350481	T	C	1	20	73	0	7	87	0.12	0.04	0.88	0.96	G	0.241	0.022359137	Triglycerides	General health
rs1106693	G	A	0	7	87	3	16	75	0.04	0.12	0.96	0.88	G	0.02	0.022359137	Obesity-related traits	Obesity
rs16877106	C	T	91	3	0	79	15	0	0.98	0.92	0.02	0.08	C	5.42	0.022346369	Weight	Appearance
rs956225	A	G	79	15	0	91	3	0	0.92	0.98	0.08	0.02	A	3.33	0.022346369	Alzheimer's disease	Brain health and disorders
rs17837497	G	A	91	3	0	79	15	0	0.98	0.92	0.02	0.08	A	2.34	0.022346369	Acute lymphoblastic leukemia childhood	Cancer
rs11248051	C	T	79	15	0	91	3	0	0.92	0.98	0.08	0.02	T	1.46	0.022346369	Parkinson's disease	Brain health and disorders
rs1353747	T	G	80	13	1	91	3	0	0.92	0.98	0.08	0.02	T	1.09	0.022346369	Breast cancer	Cancer
rs2388328	C	G	91	3	0	79	15	0	0.98	0.92	0.02	0.08	C	0.07	0.022346369	Metabolite levels  X-11787	General health
rs945631	G	A	80	13	1	91	3	0	0.92	0.98	0.08	0.02	A	0.0057	0.022346369	Trans fatty acid levels	General health
rs16867713	A	G	92	2	0	81	13	0	0.99	0.93	0.01	0.07	G	5.83	0.022345337	Diisocyanate-induced asthma	Pulmonology
rs17601696	C	T	81	13	0	92	2	0	0.93	0.99	0.07	0.01	T	4.75	0.022345337	Dysphagia	Misc
rs71316816	C	T	82	11	1	92	2	0	0.93	0.99	0.07	0.01	C	1.25	0.022345337	Alzheimer's disease in APOE e4+ carriers	Brain health and disorders
rs11225154	G	A	81	13	0	92	2	0	0.93	0.99	0.07	0.01	A	1.22	0.022345337	Polycystic ovary syndrome	Reproductive health
rs17774576	C	G	82	11	1	92	2	0	0.93	0.99	0.07	0.01	C	0.3891	0.022345337	Oleic acid 18:1n-9 plasma levels	General health
rs4453791	T	C	82	11	1	92	2	0	0.93	0.99	0.07	0.01	C	0.23	0.022345337	Social communication problems	Brain health and disorders
rs7194356	C	T	81	13	0	92	2	0	0.93	0.99	0.07	0.01	C	0.2261	0.022345337	IgG glycosylation	Immune diseases and disorders
rs13064411	A	G	82	11	1	92	2	0	0.93	0.99	0.07	0.01	G	0.142	0.022345337	Response to simvastatin treatment PCSK9 protein level change	General health
rs13015993	G	A	17	38	39	27	46	21	0.38	0.53	0.62	0.47	A	0.095	0.022343821	Thyroid hormone levels	General health
rs1861628	A	G	17	38	39	27	46	21	0.38	0.53	0.62	0.47	T	0.05	0.022343821	Serum thyroid-stimulating hormone levels	General health
rs9788333	C	G	58	34	2	76	18	0	0.80	0.90	0.20	0.10	G	28.65	0.022321429	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs57968458	G	A	79	12	3	61	28	5	0.90	0.80	0.10	0.20	A	0.33	0.022321429	Multiple myeloma and monoclonal gammopathy	Cancer
rs17621444	C	T	60	30	4	78	14	2	0.80	0.90	0.20	0.10	C	0.164	0.022321429	IgG glycosylation	Immune diseases and disorders
rs293314	C	T	1	16	77	5	28	61	0.10	0.20	0.90	0.80	G	0.03	0.022321429	Obesity-related traits	Obesity
rs7104764	G	A	5	28	61	0	18	76	0.20	0.10	0.80	0.90	G	0.03	0.022321429	Menarche age at onset	Reproductive health
rs4395908	C	G	21	45	28	34	47	13	0.46	0.61	0.54	0.39	C	0.27	0.022305679	Response to methotrexate in juvenile idiopathic arthritis	General health
rs2145998	T	A	17	39	38	27	47	20	0.39	0.54	0.61	0.46	A	0.026	0.022305679	Height	General health
rs3748069	A	G	27	48	19	17	40	37	0.54	0.39	0.46	0.61	A	6.5	0.022272727	Height	General health
rs2292239	T	G	7	41	46	15	52	27	0.29	0.44	0.71	0.56	A	1	0.022264301	Type 1 diabetes	Diabetes
rs7777484	A	G	27	52	15	52	29	13	0.56	0.71	0.44	0.29	A	0.059	0.022264301	Height	General health
rs6951643	A	G	35	43	16	21	43	30	0.60	0.45	0.40	0.55	A	1.27	0.022244921	Creutzfeldt-Jakob disease sporadic	Immune diseases and disorders
rs10187424	T	C	35	43	16	23	39	32	0.60	0.45	0.40	0.55	A	1.13	0.022244921	Prostate cancer	Cancer
rs4780401	G	T	33	47	14	13	59	22	0.60	0.45	0.40	0.55	T	1.09	0.022244921	Rheumatoid arthritis	Immune diseases and disorders
rs6545946	C	T	58	33	3	41	42	11	0.79	0.66	0.21	0.34	C	1.16	0.022226964	Crohn's disease	Digestive system and its disorders
rs17450029	T	C	36	52	6	60	29	5	0.66	0.79	0.34	0.21	T	1	0.022226964	QT interval interaction	Heart health and disorders
rs3821819	G	A	37	50	7	59	31	4	0.66	0.79	0.34	0.21	G	0.1633	0.022226964	IgG glycosylation	Immune diseases and disorders
rs218676	G	A	58	33	3	41	42	11	0.79	0.66	0.21	0.34	G	0.149	0.022226964	Economic and political preferences time	Mental aptitude and behavioural traits
rs2896019	T	G	39	46	9	58	33	3	0.66	0.79	0.34	0.21	G	0.085	0.022226964	Hematological and biochemical traits	Heart health and disorders
rs4938174	G	A	59	31	4	36	52	6	0.79	0.66	0.21	0.34	A	0.06	0.022226964	Corneal structure	General health
rs7744813	C	A	11	42	41	3	33	58	0.34	0.21	0.66	0.79	C	0.112	0.022226964	Refractive error	General health
rs734553	G	T	22	40	32	38	36	20	0.45	0.60	0.55	0.40	T	0.4	0.022222222	Uric acid levels	General health
rs9357271	T	C	27	50	17	15	46	33	0.55	0.40	0.45	0.60	T	1.47	0.022222222	Restless legs syndrome	Mental aptitude and behavioural traits
rs9975851	C	T	16	44	34	32	40	22	0.40	0.55	0.60	0.45	T	1.17	0.022222222	Airflow obstruction	Pulmonology
rs4685495	A	G	4	38	52	18	36	40	0.24	0.38	0.76	0.62	A	1.29	0.022204704	Schizophrenia	Brain health and disorders
rs737267	G	T	32	41	21	23	31	40	0.56	0.41	0.44	0.59	C	0.88	0.0222046	Urate levels	General health
rs2006970	C	A	16	51	27	34	43	17	0.44	0.59	0.56	0.41	C	0.2674	0.0222046	Metabolite levels 5-HIAA_ MHPG Ratio	Brain health and disorders
rs10873998	T	C	16	50	28	33	44	17	0.44	0.59	0.56	0.41	T	1.06	0.022192029	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs71647933	A	G	66	25	3	81	13	0	0.84	0.93	0.16	0.07	G	2.31	0.022179628	Neuropathic pain in type 2 diabetes	Diabetes
rs35260355	C	T	66	25	3	81	13	0	0.84	0.93	0.16	0.07	T	1.66	0.022179628	Neuropathic pain in type 2 diabetes	Diabetes
rs61867294	A	G	66	25	3	81	13	0	0.84	0.93	0.16	0.07	A	1.07	0.022179628	Schizophrenia	Brain health and disorders
rs2469054	G	A	82	11	1	65	27	2	0.93	0.84	0.07	0.16	A	0.0053	0.022179628	Trans fatty acid levels	General health
rs6856616	T	C	66	27	1	50	36	8	0.85	0.72	0.15	0.28	C	1.43	0.022138523	Crohn's disease	Digestive system and its disorders
rs642899	T	G	48	40	6	67	25	2	0.72	0.85	0.28	0.15	C	1	0.022138523	Behavioural disinhibition generation interaction	Brain health and disorders
rs2890652	T	C	68	23	3	49	38	7	0.85	0.72	0.15	0.28	C	0.09	0.022138523	Body mass index	Obesity
rs10189546	G	A	68	23	3	48	40	6	0.85	0.72	0.15	0.28	G	0.059	0.022138523	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs2710323	T	C	18	47	29	10	36	48	0.44	0.30	0.56	0.70	T	1.14	0.022129132	Glaucoma primary open-angle	General health
rs10472828	C	T	27	51	16	45	42	7	0.56	0.70	0.44	0.30	C	0.22	0.022129132	Height	General health
rs1993293	A	G	32	41	21	43	46	5	0.56	0.70	0.44	0.30	A	0.17	0.022129132	Coronary artery calcification	Heart health and disorders
rs4326844	A	G	9	29	56	2	21	71	0.25	0.13	0.75	0.87	A	8.679	0.022112573	Platelet count	Heart health and disorders
rs11906854	A	G	70	23	1	52	37	5	0.87	0.75	0.13	0.25	G	1.17	0.022112573	Migraine - clinic-based	Brain health and disorders
rs11104379	T	G	51	39	4	71	21	2	0.75	0.87	0.25	0.13	G	1.0638298	0.022112573	Schizophrenia	Brain health and disorders
rs12497795	C	T	53	35	6	73	17	4	0.75	0.87	0.25	0.13	T	0.0778	0.022112573	Periodontitis Mean PAL	Misc
rs11075138	A	G	0	34	60	10	38	46	0.18	0.31	0.82	0.69	G	0.5115	0.022045315	Cerebral amyloid angiopathy	Brain health and disorders
rs4818225	A	G	2	30	62	9	40	45	0.18	0.31	0.82	0.69	A	0.021	0.022045315	Educational attainment	Mental aptitude and behavioural traits
rs17189298	G	A	44	42	8	61	32	1	0.69	0.82	0.31	0.18	A	1	0.022045315	Cerebrospinal T-tau levels	Brain health and disorders
rs10153620	G	C	64	26	4	45	40	9	0.82	0.69	0.18	0.31	C	1	0.022045315	Attention deficit hyperactivity disorder combined symptoms	Brain health and disorders
rs11809180	C	T	64	26	4	39	52	3	0.82	0.69	0.18	0.31	G	1	0.022045315	Electrocardiographic traits	Heart health and disorders
rs17835319	G	A	72	19	3	85	9	0	0.87	0.95	0.13	0.05	A	0.74	0.022015824	Depressive symptoms SSRI exposure interaction	Brain health and disorders
rs2378497	A	G	73	17	4	85	9	0	0.87	0.95	0.13	0.05	G	0.33	0.022015824	Serum thyroid-stimulating hormone levels	General health
rs2231142	G	T	69	25	0	85	9	0	0.87	0.95	0.13	0.05	G	0.223	0.022015824	Urate levels in lean individuals	Obesity
rs6657811	A	T	85	9	0	71	21	2	0.95	0.87	0.05	0.13	T	0.057	0.022015824	HDL cholesterol	General health
rs7955374	C	T	72	19	3	85	9	0	0.87	0.95	0.13	0.05	T	0.04	0.022015824	Menarche age at onset	Reproductive health
rs1811103	A	T	0	25	69	1	7	86	0.13	0.05	0.87	0.95	A	0.039	0.022015824	Neuroticism	Brain health and disorders
rs7476422	G	T	13	47	34	3	41	50	0.39	0.25	0.61	0.75	G	2.06	0.022005208	Adverse response to chemotherapy in breast cancer alopecia	General health
rs3213094	C	T	55	31	8	36	43	15	0.75	0.61	0.25	0.39	A	1.28	0.022005208	Psoriasis	Immune diseases and disorders
rs877529	G	A	52	37	5	34	47	13	0.75	0.61	0.25	0.39	A	1.228	0.022005208	Multiple myeloma	Cancer
rs12946942	G	T	67	26	1	83	11	0	0.85	0.94	0.15	0.06	T	2.21	0.021988891	Adolescent idiopathic scoliosis severe	Obesity
rs16892766	A	C	83	11	0	68	24	2	0.94	0.85	0.06	0.15	C	1.2048193	0.021988891	Colorectal cancer	Cancer
rs9494145	T	C	67	26	1	83	11	0	0.85	0.94	0.15	0.06	C	0.98	0.021988891	Red blood cell traits	Immune diseases and disorders
rs17088339	T	A	66	28	0	83	11	0	0.85	0.94	0.15	0.06	A	0.68	0.021988891	Coronary artery calcification	Heart health and disorders
rs9816269	T	C	83	11	0	68	24	2	0.94	0.85	0.06	0.15	T	0.3667	0.021988891	Palmitic acid 16:0 plasma levels	General health
rs1799852	C	T	69	22	3	83	11	0	0.85	0.94	0.15	0.06	T	0.11	0.021988891	Iron status biomarkers transferrin saturation	General health
rs594206	A	G	59	30	5	35	53	6	0.79	0.65	0.21	0.35	A	36.3	0.021964505	Adverse response to chemotherapy in breast cancer alopecia cyclophosphamide+doxorubicin+_-5FU	Drug response
rs374810	G	A	39	45	10	58	32	4	0.65	0.79	0.35	0.21	G	1.34	0.021964505	Ossification of the posterior longitudinal ligament of the spine	Misc
rs2421332	T	C	58	32	4	40	43	11	0.79	0.65	0.21	0.35	C	1	0.021964505	Homeostasis model assessment of beta-cell function interaction	Misc
rs11116045	A	G	58	32	4	37	49	8	0.79	0.65	0.21	0.35	G	0.03	0.021964505	Obesity-related traits	Obesity
rs2254135	C	T	10	38	46	18	49	27	0.31	0.45	0.69	0.55	T	0.269	0.021879408	Response to hepatitis C treatment	General health
rs943466	G	A	33	37	24	43	44	7	0.55	0.69	0.45	0.31	G	0.016	0.021879408	Body mass index	Obesity
rs12129731	C	T	56	33	5	72	22	0	0.77	0.88	0.23	0.12	T	1.06	0.021815484	Schizophrenia	Brain health and disorders
rs16848425	C	T	74	18	2	53	39	2	0.88	0.77	0.12	0.23	T	0.034	0.021815484	Height	General health
rs61174036	A	G	50	40	4	29	56	9	0.74	0.61	0.26	0.39	G	0.289	0.021814896	Dementia and core Alzheimer's disease neuropathologic changes	Brain health and disorders
rs592229	G	T	16	42	36	7	34	53	0.39	0.26	0.61	0.74	G	0.048	0.021814896	Infant length	Misc
rs11800854	G	A	78	16	0	63	27	4	0.91	0.81	0.09	0.19	G	12.3	0.021779789	Periodontal microbiota	Misc
rs2235371	C	T	64	25	5	80	12	2	0.81	0.91	0.19	0.09	C	1.49	0.021779789	Nonsyndromic cleft lip with or without cleft palate	Misc
rs12456021	G	A	63	27	4	79	14	1	0.81	0.91	0.19	0.09	A	1.1	0.021779789	Multiple sclerosis	Brain health and disorders
rs17022027	C	T	62	29	3	78	16	0	0.81	0.91	0.19	0.09	C	1	0.021779789	Visceral fat	Obesity
rs927821	C	A	2	31	61	1	14	79	0.19	0.09	0.81	0.91	A	1.7024	0.021779789	Social autistic-like traits	Brain health and disorders
rs360488	A	G	3	29	62	0	16	78	0.19	0.09	0.81	0.91	A	0.09	0.021779789	Emphysema imaging phenotypes	Pulmonology
rs1006737	G	A	42	45	7	26	50	18	0.69	0.54	0.31	0.46	A	1.103	0.021764442	Schizophrenia	Brain health and disorders
rs3757840	T	G	26	50	18	45	39	10	0.54	0.69	0.46	0.31	A	0.1	0.021764442	Metabolic syndrome	Immune diseases and disorders
rs6800901	C	T	52	31	11	67	24	3	0.72	0.84	0.28	0.16	A	1.31	0.021752539	Multiple myeloma IgH translocation	Cancer
rs2239612	G	A	64	30	0	50	35	9	0.84	0.72	0.16	0.28	T	1.21	0.021752539	Esophageal cancer squamous cell	Cancer
rs17135159	A	C	49	37	8	65	28	1	0.72	0.84	0.28	0.16	A	0.107	0.021752539	Reading and spelling	Brain health and disorders
rs9420790	G	A	94	0	0	87	6	1	1.00	0.96	0.00	0.04	A	34.63	0.02173913	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs7729539	T	C	94	0	0	86	8	0	1.00	0.96	0.00	0.04	C	2.59	0.02173913	QT interval	Heart health and disorders
rs6836944	C	T	94	0	0	86	8	0	1.00	0.96	0.00	0.04	T	0.8601	0.02173913	Axial length	Misc
rs7275212	A	T	94	0	0	86	8	0	1.00	0.96	0.00	0.04	T	0.197	0.02173913	White blood cell types	Immune diseases and disorders
rs9609078	G	A	61	31	2	46	37	11	0.81	0.69	0.19	0.31	T	10.89	0.021729289	Adverse response to chemotherapy neutropenia_leucopenia gemcitabine	Drug response
rs4671393	A	G	4	27	63	11	37	46	0.19	0.31	0.81	0.69	A	0.578	0.021729289	Hemoglobin levels	Heart health and disorders
rs2749097	C	G	46	37	11	64	25	5	0.69	0.81	0.31	0.19	G	0.12	0.021729289	Alcohol consumption transferrin glycosylation	General health
rs11592657	A	G	36	50	8	54	39	1	0.65	0.78	0.35	0.22	A	1.27	0.021714206	Schizophrenia	Brain health and disorders
rs7634389	T	C	36	50	8	57	33	4	0.65	0.78	0.35	0.22	C	1.132	0.021714206	IgA nephropathy	Immune diseases and disorders
rs8118008	A	G	42	38	14	57	33	4	0.65	0.78	0.35	0.22	A	1.111	0.021714206	Parkinson's disease	Brain health and disorders
rs1953652	C	T	62	23	9	38	46	10	0.78	0.65	0.22	0.35	C	0.1488	0.021714206	IgG glycosylation	Immune diseases and disorders
rs7934606	T	C	5	29	60	1	17	76	0.21	0.10	0.79	0.90	T	1.52	0.02168727	Interstitial lung disease	Pulmonology
rs4876199	G	T	2	15	77	0	39	55	0.10	0.21	0.90	0.79	T	0.0515	0.02168727	Heschl's gyrus morphology	Brain health and disorders
rs10510452	A	G	57	35	2	76	17	1	0.79	0.90	0.21	0.10	A	1.32	0.02168727	Testicular germ cell tumor	Cancer
rs6746896	A	G	62	25	7	76	17	1	0.79	0.90	0.21	0.10	A	1.1	0.02168727	Bipolar disorder	Brain health and disorders
rs720475	G	A	60	29	5	76	17	1	0.79	0.90	0.21	0.10	G	1.06	0.02168727	Breast cancer	Cancer
rs13390641	G	A	76	17	1	61	27	6	0.90	0.79	0.10	0.21	A	0.59	0.02168727	Blood pressure anthropometric measures interaction	Heart health and disorders
rs9303196	A	T	2	22	70	9	30	55	0.14	0.26	0.86	0.74	T	1.43	0.021657419	Non-small cell lung cancer	Cancer
rs2075799	C	T	70	22	2	51	38	5	0.86	0.74	0.14	0.26	T	0.17	0.021657419	Complement C3 and C4 levels	Immune diseases and disorders
rs744910	G	A	24	53	17	45	38	11	0.54	0.68	0.46	0.32	G	1.12	0.021655824	Asthma	Immune diseases and disorders
rs4692386	T	C	10	40	44	21	45	28	0.32	0.46	0.68	0.54	A	1.0656859	0.021655824	Crohn's disease	Digestive system and its disorders
rs1886512	T	A	42	44	8	25	51	18	0.68	0.54	0.32	0.46	A	0.4	0.021655824	QRS duration	Heart health and disorders
rs7159888	G	A	21	45	28	9	42	43	0.46	0.32	0.54	0.68	A	0.26	0.021655824	N-glycan levels	General health
rs642803	C	T	24	53	17	43	42	9	0.54	0.68	0.46	0.32	T	0.036	0.021655824	Urate levels	General health
rs1466535	G	A	35	43	16	55	29	10	0.60	0.74	0.40	0.26	C	1.15	0.021633385	Abdominal aortic aneurysm	Heart health and disorders
rs1514174	C	T	34	45	15	49	41	4	0.60	0.74	0.40	0.26	C	1.04	0.021633385	Obesity	Obesity
rs4875102	G	A	6	37	51	17	41	36	0.26	0.40	0.74	0.60	A	0.12	0.021633385	Disc degeneration lumbar	Aging
rs6563210	A	G	43	41	10	22	56	16	0.68	0.53	0.32	0.47	A	0.039	0.021553381	Height	General health
rs4789400	A	G	0	6	88	1	18	75	0.03	0.11	0.97	0.89	A	0.069	0.021538462	Cannabis use initiation	General health
rs16953622	C	T	88	6	0	74	20	0	0.97	0.89	0.03	0.11	T	6.9917	0.021538462	Cognitive function	Brain health and disorders
rs71627250	C	T	89	4	1	74	20	0	0.97	0.89	0.03	0.11	A	1.65	0.021538462	Bronchopulmonary dysplasia	Pulmonology
rs1789891	C	A	76	16	2	88	6	0	0.89	0.97	0.11	0.03	A	1.47	0.021538462	Conduct disorder interaction	Brain health and disorders
rs2306864	C	G	74	20	0	88	6	0	0.89	0.97	0.11	0.03	G	1.0869565	0.021538462	Schizophrenia	Brain health and disorders
rs6028945	G	T	75	18	1	88	6	0	0.89	0.97	0.11	0.03	T	1	0.021538462	Response to TNF antagonist treatment	General health
rs9922516	A	G	89	4	1	77	14	3	0.97	0.89	0.03	0.11	G	0.02	0.021538462	Obesity-related traits	Obesity
rs6897106	T	C	39	43	12	57	32	5	0.64	0.78	0.36	0.22	C	5.653	0.021475449	Warfarin maintenance dose	General health
rs249153	T	C	55	36	3	38	45	11	0.78	0.64	0.22	0.36	C	1.41	0.021475449	Alzheimer's disease	Brain health and disorders
rs9272219	G	T	54	38	2	37	47	10	0.78	0.64	0.22	0.36	G	1.14	0.021475449	Schizophrenia	Brain health and disorders
rs17084051	C	A	55	36	3	41	39	14	0.78	0.64	0.22	0.36	A	0.126	0.021475449	Corneal curvature	General health
rs11248850	G	A	43	35	16	60	26	8	0.64	0.78	0.36	0.22	G	0.007	0.021475449	Red blood cell traits	Immune diseases and disorders
rs7587476	T	C	5	32	57	15	37	42	0.22	0.36	0.78	0.64	T	1.372	0.021475449	Neuroblastoma	Cancer
rs12185578	T	A	52	34	8	36	40	18	0.73	0.60	0.27	0.40	A	1	0.021460317	Subcutaneous adipose tissue	Obesity
rs4638315	G	A	49	40	5	35	42	17	0.73	0.60	0.27	0.40	A	0.22	0.021460317	Antibody level in response to infection	Immune diseases and disorders
rs9383153	A	G	61	30	3	45	38	11	0.81	0.68	0.19	0.32	A	0.331	0.021428571	Gambling	General health
rs2243123	T	C	47	40	7	67	23	4	0.71	0.84	0.29	0.16	G	1.08	0.021386699	Multiple sclerosis	Brain health and disorders
rs1636744	C	T	49	36	9	65	27	2	0.71	0.84	0.29	0.16	T	0.091	0.021386699	Cutaneous malignant melanoma	Cancer
rs7800944	T	C	66	25	3	46	42	6	0.84	0.71	0.16	0.29	T	0.05	0.021386699	Coffee consumption cups per day	Misc
rs11986414	A	G	10	34	50	6	19	69	0.29	0.16	0.71	0.84	A	3.72	0.021386699	Gaucher disease severity	General health
rs4294134	A	G	13	37	44	20	50	24	0.34	0.48	0.66	0.52	G	1.45	0.021366394	Paget's disease	General health
rs61792199	A	G	67	22	5	81	12	1	0.83	0.93	0.17	0.07	G	1.23	0.021343874	Tourette's syndrome or obsessive-compulsive disorder	Brain health and disorders
rs17605016	T	G	65	26	3	81	12	1	0.83	0.93	0.17	0.07	G	1.1878	0.021343874	Asthma and hay fever	Immune diseases and disorders
rs10201872	C	T	63	30	1	80	14	0	0.83	0.93	0.17	0.07	A	1.14	0.021343874	Multiple sclerosis	Brain health and disorders
rs7800244	G	T	66	24	4	80	14	0	0.83	0.93	0.17	0.07	T	1	0.021343874	Hepatitis C induced liver fibrosis	Immune diseases and disorders
rs12591650	A	G	69	18	7	80	14	0	0.83	0.93	0.17	0.07	A	1	0.021343874	Subcutaneous adipose tissue	Obesity
rs10504906	G	A	80	14	0	64	28	2	0.93	0.83	0.07	0.17	A	1	0.021343874	Fat distribution HIV	General health
rs4916483	T	C	66	24	4	80	14	0	0.83	0.93	0.17	0.07	C	0.078	0.021343874	Mean corpuscular hemoglobin	Heart health and disorders
rs8084125	T	C	64	28	2	80	14	0	0.83	0.93	0.17	0.07	G	0.03	0.021343874	Obesity-related traits	Obesity
rs17158483	C	T	69	18	7	81	12	1	0.83	0.93	0.17	0.07	A	0.03	0.021343874	Obesity-related traits	Obesity
rs616597	A	C	1	30	63	0	14	80	0.17	0.07	0.83	0.93	C	1.0701488	0.021343874	Ulcerative colitis	Immune diseases and disorders
rs4150642	G	C	2	28	64	0	14	80	0.17	0.07	0.83	0.93	G	0.358	0.021343874	Amyloid A serum levels	General health
rs1925714	A	G	2	19	73	6	32	56	0.12	0.23	0.88	0.77	G	2.8571	0.021301261	Tuberculosis	Immune diseases and disorders
rs1108252	T	C	54	36	4	72	21	1	0.77	0.88	0.23	0.12	T	1.08	0.021301261	Schizophrenia	Brain health and disorders
rs1561176	T	G	53	38	3	71	23	0	0.77	0.88	0.23	0.12	G	0.06	0.021301261	Personality dimensions	Brain health and disorders
rs9841616	T	A	50	37	7	34	43	17	0.73	0.59	0.27	0.41	T	1.0869565	0.021295363	Schizophrenia	Brain health and disorders
rs885036	A	G	13	51	30	7	37	50	0.41	0.27	0.59	0.73	A	2.13	0.021295363	Progression free survival in metastatic colorectal cancer treatment interaction	Cancer
rs2116081	T	C	20	51	23	11	42	41	0.48	0.34	0.52	0.66	T	0.1354	0.021281565	Cognitive function	Brain health and disorders
rs1019623	T	G	39	42	13	54	37	3	0.64	0.77	0.36	0.23	T	107.87	0.021247663	Hippocampal volume	Brain health and disorders
rs1036821	G	A	37	46	11	57	31	6	0.64	0.77	0.36	0.23	A	0.037	0.021247663	Height	General health
rs4963452	T	C	35	50	9	55	35	4	0.64	0.77	0.36	0.23	T	0.02	0.021247663	Phospholipid levels plasma	General health
rs2990510	T	G	52	35	7	69	23	2	0.74	0.86	0.26	0.14	G	1	0.02122807	Erectile dysfunction in type 1 diabetes	Diabetes
rs3117035	C	T	49	41	4	68	25	1	0.74	0.86	0.26	0.14	A	0.14	0.02122807	RR interval heart rate	Heart health and disorders
rs17023661	C	T	71	19	4	49	41	4	0.86	0.74	0.14	0.26	A	0.04	0.02122807	Obesity-related traits	Obesity
rs1816002	T	C	23	46	25	9	47	38	0.49	0.35	0.51	0.65	G	2.08	0.021202338	Weight	Appearance
rs11015781	G	T	43	41	10	59	33	2	0.68	0.80	0.32	0.20	A	1.2	0.02114227	Postoperative atrial fibrillation in coronary artery bypass grafting surgery	Heart health and disorders
rs10112481	G	T	16	46	32	3	46	45	0.41	0.28	0.59	0.72	A	5.12	0.021138211	Adverse response to chemotherapy in breast cancer alopecia cyclophosphamide+doxorubicin+_-5FU	Drug response
rs3091316	G	A	30	50	14	50	36	8	0.59	0.72	0.41	0.28	G	1.14	0.021138211	Crohn's disease	Digestive system and its disorders
rs1325598	A	G	17	44	33	6	40	48	0.41	0.28	0.59	0.72	A	0.044	0.021138211	Height	General health
rs261334	G	C	10	32	52	17	44	33	0.28	0.41	0.72	0.59	G	0.03	0.021138211	HDL cholesterol	General health
rs997781	A	G	4	32	58	0	20	74	0.21	0.11	0.79	0.89	A	1.63	0.021097046	MGMT methylation in smokers	General health
rs1198588	A	T	0	20	74	4	32	58	0.11	0.21	0.89	0.79	T	1.1249	0.021097046	Schizophrenia	Brain health and disorders
rs7640543	G	A	58	32	4	76	16	2	0.79	0.89	0.21	0.11	A	1.19	0.021097046	Migraine	Brain health and disorders
rs10519937	C	T	75	18	1	60	28	6	0.89	0.79	0.11	0.21	C	0.188	0.021097046	IgG glycosylation	Immune diseases and disorders
rs929843	A	C	0	36	58	0	17	77	0.19	0.09	0.81	0.91	A	0.04	0.02108768	Menarche age at onset	Reproductive health
rs7893600	A	C	5	26	63	0	17	77	0.19	0.09	0.81	0.91	A	0.04	0.02108768	Obesity-related traits	Obesity
rs72791417	A	T	62	28	4	77	17	0	0.81	0.91	0.19	0.09	A	1.4493	0.02108768	Bronchopulmonary dysplasia	Pulmonology
rs4607517	G	A	61	30	3	78	15	1	0.81	0.91	0.19	0.09	G	1.15	0.02108768	Fasting plasma glucose	General health
rs11118555	T	A	60	32	2	77	17	0	0.81	0.91	0.19	0.09	A	0.612	0.02108768	Heart rate	General health
rs2514805	A	G	67	25	2	82	12	0	0.85	0.94	0.15	0.06	G	2.95	0.021041136	Diisocyanate-induced asthma	Pulmonology
rs16976734	A	G	69	21	4	82	12	0	0.85	0.94	0.15	0.06	G	1.36	0.021041136	Chronic lymphocytic leukemia	Cancer
rs474951	T	G	64	28	2	47	39	8	0.83	0.71	0.17	0.29	T	1.2658	0.021039653	Alzheimer's disease	Brain health and disorders
rs12116643	T	C	48	37	9	64	28	2	0.71	0.83	0.29	0.17	T	0.515	0.021039653	End-stage coagulation	General health
rs11191193	A	G	49	35	10	64	28	2	0.71	0.83	0.29	0.17	A	0.023	0.021039653	Educational attainment	Mental aptitude and behavioural traits
rs2992257	C	T	72	21	1	86	8	0	0.88	0.96	0.12	0.04	T	8.63	0.021037868	Response to angiotensin II receptor blocker therapy	General health
rs12145833	T	G	72	21	1	86	8	0	0.88	0.96	0.12	0.04	T	1.19	0.021037868	Obesity early onset extreme	Obesity
rs16852912	C	T	86	8	0	72	21	1	0.96	0.88	0.04	0.12	T	1.18	0.021037868	Aging time to event	Aging
rs73194058	C	A	73	19	2	86	8	0	0.88	0.96	0.12	0.04	C	1.13	0.021037868	Rheumatoid arthritis	Immune diseases and disorders
rs1551943	G	A	71	23	0	86	8	0	0.88	0.96	0.12	0.04	G	0.026	0.021037868	Pulmonary function	Pulmonology
rs12198986	G	A	37	45	12	59	26	9	0.63	0.77	0.37	0.23	A	6.8	0.021030317	Height	General health
rs3026445	T	C	26	43	25	13	42	39	0.51	0.36	0.49	0.64	C	0.62	0.020997149	QT interval	Heart health and disorders
rs7137515	A	G	40	40	14	23	47	24	0.64	0.49	0.36	0.51	G	0.1637	0.020997149	IgG glycosylation	Immune diseases and disorders
rs7179432	T	C	22	49	23	32	56	6	0.49	0.64	0.51	0.36	C	0.1569	0.020997149	IgG glycosylation	Immune diseases and disorders
rs7616215	C	T	7	39	48	16	47	31	0.28	0.42	0.72	0.58	C	1.39	0.020988574	Behcet's disease	Immune diseases and disorders
rs2841277	C	T	26	57	11	46	43	5	0.58	0.72	0.42	0.28	T	1.15	0.020988574	Rheumatoid arthritis	Immune diseases and disorders
rs210152	G	A	4	18	72	0	10	84	0.14	0.05	0.86	0.95	A	1.09	0.020915033	Schizophrenia	Brain health and disorders
rs3094604	A	G	84	10	0	69	24	1	0.95	0.86	0.05	0.14	A	1.39	0.020915033	Febrile seizures MMR vaccine-related	General health
rs12785341	A	C	85	8	1	70	22	2	0.95	0.86	0.05	0.14	C	0.29	0.020915033	Renal sinus fat	General health
rs6716455	G	A	75	12	7	84	10	0	0.86	0.95	0.14	0.05	G	0.123	0.020915033	Alcoholism alcohol use disorder factor score	General health
rs293748	G	A	70	22	2	84	10	0	0.86	0.95	0.14	0.05	A	0.03	0.020915033	Obesity-related traits	Obesity
rs7296262	T	C	35	48	11	23	45	26	0.63	0.48	0.37	0.52	T	1.22	0.020886457	Suicide attempts in bipolar disorder	Brain health and disorders
rs38904	T	C	25	47	22	11	48	35	0.52	0.37	0.48	0.63	T	1.054	0.020886457	Inflammatory bowel disease	Immune diseases and disorders
rs404005	C	T	12	46	36	25	47	22	0.37	0.52	0.63	0.48	T	1	0.020886457	HIV-associated dementia	Brain health and disorders
rs9842133	T	C	39	40	15	23	45	26	0.63	0.48	0.37	0.52	T	0.006	0.020886457	Blood metabolite levels	Heart health and disorders
rs10447419	C	A	44	38	12	60	30	4	0.67	0.80	0.33	0.20	A	8.65	0.020869565	PR interval	Heart health and disorders
rs10848704	C	T	6	26	62	6	50	38	0.20	0.33	0.80	0.67	C	0.29	0.020869565	Quantitative traits	Misc
rs7160685	C	T	38	50	6	60	30	4	0.67	0.80	0.33	0.20	C	0.1565	0.020869565	IgG glycosylation	Immune diseases and disorders
rs2727405	G	A	46	42	6	31	46	17	0.71	0.57	0.29	0.43	A	0.03	0.020846182	Obesity-related traits	Obesity
rs4666360	G	A	23	52	19	15	41	38	0.52	0.38	0.48	0.62	C	2.136	0.020838693	Adverse response to chemotherapy neutropenia_leucopenia paclitaxel	Drug response
rs1010254	C	T	36	45	13	25	40	29	0.62	0.48	0.38	0.52	C	0.182	0.020838693	Optic nerve measurement cup area	Misc
rs2652822	T	C	37	44	13	52	39	3	0.63	0.76	0.37	0.24	C	0.085	0.020822922	Metabolic traits	Misc
rs7801581	C	T	55	33	6	32	54	8	0.76	0.63	0.24	0.37	T	0.0286	0.020822922	Waist-to-hip ratio adjusted for body mass index	Obesity
rs889398	C	T	33	52	9	54	35	5	0.63	0.76	0.37	0.24	C	0.016	0.020822922	Body mass index	Obesity
rs1991705	A	G	5	18	71	5	40	49	0.15	0.27	0.85	0.73	A	0.03	0.020822578	Obesity-related traits	Obesity
rs4817986	G	T	51	36	7	66	28	0	0.73	0.85	0.27	0.15	T	0.008	0.020822578	Fibrinogen	General health
rs4851266	C	T	56	31	7	72	20	2	0.76	0.87	0.24	0.13	T	1.05	0.020818581	Educational attainment	Mental aptitude and behavioural traits
rs1385167	A	G	70	24	0	54	35	5	0.87	0.76	0.13	0.24	G	0.0363	0.020818581	Waist-to-hip ratio adjusted for body mass index	Obesity
rs2412710	G	A	89	5	0	78	14	2	0.97	0.90	0.03	0.10	A	7	0.020815371	Triglycerides	General health
rs66861122	T	G	77	16	1	89	5	0	0.90	0.97	0.10	0.03	G	1.82	0.020815371	Response to methotrexate in juvenile idiopathic arthritis	General health
rs61776290	C	T	78	14	2	90	3	1	0.90	0.97	0.10	0.03	T	1.48	0.020815371	Alcohol dependence age at onset	General health
rs11984631	T	G	89	5	0	78	14	2	0.97	0.90	0.03	0.10	T	1.351	0.020815371	Current cigarettes per day in chronic obstructive pulmonary disease	General health
rs6892230	G	A	89	5	0	76	18	0	0.97	0.90	0.03	0.10	A	1.236	0.020815371	Refractive astigmatism	General health
rs1893217	A	G	77	16	1	89	5	0	0.90	0.97	0.10	0.03	G	1.17	0.020815371	Celiac disease	Immune diseases and disorders
rs13119723	A	G	76	18	0	89	5	0	0.90	0.97	0.10	0.03	A	1.12	0.020815371	Rheumatoid arthritis	Immune diseases and disorders
rs12722489	C	T	77	16	1	89	5	0	0.90	0.97	0.10	0.03	C	1.11	0.020815371	Crohn's disease	Digestive system and its disorders
rs8062326	G	A	89	5	0	77	16	1	0.97	0.90	0.03	0.10	T	1	0.020815371	Alcohol dependence	General health
rs2413045	A	G	0	18	76	0	5	89	0.10	0.03	0.90	0.97	A	1.07	0.020815371	Schizophrenia	Brain health and disorders
rs298182	A	G	1	16	77	0	5	89	0.10	0.03	0.90	0.97	A	0.4599	0.020815371	Verbal declarative memory	Brain health and disorders
rs304029	A	C	22	45	27	33	50	11	0.47	0.62	0.53	0.38	G	1.26	0.020795892	Diabetic kidney disease	Diabetes
rs7241993	C	T	34	48	12	16	57	21	0.62	0.47	0.38	0.53	G	1.09	0.020795892	Prostate cancer	Cancer
rs7072268	T	C	25	49	20	15	42	37	0.53	0.38	0.47	0.62	A	0.05	0.020795892	Glycated hemoglobin levels	Diabetes
rs6486121	C	T	21	47	26	34	48	12	0.47	0.62	0.53	0.38	T	0.046	0.020795892	Iron status biomarkers transferrin levels	General health
rs12948394	C	T	35	46	13	16	57	21	0.62	0.47	0.38	0.53	C	0.034	0.020795892	HDL cholesterol	General health
rs8010715	T	C	35	45	14	17	54	23	0.61	0.47	0.39	0.53	C	0.1664	0.020757994	IgG glycosylation	Immune diseases and disorders
rs1324913	G	T	34	47	13	22	44	28	0.61	0.47	0.39	0.53	G	0.03	0.020757994	Menarche age at onset	Reproductive health
rs4305276	C	G	13	47	34	24	52	18	0.39	0.53	0.61	0.47	G	0.008	0.020757994	Mean platelet volume	Heart health and disorders
rs1847202	T	C	33	48	13	15	57	22	0.61	0.46	0.39	0.54	T	0.031	0.020724947	Motion sickness	Misc
rs7894407	T	C	31	45	18	51	31	12	0.57	0.71	0.43	0.29	T	1	0.020710784	White matter hyperintensity burden	Brain health and disorders
rs7279297	A	G	43	47	4	29	49	16	0.71	0.57	0.29	0.43	G	0.12	0.020710784	Tanning	Appearance
rs2612012	A	C	49	35	10	27	53	14	0.71	0.57	0.29	0.43	A	0.02	0.020710784	Body mass index	Obesity
rs7000782	T	A	17	47	30	8	39	47	0.43	0.29	0.57	0.71	A	1.09	0.020710784	Atopic dermatitis	Immune diseases and disorders
rs6685187	A	G	10	35	49	16	49	29	0.29	0.43	0.71	0.57	A	0.043	0.020710784	Blood metabolite levels	Heart health and disorders
rs6748734	A	G	6	44	44	5	23	66	0.30	0.18	0.70	0.82	A	0.0861	0.020710175	Urinary metabolites	General health
rs4344931	A	C	6	44	44	5	23	66	0.30	0.18	0.70	0.82	A	0.02	0.020710175	Height	General health
rs6738825	A	G	27	48	19	19	37	38	0.54	0.40	0.46	0.60	A	1.06	0.020696704	Crohn's disease	Digestive system and its disorders
rs6062344	C	T	22	42	30	32	49	13	0.46	0.60	0.54	0.40	T	0.18	0.020696704	Serum thyroid-stimulating hormone levels	General health
rs6499640	G	A	30	43	21	16	44	34	0.55	0.40	0.45	0.60	A	5.25	0.020673227	Body mass index	Obesity
rs17536527	G	C	15	46	33	21	61	12	0.40	0.55	0.60	0.45	C	1.13	0.020673227	Glomerular filtration rate	General health
rs7989336	G	A	27	49	18	13	50	31	0.55	0.40	0.45	0.60	A	1.1	0.020673227	Obesity	Obesity
rs6797769	A	T	15	46	33	27	49	18	0.40	0.55	0.60	0.45	T	0.1661	0.020673227	IgG glycosylation	Immune diseases and disorders
rs984222	C	G	13	50	31	28	47	19	0.40	0.55	0.60	0.45	G	0.03	0.020673227	Waist-hip ratio	General health
rs1366200	T	G	27	50	17	14	49	31	0.55	0.41	0.45	0.59	G	1.308	0.020654484	Refractive astigmatism	General health
rs6855911	A	G	32	41	21	23	32	39	0.56	0.41	0.44	0.59	A	0.32	0.020640448	Urate levels	General health
rs310272	C	G	31	48	15	14	55	25	0.59	0.44	0.41	0.56	C	0.1	0.020640448	Preschool internalizing problems	Mental aptitude and behavioural traits
rs430727	T	C	26	53	15	14	50	30	0.56	0.41	0.44	0.59	T	0.06	0.020640448	Bone mineral density	General health
rs1321535	T	G	16	51	27	26	58	10	0.44	0.59	0.56	0.41	T	0.04	0.020640448	Phospholipid levels plasma	General health
rs1044352	G	T	29	48	17	15	49	30	0.56	0.42	0.44	0.58	T	1.14	0.020631102	Epilepsy	Brain health and disorders
rs4747241	C	T	27	53	14	14	52	28	0.57	0.43	0.43	0.57	T	11.94	0.020626432	Heschl's gyrus morphology	Brain health and disorders
rs2980098	A	G	29	49	16	8	64	22	0.57	0.43	0.43	0.57	G	9.11	0.020626432	Glomerular filtration rate	General health
rs2444896	C	A	14	43	37	8	30	56	0.38	0.24	0.62	0.76	T	1.754	0.020625021	Adverse response to chemotherapy neutropenia_leucopenia paclitaxel	Drug response
rs11675119	C	A	52	38	4	34	49	11	0.76	0.62	0.24	0.38	A	0.2541	0.020625021	Neurofibrillary tangles	Brain health and disorders
rs4149178	A	G	56	37	1	42	41	11	0.79	0.66	0.21	0.34	A	0.034	0.020609704	Urate levels	General health
rs9831754	T	G	39	47	8	62	25	7	0.66	0.79	0.34	0.21	T	0.02	0.020609704	Calcium levels	General health
rs5009270	G	A	43	46	5	28	50	16	0.70	0.56	0.30	0.44	A	1.1	0.020582146	Osteoarthritis hip	Immune diseases and disorders
rs6952809	T	C	10	36	48	20	42	32	0.30	0.44	0.70	0.56	A	1.08	0.020582146	Multiple sclerosis	Brain health and disorders
rs78788148	G	A	66	23	5	79	15	0	0.82	0.92	0.18	0.08	A	15.23	0.020579268	Diisocyanate-induced asthma	Pulmonology
rs2076756	A	G	62	31	1	80	13	1	0.82	0.92	0.18	0.08	G	1.66	0.020579268	Crohn's disease	Digestive system and its disorders
rs6015450	A	G	79	15	0	64	27	3	0.92	0.82	0.08	0.18	G	0.896	0.020579268	Systolic blood pressure	Heart health and disorders
rs181166265	T	C	80	13	1	61	33	0	0.92	0.82	0.08	0.18	C	0.2952	0.020579268	Metabolite levels HVA_MHPG ratio	Brain health and disorders
rs10995271	G	C	56	35	3	74	19	1	0.78	0.89	0.22	0.11	C	1.25	0.020546538	Crohn's disease	Digestive system and its disorders
rs11229555	G	T	58	31	5	74	19	1	0.78	0.89	0.22	0.11	A	1.0702233	0.020546538	Crohn's disease	Digestive system and its disorders
rs11154271	C	T	7	27	60	1	19	74	0.22	0.11	0.78	0.89	C	1	0.020546538	Subcutaneous adipose tissue	Obesity
rs13053817	C	A	74	19	1	54	39	1	0.89	0.78	0.11	0.22	A	1	0.020546538	Carotid atherosclerosis in HIV infection	Heart health and disorders
rs7647973	G	A	58	31	5	74	19	1	0.78	0.89	0.22	0.11	A	0.05	0.020546538	Menarche age at onset	Reproductive health
rs1671400	A	G	3	15	76	5	31	58	0.11	0.22	0.89	0.78	A	0.03	0.020546538	Obesity-related traits	Obesity
rs3217869	G	A	23	37	34	7	43	44	0.44	0.30	0.56	0.70	A	1	0.020460048	QT interval interaction	Heart health and disorders
rs1994816	G	A	48	35	11	32	41	21	0.70	0.56	0.30	0.44	A	1.76	0.020460048	Multiple myeloma IgH translocation	Cancer
rs2030323	A	C	3	31	60	0	18	76	0.20	0.10	0.80	0.90	C	1.18	0.020447465	Body mass index	Obesity
rs10767664	T	A	3	31	60	0	18	76	0.20	0.10	0.80	0.90	A	0.19	0.020447465	Body mass index	Obesity
rs12516208	G	C	59	33	2	77	16	1	0.80	0.90	0.20	0.10	C	4.598	0.020447465	Very long-chain saturated fatty acid levels fatty acid 20:0	General health
rs652888	A	G	76	18	0	59	33	2	0.90	0.80	0.10	0.20	C	2.71	0.020447465	Idiopathic membranous nephropathy	Brain health and disorders
rs9960767	A	C	77	16	1	61	29	4	0.90	0.80	0.10	0.20	C	1.23	0.020447465	Schizophrenia	Brain health and disorders
rs7652782	G	A	76	18	0	59	33	2	0.90	0.80	0.10	0.20	A	1	0.020447465	Serum uric acid levels	General health
rs2075876	G	A	67	25	2	49	39	6	0.85	0.73	0.15	0.27	A	1.18	0.020439189	Rheumatoid arthritis	Immune diseases and disorders
rs2836878	G	A	50	37	7	66	27	1	0.73	0.85	0.27	0.15	A	1.114705	0.020439189	Crohn's disease	Digestive system and its disorders
rs1173771	A	G	12	48	34	2	43	49	0.38	0.25	0.62	0.75	G	0.504	0.02043619	Systolic blood pressure	Heart health and disorders
rs35895680	C	A	44	43	7	62	30	2	0.70	0.82	0.30	0.18	C	1.06	0.020397147	Myocardial infarction	Heart health and disorders
rs6129846	C	T	62	30	2	44	43	7	0.82	0.70	0.18	0.30	C	1	0.020397147	Verbal declarative memory	Brain health and disorders
rs17730436	T	C	45	41	8	63	28	3	0.70	0.82	0.30	0.18	T	0.005	0.020397147	Renal function-related traits sCR	General health
rs7562618	T	C	8	30	56	1	23	70	0.24	0.13	0.76	0.87	C	1.0526316	0.020364812	Schizophrenia	Brain health and disorders
rs577948	A	G	39	46	9	57	34	3	0.66	0.79	0.34	0.21	G	1.37	0.020361991	Myopia pathological	General health
rs7458938	G	A	13	38	43	6	28	60	0.34	0.21	0.66	0.79	A	1.96	0.020361991	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs7616559	G	A	8	24	62	11	42	41	0.21	0.34	0.79	0.66	G	0.04	0.020361991	Carotid artery intima media thickness sex interaction	Heart health and disorders
rs9275406	G	T	27	50	17	45	40	9	0.55	0.69	0.45	0.31	T	2.1	0.020344288	Rheumatoid arthritis	Immune diseases and disorders
rs7925908	T	C	8	42	44	15	54	25	0.31	0.45	0.69	0.55	C	1	0.020344288	Glucocorticoid-induced osteonecrosis time dependent analysis	Drug response
rs7606754	A	G	12	49	33	6	36	52	0.39	0.26	0.61	0.74	A	0.07	0.020256036	Corneal structure	General health
rs1173727	T	C	12	49	33	2	44	48	0.39	0.26	0.61	0.74	T	0.034	0.020256036	Height	General health
rs11174812	C	T	54	32	8	31	53	10	0.74	0.61	0.26	0.39	A	1.14	0.020256036	Leprosy	Immune diseases and disorders
rs17451107	T	C	30	43	21	46	37	11	0.55	0.69	0.45	0.31	T	0.0295	0.020234674	Waist-to-hip ratio adjusted for body mass index	Obesity
rs6042507	T	G	2	12	80	0	4	90	0.09	0.02	0.91	0.98	A	0.09	0.020224719	Circulating myeloperoxidase levels serum	Immune diseases and disorders
rs62432346	G	A	78	16	0	90	4	0	0.91	0.98	0.09	0.02	A	4.6	0.020224719	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs17675602	A	T	79	14	1	90	4	0	0.91	0.98	0.09	0.02	T	1.21	0.020224719	Migraine - clinic-based	Brain health and disorders
rs73201076	T	C	78	16	0	90	4	0	0.91	0.98	0.09	0.02	C	1.0869565	0.020224719	Schizophrenia	Brain health and disorders
rs13259667	G	A	79	14	1	90	4	0	0.91	0.98	0.09	0.02	A	1	0.020224719	Behavioural disinhibition generation interaction	Brain health and disorders
rs10486187	T	C	81	13	0	66	26	2	0.93	0.84	0.07	0.16	T	1.886	0.020182974	Smooth-surface caries	Appearance
rs11196172	G	A	65	28	1	81	13	0	0.84	0.93	0.16	0.07	A	1.14	0.020182974	Colorectal cancer	Cancer
rs9276975	C	T	66	26	2	81	13	0	0.84	0.93	0.16	0.07	T	0.0539	0.020182974	White wine liking	Mental aptitude and behavioural traits
rs855913	A	C	1	8	85	0	1	93	0.05	0.01	0.95	0.99	A	1.08	0.020174346	Amyotrophic lateral sclerosis	Brain health and disorders
rs6041428	A	G	93	1	0	84	10	0	0.99	0.95	0.01	0.05	G	1.256	0.020174346	Vascular brain injury	Brain health and disorders
rs10997517	T	C	84	10	0	93	1	0	0.95	0.99	0.05	0.01	C	1.14	0.020174346	Migraine without aura	Brain health and disorders
rs3764400	T	C	84	10	0	93	1	0	0.95	0.99	0.05	0.01	C	1	0.020174346	Body mass index	Obesity
rs11252394	G	A	85	8	1	93	1	0	0.95	0.99	0.05	0.01	A	1	0.020174346	Asthma bronchodilator response	Immune diseases and disorders
rs799979	A	G	93	1	0	84	10	0	0.99	0.95	0.01	0.05	A	0.7513	0.020174346	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs2919024	A	G	93	1	0	85	8	1	0.99	0.95	0.01	0.05	G	0.6788	0.020174346	IgG glycosylation	Immune diseases and disorders
rs16967753	C	T	93	1	0	84	10	0	0.99	0.95	0.01	0.05	C	0.15	0.020174346	Metabolite levels Pyroglutamine	General health
rs11598867	G	A	37	54	3	14	74	6	0.68	0.54	0.32	0.46	A	0.3727	0.02013103	Urinary metabolites	General health
rs13702	T	C	42	44	8	25	52	17	0.68	0.54	0.32	0.46	A	0.29	0.02013103	HDL Cholesterol - Triglycerides HDLC-TG	General health
rs2281845	C	T	19	48	27	10	40	44	0.46	0.32	0.54	0.68	T	0.103	0.02013103	Permanent tooth development	Misc
rs2153977	C	T	43	37	14	56	35	3	0.65	0.78	0.35	0.22	T	1.491	0.020125786	Type 1 diabetes and autoimmune thyroid diseases	Diabetes
rs582580	G	A	39	45	10	57	33	4	0.65	0.78	0.35	0.22	G	1.0526316	0.020125786	Schizophrenia	Brain health and disorders
rs2779116	C	T	41	41	12	55	37	2	0.65	0.78	0.35	0.22	T	0.02	0.020125786	Glycated hemoglobin levels	Diabetes
rs4809401	T	C	75	17	2	87	7	0	0.89	0.96	0.11	0.04	T	0.021	0.020114943	Body mass index	Obesity
rs12617311	G	A	46	38	10	63	27	4	0.69	0.81	0.31	0.19	A	3	0.020099548	Menarche age at onset	Reproductive health
rs7224314	T	G	63	27	4	43	44	7	0.81	0.69	0.19	0.31	C	2.37	0.020099548	Diisocyanate-induced asthma	Pulmonology
rs9677260	G	T	64	25	5	42	46	6	0.81	0.69	0.19	0.31	T	1.07	0.020099548	Schizophrenia	Brain health and disorders
rs9271640	T	C	3	29	62	10	38	46	0.19	0.31	0.81	0.69	A	1.56	0.020099548	Oligoclonal band status in multiple sclerosis	Brain health and disorders
rs4511180	A	G	14	46	34	5	39	50	0.39	0.26	0.61	0.74	A	4.178	0.020084193	Post-traumatic stress disorder	Brain health and disorders
rs757647	G	A	53	33	8	33	48	13	0.74	0.61	0.26	0.39	A	2.4	0.020084193	Menarche age at onset	Reproductive health
rs4671386	C	A	14	46	34	6	37	51	0.39	0.26	0.61	0.74	C	1.19	0.020084193	Acne severe	Misc
rs1341665	G	A	37	40	17	53	33	8	0.61	0.74	0.39	0.26	A	1	0.020084193	Inflammatory biomarkers	Immune diseases and disorders
rs2794520	C	T	37	40	17	54	31	9	0.61	0.74	0.39	0.26	C	0.16	0.020084193	C-reactive protein levels	Immune diseases and disorders
rs17171818	C	T	53	33	8	33	48	13	0.74	0.61	0.26	0.39	C	0.04	0.020084193	Menarche age at onset	Reproductive health
rs4727338	G	C	10	32	52	3	24	67	0.28	0.16	0.72	0.84	C	0.08	0.020076323	Bone mineral density	General health
rs4729260	G	C	10	32	52	3	24	67	0.28	0.16	0.72	0.84	G	0.08	0.020076323	Bone mineral density spine	General health
rs35391	T	C	11	39	44	20	47	27	0.32	0.46	0.68	0.54	T	0.44	0.020033191	Tanning	Appearance
rs1488902	T	C	39	49	6	27	47	20	0.68	0.54	0.32	0.46	C	1.145	0.020033191	Amyotrophic lateral sclerosis	Brain health and disorders
rs909341	C	T	56	34	4	74	18	2	0.78	0.88	0.22	0.12	G	1.316	0.020032051	Atopic dermatitis	Immune diseases and disorders
rs4660531	G	T	56	34	4	72	22	0	0.78	0.88	0.22	0.12	T	1.1	0.020032051	Bipolar disorder	Brain health and disorders
rs10822050	T	C	55	36	3	73	20	1	0.78	0.88	0.22	0.12	C	1	0.020032051	Pediatric autoimmune diseases	Immune diseases and disorders
rs1800788	C	T	57	32	5	73	20	1	0.78	0.88	0.22	0.12	T	0.19	0.020032051	Fibrinogen	General health
rs2297441	G	A	4	34	56	2	18	74	0.22	0.12	0.78	0.88	A	1.09	0.020032051	Ulcerative colitis	Immune diseases and disorders
rs1325195	G	A	25	38	31	8	46	40	0.47	0.33	0.53	0.67	A	1.17	0.019941003	IgE grass sensitization	Immune diseases and disorders
rs4746822	C	T	6	50	38	18	52	24	0.33	0.47	0.67	0.53	T	0.28	0.019941003	Glycemic traits pregnancy	Reproductive health
rs633715	T	C	54	33	7	68	26	0	0.75	0.86	0.25	0.14	C	1.21	0.01993761	Body mass index	Obesity
rs2744148	A	G	85	7	2	70	21	3	0.94	0.86	0.06	0.14	G	1.12	0.019931486	Multiple sclerosis	Brain health and disorders
rs4728142	G	A	39	35	20	52	34	8	0.60	0.73	0.40	0.27	A	1.104	0.019920319	Ulcerative colitis	Immune diseases and disorders
rs129963	T	C	36	41	17	54	30	10	0.60	0.73	0.40	0.27	T	1	0.019920319	QT interval interaction	Heart health and disorders
rs17356907	A	G	41	40	13	59	28	7	0.65	0.78	0.35	0.22	G	0.081	0.019900498	Breast size	General health
rs7708474	T	G	54	38	2	43	36	15	0.78	0.65	0.22	0.35	T	0.022	0.019900498	Height	General health
rs10130259	T	C	72	20	2	85	9	0	0.87	0.95	0.13	0.05	G	0.03	0.019878081	Obesity-related traits	Obesity
rs11816631	A	G	78	16	0	61	32	1	0.91	0.82	0.09	0.18	G	1.99	0.019877301	Blood pressure	Heart health and disorders
rs6568685	A	C	4	26	64	0	16	78	0.18	0.09	0.82	0.91	A	1.07	0.019877301	Schizophrenia	Brain health and disorders
rs9263963	A	T	62	30	2	78	16	0	0.82	0.91	0.18	0.09	T	0.2567	0.019877301	IgG glycosylation	Immune diseases and disorders
rs1776897	G	T	13	37	44	16	57	21	0.34	0.47	0.66	0.53	G	0.052	0.019854323	Waist-to-hip ratio adjusted for body mass index	Obesity
rs4658552	T	C	41	43	10	25	49	20	0.66	0.53	0.34	0.47	T	0.021	0.019854323	Educational attainment	Mental aptitude and behavioural traits
rs1052483	G	T	77	15	2	61	28	5	0.90	0.80	0.10	0.20	C	6.9	0.01985371	Height	General health
rs11621969	T	C	59	32	3	75	19	0	0.80	0.90	0.20	0.10	T	2.46	0.01985371	Periodontal microbiota	Misc
rs13073817	G	A	58	34	2	75	19	0	0.80	0.90	0.20	0.10	A	1.08	0.01985371	Crohn's disease	Digestive system and its disorders
rs3751143	A	C	63	24	7	75	19	0	0.80	0.90	0.20	0.10	C	1	0.01985371	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs59329875	T	C	75	19	0	59	32	3	0.90	0.80	0.10	0.20	C	0.132	0.01985371	Hemoglobin levels	Heart health and disorders
rs1934955	A	G	59	32	3	75	19	0	0.80	0.90	0.20	0.10	A	0.03	0.01985371	Blood metabolite levels	Heart health and disorders
rs205391	T	C	3	13	78	1	36	57	0.10	0.20	0.90	0.80	A	0.03	0.01985371	Obesity-related traits	Obesity
rs1511412	A	G	2	10	82	0	3	91	0.07	0.02	0.93	0.98	A	1.87	0.019826315	Keloid	Misc
rs17128007	C	T	91	3	0	80	14	0	0.98	0.93	0.02	0.07	T	4.7991	0.019826315	Smooth-surface caries	Appearance
rs77302254	C	T	91	3	0	80	14	0	0.98	0.93	0.02	0.07	A	3.86	0.019826315	Diisocyanate-induced asthma	Pulmonology
rs2233956	T	C	80	14	0	91	3	0	0.93	0.98	0.07	0.02	G	2.77	0.019826315	Idiopathic membranous nephropathy	Brain health and disorders
rs9267488	A	G	91	3	0	81	12	1	0.98	0.93	0.02	0.07	G	2.32	0.019826315	Myositis	General health
rs11636802	A	G	80	14	0	91	3	0	0.93	0.98	0.07	0.02	G	1.41	0.019826315	Chronic lymphocytic leukemia	Cancer
rs12413578	C	T	80	14	0	91	3	0	0.93	0.98	0.07	0.02	C	1.2	0.019826315	Rheumatoid arthritis	Immune diseases and disorders
rs78867184	A	G	81	12	1	91	3	0	0.93	0.98	0.07	0.02	G	0.213	0.019826315	Metabolite levels 5-HIAA	General health
rs7070038	G	A	91	3	0	82	10	2	0.98	0.93	0.02	0.07	A	0.21	0.019826315	Coronary artery calcification	Heart health and disorders
rs16875249	G	A	91	3	0	81	12	1	0.98	0.93	0.02	0.07	A	0.176	0.019826315	Uric acid levels	General health
rs3816804	C	T	81	12	1	91	3	0	0.93	0.98	0.07	0.02	C	0.123	0.019826315	Height	General health
rs12830035	C	T	80	14	0	91	3	0	0.93	0.98	0.07	0.02	C	0.045812342	0.019826315	LDL peak particle diameter total fat intake interaction	General health
rs17176043	A	G	81	12	1	91	3	0	0.93	0.98	0.07	0.02	A	0.043	0.019826315	Educational attainment	Mental aptitude and behavioural traits
rs6838240	T	C	81	12	1	91	3	0	0.93	0.98	0.07	0.02	C	0.0372	0.019826315	Magnesium levels	General health
rs9319064	G	A	91	3	0	81	12	1	0.98	0.93	0.02	0.07	A	0.03	0.019826315	Obesity-related traits	Obesity
rs2925979	T	C	6	24	64	6	47	41	0.19	0.31	0.81	0.69	T	0.0342	0.019816445	Waist-to-hip ratio adjusted for body mass index	Obesity
rs10958409	G	A	48	33	13	63	26	5	0.69	0.81	0.31	0.19	A	1.36	0.019816445	Intracranial aneurysm	Misc
rs1231831	T	C	46	37	11	60	32	2	0.69	0.81	0.31	0.19	C	0.05	0.019816445	Metabolite levels  X-11787	General health
rs9341808	C	A	9	46	39	25	40	29	0.34	0.48	0.66	0.52	C	0.046	0.01977302	Sitting height ratio	Appearance
rs26528	T	C	26	46	22	40	44	10	0.52	0.66	0.48	0.34	G	1.1273222	0.01977302	Crohn's disease	Digestive system and its disorders
rs2302105	C	G	65	27	2	47	41	6	0.84	0.72	0.16	0.28	C	0.1688	0.019732551	IgG glycosylation	Immune diseases and disorders
rs7627468	A	G	1	29	64	8	37	49	0.16	0.28	0.84	0.72	A	1.16	0.019732551	Kidney stones	General health
rs74964132	A	G	92	2	0	83	10	1	0.99	0.94	0.01	0.06	G	6.76	0.01973165	Diisocyanate-induced asthma	Pulmonology
rs7580640	C	T	92	2	0	82	12	0	0.99	0.94	0.01	0.06	C	3.64	0.01973165	QT interval	Heart health and disorders
rs114397494	A	G	82	12	0	92	2	0	0.94	0.99	0.06	0.01	G0.0414	2.96	0.01973165	Clozapine-induced agranulocytosis	General health
rs17558301	C	G	83	10	1	92	2	0	0.94	0.99	0.06	0.01	C	1.5855	0.01973165	IgG glycosylation	Immune diseases and disorders
rs17749561	G	A	83	10	1	92	2	0	0.94	0.99	0.06	0.01	G	1.34	0.01973165	Follicular lymphoma	Cancer
rs6685273	C	T	82	12	0	92	2	0	0.94	0.99	0.06	0.01	T	1	0.01973165	Cytokine and corticosteroid-stimulated IL-6 production	Immune diseases and disorders
rs10504390	A	G	83	10	1	92	2	0	0.94	0.99	0.06	0.01	G	0.2953	0.01973165	IgG glycosylation	Immune diseases and disorders
rs5880	G	C	82	12	0	92	2	0	0.94	0.99	0.06	0.01	C	0.29	0.01973165	HDL cholesterol	General health
rs75849835	A	G	83	10	1	92	2	0	0.94	0.99	0.06	0.01	A	0.2042	0.01973165	Cerebrospinal AB1-42 levels	Brain health and disorders
rs16839632	A	G	92	2	0	83	10	1	0.99	0.94	0.01	0.06	G	0.131	0.01973165	Urate levels in obese individuals	Obesity
rs1853207	C	T	82	12	0	92	2	0	0.94	0.99	0.06	0.01	T	0.109	0.01973165	Blood metabolite levels	Heart health and disorders
rs7099380	G	A	18	55	21	11	43	40	0.48	0.35	0.52	0.65	A	1.05	0.01969697	Schizophrenia	Brain health and disorders
rs61996546	T	C	24	49	21	37	49	8	0.52	0.65	0.48	0.35	C	0.78	0.01969697	Response to methotrexate in juvenile idiopathic arthritis	General health
rs1432679	C	T	38	45	11	54	37	3	0.64	0.77	0.36	0.23	C	1.08	0.019685578	Breast cancer	Cancer
rs3738814	A	G	24	44	26	12	42	40	0.49	0.35	0.51	0.65	A	0.061	0.01962606	Height	General health
rs12994997	G	A	36	39	19	51	34	9	0.59	0.72	0.41	0.28	A	1.233	0.019615228	Crohn's disease	Digestive system and its disorders
rs10210302	C	T	36	39	19	51	34	9	0.59	0.72	0.41	0.28	T	1.19	0.019615228	Crohn's disease	Digestive system and its disorders
rs997363	C	T	18	41	35	4	44	46	0.41	0.28	0.59	0.72	C	1.986	0.019615228	Cervical cancer	Cancer
rs2479409	G	A	21	51	22	12	43	39	0.49	0.36	0.51	0.64	G	1.96	0.019560185	Cholesterol, total	General health
rs727428	T	C	6	55	33	24	45	25	0.36	0.49	0.64	0.51	T	0.126	0.019560185	Sex hormone-binding globulin levels	Reproductive health
rs2504916	T	A	4	35	55	1	21	72	0.23	0.12	0.77	0.88	T	0.306	0.019550342	Response to hepatitis C treatment	General health
rs1557765	T	C	3	37	54	0	23	71	0.23	0.12	0.77	0.88	C	0.015	0.019550342	Body mass index	Obesity
rs11107616	T	G	56	33	5	74	17	3	0.77	0.88	0.23	0.12	C	1.38	0.019550342	Diabetic kidney disease	Diabetes
rs6059594	G	A	59	27	8	73	19	2	0.77	0.88	0.23	0.12	G	0.4999	0.019550342	IgG glycosylation	Immune diseases and disorders
rs766432	C	A	4	29	61	12	36	46	0.20	0.32	0.80	0.68	C	1	0.019546983	Hemoglobin A2 levels in sickle cell anemia	Heart health and disorders
rs1360573	A	G	71	19	4	52	36	6	0.86	0.74	0.14	0.26	A	2.75	0.019534884	Periodontal microbiota	Misc
rs41997	A	G	51	38	5	68	25	1	0.74	0.86	0.26	0.14	A	1.52	0.019534884	Response to platinum-based chemotherapy in non-small-cell lung cancer	General health
rs1842076	T	C	53	34	7	67	27	0	0.74	0.86	0.26	0.14	G	1.1168399	0.019534884	Crohn's disease	Digestive system and its disorders
rs6426749	G	C	69	23	2	52	36	6	0.86	0.74	0.14	0.26	C	0.11	0.019534884	Bone mineral density	General health
rs10468017	C	T	52	36	6	70	21	3	0.74	0.86	0.26	0.14	T	0.104	0.019534884	Cardiovascular disease risk factors	Heart health and disorders
rs153750	T	G	9	30	55	2	23	69	0.26	0.14	0.74	0.86	G	1.16	0.019534884	Height	General health
rs324017	A	C	6	36	52	1	25	68	0.26	0.14	0.74	0.86	C	1.0638298	0.019534884	Schizophrenia	Brain health and disorders
rs4298437	T	C	8	32	54	2	23	69	0.26	0.14	0.74	0.86	A	1	0.019534884	Alzheimer's disease	Brain health and disorders
rs509477	C	G	15	38	41	19	56	19	0.36	0.50	0.64	0.50	C	0.0653	0.01949925	Cerebrospinal AB1-42 levels	Brain health and disorders
rs646776	C	T	5	34	55	13	42	39	0.23	0.36	0.77	0.64	T	1.19	0.019480519	Myocardial infarction early onset	Heart health and disorders
rs17373728	T	C	38	44	12	55	34	5	0.64	0.77	0.36	0.23	C	1.34	0.019480519	Diabetic kidney disease	Diabetes
rs12702514	C	T	42	36	16	59	26	9	0.64	0.77	0.36	0.23	T	1.21	0.019480519	Irritable bowel syndrome	General health
rs6102185	G	A	17	44	33	6	41	47	0.41	0.28	0.59	0.72	G	0.151	0.019473438	IgG glycosylation	Immune diseases and disorders
rs36001488	C	T	35	40	19	51	33	10	0.59	0.72	0.41	0.28	C	1	0.019473438	Pediatric autoimmune diseases	Immune diseases and disorders
rs545833	C	T	34	42	18	46	43	5	0.59	0.72	0.41	0.28	T	0.9	0.019473438	QT interval	Heart health and disorders
rs2235302	C	T	37	45	12	22	49	23	0.63	0.49	0.37	0.51	T	7.3	0.019443166	Soluble levels of adhesion molecules	General health
rs6546537	T	C	23	49	22	14	41	39	0.51	0.37	0.49	0.63	C	0.05	0.019443166	Serum thyroid-stimulating hormone levels	General health
rs28680850	G	A	46	42	6	64	28	2	0.71	0.83	0.29	0.17	A	1.26	0.019406576	Triglycerides	General health
rs1250542	G	A	45	44	5	64	28	2	0.71	0.83	0.29	0.17	A	1.15	0.019406576	Multiple sclerosis	Brain health and disorders
rs1250540	A	G	45	44	5	64	28	2	0.71	0.83	0.29	0.17	G	1.12	0.019406576	Multiple sclerosis	Brain health and disorders
rs3218251	T	A	66	24	4	44	46	4	0.83	0.71	0.17	0.29	A	1.08	0.019406576	Rheumatoid arthritis	Immune diseases and disorders
rs7230711	A	G	81	12	1	65	27	2	0.93	0.84	0.07	0.16	C	0.162	0.019402484	Immune response to anthrax vaccine	Immune diseases and disorders
rs12999542	A	C	82	10	2	64	29	1	0.93	0.84	0.07	0.16	C	0.15	0.019402484	Serum protein levels sST2	General health
rs1738074	T	C	33	43	18	48	38	8	0.58	0.71	0.42	0.29	A	1.21	0.01933847	Celiac disease	Immune diseases and disorders
rs730129	A	G	6	42	46	19	41	34	0.29	0.42	0.71	0.58	T	2.55	0.01933847	Hemostatic factors and hematological phenotypes	Heart health and disorders
rs2506991	A	G	21	48	25	36	44	14	0.48	0.62	0.52	0.38	G	3.948	0.019303255	Adverse response to chemotherapy neutropenia_leucopenia etoposide	Drug response
rs12627970	A	G	59	31	4	76	16	2	0.79	0.89	0.21	0.11	G	1.1155151	0.019301716	Inflammatory bowel disease	Immune diseases and disorders
rs12139672	A	G	57	35	2	76	16	2	0.79	0.89	0.21	0.11	G	1.0638298	0.019301716	Schizophrenia	Brain health and disorders
rs35261864	C	T	58	33	3	74	20	0	0.79	0.89	0.21	0.11	C	1.0526316	0.019301716	Schizophrenia	Brain health and disorders
rs11125529	C	A	75	18	1	59	31	4	0.89	0.79	0.11	0.21	C	0.056	0.019301716	Telomere length	Aging
rs17027258	A	G	59	31	4	75	18	1	0.79	0.89	0.21	0.11	G	0.055	0.019301716	White blood cell types	Immune diseases and disorders
rs17124955	A	G	76	16	2	56	37	1	0.89	0.79	0.11	0.21	G	0.05	0.019301716	Obesity-related traits	Obesity
rs167769	C	T	43	41	10	62	26	6	0.68	0.80	0.32	0.20	T	1.36	0.019290377	Eosinophilic esophagitis pediatric	Digestive system and its disorders
rs17596685	C	T	40	47	7	60	30	4	0.68	0.80	0.32	0.20	T	0.093	0.019290377	C-reactive protein levels	Immune diseases and disorders
rs1402837	C	T	62	26	6	44	39	11	0.80	0.68	0.20	0.32	A	0.02	0.019290377	Glycated hemoglobin levels	Diabetes
rs1043763	G	A	2	34	58	9	43	42	0.20	0.32	0.80	0.68	T	1.496	0.019290377	Adverse response to chemotherapy neutropenia_leucopenia all antimicrotubule drugs	Drug response
rs4313034	C	T	5	35	54	4	61	29	0.24	0.37	0.76	0.63	T	1.67	0.019284853	Graves' disease	Immune diseases and disorders
rs7152530	G	A	52	39	3	35	49	10	0.76	0.63	0.24	0.37	G	1.61	0.019284853	Staphylococcus aureus infection	Immune diseases and disorders
rs790356	A	G	13	47	34	29	41	24	0.39	0.53	0.61	0.47	G	1.28	0.019265846	Wilms tumor	Cancer
rs632057	T	G	11	51	32	27	45	22	0.39	0.53	0.61	0.47	G	0.081	0.019265846	Mean corpuscular hemoglobin	Heart health and disorders
rs10889569	A	T	27	45	22	9	55	30	0.53	0.39	0.47	0.61	T	0.05	0.019265846	C-reactive protein	Immune diseases and disorders
rs12788102	A	G	76	17	1	88	6	0	0.90	0.97	0.10	0.03	A	2.15	0.019259259	Malaria	Immune diseases and disorders
rs13119516	G	A	75	19	0	88	6	0	0.90	0.97	0.10	0.03	A	1.07	0.019259259	Schizophrenia	Brain health and disorders
rs3738443	C	T	75	19	0	88	6	0	0.90	0.97	0.10	0.03	A	1	0.019259259	Alcohol dependence	General health
rs10892324	T	G	35	44	15	22	44	28	0.61	0.47	0.39	0.53	G	1.64	0.019232958	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs2606736	C	T	20	48	26	34	46	14	0.47	0.61	0.53	0.39	C	0.025	0.019232958	HDL cholesterol	General health
rs13397985	T	G	61	31	2	77	17	0	0.81	0.91	0.19	0.09	G	1.45	0.019230769	Chronic lymphocytic leukemia	Cancer
rs1208285	T	C	60	33	1	77	17	0	0.81	0.91	0.19	0.09	C	1.25	0.019230769	Infantile hypertrophic pyloric stenosis	Misc
rs1495509	T	C	62	29	3	78	15	1	0.81	0.91	0.19	0.09	C	1.23	0.019230769	Cough in response to angiotensin-converting enzyme inhibitor drugs	General health
rs12930096	C	T	78	15	1	61	31	2	0.91	0.81	0.09	0.19	T	1.22	0.019230769	QT interval	Heart health and disorders
rs28512356	C	A	61	31	2	77	17	0	0.81	0.91	0.19	0.09	C	1.17	0.019230769	Psoriasis	Immune diseases and disorders
rs10948363	A	G	64	25	5	79	13	2	0.81	0.91	0.19	0.09	G	1.1	0.019230769	Alzheimer's disease late onset	Brain health and disorders
rs11064837	A	G	65	23	6	78	15	1	0.81	0.91	0.19	0.09	A	1.06	0.019230769	Schizophrenia	Brain health and disorders
rs37370	C	T	5	25	64	0	17	77	0.19	0.09	0.81	0.91	T	0.184	0.019230769	Asymmetrical dimethylarginine levels	General health
rs8068318	C	T	36	36	22	47	39	8	0.57	0.71	0.43	0.29	G	0.8	0.019210081	Creatinine levels	Immune diseases and disorders
rs10130556	C	G	30	41	23	17	41	36	0.54	0.40	0.46	0.60	G	0.014	0.019204545	Optic cup area	Misc
rs12195582	C	T	15	56	23	27	58	9	0.46	0.60	0.54	0.40	T	1.78	0.01918057	Follicular lymphoma	Cancer
rs1174864	G	A	18	40	36	28	46	20	0.40	0.54	0.60	0.46	G	0.1417	0.01918057	IgG glycosylation	Immune diseases and disorders
rs7331540	G	C	27	48	19	15	46	33	0.54	0.40	0.46	0.60	C	0.1407	0.01918057	IgG glycosylation	Immune diseases and disorders
rs2184971	A	G	26	50	18	17	42	35	0.54	0.40	0.46	0.60	G	0.085	0.01918057	Refractive error	General health
rs1569135	A	G	30	42	22	16	44	34	0.54	0.40	0.46	0.60	A	0.0225	0.01918057	Waist-to-hip ratio adjusted for body mass index	Obesity
rs4625783	T	C	27	58	9	16	54	24	0.60	0.46	0.40	0.54	T	0.019	0.01918057	Blood metabolite levels	Heart health and disorders
rs7597155	G	A	14	48	32	28	46	20	0.40	0.54	0.60	0.46	A	0.0149	0.01918057	Palmitoleic acid 16:1n-7 plasma levels	General health
rs11199914	C	T	34	43	17	19	47	28	0.59	0.45	0.41	0.55	C	1.05	0.019160998	Breast cancer	Cancer
rs10864728	A	G	17	43	34	23	57	14	0.41	0.55	0.59	0.45	A	0.052	0.019160998	Triglycerides	General health
rs592423	A	C	15	55	24	33	45	16	0.45	0.59	0.55	0.41	C	0.02	0.019160998	Adiponectin levels	Obesity
rs10489615	A	G	17	43	34	23	57	14	0.41	0.55	0.59	0.45	G	0.02	0.019160998	HDL cholesterol	General health
rs10761785	G	T	20	37	37	23	57	14	0.41	0.55	0.59	0.45	G	0.019	0.019160998	Body mass index	Obesity
rs766903	A	G	68	24	2	50	39	5	0.85	0.74	0.15	0.26	A	0.09	0.019154758	Aging time to death	Aging
rs2053831	A	G	54	31	9	69	22	3	0.74	0.85	0.26	0.15	A	0.023	0.019154758	Educational attainment	Mental aptitude and behavioural traits
rs7628864	A	G	30	44	20	19	40	35	0.55	0.41	0.45	0.59	G	0.11	0.019145803	Pubertal anthropometrics	Appearance
rs2011738	A	G	19	46	29	34	42	18	0.45	0.59	0.55	0.41	G	1.34	0.019145803	Response to angiotensin II receptor blocker therapy	General health
rs12542759	T	G	34	42	18	22	40	32	0.59	0.45	0.41	0.55	T	0.8026	0.019145803	Pit-and-Fissure caries	Misc
rs9810888	T	G	32	46	16	20	44	30	0.59	0.45	0.41	0.55	G	0.53	0.019145803	Systolic blood pressure	Heart health and disorders
rs6712720	G	C	34	37	23	7	65	22	0.56	0.42	0.44	0.58	C	0.16	0.019134964	Monocyte early outgrowth colony forming units	Immune diseases and disorders
rs920590	T	C	30	46	18	17	46	31	0.56	0.43	0.44	0.57	C	1	0.019128466	Acute lymphoblastic leukemia childhood	Cancer
rs5756813	G	T	21	38	35	28	50	16	0.43	0.56	0.57	0.44	G	0.014	0.019128466	Optic cup area	Misc
rs6758183	G	A	52	40	2	71	22	1	0.77	0.87	0.23	0.13	A	1.39	0.019098549	Corneal astigmatism	General health
rs12595305	T	C	56	32	6	70	24	0	0.77	0.87	0.23	0.13	T	1.05	0.019098549	Schizophrenia	Brain health and disorders
rs6663731	A	T	73	18	3	54	36	4	0.87	0.77	0.13	0.23	A	0.062	0.019098549	Blood metabolite levels	Heart health and disorders
rs2063730	A	C	55	34	5	71	22	1	0.77	0.87	0.23	0.13	C	0.05	0.019098549	Menarche age at onset	Reproductive health
rs7780752	T	C	55	34	5	73	18	3	0.77	0.87	0.23	0.13	T	0.029	0.019098549	Birth weight	Misc
rs1741	G	C	34	39	21	46	40	8	0.57	0.70	0.43	0.30	C	0.2	0.019088049	Plasma omega-6 polyunsaturated fatty acid levels arachidonic acid	General health
rs7629245	C	T	68	24	2	82	12	0	0.85	0.94	0.15	0.06	T	1.22	0.019047619	Airflow obstruction	Pulmonology
rs3851228	A	T	82	12	0	66	28	0	0.94	0.85	0.06	0.15	A	1.1365786	0.019047619	Crohn's disease	Digestive system and its disorders
rs10788575	G	A	68	24	2	83	10	1	0.85	0.94	0.15	0.06	A	1.06	0.019047619	Type 2 diabetes	Diabetes
rs3218097	G	A	69	22	3	82	12	0	0.85	0.94	0.15	0.06	T	0.097	0.019047619	Red blood cell count	Immune diseases and disorders
rs583583	C	T	40	46	8	58	33	3	0.67	0.79	0.33	0.21	A	1.3	0.019045905	Schizophrenia negative symptoms	Brain health and disorders
rs7817714	T	C	61	27	6	42	42	10	0.79	0.67	0.21	0.33	C	0.4448	0.019045905	Cerebral amyloid angiopathy	Brain health and disorders
rs7969151	G	A	59	31	4	43	40	11	0.79	0.67	0.21	0.33	A	0.13	0.019045905	Tanning	Appearance
rs823094	T	G	39	48	7	60	29	5	0.67	0.79	0.33	0.21	G	0.05	0.019045905	Pubertal anthropometrics	Appearance
rs1136001	G	T	33	40	21	46	39	9	0.56	0.70	0.44	0.30	T	0.35	0.018972164	Plasma omega-6 polyunsaturated fatty acid levels linoleic acid	General health
rs7200543	A	G	33	40	21	46	39	9	0.56	0.70	0.44	0.30	G	0.073	0.018972164	Metabolic traits	Misc
rs6498540	A	G	33	40	21	46	39	9	0.56	0.70	0.44	0.30	A	0.017	0.018972164	Blood metabolite levels	Heart health and disorders
rs7600502	A	G	94	0	0	87	7	0	1.00	0.96	0.00	0.04	G	0.39	0.01897019	C-reactive protein and white blood cell count	Immune diseases and disorders
rs17130643	C	T	94	0	0	87	7	0	1.00	0.96	0.00	0.04	A	0.02	0.01897019	Obesity-related traits	Obesity
rs10010758	T	C	54	33	7	39	39	16	0.75	0.62	0.25	0.38	C	1.91	0.018919984	Periodontal microbiota	Misc
rs16944158	T	G	55	31	8	36	45	13	0.75	0.62	0.25	0.38	G	0.162	0.018919984	IgG glycosylation	Immune diseases and disorders
rs11220462	G	A	73	20	1	86	8	0	0.88	0.96	0.12	0.04	T	2.01	0.018882466	Cholesterol, total	General health
rs78381888	A	G	75	16	3	86	8	0	0.88	0.96	0.12	0.04	A	1.09	0.018882466	Schizophrenia	Brain health and disorders
rs17111394	T	C	75	16	3	87	6	1	0.88	0.96	0.12	0.04	T	0.216	0.018882466	Optic nerve measurement rim area	Misc
rs2538470	A	G	9	40	45	21	41	32	0.31	0.44	0.69	0.56	A	1.0778457	0.01886223	Crohn's disease	Digestive system and its disorders
rs2602836	A	G	28	49	17	45	40	9	0.56	0.69	0.44	0.31	A	0.019	0.01886223	HDL cholesterol	General health
rs4724055	G	T	1	8	85	1	23	70	0.05	0.13	0.95	0.87	C	4.917	0.018852116	Non-substance related behavioral disinhibition	Brain health and disorders
rs4148441	A	G	2	21	71	0	10	84	0.13	0.05	0.87	0.95	G	4.117	0.018852116	Platelet count	Heart health and disorders
rs12935229	C	T	71	21	2	84	10	0	0.87	0.95	0.13	0.05	A	1.495	0.018852116	Adverse response to chemotherapy neutropenia_leucopenia all antimicrotubule drugs	Drug response
rs3815087	G	A	59	30	5	42	41	11	0.79	0.66	0.21	0.34	A	1.53	0.018812902	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis SJS_TEN	Drug response
rs252716	G	C	38	49	7	59	30	5	0.66	0.79	0.34	0.21	C	1.516	0.018812902	Eosinophilic esophagitis	Digestive system and its disorders
rs231362	A	G	12	39	43	2	36	56	0.34	0.21	0.66	0.79	G	1.08	0.018812902	Type 2 diabetes	Diabetes
rs10849432	C	T	5	19	70	3	44	47	0.15	0.27	0.85	0.73	T	1.14	0.01879555	Colorectal cancer	Cancer
rs1040393	T	C	8	34	52	2	25	67	0.27	0.15	0.73	0.85	C	1.0638298	0.01879555	Schizophrenia	Brain health and disorders
rs6556416	A	C	10	30	54	1	27	66	0.27	0.15	0.73	0.85	C	1	0.01879555	Ankylosing spondylitis	Immune diseases and disorders
rs10894604	T	G	47	44	3	66	27	1	0.73	0.85	0.27	0.15	T	0.06	0.01879555	Waist-hip ratio	General health
rs17744026	T	G	57	34	3	73	21	0	0.79	0.89	0.21	0.11	T	4	0.018787406	IgE levels in asthmatics D.p. specific	Immune diseases and disorders
rs7210086	A	C	58	32	4	75	17	2	0.79	0.89	0.21	0.11	A	1.111	0.018787406	Ulcerative colitis	Immune diseases and disorders
rs7229639	A	G	1	19	74	0	40	54	0.11	0.21	0.89	0.79	A	1.22	0.018787406	Colorectal cancer	Cancer
rs12373805	G	A	4	40	50	15	42	37	0.26	0.38	0.74	0.62	A	1.2169	0.01875	Suicide risk	General health
rs1859596	T	C	13	46	35	3	42	49	0.38	0.26	0.62	0.74	T	0.111	0.01875	Reading or mathematical ability	Brain health and disorders
rs10113213	T	C	38	40	16	53	34	7	0.62	0.74	0.38	0.26	T	1.99	0.01875	Response to methotrexate in juvenile idiopathic arthritis	General health
rs1004446	G	A	54	32	8	38	40	16	0.74	0.62	0.26	0.38	C	1.61	0.01875	Type 1 diabetes	Diabetes
rs9472155	C	T	50	40	4	38	40	16	0.74	0.62	0.26	0.38	T	1	0.01875	Vascular endothelial growth factor levels	General health
rs2011905	G	T	34	48	12	49	42	3	0.62	0.74	0.38	0.26	C	0.222	0.01875	Cytomegalovirus antibody response	Immune diseases and disorders
rs1370967	G	A	79	15	0	65	26	3	0.92	0.83	0.08	0.17	A	2.21	0.018689776	Periodontitis PAL4Q3	Misc
rs12241008	T	C	80	13	1	65	26	3	0.92	0.83	0.08	0.17	C	1.13	0.018689776	Colorectal cancer	Cancer
rs2995264	G	A	0	15	79	6	20	68	0.08	0.17	0.92	0.83	G	0.16	0.018689776	Cutaneous malignant melanoma	Cancer
rs3864639	C	T	3	26	65	1	13	80	0.17	0.08	0.83	0.92	G	0.05	0.018689776	Obesity-related traits	Obesity
rs4388249	C	T	54	35	5	70	23	1	0.76	0.87	0.24	0.13	T	1.076	0.018674136	Schizophrenia	Brain health and disorders
rs12967884	A	G	71	21	2	54	35	5	0.87	0.76	0.13	0.24	A	1	0.018674136	Subcutaneous adipose tissue	Obesity
rs7902871	A	G	71	21	2	59	25	10	0.87	0.76	0.13	0.24	G	0.12	0.018674136	Diastolic blood pressure alcohol consumption interaction	Heart health and disorders
rs2404916	A	G	48	32	14	21	61	12	0.68	0.55	0.32	0.45	G	0.02	0.018659501	Obesity-related traits	Obesity
rs7010162	C	T	19	47	28	10	40	44	0.45	0.32	0.55	0.68	G	1.22	0.018659501	Testicular germ cell tumor	Cancer
rs2451258	C	T	4	28	62	0	18	76	0.19	0.10	0.81	0.90	T	1.1	0.01863354	Rheumatoid arthritis	Immune diseases and disorders
rs302668	T	C	62	28	4	76	18	0	0.81	0.90	0.19	0.10	T	1.23	0.01863354	Frontotemporal dementia	Brain health and disorders
rs9375969	G	A	59	34	1	77	16	1	0.81	0.90	0.19	0.10	G	1	0.01863354	Visceral fat	Obesity
rs11984075	A	G	78	14	2	65	22	7	0.90	0.81	0.10	0.19	G	1	0.01863354	Celiac disease or Rheumatoid arthritis	Immune diseases and disorders
rs11712263	C	T	61	30	3	77	16	1	0.81	0.90	0.19	0.10	A	0.03	0.01863354	Obesity-related traits	Obesity
rs10801555	A	G	3	35	56	12	40	42	0.22	0.34	0.78	0.66	A	2.33	0.018590757	Age-related macular degeneration	Aging
rs3802842	C	A	2	37	55	12	40	42	0.22	0.34	0.78	0.66	C	1.13	0.018590757	Colorectal cancer	Cancer
rs1106568	G	A	3	35	56	10	44	40	0.22	0.34	0.78	0.66	G	1.0752687	0.018590757	Schizophrenia	Brain health and disorders
rs660240	T	C	3	35	56	11	42	41	0.22	0.34	0.78	0.66	T	0.17	0.018590757	Cardiovascular disease risk factors	Heart health and disorders
rs606452	A	C	6	29	59	7	50	37	0.22	0.34	0.78	0.66	C	0.043	0.018590757	Height	General health
rs4722672	C	T	5	39	50	9	55	30	0.26	0.39	0.74	0.61	G	1.0755208	0.01858784	Ulcerative colitis	Immune diseases and disorders
rs10502386	G	T	33	49	12	47	45	2	0.61	0.74	0.39	0.26	A	0.03	0.01858784	Obesity-related traits	Obesity
rs9470366	G	A	61	31	2	46	39	9	0.81	0.70	0.19	0.30	T	1.16	0.018524189	QRS duration	Heart health and disorders
rs7582141	G	T	63	27	4	47	37	10	0.81	0.70	0.19	0.30	T	0.37	0.018524189	Response to radiotherapy in prostate cancer toxicity	General health
rs7181753	C	T	61	31	2	45	41	8	0.81	0.70	0.19	0.30	T	0.128	0.018524189	Electroencephalographic traits in alcoholism	Heart health and disorders
rs10518733	A	C	45	41	8	62	29	3	0.70	0.81	0.30	0.19	C	0.068	0.018524189	Hematological and biochemical traits	Heart health and disorders
rs7702905	G	A	64	25	5	45	41	8	0.81	0.70	0.19	0.30	A	0.017	0.018524189	Toenail selenium levels	Misc
rs763780	T	C	89	5	0	78	15	1	0.97	0.91	0.03	0.09	G	3.3	0.018489985	Response to gemcitabine in pancreatic cancer	General health
rs11224899	G	A	89	5	0	77	17	0	0.97	0.91	0.03	0.09	T	1.8989	0.018489985	Formal thought disorder in schizophrenia	Brain health and disorders
rs6822844	G	T	77	17	0	89	5	0	0.91	0.97	0.09	0.03	G	1.59	0.018489985	Celiac disease	Immune diseases and disorders
rs13202860	A	T	77	17	0	89	5	0	0.91	0.97	0.09	0.03	A	0.421	0.018489985	Sexual dysfunction female	Reproductive health
rs17127169	T	G	89	5	0	78	15	1	0.97	0.91	0.03	0.09	G	0.08	0.018489985	Sitting height ratio	Appearance
rs6711606	T	G	0	17	77	0	5	89	0.09	0.03	0.91	0.97	A	2.81	0.018489985	Pancreatic cancer	Cancer
rs12214804	C	T	12	38	44	14	59	21	0.33	0.46	0.67	0.54	T	0.084	0.01847855	Height	General health
rs7599488	C	T	26	49	19	38	50	6	0.54	0.67	0.46	0.33	C	1.0526316	0.01847855	Schizophrenia	Brain health and disorders
rs6054383	G	T	25	51	18	44	38	12	0.54	0.67	0.46	0.33	T	0.016	0.01847855	Optic cup area	Misc
rs715921	G	A	51	35	8	68	22	4	0.73	0.84	0.27	0.16	A	1.2	0.018455744	Airflow obstruction	Pulmonology
rs2835872	G	A	50	37	7	66	26	2	0.73	0.84	0.27	0.16	G	0.145	0.018455744	Electroencephalographic traits in alcoholism	Heart health and disorders
rs7964120	C	T	50	37	7	68	22	4	0.73	0.84	0.27	0.16	A	0.03	0.018455744	Obesity-related traits	Obesity
rs11989843	A	G	64	30	0	48	41	5	0.84	0.73	0.16	0.27	G	0.03	0.018455744	Obesity-related traits	Obesity
rs7781370	T	C	10	31	53	3	24	67	0.27	0.16	0.73	0.84	T	0.08	0.018455744	Bone mineral density hip	General health
rs3134950	C	A	14	46	34	8	34	52	0.39	0.27	0.61	0.73	A	0.0945	0.01843318	Oleic acid 18:1n-9 plasma levels	General health
rs2276824	C	G	15	44	35	6	38	50	0.39	0.27	0.61	0.73	C	0.028	0.01843318	Waist-to-hip ratio adjusted for body mass index	Obesity
rs7553007	G	A	37	40	17	52	34	8	0.61	0.73	0.39	0.27	T	0.272	0.01843318	C-reactive protein	Immune diseases and disorders
rs4849121	G	A	28	44	22	41	43	10	0.53	0.66	0.47	0.34	G	1.15	0.018395879	IgA nephropathy	Immune diseases and disorders
rs11264213	A	G	46	33	15	28	44	22	0.66	0.53	0.34	0.47	A	1.09	0.018395879	Schizophrenia	Brain health and disorders
rs609412	A	G	39	47	8	26	48	20	0.66	0.53	0.34	0.47	A	1.07	0.018395879	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs2451932	A	G	22	44	28	13	37	44	0.47	0.34	0.53	0.66	G	0.034925025	0.018395879	LDL peak particle diameter total fat intake interaction	General health
rs4410871	T	C	11	43	40	3	36	55	0.35	0.22	0.65	0.78	T	1.14	0.018378904	Allergic sensitization	Immune diseases and disorders
rs12541902	A	C	10	45	39	5	32	57	0.35	0.22	0.65	0.78	A	0.03	0.018378904	Obesity-related traits	Obesity
rs7637230	A	G	55	36	3	38	47	9	0.78	0.65	0.22	0.35	A	1.14	0.018378904	Psoriasis	Immune diseases and disorders
rs10013166	G	A	42	39	13	58	30	6	0.65	0.78	0.35	0.22	A	0.11	0.018378904	Preschool internalizing problems	Mental aptitude and behavioural traits
rs9525638	T	C	38	47	9	58	30	6	0.65	0.78	0.35	0.22	C	0.0949	0.018378904	Bone mineral density paediatric, upper limb	General health
rs9342616	A	G	21	47	26	13	38	43	0.47	0.34	0.53	0.66	A	6.92	0.018318239	QT interval	Heart health and disorders
rs6762644	A	G	43	38	13	26	47	21	0.66	0.53	0.34	0.47	G	1.07	0.018318239	Breast cancer	Cancer
rs2160860	A	T	23	53	18	40	44	10	0.53	0.66	0.47	0.34	A	0.012	0.018318239	Blood metabolite levels	Heart health and disorders
rs8057927	T	C	73	20	1	57	33	4	0.88	0.78	0.12	0.22	C	1.342	0.018307216	Schizophrenia	Brain health and disorders
rs4129575	A	G	58	31	5	74	18	2	0.78	0.88	0.22	0.12	A	1.31	0.018307216	Schizophrenia	Brain health and disorders
rs12309274	T	G	59	29	6	75	16	3	0.78	0.88	0.22	0.12	T	1.11	0.018307216	Colorectal cancer	Cancer
rs17146964	A	G	74	18	2	56	35	3	0.88	0.78	0.12	0.22	G	0.01	0.018307216	Vertical cup-disc ratio	Misc
rs1294410	T	C	16	43	35	1	49	44	0.40	0.27	0.60	0.73	C	0.0369	0.018285714	Waist-to-hip ratio adjusted for body mass index	Obesity
rs12498735	C	T	33	47	14	48	41	5	0.60	0.73	0.40	0.27	T	19.13	0.018285714	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs56775891	C	T	35	43	16	49	39	6	0.60	0.73	0.40	0.27	T	1.06	0.018285714	Schizophrenia	Brain health and disorders
rs4727751	T	G	33	47	14	49	39	6	0.60	0.73	0.40	0.27	T	1.05	0.018285714	Schizophrenia	Brain health and disorders
rs12407028	T	C	33	47	14	46	45	3	0.60	0.73	0.40	0.27	T	0.08	0.018285714	Bone mineral density	General health
rs438465	T	C	6	34	54	3	20	71	0.24	0.14	0.76	0.86	C	0.173	0.018274854	Corneal astigmatism	General health
rs12416860	A	G	69	24	1	54	34	6	0.86	0.76	0.14	0.24	G	0.03	0.018274854	Obesity-related traits	Obesity
rs7372960	T	C	48	34	12	59	34	1	0.69	0.81	0.31	0.19	T	1.07	0.018258639	Schizophrenia	Brain health and disorders
rs2683295	T	C	45	40	9	62	28	4	0.69	0.81	0.31	0.19	C	0.083	0.018258639	Urate levels in overweight individuals	Obesity
rs2163870	A	G	42	46	6	62	28	4	0.69	0.81	0.31	0.19	G	0.057	0.018258639	Fractional exhaled nitric oxide childhood	Pulmonology
rs253664	T	C	2	25	67	1	11	82	0.15	0.07	0.85	0.93	T	0.025	0.018249216	Body mass index	Obesity
rs11053548	A	G	66	27	1	82	11	1	0.85	0.93	0.15	0.07	A	2.12	0.018249216	Systolic blood pressure in sickle cell anemia	Heart health and disorders
rs7809615	G	T	81	13	0	69	21	4	0.93	0.85	0.07	0.15	T	0.249	0.018249216	Blood metabolite ratios	Heart health and disorders
rs55649657	C	G	68	23	3	83	9	2	0.85	0.93	0.15	0.07	G	0.052	0.018249216	Cholesterol, total	General health
rs647161	C	A	11	43	40	24	42	28	0.35	0.48	0.65	0.52	A	1.17	0.018245512	Colorectal cancer	Cancer
rs12540205	C	T	23	52	19	36	51	7	0.52	0.65	0.48	0.35	C	1.0526316	0.018245512	Schizophrenia	Brain health and disorders
rs1381102	G	A	43	37	14	26	46	22	0.65	0.52	0.35	0.48	A	1	0.018245512	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs10786436	C	T	37	48	9	25	47	22	0.65	0.52	0.35	0.48	T	1.1	0.018177588	Type 1 diabetes	Diabetes
rs2042126	T	G	25	47	22	38	46	10	0.52	0.65	0.48	0.35	G	0.14	0.018177588	Sleep duration	General health
rs3761218	C	T	13	40	41	5	33	56	0.35	0.23	0.65	0.77	C	1.03	0.01817682	Bipolar disorder	Brain health and disorders
rs4524	T	C	38	46	10	58	29	7	0.65	0.77	0.35	0.23	T	1.2	0.01817682	Venous thromboembolism	Heart health and disorders
rs7111341	C	T	55	35	4	43	36	15	0.77	0.65	0.23	0.35	T	0.021	0.01817682	Body mass index	Obesity
rs6812193	C	T	50	36	8	38	36	20	0.72	0.60	0.28	0.40	C	1.19	0.018145161	Parkinson's disease	Brain health and disorders
rs10253361	C	T	13	50	31	10	32	52	0.40	0.28	0.60	0.72	T	0.076	0.018145161	Alcoholism alcohol dependence factor score	General health
rs4905994	T	C	10	32	52	11	54	29	0.28	0.40	0.72	0.60	T	0.02871	0.018145161	Magnesium levels	General health
rs7954567	G	A	51	34	9	63	31	0	0.72	0.84	0.28	0.16	A	1.0857501	0.018133969	Crohn's disease	Digestive system and its disorders
rs1904173	G	A	64	29	1	49	38	7	0.84	0.72	0.16	0.28	G	0.201	0.018133969	IgG glycosylation	Immune diseases and disorders
rs2073214	C	T	67	23	4	47	42	5	0.84	0.72	0.16	0.28	T	0.03512	0.018133969	Magnesium levels	General health
rs7647854	G	A	1	29	64	6	40	48	0.16	0.28	0.84	0.72	G	1.19	0.018133969	Major depressive disorder	Brain health and disorders
rs1014971	C	T	26	44	24	38	45	11	0.51	0.64	0.49	0.36	T	1.13	0.018114367	Bladder cancer	Cancer
rs9466056	A	G	19	54	21	15	37	42	0.49	0.36	0.51	0.64	G	0.05	0.018114367	Bone mineral density	General health
rs12032381	A	C	62	27	5	75	19	0	0.80	0.90	0.20	0.10	C	6.22	0.018080357	Dupuytren's disease	Skin related disease
rs5219	T	C	3	31	60	0	19	75	0.20	0.10	0.80	0.90	T	1.15	0.018080357	Type 2 diabetes	Diabetes
rs1265097	C	A	59	33	2	75	19	0	0.80	0.90	0.20	0.10	A	0.059	0.018080357	Height	General health
rs11201253	C	T	76	17	1	61	29	4	0.90	0.80	0.10	0.20	A	0.02	0.018080357	Obesity-related traits	Obesity
rs3109133	C	G	24	45	25	19	30	45	0.49	0.36	0.51	0.64	C	0.00315	0.018055756	Calcium levels	General health
rs4852708	C	T	78	16	0	64	27	3	0.91	0.82	0.09	0.18	C	0.2055	0.018036572	IgG glycosylation	Immune diseases and disorders
rs12940923	A	T	64	27	3	78	16	0	0.82	0.91	0.18	0.09	A	0.07	0.018036572	Circulating myeloperoxidase levels plasma	Immune diseases and disorders
rs6556412	G	A	49	37	8	32	47	15	0.72	0.59	0.28	0.41	A	1.18	0.018011257	Crohn's disease	Digestive system and its disorders
rs34753377	T	G	49	37	8	24	63	7	0.72	0.59	0.28	0.41	T	1.07	0.018011257	Schizophrenia	Brain health and disorders
rs1063856	T	C	50	35	9	33	45	16	0.72	0.59	0.28	0.41	A	0.12	0.018011257	Coagulation factor levels	General health
rs9513675	G	A	15	47	32	4	45	45	0.41	0.28	0.59	0.72	G	0.03	0.018011257	Obesity-related traits	Obesity
rs31198	T	C	42	45	7	61	29	4	0.69	0.80	0.31	0.20	T	4.8	0.018005952	Height	General health
rs3903239	A	G	45	39	10	62	27	5	0.69	0.80	0.31	0.20	G	1.14	0.018005952	Atrial fibrillation	Heart health and disorders
rs11024598	G	A	47	35	12	62	27	5	0.69	0.80	0.31	0.20	G	0.262	0.018005952	Lewy body disease	Brain health and disorders
rs10877945	G	A	42	45	7	58	35	1	0.69	0.80	0.31	0.20	A	0.03	0.018005952	Obesity-related traits	Obesity
rs1258763	C	T	14	41	39	25	44	25	0.37	0.50	0.63	0.50	A	1.52	0.018001671	Orofacial clefts	Misc
rs4415084	C	T	24	46	24	10	49	35	0.50	0.37	0.50	0.63	T	1.17	0.018001671	Breast cancer	Cancer
rs3129890	T	C	54	36	4	41	39	14	0.77	0.64	0.23	0.36	T	1.15	0.017984022	Asthma	Immune diseases and disorders
rs28441017	G	A	53	38	3	32	57	5	0.77	0.64	0.23	0.36	G	0.086	0.017984022	Anorexia nervosa	Brain health and disorders
rs492146	G	A	25	43	26	37	44	13	0.49	0.63	0.51	0.37	A	1.7544	0.017952032	Epilepsy remission after treatment	Brain health and disorders
rs859637	T	C	25	45	24	11	48	35	0.51	0.37	0.49	0.63	A	1.1	0.017952032	Celiac disease	Immune diseases and disorders
rs7503807	A	C	36	46	12	20	53	21	0.63	0.49	0.37	0.51	A	1.04	0.017952032	Obesity	Obesity
rs1321847	A	G	2	7	85	2	22	70	0.06	0.14	0.94	0.86	A	0.07	0.017938292	Body mass index	Obesity
rs7140285	C	T	83	11	0	70	22	2	0.94	0.86	0.06	0.14	T	1.55	0.017938292	Pulmonary artery enlargement in chronic obstructive pulmonary disease	Heart health and disorders
rs12155789	A	G	70	22	2	83	11	0	0.86	0.94	0.14	0.06	G	0.147	0.017938292	Asymmetrical dimethylarginine levels	General health
rs12917707	G	T	71	20	3	83	11	0	0.86	0.94	0.14	0.06	T	0.02	0.017938292	Renal function and chronic kidney disease	General health
rs7937106	T	C	87	7	0	78	12	4	0.96	0.89	0.04	0.11	C	1.69	0.01793484	Large artery stroke	Heart health and disorders
rs4713226	G	A	77	14	3	87	7	0	0.89	0.96	0.11	0.04	A	1	0.01793484	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs79588679	C	T	76	16	2	87	7	0	0.89	0.96	0.11	0.04	T	0.049	0.01793484	LDL cholesterol	General health
rs4937362	T	C	26	40	28	36	45	13	0.49	0.62	0.51	0.38	T	1.19	0.01790677	Follicular lymphoma	Cancer
rs1536407	C	A	10	51	33	23	50	21	0.38	0.51	0.62	0.49	A	1	0.01790677	Glucocorticoid-induced osteonecrosis	Drug response
rs36600	T	C	6	35	53	1	25	68	0.25	0.14	0.75	0.86	A	1.29	0.017898693	Lung cancer	Cancer
rs1545552	A	G	8	31	55	1	25	68	0.25	0.14	0.75	0.86	G	1.15	0.017898693	Height	General health
rs572169	C	T	49	43	2	70	21	3	0.75	0.86	0.25	0.14	T	1.17	0.017898693	Height	General health
rs17154917	G	T	69	23	2	49	43	2	0.86	0.75	0.14	0.25	T	0.6656	0.017898693	Pharmacokinetics of antipsychotic drugs in severe mental disorder concentration drug ratio	General health
rs516636	C	A	54	33	7	67	27	0	0.75	0.86	0.25	0.14	A	0.05	0.017898693	Body mass index	Obesity
rs6917758	A	C	52	37	5	67	27	0	0.75	0.86	0.25	0.14	C	0.04	0.017898693	Obesity-related traits	Obesity
rs509035	G	A	49	43	2	70	21	3	0.75	0.86	0.25	0.14	A	0.031	0.017898693	Height	General health
rs984440	C	T	54	33	7	70	21	3	0.75	0.86	0.25	0.14	A	0.03	0.017898693	Obesity-related traits	Obesity
rs12936587	G	A	32	46	16	45	44	5	0.59	0.71	0.41	0.29	A	1.0753	0.017883756	Coronary artery disease	Heart health and disorders
rs1470506	C	T	24	49	21	16	40	38	0.52	0.38	0.48	0.62	C	0.16	0.017865821	IgG glycosylation	Immune diseases and disorders
rs6770162	G	A	25	47	22	10	52	32	0.52	0.38	0.48	0.62	A	0.04	0.017865821	Menarche age at onset	Reproductive health
rs9371942	A	G	74	17	3	57	32	5	0.88	0.78	0.12	0.22	A	5	0.017858026	Lachrymal_Salivary gland lesion in type 1 autoimmune pancreatitis	Immune diseases and disorders
rs2212361	T	C	57	32	5	72	21	1	0.78	0.88	0.22	0.12	C	0.97	0.017858026	Attention deficit hyperactivity disorder symptoms interaction	Brain health and disorders
rs1329201	C	T	55	36	3	72	21	1	0.78	0.88	0.22	0.12	T	0.22	0.017858026	Retinopathy in non-diabetics	General health
rs12125250	C	A	56	34	4	71	23	0	0.78	0.88	0.22	0.12	C	0.124	0.017858026	Economic and political preferences	Mental aptitude and behavioural traits
rs2166898	G	A	73	19	2	54	38	2	0.88	0.78	0.12	0.22	A	0.052	0.017858026	Height	General health
rs527409	T	C	0	4	90	1	13	80	0.02	0.08	0.98	0.92	T	2.9	0.017838714	Kawasaki disease	Misc
rs16838131	G	A	90	4	0	80	13	1	0.98	0.92	0.02	0.08	A	2.26	0.017838714	Response to angiotensin II receptor blocker therapy	General health
rs17147674	T	C	90	4	0	79	15	0	0.98	0.92	0.02	0.08	T	2.2	0.017838714	Attention function in attention deficit hyperactive disorder	Brain health and disorders
rs113641325	G	C	79	15	0	90	4	0	0.92	0.98	0.08	0.02	C	1.98	0.017838714	Classic bladder exstrophy	Misc
rs12036718	G	A	79	15	0	90	4	0	0.92	0.98	0.08	0.02	T	1.68	0.017838714	Yu-Zhi constitution type in type 2 diabetes	Diabetes
rs78536982	C	T	81	11	2	90	4	0	0.92	0.98	0.08	0.02	T	1.38	0.017838714	Triglycerides	General health
rs11587682	C	T	79	15	0	90	4	0	0.92	0.98	0.08	0.02	C	1.086	0.017838714	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs1974653	C	A	80	13	1	90	4	0	0.92	0.98	0.08	0.02	A	1.06	0.017838714	Schizophrenia	Brain health and disorders
rs71642944	G	A	81	11	2	90	4	0	0.92	0.98	0.08	0.02	A	1	0.017838714	White matter hyperintensity burden	Brain health and disorders
rs72960926	C	A	79	15	0	91	2	1	0.92	0.98	0.08	0.02	A	0.3084	0.017838714	Metabolite levels MHPG	General health
rs12465996	C	T	80	13	1	90	4	0	0.92	0.98	0.08	0.02	C	0.2431	0.017838714	IgG glycosylation	Immune diseases and disorders
rs7679	T	C	79	15	0	90	4	0	0.92	0.98	0.08	0.02	C	0.07	0.017838714	HDL cholesterol	General health
rs6073972	C	G	79	15	0	90	4	0	0.92	0.98	0.08	0.02	C	0.065	0.017838714	HDL cholesterol	General health
rs2121279	C	T	80	13	1	90	4	0	0.92	0.98	0.08	0.02	T	0.029	0.017838714	Body mass index	Obesity
rs2512987	A	G	34	47	13	23	44	27	0.61	0.48	0.39	0.52	T	2.985	0.017829126	Adverse response to chemotherapy neutropenia_leucopenia doxorubicin	Drug response
rs3731827	T	C	35	45	14	25	40	29	0.61	0.48	0.39	0.52	T	1.13	0.017829126	Prostate cancer	Cancer
rs2025751	T	C	15	43	36	26	46	22	0.39	0.52	0.61	0.48	A	0.6	0.017829126	Intraocular pressure	General health
rs11752626	G	T	47	41	6	66	24	4	0.72	0.83	0.28	0.17	G	1.56	0.017828987	QT interval	Heart health and disorders
rs6858698	G	C	63	30	1	46	43	5	0.83	0.72	0.17	0.28	C	1.31	0.017828987	Chronic lymphocytic leukemia	Cancer
rs301797	C	A	65	26	3	51	33	10	0.83	0.72	0.17	0.28	A	1.07	0.017828987	Schizophrenia	Brain health and disorders
rs1163251	T	C	48	39	7	62	32	0	0.72	0.83	0.28	0.17	T	0.019	0.017828987	Blood metabolite levels	Heart health and disorders
rs9383938	G	T	85	9	0	72	21	1	0.95	0.88	0.05	0.12	T	1.28	0.017805233	Breast cancer	Cancer
rs9399137	T	C	72	21	1	85	9	0	0.88	0.95	0.12	0.05	C	0.4202	0.017805233	Hemoglobin levels	Heart health and disorders
rs11031492	T	G	72	21	1	85	9	0	0.88	0.95	0.12	0.05	G	0.2196	0.017805233	Metabolite levels HVA_5-HIAA ratio	Brain health and disorders
rs4894410	C	G	0	9	85	0	23	71	0.05	0.12	0.95	0.88	G	2.094	0.017805233	Kawasaki disease	Misc
rs7193778	C	T	1	21	72	1	7	86	0.12	0.05	0.88	0.95	T	0.046	0.017805233	Urate levels	General health
rs7660520	G	A	52	39	3	33	54	7	0.76	0.64	0.24	0.36	A	1	0.017800061	Pediatric autoimmune diseases	Immune diseases and disorders
rs13413635	A	G	57	29	8	37	46	11	0.76	0.64	0.24	0.36	G	1	0.017800061	Heart rate	General health
rs10744816	T	C	36	48	10	55	33	6	0.64	0.76	0.36	0.24	G	0.04	0.017800061	Obesity-related traits	Obesity
rs3753275	T	C	55	33	6	38	44	12	0.76	0.64	0.24	0.36	T	0.03	0.017800061	Educational attainment	Mental aptitude and behavioural traits
rs1884302	T	C	26	47	21	13	48	33	0.53	0.39	0.47	0.61	C	4.38	0.017796634	Sagittal craniosynostosis	Heart health and disorders
rs909116	T	C	23	42	29	34	45	15	0.47	0.60	0.53	0.40	T	1.17	0.017768301	Breast cancer	Cancer
rs605066	C	T	13	49	32	21	58	15	0.40	0.53	0.60	0.47	C	0.39	0.017768301	HDL cholesterol	General health
rs7204439	T	C	27	46	21	13	49	32	0.53	0.40	0.47	0.60	C	0.11	0.017768301	Disc degeneration lumbar	Aging
rs6910061	T	A	61	28	5	44	40	10	0.80	0.68	0.20	0.32	A	1.74	0.01776538	Diabetic kidney disease	Diabetes
rs761926	C	G	46	36	12	60	30	4	0.68	0.80	0.32	0.20	G	0.04	0.01776538	Obesity-related traits	Obesity
rs4457053	G	A	12	36	46	3	32	59	0.32	0.20	0.68	0.80	G	1.08	0.01776538	Type 2 diabetes	Diabetes
rs2445762	T	C	44	45	5	37	35	22	0.71	0.58	0.29	0.42	C	0.11	0.017762428	Hormone measurements	General health
rs11678036	C	T	23	41	30	31	50	13	0.46	0.60	0.54	0.40	C	0.1459	0.017744088	IgG glycosylation	Immune diseases and disorders
rs742614	A	G	36	40	18	16	55	23	0.60	0.46	0.40	0.54	A	0.095	0.017744088	Stearic acid 18:0 plasma levels	General health
rs4637667	C	A	27	48	19	16	45	33	0.54	0.41	0.46	0.59	A	1.24	0.01772396	Adolescent idiopathic scoliosis	Obesity
rs316577	G	A	36	39	19	18	50	26	0.59	0.46	0.41	0.54	A	0.23	0.01772396	Cannabis use initiation	General health
rs7763064	G	A	26	50	18	16	45	33	0.54	0.41	0.46	0.59	A	0.044	0.01772396	Birth length	Misc
rs2585417	G	A	24	54	16	11	55	28	0.54	0.41	0.46	0.59	A	0.03	0.01772396	Obesity-related traits	Obesity
rs9820695	G	A	28	47	19	22	34	38	0.55	0.41	0.45	0.59	G	0.091	0.017707891	Economic and political preferences environmentalism	Mental aptitude and behavioural traits
rs2430386	C	T	27	50	17	16	47	31	0.55	0.42	0.45	0.58	T	1.14	0.017695858	Prostate cancer	Cancer
rs6503525	G	C	17	49	28	30	48	16	0.44	0.57	0.56	0.43	C	1.33	0.017687845	Asthma	Immune diseases and disorders
rs12498742	A	G	32	41	21	24	32	38	0.56	0.43	0.44	0.57	A	0.373	0.017687845	Urate levels	General health
rs275437	T	C	13	54	27	21	63	10	0.43	0.56	0.57	0.44	A	0.04	0.017687845	Obesity-related traits	Obesity
rs941873	G	A	20	42	32	27	53	14	0.44	0.57	0.56	0.43	A	0.044	0.017683841	Height	General health
rs3890745	T	C	31	44	19	12	57	25	0.56	0.43	0.44	0.57	T	1.12	0.017683841	Rheumatoid arthritis	Immune diseases and disorders
rs9898	C	T	31	44	19	22	37	35	0.56	0.43	0.44	0.57	T	0.26	0.017683841	Activated partial thromboplastin time	Heart health and disorders
rs365836	A	G	45	42	7	32	44	18	0.70	0.57	0.30	0.43	A	4.79	0.017647059	Response to antidepressants	General health
rs2957692	A	G	48	36	10	25	58	11	0.70	0.57	0.30	0.43	G	0.015	0.017647059	Circulating vasoactive peptide levels	Immune diseases and disorders
rs11264736	C	T	17	35	42	6	34	54	0.37	0.24	0.63	0.76	T	98.69	0.017624521	Lentiform nucleus volume	Misc
rs17784882	C	A	37	45	12	52	38	4	0.63	0.76	0.37	0.24	A	0.54	0.017624521	QT interval	Heart health and disorders
rs10516430	C	T	62	26	6	74	20	0	0.80	0.89	0.20	0.11	A	0.16	0.017566688	Biochemical measures	General health
rs4642619	T	A	68	24	2	53	34	7	0.85	0.74	0.15	0.26	A	1.09	0.01754386	Schizophrenia	Brain health and disorders
rs12325245	A	T	51	38	5	68	24	2	0.74	0.85	0.26	0.15	T	1.0869565	0.01754386	Schizophrenia	Brain health and disorders
rs871392	C	T	50	40	4	68	24	2	0.74	0.85	0.26	0.15	A	0.26	0.01754386	Biochemical measures	General health
rs9895232	T	C	49	36	9	61	33	0	0.71	0.82	0.29	0.18	C	1.62	0.017539673	Proteinuria and chronic kidney disease	General health
rs1250544	G	A	45	44	5	63	29	2	0.71	0.82	0.29	0.18	G	1.16	0.017539673	Crohn's disease and psoriasis	Digestive system and its disorders
rs13041247	T	C	27	53	14	45	41	8	0.57	0.70	0.43	0.30	T	1.32	0.01753745	Nonsyndromic cleft lip with or without cleft palate	Misc
rs35964523	C	T	30	47	17	45	41	8	0.57	0.70	0.43	0.30	T	1	0.01753745	Response to statin therapy	General health
rs11031436	A	T	49	33	12	29	49	16	0.70	0.57	0.30	0.43	T	0.033	0.01753745	Optic disc area	Misc
rs10791097	T	G	19	43	32	7	43	44	0.43	0.30	0.57	0.70	T	1.08	0.01753745	Schizophrenia	Brain health and disorders
rs12712127	A	G	15	51	28	7	43	44	0.43	0.30	0.57	0.70	A	0.006	0.01753745	Fibrinogen	General health
rs3204689	G	C	44	39	11	60	29	5	0.68	0.79	0.32	0.21	C	1.46	0.017536232	Osteoarthritis hand, severe	Immune diseases and disorders
rs10214930	G	A	42	43	9	61	27	6	0.68	0.79	0.32	0.21	G	1.33	0.017536232	Hypospadias	Misc
rs3000073	G	A	60	29	5	41	45	8	0.79	0.68	0.21	0.32	G	0.007	0.017536232	Mean platelet volume	Heart health and disorders
rs871913	G	A	66	26	2	80	14	0	0.84	0.93	0.16	0.07	A	1.86	0.017524644	Yu-Zhi constitution type in type 2 diabetes	Diabetes
rs10108033	T	C	3	24	67	1	12	81	0.16	0.07	0.84	0.93	C	2.9565	0.017524644	IgG glycosylation	Immune diseases and disorders
rs2524054	A	C	3	24	67	1	12	81	0.16	0.07	0.84	0.93	A	0.37	0.017524644	CD4:CD8 lymphocyte ratio	Immune diseases and disorders
rs6457374	C	T	3	24	67	1	12	81	0.16	0.07	0.84	0.93	T	0.041	0.017524644	Height	General health
rs115882204	C	T	93	1	0	86	7	1	0.99	0.95	0.01	0.05	A	34.08	0.017486339	Diisocyanate-induced asthma	Pulmonology
rs17244419	C	T	85	9	0	93	1	0	0.95	0.99	0.05	0.01	T	8.6504	0.017486339	Cognitive function	Brain health and disorders
rs17636071	T	C	85	9	0	93	1	0	0.95	0.99	0.05	0.01	G	4.74	0.017486339	Response to cholinesterase inhibitors in Alzheimer's disease	Brain health and disorders
rs114931935	G	A	86	7	1	93	1	0	0.95	0.99	0.05	0.01	A	1.88	0.017486339	Chronic bronchitis in chronic obstructive pulmonary disease	Pulmonology
rs11568995	G	A	93	1	0	85	9	0	0.99	0.95	0.01	0.05	G	1.802	0.017486339	IgG glycosylation	Immune diseases and disorders
rs527430	G	A	93	1	0	85	9	0	0.99	0.95	0.01	0.05	G	1	0.017486339	Response to anti-depressant treatment in major depressive disorder	General health
rs11745890	T	C	85	9	0	93	1	0	0.95	0.99	0.05	0.01	C	0.5502	0.017486339	IgG glycosylation	Immune diseases and disorders
rs17823642	C	T	85	9	0	93	1	0	0.95	0.99	0.05	0.01	C	0.38	0.017486339	Metabolite levels	General health
rs12193446	A	G	85	9	0	93	1	0	0.95	0.99	0.05	0.01	A	0.1219	0.017486339	Axial length	Misc
rs77124415	C	G	85	9	0	93	1	0	0.95	0.99	0.05	0.01	C	0.059	0.017486339	Neuroticism	Brain health and disorders
rs11264330	G	A	93	1	0	85	9	0	0.99	0.95	0.01	0.05	A	0.04	0.017486339	Obesity-related traits	Obesity
rs6413458	G	A	93	1	0	85	9	0	0.99	0.95	0.01	0.05	T	0.0398	0.017486339	Lipoprotein-associated phospholipase A2 activity and mass	General health
rs3751845	G	A	93	1	0	85	9	0	0.99	0.95	0.01	0.05	A	0.03	0.017486339	Obesity-related traits	Obesity
rs12079716	T	G	93	1	0	85	9	0	0.99	0.95	0.01	0.05	C	0.03	0.017486339	Obesity-related traits	Obesity
rs13373941	T	G	93	1	0	85	9	0	0.99	0.95	0.01	0.05	C	0.03	0.017486339	Obesity-related traits	Obesity
rs2071214	G	A	0	9	85	0	1	93	0.05	0.01	0.95	0.99	G	1	0.017486339	Behavioural disinhibition generation interaction	Brain health and disorders
rs3104402	T	G	1	7	86	0	1	93	0.05	0.01	0.95	0.99	A	0.165	0.017486339	Immune response to anthrax vaccine	Immune diseases and disorders
rs3741240	G	A	41	36	17	54	33	7	0.63	0.75	0.37	0.25	A	1	0.017457017	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs6050	T	C	52	37	5	36	46	12	0.75	0.63	0.25	0.37	C	0.26	0.017457017	Fibrinogen	General health
rs6986	G	C	52	37	5	33	52	9	0.75	0.63	0.25	0.37	C	0.0079	0.017457017	Trans fatty acid levels	General health
rs275856	A	T	72	20	2	56	33	5	0.87	0.77	0.13	0.23	T	1.51	0.017437086	Type 2 diabetes	Diabetes
rs6073958	T	C	70	24	0	56	33	5	0.87	0.77	0.13	0.23	C	0.068	0.017437086	Triglycerides	General health
rs4722750	C	T	78	15	1	63	28	3	0.91	0.82	0.09	0.18	T	31.88	0.017435897	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs11255615	T	C	64	26	4	77	17	0	0.82	0.91	0.18	0.09	G	2.4	0.017435897	Adverse response to chemotherapy in breast cancer alopecia anti-microtubule	General health
rs7904985	G	A	66	22	6	77	17	0	0.82	0.91	0.18	0.09	T	1.17	0.017435897	Barrett's esophagus	Digestive system and its disorders
rs17025548	A	G	78	15	1	64	26	4	0.91	0.82	0.09	0.18	G	0.1954	0.017435897	IgG glycosylation	Immune diseases and disorders
rs12449664	G	A	63	28	3	77	17	0	0.82	0.91	0.18	0.09		0.15	0.017435897	Percentage gas trapping	Misc
rs3916164	G	A	65	24	5	78	15	1	0.82	0.91	0.18	0.09	G	0.008	0.017435897	Red blood cell traits	Immune diseases and disorders
rs17178006	T	G	81	13	0	92	1	1	0.93	0.98	0.07	0.02	G	123.8	0.017361111	Hippocampal volume	Brain health and disorders
rs16856202	T	G	81	13	0	91	3	0	0.93	0.98	0.07	0.02	C	2	0.017361111	Amyotrophic lateral sclerosis	Brain health and disorders
rs13098911	C	T	83	9	2	91	3	0	0.93	0.98	0.07	0.02	A	1.3	0.017361111	Celiac disease	Immune diseases and disorders
rs6702784	A	C	81	13	0	91	3	0	0.93	0.98	0.07	0.02	C	1.08	0.017361111	Diabetic retinopathy	Diabetes
rs17261688	A	G	81	13	0	91	3	0	0.93	0.98	0.07	0.02	G	1	0.017361111	DNA methylation variation	Misc
rs16909318	C	A	91	3	0	81	13	0	0.98	0.93	0.02	0.07	C	1	0.017361111	Visceral fat	Obesity
rs326155	A	G	91	3	0	81	13	0	0.98	0.93	0.02	0.07	G	1	0.017361111	Visceral fat	Obesity
rs79811809	A	G	82	11	1	91	3	0	0.93	0.98	0.07	0.02	A	0.2394	0.017361111	Cerebrospinal T-tau levels	Brain health and disorders
rs71413769	A	G	81	13	0	91	3	0	0.93	0.98	0.07	0.02	G	0.11	0.017361111	Glomerular filtration rate in chronic kidney disease	General health
rs7899106	A	G	91	3	0	82	11	1	0.98	0.93	0.02	0.07	G	0.044	0.017361111	Body mass index	Obesity
rs13177718	C	T	81	13	0	91	3	0	0.93	0.98	0.07	0.02	T	0.043	0.017361111	Height	General health
rs545099	C	T	0	3	91	0	13	81	0.02	0.07	0.98	0.93	C	0.2	0.017361111	Age-related nuclear cataracts	Aging
rs17582416	T	G	43	40	11	59	30	5	0.67	0.79	0.33	0.21	G	1.16	0.017317876	Crohn's disease	Digestive system and its disorders
rs11949289	G	A	41	44	9	59	30	5	0.67	0.79	0.33	0.21	T	1	0.017317876	Response to anti-depressant treatment in major depressive disorder	General health
rs10914144	T	C	3	34	57	10	42	42	0.21	0.33	0.79	0.67	T	3.417	0.017317876	Platelet count	Heart health and disorders
rs6726538	T	A	9	44	41	4	32	58	0.33	0.21	0.67	0.79	A	1.946	0.017317876	Cervical cancer	Cancer
rs6903608	C	T	4	32	58	12	38	44	0.21	0.33	0.79	0.67	G	1.7	0.017317876	Hodgkin's lymphoma	Cancer
rs3733585	A	G	40	37	17	52	36	6	0.62	0.74	0.38	0.26	C	2.58	0.017297191	Cleft plate environmental tobacco smoke interaction	Mental aptitude and behavioural traits
rs10498712	A	G	61	32	1	47	39	8	0.82	0.71	0.18	0.29	G	0.23	0.017265004	Quantitative traits	Misc
rs1673866	C	T	46	41	7	62	30	2	0.71	0.82	0.29	0.18	C	0.1439	0.017265004	IgG glycosylation	Immune diseases and disorders
rs864745	T	C	34	36	24	44	40	10	0.55	0.68	0.45	0.32	T	1.087	0.017241379	Crohn's disease	Digestive system and its disorders
rs34394770	T	C	51	37	6	66	27	1	0.74	0.85	0.26	0.15	T	1.16	0.017208742	Psoriasis	Immune diseases and disorders
rs11696845	C	T	54	31	9	67	25	2	0.74	0.85	0.26	0.15	A	0.03	0.017208742	Obesity-related traits	Obesity
rs11947645	G	A	92	2	0	83	11	0	0.99	0.94	0.01	0.06	A	5.329	0.017164654	Social autistic-like traits	Brain health and disorders
rs17348202	T	C	84	9	1	92	2	0	0.94	0.99	0.06	0.01	G	4.85	0.017164654	Paclitaxel-induced neuropathy	Brain health and disorders
rs9869689	C	T	83	11	0	92	2	0	0.94	0.99	0.06	0.01	T	1.21	0.017164654	Alzheimer's disease in APOE e4+ carriers	Brain health and disorders
rs13126505	G	A	83	11	0	92	2	0	0.94	0.99	0.06	0.01	A	1.172	0.017164654	Crohn's disease	Digestive system and its disorders
rs17154929	C	T	84	9	1	92	2	0	0.94	0.99	0.06	0.01	T	1	0.017164654	HIV-associated dementia	Brain health and disorders
rs12247397	A	G	92	2	0	84	9	1	0.99	0.94	0.01	0.06	G	1	0.017164654	Immune reponse to smallpox secreted IL-1beta	Immune diseases and disorders
rs10499138	A	T	92	2	0	83	11	0	0.99	0.94	0.01	0.06	A	1	0.017164654	Hearing impairment	General health
rs17763769	G	A	83	11	0	92	2	0	0.94	0.99	0.06	0.01	A	0.89	0.017164654	QT interval	Heart health and disorders
rs13272236	A	G	84	9	1	92	2	0	0.94	0.99	0.06	0.01	G	0.8377	0.017164654	IgG glycosylation	Immune diseases and disorders
rs17083533	G	A	83	11	0	92	2	0	0.94	0.99	0.06	0.01	A	0.74	0.017164654	Heart rate	General health
rs12518614	A	G	83	11	0	92	2	0	0.94	0.99	0.06	0.01	A	0.463	0.017164654	End-stage coagulation	General health
rs148915469	A	C	83	11	0	92	2	0	0.94	0.99	0.06	0.01	C	0.279	0.017164654	Eating disorders	Brain health and disorders
rs13107325	C	T	83	11	0	92	2	0	0.94	0.99	0.06	0.01	T	0.19	0.017164654	Body mass index	Obesity
rs115400054	C	T	83	11	0	92	2	0	0.94	0.99	0.06	0.01	C	0.054	0.017164654	Cholesterol, total	General health
rs10455872	A	G	84	9	1	93	0	1	0.94	0.99	0.06	0.01	G	0.052	0.017164654	Response to statins LDL cholesterol change	General health
rs17823744	A	G	83	11	0	92	2	0	0.94	0.99	0.06	0.01	A	0.045	0.017164654	Toenail selenium levels	Misc
rs10107366	T	C	92	2	0	83	11	0	0.99	0.94	0.01	0.06	G	0.04	0.017164654	Obesity-related traits	Obesity
rs4252023	C	T	93	0	1	85	7	2	0.99	0.94	0.01	0.06	A	0.03	0.017164654	Obesity-related traits	Obesity
rs2691543	C	T	0	11	83	0	2	92	0.06	0.01	0.94	0.99	T	3.45	0.017164654	Height	General health
rs6939321	T	C	0	2	92	0	11	83	0.01	0.06	0.99	0.94	C	0.16	0.017164654	Metabolite levels Pyroglutamine	General health
rs2143963	C	T	0	2	92	0	11	83	0.01	0.06	0.99	0.94	C	0.07	0.017164654	Metabolite levels  X-11787	General health
rs12733856	C	A	47	33	14	29	45	20	0.68	0.55	0.32	0.45	A	1.56	0.017153067	Mortality in heart failure	Heart health and disorders
rs7727544	C	T	26	51	17	43	41	10	0.55	0.68	0.45	0.32	T	0.015	0.017153067	Blood metabolite levels	Heart health and disorders
rs6049839	G	T	37	42	15	51	37	6	0.62	0.74	0.38	0.26	T	1.37	0.017144709	Systemic lupus erythematosus	Immune diseases and disorders
rs10178409	G	T	54	31	9	31	54	9	0.74	0.62	0.26	0.38	T	0.1988	0.017144709	Urinary metabolites	General health
rs41360247	T	C	82	12	0	69	23	2	0.94	0.86	0.06	0.14	C	14	0.017119379	Phytosterol levels	General health
rs55798256	A	G	83	10	1	67	27	0	0.94	0.86	0.06	0.14	G	3.1	0.017119379	Diisocyanate-induced asthma	Pulmonology
rs4530903	C	T	68	25	1	82	12	0	0.86	0.94	0.14	0.06	T	1.93	0.017119379	Lymphoma	Cancer
rs12576775	A	G	82	12	0	70	21	3	0.94	0.86	0.06	0.14	G	1.14	0.017119379	Bipolar disorder	Brain health and disorders
rs17691394	A	G	68	25	1	83	10	1	0.86	0.94	0.14	0.06	G	1	0.017119379	Carotid atherosclerosis in HIV infection	Heart health and disorders
rs9845475	T	G	68	25	1	82	12	0	0.86	0.94	0.14	0.06	G	1	0.017119379	Attention deficit hyperactivity disorder time to onset	Brain health and disorders
rs1791581	G	A	70	21	3	83	10	1	0.86	0.94	0.14	0.06	A	1	0.017119379	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs12829704	G	A	71	19	4	82	12	0	0.86	0.94	0.14	0.06	A	0.042	0.017119379	Blood metabolite levels	Heart health and disorders
rs10260606	G	C	56	35	3	42	41	11	0.78	0.66	0.22	0.34	C	0.05	0.017109729	Cholesterol, total	General health
rs315553	G	T	4	33	57	13	37	44	0.22	0.34	0.78	0.66	C	0.05	0.017109729	Obesity-related traits	Obesity
rs17212223	C	T	74	19	1	57	35	2	0.89	0.79	0.11	0.21	T	1.95	0.017088608	Narcolepsy age of onset	Brain health and disorders
rs8074980	G	A	75	17	2	58	33	3	0.89	0.79	0.11	0.21	A	0.5238	0.017088608	Hippocampal sclerosis	Brain health and disorders
rs2122469	G	A	77	16	1	88	6	0	0.90	0.97	0.10	0.03	C	18.57	0.017045455	Serum tamsulosin hydrochloride concentration	General health
rs10143078	A	C	88	6	0	77	16	1	0.97	0.90	0.03	0.10	C	4.06	0.017045455	Blood pressure	Heart health and disorders
rs17150703	G	A	76	18	0	88	6	0	0.90	0.97	0.10	0.03	A	1.18	0.017045455	Obesity early onset extreme	Obesity
rs614226	C	T	70	23	1	57	30	7	0.87	0.77	0.13	0.23	C	1.35	0.017041968	Type 1 diabetes nephropathy	Diabetes
rs2488389	G	A	70	23	1	55	34	5	0.87	0.77	0.13	0.23	A	1.1191661	0.017041968	Crohn's disease	Digestive system and its disorders
rs16992796	A	G	71	21	2	56	32	6	0.87	0.77	0.13	0.23	G	0.236	0.017041968	Electroencephalographic traits in alcoholism	Heart health and disorders
rs2681416	G	A	51	30	13	61	31	2	0.70	0.81	0.30	0.19	A	1.16	0.017004049	Diffuse large B cell lymphoma	Cancer
rs2797685	C	T	59	35	0	46	40	8	0.81	0.70	0.19	0.30	A	1.05	0.017004049	Crohn's disease	Digestive system and its disorders
rs2999399	C	T	8	34	52	17	39	38	0.27	0.39	0.73	0.61	T	1.47	0.016999261	Emphysema-related traits	Pulmonology
rs255758	C	A	9	32	53	15	43	36	0.27	0.39	0.73	0.61	C	1.42	0.016999261	Rheumatoid arthritis	Immune diseases and disorders
rs6834538	T	C	5	40	49	13	47	34	0.27	0.39	0.73	0.61	T	0.296	0.016999261	Free thyroxine concentration	General health
rs6601764	C	T	24	53	17	42	41	11	0.54	0.66	0.46	0.34	C	1.16	0.01699115	Crohn's disease	Digestive system and its disorders
rs9993810	G	A	44	37	13	22	57	15	0.66	0.54	0.34	0.46	A	0.008	0.01699115	Magnesium levels	General health
rs4810685	T	C	21	46	27	7	50	37	0.47	0.34	0.53	0.66	C	1	0.016917293	Attention deficit hyperactivity disorder time to onset	Brain health and disorders
rs650950	T	C	10	44	40	4	34	56	0.34	0.22	0.66	0.78	G	1.55	0.016911251	Bronchopulmonary dysplasia	Pulmonology
rs6863411	A	T	7	50	37	8	26	60	0.34	0.22	0.66	0.78	A	1.1018033	0.016911251	Crohn's disease	Digestive system and its disorders
rs1062158	C	T	7	50	37	8	26	60	0.34	0.22	0.66	0.78	A	1.08	0.016911251	Multiple sclerosis	Brain health and disorders
rs4243971	T	G	11	42	41	5	32	57	0.34	0.22	0.66	0.78	A	1.0574708	0.016911251	Crohn's disease	Digestive system and its disorders
rs6102059	C	T	57	32	5	43	38	13	0.78	0.66	0.22	0.34	T	0.06	0.016911251	LDL cholesterol	General health
rs822552	C	G	57	32	5	39	46	9	0.78	0.66	0.22	0.34	C	0.025	0.016911251	Height	General health
rs2181540	T	C	76	18	0	61	31	2	0.90	0.81	0.10	0.19	T	0.834	0.016881827	End-stage coagulation	General health
rs11226373	A	G	77	16	1	63	27	4	0.90	0.81	0.10	0.19	G	0.44	0.016881827	Matrix metalloproteinase levels	Cancer
rs17723470	C	T	65	23	6	76	18	0	0.81	0.90	0.19	0.10	T	0.069	0.016881827	Thyroid hormone levels	General health
rs1012053	C	A	1	33	60	1	16	77	0.19	0.10	0.81	0.90	A	1.59	0.016881827	Bipolar disorder	Brain health and disorders
rs7801190	C	G	79	15	0	64	29	1	0.92	0.84	0.08	0.16	C	1.31	0.016864295	Hypertension	Heart health and disorders
rs10797576	C	T	66	25	3	80	13	1	0.84	0.92	0.16	0.08	T	1.131	0.016864295	Parkinson's disease	Brain health and disorders
rs13273123	A	G	67	23	4	80	13	1	0.84	0.92	0.16	0.08	G	0.71	0.016864295	Height	General health
rs7235840	C	T	67	23	4	80	13	1	0.84	0.92	0.16	0.08	T	0.5571	0.016864295	Hippocampal sclerosis	Brain health and disorders
rs2782980	T	C	9	33	52	13	48	33	0.27	0.39	0.73	0.61	T	0.338	0.016860558	Blood pressure	Heart health and disorders
rs11995854	T	G	47	43	4	30	54	10	0.73	0.61	0.27	0.39	C	0.04	0.016860558	Obesity-related traits	Obesity
rs2327832	A	G	72	20	2	84	10	0	0.87	0.95	0.13	0.05	G	1.23	0.016855865	Celiac disease	Immune diseases and disorders
rs4756846	T	C	71	22	1	84	10	0	0.87	0.95	0.13	0.05	C	1	0.016855865	Obesity and osteoporosis	Obesity
rs12520016	T	G	85	8	1	71	22	1	0.95	0.87	0.05	0.13	G	0.42	0.016855865	Eye color	Appearance
rs1481012	A	G	70	24	0	84	10	0	0.87	0.95	0.13	0.05	G	0.136	0.016855865	Urate levels in obese individuals	Obesity
rs17166496	G	C	27	45	22	38	47	9	0.53	0.65	0.47	0.35	G	1.3	0.016848017	Type 1 diabetes	Diabetes
rs2273359	C	G	74	19	1	86	8	0	0.89	0.96	0.11	0.04	C	8.15	0.016794197	Response to diuretic therapy in hypertension	General health
rs12051723	G	T	74	19	1	86	8	0	0.89	0.96	0.11	0.04	T	2.2	0.016794197	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	General health
rs59824868	C	A	86	8	0	74	19	1	0.96	0.89	0.04	0.11	A	2.12	0.016794197	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs733208	G	A	73	21	0	86	8	0	0.89	0.96	0.11	0.04	A	1.435	0.016794197	Thyroid peroxidase antibody positivity	Immune diseases and disorders
rs7072055	C	A	75	17	2	86	8	0	0.89	0.96	0.11	0.04	C	0.2045	0.016794197	IgG glycosylation	Immune diseases and disorders
rs118146573	G	A	74	19	1	86	8	0	0.89	0.96	0.11	0.04	A	0.2	0.016794197	Cholesterol, total	General health
rs2729313	C	T	86	8	0	74	19	1	0.96	0.89	0.04	0.11	T	0.169	0.016794197	Asymmetrical dimethylarginine levels	General health
rs3800993	C	T	86	8	0	74	19	1	0.96	0.89	0.04	0.11	T	0.029	0.016794197	Blood metabolite levels	Heart health and disorders
rs6774852	C	T	1	19	74	0	8	86	0.11	0.04	0.89	0.96	G	0.03	0.016794197	Obesity-related traits	Obesity
rs2059238	A	C	0	21	73	0	8	86	0.11	0.04	0.89	0.96	A	0.02	0.016794197	Cardiac structure and function	Heart health and disorders
rs6894268	A	G	14	38	42	23	44	27	0.35	0.48	0.65	0.52	A	1.439	0.016783217	Eating disorders	Brain health and disorders
rs4493441	G	A	22	46	26	13	40	41	0.48	0.35	0.52	0.65	G	0.087	0.016783217	Economic and political preferences environmentalism	Mental aptitude and behavioural traits
rs7577599	T	C	60	32	2	47	37	10	0.81	0.70	0.19	0.30	A	1.43	0.016755956	Multiple myeloma IgH translocation	Cancer
rs11613331	G	A	36	41	17	46	44	4	0.60	0.72	0.40	0.28	A	0.037	0.016728331	Blood metabolite levels	Heart health and disorders
rs751008	G	A	33	47	14	52	32	10	0.60	0.72	0.40	0.28	A	0.02	0.016728331	Body mass index	Obesity
rs2828520	G	A	9	34	51	15	45	34	0.28	0.40	0.72	0.60	G	1.35	0.016728331	Major depressive disorder	Brain health and disorders
rs782590	C	T	23	51	20	33	55	6	0.52	0.64	0.48	0.36	T	0.09	0.016722796	Metabolic syndrome	Immune diseases and disorders
rs1440581	T	C	18	55	21	13	41	40	0.48	0.36	0.52	0.64	T	0.014	0.016722796	Blood metabolite levels	Heart health and disorders
rs6538678	A	G	11	43	40	7	29	58	0.35	0.23	0.65	0.77	A	1.57	0.016721946	Lupus nephritis in systemic lupus erythematosus	Immune diseases and disorders
rs2289700	C	T	57	31	6	36	51	7	0.77	0.65	0.23	0.35	A	2.13	0.016721946	Bipolar disorder	Brain health and disorders
rs2163237	C	T	39	45	10	55	35	4	0.65	0.77	0.35	0.23	C	0.1519	0.016721946	IgG glycosylation	Immune diseases and disorders
rs3771514	G	A	56	33	5	39	45	10	0.77	0.65	0.23	0.35	A	0.03	0.016721946	Obesity-related traits	Obesity
rs12722987	C	A	70	22	2	55	33	6	0.86	0.76	0.14	0.24	A	0.03	0.016670515	Obesity-related traits	Obesity
rs2537859	C	T	24	44	26	14	40	40	0.49	0.36	0.51	0.64	T	1.16	0.016666667	Bipolar disorder	Brain health and disorders
rs7395581	G	A	18	32	44	21	50	23	0.36	0.49	0.64	0.51	G	0.059	0.016666667	HDL cholesterol	General health
rs11221332	C	T	59	30	5	74	18	2	0.79	0.88	0.21	0.12	A	1.21	0.016642696	Celiac disease	Immune diseases and disorders
rs12444268	T	A	60	28	6	73	20	1	0.79	0.88	0.21	0.12	A	1.1	0.016642696	Type 1 diabetes	Diabetes
rs17381785	T	C	60	28	6	73	20	1	0.79	0.88	0.21	0.12	C	0.054	0.016642696	Urate levels in overweight individuals	Obesity
rs6453429	T	C	7	26	61	1	20	73	0.21	0.12	0.79	0.88	T	0.1918	0.016642696	Urinary metabolites	General health
rs10174573	C	T	25	45	24	34	51	9	0.51	0.63	0.49	0.37	T	1.564	0.016614746	Major depressive disorder	Brain health and disorders
rs10136766	A	G	22	51	21	31	57	6	0.51	0.63	0.49	0.37	A	0.229	0.016614746	IgG levels	Immune diseases and disorders
rs10262453	A	C	32	48	14	45	45	4	0.60	0.72	0.40	0.28	A	4.17	0.016602329	Sagittal craniosynostosis	Heart health and disorders
rs1727638	G	A	15	46	33	5	43	46	0.40	0.28	0.60	0.72	A	1	0.016602329	Cerebrospinal AB1-42 levels	Brain health and disorders
rs4794822	C	T	34	44	16	48	39	7	0.60	0.72	0.40	0.28	C	0.1	0.016602329	Neutrophil count	Immune diseases and disorders
rs12478296	C	T	48	39	7	38	36	20	0.72	0.60	0.28	0.40	A	0.03	0.016602329	Obesity-related traits	Obesity
rs12666870	T	C	47	43	4	66	25	3	0.73	0.84	0.27	0.16	G	0.04	0.016592003	Obesity-related traits	Obesity
rs6945749	G	C	6	39	49	3	25	66	0.27	0.16	0.73	0.84	C	4.554	0.016592003	Very long-chain saturated fatty acid levels fatty acid 22:0	General health
rs1192415	G	A	7	37	50	1	29	64	0.27	0.16	0.73	0.84	G	0.0959	0.016592003	Optic disc area	Misc
rs6002655	C	T	27	40	27	12	46	36	0.50	0.37	0.50	0.63	T	1.07	0.016566958	Schizophrenia	Brain health and disorders
rs3736830	G	C	12	46	36	25	44	25	0.37	0.50	0.63	0.50	G	0.18	0.016566958	Menopause age at onset	Reproductive health
rs2535633	C	G	26	42	26	14	42	38	0.50	0.37	0.50	0.63	G	0.0288	0.016566958	Body mass index	Obesity
rs204999	A	G	57	30	7	38	46	10	0.77	0.65	0.23	0.35	G	2.44	0.016541353	Idiopathic membranous nephropathy	Brain health and disorders
rs543844	A	G	13	40	41	5	34	55	0.35	0.23	0.65	0.77	G	1.06	0.016541353	Migraine	Brain health and disorders
rs1297265	A	G	36	45	13	19	55	20	0.62	0.49	0.38	0.51	A	1.11	0.016523236	Ulcerative colitis	Immune diseases and disorders
rs2018916	C	T	10	51	33	25	45	24	0.38	0.51	0.62	0.49	C	1.0638298	0.016523236	Schizophrenia	Brain health and disorders
rs2555155	G	A	25	45	24	14	43	37	0.51	0.38	0.49	0.62	G	1	0.016523236	DNA methylation variation	Misc
rs2963826	C	T	44	42	8	63	25	6	0.69	0.80	0.31	0.20	A	0.03	0.016519948	Obesity-related traits	Obesity
rs10937355	C	T	49	32	13	59	33	2	0.69	0.80	0.31	0.20	A	0.03	0.016519948	Obesity-related traits	Obesity
rs2326458	C	A	11	50	33	27	42	25	0.38	0.51	0.62	0.49	C	5.1	0.016483516	Height	General health
rs4849965	A	C	34	48	12	24	44	26	0.62	0.49	0.38	0.51	C	1.5	0.016483516	Diabetic kidney disease	Diabetes
rs6601327	G	A	17	38	39	28	40	26	0.38	0.51	0.62	0.49	G	1.27	0.016483516	Multiple myeloma hyperdiploidy	Cancer
rs2466024	G	A	26	44	24	14	44	36	0.51	0.38	0.49	0.62	A	1.21	0.016483516	Chronic lymphocytic leukemia	Cancer
rs10440635	G	A	23	50	21	12	48	34	0.51	0.38	0.49	0.62	A	1	0.016483516	Ankylosing spondylitis	Immune diseases and disorders
rs1943940	T	C	19	54	21	32	52	10	0.49	0.62	0.51	0.38	C	0.106	0.016483516	Mean arterial pressure alcohol consumption interaction	General health
rs459193	A	G	6	42	46	16	45	33	0.29	0.41	0.71	0.59	A	0.0325	0.016482318	Waist-to-hip ratio adjusted for body mass index	Obesity
rs10908458	T	C	19	53	22	31	53	10	0.48	0.61	0.52	0.39	T	3.7	0.016447744	Liver enzyme levels gamma-glutamyl transferase	General health
rs12239046	T	C	13	48	33	27	44	23	0.39	0.52	0.61	0.48	C	0.047	0.016415869	C-reactive protein levels	Immune diseases and disorders
rs6424555	T	C	15	45	34	24	51	19	0.40	0.53	0.60	0.47	T	1.05	0.016387846	Schizophrenia	Brain health and disorders
rs1041449	A	G	24	41	29	28	57	9	0.47	0.60	0.53	0.40	G	1.06	0.016387846	Prostate cancer	Cancer
rs7309	G	A	19	51	24	33	47	14	0.47	0.60	0.53	0.40	A	0.088	0.016387846	Educational attainment	Mental aptitude and behavioural traits
rs35681285	T	C	81	13	0	69	22	3	0.93	0.85	0.07	0.15	T	16.75	0.016381507	Serum tamsulosin hydrochloride concentration	General health
rs16830728	G	T	81	13	0	69	22	3	0.93	0.85	0.07	0.15	T	3.61	0.016381507	Adverse response to chemotherapy in breast cancer alopecia	General health
rs3747767	C	A	69	22	3	81	13	0	0.85	0.93	0.15	0.07	A	1.81	0.016381507	Hoarding	Misc
rs111577701	C	T	81	13	0	68	24	2	0.93	0.85	0.07	0.15	C	1.16	0.016381507	Epilepsy	Brain health and disorders
rs167890	G	A	81	13	0	66	28	0	0.93	0.85	0.07	0.15	A	1	0.016381507	Obesity-related traits	Obesity
rs10255299	G	A	81	13	0	69	22	3	0.93	0.85	0.07	0.15	G	0.241	0.016381507	C-reactive protein and white blood cell count	Immune diseases and disorders
rs17158675	G	A	82	11	1	69	22	3	0.93	0.85	0.07	0.15	A	0.03	0.016381507	Obesity-related traits	Obesity
rs2119704	C	A	76	17	1	64	24	6	0.90	0.81	0.10	0.19	C	1.22	0.0163693	Multiple sclerosis	Brain health and disorders
rs3763312	G	A	62	28	4	77	15	2	0.81	0.90	0.19	0.10	A	0.4002	0.0163693	HIV-1 viral setpoint	Immune diseases and disorders
rs16851483	G	T	62	28	4	75	19	0	0.81	0.90	0.19	0.10	T	0.052	0.0163693	Body mass index	Obesity
rs215614	G	A	6	33	55	8	51	35	0.24	0.36	0.76	0.64	G	0.22	0.016369048	Smoking behavior	General health
rs157935	T	G	43	35	16	53	37	4	0.64	0.76	0.36	0.24	T	1.23	0.016369048	Basal cell carcinoma	Cancer
rs11781551	G	A	40	41	13	55	33	6	0.64	0.76	0.36	0.24	A	0.0078	0.016369048	Carotid intima media thickness	Heart health and disorders
rs7521492	A	G	10	35	49	13	52	29	0.29	0.41	0.71	0.59	A	1.06	0.016368081	Schizophrenia	Brain health and disorders
rs4625554	A	G	33	44	17	47	39	8	0.59	0.71	0.41	0.29	G	0.1927	0.016368081	Major depressive disorder	Brain health and disorders
rs397969	T	C	35	42	17	19	50	25	0.60	0.47	0.40	0.53	C	2.131	0.016363636	Platelet count	Heart health and disorders
rs852069	A	G	21	46	27	36	40	18	0.47	0.60	0.53	0.40	G	0.04	0.016363636	Menarche age at onset	Reproductive health
rs2076295	T	G	32	47	15	22	43	29	0.59	0.46	0.41	0.54	G	1.43	0.016343207	Interstitial lung disease	Pulmonology
rs10486722	C	T	18	51	25	33	45	16	0.46	0.59	0.54	0.41	C	1.215	0.016343207	Pit-and-Fissure caries	Misc
rs989197	T	C	20	47	27	31	49	14	0.46	0.59	0.54	0.41	T	1.05	0.016343207	Schizophrenia	Brain health and disorders
rs559555	T	A	16	45	33	29	43	22	0.41	0.54	0.59	0.46	A	0.036	0.016343207	Blood metabolite ratios	Heart health and disorders
rs7719829	A	G	13	51	30	30	41	23	0.41	0.54	0.59	0.46	A	0.03	0.016343207	Obesity-related traits	Obesity
rs142463603	A	C	16	46	32	28	46	20	0.41	0.54	0.59	0.46	A	1.18	0.016326531	Prostate cancer	Cancer
rs1712517	C	T	29	52	13	21	44	29	0.59	0.46	0.41	0.54	T	1.13	0.016326531	Migraine	Brain health and disorders
rs2816958	A	G	1	25	68	6	34	54	0.14	0.24	0.86	0.76	G	1.23	0.01632081	Ulcerative colitis	Immune diseases and disorders
rs16953002	G	A	68	25	1	57	28	9	0.86	0.76	0.14	0.24	A	1.16	0.01632081	Melanoma	Cancer
rs1441756	A	C	54	34	6	68	25	1	0.76	0.86	0.24	0.14	G	0.18	0.01632081	Metabolic syndrome bivariate traits	Immune diseases and disorders
rs683250	A	G	21	43	30	30	49	15	0.45	0.58	0.55	0.42	A	27.95	0.016313583	Subcortical brain region volumes	Brain health and disorders
rs2738058	T	C	28	47	19	19	41	34	0.55	0.42	0.45	0.58	T	1.267	0.016313583	IgA nephropathy	Immune diseases and disorders
rs3761959	C	T	29	45	20	19	41	34	0.55	0.42	0.45	0.58	A	1.23	0.016313583	Graves' disease	Immune diseases and disorders
rs10789369	A	G	29	45	20	18	43	33	0.55	0.42	0.45	0.58	A	1.095	0.016313583	Schizophrenia	Brain health and disorders
rs10858945	A	G	31	47	16	13	59	22	0.58	0.45	0.42	0.55	A	0.171	0.016313583	Optic nerve measurement cup area	Misc
rs4856162	G	A	28	47	19	22	35	37	0.55	0.42	0.45	0.58	G	0.091	0.016313583	Economic and political preferences environmentalism	Mental aptitude and behavioural traits
rs12618769	C	T	66	24	4	46	44	4	0.83	0.72	0.17	0.28	T	1.25	0.016307893	Bipolar disorder	Brain health and disorders
rs710521	T	C	46	44	4	65	26	3	0.72	0.83	0.28	0.17	A	1.19	0.016307893	Urinary bladder cancer	Cancer
rs3131888	T	C	18	48	28	28	52	14	0.45	0.57	0.55	0.43	C	1.2820514	0.016304348	Schizophrenia	Brain health and disorders
rs9510795	A	G	17	46	31	26	52	16	0.43	0.55	0.57	0.45	A	1.23	0.016304348	Diabetic kidney disease	Diabetes
rs763014	T	C	28	48	18	18	44	32	0.55	0.43	0.45	0.57	C	0.24	0.016304348	Height	General health
rs6802119	C	T	17	46	31	35	34	25	0.43	0.55	0.57	0.45	C	0.2341	0.016304348	Metabolite levels HVA	General health
rs4521323	A	C	18	47	29	32	43	19	0.44	0.57	0.56	0.43	C	1.28	0.016298812	Multiple myeloma IgH translocation	Cancer
rs3021304	G	C	34	38	22	17	48	29	0.56	0.44	0.44	0.56	G	2.97	0.016296967	Vogt-Koyanagi-Harada syndrome	Heart health and disorders
rs8177240	T	G	42	45	7	59	32	3	0.69	0.80	0.31	0.20	T	0.1	0.016295311	Iron status biomarkers transferrin saturation	General health
rs2272990	T	C	1	14	79	3	26	65	0.09	0.17	0.91	0.83	T	0.39	0.016260163	Preschool internalizing problems	Mental aptitude and behavioural traits
rs1570106	T	C	4	24	66	1	14	79	0.17	0.09	0.83	0.91	T	0.026	0.016260163	Height	General health
rs12500612	G	T	67	22	5	81	10	3	0.83	0.91	0.17	0.09	G	1.7665	0.016260163	Major depressive disorder	Brain health and disorders
rs2300478	T	G	68	20	6	78	16	0	0.83	0.91	0.17	0.09	G	1.74	0.016260163	Restless legs syndrome	Mental aptitude and behavioural traits
rs7612463	C	A	81	10	3	62	32	0	0.91	0.83	0.09	0.17	C	1.1	0.016260163	Type 2 diabetes	Diabetes
rs10213084	G	T	78	16	0	64	28	2	0.91	0.83	0.09	0.17	G	1	0.016260163	Heart rate	General health
rs10057565	T	C	79	14	1	65	26	3	0.91	0.83	0.09	0.17	T	0.2	0.016260163	Coronary artery calcification	Heart health and disorders
rs4727443	C	A	38	33	23	46	40	8	0.58	0.70	0.42	0.30	C	1.3	0.016259413	Interstitial lung disease	Pulmonology
rs1294421	T	G	17	45	32	4	48	42	0.42	0.30	0.58	0.70	G	1.16	0.016259413	Waist-hip ratio	General health
rs67385638	C	G	49	34	11	27	55	12	0.70	0.58	0.30	0.42	G	0.2038	0.016259413	Hemoglobin levels	Heart health and disorders
rs5743890	T	C	78	16	0	89	5	0	0.91	0.97	0.09	0.03	A	1.64	0.016230718	Idiopathic pulmonary fibrosis	Pulmonology
rs2280543	C	T	89	5	0	79	14	1	0.97	0.91	0.03	0.09	G	1.39	0.016230718	Uterine fibroids	Cancer
rs6119286	G	A	89	5	0	78	16	0	0.97	0.91	0.03	0.09	A	1	0.016230718	Attention deficit hyperactivity disorder combined symptoms	Brain health and disorders
rs491391	A	C	89	5	0	79	14	1	0.97	0.91	0.03	0.09	A	0.407	0.016230718	Optic nerve measurement disc area	Misc
rs10057405	A	C	78	16	0	89	5	0	0.91	0.97	0.09	0.03	A	0.11	0.016230718	Temperament	Mental aptitude and behavioural traits
rs62295889	T	C	78	16	0	89	5	0	0.91	0.97	0.09	0.03	G	0.03	0.016230718	Obesity-related traits	Obesity
rs11134654	A	C	2	19	73	6	29	59	0.12	0.22	0.88	0.78	A	4.6139	0.016225962	Smooth-surface caries	Appearance
rs1000113	C	T	73	19	2	58	31	5	0.88	0.78	0.12	0.22	T	1.54	0.016225962	Crohn's disease	Digestive system and its disorders
rs2261181	C	T	71	23	0	60	27	7	0.88	0.78	0.12	0.22	T	1.16	0.016225962	Type 2 diabetes	Diabetes
rs4417	T	C	3	35	56	0	23	71	0.22	0.12	0.78	0.88	A	1	0.016225962	Fat distribution HIV	General health
rs9332998	T	C	74	17	3	57	33	4	0.88	0.78	0.12	0.22	C	0.159	0.016225962	Metabolic traits	Misc
rs9333029	A	G	74	17	3	57	33	4	0.88	0.78	0.12	0.22	A	0.07	0.016225962	Blood metabolite levels	Heart health and disorders
rs10491003	C	T	59	29	6	73	19	2	0.78	0.88	0.22	0.12	T	0.027	0.016225962	Calcium levels	General health
rs116041037	G	A	94	0	0	89	4	1	1.00	0.97	0.00	0.03	A	2.67	0.016216216	Prostate cancer	Cancer
rs144788267	G	A	94	0	0	88	6	0	1.00	0.97	0.00	0.03	A	0.83	0.016216216	Lipoprotein a levels	Heart health and disorders
rs13317079	C	A	94	0	0	88	6	0	1.00	0.97	0.00	0.03	A	0.04	0.016216216	Obesity-related traits	Obesity
rs352236	C	T	0	0	94	0	6	88	0.00	0.03	1.00	0.97	G	0.03	0.016216216	Obesity-related traits	Obesity
rs2593525	C	A	0	0	94	0	6	88	0.00	0.03	1.00	0.97	C	0.03	0.016216216	Obesity-related traits	Obesity
rs6480975	G	C	6	34	54	10	48	36	0.24	0.36	0.76	0.64	C	1.21	0.016204634	Age-related macular degeneration	Aging
rs7595103	G	A	6	34	54	6	56	32	0.24	0.36	0.76	0.64	A	1	0.016204634	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs2801405	C	T	15	38	41	5	36	53	0.36	0.24	0.64	0.76	G	0.03	0.016204634	Obesity-related traits	Obesity
rs7414227	G	A	43	34	17	55	32	7	0.64	0.76	0.36	0.24	G	99.5	0.016204634	Lentiform nucleus volume	Misc
rs9426935	C	T	43	34	17	55	32	7	0.64	0.76	0.36	0.24	C	96.63	0.016204634	Lentiform nucleus volume	Misc
rs2289252	C	T	42	36	16	55	32	7	0.64	0.76	0.36	0.24	C	0.483	0.016204634	Activated partial thromboplastin time	Heart health and disorders
rs1436953	C	T	16	48	30	7	43	44	0.43	0.30	0.57	0.70	G	1.14	0.016156125	Type 2 diabetes	Diabetes
rs10788817	C	G	12	33	49	16	48	30	0.30	0.43	0.70	0.57	G	0.11	0.016156125	Serum metabolite levels	General health
rs1682859	C	A	8	41	45	18	44	32	0.30	0.43	0.70	0.57	C	0.04	0.016156125	Obesity-related traits	Obesity
rs10211524	G	A	17	46	31	10	37	47	0.43	0.30	0.57	0.70	A	0.019	0.016156125	Blood metabolite levels	Heart health and disorders
rs1816752	A	G	28	52	14	42	47	5	0.57	0.70	0.43	0.30	G	0.05	0.016156125	Obesity-related traits	Obesity
rs3769825	A	G	34	39	21	43	44	7	0.57	0.69	0.43	0.31	T	1.19	0.01605804	Chronic lymphocytic leukemia	Cancer
rs13072744	T	C	35	37	22	40	50	4	0.57	0.69	0.43	0.31	T	0.029	0.01605804	Height	General health
rs2295602	T	C	12	45	37	7	33	54	0.37	0.25	0.63	0.75	T	0.0432	0.016047745	Glycerophospholipid levels	Diabetes
rs6888304	A	G	63	29	2	44	47	3	0.82	0.72	0.18	0.28	A	2.7	0.016038492	Liver enzyme levels gamma-glutamyl transferase	General health
rs907611	G	A	50	35	9	65	25	4	0.72	0.82	0.28	0.18	A	1.08	0.016038492	Ulcerative colitis	Immune diseases and disorders
rs10910200	G	C	7	19	68	1	51	42	0.18	0.28	0.82	0.72	G	1.35	0.016038492	Diabetic retinopathy	Diabetes
rs1154155	T	G	72	19	3	83	11	0	0.87	0.94	0.13	0.06	G	1.64	0.016013072	Narcolepsy	Brain health and disorders
rs2116830	G	T	70	23	1	83	11	0	0.87	0.94	0.13	0.06	G	1.26	0.016013072	Obesity	Obesity
rs4327428	C	A	70	23	1	83	11	0	0.87	0.94	0.13	0.06	A	0.031	0.016013072	Blood metabolite levels	Heart health and disorders
rs6427196	C	G	1	9	84	3	19	72	0.06	0.13	0.94	0.87	C	2.07	0.016013072	Venous thromboembolism	Heart health and disorders
rs574367	G	T	54	33	7	66	28	0	0.75	0.85	0.25	0.15	T	0.058	0.015991141	Body mass index	Obesity
rs529989	C	A	6	47	41	18	46	30	0.31	0.44	0.69	0.56	C	8.56	0.015964992	Illicit drug use	General health
rs12654264	A	T	30	46	18	46	37	11	0.56	0.69	0.44	0.31	T	2.7106	0.015964992	Metabolite levels	General health
rs9285425	G	A	31	44	19	48	33	13	0.56	0.69	0.44	0.31	G	1.14	0.015964992	Height	General health
rs373767	C	T	31	44	19	43	43	8	0.56	0.69	0.44	0.31	C	0.16	0.015964992	Myopia pathological	General health
rs12619788	G	A	29	48	17	46	37	11	0.56	0.69	0.44	0.31	G	0.112	0.015964992	Economic and political preferences immigration_crime	Mental aptitude and behavioural traits
rs10038095	A	T	30	46	18	46	37	11	0.56	0.69	0.44	0.31	T	0.083	0.015964992	Cholesterol, total	General health
rs10022462	C	T	43	43	8	29	48	17	0.69	0.56	0.31	0.44	T	0.012	0.015964992	Blood metabolite levels	Heart health and disorders
rs10129255	C	T	51	38	5	33	52	9	0.74	0.63	0.26	0.37	A	1.315	0.015898042	Kawasaki disease	Misc
rs7786896	C	T	13	44	37	4	40	50	0.37	0.26	0.63	0.74	T	1.05	0.015898042	Schizophrenia	Brain health and disorders
rs6701037	A	C	34	50	10	52	36	6	0.63	0.74	0.37	0.26	C	1	0.015898042	Alcohol dependence	General health
rs2954793	C	T	55	30	9	32	54	8	0.74	0.63	0.26	0.37	T	0.2305	0.015898042	Metabolite levels HVA	General health
rs6882046	A	G	50	40	4	38	42	14	0.74	0.63	0.26	0.37	A	0.024	0.015898042	Educational attainment	Mental aptitude and behavioural traits
rs2252711	T	C	60	31	3	75	18	1	0.80	0.89	0.20	0.11	T	1	0.015893967	Pulmonary function interaction	Pulmonology
rs4790881	C	A	4	29	61	1	18	75	0.20	0.11	0.80	0.89	A	0.05	0.015893967	Bone mineral density	General health
rs7103411	C	T	3	31	60	0	20	74	0.20	0.11	0.80	0.89	C	0.04	0.015893967	Menarche age at onset	Reproductive health
rs959903	G	A	45	37	12	59	30	5	0.68	0.79	0.32	0.21	A	3.81	0.015877588	Non-alcoholic fatty liver disease histology other	Obesity
rs1250546	A	G	39	49	6	56	36	2	0.68	0.79	0.32	0.21	G	1.1170506	0.015877588	Crohn's disease	Digestive system and its disorders
rs849134	A	G	34	37	23	44	40	10	0.56	0.68	0.44	0.32	A	1.13	0.015876827	Type 2 diabetes	Diabetes
rs4924935	C	T	5	32	57	2	20	72	0.22	0.13	0.78	0.87	G	1.37	0.015835777	Pancreatic cancer	Cancer
rs1320333	C	T	87	7	0	76	17	1	0.96	0.90	0.04	0.10	A	0.03	0.015824176	Obesity-related traits	Obesity
rs116146467	C	A	85	9	0	72	22	0	0.95	0.88	0.05	0.12	A	5.61	0.015801777	Diisocyanate-induced asthma	Pulmonology
rs9461776	A	G	85	9	0	72	22	0	0.95	0.88	0.05	0.12	G	2.02	0.015801777	Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection	Immune diseases and disorders
rs17173608	T	G	86	7	1	75	16	3	0.95	0.88	0.05	0.12	G	1.93	0.015801777	Suicide attempts in depression or bipolar disorder	Brain health and disorders
rs62185668	C	A	74	18	2	86	7	1	0.88	0.95	0.12	0.05	A	1.19	0.015801777	Urinary bladder cancer	Cancer
rs13082711	T	C	73	20	1	85	9	0	0.88	0.95	0.12	0.05	T	0.315	0.015801777	Systolic blood pressure	Heart health and disorders
rs34924084	C	A	72	22	0	85	9	0	0.88	0.95	0.12	0.05	A	0.297	0.015801777	Metabolite levels HVA_MHPG ratio	Brain health and disorders
rs10514317	C	T	72	22	0	86	7	1	0.88	0.95	0.12	0.05	T	0.132	0.015801777	Sex hormone-binding globulin levels	Reproductive health
rs9491696	C	G	28	48	18	45	37	12	0.55	0.68	0.45	0.32	G	0.04	0.015793402	Waist-hip ratio	General health
rs2954022	C	A	27	50	17	44	39	11	0.55	0.68	0.45	0.32	A	0.036	0.015793402	HDL cholesterol	General health
rs1962772	C	T	27	50	17	44	39	11	0.55	0.68	0.45	0.32	T	0.01	0.015793402	Plasma omega-6 polyunsaturated fatty acid levels adrenic acid	General health
rs9895098	T	C	63	28	3	48	38	8	0.82	0.71	0.18	0.29	C	2.31	0.015782828	Asthma sex interaction	Immune diseases and disorders
rs3129943	A	G	64	26	4	48	38	8	0.82	0.71	0.18	0.29	T	1.17	0.015782828	Asthma	Immune diseases and disorders
rs13139571	C	A	47	40	7	60	34	0	0.71	0.82	0.29	0.18	C	0.321	0.015782828	Systolic blood pressure	Heart health and disorders
rs8076431	C	A	62	30	2	47	40	7	0.82	0.71	0.18	0.29	C	0.2132	0.015782828	IgG glycosylation	Immune diseases and disorders
rs2556378	T	G	3	28	63	7	40	47	0.18	0.29	0.82	0.71	T	1	0.015782828	Attention deficit hyperactivity disorder	Brain health and disorders
rs4441659	A	G	5	24	65	6	42	46	0.18	0.29	0.82	0.71	A	1	0.015782828	Homeostasis model assessment of beta-cell function interaction	Misc
rs7403531	T	C	15	41	38	7	35	52	0.38	0.26	0.62	0.74	T	1.1	0.015755208	Type 2 diabetes	Diabetes
rs7560018	T	A	20	45	29	6	50	38	0.45	0.33	0.55	0.67	A	1.71	0.015714583	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs1332844	C	T	14	34	46	18	49	27	0.33	0.45	0.67	0.55	T	1.11	0.015714583	Coronary heart disease	Heart health and disorders
rs11000137	G	T	67	25	2	80	14	0	0.85	0.93	0.15	0.07	T	1.07	0.015713388	Migraine	Brain health and disorders
rs2914276	T	C	80	14	0	68	23	3	0.93	0.85	0.07	0.15	G	1	0.015713388	Recombination measurement males	Misc
rs1049296	C	T	65	29	0	80	14	0	0.85	0.93	0.15	0.07	T	0.29	0.015713388	Alcohol consumption transferrin glycosylation	General health
rs10226308	A	G	67	25	2	82	10	2	0.85	0.93	0.15	0.07	A	0.06	0.015713388	Bone mineral density	General health
rs9563576	C	T	65	25	4	78	15	1	0.82	0.91	0.18	0.09	C	0.018	0.015705521	Body mass index	Obesity
rs4544377	G	A	2	25	67	7	34	53	0.15	0.26	0.85	0.74	A	1.832	0.015679972	Systemic lupus erythematosus	Immune diseases and disorders
rs9572423	G	A	54	32	8	67	25	2	0.74	0.85	0.26	0.15	G	1.54	0.015679972	Major depressive disorder	Brain health and disorders
rs9275319	A	G	53	34	7	67	25	2	0.74	0.85	0.26	0.15	A	1.49	0.015679972	Hepatocellular carcinoma hepatitis B virus related	Cancer
rs2074955	A	G	66	27	1	57	26	11	0.85	0.74	0.15	0.26	C	1	0.015679972	Cerebrospinal P-tau181p levels	Brain health and disorders
rs6120974	T	C	66	27	1	49	42	3	0.85	0.74	0.15	0.26	T	0.055	0.015679972	Triglycerides	General health
rs7583236	T	C	67	25	2	47	46	1	0.85	0.74	0.15	0.26	G	0.04	0.015679972	Obesity-related traits	Obesity
rs12421680	G	A	22	42	30	11	41	42	0.46	0.34	0.54	0.66	A	0.41	0.015640245	Sunburns	Cancer
rs7079041	G	A	20	46	28	14	35	45	0.46	0.34	0.54	0.66	A	0.02383	0.015640245	Suicide in bipolar disorder	Brain health and disorders
rs4237643	T	G	6	38	50	16	40	38	0.27	0.38	0.73	0.62	T	16.666	0.015618949	Forced vital capacity	Pulmonology
rs2252996	G	A	9	37	48	3	29	62	0.29	0.19	0.71	0.81	A	1.2195	0.015540016	Systemic lupus erythematosus	Immune diseases and disorders
rs16876083	C	T	90	4	0	80	14	0	0.98	0.93	0.02	0.07	A	8.65	0.015518312	Diisocyanate-induced asthma	Pulmonology
rs16999165	A	G	80	14	0	90	4	0	0.93	0.98	0.07	0.02	T	1.19	0.015518312	Atopic dermatitis	Immune diseases and disorders
rs11760067	C	T	80	14	0	90	4	0	0.93	0.98	0.07	0.02	T	0.8	0.015518312	Coronary artery calcification	Heart health and disorders
rs12615264	G	T	90	4	0	81	12	1	0.98	0.93	0.02	0.07	T	0.644	0.015518312	Current cigarettes per day in chronic obstructive pulmonary disease	General health
rs11577628	A	G	82	10	2	90	4	0	0.93	0.98	0.07	0.02	A	0.123	0.015518312	Word reading	Mental aptitude and behavioural traits
rs17173637	T	C	82	10	2	90	4	0	0.93	0.98	0.07	0.02	C	0.036	0.015518312	HDL cholesterol	General health
rs9460521	G	A	90	4	0	81	12	1	0.98	0.93	0.02	0.07	A	0.03	0.015518312	Obesity-related traits	Obesity
rs6072161	T	C	27	46	21	39	45	10	0.53	0.65	0.47	0.35	C	0.1589	0.015504558	IgG glycosylation	Immune diseases and disorders
rs1014137	T	C	24	40	30	13	39	42	0.47	0.35	0.53	0.65	C	0.0241	0.015504558	White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy	Brain health and disorders
rs11026318	C	T	57	32	5	42	41	11	0.78	0.66	0.22	0.34	A	2.33	0.015498155	Multiple myeloma hyperdiploidy	Cancer
rs7798197	A	G	55	36	3	42	41	11	0.78	0.66	0.22	0.34	A	1.18	0.015498155	Intracranial aneurysm	Misc
rs12730292	C	G	41	43	10	55	36	3	0.66	0.78	0.34	0.22	C	1.1	0.015498155	Bipolar disorder	Brain health and disorders
rs10224002	A	G	57	32	5	43	39	12	0.78	0.66	0.22	0.34	G	0.07	0.015498155	Hemoglobin	Heart health and disorders
rs2280381	C	T	9	33	52	13	47	34	0.27	0.39	0.73	0.61	T	1.12	0.015488991	Rheumatoid arthritis	Immune diseases and disorders
rs340005	G	A	14	45	35	6	39	49	0.39	0.27	0.61	0.73	G	0.084	0.015488991	Gamma gluatamyl transferase levels	Immune diseases and disorders
rs955748	A	G	6	39	49	18	37	39	0.27	0.39	0.73	0.61	A	0.023	0.015488991	Height	General health
rs6930576	G	A	37	41	16	49	39	6	0.61	0.73	0.39	0.27	A	1.31	0.015488991	Type 2 diabetes nephropathy	Diabetes
rs13333054	C	T	34	47	13	49	39	6	0.61	0.73	0.39	0.27	A	1.11	0.015488991	Multiple sclerosis	Brain health and disorders
rs8025118	G	T	56	33	5	69	25	0	0.77	0.87	0.23	0.13	T	2.8961	0.015469824	Cognitive function	Brain health and disorders
rs34311866	T	C	74	19	1	74	2	18	0.89	0.80	0.11	0.20	C	1.27	0.015452067	Parkinson's disease	Brain health and disorders
rs548181	A	G	1	19	74	3	32	59	0.11	0.20	0.89	0.80	G	1.1	0.015452067	Schizophrenia	Brain health and disorders
rs17094273	G	A	76	15	3	60	30	4	0.89	0.80	0.11	0.20	A	0.2	0.015452067	Tanning	Appearance
rs4749791	C	T	33	56	5	23	53	18	0.65	0.53	0.35	0.47	A	0.03	0.015443001	Obesity-related traits	Obesity
rs17687067	A	C	49	41	4	68	22	4	0.74	0.84	0.26	0.16	C	1.0752687	0.015385927	Schizophrenia	Brain health and disorders
rs6869841	C	T	66	26	2	46	47	1	0.84	0.74	0.16	0.26	A	1.07	0.015385927	Prostate cancer	Cancer
rs720390	G	A	45	46	3	33	48	13	0.72	0.61	0.28	0.39	A	0.035	0.015365079	Height	General health
rs11016883	G	C	28	58	8	49	38	7	0.61	0.72	0.39	0.28	C	0.01	0.015365079	Waist-to-hip circumference ratio interaction	General health
rs685001	C	A	10	54	30	6	40	48	0.39	0.28	0.61	0.72	C	0.03	0.015365079	Obesity-related traits	Obesity
rs4708431	A	G	36	48	10	18	61	15	0.64	0.52	0.36	0.48	A	1	0.015332	Attention deficit hyperactivity disorder combined symptoms	Brain health and disorders
rs1372356	G	A	23	45	26	13	42	39	0.48	0.36	0.52	0.64	C	0.2	0.015332	Food antigen IgG levels	Immune diseases and disorders
rs3858145	A	G	34	52	8	25	47	22	0.64	0.52	0.36	0.48	G	0.019	0.015332	Optic cup area	Misc
rs1078806	A	G	38	48	8	54	37	3	0.66	0.77	0.34	0.23	C	1.43	0.015321544	Breast cancer	Cancer
rs1111875	C	T	45	34	15	59	27	8	0.66	0.77	0.34	0.23	G	1.19	0.015321544	Type 2 diabetes	Diabetes
rs4598195	A	C	38	48	8	58	29	7	0.66	0.77	0.34	0.23	A	1.11	0.015321544	Ulcerative colitis	Immune diseases and disorders
rs10520514	T	A	41	42	11	57	31	6	0.66	0.77	0.34	0.23	A	1	0.015321544	Fasting insulin interaction	General health
rs382140	A	G	3	30	61	10	36	48	0.19	0.30	0.81	0.70	A	0.079	0.015309247	Coffee consumption	Misc
rs183823891	C	T	47	38	9	62	28	4	0.70	0.81	0.30	0.19	T	1.07	0.015309247	Schizophrenia	Brain health and disorders
rs7114467	G	A	45	42	7	63	26	5	0.70	0.81	0.30	0.19	A	0.0713	0.015309247	Menarche age at onset	Reproductive health
rs1179624	C	T	50	32	12	61	30	3	0.70	0.81	0.30	0.19	T	0.06	0.015309247	Age-related nuclear cataracts	Aging
rs868153	T	G	45	42	7	64	24	6	0.70	0.81	0.30	0.19	G	0.007	0.015309247	Vertical cup-disc ratio	Misc
rs10061469	T	C	37	45	12	20	56	18	0.63	0.51	0.37	0.49	A	1.0531912	0.015282392	Inflammatory bowel disease	Immune diseases and disorders
rs584480	C	T	26	40	28	12	45	37	0.49	0.37	0.51	0.63	T	0.023	0.015282392	Urate levels	General health
rs3749872	C	T	0	12	82	3	20	71	0.06	0.14	0.94	0.86	C	0.5892	0.015260044	Postprandial triglyceride response to high fat diet meal	General health
rs73215715	G	A	70	22	2	82	12	0	0.86	0.94	0.14	0.06	A	4.95	0.015260044	Heschl's gyrus morphology	Brain health and disorders
rs72773978	A	T	82	12	0	70	22	2	0.94	0.86	0.06	0.14	T	1.93	0.015260044	Multiple myeloma survival	Cancer
rs10916025	G	C	70	22	2	82	12	0	0.86	0.94	0.14	0.06	G	1	0.015260044	Subcutaneous adipose tissue	Obesity
rs3813948	T	C	83	10	1	71	20	3	0.94	0.86	0.06	0.14	C	1	0.015260044	C4b binding protein levels	General health
rs10488084	A	C	82	12	0	70	22	2	0.94	0.86	0.06	0.14	C	0.18	0.015260044	Estradiol levels	General health
rs1053941	G	T	68	26	0	82	12	0	0.86	0.94	0.14	0.06	T	0.017	0.015260044	Blood metabolite levels	Heart health and disorders
rs7969761	C	T	36	41	17	45	45	4	0.60	0.72	0.40	0.28	T	0.045	0.015246976	Blood metabolite ratios	Heart health and disorders
rs1466576	T	C	36	41	17	50	35	9	0.60	0.72	0.40	0.28	G	0.03	0.015246976	Obesity-related traits	Obesity
rs4883955	T	G	8	37	49	19	37	38	0.28	0.40	0.72	0.60		2	0.015246976	Bronchopulmonary dysplasia	Pulmonology
rs3857067	T	A	13	49	32	10	33	51	0.40	0.28	0.60	0.72	A	0.51	0.015246976	QT interval	Heart health and disorders
rs2220321	G	A	20	55	19	37	44	13	0.51	0.63	0.49	0.37	A	0.03	0.015236614	Obesity-related traits	Obesity
rs244293	A	G	21	51	22	10	50	34	0.49	0.37	0.51	0.63	G	0.03	0.015236614	Menarche age at onset	Reproductive health
rs509915	A	C	77	16	1	61	32	1	0.90	0.82	0.10	0.18	C	0.02165882	0.015194682	Urate levels BMI interaction	Obesity
rs12899811	A	G	29	36	29	11	49	34	0.50	0.38	0.50	0.62	G	1.09	0.0151946	Type 2 diabetes	Diabetes
rs10740993	C	T	35	47	12	27	40	27	0.62	0.50	0.38	0.50	C	0.141	0.0151946	Primary tooth development time to first tooth eruption	Misc
rs8067378	A	G	33	50	11	22	49	23	0.62	0.49	0.38	0.51	G	1.19	0.01515629	Cervical cancer	Cancer
rs1397924	C	T	27	41	26	16	40	38	0.51	0.38	0.49	0.62	T	0.092	0.01515629	Economic and political preferences environmentalism	Mental aptitude and behavioural traits
rs629301	G	T	5	34	55	12	41	41	0.23	0.35	0.77	0.65	G	5.41	0.015153077	Cholesterol, total	General health
rs17762192	G	C	39	45	10	54	36	4	0.65	0.77	0.35	0.23	G	1.45	0.015153077	HIV-1 progression	Immune diseases and disorders
rs729397	G	C	54	36	4	36	51	7	0.77	0.65	0.23	0.35	C	1	0.015153077	Response to statin therapy	General health
rs12654812	G	A	32	48	14	48	38	8	0.60	0.71	0.40	0.29	A	0.0036	0.015134459	Renal function-related traits sCR	General health
rs704178	G	C	19	38	37	8	38	48	0.40	0.29	0.60	0.71	G	2.133	0.015134459	Hippocampal sclerosis of aging	Brain health and disorders
rs6927207	A	G	20	36	38	6	42	46	0.40	0.29	0.60	0.71	A	0.19	0.015134459	Lipoprotein a levels	Heart health and disorders
rs2414095	A	G	17	42	35	7	40	47	0.40	0.29	0.60	0.71	A	0.11	0.015134459	Follicule stimulating hormone	Reproductive health
rs3768080	A	G	16	44	34	6	42	46	0.40	0.29	0.60	0.71	A	0.07	0.015134459	Cutaneous nevi	Cancer
rs9517302	A	G	8	38	48	12	52	30	0.29	0.40	0.71	0.60	A	0.03	0.015134459	Obesity-related traits	Obesity
rs4635554	T	G	34	47	13	23	46	25	0.61	0.49	0.39	0.51	G	1.67	0.015121631	Hypertriglyceridemia	General health
rs17021463	T	G	13	47	34	25	46	23	0.39	0.51	0.61	0.49	T	1.19	0.015121631	Testicular germ cell tumor	Cancer
rs10937540	C	T	22	48	24	33	49	12	0.49	0.61	0.51	0.39	T	0.091	0.015121631	Economic and political preferences environmentalism	Mental aptitude and behavioural traits
rs6773854	T	C	67	23	4	50	38	6	0.84	0.73	0.16	0.27	C	1.44	0.015107763	B cell non-Hodgkin lymphoma	Cancer
rs12646447	T	C	51	36	7	68	21	5	0.73	0.84	0.27	0.16	C	1.14	0.015107763	Ischemic stroke	Brain health and disorders
rs12361953	C	G	69	19	6	53	32	9	0.84	0.73	0.16	0.27	C	1	0.015107763	Alzheimer's disease late onset	Brain health and disorders
rs7113211	G	A	53	32	9	65	27	2	0.73	0.84	0.27	0.16	A	0.073	0.015107763	Expressive vocabulary in infants	Mental aptitude and behavioural traits
rs17826057	G	A	80	13	1	65	28	1	0.92	0.84	0.08	0.16	A	2.65	0.01510574	Smooth-surface caries	Appearance
rs17083844	G	A	79	15	0	66	26	2	0.92	0.84	0.08	0.16	A	1	0.01510574	Systemic lupus erythematosus	Immune diseases and disorders
rs13131350	A	G	70	18	6	80	13	1	0.84	0.92	0.16	0.08	A	0.095	0.01510574	Height	General health
rs9296295	C	A	80	13	1	67	24	3	0.92	0.84	0.08	0.16	A	0.03	0.01510574	Obesity-related traits	Obesity
rs1859308	A	G	2	26	66	0	15	79	0.16	0.08	0.84	0.92	C	1.1764705	0.01510574	Primary biliary cirrhosis	Immune diseases and disorders
rs533581	T	C	31	52	11	20	51	23	0.61	0.48	0.39	0.52	C	1.363	0.015090572	Social autistic-like traits	Brain health and disorders
rs11089937	A	C	22	53	19	13	48	33	0.52	0.39	0.48	0.61	A	1.33	0.015090572	Periodontitis PAL4Q3	Misc
rs7164727	C	T	25	41	28	35	44	15	0.48	0.61	0.52	0.39	T	0.019	0.015090572	Body mass index	Obesity
rs1165472	A	G	63	25	6	46	39	9	0.80	0.70	0.20	0.30	G	2.36	0.015089784	Paclitaxel-induced neuropathy	Brain health and disorders
rs13204048	T	C	49	33	12	60	31	3	0.70	0.80	0.30	0.20	G	1.0708697	0.015089784	Crohn's disease	Digestive system and its disorders
rs7833986	G	A	61	29	4	42	47	5	0.80	0.70	0.20	0.30	A	0.12	0.015089784	Height	General health
rs229541	G	A	27	44	23	19	37	38	0.52	0.40	0.48	0.60	T	1.11	0.015063071	Type 1 diabetes	Diabetes
rs12999373	G	A	61	27	6	74	18	2	0.79	0.88	0.21	0.12	A	17.65	0.015040333	Uric acid levels	General health
rs16879765	C	T	73	20	1	59	31	4	0.88	0.79	0.12	0.21	A	1.98	0.015040333	Dupuytren's disease	Skin related disease
rs11704416	G	C	73	20	1	61	27	6	0.88	0.79	0.12	0.21	C	1.06	0.015040333	Prostate cancer	Cancer
rs168302	T	G	59	31	4	73	20	1	0.79	0.88	0.21	0.12	T	0.016	0.015040333	Airway imaging phenotypes	Pulmonology
rs1625895	T	C	1	20	73	5	29	60	0.12	0.21	0.88	0.79	T	0.12	0.015040333	Sex hormone-binding globulin levels	Reproductive health
rs4781011	T	G	14	48	32	26	47	21	0.40	0.53	0.60	0.47	T	1.15	0.01503909	Ulcerative colitis	Immune diseases and disorders
rs12069356	G	A	16	44	34	22	55	17	0.40	0.53	0.60	0.47	A	1.05	0.01503909	Schizophrenia	Brain health and disorders
rs34746873	G	A	14	48	32	26	47	21	0.40	0.53	0.60	0.47	G	0.1865	0.01503909	Neurofibrillary tangles	Brain health and disorders
rs1555543	A	C	16	57	21	37	38	19	0.47	0.60	0.53	0.40	C	0.06	0.01503909	Body mass index	Obesity
rs11168854	C	G	33	46	15	18	53	23	0.60	0.47	0.40	0.53	G	0.016	0.01503909	Body mass index	Obesity
rs2241880	A	G	36	39	19	49	35	10	0.59	0.71	0.41	0.29	G	1.45	0.015027322	Crohn's disease	Digestive system and its disorders
rs4832928	C	T	33	45	16	47	39	8	0.59	0.71	0.41	0.29	C	0.1627	0.015027322	IgG glycosylation	Immune diseases and disorders
rs727479	C	A	18	41	35	8	39	47	0.41	0.29	0.59	0.71	C	0.107	0.015027322	Estradiol levels	General health
rs1528435	C	T	8	39	47	13	51	30	0.29	0.41	0.71	0.59	T	0.023	0.015027322	Body mass index	Obesity
rs4983559	G	A	18	51	25	33	44	17	0.46	0.59	0.54	0.41	G	0.02	0.01500156	HDL cholesterol	General health
rs1551277	T	C	5	35	54	12	42	40	0.24	0.35	0.76	0.65	A	0.068	0.014992351	Anxiety disorder	Brain health and disorders
rs789942	C	A	9	48	37	3	39	52	0.35	0.24	0.65	0.76	C	0.04	0.014992351	Obesity-related traits	Obesity
rs10106298	G	A	55	33	6	38	46	10	0.76	0.65	0.24	0.35	G	1.0526316	0.014992351	Schizophrenia	Brain health and disorders
rs2984613	C	T	36	50	8	54	35	5	0.65	0.76	0.35	0.24	C	1	0.014992351	White matter hyperintensity burden	Brain health and disorders
rs10198756	A	C	54	35	5	37	48	9	0.76	0.65	0.24	0.35	C	0.2053	0.014992351	IgG glycosylation	Immune diseases and disorders
rs7947523	C	G	31	47	16	18	50	26	0.58	0.46	0.42	0.54	C	0.086	0.014987959	Emphysema imaging phenotypes	Pulmonology
rs10927101	C	A	28	46	20	16	47	31	0.54	0.42	0.46	0.58	A	1.33	0.014987959	Diabetic retinopathy	Diabetes
rs16937	A	G	20	39	35	25	52	17	0.42	0.54	0.58	0.46	A	1.06	0.014987959	Schizophrenia	Brain health and disorders
rs9883654	C	T	27	49	18	18	44	32	0.55	0.43	0.45	0.57	T	2.2	0.014977774	Response to antineoplastic agents	General health
rs9633835	G	A	32	42	20	12	59	23	0.56	0.44	0.44	0.56	G	0.018	0.014967603	Body mass index	Obesity
rs539901	T	G	91	3	0	83	10	1	0.98	0.94	0.02	0.06	G	1	0.014958449	Non-small cell lung cancer	Cancer
rs17135437	C	T	91	3	0	82	12	0	0.98	0.94	0.02	0.06	A	1	0.014958449	Response to citalopram treatment	General health
rs16830366	C	T	91	3	0	82	12	0	0.98	0.94	0.02	0.06	T	0.09	0.014958449	Waist circumference	General health
rs2007084	G	A	82	12	0	91	3	0	0.94	0.98	0.06	0.02	A	0.068	0.014958449	Blood metabolite levels	Heart health and disorders
rs9906155	T	C	91	3	0	82	12	0	0.98	0.94	0.02	0.06	T	0.05	0.014958449	Body mass index	Obesity
rs2728125	A	G	72	21	1	84	10	0	0.88	0.95	0.12	0.05	C	2.04	0.014930648	Gout	General health
rs17620991	G	C	72	21	1	85	8	1	0.88	0.95	0.12	0.05	C	1.3333333	0.014930648	Alcohol dependence	General health
rs13194053	T	C	84	10	0	71	23	0	0.95	0.88	0.05	0.12	T	1.28	0.014930648	Schizophrenia	Brain health and disorders
rs17680945	G	A	73	19	2	84	10	0	0.88	0.95	0.12	0.05	A	0.92	0.014930648	Temperament	Mental aptitude and behavioural traits
rs9492645	G	A	84	10	0	73	19	2	0.95	0.88	0.05	0.12	G	0.3363	0.014930648	IgG glycosylation	Immune diseases and disorders
rs12894211	C	T	74	17	3	85	8	1	0.88	0.95	0.12	0.05	C	0.021	0.014930648	Body mass index	Obesity
rs207145	C	T	2	19	73	0	10	84	0.12	0.05	0.88	0.95	T	0.6722	0.014930648	Age-related cataracts age at onset	Aging
rs3800131	A	C	7	42	45	15	48	31	0.30	0.41	0.70	0.59	A	0.03	0.014925373	Obesity-related traits	Obesity
rs12887386	A	G	88	6	0	77	17	0	0.97	0.91	0.03	0.09	A	1.1	0.014903313	Schizophrenia	Brain health and disorders
rs9533425	G	C	78	15	1	88	6	0	0.91	0.97	0.09	0.03	G	0.308	0.014903313	End-stage coagulation	General health
rs7595412	G	A	1	15	78	0	6	88	0.09	0.03	0.91	0.97	A	5	0.014903313	Hip bone size	Appearance
rs4376189	G	A	0	17	77	0	6	88	0.09	0.03	0.91	0.97	A	1	0.014903313	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs12910412	T	G	46	38	10	59	32	3	0.69	0.80	0.31	0.20	G	1.3	0.014880952	Chronic bronchitis and chronic obstructive pulmonary disease	Pulmonology
rs4432245	T	C	61	28	5	43	44	7	0.80	0.69	0.20	0.31	C	1	0.014880952	Body mass index	Obesity
rs6420094	A	G	42	46	6	60	30	4	0.69	0.80	0.31	0.20	G	0.01	0.014880952	Chronic kidney disease	Immune diseases and disorders
rs422421	T	C	1	30	63	5	41	48	0.17	0.27	0.83	0.73	T	0.034	0.01484436	Height	General health
rs7646881	C	A	67	22	5	53	31	10	0.83	0.73	0.17	0.27	A	1.391	0.01484436	Tetralogy of Fallot	Heart health and disorders
rs9403484	C	T	50	37	7	66	24	4	0.73	0.83	0.27	0.17	T	1.06	0.01484436	Schizophrenia	Brain health and disorders
rs4537030	T	G	53	31	10	63	30	1	0.73	0.83	0.27	0.17	G	0.087	0.01484436	Mean arterial pressure alcohol consumption interaction	General health
rs2252508	A	G	16	35	43	7	32	55	0.36	0.24	0.64	0.76	G	97.78	0.014838992	Lentiform nucleus volume	Misc
rs10863936	G	A	8	30	56	9	49	36	0.24	0.36	0.76	0.64	A	0.021	0.014838992	Height	General health
rs7283054	G	C	93	1	0	86	8	0	0.99	0.96	0.01	0.04	C	2.69	0.014834998	Stroke	Brain health and disorders
rs2233278	G	C	86	8	0	93	1	0	0.96	0.99	0.04	0.01	A	1.647	0.014834998	Psoriasis	Immune diseases and disorders
rs17404956	A	G	86	8	0	93	1	0	0.96	0.99	0.04	0.01	A	1.16	0.014834998	Diabetic retinopathy	Diabetes
rs17714988	A	G	86	8	0	93	1	0	0.96	0.99	0.04	0.01	G	1	0.014834998	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs78857879	G	A	86	8	0	93	1	0	0.96	0.99	0.04	0.01	A	1	0.014834998	White matter hyperintensity burden	Brain health and disorders
rs11845208	A	G	93	1	0	86	8	0	0.99	0.96	0.01	0.04	G	1	0.014834998	Immune reponse to smallpox secreted IL-2	Immune diseases and disorders
rs3213056	G	A	86	8	0	93	1	0	0.96	0.99	0.04	0.01	A	0.376	0.014834998	Reading and spelling	Brain health and disorders
rs74566133	C	T	86	8	0	93	1	0	0.96	0.99	0.04	0.01	C	0.249	0.014834998	Eating disorders purging via substances	Brain health and disorders
rs11951031	C	T	86	8	0	93	1	0	0.96	0.99	0.04	0.01	T	0.2	0.014834998	Bone mineral density	General health
rs12483148	T	C	86	8	0	93	1	0	0.96	0.99	0.04	0.01	G	0.03	0.014834998	Obesity-related traits	Obesity
rs13403276	T	C	86	8	0	93	1	0	0.96	0.99	0.04	0.01	G	0.03	0.014834998	Obesity-related traits	Obesity
rs641862	T	C	93	1	0	86	8	0	0.99	0.96	0.01	0.04	G	0.03	0.014834998	Obesity-related traits	Obesity
rs2194025	G	C	68	25	1	57	29	8	0.86	0.76	0.14	0.24	G	1.6	0.014802632	Retinal arteriolar caliber	General health
rs11755845	C	T	56	31	7	69	23	2	0.76	0.86	0.24	0.14	T	0.076	0.014802632	Thyroid hormone levels	General health
rs6890562	A	T	73	15	6	52	39	3	0.86	0.76	0.14	0.24	A	0.0145	0.014802632	Trans fatty acid levels	General health
rs17099388	G	A	73	15	6	52	39	3	0.86	0.76	0.14	0.24	A	0.0127	0.014802632	Trans fatty acid levels	General health
rs1980493	T	C	86	8	0	76	16	2	0.96	0.89	0.04	0.11	G	2.87	0.014778325	Idiopathic membranous nephropathy	Brain health and disorders
rs6722456	G	A	86	8	0	75	18	1	0.96	0.89	0.04	0.11	A	0.048	0.014778325	Palmitoleic acid 16:1n-7 plasma levels	General health
rs2042415	G	A	74	20	0	86	8	0	0.89	0.96	0.11	0.04	A	0.04	0.014778325	Obesity-related traits	Obesity
rs3804024	T	C	86	8	0	76	16	2	0.96	0.89	0.04	0.11	G	0.03	0.014778325	Obesity-related traits	Obesity
rs2955259	G	A	18	44	32	11	36	47	0.43	0.31	0.57	0.69	A	0.024	0.014736329	Educational attainment	Mental aptitude and behavioural traits
rs894157	C	T	2	31	61	2	15	77	0.19	0.10	0.81	0.90	G	0.03	0.014722797	Obesity-related traits	Obesity
rs729302	A	C	61	31	2	75	19	0	0.81	0.90	0.19	0.10	A	1.4706	0.014722797	Systemic lupus erythematosus	Immune diseases and disorders
rs10460436	G	A	67	19	8	76	17	1	0.81	0.90	0.19	0.10	A	0.062	0.014722797	Height	General health
rs13072940	T	A	53	35	6	39	42	13	0.75	0.64	0.25	0.36	A	1.06	0.014692654	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs10258482	C	A	53	35	6	40	40	14	0.75	0.64	0.25	0.36	A	0.196	0.014692654	Intraocular pressure	General health
rs1045241	C	T	53	35	6	40	40	14	0.75	0.64	0.25	0.36	C	0.0345	0.014692654	Waist-to-hip ratio adjusted for body mass index	Obesity
rs2904524	G	A	43	43	8	60	29	5	0.69	0.79	0.31	0.21	T	1	0.014682132	Amyotrophic lateral sclerosis age of onset	Brain health and disorders
rs3741489	T	C	71	23	0	60	28	6	0.88	0.79	0.12	0.21	C	13.9397	0.014655916	Cognitive function	Brain health and disorders
rs2694917	T	C	58	32	4	72	21	1	0.79	0.88	0.21	0.12	T	0.018	0.014655916	Blood metabolite ratios	Heart health and disorders
rs2798334	T	C	5	30	59	2	19	73	0.21	0.12	0.79	0.88	T	0.918	0.014655916	P wave duration	Heart health and disorders
rs114154155	A	G	92	2	0	84	10	0	0.99	0.95	0.01	0.05	G	34.08	0.014652015	Diisocyanate-induced asthma	Pulmonology
rs11986011	C	T	92	2	0	84	10	0	0.99	0.95	0.01	0.05	T	2.5	0.014652015	Age-related macular degeneration	Aging
rs3131379	G	A	92	2	0	84	10	0	0.99	0.95	0.01	0.05	A	2.36	0.014652015	Systemic lupus erythematosus	Immune diseases and disorders
rs17608902	C	A	84	10	0	92	2	0	0.95	0.99	0.05	0.01	A	1.25	0.014652015	Migraine - clinic-based	Brain health and disorders
rs657075	G	A	84	10	0	92	2	0	0.95	0.99	0.05	0.01	A	1.12	0.014652015	Rheumatoid arthritis	Immune diseases and disorders
rs12205363	T	C	84	10	0	92	2	0	0.95	0.99	0.05	0.01	C	0.235	0.014652015	Refractive error	General health
rs12422267	A	G	84	10	0	93	0	1	0.95	0.99	0.05	0.01	G	0.17	0.014652015	Plasma amyloid beta peptide concentrations ABx-40	Brain health and disorders
rs142014203	T	G	85	8	1	92	2	0	0.95	0.99	0.05	0.01	T	0.126	0.014652015	Bulimia nervosa	Brain health and disorders
rs11677466	A	T	84	10	0	92	2	0	0.95	0.99	0.05	0.01	A	0.064	0.014652015	Height	General health
rs2414208	A	G	92	2	0	85	8	1	0.99	0.95	0.01	0.05	G	0.03	0.014652015	Obesity-related traits	Obesity
rs8025093	A	C	92	2	0	84	10	0	0.99	0.95	0.01	0.05	C	0.03	0.014652015	Obesity-related traits	Obesity
rs2540226	A	C	18	45	31	7	45	42	0.43	0.31	0.57	0.69	T	0.13	0.01464891	Personality dimensions	Brain health and disorders
rs9376092	C	A	62	31	1	46	44	4	0.82	0.72	0.18	0.28	A	1.18	0.014594704	Myeloproliferative neoplasms	Cancer
rs286499	T	G	2	29	63	6	40	48	0.18	0.28	0.82	0.72	G	1.2	0.014594704	Chronic obstructive pulmonary disease	Immune diseases and disorders
rs2294015	C	T	8	36	50	5	23	66	0.28	0.18	0.72	0.82	G	0.211	0.014594704	Event-related brain oscillations	Brain health and disorders
rs704341	G	A	70	21	3	81	13	0	0.86	0.93	0.14	0.07	A	1.73	0.014583333	Stroke	Brain health and disorders
rs12652364	G	A	70	21	3	82	11	1	0.86	0.93	0.14	0.07	A	1.45	0.014583333	Response to methotrexate in juvenile idiopathic arthritis	General health
rs4987094	G	A	68	25	1	81	13	0	0.86	0.93	0.14	0.07	A	1.09	0.014583333	Schizophrenia	Brain health and disorders
rs2833991	A	C	83	9	2	71	19	4	0.93	0.86	0.07	0.14	C	0.3471	0.014583333	IgG glycosylation	Immune diseases and disorders
rs7306642	C	A	83	9	2	69	23	2	0.93	0.86	0.07	0.14	A	0.3	0.014583333	vWF and FVIII levels	Heart health and disorders
rs4848768	A	G	57	26	11	39	41	14	0.74	0.63	0.26	0.37	G	154.6	0.014553015	Lentiform nucleus volume	Misc
rs2523393	A	G	38	43	13	47	46	1	0.63	0.74	0.37	0.26	A	1.28	0.014553015	Multiple sclerosis	Brain health and disorders
rs4869313	T	G	10	49	35	6	36	52	0.37	0.26	0.63	0.74	T	1	0.014553015	Pediatric autoimmune diseases	Immune diseases and disorders
rs12406092	G	A	38	43	13	57	26	11	0.63	0.74	0.37	0.26	A	0.028	0.014553015	Optic disc area	Misc
rs7636	G	A	78	16	0	64	29	1	0.91	0.84	0.09	0.16	A	1.85	0.014550863	Type 2 diabetes	Diabetes
rs7202877	T	G	78	16	0	66	25	3	0.91	0.84	0.09	0.16	G	1.28	0.014550863	Type 1 diabetes	Diabetes
rs17228212	T	C	66	25	3	80	12	2	0.84	0.91	0.16	0.09	C	1.21	0.014550863	Coronary heart disease	Heart health and disorders
rs10131728	C	T	78	16	0	65	27	2	0.91	0.84	0.09	0.16	C	0.2398	0.014550863	IgG glycosylation	Immune diseases and disorders
rs288139	G	A	66	25	3	78	16	0	0.84	0.91	0.16	0.09	A	0.206	0.014550863	Eye color	Appearance
rs4841132	A	G	2	12	80	2	27	65	0.09	0.16	0.91	0.84	G	0.094	0.014550863	HDL cholesterol	General health
rs6508367	C	T	5	21	68	1	14	79	0.16	0.09	0.84	0.91	T	0.04	0.014550863	Toenail selenium levels	Misc
rs7646507	G	A	1	14	79	5	21	68	0.09	0.16	0.91	0.84	G	0.03	0.014550863	Obesity-related traits	Obesity
rs4811117	T	G	2	24	68	5	36	53	0.15	0.24	0.85	0.76	T	3.13	0.014497942	Molar-incisor hypomineralization	Misc
rs6465122	T	C	8	30	56	0	28	66	0.24	0.15	0.76	0.85	T	1.67	0.014497942	Parkinson disease and lewy body pathology	Brain health and disorders
rs12702661	A	G	5	36	53	2	24	68	0.24	0.15	0.76	0.85	A	0.04	0.014497942	Obesity-related traits	Obesity
rs4527850	T	C	53	36	5	67	26	1	0.76	0.85	0.24	0.15	T	1.23	0.014497942	Type 2 diabetes	Diabetes
rs2622590	G	A	57	28	9	67	26	1	0.76	0.85	0.24	0.15	A	0.03	0.014497942	Serum thyroid-stimulating hormone levels	General health
rs9943849	C	T	59	30	5	42	44	8	0.79	0.68	0.21	0.32	T	1.37	0.014492754	Major depressive disorder	Brain health and disorders
rs11717195	T	C	43	42	9	60	28	6	0.68	0.79	0.32	0.21	T	1.09	0.014492754	Type 2 diabetes	Diabetes
rs535066	G	T	22	39	33	10	41	43	0.44	0.32	0.56	0.68	G	1.1	0.014487548	Epilepsy	Brain health and disorders
rs322458	C	T	46	35	13	29	47	18	0.68	0.56	0.32	0.44	G	1	0.014487548	Aging facial	Aging
rs1635852	T	C	34	37	23	44	39	11	0.56	0.68	0.44	0.32	A	0.25	0.014487548	Height	General health
rs7101378	G	A	30	45	19	41	45	8	0.56	0.68	0.44	0.32	G	0.1398	0.014487548	IgG glycosylation	Immune diseases and disorders
rs1550584	C	T	26	53	15	43	41	10	0.56	0.68	0.44	0.32	C	0.1382	0.014487548	IgG glycosylation	Immune diseases and disorders
rs13330176	T	A	36	46	12	53	33	8	0.63	0.74	0.37	0.26	A	1.12	0.014419776	Rheumatoid arthritis	Immune diseases and disorders
rs436000	G	T	43	40	11	32	40	22	0.67	0.55	0.33	0.45	T	0.125	0.014413341	Economic and political preferences fairness	Mental aptitude and behavioural traits
rs1349882	G	T	43	40	11	26	52	16	0.67	0.55	0.33	0.45	T	0.092	0.014413341	Asymmetrical dimethylarginine levels	General health
rs7147503	C	T	49	37	8	64	26	4	0.72	0.82	0.28	0.18	C	0.051	0.014357873	Corneal astigmatism	General health
rs7582694	C	G	8	37	49	4	26	64	0.28	0.18	0.72	0.82	C	1.811	0.014357873	Systemic lupus erythematosus	Immune diseases and disorders
rs1126179	A	G	13	37	44	22	41	31	0.34	0.45	0.66	0.55	G	2.13	0.014343291	Molar-incisor hypomineralization	Misc
rs1044826	C	T	30	43	21	40	45	9	0.55	0.66	0.45	0.34	G	0.03	0.014343291	Obesity-related traits	Obesity
rs4880487	C	T	56	35	3	41	45	8	0.78	0.68	0.22	0.32	T	1.06	0.014312294	Migraine	Brain health and disorders
rs3765350	A	G	45	37	12	57	33	4	0.68	0.78	0.32	0.22	A	0.1159	0.014312294	Bone mineral density paediatric, total body less head	General health
rs6945071	A	G	71	22	1	56	35	3	0.87	0.78	0.13	0.22	G	1035	0.014296315	Superior frontal gyrus grey matter volume	Misc
rs149709	T	C	55	37	2	72	20	2	0.78	0.87	0.22	0.13	C	1.19	0.014296315	Acne severe	Misc
rs11014166	A	T	56	35	3	73	18	3	0.78	0.87	0.22	0.13	A	0.5	0.014296315	Systolic blood pressure	Heart health and disorders
rs2126259	T	C	2	20	72	5	31	58	0.13	0.22	0.87	0.78	A	0.11	0.014296315	HDL cholesterol	General health
rs6439168	A	G	3	35	56	1	22	71	0.22	0.13	0.78	0.87	A	0.037	0.014296315	Height	General health
rs6439167	T	C	3	35	56	1	22	71	0.22	0.13	0.78	0.87	T	0.034	0.014296315	Height	General health
rs4953345	T	A	15	41	38	7	36	51	0.38	0.27	0.62	0.73	A	1.25	0.014292659	Renal cell carcinoma	Cancer
rs2301888	G	A	36	45	13	52	34	8	0.62	0.73	0.38	0.27	G	1.19	0.014292659	Rheumatoid arthritis	Immune diseases and disorders
rs1456896	C	T	10	30	54	12	47	35	0.27	0.38	0.73	0.62	T	1.14	0.014292659	Crohn's disease	Digestive system and its disorders
rs6764184	G	T	37	43	14	48	42	4	0.62	0.73	0.38	0.27	T	0.021	0.014292659	Optic cup area	Misc
rs11075990	A	G	41	42	11	26	50	18	0.66	0.54	0.34	0.46	G	1.35	0.014277286	Body mass index	Obesity
rs7185735	A	G	41	42	11	26	50	18	0.66	0.54	0.34	0.46	G	1.33	0.014277286	Obesity	Obesity
rs10763170	T	C	29	44	21	44	36	14	0.54	0.66	0.46	0.34	A	1.28	0.014277286	Sporadic pituitary adenoma	Cancer
rs9936385	T	C	41	42	11	26	50	18	0.66	0.54	0.34	0.46	C	1.13	0.014277286	Type 2 diabetes	Diabetes
rs9939609	T	A	41	42	11	26	50	18	0.66	0.54	0.34	0.46	A	0.36	0.014277286	Body mass index	Obesity
rs7202116	A	G	41	42	11	26	50	18	0.66	0.54	0.34	0.46	G	0.036	0.014277286	Body mass index	Obesity
rs7128099	G	A	10	44	40	16	54	24	0.34	0.46	0.66	0.54	G	0.03	0.014277286	Obesity-related traits	Obesity
rs258322	A	G	3	23	68	6	35	53	0.15	0.25	0.85	0.75	A	1.7	0.014210526	Melanoma	Cancer
rs2024825	T	C	2	25	67	2	43	49	0.15	0.25	0.85	0.75	A	1.5873016	0.014210526	Leprosy	Immune diseases and disorders
rs4886776	G	A	53	35	6	66	27	1	0.75	0.85	0.25	0.15	A	1	0.014210526	Exfoliation syndrome	General health
rs17617068	T	C	55	31	8	67	25	2	0.75	0.85	0.25	0.15	T	1	0.014210526	Resting heart rate	General health
rs4821897	A	G	5	37	52	0	29	65	0.25	0.15	0.75	0.85	G	0.2976	0.014210526	IgG glycosylation	Immune diseases and disorders
rs12694997	G	A	54	33	7	66	27	1	0.75	0.85	0.25	0.15	A	0.024	0.014210526	Height	General health
rs6547537	A	G	4	43	47	13	46	35	0.27	0.38	0.73	0.62	G	0.1881	0.014171407	IgG glycosylation	Immune diseases and disorders
rs7239883	G	A	4	43	47	17	38	39	0.27	0.38	0.73	0.62	G	0.023	0.014171407	Body mass index	Obesity
rs10469966	G	A	50	37	7	37	42	15	0.73	0.62	0.27	0.38	A	0.102	0.014171407	Blood metabolite levels	Heart health and disorders
rs359312	C	T	72	20	2	83	11	0	0.87	0.94	0.13	0.06	T	3.91	0.014160034	Response to treatment for acute lymphoblastic leukemia	General health
rs13064954	G	A	84	9	1	70	24	0	0.94	0.87	0.06	0.13	A	1.94	0.014160034	Smoking cessation in chronic obstructive pulmonary disease	Heart health and disorders
rs6933404	T	C	72	20	2	83	11	0	0.87	0.94	0.13	0.06	C	1.18	0.014160034	Primary biliary cirrhosis	Immune diseases and disorders
rs17382202	C	T	70	24	0	84	9	1	0.87	0.94	0.13	0.06	T	1	0.014160034	Response to antipsychotic treatment	General health
rs836132	G	A	71	22	1	83	11	0	0.87	0.94	0.13	0.06	C	0.65	0.014160034	&beta;2-Glycoprotein I &beta;2-GPI plasma levels	Immune diseases and disorders
rs17153352	T	A	73	18	3	83	11	0	0.87	0.94	0.13	0.06	T	0.2041	0.014160034	IgG glycosylation	Immune diseases and disorders
rs7558386	A	G	22	44	28	12	42	40	0.47	0.35	0.53	0.65	G	1	0.014157014	Cerebrospinal P-tau181p levels	Brain health and disorders
rs4620037	A	C	58	30	6	35	56	3	0.78	0.67	0.22	0.33	A	0.032	0.014140271	Height	General health
rs297325	T	C	51	32	11	62	29	3	0.71	0.81	0.29	0.19	C	1	0.014133031	Obesity and osteoporosis	Obesity
rs9782914	T	C	60	33	1	49	36	9	0.81	0.71	0.19	0.29	G	1	0.014133031	Behavioural disinhibition generation interaction	Brain health and disorders
rs9548050	A	G	49	36	9	66	21	7	0.71	0.81	0.29	0.19	G	0.03	0.014133031	Obesity-related traits	Obesity
rs10936797	T	G	51	32	11	62	29	3	0.71	0.81	0.29	0.19	C	0.03	0.014133031	Obesity-related traits	Obesity
rs7411387	C	T	21	47	26	11	45	38	0.47	0.36	0.53	0.64	C	1.61	0.014102564	Interferon alpha levels in systemic lupus erythematosus	Immune diseases and disorders
rs1419881	G	A	22	45	27	8	51	35	0.47	0.36	0.53	0.64	G	1.12	0.014102564	Chronic hepatitis B infection	Immune diseases and disorders
rs6661961	T	C	25	39	30	8	51	35	0.47	0.36	0.53	0.64	T	0.338	0.014102564	Atopic dermatitis	Immune diseases and disorders
rs2836950	C	G	39	37	18	49	38	7	0.61	0.72	0.39	0.28	C	0.03	0.014055777	Menarche age at onset	Reproductive health
rs6770152	G	T	15	43	36	6	40	48	0.39	0.28	0.61	0.72	T	0.044	0.014055777	Urate levels	General health
rs9310862	G	A	22	54	18	40	40	14	0.52	0.64	0.48	0.36	G	1	0.014051794	Behavioural disinhibition generation interaction	Brain health and disorders
rs6806377	A	G	21	48	25	17	34	43	0.48	0.36	0.52	0.64	A	0.04	0.014051794	Obesity-related traits	Obesity
rs2156552	A	T	1	13	80	0	5	89	0.08	0.03	0.92	0.97	T	1.2	0.014044944	HDL cholesterol	General health
rs950173	G	A	80	13	1	89	5	0	0.92	0.97	0.08	0.03	A	167.4	0.014044944	Hippocampal volume	Brain health and disorders
rs9461741	G	C	89	5	0	79	15	0	0.97	0.92	0.03	0.08	C	2.66	0.014044944	Marginal zone lymphoma	Cancer
rs17586843	T	C	79	15	0	89	5	0	0.92	0.97	0.08	0.03	T	1.18	0.014044944	Age-related macular degeneration	Aging
rs112627313	T	A	80	13	1	89	5	0	0.92	0.97	0.08	0.03	A	1.07	0.014044944	Schizophrenia	Brain health and disorders
rs10209150	A	G	89	5	0	80	13	1	0.97	0.92	0.03	0.08	G	0.591	0.014044944	Neurofibrillary tangles	Brain health and disorders
rs2472297	C	T	80	13	1	89	5	0	0.92	0.97	0.08	0.03	T	0.31	0.014044944	Coffee consumption	Misc
rs17170849	T	C	89	5	0	79	15	0	0.97	0.92	0.03	0.08	C	0.265	0.014044944	Lifetime average cigarettes per day in chronic obstructive pulmonary disease	General health
rs74852193	G	A	80	13	1	89	5	0	0.92	0.97	0.08	0.03	G	0.2625	0.014044944	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs13213483	A	G	80	13	1	89	5	0	0.92	0.97	0.08	0.03	A	0.07009798	0.014044944	LDL peak particle diameter total fat intake interaction	General health
rs7724774	G	A	80	13	1	89	5	0	0.92	0.97	0.08	0.03	G	0.054	0.014044944	Bulimia nervosa	Brain health and disorders
rs13315871	G	A	89	5	0	79	15	0	0.97	0.92	0.03	0.08	A	0.036	0.014044944	Cholesterol, total	General health
rs13100723	C	T	80	13	1	89	5	0	0.92	0.97	0.08	0.03	A	0.03	0.014044944	Obesity-related traits	Obesity
rs13228694	C	T	80	13	1	89	5	0	0.92	0.97	0.08	0.03	A	0.03	0.014044944	Obesity-related traits	Obesity
rs6050469	G	A	89	5	0	79	15	0	0.97	0.92	0.03	0.08	A	0.03	0.014044944	Obesity-related traits	Obesity
rs76582905	A	G	63	30	1	78	15	1	0.83	0.91	0.17	0.09	G	34.08	0.014042314	Diisocyanate-induced asthma	Pulmonology
rs12150338	C	T	63	30	1	78	15	1	0.83	0.91	0.17	0.09	T	0.05	0.014042314	Calcium levels	General health
rs17147135	T	C	77	17	0	65	26	3	0.91	0.83	0.09	0.17	G	0.03	0.014042314	Obesity-related traits	Obesity
rs2412459	C	T	0	17	77	3	26	65	0.09	0.17	0.91	0.83	C	1	0.014042314	Response to haloperidol in psychosis	General health
rs4771996	G	A	4	24	66	0	17	77	0.17	0.09	0.83	0.91	G	0.03	0.014042314	Obesity-related traits	Obesity
rs4537545	C	T	19	53	22	14	41	39	0.48	0.37	0.52	0.63	T	11.5	0.01400463	C-reactive protein	Immune diseases and disorders
rs1260333	A	G	22	47	25	15	39	40	0.48	0.37	0.52	0.63	C	0.05	0.01400463	Triglycerides	General health
rs2224865	G	T	5	33	56	11	41	42	0.23	0.34	0.77	0.66	G	1.44	0.01397624	Eosinophilic esophagitis pediatric	Digestive system and its disorders
rs1550623	G	A	6	31	57	10	43	41	0.23	0.34	0.77	0.66	A	1.06	0.01397624	Breast cancer	Cancer
rs17818399	A	C	45	35	14	53	39	2	0.66	0.77	0.34	0.23	C	1.13	0.01397624	Height	General health
rs9321490	T	C	43	39	12	55	35	4	0.66	0.77	0.34	0.23	G	1.1	0.01397624	Multiple sclerosis	Brain health and disorders
rs1029534	T	G	2	24	68	1	12	81	0.15	0.07	0.85	0.93	T	1.18	0.013972056	Height	General health
rs7505784	T	C	2	10	82	3	22	69	0.07	0.15	0.93	0.85	C	0.09291562	0.013972056	LDL peak particle diameter total fat intake interaction	General health
rs1708299	A	G	2	24	68	1	12	81	0.15	0.07	0.85	0.93	A	0.04	0.013972056	Height	General health
rs2341917	A	G	81	12	1	67	26	1	0.93	0.85	0.07	0.15	G	1.17	0.013972056	Attention function in attention deficit hyperactive disorder	Brain health and disorders
rs17539620	G	T	68	24	2	81	12	1	0.85	0.93	0.15	0.07	T	0.33	0.013972056	Lipoprotein a levels	Heart health and disorders
rs11974702	A	G	80	14	0	70	20	4	0.93	0.85	0.07	0.15	A	0.184	0.013972056	Blood metabolite levels	Heart health and disorders
rs2721051	C	T	70	20	4	81	12	1	0.85	0.93	0.15	0.07	T	0.17	0.013972056	Corneal structure	General health
rs17184557	T	A	70	20	4	81	12	1	0.85	0.93	0.15	0.07	A	0.13	0.013972056	Osteoporosis-related phenotypes	Immune diseases and disorders
rs17086188	A	G	69	22	3	83	8	3	0.85	0.93	0.15	0.07	A	0.07	0.013972056	Menarche age at onset	Reproductive health
rs2069235	G	A	37	44	13	23	50	21	0.63	0.51	0.37	0.49	A	1.2658228	0.013961001	Primary biliary cirrhosis	Immune diseases and disorders
rs67250450	T	C	45	28	21	25	46	23	0.63	0.51	0.37	0.49	T	1.11	0.013961001	Rheumatoid arthritis	Immune diseases and disorders
rs228614	G	A	36	46	12	23	50	21	0.63	0.51	0.37	0.49	G	1.09	0.013961001	Multiple sclerosis	Brain health and disorders
rs1547014	T	C	11	48	35	25	42	27	0.37	0.49	0.63	0.51	T	0.013	0.013961001	Vertical cup-disc ratio	Misc
rs4409766	T	C	70	23	1	58	30	6	0.87	0.78	0.13	0.22	T	1.24	0.01395933	Systolic blood pressure	Heart health and disorders
rs12416687	T	C	56	34	4	71	21	2	0.78	0.87	0.22	0.13	T	0.59	0.01395933	Blood pressure	Heart health and disorders
rs12511469	T	A	57	32	5	70	23	1	0.78	0.87	0.22	0.13	A	0.18	0.01395933	Fibrinogen	General health
rs9951602	C	T	60	26	8	71	21	2	0.78	0.87	0.22	0.13	A	0.03	0.01395933	Obesity-related traits	Obesity
rs2922763	G	T	7	28	59	2	21	71	0.22	0.13	0.78	0.87	T	1	0.01395933	Body mass index	Obesity
rs2040494	C	T	3	36	55	2	21	71	0.22	0.13	0.78	0.87	C	0.26	0.01395933	Height	General health
rs9978142	A	T	66	26	2	51	38	5	0.84	0.74	0.16	0.26	T	0.043	0.013939081	Pulmonary function	Pulmonology
rs4871750	G	A	20	55	19	36	45	13	0.51	0.62	0.49	0.38	A	0.04	0.013920847	Obesity-related traits	Obesity
rs7635838	T	C	22	51	21	36	45	13	0.51	0.62	0.49	0.38	T	0.037	0.013920847	HDL cholesterol	General health
rs222054	C	G	51	31	12	61	30	3	0.71	0.81	0.29	0.19	C	2.54	0.013919414	Non-alcoholic fatty liver disease histology other	Obesity
rs11691652	T	G	47	39	8	61	30	3	0.71	0.81	0.29	0.19	C	0.03	0.013919414	Obesity-related traits	Obesity
rs560947	T	C	22	50	22	33	50	11	0.50	0.62	0.50	0.38	C	0.04	0.013884108	Metabolite levels  X-11787	General health
rs7725217	A	C	61	29	4	75	17	2	0.80	0.89	0.20	0.11	C	2.66	0.013879853	Hypersomnia HLA-DQB1*06:02 negative	Misc
rs1722141	A	G	5	27	62	0	21	73	0.20	0.11	0.80	0.89	A	0.067	0.013879853	Sitting height ratio	Appearance
rs10794720	T	C	0	21	73	6	25	63	0.11	0.20	0.89	0.80	T	0.01	0.013879853	Chronic kidney disease	Immune diseases and disorders
rs16936870	T	A	74	19	1	85	9	0	0.89	0.95	0.11	0.05	A	0.99	0.013872832	QT interval	Heart health and disorders
rs11708996	G	C	74	19	1	85	9	0	0.89	0.95	0.11	0.05	C	0.79	0.013872832	QRS duration	Heart health and disorders
rs3099844	C	A	85	9	0	75	17	2	0.95	0.89	0.05	0.11	A	0.15	0.013872832	Metabolic syndrome	Immune diseases and disorders
rs12748961	T	C	75	17	2	85	9	0	0.89	0.95	0.11	0.05	T	0.064	0.013872832	White blood cell types	Immune diseases and disorders
rs16894446	C	T	73	21	0	85	9	0	0.89	0.95	0.11	0.05	T	0.0167	0.013872832	Trans fatty acid levels	General health
rs2823093	G	A	47	40	7	35	43	16	0.71	0.60	0.29	0.40	G	1.09	0.013840505	Breast cancer	Cancer
rs1801274	A	G	34	46	14	26	40	28	0.61	0.49	0.39	0.51	G	1.0816648	0.013820674	Crohn's disease	Digestive system and its disorders
rs2816316	C	A	6	32	56	12	40	42	0.23	0.34	0.77	0.66	C	1.39	0.01381979	Celiac disease	Immune diseases and disorders
rs4689388	G	A	12	40	42	5	34	55	0.34	0.23	0.66	0.77	T	1.16	0.01381979	Type 2 diabetes and other traits	Diabetes
rs6052699	G	A	10	44	40	5	34	55	0.34	0.23	0.66	0.77	A	1	0.01381979	Platelet aggregation	Heart health and disorders
rs4871297	G	A	25	47	22	20	35	39	0.52	0.40	0.48	0.60	A	1.23	0.01379389	Type 1 diabetes nephropathy	Diabetes
rs2483374	A	C	27	43	24	16	43	35	0.52	0.40	0.48	0.60	C	0.03	0.01379389	Obesity-related traits	Obesity
rs17023900	A	G	76	18	0	87	7	0	0.90	0.96	0.10	0.04	G	1.41	0.013789174	Prostate cancer	Cancer
rs2273042	G	A	78	14	2	87	7	0	0.90	0.96	0.10	0.04	A	0.94	0.013789174	QT interval	Heart health and disorders
rs16840114	A	G	78	14	2	88	5	1	0.90	0.96	0.10	0.04	C	0.25	0.013789174	Anger	General health
rs76765968	T	C	78	14	2	87	7	0	0.90	0.96	0.10	0.04	T	0.064	0.013789174	Anorexia nervosa	Brain health and disorders
rs867186	A	G	87	7	0	78	14	2	0.96	0.90	0.04	0.10	G	0.0484	0.013789174	D-dimer levels	Heart health and disorders
rs2853946	A	T	31	50	13	22	46	26	0.60	0.48	0.40	0.52	A	0.017	0.013770343	White blood cell count	Immune diseases and disorders
rs2287623	G	A	25	49	20	15	47	32	0.53	0.41	0.47	0.59	G	0.027	0.01375	Cholesterol, total	General health
rs1958589	T	C	48	37	9	30	52	12	0.71	0.60	0.29	0.40	C	1	0.013740458	Celiac disease	Immune diseases and disorders
rs10889353	A	C	49	35	10	31	50	13	0.71	0.60	0.29	0.40	C	0.126	0.013740458	Triglycerides	General health
rs11207995	A	C	49	35	10	31	50	13	0.71	0.60	0.29	0.40	A	0.076	0.013740458	Cholesterol, total	General health
rs1061377	C	A	15	48	31	26	48	20	0.41	0.53	0.59	0.47	A	0.16	0.013732834	Uric acid levels	General health
rs679992	C	T	33	44	17	21	46	27	0.59	0.47	0.41	0.53	T	1.09	0.013732834	Type 2 diabetes	Diabetes
rs2173226	T	C	32	46	16	25	38	31	0.59	0.47	0.41	0.53	G	0.03	0.013732834	Obesity-related traits	Obesity
rs6901004	C	G	35	39	20	18	51	25	0.58	0.46	0.42	0.54	C	0.006	0.013718821	Blood metabolite levels	Heart health and disorders
rs3845817	T	C	20	39	35	26	49	19	0.42	0.54	0.58	0.46	T	1.1	0.013718821	Bipolar disorder	Brain health and disorders
rs2618568	C	A	16	47	31	19	63	12	0.42	0.54	0.58	0.46	C	0.044	0.013718821	Cholesterol, total	General health
rs2359536	T	C	47	38	9	62	27	5	0.70	0.80	0.30	0.20	C	1.84	0.013716327	Peripheral artery disease	Heart health and disorders
rs3766606	G	T	62	27	5	42	48	4	0.80	0.70	0.20	0.30	A	1.1060587	0.013716327	Crohn's disease	Digestive system and its disorders
rs13245690	A	G	46	40	8	58	35	1	0.70	0.80	0.30	0.20	A	0.05	0.013716327	Bone mineral density	General health
rs2254287	C	G	16	54	24	28	52	14	0.46	0.57	0.54	0.43	G	1.91	0.013707942	LDL cholesterol	General health
rs1854853	A	G	23	40	31	35	38	21	0.46	0.57	0.54	0.43	A	1.4164	0.013707942	Rheumatoid arthritis	Immune diseases and disorders
rs2094900	G	A	29	44	21	15	50	29	0.54	0.43	0.46	0.57	A	1.05	0.013707942	Schizophrenia	Brain health and disorders
rs6598541	A	G	23	40	31	27	54	13	0.46	0.57	0.54	0.43	A	0.043	0.013707942	Urate levels	General health
rs9323624	T	C	33	41	20	22	41	31	0.57	0.45	0.43	0.55	A	2.88	0.013700181	Acute urticaria and angioedema non-steroidal anti-inflammatory drug-induced	Immune diseases and disorders
rs6736848	T	C	20	45	29	29	49	16	0.45	0.57	0.55	0.43	T	1.05	0.013700181	Schizophrenia	Brain health and disorders
rs7565792	T	C	17	47	30	25	53	16	0.43	0.55	0.57	0.45	C	1.03	0.013700181	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs697739	C	T	28	48	18	19	44	31	0.55	0.44	0.45	0.56	A	2.04	0.013695529	Amyotrophic lateral sclerosis	Brain health and disorders
rs9287638	C	A	30	44	20	16	50	28	0.55	0.44	0.45	0.56	A	1.31	0.013695529	Male-pattern baldness	Appearance
rs893818	G	A	52	35	7	64	29	1	0.74	0.84	0.26	0.16	T	20.94	0.013682432	Exfoliation glaucoma or exfoliation syndrome	General health
rs1934620	A	G	64	29	1	51	37	6	0.84	0.74	0.16	0.26	A	4.2462	0.013682432	Smooth-surface caries	Appearance
rs4971486	C	G	66	25	3	51	37	6	0.84	0.74	0.16	0.26	G	1.99	0.013682432	Obesity in adult survivors of childhood cancer exposed to cranial radiation	Obesity
rs2278331	T	G	55	33	6	38	47	9	0.76	0.65	0.24	0.35	A	0.14	0.01367054	Sleep duration	General health
rs519595	A	G	5	35	54	13	39	42	0.24	0.35	0.76	0.65	G	0.6	0.01367054	Response to fenofibrate	General health
rs7174755	T	C	49	34	11	32	47	15	0.70	0.59	0.30	0.41	T	1.168	0.013645224	Major depressive disorder	Brain health and disorders
rs4530754	G	A	15	47	32	9	38	47	0.41	0.30	0.59	0.70	G	0.023	0.013645224	Cholesterol, total	General health
rs1564348	T	C	55	35	4	70	22	2	0.77	0.86	0.23	0.14	C	2.18	0.013643016	Cholesterol, total	General health
rs2744971	T	G	70	22	2	54	37	3	0.86	0.77	0.14	0.23	G	1.26	0.013643016	Height	General health
rs42041	C	G	56	33	5	69	24	1	0.77	0.86	0.23	0.14	G	1.11	0.013643016	Rheumatoid arthritis	Immune diseases and disorders
rs2814993	G	A	70	22	2	54	37	3	0.86	0.77	0.14	0.23	A	0.09	0.013643016	Height	General health
rs9815925	A	G	71	20	3	59	27	8	0.86	0.77	0.14	0.23	A	0.0374	0.013643016	Heschl's gyrus morphology	Brain health and disorders
rs13177918	C	T	62	31	1	77	16	1	0.82	0.90	0.18	0.10	T	1	0.013574661	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs6124878	G	A	64	27	3	77	16	1	0.82	0.90	0.18	0.10	A	1	0.013574661	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs16982520	A	G	76	18	0	63	29	2	0.90	0.82	0.10	0.18	A	0.13	0.013574661	Hypertension	Heart health and disorders
rs173539	C	T	54	34	6	41	40	13	0.76	0.65	0.24	0.35	T	0.255	0.013528139	Cardiovascular disease risk factors	Heart health and disorders
rs3981351	G	A	5	36	53	14	38	42	0.24	0.35	0.76	0.65	G	0.04	0.013528139	Obesity-related traits	Obesity
rs11950562	A	C	41	40	13	53	36	5	0.65	0.76	0.35	0.24	A	0.036	0.013528139	Blood metabolite levels	Heart health and disorders
rs17486278	A	C	41	40	13	57	28	9	0.65	0.76	0.35	0.24	A	0.03	0.013528139	Local histogram emphysema pattern	Pulmonology
rs3194051	A	G	61	28	5	45	41	8	0.80	0.70	0.20	0.30	G	1.07	0.013523132	Ulcerative colitis	Immune diseases and disorders
rs7279441	A	G	60	30	4	44	43	7	0.80	0.70	0.20	0.30	G	0.03	0.013523132	Self-rated health	General health
rs9368677	G	A	71	21	2	82	12	0	0.87	0.94	0.13	0.06	G	1.36	0.013473651	Atopic dermatitis	Immune diseases and disorders
rs2577704	G	A	82	12	0	71	21	2	0.94	0.87	0.06	0.13	G	0.2408	0.013473651	IgG glycosylation	Immune diseases and disorders
rs926849	C	T	6	46	42	16	47	31	0.31	0.42	0.69	0.58	C	0.13	0.013468528	Disc degeneration lumbar	Aging
rs8040868	T	C	31	47	16	44	42	8	0.58	0.69	0.42	0.31	T	1	0.013468528	Pulmonary function interaction	Pulmonology
rs1735884	C	T	1	30	63	7	36	51	0.17	0.27	0.83	0.73	G	0.04	0.013439522	Obesity-related traits	Obesity
rs10099338	A	G	66	24	4	52	34	8	0.83	0.73	0.17	0.27	G	13.28	0.013439522	Glomerular filtration rate	General health
rs10199521	C	T	67	22	5	51	36	7	0.83	0.73	0.17	0.27	T	1.46	0.013439522	Diabetic retinopathy	Diabetes
rs7561528	G	A	50	38	6	63	30	1	0.73	0.83	0.27	0.17	A	1.17	0.013439522	Alzheimer's disease late onset	Brain health and disorders
rs483905	G	A	52	34	8	64	28	2	0.73	0.83	0.27	0.17	A	1.0887091	0.013439522	Ulcerative colitis	Immune diseases and disorders
rs9532969	C	T	48	42	4	66	24	4	0.73	0.83	0.27	0.17	C	0.05	0.013439522	Metabolite levels  X-11787	General health
rs71391092	C	G	67	25	2	80	13	1	0.85	0.92	0.15	0.08	C	1.07	0.013417306	Schizophrenia	Brain health and disorders
rs3733309	A	G	69	21	4	79	15	0	0.85	0.92	0.15	0.08	A	0.021	0.013417306	Height	General health
rs2170820	C	G	10	47	37	4	39	51	0.36	0.25	0.64	0.75	C	0.063	0.013392259	Anxiety disorder	Brain health and disorders
rs6563739	G	T	5	37	52	8	51	35	0.25	0.36	0.75	0.64	G	0.03	0.013392259	Menarche age at onset	Reproductive health
rs1030420	C	T	54	33	7	39	43	12	0.75	0.64	0.25	0.36	T	0.022	0.013392259	Blood metabolite levels	Heart health and disorders
rs1926320	T	C	55	31	8	40	41	13	0.75	0.64	0.25	0.36	C	0.01	0.013392259	Vertical cup-disc ratio	Misc
rs1469622	T	C	33	42	19	45	39	10	0.57	0.69	0.43	0.31	T	1.88	0.013386759	Tooth agenesis third molar	Misc
rs9653442	C	T	26	56	12	43	43	8	0.57	0.69	0.43	0.31	G	1.11	0.013386759	Type 1 diabetes	Diabetes
rs2730245	G	C	8	43	43	17	46	31	0.31	0.43	0.69	0.57	G	0.32	0.013386759	Height	General health
rs527616	C	G	6	32	56	0	27	67	0.23	0.14	0.77	0.86	G	1.05	0.013345648	Breast cancer	Cancer
rs6983039	G	A	70	21	3	55	34	5	0.86	0.77	0.14	0.23	G	0.4445	0.013345648	IgG glycosylation	Immune diseases and disorders
rs2855812	G	T	70	21	3	58	28	8	0.86	0.77	0.14	0.23	T	0.03	0.013345648	Pulmonary function	Pulmonology
rs1001780	G	T	59	31	4	37	56	1	0.79	0.69	0.21	0.31	G	1.0752687	0.013339245	Schizophrenia	Brain health and disorders
rs2341263	C	T	59	31	4	43	44	7	0.79	0.69	0.21	0.31	C	0.04	0.013339245	Metabolite levels  X-11787	General health
rs2853552	A	G	12	34	48	3	33	58	0.31	0.21	0.69	0.79	A	0.03	0.013339245	Obesity-related traits	Obesity
rs849135	G	A	35	37	22	44	40	10	0.57	0.68	0.43	0.32	G	1.12	0.01330919	Type 2 diabetes	Diabetes
rs35412	C	G	10	40	44	15	51	28	0.32	0.43	0.68	0.57	C	0.19732696	0.01330919	Perceived skin darkness	Appearance
rs2048161	A	G	1	11	82	0	4	90	0.07	0.02	0.93	0.98	A	1	0.013272161	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs17744182	G	A	81	13	0	90	4	0	0.93	0.98	0.07	0.02	A	1.43	0.013272161	PR interval	Heart health and disorders
rs11726269	A	G	81	13	0	90	4	0	0.93	0.98	0.07	0.02	G	1.39	0.013272161	Peripheral artery disease	Heart health and disorders
rs76934034	T	C	82	11	1	90	4	0	0.93	0.98	0.07	0.02	T	1.14	0.013272161	Prostate cancer	Cancer
rs968567	C	T	81	13	0	90	4	0	0.93	0.98	0.07	0.02	C	1.12	0.013272161	Rheumatoid arthritis	Immune diseases and disorders
rs3923564	A	G	90	4	0	83	9	2	0.98	0.93	0.02	0.07	G	1	0.013272161	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs17835853	G	A	90	4	0	81	13	0	0.98	0.93	0.02	0.07	G	0.4778	0.013272161	IgG glycosylation	Immune diseases and disorders
rs11575839	G	A	90	4	0	81	13	0	0.98	0.93	0.02	0.07	A	0.23	0.013272161	Complement C3 and C4 levels	Immune diseases and disorders
rs13377206	A	T	81	13	0	90	4	0	0.93	0.98	0.07	0.02	A	0.0437	0.013272161	Heschl's gyrus morphology	Brain health and disorders
rs1509123	C	T	81	13	0	90	4	0	0.93	0.98	0.07	0.02	T	0.025	0.013272161	Blood metabolite levels	Heart health and disorders
rs4236601	G	A	53	34	7	40	40	14	0.74	0.64	0.26	0.36	A	1.27	0.013262599	Glaucoma primary open-angle	General health
rs793571	A	G	52	36	6	34	52	8	0.74	0.64	0.26	0.36	A	1.06	0.013262599	Schizophrenia	Brain health and disorders
rs4731702	C	T	38	44	12	54	32	8	0.64	0.74	0.36	0.26	T	0.59	0.013262599	HDL cholesterol	General health
rs3020331	C	T	39	42	13	53	34	7	0.64	0.74	0.36	0.26	T	0.07	0.013262599	Bone properties heel	General health
rs13241165	A	T	38	44	12	54	32	8	0.64	0.74	0.36	0.26	T	0.037	0.013262599	HDL cholesterol	General health
rs13241538	G	C	38	44	12	54	32	8	0.64	0.74	0.36	0.26	C	0.0207	0.013262599	Waist-to-hip ratio adjusted for body mass index	Obesity
rs2986961	C	T	9	43	42	19	44	31	0.32	0.44	0.68	0.56	C	1.14	0.013235691	Migraine with aura	Brain health and disorders
rs713875	C	G	32	42	20	40	47	7	0.56	0.68	0.44	0.32	C	1.08	0.013235691	Crohn's disease	Digestive system and its disorders
rs9619497	G	A	39	49	6	26	54	14	0.68	0.56	0.32	0.44	A	0.2273	0.013235691	Metabolite levels HVA-5-HIAA Factor score	General health
rs10066447	C	T	62	31	1	48	41	5	0.82	0.73	0.18	0.27	T	1	0.013209393	Visceral fat	Obesity
rs4263037	G	A	14	55	25	11	40	43	0.44	0.33	0.56	0.67	G	1.26	0.013166144	Myasthenia gravis	Brain health and disorders
rs16932667	T	G	45	36	13	28	49	17	0.67	0.56	0.33	0.44	T	0.052	0.013166144	Intelligence childhood	Mental aptitude and behavioural traits
rs4940203	C	T	35	35	24	43	40	11	0.56	0.67	0.44	0.33	A	0.05	0.013166144	Obesity-related traits	Obesity
rs1920116	G	A	46	37	11	57	34	3	0.69	0.79	0.31	0.21	G	1.3	0.013164132	Glioma high-grade	Cancer
rs11214775	G	A	56	36	2	42	45	7	0.79	0.69	0.21	0.31	G	1.08	0.013164132	Prostate cancer	Cancer
rs6127813	C	T	60	28	6	45	39	10	0.79	0.69	0.21	0.31	T	0.2843	0.013164132	Lewy body disease	Brain health and disorders
rs6931514	A	G	58	32	4	47	35	12	0.79	0.69	0.21	0.31	G	0.05	0.013164132	Birth weight	Misc
rs1775453	C	T	10	39	45	4	32	58	0.31	0.21	0.69	0.79	C	1	0.013164132	Serum protein levels sST2	General health
rs17780256	A	C	59	31	4	73	19	2	0.79	0.88	0.21	0.12	A	1.1223103	0.013149784	Ulcerative colitis	Immune diseases and disorders
rs685782	T	C	77	15	2	63	28	3	0.90	0.82	0.10	0.18	C	0.192	0.013143291	Metabolite levels Dihydroxy docosatrienoic acid	General health
rs2980003	C	T	42	35	17	52	35	7	0.63	0.74	0.37	0.26	T	22.07	0.013138878	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs13140744	C	T	40	39	15	50	39	5	0.63	0.74	0.37	0.26	T	2.2	0.013138878	Emphysema imaging phenotypes	Pulmonology
rs10016562	T	G	40	39	15	50	39	5	0.63	0.74	0.37	0.26	T	1.6	0.013138878	Emphysema imaging phenotypes	Pulmonology
rs10508881	A	G	34	36	24	37	51	6	0.55	0.66	0.45	0.34	A	1.19	0.013100437	Endometriosis	General health
rs13129697	T	G	23	38	33	15	33	46	0.45	0.34	0.55	0.66	G	0.403	0.013100437	Urate levels in lean individuals	Obesity
rs10236237	A	T	43	39	12	25	54	15	0.66	0.55	0.34	0.45	T	0.1613	0.013100437	IgG glycosylation	Immune diseases and disorders
rs2021786	T	C	21	42	31	9	45	40	0.45	0.34	0.55	0.66	T	0.1	0.013100437	Preschool internalizing problems	Mental aptitude and behavioural traits
rs10902723	T	C	26	52	16	46	33	15	0.55	0.66	0.45	0.34	G	0.01	0.013100437	Obesity-related traits	Obesity
rs3764044	T	C	85	8	1	74	18	2	0.95	0.88	0.05	0.12	G	3.68	0.013081395	Diisocyanate-induced asthma	Pulmonology
rs11231299	G	A	73	20	1	85	8	1	0.88	0.95	0.12	0.05	A	1	0.013081395	Visceral fat	Obesity
rs17702912	C	T	73	20	1	84	10	0	0.88	0.95	0.12	0.05	T	0.5171	0.013081395	Urinary metabolites	General health
rs4787294	A	T	73	20	1	84	10	0	0.88	0.95	0.12	0.05	A	0.075	0.013081395	Blood metabolite levels	Heart health and disorders
rs4327120	T	C	84	10	0	73	20	1	0.95	0.88	0.05	0.12	T	0.04	0.013081395	Body mass index	Obesity
rs2292873	C	T	74	18	2	84	10	0	0.88	0.95	0.12	0.05	A	0.03	0.013081395	Obesity-related traits	Obesity
rs16876394	T	C	84	10	0	72	22	0	0.95	0.88	0.05	0.12	T	0.03	0.013081395	Blood metabolite levels	Heart health and disorders
rs2926702	C	T	1	20	73	0	10	84	0.12	0.05	0.88	0.95	T	1	0.013081395	Non-small cell lung cancer	Cancer
rs2945733	T	G	1	20	73	0	10	84	0.12	0.05	0.88	0.95	A	0.51	0.013081395	Intraocular pressure	General health
rs7588654	C	T	3	22	69	5	35	54	0.15	0.24	0.85	0.76	T	0.051	0.01306569	Height	General health
rs1886449	C	T	67	26	1	54	35	5	0.85	0.76	0.15	0.24	A	1.51	0.01306569	Pancreatic cancer	Cancer
rs10042968	A	G	68	24	2	54	35	5	0.85	0.76	0.15	0.24	G	1.42	0.01306569	Alcohol and nictotine co-dependence	General health
rs5743030	G	A	68	24	2	55	33	6	0.85	0.76	0.15	0.24	A	1	0.01306569	Subcutaneous adipose tissue	Obesity
rs7141238	T	G	71	18	5	52	39	3	0.85	0.76	0.15	0.24	C	0.04	0.01306569	Obesity-related traits	Obesity
rs11249608	T	C	11	42	41	19	47	28	0.34	0.45	0.66	0.55	C	0.08	0.013038465	Pubertal anthropometrics	Appearance
rs163879	C	T	10	44	40	14	57	23	0.34	0.45	0.66	0.55	T	0.04	0.013038465	Bone mineral density	General health
rs12446319	T	C	25	53	16	45	34	15	0.55	0.66	0.45	0.34	A	2.026	0.013038465	Adverse response to chemotherapy neutropenia_leucopenia carboplatin	Drug response
rs9268856	C	A	49	40	5	39	40	15	0.73	0.63	0.27	0.37	C	1.24	0.013020833	Frontotemporal dementia	Brain health and disorders
rs1971762	C	T	36	46	12	48	42	4	0.63	0.73	0.37	0.27	T	0.043	0.013020833	Height	General health
rs873549	C	T	5	50	39	4	33	57	0.32	0.22	0.68	0.78	C	1.77	0.0129973	Keloid	Misc
rs4141819	C	T	5	31	58	7	46	41	0.22	0.32	0.78	0.68	C	1.15	0.0129973	Endometriosis	General health
rs7324557	A	G	11	38	45	4	33	57	0.32	0.22	0.68	0.78	G	1	0.0129973	Visceral adipose tissue adjusted for BMI	Obesity
rs546829	A	T	3	35	56	10	40	44	0.22	0.32	0.78	0.68	A	0.06	0.0129973	White blood cell types	Immune diseases and disorders
rs12946510	C	T	42	44	8	60	27	7	0.68	0.78	0.32	0.22	A	1.1311512	0.0129973	Crohn's disease	Digestive system and its disorders
rs12029080	T	G	50	36	8	64	26	4	0.72	0.82	0.28	0.18	G	10.4	0.012991179	D-dimer levels	Heart health and disorders
rs181359	G	A	52	32	10	64	26	4	0.72	0.82	0.28	0.18	T	1.1	0.012991179	Crohn's disease	Digestive system and its disorders
rs11700808	A	C	51	34	9	65	24	5	0.72	0.82	0.28	0.18	A	1	0.012991179	Middle childhood and early adolescence aggressive behavior	Brain health and disorders
rs4821112	G	A	52	32	10	64	26	4	0.72	0.82	0.28	0.18	A	0.067	0.012991179	Mean corpuscular volume	Heart health and disorders
rs4849887	T	C	4	26	64	11	30	53	0.18	0.28	0.82	0.72	T	0.166	0.012991179	Breast size	General health
rs4784165	T	G	42	39	13	28	46	20	0.65	0.54	0.35	0.46	G	1.15	0.012980132	Polycystic ovary syndrome	Reproductive health
rs675531	T	C	19	49	26	14	38	42	0.46	0.35	0.54	0.65	C	2.193	0.01292535	Recalcitrant atopic dermatitis	Immune diseases and disorders
rs11602954	G	A	67	24	3	79	14	1	0.84	0.91	0.16	0.09	G	6.46	0.012911726	Platelet count	Heart health and disorders
rs2257205	C	T	80	12	2	64	30	0	0.91	0.84	0.09	0.16	A	1.38	0.012911726	Pancreatic cancer	Cancer
rs2270676	A	G	80	12	2	67	24	3	0.91	0.84	0.09	0.16	G	1.29	0.012911726	Corneal astigmatism	General health
rs9402686	G	A	65	28	1	78	16	0	0.84	0.91	0.16	0.09	A	0.82	0.012911726	Hematological parameters	Heart health and disorders
rs7652995	G	A	2	26	66	0	16	78	0.16	0.09	0.84	0.91	G	0.5797	0.012911726	IgG glycosylation	Immune diseases and disorders
rs4820255	G	C	4	22	68	1	14	79	0.16	0.09	0.84	0.91	C	0.366	0.012911726	Sexual dysfunction female	Reproductive health
rs301	T	C	35	47	12	47	43	4	0.62	0.73	0.38	0.27	C	0.22	0.012908223	Metabolic syndrome bivariate traits	Immune diseases and disorders
rs5764106	T	C	49	39	6	35	47	12	0.73	0.62	0.27	0.38	C	0.1956	0.012908223	IgG glycosylation	Immune diseases and disorders
rs3756766	A	C	8	35	51	14	43	37	0.27	0.38	0.73	0.62	A	1.07	0.012908223	Schizophrenia	Brain health and disorders
rs1474256	C	T	23	54	17	43	35	16	0.53	0.64	0.47	0.36	G	1.2048	0.012874033	Bronchopulmonary dysplasia	Pulmonology
rs233100	G	A	28	44	22	40	41	13	0.53	0.64	0.47	0.36	G	1.08	0.012874033	Multiple sclerosis	Brain health and disorders
rs7584099	A	G	26	48	20	40	41	13	0.53	0.64	0.47	0.36	G	1	0.012874033	Response to statin therapy	General health
rs12027542	A	G	69	24	1	82	11	1	0.86	0.93	0.14	0.07	A	1.41	0.012858556	Type 2 diabetes	Diabetes
rs55833108	G	T	69	24	1	81	13	0	0.86	0.93	0.14	0.07	T	1.08	0.012858556	Schizophrenia	Brain health and disorders
rs7749924	C	T	69	24	1	81	13	0	0.86	0.93	0.14	0.07	C	0.2204	0.012858556	IgG glycosylation	Immune diseases and disorders
rs2229774	G	A	86	8	0	76	17	1	0.96	0.90	0.04	0.10	A	5.4	0.012840921	Anthracycline-induced cardiotoxicity in childhood cancer	Heart health and disorders
rs11073328	C	T	75	19	0	87	6	1	0.90	0.96	0.10	0.04	T	1.935	0.012840921	Systemic lupus erythematosus	Immune diseases and disorders
rs5770917	T	C	75	19	0	86	8	0	0.90	0.96	0.10	0.04	C	1.63	0.012840921	Narcolepsy	Brain health and disorders
rs7407664	A	G	75	19	0	86	8	0	0.90	0.96	0.10	0.04	A	0.1408	0.012840921	Cerebral amyloid deposition PET imaging	Brain health and disorders
rs10872424	C	T	76	17	1	86	8	0	0.90	0.96	0.10	0.04	T	0.12	0.012840921	Glomerular filtration rate in chronic kidney disease	General health
rs1053221	T	C	77	15	2	86	8	0	0.90	0.96	0.10	0.04	G	0.04	0.012840921	Obesity-related traits	Obesity
rs6695572	G	A	77	15	2	86	8	0	0.90	0.96	0.10	0.04	A	0.022	0.012840921	Body mass index	Obesity
rs3132580	G	A	88	6	0	78	16	0	0.97	0.91	0.03	0.09	T	2.74	0.012840267	Idiopathic membranous nephropathy	Brain health and disorders
rs13340561	T	G	88	6	0	80	12	2	0.97	0.91	0.03	0.09	G	1.6949153	0.012840267	Alcohol dependence	General health
rs16951095	C	T	78	16	0	88	6	0	0.91	0.97	0.09	0.03	C	1.3	0.012840267	Non-small cell lung cancer	Cancer
rs112509803	G	C	80	12	2	88	6	0	0.91	0.97	0.09	0.03	C	1.09	0.012840267	Schizophrenia	Brain health and disorders
rs11078697	C	T	78	16	0	88	6	0	0.91	0.97	0.09	0.03	C	1	0.012840267	IgM levels	Immune diseases and disorders
rs17056278	C	G	80	12	2	88	6	0	0.91	0.97	0.09	0.03	C	1	0.012840267	Hip circumference psychosocial stress interaction	Appearance
rs3132581	G	A	88	6	0	78	16	0	0.97	0.91	0.03	0.09	G	1	0.012840267	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs9900808	G	A	88	6	0	79	14	1	0.97	0.91	0.03	0.09	A	0.082	0.012840267	Cannabis use initiation	General health
rs1017226	T	C	79	14	1	88	6	0	0.91	0.97	0.09	0.03	C	0.030341806	0.012840267	Urate levels BMI interaction	Obesity
rs10245124	T	C	78	16	0	88	6	0	0.91	0.97	0.09	0.03	G	0.03	0.012840267	Obesity-related traits	Obesity
rs12466022	C	A	58	30	6	44	39	11	0.78	0.68	0.22	0.32	C	1.11	0.012838294	Multiple sclerosis	Brain health and disorders
rs10792832	A	G	11	39	44	3	36	55	0.32	0.22	0.68	0.78	G	1.14	0.012838294	Alzheimer's disease in APOE e4+ carriers	Brain health and disorders
rs10783624	C	A	21	47	26	14	40	40	0.47	0.36	0.53	0.64	C	1.0526316	0.012826106	Schizophrenia	Brain health and disorders
rs3110127	C	T	17	55	22	10	48	36	0.47	0.36	0.53	0.64	A	0.15	0.012826106	RR interval heart rate	Heart health and disorders
rs10508517	G	A	59	30	5	72	20	2	0.79	0.87	0.21	0.13	A	0.18	0.012820513	Quantitative traits	Misc
rs3771395	G	A	70	24	0	59	30	5	0.87	0.79	0.13	0.21	G	0.082	0.012820513	Corneal astigmatism	General health
rs6056891	G	A	3	34	57	5	14	75	0.21	0.13	0.79	0.87	G	0.03	0.012820513	Obesity-related traits	Obesity
rs9959259	G	A	56	30	8	68	23	3	0.76	0.85	0.24	0.15	A	0.02	0.012801772	Obesity-related traits	Obesity
rs4833079	T	C	52	38	4	66	27	1	0.76	0.85	0.24	0.15	T	0.013	0.012801772	Body mass index	Obesity
rs6599222	C	T	2	25	67	4	38	52	0.15	0.24	0.85	0.76	C	3.4	0.012801772	PR interval	Heart health and disorders
rs10049246	A	G	5	36	53	1	27	66	0.24	0.15	0.76	0.85	G	0.6	0.012801772	Attention deficit hyperactivity disorder symptoms interaction	Brain health and disorders
rs9421748	G	A	34	48	12	46	44	4	0.62	0.72	0.38	0.28	A	0.2526	0.012800819	Postprandial triglyceride response to high fat diet meal	General health
rs11970286	C	T	46	43	5	61	31	2	0.72	0.81	0.28	0.19	T	6.19	0.012784091	Electrocardiographic traits	Heart health and disorders
rs2131877	G	A	46	43	5	61	31	2	0.72	0.81	0.28	0.19	G	1.3	0.012784091	Non-small cell lung cancer	Cancer
rs9271192	C	A	5	43	46	4	27	63	0.28	0.19	0.72	0.81	C	1.11	0.012784091	Alzheimer's disease late onset	Brain health and disorders
rs17356983	A	G	63	27	4	49	37	8	0.81	0.72	0.19	0.28	G	0.03	0.012784091	Obesity-related traits	Obesity
rs9866825	A	C	19	52	23	7	55	32	0.48	0.37	0.52	0.63	A	1.18	0.012781497	QT interval	Heart health and disorders
rs8033195	G	C	61	31	2	76	16	2	0.81	0.89	0.19	0.11	A	174.53	0.012744265	Hippocampal volume	Brain health and disorders
rs9835973	C	T	63	27	4	75	18	1	0.81	0.89	0.19	0.11	A	1	0.012744265	Immune reponse to smallpox secreted IL-1beta	Immune diseases and disorders
rs12202284	C	A	75	18	1	59	35	0	0.89	0.81	0.11	0.19	A	0.15	0.012744265	Non-melanoma skin cancer	Cancer
rs2825388	T	A	38	42	14	25	47	22	0.63	0.52	0.37	0.48	A	1.06	0.012740142	Attention deficit hyperactivity disorder symptoms interaction	Brain health and disorders
rs2839186	C	T	24	48	22	34	49	11	0.51	0.62	0.49	0.38	T	1.26	0.012701979	Testicular germ cell tumor	Cancer
rs1562430	T	C	55	25	14	38	39	17	0.72	0.61	0.28	0.39	T	1.17	0.012698413	Breast cancer	Cancer
rs17563	A	G	35	45	14	51	33	10	0.61	0.72	0.39	0.28	G	0.239	0.012698413	Primary tooth development time to first tooth eruption	Misc
rs12718244	G	A	40	46	8	58	29	7	0.67	0.77	0.33	0.23	A	1.0833611	0.012686698	Crohn's disease	Digestive system and its disorders
rs6901250	G	A	43	40	11	56	33	5	0.67	0.77	0.33	0.23	A	0.035	0.012686698	C-reactive protein levels	Immune diseases and disorders
rs455804	A	C	2	39	53	10	42	42	0.23	0.33	0.77	0.67	C	1.19	0.012686698	Hepatocellular carcinoma	Cancer
rs6588480	A	G	4	35	55	8	46	40	0.23	0.33	0.77	0.67	A	1	0.012686698	Response to statin therapy	General health
rs2307022	A	G	9	44	41	5	33	56	0.33	0.23	0.67	0.77	A	0.016	0.012686698	Body mass index	Obesity
rs6754640	G	A	39	38	17	26	43	25	0.62	0.51	0.38	0.49	A	0.15	0.012666954	Temperament	Mental aptitude and behavioural traits
rs7902091	C	A	36	43	15	23	48	23	0.61	0.50	0.39	0.50	A	5.331	0.012635017	Schizophrenia cytomegalovirus infection interaction	Brain health and disorders
rs6927022	A	G	48	19	27	24	46	24	0.61	0.50	0.39	0.50	A	1.444	0.012635017	Ulcerative colitis	Immune diseases and disorders
rs516243	A	G	20	54	20	39	37	18	0.50	0.61	0.50	0.39	A	1.11	0.012635017	Migraine - clinic-based	Brain health and disorders
rs783540	A	G	33	49	12	23	48	23	0.61	0.50	0.39	0.50	G	1.0638298	0.012635017	Schizophrenia	Brain health and disorders
rs7395662	A	G	14	45	35	25	44	25	0.39	0.50	0.61	0.50	G	0.07	0.012635017	HDL cholesterol	General health
rs3132946	A	G	1	9	84	0	3	91	0.06	0.02	0.94	0.98	A	1.38	0.012628256	Interstitial lung disease	Pulmonology
rs13111850	C	T	1	9	84	0	3	91	0.06	0.02	0.94	0.98	G	1	0.012628256	Immune reponse to smallpox secreted IL-10	Immune diseases and disorders
rs73302615	G	A	91	3	0	83	11	0	0.98	0.94	0.02	0.06	A	15.23	0.012628256	Diisocyanate-induced asthma	Pulmonology
rs35229355	C	T	91	3	0	83	11	0	0.98	0.94	0.02	0.06	T	7.24	0.012628256	Response to treatment for acute lymphoblastic leukemia	General health
rs6585436	T	C	91	3	0	83	11	0	0.98	0.94	0.02	0.06	C	2.08	0.012628256	Cardiac repolarization	Heart health and disorders
rs8001893	C	A	91	3	0	83	11	0	0.98	0.94	0.02	0.06	A	0.3	0.012628256	Plasma amyloid beta peptide concentrations ABx-40	Brain health and disorders
rs13135092	A	G	83	11	0	91	3	0	0.94	0.98	0.06	0.02	A	0.129	0.012628256	HDL cholesterol	General health
rs17103186	C	T	91	3	0	84	9	1	0.98	0.94	0.02	0.06	C	0.11	0.012628256	Corneal curvature	General health
rs12612930	T	C	83	11	0	91	3	0	0.94	0.98	0.06	0.02	C	0.1	0.012628256	Height	General health
rs17468244	A	G	84	9	1	91	3	0	0.94	0.98	0.06	0.02	G	0.03	0.012628256	Obesity-related traits	Obesity
rs2278034	T	C	25	43	26	25	64	5	0.49	0.61	0.51	0.39		1.83	0.012606123	Bronchopulmonary dysplasia	Pulmonology
rs6793295	T	C	48	38	8	30	54	10	0.71	0.61	0.29	0.39	T	0.16	0.012600806	Multiple myeloma and monoclonal gammopathy	Cancer
rs1265112	T	C	46	42	6	62	28	4	0.71	0.81	0.29	0.19	G	4.36	0.012587413	Nevirapine-induced rash	General health
rs424232	C	T	63	26	5	50	34	10	0.81	0.71	0.19	0.29	C	1	0.012587413	Celiac disease	Immune diseases and disorders
rs3788013	C	A	36	41	17	20	52	22	0.60	0.49	0.40	0.51	A	1.1	0.012580231	Type 1 diabetes autoantibodies	Diabetes
rs2298450	C	T	37	39	18	24	44	26	0.60	0.49	0.40	0.51	C	1.0526316	0.012580231	Schizophrenia	Brain health and disorders
rs174574	A	C	25	42	27	33	47	14	0.49	0.60	0.51	0.40	A	0.08	0.012580231	Phospholipid levels plasma	General health
rs38911	G	A	25	47	22	12	52	30	0.52	0.40	0.48	0.60	G	1.0574577	0.012557305	Ulcerative colitis	Immune diseases and disorders
rs6968554	A	G	26	45	23	19	38	37	0.52	0.40	0.48	0.60	A	0.2	0.012557305	Coffee consumption	Misc
rs802734	A	G	52	37	5	66	26	2	0.75	0.84	0.25	0.16	G	1.17	0.012552665	Celiac disease	Immune diseases and disorders
rs10202497	C	A	68	22	4	51	39	4	0.84	0.75	0.16	0.25	C	1.12	0.012552665	Aging time to event	Aging
rs488248	C	T	5	34	55	13	37	44	0.23	0.34	0.77	0.66	T	2.896	0.012542126	Adverse response to chemotherapy neutropenia_leucopenia docetaxel	Drug response
rs6743376	C	A	12	39	43	9	26	59	0.34	0.23	0.66	0.77	A	0.13	0.012542126	Inflammatory biomarkers	Immune diseases and disorders
rs11120822	G	C	45	35	14	57	30	7	0.66	0.77	0.34	0.23	C	0.0931	0.012542126	Stearic acid 18:0 plasma levels	General health
rs12589282	A	C	34	43	17	19	52	23	0.59	0.48	0.41	0.52	G	1.48	0.012537313	Adverse response to chemotherapy neutropenia_leucopenia all platinum-based drugs	Drug response
rs4632195	C	T	33	45	16	21	48	25	0.59	0.48	0.41	0.52	T	1.05	0.012537313	Schizophrenia	Brain health and disorders
rs9905820	T	G	32	47	15	22	46	26	0.59	0.48	0.41	0.52	G	0.094	0.012537313	Testosterone levels	Reproductive health
rs16868246	C	G	17	43	34	30	38	26	0.41	0.52	0.59	0.48	C	0.01	0.012537313	Blood metabolite levels	Heart health and disorders
rs3803662	A	G	16	46	32	22	55	17	0.41	0.53	0.59	0.47	T	1.28	0.012520228	Breast cancer	Cancer
rs10773046	A	G	25	49	20	12	54	28	0.53	0.41	0.47	0.59	G	1.07	0.012520228	Osteoarthritis hip	Immune diseases and disorders
rs9871967	A	G	69	25	0	57	33	4	0.87	0.78	0.13	0.22	G	15.18	0.012512219	Diisocyanate-induced asthma	Pulmonology
rs798544	C	T	59	29	6	72	19	3	0.78	0.87	0.22	0.13	G	5.9	0.012512219	Height	General health
rs798554	C	T	59	29	6	72	19	3	0.78	0.87	0.22	0.13	C	1.24	0.012512219	Height	General health
rs1004467	A	G	70	23	1	58	31	5	0.87	0.78	0.13	0.22	A	1.05	0.012512219	Systolic blood pressure	Heart health and disorders
rs11079160	A	T	70	23	1	56	35	3	0.87	0.78	0.13	0.22	T	0.09	0.012512219	Urate levels in obese individuals	Obesity
rs4713103	G	T	13	49	32	9	37	48	0.40	0.29	0.60	0.71	T	0.11	0.012507817	Phospholipid levels plasma	General health
rs2307394	T	C	35	43	16	48	37	9	0.60	0.71	0.40	0.29	T	0.029	0.012507817	Urate levels	General health
rs4731207	G	A	30	49	15	20	48	26	0.58	0.47	0.42	0.53	A	0.079	0.012506026	Cutaneous malignant melanoma	Cancer
rs7551188	T	C	15	49	30	27	46	21	0.42	0.53	0.58	0.47	T	1.18	0.012506026	Crohn's disease	Digestive system and its disorders
rs4889009	G	C	18	43	33	24	52	18	0.42	0.53	0.58	0.47	G	1.14	0.012506026	Thyroid peroxidase antibody positivity	Immune diseases and disorders
rs9386791	C	T	31	39	24	17	46	31	0.54	0.43	0.46	0.57	C	0.2294	0.012494688	Red blood cell traits	Immune diseases and disorders
rs12506899	T	G	21	38	35	26	49	19	0.43	0.54	0.57	0.46	G	0.065	0.012494688	Tumor biomarkers	Cancer
rs7319045	A	G	13	54	27	28	45	21	0.43	0.54	0.57	0.46	A	0.029	0.012494688	Height	General health
rs10883437	T	A	29	49	16	19	48	27	0.57	0.46	0.43	0.54	T	2.3	0.012486197	Liver enzyme levels alanine transaminase	General health
rs4782151	C	T	32	43	19	22	42	30	0.57	0.46	0.43	0.54	C	1.91	0.012486197	Cervical cancer	Cancer
rs6832439	A	G	20	41	33	31	40	23	0.43	0.54	0.57	0.46	A	1	0.012486197	Serum uric acid levels	General health
rs7235440	C	T	27	48	19	19	43	32	0.54	0.43	0.46	0.57	G	0.03	0.012486197	Obesity-related traits	Obesity
rs2155219	G	T	28	47	19	14	54	26	0.55	0.44	0.45	0.56	T	0.1081	0.012480543	Self-reported allergy	General health
rs722599	T	C	25	54	15	18	47	29	0.55	0.44	0.45	0.56	C	0.1395	0.012477718	IgG glycosylation	Immune diseases and disorders
rs16823858	G	A	77	17	0	65	27	2	0.91	0.84	0.09	0.16	A	1.294	0.012449187	HIV-1 viral setpoint	Immune diseases and disorders
rs12131057	G	A	67	23	4	78	15	1	0.84	0.91	0.16	0.09	G	1.16	0.012449187	Rheumatoid arthritis	Immune diseases and disorders
rs9364813	G	A	77	17	0	64	29	1	0.91	0.84	0.09	0.16	G	0.265	0.012449187	Economic and political preferences immigration_crime	Mental aptitude and behavioural traits
rs2981205	C	T	65	27	2	77	17	0	0.84	0.91	0.16	0.09	T	0.06	0.012449187	Intelligence childhood	Mental aptitude and behavioural traits
rs1471403	T	C	6	44	44	13	50	31	0.30	0.40	0.70	0.60	T	0.07	0.012419275	Bone mineral density spine	General health
rs3821236	G	A	34	44	16	48	36	10	0.60	0.70	0.40	0.30	A	1.3	0.012419275	Systemic sclerosis	Brain health and disorders
rs6957923	G	A	50	32	12	30	52	12	0.70	0.60	0.30	0.40	G	1.14	0.012419275	Height	General health
rs4638749	G	A	47	38	9	36	40	18	0.70	0.60	0.30	0.40	G	0.81	0.012419275	Blood pressure	Heart health and disorders
rs9328573	A	G	33	46	15	47	38	9	0.60	0.70	0.40	0.30	G	0.053	0.012419275	Urate levels in lean individuals	Obesity
rs10269783	G	A	36	40	18	44	44	6	0.60	0.70	0.40	0.30	A	0.014	0.012419275	Body mass index	Obesity
rs10799445	A	C	56	31	7	43	38	13	0.76	0.66	0.24	0.34	A	0.032	0.012404219	Height	General health
rs17641971	T	C	39	46	9	54	35	5	0.66	0.76	0.34	0.24	T	0.025	0.012404219	Blood metabolite levels	Heart health and disorders
rs4783244	G	T	47	39	8	62	27	5	0.71	0.80	0.29	0.20	T	0.346	0.01240049	Adiponectin levels	Obesity
rs10045413	T	C	47	39	8	64	23	7	0.71	0.80	0.29	0.20	T	0.039	0.01240049	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs271674	C	T	63	25	6	45	43	6	0.80	0.71	0.20	0.29	T	0.0267	0.01240049	White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy	Brain health and disorders
rs4784934	A	G	4	29	61	7	41	46	0.20	0.29	0.80	0.71	A	0.67	0.01240049	QT interval	Heart health and disorders
rs2793086	T	G	72	21	1	83	11	0	0.88	0.94	0.12	0.06	C	3.01	0.012383901	Response to antineoplastic agents	General health
rs12446554	G	T	73	19	2	84	9	1	0.88	0.94	0.12	0.06	G	1.07	0.012383901	Obesity	Obesity
rs72953990	G	A	73	19	2	83	11	0	0.88	0.94	0.12	0.06	A	0.192	0.012383901	Gait rhythm	Appearance
rs4954683	T	C	72	21	1	84	9	1	0.88	0.94	0.12	0.06	C	0.1823	0.012383901	IgG glycosylation	Immune diseases and disorders
rs12444979	C	T	73	19	2	84	9	1	0.88	0.94	0.12	0.06	C	0.17	0.012383901	Body mass index	Obesity
rs12446632	G	A	73	19	2	84	9	1	0.88	0.94	0.12	0.06	G	0.043	0.012383901	Body mass index	Obesity
rs17100926	C	T	83	11	0	72	21	1	0.94	0.88	0.06	0.12	A	0.03	0.012383901	Obesity-related traits	Obesity
rs890749	C	T	1	21	72	0	11	83	0.12	0.06	0.88	0.94	C	3.25	0.012383901	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs2071543	G	T	63	26	5	73	21	0	0.81	0.89	0.19	0.11	G	1.41	0.012374196	IgA nephropathy	Immune diseases and disorders
rs12919130	A	G	60	32	2	73	21	0	0.81	0.89	0.19	0.11	A	1	0.012374196	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs16975985	A	G	74	19	1	63	26	5	0.89	0.81	0.11	0.19	G	0.02	0.012374196	Obesity-related traits	Obesity
rs2622604	T	C	4	28	62	0	21	73	0.19	0.11	0.81	0.89	T	0.04	0.012374196	LDL peak particle diameter total fat intake interaction	General health
rs1450439	A	G	42	47	5	30	51	13	0.70	0.59	0.30	0.41	A	67.9	0.012335019	Forced expiratory volume in 1 second	Pulmonology
rs17112901	C	T	65	27	2	53	34	7	0.84	0.74	0.16	0.26	A	0.03	0.012317265	Obesity-related traits	Obesity
rs1168987	C	T	81	12	1	71	19	4	0.93	0.86	0.07	0.14	A	2.27	0.012304332	Response to antineoplastic agents	General health
rs4684256	C	T	69	23	2	81	12	1	0.86	0.93	0.14	0.07	T	1.48	0.012304332	Systemic lupus erythematosus	Immune diseases and disorders
rs10496034	G	C	69	23	2	80	14	0	0.86	0.93	0.14	0.07	C	1.216	0.012304332	Refractive astigmatism	General health
rs6001930	T	C	81	12	1	69	23	2	0.93	0.86	0.07	0.14	C	1.14	0.012304332	Breast cancer	Cancer
rs13219957	G	A	68	25	1	80	14	0	0.86	0.93	0.14	0.07	A	0.081	0.012304332	Job-related exhaustion	Mental aptitude and behavioural traits
rs2597513	C	T	1	12	81	2	23	69	0.07	0.14	0.93	0.86	T	0.036	0.012304332	Height	General health
rs9880211	G	A	68	25	1	80	14	0	0.86	0.93	0.14	0.07	A	0.023	0.012304332	Body mass index	Obesity
rs2352039	G	T	53	36	5	38	47	9	0.76	0.65	0.24	0.35	A	8.9	0.01227265	Acute kidney injury in coronary artery bypass surgery creatinine rise	General health
rs4470914	C	T	52	38	4	39	45	10	0.76	0.65	0.24	0.35	T	0.04	0.01227265	Height	General health
rs2540948	T	C	31	48	15	47	36	11	0.59	0.69	0.41	0.31	C	0.036	0.012254902	Triglycerides	General health
rs460626	G	A	0	7	87	0	1	93	0.04	0.01	0.96	0.99	G	0.7899	0.012228261	HIV-1 viral setpoint	Immune diseases and disorders
rs619865	A	G	0	7	87	0	1	93	0.04	0.01	0.96	0.99	A	0.77	0.012228261	Freckling	Appearance
rs589398	C	T	0	7	87	0	1	93	0.04	0.01	0.96	0.99	C	0.1942	0.012228261	Cerebral amyloid deposition PET imaging	Brain health and disorders
rs1397615	T	C	0	1	93	0	7	87	0.01	0.04	0.99	0.96	A	0.03	0.012228261	Obesity-related traits	Obesity
rs9963330	C	T	93	1	0	87	7	0	0.99	0.96	0.01	0.04	A	15.23	0.012228261	Diisocyanate-induced asthma	Pulmonology
rs2068666	T	G	88	5	1	93	1	0	0.96	0.99	0.04	0.01	G	2.38	0.012228261	Clozapine-induced agranulocytosis	General health
rs17511102	A	T	87	7	0	93	1	0	0.96	0.99	0.04	0.01	T	1.4	0.012228261	Height	General health
rs1033180	C	T	87	7	0	93	1	0	0.96	0.99	0.04	0.01	A	1.21	0.012228261	Celiac disease	Immune diseases and disorders
rs75080020	T	C	88	5	1	93	1	0	0.96	0.99	0.04	0.01	T	1.13	0.012228261	Schizophrenia	Brain health and disorders
rs740145	G	C	87	7	0	93	1	0	0.96	0.99	0.04	0.01	C	0.1732	0.012228261	Corneal curvature	General health
rs78058190	G	A	87	7	0	93	1	0	0.96	0.99	0.04	0.01	A	0.141	0.012228261	HDL cholesterol	General health
rs11727676	T	C	88	5	1	93	1	0	0.96	0.99	0.04	0.01	T	0.04	0.012228261	Body mass index	Obesity
rs12136530	A	G	59	28	7	70	22	2	0.78	0.86	0.22	0.14	A	0.16	0.012223071	Lead levels in blood	General health
rs7243357	T	G	57	32	5	69	24	1	0.78	0.86	0.22	0.14	T	0.025	0.012223071	Body mass index	Obesity
rs1918690	T	C	2	22	70	3	36	55	0.14	0.22	0.86	0.78	T	1.27	0.012223071	Hypospadias	Misc
rs75116816	C	G	46	40	8	57	36	1	0.70	0.80	0.30	0.20	C	7.99	0.012222725	Heschl's gyrus morphology	Brain health and disorders
rs11205006	A	T	7	24	63	6	44	44	0.20	0.30	0.80	0.70	A	1.615	0.012222725	Atopic dermatitis	Immune diseases and disorders
rs12144049	C	T	7	24	63	6	44	44	0.20	0.30	0.80	0.70	C	1.39	0.012222725	Atopic dermatitis	Immune diseases and disorders
rs3817963	T	C	45	42	7	60	30	4	0.70	0.80	0.30	0.20	G	1.18	0.012222725	Lung adenocarcinoma	Cancer
rs9268516	C	T	47	38	9	60	30	4	0.70	0.80	0.30	0.20	T	1.15	0.012222725	Asthma	Immune diseases and disorders
rs4738873	A	G	4	30	60	8	40	46	0.20	0.30	0.80	0.70	A	0.02	0.012222725	Body mass index	Obesity
rs17058466	G	A	92	2	0	85	9	0	0.99	0.95	0.01	0.05	G	3.73	0.012204234	Attention function in attention deficit hyperactive disorder	Brain health and disorders
rs17042852	T	C	86	7	1	92	2	0	0.95	0.99	0.05	0.01	C	2.82	0.012204234	Frontotemporal dementia	Brain health and disorders
rs117633859	A	G	85	9	0	92	2	0	0.95	0.99	0.05	0.01	G	1.82	0.012204234	Vogt-Koyanagi-Harada syndrome	Heart health and disorders
rs78797168	A	G	85	9	0	92	2	0	0.95	0.99	0.05	0.01	A	1.75	0.012204234	Periodontitis CDC_AAP	Misc
rs17512836	T	C	85	9	0	92	2	0	0.95	0.99	0.05	0.01	C	1.23	0.012204234	Schizophrenia	Brain health and disorders
rs35518360	A	T	85	9	0	92	2	0	0.95	0.99	0.05	0.01	T	1.166861	0.012204234	Schizophrenia	Brain health and disorders
rs11994034	C	T	92	2	0	85	9	0	0.99	0.95	0.01	0.05	T	1	0.012204234	Attention deficit hyperactivity disorder combined symptoms	Brain health and disorders
rs11680012	G	C	86	7	1	93	0	1	0.95	0.99	0.05	0.01	C	0.581	0.012204234	Adiposity	Obesity
rs7895372	C	G	92	2	0	85	9	0	0.99	0.95	0.01	0.05	G	0.35	0.012204234	Quantitative traits	Misc
rs13144478	A	T	85	9	0	92	2	0	0.95	0.99	0.05	0.01	T	0.13	0.012204234	Resistin levels	Immune diseases and disorders
rs4522784	T	G	92	2	0	85	9	0	0.99	0.95	0.01	0.05	C	0.04	0.012204234	Obesity-related traits	Obesity
rs11590526	C	T	85	9	0	92	2	0	0.95	0.99	0.05	0.01	T	0.039	0.012204234	Educational attainment	Mental aptitude and behavioural traits
rs1265883	C	A	0	9	85	0	2	92	0.05	0.01	0.95	0.99	C	1.34	0.012204234	Graves' disease	Immune diseases and disorders
rs6784615	C	T	1	7	86	0	2	92	0.05	0.01	0.95	0.99	T	0.04	0.012204234	Waist-hip ratio	General health
rs1545843	G	A	16	47	31	7	45	42	0.42	0.31	0.58	0.69	A	1.398	0.012178785	Major depressive disorder	Brain health and disorders
rs968059	C	A	17	32	45	3	41	50	0.35	0.25	0.65	0.75	C	0.015	0.012147111	Body mass index	Obesity
rs251253	C	T	33	42	19	48	32	14	0.57	0.68	0.43	0.32	C	1.49	0.012106538	PR interval	Heart health and disorders
rs1906060	C	T	4	41	49	4	24	66	0.26	0.17	0.74	0.83	G	0.59	0.01209458	Intraocular pressure	General health
rs6110577	T	C	59	31	4	45	41	8	0.79	0.70	0.21	0.30	C	1.4	0.012053571	Obesity extreme	Obesity
rs4812829	G	A	46	39	9	61	27	6	0.70	0.79	0.30	0.21	A	1.09	0.012053571	Type 2 diabetes	Diabetes
rs9470361	G	A	58	33	3	46	39	9	0.79	0.70	0.21	0.30	A	0.87	0.012053571	QRS duration	Heart health and disorders
rs7566934	A	G	6	45	43	6	27	61	0.30	0.21	0.70	0.79	A	0.13	0.012053571	Information processing speed	Mental aptitude and behavioural traits
rs2457335	G	A	5	29	60	4	49	41	0.21	0.30	0.79	0.70	G	0.04	0.012053571	Obesity-related traits	Obesity
rs13240464	T	C	31	45	18	42	43	9	0.57	0.68	0.43	0.32	T	1.083	0.01203804	Schizophrenia	Brain health and disorders
rs2590838	G	A	17	47	30	11	39	44	0.43	0.32	0.57	0.68	G	0.03	0.01203804	Adiponectin levels	Obesity
rs11678354	T	A	58	35	1	75	16	3	0.80	0.88	0.20	0.12	A	1.259	0.012030156	PR segment	Heart health and disorders
rs7274581	T	C	73	20	1	57	37	0	0.88	0.80	0.12	0.20	T	1.1364	0.012030156	Alzheimer's disease late onset	Brain health and disorders
rs10513821	A	G	61	29	4	74	18	2	0.80	0.88	0.20	0.12	A	1	0.012030156	Pulmonary function interaction	Pulmonology
rs16958145	C	T	64	23	7	72	22	0	0.80	0.88	0.20	0.12	T	0.0021	0.012030156	Trans fatty acid levels	General health
rs130555	C	T	9	30	55	12	43	39	0.26	0.36	0.74	0.64	C	2.5	0.01202732	Pyoderma gangrenosum in inflammatory bowel disease	Immune diseases and disorders
rs4953404	G	A	5	38	51	12	43	39	0.26	0.36	0.74	0.64	G	0.006	0.01202732	Pulse pressure alcohol consumption interaction	General health
rs198389	A	G	56	28	10	34	53	7	0.74	0.64	0.26	0.36	G	0.18	0.01202732	B-type natriuretic peptide	Heart health and disorders
rs1602565	T	C	66	24	4	77	16	1	0.83	0.90	0.17	0.10	C	1.16	0.01202454	Schizophrenia	Brain health and disorders
rs11622412	C	T	77	16	1	65	26	3	0.90	0.83	0.10	0.17	T	0.323	0.01202454	Metabolite levels 5-HIAA_ MHPG Ratio	Brain health and disorders
rs10214886	T	A	76	18	0	62	32	0	0.90	0.83	0.10	0.17	A	0.19	0.01202454	Disc degeneration lumbar	Aging
rs8024343	A	T	66	24	4	76	18	0	0.83	0.90	0.17	0.10	A	0.045	0.01202454	Bulimia nervosa	Brain health and disorders
rs11097470	C	T	76	18	0	63	30	1	0.90	0.83	0.10	0.17	A	0.04	0.01202454	Obesity-related traits	Obesity
rs4328821	A	G	76	18	0	62	32	0	0.90	0.83	0.10	0.17	A	0.01	0.01202454	White blood cell count	Immune diseases and disorders
rs11810574	A	G	85	9	0	75	18	1	0.95	0.89	0.05	0.11	G	23.12	0.012024247	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs7642644	T	C	75	18	1	85	9	0	0.89	0.95	0.11	0.05	T	3.15	0.012024247	Attention function in attention deficit hyperactive disorder	Brain health and disorders
rs2270875	A	G	74	20	0	85	9	0	0.89	0.95	0.11	0.05	G	2.84	0.012024247	Response to cholinesterase inhibitors in Alzheimer's disease	Brain health and disorders
rs12451840	T	C	75	18	1	85	9	0	0.89	0.95	0.11	0.05	C	0.7321	0.012024247	IgG glycosylation	Immune diseases and disorders
rs10880784	G	T	77	14	3	85	9	0	0.89	0.95	0.11	0.05	G	0.257	0.012024247	Urate levels in obese individuals	Obesity
rs806794	A	G	28	50	16	42	42	10	0.56	0.67	0.44	0.33	A	1.26	0.01197318	Height	General health
rs10479469	A	G	46	34	14	29	48	17	0.67	0.56	0.33	0.44	G	1	0.01197318	Fat distribution HIV	General health
rs62287976	G	T	35	36	23	41	44	9	0.56	0.67	0.44	0.33	T	0.3082	0.01197318	Metabolite levels MHPG	General health
rs9377063	G	A	44	38	12	30	46	18	0.67	0.56	0.33	0.44	A	0.04	0.01197318	Obesity-related traits	Obesity
rs2814021	C	T	6	31	57	4	19	71	0.23	0.14	0.77	0.86	G	0.04	0.011951447	Obesity-related traits	Obesity
rs314370	T	C	80	14	0	89	5	0	0.93	0.97	0.07	0.03	C	7.6	0.011941619	Resting heart rate	General health
rs12666989	G	C	80	14	0	89	5	0	0.93	0.97	0.07	0.03	C	7	0.011941619	Resting heart rate	General health
rs12143327	G	A	81	12	1	89	5	0	0.93	0.97	0.07	0.03	A	3.14	0.011941619	Diisocyanate-induced asthma	Pulmonology
rs76788097	A	G	81	12	1	89	5	0	0.93	0.97	0.07	0.03	G	1.53	0.011941619	Marginal zone lymphoma	Cancer
rs7448069	C	T	80	14	0	89	5	0	0.93	0.97	0.07	0.03	T	1	0.011941619	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs9627183	G	A	89	5	0	80	14	0	0.97	0.93	0.03	0.07	C	1	0.011941619	Attention deficit hyperactivity disorder	Brain health and disorders
rs526896	T	G	34	52	8	49	41	4	0.64	0.74	0.36	0.26	T	1.15	0.011913012	Height	General health
rs16854884	A	C	52	35	7	38	44	12	0.74	0.64	0.26	0.36	C	0.103	0.011913012	Economic and political preferences feminism_equality	Mental aptitude and behavioural traits
rs4629607	G	T	19	45	30	8	47	39	0.44	0.34	0.56	0.66	G	1.0526316	0.011911852	Schizophrenia	Brain health and disorders
rs4352210	A	G	9	45	40	22	39	33	0.34	0.44	0.66	0.56	A	0.14	0.011911852	RR interval heart rate	Heart health and disorders
rs859812	C	T	28	49	17	42	41	11	0.56	0.66	0.44	0.34	T	0.2351	0.011911852	Neuritic plaque	Brain health and disorders
rs12135191	C	T	43	44	7	57	34	3	0.69	0.79	0.31	0.21	C	0.008	0.011892527	Urate levels BMI interaction	Obesity
rs2794256	A	G	8	42	44	7	26	61	0.31	0.21	0.69	0.79	A	1.39	0.011892527	Spontaneous preterm birth preterm birth	Reproductive health
rs4118325	G	A	65	25	4	51	36	7	0.82	0.73	0.18	0.27	G	4.17	0.011883712	AIDS	Immune diseases and disorders
rs9942773	A	C	63	29	2	53	32	9	0.82	0.73	0.18	0.27	A	2.07	0.011883712	Periodontal microbiota	Misc
rs1550057	A	G	49	40	5	64	27	3	0.73	0.82	0.27	0.18	C	1.39	0.011883712	Conduct disorder	Brain health and disorders
rs660895	A	G	52	34	8	63	29	2	0.73	0.82	0.27	0.18	G	1.34	0.011883712	IgA nephropathy	Immune diseases and disorders
rs7130284	C	T	48	42	4	66	23	5	0.73	0.82	0.27	0.18	T	0.1242	0.011883712	Homocysteine levels	Misc
rs2186369	T	G	64	27	3	49	40	5	0.82	0.73	0.18	0.27	T	0.0667	0.011883712	IgG glycosylation	Immune diseases and disorders
rs3828890	C	G	65	25	4	53	32	9	0.82	0.73	0.18	0.27	G	0.0069	0.011883712	Renal function-related traits sCR	General health
rs61670327	G	A	9	46	39	10	64	20	0.34	0.45	0.66	0.55	A	1.7241	0.011853959	Epilepsy remission after treatment	Brain health and disorders
rs12716641	T	C	25	54	15	37	50	7	0.55	0.66	0.45	0.34	T	1.233	0.011853959	IgA nephropathy	Immune diseases and disorders
rs7531932	G	A	19	46	29	10	44	40	0.45	0.34	0.55	0.66	A	1.05	0.011853959	Schizophrenia	Brain health and disorders
rs3849491	T	C	30	44	20	40	44	10	0.55	0.66	0.45	0.34	T	0.073	0.011853959	Sex hormone-binding globulin levels	Reproductive health
rs3129860	A	G	1	15	78	0	7	87	0.09	0.04	0.91	0.96	A	1.36	0.011837121	Hepatitis C induced liver cirrhosis	Immune diseases and disorders
rs6497490	G	T	2	13	79	0	7	87	0.09	0.04	0.91	0.96	T	0.082	0.011837121	Blood metabolite levels	Heart health and disorders
rs16966918	T	A	87	7	0	77	17	0	0.96	0.91	0.04	0.09	A	4.01	0.011837121	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs61800638	T	G	78	15	1	87	7	0	0.91	0.96	0.09	0.04	G	3.387534	0.011837121	Clozapine-induced agranulocytosis	General health
rs10800098	G	A	78	15	1	87	7	0	0.91	0.96	0.09	0.04	A	3.29	0.011837121	AIDS	Immune diseases and disorders
rs35705950	G	T	77	17	0	87	7	0	0.91	0.96	0.09	0.04	T	2.43	0.011837121	Idiopathic pulmonary fibrosis	Pulmonology
rs12134493	C	A	77	17	0	87	7	0	0.91	0.96	0.09	0.04	A	1.14	0.011837121	Migraine	Brain health and disorders
rs7624327	G	A	78	15	1	87	7	0	0.91	0.96	0.09	0.04	A	1.13	0.011837121	Eating disorders	Brain health and disorders
rs12476289	C	T	77	17	0	87	7	0	0.91	0.96	0.09	0.04	A	0.29	0.011837121	QT interval	Heart health and disorders
rs4902960	G	A	87	7	0	77	17	0	0.96	0.91	0.04	0.09	G	0.193	0.011837121	Economic and political preferences environmentalism	Mental aptitude and behavioural traits
rs17524553	T	A	78	15	1	87	7	0	0.91	0.96	0.09	0.04	T	0.15	0.011837121	Urate levels in lean individuals	Obesity
rs10496166	G	A	52	34	8	37	45	12	0.73	0.63	0.27	0.37	A	0.18	0.011803943	RR interval heart rate	Heart health and disorders
rs4839431	T	C	2	24	68	0	15	79	0.15	0.08	0.85	0.92	A	1	0.0118025	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs316020	A	G	0	15	79	3	22	69	0.08	0.15	0.92	0.85	A	0.183	0.0118025	Blood metabolite ratios	Heart health and disorders
rs316019	A	C	0	15	79	3	22	69	0.08	0.15	0.92	0.85	A	0.181	0.0118025	Blood metabolite levels	Heart health and disorders
rs552707	T	C	2	24	68	1	13	80	0.15	0.08	0.85	0.92	T	0.046	0.0118025	Height	General health
rs200113	T	C	66	28	0	80	13	1	0.85	0.92	0.15	0.08	C	28.59	0.0118025	Uric acid levels	General health
rs1923834	C	T	80	13	1	66	28	0	0.92	0.85	0.08	0.15	G	3.236	0.0118025	Adverse response to chemotherapy neutropenia_leucopenia epirubicin	Drug response
rs7088591	A	T	79	15	0	70	20	4	0.92	0.85	0.08	0.15	A	1.44	0.0118025	Blood pressure	Heart health and disorders
rs17691888	G	A	67	26	1	79	15	0	0.85	0.92	0.15	0.08	G	1.16	0.0118025	Schizophrenia	Brain health and disorders
rs7893279	T	G	67	26	1	79	15	0	0.85	0.92	0.15	0.08	T	1.125	0.0118025	Schizophrenia	Brain health and disorders
rs73044404	G	A	69	22	3	79	15	0	0.85	0.92	0.15	0.08	G	1.0752687	0.0118025	Schizophrenia	Brain health and disorders
rs1770678	T	C	80	13	1	69	22	3	0.92	0.85	0.08	0.15	G	0.03	0.0118025	Obesity-related traits	Obesity
rs3844412	A	G	21	43	30	13	39	42	0.45	0.35	0.55	0.65	A	5.22	0.01179941	Adverse response to chemotherapy in breast cancer alopecia paclitaxel	General health
rs1517114	C	G	13	39	42	22	41	31	0.35	0.45	0.65	0.55	C	4.1	0.01179941	Response to irinotecan in non-small-cell lung cancer	General health
rs1950500	T	C	13	39	42	19	47	28	0.35	0.45	0.65	0.55	T	1.16	0.01179941	Height	General health
rs7638389	G	A	10	45	39	19	47	28	0.35	0.45	0.65	0.55	A	1	0.01179941	Visceral adipose tissue adjusted for BMI	Obesity
rs1187220	C	T	42	39	13	28	47	19	0.65	0.55	0.35	0.45	T	0.024	0.01179941	Educational attainment	Mental aptitude and behavioural traits
rs10487524	G	A	71	22	1	82	12	0	0.87	0.94	0.13	0.06	T	1.6	0.011764706	Attention deficit hyperactivity disorder	Brain health and disorders
rs1023721	T	A	73	18	3	83	10	1	0.87	0.94	0.13	0.06	T	0.3141	0.011764706	IgG glycosylation	Immune diseases and disorders
rs209345	T	C	83	10	1	72	20	2	0.94	0.87	0.06	0.13	T	0.2435	0.011764706	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs4812048	C	T	71	22	1	82	12	0	0.87	0.94	0.13	0.06	C	0.09	0.011764706	Mean platelet volume	Heart health and disorders
rs16856247	C	T	82	12	0	70	24	0	0.94	0.87	0.06	0.13	T	0.0556	0.011764706	Metabolite levels	General health
rs4902647	C	T	26	50	18	38	46	10	0.54	0.65	0.46	0.35	G	1.11	0.01174812	Multiple sclerosis	Brain health and disorders
rs6974574	A	T	19	48	27	13	40	41	0.46	0.35	0.54	0.65	A	0.03	0.01174812	Height	General health
rs9845942	C	T	57	33	4	44	41	9	0.78	0.69	0.22	0.31	T	1.68	0.01173913	Eating disorder in bipolar disorder	Brain health and disorders
rs471470	C	A	10	39	45	2	37	55	0.31	0.22	0.69	0.78	A	1.1627907	0.01173913	Alzheimer's disease in APOE e4+ carriers	Brain health and disorders
rs194749	T	C	44	41	9	57	33	4	0.69	0.78	0.31	0.22	G	1.0796018	0.01173913	Crohn's disease	Digestive system and its disorders
rs1830084	A	T	44	41	9	59	29	6	0.69	0.78	0.31	0.22	A	0.43	0.01173913	Iron status biomarkers	General health
rs10744391	G	A	55	37	2	41	47	6	0.78	0.69	0.22	0.31	A	0.224	0.01173913	Renal sinus fat	General health
rs10505725	C	T	43	43	8	54	39	1	0.69	0.78	0.31	0.22	A	0.03	0.01173913	Obesity-related traits	Obesity
rs727505	G	A	59	32	3	71	23	0	0.80	0.88	0.20	0.12	A	0.2807	0.011709602	Lewy body disease	Brain health and disorders
rs7640978	C	T	71	23	0	58	34	2	0.88	0.80	0.12	0.20	T	0.038	0.011709602	Cholesterol, total	General health
rs9310995	T	C	40	41	13	24	53	17	0.64	0.54	0.36	0.46	T	0.023	0.011700012	Pulmonary function	Pulmonology
rs26478	G	A	10	31	53	13	44	37	0.27	0.37	0.73	0.63	A	4.47	0.011699887	Very long-chain saturated fatty acid levels fatty acid 20:0	General health
rs4812833	G	A	7	56	31	8	35	51	0.37	0.27	0.63	0.73	A	1.1088746	0.011699887	Ulcerative colitis	Immune diseases and disorders
rs477515	G	A	37	44	13	49	39	6	0.63	0.73	0.37	0.27	T	2.05	0.011699887	Hepatitis B vaccine response	Immune diseases and disorders
rs2395185	G	T	35	48	11	51	35	8	0.63	0.73	0.37	0.27	G	1.92	0.011699887	Ulcerative colitis	Immune diseases and disorders
rs9268923	C	T	35	48	11	51	35	8	0.63	0.73	0.37	0.27	C	1.45	0.011699887	Ulcerative colitis	Immune diseases and disorders
rs9268853	T	C	35	48	11	51	35	8	0.63	0.73	0.37	0.27	T	1.4	0.011699887	Ulcerative colitis	Immune diseases and disorders
rs4299376	G	T	5	34	55	2	24	68	0.23	0.15	0.77	0.85	G	3.01	0.011695906	Cholesterol, total	General health
rs4924410	A	C	3	22	69	5	34	55	0.15	0.23	0.85	0.77	A	1.46	0.011695906	Ewing sarcoma	Cancer
rs6667220	G	A	2	24	68	4	36	54	0.15	0.23	0.85	0.77	G	1	0.011695906	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs11645781	A	G	5	34	55	2	24	68	0.23	0.15	0.77	0.85	G	1	0.011695906	Heart rate	General health
rs4657172	C	G	3	22	69	7	30	57	0.15	0.23	0.85	0.77	C	0.81	0.011695906	QT interval	Heart health and disorders
rs12219125	G	T	58	28	8	68	24	2	0.77	0.85	0.23	0.15	T	1	0.011695906	Diabetic retinopathy	Diabetes
rs12590995	A	C	56	32	6	68	24	2	0.77	0.85	0.23	0.15	C	0.4532	0.011695906	Lewy body disease	Brain health and disorders
rs6044777	C	T	69	22	3	53	38	3	0.85	0.77	0.15	0.23	A	0.23	0.011695906	Biochemical measures	General health
rs11057841	C	T	67	26	1	55	34	5	0.85	0.77	0.15	0.23	T	0.0286	0.011695906	Lipoprotein-associated phospholipase A2 activity and mass	General health
rs2106854	C	T	70	20	4	55	34	5	0.85	0.77	0.15	0.23	T	0.019	0.011695906	Fibrinogen	General health
rs16857031	C	G	61	32	1	48	41	5	0.82	0.73	0.18	0.27	G	2.63	0.011683849	QT interval	Heart health and disorders
rs1933755	C	T	5	24	65	5	41	48	0.18	0.27	0.82	0.73	T	1.19	0.011683849	Colorectal cancer calcium intake interaction	Cancer
rs2592394	A	G	8	35	51	2	30	62	0.27	0.18	0.73	0.82	A	1	0.011683849	Magnesium levels	General health
rs10492664	C	T	64	26	4	55	27	12	0.82	0.73	0.18	0.27	C	1	0.011683849	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs9557754	G	T	28	44	22	47	26	21	0.53	0.64	0.47	0.36	G	1.23	0.011655012	QT interval	Heart health and disorders
rs7751505	A	C	27	46	21	39	42	13	0.53	0.64	0.47	0.36	C	0.07	0.011655012	Pubertal anthropometrics	Appearance
rs17724172	T	C	64	27	3	76	17	1	0.82	0.90	0.18	0.10	C	2.04	0.011633428	Cardiac Troponin-T levels	Heart health and disorders
rs1430742	T	C	65	25	4	75	19	0	0.82	0.90	0.18	0.10	C	0.11	0.011633428	Bone mineral density spine	General health
rs4332428	A	G	64	27	3	79	11	4	0.82	0.90	0.18	0.10	A	0.036	0.011633428	Height	General health
rs739310	A	G	65	25	4	75	19	0	0.82	0.90	0.18	0.10	G	0.01	0.011633428	Obesity-related traits	Obesity
rs442177	G	T	12	45	37	21	47	26	0.37	0.47	0.63	0.53	G	2.25	0.011613053	Triglycerides	General health
rs13020137	A	G	10	49	35	15	59	20	0.37	0.47	0.63	0.53	A	1.26	0.011613053	Schizophrenia	Brain health and disorders
rs6757804	C	T	15	39	40	18	53	23	0.37	0.47	0.63	0.53	G	1.2	0.011613053	Endometriosis	General health
rs7816345	C	T	50	36	8	40	37	17	0.72	0.62	0.28	0.38	T	0.151	0.01160063	Breast size	General health
rs718948	T	C	39	39	16	47	42	5	0.62	0.72	0.38	0.28	C	0.016	0.01160063	Body mass index	Obesity
rs4940576	T	C	5	42	47	17	37	40	0.28	0.38	0.72	0.62	T	1.23	0.01160063	Adolescent idiopathic scoliosis	Obesity
rs404256	T	C	14	43	37	6	40	48	0.38	0.28	0.62	0.72	C	0.2094	0.01160063	IgG glycosylation	Immune diseases and disorders
rs10938353	A	G	11	30	53	17	37	40	0.28	0.38	0.72	0.62	G	0.029	0.01160063	Body mass index	Obesity
rs215411	T	A	59	28	7	47	34	13	0.78	0.68	0.22	0.32	A	1.07	0.011592958	Schizophrenia	Brain health and disorders
rs6026584	T	C	8	44	42	3	36	55	0.32	0.22	0.68	0.78	T	0.0052	0.011592958	Renal function-related traits BUN	General health
rs10097555	G	A	25	40	29	15	40	39	0.48	0.37	0.52	0.63	A	2.5	0.011574074	Obstructive sleep apnea	Misc
rs721399	C	T	17	36	41	23	44	27	0.37	0.48	0.63	0.52	T	0.029	0.011574074	Blood metabolite levels	Heart health and disorders
rs909685	T	A	37	44	13	23	52	19	0.63	0.52	0.37	0.48	A	1.23	0.011574074	Rheumatoid arthritis	Immune diseases and disorders
rs6017317	T	G	38	41	15	22	53	19	0.62	0.52	0.38	0.48	G	1.09	0.011538018	Type 2 diabetes	Diabetes
rs2943636	G	A	22	53	19	37	43	14	0.52	0.62	0.48	0.38	G	1	0.011538018	Sexual dimorphism in anthropometric traits	Misc
rs1837495	G	A	17	37	40	23	45	26	0.38	0.48	0.62	0.52	G	1.0638298	0.011538018	Schizophrenia	Brain health and disorders
rs4638289	A	T	28	35	31	14	43	37	0.48	0.38	0.52	0.62	A	0.31	0.011538018	Amyloid A serum levels	General health
rs12526480	T	G	35	46	13	50	35	9	0.62	0.72	0.38	0.28	T	4.39	0.011505976	Mean platelet volume	Heart health and disorders
rs6427356	A	G	25	46	23	33	50	11	0.51	0.62	0.49	0.38	G	1	0.011504832	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs9271100	T	C	4	44	46	4	27	63	0.28	0.19	0.72	0.81	T	1.68	0.011494253	Leprosy	Immune diseases and disorders
rs2609255	G	T	4	27	63	9	34	51	0.19	0.28	0.81	0.72	G	1.29	0.011494253	Interstitial lung disease	Pulmonology
rs6733379	G	T	3	29	62	10	32	52	0.19	0.28	0.81	0.72	G	1	0.011494253	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs10751776	A	C	7	38	49	3	29	62	0.28	0.19	0.72	0.81	C	0.1484	0.011494253	IgG glycosylation	Immune diseases and disorders
rs9331896	C	T	14	45	35	21	51	22	0.39	0.49	0.61	0.51	T	1.1904762	0.011474469	Alzheimer's disease in APOE e4+ carriers	Brain health and disorders
rs7404095	T	C	20	53	21	11	51	32	0.49	0.39	0.51	0.61	G	1.0744067	0.011474469	Ulcerative colitis	Immune diseases and disorders
rs7839059	C	A	35	45	14	23	49	22	0.61	0.51	0.39	0.49	A	0.1	0.011474469	Bone mineral density	General health
rs11649112	G	A	69	21	4	53	37	4	0.85	0.76	0.15	0.24	A	2.49	0.011455164	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs9982601	C	T	67	25	2	59	25	10	0.85	0.76	0.15	0.24	T	1.2	0.011455164	Myocardial infarction early onset	Heart health and disorders
rs11836164	T	C	66	27	1	57	29	8	0.85	0.76	0.15	0.24	T	1	0.011455164	Mammographic density dense area	Reproductive health
rs8097810	A	G	66	27	1	52	39	3	0.85	0.76	0.15	0.24	A	0.105	0.011455164	Periodontitis Mean PAL	Misc
rs7762160	T	C	45	37	12	58	29	7	0.68	0.77	0.32	0.23	C	0.07	0.01145362	Conduct disorder symptom count	Brain health and disorders
rs955423	C	A	34	46	14	21	52	21	0.61	0.50	0.39	0.50	A	0.335	0.011446886	Body mass index	Obesity
rs8050326	G	A	22	50	22	15	44	35	0.50	0.39	0.50	0.61	A	1.45	0.011446886	Major depressive disorder	Brain health and disorders
rs1534696	C	A	27	41	26	9	57	28	0.51	0.40	0.49	0.60	C	0.0267	0.011422045	Waist-to-hip ratio adjusted for body mass index	Obesity
rs5030062	A	C	40	35	19	50	34	10	0.61	0.71	0.39	0.29	A	1	0.011415742	Plasma renin activity levels	General health
rs7612445	G	T	51	32	11	36	43	15	0.71	0.61	0.29	0.39	G	0.358	0.011415742	Heart rate	General health
rs13130484	C	T	31	53	10	46	42	6	0.61	0.71	0.39	0.29	T	0.05	0.011415742	Body mass index	Obesity
rs951366	T	C	31	53	10	47	40	7	0.61	0.71	0.39	0.29	T	0.03	0.011415742	Menarche age at onset	Reproductive health
rs1873147	G	A	9	36	49	16	41	37	0.29	0.39	0.71	0.61	C	1.431	0.011415742	Orofacial clefts	Misc
rs6539267	T	C	61	27	6	71	22	1	0.79	0.87	0.21	0.13	T	1.27	0.011410315	Tourette syndrome	Brain health and disorders
rs12190758	A	G	59	31	4	71	22	1	0.79	0.87	0.21	0.13	G	1.0638298	0.011410315	Schizophrenia	Brain health and disorders
rs17170316	G	T	60	29	5	71	22	1	0.79	0.87	0.21	0.13	A	0.325	0.011410315	Cytomegalovirus antibody response	Immune diseases and disorders
rs7825271	G	T	3	18	73	4	31	59	0.13	0.21	0.87	0.79	C	0.04	0.011410315	Obesity-related traits	Obesity
rs10741210	G	A	28	41	25	12	53	29	0.52	0.41	0.48	0.59	G	1.22	0.011380448	Alcohol dependence	General health
rs1842896	G	T	20	37	37	30	37	27	0.41	0.52	0.59	0.48	T	1.14	0.011380448	Coronary heart disease	Heart health and disorders
rs9634489	A	G	26	45	23	14	49	31	0.52	0.41	0.48	0.59	G	0.02	0.011380448	Body mass index	Obesity
rs4648845	C	T	19	40	35	21	56	17	0.41	0.52	0.59	0.48	T	1.072	0.011363636	Schizophrenia	Brain health and disorders
rs937254	G	A	23	52	19	17	44	33	0.52	0.41	0.48	0.59	A	0.077	0.011363636	HDL cholesterol	General health
rs9369898	G	A	34	42	18	26	38	30	0.59	0.48	0.41	0.52	A	0.0449	0.011363636	Homocysteine levels	Misc
rs4713169	G	C	14	50	30	17	64	13	0.41	0.52	0.59	0.48	C	0.032	0.011363636	Blood metabolite levels	Heart health and disorders
rs7660702	T	C	21	57	16	16	47	31	0.53	0.42	0.47	0.58	T	8.46	0.01134945	Electrocardiographic traits	Heart health and disorders
rs189918	T	C	17	45	32	27	45	22	0.42	0.53	0.58	0.47	C	1.0526316	0.01134945	Schizophrenia	Brain health and disorders
rs1800775	C	A	27	45	22	17	45	32	0.53	0.42	0.47	0.58	C	0.18	0.01134945	HDL cholesterol	General health
rs12411769	A	C	68	23	3	78	16	0	0.85	0.91	0.15	0.09	A	1.78	0.011346089	Seasonality	Mental aptitude and behavioural traits
rs17594526	C	T	79	14	1	67	25	2	0.91	0.85	0.09	0.15	T	1.44	0.011346089	Schizophrenia	Brain health and disorders
rs11152369	A	C	79	14	1	67	25	2	0.91	0.85	0.09	0.15	A	1.19	0.011346089	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs10488031	G	A	79	14	1	66	27	1	0.91	0.85	0.09	0.15	A	0.26	0.011346089	QT interval	Heart health and disorders
rs6988636	T	C	80	12	2	67	25	2	0.91	0.85	0.09	0.15	T	0.13	0.011346089	Urinary uromodulin levels	General health
rs4301033	G	A	80	12	2	67	25	2	0.91	0.85	0.09	0.15	G	0.036	0.011346089	Adiponectin levels	Obesity
rs29232	C	T	20	48	26	32	44	18	0.47	0.57	0.53	0.43	A	1.67	0.011337868	Nasopharyngeal carcinoma	Cancer
rs9656709	A	C	17	54	23	31	46	17	0.47	0.57	0.53	0.43	C	1	0.011337868	Behavioural disinhibition generation interaction	Brain health and disorders
rs2301696	G	C	37	40	17	41	51	2	0.61	0.71	0.39	0.29	G	1.14	0.011329756	QT interval	Heart health and disorders
rs10514585	G	A	37	40	17	44	45	5	0.61	0.71	0.39	0.29	A	0.15	0.011329756	Depression quantitative trait	Brain health and disorders
rs2521263	A	G	10	35	49	16	42	36	0.29	0.39	0.71	0.61	A	0.03	0.011329756	Obesity-related traits	Obesity
rs27323	G	A	27	47	20	19	43	32	0.54	0.43	0.46	0.57	G	0.1399	0.011328877	IgG glycosylation	Immune diseases and disorders
rs7685921	A	G	41	44	9	52	40	2	0.67	0.77	0.33	0.23	G	0.116	0.011320755	Fractional exhaled nitric oxide childhood	Pulmonology
rs12915845	C	T	43	40	11	50	44	0	0.67	0.77	0.33	0.23	C	0.03	0.011320755	Menarche age at onset	Reproductive health
rs9956878	G	T	27	50	17	17	50	27	0.55	0.45	0.45	0.55	A	0.02	0.011317338	Obesity-related traits	Obesity
rs2462686	T	C	49	37	8	59	34	1	0.72	0.81	0.28	0.19	C	1.4872	0.011314254	Major depressive disorder	Brain health and disorders
rs9542236	T	C	48	39	7	65	22	7	0.72	0.81	0.28	0.19	C	1.1	0.011314254	Age-related macular degeneration	Aging
rs7231041	T	C	63	26	5	43	49	2	0.81	0.72	0.19	0.28	G	0.04	0.011314254	Obesity-related traits	Obesity
rs3110643	T	C	75	17	2	84	10	0	0.89	0.95	0.11	0.05	C	1.65	0.011313698	Frontotemporal dementia	Brain health and disorders
rs17065417	A	C	84	10	0	73	21	0	0.95	0.89	0.05	0.11	A	1.38	0.011313698	Neuroblastoma	Cancer
rs4590408	A	G	84	10	0	74	19	1	0.95	0.89	0.05	0.11	G	0.2245	0.011313698	Metabolite levels HVA	General health
rs740160	C	T	84	10	0	76	15	3	0.95	0.89	0.05	0.11	T	0.15	0.011313698	Dehydroepiandrosterone sulphate levels	Immune diseases and disorders
rs12800752	T	C	84	10	0	74	19	1	0.95	0.89	0.05	0.11	T	0.0946	0.011313698	Menarche age at onset	Reproductive health
rs17756712	A	G	74	19	1	85	8	1	0.89	0.95	0.11	0.05	G	0.01	0.011313698	Vertical cup-disc ratio	Misc
rs77150043	C	T	62	30	2	74	20	0	0.82	0.89	0.18	0.11	T	1	0.011272142	Pediatric autoimmune diseases	Immune diseases and disorders
rs233817	C	A	63	28	3	75	18	1	0.82	0.89	0.18	0.11	C	0.05	0.011272142	Sitting height ratio	Appearance
rs6594357	T	C	15	45	34	11	34	49	0.40	0.30	0.60	0.70	T	3.33	0.011247858	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs1800682	A	G	13	49	32	11	34	49	0.40	0.30	0.60	0.70	A	1.25	0.011247858	Chronic lymphocytic leukemia	Cancer
rs6040399	A	T	14	47	33	11	34	49	0.40	0.30	0.60	0.70	T	1	0.011247858	Response to citalopram treatment	General health
rs932350	T	C	14	47	33	5	46	43	0.40	0.30	0.60	0.70	C	1	0.011247858	Verbal declarative memory	Brain health and disorders
rs4488809	T	C	34	45	15	46	40	8	0.60	0.70	0.40	0.30	C	1.26	0.011247858	Lung cancer	Cancer
rs3806308	C	T	37	39	18	46	40	8	0.60	0.70	0.40	0.30	G	1.1850245	0.011247858	Ulcerative colitis	Immune diseases and disorders
rs1421811	C	G	33	47	14	46	40	8	0.60	0.70	0.40	0.30	G	0.69	0.011247858	Blood pressure	Heart health and disorders
rs1998598	A	G	52	38	4	65	28	1	0.76	0.84	0.24	0.16	G	1.04	0.01122807	Crohn's disease	Digestive system and its disorders
rs3130941	C	G	2	21	71	0	13	81	0.13	0.07	0.87	0.93	C	0.098	0.011211461	IgE levels	Immune diseases and disorders
rs7505290	C	T	81	13	0	70	23	1	0.93	0.87	0.07	0.13	T	4.54	0.011211461	Very long-chain saturated fatty acid levels fatty acid 22:0	General health
rs56091001	C	T	71	21	2	82	11	1	0.87	0.93	0.13	0.07	T	1.28	0.011211461	Acne severe	Misc
rs11962845	A	G	70	23	1	81	13	0	0.87	0.93	0.13	0.07	A	1.23	0.011211461	Mitral valve prolapse	Heart health and disorders
rs9901756	A	C	81	13	0	71	21	2	0.93	0.87	0.07	0.13	A	1.21	0.011211461	Hypothyroidism	Immune diseases and disorders
rs11761528	C	T	81	13	0	73	17	4	0.93	0.87	0.07	0.13	T	0.16	0.011211461	Dehydroepiandrosterone sulphate levels	Immune diseases and disorders
rs9360921	T	G	81	13	0	71	21	2	0.93	0.87	0.07	0.13	T	0.042	0.011211461	Height	General health
rs13213285	C	T	81	13	0	72	19	3	0.93	0.87	0.07	0.13	A	0.04	0.011211461	Obesity-related traits	Obesity
rs6104691	G	A	53	37	4	40	45	9	0.76	0.66	0.24	0.34	A	1	0.01119403	Mammographic density dense area	Reproductive health
rs2009501	T	C	42	41	11	50	43	1	0.66	0.76	0.34	0.24	C	0.2964	0.01119403	Metabolite levels HVA_MHPG ratio	Brain health and disorders
rs7204230	T	C	54	35	5	42	41	11	0.76	0.66	0.24	0.34	T	0.008	0.01119403	Fibrinogen	General health
rs7089424	T	G	32	48	14	42	47	5	0.60	0.70	0.40	0.30	C	1.65	0.0111699	Acute lymphoblastic leukemia childhood	Cancer
rs3093024	A	G	18	40	36	10	37	47	0.40	0.30	0.60	0.70	T	1.19	0.0111699	Rheumatoid arthritis	Immune diseases and disorders
rs2078543	A	G	11	35	48	10	56	28	0.30	0.40	0.70	0.60	A	1	0.0111699	Pulmonary function interaction	Pulmonology
rs12898179	T	C	12	33	49	16	44	34	0.30	0.40	0.70	0.60	C	0.08	0.0111699	Glomerular filtration rate in chronic kidney disease	General health
rs2032366	C	T	17	42	35	9	39	46	0.40	0.30	0.60	0.70	G	0.03	0.0111699	Obesity-related traits	Obesity
rs1449572	G	T	46	42	6	61	29	4	0.71	0.80	0.29	0.20	A	1.73	0.011143243	Multiple myeloma IgH translocation	Cancer
rs1042992	C	T	61	29	4	45	44	5	0.80	0.71	0.20	0.29	T	1.07	0.011143243	Schizophrenia	Brain health and disorders
rs9266359	C	T	60	31	3	44	46	4	0.80	0.71	0.20	0.29	C	0.44	0.011143243	Systolic blood pressure	Heart health and disorders
rs870142	C	T	58	32	4	72	19	3	0.79	0.87	0.21	0.13	A	1.456	0.011130349	Congenital heart disease	Heart health and disorders
rs3824755	G	C	70	23	1	60	28	6	0.87	0.79	0.13	0.21	C	0.5	0.011130349	Blood pressure	Heart health and disorders
rs12198798	T	C	70	23	1	57	34	3	0.87	0.79	0.13	0.21	G	0.04	0.011130349	Obesity-related traits	Obesity
rs17655730	T	C	59	30	5	71	21	2	0.79	0.87	0.21	0.13	T	0.01	0.011130349	Mean platelet volume	Heart health and disorders
rs73737676	G	A	90	4	0	83	10	1	0.98	0.94	0.02	0.06	A	34.08	0.011111111	Diisocyanate-induced asthma	Pulmonology
rs6759556	A	G	90	4	0	83	10	1	0.98	0.94	0.02	0.06	A	4.478	0.011111111	Very long-chain saturated fatty acid levels fatty acid 20:0	General health
rs12704290	G	A	82	12	0	91	2	1	0.94	0.98	0.06	0.02	G	1.1111112	0.011111111	Schizophrenia	Brain health and disorders
rs11536940	G	A	90	4	0	83	10	1	0.98	0.94	0.02	0.06	A	0.384	0.011111111	Periodontitis DPAL	Misc
rs12207186	A	T	82	12	0	90	4	0	0.94	0.98	0.06	0.02	T	0.2882	0.011111111	IgG glycosylation	Immune diseases and disorders
rs8066099	C	T	90	4	0	82	12	0	0.98	0.94	0.02	0.06	A	0.03	0.011111111	Obesity-related traits	Obesity
rs10208407	G	A	90	4	0	82	12	0	0.98	0.94	0.02	0.06	A	0.03	0.011111111	Obesity-related traits	Obesity
rs1554120	A	G	82	12	0	90	4	0	0.94	0.98	0.06	0.02	A	0.0296	0.011111111	Heschl's gyrus morphology	Brain health and disorders
rs789852	T	C	2	8	84	0	4	90	0.06	0.02	0.94	0.98	A	0.25	0.011111111	QT interval	Heart health and disorders
rs299362	G	A	1	10	83	0	4	90	0.06	0.02	0.94	0.98	A	0.062	0.011111111	Bulimia nervosa	Brain health and disorders
rs3117181	C	G	1	10	83	0	4	90	0.06	0.02	0.94	0.98	C	0.02	0.011111111	Phospholipid levels plasma	General health
rs1318606	T	C	30	51	13	43	44	7	0.59	0.69	0.41	0.31	T	0.273	0.011095743	End-stage coagulation	General health
rs2072413	C	T	54	34	6	40	44	10	0.76	0.66	0.24	0.34	T	1.68	0.011073137	QT interval	Heart health and disorders
rs1050631	G	A	44	36	14	54	34	6	0.66	0.76	0.34	0.24	T	1.3	0.011073137	Esophageal squamous cell cancer length of survival	Cancer
rs295	A	C	54	34	6	37	50	7	0.76	0.66	0.24	0.34	A	0.17	0.011073137	Metabolic syndrome	Immune diseases and disorders
rs2241941	C	T	54	34	6	37	50	7	0.76	0.66	0.24	0.34	A	0.03	0.011073137	Obesity-related traits	Obesity
rs3914188	G	C	10	44	40	5	36	53	0.34	0.24	0.66	0.76	G	2.2	0.011073137	Menarche age at onset	Reproductive health
rs6736997	A	C	13	38	43	5	36	53	0.34	0.24	0.66	0.76	A	1.57	0.011073137	Pancreatic cancer	Cancer
rs639012	A	G	13	38	43	3	40	51	0.34	0.24	0.66	0.76	G	1.1627907	0.011073137	Alzheimer's disease in APOE e4+ carriers	Brain health and disorders
rs2607292	T	C	10	39	45	16	46	32	0.31	0.41	0.69	0.59	T	0.7684	0.011025257	Body mass index	Obesity
rs13223036	T	G	53	35	6	65	27	2	0.75	0.84	0.25	0.16	T	0.169	0.011013595	Bone mineral density paediatric, skull	General health
rs17040430	G	T	86	8	0	77	16	1	0.96	0.90	0.04	0.10	T	1.89	0.010989011	Bipolar disorder	Brain health and disorders
rs16878196	T	G	76	18	0	86	8	0	0.90	0.96	0.10	0.04	T	1.71	0.010989011	Attention function in attention deficit hyperactive disorder	Brain health and disorders
rs7759633	G	A	76	18	0	86	8	0	0.90	0.96	0.10	0.04	G	0.051	0.010989011	Triglycerides	General health
rs3789044	G	A	77	16	1	86	8	0	0.90	0.96	0.10	0.04	A	0.028	0.010989011	Educational attainment	Mental aptitude and behavioural traits
rs2342002	G	A	62	26	6	48	37	9	0.80	0.71	0.20	0.29	T	1.15	0.01098066	Digestive system disease Barrett's esophagus and esophageal adenocarcinoma combined	Digestive system and its disorders
rs7141420	C	T	19	41	34	8	44	42	0.42	0.32	0.58	0.68	T	0.026	0.010958322	Body mass index	Obesity
rs3131018	A	C	11	43	40	3	41	50	0.35	0.25	0.65	0.75	C	2.1	0.010957792	HIV-1 control	Immune diseases and disorders
rs948562	A	G	64	25	5	76	15	3	0.81	0.89	0.19	0.11	G	1.32	0.0109375	Lymphoma	Cancer
rs17114036	A	G	76	15	3	62	29	3	0.89	0.81	0.11	0.19	G	1.1494	0.0109375	Coronary artery disease	Heart health and disorders
rs4765913	A	T	4	27	63	1	19	74	0.19	0.11	0.81	0.89	A	1.14	0.0109375	Bipolar disorder	Brain health and disorders
rs2506155	C	A	74	19	1	63	27	4	0.89	0.81	0.11	0.19	A	1.08	0.0109375	Migraine	Brain health and disorders
rs589636	T	C	0	21	73	4	27	63	0.11	0.19	0.89	0.81	C	1	0.0109375	Hearing function	General health
rs642961	A	G	4	27	63	0	21	73	0.19	0.11	0.81	0.89	A	1	0.0109375	Orofacial clefts	Misc
rs1155563	T	C	65	28	1	79	13	2	0.84	0.91	0.16	0.09	C	0.94	0.010929315	Vitamin D levels	General health
rs17496332	A	G	66	26	2	77	17	0	0.84	0.91	0.16	0.09	A	0.028	0.010929315	Sex hormone-binding globulin levels	Reproductive health
rs2160669	C	T	2	26	66	0	17	77	0.16	0.09	0.84	0.91	G	0.03	0.010929315	Obesity-related traits	Obesity
rs2391672	G	A	44	39	11	29	50	15	0.68	0.57	0.32	0.43	A	1.06	0.010894824	Schizophrenia	Brain health and disorders
rs9298506	A	G	71	20	3	59	29	6	0.86	0.78	0.14	0.22	A	1.35	0.01086799	Intracranial aneurysm	Misc
rs1454933	A	C	70	22	2	59	29	6	0.86	0.78	0.14	0.22	C	0.04	0.01086799	Obesity-related traits	Obesity
rs2033732	T	C	5	31	58	2	22	70	0.22	0.14	0.78	0.86	C	0.019	0.01086799	Body mass index	Obesity
rs76650652	G	T	88	6	0	79	15	0	0.97	0.92	0.03	0.08	A	5.86	0.010865191	Diisocyanate-induced asthma	Pulmonology
rs7494275	A	C	79	15	0	89	4	1	0.92	0.97	0.08	0.03	C	1.732	0.010865191	Adverse response to chemotherapy neutropenia_leucopenia all topoisomerase inhibitors	Drug response
rs139961185	G	A	80	13	1	88	6	0	0.92	0.97	0.08	0.03	A	1.44	0.010865191	Triglycerides	General health
rs34517613	C	T	80	13	1	88	6	0	0.92	0.97	0.08	0.03	T	1.2	0.010865191	Amyotrophic lateral sclerosis sporadic	Brain health and disorders
rs5763911	T	C	81	11	2	88	6	0	0.92	0.97	0.08	0.03	T	0.52	0.010865191	Retinopathy in non-diabetics	General health
rs73078593	C	A	80	13	1	88	6	0	0.92	0.97	0.08	0.03	C	0.2829	0.010865191	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs17396340	G	A	79	15	0	88	6	0	0.92	0.97	0.08	0.03	A	0.008	0.010865191	Mean platelet volume	Heart health and disorders
rs2526678	G	A	82	9	3	88	6	0	0.92	0.97	0.08	0.03	A	0.0043	0.010865191	Trans fatty acid levels	General health
rs1713985	G	T	0	15	79	0	6	88	0.08	0.03	0.92	0.97	G	1.3	0.010865191	Age-related macular degeneration	Aging
rs35058679	T	C	49	42	3	39	44	11	0.74	0.65	0.26	0.35	T	1.06	0.01084773	Schizophrenia	Brain health and disorders
rs6822736	A	C	47	32	15	30	47	17	0.67	0.57	0.33	0.43	C	0.3637	0.010834659	Dementia and core Alzheimer's disease neuropathologic changes	Brain health and disorders
rs11578152	A	G	32	43	19	43	40	11	0.57	0.67	0.43	0.33	G	0.03	0.010834659	Menarche age at onset	Reproductive health
rs10956445	T	C	45	42	7	60	29	5	0.70	0.79	0.30	0.21	C	2.73	0.010825997	Response to methotrexate in juvenile idiopathic arthritis	General health
rs10941679	A	G	45	42	7	58	33	3	0.70	0.79	0.30	0.21	G	1.13	0.010825997	Breast cancer	Cancer
rs11087123	A	G	45	42	7	60	29	5	0.70	0.79	0.30	0.21	A	0.12	0.010825997	Eating disorders	Brain health and disorders
rs9933429	G	A	46	40	8	60	29	5	0.70	0.79	0.30	0.21	A	0.03	0.010825997	Obesity-related traits	Obesity
rs7543130	C	A	47	38	9	59	31	4	0.70	0.79	0.30	0.21	A	0.03	0.010825997	Aortic root size	Heart health and disorders
rs1943345	T	G	50	40	4	65	26	3	0.74	0.83	0.26	0.17	C	0.03	0.010810811	Obesity-related traits	Obesity
rs4610302	A	G	6	36	52	1	30	63	0.26	0.17	0.74	0.83	G	1.1765	0.010810811	Esophageal adenocarcinoma	Cancer
rs3104767	G	T	16	50	28	7	49	38	0.44	0.34	0.56	0.66	G	1.35	0.010777728	Restless legs syndrome	Mental aptitude and behavioural traits
rs12708980	T	G	38	49	7	30	46	18	0.66	0.56	0.34	0.44	C	0.0396	0.010777728	HDL cholesterol	General health
rs1546498	C	T	94	0	0	90	4	0	1.00	0.98	0.00	0.02	C	7.69	0.010752688	QT interval	Heart health and disorders
rs62392365	A	T	94	0	0	90	4	0	1.00	0.98	0.00	0.02	A	1.22	0.010752688	Schizophrenia	Brain health and disorders
rs117070989	C	A	94	0	0	90	4	0	1.00	0.98	0.00	0.02	C	0.934	0.010752688	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs41359445	A	T	94	0	0	90	4	0	1.00	0.98	0.00	0.02	A	0.6109	0.010752688	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs12302829	A	G	94	0	0	90	4	0	1.00	0.98	0.00	0.02	G	0.35	0.010752688	Conduct disorder symptom count	Brain health and disorders
rs59905655	C	T	94	0	0	90	4	0	1.00	0.98	0.00	0.02	A	0.03	0.010752688	Obesity-related traits	Obesity
rs12098946	C	T	94	0	0	90	4	0	1.00	0.98	0.00	0.02	A	0.02	0.010752688	Obesity-related traits	Obesity
rs2037892	G	A	56	27	11	39	43	12	0.74	0.64	0.26	0.36	A	156.7	0.010742706	Lentiform nucleus volume	Misc
rs1352075	C	T	37	47	10	52	35	7	0.64	0.74	0.36	0.26	A	1.42	0.010742706	Multiple myeloma hyperdiploidy	Cancer
rs3789119	C	T	53	33	8	37	47	10	0.74	0.64	0.26	0.36	T	0.136	0.010742706	Economic and political preferences immigration_crime	Mental aptitude and behavioural traits
rs12412942	G	A	29	47	18	37	50	7	0.56	0.66	0.44	0.34	A	1.2820514	0.01072394	Schizophrenia	Brain health and disorders
rs6500744	C	T	39	46	9	32	41	21	0.66	0.56	0.34	0.44	C	0.91	0.01072394	Conduct disorder interaction	Brain health and disorders
rs3003214	G	A	29	47	18	40	44	10	0.56	0.66	0.44	0.34	A	0.37	0.01072394	Dementia and core Alzheimer's disease neuropathologic changes	Brain health and disorders
rs13436218	T	G	80	14	0	68	26	0	0.93	0.86	0.07	0.14	C	5.92	0.010714286	Sexual dysfunction SSRI_SNRI-related	General health
rs1401327	G	A	72	22	0	83	11	0	0.88	0.94	0.12	0.06	A	1.157	0.01068999	Refractive astigmatism	General health
rs2306374	T	C	73	20	1	83	11	0	0.88	0.94	0.12	0.06	C	1.12	0.01068999	Coronary heart disease	Heart health and disorders
rs7097656	T	C	1	20	73	0	11	83	0.12	0.06	0.88	0.94	A	1.1411755	0.01068999	Crohn's disease	Digestive system and its disorders
rs12693217	T	G	0	22	72	0	11	83	0.12	0.06	0.88	0.94	G	1.0752687	0.01068999	Schizophrenia	Brain health and disorders
rs1845344	G	T	57	34	3	47	37	10	0.79	0.70	0.21	0.30	T	0.97	0.010678787	F-cell distribution	Immune diseases and disorders
rs4894535	C	T	56	36	2	46	39	9	0.79	0.70	0.21	0.30	T	0.1	0.010678787	Corneal structure	General health
rs11597390	G	A	45	41	8	56	36	2	0.70	0.79	0.30	0.21	A	0.04	0.010678787	Liver enzyme levels	General health
rs3740415	G	A	29	46	19	36	51	7	0.55	0.65	0.45	0.35	A	1.0690618	0.010673211	Ulcerative colitis	Immune diseases and disorders
rs6959212	T	C	19	46	29	13	39	42	0.45	0.35	0.55	0.65	T	0.07	0.010673211	Bone mineral density	General health
rs6558578	T	G	7	36	51	10	48	36	0.27	0.36	0.73	0.64	G	2.31	0.010642491	Cervical cancer	Cancer
rs792975	A	G	36	48	10	51	36	7	0.64	0.73	0.36	0.27	T	1.746	0.010642491	Adverse response to chemotherapy neutropenia_leucopenia paclitaxel	Drug response
rs9392918	T	C	38	44	12	54	30	10	0.64	0.73	0.36	0.27	T	0.038	0.010642491	Height	General health
rs7155434	A	C	62	28	4	74	18	2	0.81	0.88	0.19	0.12	A	3643	0.010626762	Brain structure temporal lobe volume	Brain health and disorders
rs10259199	T	C	74	18	2	63	26	5	0.88	0.81	0.12	0.19	G	0.04	0.010626762	Obesity-related traits	Obesity
rs7989332	A	C	5	26	63	0	22	72	0.19	0.12	0.81	0.88	G	2.056	0.010626762	Adverse response to chemotherapy neutropenia_leucopenia carboplatin	Drug response
rs415430	C	T	2	32	60	2	18	74	0.19	0.12	0.81	0.88	T	1	0.010626762	Parkinson's disease	Brain health and disorders
rs3760318	G	A	41	40	13	26	51	17	0.65	0.55	0.35	0.45	C	6	0.01062546	Height	General health
rs1453160	G	A	70	21	3	57	32	5	0.86	0.78	0.14	0.22	A	1	0.010621725	Subcutaneous adipose tissue	Obesity
rs6684514	G	A	57	32	5	71	19	4	0.78	0.86	0.22	0.14	A	0.086	0.010621725	Mean corpuscular hemoglobin concentration	Heart health and disorders
rs179429	A	G	2	23	69	8	26	60	0.14	0.22	0.86	0.78	A	1	0.010621725	Platelet aggregation	Heart health and disorders
rs11195128	C	T	51	37	6	64	27	3	0.74	0.82	0.26	0.18	T	1.42	0.010618882	Crohn's disease	Digestive system and its disorders
rs10078095	T	C	62	31	1	52	35	7	0.82	0.74	0.18	0.26	C	0.9	0.010618882	Height	General health
rs2273905	T	C	5	39	50	2	29	63	0.26	0.18	0.74	0.82	T	0.61	0.010618882	QT interval	Heart health and disorders
rs1979755	G	C	7	35	52	1	31	62	0.26	0.18	0.74	0.82	C	0.019	0.010618882	Body mass index	Obesity
rs30187	T	C	25	36	33	9	49	36	0.46	0.36	0.54	0.64	T	1	0.010580615	Ankylosing spondylitis	Immune diseases and disorders
rs3849570	C	A	40	41	13	24	54	16	0.64	0.54	0.36	0.46	A	0.023	0.010580615	Body mass index	Obesity
rs626277	A	C	23	40	31	10	47	37	0.46	0.36	0.54	0.64	C	0.01	0.010580615	Chronic kidney disease	Immune diseases and disorders
rs75045569	T	G	65	27	2	79	12	3	0.84	0.90	0.16	0.10	T	1.1494253	0.010547338	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs10510102	T	C	64	29	1	76	18	0	0.84	0.90	0.16	0.10	G	1.12	0.010547338	Breast cancer	Cancer
rs12889813	C	T	66	25	3	76	18	0	0.84	0.90	0.16	0.10	T	0.2	0.010547338	Antibody level in response to infection	Immune diseases and disorders
rs2192161	G	A	76	18	0	65	27	2	0.90	0.84	0.10	0.16	A	0.198	0.010547338	Non-word repetition	Brain health and disorders
rs8030136	C	T	67	23	4	77	16	1	0.84	0.90	0.16	0.10	T	0.1934	0.010547338	Periodontitis DPAL	Misc
rs6457690	G	A	76	18	0	63	31	0	0.90	0.84	0.10	0.16	A	0.19	0.010547338	Disc degeneration lumbar	Aging
rs1029296	T	C	76	18	0	63	31	0	0.90	0.84	0.10	0.16	C	0.19	0.010547338	Disc degeneration lumbar	Aging
rs1029295	T	C	76	18	0	63	31	0	0.90	0.84	0.10	0.16	C	0.19	0.010547338	Disc degeneration lumbar	Aging
rs5771040	A	G	14	41	39	5	41	48	0.37	0.27	0.63	0.73	G	0.1595	0.010546875	IgG glycosylation	Immune diseases and disorders
rs4233949	C	G	6	39	49	14	41	39	0.27	0.37	0.73	0.63	C	0.05	0.010546875	Bone mineral density	General health
rs10937405	C	T	40	39	15	51	35	8	0.63	0.73	0.37	0.27	C	1.31	0.010546875	Lung adenocarcinoma	Cancer
rs6596140	C	T	47	43	4	40	39	15	0.73	0.63	0.27	0.37	T	1	0.010546875	Hypertension	Heart health and disorders
rs2602381	T	C	28	45	21	34	52	8	0.54	0.64	0.46	0.36	A	1.42	0.010538608	Attention deficit hyperactivity disorder	Brain health and disorders
rs7953249	G	A	19	49	26	13	42	39	0.46	0.36	0.54	0.64	G	0.17	0.010538608	N-glycan levels	General health
rs11190134	G	A	28	45	21	35	50	9	0.54	0.64	0.46	0.36	G	0.011	0.010538608	Red blood cell traits	Immune diseases and disorders
rs57083693	T	C	45	40	9	57	33	4	0.69	0.78	0.31	0.22	C	1.35	0.010538599	Alcohol dependence age at onset	General health
rs12912251	G	T	46	38	10	61	25	8	0.69	0.78	0.31	0.22	G	1.1	0.010538599	Bipolar disorder	Brain health and disorders
rs1016553	A	G	2	37	55	6	46	42	0.22	0.31	0.78	0.69	A	1	0.010538599	Homeostasis model assessment of beta-cell function interaction	Misc
rs303386	C	T	9	51	34	22	44	28	0.37	0.47	0.63	0.53	A	1.766	0.010499375	Adverse response to chemotherapy neutropenia_leucopenia all topoisomerase inhibitors	Drug response
rs262741	G	A	27	45	22	34	50	10	0.53	0.63	0.47	0.37	G	0.2447	0.010462858	Lewy body disease	Brain health and disorders
rs3809346	G	A	23	53	18	38	42	14	0.53	0.63	0.47	0.37	A	0.102	0.010462858	Coronary artery calcification	Heart health and disorders
rs4968782	G	A	13	44	37	16	57	21	0.37	0.47	0.63	0.53	G	1	0.010462858	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Brain health and disorders
rs2841233	T	C	15	40	39	21	47	26	0.37	0.47	0.63	0.53	C	0.1475	0.010462858	IgG glycosylation	Immune diseases and disorders
rs11086243	C	T	34	50	10	49	38	7	0.63	0.72	0.37	0.28	T	1.37	0.01045566	Nephrotic syndrome acquired	General health
rs1538138	T	C	1	32	61	7	36	51	0.18	0.27	0.82	0.73	T	0.07	0.010437052	Corneal structure	General health
rs485842	C	T	52	34	8	62	30	2	0.73	0.82	0.27	0.18	A	0.055	0.010437052	Corneal astigmatism	General health
rs2597327	T	C	65	24	5	50	38	6	0.82	0.73	0.18	0.27	T	0.04	0.010437052	LDL peak particle diameter total fat intake interaction	General health
rs1504749	A	C	41	35	18	23	52	19	0.62	0.52	0.38	0.48	C	1.17	0.010429005	Intracranial aneurysm	Misc
rs6550435	T	G	38	41	15	25	48	21	0.62	0.52	0.38	0.48	G	1.08	0.010429005	Schizophrenia	Brain health and disorders
rs3851179	T	C	11	37	46	3	36	55	0.31	0.22	0.69	0.78	C	1.1235955	0.010405041	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs10797432	C	T	23	45	26	10	52	32	0.48	0.38	0.52	0.62	C	1.078	0.010397765	Ulcerative colitis	Immune diseases and disorders
rs10227393	C	G	55	35	4	69	22	3	0.77	0.85	0.23	0.15	C	0.08	0.01039021	Coffee consumption	Misc
rs13077101	T	C	58	29	7	68	24	2	0.77	0.85	0.23	0.15	G	0.03	0.01039021	Obesity-related traits	Obesity
rs2255280	C	A	0	10	84	0	3	91	0.05	0.02	0.95	0.98	T	1.23	0.010383556	Pancreatic cancer	Cancer
rs679515	T	C	0	10	84	0	3	91	0.05	0.02	0.95	0.98	T	1.22	0.010383556	Alzheimer's disease in APOE e4+ carriers	Brain health and disorders
rs6656401	A	G	0	10	84	0	3	91	0.05	0.02	0.95	0.98	A	1.18	0.010383556	Alzheimer's disease late onset	Brain health and disorders
rs627386	T	G	1	1	92	0	10	84	0.02	0.05	0.98	0.95	G	0.5473	0.010383556	IgG glycosylation	Immune diseases and disorders
rs4594074	A	G	0	3	91	0	10	84	0.02	0.05	0.98	0.95	A	0.4642	0.010383556	Cerebral amyloid deposition in APOEe4 non-carriers PET imaging	Brain health and disorders
rs7961894	C	T	85	8	1	91	3	0	0.95	0.98	0.05	0.02	C	3.923	0.010383556	Platelet count	Heart health and disorders
rs11209026	G	A	84	10	0	91	3	0	0.95	0.98	0.05	0.02	G	1	0.010383556	Ankylosing spondylitis	Immune diseases and disorders
rs11969893	G	A	91	3	0	84	10	0	0.98	0.95	0.02	0.05	G	0.324	0.010383556	Economic and political preferences immigration_crime	Mental aptitude and behavioural traits
rs72822868	T	C	85	8	1	91	3	0	0.95	0.98	0.05	0.02	T	0.23	0.010383556	Percentage gas trapping	Misc
rs16839626	G	A	91	3	0	84	10	0	0.98	0.95	0.02	0.05	A	0.05	0.010383556	Obesity-related traits	Obesity
rs11057405	G	A	84	10	0	91	3	0	0.95	0.98	0.05	0.02	G	0.033	0.010383556	Body mass index	Obesity
rs9293741	T	A	25	46	23	32	51	11	0.51	0.61	0.49	0.39	A	1.06	0.010369094	Schizophrenia	Brain health and disorders
rs4929947	G	C	26	44	24	39	37	18	0.51	0.61	0.49	0.39	G	0.04	0.010369094	Menarche age at onset	Reproductive health
rs10773568	G	A	38	41	15	48	39	7	0.62	0.72	0.38	0.28	A	0.074	0.010368664	Height	General health
rs1788776	G	A	9	35	50	12	47	35	0.28	0.38	0.72	0.62	A	1.11	0.010368664	Amyotrophic lateral sclerosis sporadic	Brain health and disorders
rs2041840	T	C	6	25	63	2	19	73	0.20	0.12	0.80	0.88	C	1.2	0.010337553	Chronic lymphocytic leukemia	Cancer
rs2072883	G	A	3	31	60	1	21	72	0.20	0.12	0.80	0.88	A	1.05	0.010337553	Schizophrenia	Brain health and disorders
rs61613191	G	A	71	23	0	59	33	2	0.88	0.80	0.12	0.20	A	9.56	0.010337553	Diisocyanate-induced asthma	Pulmonology
rs10494112	A	G	60	31	3	72	21	1	0.80	0.88	0.20	0.12	G	1.72	0.010337553	Paget's disease	General health
rs798502	A	C	63	25	6	72	21	1	0.80	0.88	0.20	0.12	A	1.13	0.010337553	Ulcerative colitis	Immune diseases and disorders
rs11710077	A	T	60	31	3	72	21	1	0.80	0.88	0.20	0.12	T	0.84	0.010337553	QRS duration	Heart health and disorders
rs10861342	T	C	60	31	3	73	19	2	0.80	0.88	0.20	0.12	C	0.2456	0.010337553	IgG glycosylation	Immune diseases and disorders
rs603788	G	C	16	44	34	21	53	20	0.40	0.51	0.60	0.49	G	2.08	0.010298103	Blood pressure	Heart health and disorders
rs9895661	C	T	19	38	37	23	49	22	0.40	0.51	0.60	0.49	C	0.0045	0.010298103	Renal function-related traits sCR	General health
rs10938397	A	G	31	54	9	46	42	6	0.62	0.71	0.38	0.29	G	1.16	0.010285714	Body mass index	Obesity
rs351365	T	C	6	42	46	12	48	34	0.29	0.38	0.71	0.62	C	1.1235955	0.010285714	Pancreatic cancer	Cancer
rs13241427	G	T	8	38	48	10	52	32	0.29	0.38	0.71	0.62	C	1	0.010285714	Fat distribution HIV	General health
rs498136	A	C	11	50	33	11	32	51	0.38	0.29	0.62	0.71	A	0.12	0.010285714	Cutaneous malignant melanoma	Cancer
rs7163013	C	T	14	44	36	7	40	47	0.38	0.29	0.62	0.71	G	0.04	0.010285714	Obesity-related traits	Obesity
rs7135659	G	A	14	49	31	23	50	21	0.41	0.51	0.59	0.49	G	1.99	0.010279336	PR interval	Heart health and disorders
rs2079515	G	C	14	49	31	29	38	27	0.41	0.51	0.59	0.49	C	1	0.010279336	Childhood and early adolescence aggressive behavior	Brain health and disorders
rs1107366	A	G	21	54	19	13	51	30	0.51	0.41	0.49	0.59	G	0.019	0.010279336	Metabolite levels	General health
rs870288	A	G	42	44	8	54	37	3	0.68	0.77	0.32	0.23	A	1	0.010277748	Subcutaneous adipose tissue	Obesity
rs66785688	A	G	79	15	0	69	23	2	0.92	0.86	0.08	0.14	G	3.9	0.010265184	Diisocyanate-induced asthma	Pulmonology
rs4635580	C	T	80	13	1	70	21	3	0.92	0.86	0.08	0.14	A	3.8	0.010265184	Diisocyanate-induced asthma	Pulmonology
rs1454694	T	C	68	25	1	79	15	0	0.86	0.92	0.14	0.08	C	2.12	0.010265184	Non-small cell lung cancer recurrence rate	Cancer
rs17513503	C	G	81	11	2	68	25	1	0.92	0.86	0.08	0.14	G	1.28	0.010265184	Allergic rhinitis	Immune diseases and disorders
rs76010824	G	A	69	23	2	80	13	1	0.86	0.92	0.14	0.08	A	1.26	0.010265184	Prostate cancer survival	Cancer
rs9638182	T	G	80	13	1	68	25	1	0.92	0.86	0.08	0.14	T	0.1	0.010265184	Triglycerides	General health
rs229526	G	C	63	27	4	47	43	4	0.81	0.73	0.19	0.27	C	1.216	0.010264635	Hypothyroidism	Immune diseases and disorders
rs7623788	A	G	62	29	3	51	35	8	0.81	0.73	0.19	0.27	G	0.2057	0.010264635	IgG glycosylation	Immune diseases and disorders
rs4936099	C	A	7	37	50	3	29	62	0.27	0.19	0.73	0.81	C	0.009	0.010264635	Vertical cup-disc ratio	Misc
rs2806946	A	T	7	37	50	5	25	64	0.27	0.19	0.73	0.81	A	0.0026	0.010264635	Trans fatty acid levels	General health
rs12145922	C	A	17	44	33	24	49	21	0.41	0.52	0.59	0.48	A	2.8	0.010262971	Liver enzyme levels gamma-glutamyl transferase	General health
rs10792320	A	C	25	47	22	9	60	25	0.52	0.41	0.48	0.59	A	0.02	0.010262971	Phospholipid levels plasma	General health
rs11782652	A	G	85	9	0	75	19	0	0.95	0.90	0.05	0.10	G	1	0.010262726	Epithelial ovarian cancer	Cancer
rs2887004	A	G	76	17	1	85	9	0	0.90	0.95	0.10	0.05	G	0.193	0.010262726	IgG glycosylation	Immune diseases and disorders
rs11246602	T	C	76	17	1	85	9	0	0.90	0.95	0.10	0.05	C	0.034	0.010262726	HDL cholesterol	General health
rs17665162	T	C	75	19	0	86	7	1	0.90	0.95	0.10	0.05	C	0.033	0.010262726	Body mass index	Obesity
rs12489828	G	T	17	45	32	25	48	21	0.42	0.52	0.58	0.48	T	0.0294	0.010248985	Waist-to-hip ratio adjusted for body mass index	Obesity
rs2657888	T	G	15	49	30	21	56	17	0.42	0.52	0.58	0.48	T	0.019	0.010248985	Adiponectin levels	Obesity
rs13254738	C	A	21	48	25	33	43	18	0.48	0.58	0.52	0.42	C	1.59	0.010248985	Prostate cancer	Cancer
rs2945232	T	C	22	46	26	27	55	12	0.48	0.58	0.52	0.42	C	1.0638298	0.010248985	Schizophrenia	Brain health and disorders
rs391300	T	C	18	44	32	18	63	13	0.43	0.53	0.57	0.47	G	1.28	0.010237359	Type 2 diabetes	Diabetes
rs4337252	G	C	24	51	19	15	50	29	0.53	0.43	0.47	0.57	C	1.14	0.010237359	Height	General health
rs7728043	T	C	31	46	17	21	47	26	0.57	0.47	0.43	0.53	G	0.14	0.010237359	QT interval	Heart health and disorders
rs2070776	A	G	24	51	19	19	42	33	0.53	0.43	0.47	0.57	A	0.042	0.010237359	Height	General health
rs11172113	T	C	27	45	22	19	42	33	0.53	0.43	0.47	0.57	T	0.032	0.010237359	Pulmonary function	Pulmonology
rs10737680	A	C	15	51	28	29	42	23	0.43	0.53	0.57	0.47	A	3.11	0.010228078	Age-related macular degeneration	Aging
rs5771069	A	G	28	44	22	12	57	25	0.53	0.43	0.47	0.57	G	1.17	0.010228078	Ulcerative colitis	Immune diseases and disorders
rs2671692	G	A	17	53	24	28	50	16	0.46	0.56	0.54	0.44	A	1.07	0.010221127	Rheumatoid arthritis	Immune diseases and disorders
rs9594759	C	T	30	46	18	21	45	28	0.56	0.46	0.44	0.54	T	0.17	0.010221127	Bone mineral density spine	General health
rs239198	C	T	35	36	23	20	47	27	0.56	0.46	0.44	0.54	T	0.03	0.010221127	Menarche age at onset	Reproductive health
rs11835818	T	C	31	43	20	18	50	26	0.56	0.46	0.44	0.54	T	0.022	0.010216499	Height	General health
rs10444502	A	C	29	46	19	17	51	26	0.55	0.45	0.45	0.55	C	0.17	0.010214187	Biochemical measures	General health
rs2079795	T	C	23	39	32	29	46	19	0.45	0.55	0.55	0.45	T	0.088	0.010214187	Sitting height ratio	Appearance
rs657452	A	G	18	49	27	28	48	18	0.45	0.55	0.55	0.45	A	0.023	0.010214187	Body mass index	Obesity
rs7000447	G	A	31	41	22	12	60	22	0.55	0.45	0.45	0.55	G	2.35	0.010214187	Diisocyanate-induced asthma	Pulmonology
rs5760748	C	T	26	51	17	17	50	27	0.55	0.45	0.45	0.55	C	0.00179	0.010214187	Calcium levels	General health
rs1294438	C	T	36	43	15	47	39	8	0.61	0.71	0.39	0.29	T	1	0.010206653	Mammographic density non-dense area	Reproductive health
rs11200392	C	T	48	37	9	33	49	12	0.71	0.61	0.29	0.39	A	0.04	0.010206653	Obesity-related traits	Obesity
rs552976	A	G	9	37	48	12	49	33	0.29	0.39	0.71	0.61	G	0.05	0.010206653	Glycated hemoglobin levels	Diabetes
rs3733860	C	A	67	22	5	75	19	0	0.83	0.90	0.17	0.10	A	1.19	0.010196078	Venous thromboembolism	Heart health and disorders
rs13030174	A	C	62	32	0	75	19	0	0.83	0.90	0.17	0.10	A	0.3	0.010196078	Heart rate	General health
rs7228133	G	T	66	27	1	54	36	4	0.85	0.77	0.15	0.23	C	1.255	0.01017225	Adverse response to chemotherapy neutropenia_leucopenia all antimetabolite drugs	Drug response
rs13418455	C	T	55	34	5	67	25	2	0.77	0.85	0.23	0.15	T	1.06	0.01017225	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs6544713	T	C	5	34	55	2	25	67	0.23	0.15	0.77	0.85	T	0.15	0.01017225	LDL cholesterol	General health
rs6936204	T	C	6	32	56	13	35	46	0.23	0.32	0.77	0.68	C	0.02	0.010156387	Neutrophil count	Immune diseases and disorders
rs11153730	T	C	42	43	9	54	36	4	0.68	0.77	0.32	0.23	T	1.65	0.010156387	QT interval	Heart health and disorders
rs1890566	A	G	47	33	14	52	40	2	0.68	0.77	0.32	0.23	G	1.06	0.010156387	Migraine	Brain health and disorders
rs779933	G	A	43	41	10	59	26	9	0.68	0.77	0.32	0.23	A	0.032	0.010156387	Height	General health
rs3732783	T	C	82	12	0	73	19	2	0.94	0.88	0.06	0.12	T	1.8772	0.010138249	Smooth-surface caries	Appearance
rs12537284	G	A	72	21	1	83	10	1	0.88	0.94	0.12	0.06	A	1.54	0.010138249	Systemic lupus erythematosus	Immune diseases and disorders
rs6920220	G	A	72	21	1	82	12	0	0.88	0.94	0.12	0.06	A	1.22	0.010138249	Rheumatoid arthritis	Immune diseases and disorders
rs12480328	T	C	83	10	1	71	23	0	0.94	0.88	0.06	0.12	T	1.13	0.010138249	Prostate cancer	Cancer
rs6810075	T	C	38	38	18	48	36	10	0.61	0.70	0.39	0.30	T	0.06	0.010131332	Adiponectin levels	Obesity
rs6542095	C	T	15	44	35	5	46	43	0.39	0.30	0.61	0.70	C	1.5	0.010131332	Endometriosis	General health
rs7542900	T	C	11	34	49	13	48	33	0.30	0.39	0.70	0.61	C	1.16	0.010131332	Type 2 diabetes	Diabetes
rs4875598	G	A	5	46	43	19	36	39	0.30	0.39	0.70	0.61	G	0.94	0.010131332	Attention deficit hyperactivity disorder symptoms interaction	Brain health and disorders
rs6532023	T	G	6	44	44	13	48	33	0.30	0.39	0.70	0.61	T	0.07	0.010131332	Bone mineral density paediatric, total body less head	General health
rs2738048	A	G	49	38	7	64	24	6	0.72	0.81	0.28	0.19	T	1.23	0.01010101	IgA nephropathy	Immune diseases and disorders
rs1171113	C	T	13	26	55	4	28	62	0.28	0.19	0.72	0.81	C	1.23	0.01010101	Bipolar disorder with mood-incongruent psychosis	Brain health and disorders
rs2284378	T	C	7	38	49	5	26	63	0.28	0.19	0.72	0.81	T	1.16	0.01010101	Breast cancer	Cancer
rs9307551	A	C	4	28	62	2	48	44	0.19	0.28	0.81	0.72	A	0.099	0.01010101	Refractive error	General health
rs3749946	C	A	72	20	2	66	18	10	0.87	0.80	0.13	0.20	A	1.97	0.010067804	Ulcerative colitis	Immune diseases and disorders
rs73070160	C	T	72	20	2	59	32	3	0.87	0.80	0.13	0.20	T	1.24	0.010067804	Tourette's syndrome or obsessive-compulsive disorder	Brain health and disorders
rs12681963	T	C	1	22	71	3	32	59	0.13	0.20	0.87	0.80	T	1.11	0.010067804	Migraine	Brain health and disorders
rs6813517	T	C	72	20	2	61	28	5	0.87	0.80	0.13	0.20	T	0.3686	0.010067804	Verbal declarative memory	Brain health and disorders
rs4650376	C	T	3	32	59	2	20	72	0.20	0.13	0.80	0.87	C	0.2355	0.010067804	IgG glycosylation	Immune diseases and disorders
rs2896526	A	G	60	30	4	70	24	0	0.80	0.87	0.20	0.13	G	0.221	0.010067804	Amyloid A serum levels	General health
rs6938574	T	C	2	20	72	3	32	59	0.13	0.20	0.87	0.80	T	0.04	0.010067804	Menarche age at onset	Reproductive health
rs29784	C	T	37	39	18	52	27	15	0.60	0.70	0.40	0.30	T	1.36	0.010059613	Infantile hypertrophic pyloric stenosis	Misc
rs1571878	C	T	17	41	36	10	37	47	0.40	0.30	0.60	0.70	C	1.28	0.010059613	Rheumatoid arthritis	Immune diseases and disorders
rs11876941	G	A	46	39	9	35	43	16	0.70	0.60	0.30	0.40	A	0.003	0.010059613	Body mass index interaction	Obesity
rs2872507	G	A	39	48	7	56	31	7	0.67	0.76	0.33	0.24	A	1.14	0.010040649	Crohn's disease	Digestive system and its disorders
rs10734105	G	A	10	38	46	10	56	28	0.31	0.40	0.69	0.60	G	1.27	0.009991365	Crohn's disease	Digestive system and its disorders
rs6444305	G	A	9	40	45	20	36	38	0.31	0.40	0.69	0.60	G	1.21	0.009991365	Follicular lymphoma	Cancer
rs3130783	G	A	9	40	45	16	44	34	0.31	0.40	0.69	0.60	A	1.16	0.009991365	Age-related macular degeneration	Aging
rs524732	G	A	29	54	11	45	40	9	0.60	0.69	0.40	0.31	A	1.06	0.009991365	Schizophrenia	Brain health and disorders
rs1211375	A	C	14	48	32	5	48	41	0.40	0.31	0.60	0.69	A	0.2115	0.009991365	Mean corpuscular hemoglobin	Heart health and disorders
rs9366999	G	A	33	46	15	38	54	2	0.60	0.69	0.40	0.31	A	0.03	0.009991365	Obesity-related traits	Obesity
rs3129889	G	A	1	14	79	0	7	87	0.09	0.04	0.91	0.96	G	2.97	0.009976598	Multiple sclerosis	Brain health and disorders
rs1210898	T	C	0	7	87	0	16	78	0.04	0.09	0.96	0.91	T	1.1	0.009976598	Schizophrenia	Brain health and disorders
rs12904863	T	C	88	5	1	79	14	1	0.96	0.91	0.04	0.09	C	30.31	0.009976598	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs12528714	G	T	78	16	0	87	7	0	0.91	0.96	0.09	0.04	G	2.4277	0.009976598	IgG glycosylation	Immune diseases and disorders
rs17760296	T	G	78	16	0	87	7	0	0.91	0.96	0.09	0.04	G	1.5	0.009976598	Orofacial clefts	Misc
rs17376456	A	G	78	16	0	87	7	0	0.91	0.96	0.09	0.04	A	1	0.009976598	Diabetic retinopathy	Diabetes
rs1520223	T	C	78	16	0	87	7	0	0.91	0.96	0.09	0.04	C	0.56	0.009976598	Height	General health
rs11031005	T	C	78	16	0	87	7	0	0.91	0.96	0.09	0.04	C	0.232	0.009976598	Sex hormone levels	Reproductive health
rs16853722	T	C	80	12	2	88	5	1	0.91	0.96	0.09	0.04	C	0.0064	0.009976598	Renal function-related traits BUN	General health
rs7327064	C	T	55	33	6	65	28	1	0.76	0.84	0.24	0.16	T	0.14	0.009966777	Economic and political preferences	Mental aptitude and behavioural traits
rs12142669	T	C	5	20	69	5	35	54	0.16	0.24	0.84	0.76	A	0.03	0.009966777	Obesity-related traits	Obesity
rs2765086	C	T	89	5	0	81	13	0	0.97	0.93	0.03	0.07	G	3.86	0.009931719	Weight	Appearance
rs13407662	C	T	83	9	2	89	5	0	0.93	0.97	0.07	0.03	T	1.95	0.009931719	Stroke ischemic	Brain health and disorders
rs9596270	T	C	89	5	0	81	13	0	0.97	0.93	0.03	0.07	T	1.35	0.009931719	Multiple sclerosis	Brain health and disorders
rs140505938	C	T	81	13	0	89	5	0	0.93	0.97	0.07	0.03	T	1.0940919	0.009931719	Schizophrenia	Brain health and disorders
rs1805203	T	G	82	11	1	89	5	0	0.93	0.97	0.07	0.03	G	1.0869565	0.009931719	Schizophrenia	Brain health and disorders
rs11712112	G	A	82	11	1	89	5	0	0.93	0.97	0.07	0.03	A	1.08	0.009931719	Schizophrenia	Brain health and disorders
rs7734156	G	C	83	9	2	89	5	0	0.93	0.97	0.07	0.03	C	0.3437	0.009931719	IgG glycosylation	Immune diseases and disorders
rs12748152	C	T	81	13	0	89	5	0	0.93	0.97	0.07	0.03	T	0.051	0.009931719	HDL cholesterol	General health
rs9860250	A	G	81	13	0	89	5	0	0.93	0.97	0.07	0.03	G	0.036	0.009931719	Optic disc area	Misc
rs7199343	A	T	43	39	12	54	34	6	0.66	0.76	0.34	0.24	T	1.56	0.009930248	Kawasaki disease	Misc
rs35738462	T	C	44	37	13	50	42	2	0.66	0.76	0.34	0.24	T	1.32	0.009930248	Alcohol dependence age at onset	General health
rs591323	G	A	43	39	12	51	40	3	0.66	0.76	0.34	0.24	G	1.09	0.009930248	Parkinson's disease	Brain health and disorders
rs9390123	T	C	14	49	31	9	41	44	0.41	0.31	0.59	0.69	A	1	0.009926471	Lung Cancer DNA repair capacity	Cancer
rs17169	G	T	62	31	1	74	20	0	0.82	0.89	0.18	0.11	T	2.97	0.009872072	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs10498345	T	A	74	20	0	61	33	0	0.89	0.82	0.11	0.18	T	2.33	0.009872072	Coronary spasm	Heart health and disorders
rs10090154	T	C	0	20	74	4	25	65	0.11	0.18	0.89	0.82	T	1.68	0.009872072	Prostate cancer	Cancer
rs6583954	C	T	74	20	0	63	29	2	0.89	0.82	0.11	0.18	T	1.08	0.009872072	Migraine	Brain health and disorders
rs6065906	T	C	74	20	0	64	27	3	0.89	0.82	0.11	0.18	C	0.93	0.009872072	HDL cholesterol	General health
rs744653	C	T	1	18	75	4	25	65	0.11	0.18	0.89	0.82	T	0.089	0.009872072	Iron status biomarkers ferritin levels	General health
rs11069349	G	A	76	16	2	61	33	0	0.89	0.82	0.11	0.18	A	0.0677	0.009872072	Self-reported allergy	General health
rs16985452	T	G	75	18	1	62	31	1	0.89	0.82	0.11	0.18	T	0.0137	0.009872072	Trans fatty acid levels	General health
rs1003719	A	G	31	48	15	46	36	12	0.59	0.68	0.41	0.32	A	0.1	0.009864815	Eye color traits	Appearance
rs4702718	A	G	42	44	8	32	46	16	0.68	0.59	0.32	0.41	G	0.04	0.009864815	Obesity-related traits	Obesity
rs7448080	T	C	0	16	78	0	28	66	0.09	0.15	0.91	0.85	T	1.69	0.009857612	Alcohol dependence age at onset	General health
rs754388	G	C	1	14	79	2	24	68	0.09	0.15	0.91	0.85	C	1	0.009857612	Local histogram emphysema pattern	Pulmonology
rs12699683	G	T	69	22	3	78	16	0	0.85	0.91	0.15	0.09	A	3.66	0.009857612	Paclitaxel-induced neuropathy	Brain health and disorders
rs1485395	T	C	68	24	2	78	16	0	0.85	0.91	0.15	0.09	C	1.13	0.009857612	Migraine without aura	Brain health and disorders
rs11942476	C	G	69	22	3	78	16	0	0.85	0.91	0.15	0.09	C	0.2144	0.009857612	IgG glycosylation	Immune diseases and disorders
rs115958457	C	T	92	2	0	87	6	1	0.99	0.96	0.01	0.04	A	34.43	0.009836066	Diisocyanate-induced asthma	Pulmonology
rs17167307	T	C	92	2	0	86	8	0	0.99	0.96	0.01	0.04	G	34.43	0.009836066	Diisocyanate-induced asthma	Pulmonology
rs10484157	C	T	86	8	0	92	2	0	0.96	0.99	0.04	0.01	T	10.01	0.009836066	Heschl's gyrus morphology	Brain health and disorders
rs67335251	C	T	87	6	1	92	2	0	0.96	0.99	0.04	0.01	A	3.06	0.009836066	Diisocyanate-induced asthma	Pulmonology
rs9267531	A	G	92	2	0	86	8	0	0.99	0.96	0.01	0.04	G	2.62	0.009836066	Cutaneous lupus erythematosus	Immune diseases and disorders
rs74745534	C	T	86	8	0	92	2	0	0.96	0.99	0.04	0.01	T	2.5	0.009836066	Alcohol dependence	General health
rs1800961	C	T	86	8	0	92	2	0	0.96	0.99	0.04	0.01	T	1.88	0.009836066	HDL cholesterol	General health
rs12722495	T	C	86	8	0	92	2	0	0.96	0.99	0.04	0.01	A	1.61	0.009836066	Type 1 diabetes autoantibodies	Diabetes
rs6599389	G	A	86	8	0	92	2	0	0.96	0.99	0.04	0.01	A	1.31	0.009836066	Parkinson's disease	Brain health and disorders
rs11769293	C	T	92	2	0	86	8	0	0.99	0.96	0.01	0.04	T	1.0518	0.009836066	Vascular brain injury	Brain health and disorders
rs13153333	A	G	86	8	0	93	0	1	0.96	0.99	0.04	0.01	G	1	0.009836066	Subcutaneous adipose tissue	Obesity
rs13037749	A	G	87	6	1	92	2	0	0.96	0.99	0.04	0.01	A	1	0.009836066	Hippocampal atrophy	Brain health and disorders
rs41268928	G	C	92	2	0	86	8	0	0.99	0.96	0.01	0.04	C	0.69	0.009836066	Advanced glycation end-product levels	General health
rs117224174	G	A	86	8	0	92	2	0	0.96	0.99	0.04	0.01	G	0.3986	0.009836066	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs1881744	G	A	86	8	0	92	2	0	0.96	0.99	0.04	0.01	A	0.228	0.009836066	Metabolite levels HVA_5-HIAA ratio	Brain health and disorders
rs11104803	C	G	87	6	1	92	2	0	0.96	0.99	0.04	0.01	C	0.0067	0.009836066	Trans fatty acid levels	General health
rs1036429	T	C	11	42	41	7	33	54	0.34	0.25	0.66	0.75	T	0.038	0.009824919	Pulmonary function	Pulmonology
rs3129055	A	G	44	36	14	55	31	8	0.66	0.75	0.34	0.25	G	1.51	0.009824919	Nasopharyngeal carcinoma	Cancer
rs13277113	G	A	40	44	10	53	35	6	0.66	0.75	0.34	0.25	A	1.391	0.009824919	Systemic lupus erythematosus	Immune diseases and disorders
rs2736340	C	T	40	44	10	53	35	6	0.66	0.75	0.34	0.25	A	1.19	0.009824919	Rheumatoid arthritis	Immune diseases and disorders
rs10474352	C	T	53	35	6	46	32	16	0.75	0.66	0.25	0.34	C	1.09	0.009824919	Breast cancer	Cancer
rs3749171	C	T	71	21	2	58	33	3	0.87	0.79	0.13	0.21	A	1.075187	0.009815705	Crohn's disease	Digestive system and its disorders
rs1937787	T	C	57	35	2	71	21	2	0.79	0.87	0.21	0.13	T	0.27	0.009815705	Stroke	Brain health and disorders
rs17091905	G	A	70	23	1	60	29	5	0.87	0.79	0.13	0.21	A	0.174	0.009815705	Cardiovascular disease risk factors	Heart health and disorders
rs738722	T	C	7	47	40	20	39	35	0.32	0.42	0.68	0.58	T	1.3	0.009806295	Esophageal cancer and gastric cancer	Cancer
rs4947534	T	C	9	43	42	18	43	33	0.32	0.42	0.68	0.58	T	0.018	0.009806295	Blood metabolite levels	Heart health and disorders
rs9268480	C	T	47	40	7	60	30	4	0.71	0.80	0.29	0.20	G	1.82	0.009797918	Ulcerative colitis	Immune diseases and disorders
rs11066679	G	C	57	28	9	66	25	3	0.76	0.84	0.24	0.16	C	0.08	0.009772836	Glomerular filtration rate in chronic kidney disease	General health
rs8052560	C	A	2	27	65	4	38	52	0.16	0.24	0.84	0.76	A	0.029	0.009772836	Height	General health
rs7310409	A	G	18	44	32	11	40	43	0.43	0.33	0.57	0.67	G	6.8	0.009750813	Liver enzyme levels gamma-glutamyl transferase	General health
rs10184704	T	C	44	38	12	33	42	19	0.67	0.57	0.33	0.43	C	2.3	0.009750813	Pyoderma gangrenosum in inflammatory bowel disease	Immune diseases and disorders
rs9832740	G	C	19	42	33	8	46	40	0.43	0.33	0.57	0.67	G	1.15	0.009750813	Height	General health
rs67981189	A	G	42	42	10	28	52	14	0.67	0.57	0.33	0.43	G	1.0638298	0.009750813	Schizophrenia	Brain health and disorders
rs3130559	C	T	44	38	12	30	48	16	0.67	0.57	0.33	0.43	T	1	0.009750813	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs2827312	G	T	28	52	14	42	42	10	0.57	0.67	0.43	0.33	G	0.089	0.009750813	Alcoholism heaviness of drinking	General health
rs10838681	G	A	47	32	15	30	48	16	0.67	0.57	0.33	0.43	G	0.08	0.009750813	Metabolic syndrome	Immune diseases and disorders
rs2393791	C	T	18	44	32	11	40	43	0.43	0.33	0.57	0.67	G	0.0076	0.009750813	Gamma glutamyl transpeptidase	Immune diseases and disorders
rs11154027	T	C	10	45	39	1	46	47	0.35	0.26	0.65	0.74	C	0.32	0.009724419	Heart rate	General health
rs10953615	A	G	40	43	11	51	38	5	0.65	0.74	0.35	0.26	C	7.51	0.009724419	Gallbladder cancer	Cancer
rs2373115	C	A	51	38	5	39	45	10	0.74	0.65	0.26	0.35	G	4.06	0.009724419	Alzheimer's disease late onset	Brain health and disorders
rs10899489	C	A	51	38	5	39	45	10	0.74	0.65	0.26	0.35	A	3.1	0.009724419	Menarche age at onset	Reproductive health
rs2519974	G	A	39	45	10	53	34	7	0.65	0.74	0.35	0.26	T	1.647	0.009724419	Adverse response to chemotherapy neutropenia_leucopenia cyclophosphamide	Drug response
rs10112574	G	A	54	32	8	41	41	12	0.74	0.65	0.26	0.35	A	0.025	0.009724419	Blood metabolite ratios	Heart health and disorders
rs7267348	T	C	45	35	14	30	47	17	0.66	0.57	0.34	0.43	C	1.0672358	0.009698276	Schizophrenia	Brain health and disorders
rs10763642	G	A	44	37	13	28	51	15	0.66	0.57	0.34	0.43	A	0.03	0.009698276	Obesity-related traits	Obesity
rs118067775	T	C	88	6	0	93	1	0	0.97	0.99	0.03	0.01	C	4.12	0.009678668	Clozapine-induced agranulocytosis	General health
rs11681525	C	G	88	6	0	93	1	0	0.97	0.99	0.03	0.01	C	1.1577194	0.009678668	Crohn's disease	Digestive system and its disorders
rs72700829	C	T	88	6	0	93	1	0	0.97	0.99	0.03	0.01	C	1.1363636	0.009678668	Schizophrenia	Brain health and disorders
rs7996217	T	G	93	1	0	89	4	1	0.99	0.97	0.01	0.03	T	1	0.009678668	HIV-associated dementia	Brain health and disorders
rs4251424	C	T	93	1	0	88	6	0	0.99	0.97	0.01	0.03	A	1	0.009678668	Immune reponse to smallpox secreted TNF-alpha	Immune diseases and disorders
rs6778194	A	C	93	1	0	88	6	0	0.99	0.97	0.01	0.03	C	1	0.009678668	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs11572061	A	G	93	1	0	88	6	0	0.99	0.97	0.01	0.03	A	0.59	0.009678668	Ischemic stroke	Brain health and disorders
rs11754641	C	G	88	6	0	93	1	0	0.97	0.99	0.03	0.01	C	0.29	0.009678668	Disc degeneration lumbar	Aging
rs144653651	G	A	89	4	1	93	1	0	0.97	0.99	0.03	0.01	A	0.265	0.009678668	Lead levels in blood	General health
rs7325799	C	T	93	1	0	88	6	0	0.99	0.97	0.01	0.03	T	0.1777	0.009678668	Trans fatty acid levels	General health
rs75796365	T	C	93	1	0	88	6	0	0.99	0.97	0.01	0.03	C	0.13	0.009678668	Age-related nuclear cataracts	Aging
rs2236835	G	A	88	6	0	93	1	0	0.97	0.99	0.03	0.01	A	0.128	0.009678668	Body mass index	Obesity
rs41272114	C	T	88	6	0	93	1	0	0.97	0.99	0.03	0.01	A	0.056	0.009678668	Plasma plasminogen levels	General health
rs16966085	C	T	93	1	0	88	6	0	0.99	0.97	0.01	0.03	A	0.04	0.009678668	Obesity-related traits	Obesity
rs7665957	C	T	93	1	0	88	6	0	0.99	0.97	0.01	0.03	A	0.01	0.009678668	Obesity-related traits	Obesity
rs4863687	C	T	47	39	8	56	37	1	0.71	0.79	0.29	0.21	A	1.48	0.009657462	Chronic mucus hypersecretion	Immune diseases and disorders
rs13143871	T	C	46	41	7	57	35	2	0.71	0.79	0.29	0.21	T	0.96	0.009657462	Systolic blood pressure	Heart health and disorders
rs2066938	A	G	45	43	6	59	31	4	0.71	0.79	0.29	0.21	A	0.211	0.009657462	Blood metabolite levels	Heart health and disorders
rs889312	C	A	20	42	32	9	46	39	0.44	0.34	0.56	0.66	C	1.22	0.0096486	Breast cancer	Cancer
rs7703051	C	A	30	46	18	43	38	13	0.56	0.66	0.44	0.34	A	18	0.0096486	LDL cholesterol	General health
rs7517810	C	T	31	44	19	40	44	10	0.56	0.66	0.44	0.34	T	1.22	0.0096486	Crohn's disease	Digestive system and its disorders
rs8015016	A	G	27	52	15	42	40	12	0.56	0.66	0.44	0.34	G	0.18	0.0096486	QT interval	Heart health and disorders
rs10503253	C	A	73	18	3	82	11	1	0.87	0.93	0.13	0.07	A	1.16	0.009646815	Schizophrenia	Brain health and disorders
rs1516489	A	C	72	20	2	81	13	0	0.87	0.93	0.13	0.07	C	1	0.009646815	Immune response to smallpox vaccine IL-6	Immune diseases and disorders
rs9468811	C	G	81	13	0	72	20	2	0.93	0.87	0.07	0.13	C	0.3471	0.009646815	IgG glycosylation	Immune diseases and disorders
rs12772243	A	G	71	22	1	81	13	0	0.87	0.93	0.13	0.07	G	0.2472	0.009646815	IgG glycosylation	Immune diseases and disorders
rs11986220	A	T	0	20	74	0	10	84	0.11	0.05	0.89	0.95	A	1.83	0.009633911	Prostate cancer	Cancer
rs11723864	C	G	75	18	1	84	10	0	0.89	0.95	0.11	0.05	G	1.51	0.009633911	Type 1 diabetes nephropathy	Diabetes
rs2221593	C	T	76	16	2	84	10	0	0.89	0.95	0.11	0.05	T	1.15	0.009633911	Leprosy	Immune diseases and disorders
rs7118648	T	C	84	10	0	74	20	0	0.95	0.89	0.05	0.11	G	1	0.009633911	Parkinson's disease	Brain health and disorders
rs13408808	A	G	77	14	3	84	10	0	0.89	0.95	0.11	0.05	G	0.04	0.009633911	Obesity-related traits	Obesity
rs11627075	C	A	84	10	0	75	18	1	0.95	0.89	0.05	0.11	A	0.03	0.009633911	Obesity-related traits	Obesity
rs477992	A	G	7	35	52	11	44	39	0.26	0.35	0.74	0.65	A	0.0397	0.009628519	Amino acid levels	Misc
rs6691316	C	T	10	29	55	7	52	35	0.26	0.35	0.74	0.65	G	0.03	0.009628519	Obesity-related traits	Obesity
rs9295474	C	G	49	41	4	35	52	7	0.74	0.65	0.26	0.35	G	1.16	0.009628519	Type 2 diabetes	Diabetes
rs1509569	A	G	41	40	13	49	41	4	0.65	0.74	0.35	0.26	A	0.32	0.009628519	Urinary metabolites H-NMR features	General health
rs229527	C	A	30	45	19	41	41	12	0.56	0.65	0.44	0.35	T	1.38	0.009601707	Vitiligo	Immune diseases and disorders
rs9394159	A	T	43	37	14	32	41	21	0.65	0.56	0.35	0.44	T	1.36	0.009601707	Graves' disease	Immune diseases and disorders
rs4930144	A	G	29	47	18	41	41	12	0.56	0.65	0.44	0.35	A	1	0.009601707	Celiac disease	Immune diseases and disorders
rs7120118	T	C	46	31	17	28	49	17	0.65	0.56	0.35	0.44	G	0.04	0.009601707	HDL cholesterol	General health
rs73191547	A	T	54	33	7	66	24	4	0.75	0.83	0.25	0.17	T	1.0638298	0.009589567	Schizophrenia	Brain health and disorders
rs6027511	T	C	70	22	2	60	28	6	0.86	0.79	0.14	0.21	C	122.24	0.009579668	Lentiform nucleus volume	Misc
rs2613514	A	G	70	22	2	60	28	6	0.86	0.79	0.14	0.21	G	20.12	0.009579668	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs1531070	G	A	58	32	4	71	20	3	0.79	0.86	0.21	0.14	A	1.4	0.009579668	Congenital heart malformation	Heart health and disorders
rs155076	A	G	71	20	3	59	30	5	0.86	0.79	0.14	0.21	G	1	0.009579668	White matter hyperintensity burden	Brain health and disorders
rs7312122	G	A	69	24	1	56	36	2	0.86	0.79	0.14	0.21	G	1	0.009579668	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs2516399	A	G	57	34	3	70	22	2	0.79	0.86	0.21	0.14	A	0.105	0.009579668	White blood cell types	Immune diseases and disorders
rs12286037	C	T	75	17	2	62	30	2	0.89	0.82	0.11	0.18	T	25.82	0.009572359	Triglycerides	General health
rs12425791	G	A	62	30	2	74	19	1	0.82	0.89	0.18	0.11	A	1.29	0.009572359	Stroke	Brain health and disorders
rs8089364	T	C	74	19	1	62	30	2	0.89	0.82	0.11	0.18	C	1.24	0.009572359	Body mass index	Obesity
rs4332037	C	T	75	17	2	61	32	1	0.89	0.82	0.11	0.18	T	1.11	0.009572359	Bipolar disorder	Brain health and disorders
rs11823543	G	A	75	17	2	62	30	2	0.89	0.82	0.11	0.18	A	0.35	0.009572359	Triglycerides-Blood Pressure TG-BP	General health
rs7632000	C	T	73	21	0	62	30	2	0.89	0.82	0.11	0.18	A	0.03	0.009572359	Obesity-related traits	Obesity
rs1503874	G	A	41	40	13	26	52	16	0.65	0.55	0.35	0.45	A	8.981	0.009557522	Illicit drug use	General health
rs2414059	T	A	13	58	23	12	42	40	0.45	0.35	0.55	0.65	A	1.24	0.009557522	QT interval	Heart health and disorders
rs4944092	A	G	37	48	9	30	44	20	0.65	0.55	0.35	0.45	G	1.19	0.009557522	PR interval	Heart health and disorders
rs1983891	C	T	39	44	11	33	38	23	0.65	0.55	0.35	0.45	T	1.15	0.009557522	Prostate cancer	Cancer
rs6036759	G	A	22	40	32	14	38	42	0.45	0.35	0.55	0.65	A	0.07	0.009557522	Glomerular filtration rate in chronic kidney disease	General health
rs12148088	T	C	9	49	36	3	44	47	0.36	0.27	0.64	0.73	T	92.15	0.00953701	Hippocampal volume	Brain health and disorders
rs9405444	G	A	41	39	14	51	36	7	0.64	0.73	0.36	0.27	A	2.21	0.00953701	Erythema nodosum in inflammatory bowel disease	Digestive system and its disorders
rs2290203	G	A	50	38	6	38	45	11	0.73	0.64	0.27	0.36	G	1.08	0.00953701	Breast cancer	Cancer
rs2755237	A	C	60	28	6	45	42	7	0.79	0.70	0.21	0.30	A	0.17	0.00952381	Central corneal thickness	General health
rs7108738	T	G	59	30	5	46	40	8	0.79	0.70	0.21	0.30	T	0.08	0.00952381	Bone mineral density	General health
rs9318552	C	T	34	53	7	25	53	16	0.64	0.55	0.36	0.45	T	0.389	0.009515977	Diastolic blood pressure alcohol consumption interaction	Heart health and disorders
rs13398848	A	G	78	15	1	69	21	4	0.91	0.85	0.09	0.15	G	1.59	0.009486166	Conduct disorder	Brain health and disorders
rs13034020	A	G	69	21	4	80	11	3	0.85	0.91	0.15	0.09	G	1.28	0.009486166	Hodgkin's lymphoma	Cancer
rs72733993	G	A	68	23	3	78	15	1	0.85	0.91	0.15	0.09	A	1	0.009486166	Glucocorticoid-induced osteonecrosis	Drug response
rs6724465	G	A	79	13	2	68	23	3	0.91	0.85	0.09	0.15	A	0.06	0.009486166	Height	General health
rs1702294	T	C	0	17	77	1	27	66	0.09	0.15	0.91	0.85	C	1.1273957	0.009486166	Schizophrenia	Brain health and disorders
rs2075290	C	T	2	25	67	0	17	77	0.15	0.09	0.85	0.91	C	0.41	0.009486166	Waist Circumference - Triglycerides WC-TG	General health
rs4773330	A	G	2	13	79	6	17	71	0.09	0.15	0.91	0.85	A	0.04	0.009486166	Bilirubin levels	General health
rs7592330	G	A	10	48	36	21	44	29	0.36	0.46	0.64	0.54	A	1.15	0.009477009	Multiple sclerosis	Brain health and disorders
rs4719147	T	G	14	40	40	18	50	26	0.36	0.46	0.64	0.54	T	1.13	0.009477009	Response to angiotensin II receptor blocker therapy	General health
rs7823467	T	C	13	42	39	24	38	32	0.36	0.46	0.64	0.54	T	1.085	0.009477009	Refractive astigmatism	General health
rs12716850	A	G	17	52	25	13	42	39	0.46	0.36	0.54	0.64	A	1	0.009477009	Pulmonary function interaction	Pulmonology
rs1967309	A	G	29	44	21	35	50	9	0.54	0.64	0.46	0.36	G	1.54	0.009477009	Response to Dalcetrapib treatment in acute coronary syndrome	General health
rs4406737	A	G	29	44	21	38	44	12	0.54	0.64	0.46	0.36	G	1.27	0.009477009	Chronic lymphocytic leukemia	Cancer
rs42648	A	G	29	44	21	44	32	18	0.54	0.64	0.46	0.36	A	0.0395	0.009477009	Homocysteine levels	Misc
rs1427593	T	C	15	38	41	3	45	46	0.36	0.27	0.64	0.73	A	1.49	0.009449694	Pancreatic cancer	Cancer
rs10823607	T	C	4	43	47	12	44	38	0.27	0.36	0.73	0.64	T	0.19	0.009449694	Sleep duration	General health
rs4372836	T	C	7	37	50	11	46	37	0.27	0.36	0.73	0.64	T	0.016	0.009449694	Body mass index	Obesity
rs6706693	C	T	48	41	5	41	38	15	0.73	0.64	0.27	0.36	A	1.743	0.009449694	Adverse response to chemotherapy neutropenia_leucopenia 5-fluorouracil	Drug response
rs3757354	C	T	51	35	8	38	44	12	0.73	0.64	0.27	0.36	T	1.46	0.009449694	Cholesterol, total	General health
rs716274	A	G	27	47	20	35	49	10	0.54	0.63	0.46	0.37	G	1.83	0.009440559	Small-cell lung cancer survival	Cancer
rs2621416	T	C	52	36	6	64	27	3	0.74	0.82	0.26	0.18	G	1.57	0.009416196	Lymphoma	Cancer
rs16897515	C	A	63	29	2	52	36	6	0.82	0.74	0.18	0.26	C	1.3	0.009416196	Schizophrenia	Brain health and disorders
rs2204008	C	T	54	32	8	63	29	2	0.74	0.82	0.26	0.18	T	1.13	0.009416196	Bladder cancer	Cancer
rs72717009	C	T	54	32	8	62	31	1	0.74	0.82	0.26	0.18	T	1.13	0.009416196	Rheumatoid arthritis	Immune diseases and disorders
rs12526453	C	G	54	32	8	64	27	3	0.74	0.82	0.26	0.18	C	1.12	0.009416196	Myocardial infarction early onset	Heart health and disorders
rs1488665	T	G	4	25	65	8	32	54	0.18	0.26	0.82	0.74	A	0.03	0.009416196	Obesity-related traits	Obesity
rs739031	G	T	4	25	65	6	36	52	0.18	0.26	0.82	0.74	C	0.03	0.009416196	Obesity-related traits	Obesity
rs2140773	C	A	22	44	28	16	38	40	0.47	0.37	0.53	0.63	A	2.9	0.009406573	Liver enzyme levels gamma-glutamyl transferase	General health
rs7342306	G	A	44	43	7	57	33	4	0.70	0.78	0.30	0.22	G	2.532	0.009396564	Platelet count	Heart health and disorders
rs9277535	A	G	43	45	6	57	33	4	0.70	0.78	0.30	0.22	G	1.64	0.009396564	Hepatitis B viral clearance	Immune diseases and disorders
rs6687758	A	G	45	41	8	58	31	5	0.70	0.78	0.30	0.22	G	1.12	0.009396564	Colorectal cancer	Cancer
rs9313772	C	T	48	35	11	57	33	4	0.70	0.78	0.30	0.22	T	0.335	0.009396564	Blood pressure	Heart health and disorders
rs55681231	C	A	52	27	15	57	33	4	0.70	0.78	0.30	0.22	A	0.3144	0.009396564	Metabolite levels MHPG	General health
rs9874556	A	G	15	41	38	19	51	24	0.38	0.47	0.62	0.53	A	1.3	0.009375	Alcohol dependence age at onset	General health
rs1673101	G	A	39	41	14	47	42	5	0.63	0.72	0.37	0.28	A	0.1877	0.009366391	Major depressive disorder	Brain health and disorders
rs4601530	C	T	48	40	6	39	41	14	0.72	0.63	0.28	0.37	T	0.028	0.009366391	Height	General health
rs1015166	C	T	57	33	4	68	25	1	0.78	0.86	0.22	0.14	T	2.1428	0.009358289	Type 1 diabetes and autoimmune thyroid diseases	Diabetes
rs6579245	C	T	68	25	1	56	35	3	0.86	0.78	0.14	0.22	C	0.054	0.009358289	Cholesterol, total	General health
rs10102164	G	A	71	19	4	59	29	6	0.86	0.78	0.14	0.22	A	0.03	0.009358289	Cholesterol, total	General health
rs10234749	T	G	3	35	56	0	27	67	0.22	0.14	0.78	0.86	T	0.1788	0.009358289	Palmitic acid 16:0 plasma levels	General health
rs10734234	C	T	2	23	69	4	33	57	0.14	0.22	0.86	0.78	T	0.15	0.009358289	Expressive vocabulary in infants	Mental aptitude and behavioural traits
rs8072100	A	T	12	48	34	20	50	24	0.38	0.48	0.62	0.52	A	5.059	0.009345794	Very long-chain saturated fatty acid levels fatty acid 20:0	General health
rs2957128	A	G	10	52	32	21	48	25	0.38	0.48	0.62	0.52	A	1.46	0.009345794	Paget's disease	General health
rs16872571	C	T	33	50	11	27	44	23	0.62	0.52	0.38	0.48	C	1.21	0.009345794	Vitiligo	Immune diseases and disorders
rs6667605	C	T	22	46	26	10	52	32	0.48	0.38	0.52	0.62	G	1.0831845	0.009345794	Ulcerative colitis	Immune diseases and disorders
rs4773144	A	G	23	52	19	38	40	16	0.52	0.62	0.48	0.38	G	1.08	0.009345794	Coronary artery disease	Heart health and disorders
rs979233	A	C	26	46	22	39	38	17	0.52	0.62	0.48	0.38	T	1	0.009345794	Systemic lupus erythematosus	Immune diseases and disorders
rs7628767	G	A	21	48	25	13	46	35	0.48	0.38	0.52	0.62	G	0.087	0.009345794	Economic and political preferences environmentalism	Mental aptitude and behavioural traits
rs12663356	T	C	12	49	33	23	45	26	0.39	0.48	0.61	0.52	C	1.095	0.009318914	Crohn's disease	Digestive system and its disorders
rs8082590	G	A	24	49	21	36	43	15	0.52	0.61	0.48	0.39	G	1.0649627	0.009318914	Schizophrenia	Brain health and disorders
rs180242	T	A	17	39	38	23	45	26	0.39	0.48	0.61	0.52	T	0.316	0.009318914	Heart rate	General health
rs4814176	T	C	14	45	35	18	55	21	0.39	0.48	0.61	0.52	T	0.021	0.009318914	Blood metabolite ratios	Heart health and disorders
rs9490306	C	A	72	22	0	62	29	3	0.88	0.81	0.12	0.19	A	1.08	0.009294396	Migraine	Brain health and disorders
rs1505992	A	T	15	44	35	25	42	27	0.39	0.49	0.61	0.51	A	1.1339794	0.00929432	Inflammatory bowel disease	Immune diseases and disorders
rs9891119	A	C	50	35	9	32	54	8	0.72	0.63	0.28	0.37	A	1.37	0.009286931	Crohn's disease	Digestive system and its disorders
rs1019173	A	G	49	37	8	31	56	7	0.72	0.63	0.28	0.37	A	0.1	0.009286931	Kidney function decline traits	General health
rs2962370	G	C	9	40	45	6	30	58	0.31	0.22	0.69	0.78	G	1.19	0.009275362	Bipolar disorder with mood-incongruent psychosis	Brain health and disorders
rs6833159	T	C	45	40	9	55	36	3	0.69	0.78	0.31	0.22	T	0.087	0.009275362	Underweight status	General health
rs2236313	T	C	22	49	23	12	51	31	0.49	0.40	0.51	0.60	T	1.2	0.009271978	Vitiligo	Immune diseases and disorders
rs11688816	G	A	20	55	19	34	45	15	0.51	0.60	0.49	0.40	G	0.019	0.009271978	Body mass index	Obesity
rs11969985	G	A	63	28	3	52	35	7	0.82	0.74	0.18	0.26	G	1.31	0.009252025	Glaucoma primary open-angle	General health
rs16851720	A	C	61	32	1	50	39	5	0.82	0.74	0.18	0.26	C	1	0.009252025	Hepatitis C induced liver fibrosis	Immune diseases and disorders
rs12192947	A	G	63	28	3	51	37	6	0.82	0.74	0.18	0.26	G	0.176	0.009252025	Uric acid levels	General health
rs9292777	C	T	24	46	24	17	42	35	0.50	0.40	0.50	0.60	T	1.37	0.009251856	Crohn's disease	Digestive system and its disorders
rs6461049	C	T	32	48	14	21	52	21	0.60	0.50	0.40	0.50	T	1.107	0.009251856	Schizophrenia	Brain health and disorders
rs11195062	C	A	34	43	17	23	47	24	0.59	0.49	0.41	0.51	A	1.132	0.009233926	Multiple myeloma	Cancer
rs7329174	A	G	86	8	0	77	17	0	0.96	0.91	0.04	0.09	G	1.27	0.009230769	Crohn's disease	Digestive system and its disorders
rs3756407	A	G	86	8	0	78	15	1	0.96	0.91	0.04	0.09	A	0.14	0.009230769	Metabolite levels Pyroglutamine	General health
rs1032859	T	A	0	17	77	0	8	86	0.09	0.04	0.91	0.96	A	15.54	0.009230769	Heschl's gyrus morphology	Brain health and disorders
rs2718058	A	G	30	50	14	26	40	28	0.59	0.49	0.41	0.51	A	1.0753	0.009218163	Alzheimer's disease late onset	Brain health and disorders
rs9399032	T	A	46	42	6	38	41	15	0.71	0.62	0.29	0.38	A	1.1	0.009211155	Migraine without aura	Brain health and disorders
rs12246027	G	A	49	36	9	37	43	14	0.71	0.62	0.29	0.38	A	0.012	0.009211155	Blood metabolite levels	Heart health and disorders
rs10462794	C	T	6	42	46	17	37	40	0.29	0.38	0.71	0.62	C	1	0.009211155	DNA methylation variation	Misc
rs11717455	T	C	71	21	2	81	12	1	0.87	0.93	0.13	0.07	T	1.4085	0.009206422	Systemic lupus erythematosus	Immune diseases and disorders
rs4792800	A	G	80	14	0	70	23	1	0.93	0.87	0.07	0.13	G	1	0.009206422	IgG levels	Immune diseases and disorders
rs6555855	G	A	2	21	71	0	14	80	0.13	0.07	0.87	0.93	G	0.04	0.009206422	Menarche age at onset	Reproductive health
rs11055612	C	T	35	39	20	26	39	29	0.58	0.48	0.42	0.52	C	3371.6	0.009204545	Brain structure temporal lobe volume	Brain health and disorders
rs11263763	G	A	26	45	23	10	59	25	0.52	0.42	0.48	0.58	A	1.22	0.009204545	Prostate cancer	Cancer
rs560426	C	T	16	47	31	21	55	18	0.42	0.52	0.58	0.48	G	1	0.009204545	Orofacial clefts	Misc
rs8019546	G	A	33	43	18	21	49	24	0.58	0.48	0.42	0.52	A	0.22	0.009204545	Dietary macronutrient intake	General health
rs459482	C	G	33	43	18	21	49	24	0.58	0.48	0.42	0.52	C	0.1627	0.009204545	IgG glycosylation	Immune diseases and disorders
rs11160190	A	G	23	51	20	18	43	33	0.52	0.42	0.48	0.58	G	0.037	0.009204545	Vaspin levels	Diabetes
rs10822184	T	C	27	36	31	27	54	13	0.48	0.57	0.52	0.43	T	0.058	0.009193054	Androgen levels	General health
rs12743824	C	A	26	47	21	20	41	33	0.53	0.43	0.47	0.57	C	2.3	0.009183673	Non-alcoholic fatty liver disease histology other	Obesity
rs482329	G	C	29	41	24	20	41	33	0.53	0.43	0.47	0.57	C	1.6	0.009183673	Life threatening arrhythmia	Heart health and disorders
rs1648707	A	C	33	41	20	22	45	27	0.57	0.47	0.43	0.53	C	0.94	0.009183673	Adiponectin levels	Obesity
rs7933433	G	T	31	44	19	13	62	19	0.56	0.47	0.44	0.53	T	1.11	0.009176391	Psoriasis	Immune diseases and disorders
rs1034394	A	G	28	50	16	21	46	27	0.56	0.47	0.44	0.53	G	0.2107	0.009176391	Major depressive disorder	Brain health and disorders
rs2017567	T	C	29	48	17	20	48	26	0.56	0.47	0.44	0.53	C	0.1	0.009176391	Disc degeneration lumbar	Aging
rs1981483	G	A	28	49	17	19	49	26	0.56	0.46	0.44	0.54	A	0.11	0.009171196	Disc degeneration lumbar	Aging
rs9395865	C	T	26	53	15	20	47	27	0.56	0.46	0.44	0.54	T	0.106	0.009171196	Electroencephalographic traits in alcoholism	Heart health and disorders
rs6569474	A	T	27	47	20	22	39	33	0.54	0.44	0.46	0.56	A	0.009	0.009171196	Metabolite levels	General health
rs10840293	G	A	18	50	26	26	52	16	0.46	0.55	0.54	0.45	A	1.06	0.009168081	Coronary artery disease	Heart health and disorders
rs4084594	T	C	29	44	21	16	52	26	0.54	0.45	0.46	0.55	T	1.05	0.009168081	Schizophrenia	Brain health and disorders
rs4684585	G	A	20	46	28	31	42	21	0.46	0.55	0.54	0.45	G	1	0.009168081	Response to statin therapy	General health
rs2277027	A	C	24	54	16	19	46	29	0.54	0.45	0.46	0.55	A	0.38	0.009168081	Pulmonary function	Pulmonology
rs1065656	C	G	9	41	44	5	33	56	0.31	0.23	0.69	0.77	G	1	0.009159868	Insulin-like growth factors	General health
rs605920	C	G	12	35	47	4	35	55	0.31	0.23	0.69	0.77	C	0.04	0.009159868	Cardiac Troponin-T levels	Heart health and disorders
rs17668704	A	T	56	33	5	44	41	9	0.77	0.69	0.23	0.31	A	3.38	0.009159868	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs11861787	A	C	55	35	4	43	43	8	0.77	0.69	0.23	0.31	C	1.8868	0.009159868	Epilepsy remission after treatment	Brain health and disorders
rs12971120	A	G	43	43	8	55	35	4	0.69	0.77	0.31	0.23	G	0.099	0.009159868	Refractive error	General health
rs1265159	G	A	69	22	3	59	28	7	0.85	0.78	0.15	0.22	T	2.42	0.009150327	Idiopathic membranous nephropathy	Brain health and disorders
rs9787485	C	T	60	26	8	66	28	0	0.78	0.85	0.22	0.15	T	1	0.009150327	Fasting insulin interaction	General health
rs2251746	T	C	69	20	5	77	16	1	0.84	0.90	0.16	0.10	C	19.2	0.009146341	IgE levels	Immune diseases and disorders
rs3785176	A	C	65	28	1	77	16	1	0.84	0.90	0.16	0.10	G	1.28	0.009146341	Glaucoma high intraocular pressure	General health
rs9364554	C	T	67	24	3	76	18	0	0.84	0.90	0.16	0.10	T	1.17	0.009146341	Prostate cancer	Cancer
rs9389269	T	C	65	28	1	76	18	0	0.84	0.90	0.16	0.10	T	0.6	0.009146341	Red blood cell traits	Immune diseases and disorders
rs11112046	C	T	66	26	2	77	16	1	0.84	0.90	0.16	0.10	A	0.02	0.009146341	Obesity-related traits	Obesity
rs2400954	C	T	14	44	36	8	39	47	0.38	0.29	0.62	0.71	C	1.2345679	0.009138918	Alcohol dependence	General health
rs843451	G	A	6	43	45	14	44	36	0.29	0.38	0.71	0.62	G	0.2849	0.009138918	Neuritic plaque	Brain health and disorders
rs6469656	G	A	5	40	49	4	27	63	0.27	0.19	0.73	0.81	A	1.09	0.009096422	Colorectal cancer	Cancer
rs10170310	G	A	4	27	63	4	42	48	0.19	0.27	0.81	0.73	G	1	0.009096422	Response to antipsychotic treatment	General health
rs2584363	T	C	2	17	75	0	11	83	0.11	0.06	0.89	0.94	T	0.3098	0.009084302	Lewy body disease	Brain health and disorders
rs62244881	T	C	75	17	2	83	11	0	0.89	0.94	0.11	0.06	T	1.09	0.009084302	Schizophrenia	Brain health and disorders
rs2325695	A	G	73	21	0	83	11	0	0.89	0.94	0.11	0.06	A	0.0056	0.009084302	Trans fatty acid levels	General health
rs6993770	A	T	45	42	7	34	47	13	0.70	0.61	0.30	0.39	A	3.668	0.009070081	Platelet count	Heart health and disorders
rs12590640	C	T	17	39	38	10	36	48	0.39	0.30	0.61	0.70	T	1.15	0.009070081	Malaria	Immune diseases and disorders
rs12568771	A	G	36	43	15	48	36	10	0.61	0.70	0.39	0.30	G	1.12	0.009070081	IgA nephropathy	Immune diseases and disorders
rs1268789	T	C	12	49	33	9	38	47	0.39	0.30	0.61	0.70	T	1	0.009070081	Hair morphology	Appearance
rs7970953	G	A	36	43	15	46	40	8	0.61	0.70	0.39	0.30	A	0.015	0.009070081	Body mass index	Obesity
rs10788473	C	T	48	32	14	54	36	4	0.68	0.77	0.32	0.23	T	1.27	0.009049774	Pancreatic cancer	Cancer
rs2427308	C	T	41	46	7	54	36	4	0.68	0.77	0.32	0.23	C	1.235	0.009049774	Colorectal cancer	Cancer
rs650258	T	C	4	36	54	13	34	47	0.23	0.32	0.77	0.68	G	1.12	0.009049774	Multiple sclerosis	Brain health and disorders
rs41295115	T	C	84	9	1	90	4	0	0.94	0.98	0.06	0.02	C	1.2769	0.009048938	Asthma and hay fever	Immune diseases and disorders
rs17024258	C	T	90	4	0	83	11	0	0.98	0.94	0.02	0.06	T	1.25	0.009048938	Obesity	Obesity
rs4324798	G	A	90	4	0	85	7	2	0.98	0.94	0.02	0.06	A	1.16	0.009048938	Lung adenocarcinoma	Cancer
rs13323436	T	A	83	11	0	90	4	0	0.94	0.98	0.06	0.02	A	1	0.009048938	Visceral fat	Obesity
rs35053544	T	C	83	11	0	90	4	0	0.94	0.98	0.06	0.02	C	0.173	0.009048938	Symmetrical dimethylarginine levels	General health
rs17024393	T	C	90	4	0	83	11	0	0.98	0.94	0.02	0.06	C	0.071	0.009048938	Body mass index	Obesity
rs1727313	C	G	3	30	61	1	21	72	0.19	0.12	0.81	0.88	C	1.06	0.009035984	Type 2 diabetes	Diabetes
rs1593	T	A	1	21	72	3	30	61	0.12	0.19	0.88	0.81	A	0.536	0.009035984	Activated partial thromboplastin time	Heart health and disorders
rs4073894	G	A	62	28	4	74	17	3	0.81	0.88	0.19	0.12	A	1.062	0.009035984	Educational attainment	Mental aptitude and behavioural traits
rs2205299	T	C	61	30	3	72	21	1	0.81	0.88	0.19	0.12	T	1.06	0.009035984	Schizophrenia	Brain health and disorders
rs7767572	A	G	61	30	3	74	17	3	0.81	0.88	0.19	0.12	A	0.1	0.009035984	Metabolite levels Dihydroxy docosatrienoic acid	General health
rs6728302	A	G	65	22	7	72	21	1	0.81	0.88	0.19	0.12	A	0.064	0.009035984	Height	General health
rs7571816	A	G	65	22	7	72	21	1	0.81	0.88	0.19	0.12	A	0.06	0.009035984	Height	General health
rs11057830	G	A	72	21	1	62	28	4	0.88	0.81	0.12	0.19	A	0.03	0.009035984	Vitamin E levels	General health
rs35600665	C	T	61	30	3	73	19	2	0.81	0.88	0.19	0.12	A	0.02	0.009035984	Obesity-related traits	Obesity
rs5746061	A	G	73	19	2	58	36	0	0.88	0.81	0.12	0.19	G	0.011	0.009035984	Urate levels BMI interaction	Obesity
rs13314271	T	C	35	44	15	45	41	8	0.61	0.70	0.39	0.30	T	1.13	0.009004518	Lung cancer	Cancer
rs2471042	A	G	15	44	35	8	41	45	0.39	0.30	0.61	0.70	T	2.51	0.009004518	Adverse response to chemotherapy in breast cancer alopecia anti-microtubule	General health
rs6464375	C	T	88	6	0	80	14	0	0.97	0.93	0.03	0.07	A	3.73	0.008988764	Pancreatic cancer	Cancer
rs745978	T	C	88	6	0	81	12	1	0.97	0.93	0.03	0.07	C	1	0.008988764	Visceral fat	Obesity
rs62020698	C	T	80	14	0	89	4	1	0.93	0.97	0.07	0.03	T	0.091	0.008988764	Triglycerides	General health
rs7527203	C	T	88	6	0	80	14	0	0.97	0.93	0.03	0.07	A	0.03	0.008988764	Obesity-related traits	Obesity
rs1229984	T	C	1	12	81	0	6	88	0.07	0.03	0.93	0.97	G	1.79	0.008988764	Esophageal cancer	Cancer
rs7791362	T	C	68	23	3	56	33	5	0.85	0.77	0.15	0.23	C	2.7807	0.008954678	Cognitive function	Brain health and disorders
rs3778872	C	G	66	27	1	56	33	5	0.85	0.77	0.15	0.23	C	1.77	0.008954678	QT interval	Heart health and disorders
rs6806253	A	G	56	33	5	67	25	2	0.77	0.85	0.23	0.15	A	1.5595	0.008954678	Pit-and-Fissure caries	Misc
rs516946	T	C	3	30	61	5	41	48	0.19	0.27	0.81	0.73	C	1.1	0.008948813	Type 2 diabetes	Diabetes
rs7182874	T	C	3	30	61	4	43	47	0.19	0.27	0.81	0.73	T	0.37	0.008948813	Relative hand skill in reading disability	Misc
rs4665710	A	C	2	32	60	4	43	47	0.19	0.27	0.81	0.73	C	0.082	0.008948813	Triglycerides	General health
rs7138803	G	A	50	37	7	60	32	2	0.73	0.81	0.27	0.19	A	3.28	0.008948813	Body mass index	Obesity
rs5985	C	A	49	39	6	58	36	0	0.73	0.81	0.27	0.19	C	1.077	0.008948813	End-stage coagulation	General health
rs11222084	A	T	48	41	5	62	28	4	0.73	0.81	0.27	0.19	T	0.337	0.008948813	Blood pressure	Heart health and disorders
rs184074	T	C	12	37	45	3	39	52	0.32	0.24	0.68	0.76	A	1	0.008944794	Vein graft stenosis in coronary artery bypass grafting	Heart health and disorders
rs3784262	T	C	43	41	10	54	35	5	0.68	0.76	0.32	0.24	A	1.1364	0.008944794	Digestive system disease Barrett's esophagus and esophageal adenocarcinoma combined	Digestive system and its disorders
rs1659127	G	A	54	35	5	35	57	2	0.76	0.68	0.24	0.32	A	0.041	0.008944794	Height	General health
rs1425132	A	G	32	49	13	44	42	8	0.60	0.69	0.40	0.31	T	1.43	0.008942108	Adverse response to chemotherapy neutropenia_leucopenia paclitaxel + carboplatin	Drug response
rs9727115	G	A	45	40	9	29	55	10	0.69	0.60	0.31	0.40	G	1	0.008942108	Proinsulin levels	Diabetes
rs8098316	T	G	10	39	45	14	48	32	0.31	0.40	0.69	0.60	T	0.052	0.008882742	Height	General health
rs910191	A	G	31	50	13	43	43	8	0.60	0.69	0.40	0.31	A	1	0.008882742	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs7312105	A	G	36	40	18	46	37	11	0.60	0.69	0.40	0.31	G	0.104	0.008882742	Red blood cell traits	Immune diseases and disorders
rs3130320	T	C	5	36	53	14	34	46	0.24	0.33	0.76	0.67	T	1.39	0.008844666	Systemic lupus erythematosus	Immune diseases and disorders
rs10744625	C	T	9	44	41	3	40	51	0.33	0.24	0.67	0.76	C	1	0.008844666	Fasting insulin interaction	General health
rs11708067	A	G	42	42	10	53	36	5	0.67	0.76	0.33	0.24	A	1.25	0.008844666	Type 2 diabetes	Diabetes
rs1491976	G	C	5	21	68	0	19	75	0.16	0.10	0.84	0.90	G	2.33	0.008834356	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs719593	A	G	76	17	1	65	27	2	0.90	0.84	0.10	0.16	T	2.05	0.008834356	Conduct disorder interaction	Brain health and disorders
rs349114	G	A	67	23	4	75	19	0	0.84	0.90	0.16	0.10	A	0.03	0.008834356	Obesity-related traits	Obesity
rs8756	C	A	8	44	42	15	47	32	0.32	0.41	0.68	0.59	C	6.6	0.008826314	Height	General health
rs6496044	G	A	15	47	32	11	38	45	0.41	0.32	0.59	0.68	G	1.25	0.008826314	Interstitial lung disease	Pulmonology
rs7550169	C	A	6	48	40	16	45	33	0.32	0.41	0.68	0.59	C	0.02	0.008826314	Body mass index	Obesity
rs1044573	A	G	45	38	11	30	51	13	0.68	0.59	0.32	0.41	A	1.15	0.008826314	Allergic rhinitis	Immune diseases and disorders
rs7768644	G	A	80	13	1	70	22	2	0.92	0.86	0.08	0.14	A	5.01	0.00880961	Thionamide-induced agranulocytosis in Graves' disease	General health
rs9868809	C	T	79	15	0	68	26	0	0.92	0.86	0.08	0.14	A	1.1240871	0.00880961	Crohn's disease	Digestive system and its disorders
rs255982	G	A	69	24	1	80	13	1	0.86	0.92	0.14	0.08	G	0.2077	0.00880961	IgG glycosylation	Immune diseases and disorders
rs2456203	T	C	70	24	0	61	29	4	0.87	0.80	0.13	0.20	T	1	0.008795212	Pulmonary function interaction	Pulmonology
rs8012642	G	C	5	51	38	13	52	29	0.32	0.41	0.68	0.59	C	1.06	0.008772729	Schizophrenia	Brain health and disorders
rs6675668	T	G	35	40	19	38	51	5	0.59	0.68	0.41	0.32	T	0.1651	0.008772729	Stearic acid 18:0 plasma levels	General health
rs7968682	G	T	8	45	41	15	48	31	0.32	0.41	0.68	0.59	T	0.043	0.008772729	Height	General health
rs816535	C	T	57	30	7	67	24	3	0.77	0.84	0.23	0.16	C	1.8	0.00877036	Parkinson disease and lewy body pathology	Brain health and disorders
rs2206277	C	T	53	38	3	66	26	2	0.77	0.84	0.23	0.16	A	0.17	0.00877036	Metabolic syndrome bivariate traits	Immune diseases and disorders
rs10906142	G	A	54	36	4	69	20	5	0.77	0.84	0.23	0.16	A	0.04	0.00877036	Obesity-related traits	Obesity
rs12049351	C	G	55	31	8	36	53	5	0.75	0.66	0.25	0.34	C	0.05	0.008749146	Circulating myeloperoxidase levels plasma	Immune diseases and disorders
rs6540731	G	A	43	40	11	28	53	13	0.67	0.58	0.33	0.42	A	0.05	0.008721895	Intelligence childhood	Mental aptitude and behavioural traits
rs7618915	G	A	45	45	4	58	34	2	0.72	0.80	0.28	0.20	G	1	0.008675535	Bipolar disorder	Brain health and disorders
rs11227306	C	A	47	41	6	60	30	4	0.72	0.80	0.28	0.20	A	1	0.008675535	DNA methylation variation	Misc
rs4691139	A	G	14	52	28	14	35	45	0.43	0.34	0.57	0.66	G	1.2	0.00867373	Ovarian cancer in BRCA1 mutation carriers	Cancer
rs6563898	A	G	3	42	49	9	46	39	0.26	0.34	0.74	0.66	G	1.82	0.008658009	IgE levels in asthmatics D.f. specific	Immune diseases and disorders
rs926070	G	A	16	32	46	9	30	55	0.34	0.26	0.66	0.74	A	1.27	0.008658009	Chronic lymphocytic leukemia	Cancer
rs2702888	G	C	40	44	10	49	42	3	0.66	0.74	0.34	0.26	G	1.36	0.008658009	Blood pressure	Heart health and disorders
rs11897119	T	C	49	42	3	45	34	15	0.74	0.66	0.26	0.34	C	1.36	0.008658009	PR interval	Heart health and disorders
rs7690819	A	G	27	53	14	39	46	9	0.57	0.66	0.43	0.34	G	1.63	0.008628153	Medication adherence in chronic diseases	Drug response
rs1332329	A	C	39	46	9	32	43	19	0.66	0.57	0.34	0.43	C	1.08	0.008628153	Myocardial infarction	Heart health and disorders
rs216172	G	C	32	43	19	43	38	13	0.57	0.66	0.43	0.34	C	1.05	0.008628153	Coronary artery disease	Heart health and disorders
rs4812466	G	T	45	34	15	31	45	18	0.66	0.57	0.34	0.43	T	0.2258	0.008628153	Metabolite levels HVA-5-HIAA Factor score	General health
rs17728338	G	A	82	12	0	75	16	3	0.94	0.88	0.06	0.12	A	1.64	0.008599931	Psoriasis	Immune diseases and disorders
rs16880441	C	G	74	18	2	82	12	0	0.88	0.94	0.12	0.06	G	1.63	0.008599931	Conduct disorder interaction	Brain health and disorders
rs4663866	A	C	82	12	0	74	18	2	0.94	0.88	0.06	0.12	C	1.45	0.008599931	Irritable bowel syndrome	General health
rs12427353	G	C	73	20	1	83	10	1	0.88	0.94	0.12	0.06	G	1.12	0.008599931	Type 2 diabetes	Diabetes
rs11223581	A	G	72	22	0	83	10	1	0.88	0.94	0.12	0.06	G	1	0.008599931	Immune reponse to smallpox secreted IL-2	Immune diseases and disorders
rs11191580	T	C	72	22	0	83	10	1	0.88	0.94	0.12	0.06	C	0.0295	0.008599931	Body mass index	Obesity
rs1571942	A	G	56	31	7	64	29	1	0.76	0.84	0.24	0.16	C	1	0.008596491	Diabetic retinopathy	Diabetes
rs10508552	C	G	56	31	7	63	31	0	0.76	0.84	0.24	0.16	C	1	0.008596491	Childhood and early adolescence aggressive behavior	Brain health and disorders
rs1149336	C	T	53	37	4	66	25	3	0.76	0.84	0.24	0.16	T	0.09	0.008596491	Puberty onset breast development	Reproductive health
rs4854307	T	C	69	19	6	55	33	6	0.84	0.76	0.16	0.24	C	0.0263	0.008596491	Body mass index	Obesity
rs17027130	T	C	76	18	0	85	9	0	0.90	0.95	0.10	0.05	C	2.865	0.008595989	Adverse response to chemotherapy neutropenia_leucopenia camptothecin	Drug response
rs6953213	G	A	86	7	1	76	18	0	0.95	0.90	0.05	0.10	A	2.4305	0.008595989	Smooth-surface caries	Appearance
rs55797066	T	C	85	9	0	77	16	1	0.95	0.90	0.05	0.10	C	1.33	0.008595989	Tourette's syndrome or obsessive-compulsive disorder	Brain health and disorders
rs2523607	T	A	85	9	0	76	18	0	0.95	0.90	0.05	0.10	A	1.32	0.008595989	Diffuse large B cell lymphoma	Cancer
rs34411452	T	C	76	18	0	85	9	0	0.90	0.95	0.10	0.05	T	1.06	0.008595989	Schizophrenia	Brain health and disorders
rs3734729	A	G	85	9	0	77	16	1	0.95	0.90	0.05	0.10	A	1	0.008595989	Pulmonary function interaction	Pulmonology
rs16906415	A	G	80	10	4	85	9	0	0.90	0.95	0.10	0.05	G	0.235	0.008595989	IgG glycosylation	Immune diseases and disorders
rs11176749	A	T	76	18	0	85	9	0	0.90	0.95	0.10	0.05	T	0.12	0.008595989	Expressive vocabulary in infants	Mental aptitude and behavioural traits
rs11039798	G	A	76	18	0	85	9	0	0.90	0.95	0.10	0.05	A	0.0883	0.008595989	Axial length	Misc
rs10245353	C	A	77	16	1	86	7	1	0.90	0.95	0.10	0.05	A	0.0423	0.008595989	Waist-to-hip ratio adjusted for body mass index	Obesity
rs4756059	C	T	0	9	85	1	16	77	0.05	0.10	0.95	0.90	T	0.07	0.008595989	Menarche age at onset	Reproductive health
rs11568818	T	C	39	45	10	31	44	19	0.65	0.56	0.35	0.44	A	1.1	0.008585093	Prostate cancer	Cancer
rs1014286	G	A	12	41	41	19	44	31	0.35	0.44	0.65	0.56	G	0.11	0.008585093	Serum protein levels sST2	General health
rs1932064	A	G	70	23	1	60	30	4	0.87	0.80	0.13	0.20	T	1.62	0.008570414	Yu-Zhi constitution type in type 2 diabetes	Diabetes
rs11617955	T	A	62	26	6	70	23	1	0.80	0.87	0.20	0.13	T	1.09	0.008570414	Myocardial infarction	Heart health and disorders
rs4730268	C	T	62	26	6	72	19	3	0.80	0.87	0.20	0.13	C	0.1679	0.008570414	IgG glycosylation	Immune diseases and disorders
rs7762246	T	C	58	34	2	70	23	1	0.80	0.87	0.20	0.13	G	0.03	0.008570414	Obesity-related traits	Obesity
rs5215	C	T	4	30	60	0	25	69	0.20	0.13	0.80	0.87	C	1.16	0.008570414	Type 2 diabetes	Diabetes
rs6906287	T	C	46	42	6	60	29	5	0.71	0.79	0.29	0.21	C	0.5383	0.008548957	Electrocardiographic conduction measures	Heart health and disorders
rs11771429	C	T	66	24	4	74	20	0	0.83	0.89	0.17	0.11	G	1.1905	0.008547009	Digestive system disease Barrett's esophagus and esophageal adenocarcinoma combined	Digestive system and its disorders
rs2523608	G	A	20	43	31	9	48	37	0.44	0.35	0.56	0.65	G	2.6	0.008544482	HIV-1 control	Immune diseases and disorders
rs2629751	A	G	37	48	9	29	47	18	0.65	0.56	0.35	0.44	G	1	0.008544482	Hepatitis C induced liver fibrosis	Immune diseases and disorders
rs300032	G	A	11	44	39	14	55	25	0.35	0.44	0.65	0.56	G	0.2433	0.008544482	IgG glycosylation	Immune diseases and disorders
rs4227	G	T	12	43	39	20	44	30	0.36	0.45	0.64	0.55	G	1.298	0.008506255	IgA nephropathy	Immune diseases and disorders
rs10513789	T	G	35	52	7	52	34	8	0.65	0.73	0.35	0.27	T	1.25	0.008488064	Parkinson's disease	Brain health and disorders
rs12101261	C	T	28	47	19	38	44	12	0.55	0.64	0.45	0.36	T	1.35	0.008470354	Graves' disease	Immune diseases and disorders
rs12681288	A	G	31	41	22	32	56	6	0.55	0.64	0.45	0.36	A	1.05	0.008470354	Schizophrenia	Brain health and disorders
rs7532866	A	G	41	38	15	32	39	23	0.64	0.55	0.36	0.45	A	0.021	0.008470354	Height	General health
rs59616746	C	T	79	14	1	68	25	1	0.91	0.86	0.09	0.14	C	1.2987013	0.008450311	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs114540395	C	T	79	14	1	69	23	2	0.91	0.86	0.09	0.14	T	1.1	0.008450311	Schizophrenia	Brain health and disorders
rs13008603	C	A	78	16	0	69	23	2	0.91	0.86	0.09	0.14	A	0.277	0.008450311	Red blood cell traits	Immune diseases and disorders
rs4148152	T	C	68	25	1	78	16	0	0.86	0.91	0.14	0.09	C	0.029	0.008450311	Serum uric acid levels	General health
rs2016394	G	A	27	48	19	33	53	8	0.54	0.63	0.46	0.37	G	1.05	0.008436725	Breast cancer	Cancer
rs8056446	G	A	17	52	25	13	43	38	0.46	0.37	0.54	0.63	A	1	0.008436725	Pulmonary function interaction	Pulmonology
rs12716852	G	A	17	52	25	13	43	38	0.46	0.37	0.54	0.63	G	0.025	0.008436725	Pulmonary function	Pulmonology
rs478093	A	G	5	36	53	0	32	62	0.24	0.17	0.76	0.83	G	1	0.008432284	Metabolite levels	General health
rs1460163	G	A	64	28	2	56	30	8	0.83	0.76	0.17	0.24	A	1	0.008432284	Creutzfeldt-Jakob disease	Immune diseases and disorders
rs12272917	T	C	56	30	8	66	24	4	0.76	0.83	0.24	0.17	T	0.1213	0.008432284	Bone mineral density paediatric, skull	General health
rs905938	T	C	63	30	1	52	38	4	0.83	0.76	0.17	0.24	T	0.0337	0.008432284	Waist-to-hip ratio adjusted for body mass index	Obesity
rs10260404	T	C	46	41	7	58	32	4	0.71	0.79	0.29	0.21	C	1.37	0.008428545	Amyotrophic lateral sclerosis	Brain health and disorders
rs7805747	G	A	58	32	4	50	33	11	0.79	0.71	0.21	0.29	A	1.18	0.008428545	Chronic kidney disease	Immune diseases and disorders
rs3814333	C	T	46	41	7	57	34	3	0.71	0.79	0.29	0.21	T	1.17	0.008428545	Height	General health
rs402675	T	A	46	41	7	58	32	4	0.71	0.79	0.29	0.21	A	0.097	0.008428545	Estradiol levels	General health
rs1853639	G	A	4	43	47	13	41	40	0.27	0.36	0.73	0.64	G	0.1761	0.008408882	IgG glycosylation	Immune diseases and disorders
rs10920678	A	G	4	43	47	11	45	38	0.27	0.36	0.73	0.64	A	0.015	0.008408882	Body mass index	Obesity
rs936332	C	T	23	41	30	14	42	38	0.46	0.37	0.54	0.63	G	2.27	0.008405317	Diisocyanate-induced asthma	Pulmonology
rs2033195	T	C	17	53	24	15	40	39	0.46	0.37	0.54	0.63	C	0.094	0.008405317	Body mass index	Obesity
rs12195826	A	G	12	46	36	25	37	32	0.37	0.46	0.63	0.54	A	0.05	0.008405317	Obesity-related traits	Obesity
rs17346536	A	G	26	48	20	37	43	14	0.53	0.62	0.47	0.38	G	1	0.008376083	Vein graft stenosis in coronary artery bypass grafting	Heart health and disorders
rs1402538	G	A	36	45	13	28	44	22	0.62	0.53	0.38	0.47	A	0.014	0.008376083	Optic cup area	Misc
rs3102947	G	C	4	18	72	0	39	55	0.14	0.21	0.86	0.79	G	0.06	0.008360129	IgE levels	Immune diseases and disorders
rs10492321	T	A	61	27	6	71	20	3	0.79	0.86	0.21	0.14	A	1.26	0.008360129	Height	General health
rs13002573	A	G	59	31	4	71	20	3	0.79	0.86	0.21	0.14	G	0.31	0.008360129	Blood pressure	Heart health and disorders
rs10838532	G	C	58	33	3	69	24	1	0.79	0.86	0.21	0.14	C	0.0603	0.008360129	Axial length	Misc
rs7006687	C	T	17	38	39	20	49	25	0.38	0.47	0.62	0.53	T	1	0.008348982	QT interval interaction	Heart health and disorders
rs4680719	G	A	28	43	23	35	46	13	0.53	0.62	0.47	0.38	A	0.2301	0.008348982	Metabolite levels HVA	General health
rs6931865	A	G	11	46	37	6	40	48	0.36	0.28	0.64	0.72	A	1	0.008333333	Erectile dysfunction in type 1 diabetes	Diabetes
rs4662834	A	G	10	48	36	8	36	50	0.36	0.28	0.64	0.72	A	0.08	0.008333333	Response to bleomycin chromatid breaks	General health
rs987710	G	A	11	51	32	25	40	29	0.39	0.48	0.61	0.52	G	2.01	0.008323972	Iron status biomarkers	General health
rs2126200	C	G	13	47	34	16	58	20	0.39	0.48	0.61	0.52	C	0.1392	0.008323972	IgG glycosylation	Immune diseases and disorders
rs6775909	T	C	21	48	25	14	45	35	0.48	0.39	0.52	0.61	T	0.09	0.008323972	Economic and political preferences environmentalism	Mental aptitude and behavioural traits
rs379123	T	C	25	40	29	13	47	34	0.48	0.39	0.52	0.61	T	0.005	0.008323972	Local histogram emphysema pattern	Pulmonology
rs941823	T	C	9	38	47	6	29	59	0.30	0.22	0.70	0.78	G	1.1147928	0.008313934	Ulcerative colitis	Immune diseases and disorders
rs4902100	G	A	5	46	43	5	31	58	0.30	0.22	0.70	0.78	G	1	0.008313934	Telomere length	Aging
rs10458787	A	G	6	29	59	6	44	44	0.22	0.30	0.78	0.70	G	0.09	0.008313934	Body mass index	Obesity
rs9263871	A	G	23	51	20	37	40	17	0.52	0.61	0.48	0.39	G	1.7	0.00830102	Lupus nephritis in systemic lupus erythematosus	Immune diseases and disorders
rs160441	T	C	10	54	30	24	43	27	0.39	0.48	0.61	0.52	T	1.2	0.00830102	Tuberculosis	Immune diseases and disorders
rs7704138	C	T	17	40	37	21	49	24	0.39	0.48	0.61	0.52	T	0.028	0.00830102	Height	General health
rs6755404	A	C	3	27	64	0	21	73	0.18	0.11	0.82	0.89	A	1.26	0.008281573	Malaria	Immune diseases and disorders
rs4574391	T	C	67	21	6	75	17	2	0.82	0.89	0.18	0.11	C	880	0.008281573	Superior frontal gyrus grey matter volume	Misc
rs17026156	T	C	62	31	1	75	17	2	0.82	0.89	0.18	0.11	C	2.08	0.008281573	PR interval	Heart health and disorders
rs6065777	T	G	62	31	1	74	19	1	0.82	0.89	0.18	0.11	T	1.06	0.008281573	Schizophrenia	Brain health and disorders
rs2389339	G	T	63	29	2	73	21	0	0.82	0.89	0.18	0.11	G	0.1846	0.008281573	IgG glycosylation	Immune diseases and disorders
rs13017846	A	G	62	31	1	75	17	2	0.82	0.89	0.18	0.11	G	0.069	0.008281573	QT interval	Heart health and disorders
rs2024125	G	A	17	58	19	17	41	36	0.49	0.40	0.51	0.60	G	0.02	0.008280091	Obesity-related traits	Obesity
rs12034598	A	G	51	39	4	64	27	3	0.75	0.82	0.25	0.18	A	1	0.008277027	Inflammatory biomarkers	Immune diseases and disorders
rs2066363	C	T	5	37	52	2	29	63	0.25	0.18	0.75	0.82	C	1	0.008277027	Pediatric autoimmune diseases	Immune diseases and disorders
rs13180077	T	G	6	35	53	3	27	64	0.25	0.18	0.75	0.82	G	0.14	0.008277027	Glomerular filtration rate in chronic kidney disease	General health
rs9981861	T	C	36	47	11	50	35	9	0.63	0.72	0.37	0.28	G	1.33	0.008261262	Non-small cell lung cancer survival	Cancer
rs7982677	C	A	48	39	7	41	37	16	0.72	0.63	0.28	0.37	A	1.288	0.008261262	Tetralogy of Fallot	Heart health and disorders
rs13164856	T	C	51	33	10	35	49	10	0.72	0.63	0.28	0.37	T	1.13	0.008261262	Polycystic ovary syndrome	Reproductive health
rs12297524	C	T	36	47	11	54	27	13	0.63	0.72	0.37	0.28	T	0.1258	0.008261262	Palmitic acid 16:0 plasma levels	General health
rs1364044	C	T	37	38	19	24	47	23	0.60	0.51	0.40	0.49	A	1.91	0.008261155	Stroke pediatric	Brain health and disorders
rs1416280	C	G	34	44	16	26	43	25	0.60	0.51	0.40	0.49	C	1.24	0.008261155	Longevity 90 years and older	Aging
rs2033908	C	A	39	34	21	18	59	17	0.60	0.51	0.40	0.49	A	0.045	0.008261155	Sitting height ratio	Appearance
rs3103778	A	G	22	50	22	33	45	16	0.50	0.59	0.50	0.41	G	6.3	0.008244188	PR interval	Heart health and disorders
rs174601	C	T	27	40	27	14	49	31	0.50	0.41	0.50	0.59	T	1.7	0.008244188	Liver enzyme levels alkaline phosphatase	General health
rs10821944	G	T	15	47	32	25	44	25	0.41	0.50	0.59	0.50	G	1.16	0.008244188	Rheumatoid arthritis	Immune diseases and disorders
rs742731	G	A	23	48	23	17	43	34	0.50	0.41	0.50	0.59	A	1	0.008244188	Fasting insulin interaction	General health
rs17797882	C	T	91	3	0	85	9	0	0.98	0.95	0.02	0.05	T	1.08	0.008241758	Type 2 diabetes	Diabetes
rs11827962	C	T	91	3	0	86	7	1	0.98	0.95	0.02	0.05	C	1.044	0.008241758	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs17540621	G	C	85	9	0	91	3	0	0.95	0.98	0.05	0.02	C	1	0.008241758	Response to statin therapy	General health
rs17102247	G	C	87	5	2	91	3	0	0.95	0.98	0.05	0.02	C	0.238	0.008241758	Urate levels in obese individuals	Obesity
rs56240109	A	G	85	9	0	91	3	0	0.95	0.98	0.05	0.02	G	0.219	0.008241758	Metabolite levels HVA_5-HIAA ratio	Brain health and disorders
rs17279437	G	A	85	9	0	91	3	0	0.95	0.98	0.05	0.02	A	0.094	0.008241758	Blood metabolite ratios	Heart health and disorders
rs12296063	C	T	91	3	0	85	9	0	0.98	0.95	0.02	0.05	A	0.03	0.008241758	Obesity-related traits	Obesity
rs2503322	A	G	25	45	24	21	36	37	0.51	0.41	0.49	0.59	A	1.0676966	0.008229164	Crohn's disease	Digestive system and its disorders
rs1896376	C	T	80	13	1	87	7	0	0.92	0.96	0.08	0.04	C	1.83	0.008217771	Smoking cessation in chronic obstructive pulmonary disease	Heart health and disorders
rs11579964	C	T	80	13	1	88	5	1	0.92	0.96	0.08	0.04	C	1.19	0.008217771	Major depressive disorder	Brain health and disorders
rs78944489	A	C	87	7	0	79	15	0	0.96	0.92	0.04	0.08	C	1.1111112	0.008217771	Schizophrenia	Brain health and disorders
rs2350782	T	C	80	13	1	87	7	0	0.92	0.96	0.08	0.04	C	0.505	0.008217771	Heart rate	General health
rs17520351	C	T	80	13	1	87	7	0	0.92	0.96	0.08	0.04	C	0.2	0.008217771	Metabolite levels Dihydroxy docosatrienoic acid	General health
rs9983044	C	G	87	7	0	79	15	0	0.96	0.92	0.04	0.08	C	0.07	0.008217771	Phospholipid levels plasma	General health
rs4253772	C	T	81	11	2	87	7	0	0.92	0.96	0.08	0.04	T	0.032	0.008217771	Cholesterol, total	General health
rs3135388	A	G	1	13	80	0	7	87	0.08	0.04	0.92	0.96	A	2.75	0.008217771	Multiple sclerosis	Brain health and disorders
rs314268	G	A	17	45	32	26	44	24	0.42	0.51	0.58	0.49	C	4.6	0.008216063	Height	General health
rs4663105	A	C	29	39	26	19	42	33	0.52	0.43	0.48	0.57	C	1.19	0.008204866	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs7816936	T	C	22	36	36	22	53	19	0.43	0.52	0.57	0.48	A	1.1628	0.008204866	Endometriosis	General health
rs20541	A	G	8	41	45	7	28	59	0.30	0.22	0.70	0.78	A	0.0724	0.008204792	Self-reported allergy	General health
rs13438712	T	C	44	43	7	57	32	5	0.70	0.78	0.30	0.22	G	0.03	0.008204792	Obesity-related traits	Obesity
rs7716219	T	C	9	39	46	4	34	56	0.30	0.22	0.70	0.78	T	0.03	0.008204792	Height	General health
rs2770102	G	A	21	39	34	29	40	25	0.43	0.52	0.57	0.48	G	0.014	0.008195559	Body mass index	Obesity
rs9268905	G	C	35	48	11	48	38	8	0.63	0.71	0.37	0.29	C	1	0.008192524	Cystic fibrosis severity	Immune diseases and disorders
rs35444	A	G	50	34	10	38	42	14	0.71	0.63	0.29	0.37	A	0.83	0.008192524	Systolic blood pressure	Heart health and disorders
rs1998207	G	T	45	44	5	34	50	10	0.71	0.63	0.29	0.37	A	0.04	0.008192524	Obesity-related traits	Obesity
rs3747517	T	C	7	40	47	12	46	36	0.29	0.37	0.71	0.63	T	1.33	0.008192524	Psoriasis	Immune diseases and disorders
rs593982	T	C	5	44	45	14	42	38	0.29	0.37	0.71	0.63	C	1.23	0.008192524	Atopic dermatitis	Immune diseases and disorders
rs3850579	G	A	11	48	35	7	40	47	0.37	0.29	0.63	0.71	G	0.2647	0.008192524	Dementia and core Alzheimer's disease neuropathologic changes	Brain health and disorders
rs994767	A	G	28	43	23	19	44	31	0.53	0.44	0.47	0.56	A	0.0716	0.008188129	Axial length	Misc
rs7642134	A	G	22	45	27	32	42	20	0.47	0.56	0.53	0.44	G	0.04	0.008188129	Menarche age at onset	Reproductive health
rs991316	T	C	26	48	20	11	61	22	0.53	0.44	0.47	0.56	T	1.62	0.008182565	Hypertension	Heart health and disorders
rs9302065	A	G	21	41	32	22	56	16	0.44	0.53	0.56	0.47	A	0.022	0.008182565	Blood metabolite levels	Heart health and disorders
rs35107139	A	C	28	48	18	13	61	20	0.55	0.46	0.45	0.54	C	1.1	0.008178859	Colorectal cancer	Cancer
rs2080401	A	C	22	43	29	32	40	22	0.46	0.55	0.54	0.45	C	1	0.008178859	Ear morphology	Appearance
rs4513773	A	G	20	46	28	20	63	11	0.46	0.55	0.54	0.45	G	1	0.008177008	Vascular endothelial growth factor levels	General health
rs11847263	T	G	31	41	22	24	38	32	0.55	0.46	0.45	0.54	G	0.3124	0.008177008	IgG glycosylation	Immune diseases and disorders
rs17159640	A	T	81	13	0	72	21	1	0.93	0.88	0.07	0.12	T	1.59	0.008169935	Mortality in heart failure	Heart health and disorders
rs2040862	C	T	72	21	1	81	13	0	0.88	0.93	0.12	0.07	T	1.12	0.008169935	Atrial fibrillation	Heart health and disorders
rs4905226	C	T	71	23	0	82	11	1	0.88	0.93	0.12	0.07	T	0.13	0.008169935	Social communication problems	Brain health and disorders
rs16940212	G	T	73	19	2	81	13	0	0.88	0.93	0.12	0.07	T	0.0222	0.008169935	HDL cholesterol	General health
rs12054895	G	T	60	28	6	69	23	2	0.79	0.86	0.21	0.14	T	0.2428	0.008163068	Major depressive disorder	Brain health and disorders
rs6932590	T	C	63	28	3	52	36	6	0.82	0.74	0.18	0.26	T	1.16	0.008130081	Schizophrenia	Brain health and disorders
rs11578508	A	G	53	34	7	64	26	4	0.74	0.82	0.26	0.18	A	0.51	0.008130081	Heart rate	General health
rs4911414	T	G	7	34	53	4	26	64	0.26	0.18	0.74	0.82	G	0.07	0.008130081	Tanning	Appearance
rs1172130	G	A	50	40	4	62	30	2	0.74	0.82	0.26	0.18	G	0.011	0.008130081	Mean platelet volume	Heart health and disorders
rs1547374	A	G	52	29	13	34	49	11	0.71	0.62	0.29	0.38	A	1.27	0.008126984	Pancreatic cancer	Cancer
rs12212193	A	G	37	43	14	45	43	6	0.62	0.71	0.38	0.29	G	1.09	0.008126984	Multiple sclerosis	Brain health and disorders
rs13043694	G	A	34	49	11	45	43	6	0.62	0.71	0.38	0.29	A	1	0.008126984	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs955943	C	T	77	17	0	67	26	1	0.91	0.85	0.09	0.15	A	1.41	0.008123531	Rhegmatogenous retinal detachment	General health
rs4925189	G	A	5	33	56	8	42	44	0.23	0.31	0.77	0.69	G	1	0.00810081	Cerebrospinal T-tau levels	Brain health and disorders
rs270602	T	C	13	32	49	0	43	51	0.31	0.23	0.69	0.77	T	0.0505	0.00810081	Acylcarnitine levels	General health
rs272889	A	G	13	32	49	0	43	51	0.31	0.23	0.69	0.77	A	0.039	0.00810081	Blood metabolite ratios	Heart health and disorders
rs272869	A	G	13	32	49	0	43	51	0.31	0.23	0.69	0.77	A	0.022	0.00810081	Blood metabolite levels	Heart health and disorders
rs35998080	G	T	43	44	7	55	35	4	0.69	0.77	0.31	0.23	T	1.07	0.00810081	Schizophrenia	Brain health and disorders
rs2933343	G	A	56	33	5	42	46	6	0.77	0.69	0.23	0.31	G	0.1615	0.00810081	IgG glycosylation	Immune diseases and disorders
rs1126214	T	C	37	42	15	45	42	7	0.62	0.70	0.38	0.30	G	1.25	0.008064516	Bronchopulmonary dysplasia	Pulmonology
rs2823615	A	T	43	46	5	35	46	13	0.70	0.62	0.30	0.38	A	0.04	0.008064516	Obesity-related traits	Obesity
rs756699	C	T	8	40	46	16	40	38	0.30	0.38	0.70	0.62	A	1.12	0.008064516	Multiple sclerosis	Brain health and disorders
rs7693389	G	A	3	13	78	0	10	84	0.10	0.05	0.90	0.95	G	2.66	0.008049289	Diisocyanate-induced asthma	Pulmonology
rs228916	C	T	0	19	75	0	10	84	0.10	0.05	0.90	0.95	T	0.086	0.008049289	Iron status biomarkers iron levels	General health
rs12587630	A	G	75	19	0	84	10	0	0.90	0.95	0.10	0.05	A	2.69	0.008049289	Periodontitis CDC_AAP	Misc
rs6730714	G	A	75	19	0	84	10	0	0.90	0.95	0.10	0.05	A	1.18	0.008049289	Vitamin D levels	General health
rs12220777	T	C	84	10	0	75	19	0	0.95	0.90	0.05	0.10	C	1	0.008049289	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs16887217	T	C	94	0	0	91	3	0	1.00	0.98	0.00	0.02	C	1.16	0.008042895	Orthostatic hypotension	Heart health and disorders
rs142799378	T	G	94	0	0	91	3	0	1.00	0.98	0.00	0.02	G	0.81	0.008042895	Lipoprotein a levels	Heart health and disorders
rs493573	C	T	94	0	0	91	3	0	1.00	0.98	0.00	0.02	A	0.8	0.008042895	Urate levels	General health
rs16935279	T	C	94	0	0	91	3	0	1.00	0.98	0.00	0.02	C	0.7918	0.008042895	Pharmacokinetics of antiepileptic drugs in severe mental disorder concentration drug ratio	General health
rs149565105	G	A	94	0	0	91	3	0	1.00	0.98	0.00	0.02	A	0.78	0.008042895	Lipoprotein a levels	Heart health and disorders
rs12280105	G	A	94	0	0	91	3	0	1.00	0.98	0.00	0.02	A	0.7135	0.008042895	Oleic acid 18:1n-9 plasma levels	General health
rs61744862	G	A	94	0	0	91	3	0	1.00	0.98	0.00	0.02	A	0.04	0.008042895	Obesity-related traits	Obesity
rs35659386	T	A	64	26	4	72	22	0	0.82	0.88	0.18	0.12	A	1.07	0.008035714	Schizophrenia	Brain health and disorders
rs36563	T	G	3	16	75	3	28	63	0.12	0.18	0.88	0.82	A	1.33	0.008035714	Alcohol dependence	General health
rs11697186	A	T	89	5	0	82	12	0	0.97	0.94	0.03	0.06	T	4.5	0.008028838	Response to hepatitis C treatment	General health
rs9591325	T	C	89	5	0	82	12	0	0.97	0.94	0.03	0.06		1.63	0.008028838	Primary biliary cirrhosis	Immune diseases and disorders
rs9348876	C	T	82	12	0	89	5	0	0.94	0.97	0.06	0.03	T	1.41	0.008028838	Crohn's disease	Digestive system and its disorders
rs6725887	T	C	82	12	0	89	5	0	0.94	0.97	0.06	0.03	C	1.17	0.008028838	Myocardial infarction early onset	Heart health and disorders
rs1569328	C	T	82	12	0	89	5	0	0.94	0.97	0.06	0.03	A	1.1154022	0.008028838	Crohn's disease	Digestive system and its disorders
rs73229090	C	A	82	12	0	89	5	0	0.94	0.97	0.06	0.03	C	1.1013216	0.008028838	Schizophrenia	Brain health and disorders
rs4963243	G	A	82	12	0	89	5	0	0.94	0.97	0.06	0.03	A	1	0.008028838	Immune reponse to smallpox secreted IL-2	Immune diseases and disorders
rs4820834	G	A	82	12	0	89	5	0	0.94	0.97	0.06	0.03	A	0.71	0.008028838	Coronary artery calcification	Heart health and disorders
rs13166268	C	G	82	12	0	89	5	0	0.94	0.97	0.06	0.03	C	0.4823	0.008028838	Verbal declarative memory	Brain health and disorders
rs17430337	G	A	90	3	1	82	12	0	0.97	0.94	0.03	0.06	A	0.02	0.008028838	Obesity-related traits	Obesity
rs1052693	C	T	36	43	15	46	39	9	0.61	0.70	0.39	0.30	G	0.1	0.008005003	Complement C3 and C4 levels	Immune diseases and disorders
rs6908917	G	C	9	41	44	6	32	56	0.31	0.23	0.69	0.77	C	0.1674	0.008001707	IgG glycosylation	Immune diseases and disorders
rs7117858	G	A	5	34	55	8	43	43	0.23	0.31	0.77	0.69	G	0.09	0.008001707	Bone mineral density hip	General health
rs274546	A	G	14	31	49	0	44	50	0.31	0.23	0.69	0.77	A	0.029	0.008001707	Height	General health
rs7716600	A	C	7	35	52	5	25	64	0.26	0.19	0.74	0.81	A	1.24	0.007990868	Breast cancer	Cancer
rs190369	C	T	1	33	60	7	35	52	0.19	0.26	0.81	0.74	C	0.161	0.007990868	Lifetime average cigarettes per day in chronic obstructive pulmonary disease	General health
rs400028	C	T	3	29	62	4	41	49	0.19	0.26	0.81	0.74	G	0.03	0.007990868	Obesity-related traits	Obesity
rs1874252	G	T	62	29	3	50	39	5	0.81	0.74	0.19	0.26	G	1.32	0.007990868	Alcohol dependence age at onset	General health
rs237743	G	A	61	31	2	53	33	8	0.81	0.74	0.19	0.26	A	0.041	0.007990868	Height	General health
rs10926554	C	A	68	24	2	60	27	7	0.85	0.78	0.15	0.22	A	13.13	0.007978096	Illicit drug use	General health
rs12615966	C	T	60	27	7	69	22	3	0.78	0.85	0.22	0.15	A	3.15	0.007978096	Pancreatic cancer	Cancer
rs7198849	C	T	54	39	1	67	26	1	0.78	0.85	0.22	0.15	A	1	0.007978096	Vein graft stenosis in coronary artery bypass grafting	Heart health and disorders
rs7561149	T	C	59	29	6	67	26	1	0.78	0.85	0.22	0.15	C	0.52	0.007978096	QT interval	Heart health and disorders
rs10074959	G	A	44	42	8	35	44	15	0.69	0.61	0.31	0.39	T	1.524	0.007948336	Adverse response to chemotherapy neutropenia_leucopenia all topoisomerase inhibitors	Drug response
rs10805346	T	C	18	38	38	14	30	50	0.39	0.31	0.61	0.69	C	0.164	0.007948336	Urate levels in obese individuals	Obesity
rs6495785	A	G	6	33	55	6	48	40	0.24	0.32	0.76	0.68	A	0.69	0.007907222	Menopause age at onset	Reproductive health
rs8070473	T	G	8	29	57	5	50	39	0.24	0.32	0.76	0.68	T	0.16	0.007907222	Depression quantitative trait	Brain health and disorders
rs9303280	T	C	6	48	40	8	29	57	0.32	0.24	0.68	0.76	T	0.0687	0.007907222	Self-reported allergy	General health
rs7523273	A	G	36	41	17	43	43	8	0.60	0.69	0.40	0.31	A	1.063	0.007894412	Schizophrenia	Brain health and disorders
rs10007052	C	A	41	47	6	36	41	17	0.69	0.60	0.31	0.40	A	1	0.007894412	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs1317830	A	G	46	37	11	32	49	13	0.69	0.60	0.31	0.40	G	1	0.007894412	Body mass index in non-asthmatics	Obesity
rs3847646	C	T	33	47	14	40	49	5	0.60	0.69	0.40	0.31	T	0.03	0.007894412	Calcium levels	General health
rs2834902	A	C	12	51	31	10	39	45	0.40	0.31	0.60	0.69	A	0.0359	0.007894412	Corneal curvature	General health
rs6918936	G	C	13	49	32	10	39	45	0.40	0.31	0.60	0.69	C	0.03	0.007894412	Phospholipid levels plasma	General health
rs17019602	A	G	49	40	5	64	24	6	0.73	0.81	0.27	0.19	G	1.19	0.007858861	IgA nephropathy	Immune diseases and disorders
rs773125	A	G	39	50	5	29	54	11	0.68	0.60	0.32	0.40	A	1.09	0.007843137	Rheumatoid arthritis	Immune diseases and disorders
rs12815613	A	G	67	25	2	78	14	2	0.85	0.90	0.15	0.10	A	4.654	0.007825131	Very long-chain saturated fatty acid levels fatty acid 20:0	General health
rs11055387	G	C	77	16	1	66	27	1	0.90	0.85	0.10	0.15	C	2.1853	0.007825131	Major depressive disorder	Brain health and disorders
rs17736906	A	G	67	25	2	76	18	0	0.85	0.90	0.15	0.10	A	0.7446	0.007825131	Pit-and-Fissure caries	Misc
rs457352	C	T	69	21	4	77	16	1	0.85	0.90	0.15	0.10	T	0.2401	0.007825131	Periodontitis DPAL	Misc
rs3094188	C	A	12	37	45	5	36	53	0.32	0.24	0.68	0.76	C	1.61	0.007817114	Crohn's disease	Digestive system and its disorders
rs422249	T	C	3	40	51	10	41	43	0.24	0.32	0.76	0.68	T	0.0021	0.007817114	Trans fatty acid levels	General health
rs875860	C	T	55	32	7	47	33	14	0.76	0.68	0.24	0.32	T	0.31	0.007817114	Kidney function decline traits	General health
rs12764197	A	G	54	34	6	45	37	12	0.76	0.68	0.24	0.32	G	0.03	0.007817114	Obesity-related traits	Obesity
rs7577262	G	A	71	23	0	65	23	6	0.88	0.81	0.12	0.19	A	1.71	0.007807417	Blood pressure measurement cold pressor test	Heart health and disorders
rs7460090	T	C	72	21	1	61	31	2	0.88	0.81	0.12	0.19	T	0.058	0.007807417	Height	General health
rs1109748	C	A	61	31	2	72	21	1	0.81	0.88	0.19	0.12	A	0.05	0.007807417	Phospholipid levels plasma	General health
rs35862341	T	C	56	34	4	66	27	1	0.78	0.85	0.22	0.15	C	1.521	0.007804202	Dementia and core Alzheimer's disease neuropathologic changes	Brain health and disorders
rs17362650	T	C	58	30	6	66	27	1	0.78	0.85	0.22	0.15	C	1.33	0.007804202	Alcohol dependence age at onset	General health
rs8090196	C	T	67	25	2	56	34	4	0.85	0.78	0.15	0.22	T	0.179	0.007804202	Economic and political preferences immigration_crime	Mental aptitude and behavioural traits
rs2687729	A	G	44	39	11	32	47	15	0.68	0.59	0.32	0.41	G	2.3	0.007794422	Menarche age at onset	Reproductive health
rs2999052	T	C	44	39	11	32	47	15	0.68	0.59	0.32	0.41	T	1.55	0.007794422	Hypospadias	Misc
rs1559759	C	A	70	24	0	80	14	0	0.87	0.93	0.13	0.07	A	25.59	0.007785737	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs3733017	T	G	82	10	2	70	24	0	0.93	0.87	0.07	0.13	G	10.07	0.007785737	PR interval	Heart health and disorders
rs10432496	C	T	71	22	1	82	10	2	0.87	0.93	0.13	0.07	A	1	0.007785737	Immune reponse to smallpox secreted IL-2	Immune diseases and disorders
rs2110166	C	T	80	14	0	71	22	1	0.93	0.87	0.07	0.13	C	0.5673	0.007785737	IgG glycosylation	Immune diseases and disorders
rs11060736	T	C	72	20	2	81	12	1	0.87	0.93	0.13	0.07	T	0.285	0.007785737	Gambling	General health
rs1895320	A	G	81	12	1	73	18	3	0.93	0.87	0.07	0.13	C	0.22	0.007785737	Insulin-related traits	Diabetes
rs4561508	C	T	81	12	1	71	22	1	0.93	0.87	0.07	0.13	T	0.047	0.007785737	Serum total protein level	General health
rs89107	G	A	28	54	12	45	36	13	0.59	0.67	0.41	0.33	G	0.03	0.007748184	Cardiac structure and function	Heart health and disorders
rs9275596	C	T	2	33	59	8	35	51	0.20	0.27	0.80	0.73	T	1.69	0.007733586	IgA nephropathy	Immune diseases and disorders
rs7628219	C	T	61	29	4	47	43	4	0.80	0.73	0.20	0.27	T	1.61	0.007733586	Insomnia caffeine-induced	General health
rs17336353	A	G	61	29	4	49	39	6	0.80	0.73	0.20	0.27	G	0.151	0.007733586	Response to simvastatin treatment PCSK9 protein level change	General health
rs1568657	A	G	40	46	8	55	31	8	0.67	0.75	0.33	0.25	G	1.409	0.007731162	Kawasaki disease	Misc
rs12924729	G	A	52	37	5	44	38	12	0.75	0.67	0.25	0.33	G	1.31	0.007731162	Primary biliary cirrhosis	Immune diseases and disorders
rs11687420	A	T	55	31	8	43	40	11	0.75	0.67	0.25	0.33	A	1	0.007731162	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs931726	C	T	43	40	11	52	37	5	0.67	0.75	0.33	0.25	T	0.056	0.007731162	Sitting height ratio	Appearance
rs10783779	T	G	40	45	9	27	55	12	0.66	0.58	0.34	0.42	T	0.021	0.007704346	Educational attainment	Mental aptitude and behavioural traits
rs17073641	A	C	35	38	21	46	32	16	0.57	0.66	0.43	0.34	C	1	0.007662835	Age-related macular degeneration smoking status interaction	Aging
rs7926971	A	G	33	42	19	38	48	8	0.57	0.66	0.43	0.34	A	0.023	0.007662835	Height	General health
rs9933309	T	C	10	43	41	1	46	47	0.34	0.26	0.66	0.74	C	0.07	0.007649159	Glycated hemoglobin levels	Diabetes
rs72725879	C	T	53	34	7	39	47	8	0.74	0.66	0.26	0.34	T	1.92	0.007649159	Prostate cancer	Cancer
rs2277862	C	T	65	28	1	54	37	3	0.84	0.77	0.16	0.23	T	1.19	0.00764049	Cholesterol, total	General health
rs2898681	G	A	58	29	7	68	22	4	0.77	0.84	0.23	0.16	G	0.173	0.00764049	Optic nerve measurement cup area	Misc
rs12446301	C	T	59	27	8	66	26	2	0.77	0.84	0.23	0.16	T	0.0021	0.00764049	Trans fatty acid levels	General health
rs2367563	A	G	38	47	9	32	43	19	0.65	0.57	0.35	0.43	A	5.92	0.007623585	Allergic dermatitis nickel	Immune diseases and disorders
rs11868035	G	A	30	47	17	39	45	10	0.57	0.65	0.43	0.35	G	1.18	0.007623585	Parkinson's disease	Brain health and disorders
rs7686660	T	G	39	45	10	28	51	15	0.65	0.57	0.35	0.43	T	1.16	0.007623585	Asthma	Immune diseases and disorders
rs61970269	A	T	41	41	12	26	55	13	0.65	0.57	0.35	0.43	T	0.2234	0.007623585	Metabolite levels 5-HIAA	General health
rs1030877	G	A	12	41	41	16	49	29	0.35	0.43	0.65	0.57	G	0.03	0.007623585	Obesity-related traits	Obesity
rs12669789	T	C	58	34	2	50	36	8	0.80	0.72	0.20	0.28	C	1.3	0.007614608	Intracranial aneurysm	Misc
rs308309	C	T	5	26	63	3	18	73	0.19	0.13	0.81	0.87	C	4.39	0.007594937	QRS duration	Heart health and disorders
rs2608200	A	G	2	32	60	1	22	71	0.19	0.13	0.81	0.87	A	1	0.007594937	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs4702435	C	T	2	20	72	4	28	62	0.13	0.19	0.87	0.81	G	0.04	0.007594937	Obesity-related traits	Obesity
rs13067306	G	A	62	28	4	70	24	0	0.81	0.87	0.19	0.13	A	4.86	0.007594937	Blood pressure measurement high sodium intervention	Heart health and disorders
rs11835432	A	G	63	26	5	72	20	2	0.81	0.87	0.19	0.13	T	0.6667	0.007594937	Age-related cataracts age at onset	Aging
rs3806156	G	T	30	46	18	38	46	10	0.56	0.65	0.44	0.35	T	1.42	0.007586534	Vitiligo	Immune diseases and disorders
rs6136	T	G	80	12	2	86	8	0	0.91	0.96	0.09	0.04	T	22.6	0.007575758	Soluble levels of adhesion molecules	General health
rs12472151	G	A	78	16	0	86	8	0	0.91	0.96	0.09	0.04	A	8	0.007575758	Alcohol consumption	General health
rs11008099	G	A	79	14	1	86	8	0	0.91	0.96	0.09	0.04	A	2.74	0.007575758	QT interval	Heart health and disorders
rs7431992	T	A	78	16	0	86	8	0	0.91	0.96	0.09	0.04	A	1.46	0.007575758	Alzheimer's disease late onset	Brain health and disorders
rs17145738	C	T	86	8	0	78	16	0	0.96	0.91	0.04	0.09	T	0.57	0.007575758	HDL cholesterol	General health
rs2237886	C	T	78	16	0	86	8	0	0.91	0.96	0.09	0.04	T	0.046	0.007575758	Height	General health
rs17145750	C	T	84	9	1	75	18	1	0.94	0.89	0.06	0.11	C	4.5	0.007573633	Liver enzyme levels gamma-glutamyl transferase	General health
rs10511112	T	C	74	20	0	83	11	0	0.89	0.94	0.11	0.06	C	1.11	0.007573633	Migraine	Brain health and disorders
rs13276960	G	A	76	16	2	83	11	0	0.89	0.94	0.11	0.06	G	1.0638298	0.007573633	Schizophrenia	Brain health and disorders
rs4369779	T	C	11	42	41	4	41	49	0.34	0.26	0.66	0.74	C	0.06	0.007570914	Sitting height ratio	Appearance
rs759341	G	A	52	35	7	41	42	11	0.74	0.66	0.26	0.34	A	0.16	0.007570914	Kidney function decline traits	General health
rs17188434	T	C	87	7	0	92	2	0	0.96	0.99	0.04	0.01	C	4.5	0.007568877	Menarche age at onset	Reproductive health
rs17079534	G	A	92	2	0	87	7	0	0.99	0.96	0.01	0.04	A	4.07	0.007568877	Acute lymphoblastic leukemia childhood	Cancer
rs12210810	G	C	87	7	0	92	2	0	0.96	0.99	0.04	0.01	C	3.13	0.007568877	QT interval	Heart health and disorders
rs12210733	G	A	87	7	0	92	2	0	0.96	0.99	0.04	0.01	A	2.05	0.007568877	QT interval	Heart health and disorders
rs9948784	G	A	92	2	0	87	7	0	0.99	0.96	0.01	0.04	G	1.8106	0.007568877	IgG glycosylation	Immune diseases and disorders
rs6868545	A	C	87	7	0	92	2	0	0.96	0.99	0.04	0.01	C	1.1235955	0.007568877	Schizophrenia	Brain health and disorders
rs111803315	G	A	87	7	0	92	2	0	0.96	0.99	0.04	0.01	G	1.1111112	0.007568877	Schizophrenia	Brain health and disorders
rs7015622	A	G	92	2	0	87	7	0	0.99	0.96	0.01	0.04	C	1	0.007568877	Response to anti-depressant treatment in major depressive disorder	General health
rs74019828	G	A	92	2	0	87	7	0	0.99	0.96	0.01	0.04	A	0.38	0.007568877	Telomere length	Aging
rs12203592	C	T	87	7	0	92	2	0	0.96	0.99	0.04	0.01	C	0.35	0.007568877	Tanning	Appearance
rs2298574	A	G	92	2	0	87	7	0	0.99	0.96	0.01	0.04	G	0.27	0.007568877	vWF and FVIII levels	Heart health and disorders
rs12208357	C	T	87	7	0	93	0	1	0.96	0.99	0.04	0.01	T	0.092	0.007568877	Cholesterol, total	General health
rs4777845	T	C	87	7	0	92	2	0	0.96	0.99	0.04	0.01	T	0.064	0.007568877	Adiponectin levels	Obesity
rs11709077	G	A	87	7	0	92	2	0	0.96	0.99	0.04	0.01	A	0.024	0.007568877	Body mass index	Obesity
rs12263766	A	G	92	2	0	88	5	1	0.99	0.96	0.01	0.04	G	0.02	0.007568877	Obesity-related traits	Obesity
rs2547917	G	A	65	28	1	75	19	0	0.84	0.90	0.16	0.10	A	1.997	0.007551645	Adverse response to chemotherapy neutropenia_leucopenia gemcitabine	Drug response
rs12410462	G	A	76	17	1	66	26	2	0.90	0.84	0.10	0.16	A	1.259	0.007551645	Major depressive disorder	Brain health and disorders
rs4468442	G	A	64	30	0	76	17	1	0.84	0.90	0.16	0.10	A	0.00192	0.007551645	Calcium levels	General health
rs8099213	C	T	39	43	12	31	43	20	0.64	0.56	0.36	0.44	A	1.52	0.007551622	Multiple myeloma IgH translocation	Cancer
rs12202017	A	G	28	48	18	39	42	13	0.55	0.64	0.45	0.36	A	1.07	0.007518797	Coronary artery disease	Heart health and disorders
rs11653011	T	C	31	42	21	37	46	11	0.55	0.64	0.45	0.36	G	0.04	0.007518797	Obesity-related traits	Obesity
rs9915657	T	C	15	38	41	16	52	26	0.36	0.45	0.64	0.55	T	0.068	0.007518797	Thyroid hormone levels	General health
rs6683419	G	A	11	46	37	19	46	29	0.36	0.45	0.64	0.55	G	0.027	0.007518797	Serum thyroid-stimulating hormone levels	General health
rs7313075	C	A	61	27	6	48	39	7	0.79	0.72	0.21	0.28	A	0.074	0.007501531	Height	General health
rs227724	A	T	48	39	7	60	29	5	0.72	0.79	0.28	0.21	A	0.03	0.007501531	Height	General health
rs2588809	T	C	5	29	60	6	41	47	0.21	0.28	0.79	0.72	T	1.08	0.007501531	Breast cancer	Cancer
rs7302017	G	A	13	39	42	8	34	52	0.35	0.27	0.65	0.73	G	1.71	0.007496252	Waist circumference	General health
rs2444043	C	T	16	37	41	17	51	26	0.37	0.45	0.63	0.55	T	5.24	0.007488007	Fractional exhaled nitric oxide levels	Pulmonology
rs270421	C	T	16	53	25	11	47	36	0.45	0.37	0.55	0.63	C	0.19	0.007488007	Serum thyroid-stimulating hormone levels	General health
rs9854771	G	A	29	45	20	38	43	13	0.55	0.63	0.45	0.37	G	1.1235955	0.007488007	Pancreatic cancer	Cancer
rs12538804	A	G	36	47	11	19	65	10	0.63	0.55	0.37	0.45	G	0.08	0.007488007	Urate levels in obese individuals	Obesity
rs237450	G	A	63	31	0	55	34	5	0.84	0.77	0.16	0.23	A	6.86	0.007486157	QT interval	Heart health and disorders
rs1149332	C	T	54	36	4	66	25	3	0.77	0.84	0.23	0.16	T	0.062	0.007486157	Puberty onset	Reproductive health
rs2360997	G	C	4	23	67	5	34	55	0.16	0.23	0.84	0.77	C	1.3	0.007486157	Attention deficit hyperactivity disorder symptoms interaction	Brain health and disorders
rs281768	A	T	1	29	64	2	40	52	0.16	0.23	0.84	0.77	A	1.11	0.007486157	Schizophrenia	Brain health and disorders
rs7824557	G	A	5	34	55	1	29	64	0.23	0.16	0.77	0.84	G	1	0.007486157	Retinal vascular caliber	General health
rs174577	C	A	31	40	23	39	40	15	0.54	0.63	0.46	0.37	A	0.735	0.007459207	P wave duration	Heart health and disorders
rs12129861	G	A	27	48	19	31	56	7	0.54	0.63	0.46	0.37	A	0.06	0.007459207	Uric acid levels	General health
rs174578	T	A	31	40	23	39	40	15	0.54	0.63	0.46	0.37	A	0.035	0.007459207	Blood metabolite levels	Heart health and disorders
rs6457617	C	T	13	44	37	22	42	30	0.37	0.46	0.63	0.54	T	1.61	0.007459207	Systemic sclerosis	Brain health and disorders
rs8070463	T	C	19	48	27	14	42	38	0.46	0.37	0.54	0.63	C	1	0.007459207	Ankylosing spondylitis	Immune diseases and disorders
rs1532085	A	G	13	44	37	21	44	29	0.37	0.46	0.63	0.54	G	0.13	0.007459207	HDL cholesterol	General health
rs6457620	G	C	13	44	37	22	42	30	0.37	0.46	0.63	0.54	C	0.029	0.007459207	Height	General health
rs11740474	A	T	44	34	16	52	33	9	0.65	0.73	0.35	0.27	T	1.0638298	0.007425007	Schizophrenia	Brain health and disorders
rs8048589	T	C	54	29	11	37	48	9	0.73	0.65	0.27	0.35	C	1	0.007425007	Fasting insulin interaction	General health
rs9391253	A	T	39	44	11	46	45	3	0.65	0.73	0.35	0.27	T	0.088	0.007425007	Puberty onset breast development	Reproductive health
rs2954021	A	G	19	50	25	14	44	36	0.47	0.38	0.53	0.62	A	1.4	0.007407407	Liver enzyme levels alkaline phosphatase	General health
rs6733818	G	A	30	40	24	34	48	12	0.53	0.62	0.47	0.38	G	1.1	0.007407407	Migraine without aura	Brain health and disorders
rs10514995	T	C	38	40	16	26	48	20	0.62	0.53	0.38	0.47	G	0.15	0.007407407	RR interval heart rate	Heart health and disorders
rs11639988	A	G	71	21	2	59	33	2	0.87	0.80	0.13	0.20	A	1.15	0.007396754	Obesity	Obesity
rs10861337	G	A	60	31	3	71	21	2	0.80	0.87	0.20	0.13	G	0.2653	0.007396754	IgG glycosylation	Immune diseases and disorders
rs944002	A	G	48	38	8	56	36	2	0.71	0.79	0.29	0.21	G	6.3	0.007393994	Liver enzyme levels gamma-glutamyl transferase	General health
rs7071247	G	T	60	28	6	48	38	8	0.79	0.71	0.21	0.29	T	1	0.007393994	Platelet aggregation	Heart health and disorders
rs2216228	T	C	60	28	6	45	44	5	0.79	0.71	0.21	0.29	G	0.45	0.007393994	Non-alcoholic fatty liver disease histology lobular	Obesity
rs2253017	C	T	33	49	12	23	53	18	0.61	0.53	0.39	0.47	T	1.58	0.007384331	PR segment	Heart health and disorders
rs7561273	A	G	15	43	36	19	51	24	0.39	0.47	0.61	0.53	A	0.22	0.007384331	Quantitative traits	Misc
rs6092477	G	A	23	53	18	35	45	14	0.53	0.61	0.47	0.39	G	0.068	0.007384331	Mean corpuscular volume	Heart health and disorders
rs2427345	C	T	32	50	12	29	40	25	0.61	0.52	0.39	0.48	G	1.06	0.007363092	Prostate cancer	Cancer
rs3120665	A	G	33	48	13	26	46	22	0.61	0.52	0.39	0.48	G	0.14	0.007363092	Personality dimensions	Brain health and disorders
rs3120667	A	G	33	48	13	26	46	22	0.61	0.52	0.39	0.48	A	0.118	0.007363092	Eating disorders	Brain health and disorders
rs859980	T	C	13	48	33	13	64	17	0.39	0.48	0.61	0.52	C	1.15	0.007363092	Tourette's syndrome or obsessive-compulsive disorder	Brain health and disorders
rs893949	C	T	16	42	36	20	50	24	0.39	0.48	0.61	0.52	C	1.0526316	0.007363092	Schizophrenia	Brain health and disorders
rs7529073	T	C	11	45	38	7	38	49	0.36	0.28	0.64	0.72	C	1.0526316	0.007357028	Schizophrenia	Brain health and disorders
rs10466455	T	C	49	38	7	42	37	15	0.72	0.64	0.28	0.36	T	1.3774	0.007357028	Systemic lupus erythematosus	Immune diseases and disorders
rs13382811	C	T	50	36	8	40	41	13	0.72	0.64	0.28	0.36	T	1.26	0.007357028	Myopia severe	General health
rs6993449	C	G	22	47	25	14	47	33	0.48	0.40	0.52	0.60	C	0.1528	0.00734366	IgG glycosylation	Immune diseases and disorders
rs4844614	G	T	29	39	26	31	51	12	0.52	0.60	0.48	0.40	A	0.1	0.00734366	LDL cholesterol	General health
rs4841398	C	T	3	26	65	5	35	54	0.17	0.24	0.83	0.76	G	0.02	0.007340486	Obesity-related traits	Obesity
rs1870805	A	G	15	46	33	25	42	27	0.40	0.49	0.60	0.51	A	0.03	0.007326007	Obesity-related traits	Obesity
rs2407314	G	C	23	47	24	19	39	36	0.49	0.41	0.51	0.59	C	9	0.007310109	Insulin resistance_response	Drug response
rs3769955	C	T	33	45	16	25	45	24	0.59	0.51	0.41	0.49	T	1.22	0.007310109	Febrile seizures MMR vaccine-related	General health
rs243088	A	T	23	47	24	17	43	34	0.49	0.41	0.51	0.59	T	1.09	0.007310109	Type 2 diabetes	Diabetes
rs1990193	C	A	16	45	33	22	49	23	0.41	0.49	0.59	0.51	C	0.03	0.007310109	Obesity-related traits	Obesity
rs72739921	A	G	66	25	3	75	18	1	0.84	0.89	0.16	0.11	A	6.9930067	0.007300151	Warfarin maintenance dose	General health
rs79480871	C	T	76	16	2	65	27	2	0.89	0.84	0.11	0.16	T	1.34	0.007300151	Diffuse large B cell lymphoma	Cancer
rs4952108	C	T	68	21	5	75	18	1	0.84	0.89	0.16	0.11	C	1.28	0.007300151	Primary biliary cirrhosis	Immune diseases and disorders
rs1991866	G	C	14	50	30	18	58	18	0.41	0.50	0.59	0.50	G	1.054	0.007295942	Inflammatory bowel disease	Immune diseases and disorders
rs12257178	A	G	32	46	16	20	54	20	0.59	0.50	0.41	0.50	A	5.04	0.007295942	Longitudinal alcohol consumption	General health
rs2656620	C	A	35	50	9	49	37	8	0.64	0.72	0.36	0.28	A	0.23	0.007292173	Cannabis use initiation	General health
rs1936805	C	T	25	45	24	21	37	36	0.51	0.42	0.49	0.58	T	0.0517	0.007283487	Waist-to-hip ratio adjusted for body mass index	Obesity
rs7828501	A	G	18	43	33	23	49	22	0.42	0.51	0.58	0.49	G	0.04	0.007283487	Menarche age at onset	Reproductive health
rs6583826	G	A	27	38	29	27	54	13	0.49	0.57	0.51	0.43	G	1.18	0.007272727	Type 2 diabetes	Diabetes
rs493258	T	C	18	44	32	22	52	20	0.43	0.51	0.57	0.49	C	1.16	0.007272727	Age-related macular degeneration	Aging
rs8014671	G	A	24	48	22	17	46	31	0.51	0.43	0.49	0.57	G	1.07	0.007272727	Prostate cancer	Cancer
rs2289195	G	A	21	50	23	31	46	17	0.49	0.57	0.51	0.43	A	0.038	0.007272727	Height	General health
rs333332	C	T	26	45	23	17	47	30	0.52	0.43	0.48	0.57	T	13.81	0.007263648	Heschl's gyrus morphology	Brain health and disorders
rs9630182	T	C	21	40	33	24	50	20	0.44	0.52	0.56	0.48	T	0.11	0.007256236	Bone mineral density	General health
rs763318	G	A	26	54	14	21	48	25	0.56	0.48	0.44	0.52	A	0.021	0.007256236	Height	General health
rs12027135	A	T	30	45	19	12	65	17	0.56	0.47	0.44	0.53	A	1.22	0.007250481	Cholesterol, total	General health
rs4648356	C	A	31	43	20	16	57	21	0.56	0.47	0.44	0.53	C	1.14	0.007250481	Multiple sclerosis	Brain health and disorders
rs13277237	G	A	15	53	26	22	55	17	0.44	0.53	0.56	0.47	G	1.0555866	0.007250481	Inflammatory bowel disease	Immune diseases and disorders
rs7775554	A	C	20	43	31	25	49	20	0.44	0.53	0.56	0.47	A	0.019	0.007250481	Blood metabolite levels	Heart health and disorders
rs10917468	T	C	26	52	16	23	42	29	0.55	0.47	0.45	0.53	C	1.52	0.007246377	Thyroid volume	General health
rs4557202	G	C	19	49	26	22	59	13	0.46	0.55	0.54	0.45	C	4.21	0.007243916	Menarche age at onset	Reproductive health
rs7125940	G	T	27	47	20	18	49	27	0.54	0.45	0.46	0.55	T	1.9	0.007243916	Emphysema imaging phenotypes	Pulmonology
rs997295	G	T	26	49	19	14	57	23	0.54	0.45	0.46	0.55	T	0.033	0.007243916	Motion sickness	Misc
rs3001723	G	A	28	46	20	17	52	25	0.54	0.46	0.46	0.54	A	1.07	0.007243096	Schizophrenia	Brain health and disorders
rs12413361	G	T	16	54	24	28	46	20	0.46	0.54	0.54	0.46	T	0.02	0.007243096	Height	General health
rs73132886	A	C	88	6	0	82	11	1	0.97	0.93	0.03	0.07	C	34.08	0.007223942	Diisocyanate-induced asthma	Pulmonology
rs9596863	T	G	82	11	1	88	6	0	0.93	0.97	0.07	0.03	G	15.2	0.007223942	Epilepsy and lamotrigine-induced maculopapular eruptions	Brain health and disorders
rs1479279	A	G	88	6	0	83	9	2	0.97	0.93	0.03	0.07	G	5	0.007223942	Diisocyanate-induced asthma	Pulmonology
rs9282641	G	A	81	13	0	89	4	1	0.93	0.97	0.07	0.03	G	1.21	0.007223942	Multiple sclerosis	Brain health and disorders
rs12826178	G	T	83	9	2	88	6	0	0.93	0.97	0.07	0.03	G	1.1820331	0.007223942	Schizophrenia	Brain health and disorders
rs11212364	A	G	82	11	1	88	6	0	0.93	0.97	0.07	0.03	A	0.26	0.007223942	Information processing speed	Mental aptitude and behavioural traits
rs140244541	G	A	81	13	0	88	6	0	0.93	0.97	0.07	0.03	G	0.05	0.007223942	LDL cholesterol	General health
rs579342	G	A	82	11	1	88	6	0	0.93	0.97	0.07	0.03	A	0.03	0.007223942	Obesity-related traits	Obesity
rs13398147	C	T	61	28	5	69	24	1	0.80	0.86	0.20	0.14	T	1.28	0.007211538	Adolescent idiopathic scoliosis	Obesity
rs17231506	C	T	61	28	5	69	24	1	0.80	0.86	0.20	0.14	T	0.243	0.007211538	HDL cholesterol	General health
rs1799884	C	T	60	30	4	71	20	3	0.80	0.86	0.20	0.14	A	0.208	0.007211538	Glycemic traits	General health
rs2072114	A	G	60	30	4	70	22	2	0.80	0.86	0.20	0.14	A	0.0037	0.007211538	Trans fatty acid levels	General health
rs76096589	C	T	93	1	0	89	5	0	0.99	0.97	0.01	0.03	A	5.83	0.007207207	Diisocyanate-induced asthma	Pulmonology
rs7750641	C	T	89	5	0	93	1	0	0.97	0.99	0.03	0.01	T	3.35	0.007207207	Idiopathic membranous nephropathy	Brain health and disorders
rs12638540	A	G	90	3	1	93	1	0	0.97	0.99	0.03	0.01	G	1.53	0.007207207	Mortality in heart failure	Heart health and disorders
rs9607791	G	A	89	5	0	93	1	0	0.97	0.99	0.03	0.01	A	1.17	0.007207207	Schizophrenia	Brain health and disorders
rs11025185	G	A	89	5	0	93	1	0	0.97	0.99	0.03	0.01	A	1.15	0.007207207	Hepatitis	Immune diseases and disorders
rs2241437	T	G	89	5	0	93	1	0	0.97	0.99	0.03	0.01	C	1	0.007207207	Response to methylphenidate treatment in attention-deficit_hyperactivity disorder blood pressure	Drug response
rs112295236	C	G	89	5	0	93	1	0	0.97	0.99	0.03	0.01	G	0.255	0.007207207	Sex hormone levels	Reproductive health
rs681524	T	C	89	5	0	93	1	0	0.97	0.99	0.03	0.01	C	0.2439	0.007207207	Hearing function	General health
rs11705126	G	C	89	5	0	93	1	0	0.97	0.99	0.03	0.01	C	0.236	0.007207207	Urate levels in obese individuals	Obesity
rs62471956	G	A	89	5	0	93	1	0	0.97	0.99	0.03	0.01	G	0.211	0.007207207	Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	General health
rs73082373	T	G	89	5	0	93	1	0	0.97	0.99	0.03	0.01	T	0.126	0.007207207	Periodontitis Mean PAL	Misc
rs112125027	A	G	89	5	0	93	1	0	0.97	0.99	0.03	0.01	A	0.1042	0.007207207	Periodontitis Mean PAL	Misc
rs146109287	T	C	93	1	0	89	5	0	0.99	0.97	0.01	0.03	C	0.1	0.007207207	Age-related nuclear cataracts	Aging
rs17233066	C	T	89	5	0	93	1	0	0.97	0.99	0.03	0.01	C	0.09	0.007207207	Menarche age at onset	Reproductive health
rs1154988	T	A	5	23	66	3	40	51	0.18	0.24	0.82	0.76	A	0.01	0.00720283	Fibrinogen	General health
rs3823355	C	T	52	38	4	63	29	2	0.76	0.82	0.24	0.18	T	1.5	0.00720283	Vitiligo	Immune diseases and disorders
rs404860	T	C	66	23	5	53	36	5	0.82	0.76	0.18	0.24	A	1.21	0.00720283	Asthma	Immune diseases and disorders
rs10180522	A	C	57	28	9	63	29	2	0.76	0.82	0.24	0.18	A	1	0.00720283	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs2698530	A	C	46	40	8	56	34	4	0.70	0.78	0.30	0.22	C	28.75	0.007194245	Iron status biomarkers	General health
rs2606618	T	G	59	28	7	46	40	8	0.78	0.70	0.22	0.30	T	1.6	0.007194245	Allergic rhinitis in non-asthmatics	Immune diseases and disorders
rs8045253	T	C	48	36	10	57	32	5	0.70	0.78	0.30	0.22	C	1.19	0.007194245	Hypospadias	Misc
rs12243326	T	C	55	36	3	45	42	7	0.78	0.70	0.22	0.30	C	0.08	0.007194245	Two-hour glucose challenge	Diabetes
rs3890324	C	A	58	30	6	48	36	10	0.78	0.70	0.22	0.30	C	0.06	0.007194245	Age-related nuclear cataracts	Aging
rs6755560	T	C	34	50	10	46	41	7	0.63	0.71	0.37	0.29	T	1	0.007171315	QT interval interaction	Heart health and disorders
rs11977526	G	A	38	42	14	45	43	6	0.63	0.71	0.37	0.29	A	1	0.007171315	Insulin-like growth factors	General health
rs4787008	A	G	1	19	74	0	12	82	0.11	0.06	0.89	0.94	G	1.47	0.007156109	Diabetic retinopathy	Diabetes
rs9664222	A	C	0	21	73	0	12	82	0.11	0.06	0.89	0.94	C	1.22	0.007156109	Longevity	Aging
rs3017493	G	A	2	8	84	1	19	74	0.06	0.11	0.94	0.89	G	0.2563	0.007156109	Renal transplant outcome	Misc
rs17011371	A	G	82	12	0	73	21	0	0.94	0.89	0.06	0.11	A	2.09	0.007156109	Periodontitis PAL4Q3	Misc
rs11625461	C	T	82	12	0	74	19	1	0.94	0.89	0.06	0.11	C	1.5	0.007156109	Chronic obstructive pulmonary disease	Immune diseases and disorders
rs12296850	A	G	82	12	0	73	21	0	0.94	0.89	0.06	0.11	A	1.28	0.007156109	Squamous cell carcinoma	Cancer
rs1923539	G	A	75	17	2	82	12	0	0.89	0.94	0.11	0.06	A	1	0.007156109	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs16926789	A	G	82	12	0	74	19	1	0.94	0.89	0.06	0.11	A	0.05099356	0.007156109	LDL peak particle diameter total fat intake interaction	General health
rs2970818	T	A	83	10	1	73	21	0	0.94	0.89	0.06	0.11	A	0.05	0.007156109	Phosphorus levels	General health
rs10152591	A	C	82	12	0	73	21	0	0.94	0.89	0.06	0.11	A	0.041	0.007156109	Height	General health
rs744738	G	A	82	12	0	74	19	1	0.94	0.89	0.06	0.11	A	0.03	0.007156109	Obesity-related traits	Obesity
rs4242384	C	A	0	16	78	5	16	73	0.09	0.14	0.91	0.86	C	1.88	0.0071286	Prostate cancer	Cancer
rs8021963	C	T	1	14	79	1	24	69	0.09	0.14	0.91	0.86	C	0.3002	0.0071286	Metabolite levels HVA_MHPG ratio	Brain health and disorders
rs6005807	T	C	1	14	79	2	22	70	0.09	0.14	0.91	0.86	T	0.1975	0.0071286	Cerebrospinal T-tau levels	Brain health and disorders
rs7913069	C	T	80	12	2	71	20	3	0.91	0.86	0.09	0.14	A	1.47	0.0071286	Uterine fibroids	Cancer
rs73405966	T	G	68	26	0	78	16	0	0.86	0.91	0.14	0.09	T	1.06	0.0071286	Schizophrenia	Brain health and disorders
rs2924679	G	A	79	14	1	69	24	1	0.91	0.86	0.09	0.14	A	0.03	0.0071286	Obesity-related traits	Obesity
rs4799964	T	G	85	8	1	90	4	0	0.95	0.98	0.05	0.02	G	1.267	0.007103394	Refractive astigmatism	General health
rs11982256	T	A	90	4	0	84	10	0	0.98	0.95	0.02	0.05	T	1.1627907	0.007103394	Schizophrenia	Brain health and disorders
rs9488238	A	G	90	4	0	85	8	1	0.98	0.95	0.02	0.05	A	0.28	0.007103394	Disc degeneration lumbar	Aging
rs78192384	G	A	90	4	0	84	10	0	0.98	0.95	0.02	0.05	A	0.27	0.007103394	Symmetrical dimethylarginine levels	General health
rs17011478	C	T	90	4	0	84	10	0	0.98	0.95	0.02	0.05	A	0.04	0.007103394	Obesity-related traits	Obesity
rs75825892	C	T	84	10	0	90	4	0	0.95	0.98	0.05	0.02	A	0.03	0.007103394	Obesity-related traits	Obesity
rs17148926	A	C	56	33	5	44	43	7	0.77	0.70	0.23	0.30	A	1	0.007101449	White matter hyperintensity burden	Brain health and disorders
rs11859036	C	A	51	29	14	55	35	4	0.70	0.77	0.30	0.23	A	0.128	0.007101449	Corneal astigmatism	General health
rs131794	A	C	3	37	54	10	37	47	0.23	0.30	0.77	0.70	A	0.015	0.007101449	Blood metabolite levels	Heart health and disorders
rs7078209	T	G	53	35	6	63	28	3	0.75	0.82	0.25	0.18	G	0.2812	0.007072609	Lewy body disease	Brain health and disorders
rs11163372	C	T	63	28	3	52	37	5	0.82	0.75	0.18	0.25	T	0.19	0.007072609	Temperament	Mental aptitude and behavioural traits
rs16891867	A	G	54	33	7	64	26	4	0.75	0.82	0.25	0.18	G	0.15	0.007072609	Conduct disorder symptom count	Brain health and disorders
rs17359493	A	G	74	19	1	65	26	3	0.89	0.83	0.11	0.17	G	1.13	0.00706817	Type 2 diabetes	Diabetes
rs11082098	C	A	66	24	4	73	21	0	0.83	0.89	0.17	0.11	A	1.032	0.00706817	Pit-and-Fissure caries	Misc
rs11651000	G	A	64	28	2	75	17	2	0.83	0.89	0.17	0.11	G	0.1911	0.00706817	IgG glycosylation	Immune diseases and disorders
rs3130931	T	C	3	33	58	1	25	68	0.21	0.14	0.79	0.86	C	1.54	0.007038123	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis SJS_TEN	Drug response
rs11129795	G	A	60	29	5	69	23	2	0.79	0.86	0.21	0.14	G	8.24	0.007038123	Electrocardiographic traits	Heart health and disorders
rs1460676	T	C	67	27	0	58	33	3	0.86	0.79	0.14	0.21	C	0.021	0.007038123	Body mass index	Obesity
rs17685410	G	A	59	31	4	68	25	1	0.79	0.86	0.21	0.14	A	0.018	0.007038123	Toenail selenium levels	Misc
rs41549217	G	T	78	15	1	85	9	0	0.91	0.95	0.09	0.05	T	4.6582	0.007032967	Clozapine-induced agranulocytosis	General health
rs757978	C	T	77	17	0	85	9	0	0.91	0.95	0.09	0.05	T	1.46	0.007032967	Chronic lymphocytic leukemia	Cancer
rs12613372	C	G	78	15	1	85	9	0	0.91	0.95	0.09	0.05	G	1.24	0.007032967	Type 2 diabetes	Diabetes
rs7001413	G	T	85	9	0	79	13	2	0.95	0.91	0.05	0.09	T	0.63	0.007032967	Carotid plaque burden smoking interaction	Heart health and disorders
rs1951681	G	A	85	9	0	79	13	2	0.95	0.91	0.05	0.09	G	0.194	0.007032967	Economic and political preferences environmentalism	Mental aptitude and behavioural traits
rs12921383	T	C	85	9	0	77	17	0	0.95	0.91	0.05	0.09	T	0.09	0.007032967	Homocysteine levels	Misc
rs16918254	A	G	79	13	2	85	9	0	0.91	0.95	0.09	0.05	A	0.05	0.007032967	Menarche age at onset	Reproductive health
rs1055144	C	T	78	15	1	86	7	1	0.91	0.95	0.09	0.05	T	0.04	0.007032967	Waist-hip ratio	General health
rs11890236	T	C	85	9	0	78	15	1	0.95	0.91	0.05	0.09	G	0.02	0.007032967	Obesity-related traits	Obesity
rs7763262	T	C	6	32	56	11	36	47	0.23	0.31	0.77	0.69	C	1.49	0.007013024	IgA nephropathy	Immune diseases and disorders
rs12316797	T	G	55	34	5	44	42	8	0.77	0.69	0.23	0.31	G	1	0.007013024	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs553169	T	C	10	38	46	12	49	33	0.31	0.39	0.69	0.61	A	1	0.007010438	Age-related macular degeneration smoking status interaction	Aging
rs9316505	G	A	15	43	36	6	46	42	0.39	0.31	0.61	0.69	A	0.133	0.007010438	Primary tooth development number of teeth	Misc
rs9296249	T	C	48	34	12	33	49	12	0.69	0.61	0.31	0.39	T	1.67	0.007010438	Restless legs syndrome	Mental aptitude and behavioural traits
rs7192	T	G	8	43	43	18	38	38	0.31	0.39	0.69	0.61	T	1.29	0.006961849	Non-obstructive azoospermia	Reproductive health
rs1208	G	A	17	40	37	6	47	41	0.39	0.31	0.61	0.69	A	1	0.006961849	Insulin resistance_response	Drug response
rs2227139	G	A	8	43	43	18	38	38	0.31	0.39	0.69	0.61	G	0.02	0.006961849	Hematological parameters	Heart health and disorders
rs10512472	T	C	52	36	6	62	29	3	0.74	0.81	0.26	0.19	C	3.636	0.006949299	Platelet count	Heart health and disorders
rs1668871	T	C	50	40	4	63	27	4	0.74	0.81	0.26	0.19	C	2.804	0.006949299	Platelet count	Heart health and disorders
rs17152411	A	G	62	29	3	53	34	7	0.81	0.74	0.19	0.26	A	0.019	0.006949299	Height	General health
rs11239550	A	G	46	37	11	53	37	4	0.69	0.76	0.31	0.24	G	1	0.006928733	Mean corpuscular volume	Heart health and disorders
rs2180341	G	A	6	33	55	8	43	43	0.24	0.31	0.76	0.69	G	1.41	0.006928733	Breast cancer	Cancer
rs943072	G	T	3	39	52	8	43	43	0.24	0.31	0.76	0.69	G	1.15	0.006928733	Ulcerative colitis	Immune diseases and disorders
rs739496	A	G	45	38	11	37	39	18	0.68	0.60	0.32	0.40	A	8.25	0.006915629	Platelet count	Heart health and disorders
rs9354654	C	T	11	38	45	12	51	31	0.32	0.40	0.68	0.60	C	1.67	0.006915629	Classic bladder exstrophy	Misc
rs4948496	T	C	12	51	31	8	44	42	0.40	0.32	0.60	0.68	C	1.1765	0.006915629	Systemic lupus erythematosus	Immune diseases and disorders
rs8523	G	A	14	47	33	7	46	41	0.40	0.32	0.60	0.68	A	0.115	0.006915629	Red blood cell fatty acid levels	Immune diseases and disorders
rs724577	A	C	8	44	42	13	49	32	0.32	0.40	0.68	0.60	C	0.042	0.006915629	Birth weight	Misc
rs7762018	C	A	66	28	0	58	32	4	0.85	0.79	0.15	0.21	A	3.65	0.006875477	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs210138	A	G	61	26	7	67	26	1	0.79	0.85	0.21	0.15	G	1.62	0.006875477	Testicular germ cell tumor	Cancer
rs4639966	T	C	56	36	2	69	22	3	0.79	0.85	0.21	0.15	G	1.29	0.006875477	Systemic lupus erythematosus	Immune diseases and disorders
rs6782380	C	G	71	18	5	57	34	3	0.85	0.79	0.15	0.21	C	0.18	0.006875477	Coronary artery calcification	Heart health and disorders
rs3824756	T	C	67	26	1	60	28	6	0.85	0.79	0.15	0.21	C	0.025	0.006875477	Body mass index	Obesity
rs9879311	C	T	11	39	44	16	44	34	0.32	0.40	0.68	0.60	T	1.05	0.006871698	Schizophrenia	Brain health and disorders
rs2727261	T	C	9	43	42	13	50	31	0.32	0.40	0.68	0.60	T	0.159	0.006871698	Estradiol levels	General health
rs1351394	T	C	8	45	41	15	46	33	0.32	0.40	0.68	0.60	T	0.044	0.006871698	Birth length	Misc
rs4733789	C	T	10	41	43	12	52	30	0.32	0.40	0.68	0.60	T	0.025	0.006871698	Height	General health
rs3810046	G	T	34	44	16	42	43	9	0.60	0.68	0.40	0.32	T	1	0.006871698	Response to citalopram treatment	General health
rs11787341	G	A	64	27	3	72	22	0	0.82	0.88	0.18	0.12	A	1	0.006853583	Telomere length	Aging
rs12853515	C	G	72	22	0	61	33	0	0.88	0.82	0.12	0.18	G	1	0.006853583	Fasting insulin interaction	General health
rs11635085	T	G	66	23	5	73	20	1	0.82	0.88	0.18	0.12	G	0.3	0.006853583	Food antigen IgG levels	Immune diseases and disorders
rs1526687	T	G	62	31	1	72	22	0	0.82	0.88	0.18	0.12	T	0.04	0.006853583	Cardiac Troponin-T levels	Heart health and disorders
rs2953145	G	C	0	22	72	3	27	64	0.12	0.18	0.88	0.82	C	1.84	0.006853583	Bipolar disorder	Brain health and disorders
rs12029454	G	A	54	34	6	39	50	5	0.76	0.68	0.24	0.32	A	2.98	0.006848358	QT interval	Heart health and disorders
rs1439287	G	A	55	32	7	44	40	10	0.76	0.68	0.24	0.32	A	1.37	0.006848358	Chronic lymphocytic leukemia	Cancer
rs2823286	G	A	50	42	2	41	46	7	0.76	0.68	0.24	0.32	A	1.1480856	0.006848358	Crohn's disease	Digestive system and its disorders
rs9456307	T	A	78	15	1	67	27	0	0.91	0.86	0.09	0.14	A	0.048	0.006845564	Height	General health
rs975210	G	A	78	15	1	70	21	3	0.91	0.86	0.09	0.14	A	0.035	0.006845564	Height	General health
rs12623360	T	C	77	17	0	68	25	1	0.91	0.86	0.09	0.14	C	0.024764845	0.006845564	Urate levels BMI interaction	Obesity
rs12599426	T	C	71	19	4	77	17	0	0.86	0.91	0.14	0.09	T	0.0243	0.006845564	Palmitoleic acid 16:1n-7 plasma levels	General health
rs1850744	T	C	2	23	69	0	17	77	0.14	0.09	0.86	0.91	T	0.305	0.006845564	Economic and political preferences	Mental aptitude and behavioural traits
rs9603616	C	T	51	37	6	58	36	0	0.74	0.81	0.26	0.19	C	1.11	0.006832424	Rheumatoid arthritis	Immune diseases and disorders
rs4014195	C	G	51	37	6	59	34	1	0.74	0.81	0.26	0.19	G	0.01	0.006832424	Chronic kidney disease	Immune diseases and disorders
rs1412444	C	T	41	44	9	33	45	16	0.67	0.59	0.33	0.41	T	1.07	0.006829979	Coronary artery disease	Heart health and disorders
rs4810796	G	A	31	49	14	40	46	8	0.59	0.67	0.41	0.33	A	1	0.006829979	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs10520528	T	G	18	42	34	11	41	42	0.41	0.34	0.59	0.66	T	1.3	0.006790403	Systolic blood pressure in sickle cell anemia	Heart health and disorders
rs11802770	T	C	15	48	31	10	43	41	0.41	0.34	0.59	0.66	T	0.01	0.006790403	Waist-to-hip circumference ratio interaction	General health
rs281868	G	A	28	54	12	44	37	13	0.59	0.66	0.41	0.34	G	6.3	0.006790403	Resting heart rate	General health
rs2647050	T	C	43	39	12	34	42	18	0.66	0.59	0.34	0.41	T	1.6	0.006790403	Emphysema imaging phenotypes	Pulmonology
rs2856718	C	T	43	39	12	34	42	18	0.66	0.59	0.34	0.41	C	1.28	0.006790403	Chronic hepatitis B infection	Immune diseases and disorders
rs2303369	C	T	43	39	12	30	50	14	0.66	0.59	0.34	0.41	T	0.175	0.006790403	Menopause age at onset	Reproductive health
rs76833157	T	G	81	13	0	74	18	2	0.93	0.88	0.07	0.12	C	6.67	0.006786762	Diisocyanate-induced asthma	Pulmonology
rs11059635	C	T	81	13	0	74	18	2	0.93	0.88	0.07	0.12	G	6.63	0.006786762	Adverse response to chemotherapy in breast cancer alopecia paclitaxel	General health
rs741627	G	A	73	20	1	81	13	0	0.88	0.93	0.12	0.07	G	0.1012	0.006786762	Cerebral amyloid deposition in APOEe4 non-carriers PET imaging	Brain health and disorders
rs10775480	T	C	7	33	54	11	39	44	0.25	0.32	0.75	0.68	T	1.13	0.006771697	Bladder cancer	Cancer
rs2549794	C	T	9	43	42	6	35	53	0.32	0.25	0.68	0.75	C	1.05	0.006771697	Crohn's disease	Digestive system and its disorders
rs2904804	G	T	7	33	54	5	51	38	0.25	0.32	0.75	0.68	T	0.117	0.006771697	Economic and political preferences immigration_crime	Mental aptitude and behavioural traits
rs6941712	T	C	55	31	8	43	41	10	0.75	0.68	0.25	0.32	C	149.67	0.006771697	Lentiform nucleus volume	Misc
rs12443954	A	G	52	37	5	40	47	7	0.75	0.68	0.25	0.32	A	1.08	0.006771697	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs1896857	A	G	41	42	11	28	53	13	0.66	0.58	0.34	0.42	A	1.3	0.006752904	Alcohol dependence age at onset	General health
rs3762318	G	A	2	25	67	1	39	54	0.15	0.22	0.85	0.78	A	1.45	0.006722689	Leprosy	Immune diseases and disorders
rs3130542	A	G	6	29	59	2	25	67	0.22	0.15	0.78	0.85	A	1.17	0.006722689	Chronic hepatitis B infection	Immune diseases and disorders
rs4625	A	G	60	31	3	48	42	4	0.80	0.73	0.20	0.27	G	1	0.006721553	Pediatric autoimmune diseases	Immune diseases and disorders
rs1529672	C	A	51	36	7	60	31	3	0.73	0.80	0.27	0.20	C	0.048	0.006721553	Pulmonary function	Pulmonology
rs6435862	G	T	2	33	59	6	38	50	0.20	0.27	0.80	0.73	G	1.68	0.006721553	Neuroblastoma high-risk	Cancer
rs595018	T	C	6	38	50	4	29	61	0.27	0.20	0.73	0.80	A	1.46	0.006721553	Wegener's granulomatosis	General health
rs7629490	C	T	31	46	17	44	35	15	0.57	0.65	0.43	0.35	T	1.06	0.006717421	Prostate cancer	Cancer
rs17046216	T	A	50	40	4	43	40	11	0.74	0.67	0.26	0.33	A	0.19	0.006698565	Insulin-related traits	Diabetes
rs6693388	T	C	53	34	7	44	38	12	0.74	0.67	0.26	0.33	T	0.041	0.006698565	Blood metabolite ratios	Heart health and disorders
rs878131	A	G	8	46	40	4	40	50	0.33	0.26	0.67	0.74	A	17.21	0.006698565	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs10078	G	T	6	50	38	9	30	55	0.33	0.26	0.67	0.74	C	1	0.006698565	Fat distribution HIV	General health
rs62314947	T	C	9	44	41	6	36	52	0.33	0.26	0.67	0.74	T	0.101	0.006698565	Breast size	General health
rs7595037	C	T	10	46	38	20	41	33	0.35	0.43	0.65	0.57	A	1.11	0.006683896	Multiple sclerosis	Brain health and disorders
rs10791821	G	A	64	26	4	72	21	1	0.82	0.88	0.18	0.12	G	1.57	0.006654567	Gout	General health
rs3815148	A	C	72	21	1	63	28	3	0.88	0.82	0.12	0.18	C	1.14	0.006654567	Osteoarthritis	Immune diseases and disorders
rs10159477	G	A	72	21	1	65	24	5	0.88	0.82	0.12	0.18	A	0.087	0.006654567	Red blood cell traits	Immune diseases and disorders
rs3783890	T	C	63	28	3	73	19	2	0.82	0.88	0.18	0.12	T	0.023	0.006654567	Body mass index	Obesity
rs6601299	T	C	2	19	73	2	30	62	0.12	0.18	0.88	0.82	T	0.1407	0.006654567	HDL cholesterol	General health
rs1461729	A	G	2	19	73	2	30	62	0.12	0.18	0.88	0.82	T	0.0355	0.006654567	HDL cholesterol	General health
rs301799	C	T	18	46	30	12	43	39	0.44	0.36	0.56	0.64	C	1.11	0.006652278	Thyroid peroxidase antibody positivity	Immune diseases and disorders
rs8041863	T	A	12	43	39	15	52	27	0.36	0.44	0.64	0.56	A	0.04	0.006652278	Height	General health
rs7176508	A	G	8	47	39	4	41	49	0.34	0.26	0.66	0.74	A	1.42	0.006628788	Chronic lymphocytic leukemia	Cancer
rs9374080	T	C	42	41	11	52	35	7	0.66	0.74	0.34	0.26	C	1	0.006628788	Mean corpuscular volume	Heart health and disorders
rs1171606	G	A	42	41	11	52	35	7	0.66	0.74	0.34	0.26	A	0.0497	0.006628788	Acylcarnitine levels	General health
rs7565310	A	G	29	47	18	36	48	10	0.56	0.64	0.44	0.36	A	1.53	0.006622517	Yu-Zhi constitution type in type 2 diabetes	Diabetes
rs10776614	T	C	5	41	48	3	32	59	0.27	0.20	0.73	0.80	T	1	0.006616294	Self-employment	Mental aptitude and behavioural traits
rs2678379	A	G	3	32	59	4	43	47	0.20	0.27	0.80	0.73	A	0.065	0.006616294	HDL cholesterol	General health
rs13325751	C	T	57	36	1	48	41	5	0.80	0.73	0.20	0.27	T	0.132	0.006616294	Economic and political preferences environmentalism	Mental aptitude and behavioural traits
rs6754295	T	G	59	32	3	51	35	8	0.80	0.73	0.20	0.27	C	0.07	0.006616294	HDL cholesterol	General health
rs9502893	C	T	37	45	12	30	44	20	0.63	0.55	0.37	0.45	G	1.29	0.006594566	Pancreatic cancer	Cancer
rs117526668	C	T	76	18	0	69	22	3	0.90	0.85	0.10	0.15	T	3.19	0.006587615	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs902774	G	A	67	26	1	77	16	1	0.85	0.90	0.15	0.10	A	1.17	0.006587615	Prostate cancer	Cancer
rs2647528	G	A	67	24	3	57	32	5	0.84	0.78	0.16	0.22	C	0.59	0.006578947	&beta;2-Glycoprotein I &beta;2-GPI plasma levels	Immune diseases and disorders
rs17111396	T	A	67	24	3	53	40	1	0.84	0.78	0.16	0.22	A	0.192	0.006578947	Uric acid levels	General health
rs768606	T	A	87	7	0	80	14	0	0.96	0.93	0.04	0.07	A	1.62	0.00657277	Stroke	Brain health and disorders
rs13432159	T	G	87	7	0	80	14	0	0.96	0.93	0.04	0.07	G	1	0.00657277	Response to anti-depressant treatment in major depressive disorder	General health
rs4752066	G	T	87	7	0	81	12	1	0.96	0.93	0.04	0.07	T	0.3	0.00657277	Pulmonary function in asthmatics	Pulmonology
rs72663955	T	G	81	12	1	87	7	0	0.93	0.96	0.07	0.04	G	0.2246	0.00657277	Metabolite levels HVA-5-HIAA Factor score	General health
rs16844401	G	A	80	14	0	87	7	0	0.93	0.96	0.07	0.04	A	0.015	0.00657277	Fibrinogen	General health
rs210359	A	C	0	14	80	0	7	87	0.07	0.04	0.93	0.96	A	1	0.00657277	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs813379	G	A	0	14	80	0	7	87	0.07	0.04	0.93	0.96	G	0.1	0.00657277	Serum thyroid-stimulating hormone levels	General health
rs4901847	C	T	31	41	22	36	46	12	0.55	0.63	0.45	0.37	T	1.48	0.006568384	Lupus nephritis in systemic lupus erythematosus	Immune diseases and disorders
rs4074493	C	T	38	42	14	31	41	22	0.63	0.55	0.37	0.45	C	0.36	0.006568384	Carotid plaque burden smoking interaction	Heart health and disorders
rs11082671	A	G	18	34	42	21	43	30	0.37	0.45	0.63	0.55	G	0.107	0.006568384	Height	General health
rs140068132	A	G	76	18	0	84	10	0	0.90	0.95	0.10	0.05	A	1.67	0.006568144	Breast cancer	Cancer
rs11216185	T	G	84	10	0	76	18	0	0.95	0.90	0.05	0.10	G	1.57	0.006568144	Infantile hypertrophic pyloric stenosis	Misc
rs6731302	A	G	24	38	32	17	37	40	0.46	0.38	0.54	0.62	A	1.04	0.006543932	Obesity	Obesity
rs11105468	T	A	60	29	5	44	48	2	0.79	0.72	0.21	0.28	A	1.28	0.006516291	Febrile seizures MMR vaccine-related	General health
rs16826658	T	G	51	34	9	61	27	6	0.72	0.79	0.28	0.21	G	1.2	0.006516291	Endometriosis	General health
rs7528419	A	G	60	29	5	46	44	4	0.79	0.72	0.21	0.28	A	1.11	0.006516291	Myocardial infarction	Heart health and disorders
rs673548	G	A	59	31	4	47	42	5	0.79	0.72	0.21	0.28	G	0.11	0.006516291	Metabolic syndrome	Immune diseases and disorders
rs4640244	A	G	47	42	5	57	35	2	0.72	0.79	0.28	0.21	A	0.024	0.006516291	Height	General health
rs4654899	C	A	29	42	23	35	45	14	0.53	0.61	0.47	0.39	A	969.5	0.006500072	Superior frontal gyrus grey matter volume	Misc
rs1367448	G	A	36	43	15	18	64	12	0.61	0.53	0.39	0.47	C	1.554	0.006500072	Adverse response to chemotherapy neutropenia_leucopenia all anthracycline-based drugs	Drug response
rs1632744	T	C	27	46	21	34	47	13	0.53	0.61	0.47	0.39	T	1.387	0.006500072	Adverse response to chemotherapy neutropenia_leucopenia all topoisomerase inhibitors	Drug response
rs9310732	G	A	37	41	16	26	48	20	0.61	0.53	0.39	0.47	A	1.05	0.006500072	Schizophrenia	Brain health and disorders
rs6947964	T	G	22	44	28	13	47	34	0.47	0.39	0.53	0.61	T	0.034	0.006500072	Heschl's gyrus morphology	Brain health and disorders
rs2204037	A	G	4	43	47	11	43	40	0.27	0.35	0.73	0.65	A	1.38	0.006498674	QT interval	Heart health and disorders
rs3798869	G	A	36	51	7	52	33	9	0.65	0.73	0.35	0.27	G	1.0638298	0.006498674	Schizophrenia	Brain health and disorders
rs2952768	T	C	37	49	8	48	41	5	0.65	0.73	0.35	0.27	C	0.2932	0.006498674	Opioid sensitivity	General health
rs4132509	C	A	50	37	7	39	45	10	0.73	0.65	0.27	0.35	A	0.18	0.006498674	RR interval heart rate	Heart health and disorders
rs2910490	T	C	22	45	27	11	52	31	0.47	0.39	0.53	0.61	C	1.49	0.006480601	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs11162963	C	T	15	44	35	22	45	27	0.39	0.47	0.61	0.53	T	1.09	0.006480601	Aging time to event	Aging
rs10484561	T	G	62	29	3	70	24	0	0.81	0.87	0.19	0.13	G	1.95	0.00646955	Follicular lymphoma	Cancer
rs2651244	G	A	61	31	2	70	24	0	0.81	0.87	0.19	0.13	G	1.063159	0.00646955	Ulcerative colitis	Immune diseases and disorders
rs3596	A	G	21	48	25	14	47	33	0.48	0.40	0.52	0.60	G	1.17	0.006462732	Endometriosis	General health
rs909848	T	C	23	44	27	15	45	34	0.48	0.40	0.52	0.60	C	0.1434	0.006462732	IgG glycosylation	Immune diseases and disorders
rs1533665	G	A	22	46	26	14	47	33	0.48	0.40	0.52	0.60	G	0.1	0.006462732	Personality dimensions	Brain health and disorders
rs6430553	C	T	20	50	24	16	43	35	0.48	0.40	0.52	0.60	T	0.018	0.006462732	Blood metabolite levels	Heart health and disorders
rs10865331	A	G	20	36	38	22	47	25	0.40	0.48	0.60	0.52	A	1	0.006446437	Ankylosing spondylitis	Immune diseases and disorders
rs1861050	C	T	55	35	4	66	25	3	0.77	0.84	0.23	0.16	T	1.63	0.00644353	Conduct disorder	Brain health and disorders
rs2413583	C	T	67	23	4	55	35	4	0.84	0.77	0.16	0.23	C	1.23	0.00644353	Crohn's disease	Digestive system and its disorders
rs10821905	G	A	64	29	1	56	33	5	0.84	0.77	0.16	0.23	A	0.057	0.00644353	Urate levels	General health
rs9648428	C	T	65	27	2	55	35	4	0.84	0.77	0.16	0.23	A	0.03	0.00644353	Obesity-related traits	Obesity
rs1345301	A	G	37	48	9	48	40	6	0.65	0.72	0.35	0.28	A	0.08	0.00643805	Waist circumference	General health
rs9467160	G	A	52	32	10	38	46	10	0.72	0.65	0.28	0.35	A	0.03	0.00643805	Liver enzyme levels	General health
rs7504990	T	C	14	38	42	9	34	51	0.35	0.28	0.65	0.72	A	6.95	0.00643805	Gallbladder cancer	Cancer
rs7453498	T	C	12	28	54	8	50	36	0.28	0.35	0.72	0.65	C	0.8142	0.00643805	Dementia and core Alzheimer's disease neuropathologic changes	Brain health and disorders
rs980238	C	A	6	40	48	11	44	39	0.28	0.35	0.72	0.65	A	0.1	0.00643805	Disc degeneration lumbar	Aging
rs1400974	G	A	14	38	42	3	46	45	0.35	0.28	0.65	0.72	A	0.05	0.00643805	Menarche age at onset	Reproductive health
rs2285947	G	A	26	44	24	36	39	19	0.51	0.59	0.49	0.41	A	1.17	0.006431695	Multiple cancers lung cancer, gastric cancer, and squamous cell carcinoma	Cancer
rs1546939	C	T	34	43	17	25	46	23	0.59	0.51	0.41	0.49	T	1	0.006431695	Mammographic density non-dense area	Reproductive health
rs4937076	G	A	27	42	25	35	41	18	0.51	0.59	0.49	0.41	A	0.15	0.006431695	Primary tooth development time to first tooth eruption	Misc
rs1680005	A	G	15	47	32	19	54	21	0.41	0.49	0.59	0.51	A	1.18	0.006431695	Bipolar disorder with mood-incongruent psychosis	Brain health and disorders
rs1569175	T	C	10	33	51	4	32	58	0.28	0.21	0.72	0.79	T	2.73	0.006421217	Response to treatment for acute lymphoblastic leukemia	General health
rs227163	C	T	6	41	47	5	30	59	0.28	0.21	0.72	0.79	C	1.11	0.006421217	Rheumatoid arthritis	Immune diseases and disorders
rs7173947	C	T	20	38	36	23	47	24	0.41	0.49	0.59	0.51	C	0.105	0.006418485	Hematological and biochemical traits	Heart health and disorders
rs7190997	T	C	32	46	16	19	57	18	0.59	0.51	0.41	0.49	C	1.223	0.006418485	IgA nephropathy	Immune diseases and disorders
rs264537	C	G	32	45	17	22	50	22	0.58	0.50	0.42	0.50	C	1.35	0.006406788	Periodontitis PAL4Q3	Misc
rs4409764	T	G	19	41	34	25	44	25	0.42	0.50	0.58	0.50	T	1.22	0.006406788	Crohn's disease	Digestive system and its disorders
rs11724804	G	A	26	42	26	31	47	16	0.50	0.58	0.50	0.42	A	1.22	0.006406788	Primary biliary cirrhosis	Immune diseases and disorders
rs1883460	T	A	24	46	24	30	49	15	0.50	0.58	0.50	0.42	T	1	0.006406788	Verbal declarative memory	Brain health and disorders
rs12714207	C	T	18	43	33	24	46	24	0.42	0.50	0.58	0.50	T	0.03	0.006406788	Bilirubin levels	General health
rs322662	G	A	31	47	16	25	44	25	0.58	0.50	0.42	0.50	A	0.00288	0.006406788	Calcium levels	General health
rs2964475	T	G	16	48	30	23	49	22	0.43	0.51	0.57	0.49	C	2.248	0.006396588	Adverse response to chemotherapy neutropenia_leucopenia epirubicin	Drug response
rs498154	A	G	18	44	32	23	49	22	0.43	0.51	0.57	0.49	G	1.0526316	0.006396588	Schizophrenia	Brain health and disorders
rs2154294	A	G	13	54	27	27	41	26	0.43	0.51	0.57	0.49	G	0.08	0.006396588	Alcoholism 12-month weekly alcohol consumption	General health
rs12571751	A	G	27	38	29	26	55	13	0.49	0.57	0.51	0.43	A	1.09	0.006387872	Type 2 diabetes	Diabetes
rs6811556	T	C	15	51	28	19	58	17	0.43	0.51	0.57	0.49	A	1	0.006387872	Ulcerative colitis	Immune diseases and disorders
rs7559271	G	A	25	41	28	30	46	18	0.48	0.56	0.52	0.44	G	0.388	0.006380626	Facial morphology	Appearance
rs2391388	A	C	21	40	33	24	49	21	0.44	0.52	0.56	0.48	C	0.178	0.006380626	Palmitic acid 16:0 plasma levels	General health
rs2110001	C	G	26	54	14	22	47	25	0.56	0.48	0.44	0.52	C	0.031	0.006380626	Height	General health
rs4777542	C	T	28	41	25	19	44	31	0.52	0.44	0.48	0.56	T	0.029	0.006380626	Urate levels	General health
rs1808579	C	T	21	49	24	27	52	15	0.48	0.56	0.52	0.44	C	0.022	0.006380626	Body mass index	Obesity
rs2689154	C	G	52	31	11	35	51	8	0.72	0.64	0.28	0.36	G	1.2	0.006380208	Pancreatic cancer	Cancer
rs3934007	A	G	16	35	43	10	33	51	0.36	0.28	0.64	0.72	T	1.55	0.006380208	Interferon alpha levels in systemic lupus erythematosus	Immune diseases and disorders
rs10863681	A	G	24	50	20	17	49	28	0.52	0.44	0.48	0.56	G	0.2262	0.006374841	Metabolite levels HVA-5-HIAA Factor score	General health
rs4667466	T	C	23	44	27	30	45	19	0.48	0.56	0.52	0.44	T	1.39	0.006374841	Diabetic kidney disease	Diabetes
rs10748045	A	G	28	43	23	21	42	31	0.53	0.45	0.47	0.55	G	1.78	0.006370509	Suicidal ideation in depression or bipolar disorder	Brain health and disorders
rs2271316	C	G	24	40	30	23	57	14	0.47	0.55	0.53	0.45	C	0.113	0.006367624	Blood metabolite levels	Heart health and disorders
rs1869463	A	G	30	43	21	22	44	28	0.55	0.47	0.45	0.53	A	0.0331	0.006367624	Corneal curvature	General health
rs6905288	G	A	24	37	33	27	46	21	0.45	0.53	0.55	0.47	A	0.04	0.006367624	Waist-hip ratio	General health
rs2033562	G	C	22	43	29	28	46	20	0.46	0.54	0.54	0.46	C	1.128	0.006366183	IgA nephropathy	Immune diseases and disorders
rs6427782	G	A	16	54	24	22	57	15	0.46	0.54	0.54	0.46	A	0.03	0.006366183	Menarche age at onset	Reproductive health
rs11807834	G	A	68	23	3	75	19	0	0.85	0.90	0.15	0.10	A	1.06	0.006351626	Schizophrenia	Brain health and disorders
rs16836124	T	C	75	19	0	68	23	3	0.90	0.85	0.10	0.15	G	0.03	0.006351626	Obesity-related traits	Obesity
rs979455	T	C	60	27	7	40	54	0	0.78	0.71	0.22	0.29	G	0.04	0.006330774	Obesity-related traits	Obesity
rs1061170	C	T	3	35	56	2	50	42	0.22	0.29	0.78	0.71	C	2.41	0.006330774	Age-related macular degeneration	Aging
rs7617480	A	C	4	33	57	11	32	51	0.22	0.29	0.78	0.71	A	2.4	0.006330774	Menarche age at onset	Reproductive health
rs11976180	A	C	46	42	6	35	50	9	0.71	0.64	0.29	0.36	C	0.03	0.006325029	Obesity-related traits	Obesity
rs428445	C	A	15	38	41	6	42	46	0.36	0.29	0.64	0.71	T	1.314	0.006325029	Refractive astigmatism	General health
rs7192086	T	A	2	28	64	6	32	56	0.17	0.23	0.83	0.77	T	1.12	0.006315789	Schizophrenia	Brain health and disorders
rs4819833	T	C	4	36	54	2	28	64	0.23	0.17	0.77	0.83	C	1	0.006315789	DNA methylation parent-of-origin	Misc
rs12463617	A	C	2	28	64	4	36	54	0.17	0.23	0.83	0.77	C	0.0634	0.006315789	Body mass index	Obesity
rs3814231	C	T	57	30	7	64	28	2	0.77	0.83	0.23	0.17	G	1.23	0.006315789	Vitiligo	Immune diseases and disorders
rs17040773	A	C	65	26	3	50	44	0	0.83	0.77	0.17	0.23	A	0.04	0.006315789	Bone mineral density	General health
rs2049953	C	A	1	34	59	2	21	71	0.19	0.13	0.81	0.87	C	0.26	0.006297164	Non-alcoholic fatty liver disease histology AST	Obesity
rs2238732	C	T	70	23	1	59	34	1	0.87	0.81	0.13	0.19	T	0.1815	0.006297164	Amino acid levels	Misc
rs2700987	C	A	8	39	47	10	49	35	0.29	0.37	0.71	0.63	A	1.174	0.006272401	Psoriasis	Immune diseases and disorders
rs12126655	A	G	50	33	11	36	47	11	0.71	0.63	0.29	0.37	G	0.138	0.006272401	Plasma thyroid-stimulating hormone levels	Immune diseases and disorders
rs10158897	C	T	49	35	10	37	45	12	0.71	0.63	0.29	0.37	T	0.021	0.006272401	Lipid traits	Misc
rs16964886	C	T	89	5	0	83	11	0	0.97	0.94	0.03	0.06	A	6.77	0.00625	Diisocyanate-induced asthma	Pulmonology
rs76684306	A	G	89	5	0	83	11	0	0.97	0.94	0.03	0.06	G	6.56	0.00625	Diisocyanate-induced asthma	Pulmonology
rs78538083	T	C	83	11	0	89	5	0	0.94	0.97	0.06	0.03	C	1.32	0.00625	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs2074038	G	T	85	7	2	89	5	0	0.94	0.97	0.06	0.03	T	1.136	0.00625	IgA nephropathy	Immune diseases and disorders
rs41268902	G	A	85	7	2	89	5	0	0.94	0.97	0.06	0.03	A	1.09	0.00625	Schizophrenia	Brain health and disorders
rs17228156	T	C	83	11	0	89	5	0	0.94	0.97	0.06	0.03	C	1	0.00625	Response to methylphenidate treatment in attention-deficit_hyperactivity disorder blood pressure	Drug response
rs149001306	G	A	89	5	0	83	11	0	0.97	0.94	0.03	0.06	G	0.4268	0.00625	Cerebral amyloid deposition in APOEe4 non-carriers PET imaging	Brain health and disorders
rs17666538	T	C	83	11	0	89	5	0	0.94	0.97	0.06	0.03	C	0.2848	0.00625	IgG glycosylation	Immune diseases and disorders
rs10521233	A	G	83	11	0	89	5	0	0.94	0.97	0.06	0.03	G	0.14	0.00625	Asthma childhood onset	Immune diseases and disorders
rs133047	T	C	0	11	83	0	5	89	0.06	0.03	0.94	0.97	T	1.12	0.00625	Schizophrenia	Brain health and disorders
rs2636697	G	A	0	11	83	0	5	89	0.06	0.03	0.94	0.97	G	1	0.00625	Response to antipsychotic treatment	General health
rs291671	G	A	0	11	83	0	5	89	0.06	0.03	0.94	0.97	G	0.22	0.00625	Hair color	Appearance
rs12199222	G	T	58	30	6	48	37	9	0.78	0.71	0.22	0.29	T	4.4	0.006244688	Height	General health
rs4650608	T	C	45	43	6	58	30	6	0.71	0.78	0.29	0.22	T	1.06	0.006244688	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs2766692	A	G	5	32	57	8	39	47	0.22	0.29	0.78	0.71	G	0.11	0.006244688	Electroencephalographic traits in alcoholism	Heart health and disorders
rs10495024	T	C	46	41	7	54	38	2	0.71	0.78	0.29	0.22	C	0.103	0.006244688	Testosterone levels	Reproductive health
rs116278466	G	A	91	3	0	87	6	1	0.98	0.96	0.02	0.04	A	34.08	0.00622665	Diisocyanate-induced asthma	Pulmonology
rs114280567	G	A	91	3	0	86	8	0	0.98	0.96	0.02	0.04	A	34.08	0.00622665	Diisocyanate-induced asthma	Pulmonology
rs7534824	A	G	86	8	0	91	3	0	0.96	0.98	0.04	0.02	A	2.304	0.00622665	Refractive astigmatism	General health
rs142089946	C	G	86	8	0	92	1	1	0.96	0.98	0.04	0.02	G	1.1363636	0.00622665	Schizophrenia	Brain health and disorders
rs113010081	T	C	86	8	0	91	3	0	0.96	0.98	0.04	0.02	G	1.1354866	0.00622665	Ulcerative colitis	Immune diseases and disorders
rs11725957	G	A	86	8	0	91	3	0	0.96	0.98	0.04	0.02	G	0.727	0.00622665	Response to hepatitis C treatment	General health
rs2017305	A	G	86	8	0	91	3	0	0.96	0.98	0.04	0.02	A	0.22	0.00622665	Depression quantitative trait	Brain health and disorders
rs714052	A	G	86	8	0	91	3	0	0.96	0.98	0.04	0.02	G	0.16	0.00622665	Triglycerides	General health
rs2240466	G	A	86	8	0	91	3	0	0.96	0.98	0.04	0.02	A	0.1109	0.00622665	Caffeine consumption	General health
rs13233571	C	T	86	8	0	91	3	0	0.96	0.98	0.04	0.02	C	0.054	0.00622665	C-reactive protein levels	Immune diseases and disorders
rs7577463	G	T	39	40	15	46	40	8	0.63	0.70	0.37	0.30	G	1.0638298	0.006222222	Schizophrenia	Brain health and disorders
rs1536827	C	T	3	27	64	5	35	54	0.18	0.24	0.82	0.76	C	1	0.006195147	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs6480314	G	A	5	35	54	4	25	65	0.24	0.18	0.76	0.82	A	0.244	0.006195147	Optic nerve measurement disc area	Misc
rs12942547	A	G	47	37	10	31	55	8	0.70	0.62	0.30	0.38	G	1.1087568	0.006174395	Crohn's disease	Digestive system and its disorders
rs4356975	C	T	45	41	8	28	61	5	0.70	0.62	0.30	0.38	A	0.07	0.006174395	Obesity-related traits	Obesity
rs12531478	G	A	77	15	2	83	11	0	0.90	0.94	0.10	0.06	A	2.24	0.006165703	Diabetic kidney disease	Diabetes
rs1020821	A	G	1	9	84	3	13	78	0.06	0.10	0.94	0.90	A	0.0016	0.006165703	Trans fatty acid levels	General health
rs2169143	C	G	1	9	84	3	13	78	0.06	0.10	0.94	0.90	C	0.0016	0.006165703	Trans fatty acid levels	General health
rs17183114	G	T	73	18	3	79	15	0	0.87	0.92	0.13	0.08	T	26.49	0.006162976	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs17127713	A	G	79	15	0	70	24	0	0.92	0.87	0.08	0.13	G	0.03	0.006162976	Obesity-related traits	Obesity
rs7542172	G	A	74	16	4	80	13	1	0.87	0.92	0.13	0.08	A	0.024	0.006162976	Blood metabolite levels	Heart health and disorders
rs4722551	T	C	72	20	2	80	13	1	0.87	0.92	0.13	0.08	C	0.023	0.006162976	Triglycerides	General health
rs6581612	C	A	4	35	55	7	42	45	0.23	0.30	0.77	0.70	C	63.3	0.00616271	Hippocampal volume	Brain health and disorders
rs72823592	G	A	63	25	6	69	24	1	0.80	0.86	0.20	0.14	G	1.3	0.006136214	Epilepsy generalized	Brain health and disorders
rs12779790	A	G	59	33	2	70	22	2	0.80	0.86	0.20	0.14	G	1.11	0.006136214	Type 2 diabetes	Diabetes
rs10046257	G	A	69	24	1	57	37	0	0.86	0.80	0.14	0.20	A	0.19	0.006136214	Disc degeneration lumbar	Aging
rs1488515	T	G	70	22	2	58	35	1	0.86	0.80	0.14	0.20	C	0.04	0.006136214	Obesity-related traits	Obesity
rs3733418	A	G	60	31	3	68	26	0	0.80	0.86	0.20	0.14	G	0.02	0.006136214	Obesity-related traits	Obesity
rs16966460	C	G	69	20	5	74	20	0	0.84	0.89	0.16	0.11	G	1.26	0.006134969	Bipolar disorder	Brain health and disorders
rs1374910	C	T	75	18	1	67	24	3	0.89	0.84	0.11	0.16	T	1.24	0.006134969	Type 2 diabetes	Diabetes
rs1914395	G	A	74	20	0	66	26	2	0.89	0.84	0.11	0.16	A	1.11	0.006134969	Schizophrenia	Brain health and disorders
rs117488988	A	T	69	20	5	75	18	1	0.84	0.89	0.16	0.11	A	1.08	0.006134969	Schizophrenia	Brain health and disorders
rs6019826	C	T	74	20	0	68	22	4	0.89	0.84	0.11	0.16	T	1.08	0.006134969	Schizophrenia	Brain health and disorders
rs6447650	T	C	1	28	65	0	20	74	0.16	0.11	0.84	0.89	T	0.416	0.006134969	Body mass index change over time	Obesity
rs10167079	A	G	2	16	76	1	28	65	0.11	0.16	0.89	0.84	G	0.024	0.006134969	Body mass index	Obesity
rs573666	C	T	36	44	14	46	38	10	0.62	0.69	0.38	0.31	G	1.3	0.006128831	Osteosarcoma	Cancer
rs10894239	C	A	34	48	12	46	38	10	0.62	0.69	0.38	0.31	A	0.03	0.006128831	Obesity-related traits	Obesity
rs3130573	A	G	42	45	7	38	39	17	0.69	0.61	0.31	0.39	G	1.25	0.006085445	Systemic sclerosis	Brain health and disorders
rs273913	T	C	12	33	49	0	44	50	0.30	0.23	0.70	0.77	T	0.026	0.006084608	Blood metabolite levels	Heart health and disorders
rs10857712	T	C	46	39	9	56	32	6	0.70	0.77	0.30	0.23	T	1.5129	0.006084608	Systemic lupus erythematosus	Immune diseases and disorders
rs12148477	A	G	43	45	6	53	38	3	0.70	0.77	0.30	0.23		1	0.006084608	Follicule stimulating hormone	Reproductive health
rs827382	C	T	1	32	61	4	38	52	0.18	0.24	0.82	0.76	C	1.07	0.006081081	Migraine	Brain health and disorders
rs1250229	T	C	3	28	63	2	42	50	0.18	0.24	0.82	0.76	T	0.024	0.006081081	LDL cholesterol	General health
rs6890853	G	A	53	36	5	64	26	4	0.76	0.82	0.24	0.18	G	1.47	0.006081081	Primary biliary cirrhosis	Immune diseases and disorders
rs10775360	C	T	53	36	5	62	30	2	0.76	0.82	0.24	0.18	T	0.76	0.006081081	QT interval	Heart health and disorders
rs997154	G	A	63	28	3	53	36	5	0.82	0.76	0.18	0.24	G	0.138	0.006081081	Primary tooth development time to first tooth eruption	Misc
rs4969049	T	C	63	28	3	53	36	5	0.82	0.76	0.18	0.24	C	0.004	0.006081081	Body mass index interaction	Obesity
rs11080466	A	G	36	42	16	44	40	10	0.61	0.68	0.39	0.32	C	1.47	0.006044159	Non-small cell lung cancer	Cancer
rs12635820	C	T	33	48	13	49	30	15	0.61	0.68	0.39	0.32	T	0.14	0.006044159	Glomerular filtration rate in chronic kidney disease	General health
rs1047891	C	A	42	44	8	34	46	14	0.68	0.61	0.32	0.39	A	0.027	0.006044159	HDL cholesterol	General health
rs4368253	T	C	9	42	43	12	50	32	0.32	0.39	0.68	0.61	C	1.19	0.006044159	Chronic lymphocytic leukemia	Cancer
rs337718	T	C	11	38	45	10	54	30	0.32	0.39	0.68	0.61	T	1.05	0.006044159	Schizophrenia	Brain health and disorders
rs2388436	G	A	15	44	35	11	38	45	0.39	0.32	0.61	0.68	G	0.51	0.006044159	Hoarding	Misc
rs11966200	C	T	87	6	1	79	15	0	0.96	0.92	0.04	0.08	A	1.9	0.006035226	Vitiligo	Immune diseases and disorders
rs7822239	C	A	80	13	1	86	8	0	0.92	0.96	0.08	0.04	A	1.1	0.006035226	Esophageal squamous cell carcinoma	Cancer
rs7270101	A	C	79	15	0	86	8	0	0.92	0.96	0.08	0.04	C	1	0.006035226	Chronic hepatitis C infection	Immune diseases and disorders
rs11653545	G	A	79	15	0	86	8	0	0.92	0.96	0.08	0.04	G	1	0.006035226	IgM levels	Immune diseases and disorders
rs12567355	G	A	79	15	0	86	8	0	0.92	0.96	0.08	0.04	A	0.04	0.006035226	Obesity-related traits	Obesity
rs3767633	T	A	1	13	80	0	8	86	0.08	0.04	0.92	0.96	T	0.2053	0.006035226	IgG glycosylation	Immune diseases and disorders
rs6712333	C	T	44	39	11	36	41	17	0.68	0.60	0.32	0.40	A	8.322	0.006004902	Nicotine use	General health
rs4680534	T	C	39	49	6	37	39	18	0.68	0.60	0.32	0.40	C	1.12	0.006004902	Multiple sclerosis	Brain health and disorders
rs2577720	A	C	32	49	13	45	37	12	0.60	0.68	0.40	0.32	C	0.82	0.006004902	F-cell distribution	Immune diseases and disorders
rs6065	C	T	67	27	0	61	28	5	0.86	0.80	0.14	0.20	T	4.191	0.005985654	Platelet count	Heart health and disorders
rs1016343	C	T	67	27	0	59	32	3	0.86	0.80	0.14	0.20	T	1.37	0.005985654	Prostate cancer	Cancer
rs2222328	T	C	58	34	2	69	23	2	0.80	0.86	0.20	0.14	C	0.22	0.005985654	Quantitative traits	Misc
rs13323323	G	T	60	30	4	67	27	0	0.80	0.86	0.20	0.14	G	0.1593	0.005985654	IgG glycosylation	Immune diseases and disorders
rs1562975	G	A	61	28	5	69	23	2	0.80	0.86	0.20	0.14	A	0.025	0.005985654	Height	General health
rs1861046	G	A	54	33	7	64	25	5	0.75	0.81	0.25	0.19	A	1.65	0.005973121	Conduct disorder	Brain health and disorders
rs4902243	A	G	61	31	2	52	37	5	0.81	0.75	0.19	0.25	A	0.044	0.005973121	Blood metabolite levels	Heart health and disorders
rs9314986	G	T	11	40	43	11	54	29	0.33	0.40	0.67	0.60	G	2.95	0.005967604	Biliary atresia	Digestive system and its disorders
rs3786094	T	C	31	50	13	42	42	10	0.60	0.67	0.40	0.33	C	1.531	0.005967604	Adverse response to chemotherapy neutropenia_leucopenia paclitaxel	Drug response
rs10862476	G	A	34	44	16	37	52	5	0.60	0.67	0.40	0.33	G	1.0526316	0.005967604	Schizophrenia	Brain health and disorders
rs703842	A	G	53	36	5	44	41	9	0.76	0.69	0.24	0.31	A	1.23	0.005939202	Multiple sclerosis	Brain health and disorders
rs60037734	G	T	51	40	3	44	41	9	0.76	0.69	0.24	0.31	G	1.0869565	0.005939202	Schizophrenia	Brain health and disorders
rs4852140	A	G	7	32	55	9	41	44	0.24	0.31	0.76	0.69	A	0.04	0.005939202	Obesity-related traits	Obesity
rs8133949	C	T	66	25	3	75	17	2	0.84	0.89	0.16	0.11	T	1.142	0.005935423	Hand grip strength	Appearance
rs12731372	C	T	65	27	2	74	19	1	0.84	0.89	0.16	0.11	C	0.0213	0.005935423	Waist-to-hip ratio adjusted for body mass index	Obesity
rs1881492	T	G	1	29	64	1	19	74	0.16	0.11	0.84	0.89	T	0.139	0.005935423	Refractive error	General health
rs7709212	T	C	44	37	13	32	47	15	0.66	0.59	0.34	0.41	T	1.4	0.005932203	Psoriasis	Immune diseases and disorders
rs6726292	G	A	41	43	10	29	53	12	0.66	0.59	0.34	0.41	G	1.39	0.005932203	Obesity extreme	Obesity
rs7069346	T	A	16	45	33	10	43	41	0.41	0.34	0.59	0.66	T	1.11	0.005932203	Migraine without aura	Brain health and disorders
rs1415701	G	A	43	38	13	31	48	15	0.66	0.59	0.34	0.41	G	1.19	0.00589864	Height	General health
rs7799006	C	T	36	38	20	39	46	9	0.59	0.66	0.41	0.34	C	1.059	0.00589864	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs10904908	A	G	35	40	19	37	50	7	0.59	0.66	0.41	0.34	G	0.025	0.00589864	Cholesterol, total	General health
rs9665626	C	G	0	25	69	1	14	79	0.13	0.09	0.87	0.91	G	1.1111112	0.005897343	Schizophrenia	Brain health and disorders
rs62191099	G	A	71	21	2	79	14	1	0.87	0.91	0.13	0.09	A	1.25	0.005897343	Alcohol dependence	General health
rs16839962	A	T	70	23	1	78	16	0	0.87	0.91	0.13	0.09	T	1	0.005897343	Response to statin therapy	General health
rs12914656	T	C	71	21	2	78	16	0	0.87	0.91	0.13	0.09	C	1	0.005897343	Fasting insulin interaction	General health
rs12175489	G	A	73	17	4	80	12	2	0.87	0.91	0.13	0.09	A	1	0.005897343	Visceral adipose tissue adjusted for BMI	Obesity
rs11858577	C	T	79	14	1	73	17	4	0.91	0.87	0.09	0.13	T	1	0.005897343	Subcutaneous adipose tissue	Obesity
rs12595161	G	A	80	12	2	72	19	3	0.91	0.87	0.09	0.13	A	0.4178	0.005897343	Neurofibrillary tangles	Brain health and disorders
rs62094879	C	T	69	25	0	78	16	0	0.87	0.91	0.13	0.09	T	0.2917	0.005897343	Metabolite levels MHPG	General health
rs3817428	C	G	69	25	0	79	14	1	0.87	0.91	0.13	0.09	C	0.046	0.005897343	Height	General health
rs4678181	G	A	71	21	2	78	16	0	0.87	0.91	0.13	0.09	A	0.00202	0.005897343	Calcium levels	General health
rs1801253	G	C	9	29	56	9	42	43	0.25	0.32	0.75	0.68	G	0.041	0.005871521	Birth weight	Misc
rs4684059	G	C	43	42	9	50	41	3	0.68	0.75	0.32	0.25	C	0.1691	0.005871521	IgG glycosylation	Immune diseases and disorders
rs11014249	T	G	54	33	7	45	38	11	0.75	0.68	0.25	0.32	C	0.04	0.005871521	Obesity-related traits	Obesity
rs12142465	C	A	54	32	8	59	34	1	0.74	0.81	0.26	0.19	C	1.0638298	0.005870841	Schizophrenia	Brain health and disorders
rs17316633	G	A	52	36	6	59	34	1	0.74	0.81	0.26	0.19	A	1	0.005870841	Hair morphology	Appearance
rs34707540	C	A	34	41	19	40	43	11	0.58	0.65	0.42	0.35	C	4.56621	0.005866858	Warfarin maintenance dose	General health
rs4627050	A	G	9	47	38	14	51	29	0.35	0.42	0.65	0.58	G	1.932	0.005866858	Adverse response to chemotherapy neutropenia_leucopenia cisplatin	Drug response
rs8127977	T	C	16	47	31	11	43	40	0.42	0.35	0.58	0.65	A	1.587	0.005866858	Adverse response to chemotherapy neutropenia_leucopenia all antimetabolite drugs	Drug response
rs11108495	T	C	38	47	9	33	43	18	0.65	0.58	0.35	0.42	T	1.55	0.005866858	Weight	Appearance
rs8034802	T	A	41	41	12	35	39	20	0.65	0.58	0.35	0.42	A	0.104	0.005866858	HDL cholesterol	General health
rs2808630	C	T	2	35	57	3	22	69	0.21	0.15	0.79	0.85	G	1.22	0.005844564	Lung cancer	Cancer
rs10843215	C	T	2	24	68	4	31	59	0.15	0.21	0.85	0.79	G	0.03	0.005844564	Obesity-related traits	Obesity
rs1440306	T	G	56	37	1	66	28	0	0.79	0.85	0.21	0.15	A	1.3699	0.005844564	Bronchopulmonary dysplasia	Pulmonology
rs3120139	G	A	68	24	2	57	35	2	0.85	0.79	0.15	0.21	A	0.32	0.005844564	Lp a levels	General health
rs1447276	G	A	61	27	6	69	22	3	0.79	0.85	0.21	0.15	A	0.03	0.005844564	Obesity-related traits	Obesity
rs6843082	G	A	14	52	28	15	36	43	0.43	0.35	0.57	0.65	G	1.36	0.005836808	Stroke ischemic	Brain health and disorders
rs3815854	C	T	17	46	31	6	54	34	0.43	0.35	0.57	0.65	A	1.25	0.005836808	Nonsyndromic cleft lip with or without cleft palate	Misc
rs9525625	T	C	32	44	18	35	52	7	0.57	0.65	0.43	0.35	A	1.0763987	0.005836808	Crohn's disease	Digestive system and its disorders
rs10511217	C	T	41	40	13	30	48	16	0.65	0.57	0.35	0.43	T	0.092	0.005836808	Economic and political preferences environmentalism	Mental aptitude and behavioural traits
rs12485744	T	C	41	40	13	30	48	16	0.65	0.57	0.35	0.43	T	0.091	0.005836808	Economic and political preferences environmentalism	Mental aptitude and behavioural traits
rs4764124	C	T	18	44	32	14	38	42	0.43	0.35	0.57	0.65	C	0.05	0.005836808	Pubertal anthropometrics	Appearance
rs17124372	T	C	83	10	1	74	20	0	0.94	0.89	0.06	0.11	T	5.1975	0.005813953	Smooth-surface caries	Appearance
rs10435178	G	A	82	12	0	74	20	0	0.94	0.89	0.06	0.11	A	3.55	0.005813953	Diisocyanate-induced asthma	Pulmonology
rs12049330	T	G	76	16	2	83	10	1	0.89	0.94	0.11	0.06	G	1.44	0.005813953	Major depressive disorder	Brain health and disorders
rs17428471	G	T	82	12	0	75	18	1	0.94	0.89	0.06	0.11	T	1.2	0.005813953	Blood pressure	Heart health and disorders
rs2189246	G	A	18	45	31	11	45	38	0.43	0.36	0.57	0.64	A	1.05	0.00580844	Schizophrenia	Brain health and disorders
rs3852160	C	T	10	47	37	8	65	21	0.36	0.43	0.64	0.57	C	0.526	0.00580844	Mean arterial pressure alcohol consumption interaction	General health
rs2676071	C	T	18	45	31	8	51	35	0.43	0.36	0.57	0.64	T	0.0443	0.00580844	Periodontitis Mean PAL	Misc
rs1363907	G	A	42	43	9	52	36	6	0.68	0.74	0.32	0.26	A	1.10802	0.005806961	Crohn's disease	Digestive system and its disorders
rs2269241	T	C	43	41	10	52	36	6	0.68	0.74	0.32	0.26	G	1.1	0.005806961	Type 1 diabetes	Diabetes
rs180515	A	G	46	35	13	49	42	3	0.68	0.74	0.32	0.26	G	1.09	0.005806961	Multiple sclerosis	Brain health and disorders
rs7784447	G	A	44	39	11	50	40	4	0.68	0.74	0.32	0.26	A	1	0.005806961	Obesity	Obesity
rs7956193	C	T	52	36	6	40	47	7	0.74	0.68	0.26	0.32	T	1	0.005806961	Visceral adipose tissue adjusted for BMI	Obesity
rs4890489	G	A	42	43	9	54	32	8	0.68	0.74	0.32	0.26	A	0.97	0.005806961	QRS duration	Heart health and disorders
rs4733271	A	T	8	32	54	7	47	40	0.26	0.32	0.74	0.68	A	0.04	0.005806961	Cardiac Troponin-T levels	Heart health and disorders
rs1893154	A	G	5	38	51	8	45	41	0.26	0.32	0.74	0.68	A	0.03	0.005806961	Obesity-related traits	Obesity
rs1775148	C	T	26	54	14	34	52	8	0.56	0.64	0.44	0.36	C	1.06	0.005781711	Prostate cancer	Cancer
rs1121980	G	A	40	40	14	32	42	20	0.64	0.56	0.36	0.44	A	0.02	0.005781711	HDL cholesterol	General health
rs7551222	G	A	14	40	40	19	44	31	0.36	0.44	0.64	0.56	A	1.06	0.005781711	Schizophrenia	Brain health and disorders
rs4561213	T	G	20	42	32	13	42	39	0.44	0.36	0.56	0.64	G	1	0.005781711	Magnesium levels	General health
rs211718	T	C	6	37	51	3	31	60	0.26	0.20	0.74	0.80	C	14.6	0.005773857	Metabolite levels	General health
rs10931468	C	A	61	29	4	53	33	8	0.80	0.74	0.20	0.26	A	1.5	0.005773857	Primary biliary cirrhosis	Immune diseases and disorders
rs16859140	T	C	51	37	6	58	35	1	0.74	0.80	0.26	0.20	C	1	0.005773857	Telomere length	Aging
rs9357152	A	G	61	29	4	53	33	8	0.80	0.74	0.20	0.26	G	1	0.005773857	HPV seropositivity	Reproductive health
rs10798959	C	T	50	39	5	60	31	3	0.74	0.80	0.26	0.20	T	0.2835	0.005773857	Metabolite levels HVA_MHPG ratio	Brain health and disorders
rs7552404	A	G	51	37	6	60	31	3	0.74	0.80	0.26	0.20	A	0.075	0.005773857	Blood metabolite levels	Heart health and disorders
rs4949874	T	C	51	37	6	60	31	3	0.74	0.80	0.26	0.20	T	0.073	0.005773857	Blood metabolite ratios	Heart health and disorders
rs248471	G	A	16	51	27	15	39	40	0.44	0.37	0.56	0.63	G	1.19	0.005756579	Myopia pathological	General health
rs2028414	A	C	13	43	38	19	45	30	0.37	0.44	0.63	0.56	C	0.1399	0.005756579	IgG glycosylation	Immune diseases and disorders
rs2063640	C	A	65	26	3	73	20	1	0.83	0.88	0.17	0.12	A	1.23	0.005751093	Type 2 diabetes	Diabetes
rs1449984	A	G	63	30	1	73	20	1	0.83	0.88	0.17	0.12	A	0.15	0.005751093	Depression quantitative trait	Brain health and disorders
rs4903031	A	G	63	30	1	74	18	2	0.83	0.88	0.17	0.12	G	0.032	0.005751093	C-reactive protein levels	Immune diseases and disorders
rs7758080	A	G	49	41	4	42	42	10	0.74	0.67	0.26	0.33	G	1.0790637	0.005745368	Crohn's disease	Digestive system and its disorders
rs2836326	C	G	54	31	9	41	44	9	0.74	0.67	0.26	0.33	G	0.2311	0.005745368	Metabolite levels HVA	General health
rs10034692	A	G	41	44	9	51	37	6	0.67	0.74	0.33	0.26	A	0.16	0.005745368	Mammographic density dense area	Reproductive health
rs10486567	G	A	30	44	20	40	38	16	0.55	0.63	0.45	0.37	G	1.17	0.005733006	Prostate cancer	Cancer
rs7808935	T	C	30	44	20	40	38	16	0.55	0.63	0.45	0.37	T	1.17	0.005733006	Prostate cancer	Cancer
rs1642764	C	T	29	46	19	31	56	7	0.55	0.63	0.45	0.37	C	1.14	0.005733006	Esophageal squamous cell carcinoma	Cancer
rs2470578	G	A	41	36	17	27	50	17	0.63	0.55	0.37	0.45	G	1.0526316	0.005733006	Schizophrenia	Brain health and disorders
rs4491709	T	C	27	50	17	36	46	12	0.55	0.63	0.45	0.37	T	0.102	0.005733006	Permanent tooth development	Misc
rs4954192	C	T	19	46	29	13	44	37	0.45	0.37	0.55	0.63	A	2.36	0.005733006	Diisocyanate-induced asthma	Pulmonology
rs7807268	G	C	12	46	36	15	54	25	0.37	0.45	0.63	0.55	G	1.38	0.005733006	Crohn's disease	Digestive system and its disorders
rs12541063	A	G	5	30	59	1	27	66	0.21	0.15	0.79	0.85	A	0.81	0.005712128	Blood pressure	Heart health and disorders
rs7725218	G	A	38	41	15	22	59	13	0.62	0.55	0.38	0.45	G	1.15	0.005710956	Prostate cancer	Cancer
rs11886868	C	T	22	41	31	16	39	39	0.45	0.38	0.55	0.62	T	0.48	0.005710956	Fetal hemoglobin levels	General health
rs6583437	G	A	31	41	22	35	47	12	0.55	0.62	0.45	0.38	G	0.197	0.005710956	IgG glycosylation	Immune diseases and disorders
rs16951275	T	C	36	45	13	28	47	19	0.62	0.55	0.38	0.45	T	0.032	0.005710956	Body mass index	Obesity
rs7317038	C	T	29	45	20	38	41	15	0.55	0.62	0.45	0.38	C	0.006	0.005710956	Mean platelet volume	Heart health and disorders
rs631208	A	G	38	40	16	28	46	20	0.62	0.54	0.38	0.46	A	1.18	0.005690396	IgE grass sensitization	Immune diseases and disorders
rs4733770	G	A	42	41	11	49	40	5	0.66	0.73	0.34	0.27	G	1.0526316	0.005686598	Schizophrenia	Brain health and disorders
rs2198776	C	T	44	37	13	51	36	7	0.66	0.73	0.34	0.27	A	0.03	0.005686598	Obesity-related traits	Obesity
rs860148	C	T	22	43	29	5	63	26	0.46	0.39	0.54	0.61	C	0.04	0.005671296	Metabolite levels  X-11787	General health
rs2291447	G	T	32	51	11	25	51	18	0.61	0.54	0.39	0.46	T	0.114	0.005671296	Economic and political preferences	Mental aptitude and behavioural traits
rs7136259	T	C	19	36	39	20	48	26	0.39	0.47	0.61	0.53	T	1.11	0.005653629	Coronary heart disease	Heart health and disorders
rs2124440	G	A	22	45	27	17	41	36	0.47	0.40	0.53	0.60	G	0.22	0.005637368	Monocyte count	Immune diseases and disorders
rs1380836	C	T	15	34	45	7	37	50	0.34	0.27	0.66	0.73	G	0.03	0.005630518	Obesity-related traits	Obesity
rs10036575	T	C	50	37	7	41	42	11	0.73	0.66	0.27	0.34	T	1.2345679	0.005630518	Gastric cancer	Cancer
rs3850699	A	G	48	41	5	43	38	13	0.73	0.66	0.27	0.34	A	1.1	0.005630518	Prostate cancer	Cancer
rs1706631	A	T	25	40	29	14	48	32	0.48	0.40	0.52	0.60	T	1.3548	0.00562249	Major depressive disorder	Brain health and disorders
rs2511714	T	G	32	48	14	22	54	18	0.60	0.52	0.40	0.48	G	1.19	0.00562249	Chronic lymphocytic leukemia	Cancer
rs4730430	C	T	31	49	14	19	59	16	0.59	0.52	0.41	0.48	T	1.06	0.005608974	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs495366	G	A	25	47	22	35	41	18	0.52	0.59	0.48	0.41	A	0.44	0.005608974	Matrix metalloproteinase levels	Cancer
rs4373814	G	C	31	48	15	27	42	25	0.59	0.51	0.41	0.49	G	0.373	0.005596802	Systolic blood pressure	Heart health and disorders
rs12740374	G	T	60	29	5	48	41	5	0.79	0.73	0.21	0.27	T	0.23	0.005594406	LDL cholesterol	General health
rs1122794	C	A	46	45	3	57	35	2	0.73	0.79	0.27	0.21	A	0.2281	0.005594406	Red blood cell traits	Immune diseases and disorders
rs2083637	A	G	50	37	7	57	35	2	0.73	0.79	0.27	0.21	G	0.11	0.005594406	HDL cholesterol	General health
rs4609139	A	T	49	39	6	58	33	3	0.73	0.79	0.27	0.21	T	0.081	0.005594406	Bone mineral density	General health
rs3755157	C	T	57	35	2	47	43	4	0.79	0.73	0.21	0.27	T	0.07	0.005594406	Glycated hemoglobin levels	Diabetes
rs11871801	A	C	68	22	4	58	31	5	0.84	0.78	0.16	0.22	A	1.15	0.005587624	Crohn's disease	Digestive system and its disorders
rs9274623	G	T	67	24	3	58	31	5	0.84	0.78	0.16	0.22	G	1.1363636	0.005587624	Schizophrenia	Brain health and disorders
rs4792793	C	G	66	26	2	56	35	3	0.84	0.78	0.16	0.22	C	0.12	0.005587624	Metabolite levels Pyroglutamine	General health
rs256438	T	G	56	35	3	68	22	4	0.78	0.84	0.22	0.16	C	0.05	0.005587624	Serum thyroid-stimulating hormone levels	General health
rs6575836	G	A	4	33	57	1	28	65	0.22	0.16	0.78	0.84	G	4	0.005587624	Tuberculosis	Immune diseases and disorders
rs75515191	T	G	88	6	0	82	12	0	0.97	0.94	0.03	0.06	C	15.21	0.005586592	Diisocyanate-induced asthma	Pulmonology
rs9266629	T	C	82	12	0	88	6	0	0.94	0.97	0.06	0.03	C	1	0.005586592	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs6132333	T	C	88	6	0	83	10	1	0.97	0.94	0.03	0.06	C	0.5397	0.005586592	IgG glycosylation	Immune diseases and disorders
rs6794092	G	A	89	4	1	83	10	1	0.97	0.94	0.03	0.06	G	0.167	0.005586592	Body mass index	Obesity
rs11101730	A	T	82	12	0	88	6	0	0.94	0.97	0.06	0.03	A	0.055	0.005586592	Blood metabolite levels	Heart health and disorders
rs9768139	G	A	24	47	23	26	57	11	0.51	0.58	0.49	0.42	G	0.00176	0.005585955	Calcium levels	General health
rs7195303	G	A	1	14	79	0	9	85	0.09	0.05	0.91	0.95	G	2.1	0.005584046	Crohn's disease time to surgery	Brain health and disorders
rs1401492	C	T	85	9	0	79	14	1	0.95	0.91	0.05	0.09	C	16	0.005584046	Insulin resistance_response	Drug response
rs7771911	C	A	78	16	0	86	7	1	0.91	0.95	0.09	0.05	A	1	0.005584046	Immune reponse to smallpox secreted IL-12p40	Immune diseases and disorders
rs16928809	G	A	79	14	1	85	9	0	0.91	0.95	0.09	0.05	A	0.06	0.005584046	Bilirubin levels	General health
rs3782089	C	T	78	16	0	85	9	0	0.91	0.95	0.09	0.05	T	0.058	0.005584046	Height	General health
rs4526895	A	G	74	17	3	63	29	2	0.88	0.82	0.12	0.18	C	1.38	0.005580357	Yu-Zhi constitution type in type 2 diabetes	Diabetes
rs7521681	G	A	64	27	3	72	21	1	0.82	0.88	0.18	0.12	A	1.1491	0.005580357	Asthma and hay fever	Immune diseases and disorders
rs11221522	G	A	75	15	4	63	29	2	0.88	0.82	0.12	0.18	A	0.2412	0.005580357	Metabolite levels 5-HIAA	General health
rs2566755	T	C	65	25	4	72	21	1	0.82	0.88	0.18	0.12	C	0.1	0.005580357	Bone mineral density hip	General health
rs4947019	C	G	63	29	2	73	19	2	0.82	0.88	0.18	0.12	G	0.01	0.005580357	Hematological parameters	Heart health and disorders
rs2947253	G	A	3	27	64	3	17	74	0.18	0.12	0.82	0.88	G	3.38	0.005580357	Paclitaxel-induced neuropathy	Brain health and disorders
rs10151037	G	T	48	40	6	37	49	8	0.72	0.65	0.28	0.35	A	0.03	0.005577006	Obesity-related traits	Obesity
rs9976767	A	G	35	38	21	20	54	20	0.57	0.50	0.43	0.50	C	1.16	0.00557642	Type 1 diabetes	Diabetes
rs7601312	A	G	27	54	13	29	36	29	0.57	0.50	0.43	0.50	G	1.0638298	0.00557642	Schizophrenia	Brain health and disorders
rs416603	A	T	24	48	22	18	46	30	0.51	0.44	0.49	0.56	T	1.06	0.00556123	Type 1 diabetes	Diabetes
rs10098310	G	A	15	52	27	21	54	19	0.44	0.51	0.56	0.49	A	0.0338	0.00556123	White blood cell count	Immune diseases and disorders
rs1462163	C	T	20	42	32	19	58	17	0.44	0.51	0.56	0.49	T	0.031028014	0.00556123	LDL peak particle diameter total fat intake interaction	General health
rs915364	C	A	26	54	14	23	46	25	0.56	0.49	0.44	0.51	A	0.009	0.00556123	Magnesium levels	General health
rs7833787	A	G	22	47	25	27	51	16	0.48	0.56	0.52	0.44	A	0.04	0.005555556	Obesity-related traits	Obesity
rs2195525	C	T	13	58	23	25	48	21	0.45	0.52	0.55	0.48	T	0.025	0.00555115	Urate levels	General health
rs7715256	G	T	23	52	19	21	42	31	0.52	0.45	0.48	0.55	G	0.018	0.00555115	Body mass index	Obesity
rs9318086	A	G	22	55	17	15	55	24	0.53	0.45	0.47	0.55	A	1.32	0.005548007	Myopia pathological	General health
rs7075426	G	A	29	42	23	19	48	27	0.53	0.46	0.47	0.54	A	1.11	0.005546123	Migraine without aura	Brain health and disorders
rs899435	C	A	28	46	20	17	54	23	0.54	0.47	0.46	0.53	A	0.15	0.005546123	Coronary artery calcification	Heart health and disorders
rs35548558	T	C	29	43	22	13	61	20	0.54	0.46	0.46	0.54	T	0.027	0.005545496	Neuroticism	Brain health and disorders
rs2569991	C	A	12	42	40	6	41	47	0.35	0.28	0.65	0.72	C	0.2	0.005525946	Periodontitis DPAL	Misc
rs860873	G	A	40	42	12	48	39	7	0.65	0.72	0.35	0.28	A	0.1472	0.005525946	Stearic acid 18:0 plasma levels	General health
rs11248534	C	T	48	39	7	39	44	11	0.72	0.65	0.28	0.35	T	0.0023	0.005525946	Trans fatty acid levels	General health
rs9891572	C	T	59	30	5	50	36	8	0.79	0.72	0.21	0.28	A	0.05	0.005511329	HDL cholesterol	General health
rs11623869	G	T	45	46	3	60	28	6	0.72	0.79	0.28	0.21	T	0.04	0.005511329	Bone mineral density	General health
rs139326003	G	A	81	13	0	74	19	1	0.93	0.89	0.07	0.11	A	4.2	0.005503956	Emphysema imaging phenotypes	Pulmonology
rs17126268	T	C	83	9	2	76	15	3	0.93	0.89	0.07	0.11	C	2.78	0.005503956	Glomerular filtration rate	General health
rs1035209	C	T	73	21	0	81	13	0	0.89	0.93	0.11	0.07	T	1.12	0.005503956	Colorectal cancer	Cancer
rs7833268	G	C	77	13	4	82	11	1	0.89	0.93	0.11	0.07	C	1	0.005503956	Subcutaneous adipose tissue	Obesity
rs6961611	T	C	76	15	3	82	11	1	0.89	0.93	0.11	0.07	T	0.63	0.005503956	Information processing speed	Mental aptitude and behavioural traits
rs11025523	G	A	73	21	0	82	11	1	0.89	0.93	0.11	0.07	A	0.04	0.005503956	Obesity-related traits	Obesity
rs3097645	G	C	0	21	73	0	13	81	0.11	0.07	0.89	0.93	C	0.2253	0.005503956	IgG glycosylation	Immune diseases and disorders
rs10109414	C	T	40	41	13	46	42	6	0.64	0.71	0.36	0.29	T	1	0.005477232	Chronic kidney disease	Immune diseases and disorders
rs78037194	C	G	60	26	8	66	25	3	0.78	0.84	0.22	0.16	G	1.0869565	0.00547041	Schizophrenia	Brain health and disorders
rs11247009	G	A	57	32	5	65	27	2	0.78	0.84	0.22	0.16	A	0.03	0.00547041	Body mass index	Obesity
rs11984041	C	T	76	18	0	71	19	4	0.90	0.86	0.10	0.14	A	1.42	0.005438066	Stroke	Brain health and disorders
rs11969002	G	A	76	18	0	67	27	0	0.90	0.86	0.10	0.14	A	0.2	0.005438066	Disc degeneration lumbar	Aging
rs7744666	T	C	76	18	0	67	27	0	0.90	0.86	0.10	0.14	C	0.2	0.005438066	Disc degeneration lumbar	Aging
rs9469300	G	A	76	18	0	67	27	0	0.90	0.86	0.10	0.14	A	0.19	0.005438066	Disc degeneration lumbar	Aging
rs3749982	T	A	76	18	0	67	27	0	0.90	0.86	0.10	0.14	A	0.19	0.005438066	Disc degeneration lumbar	Aging
rs2681472	A	G	71	19	4	77	16	1	0.86	0.90	0.14	0.10	A	0.15	0.005438066	Hypertension	Heart health and disorders
rs12666612	T	C	70	21	3	77	16	1	0.86	0.90	0.14	0.10	G	0.03	0.005438066	Obesity-related traits	Obesity
rs4748741	T	A	1	4	89	0	2	92	0.03	0.01	0.97	0.99	T	0.35	0.005434783	Urate levels in lean individuals	Obesity
rs11129773	C	T	88	6	0	92	2	0	0.97	0.99	0.03	0.01	A	17.899	0.005434783	Illicit drug use	General health
rs1270942	A	G	92	2	0	88	6	0	0.99	0.97	0.01	0.03	C	3.0494	0.005434783	Type 1 diabetes and autoimmune thyroid diseases	Diabetes
rs558702	G	A	92	2	0	88	6	0	0.99	0.97	0.01	0.03	A	2.276	0.005434783	Systemic lupus erythematosus	Immune diseases and disorders
rs1801282	C	G	88	6	0	92	2	0	0.97	0.99	0.03	0.01	C	1.16	0.005434783	Type 2 diabetes	Diabetes
rs62341097	G	A	88	6	0	92	2	0	0.97	0.99	0.03	0.01	A	1.1474	0.005434783	Neuritic plaque	Brain health and disorders
rs34596385	C	T	88	6	0	92	2	0	0.97	0.99	0.03	0.01	T	1	0.005434783	Telomere length	Aging
rs17466626	A	G	88	6	0	92	2	0	0.97	0.99	0.03	0.01	G	1	0.005434783	Pediatric autoimmune diseases	Immune diseases and disorders
rs73126576	T	C	88	6	0	92	2	0	0.97	0.99	0.03	0.01	T	0.2897	0.005434783	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs10109725	G	T	88	6	0	92	2	0	0.97	0.99	0.03	0.01	T	0.28	0.005434783	Emphysema imaging phenotypes	Pulmonology
rs3115775	T	C	88	6	0	92	2	0	0.97	0.99	0.03	0.01	C	0.18	0.005434783	Urate levels in obese individuals	Obesity
rs17278117	A	G	89	4	1	92	2	0	0.97	0.99	0.03	0.01	A	0.093	0.005434783	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs16958432	G	A	92	2	0	88	6	0	0.99	0.97	0.01	0.03	A	0.085	0.005434783	Sitting height ratio	Appearance
rs16958440	C	G	92	2	0	88	6	0	0.99	0.97	0.01	0.03	G	0.085	0.005434783	Sitting height ratio	Appearance
rs4369815	T	G	88	6	0	92	2	0	0.97	0.99	0.03	0.01	T	0.06	0.005434783	Menarche age at onset	Reproductive health
rs11564386	T	C	92	2	0	88	6	0	0.99	0.97	0.01	0.03	G	0.03	0.005434783	Obesity-related traits	Obesity
rs11104877	T	G	88	6	0	92	2	0	0.97	0.99	0.03	0.01	T	0.0079	0.005434783	Trans fatty acid levels	General health
rs11104850	G	A	88	6	0	92	2	0	0.97	0.99	0.03	0.01	A	0.0078	0.005434783	Trans fatty acid levels	General health
rs11193561	C	T	49	37	8	55	37	2	0.72	0.78	0.28	0.22	A	1.19	0.005432322	Endometriosis	General health
rs28411352	C	T	47	41	6	59	29	6	0.72	0.78	0.28	0.22	T	1.11	0.005432322	Rheumatoid arthritis	Immune diseases and disorders
rs7823498	C	T	7	27	60	7	39	48	0.22	0.28	0.78	0.72	T	2	0.005432322	Emphysema imaging phenotypes	Pulmonology
rs11852984	A	C	50	33	11	38	44	12	0.71	0.64	0.29	0.36	C	1.802	0.005430766	Suicide behavior	Brain health and disorders
rs2736098	C	T	63	28	3	73	18	3	0.82	0.87	0.18	0.13	C	1.25	0.005421817	Pancreatic cancer	Cancer
rs6567160	T	C	72	20	2	62	30	2	0.87	0.82	0.13	0.18	C	0.09	0.005421817	Body mass index	Obesity
rs6538140	G	A	5	46	43	10	49	35	0.30	0.37	0.70	0.63	G	4.3478	0.005386454	Tuberculosis	Immune diseases and disorders
rs11012732	A	G	49	34	11	36	47	11	0.70	0.63	0.30	0.37	A	1.46	0.005386454	Meningioma	Cancer
rs2274273	G	A	47	38	9	35	49	10	0.70	0.63	0.30	0.37	A	0.185	0.005386454	Protein biomarker	General health
rs7648449	C	T	55	35	4	65	26	3	0.77	0.83	0.23	0.17	C	1.0752687	0.005359911	Schizophrenia	Brain health and disorders
rs12595292	G	A	56	33	5	65	26	3	0.77	0.83	0.23	0.17	A	0.1065	0.005359911	LDL cholesterol	General health
rs7071206	T	C	66	24	4	55	35	4	0.83	0.77	0.17	0.23	T	0.06	0.005359911	Bone mineral density	General health
rs13086738	A	G	59	28	7	48	38	8	0.78	0.71	0.22	0.29	G	1.84	0.005357143	Eating disorder in bipolar disorder	Brain health and disorders
rs6499188	G	A	8	38	48	8	26	60	0.29	0.22	0.71	0.78	A	1.14	0.005357143	Ulcerative colitis	Immune diseases and disorders
rs2228391	T	C	94	0	0	93	0	1	1.00	0.99	0.00	0.01	C	3.32	0.005347594	Thionamide-induced agranulocytosis in Graves' disease	General health
rs4611001	A	G	94	0	0	92	2	0	1.00	0.99	0.00	0.01	A	1.79	0.005347594	Longevity 90 years and older	Aging
rs17045328	A	G	94	0	0	92	2	0	1.00	0.99	0.00	0.01	G	1.38	0.005347594	Type 2 diabetes	Diabetes
rs185414370	T	C	94	0	0	92	2	0	1.00	0.99	0.00	0.01	C	0.82	0.005347594	Lipoprotein a levels	Heart health and disorders
rs13222543	C	T	94	0	0	93	0	1	1.00	0.99	0.00	0.01	T	0.49	0.005347594	Blood metabolite ratios	Heart health and disorders
rs55794209	C	A	94	0	0	92	2	0	1.00	0.99	0.00	0.01	A	0.227	0.005347594	Serum dimethylarginine levels asymmetric_symetric ratio	General health
rs10044242	C	G	94	0	0	92	2	0	1.00	0.99	0.00	0.01	G	0.02	0.005347594	Obesity-related traits	Obesity
rs11866328	G	T	48	35	11	37	44	13	0.70	0.63	0.30	0.37	G	1.68	0.005344211	Hepatitis B	Immune diseases and disorders
rs12708716	A	G	44	43	7	38	42	14	0.70	0.63	0.30	0.37	G	1	0.005344211	Type 1 diabetes	Diabetes
rs4273729	C	G	5	48	41	15	41	38	0.31	0.38	0.69	0.62		1.59	0.005303958	Chronic hepatitis C infection	Immune diseases and disorders
rs9275572	A	G	5	48	41	15	41	38	0.31	0.38	0.69	0.62	A	1.3	0.005303958	Hepatocellular carcinoma	Cancer
rs1465330	T	A	33	51	10	43	44	7	0.62	0.69	0.38	0.31	A	1.1905	0.005303958	Large artery stroke	Heart health and disorders
rs9275524	T	C	5	48	41	15	41	38	0.31	0.38	0.69	0.62	T	1.07	0.005303958	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs4253252	T	G	16	39	39	11	36	47	0.38	0.31	0.62	0.69	T	0.086	0.005303958	Blood metabolite levels	Heart health and disorders
rs7144383	G	A	0	9	85	0	4	90	0.05	0.02	0.95	0.98	G	1.44	0.005297733	Idiopathic pulmonary fibrosis	Pulmonology
rs2612034	T	C	1	7	86	0	4	90	0.05	0.02	0.95	0.98	T	0.0016	0.005297733	Trans fatty acid levels	General health
rs2680664	A	G	1	7	86	0	4	90	0.05	0.02	0.95	0.98	A	0.0016	0.005297733	Trans fatty acid levels	General health
rs2233424	C	T	90	4	0	85	9	0	0.98	0.95	0.02	0.05	T	1.33	0.005297733	Rheumatoid arthritis	Immune diseases and disorders
rs13220141	A	T	85	9	0	90	4	0	0.95	0.98	0.05	0.02	A	1.27	0.005297733	Leprosy	Immune diseases and disorders
rs2233434	A	G	90	4	0	85	9	0	0.98	0.95	0.02	0.05	G	1.2	0.005297733	Rheumatoid arthritis	Immune diseases and disorders
rs17770015	C	G	85	9	0	90	4	0	0.95	0.98	0.05	0.02	G	1.17	0.005297733	Migraine without aura	Brain health and disorders
rs12586774	G	T	91	2	1	85	9	0	0.98	0.95	0.02	0.05	A	0.03	0.005297733	Obesity-related traits	Obesity
rs4846922	T	C	11	33	50	5	33	56	0.29	0.23	0.71	0.77	T	0.08	0.005285567	Metabolic syndrome	Immune diseases and disorders
rs9815663	C	T	52	41	1	47	39	8	0.77	0.71	0.23	0.29	T	0.17	0.005285567	Asthma childhood onset	Immune diseases and disorders
rs7601713	A	C	4	27	63	4	17	73	0.19	0.13	0.81	0.87	A	0.16	0.005274262	QT interval	Heart health and disorders
rs13048019	C	T	62	29	3	71	21	2	0.81	0.87	0.19	0.13	T	2.02	0.005274262	Amyotrophic lateral sclerosis	Brain health and disorders
rs4679904	C	T	62	29	3	71	21	2	0.81	0.87	0.19	0.13	G	1.38	0.005274262	Primary biliary cirrhosis	Immune diseases and disorders
rs76832595	A	C	61	31	2	70	23	1	0.81	0.87	0.19	0.13	A	1.08	0.005274262	Schizophrenia	Brain health and disorders
rs6097169	G	A	69	25	0	64	25	5	0.87	0.81	0.13	0.19	A	1	0.005274262	Body mass index in non-asthmatics	Obesity
rs7722600	A	G	70	23	1	62	29	3	0.87	0.81	0.13	0.19	A	1	0.005274262	Heart rate	General health
rs4938573	C	T	1	31	62	7	30	57	0.18	0.23	0.82	0.77	C	1.34	0.005255614	Follicular lymphoma	Cancer
rs3781264	A	G	55	34	5	63	29	2	0.77	0.82	0.23	0.18	C	1.36	0.005255614	Esophageal cancer and gastric cancer	Cancer
rs17664743	G	A	64	27	3	53	38	3	0.82	0.77	0.18	0.23	A	0.0665	0.005255614	Self-reported allergy	General health
rs78153629	T	C	67	26	1	75	19	0	0.85	0.90	0.15	0.10	T	17.44	0.005238311	Heschl's gyrus morphology	Brain health and disorders
rs5742692	A	G	75	19	0	66	28	0	0.90	0.85	0.10	0.15	G	0.07	0.005238311	Height	General health
rs4253311	A	G	19	35	40	12	36	46	0.39	0.32	0.61	0.68	A	1	0.005229122	Plasma renin activity levels	General health
rs12668095	G	C	81	12	1	72	22	0	0.93	0.88	0.07	0.12	C	3.4	0.005228758	Epilepsy and lamotrigine-induced maculopapular eruptions	Brain health and disorders
rs7769061	A	G	80	14	0	73	20	1	0.93	0.88	0.07	0.12	G	1.54	0.005228758	Psoriasis	Immune diseases and disorders
rs62468577	C	T	81	12	1	73	20	1	0.93	0.88	0.07	0.12	G	1.5385	0.005228758	Bronchopulmonary dysplasia	Pulmonology
rs10883832	T	G	72	22	0	81	12	1	0.88	0.93	0.12	0.07	T	1.16	0.005228758	Schizophrenia	Brain health and disorders
rs6565887	T	C	80	14	0	73	20	1	0.93	0.88	0.07	0.12	G	0.2924	0.005228758	Renal transplant outcome	Misc
rs72875462	C	A	80	14	0	74	18	2	0.93	0.88	0.07	0.12	C	0.148	0.005228758	LDL cholesterol	General health
rs16912210	A	G	82	10	2	72	22	0	0.93	0.88	0.07	0.12	G	0.05	0.005228758	Obesity-related traits	Obesity
rs11191560	T	C	72	22	0	81	12	1	0.88	0.93	0.12	0.07	C	0.031	0.005228758	Body mass index	Obesity
rs9397738	G	A	0	22	72	0	14	80	0.12	0.07	0.88	0.93	G	0.0039	0.005228758	Renal function-related traits eGRFcrea	General health
rs9310736	A	G	5	34	55	9	38	47	0.23	0.30	0.77	0.70	A	0.21	0.005217391	Red blood cell traits	Immune diseases and disorders
rs13109457	G	A	54	36	4	46	40	8	0.77	0.70	0.23	0.30	A	6.3	0.005217391	D-dimer levels	Heart health and disorders
rs11887188	C	T	84	10	0	77	17	0	0.95	0.91	0.05	0.09	T	3.28	0.005200042	Blood pressure measurement high sodium and potassium intervention	Heart health and disorders
rs10233425	T	C	84	10	0	77	17	0	0.95	0.91	0.05	0.09	C	1.88	0.005200042	Amyotrophic lateral sclerosis	Brain health and disorders
rs58262369	C	T	78	15	1	84	10	0	0.91	0.95	0.09	0.05	T	1.28	0.005200042	Prostate cancer	Cancer
rs1498095	T	C	78	15	1	84	10	0	0.91	0.95	0.09	0.05	T	1	0.005200042	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs7114000	A	G	12	38	44	16	43	35	0.33	0.40	0.67	0.60	A	0.1503	0.005161409	Menarche age at onset	Reproductive health
rs10928150	G	A	30	53	11	37	52	5	0.60	0.67	0.40	0.33	A	0.07	0.005161409	Glomerular filtration rate in chronic kidney disease	General health
rs4549702	C	G	31	51	12	44	38	12	0.60	0.67	0.40	0.33	G	0.02	0.005161409	Body mass index interaction	Obesity
rs2184898	G	A	55	33	6	66	22	6	0.76	0.82	0.24	0.18	A	1.33	0.005157056	Conduct disorder	Brain health and disorders
rs17135859	T	C	63	28	3	52	39	3	0.82	0.76	0.18	0.24	C	0.97	0.005157056	F-cell distribution	Immune diseases and disorders
rs7186908	G	C	57	29	8	46	39	9	0.76	0.70	0.24	0.30	C	2	0.005152426	Liver enzyme levels alkaline phosphatase	General health
rs6586354	G	A	51	41	2	41	49	4	0.76	0.70	0.24	0.30	A	0.2802	0.005152426	Pharmacokinetics of antipsychotic drugs in severe mental disorder concentration drug ratio	General health
rs13144232	G	A	49	33	12	57	29	8	0.70	0.76	0.30	0.24	G	0.1638	0.005152426	IgG glycosylation	Immune diseases and disorders
rs2292298	A	G	49	33	12	57	29	8	0.70	0.76	0.30	0.24	G	0.1504	0.005152426	IgG glycosylation	Immune diseases and disorders
rs16946931	T	C	62	28	4	70	22	2	0.81	0.86	0.19	0.14	C	1.681	0.005136634	Social autistic-like traits	Brain health and disorders
rs11763760	C	T	72	18	4	60	32	2	0.86	0.81	0.14	0.19	C	0.1815	0.005136634	IgG glycosylation	Immune diseases and disorders
rs1033394	C	T	5	26	63	0	26	68	0.19	0.14	0.81	0.86	C	1.0638298	0.005136634	Schizophrenia	Brain health and disorders
rs6497436	T	C	2	32	60	1	24	69	0.19	0.14	0.81	0.86	T	1	0.005136634	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs1038903	C	T	5	26	63	0	26	68	0.19	0.14	0.81	0.86	T	0.04	0.005136634	Menarche age at onset	Reproductive health
rs7756935	C	A	1	24	69	3	30	61	0.14	0.19	0.86	0.81	A	0.027	0.005136634	Lipoprotein-associated phospholipase A2 activity and mass	General health
rs7186128	G	A	5	53	36	6	64	24	0.34	0.40	0.66	0.60	G	2.5	0.005130073	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	General health
rs862034	A	G	10	56	28	11	41	42	0.40	0.34	0.60	0.66	A	0.028	0.005130073	Height	General health
rs6140050	C	A	11	42	41	13	51	30	0.34	0.41	0.66	0.59	C	0.047	0.005100347	Sitting height ratio	Appearance
rs16858082	T	C	36	39	19	37	50	7	0.59	0.66	0.41	0.34	T	0.0324	0.005100347	Body mass index	Obesity
rs2281636	T	G	10	44	40	16	45	33	0.34	0.41	0.66	0.59	A	0.03	0.005100347	Obesity-related traits	Obesity
rs188133	G	A	11	42	41	18	41	35	0.34	0.41	0.66	0.59	A	0.021	0.005100347	Educational attainment	Mental aptitude and behavioural traits
rs17149161	C	A	54	34	6	44	42	8	0.76	0.69	0.24	0.31	A	1.87	0.005090498	Multiple sclerosis	Brain health and disorders
rs218237	C	T	54	34	6	45	40	9	0.76	0.69	0.24	0.31	T	0.111	0.005090498	Red blood cell count	Immune diseases and disorders
rs2148072	G	A	45	40	9	53	36	5	0.69	0.76	0.31	0.24	G	0.0723	0.005090498	Bone mineral density paediatric, upper limb	General health
rs12313946	C	A	53	36	5	48	34	12	0.76	0.69	0.24	0.31	C	0.065	0.005090498	White blood cell count	Immune diseases and disorders
rs2297991	T	C	14	37	43	16	46	32	0.35	0.41	0.65	0.59	T	0.042	0.005072181	Cholesterol, total	General health
rs4629203	T	C	42	39	13	28	54	12	0.65	0.59	0.35	0.41	G	0.03	0.005072181	Obesity-related traits	Obesity
rs13030978	C	T	55	32	7	61	31	2	0.76	0.81	0.24	0.19	T	3.7	0.005063821	Liver enzyme levels gamma-glutamyl transferase	General health
rs4387258	G	A	64	25	5	51	40	3	0.81	0.76	0.19	0.24	G	1	0.005063821	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs3135350	C	T	1	11	82	0	7	87	0.07	0.04	0.93	0.96	G	0.51	0.00505618	Food antigen IgG levels	Immune diseases and disorders
rs144803255	G	A	81	13	0	87	7	0	0.93	0.96	0.07	0.04	A	4.1709	0.00505618	Clozapine-induced agranulocytosis	General health
rs28375794	T	C	87	7	0	82	11	1	0.96	0.93	0.04	0.07	G	3.76	0.00505618	Diisocyanate-induced asthma	Pulmonology
rs161857	A	T	87	7	0	81	13	0	0.96	0.93	0.04	0.07	T	3	0.00505618	Pyoderma gangrenosum in inflammatory bowel disease	Immune diseases and disorders
rs5743894	T	C	81	13	0	87	7	0	0.93	0.96	0.07	0.04	G	1.49	0.00505618	Idiopathic pulmonary fibrosis	Pulmonology
rs378352	G	A	81	13	0	87	7	0	0.93	0.96	0.07	0.04	T	1.26	0.00505618	Chronic hepatitis B infection	Immune diseases and disorders
rs13263568	T	G	81	13	0	87	7	0	0.93	0.96	0.07	0.04	G	1.1	0.00505618	Migraine	Brain health and disorders
rs12542677	C	T	81	13	0	87	7	0	0.93	0.96	0.07	0.04	A	1	0.00505618	Immune reponse to smallpox secreted IL-1beta	Immune diseases and disorders
rs6724422	C	T	87	7	0	81	13	0	0.96	0.93	0.04	0.07	T	1	0.00505618	Response to anti-depressant treatment in major depressive disorder	General health
rs7187223	A	G	87	7	0	81	13	0	0.96	0.93	0.04	0.07	A	0.251	0.00505618	Non-word repetition	Brain health and disorders
rs78546022	A	G	81	13	0	88	5	1	0.93	0.96	0.07	0.04	G	0.2221	0.00505618	Metabolite levels HVA_5-HIAA ratio	Brain health and disorders
rs12542166	A	C	81	13	0	87	7	0	0.93	0.96	0.07	0.04	C	0.1056	0.00505618	White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy	Brain health and disorders
rs56148675	T	C	81	13	0	87	7	0	0.93	0.96	0.07	0.04	T	0.076	0.00505618	Bulimia nervosa	Brain health and disorders
rs6978712	C	T	75	18	1	65	29	0	0.89	0.85	0.11	0.15	A	2.02	0.005055233	Medication adherence in chronic diseases	Drug response
rs9970807	C	T	77	14	3	68	23	3	0.89	0.85	0.11	0.15	C	1.12	0.005055233	Myocardial infarction	Heart health and disorders
rs2153299	T	C	33	43	18	38	46	10	0.58	0.65	0.42	0.35	G	0.04	0.005045529	Obesity-related traits	Obesity
rs422951	T	C	44	41	9	56	29	9	0.69	0.75	0.31	0.25	G	1.27	0.005031447	Chronic hepatitis B infection	Immune diseases and disorders
rs1822881	A	G	55	31	8	46	37	11	0.75	0.69	0.25	0.31	A	1	0.005031447	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs6080212	G	A	67	27	0	59	33	2	0.86	0.80	0.14	0.20	A	2.2	0.005008013	Emphysema imaging phenotypes	Pulmonology
rs1329313	C	T	38	44	12	34	39	21	0.64	0.57	0.36	0.43	T	1.06	0.0049966	Schizophrenia	Brain health and disorders
rs10453441	A	G	37	46	11	18	71	5	0.64	0.57	0.36	0.43	A	0.051	0.0049966	Corneal curvature	General health
rs9358372	G	A	17	47	30	12	44	38	0.43	0.36	0.57	0.64	G	1.089	0.0049966	Inflammatory bowel disease	Immune diseases and disorders
rs10490775	C	T	81	11	2	71	23	0	0.92	0.88	0.08	0.12	A	2.3	0.004982871	Fuchs's corneal dystrophy	General health
rs11495908	A	G	72	21	1	79	15	0	0.88	0.92	0.12	0.08	G	0.03	0.004982871	Obesity-related traits	Obesity
rs6894797	A	G	75	15	4	80	13	1	0.88	0.92	0.12	0.08	G	0.03	0.004982871	Obesity-related traits	Obesity
rs11581667	C	T	54	33	7	62	28	4	0.75	0.81	0.25	0.19	C	0.196	0.004975534	IgG glycosylation	Immune diseases and disorders
rs7453920	A	G	11	38	45	4	40	50	0.32	0.26	0.68	0.74	G	2.31	0.004975124	Chronic hepatitis B infection	Immune diseases and disorders
rs11190870	T	C	39	41	14	36	34	24	0.63	0.56	0.37	0.44	T	1.61	0.004974246	Adolescent idiopathic scoliosis	Obesity
rs4362	T	C	21	40	33	13	43	38	0.44	0.37	0.56	0.63	T	0.061	0.004974246	Blood metabolite levels	Heart health and disorders
rs2573625	C	T	19	44	31	14	41	39	0.44	0.37	0.56	0.63	T	0.029	0.004974246	Height	General health
rs261967	A	C	28	49	17	38	42	14	0.56	0.63	0.44	0.37	C	3.77	0.004953252	Body mass index	Obesity
rs6536024	T	C	28	49	17	38	42	14	0.56	0.63	0.44	0.37	C	1.25	0.004953252	Venous thromboembolism	Heart health and disorders
rs1534422	G	A	28	48	18	34	49	11	0.55	0.62	0.45	0.38	G	1.08	0.004933586	Type 1 diabetes	Diabetes
rs2664035	G	A	38	41	15	24	56	14	0.62	0.55	0.38	0.45	A	1.08	0.004933586	Rheumatoid arthritis	Immune diseases and disorders
rs9572182	T	C	29	46	19	39	39	16	0.55	0.62	0.45	0.38	T	1	0.004933586	Homeostasis model assessment of beta-cell function interaction	Misc
rs2241423	G	A	36	45	13	28	48	18	0.62	0.55	0.38	0.45	G	0.13	0.004933586	Body mass index	Obesity
rs6734238	A	G	41	35	18	28	48	18	0.62	0.55	0.38	0.45	G	0.108	0.004933586	C-reactive protein	Immune diseases and disorders
rs12703441	A	G	30	44	20	34	49	11	0.55	0.62	0.45	0.38	C	0.062	0.004933586	Anxiety disorder	Brain health and disorders
rs419076	T	C	11	49	34	18	48	28	0.38	0.45	0.62	0.55	T	0.409	0.004933586	Systolic blood pressure	Heart health and disorders
rs9357506	A	G	23	57	14	33	50	11	0.55	0.62	0.45	0.38	G	0.016	0.00491522	Body mass index	Obesity
rs185819	T	C	15	42	37	20	45	29	0.38	0.45	0.62	0.55	T	5.2	0.00491522	Height	General health
rs7206971	G	A	33	49	12	26	50	18	0.61	0.54	0.39	0.46	A	1.01	0.004898125	Cholesterol, total	General health
rs6586282	C	T	58	35	1	51	38	5	0.80	0.74	0.20	0.26	T	1	0.004891854	Blood and toenail selenium levels	Heart health and disorders
rs7641070	A	G	58	34	2	70	20	4	0.80	0.85	0.20	0.15	G	1.0526316	0.004887586	Schizophrenia	Brain health and disorders
rs2370759	G	A	61	28	5	66	28	0	0.80	0.85	0.20	0.15	G	0.237	0.004887586	Sexual dysfunction female	Reproductive health
rs17450430	A	T	59	32	3	68	24	2	0.80	0.85	0.20	0.15	A	0.035	0.004887586	Height	General health
rs10905868	A	G	68	24	2	59	32	3	0.85	0.80	0.15	0.20	G	0.02	0.004887586	Obesity-related traits	Obesity
rs2247056	T	C	3	24	67	1	19	74	0.16	0.11	0.84	0.89	T	2.99	0.004886878	Triglycerides	General health
rs6772112	C	T	2	26	66	1	19	74	0.16	0.11	0.84	0.89	T	0.038	0.004886878	Height	General health
rs17208368	C	A	65	28	1	74	19	1	0.84	0.89	0.16	0.11	A	1.41	0.004886878	Hypospadias	Misc
rs35593266	G	A	75	17	2	68	22	4	0.89	0.84	0.11	0.16	A	0.2196	0.004886878	Metabolite levels HVA_5-HIAA ratio	Brain health and disorders
rs16918636	T	C	65	28	1	75	17	2	0.84	0.89	0.16	0.11	T	0.03	0.004886878	Menarche age at onset	Reproductive health
rs160451	T	C	11	52	31	21	45	28	0.39	0.46	0.61	0.54	C	1.2820514	0.004882276	Leprosy	Immune diseases and disorders
rs4430796	G	A	28	45	21	36	42	16	0.54	0.61	0.46	0.39	A	1.19	0.004882276	Endometrial cancer	Cancer
rs7948471	G	A	29	43	22	35	44	15	0.54	0.61	0.46	0.39	A	0.26	0.004882276	Sickle cell anemia haemolysis	Heart health and disorders
rs12545109	A	C	5	40	49	9	44	41	0.27	0.33	0.73	0.67	A	0.04	0.00487013	Obesity-related traits	Obesity
rs7659024	G	A	51	36	7	42	42	10	0.73	0.67	0.27	0.33	A	1.53	0.00487013	Venous thromboembolism	Heart health and disorders
rs2066865	G	A	51	36	7	42	42	10	0.73	0.67	0.27	0.33	A	1.24	0.00487013	Venous thromboembolism	Heart health and disorders
rs17767419	C	T	51	36	7	41	44	9	0.73	0.67	0.27	0.33	T	0.068	0.00487013	Thyroid volume	General health
rs3813582	T	C	51	36	7	41	44	9	0.73	0.67	0.27	0.33	T	0.068	0.00487013	Thyroid function	Immune diseases and disorders
rs11225055	T	C	76	18	0	83	11	0	0.90	0.94	0.10	0.06	C	3.49	0.004869323	Response to methotrexate in juvenile idiopathic arthritis	General health
rs2523989	C	T	77	16	1	83	11	0	0.90	0.94	0.10	0.06	A	1.7499	0.004869323	Type 1 diabetes and autoimmune thyroid diseases	Diabetes
rs13067593	A	G	77	16	1	83	11	0	0.90	0.94	0.10	0.06	G	1	0.004869323	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs7758128	C	A	83	11	0	76	18	0	0.94	0.90	0.06	0.10	A	1	0.004869323	Vitiligo	Immune diseases and disorders
rs10040989	G	A	76	18	0	83	11	0	0.90	0.94	0.10	0.06	A	0.85	0.004869323	QT interval	Heart health and disorders
rs4513829	A	G	79	12	3	83	11	0	0.90	0.94	0.10	0.06	G	0.179	0.004869323	Symmetrical dimethylarginine levels	General health
rs145241704	T	G	84	9	1	76	18	0	0.94	0.90	0.06	0.10	T	0.143	0.004869323	Anorexia nervosa	Brain health and disorders
rs7649275	G	A	1	9	84	3	12	79	0.06	0.10	0.94	0.90	A	0.0016	0.004869323	Trans fatty acid levels	General health
rs1020820	G	A	1	9	84	3	12	79	0.06	0.10	0.94	0.90	A	0.0016	0.004869323	Trans fatty acid levels	General health
rs8002861	G	A	20	48	26	15	45	34	0.47	0.40	0.53	0.60	A	1.1111112	0.004867652	Leprosy	Immune diseases and disorders
rs13168670	T	C	23	42	29	18	39	37	0.47	0.40	0.53	0.60	T	1.05	0.004867652	Schizophrenia	Brain health and disorders
rs7834588	C	T	34	45	15	31	38	25	0.60	0.53	0.40	0.47	T	0.03	0.004867652	Response to Vitamin E supplementation	General health
rs72763355	G	A	90	4	0	93	1	0	0.98	0.99	0.02	0.01	A	297.72	0.004851752	Hippocampal volume	Brain health and disorders
rs3130544	C	A	90	4	0	93	1	0	0.98	0.99	0.02	0.01	A	3.34	0.004851752	Idiopathic membranous nephropathy	Brain health and disorders
rs13081389	A	G	93	1	0	90	4	0	0.99	0.98	0.01	0.02	A	1.24	0.004851752	Type 2 diabetes	Diabetes
rs73396800	G	C	90	4	0	93	1	0	0.98	0.99	0.02	0.01	G	1.1904762	0.004851752	Schizophrenia	Brain health and disorders
rs13176547	C	T	90	4	0	93	1	0	0.98	0.99	0.02	0.01	T	1.14	0.004851752	Schizophrenia	Brain health and disorders
rs72963233	T	C	90	4	0	93	1	0	0.98	0.99	0.02	0.01	C	1.1235955	0.004851752	Schizophrenia	Brain health and disorders
rs9807334	G	A	90	4	0	93	1	0	0.98	0.99	0.02	0.01	A	1	0.004851752	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs10910018	G	A	93	1	0	90	4	0	0.99	0.98	0.01	0.02	A	1	0.004851752	Visceral fat	Obesity
rs12931267	C	G	90	4	0	93	1	0	0.98	0.99	0.02	0.01	G	0.441	0.004851752	Skin sensitivity to sun	Appearance
rs1805007	C	T	90	4	0	93	1	0	0.98	0.99	0.02	0.01	C	0.39	0.004851752	Tanning	Appearance
rs1800562	G	A	91	2	1	93	1	0	0.98	0.99	0.02	0.01	A	0.3558	0.004851752	Mean corpuscular hemoglobin	Heart health and disorders
rs117145500	A	C	90	4	0	93	1	0	0.98	0.99	0.02	0.01	C	0.276	0.004851752	Sex hormone levels	Reproductive health
rs9836672	C	T	90	4	0	93	1	0	0.98	0.99	0.02	0.01	T	0.27	0.004851752	Sleep quality	General health
rs12206204	C	T	91	2	1	93	1	0	0.98	0.99	0.02	0.01	T	0.18	0.004851752	Bilirubin levels	General health
rs72959041	G	A	93	1	0	90	4	0	0.99	0.98	0.01	0.02	A	0.1755	0.004851752	Waist-to-hip ratio adjusted for body mass index	Obesity
rs16895802	C	G	93	1	0	90	4	0	0.99	0.98	0.01	0.02	C	0.103	0.004851752	Height	General health
rs11658587	C	T	90	4	0	93	1	0	0.98	0.99	0.02	0.01	A	0.03	0.004851752	Obesity-related traits	Obesity
rs863750	C	T	30	38	26	32	47	15	0.52	0.59	0.48	0.41	T	0.0353	0.004841991	Waist-to-hip ratio adjusted for body mass index	Obesity
rs5749446	T	C	29	40	25	34	43	17	0.52	0.59	0.48	0.41	T	0.007	0.004841991	Red blood cell traits	Immune diseases and disorders
rs10933436	C	A	30	50	14	28	41	25	0.59	0.52	0.41	0.48	A	1.06	0.004830918	Coronary heart disease	Heart health and disorders
rs1008126	C	T	17	44	33	20	51	23	0.41	0.48	0.59	0.52	C	0.09	0.004830918	Metabolite levels Pyroglutamine	General health
rs2284063	A	G	23	51	20	35	40	19	0.52	0.59	0.48	0.41	G	0.08	0.004830918	Cutaneous nevi	Cancer
rs4953076	G	C	7	37	50	11	41	42	0.27	0.34	0.73	0.66	G	1.15	0.004821213	Height	General health
rs10860392	C	T	4	43	47	11	41	42	0.27	0.34	0.73	0.66	T	1.06	0.004821213	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs3923809	A	G	42	41	11	51	35	8	0.66	0.73	0.34	0.27	A	1.9	0.004821213	Restless legs syndrome	Mental aptitude and behavioural traits
rs10875976	G	A	40	45	9	54	29	11	0.66	0.73	0.34	0.27	A	1.04	0.004821213	Obesity	Obesity
rs10761779	A	G	44	37	13	45	47	2	0.66	0.73	0.34	0.27	G	0.03	0.004821213	Liver enzyme levels	General health
rs7896783	G	A	44	37	13	45	47	2	0.66	0.73	0.34	0.27	A	0.01	0.004821213	Fibrinogen	General health
rs704017	A	G	33	43	18	21	54	19	0.58	0.51	0.42	0.49	G	1.1	0.004820996	Colorectal cancer	Cancer
rs12587311	T	C	23	46	25	17	45	32	0.49	0.42	0.51	0.58	T	0.01	0.004820996	Phospholipid levels plasma	General health
rs174449	G	A	25	46	23	29	51	14	0.51	0.58	0.49	0.42	A	0.0021	0.004820996	Trans fatty acid levels	General health
rs9555810	C	G	51	37	6	60	30	4	0.74	0.80	0.26	0.20	G	2.3	0.004812473	Menarche age at onset	Reproductive health
rs12883788	C	T	51	37	6	60	30	4	0.74	0.80	0.26	0.20	T	1.06	0.004812473	Schizophrenia	Brain health and disorders
rs7215990	G	A	48	43	3	60	30	4	0.74	0.80	0.26	0.20	G	0.04	0.004812473	Menarche age at onset	Reproductive health
rs9434723	G	A	60	30	4	52	35	7	0.80	0.74	0.20	0.26	A	0.029	0.004812473	Height	General health
rs174575	C	G	52	35	7	61	28	5	0.74	0.80	0.26	0.20	C	0.0021	0.004812473	Trans fatty acid levels	General health
rs11168036	T	G	23	47	24	28	50	16	0.49	0.56	0.51	0.44	T	1.12	0.004798001	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs4336372	T	C	21	51	22	33	40	21	0.49	0.56	0.51	0.44	C	0.65	0.004798001	Response to anti-TNF treatment in rheumatoid arthritis	General health
rs710446	T	C	33	40	21	24	45	25	0.56	0.49	0.44	0.51	G	0.36	0.004798001	Activated partial thromboplastin time	Heart health and disorders
rs926938	A	G	23	50	21	14	55	25	0.51	0.44	0.49	0.56	A	1.27	0.004792559	Autism	Brain health and disorders
rs7237848	C	T	14	55	25	20	56	18	0.44	0.51	0.56	0.49	T	0.067	0.004792559	White blood cell types	Immune diseases and disorders
rs61021925	T	C	27	50	17	18	55	21	0.55	0.48	0.45	0.52	T	1.05	0.004788214	Schizophrenia	Brain health and disorders
rs2081015	C	T	20	44	30	21	55	18	0.45	0.52	0.55	0.48	T	0.035	0.004788214	Carotid artery intima media thickness sex interaction	Heart health and disorders
rs4767234	A	C	15	55	24	22	54	18	0.45	0.52	0.55	0.48	A	1.17	0.00478496	Airflow obstruction	Pulmonology
rs3763317	C	T	15	55	24	28	42	24	0.45	0.52	0.55	0.48	C	0.12	0.00478496	Complement C3 and C4 levels	Immune diseases and disorders
rs9834560	C	A	19	52	23	27	49	18	0.48	0.55	0.52	0.45	C	0.041	0.00478496	Motion sickness	Misc
rs2439302	G	C	18	50	26	29	41	24	0.46	0.53	0.54	0.47	G	1.36	0.004782793	Thyroid cancer	Cancer
rs6879260	T	C	17	54	23	24	53	17	0.47	0.54	0.53	0.46	T	0.022	0.004781711	Height	General health
rs1024161	T	C	20	47	27	26	48	20	0.46	0.53	0.54	0.47	A	1.44	0.004781711	Alopecia areata	Immune diseases and disorders
rs6063399	A	G	26	48	20	22	43	29	0.53	0.46	0.47	0.54	A	0.03	0.004781711	Obesity-related traits	Obesity
rs10498633	G	T	59	31	4	68	23	3	0.79	0.85	0.21	0.15	G	1.1494253	0.004774637	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs6059101	C	T	57	35	2	67	25	2	0.79	0.85	0.21	0.15	A	1	0.004774637	Ulcerative colitis	Immune diseases and disorders
rs2826340	A	T	67	25	2	58	33	3	0.85	0.79	0.15	0.21	T	1	0.004774637	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs936094	T	C	68	23	3	55	39	0	0.85	0.79	0.15	0.21	C	1	0.004774637	Acute lymphoblastic leukemia childhood	Cancer
rs730497	G	A	59	31	4	68	23	3	0.79	0.85	0.21	0.15	A	0.03	0.004774637	Glycated hemoglobin levels	Diabetes
rs17262815	T	C	71	22	1	80	12	2	0.87	0.91	0.13	0.09	C	1.36	0.004761905	Hypospadias	Misc
rs78392994	T	C	78	16	0	72	20	2	0.91	0.87	0.09	0.13	T	1.09	0.004761905	Schizophrenia	Brain health and disorders
rs11777345	C	G	78	16	0	70	24	0	0.91	0.87	0.09	0.13	C	0.19	0.004761905	Waist-hip ratio	General health
rs7822058	T	C	3	18	73	1	14	79	0.13	0.09	0.87	0.91	A	0.04	0.004761905	Obesity-related traits	Obesity
rs380390	G	C	5	40	49	3	33	58	0.27	0.21	0.73	0.79	C	4.6	0.00473711	Age-related macular degeneration	Aging
rs10743889	G	T	5	40	49	3	33	58	0.27	0.21	0.73	0.79	C	0.04	0.00473711	Obesity-related traits	Obesity
rs28374715	A	G	61	27	6	49	40	5	0.79	0.73	0.21	0.27	A	1.082	0.00473711	Ulcerative colitis	Immune diseases and disorders
rs3853601	C	G	74	18	2	69	19	6	0.88	0.84	0.12	0.16	G	1.13	0.004731585	Atopic dermatitis	Immune diseases and disorders
rs12723316	G	A	73	20	1	65	27	2	0.88	0.84	0.12	0.16	G	1.0752687	0.004731585	Schizophrenia	Brain health and disorders
rs17124581	T	C	64	29	1	73	20	1	0.84	0.88	0.16	0.12	T	0.27	0.004731585	Information processing speed	Mental aptitude and behavioural traits
rs9607469	G	A	74	18	2	66	25	3	0.88	0.84	0.12	0.16	A	0.053	0.004731585	Optic disc area	Misc
rs12571964	C	T	66	25	3	73	20	1	0.84	0.88	0.16	0.12	A	0.05	0.004731585	Obesity-related traits	Obesity
rs4234898	T	C	2	18	74	0	31	63	0.12	0.16	0.88	0.84	T	1	0.004731585	Speech perception in dyslexia	Brain health and disorders
rs249954	G	A	47	41	6	38	47	9	0.72	0.65	0.28	0.35	A	1.07	0.004729996	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs651164	A	G	6	41	47	7	51	36	0.28	0.35	0.72	0.65	G	1.15	0.004729996	Prostate cancer	Cancer
rs2269426	G	A	41	40	13	47	40	7	0.65	0.71	0.35	0.29	T	4.6	0.0046875	Eosinophil counts	General health
rs11864208	C	T	37	48	9	48	38	8	0.65	0.71	0.35	0.29	C	1.27	0.0046875	Schizophrenia	Brain health and disorders
rs7100025	G	A	12	42	40	6	42	46	0.35	0.29	0.65	0.71	G	1	0.0046875	Pediatric autoimmune diseases	Immune diseases and disorders
rs2097677	G	A	58	32	4	65	28	1	0.79	0.84	0.21	0.16	A	0.101	0.004668534	C-reactive protein	Immune diseases and disorders
rs11161521	T	C	57	34	3	66	26	2	0.79	0.84	0.21	0.16	T	0.07	0.004668534	Blood metabolite levels	Heart health and disorders
rs4785763	A	C	6	28	60	8	35	51	0.21	0.27	0.79	0.73	A	1.36	0.00466551	Melanoma	Cancer
rs702634	G	A	6	39	49	0	40	54	0.27	0.21	0.73	0.79	A	1.06	0.00466551	Type 2 diabetes	Diabetes
rs11989122	G	A	3	34	57	5	41	48	0.21	0.27	0.79	0.73	T	0.36	0.00466551	Height	General health
rs12037343	G	T	80	14	0	86	8	0	0.93	0.96	0.07	0.04	T	2.2172	0.004622496	Smooth-surface caries	Appearance
rs7911712	G	A	81	12	1	86	8	0	0.93	0.96	0.07	0.04	A	2.05	0.004622496	Emphysema-related traits	Pulmonology
rs14168	A	C	87	6	1	81	12	1	0.96	0.93	0.04	0.07	A	1	0.004622496	Mammographic density non-dense area	Reproductive health
rs241428	T	G	86	8	0	80	14	0	0.96	0.93	0.04	0.07	G	0.23	0.004622496	Complement C3 and C4 levels	Immune diseases and disorders
rs2665390	C	T	0	8	86	1	12	81	0.04	0.07	0.96	0.93	C	1.46	0.004622496	Ovarian cancer in BRCA1 mutation carriers	Cancer
rs12691052	G	A	84	10	0	89	5	0	0.95	0.97	0.05	0.03	A	34.03	0.004616805	Diisocyanate-induced asthma	Pulmonology
rs4938642	G	C	85	8	1	89	5	0	0.95	0.97	0.05	0.03	C	4.73	0.004616805	Platelet count	Heart health and disorders
rs2808382	G	C	84	10	0	89	5	0	0.95	0.97	0.05	0.03	C	2.7742	0.004616805	Clozapine-induced agranulocytosis	General health
rs3130564	C	T	84	10	0	89	5	0	0.95	0.97	0.05	0.03	T	2.62	0.004616805	Idiopathic membranous nephropathy	Brain health and disorders
rs114997855	G	A	89	5	0	84	10	0	0.97	0.95	0.03	0.05	A	1.67	0.004616805	Prostate cancer survival	Cancer
rs17766408	T	C	84	10	0	89	5	0	0.95	0.97	0.05	0.03	T	1.08	0.004616805	Schizophrenia	Brain health and disorders
rs16970881	G	A	84	10	0	89	5	0	0.95	0.97	0.05	0.03	A	1	0.004616805	Immune reponse to smallpox secreted IL-10	Immune diseases and disorders
rs16871226	A	G	84	10	0	90	3	1	0.95	0.97	0.05	0.03	G	0.5182	0.004616805	IgG glycosylation	Immune diseases and disorders
rs7584755	C	T	89	5	0	84	10	0	0.97	0.95	0.03	0.05	C	0.4674	0.004616805	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs78683678	C	T	84	10	0	89	5	0	0.95	0.97	0.05	0.03	T	0.168	0.004616805	Asymmetrical dimethylarginine levels	General health
rs12134663	A	C	84	10	0	89	5	0	0.95	0.97	0.05	0.03	A	0.101	0.004616805	Homocysteine levels	Misc
rs8120917	G	A	89	5	0	84	10	0	0.97	0.95	0.03	0.05	A	0.03	0.004616805	Obesity-related traits	Obesity
rs708382	T	C	38	44	12	46	40	8	0.64	0.70	0.36	0.30	T	2.439	0.004608295	Platelet count	Heart health and disorders
rs12480819	A	G	46	40	8	37	46	11	0.70	0.64	0.30	0.36	G	1.15	0.004608295	Migraine - clinic-based	Brain health and disorders
rs2238300	G	A	49	34	11	37	46	11	0.70	0.64	0.30	0.36	A	0.021	0.004608295	Height	General health
rs534870	G	A	7	38	49	6	29	59	0.28	0.22	0.72	0.78	A	0.03	0.004597439	Adiposity	Obesity
rs1046080	C	A	7	27	60	8	36	50	0.22	0.28	0.78	0.72	A	0.027	0.004597439	Blood metabolite ratios	Heart health and disorders
rs3796392	G	A	72	21	1	66	24	4	0.88	0.83	0.12	0.17	A	15.21	0.004587935	Diisocyanate-induced asthma	Pulmonology
rs879324	G	A	65	26	3	71	23	0	0.83	0.88	0.17	0.12	A	1.25	0.004587935	Stroke ischemic	Brain health and disorders
rs2677780	G	A	3	26	65	0	23	71	0.17	0.12	0.83	0.88	A	6.3471	0.004587935	Smooth-surface caries	Appearance
rs56823429	C	A	4	24	66	0	23	71	0.17	0.12	0.83	0.88	A	0.037	0.004587935	HDL cholesterol	General health
rs227458	T	C	3	13	78	0	12	82	0.10	0.06	0.90	0.94	C	1	0.00458158	Visceral adipose tissue adjusted for BMI	Obesity
rs17702901	G	A	77	15	2	83	10	1	0.90	0.94	0.10	0.06	A	6.64	0.00458158	Weight loss gastric bypass surgery	Obesity
rs17169807	T	C	83	10	1	75	19	0	0.94	0.90	0.06	0.10	T	2.5493	0.00458158	Smooth-surface caries	Appearance
rs4379368	C	T	82	12	0	77	15	2	0.94	0.90	0.06	0.10	T	1.2	0.00458158	Migraine - clinic-based	Brain health and disorders
rs17367504	A	G	76	17	1	82	12	0	0.90	0.94	0.10	0.06	G	0.85	0.00458158	Systolic blood pressure	Heart health and disorders
rs76351433	A	C	83	10	1	76	17	1	0.94	0.90	0.06	0.10	C	0.692	0.00458158	Current cigarettes per day in chronic obstructive pulmonary disease	General health
rs12527942	C	T	76	17	1	82	12	0	0.90	0.94	0.10	0.06	T	0.32	0.00458158	Percentage gas trapping	Misc
rs12500138	C	T	82	12	0	75	19	0	0.94	0.90	0.06	0.10	T	0.2839	0.00458158	Cognitive function	Brain health and disorders
rs8192472	C	T	38	43	13	41	49	4	0.63	0.70	0.37	0.30	A	4.85	0.004571429	Body mass index	Obesity
rs4233356	A	G	8	41	45	5	59	30	0.30	0.37	0.70	0.63	T	2.51	0.004571429	Interstitial lung disease	Pulmonology
rs10139550	C	G	37	45	12	46	39	9	0.63	0.70	0.37	0.30	G	1.05	0.004571429	Myocardial infarction	Heart health and disorders
rs794728	G	T	13	43	38	9	39	46	0.37	0.30	0.63	0.70	T	0.42	0.004571429	Depressive symptoms SSRI exposure interaction	Brain health and disorders
rs10131141	C	T	9	39	46	8	53	33	0.30	0.37	0.70	0.63	G	0.04	0.004571429	Obesity-related traits	Obesity
rs1583686	T	C	3	25	66	2	37	55	0.16	0.22	0.84	0.78	A	0.04	0.004568713	Obesity-related traits	Obesity
rs10074525	C	T	1	29	64	2	37	55	0.16	0.22	0.84	0.78	G	0.03	0.004568713	Obesity-related traits	Obesity
rs17116334	C	T	64	29	1	60	27	7	0.84	0.78	0.16	0.22	T	1.3	0.004568713	Conduct disorder interaction	Brain health and disorders
rs6585424	A	G	59	29	6	63	31	0	0.78	0.84	0.22	0.16	G	1	0.004568713	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs2504183	G	A	58	31	5	64	29	1	0.78	0.84	0.22	0.16	G	0.1943	0.004568713	IgG glycosylation	Immune diseases and disorders
rs245914	G	T	57	33	4	66	25	3	0.78	0.84	0.22	0.16	A	0.03	0.004568713	Obesity-related traits	Obesity
rs10915864	A	G	56	35	3	65	27	2	0.78	0.84	0.22	0.16	G	0.03	0.004568713	Obesity-related traits	Obesity
rs3733606	C	T	69	25	0	77	17	0	0.87	0.91	0.13	0.09	G	5.65	0.004562304	Platelet count	Heart health and disorders
rs13028485	G	A	78	15	1	70	23	1	0.91	0.87	0.09	0.13	A	2.17	0.004562304	Multiple myeloma IgH translocation	Cancer
rs11017221	C	T	69	25	0	78	15	1	0.87	0.91	0.13	0.09	T	1.09	0.004562304	Migraine	Brain health and disorders
rs2074488	G	T	71	21	2	77	17	0	0.87	0.91	0.13	0.09	T	1	0.004562304	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs12328675	T	C	78	15	1	70	23	1	0.91	0.87	0.09	0.13	C	0.68	0.004562304	HDL cholesterol	General health
rs11149058	T	C	39	40	15	43	44	7	0.63	0.69	0.37	0.31	T	1.22	0.00453629	Tourette's syndrome or obsessive-compulsive disorder	Brain health and disorders
rs34245511	G	C	45	40	9	39	40	15	0.69	0.63	0.31	0.37	C	1.144	0.00453629	Colorectal cancer	Cancer
rs1887320	G	A	46	38	10	36	46	12	0.69	0.63	0.31	0.37	A	0.78	0.00453629	Systolic blood pressure	Heart health and disorders
rs947583	T	C	37	44	13	43	44	7	0.63	0.69	0.37	0.31	C	0.04	0.00453629	Phosphorus levels	General health
rs6873793	C	T	15	40	39	7	44	43	0.37	0.31	0.63	0.69	C	1.47	0.00453629	QT interval	Heart health and disorders
rs320461	T	C	6	30	58	7	39	48	0.22	0.28	0.78	0.72	A	1.697	0.004532684	Suicide	Mental aptitude and behavioural traits
rs10948172	A	G	55	36	3	49	37	8	0.78	0.72	0.22	0.28	G	1.08	0.004532684	Osteoarthritis	Immune diseases and disorders
rs10166461	G	A	58	30	6	46	43	5	0.78	0.72	0.22	0.28	A	0.2636	0.004532684	Neurofibrillary tangles	Brain health and disorders
rs4925325	G	A	48	39	7	57	32	5	0.72	0.78	0.28	0.22	A	0.03	0.004532684	Obesity-related traits	Obesity
rs1971791	G	A	39	39	16	42	45	7	0.62	0.69	0.38	0.31	G	1.26	0.004502814	Amyotrophic lateral sclerosis	Brain health and disorders
rs1218582	G	A	34	49	11	44	41	9	0.62	0.69	0.38	0.31	G	1.06	0.004502814	Prostate cancer	Cancer
rs11820646	T	C	15	41	38	9	41	44	0.38	0.31	0.62	0.69	C	1.05	0.004502814	Breast cancer	Cancer
rs1442779	A	G	12	47	35	7	45	42	0.38	0.31	0.62	0.69	A	0.0543	0.004502814	Periodontitis Mean PAL	Misc
rs3790160	T	C	12	47	35	9	41	44	0.38	0.31	0.62	0.69	T	0.05	0.004502814	Bone mineral density	General health
rs12195230	G	C	55	36	3	63	30	1	0.78	0.83	0.22	0.17	G	1.79	0.004474673	Blood pressure	Heart health and disorders
rs1048466	G	A	57	32	5	64	28	2	0.78	0.83	0.22	0.17	G	1.22	0.004474673	Obesity early onset extreme	Obesity
rs2283228	A	C	55	36	3	65	26	3	0.78	0.83	0.22	0.17	A	1.2	0.004474673	Type 2 diabetes	Diabetes
rs4503880	T	C	7	28	59	1	30	63	0.22	0.17	0.78	0.83	T	3.6	0.004474673	Liver enzyme levels gamma-glutamyl transferase	General health
rs7794356	G	A	56	33	5	51	32	11	0.77	0.71	0.23	0.29	A	110	0.004471049	Response to montelukast in asthma change in FEV1	General health
rs56205728	G	A	61	23	10	44	46	4	0.77	0.71	0.23	0.29	A	1.074	0.004471049	Schizophrenia	Brain health and disorders
rs66800491	G	A	46	42	6	56	33	5	0.71	0.77	0.29	0.23	G	0.078	0.004471049	Motion sickness	Misc
rs4982731	C	T	12	36	46	11	50	33	0.32	0.38	0.68	0.62	C	1.36	0.004470939	Acute lymphoblastic leukemia childhood	Cancer
rs6590334	T	C	15	42	37	6	48	40	0.38	0.32	0.62	0.68	T	1.14	0.004470939	Psoriasis	Immune diseases and disorders
rs6012564	G	A	10	52	32	8	44	42	0.38	0.32	0.62	0.68	G	0.12	0.004470939	Anger	General health
rs7191700	C	T	66	23	5	70	24	0	0.82	0.87	0.18	0.13	C	1.15	0.00445471	Multiple sclerosis	Brain health and disorders
rs12023718	T	C	70	24	0	63	29	2	0.87	0.82	0.13	0.18	G	0.03	0.00445471	Obesity-related traits	Obesity
rs7554607	A	G	38	39	17	42	43	9	0.61	0.68	0.39	0.32	A	1.49	0.004440607	Acute lymphoblastic leukemia childhood	Cancer
rs727153	T	C	7	41	46	5	34	55	0.29	0.23	0.71	0.77	C	1.63	0.004412355	Alzheimer's disease	Brain health and disorders
rs381815	C	T	46	41	7	53	38	3	0.71	0.77	0.29	0.23	T	0.65	0.004412355	Systolic blood pressure	Heart health and disorders
rs6935723	T	C	45	36	13	36	42	16	0.67	0.61	0.33	0.39	C	2.46	0.004411765	Response to thiopurine immunosuppressants in inflammatory bowel disease pancreatitis azathioprine and mercaptopurine	General health
rs10822136	C	T	34	46	14	38	50	6	0.61	0.67	0.39	0.33	C	0.2106	0.004411765	IgG glycosylation	Immune diseases and disorders
rs3124314	T	C	17	40	37	9	44	41	0.39	0.33	0.61	0.67	T	1	0.004411765	Hair morphology	Appearance
rs1722133	C	T	11	52	31	11	40	43	0.39	0.33	0.61	0.67	T	0.05	0.004411765	Sitting height ratio	Appearance
rs645040	G	T	5	23	66	3	37	54	0.18	0.23	0.82	0.77	G	2.22	0.004385965	Triglycerides	General health
rs10012953	A	G	67	21	6	56	33	5	0.82	0.77	0.18	0.23	G	0.03	0.004385965	Obesity-related traits	Obesity
rs4568876	C	T	16	43	35	9	45	40	0.40	0.34	0.60	0.66	T	0.018	0.004384362	Body mass index	Obesity
rs10906115	A	G	34	45	15	42	41	11	0.60	0.66	0.40	0.34	A	1.13	0.004384362	Type 2 diabetes	Diabetes
rs16884711	A	C	79	12	3	69	24	1	0.90	0.86	0.10	0.14	C	0.1931	0.004381161	IgG glycosylation	Immune diseases and disorders
rs3931397	G	T	76	18	0	68	26	0	0.90	0.86	0.10	0.14	T	0.12	0.004381161	Corneal structure	General health
rs17770334	A	C	91	3	0	87	7	0	0.98	0.96	0.02	0.04	C	3.1	0.004371585	Pyoderma gangrenosum in inflammatory bowel disease	Immune diseases and disorders
rs12721025	G	A	87	7	0	91	3	0	0.96	0.98	0.04	0.02	A	1.59	0.004371585	Infantile hypertrophic pyloric stenosis	Misc
rs17391905	T	G	91	3	0	87	7	0	0.98	0.96	0.02	0.04	G	1.35	0.004371585	QRS duration	Heart health and disorders
rs72697068	G	A	88	5	1	91	3	0	0.96	0.98	0.04	0.02	A	1.11	0.004371585	Schizophrenia	Brain health and disorders
rs1392089	C	T	88	5	1	91	3	0	0.96	0.98	0.04	0.02	A	1	0.004371585	Immune reponse to smallpox secreted IL-2	Immune diseases and disorders
rs17342717	C	T	87	7	0	91	3	0	0.96	0.98	0.04	0.02	T	0.38	0.004371585	Red blood cell traits	Immune diseases and disorders
rs2072209	A	G	87	7	0	91	3	0	0.96	0.98	0.04	0.02	G	0.3742	0.004371585	IgG glycosylation	Immune diseases and disorders
rs76693355	T	C	87	7	0	92	1	1	0.96	0.98	0.04	0.02	T	0.35	0.004371585	Intraocular pressure	General health
rs17403780	T	A	87	7	0	91	3	0	0.96	0.98	0.04	0.02	T	0.3351	0.004371585	IgG glycosylation	Immune diseases and disorders
rs11217863	G	A	87	7	0	92	1	1	0.96	0.98	0.04	0.02	A	0.3	0.004371585	Intraocular pressure	General health
rs1961649	A	T	87	7	0	91	3	0	0.96	0.98	0.04	0.02	T	0.2234	0.004371585	Metabolite levels HVA_5-HIAA ratio	Brain health and disorders
rs7618314	T	C	91	3	0	87	7	0	0.98	0.96	0.02	0.04	T	0.069	0.004371585	Airway responsiveness in chronic obstructive pulmonary disease	Pulmonology
rs11950938	C	G	91	3	0	87	7	0	0.98	0.96	0.02	0.04	C	0.061	0.004371585	Height	General health
rs2596466	T	C	87	7	0	91	3	0	0.96	0.98	0.04	0.02	C	0.05	0.004371585	Beta-2 microglubulin plasma levels	Cancer
rs7581919	C	T	0	7	87	1	1	92	0.04	0.02	0.96	0.98	C	1.85	0.004371585	Conduct disorder	Brain health and disorders
rs10884482	T	C	0	7	87	0	3	91	0.04	0.02	0.96	0.98	T	1	0.004371585	Mammographic density non-dense area	Reproductive health
rs4398173	A	G	34	44	16	41	42	11	0.60	0.66	0.40	0.34	G	1	0.004358354	Response to citalopram treatment	General health
rs12636651	T	C	43	38	13	36	40	18	0.66	0.60	0.34	0.40	G	0.05	0.004358354	Obesity-related traits	Obesity
rs3134931	T	C	45	34	15	36	40	18	0.66	0.60	0.34	0.40	T	0.05	0.004358354	Circulating myeloperoxidase levels serum	Immune diseases and disorders
rs7932614	A	G	15	46	33	11	42	41	0.40	0.34	0.60	0.66	A	0.246	0.004358354	Gait variability	Appearance
rs1937020	C	T	17	42	35	12	40	42	0.40	0.34	0.60	0.66	T	0.041	0.004358354	Anorexia nervosa	Brain health and disorders
rs621942	C	A	54	35	5	47	38	9	0.76	0.70	0.24	0.30	A	1.22	0.004356436	Tourette syndrome	Brain health and disorders
rs11190140	T	C	18	41	35	10	45	39	0.41	0.35	0.59	0.65	T	1.2	0.004333694	Crohn's disease	Digestive system and its disorders
rs7563201	G	A	32	47	15	40	43	11	0.59	0.65	0.41	0.35	G	1.13	0.004333694	Polycystic ovary syndrome	Reproductive health
rs35662245	T	A	32	47	15	41	41	12	0.59	0.65	0.41	0.35	A	1.06	0.004333694	Schizophrenia	Brain health and disorders
rs9594738	C	T	31	49	14	40	43	11	0.59	0.65	0.41	0.35	T	0.15	0.004333694	Bone mineral density	General health
rs9533090	C	T	31	49	14	40	43	11	0.59	0.65	0.41	0.35	T	0.1	0.004333694	Bone mineral density	General health
rs2500535	A	G	5	24	65	2	21	71	0.18	0.13	0.82	0.87	A	29.7	0.004330856	Response to antidepressants	General health
rs10916248	A	T	64	26	4	70	23	1	0.82	0.87	0.18	0.13	A	1	0.004330856	QT interval interaction	Heart health and disorders
rs8037790	G	A	69	25	0	61	32	1	0.87	0.82	0.13	0.18	A	0.443	0.004330856	Dementia and core Alzheimer's disease neuropathologic changes	Brain health and disorders
rs11958404	A	T	71	21	2	63	28	3	0.87	0.82	0.13	0.18	T	0.2522	0.004330856	IgG glycosylation	Immune diseases and disorders
rs1874326	A	G	1	23	70	6	22	66	0.13	0.18	0.87	0.82	G	0.22	0.004330856	Quantitative traits	Misc
rs11119805	T	A	64	26	4	71	21	2	0.82	0.87	0.18	0.13	A	0.168	0.004330856	Stearic acid 18:0 plasma levels	General health
rs17081935	C	T	64	26	4	71	21	2	0.82	0.87	0.18	0.13	T	0.031	0.004330856	Height	General health
rs3805389	G	A	63	28	3	69	25	0	0.82	0.87	0.18	0.13	A	0.0272	0.004330856	Waist-to-hip ratio adjusted for body mass index	Obesity
rs3099143	A	C	81	13	0	74	20	0	0.93	0.89	0.07	0.11	C	2.126	0.004329004	Recalcitrant atopic dermatitis	Immune diseases and disorders
rs7011507	G	A	76	16	2	82	11	1	0.89	0.93	0.11	0.07	G	1.1094613	0.004329004	Ulcerative colitis	Immune diseases and disorders
rs6777876	A	G	75	18	1	81	13	0	0.89	0.93	0.11	0.07	G	1	0.004329004	Alcohol dependence	General health
rs2363719	G	A	81	13	0	76	16	2	0.93	0.89	0.07	0.11	A	0.97	0.004329004	QT interval	Heart health and disorders
rs7333181	G	A	76	16	2	81	13	0	0.89	0.93	0.11	0.07	A	0.52	0.004329004	Menopause age at onset	Reproductive health
rs111226991	C	A	82	11	1	75	18	1	0.93	0.89	0.07	0.11	A	0.18	0.004329004	Glomerular filtration rate in chronic kidney disease	General health
rs501764	G	T	0	20	74	0	13	81	0.11	0.07	0.89	0.93	C	1.39	0.004329004	Hodgkin's lymphoma	Cancer
rs925098	G	A	9	48	37	14	50	30	0.35	0.41	0.65	0.59	G	0.056	0.004310345	Height	General health
rs6831256	A	G	21	36	37	15	36	43	0.41	0.35	0.59	0.65	G	0.026	0.004310345	Triglycerides	General health
rs7759742	T	A	8	50	36	14	50	30	0.35	0.41	0.65	0.59	A	0.0241	0.004310345	Waist-to-hip ratio adjusted for body mass index	Obesity
rs3019286	G	A	34	42	18	39	44	11	0.59	0.65	0.41	0.35	A	1.402	0.004310345	Suicide behavior	Brain health and disorders
rs9330316	A	G	33	44	17	40	42	12	0.59	0.65	0.41	0.35	A	1.06	0.004310345	Schizophrenia	Brain health and disorders
rs8181477	A	C	31	48	15	41	40	13	0.59	0.65	0.41	0.35	C	0.04	0.004310345	Obesity-related traits	Obesity
rs7797976	C	T	46	39	9	51	40	3	0.70	0.76	0.30	0.24	T	1	0.00430314	Pediatric bone mineral content radius	Misc
rs10079417	C	T	53	36	5	43	45	6	0.76	0.70	0.24	0.30	T	0.018	0.00430314	Toenail selenium levels	Misc
rs12693043	C	T	44	43	7	54	34	6	0.70	0.76	0.30	0.24	C	0.008	0.00430314	Urate levels BMI interaction	Obesity
rs3135338	C	T	14	39	41	17	45	32	0.36	0.42	0.64	0.58	A	3.43	0.004288267	Multiple sclerosis	Brain health and disorders
rs4800452	C	T	12	43	39	15	49	30	0.36	0.42	0.64	0.58	T	0.051	0.004288267	Height	General health
rs6084875	G	A	31	46	17	37	46	11	0.57	0.64	0.43	0.36	A	1.356	0.004267425	Systemic lupus erythematosus	Immune diseases and disorders
rs11959928	T	A	31	46	17	35	50	9	0.57	0.64	0.43	0.36	A	0.01	0.004267425	Chronic kidney disease	Immune diseases and disorders
rs3213787	A	G	79	15	0	85	9	0	0.92	0.95	0.08	0.05	A	2.8	0.004261364	Glaucoma	General health
rs184483498	G	A	81	11	2	85	9	0	0.92	0.95	0.08	0.05	A	2.53	0.004261364	Classic bladder exstrophy	Misc
rs6094710	G	A	85	9	0	79	15	0	0.95	0.92	0.05	0.08	A	1.28	0.004261364	Osteoarthritis hip	Immune diseases and disorders
rs17497526	T	C	79	15	0	85	9	0	0.92	0.95	0.08	0.05	G	1	0.004261364	Parkinson's disease	Brain health and disorders
rs924633	A	T	85	9	0	80	13	1	0.95	0.92	0.05	0.08	A	0.18	0.004261364	Emphysema imaging phenotypes	Pulmonology
rs12127588	G	A	79	15	0	85	9	0	0.92	0.95	0.08	0.05	A	0.09	0.004261364	Mean corpuscular hemoglobin	Heart health and disorders
rs2158836	A	G	8	42	44	9	29	56	0.31	0.25	0.69	0.75	A	1.21	0.004252328	Ulcerative colitis	Immune diseases and disorders
rs2028299	C	A	4	39	51	11	36	47	0.25	0.31	0.75	0.69	C	1.13	0.004252328	Type 2 diabetes	Diabetes
rs2229116	A	G	48	34	12	57	27	10	0.69	0.75	0.31	0.25	G	1	0.004252328	Carotid atherosclerosis in HIV infection	Heart health and disorders
rs543874	A	G	53	35	6	46	38	10	0.75	0.69	0.25	0.31	G	0.22	0.004252328	Body mass index	Obesity
rs580140	A	G	52	37	5	42	46	6	0.75	0.69	0.25	0.31	G	0.184	0.004252328	Renal sinus fat	General health
rs11065028	C	T	5	48	41	5	37	52	0.31	0.25	0.69	0.75	G	0.03	0.004252328	Obesity-related traits	Obesity
rs1550546	T	C	30	47	17	37	45	12	0.57	0.63	0.43	0.37	T	1	0.004247788	Verbal declarative memory	Brain health and disorders
rs4765127	G	T	43	33	18	30	47	17	0.63	0.57	0.37	0.43	T	0.44	0.004247788	HDL cholesterol	General health
rs8050187	T	C	39	41	14	29	49	16	0.63	0.57	0.37	0.43	T	0.044	0.004247788	Anorexia nervosa	Brain health and disorders
rs9275224	A	G	13	43	38	19	43	32	0.37	0.43	0.63	0.57	G	1.38	0.004247788	IgA nephropathy	Immune diseases and disorders
rs9497965	C	T	38	42	14	27	52	15	0.63	0.56	0.37	0.44	T	0.067	0.004229323	Thyroid hormone levels	General health
rs7226677	A	G	53	37	4	61	31	2	0.76	0.81	0.24	0.19	G	1.24	0.004222973	Bipolar disorder	Brain health and disorders
rs1359790	G	A	54	35	5	62	29	3	0.76	0.81	0.24	0.19	G	1.15	0.004222973	Type 2 diabetes	Diabetes
rs4318720	G	A	57	29	8	61	31	2	0.76	0.81	0.24	0.19	A	0.28	0.004222973	QT interval	Heart health and disorders
rs7203459	T	C	62	29	3	54	35	5	0.81	0.76	0.19	0.24	C	0.0706	0.004222973	Self-reported allergy	General health
rs1171616	G	T	2	31	61	3	39	52	0.19	0.24	0.81	0.76	T	0.0979	0.004222973	Acylcarnitine levels	General health
rs1171615	C	T	2	31	61	3	39	52	0.19	0.24	0.81	0.76	T	0.077	0.004222973	Blood metabolite ratios	Heart health and disorders
rs9900972	A	G	2	31	61	6	33	55	0.19	0.24	0.81	0.76	A	0.02	0.004222973	Obesity-related traits	Obesity
rs17193122	G	A	71	19	4	75	19	0	0.86	0.90	0.14	0.10	A	9.59	0.004216074	Thionamide-induced agranulocytosis in Graves' disease	General health
rs10048146	A	G	76	17	1	70	21	3	0.90	0.86	0.10	0.14	A	0.05	0.004216074	Bone mineral density	General health
rs7518099	C	T	3	21	70	0	19	75	0.14	0.10	0.86	0.90	G	0.94	0.004216074	Intraocular pressure	General health
rs861020	A	G	4	27	63	1	24	69	0.19	0.14	0.81	0.86	A	1.443	0.004215457	Orofacial clefts	Misc
rs10875746	A	C	61	31	2	68	26	0	0.81	0.86	0.19	0.14	A	1.2	0.004215457	Longevity 90 years and older	Aging
rs10487245	G	A	69	24	1	61	31	2	0.86	0.81	0.14	0.19	A	0.03	0.004215457	Obesity-related traits	Obesity
rs11126666	G	A	63	27	4	69	24	1	0.81	0.86	0.19	0.14	A	0.026	0.004215457	Body mass index	Obesity
rs4547811	T	C	41	47	6	47	46	1	0.69	0.74	0.31	0.26	C	6.4	0.00420387	Liver enzyme levels gamma-glutamyl transferase	General health
rs12913547	T	C	52	36	6	43	43	8	0.74	0.69	0.26	0.31	T	0.08	0.00420387	Corneal structure	General health
rs274567	C	T	49	31	14	49	42	3	0.69	0.74	0.31	0.26	T	0.018	0.00420387	Blood metabolite levels	Heart health and disorders
rs6601530	G	A	12	35	47	4	40	50	0.31	0.26	0.69	0.74	G	0.0078	0.00420387	Carotid intima media thickness	Heart health and disorders
rs17119	G	A	14	44	36	14	56	24	0.38	0.45	0.62	0.55	G	1.0885191	0.004195804	Crohn's disease	Digestive system and its disorders
rs9272346	G	A	22	40	32	12	48	34	0.45	0.38	0.55	0.62	G	1	0.004195804	Type 1 diabetes	Diabetes
rs448378	G	A	11	50	33	18	48	28	0.38	0.45	0.62	0.55	A	0.51	0.004195804	Systolic blood pressure	Heart health and disorders
rs6882776	G	A	32	38	24	31	52	11	0.54	0.61	0.46	0.39	G	0.301	0.004166667	Heart rate	General health
rs303795	C	T	32	50	12	30	42	22	0.61	0.54	0.39	0.46	C	0.03	0.004166667	LDL peak particle diameter total fat intake interaction	General health
rs1464321	A	C	51	37	6	43	42	9	0.74	0.68	0.26	0.32	A	0.024	0.004157647	Body mass index	Obesity
rs700752	C	G	15	57	22	17	41	36	0.46	0.40	0.54	0.60	G	1	0.004153686	Insulin-like growth factors	General health
rs1449263	C	T	22	43	29	17	41	36	0.46	0.40	0.54	0.60	T	0.0363	0.004153686	White blood cell count	Immune diseases and disorders
rs10490924	G	T	53	36	5	59	34	1	0.76	0.81	0.24	0.19	T	3.67	0.004148001	Age-related macular degeneration CNV	Aging
rs4845604	G	A	61	30	3	50	42	2	0.81	0.76	0.19	0.24	A	1.0955864	0.004148001	Crohn's disease	Digestive system and its disorders
rs6138150	T	C	55	32	7	64	24	6	0.76	0.81	0.24	0.19	T	1	0.004148001	Response to TNF antagonist treatment	General health
rs3846635	A	G	59	34	1	53	36	5	0.81	0.76	0.19	0.24	G	1	0.004148001	Visceral fat	Obesity
rs11239544	C	T	53	36	5	64	24	6	0.76	0.81	0.24	0.19	T	0.037	0.004148001	Cholesterol, total	General health
rs970548	A	C	53	36	5	64	24	6	0.76	0.81	0.24	0.19	C	0.026	0.004148001	HDL cholesterol	General health
rs472913	G	C	22	32	40	24	40	30	0.40	0.47	0.60	0.53	C	1.18	0.00414174	Bipolar disorder	Brain health and disorders
rs7839040	G	A	30	51	13	24	51	19	0.59	0.53	0.41	0.47	G	1.81	0.004130809	Response to methotrexate in juvenile idiopathic arthritis	General health
rs4245116	T	C	27	45	22	33	45	16	0.53	0.59	0.47	0.41	T	0.03	0.004130809	Coffee consumption cups per day	Misc
rs12595433	G	A	31	49	14	22	55	17	0.59	0.53	0.41	0.47	A	0.03	0.004130809	Obesity-related traits	Obesity
rs2406342	G	T	34	42	18	25	48	21	0.59	0.52	0.41	0.48	T	1.697	0.004120879	Adverse response to chemotherapy neutropenia_leucopenia cisplatin	Drug response
rs6066825	A	G	23	44	27	16	46	32	0.48	0.41	0.52	0.59	A	1.09	0.004120879	Colorectal cancer	Cancer
rs4475146	C	A	34	42	18	28	42	24	0.59	0.52	0.41	0.48	A	0.4682	0.004120879	Gout	General health
rs6973609	G	A	20	50	24	17	44	33	0.48	0.41	0.52	0.59	G	0.03	0.004120879	Obesity-related traits	Obesity
rs9991328	C	T	20	50	24	13	52	29	0.48	0.41	0.52	0.59	T	0.029	0.004120879	Waist-to-hip ratio adjusted for body mass index	Obesity
rs150992	A	G	41	45	8	53	32	9	0.68	0.73	0.32	0.27	A	0.017	0.004113548	Body mass index	Obesity
rs4776970	A	T	21	49	24	12	55	27	0.48	0.42	0.52	0.58	A	2.55	0.004111936	Body mass index	Obesity
rs7632427	T	C	32	45	17	24	49	21	0.58	0.52	0.42	0.48	T	1.37	0.004111936	Orofacial clefts	Misc
rs8056064	A	G	69	23	2	61	30	3	0.86	0.81	0.14	0.19	G	1.68	0.004107713	Multiple myeloma IgH translocation	Cancer
rs2254546	A	G	1	19	74	2	10	82	0.11	0.07	0.89	0.93	G	1.85	0.004105572	Kawasaki disease	Misc
rs1001579	G	A	2	17	75	0	14	80	0.11	0.07	0.89	0.93	G	0.182	0.004105572	IgG glycosylation	Immune diseases and disorders
rs4890568	G	A	3	15	76	2	10	82	0.11	0.07	0.89	0.93	G	0.087	0.004105572	Hematological and biochemical traits	Heart health and disorders
rs7011192	G	A	73	21	0	81	12	1	0.89	0.93	0.11	0.07	A	2.453	0.004105572	Suicide	Mental aptitude and behavioural traits
rs2069757	G	A	75	17	2	81	12	1	0.89	0.93	0.11	0.07	A	1.59	0.004105572	Hodgkin's lymphoma	Cancer
rs2236007	G	A	74	19	1	82	10	2	0.89	0.93	0.11	0.07	G	1.08	0.004105572	Breast cancer	Cancer
rs6892553	T	C	81	12	1	75	17	2	0.93	0.89	0.07	0.11	G	1.08	0.004105572	Orthostatic hypotension	Heart health and disorders
rs11700462	G	A	81	12	1	74	19	1	0.93	0.89	0.07	0.11	G	0.2827	0.004105572	IgG glycosylation	Immune diseases and disorders
rs12294104	C	T	73	21	0	80	14	0	0.89	0.93	0.11	0.07	T	0.225	0.004105572	Menopause age at onset	Reproductive health
rs909814	T	C	16	48	30	22	48	24	0.43	0.49	0.57	0.51	T	0.103	0.004103967	Testosterone levels	Reproductive health
rs9870680	C	T	21	54	19	30	48	16	0.51	0.57	0.49	0.43	T	1.19	0.004103967	Major depressive disorder broad	Brain health and disorders
rs10849915	T	C	34	40	20	21	54	19	0.57	0.51	0.43	0.49	G	0.55	0.004103967	Alcohol consumption	General health
rs8067545	T	C	24	45	25	18	45	31	0.49	0.43	0.51	0.57	C	1.0526316	0.004096961	Schizophrenia	Brain health and disorders
rs457162	A	T	89	4	1	83	11	0	0.97	0.94	0.03	0.06	T	1.85	0.004096346	QT interval	Heart health and disorders
rs6984045	T	C	88	6	0	83	11	0	0.97	0.94	0.03	0.06	C	1.59	0.004096346	Multiple sclerosis	Brain health and disorders
rs3782889	A	G	88	6	0	83	11	0	0.97	0.94	0.03	0.06	C	1.26	0.004096346	Coronary heart disease	Heart health and disorders
rs11189853	A	G	84	9	1	88	6	0	0.94	0.97	0.06	0.03	G	1.16	0.004096346	Migraine without aura	Brain health and disorders
rs10857636	C	T	88	6	0	83	11	0	0.97	0.94	0.03	0.06	T	1	0.004096346	Response to anti-depressant treatment in major depressive disorder	General health
rs34704559	T	G	83	11	0	88	6	0	0.94	0.97	0.06	0.03	G	0.435	0.004096346	Neuritic plaque	Brain health and disorders
rs1521418	G	C	83	11	0	88	6	0	0.94	0.97	0.06	0.03	C	0.2105	0.004096346	Cognitive function	Brain health and disorders
rs6016142	C	T	84	9	1	88	6	0	0.94	0.97	0.06	0.03	T	0.179	0.004096346	Estradiol levels	General health
rs7226835	C	A	83	11	0	88	6	0	0.94	0.97	0.06	0.03	A	0.04	0.004096346	Obesity-related traits	Obesity
rs10502868	T	C	88	6	0	84	9	1	0.97	0.94	0.03	0.06	G	0.04	0.004096346	Biochemical measures	General health
rs473892	T	C	28	49	17	22	49	23	0.56	0.49	0.44	0.51	T	117.1	0.004085802	Forced expiratory volume in 1 second environmental interaction	Pulmonology
rs950146	G	T	25	43	26	32	41	21	0.49	0.56	0.51	0.44	C	1	0.004085802	Erectile dysfunction in type 1 diabetes	Diabetes
rs7107217	A	C	20	44	30	18	60	16	0.45	0.51	0.55	0.49	C	1.18	0.004081633	Type 2 diabetes	Diabetes
rs1524058	T	C	24	48	22	19	46	29	0.51	0.45	0.49	0.55	T	0.07	0.004081633	Bone mineral density spine	General health
rs1858111	G	A	20	44	30	25	46	23	0.45	0.51	0.55	0.49	G	0.039	0.004081633	Motion sickness	Misc
rs433755	A	C	18	48	28	21	54	19	0.45	0.51	0.55	0.49	C	0.03	0.004081633	Obesity-related traits	Obesity
rs8079702	G	A	22	47	25	28	47	19	0.48	0.55	0.52	0.45	G	1.62	0.004078396	Primary tooth development time to first tooth eruption	Misc
rs193741	G	A	3	41	50	4	29	61	0.25	0.20	0.75	0.80	A	0.64	0.004076973	&beta;2-Glycoprotein I &beta;2-GPI plasma levels	Immune diseases and disorders
rs12576239	C	T	60	31	3	51	39	4	0.80	0.75	0.20	0.25	T	1.75	0.004076973	QT interval	Heart health and disorders
rs9822268	G	A	60	31	3	50	41	3	0.80	0.75	0.20	0.25	A	1.21	0.004076973	Ulcerative colitis	Immune diseases and disorders
rs72882854	G	A	52	37	5	57	37	0	0.75	0.80	0.25	0.20	A	1.06	0.004076973	Schizophrenia	Brain health and disorders
rs11974269	A	C	61	29	4	52	37	5	0.80	0.75	0.20	0.25	C	0.05	0.004076973	Obesity-related traits	Obesity
rs2242194	C	G	19	52	23	23	56	15	0.48	0.54	0.52	0.46	G	1.0526316	0.004076087	Schizophrenia	Brain health and disorders
rs6835098	T	C	19	49	26	24	51	19	0.46	0.53	0.54	0.47	T	0.2278	0.004074703	Dementia and core Alzheimer's disease neuropathologic changes	Brain health and disorders
rs4329	A	G	24	40	30	22	56	16	0.47	0.53	0.53	0.47	G	0.134	0.004074242	Metabolic traits	Misc
rs17321515	A	G	26	48	20	19	50	25	0.53	0.47	0.47	0.53	G	0.08	0.004074242	Triglycerides	General health
rs6804842	A	G	21	46	27	24	52	18	0.47	0.53	0.53	0.47	G	0.02	0.004074242	Body mass index	Obesity
rs7742824	G	A	49	39	6	43	40	11	0.73	0.67	0.27	0.33	A	1.185	0.004071469	Major depressive disorder	Brain health and disorders
rs11552708	G	A	68	24	2	75	18	1	0.85	0.89	0.15	0.11	G	1	0.004065041	IgM levels	Immune diseases and disorders
rs4986894	T	C	74	20	0	68	24	2	0.89	0.85	0.11	0.15	T	0.042	0.004065041	Blood metabolite levels	Heart health and disorders
rs13054085	G	A	69	22	3	74	20	0	0.85	0.89	0.15	0.11	A	0.03	0.004065041	Obesity-related traits	Obesity
rs7914606	T	C	74	20	0	70	20	4	0.89	0.85	0.11	0.15	T	0.0077	0.004065041	Trans fatty acid levels	General health
rs10493631	T	C	49	38	7	44	37	13	0.72	0.66	0.28	0.34	G	0.04	0.004031318	Obesity-related traits	Obesity
rs17059400	A	C	56	28	10	60	30	4	0.74	0.80	0.26	0.20	C	18.365	0.004009623	Illicit drug use	General health
rs11168187	A	G	60	30	4	54	32	8	0.80	0.74	0.20	0.26	G	0.009	0.004009623	Vertical cup-disc ratio	Misc
rs7147624	T	G	4	30	60	6	36	52	0.20	0.26	0.80	0.74	T	1	0.004009623	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs9428104	A	G	5	28	61	6	36	52	0.20	0.26	0.80	0.74	A	0.043	0.004009623	Height	General health
rs17832777	A	C	66	28	0	61	29	4	0.85	0.80	0.15	0.20	C	1	0.004006926	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs6767019	A	C	68	24	2	60	31	3	0.85	0.80	0.15	0.20	C	0.03	0.004006926	Obesity-related traits	Obesity
rs4553720	T	C	14	37	43	9	36	49	0.35	0.29	0.65	0.71	T	1.547	0.003956446	Adverse response to chemotherapy neutropenia_leucopenia docetaxel	Drug response
rs12722556	C	A	85	8	1	79	14	1	0.95	0.91	0.05	0.09	A	4.6	0.003956044	Diisocyanate-induced asthma	Pulmonology
rs34324219	C	A	78	16	0	85	8	1	0.91	0.95	0.09	0.05	A	0.292	0.003956044	Vitamin B levels in ischemic stroke	General health
rs11031002	T	A	78	16	0	84	10	0	0.91	0.95	0.09	0.05	A	0.221	0.003956044	Sex hormone levels	Reproductive health
rs11217223	A	G	79	14	1	85	8	1	0.91	0.95	0.09	0.05	G	0.04	0.003956044	Obesity-related traits	Obesity
rs925946	T	G	8	33	53	4	31	59	0.26	0.21	0.74	0.79	T	3.85	0.003945707	Body mass index	Obesity
rs483069	A	C	58	33	3	49	41	4	0.79	0.74	0.21	0.26	A	0.46	0.003945707	Depressive symptoms SSRI exposure interaction	Brain health and disorders
rs2304725	T	C	60	29	5	50	39	5	0.79	0.74	0.21	0.26	C	0.026	0.003945707	Pulmonary function in asthmatics	Pulmonology
rs10514475	G	A	74	19	1	70	19	5	0.89	0.85	0.11	0.15	A	1.11	0.00392638	Depressive symptoms SSRI exposure interaction	Brain health and disorders
rs7383287	A	G	73	21	0	67	25	2	0.89	0.85	0.11	0.15	A	1.07	0.00392638	Schizophrenia	Brain health and disorders
rs6919908	T	C	2	25	67	1	19	74	0.15	0.11	0.85	0.89	T	0.23	0.00392638	Multiple myeloma and monoclonal gammopathy	Cancer
rs17808461	C	T	65	29	0	73	21	0	0.85	0.89	0.15	0.11	A	0.02	0.00392638	Obesity-related traits	Obesity
rs4902642	G	A	40	42	12	48	37	9	0.65	0.71	0.35	0.29	G	1.07	0.003921569	Crohn's disease	Digestive system and its disorders
rs6088792	C	T	59	32	3	67	25	2	0.80	0.85	0.20	0.15	T	4.7	0.003912476	Height	General health
rs6716753	T	C	59	32	3	65	29	0	0.80	0.85	0.20	0.15	C	1.134	0.003912476	Crohn's disease	Digestive system and its disorders
rs9355814	C	T	63	24	7	67	25	2	0.80	0.85	0.20	0.15	T	0.33	0.003912476	Lipoprotein a levels	Heart health and disorders
rs2071426	T	C	59	32	3	67	25	2	0.80	0.85	0.20	0.15	T	0.055	0.003912476	Blood metabolite levels	Heart health and disorders
rs7144481	C	T	0	29	65	4	30	60	0.15	0.20	0.85	0.80	C	1	0.003912476	Maximal oxygen uptake response	Pulmonology
rs4925295	G	A	1	20	73	0	15	79	0.12	0.08	0.88	0.92	A	0.52	0.003906561	&beta;2-Glycoprotein I &beta;2-GPI plasma levels	Immune diseases and disorders
rs7922491	G	A	72	22	0	79	15	0	0.88	0.92	0.12	0.08	A	1.13	0.003906561	Asthma	Immune diseases and disorders
rs131788	T	C	7	36	51	5	30	59	0.27	0.21	0.73	0.79	A	0.04	0.003885004	Obesity-related traits	Obesity
rs7830933	A	G	57	34	3	52	34	8	0.79	0.73	0.21	0.27	A	0.0374	0.003885004	Waist-to-hip ratio adjusted for body mass index	Obesity
rs16971217	C	G	51	36	7	56	36	2	0.73	0.79	0.27	0.21	C	0.009	0.003885004	Mean platelet volume	Heart health and disorders
rs10754644	A	G	45	41	8	39	42	13	0.70	0.64	0.30	0.36	G	0.09	0.003856574	Economic and political preferences feminism_equality	Mental aptitude and behavioural traits
rs3742207	T	G	51	35	8	58	31	5	0.73	0.78	0.27	0.22	C	21	0.003827312	Arterial stiffness	Heart health and disorders
rs7816924	C	T	58	31	5	47	43	4	0.78	0.73	0.22	0.27	A	2.14	0.003827312	Response to antidepressant treatment citalopram	General health
rs1805576	C	G	62	23	9	48	41	5	0.78	0.73	0.22	0.27	G	1.79	0.003827312	Bipolar disorder and eating disorder	Brain health and disorders
rs893971	A	G	50	37	7	53	41	0	0.73	0.78	0.27	0.22	T	1.15	0.003827312	Conduct disorder interaction	Brain health and disorders
rs6815464	C	G	51	35	8	58	31	5	0.73	0.78	0.27	0.22	G	1.1236	0.003827312	Type 2 diabetes	Diabetes
rs1007358	A	G	55	37	2	49	39	6	0.78	0.73	0.22	0.27	A	0.021	0.003827312	Height	General health
rs5752326	C	T	5	31	58	5	41	48	0.22	0.27	0.78	0.73	T	0.31	0.003827312	Ischemic stroke	Brain health and disorders
rs10074991	G	A	47	36	11	38	43	13	0.69	0.63	0.31	0.37	G	1.2048193	0.003826329	Cardia gastric cancer	Cancer
rs1327235	A	G	46	38	10	35	49	10	0.69	0.63	0.31	0.37	G	0.34	0.003826329	Systolic blood pressure	Heart health and disorders
rs826221	A	G	59	31	4	65	28	1	0.79	0.84	0.21	0.16	A	2.66	0.003823821	Systolic blood pressure in sickle cell anemia	Heart health and disorders
rs16940186	T	C	65	28	1	56	37	1	0.84	0.79	0.16	0.21	G	1.56	0.003823821	Ulcerative colitis	Immune diseases and disorders
rs7916968	A	G	69	20	5	60	29	5	0.84	0.79	0.16	0.21	G	1.09	0.003823821	Migraine	Brain health and disorders
rs12444261	G	T	57	35	2	66	26	2	0.79	0.84	0.21	0.16	T	0.79	0.003823821	QT interval	Heart health and disorders
rs8037818	C	T	1	28	65	3	33	58	0.16	0.21	0.84	0.79	G	0.04	0.003823821	Obesity-related traits	Obesity
rs6569992	G	A	68	22	4	73	20	1	0.84	0.88	0.16	0.12	A	0.75	0.00379867	Red blood cell traits	Immune diseases and disorders
rs7090512	C	T	10	39	45	13	44	37	0.31	0.37	0.69	0.63	G	1.19	0.003797508	Multiple sclerosis	Brain health and disorders
rs2073080	C	T	48	40	6	55	36	3	0.72	0.78	0.28	0.22	T	1.47	0.003772446	Nonalcoholic fatty liver disease	Obesity
rs270545	G	A	50	36	8	59	28	7	0.72	0.78	0.28	0.22	G	1.37	0.003772446	Major depressive disorder	Brain health and disorders
rs2328223	A	C	49	38	7	58	30	6	0.72	0.78	0.28	0.22	C	0.03	0.003772446	LDL cholesterol	General health
rs2856717	A	G	2	38	54	9	34	51	0.22	0.28	0.78	0.72	G	1.38	0.003772446	IgA nephropathy	Immune diseases and disorders
rs3116494	G	A	7	38	49	5	32	57	0.28	0.22	0.72	0.78	G	1.080307	0.003772446	Ulcerative colitis	Immune diseases and disorders
rs4675361	C	T	7	38	49	5	32	57	0.28	0.22	0.72	0.78	T	0.0323	0.003772446	Heschl's gyrus morphology	Brain health and disorders
rs12148337	T	C	39	39	16	41	46	7	0.62	0.68	0.38	0.32	T	1.06	0.003770058	Schizophrenia	Brain health and disorders
rs7955516	A	C	41	46	7	38	41	15	0.68	0.62	0.32	0.38	C	0.02	0.003770058	Adiponectin levels	Obesity
rs10917477	A	G	36	44	14	42	43	9	0.62	0.68	0.38	0.32	A	0.058	0.003743928	Thyroid function	Immune diseases and disorders
rs7128198	C	T	33	50	11	45	37	12	0.62	0.68	0.38	0.32	T	0.036	0.003743928	Cholesterol, total	General health
rs6457327	A	C	11	50	33	12	37	45	0.38	0.32	0.62	0.68	C	1.69	0.003743928	Follicular lymphoma	Cancer
rs10751667	A	T	12	37	45	15	42	37	0.32	0.38	0.68	0.62	T	1.0753	0.003743928	Alzheimer's disease late onset	Brain health and disorders
rs7837791	G	T	9	43	42	13	46	35	0.32	0.38	0.68	0.62	T	0.106	0.003743928	Refractive error	General health
rs10513788	A	T	56	36	2	66	25	3	0.79	0.84	0.21	0.16	T	2.688	0.003740476	Cognitive function	Brain health and disorders
rs9394438	G	A	59	30	5	67	23	4	0.79	0.84	0.21	0.16	G	0.1671	0.003740476	IgG glycosylation	Immune diseases and disorders
rs2237892	C	T	56	36	2	65	27	2	0.79	0.84	0.21	0.16	T	0.0298	0.003740476	Body mass index	Obesity
rs3015469	G	A	6	28	60	5	21	68	0.21	0.16	0.79	0.84	G	0.11	0.003740476	Plasma amyloid beta peptide concentrations ABx-40	Brain health and disorders
rs12402265	G	A	71	23	0	78	16	0	0.88	0.91	0.12	0.09	A	1.23	0.00372822	Cervical artery dissection	Reproductive health
rs11842874	A	G	78	16	0	71	23	0	0.91	0.88	0.09	0.12	A	1.17	0.00372822	Osteoarthritis	Immune diseases and disorders
rs9818870	C	T	72	21	1	79	14	1	0.88	0.91	0.12	0.09	T	1.11	0.00372822	Coronary artery disease	Heart health and disorders
rs1084004	T	C	9	35	50	4	35	55	0.28	0.23	0.72	0.77	A	0.03	0.003720238	Obesity-related traits	Obesity
rs1883414	G	A	47	41	6	55	35	4	0.72	0.77	0.28	0.23	G	1.22	0.003720238	IgA nephropathy	Immune diseases and disorders
rs2364403	G	A	56	33	5	47	41	6	0.77	0.72	0.23	0.28	A	1	0.003720238	Amyotrophic lateral sclerosis age of onset	Brain health and disorders
rs236373	C	T	30	55	9	45	36	13	0.61	0.67	0.39	0.33	C	1	0.003719072	Heart rate	General health
rs939658	A	G	9	45	40	20	34	40	0.34	0.39	0.66	0.61	G	0.15	0.003695446	Refractive error	General health
rs8050136	C	A	42	41	11	35	44	15	0.66	0.61	0.34	0.39	A	8.04	0.003695446	Body mass index	Obesity
rs6027755	G	A	35	44	15	41	43	10	0.61	0.66	0.39	0.34	A	1.09	0.003695446	Non-alcoholic fatty liver disease histology other	Obesity
rs4947296	T	C	77	17	0	83	11	0	0.91	0.94	0.09	0.06	C	1.77	0.003694581	Graves' disease	Immune diseases and disorders
rs6956741	A	G	78	15	1	83	11	0	0.91	0.94	0.09	0.06	G	1	0.003694581	Amyotrophic lateral sclerosis age of onset	Brain health and disorders
rs2071278	A	G	78	15	1	84	9	1	0.91	0.94	0.09	0.06	G	0.13	0.003694581	Complement C3 and C4 levels	Immune diseases and disorders
rs9321063	A	G	83	11	0	77	17	0	0.94	0.91	0.06	0.09	A	0.07	0.003694581	Metabolite levels  X-11787	General health
rs2812533	T	C	0	17	77	1	9	84	0.09	0.06	0.91	0.94	C	1.07	0.003694581	Type 2 diabetes	Diabetes
rs9285624	C	T	1	15	78	0	11	83	0.09	0.06	0.91	0.94	C	0.16	0.003694581	Verbal declarative memory	Brain health and disorders
rs1499972	A	C	0	12	82	0	7	87	0.06	0.04	0.94	0.96	C	1.0869565	0.003685685	Schizophrenia	Brain health and disorders
rs2250402	G	T	0	12	82	0	7	87	0.06	0.04	0.94	0.96	T	0.0592	0.003685685	Corneal curvature	General health
rs1934954	T	C	82	12	0	87	7	0	0.94	0.96	0.06	0.04	T	7.1429	0.003685685	Tuberculosis	Immune diseases and disorders
rs62200787	T	A	82	12	0	87	7	0	0.94	0.96	0.06	0.04	T	1.098901	0.003685685	Schizophrenia	Brain health and disorders
rs72934505	T	G	82	12	0	87	7	0	0.94	0.96	0.06	0.04	T	1	0.003685685	White matter hyperintensity burden	Brain health and disorders
rs2377339	A	G	84	8	2	87	7	0	0.94	0.96	0.06	0.04	G	1	0.003685685	Addiction	Brain health and disorders
rs140913323	T	G	83	10	1	88	5	1	0.94	0.96	0.06	0.04	T	0.4822	0.003685685	Cerebrospinal AB1-42 levels	Brain health and disorders
rs9942541	C	T	87	7	0	82	12	0	0.96	0.94	0.04	0.06	T	0.23	0.003685685	Social communication problems	Brain health and disorders
rs3771381	A	T	82	12	0	87	7	0	0.94	0.96	0.06	0.04	A	0.045	0.003685685	Height	General health
rs1515641	G	A	73	19	2	65	27	2	0.88	0.84	0.12	0.16	A	1	0.003680699	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs11734132	G	C	63	31	0	72	21	1	0.84	0.88	0.16	0.12	G	0.1	0.003680699	Mean platelet volume	Heart health and disorders
rs1469039	G	A	72	21	1	65	27	2	0.88	0.84	0.12	0.16	A	0.05	0.003680699	Menarche age at onset	Reproductive health
rs12467609	C	T	13	38	43	12	51	31	0.34	0.40	0.66	0.60	T	1	0.003673011	Subcutaneous adipose tissue	Obesity
rs4304977	G	A	20	35	39	12	40	42	0.40	0.34	0.60	0.66	A	1	0.003673011	DNA methylation variation	Misc
rs887829	C	T	42	40	12	33	47	14	0.66	0.60	0.34	0.40	T	0.11449965	0.003673011	Total bilirubin levels in HIV-1 infection	Immune diseases and disorders
rs8057551	A	G	34	45	15	36	52	6	0.60	0.66	0.40	0.34	G	0.11	0.003673011	Bone mineral density	General health
rs9657904	T	C	57	30	7	46	42	6	0.77	0.71	0.23	0.29	T	1.4	0.003670533	Multiple sclerosis	Brain health and disorders
rs1794275	G	A	46	42	6	55	34	5	0.71	0.77	0.29	0.23	A	1.3	0.003670533	IgA nephropathy	Immune diseases and disorders
rs16891077	G	A	47	40	7	58	28	8	0.71	0.77	0.29	0.23	A	1	0.003670533	Fasting insulin interaction	General health
rs3817928	A	G	55	34	5	46	42	6	0.77	0.71	0.23	0.29	A	0.42	0.003670533	Pulmonary function	Pulmonology
rs262147	T	C	86	8	0	90	4	0	0.96	0.98	0.04	0.02	T	150.06	0.003663004	Hippocampal volume	Brain health and disorders
rs13146780	T	C	86	8	0	90	4	0	0.96	0.98	0.04	0.02	C	1.23	0.003663004	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs12155400	A	G	87	6	1	90	4	0	0.96	0.98	0.04	0.02	A	0.73	0.003663004	Retinopathy in non-diabetics	General health
rs61797053	G	A	86	8	0	90	4	0	0.96	0.98	0.04	0.02	A	0.67	0.003663004	Airway imaging phenotypes	Pulmonology
rs11994937	C	T	90	4	0	87	6	1	0.98	0.96	0.02	0.04	C	0.5011	0.003663004	IgG glycosylation	Immune diseases and disorders
rs10521222	C	T	86	8	0	90	4	0	0.96	0.98	0.04	0.02	C	0.104	0.003663004	C-reactive protein levels	Immune diseases and disorders
rs12209223	C	A	86	8	0	90	4	0	0.96	0.98	0.04	0.02	A	0.051	0.003663004	Height	General health
rs4566392	C	A	86	8	0	90	4	0	0.96	0.98	0.04	0.02	A	0.037	0.003663004	Body mass index	Obesity
rs7826834	C	T	90	4	0	86	8	0	0.98	0.96	0.02	0.04	T	0.02	0.003663004	Plasma omega-6 polyunsaturated fatty acid levels gamma-linolenic acid	General health
rs132390	C	T	0	4	90	0	8	86	0.02	0.04	0.98	0.96	C	1.12	0.003663004	Breast cancer	Cancer
rs10195263	G	A	0	4	90	0	8	86	0.02	0.04	0.98	0.96	G	1	0.003663004	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs2817937	C	T	0	8	86	0	4	90	0.04	0.02	0.96	0.98	C	0.25	0.003663004	Primary tooth development number of teeth	Misc
rs7561317	A	G	2	28	64	4	33	57	0.17	0.22	0.83	0.78	G	6.12	0.00366201	Body mass index	Obesity
rs6676375	T	C	58	31	5	67	22	5	0.78	0.83	0.22	0.17	T	3.0303	0.00366201	Tuberculosis	Immune diseases and disorders
rs17168486	C	T	58	31	5	64	28	2	0.78	0.83	0.22	0.17	T	1.13	0.00366201	Type 2 diabetes	Diabetes
rs3774372	T	C	64	28	2	57	33	4	0.83	0.78	0.17	0.22	T	0.298	0.00366201	Blood pressure	Heart health and disorders
rs11809230	C	T	64	28	2	57	33	4	0.83	0.78	0.17	0.22	T	0.29	0.00366201	Cannabis use initiation	General health
rs1375785	A	C	4	24	66	4	33	57	0.17	0.22	0.83	0.78	A	0.2	0.00366201	Information processing speed	Mental aptitude and behavioural traits
rs2274136	C	T	2	28	64	5	31	58	0.17	0.22	0.83	0.78	G	0.03	0.00366201	Obesity-related traits	Obesity
rs7694379	G	A	39	45	10	28	56	10	0.65	0.60	0.35	0.40	A	2.129	0.003651728	Platelet count	Heart health and disorders
rs10160456	C	T	11	43	40	16	44	34	0.35	0.40	0.65	0.60	C	0.0681	0.003651728	Bone mineral density paediatric, skull	General health
rs6854783	G	A	12	42	40	16	45	33	0.35	0.41	0.65	0.59	A	0.06	0.003631562	Height	General health
rs1884897	A	G	11	44	39	16	45	33	0.35	0.41	0.65	0.59	G	0.016	0.003631562	Body mass index	Obesity
rs9420	A	G	8	29	57	8	39	47	0.24	0.29	0.76	0.71	A	1.068	0.003623188	Schizophrenia	Brain health and disorders
rs11750568	A	G	12	31	51	5	35	54	0.29	0.24	0.71	0.76	A	0.02	0.003623188	Height	General health
rs3129720	T	C	3	27	64	3	36	55	0.18	0.22	0.82	0.78	C	1.16	0.00358804	Hypothyroidism	Immune diseases and disorders
rs7961581	C	T	6	30	58	1	31	62	0.22	0.18	0.78	0.82	C	1.09	0.00358804	Type 2 diabetes	Diabetes
rs2190016	C	T	5	32	57	3	27	64	0.22	0.18	0.78	0.82	T	1	0.00358804	Mammographic density non-dense area	Reproductive health
rs7779014	C	T	54	34	6	46	40	8	0.76	0.70	0.24	0.30	T	0.48	0.003578074	Multiple sclerosis	Brain health and disorders
rs758944	C	A	54	34	6	46	40	8	0.76	0.70	0.24	0.30	T	0.48	0.003578074	Multiple sclerosis	Brain health and disorders
rs12428086	T	C	46	40	8	51	40	3	0.70	0.76	0.30	0.24	G	0.04	0.003578074	Obesity-related traits	Obesity
rs12450239	G	A	46	40	8	52	38	4	0.70	0.76	0.30	0.24	A	0.026	0.003578074	Body mass index	Obesity
rs9305406	G	A	15	39	40	11	58	25	0.37	0.43	0.63	0.57	G	1	0.003577447	Response to statin therapy	General health
rs6464816	G	A	67	22	5	72	20	2	0.83	0.87	0.17	0.13	A	1	0.003571429	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs7158300	C	T	71	22	1	66	24	4	0.87	0.83	0.13	0.17	T	0.056	0.003571429	Height	General health
rs16899524	C	T	71	22	1	65	26	3	0.87	0.83	0.13	0.17	C	0.04	0.003571429	Beta-2 microglubulin plasma levels	Cancer
rs6010044	A	C	65	26	3	70	24	0	0.83	0.87	0.17	0.13	A	0.008	0.003571429	Fibrinogen	General health
rs4723619	T	C	78	15	1	72	20	2	0.91	0.87	0.09	0.13	C	3.01	0.003567528	Response to treatment for acute lymphoblastic leukemia	General health
rs10484554	C	T	80	11	3	71	22	1	0.91	0.87	0.09	0.13	T	2.8	0.003567528	Psoriasis	Immune diseases and disorders
rs12191877	C	T	80	11	3	71	22	1	0.91	0.87	0.09	0.13	T	2.64	0.003567528	Psoriasis	Immune diseases and disorders
rs16861329	C	T	71	22	1	78	15	1	0.87	0.91	0.13	0.09	G	1.09	0.003567528	Type 2 diabetes	Diabetes
rs12534221	C	A	70	24	0	77	17	0	0.87	0.91	0.13	0.09	A	1	0.003567528	Cerebrospinal AB1-42 levels	Brain health and disorders
rs6041	G	A	77	17	0	71	22	1	0.91	0.87	0.09	0.13	G	0.877	0.003567528	End-stage coagulation	General health
rs6853847	A	C	77	17	0	72	20	2	0.91	0.87	0.09	0.13	C	0.4788	0.003567528	IgG glycosylation	Immune diseases and disorders
rs1998359	C	G	71	22	1	78	15	1	0.87	0.91	0.13	0.09	G	0.0809	0.003567528	Self-reported allergy	General health
rs12356193	A	G	71	22	1	77	17	0	0.87	0.91	0.13	0.09	A	0.08	0.003567528	Uric acid levels	General health
rs78661745	C	T	70	24	0	78	15	1	0.87	0.91	0.13	0.09	C	0.068	0.003567528	Bulimia nervosa	Brain health and disorders
rs3816183	T	C	2	20	72	0	17	77	0.13	0.09	0.87	0.91	T	1.58	0.003567528	Hypospadias	Misc
rs1192691	G	T	2	13	79	0	24	70	0.09	0.13	0.91	0.87	C	1.23	0.003567528	Epithelial ovarian cancer	Cancer
rs6463768	C	G	2	20	72	0	17	77	0.13	0.09	0.87	0.91	C	0.19	0.003567528	Metabolite levels Pyroglutamine	General health
rs4649444	C	A	33	51	10	29	48	17	0.62	0.56	0.38	0.44	A	1	0.003546411	Homeostasis model assessment of beta-cell function interaction	Misc
rs4720952	G	A	18	46	30	14	43	37	0.44	0.38	0.56	0.62	G	0.1583	0.003546411	IgG glycosylation	Immune diseases and disorders
rs4143116	G	A	47	37	10	54	33	7	0.70	0.75	0.30	0.25	A	2.28	0.003535068	Diisocyanate-induced asthma	Pulmonology
rs28834970	T	C	47	37	10	57	27	10	0.70	0.75	0.30	0.25	C	1.1	0.003535068	Alzheimer's disease late onset	Brain health and disorders
rs58950470	G	T	50	31	13	52	37	5	0.70	0.75	0.30	0.25	T	1.05	0.003535068	Schizophrenia	Brain health and disorders
rs11098499	C	T	43	45	6	52	37	5	0.70	0.75	0.30	0.25	C	0.048	0.003535068	Corneal astigmatism	General health
rs9833094	C	T	30	45	19	30	56	8	0.56	0.62	0.44	0.38	T	2.95	0.003532331	Acute urticaria and angioedema non-steroidal anti-inflammatory drug-induced	Immune diseases and disorders
rs2857151	A	G	20	43	31	15	42	37	0.44	0.38	0.56	0.62	G	1.47	0.003532331	Kawasaki disease	Misc
rs2981582	A	G	14	44	36	18	47	29	0.38	0.44	0.62	0.56	A	1.26	0.003532331	Breast cancer	Cancer
rs898518	C	A	15	53	26	18	36	40	0.44	0.38	0.56	0.62	A	1.2	0.003532331	Chronic lymphocytic leukemia	Cancer
rs624988	T	C	19	34	41	22	39	33	0.38	0.44	0.62	0.56	T	1.09	0.003532331	Rheumatoid arthritis	Immune diseases and disorders
rs4930561	G	A	18	36	40	21	41	32	0.38	0.44	0.62	0.56	G	0.185	0.003532331	IgG glycosylation	Immune diseases and disorders
rs4510656	C	A	28	48	18	35	45	14	0.55	0.61	0.45	0.39	C	1.1236	0.003519181	Bladder cancer	Cancer
rs6716963	A	G	19	46	29	14	45	35	0.45	0.39	0.55	0.61	A	1.06	0.003519181	Schizophrenia	Brain health and disorders
rs55974252	C	G	54	37	3	64	26	4	0.77	0.82	0.23	0.18	C	1.12	0.003518221	Psoriasis	Immune diseases and disorders
rs255052	G	A	57	31	6	64	26	4	0.77	0.82	0.23	0.18	A	0.74	0.003518221	HDL cholesterol	General health
rs6235	C	G	55	35	4	64	26	4	0.77	0.82	0.23	0.18	G	0.0056	0.003518221	Glycemic traits pregnancy	Reproductive health
rs11265461	T	C	33	48	13	28	47	19	0.61	0.55	0.39	0.45	C	1.45	0.003506941	Schizophrenia treatment resistant	Brain health and disorders
rs5015480	C	T	33	37	24	42	30	22	0.55	0.61	0.45	0.39	C	1.18	0.003506941	Type 2 diabetes	Diabetes
rs6844339	A	G	34	46	14	33	37	24	0.61	0.55	0.39	0.45	G	0.03	0.003506941	Obesity-related traits	Obesity
rs11118993	A	G	15	45	34	16	54	24	0.40	0.46	0.60	0.54	A	0.2051	0.003495594	Neurofibrillary tangles	Brain health and disorders
rs7927894	C	T	52	36	6	44	42	8	0.74	0.69	0.26	0.31	T	1.16	0.00349406	Crohn's disease	Digestive system and its disorders
rs2412488	A	G	11	36	47	5	38	51	0.31	0.26	0.69	0.74	A	1	0.00349406	DNA methylation variation	Misc
rs853356	G	A	54	32	8	47	36	11	0.74	0.69	0.26	0.31	A	0.04	0.00349406	Height	General health
rs10852453	T	A	22	43	29	10	56	28	0.46	0.40	0.54	0.60	T	0.1462	0.003485123	IgG glycosylation	Immune diseases and disorders
rs9355610	G	A	29	43	22	32	48	14	0.54	0.60	0.46	0.40	G	1.19	0.003485123	Graves' disease	Immune diseases and disorders
rs11887277	T	C	33	46	15	26	49	19	0.60	0.54	0.40	0.46	A	0.04	0.003485123	Obesity-related traits	Obesity
rs1476698	A	G	26	49	19	35	42	17	0.54	0.60	0.46	0.40	A	0.007	0.003485123	Fibrinogen	General health
rs1351435	T	G	0	2	92	0	5	89	0.01	0.03	0.99	0.97	A	0.04	0.003484321	Obesity-related traits	Obesity
rs1448284	A	G	89	5	0	92	2	0	0.97	0.99	0.03	0.01	T	9939.9	0.003484321	Brain structure temporal lobe volume	Brain health and disorders
rs17140547	C	T	92	2	0	89	5	0	0.99	0.97	0.01	0.03	T	532.56	0.003484321	Lentiform nucleus volume	Misc
rs114190122	A	G	92	2	0	89	5	0	0.99	0.97	0.01	0.03	G	34.03	0.003484321	Diisocyanate-induced asthma	Pulmonology
rs16856332	T	G	92	2	0	90	3	1	0.99	0.97	0.01	0.03	T	3.9	0.003484321	Liver enzyme levels alkaline phosphatase	General health
rs145848414	G	A	92	2	0	89	5	0	0.99	0.97	0.01	0.03	A	2.29	0.003484321	Alzheimer's disease late onset	Brain health and disorders
rs1326986	T	C	89	5	0	92	2	0	0.97	0.99	0.03	0.01	C	1.9	0.003484321	Ankylosing spondylitis	Immune diseases and disorders
rs55834529	A	G	92	2	0	89	5	0	0.99	0.97	0.01	0.03	A	1.24	0.003484321	Schizophrenia	Brain health and disorders
rs118162387	G	A	89	5	0	92	2	0	0.97	0.99	0.03	0.01	G	1.1627907	0.003484321	Schizophrenia	Brain health and disorders
rs11064768	A	G	89	5	0	92	2	0	0.97	0.99	0.03	0.01	A	1	0.003484321	Schizophrenia	Brain health and disorders
rs7680468	G	T	89	5	0	92	2	0	0.97	0.99	0.03	0.01	T	1	0.003484321	Telomere length	Aging
rs117372389	G	T	89	5	0	92	2	0	0.97	0.99	0.03	0.01	T	1	0.003484321	Pediatric autoimmune diseases	Immune diseases and disorders
rs113524839	C	T	89	5	0	92	2	0	0.97	0.99	0.03	0.01	T	1	0.003484321	Alzheimer's disease biomarkers	Brain health and disorders
rs117025875	G	A	92	2	0	89	5	0	0.99	0.97	0.01	0.03	G	0.8594	0.003484321	Cerebrospinal fluid p-Tau181p:AB1-42 ratio	Brain health and disorders
rs62174474	T	C	89	5	0	92	2	0	0.97	0.99	0.03	0.01	C	0.7084	0.003484321	Vascular brain injury	Brain health and disorders
rs17124610	C	T	92	2	0	89	5	0	0.99	0.97	0.01	0.03	C	0.6724	0.003484321	IgG glycosylation	Immune diseases and disorders
rs1058065	G	A	89	5	0	92	2	0	0.97	0.99	0.03	0.01	G	0.54	0.003484321	IgG glycosylation	Immune diseases and disorders
rs79578553	G	A	92	2	0	89	5	0	0.99	0.97	0.01	0.03	A	0.14	0.003484321	Red wine liking	Mental aptitude and behavioural traits
rs6922617	G	A	89	5	0	92	2	0	0.97	0.99	0.03	0.01	A	0.094	0.003484321	Alzheimer's disease biomarkers	Brain health and disorders
rs2540647	G	A	89	5	0	92	2	0	0.97	0.99	0.03	0.01	A	0.059	0.003484321	Blood metabolite ratios	Heart health and disorders
rs10490626	G	A	89	5	0	92	2	0	0.97	0.99	0.03	0.01	A	0.042	0.003484321	Cholesterol, total	General health
rs2596542	C	T	18	41	35	23	42	29	0.41	0.47	0.59	0.53	A	1.39	0.003475513	Hepatocellular carcinoma	Cancer
rs16890979	C	T	35	41	18	28	44	22	0.59	0.53	0.41	0.47	C	0.254	0.003475513	Urate levels in lean individuals	Obesity
rs679711	T	C	23	42	29	11	55	28	0.47	0.41	0.53	0.59	T	0.1	0.003475513	Sleep depth	General health
rs938554	C	G	18	41	35	22	44	28	0.41	0.47	0.59	0.53	C	0.035	0.003475513	Blood metabolite levels	Heart health and disorders
rs2335704	C	A	1	23	70	2	29	63	0.13	0.18	0.87	0.82	C	1.19	0.003469963	Tuberculosis	Immune diseases and disorders
rs13095226	T	C	77	16	1	82	12	0	0.90	0.94	0.10	0.06	C	1.24	0.003468208	Age-related macular degeneration	Aging
rs11121321	C	T	76	18	0	83	10	1	0.90	0.94	0.10	0.06	T	0.82	0.003468208	Cannabis use initiation	General health
rs9832314	A	G	83	10	1	76	18	0	0.94	0.90	0.06	0.10	G	0.2992	0.003468208	IgG glycosylation	Immune diseases and disorders
rs11841001	G	A	82	12	0	77	16	1	0.94	0.90	0.06	0.10	A	0.208	0.003468208	Corneal astigmatism	General health
rs7447447	C	T	78	14	2	82	12	0	0.90	0.94	0.10	0.06	T	0.1521	0.003468208	Caffeine consumption	General health
rs2523809	G	T	77	16	1	82	12	0	0.90	0.94	0.10	0.06	T	0.06	0.003468208	IgE levels	Immune diseases and disorders
rs7957589	A	T	82	12	0	76	18	0	0.94	0.90	0.06	0.10	T	0.047	0.003468208	Motion sickness	Misc
rs2447097	T	G	23	43	28	15	48	31	0.47	0.41	0.53	0.59	A	1.53	0.003466751	Autism spectrum disorder	Brain health and disorders
rs7501939	T	C	18	42	34	20	49	25	0.41	0.47	0.59	0.53	C	1.28	0.003466751	Testicular germ cell tumor	Cancer
rs314276	A	C	17	44	33	21	47	26	0.41	0.47	0.59	0.53	C	0.14	0.003466751	Menarche age at onset	Reproductive health
rs336284	A	G	22	46	26	18	43	33	0.48	0.42	0.52	0.58	A	1.661	0.003458823	Suicide	Mental aptitude and behavioural traits
rs2236256	C	A	25	48	21	33	43	18	0.52	0.58	0.48	0.42	C	1.23	0.003458823	Chronic lymphocytic leukemia	Cancer
rs4823246	G	A	6	37	51	10	39	45	0.26	0.31	0.74	0.69	G	0.1	0.003454947	Economic and political preferences feminism_equality	Mental aptitude and behavioural traits
rs2980879	A	T	7	45	42	4	41	49	0.31	0.26	0.69	0.74	T	0.03	0.003454947	Adiponectin levels	Obesity
rs42235	C	T	51	37	6	40	49	5	0.74	0.69	0.26	0.31	T	1.28	0.003454947	Height	General health
rs2384550	G	A	52	35	7	42	45	7	0.74	0.69	0.26	0.31	A	0.35	0.003454947	Diastolic blood pressure	Heart health and disorders
rs798943	G	A	44	41	9	51	37	6	0.69	0.74	0.31	0.26	G	0.2016	0.003454947	Bone mineral density paediatric, upper limb	General health
rs2154490	A	G	1	33	60	2	40	52	0.19	0.23	0.81	0.77	A	1	0.003452244	Glucocorticoid-induced osteonecrosis	Drug response
rs1171614	T	C	2	31	61	2	40	52	0.19	0.23	0.81	0.77	T	0.079	0.003452244	Urate levels	General health
rs7975161	T	C	3	38	53	2	31	61	0.23	0.19	0.77	0.81	T	0.023	0.003452244	Toenail selenium levels	Misc
rs6662509	C	T	62	29	3	52	40	2	0.81	0.77	0.19	0.23	T	1.23	0.003452244	Height	General health
rs2521501	A	T	55	34	5	61	31	2	0.77	0.81	0.23	0.19	T	0.65	0.003452244	Systolic blood pressure	Heart health and disorders
rs9328448	A	G	61	31	2	57	30	7	0.81	0.77	0.19	0.23	A	0.17	0.003452244	Coronary artery calcification	Heart health and disorders
rs12598357	A	G	26	44	24	25	57	12	0.51	0.57	0.49	0.43	G	1	0.003445428	Pediatric autoimmune diseases	Immune diseases and disorders
rs2236653	C	T	29	48	17	20	55	19	0.56	0.51	0.44	0.49	T	1.5	0.003439943	Liver enzyme levels alkaline phosphatase	General health
rs1859962	G	T	22	49	23	20	42	32	0.49	0.44	0.51	0.56	G	1.27	0.003439943	Prostate cancer	Cancer
rs7084921	C	T	28	50	16	25	45	24	0.56	0.51	0.44	0.49	T	0.03	0.003439943	Bone mineral density	General health
rs1318862	C	T	22	50	22	22	39	33	0.50	0.44	0.50	0.56	T	26.86	0.003435255	Subcortical brain region volumes	Brain health and disorders
rs12651329	T	C	17	60	17	20	43	31	0.50	0.44	0.50	0.56	C	1	0.003435255	Amyotrophic lateral sclerosis age of onset	Brain health and disorders
rs1861612	G	A	23	49	22	21	42	31	0.51	0.45	0.49	0.55	T	1.29	0.003431359	Type 2 diabetes	Diabetes
rs7745274	G	A	26	43	25	20	44	30	0.51	0.45	0.49	0.55	A	1.15	0.003431359	Waist-hip ratio	General health
rs10009409	C	T	24	44	26	23	57	14	0.49	0.55	0.51	0.45	T	1.09	0.003428248	Prostate cancer	Cancer
rs243021	G	A	23	46	25	30	43	21	0.49	0.55	0.51	0.45	A	1.08	0.003428248	Type 2 diabetes	Diabetes
rs690037	C	T	27	42	25	20	45	29	0.51	0.45	0.49	0.55	C	0.208	0.003428248	Optic nerve measurement cup area	Misc
rs2608053	T	C	21	44	29	23	51	20	0.46	0.52	0.54	0.48	G	1.2	0.003425918	Hodgkin's lymphoma	Cancer
rs7780564	A	C	27	48	19	22	47	25	0.54	0.48	0.46	0.52	C	1	0.003425918	Insulin-like growth factors	General health
rs7108470	A	G	25	47	22	20	46	28	0.52	0.46	0.48	0.54	G	0.1516	0.003425918	IgG glycosylation	Immune diseases and disorders
rs1056667	T	C	18	50	26	24	49	21	0.46	0.52	0.54	0.48	T	0.093	0.003425918	Educational attainment	Mental aptitude and behavioural traits
rs2005705	A	G	19	49	26	20	58	16	0.46	0.52	0.54	0.48	G	1.35	0.003424367	Prostate cancer early onset	Cancer
rs198160	G	T	24	50	20	15	57	22	0.52	0.46	0.48	0.54	G	1.0526316	0.003424367	Schizophrenia	Brain health and disorders
rs10906189	G	A	18	54	22	28	45	21	0.48	0.54	0.52	0.46	A	1	0.003424367	QT interval interaction	Heart health and disorders
rs3095254	C	G	23	41	30	28	42	24	0.46	0.52	0.54	0.48	C	0.074	0.003424367	White blood cell types	Immune diseases and disorders
rs2505675	C	T	31	37	26	26	36	32	0.53	0.47	0.47	0.53	T	4.5455	0.003423592	Tuberculosis	Immune diseases and disorders
rs11730701	G	A	26	47	21	20	48	26	0.53	0.47	0.47	0.53	G	1.0526316	0.003423592	Schizophrenia	Brain health and disorders
rs1993709	A	G	0	18	76	1	23	70	0.10	0.13	0.90	0.87	G	1.38	0.003422027	Obesity early onset extreme	Obesity
rs13191343	C	T	79	12	3	70	23	1	0.90	0.87	0.10	0.13	T	2.37	0.003422027	Psoriatic arthritis	Immune diseases and disorders
rs11820589	G	A	77	16	1	69	25	0	0.90	0.87	0.10	0.13	A	0.32	0.003422027	Metabolic syndrome bivariate traits	Immune diseases and disorders
rs11825181	G	A	77	16	1	69	25	0	0.90	0.87	0.10	0.13	A	0.076	0.003422027	Blood metabolite levels	Heart health and disorders
rs239339	G	T	71	21	2	77	16	1	0.87	0.90	0.13	0.10	A	0.03	0.003422027	Obesity-related traits	Obesity
rs12234571	T	G	76	18	0	71	21	2	0.90	0.87	0.10	0.13	C	0.03	0.003422027	Obesity-related traits	Obesity
rs288232	C	T	70	23	1	76	18	0	0.87	0.90	0.13	0.10	C	0.023	0.003422027	Body mass index	Obesity
rs7445832	T	A	48	42	4	44	40	10	0.73	0.68	0.27	0.32	A	1.15	0.003417635	Alcohol and nictotine co-dependence	General health
rs17300741	A	G	41	46	7	47	44	3	0.68	0.73	0.32	0.27	A	0.06	0.003417635	Uric acid levels	General health
rs61759167	C	T	43	42	9	48	42	4	0.68	0.73	0.32	0.27	T	0.047	0.003417635	Motion sickness	Misc
rs2383393	A	G	9	42	43	8	34	52	0.32	0.27	0.68	0.73	G	0.1	0.003417635	Body mass index	Obesity
rs2246208	C	T	6	33	55	5	26	63	0.24	0.19	0.76	0.81	T	0.0025	0.003389831	Trans fatty acid levels	General health
rs17268785	A	G	62	28	4	53	37	4	0.81	0.76	0.19	0.24	G	3.2	0.003389831	Menarche age at onset	Reproductive health
rs35675666	G	T	62	28	4	51	41	2	0.81	0.76	0.19	0.24	G	1.08	0.003389831	Ulcerative colitis	Immune diseases and disorders
rs6747380	G	A	62	28	4	54	35	5	0.81	0.76	0.19	0.24	A	0.07	0.003389831	Menarche age at onset	Reproductive health
rs1938679	C	T	61	30	3	51	41	2	0.81	0.76	0.19	0.24	T	0.032	0.003389831	Height	General health
rs6852678	C	T	58	27	9	63	26	5	0.76	0.81	0.24	0.19	T	0.0235	0.003389831	Magnesium levels	General health
rs4918918	T	C	6	39	49	8	45	41	0.27	0.32	0.73	0.68	T	1.18	0.003382035	Suicide risk	General health
rs6042314	G	C	6	39	49	12	37	45	0.27	0.32	0.73	0.68	C	0.058	0.003382035	Intelligence childhood	Mental aptitude and behavioural traits
rs733254	C	A	45	37	12	52	33	9	0.68	0.73	0.32	0.27	A	0.041	0.003382035	Height	General health
rs3130501	A	G	3	28	63	1	24	69	0.18	0.14	0.82	0.86	G	1.74	0.003375527	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis SJS_TEN	Drug response
rs3132524	T	C	3	28	63	1	24	69	0.18	0.14	0.82	0.86	G	1.07	0.003375527	Type 2 diabetes	Diabetes
rs1799964	T	C	62	30	2	69	24	1	0.82	0.86	0.18	0.14	C	1.19	0.003375527	Crohn's disease	Digestive system and its disorders
rs264	G	A	71	20	3	61	32	1	0.86	0.82	0.14	0.18	A	1.1111	0.003375527	Coronary artery disease	Heart health and disorders
rs12924103	T	C	63	28	3	70	22	2	0.82	0.86	0.18	0.14	T	1	0.003375527	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs11647507	A	C	63	28	3	70	22	2	0.82	0.86	0.18	0.14	A	1	0.003375527	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs10521115	G	A	63	28	3	70	22	2	0.82	0.86	0.18	0.14	A	1	0.003375527	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs11642377	G	A	63	28	3	70	22	2	0.82	0.86	0.18	0.14	A	1	0.003375527	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs2883428	A	G	64	26	4	70	22	2	0.82	0.86	0.18	0.14	A	1	0.003375527	White matter hyperintensity burden	Brain health and disorders
rs4307732	G	A	69	24	1	63	28	3	0.86	0.82	0.14	0.18	A	0.056	0.003375527	Cholesterol, total	General health
rs10504249	A	G	82	11	1	86	8	0	0.93	0.96	0.07	0.04	G	3.22	0.003353454	Blood pressure measurement low sodium intervention	Heart health and disorders
rs17125944	T	C	82	11	1	87	6	1	0.93	0.96	0.07	0.04	C	1.14	0.003353454	Alzheimer's disease late onset	Brain health and disorders
rs737092	T	C	9	44	41	2	48	44	0.33	0.28	0.67	0.72	C	0.216	0.003348065	Red blood cell traits	Immune diseases and disorders
rs1024020	T	C	9	34	51	10	42	42	0.28	0.33	0.72	0.67	A	0.18	0.003348065	RR interval heart rate	Heart health and disorders
rs4658101	A	G	7	38	49	10	42	42	0.28	0.33	0.72	0.67	A	0.015	0.003348065	Vertical cup-disc ratio	Misc
rs1669070	C	T	43	40	11	50	36	8	0.67	0.72	0.33	0.28	T	3.02	0.003348065	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs9495528	C	T	49	38	7	41	44	9	0.72	0.67	0.28	0.33	C	0.171	0.003348065	Urate levels in lean individuals	Obesity
rs6432860	A	G	6	34	54	5	27	62	0.24	0.20	0.76	0.80	G	1.29	0.003330729	Febrile seizures MMR vaccine-unrelated	General health
rs4760099	A	G	8	30	56	2	33	59	0.24	0.20	0.76	0.80	A	0.1636	0.003330729	Urinary metabolites	General health
rs11803434	A	G	56	30	8	61	29	4	0.76	0.80	0.24	0.20	G	3.57	0.003330729	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs3750848	T	G	53	36	5	58	35	1	0.76	0.80	0.24	0.20	C	3.12	0.003330729	Age-related macular degeneration extreme sampling	Aging
rs7896518	A	G	45	35	14	43	49	2	0.66	0.72	0.34	0.28	A	5.18	0.00331565	Mean platelet volume	Heart health and disorders
rs10761731	A	T	45	35	14	43	49	2	0.66	0.72	0.34	0.28	T	2.38	0.00331565	Triglycerides	General health
rs10740118	G	C	45	35	14	43	49	2	0.66	0.72	0.34	0.28	C	0.25	0.00331565	Plasma omega-6 polyunsaturated fatty acid levels linoleic acid	General health
rs7075195	A	G	45	35	14	43	49	2	0.66	0.72	0.34	0.28	A	0.13	0.00331565	Mean platelet volume	Heart health and disorders
rs957140	G	A	41	43	10	49	37	8	0.66	0.72	0.34	0.28	A	0.045	0.00331565	Homocysteine levels	Misc
rs9297357	C	T	9	45	40	5	43	46	0.34	0.28	0.66	0.72	T	1.07	0.00331565	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs7671189	T	C	11	41	42	8	37	49	0.34	0.28	0.66	0.72	A	0.03	0.00331565	Obesity-related traits	Obesity
rs4836519	T	C	69	24	1	75	19	0	0.86	0.90	0.14	0.10	T	1.072	0.003289695	Inflammatory bowel disease	Immune diseases and disorders
rs40363	G	A	64	25	5	68	25	1	0.81	0.86	0.19	0.14	G	11.1111	0.003287446	Tuberculosis	Immune diseases and disorders
rs7957197	T	A	69	23	2	61	31	2	0.86	0.81	0.14	0.19	T	1.07	0.003287446	Type 2 diabetes	Diabetes
rs447	T	C	4	27	63	1	25	68	0.19	0.14	0.81	0.86	C	1.025	0.003287446	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs198846	A	G	4	27	63	2	23	69	0.19	0.14	0.81	0.86	A	1	0.003287446	Hemoglobin	Heart health and disorders
rs343604	T	C	2	31	61	0	27	67	0.19	0.14	0.81	0.86	T	1	0.003287446	Acute lymphoblastic leukemia childhood	Cancer
rs4781563	G	A	67	27	0	62	29	3	0.86	0.81	0.14	0.19	A	0.163	0.003287446	Bilirubin levels	General health
rs16917919	A	G	39	46	9	48	38	8	0.66	0.71	0.34	0.29	A	147.6	0.003284719	Brain structure hippocampal volume	Brain health and disorders
rs2736337	T	C	40	44	10	47	40	7	0.66	0.71	0.34	0.29	C	1.15	0.003284719	Rheumatoid arthritis	Immune diseases and disorders
rs6545803	G	T	48	38	8	39	46	9	0.71	0.66	0.29	0.34	G	1	0.003284719	Nevirapine-induced rash	General health
rs11079321	G	A	45	34	15	48	38	8	0.66	0.71	0.34	0.29	A	0.16	0.003284719	Coronary artery calcification	Heart health and disorders
rs4845459	C	A	7	50	37	8	38	48	0.34	0.29	0.66	0.71	A	1.32	0.003284719	Psoriasis	Immune diseases and disorders
rs6062504	A	G	9	36	49	10	44	40	0.29	0.34	0.71	0.66	A	1.1168494	0.003284719	Crohn's disease	Digestive system and its disorders
rs3099557	G	A	9	36	49	13	38	43	0.29	0.34	0.71	0.66	A	0.148	0.003284719	Blood metabolite levels	Heart health and disorders
rs10440833	T	A	60	30	4	53	35	6	0.80	0.75	0.20	0.25	A	1.25	0.003274712	Type 2 diabetes	Diabetes
rs4950928	G	C	2	34	58	7	33	54	0.20	0.25	0.80	0.75	G	0.3	0.003274712	YKL-40 levels	Diabetes
rs744487	A	C	53	35	6	60	30	4	0.75	0.80	0.25	0.20	A	0.069	0.003274712	LDL cholesterol	General health
rs7586540	G	A	0	19	75	0	13	81	0.10	0.07	0.90	0.93	A	0.43	0.003270349	Coronary artery calcification	Heart health and disorders
rs11164654	T	C	2	15	77	0	13	81	0.10	0.07	0.90	0.93	C	0.044	0.003270349	Cholesterol, total	General health
rs10262995	C	T	83	9	2	75	19	0	0.93	0.90	0.07	0.10	A	12.84	0.003270349	Acute kidney injury in coronary artery bypass surgery creatinine rise	General health
rs12288023	T	C	82	11	1	75	19	0	0.93	0.90	0.07	0.10	C	0.27	0.003270349	Serum metabolite levels	General health
rs115849089	G	A	75	19	0	81	13	0	0.90	0.93	0.10	0.07	A	0.162	0.003270349	HDL cholesterol	General health
rs7601155	C	T	81	13	0	76	17	1	0.93	0.90	0.07	0.10	T	0.06	0.003270349	Waist circumference	General health
rs13010639	C	T	77	15	2	81	13	0	0.90	0.93	0.10	0.07	A	0.04	0.003270349	Obesity-related traits	Obesity
rs17513268	A	G	76	17	1	82	11	1	0.90	0.93	0.10	0.07	G	0.03	0.003270349	Obesity-related traits	Obesity
rs7481311	T	C	12	31	51	13	39	42	0.29	0.35	0.71	0.65	T	3.15	0.003255208	Body mass index	Obesity
rs4379723	T	C	43	37	14	42	49	3	0.65	0.71	0.35	0.29	T	5.4297	0.003255208	Platelet count	Heart health and disorders
rs420259	A	G	45	43	6	38	47	9	0.71	0.65	0.29	0.35	A	2.08	0.003255208	Bipolar disorder	Brain health and disorders
rs61841072	A	G	40	43	11	44	45	5	0.65	0.71	0.35	0.29	G	1.3157895	0.003255208	Schizophrenia	Brain health and disorders
rs7910927	T	G	43	37	14	42	49	3	0.65	0.71	0.35	0.29	T	0.05	0.003255208	Sex hormone-binding globulin levels	Reproductive health
rs10889348	A	T	48	37	9	37	49	8	0.71	0.65	0.29	0.35	A	0.043	0.003255208	LDL cholesterol	General health
rs12355784	C	A	43	37	14	42	49	3	0.65	0.71	0.35	0.29	A	0.03	0.003255208	Liver enzyme levels	General health
rs10166311	G	A	42	39	13	50	33	11	0.65	0.71	0.35	0.29	A	0.023	0.003255208	Educational attainment	Mental aptitude and behavioural traits
rs6681544	C	T	62	25	7	54	32	8	0.79	0.74	0.21	0.26	C	0.04	0.003221573	Metabolite levels  X-11787	General health
rs7710178	G	T	69	22	3	62	28	4	0.85	0.81	0.15	0.19	T	0.129	0.003205128	Airway responsiveness in chronic obstructive pulmonary disease	Pulmonology
rs12229663	A	G	68	24	2	63	26	5	0.85	0.81	0.15	0.19	G	0.099	0.003205128	Refractive error	General health
rs11230874	T	G	60	32	2	67	26	1	0.81	0.85	0.19	0.15	T	0.07	0.003205128	Phospholipid levels plasma	General health
rs12546962	A	G	64	24	6	66	28	0	0.81	0.85	0.19	0.15	G	0.016	0.003205128	Body mass index	Obesity
rs2149954	C	T	48	35	11	39	43	12	0.70	0.64	0.30	0.36	T	1.07	0.003200205	Longevity 85 years and older	Aging
rs2903308	A	G	10	48	36	7	44	43	0.36	0.31	0.64	0.69	A	1	0.003174603	Response to citalopram treatment	General health
rs3102460	C	T	11	46	37	7	44	43	0.36	0.31	0.64	0.69	G	0.03	0.003174603	Obesity-related traits	Obesity
rs2009196	C	G	3	34	57	6	37	51	0.21	0.26	0.79	0.74	C	1.41	0.003171123	Periodontitis CDC_AAP	Misc
rs1864163	G	A	59	30	5	50	39	5	0.79	0.74	0.21	0.26	G	1.22	0.003171123	Age-related macular degeneration	Aging
rs9560113	A	G	51	37	6	58	32	4	0.74	0.79	0.26	0.21	G	0.05	0.003171123	Menarche age at onset	Reproductive health
rs8023845	G	T	69	23	2	75	18	1	0.86	0.89	0.14	0.11	G	1.27	0.003168855	Chronic lymphocytic leukemia	Cancer
rs10495903	C	T	74	20	0	69	23	2	0.89	0.86	0.11	0.14	T	1.14	0.003168855	Crohn's disease	Digestive system and its disorders
rs894638	T	C	76	16	2	68	25	1	0.89	0.86	0.11	0.14	C	0.1	0.003168855	Glomerular filtration rate in chronic kidney disease	General health
rs1445130	A	G	75	18	1	69	23	2	0.89	0.86	0.11	0.14	A	0.056	0.003168855	Bulimia nervosa	Brain health and disorders
rs2229205	C	T	75	18	1	68	25	1	0.89	0.86	0.11	0.14	T	0.04	0.003168855	LDL peak particle diameter total fat intake interaction	General health
rs7218361	A	G	0	9	85	0	5	89	0.05	0.03	0.95	0.97	A	1.25	0.003157064	Polycystic ovary syndrome	Reproductive health
rs3812316	C	G	85	9	0	89	5	0	0.95	0.97	0.05	0.03	C	10.5	0.003157064	Triglycerides	General health
rs9345396	C	T	85	9	0	89	5	0	0.95	0.97	0.05	0.03	T	5.78	0.003157064	Stroke	Brain health and disorders
rs3134792	T	G	89	5	0	85	9	0	0.97	0.95	0.03	0.05	C	3.93	0.003157064	Idiopathic membranous nephropathy	Brain health and disorders
rs2275606	G	A	85	9	0	90	3	1	0.95	0.97	0.05	0.03	A	1.3	0.003157064	Leprosy	Immune diseases and disorders
rs71636213	T	G	86	7	1	89	5	0	0.95	0.97	0.05	0.03	G	1.18	0.003157064	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs10054413	A	G	85	9	0	89	5	0	0.95	0.97	0.05	0.03	G	0.12	0.003157064	Glomerular filtration rate in chronic kidney disease	General health
rs6859667	T	C	89	5	0	85	9	0	0.97	0.95	0.03	0.05	T	0.045	0.003157064	Toenail selenium levels	Misc
rs11178918	A	G	62	27	5	67	25	2	0.80	0.85	0.20	0.15	G	0.184	0.003128055	Economic and political preferences time	Mental aptitude and behavioural traits
rs7776054	A	G	66	27	1	60	31	3	0.85	0.80	0.15	0.20	G	0.1762	0.003128055	Hemoglobin levels	Heart health and disorders
rs17786744	A	G	38	42	14	43	42	9	0.63	0.68	0.37	0.32	A	0.029	0.003126954	Urate levels	General health
rs314313	T	C	59	29	6	49	40	5	0.78	0.73	0.22	0.27	G	1.0734991	0.003123193	Crohn's disease	Digestive system and its disorders
rs630662	A	G	7	27	60	9	32	53	0.22	0.27	0.78	0.73	A	1	0.003123193	Acute lymphoblastic leukemia childhood	Cancer
rs12950390	T	C	52	34	8	59	29	6	0.73	0.78	0.27	0.22	C	0.1687	0.003123193	IgG glycosylation	Immune diseases and disorders
rs10463316	A	G	53	32	9	57	33	4	0.73	0.78	0.27	0.22	A	0.14	0.003123193	Metabolite levels Pyroglutamine	General health
rs11062040	C	T	17	37	40	9	43	42	0.38	0.32	0.62	0.68	A	1.4	0.003104819	Response to gemcitabine in pancreatic cancer	General health
rs11240285	G	C	80	14	0	75	18	1	0.93	0.89	0.07	0.11	G	34.08	0.003095975	Diisocyanate-induced asthma	Pulmonology
rs72748303	G	A	80	14	0	74	20	0	0.93	0.89	0.07	0.11	A	3.33	0.003095975	Classic bladder exstrophy	Misc
rs4256159	C	T	74	20	0	81	12	1	0.89	0.93	0.11	0.07	A	1.1343944	0.003095975	Crohn's disease	Digestive system and its disorders
rs12722515	C	A	75	18	1	80	14	0	0.89	0.93	0.11	0.07	A	1.1332967	0.003095975	Crohn's disease	Digestive system and its disorders
rs7815720	G	A	80	14	0	75	18	1	0.93	0.89	0.07	0.11	A	1.02	0.003095975	Intraocular pressure	General health
rs12249434	C	T	80	14	0	76	16	2	0.93	0.89	0.07	0.11	A	0.22	0.003095975	Anger	General health
rs2733954	T	C	44	38	12	36	44	14	0.67	0.62	0.33	0.38	C	1.14	0.003083755	Leprosy	Immune diseases and disorders
rs2039553	A	G	11	50	33	10	42	42	0.38	0.33	0.62	0.67	A	1.73	0.003083755	Pancreatic cancer	Cancer
rs11465804	T	G	85	9	0	80	14	0	0.95	0.93	0.05	0.07	T	2.5	0.003079197	Crohn's disease	Digestive system and its disorders
rs1391576	C	T	80	14	0	85	9	0	0.93	0.95	0.07	0.05	T	0.033	0.003079197	Body mass index	Obesity
rs1516459	T	C	1	7	86	0	14	80	0.05	0.07	0.95	0.93	C	0.27	0.003079197	Eating disorders purging via substances	Brain health and disorders
rs10794613	C	G	55	36	3	46	45	3	0.78	0.73	0.22	0.27	G	1.43	0.003077625	Smoking cessation in chronic obstructive pulmonary disease	Heart health and disorders
rs782971	A	G	43	39	12	34	47	13	0.66	0.61	0.34	0.39	G	0.02	0.003063725	Body mass index	Obesity
rs314590	G	A	4	20	70	0	21	73	0.15	0.11	0.85	0.89	G	0.02	0.003058104	Obesity-related traits	Obesity
rs68043594	T	C	75	17	2	66	28	0	0.89	0.85	0.11	0.15	T	55.555557	0.003058104	Warfarin maintenance dose	General health
rs12970134	G	A	74	19	1	68	24	2	0.89	0.85	0.11	0.15	A	4.38	0.003058104	Body mass index	Obesity
rs10444533	C	T	68	24	2	75	17	2	0.85	0.89	0.15	0.11	C	1.458	0.003058104	Social autistic-like traits	Brain health and disorders
rs4759375	C	T	69	22	3	75	17	2	0.85	0.89	0.15	0.11	T	0.86	0.003058104	HDL cholesterol	General health
rs4590817	G	C	74	19	1	69	22	3	0.89	0.85	0.11	0.15	G	0.576	0.003058104	Blood pressure	Heart health and disorders
rs12471016	C	T	67	26	1	73	21	0	0.85	0.89	0.15	0.11	T	0.25	0.003058104	Plasma omega-6 polyunsaturated fatty acid levels arachidonic acid	General health
rs7094971	A	G	73	21	0	66	28	0	0.89	0.85	0.11	0.15	G	0.049	0.003058104	Metabolic traits	Misc
rs12142335	G	A	66	26	2	61	28	5	0.84	0.80	0.16	0.20	A	9.713	0.003055768	Adverse response to chemotherapy neutropenia_leucopenia cisplatin	Drug response
rs3007243	A	G	68	22	4	60	30	4	0.84	0.80	0.16	0.20	G	0.8386	0.003055768	Hippocampal sclerosis	Brain health and disorders
rs36116061	T	G	61	28	5	67	24	3	0.80	0.84	0.20	0.16	T	0.0619	0.003055768	Cerebral amyloid deposition PET imaging	Brain health and disorders
rs13375749	T	C	63	24	7	66	26	2	0.80	0.84	0.20	0.16	T	0.03	0.003055768	Blood metabolite levels	Heart health and disorders
rs80092143	C	G	66	26	2	58	34	2	0.84	0.80	0.16	0.20	C	0.0065	0.003055768	Gait rhythm	Appearance
rs17663555	C	G	59	32	3	65	28	1	0.80	0.84	0.20	0.16	G	0.004	0.003055768	Renal function-related traits BUN	General health
rs2808634	T	C	2	34	58	3	24	67	0.20	0.16	0.80	0.84	T	0.153	0.003055768	C-reactive protein	Immune diseases and disorders
rs33794	A	G	40	44	10	36	42	16	0.66	0.61	0.34	0.39	A	55.9	0.003044696	Forced expiratory volume in 1 second	Pulmonology
rs961253	C	A	35	44	15	41	42	11	0.61	0.66	0.39	0.34	A	1.12	0.003044696	Colorectal cancer	Cancer
rs7318731	A	C	18	38	38	10	44	40	0.39	0.34	0.61	0.66	A	0.14	0.003044696	RR interval heart rate	Heart health and disorders
rs7633075	G	T	40	44	10	36	42	16	0.66	0.61	0.34	0.39	T	0.133	0.003044696	Symmetrical dimethylarginine levels	General health
rs4148324	T	G	42	40	12	35	44	15	0.66	0.61	0.34	0.39	T	0.109	0.003044696	Blood metabolite levels	Heart health and disorders
rs17608059	C	T	39	36	19	41	42	11	0.61	0.66	0.39	0.34	T	0.094	0.003044696	Temperament	Mental aptitude and behavioural traits
rs6588505	C	T	36	52	6	35	44	15	0.66	0.61	0.34	0.39	A	0.03	0.003044696	Obesity-related traits	Obesity
rs1515110	G	T	10	44	40	16	42	36	0.34	0.39	0.66	0.61	T	0.022	0.003044696	Adiponectin levels	Obesity
rs11655237	C	T	50	36	8	54	37	3	0.72	0.77	0.28	0.23	T	1.26	0.003034276	Pancreatic cancer	Cancer
rs7900909	T	C	53	30	11	58	29	7	0.72	0.77	0.28	0.23	C	1	0.003034276	Response to statin therapy	General health
rs7588010	C	A	40	43	11	31	51	12	0.65	0.60	0.35	0.40	A	2.72	0.003026634	Diisocyanate-induced asthma	Pulmonology
rs10017284	A	G	39	45	10	36	41	17	0.65	0.60	0.35	0.40	G	0.85	0.003026634	F-cell distribution	Immune diseases and disorders
rs1689800	A	G	37	39	18	41	41	12	0.60	0.65	0.40	0.35	G	0.47	0.003026634	HDL cholesterol	General health
rs1874984	G	C	36	41	17	35	53	6	0.60	0.65	0.40	0.35	C	0.04	0.003026634	Menarche age at onset	Reproductive health
rs4762767	A	G	11	44	39	15	46	33	0.35	0.40	0.65	0.60	G	0.027	0.00300951	Pulmonary function	Pulmonology
rs1219648	A	G	37	47	10	30	51	13	0.64	0.59	0.36	0.41	G	1.32	0.002993295	Breast cancer	Cancer
rs10502861	C	T	41	39	14	33	45	16	0.64	0.59	0.36	0.41	C	1.28	0.002993295	Male-pattern baldness	Appearance
rs4822983	C	T	37	47	10	36	39	19	0.64	0.59	0.36	0.41	T	1.27	0.002993295	Esophageal cancer squamous cell	Cancer
rs2167364	T	C	49	37	8	58	28	8	0.72	0.77	0.28	0.23	G	1.32	0.002993016	Acute lymphoblastic leukemia childhood	Cancer
rs10212363	G	A	45	45	4	55	34	5	0.72	0.77	0.28	0.23	A	0.73	0.002993016	Waist-to-hip circumference ratio interaction	General health
rs13067731	C	T	58	33	3	66	25	3	0.79	0.84	0.21	0.16	T	0.04	0.002987862	Menarche age at onset	Reproductive health
rs4269383	A	G	34	42	18	35	50	9	0.59	0.64	0.41	0.36	C	1.2	0.002977963	Pancreatic cancer	Cancer
rs6855885	A	G	15	48	31	13	42	39	0.41	0.36	0.59	0.64	A	1.11	0.002977963	Colorectal cancer calcium intake interaction	Cancer
rs2535627	T	C	16	46	32	14	40	40	0.41	0.36	0.59	0.64	T	1.071	0.002977963	Schizophrenia	Brain health and disorders
rs12332385	T	A	14	40	40	19	40	35	0.36	0.41	0.64	0.59	T	1.0526316	0.002977963	Schizophrenia	Brain health and disorders
rs1164064	G	A	39	42	13	30	50	14	0.64	0.59	0.36	0.41	A	0.134	0.002977963	Corneal astigmatism	General health
rs478304	G	T	13	43	38	17	45	32	0.37	0.42	0.63	0.58	T	1.2	0.00296349	Acne severe	Misc
rs7104745	G	A	14	41	39	13	53	28	0.37	0.42	0.63	0.58	G	0.07	0.00296349	Breast size	General health
rs6741522	G	A	74	18	2	67	25	2	0.88	0.85	0.12	0.15	A	1.26	0.002956259	Cervical artery dissection	Reproductive health
rs12367448	C	A	72	22	0	65	29	0	0.88	0.85	0.12	0.15	C	0.2468	0.002956259	IgG glycosylation	Immune diseases and disorders
rs10995190	G	A	73	20	1	67	25	2	0.88	0.85	0.12	0.15	A	0.18	0.002956259	Percent mammographic density	General health
rs12606301	G	A	67	25	2	74	18	2	0.85	0.88	0.15	0.12	G	0.171	0.002956259	Economic and political preferences immigration_crime	Mental aptitude and behavioural traits
rs7825175	G	A	72	22	0	67	25	2	0.88	0.85	0.12	0.15	A	0.084	0.002956259	Thyroid hormone levels	General health
rs2882926	A	T	2	25	67	1	20	73	0.15	0.12	0.85	0.88	A	1.56	0.002956259	Periodontitis PAL4Q3	Misc
rs2647012	T	C	3	39	52	9	36	49	0.24	0.29	0.76	0.71	G	1.56	0.002953725	Follicular lymphoma	Cancer
rs7897654	T	C	49	36	9	56	31	7	0.71	0.76	0.29	0.24	T	1.2	0.002953725	Schizophrenia	Brain health and disorders
rs2847500	G	A	55	33	6	47	40	7	0.76	0.71	0.24	0.29	A	1.14	0.002953725	Psoriasis	Immune diseases and disorders
rs2235649	C	T	54	35	5	47	40	7	0.76	0.71	0.24	0.29	T	0.018	0.002953725	Blood metabolite levels	Heart health and disorders
rs1144713	A	G	15	40	39	18	44	32	0.37	0.43	0.63	0.57	A	0.02	0.002949853	Obesity-related traits	Obesity
rs11741861	A	G	75	17	2	81	11	2	0.89	0.92	0.11	0.08	G	1.3292114	0.002941176	Crohn's disease	Digestive system and its disorders
rs9788927	A	C	74	19	1	79	15	0	0.89	0.92	0.11	0.08	A	1.019	0.002941176	Pit-and-Fissure caries	Misc
rs9493873	T	C	73	21	0	80	13	1	0.89	0.92	0.11	0.08	G	1	0.002941176	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs7349332	C	T	74	19	1	79	15	0	0.89	0.92	0.11	0.08	T	1	0.002941176	Hair morphology	Appearance
rs10497324	A	G	75	17	2	79	15	0	0.89	0.92	0.11	0.08	A	1	0.002941176	DNA methylation parent-of-origin	Misc
rs7545126	C	T	79	15	0	74	19	1	0.92	0.89	0.08	0.11	A	0.03	0.002941176	Obesity-related traits	Obesity
rs2073643	T	C	33	41	20	30	57	7	0.57	0.62	0.43	0.38	T	1.11	0.00293703	Asthma	Immune diseases and disorders
rs10497813	G	T	32	43	19	35	47	12	0.57	0.62	0.43	0.38	G	0.0734	0.00293703	Self-reported allergy	General health
rs1495965	C	T	13	45	36	18	45	31	0.38	0.43	0.62	0.57	G	1.35	0.00293703	Behcet's disease	Immune diseases and disorders
rs10033900	T	C	20	41	33	12	47	35	0.43	0.38	0.57	0.62	T	1.31	0.00293703	Age-related macular degeneration CNV	Aging
rs10190052	T	C	2	28	64	4	32	58	0.17	0.21	0.83	0.79	C	1.07	0.002923977	Type 2 diabetes	Diabetes
rs219780	C	T	68	20	6	61	26	7	0.83	0.79	0.17	0.21	C	1.25	0.002923977	Kidney stones	General health
rs2231884	C	T	60	28	6	68	20	6	0.79	0.83	0.21	0.17	T	1.083	0.002923977	Inflammatory bowel disease	Immune diseases and disorders
rs5998432	C	T	58	32	4	65	26	3	0.79	0.83	0.21	0.17	T	1	0.002923977	Cerebrospinal T-tau levels	Brain health and disorders
rs9815354	G	A	64	28	2	57	34	3	0.83	0.79	0.17	0.21	A	0.49	0.002923977	Diastolic blood pressure	Heart health and disorders
rs708547	T	C	65	26	3	58	32	4	0.83	0.79	0.17	0.21	A	0.18	0.002923977	Response to bleomycin chromatid breaks	General health
rs740083	C	T	65	26	3	58	32	4	0.83	0.79	0.17	0.21	A	0.05	0.002923977	Serum thyroid-stimulating hormone levels	General health
rs2618516	T	C	10	35	49	2	42	50	0.29	0.24	0.71	0.76	T	0.0018	0.002916292	Brain connectivity	Brain health and disorders
rs7789940	A	G	54	34	6	46	41	7	0.76	0.71	0.24	0.29	G	1.87	0.002916292	Multiple sclerosis	Brain health and disorders
rs925255	C	T	44	45	5	54	34	6	0.71	0.76	0.29	0.24	A	1.1052196	0.002916292	Crohn's disease	Digestive system and its disorders
rs4886238	G	A	54	34	6	47	39	8	0.76	0.71	0.24	0.29	A	0.17	0.002916292	Menopause age at onset	Reproductive health
rs55768019	A	G	38	39	17	31	43	20	0.61	0.56	0.39	0.44	G	1.25	0.002913753	Alcohol dependence	General health
rs10748128	G	T	33	49	12	28	49	17	0.61	0.56	0.39	0.44	T	1.19	0.002913753	Height	General health
rs11129295	C	T	30	45	19	36	43	15	0.56	0.61	0.44	0.39	A	1.11	0.002913753	Multiple sclerosis	Brain health and disorders
rs8077059	C	T	15	53	26	15	43	36	0.44	0.39	0.56	0.61	C	0.081	0.002913753	Sex hormone-binding globulin levels	Reproductive health
rs7588567	T	C	30	44	20	32	50	12	0.55	0.61	0.45	0.39	G	1.18	0.002903263	Glaucoma primary open-angle	General health
rs17374222	C	A	17	50	27	13	48	33	0.45	0.39	0.55	0.61	A	1.13	0.002903263	Rheumatoid arthritis	Immune diseases and disorders
rs2051090	G	A	37	39	18	30	43	21	0.60	0.55	0.40	0.45	G	1.19	0.002893519	Non-alcoholic fatty liver disease	Obesity
rs6968865	A	T	29	45	20	34	45	15	0.55	0.60	0.45	0.40	T	0.26	0.002893519	Coffee consumption	Misc
rs6699417	C	T	17	42	35	16	54	24	0.40	0.46	0.60	0.54	T	0.021	0.002884504	Height	General health
rs10913469	T	C	53	35	6	52	28	14	0.75	0.70	0.25	0.30	C	3.36	0.002880615	Body mass index	Obesity
rs9789483	A	G	49	34	11	51	39	4	0.70	0.75	0.30	0.25	A	1.05	0.002880615	Schizophrenia	Brain health and disorders
rs2189234	T	G	20	47	27	18	41	35	0.46	0.41	0.54	0.59	A	1.0847058	0.002876208	Ulcerative colitis	Immune diseases and disorders
rs9892651	C	T	16	55	23	9	59	26	0.46	0.41	0.54	0.59	C	0.74	0.002876208	QT interval	Heart health and disorders
rs6062788	G	A	18	51	25	14	49	31	0.46	0.41	0.54	0.59	A	0.022	0.002876208	Body mass index	Obesity
rs1407335	A	C	32	46	16	27	46	21	0.59	0.53	0.41	0.47	A	0.04	0.002868617	Metabolite levels  X-11787	General health
rs754466	A	T	58	31	5	63	29	2	0.78	0.82	0.22	0.18	T	3.5	0.002863791	Liver enzyme levels gamma-glutamyl transferase	General health
rs1690139	T	C	63	29	2	58	31	5	0.82	0.78	0.18	0.22	G	1.67	0.002863791	Chronic mucus hypersecretion	Immune diseases and disorders
rs4962416	T	C	58	31	5	66	23	5	0.78	0.82	0.22	0.18	C	1.17	0.002863791	Prostate cancer	Cancer
rs3218255	G	A	68	22	4	72	21	1	0.84	0.88	0.16	0.12	G	4	0.002862317	Tuberculosis	Immune diseases and disorders
rs12605822	G	A	67	24	3	72	21	1	0.84	0.88	0.16	0.12	A	3.3	0.002862317	Emphysema imaging phenotypes	Pulmonology
rs7111562	T	C	73	19	2	66	26	2	0.88	0.84	0.12	0.16	C	0.2417	0.002862317	IgG glycosylation	Immune diseases and disorders
rs11601602	A	G	64	30	0	72	21	1	0.84	0.88	0.16	0.12	G	0.04	0.002862317	Obesity-related traits	Obesity
rs11977715	A	G	3	24	67	2	19	73	0.16	0.12	0.84	0.88	A	1	0.002862317	Middle childhood and early adolescence aggressive behavior	Brain health and disorders
rs7541937	T	G	33	43	18	22	55	17	0.58	0.53	0.42	0.47	G	0.07	0.002861722	Glomerular filtration rate in chronic kidney disease	General health
rs6707588	T	C	19	51	24	13	53	28	0.47	0.42	0.53	0.58	T	1.06	0.002861722	Schizophrenia	Brain health and disorders
rs1173766	T	C	18	43	33	18	53	23	0.42	0.47	0.58	0.53	C	0.63	0.002861722	Blood pressure	Heart health and disorders
rs769111	T	G	28	52	14	26	46	22	0.57	0.52	0.43	0.48	T	1.23	0.002855511	Tourette syndrome	Brain health and disorders
rs12928404	T	C	24	43	27	13	55	26	0.48	0.43	0.52	0.57	C	1	0.002849977	Pediatric autoimmune diseases	Immune diseases and disorders
rs11022756	A	C	20	41	33	17	57	20	0.43	0.48	0.57	0.52	A	0.05	0.002849977	Menarche age at onset	Reproductive health
rs441460	G	A	29	49	16	27	43	24	0.57	0.52	0.43	0.48	G	3.08	0.002849977	Platelet count	Heart health and disorders
rs6876835	A	G	30	47	17	26	45	23	0.57	0.52	0.43	0.48	A	1	0.002849977	Visceral fat	Obesity
rs10138297	A	G	84	10	0	80	13	1	0.95	0.92	0.05	0.08	G	2.63	0.002849003	Erythema nodosum in inflammatory bowel disease	Digestive system and its disorders
rs10488631	T	C	81	11	2	85	8	1	0.92	0.95	0.08	0.05	C	1.5	0.002849003	Systemic sclerosis	Brain health and disorders
rs12692398	G	A	80	13	1	85	8	1	0.92	0.95	0.08	0.05	A	1.44	0.002849003	Chronic bronchitis and chronic obstructive pulmonary disease	Pulmonology
rs11640439	G	A	79	15	0	84	10	0	0.92	0.95	0.08	0.05	A	0.24	0.002849003	Sleep duration	General health
rs34872471	T	C	52	36	6	42	47	5	0.74	0.70	0.26	0.30	C	1.32	0.0028466	Type 2 diabetes	Diabetes
rs16857609	C	T	49	33	12	53	34	7	0.70	0.74	0.30	0.26	T	1.08	0.0028466	Breast cancer	Cancer
rs10273639	T	C	24	48	22	29	48	17	0.51	0.56	0.49	0.44	C	1.36	0.002845112	Pancreatitis	General health
rs7077164	C	T	32	42	20	24	48	22	0.56	0.51	0.44	0.49	A	0.67	0.002845112	Non-alcoholic fatty liver disease histology lobular	Obesity
rs4237591	T	C	31	44	19	22	52	20	0.56	0.51	0.44	0.49	G	0.33	0.002845112	Non-alcoholic fatty liver disease histology lobular	Obesity
rs16843372	T	C	31	44	19	25	46	23	0.56	0.51	0.44	0.49	G	0.04	0.002845112	Obesity-related traits	Obesity
rs555017	A	G	19	44	31	26	40	28	0.44	0.49	0.56	0.51	T	0.15	0.002845112	Anger	General health
rs1958560	G	A	21	40	33	18	56	20	0.44	0.49	0.56	0.51	A	0.03	0.002845112	Menarche age at onset	Reproductive health
rs792064	C	T	26	43	25	19	67	8	0.51	0.56	0.49	0.44	T	1.64	0.002840909	Proteinuria and chronic kidney disease	General health
rs6686929	C	T	25	45	24	29	47	18	0.51	0.56	0.49	0.44	G	0.03	0.002840909	Obesity-related traits	Obesity
rs1042779	A	G	27	50	17	23	48	23	0.55	0.50	0.45	0.50	A	1.19	0.002837362	Bipolar disorder	Brain health and disorders
rs1960918	C	T	22	50	22	27	50	17	0.50	0.55	0.50	0.45	A	1	0.002837362	Ear morphology	Appearance
rs11742570	T	C	23	48	23	21	42	31	0.50	0.45	0.50	0.55	C	1.33	0.002837362	Crohn's disease	Digestive system and its disorders
rs6896969	A	C	23	48	23	21	42	31	0.50	0.45	0.50	0.55	C	1.1	0.002837362	Multiple sclerosis	Brain health and disorders
rs6451493	G	T	23	48	23	21	42	31	0.50	0.45	0.50	0.55	T	1.08	0.002837362	Ulcerative colitis	Immune diseases and disorders
rs174448	G	A	23	49	22	18	49	27	0.51	0.45	0.49	0.55	A	0.05	0.002834467	Phospholipid levels plasma	General health
rs11190141	C	T	29	44	21	19	54	21	0.54	0.49	0.46	0.51	C	1.34	0.002832219	Crohn's disease	Digestive system and its disorders
rs7578035	T	G	30	42	22	22	48	24	0.54	0.49	0.46	0.51	G	1.09	0.002832219	Bipolar disorder	Brain health and disorders
rs360932	G	A	21	50	23	26	50	18	0.49	0.54	0.51	0.46	A	1.06	0.002832219	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs524952	T	A	26	44	24	19	48	27	0.51	0.46	0.49	0.54	A	0.158	0.002832219	Refractive error	General health
rs1041536	T	C	21	50	23	23	56	15	0.49	0.54	0.51	0.46	T	0.0982	0.002832219	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs888789	A	G	18	51	25	24	49	21	0.46	0.52	0.54	0.48	A	0.024	0.002830616	Body mass index	Obesity
rs737008	G	T	20	51	23	24	53	17	0.48	0.54	0.52	0.46	A	0.04	0.002830616	Obesity-related traits	Obesity
rs395157	C	T	23	44	27	27	46	21	0.48	0.53	0.52	0.47	A	1.1031193	0.002829655	Crohn's disease	Digestive system and its disorders
rs1805096	G	A	26	47	21	19	51	24	0.53	0.47	0.47	0.53	A	0.113	0.002829335	C-reactive protein	Immune diseases and disorders
rs1938492	A	C	26	47	21	19	51	24	0.53	0.47	0.47	0.53	A	0.008	0.002829335	Fibrinogen	General health
rs2282301	G	A	54	31	9	44	42	8	0.74	0.69	0.26	0.31	A	2.88	0.002814161	Conduct disorder interaction	Brain health and disorders
rs2237897	C	T	55	36	3	62	30	2	0.78	0.82	0.22	0.18	C	1.33	0.002807018	Type 2 diabetes	Diabetes
rs1594829	C	T	58	30	6	65	24	5	0.78	0.82	0.22	0.18	C	1.15	0.002807018	Height	General health
rs2138798	G	T	61	32	1	55	36	3	0.82	0.78	0.18	0.22	A	0.03	0.002807018	Obesity-related traits	Obesity
rs231513	C	G	0	16	78	2	18	74	0.09	0.12	0.91	0.88	C	4.3471	0.002802865	Cognitive function	Brain health and disorders
rs10176394	T	C	74	18	2	78	16	0	0.88	0.91	0.12	0.09	T	1.7701	0.002802865	Smooth-surface caries	Appearance
rs6426514	G	A	73	20	1	78	16	0	0.88	0.91	0.12	0.09	A	1.51	0.002802865	Type 2 diabetes	Diabetes
rs11191548	T	C	72	22	0	79	14	1	0.88	0.91	0.12	0.09	T	1.16	0.002802865	Systolic blood pressure	Heart health and disorders
rs2189812	C	G	2	18	74	1	14	79	0.12	0.09	0.88	0.91	C	0.1624	0.002802865	IgG glycosylation	Immune diseases and disorders
rs1414874	C	A	78	16	0	74	18	2	0.91	0.88	0.09	0.12	A	0.1121	0.002802865	Self-reported allergy	General health
rs10004195	T	A	50	38	6	48	33	13	0.73	0.69	0.27	0.31	A	1.43	0.002783218	Helicobacter pylori serologic status	Immune diseases and disorders
rs1933737	T	C	52	34	8	43	43	8	0.73	0.69	0.27	0.31	T	0.034	0.002783218	Urate levels	General health
rs74609360	C	T	85	8	1	88	6	0	0.95	0.97	0.05	0.03	A	4.14	0.002777778	Diisocyanate-induced asthma	Pulmonology
rs3217810	C	T	85	8	1	88	6	0	0.95	0.97	0.05	0.03	T	1.2	0.002777778	Colorectal cancer	Cancer
rs13196329	A	C	88	6	0	85	8	1	0.97	0.95	0.03	0.05	C	1	0.002777778	Visceral fat	Obesity
rs16910421	G	A	88	6	0	84	10	0	0.97	0.95	0.03	0.05	A	1	0.002777778	Visceral fat	Obesity
rs55645543	T	C	85	8	1	88	6	0	0.95	0.97	0.05	0.03	C	0.228	0.002777778	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs7081678	G	A	84	10	0	88	6	0	0.95	0.97	0.05	0.03	A	0.03	0.002777778	Waist-hip ratio	General health
rs971074	C	T	64	29	1	71	22	1	0.84	0.87	0.16	0.13	G	1.33	0.002775418	Upper aerodigestive tract cancers	Cancer
rs75575209	A	T	73	18	3	66	25	3	0.87	0.84	0.13	0.16	T	1.1111112	0.002775418	Schizophrenia	Brain health and disorders
rs7739678	A	G	73	18	3	68	21	5	0.87	0.84	0.13	0.16	G	0.03	0.002775418	Obesity-related traits	Obesity
rs9818941	G	A	7	37	50	10	40	44	0.27	0.32	0.73	0.68	A	0.028	0.002753697	Height	General health
rs6981717	T	C	51	35	8	45	38	11	0.73	0.68	0.27	0.32	C	1.0526316	0.002753697	Schizophrenia	Brain health and disorders
rs151361	A	G	61	31	2	57	31	6	0.81	0.77	0.19	0.23	A	4.49	0.002753399	Mean platelet volume	Heart health and disorders
rs16831128	A	G	62	29	3	55	35	4	0.81	0.77	0.19	0.23	G	1.45	0.002753399	Conduct disorder	Brain health and disorders
rs10037670	A	G	58	29	7	62	29	3	0.77	0.81	0.23	0.19	G	1	0.002753399	Behavioural disinhibition generation interaction	Brain health and disorders
rs13407123	T	C	59	27	8	61	31	2	0.77	0.81	0.23	0.19	T	1	0.002753399	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs2943641	T	C	10	41	43	9	34	51	0.32	0.28	0.68	0.72	C	1.19	0.002725529	Type 2 diabetes and other traits	Diabetes
rs2176040	A	G	10	41	43	9	34	51	0.32	0.28	0.68	0.72	A	0.024	0.002725529	Body mass index	Obesity
rs399604	T	C	46	44	4	42	43	9	0.72	0.68	0.28	0.32	C	2.346	0.002725529	Platelet count	Heart health and disorders
rs1516570	G	A	41	45	8	53	30	11	0.68	0.72	0.32	0.28	A	1.06	0.002725529	Schizophrenia	Brain health and disorders
rs17175227	G	A	91	3	0	89	4	1	0.98	0.97	0.02	0.03	G	7.1429	0.002724796	Tuberculosis	Immune diseases and disorders
rs45479699	G	A	91	3	0	88	6	0	0.98	0.97	0.02	0.03	A	5.62	0.002724796	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs11766298	C	T	88	6	0	91	3	0	0.97	0.98	0.03	0.02	T	4.41	0.002724796	Response to fenofibrate	General health
rs10495332	T	C	91	3	0	88	6	0	0.98	0.97	0.02	0.03	T	4.119	0.002724796	Smooth-surface caries	Appearance
rs181099388	T	G	88	6	0	91	3	0	0.97	0.98	0.03	0.02	G	2.84	0.002724796	Classic bladder exstrophy	Misc
rs3130614	T	A	91	3	0	88	6	0	0.98	0.97	0.02	0.03	A	2.31	0.002724796	Myositis	General health
rs8321	A	C	91	3	0	91	0	3	0.98	0.97	0.02	0.03	G	1	0.002724796	AIDS progression	Immune diseases and disorders
rs17347800	G	A	88	6	0	91	3	0	0.97	0.98	0.03	0.02	A	0.51	0.002724796	Stroke	Brain health and disorders
rs4645543	C	T	91	3	0	88	6	0	0.98	0.97	0.02	0.03	T	0.42	0.002724796	Circulating phylloquinone levels	Immune diseases and disorders
rs111231532	C	T	88	6	0	91	3	0	0.97	0.98	0.03	0.02	C	0.2659	0.002724796	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs12665607	T	A	88	6	0	91	3	0	0.97	0.98	0.03	0.02	A	0.17	0.002724796	Mammographic density dense area	Reproductive health
rs72952442	G	A	91	3	0	89	4	1	0.98	0.97	0.02	0.03	G	0.16	0.002724796	Cerebral amyloid deposition in APOEe4 non-carriers PET imaging	Brain health and disorders
rs10510138	C	T	88	6	0	91	3	0	0.97	0.98	0.03	0.02	A	0.02	0.002724796	Obesity-related traits	Obesity
rs1076540	C	T	53	38	3	62	28	4	0.77	0.81	0.23	0.19	C	4.8	0.002702703	Liver enzyme levels gamma-glutamyl transferase	General health
rs1595014	T	A	57	30	7	63	26	5	0.77	0.81	0.23	0.19	T	1.1904762	0.002702703	Alzheimer's disease APOE e4 interaction	Brain health and disorders
rs2837960	T	G	60	32	2	57	30	7	0.81	0.77	0.19	0.23	G	1.05	0.002702703	Rheumatoid arthritis	Immune diseases and disorders
rs2893923	C	T	57	30	7	59	34	1	0.77	0.81	0.23	0.19	T	1	0.002702703	Platelet aggregation	Heart health and disorders
rs1885486	G	A	41	44	9	51	33	10	0.67	0.72	0.33	0.28	A	1.18	0.002698651	Height	General health
rs468327	G	A	46	43	5	41	44	9	0.72	0.67	0.28	0.33	G	0.39	0.002698651	Urinary metabolites H-NMR features	General health
rs2857281	A	C	70	23	1	65	26	3	0.87	0.83	0.13	0.17	C	11.92	0.002694825	Trichloroethylene-induced hypersensitivity syndrome	General health
rs972540	A	G	66	24	4	69	25	0	0.83	0.87	0.17	0.13	G	0.018	0.002694825	Body mass index	Obesity
rs2105325	A	C	3	26	65	1	23	70	0.17	0.13	0.83	0.87	C	1.12	0.002694825	Rheumatoid arthritis	Immune diseases and disorders
rs7740107	T	A	2	28	64	1	23	70	0.17	0.13	0.83	0.87	A	0.042	0.002694825	Height	General health
rs9899375	C	T	93	1	0	91	3	0	0.99	0.98	0.01	0.02	T	2.57	0.002688172	Stroke	Brain health and disorders
rs61894547	C	T	93	1	0	91	3	0	0.99	0.98	0.01	0.02	T	2.439	0.002688172	Eosinophilic esophagitis	Digestive system and its disorders
rs116909374	C	T	91	3	0	93	1	0	0.98	0.99	0.02	0.01	T	2.09	0.002688172	Thyroid cancer	Cancer
rs555091	T	C	93	1	0	91	3	0	0.99	0.98	0.01	0.02	C	1.92	0.002688172	Glaucoma	General health
rs7545047	G	A	91	3	0	93	1	0	0.98	0.99	0.02	0.01	A	1.78	0.002688172	QT interval	Heart health and disorders
rs6976769	A	C	91	3	0	93	1	0	0.98	0.99	0.02	0.01	C	1.458	0.002688172	Epithelial ovarian cancer	Cancer
rs77221366	C	T	91	3	0	93	1	0	0.98	0.99	0.02	0.01	C	1.1627907	0.002688172	Schizophrenia	Brain health and disorders
rs79212538	G	T	91	3	0	93	1	0	0.98	0.99	0.02	0.01	T	1.15	0.002688172	Schizophrenia	Brain health and disorders
rs76405237	G	T	93	1	0	91	3	0	0.99	0.98	0.01	0.02	G	1.1494253	0.002688172	Schizophrenia	Brain health and disorders
rs6057651	G	A	91	3	0	93	1	0	0.98	0.99	0.02	0.01	A	1	0.002688172	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs17605562	C	T	91	3	0	93	1	0	0.98	0.99	0.02	0.01	T	1	0.002688172	Hair morphology	Appearance
rs6057652	A	C	91	3	0	93	1	0	0.98	0.99	0.02	0.01	A	1	0.002688172	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs12562437	C	T	93	1	0	91	3	0	0.99	0.98	0.01	0.02	T	1	0.002688172	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs147852159	A	G	93	1	0	91	3	0	0.99	0.98	0.01	0.02	G	1	0.002688172	White matter hyperintensity burden	Brain health and disorders
rs17539289	C	A	91	3	0	93	1	0	0.98	0.99	0.02	0.01	A	0.6468	0.002688172	Dementia and core Alzheimer's disease neuropathologic changes	Brain health and disorders
rs184148048	A	T	93	1	0	91	3	0	0.99	0.98	0.01	0.02	A	0.5763	0.002688172	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs79947075	C	T	91	3	0	93	1	0	0.98	0.99	0.02	0.01	C	0.5473	0.002688172	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs1064524	C	T	91	3	0	93	1	0	0.98	0.99	0.02	0.01	T	0.5404	0.002688172	Smooth-surface caries	Appearance
rs191241826	C	T	91	3	0	93	1	0	0.98	0.99	0.02	0.01	C	0.4843	0.002688172	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs7731390	C	G	91	3	0	93	1	0	0.98	0.99	0.02	0.01	C	0.3846	0.002688172	IgG glycosylation	Immune diseases and disorders
rs78704734	G	A	91	3	0	93	1	0	0.98	0.99	0.02	0.01	G	0.3733	0.002688172	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs379440	T	C	91	3	0	93	1	0	0.98	0.99	0.02	0.01	G	0.34	0.002688172	vWF and FVIII levels	Heart health and disorders
rs1150561	G	A	91	3	0	93	1	0	0.98	0.99	0.02	0.01	G	0.175	0.002688172	Urate levels in lean individuals	Obesity
rs13132430	G	A	91	3	0	93	1	0	0.98	0.99	0.02	0.01	A	0.17	0.002688172	HDL cholesterol	General health
rs7927044	G	A	91	3	0	93	1	0	0.98	0.99	0.02	0.01	A	0.16	0.002688172	Asthma childhood onset	Immune diseases and disorders
rs17541203	T	C	91	3	0	93	1	0	0.98	0.99	0.02	0.01	C	0.13	0.002688172	Pubertal anthropometrics	Appearance
rs62057608	C	T	91	3	0	93	1	0	0.98	0.99	0.02	0.01	A	0.03	0.002688172	Obesity-related traits	Obesity
rs17161553	T	C	72	21	1	77	17	0	0.88	0.91	0.12	0.09	C	1.6947	0.002678571	IgG glycosylation	Immune diseases and disorders
rs10255295	A	G	73	19	2	79	13	2	0.88	0.91	0.12	0.09	G	1.31	0.002678571	Bipolar disorder with mood-incongruent psychosis	Brain health and disorders
rs12413409	G	A	71	23	0	79	13	2	0.88	0.91	0.12	0.09	G	1.29	0.002678571	Intracranial aneurysm	Misc
rs6971499	T	C	77	17	0	72	21	1	0.91	0.88	0.09	0.12	T	1.27	0.002678571	Pancreatic cancer	Cancer
rs4862562	A	C	78	15	1	71	23	0	0.91	0.88	0.09	0.12	C	1	0.002678571	Cytokine and corticosteroid-stimulated IL-6 production	Immune diseases and disorders
rs10466033	A	G	77	17	0	72	21	1	0.91	0.88	0.09	0.12	G	0.437	0.002678571	Breast size	General health
rs2242420	C	T	77	17	0	72	21	1	0.91	0.88	0.09	0.12	T	0.163	0.002678571	Hematological and biochemical traits	Heart health and disorders
rs7674118	C	T	77	17	0	72	21	1	0.91	0.88	0.09	0.12	T	0.15	0.002678571	Glomerular filtration rate in chronic kidney disease	General health
rs785422	C	T	77	17	0	72	21	1	0.91	0.88	0.09	0.12	T	0.14	0.002678571	Corneal structure	General health
rs17394429	G	A	71	23	0	77	17	0	0.88	0.91	0.12	0.09	A	0.03	0.002678571	Obesity-related traits	Obesity
rs2660304	G	T	0	17	77	1	21	72	0.09	0.12	0.91	0.88	T	1.12	0.002678571	Schizophrenia	Brain health and disorders
rs2315008	T	G	9	36	49	10	43	41	0.29	0.34	0.71	0.66	G	1.36	0.002673003	Inflammatory bowel disease	Immune diseases and disorders
rs140355816	C	G	94	0	0	93	1	0	1.00	0.99	0.00	0.01	G	1.591	0.002666667	Colorectal cancer	Cancer
rs2229288	C	A	94	0	0	93	1	0	1.00	0.99	0.00	0.01	C	1	0.002666667	Glucocorticoid-induced osteonecrosis	Drug response
rs1641895	C	T	94	0	0	93	1	0	1.00	0.99	0.00	0.01	T	1	0.002666667	Visceral adipose tissue adjusted for BMI	Obesity
rs114162361	C	T	94	0	0	93	1	0	1.00	0.99	0.00	0.01	C	0.6189	0.002666667	Cerebrospinal fluid t-tau:AB1-42 ratio	Brain health and disorders
rs13245023	C	G	94	0	0	93	1	0	1.00	0.99	0.00	0.01	C	0.4218	0.002666667	IgG glycosylation	Immune diseases and disorders
rs11809789	G	A	94	0	0	93	1	0	1.00	0.99	0.00	0.01	A	0.396	0.002666667	Bilirubin levels	General health
rs17879146	T	G	94	0	0	93	1	0	1.00	0.99	0.00	0.01	T	0.2549	0.002666667	Periodontitis Mean PAL	Misc
rs3753573	G	A	94	0	0	93	1	0	1.00	0.99	0.00	0.01	A	0.03	0.002666667	Obesity-related traits	Obesity
rs6732655	A	T	6	33	55	5	27	62	0.24	0.20	0.76	0.80	T	1.12	0.00265472	Epilepsy	Brain health and disorders
rs1549309	G	A	64	23	7	52	39	3	0.80	0.76	0.20	0.24	A	0.27	0.00265472	Dietary macronutrient intake	General health
rs17667932	T	C	79	14	1	84	9	1	0.91	0.94	0.09	0.06	G	2.368	0.002653083	Kawasaki disease	Misc
rs7236477	A	G	85	7	2	78	16	0	0.94	0.91	0.06	0.09	G	2.22	0.002653083	Eosinophilic esophagitis pediatric	Digestive system and its disorders
rs11031006	G	A	78	16	0	83	11	0	0.91	0.94	0.09	0.06	A	1.16	0.002653083	Polycystic ovary syndrome	Reproductive health
rs4730250	A	G	79	14	1	83	11	0	0.91	0.94	0.09	0.06	G	1.15	0.002653083	Osteoarthritis	Immune diseases and disorders
rs2272205	T	C	78	16	0	84	9	1	0.91	0.94	0.09	0.06	G	1	0.002653083	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs9582259	T	G	84	9	1	80	12	2	0.94	0.91	0.06	0.09	C	1	0.002653083	Immune reponse to smallpox secreted IL-1beta	Immune diseases and disorders
rs17706439	G	A	83	11	0	80	12	2	0.94	0.91	0.06	0.09	A	0.18	0.002653083	RR interval heart rate	Heart health and disorders
rs11044734	G	C	78	16	0	83	11	0	0.91	0.94	0.09	0.06	G	0.112	0.002653083	Lifetime average cigarettes per day in chronic obstructive pulmonary disease	General health
rs12531027	T	C	78	16	0	83	11	0	0.91	0.94	0.09	0.06	G	0.04	0.002653083	Obesity-related traits	Obesity
rs7578047	A	G	46	41	7	40	44	10	0.71	0.66	0.29	0.34	C	0.22	0.00264853	Anger	General health
rs12330322	C	T	48	37	9	36	52	6	0.71	0.66	0.29	0.34	T	0.034	0.00264853	Height	General health
rs7923609	A	G	43	37	14	41	50	3	0.65	0.70	0.35	0.30	G	2.2	0.002625182	Liver enzyme levels alkaline phosphatase	General health
rs9567307	A	G	45	42	7	40	43	11	0.70	0.65	0.30	0.35	T	1.58	0.002625182	Leprosy	Immune diseases and disorders
rs4657482	A	G	8	49	37	6	44	44	0.35	0.30	0.65	0.70	A	1.43	0.002625182	Testicular germ cell tumor	Cancer
rs2019960	T	C	42	48	4	39	45	10	0.70	0.65	0.30	0.35	G	1.37	0.002625182	Hodgkin's lymphoma	Cancer
rs2720460	A	G	42	39	13	46	40	8	0.65	0.70	0.35	0.30	A	1.32	0.002625182	Testicular germ cell tumor	Cancer
rs11157317	C	T	41	41	12	45	42	7	0.65	0.70	0.35	0.30	A	1.29	0.002625182	Multiple myeloma hyperdiploidy	Cancer
rs7587205	G	T	42	39	13	48	36	10	0.65	0.70	0.35	0.30	T	1	0.002625182	Response to angiotensin II receptor blocker therapy opposite direction w_ diuretic therapy	Drug response
rs9820070	A	C	50	32	12	43	37	14	0.70	0.65	0.30	0.35	C	0.087	0.002625182	Hematological and biochemical traits	Heart health and disorders
rs683395	G	A	0	26	68	3	27	64	0.14	0.18	0.86	0.82	G	1.47	0.002619901	Bipolar disorder	Brain health and disorders
rs4248154	C	T	64	27	3	68	26	0	0.82	0.86	0.18	0.14	C	1.38	0.002619901	Graves' disease	Immune diseases and disorders
rs4508864	C	T	68	26	0	62	31	1	0.86	0.82	0.14	0.18	T	1	0.002619901	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs6559140	T	A	68	26	0	62	31	1	0.86	0.82	0.14	0.18	A	0.2159	0.002619901	Metabolite levels 5-HIAA	General health
rs10049992	T	G	65	25	4	68	26	0	0.82	0.86	0.18	0.14	G	0.2007	0.002619901	IgG glycosylation	Immune diseases and disorders
rs3741414	C	T	67	21	6	71	20	3	0.82	0.86	0.18	0.14	T	0.072	0.002619901	Urate levels	General health
rs61352607	G	T	67	21	6	71	20	3	0.82	0.86	0.18	0.14	G	0.038	0.002619901	Triglycerides	General health
rs12053254	T	C	70	22	2	63	29	2	0.86	0.82	0.14	0.18	G	0.03	0.002619901	Obesity-related traits	Obesity
rs7138744	A	G	56	30	8	61	28	5	0.76	0.80	0.24	0.20	A	1.4071	0.002609263	Smooth-surface caries	Appearance
rs3779195	T	A	52	38	4	63	24	7	0.76	0.80	0.24	0.20	A	0.028	0.002609263	Sex hormone-binding globulin levels	Reproductive health
rs2071277	T	C	39	44	11	46	39	9	0.65	0.70	0.35	0.30	C	1.3	0.002602911	Age-related macular degeneration	Aging
rs1175000	T	C	42	38	14	44	43	7	0.65	0.70	0.35	0.30	C	0.05	0.002602911	Height	General health
rs7998314	A	C	7	44	43	7	53	34	0.31	0.36	0.69	0.64	A	0.04	0.002581673	Obesity-related traits	Obesity
rs76588427	G	A	77	16	1	71	22	1	0.90	0.87	0.10	0.13	A	2.05	0.002566296	Marginal zone lymphoma	Cancer
rs3211770	G	A	76	18	0	72	20	2	0.90	0.87	0.10	0.13	G	0.534	0.002566296	End-stage coagulation	General health
rs1003247	T	C	60	29	5	54	33	7	0.79	0.75	0.21	0.25	C	2.2814	0.002566159	Cognitive function	Brain health and disorders
rs1484948	T	C	51	39	4	59	31	4	0.75	0.79	0.25	0.21	G	0.16	0.002566159	RR interval heart rate	Heart health and disorders
rs1466921	T	C	3	41	50	1	37	56	0.25	0.21	0.75	0.79	T	0.353	0.002566159	Left superior temporal gyrus thickness schizophrenia interaction	Brain health and disorders
rs133911	G	A	6	27	61	8	31	55	0.21	0.25	0.79	0.75	G	0.3047	0.002566159	Lewy body disease	Brain health and disorders
rs4680	G	A	37	46	11	45	39	10	0.64	0.69	0.36	0.31	A	0.049	0.002561427	Blood metabolite levels	Heart health and disorders
rs643177	T	C	8	43	43	16	36	42	0.31	0.36	0.69	0.64	T	1.25	0.002561427	Psoriasis	Immune diseases and disorders
rs582757	C	T	8	43	43	16	36	42	0.31	0.36	0.69	0.64	T	1.2468828	0.002561427	Psoriasis	Immune diseases and disorders
rs580384	C	T	1	25	68	2	30	62	0.14	0.18	0.86	0.82	C	0.124	0.002550091	Breast size	General health
rs9311745	T	C	68	25	1	61	32	1	0.86	0.82	0.14	0.18	C	2.9914	0.002550091	Pit-and-Fissure caries	Misc
rs10019888	A	G	69	23	2	62	30	2	0.86	0.82	0.14	0.18	G	0.027	0.002550091	HDL cholesterol	General health
rs17817449	T	G	45	38	11	38	43	13	0.68	0.63	0.32	0.37	T	1.09	0.002542134	Breast cancer	Cancer
rs4790333	C	T	42	44	8	34	51	9	0.68	0.63	0.32	0.37	T	1	0.002542134	Proinsulin levels	Diabetes
rs16948048	A	G	38	43	13	44	40	10	0.63	0.68	0.37	0.32	G	0.31	0.002542134	Diastolic blood pressure	Heart health and disorders
rs11765886	T	C	13	43	38	10	40	44	0.37	0.32	0.63	0.68	C	0.1625	0.002542134	IgG glycosylation	Immune diseases and disorders
rs2145272	G	A	10	40	44	11	47	36	0.32	0.37	0.68	0.63	A	0.063	0.002542134	Height	General health
rs914187	T	C	14	41	39	10	40	44	0.37	0.32	0.63	0.68	C	0.014	0.002542134	Body mass index	Obesity
rs1329424	T	G	3	34	57	8	32	54	0.21	0.26	0.79	0.74	T	1.88	0.002525253	Age-related macular degeneration	Aging
rs513088	G	C	6	36	52	3	34	57	0.26	0.21	0.74	0.79	G	1.0526316	0.002525253	Schizophrenia	Brain health and disorders
rs11099660	C	T	49	29	16	36	46	12	0.68	0.63	0.32	0.37	C	1.57	0.002523758	Frontotemporal dementia	Brain health and disorders
rs7193144	T	C	43	40	11	37	43	14	0.67	0.62	0.33	0.38	T	1.37	0.002506266	Sasang constitutional medicine type So-Eum	Misc
rs8043757	A	T	43	40	11	37	43	14	0.67	0.62	0.33	0.38	T	1.23	0.002506266	Obesity	Obesity
rs10262624	C	T	14	44	36	14	35	45	0.38	0.34	0.62	0.66	C	1.0526316	0.002489627	Schizophrenia	Brain health and disorders
rs10510110	T	C	17	38	39	13	37	44	0.38	0.34	0.62	0.66	C	1.05	0.002489627	Type 2 diabetes	Diabetes
rs7705819	C	T	13	46	35	10	43	41	0.38	0.34	0.62	0.66	T	0.23	0.002489627	Stroke	Brain health and disorders
rs2865126	A	G	8	33	53	4	33	57	0.26	0.22	0.74	0.78	A	0.2663	0.002486402	Metabolite levels 5-HIAA_ MHPG Ratio	Brain health and disorders
rs13358904	A	G	62	29	3	67	26	1	0.81	0.85	0.19	0.15	G	3.049	0.002484913	Suicide ideation score in major depressive disorder	Brain health and disorders
rs11190179	G	A	77	17	0	82	12	0	0.91	0.94	0.09	0.06	G	0.65	0.002484349	&beta;2-Glycoprotein I &beta;2-GPI plasma levels	Immune diseases and disorders
rs6818964	C	T	85	7	2	87	7	0	0.94	0.96	0.06	0.04	T	5.63	0.00248293	Smooth-surface caries	Appearance
rs17501712	G	T	85	7	2	87	7	0	0.94	0.96	0.06	0.04	T	1	0.00248293	Subcutaneous adipose tissue	Obesity
rs10906824	G	A	87	7	0	83	11	0	0.96	0.94	0.04	0.06	A	0.9719	0.00248293	Hippocampal sclerosis	Brain health and disorders
rs34014631	G	A	87	7	0	83	11	0	0.96	0.94	0.04	0.06	A	0.47	0.00248293	Coronary artery calcification	Heart health and disorders
rs901683	G	A	87	7	0	83	11	0	0.96	0.94	0.04	0.06	A	0.364	0.00248293	Red blood cell traits	Immune diseases and disorders
rs1874124	C	T	84	9	1	87	7	0	0.94	0.96	0.06	0.04	C	0.054	0.00248293	Cholesterol, total	General health
rs10270805	A	G	0	11	83	0	7	87	0.06	0.04	0.94	0.96	A	1	0.00248293	Response to statin therapy	General health
rs261360	G	A	40	44	10	38	39	17	0.66	0.61	0.34	0.39	A	1	0.002473811	Hair morphology	Appearance
rs4838605	C	T	44	36	14	34	47	13	0.66	0.61	0.34	0.39	C	1	0.002473811	Diabetic retinopathy	Diabetes
rs9899891	G	A	21	31	42	7	50	37	0.39	0.34	0.61	0.66	A	1	0.002473811	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs6742078	G	T	42	40	12	35	45	14	0.66	0.61	0.34	0.39	T	0.3358	0.002473811	Circulating cell-free DNA	Misc
rs1436900	C	T	15	43	36	7	50	37	0.39	0.34	0.61	0.66	T	0.142	0.002473811	Optic nerve measurement cup area	Misc
rs2645294	C	T	14	36	44	10	53	31	0.34	0.39	0.66	0.61	T	0.035	0.002473811	Waist-to-hip ratio adjusted for body mass index	Obesity
rs1368578	A	G	1	23	70	0	19	75	0.13	0.10	0.87	0.90	A	0.04	0.002464403	Obesity-related traits	Obesity
rs2005	A	G	1	17	76	0	25	69	0.10	0.13	0.90	0.87	A	0.03	0.002464403	Obesity-related traits	Obesity
rs6056	C	T	69	25	0	75	19	0	0.87	0.90	0.13	0.10	A	12.94	0.002464403	Fibrinogen	General health
rs4898641	G	A	69	25	0	75	19	0	0.87	0.90	0.13	0.10	G	4.88	0.002464403	Longitudinal alcohol consumption	General health
rs11228565	G	A	77	15	2	69	25	0	0.90	0.87	0.10	0.13	A	1.23	0.002464403	Prostate cancer	Cancer
rs9922134	C	T	78	13	3	71	21	2	0.90	0.87	0.10	0.13	C	1	0.002464403	Maximal oxygen uptake response	Pulmonology
rs2030062	A	G	72	19	3	75	19	0	0.87	0.90	0.13	0.10	G	0.03	0.002464403	Obesity-related traits	Obesity
rs13434995	A	G	69	25	0	75	19	0	0.87	0.90	0.13	0.10	G	0.023	0.002464403	Adiponectin levels	Obesity
rs678347	G	A	16	42	36	9	47	38	0.39	0.35	0.61	0.65	G	1.1	0.002458792	Rheumatoid arthritis	Immune diseases and disorders
rs182052	G	A	37	40	17	41	41	12	0.61	0.65	0.39	0.35	G	0.062	0.002458792	Adiponectin levels	Obesity
rs9217	T	C	38	38	18	43	37	14	0.61	0.65	0.39	0.35	T	0.028	0.002458792	Height	General health
rs9264638	G	A	8	34	52	5	32	57	0.27	0.22	0.73	0.78	A	0.04	0.002449479	Beta-2 microglubulin plasma levels	Cancer
rs2072183	G	C	58	30	6	49	40	5	0.78	0.73	0.22	0.27	C	2.01	0.002449479	Cholesterol, total	General health
rs4061073	A	G	50	38	6	59	28	7	0.73	0.78	0.27	0.22	G	0.015	0.002449479	Body mass index	Obesity
rs9466930	C	G	9	48	37	12	51	31	0.35	0.40	0.65	0.60	C	1.501	0.002444545	Major depressive disorder	Brain health and disorders
rs10832417	T	G	33	47	14	35	52	7	0.60	0.65	0.40	0.35	T	1.3	0.002444545	Blood pressure measurement high sodium intervention	Heart health and disorders
rs163182	G	C	33	47	14	40	42	12	0.60	0.65	0.40	0.35	C	1.28	0.002444545	Type 2 diabetes	Diabetes
rs10495928	A	G	41	40	13	32	49	13	0.65	0.60	0.35	0.40	G	0.06	0.002444545	Hemoglobin	Heart health and disorders
rs10512627	G	C	42	38	14	36	41	17	0.65	0.60	0.35	0.40	C	0.006	0.002444545	Mean platelet volume	Heart health and disorders
rs1933488	A	G	38	45	11	31	50	13	0.64	0.60	0.36	0.40	A	1.12	0.002431045	Prostate cancer	Cancer
rs1502844	C	T	14	48	32	12	43	39	0.40	0.36	0.60	0.64	C	1.09	0.002431045	Schizophrenia	Brain health and disorders
rs10168349	G	C	41	39	14	32	48	14	0.64	0.60	0.36	0.40	C	0.19	0.002431045	Hematocrit	General health
rs1598106	C	G	9	49	36	18	40	36	0.36	0.40	0.64	0.60	C	0.1642	0.002431045	IgG glycosylation	Immune diseases and disorders
rs6740660	G	A	68	23	3	61	30	3	0.85	0.81	0.15	0.19	G	3.386	0.002423943	Adverse response to chemotherapy neutropenia_leucopenia 5-fluorouracil	Drug response
rs16986953	G	A	70	19	5	61	30	3	0.85	0.81	0.15	0.19	A	1.08	0.002423943	Myocardial infarction	Heart health and disorders
rs6120849	C	T	61	30	3	66	27	1	0.81	0.85	0.19	0.15	T	0.14	0.002423943	Protein C levels	General health
rs1152846	T	C	10	48	36	12	53	29	0.36	0.41	0.64	0.59	G	0.09	0.002418271	Body mass index	Obesity
rs2013208	C	T	16	45	33	14	40	40	0.41	0.36	0.59	0.64	T	0.025	0.002418271	HDL cholesterol	General health
rs4958351	G	A	51	35	8	55	35	4	0.73	0.77	0.27	0.23	A	1.75	0.002414365	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Immune diseases and disorders
rs9356171	A	G	51	35	8	53	39	2	0.73	0.77	0.27	0.23	G	1	0.002414365	Diisocyanate-induced asthma	Pulmonology
rs10494270	A	G	56	33	5	52	33	9	0.77	0.73	0.23	0.27	A	0.0687	0.002414365	Acylcarnitine levels	General health
rs2844665	T	C	16	46	32	13	43	38	0.41	0.37	0.59	0.63	C	1.54	0.002406203	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis SJS_TEN	Drug response
rs9469220	G	A	16	46	32	14	41	39	0.41	0.37	0.59	0.63	A	1.14	0.002406203	Crohn's disease	Digestive system and its disorders
rs10197940	T	C	34	42	18	38	43	13	0.59	0.63	0.41	0.37	T	1.12	0.002406203	Lung cancer	Cancer
rs4458523	T	G	14	41	39	17	44	33	0.37	0.41	0.63	0.59	G	1.09	0.002406203	Type 2 diabetes	Diabetes
rs12670403	C	A	41	37	16	28	54	12	0.63	0.59	0.37	0.41	C	0.294	0.002406203	Metabolic traits	Misc
rs3741298	C	T	12	45	37	16	46	32	0.37	0.41	0.63	0.59	G	0.04	0.002406203	Obesity-related traits	Obesity
rs1420956	T	C	18	42	34	13	43	38	0.41	0.37	0.59	0.63	A	0.03	0.002406203	Obesity-related traits	Obesity
rs12757404	A	G	26	58	10	37	45	12	0.59	0.63	0.41	0.37	A	0.01	0.002406203	Lipid traits	Misc
rs1124480	T	C	28	53	13	39	40	15	0.58	0.63	0.42	0.37	C	1	0.00239482	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs7690467	T	C	38	41	15	28	52	14	0.62	0.57	0.38	0.43	T	1.12	0.002384106	Eating disorders	Brain health and disorders
rs4846480	A	T	30	48	16	37	43	14	0.57	0.62	0.43	0.38	A	1	0.002384106	Chronic obstructive pulmonary disease severe	Immune diseases and disorders
rs1890995	G	A	30	48	16	36	45	13	0.57	0.62	0.43	0.38	A	0.033	0.002384106	Height	General health
rs587706	T	G	31	46	17	38	41	15	0.57	0.62	0.43	0.38	G	0.03	0.002384106	LDL peak particle diameter total fat intake interaction	General health
rs6683225	T	C	19	42	33	13	45	36	0.43	0.38	0.57	0.62	G	0.03	0.002384106	Obesity-related traits	Obesity
rs1835740	T	C	8	28	58	5	42	47	0.23	0.28	0.77	0.72	A	1.18	0.002380952	Migraine	Brain health and disorders
rs6467136	A	G	17	47	30	12	48	34	0.43	0.38	0.57	0.62	G	1.11	0.002374044	Type 2 diabetes	Diabetes
rs1231206	G	A	32	43	19	37	42	15	0.57	0.62	0.43	0.38	A	1.07	0.002374044	Coronary heart disease	Heart health and disorders
rs4820539	A	G	16	49	29	14	44	36	0.43	0.38	0.57	0.62	A	0.03	0.002374044	Bone mineral density	General health
rs7786808	A	G	14	53	27	8	56	30	0.43	0.38	0.57	0.62	G	0.03	0.002374044	Obesity-related traits	Obesity
rs6954796	C	G	1	24	69	1	18	75	0.14	0.11	0.86	0.89	C	0.124	0.002371542	Non-word repetition	Brain health and disorders
rs13328379	C	T	71	20	3	75	18	1	0.86	0.89	0.14	0.11	T	3.41	0.002371542	Attention function in attention deficit hyperactive disorder	Brain health and disorders
rs9348440	C	T	75	18	1	70	22	2	0.89	0.86	0.11	0.14	A	0.246	0.002371542	Glycemic traits	General health
rs2717128	A	G	74	20	0	68	26	0	0.89	0.86	0.11	0.14	G	0.19	0.002371542	RR interval heart rate	Heart health and disorders
rs7590268	T	G	65	28	1	62	27	5	0.84	0.80	0.16	0.20	G	1.42	0.002366807	Orofacial clefts	Misc
rs12061601	T	C	64	30	0	62	27	5	0.84	0.80	0.16	0.20	C	1.41	0.002366807	QT interval	Heart health and disorders
rs11599218	G	A	62	27	5	66	26	2	0.80	0.84	0.20	0.16	G	1.0638298	0.002366807	Schizophrenia	Brain health and disorders
rs7209395	T	C	62	27	5	67	24	3	0.80	0.84	0.20	0.16	T	0.44	0.002366807	&beta;2-Glycoprotein I &beta;2-GPI plasma levels	Immune diseases and disorders
rs1509378	A	G	18	46	30	9	55	30	0.44	0.39	0.56	0.61	A	1.06	0.002364618	Schizophrenia	Brain health and disorders
rs2504063	A	G	29	48	17	37	41	16	0.56	0.61	0.44	0.39	A	0.08	0.002364618	Bone mineral density spine	General health
rs1026153	G	A	14	45	35	15	52	27	0.39	0.44	0.61	0.56	A	0.002	0.002364618	Trans fatty acid levels	General health
rs12432904	G	T	33	48	13	21	63	10	0.61	0.56	0.39	0.44	G	1.0526316	0.002355815	Schizophrenia	Brain health and disorders
rs35212277	G	A	37	40	17	24	57	13	0.61	0.56	0.39	0.44	A	0.2664	0.002355815	Metabolite levels 5-HIAA_ MHPG Ratio	Brain health and disorders
rs1505368	G	A	31	43	20	35	44	15	0.56	0.61	0.44	0.39	A	0.097	0.002355815	Symmetrical dimethylarginine levels	General health
rs11675434	C	T	29	47	18	32	50	12	0.56	0.61	0.44	0.39	T	0.0202	0.002355815	Thyroid peroxidase antibody levels	Immune diseases and disorders
rs7964748	A	G	53	37	4	46	43	5	0.76	0.72	0.24	0.28	G	4.06	0.002349141	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs17174870	C	T	49	37	8	54	35	5	0.72	0.76	0.28	0.24	G	1.11	0.002349141	Multiple sclerosis	Brain health and disorders
rs28669119	G	A	52	39	3	47	41	6	0.76	0.72	0.24	0.28	G	1.0752687	0.002349141	Schizophrenia	Brain health and disorders
rs17057051	A	G	50	35	9	59	25	10	0.72	0.76	0.28	0.24	G	1.0649383	0.002349141	Crohn's disease	Digestive system and its disorders
rs412000	G	C	33	38	23	35	43	16	0.55	0.60	0.45	0.40	C	0.1641	0.002347622	Primary tooth development time to first tooth eruption	Misc
rs411988	G	A	33	38	23	35	43	16	0.55	0.60	0.45	0.40	A	0.044	0.002347622	Iron status biomarkers ferritin levels	General health
rs7515577	C	A	1	16	77	0	13	81	0.10	0.07	0.90	0.93	C	1.18	0.002337541	Cholesterol, total	General health
rs17672135	T	C	77	16	1	82	11	1	0.90	0.93	0.10	0.07	T	1.43	0.002337541	Coronary heart disease	Heart health and disorders
rs12997796	A	G	76	18	0	81	13	0	0.90	0.93	0.10	0.07	A	1.07	0.002337541	Schizophrenia	Brain health and disorders
rs10058621	T	C	82	11	1	76	18	0	0.93	0.90	0.07	0.10	C	1	0.002337541	Verbal declarative memory	Brain health and disorders
rs13245899	A	G	77	16	1	81	13	0	0.90	0.93	0.10	0.07	G	0.447	0.002337541	Heart rate	General health
rs16939046	T	C	77	16	1	81	13	0	0.90	0.93	0.10	0.07	T	0.22	0.002337541	Information processing speed	Mental aptitude and behavioural traits
rs6669119	C	T	81	13	0	79	12	3	0.93	0.90	0.07	0.10	T	0.14	0.002337541	Percentage gas trapping	Misc
rs12445126	G	A	81	13	0	77	16	1	0.93	0.90	0.07	0.10	G	0.088	0.002337541	Corneal astigmatism	General health
rs10772915	G	A	32	47	15	31	40	23	0.59	0.54	0.41	0.46	G	1	0.002333017	Visceral fat	Obesity
rs230529	T	C	18	50	26	12	53	29	0.46	0.41	0.54	0.59	T	1.45	0.002333017	Schizophrenia treatment resistant	Brain health and disorders
rs10883365	G	A	18	41	35	18	50	26	0.41	0.46	0.59	0.54	G	1.2	0.002333017	Crohn's disease	Digestive system and its disorders
rs1635501	C	T	19	39	36	15	56	23	0.41	0.46	0.59	0.54	C	0.164	0.002333017	Menopause age at onset	Reproductive health
rs198811	C	T	20	38	36	23	41	30	0.41	0.46	0.59	0.54	A	1.69	0.002326583	Narcolepsy with cataplexy	Brain health and disorders
rs883079	C	T	14	50	30	19	49	26	0.41	0.46	0.59	0.54	C	0.49	0.002326583	QRS duration	Heart health and disorders
rs38313	G	A	28	45	21	29	52	13	0.54	0.59	0.46	0.41	G	0.021	0.002326583	Body mass index	Obesity
rs795484	T	C	11	32	51	10	26	58	0.29	0.24	0.71	0.76	A	16.1	0.002318841	Morphine dose requirement in tonsillectomy and adenoidectomy surgery	Misc
rs1456893	G	A	7	32	55	5	44	45	0.24	0.29	0.76	0.71	A	1.2	0.002318841	Crohn's disease	Digestive system and its disorders
rs7227483	A	G	7	40	47	6	34	54	0.29	0.24	0.71	0.76	G	0.0083	0.002318841	Renal function-related traits BUN	General health
rs4655303	A	T	32	44	18	21	57	16	0.57	0.53	0.43	0.47	T	0.2187	0.00231541	Metabolite levels 5-HIAA	General health
rs7512679	C	T	30	48	16	26	47	21	0.57	0.53	0.43	0.47	T	0.092	0.00231541	Emphysema imaging phenotypes	Pulmonology
rs991967	A	C	30	48	16	30	39	25	0.57	0.53	0.43	0.47	A	0.034	0.00231541	Height	General health
rs2096176	C	T	26	47	21	30	48	16	0.53	0.57	0.47	0.43	A	0.02	0.00231541	Obesity-related traits	Obesity
rs931812	C	T	58	34	2	64	29	1	0.80	0.84	0.20	0.16	C	1	0.002313176	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs1582861	C	T	25	48	21	28	51	15	0.52	0.57	0.48	0.43	T	1	0.002310655	Subcutaneous adipose tissue	Obesity
rs12712133	A	G	19	52	23	17	47	30	0.48	0.43	0.52	0.57	A	1.14	0.002310655	Primary biliary cirrhosis	Immune diseases and disorders
rs2456930	C	T	20	51	23	23	36	35	0.48	0.44	0.52	0.56	G	3843.9	0.002306444	Brain structure temporal lobe volume	Brain health and disorders
rs7602460	A	G	37	32	25	25	47	22	0.56	0.52	0.44	0.48	A	2.42	0.002306444	Atrioventricular conduction	Heart health and disorders
rs2867461	A	G	15	52	27	25	41	28	0.44	0.48	0.56	0.52	A	1.13	0.002306444	Rheumatoid arthritis	Immune diseases and disorders
rs4472734	C	T	23	60	11	26	45	23	0.56	0.52	0.44	0.48	T	0.024	0.002306444	Height	General health
rs9375674	A	G	16	51	27	20	52	22	0.44	0.49	0.56	0.51	A	0.158	0.002302772	Renal sinus fat	General health
rs2725236	G	A	22	39	33	20	52	22	0.44	0.49	0.56	0.51	A	0.065	0.002302772	Caffeine consumption	General health
rs837841	C	A	31	34	29	31	43	20	0.51	0.56	0.49	0.44	T	1.279	0.002302772	Adverse response to chemotherapy neutropenia_leucopenia docetaxel	Drug response
rs10854398	T	C	25	44	25	19	47	28	0.50	0.45	0.50	0.55	C	1.178	0.002297025	Suicide risk	General health
rs3219090	T	C	26	42	26	22	59	13	0.50	0.55	0.50	0.45	C	1.15	0.002297025	Melanoma	Cancer
rs3849046	C	T	18	49	27	20	54	20	0.45	0.50	0.55	0.50	T	1.063	0.002297025	Schizophrenia	Brain health and disorders
rs3816587	C	T	26	41	27	27	48	19	0.49	0.54	0.51	0.46	C	1.09	0.002294943	Rheumatoid arthritis	Immune diseases and disorders
rs427576	A	C	25	47	22	13	62	19	0.52	0.47	0.48	0.53	C	2.62	0.002292345	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs2833610	A	G	24	49	21	20	48	26	0.52	0.47	0.48	0.53	A	1.17	0.002292345	Type 2 diabetes	Diabetes
rs1892534	C	T	26	45	23	18	52	24	0.52	0.47	0.48	0.53	A	0.17	0.002292345	C-reactive protein	Immune diseases and disorders
rs1816537	A	C	19	53	22	22	56	16	0.48	0.53	0.52	0.47	C	0.02	0.002292345	Body mass index	Obesity
rs889014	C	T	26	47	21	21	48	25	0.53	0.48	0.47	0.52	T	0.047	0.002291826	Height	General health
rs6700896	C	T	26	46	22	19	51	24	0.52	0.47	0.48	0.53	T	14.8	0.002291826	C-reactive protein	Immune diseases and disorders
rs541862	T	C	75	17	2	68	25	1	0.89	0.86	0.11	0.14	T	1.89	0.002286585	Age-related macular degeneration	Aging
rs956096	A	G	67	27	0	73	21	0	0.86	0.89	0.14	0.11	A	1.07	0.002286585	Schizophrenia	Brain health and disorders
rs11933531	G	A	71	19	4	74	19	1	0.86	0.89	0.14	0.11	A	1	0.002286585	DNA methylation variation	Misc
rs9883650	T	G	73	21	0	69	23	2	0.89	0.86	0.11	0.14	C	1	0.002286585	Immune reponse to smallpox secreted IL-1beta	Immune diseases and disorders
rs2268118	G	T	74	19	1	69	23	2	0.89	0.86	0.11	0.14	A	1	0.002286585	Immune reponse to smallpox secreted IL-2	Immune diseases and disorders
rs12409639	G	A	74	19	1	68	25	1	0.89	0.86	0.11	0.14	A	0.2	0.002286585	Prostate-specific antigen levels	Cancer
rs9627735	A	T	73	21	0	67	27	0	0.89	0.86	0.11	0.14	T	0.152	0.002286585	Symmetrical dimethylarginine levels	General health
rs6044834	T	G	73	21	0	67	27	0	0.89	0.86	0.11	0.14	C	0.04	0.002286585	Obesity-related traits	Obesity
rs2389438	C	A	68	25	1	75	17	2	0.86	0.89	0.14	0.11	C	0.028	0.002286585	Body mass index	Obesity
rs4857855	C	T	59	31	4	65	26	3	0.79	0.83	0.21	0.17	T	9.4	0.002262757	Eosinophil counts	General health
rs878889	G	A	61	27	6	66	24	4	0.79	0.83	0.21	0.17	A	1.43	0.002262757	Type 1 diabetes nephropathy	Diabetes
rs10189761	T	A	2	28	64	4	31	59	0.17	0.21	0.83	0.79	A	1.24	0.002262757	Obesity	Obesity
rs2319125	T	C	59	31	4	66	24	4	0.79	0.83	0.21	0.17	C	0.42	0.002262757	&beta;2-Glycoprotein I &beta;2-GPI plasma levels	Immune diseases and disorders
rs6499755	T	C	49	34	11	53	34	7	0.70	0.74	0.30	0.26	C	1.22	0.002262443	Hypospadias	Misc
rs11257655	C	T	52	36	6	42	48	4	0.74	0.70	0.26	0.30	T	1.15	0.002262443	Type 2 diabetes	Diabetes
rs874040	G	C	55	30	9	45	42	7	0.74	0.70	0.26	0.30	C	1.14	0.002262443	Rheumatoid arthritis	Immune diseases and disorders
rs7681423	C	T	53	34	7	46	40	8	0.74	0.70	0.26	0.30	T	0.29	0.002262443	Fibrinogen	General health
rs7567288	T	C	53	34	7	46	40	8	0.74	0.70	0.26	0.30	T	0.032	0.002262443	Height	General health
rs62436827	A	G	84	8	2	86	8	0	0.94	0.96	0.06	0.04	G	1.49	0.002247191	Triglycerides	General health
rs76503615	G	A	87	6	1	82	12	0	0.96	0.94	0.04	0.06	A	1.11	0.002247191	Schizophrenia	Brain health and disorders
rs789560	G	T	82	12	0	86	8	0	0.94	0.96	0.06	0.04	G	1	0.002247191	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs2854275	C	A	86	8	0	82	12	0	0.96	0.94	0.04	0.06	T	0.45	0.002247191	Epstein-Barr virus immune response EBNA-1	Immune diseases and disorders
rs1884136	G	T	82	12	0	86	8	0	0.94	0.96	0.06	0.04	T	0.2	0.002247191	Information processing speed	Mental aptitude and behavioural traits
rs16894878	G	T	90	4	0	87	7	0	0.98	0.96	0.02	0.04	A	34.08	0.002241594	Diisocyanate-induced asthma	Pulmonology
rs3131060	G	A	87	7	0	90	4	0	0.96	0.98	0.04	0.02	A	2.3	0.002241594	Cutaneous lupus erythematosus	Immune diseases and disorders
rs17066873	T	C	90	4	0	87	7	0	0.98	0.96	0.02	0.04	C	0.9277	0.002241594	Pharmacokinetics of antiepileptic drugs in severe mental disorder concentration drug ratio	General health
rs7698250	C	T	90	4	0	87	7	0	0.98	0.96	0.02	0.04	T	0.463	0.002241594	Pulmonary emphysema	Pulmonology
rs17783561	A	T	87	7	0	90	4	0	0.96	0.98	0.04	0.02	T	0.2748	0.002241594	IgG glycosylation	Immune diseases and disorders
rs1145652	A	G	87	7	0	90	4	0	0.96	0.98	0.04	0.02	A	0.04	0.002241594	Phospholipid levels plasma	General health
rs28362944	T	C	87	7	0	92	0	2	0.96	0.98	0.04	0.02	G	0.03	0.002241594	Obesity-related traits	Obesity
rs11731298	C	T	87	7	0	90	4	0	0.96	0.98	0.04	0.02	A	0.03	0.002241594	Obesity-related traits	Obesity
rs6604026	T	C	45	41	8	52	35	7	0.70	0.74	0.30	0.26	G	1.17	0.002236198	Multiple sclerosis	Brain health and disorders
rs3829251	G	A	45	41	8	53	33	8	0.70	0.74	0.30	0.26	A	0.18	0.002236198	Vitamin D levels	General health
rs6867983	C	T	50	39	5	42	47	5	0.74	0.70	0.26	0.30	T	0.02	0.002236198	Triglycerides	General health
rs9400467	C	T	6	37	51	12	33	49	0.26	0.30	0.74	0.70	T	0.012	0.002236198	Blood metabolite levels	Heart health and disorders
rs6540223	C	T	7	26	61	1	31	62	0.21	0.18	0.79	0.82	T	0.0631	0.00221529	Axial length	Misc
rs7130588	A	G	59	30	5	63	29	2	0.79	0.82	0.21	0.18	G	1.09	0.00221529	Asthma	Immune diseases and disorders
rs3893377	C	T	65	25	4	57	34	3	0.82	0.79	0.18	0.21	C	0.289	0.00221529	Current cigarettes per day in chronic obstructive pulmonary disease	General health
rs603446	C	T	57	34	3	63	29	2	0.79	0.82	0.21	0.18	T	0.0876	0.00221529	Triglycerides	General health
rs11134338	G	A	63	29	2	56	36	2	0.82	0.79	0.18	0.21	A	0.03	0.00221529	Obesity-related traits	Obesity
rs6030712	G	A	60	28	6	64	27	3	0.79	0.82	0.21	0.18	A	0.021	0.00221529	Height	General health
rs7686384	C	T	65	25	4	58	32	4	0.82	0.79	0.18	0.21	A	0.01	0.00221529	Obesity-related traits	Obesity
rs1539019	A	C	4	42	48	8	42	44	0.27	0.31	0.73	0.69	A	0.04	0.002211166	Fibrinogen	General health
rs1531590	T	C	52	34	8	44	42	8	0.73	0.69	0.27	0.31	C	0.1794	0.002211166	IgG glycosylation	Immune diseases and disorders
rs601339	A	G	51	36	7	42	46	6	0.73	0.69	0.27	0.31	G	0.03	0.002211166	Adiponectin levels	Obesity
rs2660869	G	C	81	12	1	77	15	2	0.93	0.90	0.07	0.10	C	4.39	0.002208676	Height	General health
rs2569872	G	C	82	10	2	76	17	1	0.93	0.90	0.07	0.10	C	0.2821	0.002208676	Metabolite levels HVA_MHPG ratio	Brain health and disorders
rs1952138	C	T	75	19	0	80	14	0	0.90	0.93	0.10	0.07	C	0.1724	0.002208676	IgG glycosylation	Immune diseases and disorders
rs17439299	A	G	81	12	1	75	19	0	0.93	0.90	0.07	0.10	G	0.03	0.002208676	Obesity-related traits	Obesity
rs225848	G	A	0	19	75	1	12	81	0.10	0.07	0.90	0.93	G	4.42	0.002208676	Sexual dysfunction SSRI_SNRI-related	General health
rs11018023	G	A	66	28	0	73	20	1	0.85	0.88	0.15	0.12	A	0.21	0.002208589	Temperament	Mental aptitude and behavioural traits
rs62090893	G	A	76	14	4	68	24	2	0.88	0.85	0.12	0.15	G	0.085	0.002208589	Anorexia nervosa	Brain health and disorders
rs1474476	T	G	1	20	73	3	22	69	0.12	0.15	0.88	0.85	A	0.03	0.002208589	Obesity-related traits	Obesity
rs9686661	C	T	48	41	5	42	45	7	0.73	0.69	0.27	0.31	T	2.57	0.002187286	Triglycerides	General health
rs4921493	T	C	54	29	11	40	49	5	0.73	0.69	0.27	0.31	T	1.26	0.002187286	Psoriasis	Immune diseases and disorders
rs9595908	T	C	43	43	8	50	37	7	0.69	0.73	0.31	0.27	T	0.014	0.002187286	Body mass index	Obesity
rs8048576	G	A	55	37	2	62	30	2	0.78	0.82	0.22	0.18	A	1	0.002170543	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs7236632	G	A	4	26	64	2	37	55	0.18	0.22	0.82	0.78	A	1	0.002170543	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs555212	A	G	5	31	58	3	28	63	0.22	0.18	0.78	0.82	G	0.367	0.002170543	End-stage coagulation	General health
rs7791745	T	C	3	28	63	3	35	56	0.18	0.22	0.82	0.78	T	0.196	0.002170543	Mean arterial pressure alcohol consumption interaction	General health
rs9535307	A	C	5	24	65	4	33	57	0.18	0.22	0.82	0.78	A	0.03	0.002170543	Obesity-related traits	Obesity
rs1800693	T	C	49	38	7	43	42	9	0.72	0.68	0.28	0.32	C	1.22	0.002164502	Primary biliary cirrhosis	Immune diseases and disorders
rs742132	A	G	48	40	6	43	42	9	0.72	0.68	0.28	0.32	A	0.05	0.002164502	Uric acid levels	General health
rs12190007	G	A	49	38	7	40	48	6	0.72	0.68	0.28	0.32	A	0.03	0.002164502	Obesity-related traits	Obesity
rs771767	A	G	10	32	52	12	36	46	0.28	0.32	0.72	0.68	A	1.1	0.002164502	Multiple sclerosis	Brain health and disorders
rs6781182	T	C	8	37	49	10	41	43	0.28	0.32	0.72	0.68	T	1	0.002142761	Visceral adipose tissue adjusted for BMI	Obesity
rs11216435	C	T	44	39	11	46	43	5	0.68	0.72	0.32	0.28	T	4.41	0.002142761	Menarche age at onset	Reproductive health
rs753760	C	G	49	37	8	43	41	10	0.72	0.68	0.28	0.32	C	0.131	0.002142761	Thyroid hormone levels	General health
rs2407103	A	G	68	23	3	71	23	0	0.85	0.88	0.15	0.12	C	15	0.002136752	Insulin resistance_response	Drug response
rs12742923	C	T	68	23	3	72	21	1	0.85	0.88	0.15	0.12	T	1	0.002136752	HIV-associated dementia	Brain health and disorders
rs17250963	G	A	72	21	1	67	25	2	0.88	0.85	0.12	0.15	A	1	0.002136752	Homeostasis model assessment of insulin resistance interaction	Misc
rs11241713	C	A	66	27	1	73	19	2	0.85	0.88	0.15	0.12	T	0.79	0.002136752	Amyotrophic lateral sclerosis	Brain health and disorders
rs11709625	C	A	69	21	4	74	17	3	0.85	0.88	0.15	0.12	A	0.102	0.002136752	Hematological and biochemical traits	Heart health and disorders
rs13069049	A	T	69	21	4	74	17	3	0.85	0.88	0.15	0.12	T	0.0182	0.002136752	Metabolite levels	General health
rs13069000	C	G	69	21	4	74	17	3	0.85	0.88	0.15	0.12	G	0.0093	0.002136752	Renal function-related traits BUN	General health
rs62343714	T	C	3	23	68	2	19	73	0.15	0.12	0.85	0.88	T	0.12	0.002136752	Emphysema imaging phenotypes	Pulmonology
rs12884395	A	G	62	29	3	53	40	1	0.81	0.78	0.19	0.22	G	0.02	0.002128306	Obesity-related traits	Obesity
rs11677370	T	A	41	44	9	50	34	10	0.67	0.71	0.33	0.29	T	1.35	0.002122016	Type 2 diabetes	Diabetes
rs3865188	A	T	48	38	8	38	50	6	0.71	0.67	0.29	0.33	T	0.11	0.002122016	Adiponectin levels	Obesity
rs10934447	G	A	42	42	10	49	36	9	0.67	0.71	0.33	0.29	A	0.035	0.002122016	Neuroticism	Brain health and disorders
rs386965	C	T	8	39	47	8	47	39	0.29	0.34	0.71	0.66	G	1.09	0.00210222	Multiple sclerosis	Brain health and disorders
rs10219670	C	A	13	37	44	6	43	45	0.34	0.29	0.66	0.71	C	1	0.00210222	Alzheimer's disease biomarkers	Brain health and disorders
rs543650	T	G	16	31	47	9	37	48	0.34	0.29	0.66	0.71	T	0.034	0.00210222	Height	General health
rs17638464	G	A	79	15	0	74	20	0	0.92	0.89	0.08	0.11	G	1.38	0.00209468	Height	General health
rs1128334	C	T	81	11	2	76	16	2	0.92	0.89	0.08	0.11	A	1.29	0.00209468	Systemic lupus erythematosus	Immune diseases and disorders
rs960246	T	G	2	16	76	3	9	82	0.11	0.08	0.89	0.92	T	0.219	0.00209468	C-reactive protein and white blood cell count	Immune diseases and disorders
rs7503953	A	C	4	28	62	1	41	52	0.19	0.23	0.81	0.77	A	1.5	0.002088394	Wegener's granulomatosis	General health
rs1278769	A	G	5	33	56	3	30	61	0.23	0.19	0.77	0.81	G	1.27	0.002088394	Interstitial lung disease	Pulmonology
rs1171617	G	T	3	30	61	3	37	54	0.19	0.23	0.81	0.77	T	0.036	0.002088394	Blood metabolite levels	Heart health and disorders
rs887864	G	A	8	40	46	10	44	40	0.30	0.34	0.70	0.66	A	1.16	0.002083333	Allergic rhinitis	Immune diseases and disorders
rs10043228	C	T	71	22	1	67	24	3	0.87	0.84	0.13	0.16	T	1.32	0.002070393	Asthma or chronic obstructive pulmonary disease	Immune diseases and disorders
rs2811474	G	C	69	20	5	71	22	1	0.84	0.87	0.16	0.13	G	1.0638298	0.002070393	Schizophrenia	Brain health and disorders
rs9357377	G	A	68	22	4	71	22	1	0.84	0.87	0.16	0.13	A	0.2747	0.002070393	Metabolite levels 5-HIAA_ MHPG Ratio	Brain health and disorders
rs13042473	T	G	66	26	2	71	22	1	0.84	0.87	0.16	0.13	G	0.09	0.002070393	Fractional exhaled nitric oxide childhood	Pulmonology
rs2395528	T	C	2	20	72	1	28	65	0.13	0.16	0.87	0.84	T	1.46	0.002070393	Conduct disorder interaction	Brain health and disorders
rs939583	C	T	2	26	66	2	20	72	0.16	0.13	0.84	0.87	C	0.07	0.002070393	Body mass index	Obesity
rs1944146	A	G	39	45	10	46	39	9	0.65	0.70	0.35	0.30	A	1.08	0.002065316	Refractive astigmatism	General health
rs2242285	A	G	9	39	46	9	47	38	0.30	0.35	0.70	0.65	A	0.37	0.002065316	QRS duration	Heart health and disorders
rs2517388	T	G	39	45	10	45	41	8	0.65	0.70	0.35	0.30	T	0.2146	0.002065316	Menopause age at onset	Reproductive health
rs11911275	A	G	12	41	41	4	49	41	0.35	0.30	0.65	0.70	G	0.08	0.002065316	Age-related nuclear cataracts	Aging
rs1178326	T	C	85	9	0	82	11	1	0.95	0.93	0.05	0.07	C	8.1	0.002054443	Epilepsy and lamotrigine-induced maculopapular eruptions	Brain health and disorders
rs11720887	G	A	85	9	0	81	13	0	0.95	0.93	0.05	0.07	A	1.87	0.002054443	Proteinuria and chronic kidney disease	General health
rs11199254	C	T	81	13	0	85	9	0	0.93	0.95	0.07	0.05	C	1.5588	0.002054443	IgG glycosylation	Immune diseases and disorders
rs35597309	G	A	85	9	0	81	13	0	0.95	0.93	0.05	0.07	A	1.19	0.002054443	Esophageal squamous cell carcinoma	Cancer
rs7303433	A	G	85	9	0	82	11	1	0.95	0.93	0.05	0.07	G	1.1111112	0.002054443	Schizophrenia	Brain health and disorders
rs7129220	G	A	82	11	1	85	9	0	0.93	0.95	0.07	0.05	G	0.619	0.002054443	Systolic blood pressure	Heart health and disorders
rs9906289	C	T	85	9	0	82	11	1	0.95	0.93	0.05	0.07	T	0.083	0.002054443	Motion sickness	Misc
rs7356941	G	A	81	13	0	85	9	0	0.93	0.95	0.07	0.05	G	0.057	0.002054443	Airway responsiveness in chronic obstructive pulmonary disease	Pulmonology
rs17806888	T	C	81	13	0	85	9	0	0.93	0.95	0.07	0.05	T	0.036	0.002054443	Height	General health
rs11155053	C	T	81	13	0	85	9	0	0.93	0.95	0.07	0.05	A	0.03	0.002054443	Obesity-related traits	Obesity
rs9580312	A	G	56	32	6	61	29	4	0.77	0.80	0.23	0.20	G	1.33	0.002050638	Adverse response to chemotherapy neutropenia_leucopenia all antimetabolite drugs	Drug response
rs744016	C	T	55	34	5	59	33	2	0.77	0.80	0.23	0.20	A	0.17	0.002050638	RR interval heart rate	Heart health and disorders
rs2066940	T	C	56	32	6	62	27	5	0.77	0.80	0.23	0.20	T	0.044	0.002050638	Sitting height ratio	Appearance
rs6504108	C	T	1	35	58	3	38	53	0.20	0.23	0.80	0.77	C	0.019	0.002050638	Body mass index	Obesity
rs9872999	C	T	14	39	41	8	43	43	0.36	0.31	0.64	0.69	T	11.72	0.002031746	Iron status biomarkers	General health
rs12446487	A	C	43	43	8	43	35	16	0.69	0.64	0.31	0.36	C	1.0869565	0.002031746	Schizophrenia	Brain health and disorders
rs13136331	C	T	38	45	11	46	37	11	0.64	0.69	0.36	0.31	T	0.048	0.002031746	Sitting height ratio	Appearance
rs10773920	A	C	39	43	12	36	57	1	0.64	0.69	0.36	0.31	C	0.03	0.002031746	Obesity-related traits	Obesity
rs1498694	A	G	12	43	39	10	39	45	0.36	0.31	0.64	0.69	A	0.008	0.002031746	Blood metabolite levels	Heart health and disorders
rs2206271	T	A	38	45	11	45	39	10	0.64	0.69	0.36	0.31	A	0.0055	0.002031746	Renal function-related traits BUN	General health
rs4956211	G	A	41	38	15	46	36	12	0.64	0.68	0.36	0.32	A	1.33	0.002016129	Systemic lupus erythematosus	Immune diseases and disorders
rs2941740	A	G	42	36	16	46	36	12	0.64	0.68	0.36	0.32	G	0.07	0.002016129	Bone mineral density hip	General health
rs1275468	T	C	13	42	39	10	40	44	0.36	0.32	0.64	0.68	C	1.13	0.002016129	Polycystic ovary syndrome	Reproductive health
rs270601	T	C	8	29	57	0	38	56	0.24	0.20	0.76	0.80	T	0.0433	0.002014885	Acylcarnitine levels	General health
rs13402330	T	A	53	37	4	59	32	3	0.76	0.80	0.24	0.20	A	5.27	0.002014885	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs11693319	C	T	64	22	8	54	35	5	0.80	0.76	0.20	0.24	T	4.72	0.002014885	Blood pressure measurement cold pressor test	Heart health and disorders
rs13187289	C	G	62	26	6	51	41	2	0.80	0.76	0.20	0.24	G	3	0.002014885	Menarche age at onset	Reproductive health
rs13429458	A	C	73	17	4	66	25	3	0.87	0.84	0.13	0.16	A	1.49	0.002008929	Polycystic ovary syndrome	Reproductive health
rs6537837	C	T	73	17	4	66	25	3	0.87	0.84	0.13	0.16	T	1.43	0.002008929	Major depressive disorder	Brain health and disorders
rs11127485	C	T	2	27	65	2	21	71	0.16	0.13	0.84	0.87	T	1.23	0.002008929	Obesity early onset extreme	Obesity
rs6548238	T	C	2	27	65	2	21	71	0.16	0.13	0.84	0.87	C	0.26	0.002008929	Body mass index	Obesity
rs6794649	G	C	66	25	3	69	25	0	0.84	0.87	0.16	0.13	C	0.2074	0.002008929	IgG glycosylation	Immune diseases and disorders
rs1937579	C	T	3	25	66	0	25	69	0.16	0.13	0.84	0.87	T	0.19	0.002008929	Coronary artery calcification	Heart health and disorders
rs13021737	A	G	2	27	65	2	21	71	0.16	0.13	0.84	0.87	G	0.069	0.002008929	Body mass index	Obesity
rs2575029	T	C	4	17	73	3	25	66	0.13	0.16	0.87	0.84	A	0.03	0.002008929	Obesity-related traits	Obesity
rs10898392	G	T	36	47	11	43	41	10	0.63	0.68	0.37	0.32	T	1	0.002001251	Height	General health
rs7092703	C	T	37	44	13	36	54	4	0.63	0.67	0.37	0.33	C	0.054	0.001987084	Corneal astigmatism	General health
rs6691847	T	C	7	32	55	5	29	60	0.24	0.21	0.76	0.79	C	1.32	0.001980999	Non-alcoholic fatty liver disease	Obesity
rs8077577	C	T	50	42	2	57	35	2	0.76	0.79	0.24	0.21	A	0.03	0.001980999	Obesity-related traits	Obesity
rs8077889	A	C	56	37	1	52	38	4	0.79	0.76	0.21	0.24	C	0.025	0.001980999	Triglycerides	General health
rs2806971	A	G	6	34	54	5	29	60	0.24	0.21	0.76	0.79	A	0.0025	0.001980999	Trans fatty acid levels	General health
rs7808970	A	G	35	47	12	43	39	12	0.62	0.66	0.38	0.34	G	0.52	0.001973603	QT interval	Heart health and disorders
rs1884139	G	T	40	37	17	43	39	12	0.62	0.66	0.38	0.34	T	0.18	0.001973603	Symmetrical dimethylarginine levels	General health
rs7654585	A	G	9	45	40	15	41	38	0.34	0.38	0.66	0.62	A	0.04	0.001973603	Obesity-related traits	Obesity
rs13015447	A	C	33	50	11	43	38	13	0.62	0.66	0.38	0.34	G	1.41	0.001960784	Amyotrophic lateral sclerosis	Brain health and disorders
rs7226855	A	G	12	48	34	9	46	39	0.38	0.34	0.62	0.66	A	1.25	0.001960784	Colorectal cancer	Cancer
rs2571391	A	C	36	52	6	32	52	10	0.66	0.62	0.34	0.38	C	0.06	0.001960784	IgE levels	Immune diseases and disorders
rs2153535	C	G	34	48	12	40	44	10	0.62	0.66	0.38	0.34	G	0.046	0.001960784	Motion sickness	Misc
rs2177312	G	T	1	24	69	5	22	67	0.14	0.17	0.86	0.83	T	4.584	0.001951854	Very long-chain saturated fatty acid levels fatty acid 22:0	General health
rs1106766	C	T	68	20	6	71	20	3	0.83	0.86	0.17	0.14	T	5.16	0.001951854	Urate levels	General health
rs11613352	C	T	68	20	6	71	20	3	0.83	0.86	0.17	0.14	T	0.46	0.001951854	HDL cholesterol	General health
rs1879734	T	C	58	32	4	50	41	3	0.79	0.75	0.21	0.25	T	1.23	0.001948853	Mitral valve prolapse	Heart health and disorders
rs6666258	G	C	59	30	5	51	39	4	0.79	0.75	0.21	0.25	C	1.18	0.001948853	Atrial fibrillation	Heart health and disorders
rs10508372	G	A	59	30	5	52	37	5	0.79	0.75	0.21	0.25	C	1.16	0.001948853	Asthma	Immune diseases and disorders
rs891992	T	C	62	24	8	53	35	6	0.79	0.75	0.21	0.25	G	0.03	0.001948853	Obesity-related traits	Obesity
rs6584283	T	C	17	39	38	8	49	37	0.39	0.35	0.61	0.65	T	1.22	0.001948606	Ulcerative colitis	Immune diseases and disorders
rs207282	T	C	13	39	42	15	43	36	0.35	0.39	0.65	0.61	T	1.05	0.001948606	Schizophrenia	Brain health and disorders
rs342296	G	A	33	49	12	43	37	14	0.61	0.65	0.39	0.35	G	0.16	0.001948606	Mean platelet volume	Heart health and disorders
rs4788196	A	G	36	50	8	31	52	11	0.65	0.61	0.35	0.39	G	0.07	0.001937046	Pubertal anthropometrics	Appearance
rs11247915	C	A	34	46	14	42	38	14	0.61	0.65	0.39	0.35	A	0.03	0.001937046	Obesity-related traits	Obesity
rs4131099	G	A	34	53	7	34	45	15	0.64	0.60	0.36	0.40	A	0.11	0.001926086	Personality dimensions	Brain health and disorders
rs11838776	G	A	55	30	9	55	37	2	0.74	0.78	0.26	0.22	A	1.07	0.001918334	Coronary artery disease	Heart health and disorders
rs7785730	A	G	54	39	1	52	36	6	0.78	0.74	0.22	0.26	G	0.106	0.001918334	Free thyroxine concentration	General health
rs9296095	T	C	39	42	13	30	52	12	0.64	0.60	0.36	0.40	G	4.8	0.001915709	Platelet count	Heart health and disorders
rs77885874	C	G	86	8	0	90	3	1	0.96	0.97	0.04	0.03	G	7.7	0.001907184	Diisocyanate-induced asthma	Pulmonology
rs12638075	T	C	89	5	0	86	8	0	0.97	0.96	0.03	0.04	C	1.376	0.001907184	Refractive astigmatism	General health
rs5752209	C	G	89	5	0	86	8	0	0.97	0.96	0.03	0.04	C	0.01	0.001907184	Trans fatty acid levels	General health
rs8184969	C	T	89	5	0	86	8	0	0.97	0.96	0.03	0.04	T	0.0087	0.001907184	Trans fatty acid levels	General health
rs10460009	C	T	73	20	1	78	15	1	0.88	0.91	0.12	0.09	C	1.35	0.001902153	Type 2 diabetes	Diabetes
rs13170232	T	A	79	13	2	72	22	0	0.91	0.88	0.09	0.12	T	1.098901	0.001902153	Schizophrenia	Brain health and disorders
rs13217797	T	C	78	15	1	73	20	1	0.91	0.88	0.09	0.12	T	1.06	0.001902153	Schizophrenia	Brain health and disorders
rs75200691	T	G	72	22	0	78	15	1	0.88	0.91	0.12	0.09	T	0.15	0.001902153	Emphysema imaging phenotypes	Pulmonology
rs6472903	G	T	2	13	79	0	22	72	0.09	0.12	0.91	0.88	T	1.1	0.001902153	Breast cancer	Cancer
rs11045000	G	A	69	23	2	64	27	3	0.86	0.82	0.14	0.18	A	1.28	0.001898734	Ossification of the posterior longitudinal ligament of the spine	Misc
rs1913185	T	G	68	25	1	68	19	7	0.86	0.82	0.14	0.18	C	0.04	0.001898734	Obesity-related traits	Obesity
rs1682825	C	T	4	25	65	2	23	69	0.18	0.14	0.82	0.86	T	0.118	0.001898734	Economic and political preferences feminism_equality	Mental aptitude and behavioural traits
rs11750092	C	T	84	10	0	81	12	1	0.95	0.93	0.05	0.07	T	1.07	0.001893939	Migraine	Brain health and disorders
rs4078978	C	T	80	14	0	84	10	0	0.93	0.95	0.07	0.05	A	1	0.001893939	Immune reponse to smallpox secreted IFN-alpha	Immune diseases and disorders
rs12468965	G	A	81	12	1	85	8	1	0.93	0.95	0.07	0.05	G	0.5067	0.001893939	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs11825709	A	G	85	8	1	80	14	0	0.95	0.93	0.05	0.07	G	0.02	0.001893939	Obesity-related traits	Obesity
rs4813003	C	T	58	30	6	52	35	7	0.78	0.74	0.22	0.26	C	1.41	0.001889339	Kawasaki disease	Misc
rs6107516	G	A	51	37	6	55	36	3	0.74	0.78	0.26	0.22	C	1.35	0.001889339	Creutzfeldt-Jakob disease sporadic	Immune diseases and disorders
rs6909430	G	A	3	36	55	5	39	50	0.22	0.26	0.78	0.74	G	0.49	0.001889339	Quantitative traits	Misc
rs2819348	T	C	50	39	5	56	34	4	0.74	0.78	0.26	0.22	C	0.078	0.001889339	Breast size	General health
rs4518370	A	G	19	41	34	17	37	40	0.42	0.38	0.58	0.62	G	0.11	0.001887906	Osteoarthritis biomarkers	General health
rs6932730	T	C	30	47	17	32	51	11	0.57	0.61	0.43	0.39	T	1.14	0.001872002	Allergic sensitization	Immune diseases and disorders
rs7069923	C	T	33	49	12	29	49	16	0.61	0.57	0.39	0.43	C	0.19	0.001872002	Quantitative traits	Misc
rs7642243	C	G	18	45	31	10	53	31	0.43	0.39	0.57	0.61	C	0.048	0.001872002	Blood metabolite levels	Heart health and disorders
rs1346786	C	T	33	49	12	31	45	18	0.61	0.57	0.39	0.43	T	0.015	0.001872002	Optic cup area	Misc
rs4330281	T	C	16	42	36	17	48	29	0.39	0.44	0.61	0.56	C	1.0638298	0.001864802	Schizophrenia	Brain health and disorders
rs602848	C	G	5	33	56	9	32	53	0.23	0.27	0.77	0.73	C	1.18	0.001861773	Migraine - clinic-based	Brain health and disorders
rs1837253	T	C	3	37	54	7	36	51	0.23	0.27	0.77	0.73	C	1.17	0.001861773	Asthma	Immune diseases and disorders
rs2742234	C	T	10	30	54	3	37	54	0.27	0.23	0.73	0.77	T	1	0.001861773	Hirschsprung disease	Brain health and disorders
rs10032931	T	C	3	37	54	6	38	50	0.23	0.27	0.77	0.73	C	0.195	0.001861773	Optic nerve measurement cup-to-disc ratio	Misc
rs2486152	A	G	9	25	60	9	32	53	0.23	0.27	0.77	0.73	A	0.1	0.001861773	Metabolite levels Pyroglutamine	General health
rs13192471	T	C	48	42	4	56	33	5	0.73	0.77	0.27	0.23	G	1.97	0.001861773	Rheumatoid arthritis	Immune diseases and disorders
rs873917	T	G	16	43	35	17	49	28	0.40	0.44	0.60	0.56	T	1.16	0.001858088	Amyotrophic lateral sclerosis	Brain health and disorders
rs9286879	A	G	30	45	19	33	47	14	0.56	0.60	0.44	0.40	G	1.19	0.001858088	Crohn's disease	Digestive system and its disorders
rs10503871	C	T	32	49	13	31	43	20	0.60	0.56	0.40	0.44	C	0.04	0.001858088	Metabolite levels  X-11787	General health
rs4731889	A	G	20	44	30	14	48	32	0.45	0.40	0.55	0.60	A	0.0856	0.001851852	Oleic acid 18:1n-9 plasma levels	General health
rs6732189	G	A	31	42	21	31	50	13	0.55	0.60	0.45	0.40	A	0.023	0.001851852	Educational attainment	Mental aptitude and behavioural traits
rs2255221	G	T	69	22	3	64	26	4	0.85	0.82	0.15	0.18	T	2.7	0.001849188	HIV-1 control	Immune diseases and disorders
rs6684428	T	A	62	30	2	69	22	3	0.82	0.85	0.18	0.15	A	1.23	0.001849188	Airflow obstruction	Pulmonology
rs17080102	G	C	65	24	5	69	22	3	0.82	0.85	0.18	0.15	C	1.02	0.001849188	Blood pressure	Heart health and disorders
rs1557488	T	C	3	22	69	3	28	63	0.15	0.18	0.85	0.82	T	1	0.001849188	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs2710833	T	C	1	26	67	2	30	62	0.15	0.18	0.85	0.82	A	0.41	0.001849188	Non-alcoholic fatty liver disease histology AST	Obesity
rs2363709	G	A	5	24	65	1	26	67	0.18	0.15	0.82	0.85	G	0.12	0.001849188	IgE levels	Immune diseases and disorders
rs11690256	C	T	61	32	1	68	24	2	0.82	0.85	0.18	0.15	T	0.099	0.001849188	Symmetrical dimethylarginine levels	General health
rs9488822	A	T	35	41	18	31	41	22	0.59	0.55	0.41	0.45	T	1.18	0.001846083	Cholesterol, total	General health
rs6073450	G	A	28	47	19	38	35	21	0.55	0.59	0.45	0.41	A	1.11	0.001846083	Pancreatic cancer	Cancer
rs4374383	A	G	17	43	34	22	41	31	0.41	0.45	0.59	0.55	A	1	0.001846083	Hepatitis C induced liver fibrosis	Immune diseases and disorders
rs2738113	G	T	17	52	25	18	42	34	0.46	0.41	0.54	0.59	G	1.15	0.001840773	Endometriosis	General health
rs6773957	A	G	26	50	18	29	52	13	0.54	0.59	0.46	0.41	A	1	0.001840773	Adiponectin levels	Obesity
rs994533	G	C	33	44	17	29	44	21	0.59	0.54	0.41	0.46	C	0.027	0.001840773	Height	General health
rs2285803	T	C	3	38	53	8	35	51	0.23	0.27	0.77	0.73	A	1.192	0.00183555	Multiple myeloma	Cancer
rs2077233	G	A	55	34	5	53	31	10	0.77	0.73	0.23	0.27	A	2.3061	0.00183555	Cognitive function	Brain health and disorders
rs12258967	C	G	57	30	7	46	45	3	0.77	0.73	0.23	0.27	G	0.431	0.00183555	Blood pressure	Heart health and disorders
rs10803016	G	T	17	46	31	21	46	27	0.43	0.47	0.57	0.53	T	0.16	0.001831502	Coronary artery calcification	Heart health and disorders
rs6684205	A	G	30	48	16	30	40	24	0.57	0.53	0.43	0.47	A	0.028	0.001831502	Height	General health
rs11113818	C	T	28	43	23	29	49	16	0.53	0.57	0.47	0.43	T	1.16	0.001827527	Response to methotrexate in juvenile idiopathic arthritis	General health
rs9506514	C	A	27	53	14	29	41	24	0.57	0.53	0.43	0.47	A	0.17	0.001827527	Coronary artery calcification	Heart health and disorders
rs7979473	A	G	20	42	32	18	54	22	0.44	0.48	0.56	0.52	A	0.119	0.001823985	C-reactive protein	Immune diseases and disorders
rs2144134	C	G	33	32	29	31	44	19	0.52	0.56	0.48	0.44	G	0.09	0.001823985	Body mass index interaction	Obesity
rs174528	T	C	29	40	25	29	48	17	0.52	0.56	0.48	0.44	T	0.003	0.001823985	Trans fatty acid levels	General health
rs1342038	G	A	24	49	21	33	39	22	0.52	0.56	0.48	0.44	G	1.49	0.001820872	Diabetic retinopathy	Diabetes
rs6804441	A	G	78	14	2	71	23	0	0.90	0.88	0.10	0.12	A	1.2658	0.001820167	Systemic lupus erythematosus	Immune diseases and disorders
rs45483501	C	G	76	18	0	71	23	0	0.90	0.88	0.10	0.12	C	1.22	0.001820167	Diffuse large B cell lymphoma	Cancer
rs11711441	G	A	72	21	1	76	18	0	0.88	0.90	0.12	0.10	G	1.19	0.001820167	Parkinson's disease	Brain health and disorders
rs16912285	A	G	74	17	3	76	18	0	0.88	0.90	0.12	0.10	G	1	0.001820167	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs11191593	T	C	71	23	0	78	14	2	0.88	0.90	0.12	0.10	T	0.66	0.001820167	Blood pressure	Heart health and disorders
rs28927680	C	G	77	16	1	71	23	0	0.90	0.88	0.10	0.12	G	0.26	0.001820167	Triglycerides	General health
rs574773	C	T	78	14	2	73	19	2	0.90	0.88	0.10	0.12	T	0.197	0.001820167	Economic and political preferences	Mental aptitude and behavioural traits
rs9941219	C	T	76	18	0	71	23	0	0.90	0.88	0.10	0.12	A	0.154	0.001820167	Liver enzyme levels alanine transaminase	General health
rs12986445	T	A	20	44	30	19	54	21	0.45	0.49	0.55	0.51	A	0.17	0.001818182	Multiple myeloma and monoclonal gammopathy	Cancer
rs3094548	G	C	18	48	28	26	40	28	0.45	0.49	0.55	0.51	G	0.029	0.001818182	Pulmonary function	Pulmonology
rs469568	A	C	29	45	20	28	39	27	0.55	0.51	0.45	0.49	T	1.77	0.001815912	Stroke pediatric	Brain health and disorders
rs10774021	C	T	27	41	26	28	47	19	0.51	0.55	0.49	0.45	C	1.05	0.001815912	Chronic kidney disease	Immune diseases and disorders
rs10797919	G	C	26	43	25	28	47	19	0.51	0.55	0.49	0.45	G	1	0.001815912	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs10010325	C	A	29	45	20	23	49	22	0.55	0.51	0.45	0.49	A	0.024	0.001815912	Height	General health
rs2659703	G	A	31	40	23	19	56	19	0.54	0.50	0.46	0.50	A	1	0.001814059	Plasma omega-6 polyunsaturated fatty acid levels gamma-linolenic acid	General health
rs4985155	A	G	27	40	27	22	58	14	0.50	0.54	0.50	0.46	A	0.01	0.001814059	Plasma omega-6 polyunsaturated fatty acid levels gamma-linolenic acid	General health
rs922107	A	G	16	54	24	21	52	21	0.46	0.50	0.54	0.50	G	1.788	0.001814059	Adverse response to chemotherapy neutropenia_leucopenia paclitaxel + carboplatin	Drug response
rs4950806	T	C	22	51	21	20	47	27	0.51	0.46	0.49	0.54	T	0.14	0.00181262	Butyrylcholinesterase levels	Cancer
rs1129700	T	C	25	45	24	20	47	27	0.51	0.46	0.49	0.54	T	0.03	0.00181262	Menarche age at onset	Reproductive health
rs12195417	T	C	27	47	20	21	51	22	0.54	0.49	0.46	0.51	C	1.0526316	0.00181262	Schizophrenia	Brain health and disorders
rs1936800	C	T	26	49	19	25	43	26	0.54	0.49	0.46	0.51	C	0.02	0.00181262	HDL cholesterol	General health
rs12449000	T	C	23	42	29	22	52	20	0.47	0.51	0.53	0.49	T	1.05	0.001811594	Schizophrenia	Brain health and disorders
rs1956388	G	A	25	46	23	22	44	28	0.51	0.47	0.49	0.53	A	1	0.001811594	Ulcerative colitis	Immune diseases and disorders
rs6928289	G	A	29	42	23	18	56	20	0.53	0.49	0.47	0.51	G	15.56	0.001811594	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs6426833	G	A	23	46	25	28	44	22	0.49	0.53	0.51	0.47	G	1.37	0.001811594	Ulcerative colitis	Immune diseases and disorders
rs2077212	G	C	21	50	23	26	48	20	0.49	0.53	0.51	0.47	G	1.36	0.001811594	Diabetic kidney disease	Diabetes
rs6785504	G	T	25	41	28	29	41	24	0.48	0.53	0.52	0.47	T	2.11	0.001810979	Response to antineoplastic agents	General health
rs7819988	T	C	26	45	23	20	49	25	0.52	0.47	0.48	0.53	T	1.32	0.001810979	Periodontitis CDC_AAP	Misc
rs35881094	T	G	25	47	22	22	45	27	0.52	0.47	0.48	0.53	G	1.16	0.001810979	Tourette's syndrome or obsessive-compulsive disorder	Brain health and disorders
rs6079395	G	A	22	55	17	23	45	26	0.53	0.48	0.47	0.52	A	0.92	0.001810979	Non-alcoholic fatty liver disease histology other	Obesity
rs9284954	C	A	23	45	26	28	43	23	0.48	0.53	0.52	0.47	C	0.1418	0.001810979	IgG glycosylation	Immune diseases and disorders
rs8032675	T	C	24	51	19	18	55	21	0.53	0.48	0.47	0.52	T	0.04	0.001810979	Menarche age at onset	Reproductive health
rs13428823	G	A	20	50	24	30	38	26	0.48	0.52	0.52	0.48	G	1.17	0.001810774	Height	General health
rs7936591	C	T	49	38	7	53	37	4	0.72	0.76	0.28	0.24	T	2.08	0.00181059	Attention function in attention deficit hyperactive disorder	Brain health and disorders
rs1588265	A	G	51	34	9	54	35	5	0.72	0.76	0.28	0.24	C	1.18	0.00181059	Asthma	Immune diseases and disorders
rs13128441	C	T	3	39	52	8	36	50	0.24	0.28	0.76	0.72	C	1	0.00181059	Celiac disease	Immune diseases and disorders
rs1991867	C	T	9	34	51	3	39	52	0.28	0.24	0.72	0.76	C	0.044	0.00181059	D-dimer levels	Heart health and disorders
rs6574644	G	A	8	36	50	6	33	55	0.28	0.24	0.72	0.76	G	0.03	0.00181059	Obesity-related traits	Obesity
rs12434047	G	A	60	33	1	67	25	2	0.81	0.85	0.19	0.15	G	0.127	0.001802885	Economic and political preferences fairness	Mental aptitude and behavioural traits
rs35063026	C	T	90	4	0	92	2	0	0.98	0.99	0.02	0.01	T	20.29	0.001801802	Facial pigmentation	Appearance
rs389884	A	G	92	2	0	90	4	0	0.99	0.98	0.01	0.02	C	3.65	0.001801802	Idiopathic membranous nephropathy	Brain health and disorders
rs3094067	T	G	90	4	0	92	2	0	0.98	0.99	0.02	0.01	G	2.32	0.001801802	Cutaneous lupus erythematosus	Immune diseases and disorders
rs114444506	T	C	90	4	0	92	2	0	0.98	0.99	0.02	0.01	C	2.11	0.001801802	Febrile seizures MMR vaccine-related	General health
rs11206226	A	G	90	4	0	92	2	0	0.98	0.99	0.02	0.01	A	1.72	0.001801802	Nonalcoholic fatty liver disease	Obesity
rs4282438	T	G	90	4	0	92	2	0	0.98	0.99	0.02	0.01	G	1.58	0.001801802	Sjogren's syndrome	Immune diseases and disorders
rs16864170	T	C	90	4	0	92	2	0	0.98	0.99	0.02	0.01	C	1.3	0.001801802	Chronic kidney disease	Immune diseases and disorders
rs11215609	G	T	92	2	0	90	4	0	0.99	0.98	0.01	0.02	T	1.26	0.001801802	Schizophrenia	Brain health and disorders
rs3117582	T	G	92	2	0	90	4	0	0.99	0.98	0.01	0.02	C	1.24	0.001801802	Lung cancer	Cancer
rs4764043	C	T	90	4	0	92	2	0	0.98	0.99	0.02	0.01	T	1.17	0.001801802	Aging time to event	Aging
rs141216273	C	A	92	2	0	90	4	0	0.99	0.98	0.01	0.02	A	1.14	0.001801802	Schizophrenia	Brain health and disorders
rs79090407	A	G	92	2	0	90	4	0	0.99	0.98	0.01	0.02	A	1.12	0.001801802	Schizophrenia	Brain health and disorders
rs34132583	G	A	90	4	0	92	2	0	0.98	0.99	0.02	0.01	A	0.9231	0.001801802	Hippocampal sclerosis	Brain health and disorders
rs12051272	G	T	90	4	0	92	2	0	0.98	0.99	0.02	0.01	T	0.26	0.001801802	Adiponectin levels	Obesity
rs61999321	C	T	90	4	0	92	2	0	0.98	0.99	0.02	0.01	A	0.03	0.001801802	Obesity-related traits	Obesity
rs6488898	G	A	0	4	90	0	2	92	0.02	0.01	0.98	0.99	G	0.053	0.001801802	Adiponectin levels	Obesity
rs1372072	G	A	54	34	6	49	37	8	0.76	0.72	0.24	0.28	A	1.2	0.001786821	Primary biliary cirrhosis	Immune diseases and disorders
rs56167332	C	A	52	31	11	51	40	3	0.72	0.76	0.28	0.24	A	1.1859788	0.001786821	Crohn's disease	Digestive system and its disorders
rs755374	C	T	52	31	11	51	40	3	0.72	0.76	0.28	0.24	T	1	0.001786821	Pediatric autoimmune diseases	Immune diseases and disorders
rs895636	C	T	53	36	5	47	41	6	0.76	0.72	0.24	0.28	A	0.0393	0.001786821	Metabolite levels	General health
rs1351164	T	C	50	35	9	53	36	5	0.72	0.76	0.28	0.24	T	0.034	0.001786821	Height	General health
rs6678676	T	C	5	36	53	12	29	53	0.24	0.28	0.76	0.72	C	1.0638298	0.001786821	Schizophrenia	Brain health and disorders
rs476428	G	A	49	36	9	52	37	5	0.71	0.75	0.29	0.25	G	1.1627907	0.001764176	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs10777332	C	T	56	29	9	49	36	9	0.75	0.71	0.25	0.29	A	0.24	0.001764176	Biochemical measures	General health
rs7713317	A	G	52	37	5	49	36	9	0.75	0.71	0.25	0.29	G	0.017	0.001764176	Body mass index	Obesity
rs1546044	A	T	3	41	50	10	34	50	0.25	0.29	0.75	0.71	A	1.05	0.001764176	Schizophrenia	Brain health and disorders
rs897080	C	T	4	22	68	6	24	64	0.16	0.19	0.84	0.81	T	0.028	0.001759531	Height	General health
rs7616330	C	A	65	28	1	60	32	2	0.84	0.81	0.16	0.19	A	1.72	0.001759531	QT interval	Heart health and disorders
rs12936361	T	C	66	26	2	58	36	0	0.84	0.81	0.16	0.19	T	0.2338	0.001759531	Periodontitis DPAL	Misc
rs7241918	G	T	1	13	80	0	11	83	0.08	0.06	0.92	0.94	G	1.31	0.001758242	HDL cholesterol	General health
rs6586030	A	G	0	15	79	0	11	83	0.08	0.06	0.92	0.94	G	1.115	0.001758242	Inflammatory bowel disease	Immune diseases and disorders
rs11710497	A	G	80	13	1	83	11	0	0.92	0.94	0.08	0.06	A	5.29	0.001758242	Longitudinal alcohol consumption	General health
rs11082438	G	T	83	11	0	81	11	2	0.94	0.92	0.06	0.08	G	1.33	0.001758242	Follicular lymphoma	Cancer
rs12498839	G	A	83	11	0	79	15	0	0.94	0.92	0.06	0.08	A	1.11	0.001758242	Schizophrenia	Brain health and disorders
rs2295015	A	G	80	13	1	84	9	1	0.92	0.94	0.08	0.06	A	0.07	0.001758242	LDL peak particle diameter total fat intake interaction	General health
rs7627289	G	A	70	24	0	76	17	1	0.87	0.90	0.13	0.10	A	1	0.001745932	Visceral fat	Obesity
rs10232860	T	C	75	19	0	73	18	3	0.90	0.87	0.10	0.13	G	1	0.001745932	Vein graft stenosis in coronary artery bypass grafting	Heart health and disorders
rs10829848	C	T	71	22	1	77	15	2	0.87	0.90	0.13	0.10	T	0.3	0.001745932	Insulin-related traits	Diabetes
rs17548918	T	C	75	19	0	71	22	1	0.90	0.87	0.10	0.13	C	0.26	0.001745932	Anxiety disorder	Brain health and disorders
rs17398575	G	A	70	24	0	76	17	1	0.87	0.90	0.13	0.10	A	0.1619	0.001745932	Carotid intima media thickness	Heart health and disorders
rs2967951	C	T	49	35	10	53	34	7	0.71	0.74	0.29	0.26	T	0.8064	0.001742594	Body mass index	Obesity
rs11677911	G	T	52	36	6	41	51	2	0.74	0.71	0.26	0.29	T	0.015	0.001742594	Body mass index	Obesity
rs878939	A	G	60	31	3	66	25	3	0.80	0.84	0.20	0.16	G	6.431	0.001718869	Warfarin maintenance dose	General health
rs10922438	G	A	62	27	5	64	29	1	0.80	0.84	0.20	0.16	T	2.301	0.001718869	Adverse response to chemotherapy neutropenia_leucopenia cyclophosphamide	Drug response
rs12725198	G	A	63	31	0	60	31	3	0.84	0.80	0.16	0.20	A	1.85	0.001718869	Cardiac Troponin-T levels	Heart health and disorders
rs6568421	A	G	58	35	1	66	25	3	0.80	0.84	0.20	0.16	G	1.13	0.001718869	Crohn's disease	Digestive system and its disorders
rs1182188	T	C	63	25	6	67	23	4	0.80	0.84	0.20	0.16	A	1.1136187	0.001718869	Ulcerative colitis	Immune diseases and disorders
rs1016883	G	A	61	29	4	65	27	2	0.80	0.84	0.20	0.16	G	1.1	0.001718869	Ulcerative colitis	Immune diseases and disorders
rs1825500	C	T	66	25	3	62	27	5	0.84	0.80	0.16	0.20	C	0.129	0.001718869	Urate levels in lean individuals	Obesity
rs321358	A	G	58	35	1	64	29	1	0.80	0.84	0.20	0.16	G	0.026	0.001718869	Body mass index	Obesity
rs7529925	C	T	4	29	61	2	27	65	0.20	0.16	0.80	0.84	C	0.014	0.001718869	Red blood cell traits	Immune diseases and disorders
rs7162542	C	G	5	47	42	7	36	51	0.30	0.27	0.70	0.73	C	0.046	0.001702394	Height	General health
rs9260489	T	G	8	34	52	9	39	46	0.27	0.30	0.73	0.70	G	0.04	0.001702394	Beta-2 microglubulin plasma levels	Cancer
rs7208487	T	G	48	42	4	47	37	10	0.73	0.70	0.27	0.30	T	1.32	0.001702394	Primary biliary cirrhosis	Immune diseases and disorders
rs12153243	A	T	45	40	9	49	39	6	0.69	0.73	0.31	0.27	T	1.05	0.001683675	Migraine	Brain health and disorders
rs9687846	G	A	48	41	5	43	44	7	0.73	0.69	0.27	0.31	A	0.0409	0.001683675	Waist-to-hip ratio adjusted for body mass index	Obesity
rs11113894	G	A	43	44	7	51	35	8	0.69	0.73	0.31	0.27	A	0.03	0.001683675	Obesity-related traits	Obesity
rs1286083	T	C	64	28	2	61	28	5	0.83	0.80	0.17	0.20	T	0.05	0.001680672	Bone mineral density	General health
rs6964833	T	C	60	30	4	66	24	4	0.80	0.83	0.20	0.17	T	0.04	0.001680672	Menarche age at onset	Reproductive health
rs456867	C	T	66	24	4	63	24	7	0.83	0.80	0.17	0.20	T	0.038	0.001680672	Urate levels	General health
rs11985951	T	C	70	23	1	76	16	2	0.87	0.89	0.13	0.11	T	3.36	0.001678416	Cervical cancer	Cancer
rs2293370	G	A	72	19	3	75	18	1	0.87	0.89	0.13	0.11	G	1.42	0.001678416	Primary biliary cirrhosis	Immune diseases and disorders
rs4273077	A	G	76	16	2	70	23	1	0.89	0.87	0.11	0.13	G	0.088	0.001678416	Hematological and biochemical traits	Heart health and disorders
rs13068893	C	G	71	21	2	75	18	1	0.87	0.89	0.13	0.11	G	0.00208	0.001678416	Calcium levels	General health
rs7240405	A	G	1	18	75	2	21	71	0.11	0.13	0.89	0.87	A	2.27	0.001678416	HDL cholesterol	General health
rs1521882	G	A	1	23	70	2	16	76	0.13	0.11	0.87	0.89	A	1	0.001678416	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs11779860	T	C	48	40	6	45	39	10	0.72	0.69	0.28	0.31	C	0.61	0.001665817	QT interval	Heart health and disorders
rs6673480	C	T	88	6	0	85	9	0	0.97	0.95	0.03	0.05	T	1.35	0.00166205	IgE grass sensitization	Immune diseases and disorders
rs3734805	A	C	88	6	0	85	9	0	0.97	0.95	0.03	0.05	C	1.19	0.00166205	Breast cancer	Cancer
rs11023787	C	T	86	7	1	88	6	0	0.95	0.97	0.05	0.03	T	1	0.00166205	Bone mineral density wrist	General health
rs77490164	C	T	88	6	0	85	9	0	0.97	0.95	0.03	0.05	T	0.1282	0.00166205	Periodontitis Mean PAL	Misc
rs10516526	A	G	88	6	0	85	9	0	0.97	0.95	0.03	0.05	G	0.089	0.00166205	Pulmonary function	Pulmonology
rs210142	T	C	4	25	65	2	35	57	0.18	0.21	0.82	0.79	C	1.4	0.001644737	Chronic lymphocytic leukemia	Cancer
rs13376333	C	T	60	29	5	61	33	0	0.79	0.82	0.21	0.18	T	1.52	0.001644737	Atrial fibrillation	Heart health and disorders
rs16946160	G	A	63	29	2	62	25	7	0.82	0.79	0.18	0.21	A	1.39	0.001644737	Nephrotic syndrome acquired	General health
rs13178362	T	C	61	27	6	63	29	2	0.79	0.82	0.21	0.18	T	1.3333	0.001644737	Alzheimer's disease	Brain health and disorders
rs4450798	G	T	58	33	3	62	31	1	0.79	0.82	0.21	0.18	T	1.26	0.001644737	Bipolar disorder with mood-incongruent psychosis	Brain health and disorders
rs2758886	G	A	61	27	6	65	25	4	0.79	0.82	0.21	0.18	A	0.023	0.001644737	Cholesterol, total	General health
rs4565302	T	C	82	12	0	78	16	0	0.94	0.91	0.06	0.09	C	2.94	0.001642036	Mammographic density	Reproductive health
rs465969	G	A	78	16	0	82	12	0	0.91	0.94	0.09	0.06	A	1.403	0.001642036	Psoriasis	Immune diseases and disorders
rs10953541	C	T	79	14	1	82	12	0	0.91	0.94	0.09	0.06	C	1.08	0.001642036	Coronary heart disease	Heart health and disorders
rs17790731	C	T	82	12	0	79	14	1	0.94	0.91	0.06	0.09	A	0.531	0.001642036	Pharmacokinetics of antiepileptic drugs in severe mental disorder concentration drug ratio	General health
rs6928844	C	G	79	14	1	82	12	0	0.91	0.94	0.09	0.06	C	0.285	0.001642036	IgG glycosylation	Immune diseases and disorders
rs10503669	C	A	78	16	0	83	10	1	0.91	0.94	0.09	0.06	T	0.0426	0.001642036	HDL cholesterol	General health
rs17013497	C	T	79	14	1	82	12	0	0.91	0.94	0.09	0.06	T	0.03	0.001642036	Educational attainment	Mental aptitude and behavioural traits
rs10918270	G	A	48	38	8	44	39	11	0.71	0.68	0.29	0.32	A	2.26	0.001632517	Parkinson's disease age of onset	Brain health and disorders
rs4281086	C	A	8	45	41	4	46	44	0.32	0.29	0.68	0.71	C	0.04	0.001632517	Obesity-related traits	Obesity
rs1751492	C	T	10	42	42	4	47	43	0.33	0.29	0.67	0.71	C	7.6	0.001617002	Soluble leptin receptor levels	General health
rs6863015	C	A	50	33	11	40	46	8	0.71	0.67	0.29	0.33	C	1.25	0.001617002	Leprosy	Immune diseases and disorders
rs2423942	A	G	13	36	45	8	39	47	0.33	0.29	0.67	0.71	T	1	0.001617002	Male fertility	Reproductive health
rs10770705	A	C	11	40	43	5	45	44	0.33	0.29	0.67	0.71	A	0.033	0.001617002	Height	General health
rs1800789	G	A	68	26	0	73	21	0	0.86	0.89	0.14	0.11	A	0.09	0.001616763	Fibrinogen	General health
rs1440088	T	G	58	32	4	63	28	3	0.79	0.82	0.21	0.18	A	1.0840102	0.001610882	Ulcerative colitis	Immune diseases and disorders
rs728616	G	T	59	30	5	65	24	5	0.79	0.82	0.21	0.18	T	1	0.001610882	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs1871395	A	G	63	28	3	59	30	5	0.82	0.79	0.18	0.21	A	0.11	0.001610882	Blood metabolite levels	Heart health and disorders
rs10790268	A	G	1	32	61	5	30	59	0.18	0.21	0.82	0.79	G	1.17	0.001610882	Rheumatoid arthritis	Immune diseases and disorders
rs9601248	C	T	13	37	44	6	44	44	0.34	0.30	0.66	0.70	C	1.3841	0.001602197	Major depressive disorder	Brain health and disorders
rs12922317	A	G	45	42	7	44	37	13	0.70	0.66	0.30	0.34	G	1.174	0.001602197	Schizophrenia	Brain health and disorders
rs728926	C	T	44	43	7	42	40	12	0.70	0.66	0.30	0.34	T	0.57	0.001588073	QT interval	Heart health and disorders
rs11001819	G	A	39	46	9	47	37	10	0.66	0.70	0.34	0.30	G	0.029	0.001588073	Pulmonary function	Pulmonology
rs2102808	G	T	63	27	4	54	39	1	0.81	0.78	0.19	0.22	C	1.18	0.001578947	Parkinson's disease	Brain health and disorders
rs354033	G	A	61	31	2	56	35	3	0.81	0.78	0.19	0.22	G	1.11	0.001578947	Multiple sclerosis	Brain health and disorders
rs2255811	G	A	3	29	62	5	31	58	0.19	0.22	0.81	0.78	G	0.041	0.001578947	Triglycerides	General health
rs17360053	T	C	59	29	6	59	35	0	0.78	0.81	0.22	0.19	G	0.03	0.001578947	Obesity-related traits	Obesity
rs718444	C	T	44	42	8	40	43	11	0.69	0.65	0.31	0.35	T	1.14	0.001574601	Height	General health
rs7611694	A	C	43	44	7	39	45	10	0.69	0.65	0.31	0.35	A	1.1	0.001574601	Prostate cancer	Cancer
rs231356	A	T	40	43	11	41	48	5	0.65	0.69	0.35	0.31	T	1.09	0.001574601	Type 2 diabetes	Diabetes
rs1447352	G	A	10	38	46	9	47	38	0.31	0.35	0.69	0.65	G	0.05	0.001574601	Metabolic traits	Misc
rs8032158	T	C	42	38	14	41	47	6	0.65	0.69	0.35	0.31	C	1.51	0.001561753	Keloid	Misc
rs59888335	C	T	37	48	9	44	41	9	0.65	0.69	0.35	0.31	T	1.05	0.001561753	Schizophrenia	Brain health and disorders
rs7812879	T	C	1	20	73	4	19	71	0.12	0.14	0.88	0.86	G	1.45	0.001560257	Systemic lupus erythematosus	Immune diseases and disorders
rs10789491	A	G	3	21	70	3	16	75	0.14	0.12	0.86	0.88	G	0.312	0.001560257	Response to hepatitis C treatment	General health
rs738144	G	A	1	25	68	0	22	72	0.14	0.12	0.86	0.88	G	0.1878	0.001560257	IgG glycosylation	Immune diseases and disorders
rs7809234	A	T	72	22	0	69	23	2	0.88	0.86	0.12	0.14	A	0.049	0.001560257	Blood metabolite ratios	Heart health and disorders
rs11024074	T	C	42	44	8	41	39	14	0.68	0.64	0.32	0.36	T	0.33	0.001549505	Diastolic blood pressure	Heart health and disorders
rs314263	C	T	13	41	40	10	40	44	0.36	0.32	0.64	0.68	T	0.043	0.001549505	Height	General health
rs6753739	A	G	8	44	42	10	47	37	0.32	0.36	0.68	0.64	A	0.031	0.001549505	Height	General health
rs7078160	G	A	61	30	3	56	34	4	0.81	0.78	0.19	0.22	A	1.29	0.001548787	Nonsyndromic cleft lip with or without cleft palate	Misc
rs12762955	A	C	59	34	1	58	30	6	0.81	0.78	0.19	0.22	C	1.17	0.001548787	Response to angiotensin II receptor blocker therapy	General health
rs4785204	C	T	78	15	1	82	11	1	0.91	0.93	0.09	0.07	T	1.24	0.001541426	Esophageal cancer squamous cell	Cancer
rs57996174	T	C	78	15	1	81	13	0	0.91	0.93	0.09	0.07	C	1.13	0.001541426	Psoriasis	Immune diseases and disorders
rs9839776	C	T	44	39	11	34	52	8	0.68	0.64	0.32	0.36	T	1.158	0.001537834	Anorexia nervosa	Brain health and disorders
rs2068012	T	C	44	39	11	35	50	9	0.68	0.64	0.32	0.36	C	1.0718113	0.001537834	Schizophrenia	Brain health and disorders
rs2943645	C	T	10	41	43	14	40	40	0.32	0.36	0.68	0.64	T	0.029	0.001537834	Triglycerides	General health
rs13042885	C	T	39	42	13	41	45	8	0.64	0.68	0.36	0.32	C	0.008	0.001537834	Mean platelet volume	Heart health and disorders
rs6065094	A	G	12	45	37	6	50	38	0.37	0.33	0.63	0.67	G	1.0775862	0.001526718	Schizophrenia	Brain health and disorders
rs821470	A	G	41	37	16	42	42	10	0.63	0.67	0.37	0.33	A	1.25	0.001526718	Bipolar disorder and schizophrenia	Brain health and disorders
rs12456492	A	G	41	44	9	39	41	14	0.67	0.63	0.33	0.37	G	1.11	0.001526718	Parkinson's disease	Brain health and disorders
rs1612141	G	A	42	42	10	42	35	17	0.67	0.63	0.33	0.37	A	1	0.001526718	QT interval interaction	Heart health and disorders
rs7916441	G	C	42	42	10	41	37	16	0.67	0.63	0.33	0.37	G	0.051	0.001526718	Sitting height ratio	Appearance
rs2249296	T	C	5	27	62	6	31	57	0.20	0.23	0.80	0.77	C	1.69	0.00152027	Crohn's disease-related phenotypes	Digestive system and its disorders
rs958994	G	A	4	35	55	6	25	63	0.23	0.20	0.77	0.80	G	1	0.00152027	Carotid atherosclerosis in HIV infection	Heart health and disorders
rs157093	C	T	55	35	4	61	29	4	0.77	0.80	0.23	0.20	T	0.3615	0.00152027	Verbal declarative memory	Brain health and disorders
rs7578982	T	C	55	35	4	62	27	5	0.77	0.80	0.23	0.20	T	0.054	0.00152027	White blood cell types	Immune diseases and disorders
rs17430279	A	G	56	33	5	61	29	4	0.77	0.80	0.23	0.20	G	0.03	0.00152027	Obesity-related traits	Obesity
rs7832232	A	G	35	48	11	41	43	10	0.63	0.66	0.37	0.34	A	1.45	0.001516136	Pancreatic cancer	Cancer
rs4494548	G	A	73	19	2	68	24	2	0.88	0.85	0.12	0.15	A	0.17	0.001508296	Urinary uromodulin levels	General health
rs1997111	A	C	13	45	36	8	48	38	0.38	0.34	0.62	0.66	T	1	0.00150607	Cerebrospinal T-tau levels	Brain health and disorders
rs11225434	T	C	39	46	9	40	37	17	0.66	0.62	0.34	0.38	C	0.39	0.00150607	Matrix metalloproteinase levels	Cancer
rs9473924	G	T	40	44	10	36	45	13	0.66	0.62	0.34	0.38	T	0.0308	0.00150607	Body mass index	Obesity
rs13236689	T	G	38	47	9	33	50	11	0.65	0.62	0.35	0.38	T	4.18	0.001496503	Mean platelet volume	Heart health and disorders
rs10237067	G	A	5	28	61	2	40	52	0.20	0.23	0.80	0.77	A	0.072	0.00149328	Lifetime average cigarettes per day in chronic obstructive pulmonary disease	General health
rs72974161	C	T	58	28	8	59	32	3	0.77	0.80	0.23	0.20	A	2.83	0.00149328	Diisocyanate-induced asthma	Pulmonology
rs7944004	T	G	41	40	13	36	43	15	0.65	0.61	0.35	0.39	T	1.2	0.001487418	Chronic lymphocytic leukemia	Cancer
rs869834	T	C	35	45	14	42	38	14	0.61	0.65	0.39	0.35	T	1	0.001487418	Subcutaneous adipose tissue	Obesity
rs11839514	A	G	40	41	13	30	54	10	0.64	0.61	0.36	0.39	G	1	0.001478799	Visceral fat	Obesity
rs11764932	G	A	35	44	15	38	45	11	0.61	0.64	0.39	0.36	A	0.09	0.001478799	Kidney function decline traits	General health
rs2415487	T	G	37	40	17	39	43	12	0.61	0.64	0.39	0.36	G	0.02	0.001478799	Body mass index	Obesity
rs1079204	G	A	88	5	1	85	8	1	0.96	0.95	0.04	0.05	A	8.4526	0.001474685	Smooth-surface caries	Appearance
rs2032381	G	T	84	10	0	88	5	1	0.95	0.96	0.05	0.04	G	5.6947	0.001474685	Smooth-surface caries	Appearance
rs3798305	C	T	87	7	0	84	10	0	0.96	0.95	0.04	0.05	T	4.8339	0.001474685	Smooth-surface caries	Appearance
rs2202157	C	T	84	10	0	87	7	0	0.95	0.96	0.05	0.04	T	4	0.001474685	Tuberculosis	Immune diseases and disorders
rs12210761	G	A	84	10	0	87	7	0	0.95	0.96	0.05	0.04	A	2.4458	0.001474685	Major depressive disorder	Brain health and disorders
rs149864795	G	A	87	7	0	86	6	2	0.96	0.95	0.04	0.05	A	2.216	0.001474685	Eosinophilic esophagitis	Digestive system and its disorders
rs10514718	C	G	85	8	1	87	7	0	0.95	0.96	0.05	0.04	C	2.12	0.001474685	Major depressive disorder	Brain health and disorders
rs9866141	C	T	85	8	1	87	7	0	0.95	0.96	0.05	0.04	T	1.88	0.001474685	Smoking cessation in chronic obstructive pulmonary disease	Heart health and disorders
rs549182	G	A	87	7	0	85	8	1	0.96	0.95	0.04	0.05	A	1.59	0.001474685	Ulcerative colitis	Immune diseases and disorders
rs11054786	T	C	85	8	1	87	7	0	0.95	0.96	0.05	0.04	T	0.59	0.001474685	Tandem gait	Misc
rs10484358	G	T	87	7	0	84	10	0	0.96	0.95	0.04	0.05	T	0.4258	0.001474685	Major depressive disorder	Brain health and disorders
rs77292326	T	A	84	10	0	87	7	0	0.95	0.96	0.05	0.04	A	0.294	0.001474685	Tandem gait	Misc
rs13196561	C	A	84	10	0	87	7	0	0.95	0.96	0.05	0.04	C	0.04	0.001474685	Menarche age at onset	Reproductive health
rs1459104	G	A	84	10	0	87	7	0	0.95	0.96	0.05	0.04	A	0.03	0.001474685	Body mass index	Obesity
rs57960711	C	G	87	7	0	84	10	0	0.96	0.95	0.04	0.05	G	0.03	0.001474685	Obesity-related traits	Obesity
rs4083482	C	T	88	5	1	84	10	0	0.96	0.95	0.04	0.05	T	0.03	0.001474685	Plasma omega-6 polyunsaturated fatty acid levels adrenic acid	General health
rs12619285	A	G	40	40	14	31	51	12	0.64	0.60	0.36	0.40	G	6.3	0.001470632	Eosinophil counts	General health
rs12617721	A	C	34	45	15	33	54	7	0.60	0.64	0.40	0.36	C	1.2	0.001470632	Bipolar disorder with mood-incongruent psychosis	Brain health and disorders
rs7578326	A	G	39	42	13	35	43	16	0.64	0.60	0.36	0.40	A	1.11	0.001470632	Type 2 diabetes	Diabetes
rs3129882	G	A	14	40	40	17	41	36	0.36	0.40	0.64	0.60	G	1.38	0.001470632	Parkinson's disease	Brain health and disorders
rs3825199	A	G	61	27	6	54	35	5	0.79	0.76	0.21	0.24	C	6.2	0.00146771	Height	General health
rs2887571	A	G	60	29	5	54	35	5	0.79	0.76	0.21	0.24	A	0.04	0.00146771	Bone mineral density	General health
rs11902417	G	A	58	33	3	53	37	4	0.79	0.76	0.21	0.24	G	0.02	0.00146771	HDL cholesterol	General health
rs1448190	A	C	11	47	36	14	48	32	0.37	0.40	0.63	0.60	A	0.03	0.001462905	Obesity-related traits	Obesity
rs6946131	T	C	35	49	10	33	46	15	0.63	0.60	0.37	0.40	T	1.387	0.001462905	Systemic lupus erythematosus	Immune diseases and disorders
rs742071	G	T	41	37	16	32	48	14	0.63	0.60	0.37	0.40	T	1.316	0.001462905	Orofacial clefts	Misc
rs903107	T	C	38	43	13	29	54	11	0.63	0.60	0.37	0.40	G	0.104	0.001462905	Liver enzyme levels alanine transaminase	General health
rs11924390	T	C	41	37	16	28	56	10	0.63	0.60	0.37	0.40	C	0.06	0.001462905	Adiponectin levels	Obesity
rs1013209	C	T	37	45	12	32	48	14	0.63	0.60	0.37	0.40	T	0.025	0.001462905	Height	General health
rs17084405	G	A	68	23	3	71	22	1	0.85	0.87	0.15	0.13	A	12.1	0.001460366	Epilepsy and lamotrigine-induced maculopapular eruptions	Brain health and disorders
rs2302045	G	A	71	22	1	68	23	3	0.87	0.85	0.13	0.15	T	0.4064	0.001460366	Pharmacokinetics of antipsychotic drugs in severe mental disorder concentration drug ratio	General health
rs11542478	A	C	67	25	2	71	22	1	0.85	0.87	0.15	0.13	A	0.19	0.001460366	Information processing speed	Mental aptitude and behavioural traits
rs6561030	C	A	71	22	1	68	23	3	0.87	0.85	0.13	0.15	A	0.05	0.001460366	Height	General health
rs1514175	A	G	33	45	16	36	46	12	0.59	0.63	0.41	0.37	A	0.07	0.001455604	Body mass index	Obesity
rs2596230	T	C	80	14	0	77	16	1	0.93	0.90	0.07	0.10	G	1.56	0.001453488	Diabetic kidney disease	Diabetes
rs11983798	G	A	80	14	0	77	16	1	0.93	0.90	0.07	0.10	T	1	0.001453488	Alzheimer's disease late onset	Brain health and disorders
rs17648246	A	G	77	16	1	80	14	0	0.90	0.93	0.10	0.07	A	0.275	0.001453488	Oleic acid 18:1n-9 plasma levels	General health
rs16993271	G	A	76	18	0	81	12	1	0.90	0.93	0.10	0.07	G	0.176	0.001453488	Urate levels in lean individuals	Obesity
rs2797501	G	A	0	18	76	0	14	80	0.10	0.07	0.90	0.93	A	1.61	0.001453488	Osteosarcoma	Cancer
rs6813195	C	T	35	47	12	41	28	25	0.62	0.59	0.38	0.41	C	1.08	0.001448718	Type 2 diabetes	Diabetes
rs1431005	G	A	29	52	13	34	49	11	0.59	0.62	0.41	0.38	A	1	0.001448718	Response to statin therapy	General health
rs7561268	A	C	33	44	17	39	39	16	0.59	0.62	0.41	0.38	C	0.03	0.001448718	Obesity-related traits	Obesity
rs7775228	T	C	59	30	5	52	38	4	0.79	0.76	0.21	0.24	A	1.17	0.001443464	Asthma	Immune diseases and disorders
rs941853	G	A	58	32	4	54	34	6	0.79	0.76	0.21	0.24	A	0.03	0.001443464	Obesity-related traits	Obesity
rs293428	A	G	36	44	14	31	47	16	0.62	0.58	0.38	0.42	A	0.029	0.001442237	Sex hormone-binding globulin levels	Reproductive health
rs4673659	A	C	16	40	38	15	49	30	0.38	0.42	0.62	0.58	C	1.42	0.001442237	Asthma sex interaction	Immune diseases and disorders
rs2283792	T	G	11	50	33	17	45	32	0.38	0.42	0.62	0.58	C	1.1	0.001442237	Multiple sclerosis	Brain health and disorders
rs2044029	A	G	15	43	36	18	44	32	0.39	0.43	0.61	0.57	A	1.17	0.00143615	Airflow obstruction	Pulmonology
rs9577381	A	T	10	53	31	18	44	32	0.39	0.43	0.61	0.57	A	0.0714	0.00143615	Axial length	Misc
rs7701886	G	A	31	46	17	37	41	16	0.57	0.61	0.43	0.39	A	0.03	0.00143615	Menarche age at onset	Reproductive health
rs503464	T	A	33	41	20	38	38	18	0.57	0.61	0.43	0.39	A	3.2	0.001430448	Emphysema imaging phenotypes	Pulmonology
rs6961860	C	T	37	40	17	29	49	16	0.61	0.57	0.39	0.43	G	1.283	0.001430448	Adverse response to chemotherapy neutropenia_leucopenia all antimicrotubule drugs	Drug response
rs12451788	A	G	35	44	15	26	55	13	0.61	0.57	0.39	0.43	G	1	0.001430448	Diisocyanate-induced asthma	Pulmonology
rs2517532	A	G	17	47	30	18	38	38	0.43	0.39	0.57	0.61	G	1.16	0.001430448	Hypothyroidism	Immune diseases and disorders
rs7611238	G	A	35	43	16	31	44	19	0.60	0.56	0.40	0.44	A	0.018	0.001425123	Body mass index	Obesity
rs12024204	A	G	14	47	33	15	52	27	0.40	0.44	0.60	0.56	G	1.22	0.001425123	Endometriosis	General health
rs4420311	G	A	21	40	33	7	61	26	0.44	0.40	0.56	0.60	G	0.0872	0.001425123	Bone mineral density paediatric, total body less head	General health
rs2300747	A	G	58	31	5	54	33	7	0.78	0.75	0.22	0.25	A	1.37	0.001420455	Multiple sclerosis	Brain health and disorders
rs4927850	T	C	4	39	51	2	37	55	0.25	0.22	0.75	0.78	A	1.24	0.001420455	Pancreatic cancer	Cancer
rs6893300	C	A	55	31	8	56	35	3	0.75	0.78	0.25	0.22	C	1	0.001420455	Resting heart rate	General health
rs1529102	G	A	15	53	26	18	40	36	0.44	0.40	0.56	0.60	A	0.07	0.001420166	Breast size	General health
rs2903492	G	A	2	26	66	2	21	71	0.16	0.13	0.84	0.87	A	1.26	0.001416029	Body mass index	Obesity
rs6711012	G	C	2	26	66	2	21	71	0.16	0.13	0.84	0.87	C	1.18	0.001416029	Obesity	Obesity
rs2867125	T	C	2	26	66	2	21	71	0.16	0.13	0.84	0.87	C	0.31	0.001416029	Body mass index	Obesity
rs59406683	A	T	70	23	1	67	24	3	0.87	0.84	0.13	0.16	A	1.2048193	0.001416029	Alzheimer's disease in APOE e4+ carriers	Brain health and disorders
rs74225573	T	C	69	25	0	65	28	1	0.87	0.84	0.13	0.16	C	0.16	0.001416029	Corneal curvature	General health
rs6881280	A	G	67	24	3	71	21	2	0.84	0.87	0.16	0.13	G	0.1157	0.001416029	Self-reported allergy	General health
rs8042374	A	G	35	41	18	30	44	20	0.59	0.55	0.41	0.45	A	1.093	0.001415571	Schizophrenia	Brain health and disorders
rs4410790	T	C	29	45	20	31	48	15	0.55	0.59	0.45	0.41	T	0.15	0.001411331	Caffeine consumption	General health
rs1986112	G	A	33	43	18	26	50	18	0.58	0.54	0.42	0.46	A	1.05	0.001407439	Schizophrenia	Brain health and disorders
rs516732	C	T	30	48	16	25	51	18	0.57	0.54	0.43	0.46	C	121.6	0.001403891	Forced expiratory volume in 1 second environmental interaction	Pulmonology
rs938291	G	C	26	49	19	23	62	9	0.54	0.57	0.46	0.43	G	0.53	0.001403891	QT interval	Heart health and disorders
rs2275426	G	A	32	44	18	29	43	22	0.57	0.54	0.43	0.46	A	0.015	0.001403891	Body mass index	Obesity
rs61159171	C	T	29	49	16	23	54	17	0.57	0.53	0.43	0.47	T	0.075	0.00140068	Breast size	General health
rs6506569	T	C	17	47	30	20	48	26	0.43	0.47	0.57	0.53	G	1.98	0.00140068	Response to methotrexate in rheumatoid arthritis	General health
rs1410996	G	A	14	53	27	20	48	26	0.43	0.47	0.57	0.53	G	0.203	0.00140068	End-stage coagulation	General health
rs1491942	C	G	58	30	6	52	36	6	0.78	0.74	0.22	0.26	G	1.27	0.001398601	Parkinson's disease	Brain health and disorders
rs10895547	C	T	52	36	6	57	32	5	0.74	0.78	0.26	0.22	T	0.0747	0.001398601	LDL cholesterol	General health
rs7240004	A	G	33	40	21	28	43	23	0.56	0.53	0.44	0.47	A	1.0858526	0.001397803	Ulcerative colitis	Immune diseases and disorders
rs597319	A	G	26	47	21	29	48	17	0.53	0.56	0.47	0.44	G	0.07	0.001397803	Bone properties heel	General health
rs2273061	G	A	22	46	26	19	45	30	0.48	0.44	0.52	0.56	A	0.07	0.001395256	Bone mineral density	General health
rs7971536	T	A	20	43	31	16	58	20	0.44	0.48	0.56	0.52	A	0.028	0.001395256	Height	General health
rs9821642	A	G	29	47	18	30	38	26	0.56	0.52	0.44	0.48	G	0.092	0.001395256	Economic and political preferences environmentalism	Mental aptitude and behavioural traits
rs4685408	G	A	21	62	11	23	51	20	0.55	0.52	0.45	0.48	G	1.12	0.001393035	Psoriasis	Immune diseases and disorders
rs4787491	A	G	29	46	19	23	51	20	0.55	0.52	0.45	0.48	G	0.016	0.001393035	Body mass index	Obesity
rs1198872	C	T	31	41	22	25	46	23	0.55	0.51	0.45	0.49	T	2.04	0.001391136	Cardiac Troponin-T levels	Heart health and disorders
rs2736100	C	A	22	41	31	20	52	22	0.45	0.49	0.55	0.51	C	1.39	0.001391136	Glioma high-grade	Cancer
rs2469184	A	G	23	39	32	21	50	23	0.45	0.49	0.55	0.51	A	0.162	0.001391136	Activated partial thromboplastin time	Heart health and disorders
rs4348174	T	C	25	53	16	25	46	23	0.55	0.51	0.45	0.49	C	0.05	0.001391136	Serum thyroid-stimulating hormone levels	General health
rs2523946	C	T	27	39	28	17	52	25	0.49	0.46	0.51	0.54	C	1.317	0.001389558	IgA nephropathy	Immune diseases and disorders
rs11062102	T	C	27	41	26	27	48	19	0.51	0.54	0.49	0.46	T	0.1755	0.001389558	Urinary metabolites	General health
rs75751297	T	A	17	60	17	17	67	10	0.50	0.54	0.50	0.46	A	2.4	0.001388299	Emphysema imaging phenotypes	Pulmonology
rs4420065	T	C	21	45	28	23	48	23	0.46	0.50	0.54	0.50	C	0.09	0.001388299	C-reactive protein levels	Immune diseases and disorders
rs637644	A	G	21	46	27	26	43	25	0.47	0.51	0.53	0.49	G	32.5	0.001387355	Adverse response to chemotherapy in breast cancer alopecia cyclophosphamide+doxorubicin+_-5FU	Drug response
rs1000589	G	T	25	45	24	21	46	27	0.51	0.47	0.49	0.53	T	1.27	0.001387355	Pancreatic cancer	Cancer
rs4256980	C	G	25	43	26	28	44	22	0.49	0.53	0.51	0.47	G	0.023	0.001387355	Body mass index	Obesity
rs2986971	A	G	23	50	21	18	53	23	0.51	0.47	0.49	0.53	G	0.49	0.001386727	Non-alcoholic fatty liver disease histology lobular	Obesity
rs1660895	A	T	26	45	23	21	48	25	0.52	0.48	0.48	0.52	A	1.3	0.001386413	Alcohol dependence age at onset	General health
rs331615	T	A	23	51	20	23	44	27	0.52	0.48	0.48	0.52	T	0.06	0.001386413	White blood cell types	Immune diseases and disorders
rs9399599	A	T	20	51	23	21	56	17	0.48	0.52	0.52	0.48	T	0.032	0.001386413	Plasma plasminogen activator levels	General health
rs1877030	T	C	4	35	55	9	31	54	0.23	0.26	0.77	0.74	C	1.09	0.001377832	Rheumatoid arthritis	Immune diseases and disorders
rs10950840	C	T	5	39	50	2	39	53	0.26	0.23	0.74	0.77	G	0.04	0.001377832	Obesity-related traits	Obesity
rs17301259	A	G	55	35	4	48	43	3	0.77	0.74	0.23	0.26	A	6.93	0.001377832	Heschl's gyrus morphology	Brain health and disorders
rs10778699	G	A	53	33	8	56	33	5	0.74	0.77	0.26	0.23	A	4.28	0.001377832	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs7720886	A	G	59	27	8	50	39	5	0.77	0.74	0.23	0.26	G	2.87	0.001377832	Diisocyanate-induced asthma	Pulmonology
rs908084	G	A	80	13	1	78	13	3	0.92	0.90	0.08	0.10	A	3.97	0.001375989	Diisocyanate-induced asthma	Pulmonology
rs196889	C	T	76	17	1	80	13	1	0.90	0.92	0.10	0.08	T	0.68	0.001375989	Seasonality	Mental aptitude and behavioural traits
rs16907751	C	T	80	13	1	76	17	1	0.92	0.90	0.08	0.10	C	0.047	0.001375989	Body mass index	Obesity
rs7146198	A	C	2	11	81	1	17	76	0.08	0.10	0.92	0.90	A	0.048	0.001375989	Corneal curvature	General health
rs17533156	C	T	68	26	0	64	29	1	0.86	0.84	0.14	0.16	T	4.475	0.001374911	Very long-chain saturated fatty acid levels fatty acid 20:0	General health
rs7547921	C	A	67	23	4	69	24	1	0.84	0.86	0.16	0.14	A	1	0.001374911	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs4842666	T	C	71	20	3	65	27	2	0.86	0.84	0.14	0.16	T	0.91	0.001374911	Blood pressure	Heart health and disorders
rs17036350	C	T	68	26	0	64	29	1	0.86	0.84	0.14	0.16	T	0.178	0.001374911	Corneal curvature	General health
rs2279463	A	G	69	24	1	67	23	4	0.86	0.84	0.14	0.16	G	0.01	0.001374911	Chronic kidney disease	Immune diseases and disorders
rs149183310	A	T	89	5	0	91	3	0	0.97	0.98	0.03	0.02	T	1.52	0.001358696	Tourette's syndrome or obsessive-compulsive disorder	Brain health and disorders
rs11805526	C	T	89	5	0	91	3	0	0.97	0.98	0.03	0.02	T	1.3355	0.001358696	Neuritic plaque	Brain health and disorders
rs17061048	T	A	89	5	0	91	3	0	0.97	0.98	0.03	0.02	T	1.1618136	0.001358696	Crohn's disease	Digestive system and its disorders
rs2228467	T	C	89	5	0	91	3	0	0.97	0.98	0.03	0.02	G	1	0.001358696	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Brain health and disorders
rs6832151	G	T	4	36	54	3	44	47	0.23	0.27	0.77	0.73	G	1.24	0.001358081	Graves' disease	Immune diseases and disorders
rs13401620	G	A	57	30	7	49	40	5	0.77	0.73	0.23	0.27	A	0.095	0.001358081	Breast size	General health
rs1541160	C	T	7	37	50	3	39	52	0.27	0.24	0.73	0.76	C	0.58	0.001339286	Amyotrophic lateral sclerosis	Brain health and disorders
rs1192419	A	G	7	37	50	6	33	55	0.27	0.24	0.73	0.76	A	0.087	0.001339286	Optic disc area	Misc
rs62355986	G	C	51	35	8	52	39	3	0.73	0.76	0.27	0.24	C	1.06	0.001339286	Schizophrenia	Brain health and disorders
rs7903146	C	T	54	35	5	48	41	5	0.76	0.73	0.24	0.27	C	0.029	0.001339286	Body mass index	Obesity
rs429608	G	A	70	21	3	65	26	3	0.86	0.83	0.14	0.17	G	2.16	0.001336684	Age-related macular degeneration	Aging
rs651821	C	T	2	23	69	2	28	64	0.14	0.17	0.86	0.83	C	0.17	0.001336684	Lipid traits	Misc
rs2647044	G	A	86	8	0	83	11	0	0.96	0.94	0.04	0.06	A	8.3	0.001326847	Type 1 diabetes	Diabetes
rs9405098	G	A	86	8	0	84	9	1	0.96	0.94	0.04	0.06	A	1.37	0.001326847	Hepatitis C induced liver cirrhosis	Immune diseases and disorders
rs7525133	G	A	84	9	1	86	8	0	0.94	0.96	0.06	0.04	A	1	0.001326847	Visceral adipose tissue adjusted for BMI	Obesity
rs7294372	T	C	86	8	0	86	5	3	0.96	0.94	0.04	0.06	T	1	0.001326847	Visceral fat	Obesity
rs10452033	G	A	54	34	6	47	42	5	0.76	0.72	0.24	0.28	A	2.122	0.001321392	Electrocardiographic traits	Heart health and disorders
rs1517037	C	T	55	32	7	51	34	9	0.76	0.72	0.24	0.28	C	1.1494253	0.001321392	Pancreatic cancer	Cancer
rs2523557	G	A	5	42	47	4	38	52	0.28	0.24	0.72	0.76	C	7.33	0.001321392	Trichloroethylene-induced hypersensitivity syndrome	General health
rs6971925	T	C	2	16	76	0	16	78	0.11	0.09	0.89	0.91	T	13.91	0.00130719	Response to treatment for acute lymphoblastic leukemia	General health
rs12678919	A	G	78	16	0	77	14	3	0.91	0.89	0.09	0.11	G	2.25	0.00130719	HDL cholesterol	General health
rs3743772	C	A	80	12	2	75	18	1	0.91	0.89	0.09	0.11	A	0.64	0.00130719	Depressive symptoms SSRI exposure interaction	Brain health and disorders
rs1909881	A	G	78	16	0	75	18	1	0.91	0.89	0.09	0.11	G	0.03	0.00130719	Obesity-related traits	Obesity
rs35509282	T	A	48	39	7	51	39	4	0.72	0.75	0.28	0.25	A	1.53	0.001304348	Colorectal cancer	Cancer
rs3783637	C	T	67	26	1	66	23	5	0.85	0.82	0.15	0.18	C	1.1	0.001301067	Rheumatoid arthritis	Immune diseases and disorders
rs6070116	A	G	63	29	2	68	24	2	0.82	0.85	0.18	0.15	G	1	0.001301067	Response to statin therapy	General health
rs6502557	G	A	67	26	1	63	29	2	0.85	0.82	0.15	0.18	G	0.2172	0.001301067	IgG glycosylation	Immune diseases and disorders
rs236918	G	C	66	23	5	69	22	3	0.82	0.85	0.18	0.15	C	0.038	0.001301067	Iron status biomarkers	General health
rs216205	C	T	10	34	50	5	38	51	0.29	0.26	0.71	0.74	T	1.24	0.001288106	Mitral valve prolapse	Heart health and disorders
rs11583043	C	T	50	40	4	49	36	9	0.74	0.71	0.26	0.29	A	1.0797532	0.001288106	Ulcerative colitis	Immune diseases and disorders
rs3809566	A	G	7	35	52	7	41	46	0.26	0.29	0.74	0.71	G	2.443	0.001272624	Platelet count	Heart health and disorders
rs4245739	C	A	10	35	49	11	27	56	0.29	0.26	0.71	0.74	C	1.19	0.001272624	Breast cancer estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative	Cancer
rs7238078	T	G	48	37	9	51	37	6	0.71	0.74	0.29	0.26	A	1.12	0.001272624	Multiple sclerosis	Brain health and disorders
rs8045334	G	A	48	37	9	53	33	8	0.71	0.74	0.29	0.26	G	0.126	0.001272624	Cerebrospinal T-tau levels	Brain health and disorders
rs7102705	A	G	6	37	51	7	41	46	0.26	0.29	0.74	0.71	A	0.086	0.001272624	Breast size	General health
rs893817	G	A	7	41	46	5	39	50	0.29	0.26	0.71	0.74	G	0.02	0.001272624	Aortic root size	Heart health and disorders
rs6501431	C	T	3	28	63	2	25	67	0.18	0.15	0.82	0.85	T	23.053	0.001267813	Forced vital capacity	Pulmonology
rs2596449	A	G	4	26	64	4	21	69	0.18	0.15	0.82	0.85	A	6.35	0.001267813	Thionamide-induced agranulocytosis in Graves' disease	General health
rs718433	G	A	13	30	51	7	36	51	0.30	0.27	0.70	0.73	G	0.59	0.001257862	Intraocular pressure	General health
rs11078895	A	G	4	42	48	9	38	47	0.27	0.30	0.73	0.70	A	0.00201	0.001257862	Calcium levels	General health
rs1883415	A	C	46	40	8	53	32	9	0.70	0.73	0.30	0.27	C	3.1	0.001257862	Liver enzyme levels alkaline phosphatase	General health
rs12436663	G	A	49	40	5	47	38	9	0.73	0.70	0.27	0.30		1.54	0.001257862	Response to zileuton treatment in asthma FEV1 change interaction	Drug response
rs3936510	G	T	49	40	5	45	42	7	0.73	0.70	0.27	0.30	T	0.0416	0.001257862	Waist-to-hip ratio adjusted for body mass index	Obesity
rs8006385	A	G	77	17	0	75	17	2	0.91	0.89	0.09	0.11	G	3.587	0.001245718	Platelet count	Heart health and disorders
rs73071352	A	G	75	17	2	77	17	0	0.89	0.91	0.11	0.09	G	0.25	0.001245718	Multiple myeloma and monoclonal gammopathy	Cancer
rs74834049	T	A	73	21	0	78	15	1	0.89	0.91	0.11	0.09	A	0.12	0.001245718	Percentage gas trapping	Misc
rs6069325	T	G	78	15	1	74	19	1	0.91	0.89	0.09	0.11	T	0.069	0.001245718	Motion sickness	Misc
rs4958456	C	T	79	13	2	75	17	2	0.91	0.89	0.09	0.11	A	0.04	0.001245718	Obesity-related traits	Obesity
rs4751178	A	G	9	39	46	7	37	50	0.30	0.27	0.70	0.73	G	1	0.001243781	Speech perception in dyslexia	Brain health and disorders
rs7188445	G	A	51	35	8	44	43	7	0.73	0.70	0.27	0.30	A	0.032	0.001243781	Urate levels	General health
rs12735613	G	A	63	27	4	66	26	2	0.81	0.84	0.19	0.16	A	0.08	0.001236705	Height	General health
rs6855088	A	G	62	29	3	66	26	2	0.81	0.84	0.19	0.16	G	0.03	0.001236705	Obesity-related traits	Obesity
rs9929218	G	A	48	40	6	47	36	11	0.72	0.69	0.28	0.31	G	1.1	0.001230349	Colorectal cancer	Cancer
rs8008758	G	T	41	48	5	44	48	2	0.69	0.72	0.31	0.28	A	0.39	0.001230349	Body mass index interaction	Obesity
rs17798991	G	T	51	34	9	44	42	8	0.72	0.69	0.28	0.31	A	0.03	0.001230349	Obesity-related traits	Obesity
rs2338971	T	C	9	41	44	7	39	48	0.31	0.28	0.69	0.72	C	1.35	0.001217532	Parkinson's disease	Brain health and disorders
rs8044995	G	A	49	37	8	44	41	9	0.72	0.69	0.28	0.31	A	1.081	0.001217532	Schizophrenia	Brain health and disorders
rs2077586	A	G	42	45	7	47	41	6	0.69	0.72	0.31	0.28	A	1.07	0.001217532	Schizophrenia	Brain health and disorders
rs4353250	T	C	6	47	41	6	41	47	0.31	0.28	0.69	0.72	T	0.27	0.001217532	Amyloid A serum levels	General health
rs7129556	C	T	61	30	3	66	25	3	0.81	0.84	0.19	0.16	T	2.07	0.001207554	Weight loss gastric bypass surgery	Obesity
rs573872	T	G	67	23	4	60	32	2	0.84	0.81	0.16	0.19	G	1.41	0.001207554	Infantile hypertrophic pyloric stenosis	Misc
rs7534091	A	G	62	28	4	65	27	2	0.81	0.84	0.19	0.16	A	1.22	0.001207554	Height	General health
rs17736767	C	G	62	28	4	65	27	2	0.81	0.84	0.19	0.16	G	0.208	0.001207554	Renal sinus fat	General health
rs7536458	T	G	62	28	4	65	27	2	0.81	0.84	0.19	0.16	G	0.064	0.001207554	Infant length	Misc
rs4660306	T	C	2	32	60	3	25	66	0.19	0.16	0.81	0.84	T	0.0435	0.001207554	Homocysteine levels	Misc
rs17614462	G	A	85	9	0	84	8	2	0.95	0.94	0.05	0.06	A	0.03	0.001207243	Obesity-related traits	Obesity
rs1440072	C	T	0	12	82	1	7	86	0.06	0.05	0.94	0.95	C	0.06	0.001207243	Body mass index	Obesity
rs6693017	T	G	44	40	10	48	38	8	0.68	0.71	0.32	0.29	G	0.24	0.001205303	Monocyte early outgrowth colony forming units	Immune diseases and disorders
rs736825	C	G	43	42	9	45	44	5	0.68	0.71	0.32	0.29	C	0.05	0.001205303	Bone mineral density	General health
rs2072153	G	C	50	34	10	43	42	9	0.71	0.68	0.29	0.32	C	0.021	0.001205303	Height	General health
rs140081212	A	G	9	36	49	12	36	46	0.29	0.32	0.71	0.68	G	1.2658228	0.001205303	Gastric adenocarcinoma histologically verified	Cancer
rs8016947	T	G	10	34	50	8	44	42	0.29	0.32	0.71	0.68	G	1.26	0.001205303	Psoriasis	Immune diseases and disorders
rs2221894	G	A	10	34	50	9	42	43	0.29	0.32	0.71	0.68	G	0.02	0.001205303	Obesity-related traits	Obesity
rs10767971	T	C	11	39	44	10	35	49	0.32	0.29	0.68	0.71	T	3.24	0.001193634	Parkinson's disease age of onset	Brain health and disorders
rs6919939	G	A	10	41	43	4	47	43	0.32	0.29	0.68	0.71	A	1.05	0.001193634	Schizophrenia	Brain health and disorders
rs2708240	G	A	10	41	43	7	41	46	0.32	0.29	0.68	0.71	A	1	0.001193634	QT interval interaction	Heart health and disorders
rs11655470	C	T	40	47	7	49	35	10	0.68	0.71	0.32	0.29	T	0.048	0.001193634	Head circumference infant	Misc
rs1464807	G	T	74	18	2	76	18	0	0.88	0.90	0.12	0.10	T	1	0.001190476	Attention deficit hyperactivity disorder	Brain health and disorders
rs6879627	T	C	3	16	75	2	14	78	0.12	0.10	0.88	0.90	G	1.25	0.001190476	Pancreatic cancer	Cancer
rs10133840	C	G	1	20	73	1	16	77	0.12	0.10	0.88	0.90	C	0.01	0.001190476	Body mass index interaction	Obesity
rs3825214	G	A	4	48	42	7	48	39	0.30	0.33	0.70	0.67	G	7.36	0.001182499	Electrocardiographic traits	Heart health and disorders
rs965808	C	A	9	44	41	8	40	46	0.33	0.30	0.67	0.70	G	1	0.001182499	DNA methylation variation	Misc
rs11890028	T	G	61	29	4	66	24	4	0.80	0.83	0.20	0.17	T	1.18	0.001180192	Epilepsy generalized	Brain health and disorders
rs2278483	C	T	63	30	1	63	25	6	0.83	0.80	0.17	0.20	T	0.041	0.001180192	Height	General health
rs2877716	T	C	9	45	40	10	37	47	0.34	0.30	0.66	0.70	C	0.09	0.001171875	Two-hour glucose challenge	Diabetes
rs2806949	A	G	10	37	47	10	43	41	0.30	0.34	0.70	0.66	A	0.0026	0.001171875	Trans fatty acid levels	General health
rs1343607	A	G	10	37	47	10	43	41	0.30	0.34	0.70	0.66	A	0.0026	0.001171875	Trans fatty acid levels	General health
rs1265093	G	A	39	47	8	46	39	9	0.66	0.70	0.34	0.30	A	1	0.001171875	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs1008084	G	A	42	41	11	45	41	8	0.66	0.70	0.34	0.30	G	0.01	0.001171875	Red blood cell traits	Immune diseases and disorders
rs1801214	C	T	11	42	41	7	44	43	0.34	0.31	0.66	0.69	T	1.13	0.00116174	Type 2 diabetes	Diabetes
rs2901331	G	A	45	34	15	40	50	4	0.66	0.69	0.34	0.31	A	1	0.00116174	Response to statin therapy	General health
rs34487851	A	G	41	42	11	43	44	7	0.66	0.69	0.34	0.31	G	0.2523	0.00116174	Neurofibrillary tangles	Brain health and disorders
rs10937544	A	C	43	38	13	45	40	9	0.66	0.69	0.34	0.31	C	0.088	0.00116174	Economic and political preferences environmentalism	Mental aptitude and behavioural traits
rs2744203	G	C	62	31	1	60	30	4	0.82	0.80	0.18	0.20	C	0.2327	0.001154468	IgG glycosylation	Immune diseases and disorders
rs4591358	T	C	44	41	9	37	49	8	0.69	0.65	0.31	0.35	C	1.578	0.001152074	Adverse response to chemotherapy neutropenia_leucopenia all antimicrotubule drugs	Drug response
rs6790925	C	T	42	45	7	41	41	12	0.69	0.65	0.31	0.35	T	1.15	0.001152074	Migraine - clinic-based	Brain health and disorders
rs7332115	T	G	43	43	8	40	43	11	0.69	0.65	0.31	0.35	T	0.023	0.001152074	Height	General health
rs1939875	A	G	13	40	41	6	48	40	0.35	0.32	0.65	0.68	T	1.54	0.001142857	Eosinophilic esophagitis pediatric	Digestive system and its disorders
rs2125623	C	T	45	38	11	41	40	13	0.68	0.65	0.32	0.35	C	1.23	0.001142857	Mortality in heart failure	Heart health and disorders
rs6056869	G	A	45	38	11	38	46	10	0.68	0.65	0.32	0.35	A	1.12	0.001142857	Psoriasis	Immune diseases and disorders
rs10875912	T	C	42	44	8	40	42	12	0.68	0.65	0.32	0.35	T	0.09	0.001142857	Percentage gas trapping	Misc
rs60678552	C	G	78	13	3	73	19	2	0.90	0.88	0.10	0.12	C	7.73	0.001140576	Heschl's gyrus morphology	Brain health and disorders
rs9546711	G	A	72	21	1	75	19	0	0.88	0.90	0.12	0.10	A	1.66	0.001140576	Coronary heart disease	Heart health and disorders
rs2073505	G	A	71	23	0	76	17	1	0.88	0.90	0.12	0.10	A	1.1113101	0.001140576	Crohn's disease	Digestive system and its disorders
rs16973500	C	T	71	23	0	76	17	1	0.88	0.90	0.12	0.10	C	1	0.001140576	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs17655565	T	C	78	13	3	73	19	2	0.90	0.88	0.10	0.12	C	0.12	0.001140576	Plasma amyloid beta peptide concentrations ABx-42	Brain health and disorders
rs1144333	A	G	4	26	64	1	37	56	0.18	0.21	0.82	0.79	G	1.32	0.00113025	Attention function in attention deficit hyperactive disorder	Brain health and disorders
rs258324	T	G	5	29	60	4	26	64	0.21	0.18	0.79	0.82	T	0.054	0.00113025	Height	General health
rs1799990	A	G	38	44	12	43	40	11	0.64	0.67	0.36	0.33	A	1	0.001125704	Creutzfeldt-Jakob disease	Immune diseases and disorders
rs607541	C	A	40	40	14	42	42	10	0.64	0.67	0.36	0.33	C	0.03	0.001125704	Obesity-related traits	Obesity
rs9271858	A	G	51	23	20	33	53	8	0.66	0.63	0.34	0.37	G	1.41	0.001117735	Leishmaniasis visceral	Immune diseases and disorders
rs183211	G	A	43	39	12	40	39	15	0.66	0.63	0.34	0.37	A	1.25	0.001117735	Ovarian cancer in BRCA1 mutation carriers	Cancer
rs11603023	T	C	9	46	39	16	38	40	0.34	0.37	0.66	0.63	T	0.022	0.001110152	Cholesterol, total	General health
rs1018827	A	G	1	11	82	0	10	84	0.07	0.05	0.93	0.95	A	2.52	0.001108511	Venous thromboembolism	Heart health and disorders
rs11887534	G	C	81	13	0	84	10	0	0.93	0.95	0.07	0.05	C	2.2	0.001108511	Gallstones	Misc
rs12422544	T	C	81	13	0	84	10	0	0.93	0.95	0.07	0.05	G	1.4551913	0.001108511	Crohn's disease	Digestive system and its disorders
rs9578438	C	T	84	10	0	81	13	0	0.95	0.93	0.05	0.07	T	1.2374	0.001108511	Neuritic plaque	Brain health and disorders
rs9540294	T	G	56	36	2	61	31	2	0.79	0.81	0.21	0.19	G	2.655	0.00110742	Recalcitrant atopic dermatitis	Immune diseases and disorders
rs11971779	G	A	61	31	2	55	38	1	0.81	0.79	0.19	0.21	A	2.43	0.00110742	Diisocyanate-induced asthma	Pulmonology
rs12367822	G	T	59	30	5	65	23	6	0.79	0.81	0.21	0.19	T	1	0.00110742	Platelet aggregation	Heart health and disorders
rs7786877	A	G	59	30	5	63	27	4	0.79	0.81	0.21	0.19	G	1	0.00110742	Mean corpuscular volume	Heart health and disorders
rs4658627	G	A	59	30	5	63	27	4	0.79	0.81	0.21	0.19	A	0.13	0.00110742	Asthma childhood onset	Immune diseases and disorders
rs7521902	C	A	59	30	5	65	23	6	0.79	0.81	0.21	0.19	A	0.05	0.00110742	Bone mineral density	General health
rs216452	C	T	39	45	10	33	51	10	0.65	0.62	0.35	0.38	T	1.05	0.001102941	Schizophrenia	Brain health and disorders
rs1245541	G	A	35	47	12	36	51	7	0.62	0.65	0.38	0.35	G	1	0.001102941	Insulin-like growth factors	General health
rs2023472	A	G	10	45	39	12	47	35	0.35	0.38	0.65	0.62	A	0.03	0.001102941	Beta-2 microglubulin plasma levels	Cancer
rs4800148	G	A	12	42	40	13	46	35	0.35	0.38	0.65	0.62	A	6.4	0.001096091	Height	General health
rs17565841	G	A	77	14	3	70	24	0	0.89	0.87	0.11	0.13	A	2.84	0.00109529	Parkinson's disease age of onset	Brain health and disorders
rs1256328	C	T	71	22	1	75	18	1	0.87	0.89	0.13	0.11	T	1.21	0.00109529	Kidney stones	General health
rs17834666	G	A	76	16	2	72	20	2	0.89	0.87	0.11	0.13	A	0.2201	0.00109529	Metabolite levels HVA	General health
rs11727189	G	T	88	6	0	92	0	2	0.97	0.98	0.03	0.02	T	64.7	0.001092896	Pulmonary function	Pulmonology
rs77156671	C	T	89	4	1	90	4	0	0.97	0.98	0.03	0.02	A	15.23	0.001092896	Diisocyanate-induced asthma	Pulmonology
rs2279695	C	T	90	4	0	88	6	0	0.98	0.97	0.02	0.03	A	15.23	0.001092896	Diisocyanate-induced asthma	Pulmonology
rs72698613	G	A	88	6	0	90	4	0	0.97	0.98	0.03	0.02	A	2.39	0.001092896	Epilepsy remission after treatment	Brain health and disorders
rs17375901	C	T	90	4	0	88	6	0	0.98	0.97	0.02	0.03	T	1.26	0.001092896	Atrial fibrillation	Heart health and disorders
rs79947808	G	A	88	6	0	90	4	0	0.97	0.98	0.03	0.02	G	1.1363636	0.001092896	Schizophrenia	Brain health and disorders
rs12374220	C	T	88	6	0	90	4	0	0.97	0.98	0.03	0.02	T	1	0.001092896	Plasma renin activity levels	General health
rs7581969	C	T	90	4	0	88	6	0	0.98	0.97	0.02	0.03	C	0.5508	0.001092896	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs12602486	T	G	90	4	0	89	4	1	0.98	0.97	0.02	0.03	G	0.362	0.001092896	Glycated hemoglobin levels	Diabetes
rs117147010	C	T	88	6	0	90	4	0	0.97	0.98	0.03	0.02	T	0.358	0.001092896	Symmetrical dimethylarginine levels	General health
rs3739070	A	C	90	4	0	91	0	3	0.98	0.97	0.02	0.03	A	0.25	0.001092896	Iris characteristics	Misc
rs17638544	C	T	90	4	0	88	6	0	0.98	0.97	0.02	0.03	T	0.13	0.001092896	Bone mineral density	General health
rs1514178	T	C	90	4	0	88	6	0	0.98	0.97	0.02	0.03	T	0.07	0.001092896	Phospholipid levels plasma	General health
rs6902257	G	A	90	4	0	88	6	0	0.98	0.97	0.02	0.03	A	0.04	0.001092896	Obesity-related traits	Obesity
rs2074238	T	C	0	6	88	0	4	90	0.03	0.02	0.97	0.98	T	7.88	0.001092896	QT interval	Heart health and disorders
rs961764	C	G	12	43	39	12	49	33	0.36	0.39	0.64	0.61	C	0.024	0.001089588	Height	General health
rs7900239	A	G	6	24	64	5	31	58	0.19	0.22	0.81	0.78	A	1.09	0.001085871	Migraine	Brain health and disorders
rs1847134	A	C	58	36	0	57	33	4	0.81	0.78	0.19	0.22	A	1.58	0.001085871	Eye color	Appearance
rs6967330	G	A	62	28	4	59	29	6	0.81	0.78	0.19	0.22	A	1.26	0.001085871	Asthma childhood onset	Immune diseases and disorders
rs2115172	A	G	35	44	15	42	36	16	0.61	0.64	0.39	0.36	A	2.71	0.001083424	Weight	Appearance
rs7538876	G	A	33	48	13	44	32	18	0.61	0.64	0.39	0.36	A	1.28	0.001083424	Basal cell carcinoma	Cancer
rs96067	G	A	17	40	37	16	36	42	0.39	0.36	0.61	0.64	A	0.03	0.001083424	Corneal structure	General health
rs342293	C	G	32	50	12	40	40	14	0.61	0.64	0.39	0.36	G	0.02	0.001083424	Mean platelet volume	Heart health and disorders
rs10433903	T	C	36	41	17	38	43	13	0.60	0.63	0.40	0.37	T	1.33	0.001077586	Obesity extreme	Obesity
rs2811893	T	C	35	43	16	32	55	7	0.60	0.63	0.40	0.37	T	1	0.001077586	Diabetic retinopathy	Diabetes
rs2969180	G	A	35	49	10	33	47	14	0.63	0.60	0.37	0.40	A	0.101	0.001077586	Refractive error	General health
rs6501384	C	T	35	42	17	38	42	14	0.60	0.63	0.40	0.37	T	1.41	0.001072067	Eosinophilic esophagitis pediatric	Digestive system and its disorders
rs11010067	C	G	38	42	14	28	56	10	0.63	0.60	0.37	0.40	G	1.1415846	0.001072067	Crohn's disease	Digestive system and its disorders
rs9523848	G	T	33	46	15	37	44	13	0.60	0.63	0.40	0.37	T	0.081	0.001072067	Breast size	General health
rs211829	T	C	34	49	11	27	57	10	0.62	0.59	0.38	0.41	T	1.061	0.001066856	Schizophrenia	Brain health and disorders
rs12431410	C	T	15	47	32	13	45	36	0.41	0.38	0.59	0.62	C	1.0526316	0.001066856	Schizophrenia	Brain health and disorders
rs10745527	G	T	13	51	30	10	51	33	0.41	0.38	0.59	0.62	G	0.16	0.001066856	vWF and FVIII levels	Heart health and disorders
rs261291	T	C	33	45	16	35	47	12	0.59	0.62	0.41	0.38	C	0.122	0.001066856	HDL cholesterol	General health
rs2222800	A	C	10	51	33	16	45	33	0.38	0.41	0.62	0.59	A	0.04	0.001066856	Metabolite levels  X-11787	General health
rs11978267	A	G	58	30	6	62	27	5	0.78	0.80	0.22	0.20	G	1.69	0.001065507	Acute lymphoblastic leukemia childhood	Cancer
rs200639	C	G	11	56	27	11	50	33	0.41	0.38	0.59	0.62	G	4.157	0.001061947	Warfarin maintenance dose	General health
rs1063355	T	G	15	48	31	12	48	34	0.41	0.38	0.59	0.62	A	1.43	0.001061947	Ulcerative colitis	Immune diseases and disorders
rs11774576	C	T	15	49	30	17	39	38	0.42	0.39	0.58	0.61	A	1.699	0.001057331	Adverse response to chemotherapy neutropenia_leucopenia cisplatin	Drug response
rs11662297	A	G	32	45	17	26	63	5	0.58	0.61	0.42	0.39	G	0.03	0.001057331	Obesity-related traits	Obesity
rs13006833	G	C	38	39	17	30	49	15	0.61	0.58	0.39	0.42	G	0.0293	0.001057331	Urinary metabolites	General health
rs10028773	C	G	33	49	12	32	45	17	0.61	0.58	0.39	0.42	C	0.02	0.001057331	Educational attainment	Mental aptitude and behavioural traits
rs10157379	C	T	12	49	33	16	47	31	0.39	0.42	0.61	0.58	T	0.01	0.001057331	Fibrinogen	General health
rs1823125	A	G	75	17	2	72	19	3	0.89	0.87	0.11	0.13	G	3.14	0.001054018	Sleep duration	General health
rs3744728	T	C	74	19	1	70	23	1	0.89	0.87	0.11	0.13	C	1.51	0.001054018	Bipolar disorder with mood-incongruent psychosis	Brain health and disorders
rs9302752	T	C	17	40	37	19	42	33	0.39	0.43	0.61	0.57	G	1.59	0.001053001	Leprosy	Immune diseases and disorders
rs2118666	G	T	25	58	11	32	50	12	0.57	0.61	0.43	0.39	T	4.95	0.001053001	Information processing speed	Mental aptitude and behavioural traits
rs2062305	G	A	32	44	18	30	54	10	0.57	0.61	0.43	0.39	G	1.1	0.001053001	Crohn's disease	Digestive system and its disorders
rs1692120	G	A	34	40	20	36	42	16	0.57	0.61	0.43	0.39	A	0.01	0.001053001	Phospholipid levels plasma	General health
rs2669010	A	G	30	47	17	35	43	16	0.57	0.60	0.43	0.40	A	1.28	0.001048951	Systemic lupus erythematosus	Immune diseases and disorders
rs6439371	G	A	11	53	30	14	53	27	0.40	0.43	0.60	0.57	G	2.3	0.001048951	Menarche age at onset	Reproductive health
rs3096299	G	A	16	49	29	15	45	34	0.43	0.40	0.57	0.60	G	1.54	0.001048951	Multiple myeloma IgH translocation	Cancer
rs4148087	G	A	56	33	5	60	30	4	0.77	0.80	0.23	0.20	A	2	0.001046244	Eating disorder in bipolar disorder	Brain health and disorders
rs11805303	C	T	59	32	3	57	31	6	0.80	0.77	0.20	0.23	T	1.39	0.001046244	Crohn's disease	Digestive system and its disorders
rs3135363	A	G	58	34	2	57	31	6	0.80	0.77	0.20	0.23	C	1.37	0.001046244	Hepatitis C induced liver cirrhosis	Immune diseases and disorders
rs10488029	A	G	62	26	6	56	33	5	0.80	0.77	0.20	0.23	G	0.2329	0.001046244	IgG glycosylation	Immune diseases and disorders
rs9287237	G	T	60	30	4	53	39	2	0.80	0.77	0.20	0.23	T	0.19	0.001046244	Bone mineral density	General health
rs4521516	G	C	56	33	5	61	28	5	0.77	0.80	0.23	0.20	G	0.008	0.001046244	Mean platelet volume	Heart health and disorders
rs1983546	A	G	20	42	32	15	46	33	0.44	0.40	0.56	0.60	G	0.81	0.001045175	QT interval	Heart health and disorders
rs7442295	A	G	35	42	17	33	40	21	0.60	0.56	0.40	0.44	C	0.35	0.001045175	Urate levels	General health
rs946836	C	T	33	46	15	30	46	18	0.60	0.56	0.40	0.44	T	0.3	0.001045175	White matter integrity	Brain health and disorders
rs507080	G	A	32	47	15	28	49	17	0.59	0.56	0.41	0.44	A	0.51	0.001041667	Serum metabolite levels	General health
rs4657178	C	T	32	46	16	30	44	20	0.59	0.55	0.41	0.45	T	2.19	0.001038422	QT interval	Heart health and disorders
rs1018326	T	C	21	42	31	12	54	28	0.45	0.41	0.55	0.59	C	1.24	0.001038422	Ankylosing spondylitis	Immune diseases and disorders
rs4778879	A	G	32	46	16	28	48	18	0.59	0.55	0.41	0.45	G	0.102	0.001038422	Refractive error	General health
rs704	G	A	17	50	27	12	54	28	0.45	0.41	0.55	0.59	A	0.03	0.001038422	Osteoprotegerin levels	Immune diseases and disorders
rs8027587	A	G	32	45	17	34	35	25	0.58	0.55	0.42	0.45	G	0.03	0.001035435	Obesity-related traits	Obesity
rs6947830	G	A	18	50	26	21	38	35	0.46	0.43	0.54	0.57	A	0.1	0.001032702	Metabolic syndrome	Immune diseases and disorders
rs7679475	A	G	25	51	18	30	47	17	0.54	0.57	0.46	0.43	A	1.6198	0.00103022	Type 1 diabetes and autoimmune thyroid diseases	Diabetes
rs6719884	A	C	17	47	30	19	49	26	0.43	0.46	0.57	0.54	A	1.35	0.00103022	Myasthenia gravis	Brain health and disorders
rs7784776	A	G	28	45	21	23	61	10	0.54	0.57	0.46	0.43	G	0.39	0.00103022	QRS duration	Heart health and disorders
rs4663476	T	G	3	38	53	3	33	58	0.23	0.21	0.77	0.79	G	1.23	0.001028003	Response to angiotensin II receptor blocker therapy	General health
rs1538774	C	G	6	32	56	2	35	57	0.23	0.21	0.77	0.79	G	1.09	0.001028003	Schizophrenia	Brain health and disorders
rs6834314	A	G	57	35	2	54	36	4	0.79	0.77	0.21	0.23	A	2.6	0.001028003	Liver enzyme levels alanine transaminase	General health
rs1110701	A	G	59	26	9	60	29	5	0.77	0.79	0.23	0.21	G	1.69	0.001028003	Acute lymphoblastic leukemia childhood	Cancer
rs2447820	G	T	54	36	4	60	29	5	0.77	0.79	0.23	0.21	T	1.09	0.001028003	Migraine	Brain health and disorders
rs4938303	C	T	15	52	27	19	50	25	0.44	0.47	0.56	0.53	T	0.07	0.001027984	Triglycerides	General health
rs722258	C	T	28	49	17	25	49	20	0.56	0.53	0.44	0.47	T	8.03	0.001025992	Sleep time	General health
rs12778642	G	T	33	39	22	28	43	23	0.56	0.53	0.44	0.47	A	1.0610541	0.001025992	Ulcerative colitis	Immune diseases and disorders
rs9262631	C	A	80	14	0	84	9	1	0.93	0.94	0.07	0.06	A	7.09	0.001025641	Thionamide-induced agranulocytosis in Graves' disease	General health
rs9262632	A	G	80	14	0	84	9	1	0.93	0.94	0.07	0.06	G	3.1	0.001025641	HIV-1 control	Immune diseases and disorders
rs17642749	T	G	83	11	0	80	14	0	0.94	0.93	0.06	0.07	G	2.97	0.001025641	Asthma sex interaction	Immune diseases and disorders
rs17482753	G	T	80	14	0	84	9	1	0.93	0.94	0.07	0.06	T	2.02	0.001025641	HDL cholesterol	General health
rs12418204	G	A	83	11	0	81	12	1	0.94	0.93	0.06	0.07	G	0.305	0.001025641	Optic nerve measurement cup area	Misc
rs1915146	A	G	22	40	32	21	48	25	0.45	0.48	0.55	0.52	G	0.03	0.00102424	Menarche age at onset	Reproductive health
rs700750	C	A	17	56	21	19	46	29	0.48	0.45	0.52	0.55	A	0.03	0.00102424	Obesity-related traits	Obesity
rs56193103	G	T	22	53	19	25	53	16	0.52	0.55	0.48	0.45	T	5.52	0.001022727	Heschl's gyrus morphology	Brain health and disorders
rs11242675	C	T	23	45	26	22	41	31	0.48	0.45	0.52	0.55	T	1.06	0.001022727	Breast cancer	Cancer
rs12286929	A	G	28	46	20	22	52	20	0.54	0.51	0.46	0.49	G	0.022	0.00102145	Body mass index	Obesity
rs13281615	A	G	24	40	30	21	52	21	0.47	0.50	0.53	0.50	G	1.09	0.001019599	Breast cancer	Cancer
rs10077875	G	A	22	44	28	21	52	21	0.47	0.50	0.53	0.50	G	0.03	0.001019599	Obesity-related traits	Obesity
rs6076960	A	C	23	48	23	21	58	15	0.50	0.53	0.50	0.47	A	1.2722	0.001019599	Smooth-surface caries	Appearance
rs6885032	G	C	26	48	20	24	46	24	0.53	0.50	0.47	0.50	G	0.049	0.001019599	Sitting height ratio	Appearance
rs2177596	A	T	30	39	25	19	55	20	0.53	0.49	0.47	0.51	T	0.017	0.001019022	Body mass index	Obesity
rs1278329	T	G	24	48	22	17	56	21	0.51	0.48	0.49	0.52	G	0.2671	0.001018676	Metabolite levels 5-HIAA_ MHPG Ratio	Brain health and disorders
rs12148488	G	T	28	42	24	20	52	22	0.52	0.49	0.48	0.51	T	0.07	0.001018676	Caffeine consumption	General health
rs3930234	T	C	1	20	73	2	22	70	0.12	0.14	0.88	0.86	C	0.104	0.00101626	Alcoholism alcohol use disorder factor score	General health
rs3096697	G	A	72	22	0	70	22	2	0.88	0.86	0.12	0.14	T	2.58	0.00101626	Idiopathic membranous nephropathy	Brain health and disorders
rs3134945	C	A	72	22	0	70	22	2	0.88	0.86	0.12	0.14	T	2.54	0.00101626	Idiopathic membranous nephropathy	Brain health and disorders
rs3096696	C	A	72	22	0	70	22	2	0.88	0.86	0.12	0.14	A	1.478	0.00101626	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Immune diseases and disorders
rs2853953	G	A	75	16	3	69	24	1	0.88	0.86	0.12	0.14	A	1.47	0.00101626	Chronic hepatitis B infection	Immune diseases and disorders
rs3730682	A	G	71	20	3	73	20	1	0.86	0.88	0.14	0.12	G	1.16	0.00101626	Psoriasis	Immune diseases and disorders
rs7808424	T	G	70	22	2	74	18	2	0.86	0.88	0.14	0.12	G	1.1	0.00101626	Coronary heart disease	Heart health and disorders
rs12588287	T	C	73	20	1	70	22	2	0.88	0.86	0.12	0.14	T	0.19	0.00101626	Coronary artery calcification	Heart health and disorders
rs11170468	A	C	69	24	1	72	22	0	0.86	0.88	0.14	0.12	A	0.02	0.00101626	Body mass index	Obesity
rs3793917	C	G	53	36	5	55	37	2	0.76	0.78	0.24	0.22	G	3.4	0.000994313	Age-related macular degeneration	Aging
rs11096990	C	T	58	31	5	52	38	4	0.78	0.76	0.22	0.24	T	2.0117	0.000994313	Cognitive function	Brain health and disorders
rs10849023	C	T	54	34	6	57	33	4	0.76	0.78	0.24	0.22	C	0.008	0.000994313	Red blood cell traits	Immune diseases and disorders
rs964184	G	C	5	36	53	3	35	56	0.24	0.22	0.76	0.78	C	0.3023	0.000994313	Postprandial triglyceride response to high fat diet meal	General health
rs1511453	G	A	68	25	1	73	19	2	0.86	0.88	0.14	0.12	A	4.95	0.000981595	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs6125048	G	T	73	19	2	69	23	2	0.88	0.86	0.12	0.14	T	2.73	0.000981595	Response to treatment for acute lymphoblastic leukemia	General health
rs116002988	C	T	73	19	2	67	27	0	0.88	0.86	0.12	0.14	C	2.04	0.000981595	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs2949006	T	G	1	21	72	3	21	70	0.12	0.14	0.88	0.86	T	1.102	0.000981595	Schizophrenia	Brain health and disorders
rs10463832	C	A	73	19	2	69	23	2	0.88	0.86	0.12	0.14	A	1	0.000981595	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs17382723	C	G	71	19	4	71	23	0	0.86	0.88	0.14	0.12	C	0.206	0.000981595	Height	General health
rs17291845	G	A	71	19	4	74	17	3	0.86	0.88	0.14	0.12	A	0.19	0.000981595	Information processing speed	Mental aptitude and behavioural traits
rs9289146	C	T	68	25	1	71	23	0	0.86	0.88	0.14	0.12	A	0.04	0.000981595	Obesity-related traits	Obesity
rs13004938	A	G	69	23	2	72	21	1	0.86	0.88	0.14	0.12	G	0.04	0.000981595	Obesity-related traits	Obesity
rs6821987	G	C	71	23	0	70	21	3	0.88	0.86	0.12	0.14	C	0.0023	0.000981595	Trans fatty acid levels	General health
rs882300	T	C	6	35	53	3	36	55	0.25	0.22	0.75	0.78	C	1.19	0.000978742	Multiple sclerosis	Brain health and disorders
rs4862307	A	T	50	41	3	55	36	3	0.75	0.78	0.25	0.22	T	0.098	0.000978742	Serum dimethylarginine levels asymmetric_symetric ratio	General health
rs9276606	A	T	56	34	4	52	37	5	0.78	0.75	0.22	0.25	T	0.09	0.000978742	Complement C3 and C4 levels	Immune diseases and disorders
rs17685	G	A	58	30	6	52	37	5	0.78	0.75	0.22	0.25	A	0.08	0.000978742	Coffee consumption	Misc
rs6922893	A	G	3	41	50	4	34	56	0.25	0.22	0.75	0.78	A	0.03	0.000978742	Obesity-related traits	Obesity
rs3117098	G	A	5	38	51	3	37	54	0.26	0.23	0.74	0.77	G	1.16	0.000963948	Asthma	Immune diseases and disorders
rs9938149	C	A	7	29	58	8	32	54	0.23	0.26	0.77	0.74	A	0.17	0.000963948	Corneal structure	General health
rs10940138	C	T	53	34	7	56	33	5	0.74	0.77	0.26	0.23	T	5.64	0.000963948	Menarche age at onset	Reproductive health
rs13428812	A	G	51	38	5	56	33	5	0.74	0.77	0.26	0.23	G	1.06	0.000963948	Crohn's disease	Digestive system and its disorders
rs9296009	A	T	51	38	5	57	31	6	0.74	0.77	0.26	0.23	T	0.2111	0.000963948	IgG glycosylation	Immune diseases and disorders
rs77956314	T	C	79	15	0	82	12	0	0.92	0.94	0.08	0.06	T	55.18	0.00095511	Subcortical brain region volumes	Brain health and disorders
rs11648716	A	G	82	12	0	79	15	0	0.94	0.92	0.06	0.08	G	39.68	0.00095511	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs2361755	G	C	79	15	0	82	12	0	0.92	0.94	0.08	0.06	C	1.1951665	0.00095511	Crohn's disease	Digestive system and its disorders
rs10055544	G	A	82	12	0	82	9	3	0.94	0.92	0.06	0.08	A	1	0.00095511	Immune reponse to smallpox secreted IL-10	Immune diseases and disorders
rs11689435	C	T	83	10	1	79	15	0	0.94	0.92	0.06	0.08	T	0.2941	0.00095511	Metabolite levels MHPG	General health
rs12987661	T	C	82	12	0	80	13	1	0.94	0.92	0.06	0.08	C	0.13	0.00095511	Metabolite levels Dihydroxy docosatrienoic acid	General health
rs73717741	C	G	79	15	0	82	12	0	0.92	0.94	0.08	0.06	C	0.084	0.00095511	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs7356884	A	G	82	12	0	79	15	0	0.94	0.92	0.06	0.08	G	0.03	0.00095511	Obesity-related traits	Obesity
rs2187375	A	G	1	13	80	0	12	82	0.08	0.06	0.92	0.94	A	0.022	0.00095511	Blood metabolite levels	Heart health and disorders
rs10800713	T	A	4	41	49	4	36	54	0.26	0.23	0.74	0.77	A	2.431	0.000949884	Tandem gait	Misc
rs2786111	C	T	6	37	51	1	42	51	0.26	0.23	0.74	0.77	C	2.26	0.000949884	Lupus nephritis in systemic lupus erythematosus	Immune diseases and disorders
rs2853676	T	C	10	29	55	7	30	57	0.26	0.23	0.74	0.77	A	1.26	0.000949884	Glioma	Cancer
rs11082321	G	A	55	29	10	56	32	6	0.74	0.77	0.26	0.23	A	1.08	0.000949884	Breast cancer	Cancer
rs2452591	C	A	55	34	5	51	37	6	0.77	0.74	0.23	0.26	A	0.2693	0.000949884	Lewy body disease	Brain health and disorders
rs12304921	A	G	69	22	3	72	20	2	0.85	0.87	0.15	0.13	G	2.5	0.000949668	Type 2 diabetes	Diabetes
rs16902094	A	G	68	24	2	73	18	3	0.85	0.87	0.15	0.13	G	1.21	0.000949668	Prostate cancer	Cancer
rs7841189	C	T	71	22	1	68	24	2	0.87	0.85	0.13	0.15	C	0.18	0.000949668	Metabolic syndrome	Immune diseases and disorders
rs10519227	T	A	68	24	2	72	20	2	0.85	0.87	0.15	0.13	A	0.095	0.000949668	Thyroid hormone levels	General health
rs831571	T	C	2	24	68	1	22	71	0.15	0.13	0.85	0.87	c	1.09	0.000949668	Type 2 diabetes	Diabetes
rs1812175	A	G	7	36	51	4	37	53	0.27	0.24	0.73	0.76	A	0.068	0.000936505	Infant length	Misc
rs1822818	T	C	50	38	6	57	29	8	0.73	0.76	0.27	0.24	T	1.7737	0.000936505	Major depressive disorder	Brain health and disorders
rs12486865	G	C	54	30	10	56	31	7	0.73	0.76	0.27	0.24	G	1	0.000936505	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs1268843	A	C	6	34	54	6	39	49	0.24	0.27	0.76	0.73	A	1.19	0.00092377	Endometriosis	General health
rs1606355	G	A	5	41	48	7	32	55	0.27	0.24	0.73	0.76	A	0.2	0.00092377	Metabolite levels Pyroglutamine	General health
rs7689420	T	C	7	37	50	4	38	52	0.27	0.24	0.73	0.76	T	0.073	0.00092377	Height	General health
rs1870323	A	G	48	41	5	52	38	4	0.73	0.76	0.27	0.24	T	2.92	0.00092377	Adverse response to chemotherapy in breast cancer alopecia anti-microtubule	General health
rs4725982	C	T	50	37	7	54	34	6	0.73	0.76	0.27	0.24	A	2.08	0.00092377	Electrocardiographic traits	Heart health and disorders
rs8181588	T	C	51	40	3	49	39	6	0.76	0.73	0.24	0.27	A	1.3	0.00092377	Type 2 diabetes	Diabetes
rs12518099	A	G	53	31	10	55	32	7	0.73	0.76	0.27	0.24	C	1.16	0.00092377	Type 2 diabetes and other traits	Diabetes
rs17138114	A	G	71	21	2	66	27	1	0.87	0.85	0.13	0.15	G	0.04	0.000920175	Obesity-related traits	Obesity
rs2974438	G	A	67	25	2	70	23	1	0.85	0.87	0.15	0.13	A	0.037	0.000920175	Height	General health
rs117628011	C	T	89	5	0	87	7	0	0.97	0.96	0.03	0.04	A	3.06	0.000915751	Diisocyanate-induced asthma	Pulmonology
rs58600253	C	T	88	5	1	89	5	0	0.96	0.97	0.04	0.03	T	1.22	0.000915751	Leprosy	Immune diseases and disorders
rs11643447	A	T	87	7	0	89	5	0	0.96	0.97	0.04	0.03	T	1	0.000915751	Visceral adipose tissue adjusted for BMI	Obesity
rs1406503	G	C	87	7	0	89	5	0	0.96	0.97	0.04	0.03	C	0.07	0.000915751	Body mass index	Obesity
rs16861990	A	C	89	5	0	87	7	0	0.97	0.96	0.03	0.04	C	0.0614	0.000915751	D-dimer levels	Heart health and disorders
rs11601906	C	T	87	7	0	89	5	0	0.96	0.97	0.04	0.03	A	0.04	0.000915751	Obesity-related traits	Obesity
rs17150243	T	G	88	5	1	90	3	1	0.96	0.97	0.04	0.03	C	0.03	0.000915751	Obesity-related traits	Obesity
rs7656244	C	A	50	36	8	55	31	8	0.72	0.75	0.28	0.25	A	1.394	0.000911644	Kawasaki disease	Misc
rs3765524	C	T	52	37	5	46	44	4	0.75	0.72	0.25	0.28	T	1.35	0.000911644	Esophageal cancer and gastric cancer	Cancer
rs3764261	C	A	53	35	6	48	40	6	0.75	0.72	0.25	0.28	A	1.15	0.000911644	Age-related macular degeneration	Aging
rs2895811	T	C	49	38	7	54	33	7	0.72	0.75	0.28	0.25	C	1.07	0.000911644	Coronary heart disease	Heart health and disorders
rs62494762	T	C	52	37	5	50	36	8	0.75	0.72	0.25	0.28	C	0.3065	0.000911644	Metabolite levels HVA_MHPG ratio	Brain health and disorders
rs9913711	G	C	9	34	51	4	39	51	0.28	0.25	0.72	0.75	C	2.4	0.000911644	Liver enzyme levels gamma-glutamyl transferase	General health
rs3894944	G	A	7	33	54	2	48	44	0.25	0.28	0.75	0.72	A	0.18	0.000911644	Coronary artery calcification	Heart health and disorders
rs1832871	A	G	10	32	52	4	39	51	0.28	0.25	0.72	0.75	A	0.025	0.000911644	Height	General health
rs6820391	C	A	52	31	11	51	38	5	0.72	0.74	0.28	0.26	A	1.24	0.00090009	Cervical artery dissection	Reproductive health
rs142958719	G	A	49	37	8	52	36	6	0.72	0.74	0.28	0.26	G	1.1627907	0.00090009	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs7155603	A	G	52	36	6	47	41	6	0.74	0.72	0.26	0.28	G	1.16	0.00090009	Rheumatoid arthritis	Immune diseases and disorders
rs7101446	T	G	48	39	7	48	44	2	0.72	0.74	0.28	0.26	T	0.145	0.00090009	Economic and political preferences	Mental aptitude and behavioural traits
rs9374842	C	T	7	34	53	4	45	45	0.26	0.28	0.74	0.72	T	0.02	0.00090009	Body mass index	Obesity
rs6479874	T	C	0	16	78	1	11	82	0.09	0.07	0.91	0.93	T	1.09	0.000894365	Migraine	Brain health and disorders
rs2870946	T	C	82	11	1	78	16	0	0.93	0.91	0.07	0.09	G	1.54	0.000894365	Ulcerative colitis	Immune diseases and disorders
rs36104021	C	G	78	16	0	81	13	0	0.91	0.93	0.09	0.07	C	1.08	0.000894365	Schizophrenia	Brain health and disorders
rs9635542	A	G	82	11	1	79	14	1	0.93	0.91	0.07	0.09	G	1	0.000894365	Lung cancer asbestos exposure interaction	Cancer
rs17132261	C	T	83	9	2	78	16	0	0.93	0.91	0.07	0.09	T	0.06	0.000894365	Cardiac structure and function	Heart health and disorders
rs111361850	C	T	93	1	0	92	2	0	0.99	0.99	0.01	0.01	A	34.08	0.000893655	Diisocyanate-induced asthma	Pulmonology
rs118079879	C	T	93	1	0	92	2	0	0.99	0.99	0.01	0.01	A	5.93	0.000893655	Diisocyanate-induced asthma	Pulmonology
rs7775397	T	G	92	2	0	93	1	0	0.99	0.99	0.01	0.01	G	3.83	0.000893655	Idiopathic membranous nephropathy	Brain health and disorders
rs542340	A	G	93	1	0	92	2	0	0.99	0.99	0.01	0.01	G	1.95	0.000893655	Glaucoma	General health
rs2272046	A	C	93	1	0	93	0	1	0.99	0.99	0.01	0.01	A	1.43	0.000893655	Polycystic ovary syndrome	Reproductive health
rs181715218	T	C	93	1	0	92	2	0	0.99	0.99	0.01	0.01	T	1.3	0.000893655	Serum dimethylarginine levels asymmetric_symetric ratio	General health
rs10995485	G	C	93	1	0	92	2	0	0.99	0.99	0.01	0.01	G	1.18	0.000893655	Response to fenofibrate	General health
rs17123726	A	G	92	2	0	93	1	0	0.99	0.99	0.01	0.01	A	1	0.000893655	Attention deficit hyperactivity disorder combined symptoms	Brain health and disorders
rs765684	A	G	92	2	0	93	1	0	0.99	0.99	0.01	0.01	G	1	0.000893655	Sexual dimorphism in anthropometric traits	Misc
rs2059397	C	G	93	1	0	93	0	1	0.99	0.99	0.01	0.01	G	1	0.000893655	Visceral adipose tissue adjusted for BMI	Obesity
rs149969998	G	T	93	1	0	92	2	0	0.99	0.99	0.01	0.01	G	0.6459	0.000893655	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs77216358	A	G	93	1	0	92	2	0	0.99	0.99	0.01	0.01	A	0.47	0.000893655	Intraocular pressure	General health
rs80040504	G	A	93	1	0	92	2	0	0.99	0.99	0.01	0.01	A	0.47	0.000893655	Intraocular pressure	General health
rs2305013	A	T	93	1	0	92	2	0	0.99	0.99	0.01	0.01	A	0.39	0.000893655	Intraocular pressure	General health
rs11465699	G	A	92	2	0	93	1	0	0.99	0.99	0.01	0.01	A	0.14	0.000893655	Serum protein levels sST2	General health
rs17780304	G	A	92	2	0	93	1	0	0.99	0.99	0.01	0.01	A	0.03	0.000893655	Obesity-related traits	Obesity
rs2233287	G	A	70	22	2	68	22	4	0.86	0.84	0.14	0.16	A	1.31	0.000892857	Systemic sclerosis	Brain health and disorders
rs1516725	T	C	3	20	71	4	22	68	0.14	0.16	0.86	0.84	C	1.21	0.000892857	Body mass index	Obesity
rs17765925	C	G	71	20	3	66	26	2	0.86	0.84	0.14	0.16	G	1	0.000892857	Verbal declarative memory	Brain health and disorders
rs7134472	G	A	51	37	6	46	42	6	0.74	0.71	0.26	0.29	A	1.0596101	0.000889079	Crohn's disease	Digestive system and its disorders
rs13008299	T	G	51	37	6	44	46	4	0.74	0.71	0.26	0.29	G	0.068	0.000889079	Diastolic blood pressure alcohol consumption interaction	Heart health and disorders
rs7534485	C	T	47	39	8	51	36	7	0.71	0.73	0.29	0.27	G	2.2	0.00087858	Diisocyanate-induced asthma	Pulmonology
rs12670798	T	C	52	34	8	50	33	11	0.73	0.71	0.27	0.29	T	1.7	0.00087858	Cholesterol, total	General health
rs6890695	C	G	10	36	48	7	37	50	0.30	0.27	0.70	0.73	G	1.1494253	0.000868568	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs6887317	A	G	9	38	47	7	37	50	0.30	0.27	0.70	0.73	A	0.2466	0.000868568	Lewy body disease	Brain health and disorders
rs41297816	A	G	50	37	7	45	42	7	0.73	0.70	0.27	0.30	G	1.3513513	0.000868568	Schizophrenia	Brain health and disorders
rs4321143	A	G	48	41	5	45	42	7	0.73	0.70	0.27	0.30	G	1.13	0.000868568	Conduct disorder interaction	Brain health and disorders
rs3024321	A	G	45	42	7	47	43	4	0.70	0.73	0.30	0.27	A	0.891	0.000868568	End-stage coagulation	General health
rs4937314	A	G	70	21	3	64	29	1	0.86	0.84	0.14	0.16	C	1	0.000867491	Alzheimer's disease late onset	Brain health and disorders
rs933117	G	A	66	25	3	69	23	2	0.84	0.86	0.16	0.14	A	0.8491	0.000867491	Body mass index	Obesity
rs1656404	G	A	66	25	3	67	27	0	0.84	0.86	0.16	0.14	A	0.153	0.000867491	Refractive error	General health
rs12428035	C	T	67	27	0	65	27	2	0.86	0.84	0.14	0.16	T	0.013	0.000867491	Response to statins LDL cholesterol change	General health
rs1154053	G	C	2	27	65	2	23	69	0.16	0.14	0.84	0.86	C	0.13	0.000867491	Disc degeneration lumbar	Aging
rs30388	T	G	44	43	7	47	42	5	0.70	0.72	0.30	0.28	T	2.88	0.000859018	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs2290159	G	C	52	32	10	44	43	7	0.72	0.70	0.28	0.30	C	1.42	0.000859018	Cholesterol, total	General health
rs11743303	A	G	47	42	5	44	43	7	0.72	0.70	0.28	0.30	G	1	0.000859018	Sexual dimorphism in anthropometric traits	Misc
rs11722228	C	T	45	41	8	52	32	10	0.70	0.72	0.30	0.28	T	0.043	0.000859018	Serum uric acid levels	General health
rs2075672	A	G	9	34	51	12	33	49	0.28	0.30	0.72	0.70	A	0.022	0.000859018	Red blood cell traits	Immune diseases and disorders
rs67437545	A	G	47	41	6	46	38	10	0.72	0.69	0.28	0.31	A	14.48	0.000849907	Heschl's gyrus morphology	Brain health and disorders
rs9953270	T	C	50	35	9	47	36	11	0.72	0.69	0.28	0.31	G	1.3333	0.000849907	Bronchopulmonary dysplasia	Pulmonology
rs17197037	G	A	47	36	11	47	41	6	0.69	0.72	0.31	0.28	A	1.17	0.000849907	Bipolar disorder	Brain health and disorders
rs35094601	A	G	47	41	6	42	46	6	0.72	0.69	0.28	0.31	G	1.0526316	0.000849907	Schizophrenia	Brain health and disorders
rs3822262	T	G	48	34	12	48	39	7	0.69	0.72	0.31	0.28	C	0.03	0.000849907	Obesity-related traits	Obesity
rs625132	A	G	5	18	71	4	24	66	0.15	0.17	0.85	0.83	G	4.236	0.000843882	Platelet count	Heart health and disorders
rs6859219	C	A	65	26	3	69	22	3	0.83	0.85	0.17	0.15	C	1.28	0.000843882	Rheumatoid arthritis	Immune diseases and disorders
rs12140275	A	T	66	24	4	67	26	1	0.83	0.85	0.17	0.15	A	1.11	0.000843882	Rheumatoid arthritis	Immune diseases and disorders
rs7521837	T	C	67	22	5	67	26	1	0.83	0.85	0.17	0.15	T	1.06	0.000843882	Schizophrenia	Brain health and disorders
rs2913737	G	A	65	26	3	70	20	4	0.83	0.85	0.17	0.15	A	0.03	0.000843882	Obesity-related traits	Obesity
rs2187668	C	T	80	14	0	79	13	2	0.93	0.91	0.07	0.09	A	4.32	0.000841515	Idiopathic membranous nephropathy	Brain health and disorders
rs368433	T	C	79	13	2	80	14	0	0.91	0.93	0.09	0.07	C	1.37	0.000841515	Helicobacter pylori serologic status	Immune diseases and disorders
rs1403155	G	A	77	17	0	80	14	0	0.91	0.93	0.09	0.07	A	1	0.000841515	Immune reponse to smallpox secreted IL-2	Immune diseases and disorders
rs4701523	A	T	81	12	1	78	15	1	0.93	0.91	0.07	0.09	T	1	0.000841515	Visceral fat	Obesity
rs351328	A	C	0	14	80	0	17	77	0.07	0.09	0.93	0.91	A	2.7	0.000841515	Diisocyanate-induced asthma	Pulmonology
rs4533251	T	G	1	12	81	0	17	77	0.07	0.09	0.93	0.91	T	1	0.000841515	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs7092929	A	C	8	38	48	10	39	45	0.29	0.31	0.71	0.69	A	0.21	0.000841213	Coronary artery calcification	Heart health and disorders
rs12401457	G	A	46	37	11	47	40	7	0.69	0.71	0.31	0.29	G	0.097	0.000841213	Urate levels in overweight individuals	Obesity
rs7072574	G	A	45	39	10	48	38	8	0.69	0.71	0.31	0.29	A	0.009	0.000841213	Vertical cup-disc ratio	Misc
rs11944965	C	T	43	42	9	47	39	8	0.68	0.71	0.32	0.29	T	1.986	0.000832917	Adverse response to chemotherapy neutropenia_leucopenia cisplatin	Drug response
rs1104918	T	G	43	42	9	47	39	8	0.68	0.71	0.32	0.29	T	1.07	0.000832917	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs2301271	A	G	11	39	44	6	44	44	0.32	0.30	0.68	0.70	T	1.47	0.000825001	Systemic lupus erythematosus	Immune diseases and disorders
rs3764147	A	G	45	42	7	42	43	9	0.70	0.68	0.30	0.32	G	1.25	0.000825001	Crohn's disease	Digestive system and its disorders
rs16887812	C	T	50	32	12	45	37	12	0.70	0.68	0.30	0.32	T	1.1	0.000825001	Allergic sensitization	Immune diseases and disorders
rs1902272	T	C	49	34	11	42	43	9	0.70	0.68	0.30	0.32	C	0.3074	0.000825001	Metabolite levels HVA_MHPG ratio	Brain health and disorders
rs4144027	T	C	39	49	6	47	38	9	0.68	0.70	0.32	0.30	T	0.012	0.000825001	Blood metabolite levels	Heart health and disorders
rs11892031	A	C	68	23	3	64	27	3	0.85	0.82	0.15	0.18	A	1.17	0.000821862	Bladder cancer	Cancer
rs9528384	A	G	68	23	3	66	23	5	0.85	0.82	0.15	0.18	G	1	0.000821862	Verbal declarative memory	Brain health and disorders
rs3018362	A	G	9	44	41	8	41	45	0.33	0.30	0.67	0.70	A	0.07	0.000817448	Bone mineral density hip	General health
rs4474258	C	T	45	36	13	44	43	7	0.67	0.70	0.33	0.30	A	1.89	0.000817448	Adverse response to chemotherapy in breast cancer alopecia cyclophosphamide+epirubicin+_-5FU	Drug response
rs2376682	T	C	46	39	9	42	42	10	0.70	0.67	0.30	0.33	G	1	0.000817448	Diisocyanate-induced asthma	Pulmonology
rs623011	A	G	14	35	45	8	42	44	0.34	0.31	0.66	0.69	A	5.47	0.000810241	Thyrotoxic hypokalemic periodic paralysis	Misc
rs6832769	G	A	8	47	39	13	32	49	0.34	0.31	0.66	0.69	A	0.14	0.000810241	Personality dimensions	Brain health and disorders
rs10747472	G	C	11	36	47	11	41	42	0.31	0.34	0.69	0.66	C	0.018	0.000810241	Body mass index	Obesity
rs8177253	C	T	42	46	6	43	39	12	0.69	0.66	0.31	0.34	T	19.86	0.000810241	Iron status biomarkers	General health
rs2089222	G	A	44	37	13	43	44	7	0.66	0.69	0.34	0.31	A	2.26	0.000810241	Acute lymphoblastic leukemia childhood	Cancer
rs7117932	C	T	49	32	13	38	49	7	0.69	0.66	0.31	0.34	A	0.03	0.000810241	Obesity-related traits	Obesity
rs10519203	G	A	12	40	42	9	41	44	0.34	0.31	0.66	0.69	A	0.048	0.000803368	Fibrinogen levels smoking status, alcohol consumption or body mass index interaction	General health
rs11970772	T	A	47	35	12	41	42	11	0.69	0.66	0.31	0.34	T	0.58	0.000803368	Hematological parameters	Heart health and disorders
rs2293582	G	A	66	26	2	63	28	3	0.84	0.82	0.16	0.18	A	1.21	0.000801282	Colorectal cancer	Cancer
rs138904061	T	C	68	22	4	63	28	3	0.84	0.82	0.16	0.18	C	0.09	0.000801282	Glomerular filtration rate in chronic kidney disease	General health
rs12534093	T	A	69	20	5	62	30	2	0.84	0.82	0.16	0.18	A	0.064	0.000801282	Infant length	Misc
rs1801222	A	G	3	28	63	1	28	65	0.18	0.16	0.82	0.84	A	0.0453	0.000801282	Homocysteine levels	Misc
rs9940464	T	C	41	46	7	39	45	10	0.68	0.65	0.32	0.35	T	1.17	0.000796813	Malaria	Immune diseases and disorders
rs1116547	C	T	44	40	10	42	39	13	0.68	0.65	0.32	0.35	T	0.396	0.000796813	Cerebral amyloid angiopathy	Brain health and disorders
rs1348582	T	C	43	42	9	41	41	12	0.68	0.65	0.32	0.35	G	0.2	0.000796813	QT interval	Heart health and disorders
rs6988306	C	T	81	11	2	76	18	0	0.92	0.90	0.08	0.10		2.7778	0.000795123	Bronchopulmonary dysplasia	Pulmonology
rs75691080	C	T	81	11	2	77	16	1	0.92	0.90	0.08	0.10	T	0.16	0.000795123	Cutaneous malignant melanoma	Cancer
rs12773465	A	G	79	15	0	79	12	3	0.92	0.90	0.08	0.10	G	0.159	0.000795123	Mean arterial pressure alcohol consumption interaction	General health
rs8045405	G	A	1	16	77	3	9	82	0.10	0.08	0.90	0.92	G	11.38	0.000795123	QT interval	Heart health and disorders
rs3934467	C	T	41	45	8	37	48	9	0.68	0.65	0.32	0.35	T	2.74	0.000790564	QT interval	Heart health and disorders
rs1444418	A	G	43	41	10	41	40	13	0.68	0.65	0.32	0.35	A	1.17	0.000790564	Atopic dermatitis	Immune diseases and disorders
rs504918	C	T	15	36	43	8	45	41	0.35	0.32	0.65	0.68	C	1.0526316	0.000790564	Schizophrenia	Brain health and disorders
rs1805465	C	T	87	6	1	88	6	0	0.96	0.97	0.04	0.03	T	2.339	0.000789266	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Immune diseases and disorders
rs1150754	C	T	86	8	0	88	6	0	0.96	0.97	0.04	0.03	A	2.21	0.000789266	Systemic lupus erythematosus	Immune diseases and disorders
rs116446171	C	G	87	6	1	88	6	0	0.96	0.97	0.04	0.03	G	2.2	0.000789266	Diffuse large B cell lymphoma	Cancer
rs12188300	A	T	86	8	0	88	6	0	0.96	0.97	0.04	0.03	T	1.7	0.000789266	Psoriatic arthritis	Immune diseases and disorders
rs11635553	G	A	88	6	0	87	6	1	0.97	0.96	0.03	0.04	G	1.0812	0.000789266	IgG glycosylation	Immune diseases and disorders
rs6728021	A	G	86	8	0	88	6	0	0.96	0.97	0.04	0.03	G	1	0.000789266	Immune response to smallpox vaccine IL-6	Immune diseases and disorders
rs11212260	T	C	86	8	0	88	6	0	0.96	0.97	0.04	0.03	C	0.455	0.000789266	IgG glycosylation	Immune diseases and disorders
rs17719439	G	A	89	4	1	86	8	0	0.97	0.96	0.03	0.04	G	0.4037	0.000789266	IgG glycosylation	Immune diseases and disorders
rs17538444	C	T	86	8	0	88	6	0	0.96	0.97	0.04	0.03	T	0.3905	0.000789266	Major depressive disorder	Brain health and disorders
rs13021885	C	T	88	6	0	86	8	0	0.97	0.96	0.03	0.04	C	0.3904	0.000789266	IgG glycosylation	Immune diseases and disorders
rs4676410	G	A	42	37	15	40	46	8	0.64	0.67	0.36	0.33	A	1.38	0.000784609	Sclerosing cholangitis and ulcerative colitis combined	Cancer
rs11731175	G	T	35	51	8	40	46	8	0.64	0.67	0.36	0.33	T	1.06	0.000784609	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs4975209	C	T	4	27	63	2	27	65	0.19	0.16	0.81	0.84	C	0.2237	0.000782014	Neurofibrillary tangles	Brain health and disorders
rs4792143	C	T	60	33	1	67	23	4	0.81	0.84	0.19	0.16	T	1.0989	0.000782014	Ischemic stroke	Brain health and disorders
rs12517041	A	G	63	27	4	69	19	6	0.81	0.84	0.19	0.16	G	0.00411	0.000782014	Calcium levels	General health
rs3812163	A	T	38	44	12	44	37	13	0.64	0.66	0.36	0.34	A	0.036	0.000778938	Height	General health
rs9649465	G	A	41	37	16	41	42	11	0.63	0.66	0.37	0.34	A	1.06	0.000773539	Migraine	Brain health and disorders
rs2853677	G	A	15	40	39	9	47	38	0.37	0.35	0.63	0.65	C	1.41	0.000768403	Lung adenocarcinoma	Cancer
rs10181042	C	T	37	44	13	42	39	13	0.63	0.65	0.37	0.35	T	1.14	0.000768403	Crohn's disease	Digestive system and its disorders
rs7134375	C	A	43	37	14	36	46	12	0.65	0.63	0.35	0.37	A	0.4	0.000768403	HDL cholesterol	General health
rs6983473	A	T	42	34	18	44	35	15	0.63	0.65	0.37	0.35	A	0.04	0.000768403	Cardiac Troponin-T levels	Heart health and disorders
rs10895140	A	G	11	43	40	14	42	38	0.35	0.37	0.65	0.63	G	0.04	0.000768403	Menarche age at onset	Reproductive health
rs17194885	A	C	64	28	2	59	34	1	0.83	0.81	0.17	0.19	A	0.61	0.000763942	Retinopathy in non-diabetics	General health
rs604222	G	A	64	28	2	59	34	1	0.83	0.81	0.17	0.19	A	0.2173	0.000763942	Major depressive disorder	Brain health and disorders
rs35610040	T	C	62	28	4	63	30	1	0.81	0.83	0.19	0.17	G	0.0562	0.000763942	Plasma cystastin c levels in acute coronary syndrome	Heart health and disorders
rs137686	C	G	3	30	61	1	30	63	0.19	0.17	0.81	0.83	C	0.2524	0.000763942	IgG glycosylation	Immune diseases and disorders
rs862946	T	C	1	30	63	3	30	61	0.17	0.19	0.83	0.81	A	0.043	0.000763942	Liver enzyme levels aspartate transaminase	General health
rs1918974	C	T	12	47	35	11	44	39	0.38	0.35	0.62	0.65	T	0.27	0.000763522	Diastolic blood pressure	Heart health and disorders
rs4624820	G	A	13	46	35	12	43	39	0.38	0.36	0.62	0.64	G	1.6393	0.000758887	Testicular germ cell tumor	Cancer
rs4917300	T	C	9	49	36	15	42	37	0.36	0.38	0.64	0.62	T	1.27	0.000758887	Amyotrophic lateral sclerosis	Brain health and disorders
rs2989476	G	C	19	29	46	14	44	36	0.36	0.38	0.64	0.62	C	1.16	0.000758887	Bipolar disorder	Brain health and disorders
rs2800	C	T	14	45	35	17	34	43	0.39	0.36	0.61	0.64	G	0.61	0.000754489	Non-alcoholic fatty liver disease histology other	Obesity
rs3110496	A	G	16	36	42	14	45	35	0.36	0.39	0.64	0.61	A	0.022	0.000754489	Height	General health
rs12525220	G	A	78	16	0	76	17	1	0.91	0.90	0.09	0.10	A	3.015	0.000754085	Rheumatoid arthritis	Immune diseases and disorders
rs10221833	G	C	78	16	0	75	19	0	0.91	0.90	0.09	0.10	C	1	0.000754085	Response to statin therapy	General health
rs3095008	G	A	13	48	33	13	43	38	0.39	0.37	0.61	0.63	T	1	0.000750323	Adverse response to chemotherapy neutropenia_leucopenia etoposide	Drug response
rs2248551	G	A	62	27	5	64	27	3	0.80	0.82	0.20	0.18	A	4.022	0.000746965	L-arginine levels	General health
rs12120353	C	A	60	31	3	65	25	4	0.80	0.82	0.20	0.18	A	2.13	0.000746965	Anxiety disorder	Brain health and disorders
rs944899	G	A	31	51	12	33	52	9	0.60	0.63	0.40	0.37	A	1.4	0.00074638	Chronic mucus hypersecretion	Immune diseases and disorders
rs7671266	T	C	16	38	40	12	51	31	0.37	0.40	0.63	0.60	T	0.305	0.00074638	Cardiovascular disease risk factors	Heart health and disorders
rs2395730	C	A	15	45	34	14	42	38	0.40	0.37	0.60	0.63	C	0.044	0.00074638	Pulmonary function	Pulmonology
rs7119	C	T	38	41	15	33	46	15	0.62	0.60	0.38	0.40	T	1.24	0.000742655	Type 2 diabetes	Diabetes
rs2429030	T	C	33	46	15	37	43	14	0.60	0.62	0.40	0.38	T	1.05	0.000742655	Schizophrenia	Brain health and disorders
rs2176598	T	C	13	45	36	14	48	32	0.38	0.40	0.62	0.60	T	0.024	0.000742655	Body mass index	Obesity
rs9273373	A	G	15	47	32	12	48	34	0.41	0.38	0.59	0.62	G	1.24	0.000739142	Asthma and hay fever	Immune diseases and disorders
rs12431733	T	C	33	45	16	32	52	10	0.59	0.62	0.41	0.38	T	1.13	0.000739142	Parkinson's disease	Brain health and disorders
rs6917512	C	T	33	45	16	32	52	10	0.59	0.62	0.41	0.38	C	1.0526316	0.000739142	Schizophrenia	Brain health and disorders
rs7781977	C	T	35	46	13	30	51	13	0.62	0.59	0.38	0.41	C	0.1658	0.000739142	IgG glycosylation	Immune diseases and disorders
rs1033023	T	A	31	53	10	28	54	12	0.61	0.59	0.39	0.41	A	1.06	0.000735835	Schizophrenia	Brain health and disorders
rs4631830	T	C	37	41	16	34	42	18	0.61	0.59	0.39	0.41	C	0.12	0.000735835	Prostate-specific antigen levels	Cancer
rs7915137	T	C	34	47	13	31	48	15	0.61	0.59	0.39	0.41	G	0.03	0.000735835	Obesity-related traits	Obesity
rs869244	G	A	33	48	13	31	47	16	0.61	0.58	0.39	0.42	A	1	0.00073273	Platelet aggregation	Heart health and disorders
rs7312625	G	A	15	49	30	11	52	31	0.42	0.39	0.58	0.61	A	3.23	0.00073273	PR interval	Heart health and disorders
rs1020064	T	G	4	30	60	3	28	63	0.20	0.18	0.80	0.82	G	2.94	0.000730994	AIDS	Immune diseases and disorders
rs6908425	T	C	4	30	60	5	24	65	0.20	0.18	0.80	0.82	C	1.21	0.000730994	Crohn's disease	Digestive system and its disorders
rs2252865	T	C	4	26	64	5	28	61	0.18	0.20	0.82	0.80	T	1.03	0.000730994	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs1335645	A	G	63	28	3	58	34	2	0.82	0.80	0.18	0.20	A	4.3	0.000730994	Liver enzyme levels gamma-glutamyl transferase	General health
rs7341475	G	A	60	30	4	64	26	4	0.80	0.82	0.20	0.18	G	1.58	0.000730994	Schizophrenia	Brain health and disorders
rs36109662	A	G	62	30	2	58	34	2	0.82	0.80	0.18	0.20	G	1.0869565	0.000730994	Schizophrenia	Brain health and disorders
rs3923518	C	A	64	26	4	59	32	3	0.82	0.80	0.18	0.20	A	1.06	0.000730994	Migraine	Brain health and disorders
rs10521114	G	A	63	28	3	60	30	4	0.82	0.80	0.18	0.20	A	1	0.000730994	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs12317268	A	G	63	28	3	61	28	5	0.82	0.80	0.18	0.20	A	0.138	0.000730994	Blood metabolite levels	Heart health and disorders
rs798497	A	G	62	26	6	61	32	1	0.80	0.82	0.20	0.18	G	0.06	0.000730994	Height	General health
rs2078087	C	T	62	30	2	57	36	1	0.82	0.80	0.18	0.20	A	0.03	0.000730994	Obesity-related traits	Obesity
rs7968440	A	G	59	32	3	62	30	2	0.80	0.82	0.20	0.18	A	0.006	0.000730994	Fibrinogen	General health
rs2270368	G	A	17	41	36	19	42	33	0.40	0.43	0.60	0.57	G	1.5	0.00072982	Leprosy	Immune diseases and disorders
rs225132	T	G	33	47	14	33	42	19	0.60	0.57	0.40	0.43	G	1.1236	0.00072982	Ischemic stroke	Brain health and disorders
rs6030171	T	C	30	48	16	36	41	17	0.57	0.60	0.43	0.40	C	0.148	0.00072982	IgG glycosylation	Immune diseases and disorders
rs1561288	C	T	31	46	17	37	39	18	0.57	0.60	0.43	0.40	T	0.055	0.00072982	Body mass index	Obesity
rs10207060	T	G	17	46	31	11	53	30	0.43	0.40	0.57	0.60	A	0.04	0.00072982	Obesity-related traits	Obesity
rs7834765	G	T	37	38	19	25	57	12	0.60	0.57	0.40	0.43	T	3.15	0.000727104	Lupus nephritis in systemic lupus erythematosus	Immune diseases and disorders
rs7115578	G	A	34	44	16	32	43	19	0.60	0.57	0.40	0.43	A	1.86	0.000727104	Response to treatment for acute lymphoblastic leukemia	General health
rs2281727	A	G	31	44	19	34	43	17	0.56	0.59	0.44	0.41	G	1.07	0.000724575	Coronary artery disease	Heart health and disorders
rs7841806	C	T	33	40	21	24	63	7	0.56	0.59	0.44	0.41	C	0.086	0.000724575	Urate levels in overweight individuals	Obesity
rs17008402	A	G	34	41	19	29	46	19	0.58	0.55	0.42	0.45	G	1	0.000720067	Subcutaneous adipose tissue	Obesity
rs231735	G	T	20	44	30	17	45	32	0.45	0.42	0.55	0.58	T	1.17	0.000720067	Rheumatoid arthritis	Immune diseases and disorders
rs9936833	C	T	20	44	30	16	47	31	0.45	0.42	0.55	0.58	C	1.14	0.000720067	Barrett's esophagus	Digestive system and its disorders
rs2403083	C	A	18	43	33	21	42	31	0.42	0.45	0.58	0.55	C	0.11	0.000720067	Plasma amyloid beta peptide concentrations ABx-40	Brain health and disorders
rs4351	G	A	19	42	33	15	55	24	0.43	0.45	0.57	0.55	A	1	0.000718081	Metabolite levels	General health
rs2610025	C	A	27	49	18	31	46	17	0.55	0.57	0.45	0.43	A	0.02332	0.000718081	Suicide in bipolar disorder	Brain health and disorders
rs9864370	T	C	77	17	0	76	16	2	0.91	0.89	0.09	0.11	G	2.04	0.000717532	Multiple myeloma hyperdiploidy	Cancer
rs12295638	T	C	74	20	0	77	17	0	0.89	0.91	0.11	0.09	C	1.49	0.000717532	Obesity extreme	Obesity
rs11597068	A	G	78	15	1	74	20	0	0.91	0.89	0.09	0.11	G	1.37	0.000717532	Menopause age at onset	Reproductive health
rs12524865	C	A	26	50	18	32	43	19	0.54	0.57	0.46	0.43	C	1.11	0.000716271	Coronary heart disease	Heart health and disorders
rs12709013	T	C	27	48	19	28	51	15	0.54	0.57	0.46	0.43	T	0.027	0.000716271	Blood metabolite ratios	Heart health and disorders
rs2838088	C	T	62	29	3	56	37	1	0.81	0.79	0.19	0.21	A	4.48	0.000715948	Adverse response to chemotherapy in breast cancer alopecia paclitaxel	General health
rs34102591	A	G	59	31	4	63	27	4	0.79	0.81	0.21	0.19	G	1.0752687	0.000715948	Schizophrenia	Brain health and disorders
rs12671878	C	A	64	25	5	60	29	5	0.81	0.79	0.19	0.21	A	1	0.000715948	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs6947495	A	T	64	25	5	59	31	4	0.81	0.79	0.19	0.21	A	1	0.000715948	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs2256183	A	G	5	25	64	6	27	61	0.19	0.21	0.81	0.79	A	0.04	0.000715948	Height	General health
rs10038113	T	C	30	46	18	24	53	17	0.56	0.54	0.44	0.46	T	1.33	0.000714633	Autism	Brain health and disorders
rs7810727	C	T	28	50	16	26	49	19	0.56	0.54	0.44	0.46	T	1.11	0.000714633	Migraine without aura	Brain health and disorders
rs9636107	A	G	33	40	21	30	41	23	0.56	0.54	0.44	0.46	G	1.0752687	0.000714633	Schizophrenia	Brain health and disorders
rs11690935	G	A	33	35	26	30	46	18	0.54	0.56	0.46	0.44	G	1.0526316	0.000714633	Schizophrenia	Brain health and disorders
rs1365505	C	T	20	42	32	22	43	29	0.44	0.46	0.56	0.54	T	0.025	0.000714633	Blood metabolite ratios	Heart health and disorders
rs7173743	T	C	22	45	27	14	56	24	0.47	0.45	0.53	0.55	C	1.0753	0.000711865	Coronary artery disease	Heart health and disorders
rs10773049	T	C	26	38	30	19	47	28	0.48	0.45	0.52	0.55	C	0.014	0.000710732	Body mass index	Obesity
rs282708	A	G	27	43	24	23	56	15	0.52	0.54	0.48	0.46	A	1	0.000709764	Acute lymphoblastic leukemia childhood	Cancer
rs10041997	G	A	23	45	26	18	50	26	0.48	0.46	0.52	0.54	A	0.138	0.000709764	Body mass index change over time	Obesity
rs12753193	G	A	21	45	28	16	60	18	0.46	0.49	0.54	0.51	G	0.13	0.000708958	Metabolic traits	Misc
rs7911264	T	C	25	43	26	20	48	26	0.49	0.47	0.51	0.53	C	1.066	0.000708316	Inflammatory bowel disease	Immune diseases and disorders
rs11951515	T	C	24	47	23	31	38	25	0.51	0.53	0.49	0.47	C	0.04	0.000708316	Metabolite levels  X-11787	General health
rs2517510	T	G	21	51	22	23	42	29	0.49	0.47	0.51	0.53	T	0.0129	0.000708316	White blood cell count	Immune diseases and disorders
rs871012	G	C	30	39	25	22	50	22	0.53	0.50	0.47	0.50	C	0.1473	0.000707834	IgG glycosylation	Immune diseases and disorders
rs706779	T	C	25	44	25	22	45	27	0.50	0.47	0.50	0.53	A	1.27	0.000707834	Vitiligo	Immune diseases and disorders
rs9574309	T	C	19	51	24	16	62	16	0.47	0.50	0.53	0.50	C	0.1596	0.000707834	IgG glycosylation	Immune diseases and disorders
rs9531686	T	G	20	49	25	22	50	22	0.47	0.50	0.53	0.50	T	0.038	0.000707834	Anorexia nervosa	Brain health and disorders
rs27419	C	T	26	46	22	21	51	22	0.52	0.49	0.48	0.51	C	1.0526316	0.000707514	Schizophrenia	Brain health and disorders
rs2587949	C	G	26	46	22	24	45	25	0.52	0.49	0.48	0.51	G	0.1432	0.000707514	Periodontitis DPAL	Misc
rs7972528	C	T	25	47	22	19	54	21	0.52	0.49	0.48	0.51	T	0.016	0.000707354	Optic cup area	Misc
rs4780355	T	C	23	50	21	21	49	24	0.51	0.48	0.49	0.52	T	1.16	0.000707354	Crohn's disease and psoriasis	Digestive system and its disorders
rs8054347	G	A	21	49	24	23	50	21	0.48	0.51	0.52	0.49	A	1.06	0.000707354	Schizophrenia	Brain health and disorders
rs60241046	G	A	61	30	3	56	36	2	0.81	0.79	0.19	0.21	A	4.48	0.000701754	Diisocyanate-induced asthma	Pulmonology
rs11867934	T	C	6	24	64	3	34	57	0.19	0.21	0.81	0.79	C	1.43	0.000701754	Diabetic retinopathy	Diabetes
rs6686886	G	A	4	28	62	3	34	57	0.19	0.21	0.81	0.79	G	1	0.000701754	Subcutaneous adipose tissue	Obesity
rs2935776	A	G	59	30	5	62	28	4	0.79	0.81	0.21	0.19	C	1	0.000701754	Cerebrospinal T-tau levels	Brain health and disorders
rs6708110	G	C	63	26	5	58	32	4	0.81	0.79	0.19	0.21	G	0.6567	0.000701754	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs7339349	T	C	4	28	62	4	32	58	0.19	0.21	0.81	0.79	T	0.3467	0.000701754	Neurofibrillary tangles	Brain health and disorders
rs17038182	G	C	62	28	4	58	32	4	0.81	0.79	0.19	0.21	C	0.3	0.000701754	Height	General health
rs17001654	C	G	61	26	7	59	34	1	0.79	0.81	0.21	0.19	G	0.032	0.000701754	Body mass index	Obesity
rs16895812	T	C	63	26	5	58	32	4	0.81	0.79	0.19	0.21	G	0.03	0.000701754	Obesity-related traits	Obesity
rs7419134	G	A	88	5	1	85	9	0	0.96	0.95	0.04	0.05	A	4.726	0.000694444	Very long-chain saturated fatty acid levels fatty acid 22:0	General health
rs3131296	C	T	88	5	1	85	9	0	0.96	0.95	0.04	0.05	G	1.19	0.000694444	Schizophrenia	Brain health and disorders
rs72817562	G	T	85	9	0	87	7	0	0.95	0.96	0.05	0.04	T	0.035	0.000694444	Neuroticism	Brain health and disorders
rs1442407	G	T	62	23	9	60	31	3	0.78	0.80	0.22	0.20	T	1.98	0.00068835	Systolic blood pressure in sickle cell anemia	Heart health and disorders
rs3197999	G	A	60	31	3	56	35	3	0.80	0.78	0.20	0.22	A	1.22	0.00068835	Crohn's disease	Digestive system and its disorders
rs9858542	G	A	60	31	3	56	35	3	0.80	0.78	0.20	0.22	A	1.09	0.00068835	Crohn's disease	Digestive system and its disorders
rs17120471	T	C	57	33	4	61	29	4	0.78	0.80	0.22	0.20	C	0.2366	0.00068835	IgG glycosylation	Immune diseases and disorders
rs9858213	G	T	60	31	3	56	35	3	0.80	0.78	0.20	0.22	T	0.028	0.00068835	Educational attainment	Mental aptitude and behavioural traits
rs7765379	T	G	76	18	0	74	19	1	0.90	0.89	0.10	0.11	A	4.55	0.000684775	Enteric fever	Immune diseases and disorders
rs11044737	G	A	76	15	3	76	18	0	0.89	0.90	0.11	0.10	G	0.112	0.000684775	Lifetime average cigarettes per day in chronic obstructive pulmonary disease	General health
rs12899618	G	A	77	16	1	73	21	0	0.90	0.89	0.10	0.11	G	0.06	0.000684775	Pulmonary function	Pulmonology
rs7764819	T	G	76	18	0	74	19	1	0.90	0.89	0.10	0.11	T	0.001	0.000684775	Pulmonary function interaction	Pulmonology
rs7219585	A	G	1	16	77	1	19	74	0.10	0.11	0.90	0.89	A	0.2	0.000684775	Information processing speed	Mental aptitude and behavioural traits
rs13401811	G	A	58	30	6	61	28	5	0.78	0.80	0.22	0.20	G	1.41	0.000675676	Chronic lymphocytic leukemia	Cancer
rs2324999	C	T	57	36	1	60	26	8	0.80	0.78	0.20	0.22	T	1	0.000675676	Subcutaneous adipose tissue	Obesity
rs6557600	A	G	56	34	4	60	30	4	0.78	0.80	0.22	0.20	A	0.13	0.000675676	Preschool internalizing problems	Mental aptitude and behavioural traits
rs10480300	C	T	60	30	4	56	34	4	0.80	0.78	0.20	0.22	T	0.035	0.000675676	Urate levels	General health
rs10762058	C	G	5	28	61	6	30	58	0.20	0.22	0.80	0.78	G	5	0.000675676	Asthma toluene diisocyanate-induced	Immune diseases and disorders
rs10745332	G	A	2	35	57	3	37	54	0.21	0.23	0.79	0.77	A	0.96	0.00066368	Systolic blood pressure	Heart health and disorders
rs12068654	T	G	63	23	8	56	33	5	0.79	0.77	0.21	0.23	T	3.23	0.00066368	Cervical cancer	Cancer
rs11079757	G	A	59	31	4	54	37	3	0.79	0.77	0.21	0.23	A	2.2	0.00066368	Erythema nodosum in inflammatory bowel disease	Digestive system and its disorders
rs9868898	A	G	60	29	5	58	29	7	0.79	0.77	0.21	0.23	G	1.49	0.00066368	Crohn's disease-related phenotypes	Digestive system and its disorders
rs2358462	T	C	53	39	2	58	33	3	0.77	0.79	0.23	0.21	G	0.6	0.00066368	Non-alcoholic fatty liver disease histology other	Obesity
rs2919009	C	T	59	30	5	53	38	3	0.79	0.77	0.21	0.23	A	0.04	0.000652316	Obesity-related traits	Obesity
rs7493	G	C	59	29	6	54	35	5	0.78	0.76	0.22	0.24	C	1.06	0.00064154	Yu-Zhi constitution type in type 2 diabetes	Diabetes
rs11935103	C	T	54	35	5	58	31	5	0.76	0.78	0.24	0.22	T	1	0.00064154	Response to citalopram treatment	General health
rs756199	A	G	54	35	5	57	33	4	0.76	0.78	0.24	0.22	G	0.05	0.00064154	Height	General health
rs4963124	G	C	4	33	57	4	37	53	0.22	0.24	0.78	0.76	C	1.71	0.00064154	Proteinuria and chronic kidney disease	General health
rs11200638	G	A	53	36	5	54	38	2	0.76	0.78	0.24	0.22	A	1.6	0.000631313	Age-related macular degeneration wet	Aging
rs1949200	A	T	55	32	7	55	36	3	0.76	0.78	0.24	0.22	T	0.18	0.000631313	Sleep quality	General health
rs962993	C	T	52	38	4	58	30	6	0.76	0.78	0.24	0.22	T	0.0707	0.000631313	Self-reported allergy	General health
rs2065415	A	G	1	18	75	2	19	73	0.11	0.12	0.89	0.88	G	12.913	0.000628536	Warfarin maintenance dose	General health
rs12155172	A	G	0	23	71	2	16	76	0.12	0.11	0.88	0.89	A	1.11	0.000628536	Prostate cancer	Cancer
rs6894385	A	C	71	23	0	75	18	1	0.88	0.89	0.12	0.11	C	9.92	0.000628536	QT interval	Heart health and disorders
rs12134279	C	T	72	21	1	74	20	0	0.88	0.89	0.12	0.11	T	1.34	0.000628536	Primary biliary cirrhosis	Immune diseases and disorders
rs17420782	A	G	71	23	0	74	20	0	0.88	0.89	0.12	0.11	G	0.55	0.000628536	Anxiety in major depressive disorder	Brain health and disorders
rs111426949	C	T	74	20	0	74	17	3	0.89	0.88	0.11	0.12	T	0.2871	0.000628536	Metabolite levels HVA_MHPG ratio	Brain health and disorders
rs12127679	C	T	58	29	7	54	33	7	0.77	0.75	0.23	0.25	T	22.31	0.000621601	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs55847827	A	G	55	35	4	51	39	4	0.77	0.75	0.23	0.25	G	1.8	0.000621601	Proteinuria in chronic kidney disease	General health
rs2274223	A	G	52	37	5	56	33	5	0.75	0.77	0.25	0.23	G	1.34	0.000621601	Esophageal cancer	Cancer
rs10499194	C	T	53	35	6	59	27	8	0.75	0.77	0.25	0.23	C	1.33	0.000621601	Rheumatoid arthritis	Immune diseases and disorders
rs13192841	G	A	53	35	6	59	27	8	0.75	0.77	0.25	0.23	A	1.1	0.000621601	Multiple sclerosis	Brain health and disorders
rs11711311	T	G	56	33	5	54	33	7	0.77	0.75	0.23	0.25	G	0.1632	0.000621601	IgG glycosylation	Immune diseases and disorders
rs821840	A	G	56	33	5	52	37	5	0.77	0.75	0.23	0.25	A	0.045	0.000621601	Triglycerides	General health
rs13358864	T	A	84	10	0	86	8	0	0.95	0.96	0.05	0.04	A	24.09	0.000620732	Uric acid levels	General health
rs71568191	G	A	84	10	0	86	8	0	0.95	0.96	0.05	0.04	A	8.9	0.000620732	Epilepsy and lamotrigine-induced maculopapular eruptions	Brain health and disorders
rs1970525	C	G	85	8	1	87	6	1	0.95	0.96	0.05	0.04	G	2.89	0.000620732	Periodontal microbiota	Misc
rs11988997	C	T	84	10	0	86	8	0	0.95	0.96	0.05	0.04	T	1.359	0.000620732	Pancreatitis	General health
rs6021270	T	C	84	10	0	87	6	1	0.95	0.96	0.05	0.04	C	0.1517	0.000620732	Self-reported allergy	General health
rs2066807	C	G	84	10	0	86	8	0	0.95	0.96	0.05	0.04	C	0.054	0.000620732	Height	General health
rs6508673	C	T	86	8	0	84	10	0	0.96	0.95	0.04	0.05	A	0.04	0.000620732	Obesity-related traits	Obesity
rs10740455	A	T	1	6	87	0	10	84	0.04	0.05	0.96	0.95	A	1	0.000620732	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs2252586	C	T	55	34	5	53	34	7	0.77	0.74	0.23	0.26	T	1.18	0.00061237	Glioma	Cancer
rs13256369	T	C	57	30	7	48	44	2	0.77	0.74	0.23	0.26	G	0.03	0.00061237	Obesity-related traits	Obesity
rs4862046	A	G	2	20	72	1	19	74	0.13	0.11	0.87	0.89	G	0.2767	0.00060423	IgG glycosylation	Immune diseases and disorders
rs2304003	T	C	4	16	74	0	21	73	0.13	0.11	0.87	0.89	T	0.14	0.00060423	Social communication problems	Brain health and disorders
rs67900830	T	A	74	19	1	71	22	1	0.89	0.87	0.11	0.13	A	1.4705882	0.00060423	Schizophrenia	Brain health and disorders
rs12153855	T	C	73	21	0	71	22	1	0.89	0.87	0.11	0.13	C	1.44	0.00060423	Age-related macular degeneration	Aging
rs2332267	C	T	72	20	2	73	21	0	0.87	0.89	0.13	0.11	T	0.42	0.00060423	Coronary artery calcification	Heart health and disorders
rs1476587	A	G	75	17	2	71	22	1	0.89	0.87	0.11	0.13	G	0.283	0.00060423	Brachial circumference	Pulmonology
rs71327718	C	G	71	22	1	73	21	0	0.87	0.89	0.13	0.11	G	0.2152	0.00060423	Metabolite levels HVA_5-HIAA ratio	Brain health and disorders
rs10467147	G	A	51	37	6	53	37	4	0.74	0.76	0.26	0.24	A	0.03	0.000603591	Obesity-related traits	Obesity
rs10204325	C	T	53	36	5	50	38	6	0.76	0.73	0.24	0.27	T	0.134	0.000595238	Economic and political preferences fairness	Mental aptitude and behavioural traits
rs8023580	T	C	50	38	6	53	36	5	0.73	0.76	0.27	0.24	T	0.038	0.000595238	Sex hormone-binding globulin levels	Reproductive health
rs1719271	A	G	54	33	7	52	33	9	0.75	0.73	0.25	0.27	G	3.414	0.000587285	Platelet count	Heart health and disorders
rs10086908	T	C	48	41	5	53	35	6	0.73	0.75	0.27	0.25	T	1.17	0.000587285	Prostate cancer	Cancer
rs12570744	C	T	51	35	8	51	39	4	0.73	0.75	0.27	0.25	T	0.49	0.000587285	Response to anti-TNF treatment in rheumatoid arthritis	General health
rs4460308	T	C	51	35	8	51	39	4	0.73	0.75	0.27	0.25	C	0.11	0.000587285	Social communication problems	Brain health and disorders
rs11800820	C	T	52	33	9	50	41	3	0.73	0.75	0.27	0.25	A	0.03	0.000587285	Obesity-related traits	Obesity
rs9263739	C	T	70	23	1	73	20	1	0.87	0.88	0.13	0.12	T	2.73	0.000582035	Ulcerative colitis	Immune diseases and disorders
rs11679640	C	G	70	23	1	74	18	2	0.87	0.88	0.13	0.12	C	1	0.000582035	White matter hyperintensity burden	Brain health and disorders
rs6563353	C	T	70	23	1	73	20	1	0.87	0.88	0.13	0.12	A	1	0.000582035	Response to citalopram treatment	General health
rs12144715	A	T	74	18	2	70	23	1	0.88	0.87	0.12	0.13	T	0.636	0.000582035	Response to hepatitis C treatment	General health
rs34073438	G	A	70	23	1	73	20	1	0.87	0.88	0.13	0.12	A	0.0401	0.000582035	Heschl's gyrus morphology	Brain health and disorders
rs8076220	T	C	75	16	3	70	23	1	0.88	0.87	0.12	0.13	G	0.04	0.000582035	Obesity-related traits	Obesity
rs7587026	C	A	55	30	9	50	36	8	0.74	0.72	0.26	0.28	A	1.42	0.00057971	Mesial temporal lobe epilepsy with hippocampal sclerosis	Brain health and disorders
rs59586681	A	T	51	34	9	53	34	7	0.72	0.74	0.28	0.26	T	1.16	0.00057971	Basal cell carcinoma	Cancer
rs2843012	G	A	51	38	5	47	42	5	0.74	0.72	0.26	0.28	A	0.218	0.00057971	Metabolite levels 5-HIAA	General health
rs2234978	T	C	7	35	52	6	41	47	0.26	0.28	0.74	0.72	A	1.32	0.000572492	Immunoglobulin A	Immune diseases and disorders
rs8093481	A	G	48	43	3	45	45	4	0.74	0.72	0.26	0.28	A	1.79	0.000572492	Yu-Zhi constitution type in type 2 diabetes	Diabetes
rs731565	G	A	52	35	7	47	41	6	0.74	0.72	0.26	0.28	T	1.58	0.000572492	Diabetic kidney disease	Diabetes
rs7134599	G	A	51	37	6	47	41	6	0.74	0.72	0.26	0.28	A	1.19	0.000572492	Ulcerative colitis	Immune diseases and disorders
rs7181230	A	G	52	35	7	47	41	6	0.74	0.72	0.26	0.28	G	0.05	0.000572492	Dehydroepiandrosterone sulphate levels	Immune diseases and disorders
rs889956	G	A	49	36	9	49	40	5	0.71	0.73	0.29	0.27	A	0.023	0.000565611	Educational attainment	Mental aptitude and behavioural traits
rs2517713	G	T	8	34	52	12	30	52	0.27	0.29	0.73	0.71	A	1.88	0.000565611	Nasopharyngeal carcinoma	Cancer
rs10515808	C	A	83	11	0	85	9	0	0.94	0.95	0.06	0.05	A	3.08	0.000561798	Weight loss gastric bypass surgery	Obesity
rs11218343	T	C	85	9	0	83	11	0	0.95	0.94	0.05	0.06	T	1.3	0.000561798	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs2501276	C	T	84	9	1	85	9	0	0.94	0.95	0.06	0.05	A	1	0.000561798	Immune response to smallpox vaccine IL-6	Immune diseases and disorders
rs114067101	A	G	86	5	3	85	9	0	0.94	0.95	0.06	0.05	G	0.102	0.000561798	Cholesterol, total	General health
rs9270986	A	C	3	20	71	2	19	73	0.14	0.12	0.86	0.88	A	1.43	0.000561693	Myasthenia gravis	Brain health and disorders
rs864265	T	G	2	22	70	0	23	71	0.14	0.12	0.86	0.88	G	0.13	0.000561693	Adiponectin levels	Obesity
rs2904090	T	C	72	18	4	71	23	0	0.86	0.88	0.14	0.12	C	2.22	0.000561693	Mammographic density	Reproductive health
rs12604324	G	A	69	24	1	74	17	3	0.86	0.88	0.14	0.12	A	1.8953	0.000561693	Dementia and core Alzheimer's disease neuropathologic changes	Brain health and disorders
rs3130284	T	C	71	23	0	70	22	2	0.88	0.86	0.12	0.14	C	1.464	0.000561693	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Immune diseases and disorders
rs1482292	C	A	71	23	0	68	26	0	0.88	0.86	0.12	0.14	C	1.0869565	0.000561693	Schizophrenia	Brain health and disorders
rs4570936	C	T	72	21	1	69	24	1	0.88	0.86	0.12	0.14	T	0.05	0.000561693	Serum thyroid-stimulating hormone levels	General health
rs2325694	G	A	69	24	1	73	19	2	0.86	0.88	0.14	0.12	A	0.0056	0.000561693	Trans fatty acid levels	General health
rs13103223	T	C	71	23	0	71	20	3	0.88	0.86	0.12	0.14	T	0.0023	0.000561693	Trans fatty acid levels	General health
rs10014313	T	C	71	23	0	71	20	3	0.88	0.86	0.12	0.14	T	0.0023	0.000561693	Trans fatty acid levels	General health
rs6821057	C	G	71	23	0	71	20	3	0.88	0.86	0.12	0.14	C	0.0023	0.000561693	Trans fatty acid levels	General health
rs9863706	C	T	48	37	9	46	45	3	0.71	0.73	0.29	0.27	T	0.031	0.00055905	Height	General health
rs11254363	A	G	47	38	9	49	38	7	0.70	0.72	0.30	0.28	A	21.49	0.000552792	Folate pathway vitamin levels	General health
rs1074683	C	G	45	42	7	48	40	6	0.70	0.72	0.30	0.28	C	1.21	0.000552792	Height	General health
rs11118883	G	A	50	36	8	46	40	8	0.72	0.70	0.28	0.30	A	1.12	0.000552792	Colorectal cancer	Cancer
rs1861960	T	G	5	46	43	11	30	53	0.30	0.28	0.70	0.72	T	1.07	0.000552792	Migraine	Brain health and disorders
rs4699982	A	T	50	32	12	45	46	3	0.70	0.72	0.30	0.28	T	0.1943	0.000552792	IgG glycosylation	Immune diseases and disorders
rs7141336	A	G	48	40	6	41	50	3	0.72	0.70	0.28	0.30	C	0.19	0.000552792	Anxiety disorder	Brain health and disorders
rs7829127	A	G	50	32	12	50	36	8	0.70	0.72	0.30	0.28	G	0.116	0.000552792	Refractive error	General health
rs7385804	C	A	9	34	51	13	30	51	0.28	0.30	0.72	0.70	A	0.054	0.000552792	Iron status biomarkers transferrin saturation	General health
rs9659323	A	G	45	42	7	50	36	8	0.70	0.72	0.30	0.28	A	0.02	0.000552792	Body mass index	Obesity
rs3781426	C	T	46	44	4	45	42	7	0.72	0.70	0.28	0.30	T	0.019	0.000552792	Height	General health
rs39861	A	G	48	39	7	46	39	9	0.72	0.70	0.28	0.30	C	1.26	0.000546822	Epilepsy generalized	Brain health and disorders
rs3743266	T	C	48	35	11	50	35	9	0.70	0.72	0.30	0.28	T	0.04	0.000546822	Menarche age at onset	Reproductive health
rs17410962	G	A	71	22	1	69	23	2	0.87	0.86	0.13	0.14	G	0.1064	0.000542986	Triglycerides	General health
rs10502431	G	C	68	25	1	71	22	1	0.86	0.87	0.14	0.13	C	0.087	0.000542986	Urate levels in overweight individuals	Obesity
rs3771317	T	C	44	42	8	48	38	8	0.69	0.71	0.31	0.29	C	1.4084507	0.000541126	Primary biliary cirrhosis	Immune diseases and disorders
rs10086568	G	A	45	44	5	45	40	9	0.71	0.69	0.29	0.31	A	1.16	0.000541126	IgA nephropathy	Immune diseases and disorders
rs2077224	C	A	45	40	9	47	40	7	0.69	0.71	0.31	0.29	A	1	0.000541126	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs164133	G	C	45	40	9	48	38	8	0.69	0.71	0.31	0.29	C	0.72	0.000541126	QT interval	Heart health and disorders
rs3811647	G	A	42	46	6	47	40	7	0.69	0.71	0.31	0.29	A	0.358	0.000541126	Alcohol consumption transferrin glycosylation	General health
rs11651708	T	A	48	38	8	45	40	9	0.71	0.69	0.29	0.31	A	0.16	0.000541126	Coronary artery calcification	Heart health and disorders
rs7120	G	A	44	42	8	46	42	6	0.69	0.71	0.31	0.29	A	0.03	0.000541126	Obesity-related traits	Obesity
rs925735	C	G	8	42	44	10	34	50	0.31	0.29	0.69	0.71	G	0.02	0.000541126	Adiponectin levels	Obesity
rs74346392	T	C	91	3	0	92	2	0	0.98	0.99	0.02	0.01	G	7.7	0.000539084	Diisocyanate-induced asthma	Pulmonology
rs111646341	A	G	91	3	0	92	2	0	0.98	0.99	0.02	0.01	A	5.8	0.000539084	Emphysema imaging phenotypes	Pulmonology
rs13237474	C	T	91	3	0	92	2	0	0.98	0.99	0.02	0.01	T	3.05	0.000539084	Periodontitis CDC_AAP	Misc
rs117626015	T	C	92	2	0	91	3	0	0.99	0.98	0.01	0.02	C	2.43	0.000539084	Pneumoconiosis in silica exposure	Pulmonology
rs13070584	C	T	91	3	0	92	2	0	0.98	0.99	0.02	0.01	T	1.42	0.000539084	Chronic kidney disease and serum creatinine levels	Immune diseases and disorders
rs76456399	C	A	91	3	0	92	2	0	0.98	0.99	0.02	0.01	A	1.2	0.000539084	Schizophrenia	Brain health and disorders
rs16882396	C	G	91	3	0	92	2	0	0.98	0.99	0.02	0.01	C	1.1568	0.000539084	Smooth-surface caries	Appearance
rs17036101	G	A	92	2	0	91	3	0	0.99	0.98	0.01	0.02	G	1.15	0.000539084	Type 2 diabetes	Diabetes
rs2021783	C	T	91	3	0	92	2	0	0.98	0.99	0.02	0.01	C	0.68	0.000539084	Systolic blood pressure	Heart health and disorders
rs148982377	T	C	91	3	0	93	0	1	0.98	0.99	0.02	0.01	C	0.331	0.000539084	Sex hormone levels	Reproductive health
rs16844841	A	C	91	3	0	92	2	0	0.98	0.99	0.02	0.01	C	0.3163	0.000539084	IgG glycosylation	Immune diseases and disorders
rs16844846	T	G	91	3	0	92	2	0	0.98	0.99	0.02	0.01	G	0.3154	0.000539084	IgG glycosylation	Immune diseases and disorders
rs2070600	C	T	92	2	0	91	3	0	0.99	0.98	0.01	0.02	T	0.23	0.000539084	Percentage gas trapping	Misc
rs61862032	T	C	91	3	0	92	2	0	0.98	0.99	0.02	0.01	T	0.1957	0.000539084	Periodontitis Mean PAL	Misc
rs13204086	C	T	91	3	0	92	2	0	0.98	0.99	0.02	0.01	T	0.1616	0.000539084	Periodontitis Mean PAL	Misc
rs11754509	A	G	91	3	0	93	0	1	0.98	0.99	0.02	0.01	G	0.03	0.000539084	Obesity-related traits	Obesity
rs1379326	T	C	45	43	6	45	39	10	0.71	0.69	0.29	0.31	C	1.78	0.00053569	Interstitial lung disease	Pulmonology
rs7909791	C	A	47	39	8	46	37	11	0.71	0.69	0.29	0.31	A	1	0.00053569	White matter hyperintensity burden	Brain health and disorders
rs10849441	A	G	45	39	10	40	53	1	0.69	0.71	0.31	0.29	G	0.03	0.00053569	Obesity-related traits	Obesity
rs5768709	A	G	42	48	4	41	46	7	0.70	0.68	0.30	0.32	G	1.25	0.000530504	Pancreatic cancer	Cancer
rs7608910	A	G	42	44	8	46	40	8	0.68	0.70	0.32	0.30	G	1.1281834	0.000530504	Crohn's disease	Digestive system and its disorders
rs1566080	A	C	11	38	45	10	36	48	0.32	0.30	0.68	0.70	A	0.03	0.000530504	Obesity-related traits	Obesity
rs4338740	T	C	68	24	2	71	21	2	0.85	0.87	0.15	0.13	T	0.067	0.000525732	Thyroid volume	General health
rs4869908	G	A	43	45	6	40	47	7	0.70	0.68	0.30	0.32	G	2.5	0.000525555	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs778371	A	G	44	43	7	49	29	16	0.70	0.68	0.30	0.32	G	1.09	0.000525555	Schizophrenia	Brain health and disorders
rs1644305	G	A	46	35	13	45	41	8	0.68	0.70	0.32	0.30	A	1	0.000525555	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs1026364	G	T	45	41	8	41	45	8	0.70	0.68	0.30	0.32	T	0.03	0.000525555	Bone mineral density	General health
rs11633886	G	T	42	42	10	46	38	10	0.67	0.69	0.33	0.31	C	2.24	0.000520833	Diisocyanate-induced asthma	Pulmonology
rs8066985	A	G	11	37	46	7	49	38	0.31	0.34	0.69	0.66	A	0.0266	0.000516329	Waist-to-hip ratio adjusted for body mass index	Obesity
rs672203	A	G	43	43	8	44	37	13	0.69	0.66	0.31	0.34	A	5.33	0.000516329	Adverse response to chemotherapy in breast cancer alopecia cyclophosphamide+doxorubicin+_-5FU	Drug response
rs12615435	T	G	82	12	0	85	8	1	0.94	0.95	0.06	0.05	T	2.214	0.000513611	Adverse response to chemotherapy neutropenia_leucopenia all anthracycline-based drugs	Drug response
rs11175593	C	T	82	12	0	84	10	0	0.94	0.95	0.06	0.05	T	1.54	0.000513611	Crohn's disease	Digestive system and its disorders
rs13385731	T	C	83	10	1	84	10	0	0.94	0.95	0.06	0.05	A	1.43	0.000513611	Systemic lupus erythematosus	Immune diseases and disorders
rs1659258	A	G	84	10	0	82	12	0	0.95	0.94	0.05	0.06	A	1	0.000513611	Visceral fat	Obesity
rs2279434	C	T	85	8	1	82	12	0	0.95	0.94	0.05	0.06	T	0.128	0.000513611	Mean corpuscular hemoglobin	Heart health and disorders
rs10097731	G	T	83	10	1	84	10	0	0.94	0.95	0.06	0.05	T	0.025	0.000513611	Serum total protein level	General health
rs7128311	C	T	0	10	84	0	12	82	0.05	0.06	0.95	0.94	C	13.9	0.000513611	Response to treatment for acute lymphoblastic leukemia	General health
rs1820616	T	C	1	8	85	1	10	83	0.05	0.06	0.95	0.94	T	0.113	0.000513611	Fractional exhaled nitric oxide childhood	Pulmonology
rs27434	A	G	12	36	46	8	48	38	0.32	0.34	0.68	0.66	A	1.19	0.000512033	Ankylosing spondylitis	Immune diseases and disorders
rs9990333	C	T	44	36	14	44	40	10	0.66	0.68	0.34	0.32	T	0.039	0.000512033	Iron status biomarkers transferrin saturation	General health
rs1016988	T	C	72	18	4	68	23	3	0.86	0.85	0.14	0.15	G	6.84	0.000509771	Fibrinogen	General health
rs12801636	G	A	41	41	12	43	41	10	0.65	0.68	0.35	0.32	A	0.024	0.000507937	HDL cholesterol	General health
rs1044873	C	T	40	46	8	39	44	11	0.67	0.65	0.33	0.35	C	1.29	0.000504032	Chronic lymphocytic leukemia	Cancer
rs987052	T	C	45	36	13	41	40	13	0.67	0.65	0.33	0.35	G	0.03	0.000504032	Obesity-related traits	Obesity
rs4234798	T	G	10	42	42	12	42	40	0.33	0.35	0.67	0.65	T	1	0.000504032	Insulin-like growth factors	General health
rs12212674	T	A	40	41	13	39	47	8	0.64	0.66	0.36	0.34	A	1.099	0.000500313	Refractive astigmatism	General health
rs8177179	G	A	14	39	41	10	43	41	0.36	0.34	0.64	0.66	A	0.154	0.000500313	Iron status biomarkers transferrin levels	General health
rs200810	T	C	40	45	9	40	41	13	0.66	0.64	0.34	0.36	T	0.014	0.000500313	Body mass index	Obesity
rs2270221	C	T	42	40	12	36	48	10	0.66	0.64	0.34	0.36	A	1.2	0.000496771	Endometriosis	General health
rs4444235	T	C	35	50	9	40	44	10	0.64	0.66	0.36	0.34	C	1.11	0.000496771	Colorectal cancer	Cancer
rs4607103	C	T	41	42	11	38	44	12	0.66	0.64	0.34	0.36	C	1.09	0.000496771	Type 2 diabetes	Diabetes
rs1941342	A	T	38	44	12	43	38	13	0.64	0.66	0.36	0.34	A	1.06	0.000496771	Schizophrenia	Brain health and disorders
rs11255400	G	A	68	25	1	67	24	3	0.86	0.84	0.14	0.16	G	0.2863	0.000494968	IgG glycosylation	Immune diseases and disorders
rs10189629	C	A	64	30	0	72	17	5	0.84	0.86	0.16	0.14	A	0.1448	0.000494968	Self-reported allergy	General health
rs10882165	A	T	39	41	14	37	49	8	0.63	0.65	0.37	0.35	T	0.107	0.000493401	Refractive error	General health
rs12913538	G	A	42	37	15	33	51	10	0.64	0.62	0.36	0.38	A	0.1	0.000487151	Sleep depth	General health
rs6689306	A	G	13	46	35	9	50	35	0.38	0.36	0.62	0.64	A	1.06	0.000484262	Coronary artery disease	Heart health and disorders
rs7209700	A	G	34	52	8	32	52	10	0.64	0.62	0.36	0.38	G	0.1681	0.000484262	IgG glycosylation	Immune diseases and disorders
rs9507983	T	C	39	38	17	36	48	10	0.62	0.64	0.38	0.36	C	0.02	0.000484262	Body mass index	Obesity
rs2270450	C	T	39	37	18	36	47	11	0.61	0.63	0.39	0.37	T	1.75	0.000481522	Hashimoto thyroiditis versus Graves' disease	Immune diseases and disorders
rs4771859	T	C	15	43	36	12	45	37	0.39	0.37	0.61	0.63	G	1.328	0.000481522	Adverse response to chemotherapy neutropenia_leucopenia all antimicrotubule drugs	Drug response
rs2527866	C	A	35	49	10	37	41	16	0.63	0.61	0.37	0.39	C	0.27	0.000481522	Quantitative traits	Misc
rs4917017	G	A	35	45	14	34	51	9	0.61	0.63	0.39	0.37	G	0.1974	0.000481522	IgG glycosylation	Immune diseases and disorders
rs4765219	C	A	43	33	18	33	49	12	0.63	0.61	0.37	0.39	C	0.0366	0.000481522	Waist-to-hip ratio adjusted for body mass index	Obesity
rs963167	A	G	3	25	66	5	18	71	0.16	0.15	0.84	0.85	C	0.65	0.000481206	&beta;2-Glycoprotein I &beta;2-GPI plasma levels	Immune diseases and disorders
rs4846923	T	G	1	29	64	2	24	68	0.16	0.15	0.84	0.85	G	0.055	0.000481206	HDL cholesterol	General health
rs11766624	A	G	70	20	4	65	27	2	0.85	0.84	0.15	0.16	G	0.04	0.000481206	Obesity-related traits	Obesity
rs59043219	G	A	34	46	14	37	44	13	0.61	0.63	0.39	0.37	A	1.19	0.000478927	Alzheimer's disease APOE e4 interaction	Brain health and disorders
rs76886731	A	T	34	48	12	33	46	15	0.62	0.60	0.38	0.40	T	1.24	0.000474158	Leprosy	Immune diseases and disorders
rs2919856	A	T	34	44	16	33	50	11	0.60	0.62	0.40	0.38	T	0.1475	0.000474158	IgG glycosylation	Immune diseases and disorders
rs11727767	A	G	13	46	35	18	40	36	0.38	0.40	0.62	0.60	A	0.03	0.000474158	Obesity-related traits	Obesity
rs4418214	T	C	81	13	0	83	11	0	0.93	0.94	0.07	0.06	C	4.4	0.000473485	HIV-1 control	Immune diseases and disorders
rs17004598	T	G	82	11	1	83	11	0	0.93	0.94	0.07	0.06	C	2.57	0.000473485	Eosinophilic esophagitis	Digestive system and its disorders
rs7705924	A	G	84	9	1	81	13	0	0.94	0.93	0.06	0.07	G	1.48	0.000473485	Crohn's disease	Digestive system and its disorders
rs1894116	A	G	83	11	0	81	13	0	0.94	0.93	0.06	0.07	G	1.27	0.000473485	Polycystic ovary syndrome	Reproductive health
rs1572312	G	T	81	13	0	83	11	0	0.93	0.94	0.07	0.06	C	1	0.000473485	Maximal oxygen uptake response	Pulmonology
rs41418949	C	T	84	9	1	82	11	1	0.94	0.93	0.06	0.07	T	0.358	0.000473485	Economic and political preferences time	Mental aptitude and behavioural traits
rs1113932	T	C	82	11	1	83	11	0	0.93	0.94	0.07	0.06	G	0.2881	0.000473485	Hemoglobin A2 levels in sickle cell anemia	Heart health and disorders
rs9486594	T	C	81	13	0	84	9	1	0.93	0.94	0.07	0.06	T	0.058	0.000473485	Airway responsiveness in chronic obstructive pulmonary disease	Pulmonology
rs1604805	T	C	82	11	1	83	11	0	0.93	0.94	0.07	0.06	G	0.02	0.000473485	Obesity-related traits	Obesity
rs62229266	A	T	39	37	18	28	55	11	0.61	0.59	0.39	0.41	T	1.22	0.000471976	Mitral valve prolapse	Heart health and disorders
rs6878284	C	T	15	47	32	14	45	35	0.41	0.39	0.59	0.61	C	1.09	0.000471976	Schizophrenia	Brain health and disorders
rs11067278	G	C	31	49	14	33	49	12	0.59	0.61	0.41	0.39	C	0.085	0.000471976	Urate levels in overweight individuals	Obesity
rs8005845	C	T	15	48	31	15	44	35	0.41	0.39	0.59	0.61	T	0.047	0.000469925	Body mass index	Obesity
rs9289301	G	C	68	23	3	66	24	4	0.85	0.83	0.15	0.17	C	0.031	0.000468384	Educational attainment	Mental aptitude and behavioural traits
rs7641175	G	A	5	22	67	2	25	67	0.17	0.15	0.83	0.85	A	2.757	0.000468384	Platelet count	Heart health and disorders
rs10769908	C	T	18	43	33	18	39	37	0.42	0.40	0.58	0.60	C	1	0.000468	Body mass index	Obesity
rs6598163	G	A	30	52	12	29	50	15	0.60	0.57	0.40	0.43	G	1.15	0.0004662	Migraine	Brain health and disorders
rs8001976	C	T	28	52	14	34	44	16	0.57	0.60	0.43	0.40	T	1.09	0.0004662	Aging time to event	Aging
rs7694661	C	A	29	50	15	35	42	17	0.57	0.60	0.43	0.40	A	0.04	0.0004662	Obesity-related traits	Obesity
rs11599750	C	T	32	48	14	31	46	17	0.60	0.57	0.40	0.43	T	0.028	0.0004662	Height	General health
rs2524079	G	A	34	44	16	33	42	19	0.60	0.57	0.40	0.43	A	0.0148	0.0004662	White blood cell count	Immune diseases and disorders
rs1573535	A	T	20	41	33	18	41	35	0.43	0.41	0.57	0.59	A	0.026	0.000464522	Cannabis use initiation	General health
rs224090	T	C	17	44	33	16	50	28	0.41	0.44	0.59	0.56	A	1.1376477	0.000462963	Crohn's disease	Digestive system and its disorders
rs13043330	T	C	18	47	29	17	45	32	0.44	0.42	0.56	0.58	C	1	0.000461521	Visceral adipose tissue adjusted for BMI	Obesity
rs7953704	A	G	18	43	33	17	49	28	0.42	0.44	0.58	0.56	A	0.029	0.000461521	Urate levels	General health
rs236586	A	G	35	39	20	22	61	11	0.58	0.56	0.42	0.44	G	0.64	0.000461521	QT interval	Heart health and disorders
rs9926296	A	G	21	42	31	17	46	31	0.45	0.43	0.55	0.57	A	1.27	0.000460193	Vitiligo	Immune diseases and disorders
rs13010713	A	G	20	44	30	12	56	26	0.45	0.43	0.55	0.57	G	1.13	0.000460193	Celiac disease	Immune diseases and disorders
rs1292011	A	G	31	46	17	25	54	15	0.57	0.55	0.43	0.45	A	1.09	0.000460193	Breast cancer	Cancer
rs2917569	T	C	17	46	31	14	56	24	0.43	0.45	0.57	0.55	T	1.06	0.000460193	Schizophrenia	Brain health and disorders
rs2712381	A	C	18	48	28	13	54	27	0.45	0.43	0.55	0.57	A	0.23	0.000460193	Monocyte count	Immune diseases and disorders
rs4604732	C	T	15	50	29	14	56	24	0.43	0.45	0.57	0.55	T	0.08	0.000460193	Plasma omega-6 polyunsaturated fatty acid levels dihomo-gamma-linolenic acid	General health
rs1913517	A	G	18	49	27	20	41	33	0.45	0.43	0.55	0.57	A	1.24	0.000458979	Systemic lupus erythematosus	Immune diseases and disorders
rs10979	G	A	16	49	29	18	49	27	0.43	0.45	0.57	0.55	A	1.1943	0.000458979	Hypospadias	Misc
rs12042938	C	T	16	53	25	16	49	29	0.45	0.43	0.55	0.57	C	1	0.000458979	Neuranatomic and neurocognitive phenotypes	Brain health and disorders
rs10039254	A	G	30	46	18	30	42	22	0.56	0.54	0.44	0.46	A	1	0.000457875	Attention deficit hyperactivity disorder time to onset	Brain health and disorders
rs13006863	C	T	61	33	0	67	24	3	0.82	0.84	0.18	0.16	A	1	0.000456413	Immune reponse to smallpox secreted TNF-alpha	Immune diseases and disorders
rs12893597	C	T	65	28	1	63	29	2	0.84	0.82	0.16	0.18	T	1	0.000456413	Maximal oxygen uptake response	Pulmonology
rs10906233	C	T	67	24	3	64	27	3	0.84	0.82	0.16	0.18	C	0.288	0.000456413	Eating disorders	Brain health and disorders
rs3920498	G	C	64	27	3	66	26	2	0.82	0.84	0.18	0.16	G	0.139	0.000456413	Bone mineral density paediatric, skull	General health
rs4656461	G	A	5	20	69	2	29	63	0.16	0.18	0.84	0.82	G	1.38	0.000456413	Glaucoma primary open-angle	General health
rs444929	C	T	3	27	64	5	20	69	0.18	0.16	0.82	0.84	C	1.26	0.000456413	Hodgkin's lymphoma	Cancer
rs1008953	T	C	3	24	67	3	27	64	0.16	0.18	0.84	0.82	C	1.14	0.000456413	Psoriasis	Immune diseases and disorders
rs3813579	G	A	28	48	18	26	48	20	0.55	0.53	0.45	0.47	A	1.32	0.000455996	Thyroid volume	General health
rs9811920	G	A	31	42	21	24	52	18	0.55	0.53	0.45	0.47	A	0.0803	0.000455996	Axial length	Misc
rs10400317	C	T	28	44	22	26	52	16	0.53	0.55	0.47	0.45	T	0.0054	0.000455996	Trans fatty acid levels	General health
rs8064454	A	C	28	43	23	27	49	18	0.53	0.55	0.47	0.45	C	1.24	0.000455218	Prostate cancer	Cancer
rs494453	T	C	27	49	18	27	45	22	0.55	0.53	0.45	0.47	C	1	0.000455218	Osteoporosis-related phenotypes	Immune diseases and disorders
rs7314811	T	C	22	55	17	31	41	22	0.53	0.55	0.47	0.45	C	0.1452	0.000455218	IgG glycosylation	Immune diseases and disorders
rs2112347	T	G	26	47	21	29	45	20	0.53	0.55	0.47	0.45	T	0.1	0.000455218	Body mass index	Obesity
rs10040979	G	A	18	49	27	24	41	29	0.45	0.47	0.55	0.53	G	1.452	0.000455218	Adverse response to chemotherapy neutropenia_leucopenia all anthracycline-based drugs	Drug response
rs4792394	C	A	21	43	30	20	49	25	0.45	0.47	0.55	0.53	C	0.06	0.000455218	Conduct disorder symptom count	Brain health and disorders
rs7720838	G	T	24	50	20	28	46	20	0.52	0.54	0.48	0.46	G	0.0785	0.000454545	Self-reported allergy	General health
rs7542375	T	G	27	44	23	25	52	17	0.52	0.54	0.48	0.46	C	0.02	0.000454545	Obesity-related traits	Obesity
rs9362054	T	C	22	43	29	24	43	27	0.46	0.48	0.54	0.52	T	1.4	0.000453978	Diabetic retinopathy in type 2 diabetes	Diabetes
rs6104690	G	A	23	45	26	19	49	26	0.48	0.46	0.52	0.54	A	1.1236	0.000453978	Bladder cancer	Cancer
rs6959964	T	C	22	47	25	21	45	28	0.48	0.46	0.52	0.54	C	0.2574	0.000453978	Postprandial triglyceride response to high fat diet meal	General health
rs1582931	G	A	22	47	25	21	45	28	0.48	0.46	0.52	0.54	A	0.023	0.000453978	Height	General health
rs2284033	G	A	22	53	19	30	41	23	0.52	0.54	0.48	0.46	G	1.12	0.000453978	Asthma	Immune diseases and disorders
rs11619878	G	A	23	55	16	23	51	20	0.54	0.52	0.46	0.48	G	0.1632	0.000453978	IgG glycosylation	Immune diseases and disorders
rs3001032	T	C	28	45	21	28	41	25	0.54	0.52	0.46	0.48	T	0.02	0.000453978	Adiponectin levels	Obesity
rs706293	G	A	25	51	18	27	43	24	0.54	0.52	0.46	0.48	G	0.011063864	0.000453978	Urate levels BMI interaction	Obesity
rs2392510	C	T	20	48	26	21	50	23	0.47	0.49	0.53	0.51	T	1.15	0.000453515	Periodontitis	Misc
rs6054374	C	T	24	48	22	22	56	16	0.51	0.53	0.49	0.47	T	0.007	0.000453515	Vertical cup-disc ratio	Misc
rs11026407	C	A	22	49	23	20	49	25	0.49	0.47	0.51	0.53	C	0.125	0.000453155	Plasma thyroid-stimulating hormone levels	Immune diseases and disorders
rs1937332	A	G	26	42	26	22	46	26	0.50	0.48	0.50	0.52	G	2.6	0.000452899	Atrioventricular conduction	Heart health and disorders
rs9951925	C	A	23	44	27	27	40	27	0.48	0.50	0.52	0.50	C	1	0.000452899	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs3822072	G	A	23	52	19	20	54	20	0.52	0.50	0.48	0.50	A	0.025	0.000452899	HDL cholesterol	General health
rs9641855	G	A	25	48	21	25	44	25	0.52	0.50	0.48	0.50	G	0.02	0.000452899	Obesity-related traits	Obesity
rs2346177	G	A	25	45	24	21	49	24	0.51	0.48	0.49	0.52	A	0.0728	0.000452745	HDL cholesterol	General health
rs7405404	T	C	3	25	66	4	26	64	0.16	0.18	0.84	0.82	T	1.08	0.000445214	Schizophrenia	Brain health and disorders
rs2542151	G	T	1	32	61	3	25	66	0.18	0.16	0.82	0.84	C	1	0.000445214	Type 1 diabetes	Diabetes
rs80174646	G	T	82	12	0	80	14	0	0.94	0.93	0.06	0.07	C	1.614317	0.00043956	Ulcerative colitis	Immune diseases and disorders
rs13279799	T	C	81	12	1	83	10	1	0.93	0.94	0.07	0.06	G	1.28	0.00043956	Ossification of the posterior longitudinal ligament of the spine	Misc
rs2271404	T	C	81	12	1	82	12	0	0.93	0.94	0.07	0.06	G	1.17	0.00043956	Atopic dermatitis	Immune diseases and disorders
rs9372120	T	G	81	12	1	82	12	0	0.93	0.94	0.07	0.06	G	1.11	0.00043956	Rheumatoid arthritis	Immune diseases and disorders
rs7130144	C	T	80	14	0	82	12	0	0.93	0.94	0.07	0.06	C	0.256	0.00043956	Urate levels in lean individuals	Obesity
rs4869419	A	G	81	12	1	82	12	0	0.93	0.94	0.07	0.06	G	0.2	0.00043956	Natriuretic peptide levels	General health
rs76866386	T	C	82	12	0	80	14	0	0.94	0.93	0.06	0.07	T	0.139	0.00043956	Cholesterol, total	General health
rs11037473	G	A	83	10	1	80	14	0	0.94	0.93	0.06	0.07	A	0.069	0.00043956	Birth length	Misc
rs3016539	C	T	1	10	83	0	14	80	0.06	0.07	0.94	0.93	A	1.5	0.00043956	Pancreatic cancer	Cancer
rs3792615	T	C	64	27	3	62	28	4	0.82	0.81	0.18	0.19	T	1.93	0.000424869	Type 2 diabetes	Diabetes
rs13027106	T	C	63	26	5	64	27	3	0.81	0.82	0.19	0.18	C	1.0752687	0.000424869	Schizophrenia	Brain health and disorders
rs8089099	G	A	61	30	3	62	31	1	0.81	0.82	0.19	0.18	A	1	0.000424869	Pulmonary function interaction	Pulmonology
rs9563960	A	G	62	28	4	61	33	0	0.81	0.82	0.19	0.18	G	0.1591	0.000424869	IgG glycosylation	Immune diseases and disorders
rs1440620	T	C	61	30	3	61	33	0	0.81	0.82	0.19	0.18	T	0.116	0.000424869	Dietary macronutrient intake	General health
rs2623325	C	A	65	25	4	62	28	4	0.82	0.81	0.18	0.19	A	0.039	0.000424869	Optic cup area	Misc
rs1868152	A	G	4	28	62	2	29	63	0.19	0.18	0.81	0.82	A	15.679	0.000424869	Illicit drug use	General health
rs10033464	T	G	2	29	63	4	28	62	0.18	0.19	0.82	0.81	T	1.39	0.000424869	Atrial fibrillation_atrial flutter	Heart health and disorders
rs13278529	T	G	64	26	4	60	31	3	0.82	0.80	0.18	0.20	G	174.4	0.000415608	Forced expiratory volume in 1 second environmental interaction	Pulmonology
rs4149080	G	C	61	29	4	64	26	4	0.80	0.82	0.20	0.18	C	12	0.000415608	Methotrexate clearance acute lymphoblastic leukemia	Cancer
rs11045879	T	C	61	29	4	64	26	4	0.80	0.82	0.20	0.18	T	1.8	0.000415608	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs871606	T	C	59	33	2	65	24	5	0.80	0.82	0.20	0.18	T	0.429	0.000415608	Blood pressure	Heart health and disorders
rs4149081	G	A	61	29	4	64	26	4	0.80	0.82	0.20	0.18	A	0.209	0.000415608	Metabolic traits	Misc
rs16850317	T	G	79	15	0	82	11	1	0.92	0.93	0.08	0.07	T	0.3519	0.000410509	Periodontitis DPAL	Misc
rs2176862	C	T	81	13	0	80	13	1	0.93	0.92	0.07	0.08	T	0.15	0.000410509	Plasma amyloid beta peptide concentrations ABx-42	Brain health and disorders
rs1059513	T	C	79	15	0	82	11	1	0.92	0.93	0.08	0.07	C	0.12	0.000410509	IgE levels	Immune diseases and disorders
rs676210	G	A	61	31	2	59	32	3	0.81	0.80	0.19	0.20	G	10.5	0.00040689	LDL oxidized	General health
rs13278732	C	T	63	27	4	61	28	5	0.81	0.80	0.19	0.20	T	1.31	0.00040689	Eosinophilic esophagitis pediatric	Digestive system and its disorders
rs113681054	T	C	61	28	5	63	27	4	0.80	0.81	0.20	0.19	T	0.062	0.00040689	AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor	Heart health and disorders
rs2932538	A	G	2	34	58	2	31	61	0.20	0.19	0.80	0.81	G	0.388	0.00040689	Systolic blood pressure	Heart health and disorders
rs9266772	T	C	58	33	3	61	30	3	0.79	0.81	0.21	0.19	C	0.104	0.000398671	Self-reported allergy	General health
rs4293393	A	G	62	27	5	60	28	6	0.80	0.79	0.20	0.21	T	1.25	0.000390913	Chronic kidney disease and serum creatinine levels	Immune diseases and disorders
rs1321313	C	T	60	31	3	58	32	4	0.80	0.79	0.20	0.21	C	0.8129	0.000390913	Electrocardiographic conduction measures	Heart health and disorders
rs17009617	G	A	57	34	3	60	31	3	0.79	0.80	0.21	0.20	A	0.45	0.000390913	Plasma omega-6 polyunsaturated fatty acid levels linoleic acid	General health
rs1500251	G	A	58	35	1	61	26	7	0.80	0.79	0.20	0.21	A	0.0545	0.000390913	Periodontitis Mean PAL	Misc
rs2524299	A	T	59	30	5	61	29	4	0.79	0.80	0.21	0.20	A	0.0037	0.000390913	Trans fatty acid levels	General health
rs758386	A	G	0	3	91	0	4	90	0.02	0.02	0.98	0.98	A	1	0.000387147	Immune reponse to smallpox secreted TNF-alpha	Immune diseases and disorders
rs1039049	G	A	0	3	91	0	4	90	0.02	0.02	0.98	0.98	G	0.6584	0.000387147	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs12607055	G	C	91	2	1	91	3	0	0.98	0.98	0.02	0.02	C	3.5	0.000387147	Pyoderma gangrenosum in inflammatory bowel disease	Immune diseases and disorders
rs2922994	A	G	91	3	0	90	4	0	0.98	0.98	0.02	0.02	G	1.64	0.000387147	Marginal zone lymphoma	Cancer
rs7752903	T	G	90	4	0	91	3	0	0.98	0.98	0.02	0.02	G	1.41	0.000387147	Rheumatoid arthritis	Immune diseases and disorders
rs726288	C	T	90	4	0	91	3	0	0.98	0.98	0.02	0.02	T	1.22	0.000387147	Rheumatoid arthritis	Immune diseases and disorders
rs6057659	G	A	91	3	0	90	4	0	0.98	0.98	0.02	0.02	A	1	0.000387147	Attention deficit hyperactivity disorder combined symptoms	Brain health and disorders
rs16951021	T	C	91	3	0	90	4	0	0.98	0.98	0.02	0.02	T	1	0.000387147	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs75316710	A	G	91	3	0	90	4	0	0.98	0.98	0.02	0.02	A	0.4405	0.000387147	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs150639459	C	T	90	4	0	91	3	0	0.98	0.98	0.02	0.02	C	0.415	0.000387147	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs78592102	C	T	91	3	0	90	4	0	0.98	0.98	0.02	0.02	C	0.2414	0.000387147	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs138570705	G	A	91	3	0	91	2	1	0.98	0.98	0.02	0.02	A	0.115	0.000387147	Triglycerides	General health
rs17277546	G	A	90	4	0	92	1	1	0.98	0.98	0.02	0.02	A	0.11	0.000387147	Dehydroepiandrosterone sulphate levels	Immune diseases and disorders
rs35131626	C	A	90	4	0	91	3	0	0.98	0.98	0.02	0.02	A	0.04	0.000387147	Obesity-related traits	Obesity
rs13058467	T	C	79	14	1	80	14	0	0.91	0.93	0.09	0.07	C	4.4	0.000385356	Molar-incisor hypomineralization	Misc
rs72637224	C	T	81	12	1	79	14	1	0.93	0.91	0.07	0.09	T	3.6	0.000385356	Emphysema imaging phenotypes	Pulmonology
rs2341260	C	T	5	31	58	1	36	57	0.22	0.20	0.78	0.80	T	0.05	0.000383583	Cardiac Troponin-T levels	Heart health and disorders
rs478881	A	G	3	35	56	4	30	60	0.22	0.20	0.78	0.80	A	0.03	0.000383583	Obesity-related traits	Obesity
rs2107595	G	A	54	38	2	58	33	3	0.78	0.79	0.22	0.21	A	1.39	0.000376648	Stroke ischemic	Brain health and disorders
rs10485813	A	G	57	35	2	58	30	6	0.79	0.78	0.21	0.22	A	1	0.000376648	Attention deficit hyperactivity disorder	Brain health and disorders
rs11991744	C	A	8	26	60	5	29	60	0.22	0.21	0.78	0.79	C	0.787	0.000376648	Electrocardiographic traits	Heart health and disorders
rs804292	G	A	4	35	55	4	32	58	0.23	0.21	0.77	0.79	G	0.414	0.000370081	Alcohol dependence	General health
rs1491818	A	G	55	35	4	57	34	3	0.77	0.79	0.23	0.21	C	1	0.000370081	Amyotrophic lateral sclerosis age of onset	Brain health and disorders
rs11718502	C	T	55	35	4	58	32	4	0.77	0.79	0.23	0.21	T	0.05767	0.000370081	Magnesium levels	General health
rs4820294	G	A	57	30	7	57	33	4	0.77	0.78	0.23	0.22	A	1	0.000363857	Fat distribution HIV	General health
rs2622633	G	A	57	33	4	53	38	3	0.78	0.77	0.22	0.23	A	0.2	0.000363857	Coronary artery calcification	Heart health and disorders
rs4959027	A	G	4	33	57	4	36	54	0.22	0.23	0.78	0.77	G	0.09	0.000363857	Pubertal anthropometrics	Appearance
rs344364	G	A	52	40	2	56	35	3	0.77	0.78	0.23	0.22	A	0.08	0.000363857	Glomerular filtration rate in chronic kidney disease	General health
rs6289	A	G	58	31	5	55	34	5	0.78	0.77	0.22	0.23	G	0.03	0.000363857	Obesity-related traits	Obesity
rs73077895	G	A	80	11	3	79	15	0	0.91	0.92	0.09	0.08	A	5.35	0.000363372	Classic bladder exstrophy	Misc
rs8141797	A	G	80	13	1	77	17	0	0.92	0.91	0.08	0.09	G	1.52	0.000363372	Amyotrophic lateral sclerosis	Brain health and disorders
rs3755955	G	A	77	17	0	79	15	0	0.91	0.92	0.09	0.08	A	0.06	0.000363372	Bone mineral density	General health
rs10841753	T	C	59	28	7	52	39	3	0.78	0.76	0.22	0.24	T	7.1	0.000357953	Methotrexate phramacokinetics acute lymphoblastic leukemia	Cancer
rs4280164	G	A	54	35	5	58	30	6	0.76	0.78	0.24	0.22	G	3.872	0.000357953	Parent of origin effect on language impairment paternal	Misc
rs11705555	A	C	58	30	6	52	39	3	0.78	0.76	0.22	0.24	C	1.23	0.000357953	Mitral valve prolapse	Heart health and disorders
rs1795708	T	C	60	26	8	51	41	2	0.78	0.76	0.22	0.24	G	0.04	0.000357953	Obesity-related traits	Obesity
rs7687906	G	T	6	30	58	6	33	55	0.22	0.24	0.78	0.76	C	0.03	0.000357953	Obesity-related traits	Obesity
rs12095069	T	C	56	33	5	53	36	5	0.77	0.76	0.23	0.24	T	1.36	0.000352347	Attention function in attention deficit hyperactive disorder	Brain health and disorders
rs9346455	T	G	53	39	2	51	40	3	0.77	0.76	0.23	0.24	G	0.013	0.000352347	Antipsychotic drug-induced weight gain time interaction	Drug response
rs910049	T	C	12	23	59	6	32	56	0.25	0.23	0.75	0.77	A	1.46	0.000347021	Hepatitis C induced liver cirrhosis	Immune diseases and disorders
rs6808574	T	C	7	30	57	6	35	53	0.23	0.25	0.77	0.75	C	1.07	0.000347021	Type 2 diabetes	Diabetes
rs2106261	C	T	54	33	7	57	30	7	0.75	0.77	0.25	0.23	T	1.25	0.000347021	Atrial fibrillation	Heart health and disorders
rs10491431	C	A	52	40	2	51	39	4	0.77	0.75	0.23	0.25	A	0.081	0.000347021	Blood metabolite levels	Heart health and disorders
rs12050161	T	C	53	35	6	53	38	3	0.75	0.77	0.25	0.23	T	0.07	0.000347021	Periodontitis Mean PAL	Misc
rs17077540	A	G	77	16	1	79	14	1	0.90	0.91	0.10	0.09	G	1.61	0.000343997	Major depressive disorder	Brain health and disorders
rs10498635	C	T	78	16	0	76	18	0	0.91	0.90	0.09	0.10	C	1.44	0.000343997	Paget's disease	General health
rs1906493	G	T	80	12	2	77	16	1	0.91	0.90	0.09	0.10	A	1.19	0.000343997	Crohn's disease	Digestive system and its disorders
rs1530947	T	C	77	16	1	78	16	0	0.90	0.91	0.10	0.09	T	1	0.000343997	Visceral fat	Obesity
rs9296949	C	T	78	14	2	79	14	1	0.90	0.91	0.10	0.09	T	0.3021	0.000343997	Metabolite levels HVA_MHPG ratio	Brain health and disorders
rs12549576	A	G	77	16	1	78	16	0	0.90	0.91	0.10	0.09	G	0.3	0.000343997	Bilirubin levels	General health
rs205611	A	G	78	16	0	79	12	3	0.91	0.90	0.09	0.10	A	0.12	0.000343997	Iris characteristics	Misc
rs6599388	C	T	50	40	4	52	39	3	0.74	0.76	0.26	0.24	T	1.16	0.000341958	Parkinson's disease	Brain health and disorders
rs655766	C	T	52	36	6	53	37	4	0.74	0.76	0.26	0.24	T	0.08	0.000341958	Percentage gas trapping	Misc
rs4726279	T	A	51	37	6	52	38	4	0.74	0.76	0.26	0.24	T	2.7	0.000337142	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs7513464	G	C	55	32	7	50	39	5	0.76	0.74	0.24	0.26	C	0.063	0.000337142	Height	General health
rs6091737	T	C	52	35	7	51	40	3	0.74	0.76	0.26	0.24	T	0.02	0.000337142	Calcium levels	General health
rs6986153	G	A	9	29	56	6	38	50	0.25	0.27	0.75	0.73	G	1.67	0.000332557	Neuropathic pain in type 2 diabetes	Diabetes
rs703970	A	C	5	40	49	6	35	53	0.27	0.25	0.73	0.75	C	1.01	0.000332557	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs2725544	C	A	5	40	49	7	33	54	0.27	0.25	0.73	0.75	C	0.12	0.000332557	Insomnia	General health
rs9533799	C	A	53	35	6	51	36	7	0.75	0.73	0.25	0.27	A	1.17	0.000332557	Amyotrophic lateral sclerosis	Brain health and disorders
rs7927997	C	T	53	35	6	51	36	7	0.75	0.73	0.25	0.27	T	1.17	0.000332557	Crohn's disease	Digestive system and its disorders
rs11581062	A	G	49	40	5	54	33	7	0.73	0.75	0.27	0.25	G	1.12	0.000332557	Multiple sclerosis	Brain health and disorders
rs172629	C	G	53	35	6	48	42	4	0.75	0.73	0.25	0.27	G	1	0.000332557	Mean corpuscular volume	Heart health and disorders
rs10464366	A	T	51	36	7	52	37	5	0.73	0.75	0.27	0.25	T	0.1748	0.000332557	IgG glycosylation	Immune diseases and disorders
rs328506	T	C	4	40	50	6	39	49	0.26	0.27	0.74	0.73	C	1.11	0.000328192	Type 2 diabetes	Diabetes
rs13303128	C	T	5	38	51	3	45	46	0.26	0.27	0.74	0.73	C	0.2833	0.000328192	Metabolite levels MHPG	General health
rs1420101	C	T	52	33	9	52	36	6	0.73	0.74	0.27	0.26	A	6.4	0.000328192	Eosinophil counts	General health
rs10043775	T	C	53	34	7	47	43	4	0.74	0.73	0.26	0.27	T	2.06	0.000328192	Periodontal microbiota	Misc
rs2950390	C	T	50	37	7	53	34	7	0.73	0.74	0.27	0.26	C	0.008	0.000328192	Mean platelet volume	Heart health and disorders
rs798336	C	T	0	19	75	1	15	78	0.10	0.09	0.90	0.91	T	1	0.000326797	Mammographic density dense area	Reproductive health
rs16951120	C	T	79	13	2	77	15	2	0.91	0.90	0.09	0.10	T	4.49	0.000326797	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs6946494	A	G	77	15	2	78	15	1	0.90	0.91	0.10	0.09	A	1	0.000326797	Visceral adipose tissue adjusted for BMI	Obesity
rs10665	A	G	77	17	0	77	15	2	0.91	0.90	0.09	0.10	A	0.847	0.000326797	End-stage coagulation	General health
rs11114027	G	T	77	15	2	78	15	1	0.90	0.91	0.10	0.09	A	0.03	0.000326797	Obesity-related traits	Obesity
rs10065813	C	T	79	13	2	77	15	2	0.91	0.90	0.09	0.10	A	0.03	0.000326797	Obesity-related traits	Obesity
rs9877396	T	C	49	38	7	51	37	6	0.72	0.74	0.28	0.26		2	0.000324032	Bronchopulmonary dysplasia	Pulmonology
rs312691	T	C	51	33	10	50	38	6	0.72	0.73	0.28	0.27	C	3.2	0.000320068	Thyrotoxic hypokalemic periodic paralysis	Misc
rs4793501	C	T	7	39	48	5	40	49	0.28	0.27	0.72	0.73	C	0.08	0.000320068	Refractive error	General health
rs1092913	G	A	49	35	10	50	36	8	0.71	0.72	0.29	0.28	T	1.45	0.000312685	Breast cancer	Cancer
rs7274811	G	T	46	41	7	46	44	4	0.71	0.72	0.29	0.28	T	0.041	0.000312685	Height	General health
rs12646911	G	A	4	47	43	5	42	47	0.29	0.28	0.71	0.72	A	1.89	0.000312685	Obesity in adult survivors of childhood cancer exposed to cranial radiation	Obesity
rs11028175	G	A	77	16	1	74	20	0	0.90	0.89	0.10	0.11	A	0.87	0.000311429	Depressive symptoms SSRI exposure interaction	Brain health and disorders
rs17477177	T	C	74	20	0	77	16	1	0.89	0.90	0.11	0.10	T	0.418	0.000311429	Blood pressure	Heart health and disorders
rs113027826	T	C	77	16	1	75	18	1	0.90	0.89	0.10	0.11	T	0.4164	0.000311429	Cerebrospinal fluid t-tau:AB1-42 ratio	Brain health and disorders
rs17498581	C	T	76	18	0	75	18	1	0.90	0.89	0.10	0.11	T	0.024	0.000311429	Toenail selenium levels	Misc
rs12478665	C	T	50	32	12	49	37	8	0.70	0.72	0.30	0.28	T	112.18	0.000309246	Hippocampal volume	Brain health and disorders
rs7295246	T	G	49	37	8	48	36	10	0.72	0.70	0.28	0.30	G	1.07	0.000309246	Alzheimer's disease late onset	Brain health and disorders
rs2834442	T	A	6	41	47	11	34	49	0.28	0.30	0.72	0.70	A	0.026	0.000309246	Height	General health
rs678962	T	G	48	35	11	51	32	11	0.70	0.71	0.30	0.29	G	5.4	0.000305966	Height	General health
rs7630877	G	A	48	38	8	45	41	8	0.71	0.70	0.29	0.30	A	1.32	0.000305966	Type 2 diabetes	Diabetes
rs5759167	G	T	46	42	6	45	41	8	0.71	0.70	0.29	0.30	G	1.18	0.000305966	Prostate cancer	Cancer
rs1534166	A	G	47	37	10	52	30	12	0.70	0.71	0.30	0.29	A	0.289	0.000305966	Alcohol consumption transferrin glycosylation	General health
rs6017342	A	C	7	44	43	5	45	44	0.31	0.29	0.69	0.71	C	1.228	0.000302837	Ulcerative colitis	Immune diseases and disorders
rs10777165	C	T	13	32	49	8	39	47	0.31	0.29	0.69	0.71	C	1.0526316	0.000302837	Schizophrenia	Brain health and disorders
rs7580717	G	A	44	42	8	45	43	6	0.69	0.71	0.31	0.29	G	1.131	0.000302837	Multiple myeloma	Cancer
rs3757458	G	A	89	5	0	90	4	0	0.97	0.98	0.03	0.02	A	8	0.000302755	QT interval	Heart health and disorders
rs16867528	C	T	89	5	0	90	4	0	0.97	0.98	0.03	0.02	A	7.39	0.000302755	Diisocyanate-induced asthma	Pulmonology
rs9513373	T	C	89	5	0	90	4	0	0.97	0.98	0.03	0.02	C	4.18	0.000302755	Clozapine-induced agranulocytosis	General health
rs141308780	A	G	90	4	0	89	5	0	0.98	0.97	0.02	0.03	G	1.2987013	0.000302755	Schizophrenia	Brain health and disorders
rs11064881	G	A	90	4	0	90	3	1	0.98	0.97	0.02	0.03	A	1.1273501	0.000302755	Ulcerative colitis	Immune diseases and disorders
rs3136739	A	G	89	5	0	90	4	0	0.97	0.98	0.03	0.02	A	0.063	0.000302755	Plasma plasminogen activator levels	General health
rs8133843	G	A	9	41	44	8	40	46	0.31	0.30	0.69	0.70	A	1.09	0.00029985	Rheumatoid arthritis	Immune diseases and disorders
rs10508921	C	T	77	15	2	75	17	2	0.90	0.89	0.10	0.11	T	25.7	0.000297619	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs28375034	G	A	75	17	2	76	17	1	0.89	0.90	0.11	0.10	G	1.0752687	0.000297619	Schizophrenia	Brain health and disorders
rs7199390	A	T	74	19	1	75	19	0	0.89	0.90	0.11	0.10	T	0.19	0.000297619	Social communication problems	Brain health and disorders
rs7085433	G	A	73	21	0	77	15	2	0.89	0.90	0.11	0.10	A	0.102	0.000297619	Mean corpuscular hemoglobin	Heart health and disorders
rs113835537	A	G	74	19	1	75	19	0	0.89	0.90	0.11	0.10	A	0.012	0.000297619	Airway imaging phenotypes	Pulmonology
rs682238	C	G	2	17	75	0	19	75	0.11	0.10	0.89	0.90	C	0.03	0.000297619	Calcium levels	General health
rs2075423	G	T	44	40	10	46	39	9	0.68	0.70	0.32	0.30	G	1.08	0.000297	Type 2 diabetes	Diabetes
rs12510251	G	A	40	48	6	43	45	6	0.68	0.70	0.32	0.30	A	1.07	0.000297	Schizophrenia	Brain health and disorders
rs2245368	C	T	12	33	49	6	48	40	0.30	0.32	0.70	0.68	C	0.034	0.000297	Body mass index	Obesity
rs4852146	C	T	14	33	47	7	44	43	0.32	0.31	0.68	0.69	C	0.19	0.000294281	Circulating phylloquinone levels	Immune diseases and disorders
rs7267979	A	G	14	34	46	7	45	42	0.33	0.31	0.67	0.69	G	1.5	0.000291687	Liver enzyme levels alkaline phosphatase	General health
rs273259	A	G	41	44	9	45	39	10	0.67	0.69	0.33	0.31	A	1.41	0.000291687	Febrile seizures MMR vaccine-related	General health
rs751728	C	T	42	42	10	43	43	8	0.67	0.69	0.33	0.31	T	1.32	0.000291687	Crohn's disease	Digestive system and its disorders
rs1326934	C	T	9	44	41	7	45	42	0.33	0.31	0.67	0.69	T	1.19	0.000291687	Diabetic nephropathy in type 1 diabetes	Diabetes
rs30360	G	T	7	48	39	10	39	45	0.33	0.31	0.67	0.69	G	1	0.000291687	Fasting insulin interaction	General health
rs1396515	G	C	11	37	46	5	52	37	0.31	0.33	0.69	0.67	C	0.98	0.000291687	QT interval	Heart health and disorders
rs10823991	A	T	13	34	47	10	43	41	0.32	0.34	0.68	0.66	A	0.138	0.000289212	Gait rhythm	Appearance
rs9381040	C	T	41	46	7	43	39	12	0.68	0.66	0.32	0.34	C	1.0753	0.000289212	Alzheimer's disease late onset	Brain health and disorders
rs259067	C	T	43	39	12	41	46	7	0.66	0.68	0.34	0.32	A	1	0.000289212	Obesity	Obesity
rs1425609	G	A	41	43	10	43	42	9	0.66	0.68	0.34	0.32	A	0.08	0.000289212	Aging time to death	Aging
rs6693295	C	T	46	35	13	37	50	7	0.68	0.66	0.32	0.34	T	1.15	0.000286853	Migraine - clinic-based	Brain health and disorders
rs2463822	T	C	2	16	76	1	20	73	0.11	0.12	0.89	0.88	T	1	0.000285144	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs17664267	G	T	74	18	2	75	18	1	0.88	0.89	0.12	0.11	T	1.39	0.000285144	Conduct disorder interaction	Brain health and disorders
rs13148903	A	G	73	20	1	74	20	0	0.88	0.89	0.12	0.11	G	1	0.000285144	Response to statin therapy	General health
rs356182	G	A	11	40	43	9	47	38	0.33	0.35	0.67	0.65	G	1.32	0.000284603	Parkinson's disease	Brain health and disorders
rs7632299	G	A	40	43	11	42	42	10	0.65	0.67	0.35	0.33	A	0.45	0.000284603	Non-alcoholic fatty liver disease histology lobular	Obesity
rs6732028	A	G	44	35	15	45	36	13	0.65	0.67	0.35	0.33	G	0.06	0.000284603	Obesity-related traits	Obesity
rs9883204	T	C	10	45	39	12	38	44	0.35	0.33	0.65	0.67	C	0.06	0.000284603	Birth weight	Misc
rs4130047	T	C	40	45	9	38	46	10	0.66	0.65	0.34	0.35	C	1.16	0.000282459	Parkinson's disease	Brain health and disorders
rs2840445	G	A	40	42	12	41	43	10	0.65	0.66	0.35	0.34	A	0.22	0.000282459	Dietary macronutrient intake	General health
rs724950	T	C	11	41	42	9	48	37	0.34	0.35	0.66	0.65	A	0.04	0.000282459	Obesity-related traits	Obesity
rs8040855	G	C	8	50	36	12	39	43	0.35	0.34	0.65	0.66	C	0.035	0.000282459	Bulimia nervosa	Brain health and disorders
rs1129555	A	G	14	38	42	9	45	40	0.35	0.34	0.65	0.66	A	0.035	0.000282459	LDL cholesterol	General health
rs6025281	C	T	9	48	37	8	47	39	0.35	0.34	0.65	0.66	T	0.021	0.000282459	Educational attainment	Mental aptitude and behavioural traits
rs11756438	C	A	40	44	10	35	51	8	0.66	0.64	0.34	0.36	A	1.4	0.000280418	QT interval	Heart health and disorders
rs2049805	T	C	15	37	42	13	38	43	0.36	0.34	0.64	0.66	T	0.0072	0.000280418	Renal function-related traits BUN	General health
rs1805017	C	T	40	40	14	40	43	11	0.64	0.65	0.36	0.35	T	11.1	0.000278474	Lipoprotein-associated phospholipase A2 activity and mass	General health
rs6506122	T	C	9	50	35	9	47	38	0.36	0.35	0.64	0.65	C	1.82	0.000278474	Response to methotrexate in juvenile idiopathic arthritis	General health
rs7085104	A	G	38	44	12	40	43	11	0.64	0.65	0.36	0.35	A	1.11	0.000278474	Schizophrenia	Brain health and disorders
rs11191419	T	A	38	44	12	40	43	11	0.64	0.65	0.36	0.35	T	1.1037527	0.000278474	Schizophrenia	Brain health and disorders
rs1023500	T	C	41	38	15	35	53	6	0.64	0.65	0.36	0.35	T	1.08	0.000278474	Schizophrenia	Brain health and disorders
rs7665090	A	G	11	47	36	11	44	39	0.37	0.35	0.63	0.65	C	1.26	0.000276625	Primary biliary cirrhosis	Immune diseases and disorders
rs1054037	C	T	11	47	36	11	44	39	0.37	0.35	0.63	0.65	T	1.22	0.000276625	Primary biliary cirrhosis	Immune diseases and disorders
rs9804200	C	T	11	45	38	13	44	37	0.36	0.37	0.64	0.63	C	8.39	0.000274868	Sleep time	General health
rs8014131	C	A	37	47	10	40	38	16	0.64	0.63	0.36	0.37	A	4.61	0.000274868	Menarche age at onset	Reproductive health
rs9267911	T	C	39	40	15	40	41	13	0.63	0.64	0.37	0.36	T	1.5	0.000274868	Crohn's disease	Digestive system and its disorders
rs10945919	A	G	38	45	11	35	48	11	0.64	0.63	0.36	0.37	G	1	0.000274868	Response to TNF antagonist treatment	General health
rs1131351	C	G	34	50	10	33	55	6	0.63	0.64	0.37	0.36	C	0.51	0.000274868	Seasonality	Mental aptitude and behavioural traits
rs38989	A	G	37	44	13	39	43	12	0.63	0.64	0.37	0.36	G	0.1524	0.000274868	IgG glycosylation	Immune diseases and disorders
rs2113818	T	C	42	34	18	33	55	6	0.63	0.64	0.37	0.36	T	0.015	0.000274868	Optic cup area	Misc
rs457603	C	T	3	15	76	2	19	73	0.11	0.12	0.89	0.88	G	0.07	0.000273823	Liver enzyme levels aspartate transaminase	General health
rs7494064	C	T	2	17	75	0	23	71	0.11	0.12	0.89	0.88	G	0.04	0.000273823	Obesity-related traits	Obesity
rs3129939	A	G	74	19	1	73	19	2	0.89	0.88	0.11	0.12	G	2.6	0.000273823	Idiopathic membranous nephropathy	Brain health and disorders
rs16827293	C	T	72	21	1	74	19	1	0.88	0.89	0.12	0.11	A	0.44	0.000273823	Waist-to-hip circumference ratio interaction	General health
rs17646946	G	A	73	21	0	71	23	0	0.89	0.88	0.11	0.12	A	0.29	0.000273823	Common traits Other	Misc
rs1023252	G	T	72	21	1	73	21	0	0.88	0.89	0.12	0.11	T	0.2	0.000273823	Natriuretic peptide levels	General health
rs732949	A	C	71	23	0	75	17	2	0.88	0.89	0.12	0.11	C	0.166	0.000273823	Immune response to anthrax vaccine	Immune diseases and disorders
rs10514168	C	A	74	17	3	73	21	0	0.88	0.89	0.12	0.11	C	0.047	0.000273823	Motion sickness	Misc
rs2281558	G	T	74	19	1	72	21	1	0.89	0.88	0.11	0.12	T	0.015	0.000273823	Calcium levels	General health
rs12966547	G	A	37	43	14	41	38	15	0.62	0.64	0.38	0.36	G	1.4	0.000273199	Schizophrenia	Brain health and disorders
rs1436955	C	T	34	52	8	35	47	12	0.64	0.62	0.36	0.38	C	1.13	0.000273199	Type 2 diabetes	Diabetes
rs4801131	C	T	37	43	14	41	38	15	0.62	0.64	0.38	0.36	C	1.08	0.000273199	Schizophrenia	Brain health and disorders
rs11874716	T	G	37	43	14	41	38	15	0.62	0.64	0.38	0.36	T	1.07	0.000273199	Schizophrenia	Brain health and disorders
rs7156960	C	G	41	38	15	36	45	13	0.64	0.62	0.36	0.38	G	1	0.000273199	Acute lymphoblastic leukemia childhood	Cancer
rs7596264	A	G	38	44	12	34	49	11	0.64	0.62	0.36	0.38	G	0.4449	0.000273199	Vascular brain injury	Brain health and disorders
rs4766152	T	C	15	38	41	14	43	37	0.36	0.38	0.64	0.62	G	0.223	0.000273199	Cytomegalovirus antibody response	Immune diseases and disorders
rs8028313	C	G	37	45	12	35	46	13	0.63	0.62	0.37	0.38	C	1.08	0.000271616	Obesity	Obesity
rs4761097	G	A	13	44	37	16	41	37	0.37	0.39	0.63	0.61	G	1	0.000270116	Behavioural disinhibition generation interaction	Brain health and disorders
rs6180	A	C	39	40	15	35	45	14	0.63	0.61	0.37	0.39	A	0.018	0.000270116	Height	General health
rs12594515	G	C	38	41	15	31	52	11	0.62	0.61	0.38	0.39	C	1.71	0.000268697	Weight	Appearance
rs2070729	C	A	16	41	37	13	50	31	0.39	0.40	0.61	0.60	A	2.394	0.000266091	Platelet count	Heart health and disorders
rs2635047	C	T	34	44	16	35	45	14	0.60	0.61	0.40	0.39	T	0.02	0.000266091	Educational attainment	Mental aptitude and behavioural traits
rs3843585	T	C	34	43	17	34	46	14	0.59	0.61	0.41	0.39	T	1	0.000264901	Middle childhood and early adolescence aggressive behavior	Brain health and disorders
rs2444240	T	G	36	42	16	33	45	16	0.61	0.59	0.39	0.41	T	0.0365	0.000264901	Corneal curvature	General health
rs1015003	G	T	19	40	35	14	47	33	0.41	0.40	0.59	0.60	G	3.94	0.000263783	Heart rate	General health
rs6861497	A	G	20	38	36	13	49	32	0.41	0.40	0.59	0.60	A	2.34	0.000263783	QRS duration	Heart health and disorders
rs16904191	A	G	31	51	12	32	46	16	0.60	0.59	0.40	0.41	G	1.07	0.000263783	Migraine	Brain health and disorders
rs4458264	C	T	29	52	13	28	57	9	0.59	0.60	0.41	0.40	T	1	0.000263783	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs1488193	A	G	0	22	72	0	24	70	0.12	0.13	0.88	0.87	G	0.23	0.000263505	Economic and political preferences	Mental aptitude and behavioural traits
rs4750829	A	G	2	18	74	0	24	70	0.12	0.13	0.88	0.87	A	0.03	0.000263505	Obesity-related traits	Obesity
rs349475	T	C	20	39	35	18	40	36	0.42	0.40	0.58	0.60	T	0.18	0.000262735	Depression quantitative trait	Brain health and disorders
rs9287989	T	C	34	44	16	32	45	17	0.60	0.58	0.40	0.42	C	1.8	0.000262735	Periodontal microbiota	Misc
rs10067755	A	G	30	52	12	36	37	21	0.60	0.58	0.40	0.42	C	0.12	0.000262735	Waist-to-hip circumference ratio interaction	General health
rs4984406	T	C	36	40	18	30	49	15	0.60	0.58	0.40	0.42	T	0.019	0.000262735	Body mass index	Obesity
rs3779273	G	A	29	50	15	29	53	12	0.57	0.59	0.43	0.41	G	0.015	0.000261757	Body mass index	Obesity
rs10091038	A	C	16	45	33	14	52	28	0.41	0.43	0.59	0.57	A	1	0.000261757	Response to statin therapy	General health
rs4402823	T	C	29	52	13	22	63	9	0.59	0.57	0.41	0.43	T	1	0.000260847	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs1513670	T	C	17	48	29	10	59	25	0.44	0.42	0.56	0.58	A	0.08	0.000260003	Bone mineral density hip	General health
rs6473223	T	C	17	48	29	15	49	30	0.44	0.42	0.56	0.58	T	0.0668	0.000260003	Self-reported allergy	General health
rs1549059	T	C	21	37	36	21	40	33	0.42	0.44	0.58	0.56	A	0.03	0.000260003	Obesity-related traits	Obesity
rs1378552	C	T	30	48	16	29	47	18	0.57	0.56	0.43	0.44	T	0.032	0.000259224	Motion sickness	Misc
rs2111398	A	G	16	48	30	11	61	22	0.43	0.44	0.57	0.56	G	0.087	0.000259224	Cutaneous malignant melanoma	Cancer
rs7742212	G	A	19	46	29	15	51	28	0.45	0.43	0.55	0.57	A	1.05	0.000258509	Schizophrenia	Brain health and disorders
rs227425	T	G	21	44	29	18	47	29	0.46	0.44	0.54	0.56	G	1	0.000257268	Bone mineral density	General health
rs6472155	G	A	20	43	31	14	58	22	0.44	0.46	0.56	0.54	A	0.23	0.000257268	Retinopathy in non-diabetics	General health
rs9847710	T	C	29	46	19	32	37	25	0.55	0.54	0.45	0.46	G	1.067568	0.000256739	Ulcerative colitis	Immune diseases and disorders
rs1520724	C	T	22	41	31	21	46	27	0.45	0.47	0.55	0.53	G	0.03	0.000256272	Obesity-related traits	Obesity
rs11676922	T	A	24	55	15	27	46	21	0.55	0.53	0.45	0.47	T	1.133	0.000256272	Rheumatoid arthritis	Immune diseases and disorders
rs11997175	C	T	27	48	19	24	51	19	0.54	0.53	0.46	0.47	C	0.014	0.000255864	Body mass index	Obesity
rs1902341	C	T	15	56	23	19	51	24	0.46	0.47	0.54	0.53	G	1.31	0.000255864	Peripheral artery disease	Heart health and disorders
rs12446492	T	A	25	39	30	15	56	23	0.47	0.46	0.53	0.54	A	0.15	0.000255864	Urinary uromodulin levels	General health
rs10931041	C	T	26	46	22	29	43	22	0.52	0.54	0.48	0.46	A	0.02	0.000255515	Waist-to-hip circumference ratio interaction	General health
rs11027857	G	A	23	51	20	21	58	15	0.52	0.53	0.48	0.47	A	1.064	0.000255225	Schizophrenia	Brain health and disorders
rs7631605	C	T	31	35	28	27	46	21	0.52	0.53	0.48	0.47	T	1	0.000255225	Cerebrospinal P-tau181p levels	Brain health and disorders
rs1292053	A	G	29	41	24	24	48	22	0.53	0.51	0.47	0.49	G	1.0954721	0.000254994	Crohn's disease	Digestive system and its disorders
rs479526	T	C	25	43	26	23	44	27	0.49	0.48	0.51	0.52	T	0.093	0.00025482	Reading and spelling	Brain health and disorders
rs1546924	T	C	27	39	28	17	56	21	0.49	0.48	0.51	0.52	T	0.014	0.00025482	Body mass index	Obesity
rs4835796	T	G	24	43	27	25	44	25	0.48	0.50	0.52	0.50	G	2.89	0.000254705	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs4468572	T	C	24	46	24	23	51	20	0.50	0.52	0.50	0.48	C	1.08	0.000254705	Coronary artery disease	Heart health and disorders
rs959695	T	C	25	47	22	22	50	22	0.52	0.50	0.48	0.50	C	1	0.000254705	Hippocampal atrophy	Brain health and disorders
rs12464624	G	C	26	42	26	21	55	18	0.50	0.52	0.50	0.48	C	0.082	0.000254705	Urate levels in overweight individuals	Obesity
rs1383484	C	T	24	49	21	26	42	26	0.52	0.50	0.48	0.50	T	0.04	0.000254705	Height	General health
rs6704768	G	A	23	50	21	28	37	29	0.51	0.49	0.49	0.51	G	1.0752687	0.000254647	Schizophrenia	Brain health and disorders
rs11042023	T	C	25	43	26	26	44	24	0.49	0.51	0.51	0.49	C	1.07	0.000254647	Obesity	Obesity
rs2090104	A	G	24	44	26	21	53	20	0.49	0.51	0.51	0.49	G	0.1533	0.000254647	IgG glycosylation	Immune diseases and disorders
rs1999805	G	A	22	52	20	22	49	23	0.51	0.49	0.49	0.51	C	0.09	0.000254647	Bone mineral density spine	General health
rs17668565	T	C	25	46	23	23	47	24	0.51	0.49	0.49	0.51	G	0.03	0.000254647	Obesity-related traits	Obesity
rs9270984	T	G	2	21	71	2	19	73	0.13	0.12	0.87	0.88	T	1.73	0.000254065	Systemic lupus erythematosus	Immune diseases and disorders
rs8008716	A	G	72	19	3	71	23	0	0.87	0.88	0.13	0.12	G	1.712	0.000254065	Eosinophilic esophagitis	Digestive system and its disorders
rs10516635	G	A	72	21	1	70	23	1	0.88	0.87	0.12	0.13	A	1	0.000254065	Visceral adipose tissue adjusted for BMI	Obesity
rs9918079	G	A	70	23	1	72	21	1	0.87	0.88	0.13	0.12	A	0.04	0.000254065	Obesity-related traits	Obesity
rs16935110	A	T	73	19	2	70	23	1	0.88	0.87	0.12	0.13	T	0.03	0.000254065	Obesity-related traits	Obesity
rs886424	C	T	88	6	0	89	5	0	0.97	0.97	0.03	0.03	A	2.2107	0.000249066	Type 1 diabetes and autoimmune thyroid diseases	Diabetes
rs3757318	G	A	89	5	0	88	6	0	0.97	0.97	0.03	0.03	A	1.33	0.000249066	Breast cancer estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative	Cancer
rs11757661	G	A	88	6	0	90	3	1	0.97	0.97	0.03	0.03	A	1	0.000249066	Subcutaneous adipose tissue	Obesity
rs1127354	C	A	89	5	0	88	6	0	0.97	0.97	0.03	0.03	A	1	0.000249066	Ribavirin-induced anemia	Heart health and disorders
rs114646238	T	C	89	5	0	88	6	0	0.97	0.97	0.03	0.03	C	0.2801	0.000249066	Metabolite levels HVA_MHPG ratio	Brain health and disorders
rs2290419	A	G	88	6	0	89	5	0	0.97	0.97	0.03	0.03	G	0.18	0.000249066	Cutaneous malignant melanoma	Cancer
rs74879986	G	A	88	6	0	89	5	0	0.97	0.97	0.03	0.03	G	0.14	0.000249066	Bulimia nervosa	Brain health and disorders
rs17212303	C	G	89	4	1	89	5	0	0.97	0.97	0.03	0.03	C	0.094	0.000249066	Age at smoking initiation in chronic obstructive pulmonary disease	Pulmonology
rs10518406	A	G	88	6	0	89	5	0	0.97	0.97	0.03	0.03	G	0.061	0.000249066	Body mass index	Obesity
rs5752223	C	T	89	5	0	88	6	0	0.97	0.97	0.03	0.03	T	0.0087	0.000249066	Trans fatty acid levels	General health
rs2455012	A	G	0	6	88	0	5	89	0.03	0.03	0.97	0.97	T	2.17	0.000249066	Staphylococcus aureus infection	Immune diseases and disorders
rs13117307	C	T	70	24	0	71	20	3	0.87	0.86	0.13	0.14	T	1.28	0.000245399	Cervical cancer	Cancer
rs76904798	C	T	69	24	1	70	24	0	0.86	0.87	0.14	0.13	T	1.155	0.000245399	Parkinson's disease	Brain health and disorders
rs7008026	T	C	71	20	3	70	24	0	0.86	0.87	0.14	0.13	C	1.0638298	0.000245399	Schizophrenia	Brain health and disorders
rs4295627	T	G	69	23	2	70	23	1	0.86	0.87	0.14	0.13	G	1.36	0.000237417	Glioma	Cancer
rs7554511	C	A	69	25	0	69	23	2	0.87	0.86	0.13	0.14	C	1.14	0.000237417	Crohn's disease	Digestive system and its disorders
rs4282339	G	A	69	23	2	71	21	2	0.86	0.87	0.14	0.13	A	0.036	0.000237417	Height	General health
rs662799	G	A	2	21	71	1	25	68	0.13	0.14	0.87	0.86	A	0.14	0.000237417	Lipid traits	Misc
rs771390	T	C	0	26	68	1	26	67	0.14	0.15	0.86	0.85	C	1.22	0.000230044	Epilepsy generalized	Brain health and disorders
rs17085007	T	C	69	22	3	70	22	2	0.85	0.86	0.15	0.14	G	1.1413064	0.000230044	Ulcerative colitis	Immune diseases and disorders
rs16868941	G	A	68	25	1	66	27	1	0.86	0.85	0.14	0.15	A	0.056	0.000223214	Coffee consumption	Misc
rs157089	T	G	67	24	3	67	26	1	0.84	0.85	0.16	0.15	T	5.714286	0.000216873	Warfarin maintenance dose	General health
rs6077251	C	T	68	24	2	67	24	3	0.85	0.84	0.15	0.16	T	2.065	0.000216873	Adverse response to chemotherapy neutropenia_leucopenia cisplatin	Drug response
rs7192208	T	G	68	24	2	64	30	0	0.85	0.84	0.15	0.16	G	0.4832	0.000216873	White matter integrity	Brain health and disorders
rs13391419	C	A	87	7	0	88	6	0	0.96	0.97	0.04	0.03	A	3.9	0.000211909	Diisocyanate-induced asthma	Pulmonology
rs77569859	T	C	87	7	0	88	6	0	0.96	0.97	0.04	0.03	G	1.98	0.000211909	Eosinophilic esophagitis	Digestive system and its disorders
rs577969	C	T	89	4	1	87	7	0	0.97	0.96	0.03	0.04	T	1.13	0.000211909	Migraine	Brain health and disorders
rs17678683	T	G	88	6	0	87	7	0	0.97	0.96	0.03	0.04	G	1.08	0.000211909	Myocardial infarction	Heart health and disorders
rs62277617	A	G	87	7	0	88	6	0	0.96	0.97	0.04	0.03	G	0.7386	0.000211909	Hippocampal sclerosis	Brain health and disorders
rs703556	A	G	88	6	0	88	5	1	0.97	0.96	0.03	0.04	A	0.41	0.000211909	Mammographic density dense area	Reproductive health
rs17366568	G	A	87	7	0	88	6	0	0.96	0.97	0.04	0.03	G	0.13	0.000211909	Adiponectin levels	Obesity
rs16842559	T	C	87	7	0	88	6	0	0.96	0.97	0.04	0.03	T	0.106	0.000211909	C-reactive protein	Immune diseases and disorders
rs75638626	T	C	88	6	0	87	7	0	0.97	0.96	0.03	0.04	C	0.08	0.000211909	Age-related nuclear cataracts	Aging
rs1413020	C	G	87	7	0	88	6	0	0.96	0.97	0.04	0.03	G	0.02	0.000211909	Body mass index interaction	Obesity
rs7077606	C	T	67	23	4	68	23	3	0.84	0.85	0.16	0.15	T	5.44	0.00021097	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs7603514	G	A	66	25	3	66	27	1	0.84	0.85	0.16	0.15	A	1.36	0.00021097	Obesity extreme	Obesity
rs11903757	T	C	67	23	4	65	29	0	0.84	0.85	0.16	0.15	C	1.16	0.00021097	Colorectal cancer	Cancer
rs4875320	A	T	66	25	3	66	27	1	0.84	0.85	0.16	0.15	A	0.0999	0.00021097	HDL cholesterol	General health
rs4895441	A	G	64	29	1	65	29	0	0.84	0.85	0.16	0.15	A	0.0928	0.00021097	Mean corpuscular hemoglobin concentration	Heart health and disorders
rs12048046	T	C	65	28	1	66	24	4	0.84	0.83	0.16	0.17	T	1.52	0.000205465	Periodontitis CDC_AAP	Misc
rs6871803	G	T	66	26	2	67	22	5	0.84	0.83	0.16	0.17	T	0.176	0.000205465	Uric acid levels	General health
rs17864092	T	C	67	24	3	67	22	5	0.84	0.83	0.16	0.17	T	0.17	0.000205465	Depression quantitative trait	Brain health and disorders
rs2107357	A	G	3	27	64	0	31	63	0.18	0.16	0.82	0.84	A	0.0879	0.000200321	Self-reported allergy	General health
rs183345681	G	A	61	32	1	66	24	4	0.82	0.83	0.18	0.17	A	2.4	0.000195503	Emphysema imaging phenotypes	Pulmonology
rs12306296	G	A	65	26	3	61	32	1	0.83	0.82	0.17	0.18	G	1.67	0.000195503	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs2242652	G	A	64	28	2	63	28	3	0.83	0.82	0.17	0.18	G	1.15	0.000195503	Prostate cancer	Cancer
rs363598	T	C	65	26	3	63	28	3	0.83	0.82	0.17	0.18	C	1.006	0.000195503	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs6834498	C	T	63	28	3	60	32	2	0.82	0.81	0.18	0.19	A	0.16	0.000186741	Anger	General health
rs11923600	G	A	61	32	1	63	26	5	0.82	0.81	0.18	0.19	G	0.084	0.000186741	Height	General health
rs483465	A	G	4	28	62	2	30	62	0.19	0.18	0.81	0.82	A	0.045	0.000186741	HDL cholesterol	General health
rs62204504	T	C	86	8	0	87	7	0	0.96	0.96	0.04	0.04	C	3.22	0.000184672	Clozapine-induced agranulocytosis	General health
rs72858496	C	T	87	7	0	86	8	0	0.96	0.96	0.04	0.04	T	1.46	0.000184672	Renal cell carcinoma	Cancer
rs10771399	A	G	86	8	0	87	7	0	0.96	0.96	0.04	0.04	G	1.3889	0.000184672	Breast cancer estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative	Cancer
rs17083838	G	A	87	7	0	86	8	0	0.96	0.96	0.04	0.04	A	1.37	0.000184672	Sporadic pituitary adenoma	Cancer
rs7555082	G	A	86	8	0	87	7	0	0.96	0.96	0.04	0.04	A	1.1317531	0.000184672	Crohn's disease	Digestive system and its disorders
rs2278255	C	G	86	8	0	87	7	0	0.96	0.96	0.04	0.04	G	1	0.000184672	Visceral fat	Obesity
rs17744121	A	G	87	7	0	90	0	4	0.96	0.96	0.04	0.04	G	1	0.000184672	Visceral fat	Obesity
rs12624302	T	C	86	8	0	87	7	0	0.96	0.96	0.04	0.04	T	0.4923	0.000184672	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs16952065	C	T	87	7	0	86	8	0	0.96	0.96	0.04	0.04	C	0.4401	0.000184672	IgG glycosylation	Immune diseases and disorders
rs56118546	T	G	86	8	0	87	7	0	0.96	0.96	0.04	0.04	T	0.039	0.000184672	Neuroticism	Brain health and disorders
rs62296075	A	G	87	7	0	86	8	0	0.96	0.96	0.04	0.04	G	0.03	0.000184672	Obesity-related traits	Obesity
rs2582532	T	C	4	27	63	2	33	59	0.19	0.20	0.81	0.80	C	1.18	0.000182749	Rheumatoid arthritis	Immune diseases and disorders
rs8022206	G	A	64	25	5	58	35	1	0.81	0.80	0.19	0.20	G	3.197	0.000182749	Platelet count	Heart health and disorders
rs204993	A	G	63	25	6	64	25	5	0.80	0.81	0.20	0.19	A	1.17	0.000182749	Asthma	Immune diseases and disorders
rs2977125	A	T	63	27	4	60	31	3	0.81	0.80	0.19	0.20	T	1.0638298	0.000182749	Schizophrenia	Brain health and disorders
rs9472138	C	T	61	29	4	62	29	3	0.80	0.81	0.20	0.19	T	1.06	0.000182749	Type 2 diabetes	Diabetes
rs2192271	C	T	64	25	5	60	31	3	0.81	0.80	0.19	0.20	T	1	0.000182749	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs3743200	C	T	60	32	2	59	32	3	0.81	0.80	0.19	0.20	A	0.16	0.000178987	RR interval heart rate	Heart health and disorders
rs11167764	A	C	2	32	60	7	24	63	0.19	0.20	0.81	0.80	C	1.06	0.000178987	Crohn's disease	Digestive system and its disorders
rs1042034	C	T	2	32	60	3	32	59	0.19	0.20	0.81	0.80	C	0.9	0.000178987	HDL cholesterol	General health
rs210134	A	G	5	27	62	2	35	57	0.20	0.21	0.80	0.79	G	4.957	0.000175439	Platelet count	Heart health and disorders
rs7187365	T	C	3	33	58	2	33	59	0.21	0.20	0.79	0.80	C	1.22	0.000175439	Obesity early onset extreme	Obesity
rs6809854	A	G	58	33	3	59	33	2	0.79	0.80	0.21	0.20	G	1.14	0.000175439	Psoriasis	Immune diseases and disorders
rs4918798	C	A	58	34	2	56	36	2	0.80	0.79	0.20	0.21	C	6.22	0.000172087	Warfarin maintenance dose	General health
rs17772222	A	G	57	34	3	57	36	1	0.79	0.80	0.21	0.20	A	0.21	0.000172087	Coronary artery calcification	Heart health and disorders
rs12602901	G	C	59	32	3	59	30	5	0.80	0.79	0.20	0.21	C	0.037	0.000172087	Blood metabolite levels	Heart health and disorders
rs1934963	T	C	58	34	2	56	36	2	0.80	0.79	0.20	0.21	T	0.029	0.000172087	Blood metabolite levels	Heart health and disorders
rs1672691	C	T	60	27	7	60	29	5	0.78	0.79	0.22	0.21	A	2.5	0.000168919	Diisocyanate-induced asthma	Pulmonology
rs7779018	A	G	59	31	4	55	37	2	0.79	0.78	0.21	0.22	A	1.06	0.000168919	Schizophrenia	Brain health and disorders
rs10916661	G	A	57	34	3	55	36	3	0.79	0.78	0.21	0.22	A	4.426	0.00016592	Warfarin maintenance dose	General health
rs6964969	A	G	58	30	6	59	30	5	0.78	0.79	0.22	0.21	C	1.67	0.00016592	Acute lymphoblastic leukemia childhood	Cancer
rs4132601	T	G	58	30	6	59	30	5	0.78	0.79	0.22	0.21	G	1.43	0.00016592	Acute lymphoblastic leukemia childhood	Cancer
rs11078597	T	C	57	32	5	59	30	5	0.78	0.79	0.22	0.21	C	0.0205	0.00016592	Serum albumin level	General health
rs154663	T	C	6	30	58	6	28	60	0.22	0.21	0.78	0.79	T	0.084	0.00016592	Height	General health
rs3094084	A	T	86	8	0	85	9	0	0.96	0.95	0.04	0.05	T	2.3	0.000163854	Cutaneous lupus erythematosus	Immune diseases and disorders
rs458017	T	C	85	9	0	86	8	0	0.95	0.96	0.05	0.04	G	1.37	0.000163854	Psoriasis	Immune diseases and disorders
rs6806528	C	T	86	7	1	87	6	1	0.95	0.96	0.05	0.04	A	1.19	0.000163854	Celiac disease	Immune diseases and disorders
rs17609240	T	G	3	37	54	6	29	59	0.23	0.22	0.77	0.78	G	0.02	0.000163079	Hematological parameters	Heart health and disorders
rs10516487	G	A	56	35	3	52	41	1	0.78	0.77	0.22	0.23	G	1.38	0.000163079	Systemic lupus erythematosus	Immune diseases and disorders
rs11641231	C	G	57	31	6	57	33	4	0.77	0.78	0.23	0.22	G	1	0.000163079	Response to statin therapy	General health
rs7273787	A	G	60	27	7	53	39	2	0.78	0.77	0.22	0.23	A	0.022	0.000163079	Height	General health
rs2642442	C	T	5	34	55	4	34	56	0.23	0.22	0.77	0.78	T	1.38	0.000160385	Cholesterol, total	General health
rs6429703	T	C	3	37	54	6	33	55	0.23	0.24	0.77	0.76	T	2.942	0.000157828	Adverse response to chemotherapy neutropenia_leucopenia paclitaxel + carboplatin	Drug response
rs11098403	A	G	57	29	8	56	33	5	0.76	0.77	0.24	0.23	G	1.15	0.000157828	Schizophrenia	Brain health and disorders
rs10896135	G	C	56	31	7	55	35	4	0.76	0.77	0.24	0.23	G	1.12	0.000157828	Bipolar disorder	Brain health and disorders
rs2018293	C	T	56	33	5	54	35	5	0.77	0.76	0.23	0.24	T	0.3091	0.000157828	Vascular brain injury	Brain health and disorders
rs2250149	T	C	57	31	6	55	33	6	0.77	0.76	0.23	0.24	T	0.114	0.000157828	Economic and political preferences feminism_equality	Mental aptitude and behavioural traits
rs13387221	G	A	51	41	2	57	31	6	0.76	0.77	0.24	0.23	A	0.064	0.000157828	Intelligence childhood	Mental aptitude and behavioural traits
rs2675399	A	G	54	37	3	53	37	4	0.77	0.76	0.23	0.24	G	0.03	0.000157828	Obesity-related traits	Obesity
rs9934935	G	A	58	27	9	53	39	2	0.76	0.77	0.24	0.23	A	0.0018	0.000157828	Trans fatty acid levels	General health
rs1317209	G	A	51	40	3	56	32	6	0.76	0.77	0.24	0.23	T	1.34	0.0001554	Ulcerative colitis	Immune diseases and disorders
rs339331	T	C	56	32	6	53	36	5	0.77	0.76	0.23	0.24	T	1.2820514	0.0001554	Prostate cancer	Cancer
rs3791556	G	A	56	30	8	58	28	8	0.76	0.77	0.24	0.23	A	1.08	0.0001554	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs10901513	T	C	52	38	4	54	36	4	0.76	0.77	0.24	0.23	T	1	0.0001554	Visceral fat	Obesity
rs6982250	C	T	54	34	6	56	32	6	0.76	0.77	0.24	0.23	T	0.046	0.0001554	Height	General health
rs1919922	C	T	59	25	10	53	35	6	0.76	0.75	0.24	0.25	T	155.52	0.000153092	Lentiform nucleus volume	Misc
rs10457838	C	T	54	33	7	53	37	4	0.75	0.76	0.25	0.24	C	6.702	0.000153092	Post-traumatic stress disorder	Brain health and disorders
rs897876	C	T	55	33	6	49	43	2	0.76	0.75	0.24	0.25	T	1.036	0.000153092	Pulse pressure in young-onset hypertension	Heart health and disorders
rs2242663	T	C	55	32	7	54	32	8	0.76	0.74	0.24	0.26	T	1.2	0.000150898	Bipolar disorder	Brain health and disorders
rs10517086	G	A	55	30	9	53	36	5	0.74	0.76	0.26	0.24	A	1.09	0.000150898	Type 1 diabetes	Diabetes
rs2332700	C	G	8	32	54	5	36	53	0.26	0.24	0.74	0.76	C	1.08	0.000150898	Schizophrenia	Brain health and disorders
rs2392362	T	C	7	32	55	5	38	51	0.24	0.26	0.76	0.74	T	0.14	0.000150898	Information processing speed	Mental aptitude and behavioural traits
rs1344555	C	T	54	34	6	52	36	6	0.76	0.74	0.24	0.26	T	0.034	0.000150898	Pulmonary function	Pulmonology
rs12638862	A	G	52	35	7	50	41	3	0.74	0.75	0.26	0.25	A	1.37	0.00014881	Multiple myeloma IgH translocation	Cancer
rs11764116	G	T	49	41	4	55	31	8	0.74	0.75	0.26	0.25	A	1	0.00014881	Ulcerative colitis	Immune diseases and disorders
rs2585617	A	G	0	10	84	1	7	86	0.05	0.05	0.95	0.95	A	0.03	0.000147427	Phospholipid levels plasma	General health
rs11063421	T	C	86	7	1	84	10	0	0.95	0.95	0.05	0.05	T	1.08	0.000147427	Schizophrenia	Brain health and disorders
rs35829183	C	T	84	10	0	85	9	0	0.95	0.95	0.05	0.05	C	0.081	0.000147427	White wine liking	Mental aptitude and behavioural traits
rs3749779	A	C	85	8	1	85	9	0	0.95	0.95	0.05	0.05	C	0.02	0.000147427	Obesity-related traits	Obesity
rs4760854	G	A	11	26	57	10	30	54	0.26	0.27	0.74	0.73	G	0.1574	0.000146821	IgG glycosylation	Immune diseases and disorders
rs4657015	A	G	8	35	51	8	33	53	0.27	0.26	0.73	0.74	G	1	0.000144928	Visceral adipose tissue adjusted for BMI	Obesity
rs6677604	G	A	51	37	6	50	37	7	0.74	0.73	0.26	0.27	G	1.57	0.000144928	IgA nephropathy	Immune diseases and disorders
rs17302400	C	T	49	39	6	51	37	6	0.73	0.74	0.27	0.26	T	1	0.000144928	Visceral adipose tissue adjusted for BMI	Obesity
rs55940034	A	G	53	30	11	49	40	5	0.72	0.73	0.28	0.27	G	1.07	0.000143123	Myocardial infarction	Heart health and disorders
rs12582168	T	C	47	41	6	48	41	5	0.72	0.73	0.28	0.27	C	1.454	0.000141403	Adverse response to chemotherapy neutropenia_leucopenia all antimetabolite drugs	Drug response
rs1316298	A	G	50	37	7	52	31	11	0.73	0.72	0.27	0.28	T	1.41	0.000141403	Lung cancer smoking interaction	Cancer
rs1106634	G	A	52	31	11	51	35	8	0.72	0.73	0.28	0.27	A	1.3	0.000141403	Major depressive disorder broad	Brain health and disorders
rs26232	C	T	48	41	5	50	35	9	0.73	0.72	0.27	0.28	C	1.14	0.000141403	Rheumatoid arthritis	Immune diseases and disorders
rs758324	G	T	9	36	49	8	36	50	0.29	0.28	0.71	0.72	T	1.1627907	0.000139762	Alzheimer's disease in APOE e4- carriers	Brain health and disorders
rs2318131	A	C	48	39	7	47	39	8	0.72	0.71	0.28	0.29	C	0.038	0.000138198	Motion sickness	Misc
rs2423279	T	C	48	38	8	44	44	6	0.71	0.70	0.29	0.30	C	1.14	0.000136705	Colorectal cancer	Cancer
rs9871864	T	C	44	46	4	47	38	9	0.71	0.70	0.29	0.30	G	1	0.000136705	Behavioural disinhibition generation interaction	Brain health and disorders
rs3822735	A	G	8	40	46	4	46	44	0.30	0.29	0.70	0.71	G	2.062	0.000136705	Adverse response to chemotherapy neutropenia_leucopenia carboplatin	Drug response
rs1159268	G	A	46	41	7	46	39	9	0.71	0.70	0.29	0.30	A	1.17	0.000135281	Acne severe	Misc
rs13004237	A	G	50	31	13	46	41	7	0.70	0.71	0.30	0.29	G	1.0526316	0.000135281	Schizophrenia	Brain health and disorders
rs7672495	T	C	45	41	8	41	51	2	0.70	0.71	0.30	0.29	C	1	0.000135281	Pediatric autoimmune diseases	Immune diseases and disorders
rs1394125	G	A	43	45	6	45	43	6	0.70	0.71	0.30	0.29	A	0.043	0.000135281	Urate levels	General health
rs1682361	G	C	12	34	48	10	36	48	0.31	0.30	0.69	0.70	G	1.0526316	0.000133923	Schizophrenia	Brain health and disorders
rs5004866	T	A	1	56	37	1	54	39	0.31	0.30	0.69	0.70	T	0.3029	0.000133923	Metabolite levels MHPG	General health
rs9264942	T	C	47	38	9	43	44	7	0.70	0.69	0.30	0.31	C	1.145	0.000133923	Crohn's disease	Digestive system and its disorders
rs10886159	T	C	47	38	9	47	36	11	0.70	0.69	0.30	0.31	C	1	0.000133923	Celiac disease	Immune diseases and disorders
rs114945094	G	A	48	36	10	46	38	10	0.70	0.69	0.30	0.31	G	0.135	0.000133923	Anorexia nervosa	Brain health and disorders
rs993925	C	T	45	42	7	43	44	7	0.70	0.69	0.30	0.31	T	0.034	0.000133923	Pulmonary function	Pulmonology
rs7625357	C	T	48	33	13	46	39	9	0.69	0.70	0.31	0.30	T	1	0.000132626	Childhood and early adolescence aggressive behavior	Brain health and disorders
rs7712671	G	A	45	40	9	41	46	7	0.69	0.68	0.31	0.32	G	1.0526316	0.000131389	Schizophrenia	Brain health and disorders
rs1033667	C	T	40	50	4	44	40	10	0.69	0.68	0.31	0.32	T	0.025	0.000131389	Optic cup area	Misc
rs273914	A	T	14	32	48	4	50	40	0.32	0.31	0.68	0.69	A	0.023	0.000131389	Blood metabolite levels	Heart health and disorders
rs6538761	A	C	11	39	44	5	49	40	0.32	0.31	0.68	0.69	A	1.24	0.000130208	Autism	Brain health and disorders
rs7015657	C	G	42	43	9	46	37	11	0.68	0.69	0.32	0.31	G	1.15	0.000130208	Migraine with aura	Brain health and disorders
rs12242110	A	G	44	41	9	38	51	5	0.69	0.68	0.31	0.32	G	1.15	0.000130208	Crohn's disease	Digestive system and its disorders
rs3751913	T	C	48	31	15	40	45	9	0.68	0.66	0.32	0.34	C	1.23	0.000128008	Follicular lymphoma	Cancer
rs8069176	G	A	39	47	8	45	37	12	0.66	0.68	0.34	0.32	A	0.066	0.000128008	Fractional exhaled nitric oxide childhood	Pulmonology
rs747650	C	T	37	49	8	40	45	9	0.65	0.66	0.35	0.34	G	1.24	0.000126008	Acne severe	Misc
rs7014346	A	G	9	45	40	11	43	40	0.34	0.35	0.66	0.65	A	1.19	0.000126008	Colorectal cancer	Cancer
rs7112925	C	T	41	43	10	41	41	12	0.66	0.65	0.34	0.35	T	0.024	0.000126008	Height	General health
rs9469003	T	C	40	44	10	41	40	13	0.66	0.65	0.34	0.35	C	1.73	0.000125078	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis SJS_TEN	Drug response
rs8049367	T	C	43	38	13	39	44	11	0.66	0.65	0.34	0.35	C	1.35	0.000125078	Nonsyndromic cleft lip with or without cleft palate	Misc
rs1925265	A	G	41	42	11	40	42	12	0.66	0.65	0.34	0.35	G	0.2912	0.000125078	Metabolite levels MHPG	General health
rs3853824	T	C	11	43	40	11	45	38	0.35	0.36	0.65	0.64	A	1.0847627	0.000124193	Crohn's disease	Digestive system and its disorders
rs2908835	C	T	41	41	12	40	41	13	0.65	0.64	0.35	0.36	T	0.14	0.000124193	Information processing speed	Mental aptitude and behavioural traits
rs9268877	A	G	13	42	39	12	42	40	0.36	0.35	0.64	0.65	T	1.45	0.00012335	Ulcerative colitis	Immune diseases and disorders
rs2562784	A	G	40	42	12	37	46	11	0.65	0.64	0.35	0.36	G	0.34	0.00012335	Height	General health
rs10510921	A	G	83	11	0	82	12	0	0.94	0.94	0.06	0.06	G	3.52	0.000123168	Clozapine-induced agranulocytosis	General health
rs13081855	G	T	82	12	0	83	11	0	0.94	0.94	0.06	0.06	T	1.23	0.000123168	Age-related macular degeneration	Aging
rs3755206	T	G	83	10	1	84	9	1	0.94	0.94	0.06	0.06	T	0.048	0.000123168	Height	General health
rs6687813	A	C	0	11	83	1	10	83	0.06	0.06	0.94	0.94	A	10.1	0.000123168	D-dimer levels	Heart health and disorders
rs1890185	A	G	39	41	14	38	45	11	0.63	0.64	0.37	0.36	G	1.06	0.000122549	Migraine	Brain health and disorders
rs1894407	C	A	37	44	13	39	42	13	0.63	0.64	0.37	0.36	C	1.17	0.000121788	Thyroid peroxidase antibody positivity	Immune diseases and disorders
rs9803659	T	C	37	44	13	42	36	16	0.63	0.64	0.37	0.36	C	0.03	0.000121788	Liver enzyme levels	General health
rs1129187	G	T	36	45	13	39	41	14	0.62	0.63	0.38	0.37	T	1.13	0.000121065	Alzheimer's disease in APOE e4+ carriers	Brain health and disorders
rs1466788	A	G	15	41	38	9	51	34	0.38	0.37	0.62	0.63	A	0.007	0.000121065	Blood metabolite levels	Heart health and disorders
rs2478118	C	T	39	40	15	36	44	14	0.63	0.62	0.37	0.38	T	1.61	0.00012038	Lupus nephritis in systemic lupus erythematosus	Immune diseases and disorders
rs2043112	G	A	40	35	19	34	49	11	0.61	0.62	0.39	0.38	A	0.04	0.000119732	Obesity-related traits	Obesity
rs10427255	C	T	15	41	38	16	41	37	0.38	0.39	0.62	0.61	C	1.32	0.000119732	Common traits Other	Misc
rs9292468	T	C	13	48	33	8	56	30	0.39	0.38	0.61	0.62	T	1.18	0.000119119	Height	General health
rs1095368	T	C	34	48	12	31	52	11	0.62	0.61	0.38	0.39	C	0.1528	0.000119119	IgG glycosylation	Immune diseases and disorders
rs11958779	G	A	17	40	37	14	44	36	0.39	0.38	0.61	0.62	A	0.027	0.000119119	Height	General health
rs711355	T	C	16	43	35	12	49	33	0.40	0.39	0.60	0.61	T	1	0.00011854	Response to antipsychotic treatment	General health
rs7941030	T	C	31	51	12	38	39	17	0.60	0.61	0.40	0.39	G	0.31	0.00011854	HDL cholesterol	General health
rs10189230	T	A	37	39	18	35	45	14	0.60	0.61	0.40	0.39	T	0.092	0.00011854	Urate levels in lean individuals	Obesity
rs17041	A	G	31	51	12	35	45	14	0.60	0.61	0.40	0.39	A	0.03	0.00011854	Obesity-related traits	Obesity
rs3007729	T	C	32	48	14	34	46	14	0.60	0.61	0.40	0.39	T	1.35	0.000117994	Diabetic retinopathy	Diabetes
rs6750634	G	A	37	40	17	32	48	14	0.61	0.60	0.39	0.40	A	0.2936	0.000117994	Metabolite levels HVA_MHPG ratio	Brain health and disorders
rs2580816	C	T	37	40	17	32	48	14	0.61	0.60	0.39	0.40	T	0.045	0.000117994	Height	General health
rs10504073	C	T	11	52	31	16	44	34	0.39	0.40	0.61	0.60	T	0.031	0.000117994	Blood metabolite ratios	Heart health and disorders
rs1895585	A	G	14	49	31	13	49	32	0.41	0.40	0.59	0.60	A	3.19	0.000117481	PR interval	Heart health and disorders
rs181500	G	T	19	39	36	15	45	34	0.41	0.40	0.59	0.60	T	1.24	0.000117481	Bipolar disorder and schizophrenia	Brain health and disorders
rs1514177	C	G	33	45	16	32	49	13	0.59	0.60	0.41	0.40	C	1.06	0.000117481	Obesity	Obesity
rs2001970	T	C	34	45	15	31	49	14	0.60	0.59	0.40	0.41	T	1	0.000117481	Visceral fat	Obesity
rs2227667	A	G	36	41	17	32	47	15	0.60	0.59	0.40	0.41	A	0.027	0.000117481	Plasma plasminogen activator levels	General health
rs12653946	C	T	33	44	17	29	54	11	0.59	0.60	0.41	0.40	T	1.39	0.000117	Prostate cancer	Cancer
rs2331841	G	A	35	42	17	30	50	14	0.60	0.59	0.40	0.41	A	0.046	0.000117	Body mass index	Obesity
rs1522232	T	C	32	45	17	40	31	23	0.58	0.59	0.42	0.41	C	2.22	0.00011655	AIDS	Immune diseases and disorders
rs9914266	T	C	32	45	17	34	43	17	0.58	0.59	0.42	0.41	C	1.05	0.00011655	Myocardial infarction	Heart health and disorders
rs1836127	G	T	35	41	18	34	41	19	0.59	0.58	0.41	0.42	A	0.76	0.00011655	Non-alcoholic fatty liver disease histology other	Obesity
rs4256430	G	A	27	54	13	32	46	16	0.57	0.59	0.43	0.41	A	0.099	0.000116131	Electroencephalographic traits in alcoholism	Heart health and disorders
rs4929949	T	C	34	42	18	34	40	20	0.59	0.57	0.41	0.43	C	0.06	0.000116131	Body mass index	Obesity
rs706334	A	C	34	42	18	30	48	16	0.59	0.57	0.41	0.43	A	0.036302876	0.000116131	LDL peak particle diameter total fat intake interaction	General health
rs929641	A	G	29	52	13	34	40	20	0.59	0.57	0.41	0.43	A	0.02	0.000116131	Body mass index	Obesity
rs12822507	A	G	32	43	19	36	37	21	0.57	0.58	0.43	0.42	A	1.1628	0.000115741	Systemic lupus erythematosus	Immune diseases and disorders
rs1678542	C	G	35	39	20	34	39	21	0.58	0.57	0.42	0.43	C	1.12	0.000115741	Rheumatoid arthritis	Immune diseases and disorders
rs2693698	A	G	15	49	30	23	35	36	0.42	0.43	0.58	0.57	G	1.0649627	0.000115741	Schizophrenia	Brain health and disorders
rs3091315	A	G	28	52	14	29	48	17	0.57	0.56	0.43	0.44	G	1.1525311	0.00011538	Crohn's disease	Digestive system and its disorders
rs283610	A	G	29	48	17	34	40	20	0.56	0.57	0.44	0.43	G	0.03	0.00011538	Obesity-related traits	Obesity
rs5749696	T	C	18	47	29	18	45	31	0.44	0.43	0.56	0.57	C	1.0526316	0.000115048	Schizophrenia	Brain health and disorders
rs652722	C	T	33	40	21	27	50	17	0.56	0.55	0.44	0.45	C	2.75	0.000114745	Body mass index	Obesity
rs1461503	A	C	34	38	22	27	50	17	0.56	0.55	0.44	0.45	C	0.05	0.000114745	Menarche age at onset	Reproductive health
rs667282	T	C	32	42	20	32	40	22	0.56	0.55	0.44	0.45	C	0.033	0.000114745	Smoking behavior	General health
rs4791774	A	G	18	48	28	16	50	28	0.45	0.44	0.55	0.56	G	1.56	0.000114745	Nonsyndromic cleft lip with or without cleft palate	Misc
rs2675609	T	C	20	44	30	19	44	31	0.45	0.44	0.55	0.56	T	0.036	0.000114745	Serum total protein level	General health
rs4727963	C	T	32	39	23	34	37	23	0.55	0.56	0.45	0.44	C	2.094	0.000114469	Adverse response to chemotherapy neutropenia_leucopenia docetaxel	Drug response
rs231770	C	T	27	49	18	30	45	19	0.55	0.56	0.45	0.44	T	1.39	0.000114469	Myasthenia gravis	Brain health and disorders
rs600550	C	T	24	55	15	30	45	19	0.55	0.56	0.45	0.44	T	0.0137	0.000114469	Lipoprotein-associated phospholipase A2 activity and mass	General health
rs4942486	T	C	21	42	31	23	40	31	0.45	0.46	0.55	0.54	T	0.024	0.00011422	LDL cholesterol	General health
rs7174156	A	G	27	49	18	25	51	18	0.55	0.54	0.45	0.46	A	1.6	0.000113999	Response to efavirenz-containing treatment in HIV 1 infection virologic failure	General health
rs3736485	A	G	27	47	20	33	37	24	0.54	0.55	0.46	0.45	A	0.019	0.000113999	Body mass index	Obesity
rs2047937	C	T	26	49	19	28	47	19	0.54	0.55	0.46	0.45	C	0.0159	0.000113999	Waist-to-hip ratio adjusted for body mass index	Obesity
rs2609653	C	T	0	12	82	1	11	82	0.06	0.07	0.94	0.93	T	1.13	0.00011396	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs237238	A	G	81	13	0	82	12	0	0.93	0.94	0.07	0.06	A	0.156	0.00011396	Alcoholism 12-month weekly alcohol consumption	General health
rs4985726	C	G	82	12	0	82	11	1	0.94	0.93	0.06	0.07	G	0.135	0.00011396	Non-albumin protein levels	General health
rs5744897	C	T	84	7	3	82	12	0	0.93	0.94	0.07	0.06	C	0.087	0.00011396	Urate levels in overweight individuals	Obesity
rs9901675	G	A	81	13	0	82	12	0	0.93	0.94	0.07	0.06	A	0.057	0.00011396	Sex hormone-binding globulin levels	Reproductive health
rs16886173	T	G	81	13	0	82	12	0	0.93	0.94	0.07	0.06	G	0.028950978	0.00011396	Urate levels BMI interaction	Obesity
rs6733839	C	T	29	44	21	24	52	18	0.54	0.53	0.46	0.47	T	1.2	0.000113804	Alzheimer's disease in APOE e4+ carriers	Brain health and disorders
rs1401454	C	T	21	46	27	19	48	27	0.47	0.46	0.53	0.54	T	0.55	0.000113804	Blood pressure	Heart health and disorders
rs7953959	C	T	26	36	32	16	54	24	0.47	0.46	0.53	0.54	C	0.1389	0.000113804	IgG glycosylation	Immune diseases and disorders
rs2227551	G	T	19	51	24	21	45	28	0.47	0.46	0.53	0.54	C	1.1045585	0.000113636	Crohn's disease	Digestive system and its disorders
rs6539247	T	C	20	47	27	19	51	24	0.46	0.47	0.54	0.53	T	0.82	0.000113636	Attention function in attention deficit hyperactive disorder	Brain health and disorders
rs3105593	C	T	15	57	22	19	51	24	0.46	0.47	0.54	0.53	T	0.66	0.000113636	QT interval	Heart health and disorders
rs4911259	T	G	21	46	27	23	44	27	0.47	0.48	0.53	0.52	G	1.075	0.000113494	Inflammatory bowel disease	Immune diseases and disorders
rs34884278	C	T	24	42	28	17	54	23	0.48	0.47	0.52	0.53	C	1	0.000113494	Pediatric autoimmune diseases	Immune diseases and disorders
rs4395360	C	T	22	46	26	24	40	30	0.48	0.47	0.52	0.53	C	0.017	0.000113494	Body mass index	Obesity
rs1398024	G	T	25	50	19	23	52	19	0.53	0.52	0.47	0.48	A	1.23	0.000113494	Crohn's disease and sarcoidosis combined	Digestive system and its disorders
rs494459	C	T	25	49	20	27	43	24	0.53	0.52	0.47	0.48	T	0.02	0.000113379	Height	General health
rs159497	C	T	22	47	25	22	45	27	0.48	0.47	0.52	0.53	C	131.9	0.000113379	Forced expiratory volume in 1 second environmental interaction	Pulmonology
rs8080944	G	A	22	45	27	20	51	23	0.47	0.48	0.53	0.52	A	0.341	0.000113379	Primary tooth development time to first tooth eruption	Misc
rs12045693	C	A	23	45	26	10	69	15	0.48	0.47	0.52	0.53	C	0.1539	0.000113379	IgG glycosylation	Immune diseases and disorders
rs7795991	A	G	24	44	26	16	58	20	0.49	0.48	0.51	0.52	G	1.05	0.000113289	Type 2 diabetes	Diabetes
rs2858331	A	G	23	46	25	24	42	28	0.49	0.48	0.51	0.52	G	1	0.000113289	IgE levels	Immune diseases and disorders
rs6421315	G	C	28	42	24	22	52	20	0.52	0.51	0.48	0.49	C	0.2363	0.000113289	IgG glycosylation	Immune diseases and disorders
rs12589060	A	G	23	47	24	21	49	24	0.49	0.48	0.51	0.52	G	1	0.000113225	Hormone measurements	General health
rs2442719	C	T	23	45	26	22	49	23	0.48	0.49	0.52	0.51	A	0.3298	0.000113225	HIV-1 viral setpoint	Immune diseases and disorders
rs634990	T	C	27	43	24	23	49	22	0.52	0.51	0.48	0.49	C	0.23	0.000113225	Refractive error	General health
rs7920888	T	C	25	41	28	20	53	21	0.48	0.49	0.52	0.51	A	0.03	0.000113225	Obesity-related traits	Obesity
rs2294025	G	A	23	46	25	23	48	23	0.49	0.50	0.51	0.50	T	1.16	0.000113186	Graves' disease	Immune diseases and disorders
rs2468677	G	T	25	42	27	19	56	19	0.49	0.50	0.51	0.50	G	1	0.000113186	Adiponectin levels	Obesity
rs264272	G	T	25	42	27	27	40	27	0.49	0.50	0.51	0.50	T	0.1712	0.000113186	Major depressive disorder	Brain health and disorders
rs4692589	A	G	27	40	27	24	44	26	0.50	0.49	0.50	0.51	C	0.067	0.000113186	Anxiety disorder	Brain health and disorders
rs2030746	C	T	24	46	24	26	44	24	0.50	0.51	0.50	0.49	T	0.021	0.000113186	LDL cholesterol	General health
rs2494938	G	A	23	47	24	23	49	22	0.49	0.51	0.51	0.49	A	1.18	0.000113173	Multiple cancers lung cancer, gastric cancer, and squamous cell carcinoma	Cancer
rs12655917	G	A	80	14	0	81	13	0	0.93	0.93	0.07	0.07	C	40	0.000106123	Insulin resistance_response	Drug response
rs11564258	G	A	80	14	0	81	13	0	0.93	0.93	0.07	0.07	A	1.74	0.000106123	Crohn's disease	Digestive system and its disorders
rs16893526	G	A	80	14	0	82	11	1	0.93	0.93	0.07	0.07	G	1.13	0.000106123	Coronary heart disease	Heart health and disorders
rs2068824	T	C	81	12	1	82	11	1	0.93	0.93	0.07	0.07	C	1	0.000106123	Celiac disease	Immune diseases and disorders
rs11771526	A	G	81	13	0	80	14	0	0.93	0.93	0.07	0.07	G	0.027	0.000106123	Body mass index	Obesity
rs12355831	A	G	83	7	4	81	12	1	0.92	0.93	0.08	0.07	G	1.09	9.93739E-05	Migraine	Brain health and disorders
rs10517133	G	C	81	11	2	80	14	0	0.92	0.93	0.08	0.07	C	1	9.93739E-05	Adiponectin levels	Obesity
rs328	C	G	80	14	0	80	13	1	0.93	0.92	0.07	0.08	G	0.17	9.93739E-05	HDL cholesterol	General health
rs1503351	A	G	81	12	1	79	15	0	0.93	0.92	0.07	0.08	A	0.1699	9.93739E-05	Cerebrospinal AB1-42 levels	Brain health and disorders
rs749052	T	C	82	10	2	81	11	2	0.93	0.92	0.07	0.08	T	0.067	9.93739E-05	Height	General health
rs325	T	C	80	14	0	80	13	1	0.93	0.92	0.07	0.08	T	0.05	9.93739E-05	HDL cholesterol	General health
rs1167125	C	A	1	13	80	0	14	80	0.08	0.07	0.92	0.93	C	0.03	9.93739E-05	Obesity-related traits	Obesity
rs17104363	T	C	80	13	1	78	16	0	0.92	0.91	0.08	0.09	G	0.04	9.35016E-05	Obesity-related traits	Obesity
rs1079866	C	G	79	13	2	78	16	0	0.91	0.91	0.09	0.09	G	3.9	8.8347E-05	Menarche age at onset	Reproductive health
rs17387100	A	G	79	14	1	79	13	2	0.91	0.91	0.09	0.09	G	1.76	8.8347E-05	Suicide attempts in depression or bipolar disorder	Brain health and disorders
rs1007190	C	T	78	15	1	78	16	0	0.91	0.91	0.09	0.09	T	1	8.8347E-05	DNA methylation variation	Misc
rs8023715	C	A	76	18	0	77	17	0	0.90	0.91	0.10	0.09	A	1.812	8.37872E-05	Systemic lupus erythematosus	Immune diseases and disorders
rs6057648	C	A	76	18	0	77	17	0	0.90	0.91	0.10	0.09	A	1	8.37872E-05	Attention deficit hyperactivity disorder combined symptoms	Brain health and disorders
rs12621256	A	G	78	15	1	78	14	2	0.91	0.90	0.09	0.10	G	0.092	8.37872E-05	Liver enzyme levels alanine transaminase	General health
rs1524976	A	G	2	14	78	0	19	75	0.10	0.10	0.90	0.90	A	8	7.97257E-05	PR interval	Heart health and disorders
rs2416257	C	T	77	16	1	75	19	0	0.90	0.90	0.10	0.10	G	6.1	7.97257E-05	Eosinophil counts	General health
rs33980500	C	T	76	18	0	76	17	1	0.90	0.90	0.10	0.10	T	1.95	7.97257E-05	Psoriatic arthritis	Immune diseases and disorders
rs13232179	T	A	75	19	0	76	18	0	0.90	0.90	0.10	0.10	A	1.67	7.97257E-05	Coronary heart disease	Heart health and disorders
rs11840092	T	C	74	19	1	75	18	1	0.89	0.89	0.11	0.11	C	1.37	7.28067E-05	Alcohol dependence age at onset	General health
rs12272004	C	A	75	18	1	73	21	0	0.89	0.89	0.11	0.11	A	0.07	7.28067E-05	Carotenoid and tocopherol levels	General health
rs267759	A	G	1	20	73	2	17	75	0.12	0.11	0.88	0.89	A	3.23	6.98373E-05	Response to treatment for acute lymphoblastic leukemia	General health
rs3127573	A	G	74	19	1	73	20	1	0.89	0.88	0.11	0.12	G	1.1	6.98373E-05	Creatinine levels	Immune diseases and disorders
rs12364992	A	G	74	19	1	74	18	2	0.89	0.88	0.11	0.12	G	0.03	6.98373E-05	Obesity-related traits	Obesity
rs2326810	G	C	74	18	2	72	21	1	0.88	0.88	0.12	0.12	G	1.41	6.71366E-05	Major depressive disorder broad	Brain health and disorders
rs12513840	A	G	73	19	2	73	20	1	0.88	0.88	0.12	0.12	A	1	6.71366E-05	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs1045714	A	G	74	18	2	72	21	1	0.88	0.88	0.12	0.12	G	0.081	6.71366E-05	Urate levels in lean individuals	Obesity
rs7328464	C	T	75	16	3	72	21	1	0.88	0.88	0.12	0.12	A	0.04	6.71366E-05	Obesity-related traits	Obesity
rs1346	A	T	73	19	2	72	22	0	0.88	0.88	0.12	0.12	T	0.023	6.71366E-05	Optic cup area	Misc
rs1734907	A	G	4	14	76	1	21	72	0.12	0.12	0.88	0.88	A	1.07	6.71366E-05	Schizophrenia	Brain health and disorders
rs7950811	C	A	73	19	2	71	22	1	0.88	0.87	0.12	0.13	A	1.65	6.46705E-05	Conduct disorder	Brain health and disorders
rs10866713	G	A	73	18	3	72	21	1	0.87	0.88	0.13	0.12	A	1.17	6.46705E-05	Multiple sclerosis	Brain health and disorders
rs11135910	C	T	73	19	2	70	24	0	0.88	0.87	0.12	0.13	A	1.11	6.46705E-05	Prostate cancer	Cancer
rs11191416	T	G	70	24	0	73	19	2	0.87	0.88	0.13	0.12	T	1.08	6.46705E-05	Coronary artery disease	Heart health and disorders
rs12523164	T	C	73	19	2	71	22	1	0.88	0.87	0.12	0.13	T	1	6.46705E-05	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs4835929	T	G	73	19	2	71	22	1	0.88	0.87	0.12	0.13	T	1	6.46705E-05	Attention deficit hyperactivity disorder hyperactivity-impulsivity symptoms	Brain health and disorders
rs17115100	G	T	70	24	0	71	21	2	0.87	0.87	0.13	0.13	G	1.25	6.24103E-05	Parkinson's disease	Brain health and disorders
rs11206510	T	C	72	20	2	72	19	3	0.87	0.87	0.13	0.13	T	1.15	6.24103E-05	Myocardial infarction early onset	Heart health and disorders
rs7522462	G	A	69	25	0	71	22	1	0.87	0.87	0.13	0.13	G	1.11	6.24103E-05	Multiple sclerosis	Brain health and disorders
rs8083633	T	C	72	19	3	70	24	0	0.87	0.87	0.13	0.13	T	0.154	6.24103E-05	Economic and political preferences time	Mental aptitude and behavioural traits
rs4888671	G	A	71	22	1	70	23	1	0.87	0.87	0.13	0.13	A	0.03	6.24103E-05	Obesity-related traits	Obesity
rs12457996	T	C	72	19	3	70	22	2	0.87	0.86	0.13	0.14	T	1.15	6.03318E-05	Major depressive disorder	Brain health and disorders
rs13385025	G	A	70	22	2	69	25	0	0.86	0.87	0.14	0.13	A	1.11	6.03318E-05	Rheumatoid arthritis	Immune diseases and disorders
rs2369955	A	C	71	21	2	70	22	2	0.87	0.86	0.13	0.14	A	0.136	6.03318E-05	Alcoholism heaviness of drinking	General health
rs958798	G	T	72	19	3	70	22	2	0.87	0.86	0.13	0.14	T	0.03	6.03318E-05	Self-rated health	General health
rs11900673	C	T	69	23	2	70	22	2	0.86	0.86	0.14	0.14	T	1.11	5.84146E-05	Rheumatoid arthritis	Immune diseases and disorders
rs6670165	C	T	69	23	2	72	18	4	0.86	0.86	0.14	0.14	T	1.08	5.84146E-05	Schizophrenia	Brain health and disorders
rs9329350	C	T	67	27	0	69	24	1	0.86	0.86	0.14	0.14	G	0.3006	5.84146E-05	IgG glycosylation	Immune diseases and disorders
rs56130071	G	C	69	23	2	71	20	3	0.86	0.86	0.14	0.14	C	0.057	5.84146E-05	LDL cholesterol	General health
rs11184708	A	T	70	21	3	70	22	2	0.86	0.86	0.14	0.14	T	0.03	5.84146E-05	Waist-to-hip circumference ratio interaction	General health
rs11855415	A	T	3	22	69	1	25	68	0.15	0.14	0.85	0.86	A	0.35	5.66412E-05	Handedness in dyslexia	Misc
rs7555523	C	A	3	21	70	0	28	66	0.14	0.15	0.86	0.85	C	0.28	5.66412E-05	Intraocular pressure	General health
rs5370	G	T	67	26	1	68	25	1	0.85	0.86	0.15	0.14	T	2.955	5.66412E-05	Circulating vasoactive peptide levels	Immune diseases and disorders
rs17249754	G	A	71	19	4	70	20	4	0.86	0.85	0.14	0.15	G	1.03	5.66412E-05	Systolic blood pressure	Heart health and disorders
rs6445035	G	A	70	21	3	67	26	1	0.86	0.85	0.14	0.15	A	1	5.66412E-05	Aspirin hydrolysis plasma	General health
rs2681492	T	C	71	19	4	70	20	4	0.86	0.85	0.14	0.15	T	0.85	5.66412E-05	Systolic blood pressure	Heart health and disorders
rs11584383	T	C	65	29	0	69	22	3	0.85	0.85	0.15	0.15	T	1.18	5.49964E-05	Crohn's disease	Digestive system and its disorders
rs11897432	G	A	67	25	2	69	22	3	0.85	0.85	0.15	0.15	A	1	5.49964E-05	DNA methylation variation	Misc
rs7650267	T	C	68	24	2	67	25	2	0.85	0.85	0.15	0.15	G	0.04	5.49964E-05	Obesity-related traits	Obesity
rs302010	A	G	0	29	65	4	20	70	0.15	0.15	0.85	0.85	G	1.0638298	5.49964E-05	Schizophrenia	Brain health and disorders
rs9485372	G	A	66	27	1	68	22	4	0.85	0.84	0.15	0.16	G	1.11	5.34674E-05	Breast cancer	Cancer
rs12325410	T	G	69	20	5	67	25	2	0.84	0.85	0.16	0.15	T	1.09	5.34674E-05	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs2980976	G	A	67	25	2	66	26	2	0.85	0.84	0.15	0.16	A	1	5.34674E-05	Response to antipsychotic treatment	General health
rs12265836	T	G	68	22	4	67	25	2	0.84	0.85	0.16	0.15	C	0.03	5.34674E-05	Obesity-related traits	Obesity
rs2521572	T	G	1	27	66	3	24	67	0.15	0.16	0.85	0.84	T	0.05	5.34674E-05	Phospholipid levels plasma	General health
rs13004083	A	G	67	23	4	68	22	4	0.84	0.84	0.16	0.16	A	1.47	5.20427E-05	Febrile seizures MMR vaccine-related	General health
rs3757837	T	C	67	24	3	64	29	1	0.84	0.84	0.16	0.16	C	1.27	5.20427E-05	Osteoarthritis hip	Immune diseases and disorders
rs6844153	C	T	67	23	4	68	22	4	0.84	0.84	0.16	0.16	T	0.02	5.20427E-05	Phospholipid levels plasma	General health
rs7168353	G	C	65	26	3	68	21	5	0.83	0.84	0.17	0.16	C	1	5.07125E-05	Response to angiotensin II receptor blocker therapy opposite direction w_ diuretic therapy	Drug response
rs73591976	C	A	66	25	3	66	24	4	0.84	0.83	0.16	0.17	A	0.096	5.07125E-05	HDL cholesterol	General health
rs2665838	C	G	67	22	5	64	29	1	0.83	0.84	0.17	0.16	C	0.042	5.07125E-05	Height	General health
rs6792584	G	A	2	27	65	3	26	65	0.16	0.17	0.84	0.83	G	1.24	5.07125E-05	Corneal astigmatism	General health
rs1980422	C	T	5	24	65	3	27	64	0.18	0.18	0.82	0.82	C	1.13	4.83022E-05	Rheumatoid arthritis	Immune diseases and disorders
rs12449465	T	C	64	26	4	61	33	0	0.82	0.82	0.18	0.18	G	1.26	4.83022E-05	Endometriosis	General health
rs17087335	G	T	64	26	4	61	33	0	0.82	0.82	0.18	0.18	T	1.06	4.83022E-05	Coronary artery disease	Heart health and disorders
rs6465468	G	T	66	22	6	61	33	0	0.82	0.82	0.18	0.18	T	0.025	4.83022E-05	Body mass index	Obesity
rs8056650	G	A	61	32	1	61	31	2	0.82	0.81	0.18	0.19	G	302.5	4.72077E-05	Brain structure hippocampal volume	Brain health and disorders
rs176095	A	G	65	23	6	64	26	4	0.81	0.82	0.19	0.18	T	1.4	4.72077E-05	Atopic dermatitis	Immune diseases and disorders
rs216518	C	A	63	28	3	60	33	1	0.82	0.81	0.18	0.19	A	1.21	4.72077E-05	Allergic rhinitis	Immune diseases and disorders
rs2297909	G	A	59	35	0	65	24	5	0.81	0.82	0.19	0.18	G	1	4.72077E-05	Ankylosing spondylitis	Immune diseases and disorders
rs589756	C	A	62	29	3	60	34	0	0.81	0.82	0.19	0.18	A	0.04	4.72077E-05	Obesity-related traits	Obesity
rs1005390	T	G	62	29	3	61	32	1	0.81	0.82	0.19	0.18	T	0.035	4.72077E-05	Blood metabolite ratios	Heart health and disorders
rs1556640	C	T	2	30	62	0	35	59	0.18	0.19	0.82	0.81	T	0.075	4.72077E-05	Bulimia nervosa	Brain health and disorders
rs4322600	A	G	4	28	62	3	29	62	0.19	0.19	0.81	0.81	G	1.18	4.61787E-05	Breast cancer	Cancer
rs10052657	C	A	62	28	4	59	35	0	0.81	0.81	0.19	0.19	C	1.49	4.61787E-05	Esophageal cancer	Cancer
rs1474055	C	T	63	27	4	59	34	1	0.81	0.81	0.19	0.19	T	1.214	4.61787E-05	Parkinson's disease	Brain health and disorders
rs7601137	T	C	63	25	6	60	32	2	0.80	0.81	0.20	0.19	T	2.32	4.521E-05	Mammographic density	Reproductive health
rs312457	G	A	3	30	61	2	33	59	0.19	0.20	0.81	0.80	G	1.2	4.521E-05	Type 2 diabetes	Diabetes
rs347685	C	A	5	26	63	4	29	61	0.19	0.20	0.81	0.80	C	1.09	4.521E-05	Chronic kidney disease	Immune diseases and disorders
rs7201408	A	G	62	28	4	61	29	4	0.81	0.80	0.19	0.20	A	1	4.521E-05	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs7185264	G	A	62	28	4	61	29	4	0.81	0.80	0.19	0.20	A	1	4.521E-05	Attention deficit hyperactivity disorder inattention symptoms	Brain health and disorders
rs10009321	G	T	4	29	61	3	30	61	0.20	0.19	0.80	0.81	G	0.2186	4.521E-05	Neurofibrillary tangles	Brain health and disorders
rs149740259	G	A	59	33	2	57	36	1	0.80	0.80	0.20	0.20	A	0.2412	4.42968E-05	Periodontitis Mean PAL	Misc
rs7557067	A	G	60	31	3	60	30	4	0.80	0.80	0.20	0.20	G	0.08	4.42968E-05	Triglycerides	General health
rs7826906	G	A	2	34	58	5	27	62	0.20	0.20	0.80	0.80	G	1.316	4.42968E-05	Gastritis	Cancer
rs40200	A	G	5	28	61	2	33	59	0.20	0.20	0.80	0.80	G	0.67	4.42968E-05	Urinary metabolites H-NMR features	General health
rs274068	C	A	5	29	60	4	30	60	0.21	0.20	0.79	0.80	C	2.85	4.34348E-05	Lupus nephritis in systemic lupus erythematosus	Immune diseases and disorders
rs1320976	G	A	57	36	1	60	29	5	0.80	0.79	0.20	0.21	A	2.06	4.34348E-05	QT interval	Heart health and disorders
rs1318653	T	C	60	30	4	57	35	2	0.80	0.79	0.20	0.21	T	1.43	4.34348E-05	Febrile seizures MMR vaccine-related	General health
rs1931575	T	C	59	32	3	61	27	6	0.80	0.79	0.20	0.21	T	0.0178	4.34348E-05	Palmitoleic acid 16:1n-7 plasma levels	General health
rs2118405	T	C	2	35	57	4	32	58	0.21	0.21	0.79	0.79	T	4.782	4.26203E-05	Very long-chain saturated fatty acid levels fatty acid 22:0	General health
rs1049564	G	A	58	33	3	60	28	6	0.79	0.79	0.21	0.21	T	2.08	4.26203E-05	Interferon alpha levels in systemic lupus erythematosus	Immune diseases and disorders
rs3129269	C	A	57	35	2	56	36	2	0.79	0.79	0.21	0.21	C	1.29	4.26203E-05	IgA nephropathy	Immune diseases and disorders
rs746080	T	G	5	29	60	5	30	59	0.21	0.21	0.79	0.79	T	1	4.26203E-05	Visceral adipose tissue adjusted for BMI	Obesity
rs435066	T	C	59	31	4	57	34	3	0.79	0.79	0.21	0.21	C	0.1812	4.26203E-05	IgG glycosylation	Immune diseases and disorders
rs322668	G	A	6	27	61	2	36	56	0.21	0.21	0.79	0.79	G	0.159	4.26203E-05	IgG glycosylation	Immune diseases and disorders
rs6122972	A	G	60	28	6	55	37	2	0.79	0.78	0.21	0.22	A	2.02	4.18498E-05	Bipolar disorder	Brain health and disorders
rs12580100	A	G	56	35	3	59	30	5	0.78	0.79	0.22	0.21	A	1.284	4.18498E-05	Psoriasis	Immune diseases and disorders
rs10094872	A	T	58	32	4	53	41	0	0.79	0.78	0.21	0.22	T	1.26	4.18498E-05	Urinary bladder cancer	Cancer
rs17712049	T	C	5	30	59	4	33	57	0.21	0.22	0.79	0.78	C	1.569	4.18498E-05	Refractive astigmatism	General health
rs12713956	A	G	57	33	4	55	36	3	0.78	0.78	0.22	0.22	G	4.86	4.11201E-05	LDL cholesterol	General health
rs17511627	A	C	59	28	7	56	35	3	0.78	0.78	0.22	0.22	C	1.75	4.11201E-05	Alzheimer's disease	Brain health and disorders
rs983332	G	T	60	26	8	58	31	5	0.78	0.78	0.22	0.22	A	1	4.11201E-05	Response to TNF antagonist treatment	General health
rs1800813	G	A	56	35	3	57	32	5	0.78	0.78	0.22	0.22	G	0.1	4.11201E-05	Corneal curvature	General health
rs8046148	A	G	3	36	55	6	31	57	0.22	0.23	0.78	0.77	G	1.32	4.04285E-05	Testicular germ cell tumor	Cancer
rs9508025	C	G	57	32	5	57	31	6	0.78	0.77	0.22	0.23	C	1.14	4.04285E-05	Coronary heart disease	Heart health and disorders
rs248812	C	A	3	37	54	3	36	55	0.23	0.22	0.77	0.78	A	0.26	4.04285E-05	Stroke	Brain health and disorders
rs247616	C	T	56	33	5	55	34	5	0.77	0.77	0.23	0.23	T	2.99	3.97725E-05	Cardiovascular disease risk factors	Heart health and disorders
rs11037965	C	T	52	40	2	53	39	2	0.77	0.77	0.23	0.23	T	1.4	3.97725E-05	Blood pressure measurement high sodium intervention	Heart health and disorders
rs11597473	G	C	56	33	5	55	34	5	0.77	0.77	0.23	0.23	G	1.0638298	3.97725E-05	Schizophrenia	Brain health and disorders
rs61041336	A	G	54	36	4	52	41	1	0.77	0.77	0.23	0.23	G	0.4512	3.97725E-05	Neuritic plaque	Brain health and disorders
rs247617	C	A	56	33	5	55	34	5	0.77	0.77	0.23	0.23	C	0.0509	3.97725E-05	HDL cholesterol	General health
rs3816063	C	T	57	31	6	54	36	4	0.77	0.77	0.23	0.23	A	0.03	3.97725E-05	Obesity-related traits	Obesity
rs2241193	T	C	8	29	57	7	32	55	0.24	0.24	0.76	0.76	C	1	3.85579E-05	Visceral fat	Obesity
rs16860328	A	G	56	30	8	53	37	4	0.76	0.76	0.24	0.24	G	0.04	3.85579E-05	Menarche age at onset	Reproductive health
rs10496584	A	G	58	26	10	53	35	6	0.76	0.75	0.24	0.25	G	158.69	3.79954E-05	Lentiform nucleus volume	Misc
rs10520045	G	T	55	31	8	52	38	4	0.75	0.76	0.25	0.24	T	1.32	3.79954E-05	Major depressive disorder	Brain health and disorders
rs10229583	G	A	58	26	10	49	43	2	0.76	0.75	0.24	0.25	G	1.14	3.79954E-05	Type 2 diabetes	Diabetes
rs1047014	T	C	52	37	5	57	28	9	0.75	0.76	0.25	0.24	T	0.032	3.79954E-05	Height	General health
rs166040	A	G	5	36	53	5	37	52	0.24	0.25	0.76	0.75	G	1.6054	3.79954E-05	Major depressive disorder	Brain health and disorders
rs1153188	T	A	7	32	55	4	39	51	0.24	0.25	0.76	0.75	A	1.08	3.79954E-05	Type 2 diabetes	Diabetes
rs6750047	A	G	5	36	53	5	37	52	0.24	0.25	0.76	0.75	A	0.092	3.79954E-05	Cutaneous malignant melanoma	Cancer
rs1532331	G	T	6	34	54	2	43	49	0.24	0.25	0.76	0.75	G	0.03	3.79954E-05	Menarche age at onset	Reproductive health
rs12564022	C	T	49	42	3	54	33	7	0.74	0.75	0.26	0.25	T	1.17	3.74602E-05	Psoriasis	Immune diseases and disorders
rs60624478	G	A	52	37	5	48	44	2	0.75	0.74	0.25	0.26	A	1.17	3.74602E-05	Response to methotrexate in juvenile idiopathic arthritis	General health
rs220836	C	T	4	40	50	6	35	53	0.26	0.25	0.74	0.75	G	0.03	3.74602E-05	Obesity-related traits	Obesity
rs4795067	A	G	51	37	6	53	34	7	0.74	0.74	0.26	0.26	G	1.2	3.69508E-05	Psoriasis	Immune diseases and disorders
rs2309717	C	A	47	45	2	50	40	4	0.74	0.74	0.26	0.26	A	1.143	3.69508E-05	Refractive astigmatism	General health
rs10229603	T	C	51	37	6	51	38	5	0.74	0.74	0.26	0.26	C	1	3.69508E-05	Attention deficit hyperactivity disorder and conduct disorder	Brain health and disorders
rs9847987	C	T	48	43	3	49	42	3	0.74	0.74	0.26	0.26	T	0.2696	3.69508E-05	Neuritic plaque	Brain health and disorders
rs10799824	G	A	51	37	6	52	36	6	0.74	0.74	0.26	0.26	A	0.123	3.69508E-05	Thyroid hormone levels	General health
rs2081687	T	C	4	41	49	6	38	50	0.26	0.27	0.74	0.73	T	0.038	3.64657E-05	Cholesterol, total	General health
rs10938494	G	A	51	36	7	55	29	10	0.73	0.74	0.27	0.26	A	0.06	3.64657E-05	Sphingolipid levels	Misc
rs6075982	C	T	54	31	9	51	36	7	0.74	0.73	0.26	0.27	A	0.04	3.64657E-05	Obesity-related traits	Obesity
rs4973341	C	T	10	30	54	8	35	51	0.27	0.27	0.73	0.73	T	1.2195122	3.60036E-05	Primary biliary cirrhosis	Immune diseases and disorders
rs2806933	A	C	9	33	52	5	40	49	0.27	0.27	0.73	0.73	A	0.0025	3.60036E-05	Trans fatty acid levels	General health
rs17135875	T	C	50	38	6	48	41	5	0.73	0.73	0.27	0.27	C	4.81	3.60036E-05	Blood pressure measurement cold pressor test	Heart health and disorders
rs987870	A	G	46	46	2	51	35	8	0.73	0.73	0.27	0.27	C	1.4	3.60036E-05	Asthma	Immune diseases and disorders
rs12719740	G	A	52	34	8	51	35	8	0.73	0.73	0.27	0.27	T	1.15	3.60036E-05	Arthritis juvenile idiopathic	Immune diseases and disorders
rs417065	C	A	49	39	6	49	38	7	0.73	0.72	0.27	0.28	A	1.17	3.55631E-05	Psoriasis	Immune diseases and disorders
rs2887631	G	A	6	40	48	3	45	46	0.28	0.27	0.72	0.73	G	1	3.55631E-05	Behavioural disinhibition generation interaction	Brain health and disorders
rs4311394	A	G	50	37	7	49	38	7	0.73	0.72	0.27	0.28	G	0.96	3.55631E-05	Adiponectin levels	Obesity
rs6450176	G	A	50	37	7	49	38	7	0.73	0.72	0.27	0.28	A	0.49	3.55631E-05	HDL cholesterol	General health
rs17101923	G	T	49	39	6	51	34	9	0.73	0.72	0.27	0.28	G	0.212	3.55631E-05	Primary tooth development time to first tooth eruption	Misc
rs17144465	A	G	51	34	9	47	41	6	0.72	0.72	0.28	0.28	G	1.56	3.51432E-05	Major depressive disorder broad	Brain health and disorders
rs11156875	A	G	49	37	8	49	38	7	0.72	0.72	0.28	0.28	A	1.07	3.51432E-05	Schizophrenia	Brain health and disorders
rs3804047	A	G	49	37	8	46	42	6	0.72	0.71	0.28	0.29	C	1.52	3.47427E-05	Staphylococcus aureus infection	Immune diseases and disorders
rs9472414	T	A	50	34	10	48	39	7	0.71	0.72	0.29	0.28	A	0.026	3.47427E-05	Height	General health
rs4552569	C	T	7	39	48	6	42	46	0.28	0.29	0.72	0.71	C	1.21	3.47427E-05	Ankylosing spondylitis	Immune diseases and disorders
rs13402855	C	T	5	43	46	5	44	45	0.28	0.29	0.72	0.71	C	0.2262	3.47427E-05	Metabolite levels 5-HIAA	General health
rs11177669	G	A	48	37	9	41	52	1	0.71	0.71	0.29	0.29	A	4.5	3.43607E-05	Height	General health
rs11891401	T	A	48	37	9	48	38	8	0.71	0.71	0.29	0.29	T	0.67	3.43607E-05	Blood pressure	Heart health and disorders
rs9874923	C	T	47	40	7	47	39	8	0.71	0.71	0.29	0.29	T	0.104	3.43607E-05	Mean arterial pressure alcohol consumption interaction	General health
rs2060793	A	G	8	38	48	8	39	47	0.29	0.29	0.71	0.71	A	0.25	3.43607E-05	Vitamin D levels	General health
rs10919388	A	C	11	32	51	5	45	44	0.29	0.29	0.71	0.71	C	0.0334	3.43607E-05	Waist-to-hip ratio adjusted for body mass index	Obesity
rs1341239	A	C	10	35	49	5	46	43	0.29	0.30	0.71	0.70	T	1.2	3.39963E-05	Paget's disease	General health
rs11264799	C	T	48	37	9	47	38	9	0.71	0.70	0.29	0.30	C	1.135	3.39963E-05	IgA nephropathy	Immune diseases and disorders
rs2282930	G	A	46	40	8	47	39	8	0.70	0.71	0.30	0.29	A	0.03	3.39963E-05	Bone mineral density	General health
rs4937126	G	A	43	45	6	44	44	6	0.70	0.70	0.30	0.30	G	1.06	3.36485E-05	Coronary heart disease	Heart health and disorders
rs10091374	T	A	47	38	9	45	41	8	0.70	0.70	0.30	0.30	A	0.043	3.36485E-05	Cardiac Troponin-T levels	Heart health and disorders
rs1048886	A	G	46	39	9	46	38	10	0.70	0.69	0.30	0.31	G	1.54	3.33167E-05	Type 2 diabetes	Diabetes
rs34075049	G	A	47	36	11	39	53	2	0.69	0.70	0.31	0.30	A	0.5887	3.33167E-05	Neurofibrillary tangles	Brain health and disorders
rs130067	T	G	41	47	6	44	42	8	0.69	0.69	0.31	0.31	G	1.05	3.3E-05	Prostate cancer	Cancer
rs4468361	T	C	11	37	46	6	46	42	0.31	0.31	0.69	0.69	T	1	3.3E-05	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs3903703	A	G	11	37	46	10	40	44	0.31	0.32	0.69	0.68	A	4.524	3.26979E-05	Very long-chain saturated fatty acid levels fatty acid 24:0	General health
rs4757391	C	T	11	38	45	8	43	43	0.32	0.31	0.68	0.69	C	0.88	3.26979E-05	Systolic blood pressure	Heart health and disorders
rs9393915	C	T	40	48	6	39	51	4	0.68	0.69	0.32	0.31	T	0.042	3.26979E-05	Blood metabolite ratios	Heart health and disorders
rs8033957	T	C	44	41	9	46	36	12	0.69	0.68	0.31	0.32	G	0.03	3.26979E-05	Obesity-related traits	Obesity
rs555267	G	T	45	38	11	44	41	9	0.68	0.69	0.32	0.31	T	0.016	3.26979E-05	Body mass index	Obesity
rs274557	T	C	48	32	14	40	47	7	0.68	0.68	0.32	0.32	T	0.14	3.24097E-05	Plasma omega-6 polyunsaturated fatty acid levels arachidonic acid	General health
rs6085533	T	A	44	39	11	43	42	9	0.68	0.68	0.32	0.32	A	0.04	3.24097E-05	Metabolite levels  X-11787	General health
rs1021188	C	T	7	47	40	7	48	39	0.32	0.33	0.68	0.67	C	3.89	3.21347E-05	Bone mineral density	General health
rs5757717	T	C	13	36	45	8	45	41	0.33	0.32	0.67	0.68	C	1.0752687	3.21347E-05	Schizophrenia	Brain health and disorders
rs4072037	C	T	12	38	44	12	39	43	0.33	0.34	0.67	0.66	C	0.012	3.18725E-05	Magnesium levels	General health
rs7705093	C	T	40	45	9	41	44	9	0.66	0.67	0.34	0.33	T	2.2	3.18725E-05	Birdshot chorioretinopathy	Misc
rs2675968	C	T	40	45	9	48	30	16	0.66	0.67	0.34	0.33	T	1.016	3.18725E-05	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia combined	Brain health and disorders
rs12707249	C	T	41	43	10	39	48	7	0.66	0.67	0.34	0.33	A	0.02	3.18725E-05	Obesity-related traits	Obesity
rs7729447	G	A	43	39	12	44	36	14	0.66	0.66	0.34	0.34	G	0.46	3.16226E-05	Blood pressure	Heart health and disorders
rs2388896	A	G	11	41	42	12	40	42	0.34	0.34	0.66	0.66	G	1.28	3.16226E-05	Tetralogy of Fallot	Heart health and disorders
rs12617656	T	C	43	38	13	44	35	15	0.66	0.65	0.34	0.35	T	1.557	3.13844E-05	Rheumatoid arthritis	Immune diseases and disorders
rs1337332	A	C	13	39	42	12	42	40	0.35	0.35	0.65	0.65	C	0.022	3.11575E-05	Body mass index	Obesity
rs10822145	C	T	42	38	14	37	49	8	0.65	0.65	0.35	0.35	C	0.038	3.11575E-05	Triglycerides	General health
rs35669975	C	G	42	37	15	42	38	14	0.64	0.65	0.36	0.35	C	1.92	3.09416E-05	Obesity in adult survivors of childhood cancer exposed to cranial radiation	Obesity
rs13210323	A	C	41	39	14	38	46	10	0.64	0.65	0.36	0.35	A	1.17	3.09416E-05	Height	General health
rs9788721	C	T	13	40	41	13	41	40	0.35	0.36	0.65	0.64	T	0.007	3.09416E-05	Local histogram emphysema pattern	Pulmonology
rs161802	G	T	36	48	10	37	47	10	0.64	0.64	0.36	0.36	T	1.1111	3.07361E-05	Ischemic stroke	Brain health and disorders
rs648516	C	T	42	36	16	40	41	13	0.64	0.64	0.36	0.36	T	1.06	3.07361E-05	Schizophrenia	Brain health and disorders
rs11710456	G	A	36	48	10	34	53	7	0.64	0.64	0.36	0.36	G	0.6427	3.07361E-05	IgG glycosylation	Immune diseases and disorders
rs9940128	G	A	40	41	13	39	42	13	0.64	0.64	0.36	0.36	A	0.083	3.07361E-05	Body mass index	Obesity
rs7914558	G	A	39	41	14	38	44	12	0.63	0.64	0.37	0.36	G	1.22	3.05409E-05	Schizophrenia	Brain health and disorders
rs2431623	A	G	40	40	14	37	45	12	0.64	0.63	0.36	0.37	G	0.091	3.05409E-05	Asymmetrical dimethylarginine levels	General health
rs3885907	C	A	10	49	35	13	42	39	0.37	0.36	0.63	0.64	G	2.66	3.05409E-05	Adverse response to chemotherapy in breast cancer alopecia cyclophosphamide+epirubicin+_-5FU	Drug response
rs385492	T	C	13	42	39	14	41	39	0.36	0.37	0.64	0.63	T	1.06	3.05409E-05	Schizophrenia	Brain health and disorders
rs3793947	G	A	36	47	11	32	54	8	0.63	0.63	0.37	0.37	G	1.0764	3.03555E-05	Parkinson's disease	Brain health and disorders
rs2315656	G	A	9	53	32	9	52	33	0.38	0.37	0.62	0.63	G	0.03	3.01796E-05	Obesity-related traits	Obesity
rs11073058	G	T	38	40	16	35	47	12	0.62	0.62	0.38	0.38	T	0.09	3.00129E-05	Axial length	Misc
rs6500602	T	C	16	41	37	10	52	32	0.39	0.38	0.61	0.62	T	1.06	2.98552E-05	Schizophrenia	Brain health and disorders
rs634308	C	T	10	52	32	15	43	36	0.38	0.39	0.62	0.61	G	0.1	2.98552E-05	Immune response to anthrax vaccine	Immune diseases and disorders
rs3869109	A	G	14	46	34	17	39	38	0.39	0.39	0.61	0.61	G	1.14	2.97062E-05	Coronary heart disease	Heart health and disorders
rs9316337	G	A	34	46	14	36	43	15	0.61	0.61	0.39	0.39	G	1.0526316	2.97062E-05	Schizophrenia	Brain health and disorders
rs1332099	T	C	15	43	36	12	50	32	0.39	0.39	0.61	0.61	T	1	2.97062E-05	Pediatric autoimmune diseases	Immune diseases and disorders
rs62441014	T	C	37	40	17	36	43	15	0.61	0.61	0.39	0.39	C	0.07	2.97062E-05	Glomerular filtration rate in chronic kidney disease	General health
rs1891159	A	G	18	37	39	16	42	36	0.39	0.39	0.61	0.61	A	0.04	2.97062E-05	Obesity-related traits	Obesity
rs16896742	A	G	29	56	9	32	51	11	0.61	0.61	0.39	0.39	G	0.04	2.97062E-05	Menarche age at onset	Reproductive health
rs9548988	C	T	37	39	18	33	48	13	0.60	0.61	0.40	0.39	T	1.1	2.95657E-05	Ulcerative colitis	Immune diseases and disorders
rs7551732	T	A	17	41	36	13	50	31	0.40	0.40	0.60	0.60	A	0.027	2.94334E-05	Height	General health
rs12032672	A	C	31	50	13	32	49	13	0.60	0.60	0.40	0.40	C	1.99	2.94334E-05	Periodontal microbiota	Misc
rs2301436	C	T	34	44	16	33	47	14	0.60	0.60	0.40	0.40	T	1.21	2.94334E-05	Crohn's disease	Digestive system and its disorders
rs13135284	T	C	17	42	35	15	47	32	0.40	0.41	0.60	0.59	C	1	2.93092E-05	DNA methylation parent-of-origin	Misc
rs2742417	C	T	32	47	15	33	46	15	0.59	0.60	0.41	0.40	T	1	2.93092E-05	Response to anti-depressant treatment in major depressive disorder	General health
rs367543	C	T	19	40	35	16	45	33	0.41	0.41	0.59	0.59	T	1.05	2.91928E-05	Schizophrenia	Brain health and disorders
rs6990042	G	T	13	51	30	12	54	28	0.41	0.41	0.59	0.59	G	0.019	2.91928E-05	Body mass index	Obesity
rs1397142	G	A	34	42	18	29	53	12	0.59	0.59	0.41	0.41	A	0.03	2.91928E-05	Obesity-related traits	Obesity
rs359268	T	C	28	53	13	33	44	17	0.58	0.59	0.42	0.41	C	2.81	2.90841E-05	Hypersomnia HLA-DQB1*06:02 negative	Misc
rs1612122	A	T	35	40	19	30	49	15	0.59	0.58	0.41	0.42	T	1.17	2.90841E-05	Major depressive disorder broad	Brain health and disorders
rs10051722	A	C	30	49	15	33	44	17	0.58	0.59	0.42	0.41	C	1.0947279	2.90841E-05	Crohn's disease	Digestive system and its disorders
rs59336	T	A	32	46	16	25	59	10	0.59	0.58	0.41	0.42	T	1.09	2.90841E-05	Colorectal cancer	Cancer
rs6968385	C	T	31	47	16	28	54	12	0.58	0.59	0.42	0.41	T	1	2.90841E-05	Attention deficit hyperactivity disorder time to onset	Brain health and disorders
rs4821132	C	T	32	46	16	33	43	18	0.59	0.58	0.41	0.42	C	1	2.90841E-05	Visceral adipose tissue adjusted for BMI	Obesity
rs1227756	G	A	29	51	14	34	42	18	0.58	0.59	0.42	0.41	G	0.57	2.90841E-05	Non-alcoholic fatty liver disease histology lobular	Obesity
rs6670655	T	C	16	47	31	18	42	34	0.42	0.41	0.58	0.59	T	1.26	2.90841E-05	Height	General health
rs7917772	G	A	16	47	31	10	58	26	0.42	0.41	0.58	0.59	A	0.0269	2.90841E-05	Waist-to-hip ratio adjusted for body mass index	Obesity
rs2282978	T	C	31	45	18	25	58	11	0.57	0.57	0.43	0.43	C	5.8	2.88892E-05	Height	General health
rs6845621	G	A	31	45	18	33	40	21	0.57	0.56	0.43	0.44	C	5.53	2.88027E-05	Adverse response to chemotherapy in breast cancer alopecia cyclophosphamide+doxorubicin+_-5FU	Drug response
rs2510897	A	C	28	50	16	34	39	21	0.56	0.57	0.44	0.43	A	0.029	2.88027E-05	Height	General health
rs1079572	G	A	15	53	26	18	46	30	0.44	0.44	0.56	0.56	G	16.258	2.87233E-05	Forced vital capacity	Pulmonology
rs10784762	C	T	22	38	34	20	43	31	0.44	0.44	0.56	0.56	T	2.38	2.87233E-05	QRS duration	Heart health and disorders
rs6983777	A	G	22	38	34	16	51	27	0.44	0.44	0.56	0.56	A	1	2.87233E-05	Attention deficit hyperactivity disorder combined symptoms	Brain health and disorders
rs12485738	A	G	16	51	27	15	52	27	0.44	0.44	0.56	0.56	A	0.02	2.87233E-05	Mean platelet volume	Heart health and disorders
rs12691307	A	G	28	49	17	24	58	12	0.56	0.56	0.44	0.44	A	1.073	2.87233E-05	Schizophrenia	Brain health and disorders
rs1432133	A	G	19	45	30	13	58	23	0.44	0.45	0.56	0.55	T	1.02	2.86508E-05	Hepatitis	Immune diseases and disorders
rs153916	C	T	17	50	27	16	51	27	0.45	0.44	0.55	0.56	T	0.031	2.86508E-05	Pulmonary function	Pulmonology
rs231779	C	T	28	48	18	29	45	20	0.55	0.55	0.45	0.45	T	1.126	2.85853E-05	Hypothyroidism	Immune diseases and disorders
rs6940729	T	A	27	50	17	30	43	21	0.55	0.55	0.45	0.45	T	0.027	2.85853E-05	Plasma homocysteine levels	Heart health and disorders
rs6712515	T	C	24	55	15	28	48	18	0.55	0.55	0.45	0.45	T	0.026	2.85853E-05	Educational attainment	Mental aptitude and behavioural traits
rs738322	A	G	17	50	27	21	43	30	0.45	0.45	0.55	0.55	G	0.06	2.85853E-05	Cutaneous nevi	Cancer
rs11714574	A	T	28	46	20	29	45	20	0.54	0.55	0.46	0.45	T	2.38	2.85266E-05	Response to abacavir-containing treatment in HIV-1 infection virologic failure	General health
rs3112612	G	A	18	49	27	21	44	29	0.45	0.46	0.55	0.54	T	1.15	2.85266E-05	Breast cancer	Cancer
rs6429082	T	C	20	45	29	20	46	28	0.45	0.46	0.55	0.54	C	1	2.85266E-05	Adiposity	Obesity
rs1624802	A	G	26	50	18	26	51	17	0.54	0.55	0.46	0.45	A	0.02	2.85266E-05	Obesity-related traits	Obesity
rs2191349	G	T	18	51	25	22	42	30	0.46	0.46	0.54	0.54	T	1	2.84746E-05	Fasting glucose-related traits	General health
rs1108842	A	C	21	44	29	17	53	24	0.46	0.46	0.54	0.54	C	0.03	2.84746E-05	Adiponectin levels	Obesity
rs13083798	A	G	21	44	29	17	53	24	0.46	0.46	0.54	0.54	A	0.0283	2.84746E-05	Waist-to-hip ratio adjusted for body mass index	Obesity
rs3893464	G	A	28	46	20	30	41	23	0.54	0.54	0.46	0.46	G	1.53	2.84746E-05	Graves' disease	Immune diseases and disorders
rs4218	C	G	26	50	18	31	39	24	0.54	0.54	0.46	0.46	G	0.1	2.84746E-05	Social communication problems	Brain health and disorders
rs6854137	T	G	27	46	21	28	45	21	0.53	0.54	0.47	0.46	A	1	2.84293E-05	Vein graft stenosis in coronary artery bypass grafting	Heart health and disorders
rs934734	G	A	22	44	28	23	43	28	0.47	0.47	0.53	0.53	G	1.142	2.83905E-05	Rheumatoid arthritis	Immune diseases and disorders
rs837763	C	T	19	51	24	15	58	21	0.47	0.47	0.53	0.53	C	0.088	2.83905E-05	Mean corpuscular hemoglobin concentration	Heart health and disorders
rs12537	C	T	26	47	21	26	46	22	0.53	0.52	0.47	0.48	C	1.407	2.83583E-05	IgA nephropathy	Immune diseases and disorders
rs8049439	T	C	29	41	24	27	44	23	0.53	0.52	0.47	0.48	T	0.086	2.83583E-05	Educational attainment	Mental aptitude and behavioural traits
rs4929923	T	C	25	40	29	21	49	24	0.48	0.48	0.52	0.52	T	2.3	2.83326E-05	Menarche age at onset	Reproductive health
rs2180439	C	T	27	37	30	23	46	25	0.48	0.49	0.52	0.51	C	1.82	2.83134E-05	Male-pattern baldness	Appearance
rs4735692	A	G	28	36	30	23	47	24	0.49	0.49	0.51	0.51	A	1.06	2.83006E-05	Obesity	Obesity
rs941576	A	G	23	47	24	19	56	19	0.49	0.50	0.51	0.50	A	1.11	2.82941E-05	Type 1 diabetes	Diabetes
rs7165042	C	G	24	46	24	23	49	22	0.50	0.51	0.50	0.49	C	1.06	2.82941E-05	Myocardial infarction	Heart health and disorders
rs11713169	A	C	86	8	0	86	8	0	0.96	0.96	0.04	0.04	C	0.052	1.36249E-15	Motion sickness	Misc
rs3769124	G	A	86	8	0	86	8	0	0.96	0.96	0.04	0.04	G	0.047	1.36249E-15	Pulmonary function	Pulmonology
rs13170526	T	G	88	6	0	88	6	0	0.97	0.97	0.03	0.03	C	0.03	8.98345E-16	Obesity-related traits	Obesity
rs56343172	C	T	83	11	0	84	9	1	0.94	0.94	0.06	0.06	T	5.15	8.81735E-16	Thionamide-induced agranulocytosis in Graves' disease	General health
rs7077361	T	C	84	9	1	83	11	0	0.94	0.94	0.06	0.06	T	1.19	8.81735E-16	Parkinson's disease	Brain health and disorders
rs11825685	C	T	84	9	1	83	11	0	0.94	0.94	0.06	0.06	C	0.227	8.81735E-16	IgG glycosylation	Immune diseases and disorders
rs16966389	G	A	80	11	3	77	17	0	0.91	0.91	0.09	0.09	G	2.73	6.74918E-16	Hypersomnia HLA-DQB1*06:02 negative	Misc
rs11867410	T	C	90	4	0	90	4	0	0.98	0.98	0.02	0.02	C	4.21	4.99827E-16	Blood pressure measurement high sodium and potassium intervention	Heart health and disorders
rs142453246	A	T	90	4	0	90	4	0	0.98	0.98	0.02	0.02	T	1.25	4.99827E-16	Schizophrenia	Brain health and disorders
rs9257809	A	G	90	4	0	90	4	0	0.98	0.98	0.02	0.02	A	1.21	4.99827E-16	Barrett's esophagus	Digestive system and its disorders
rs10162694	C	A	78	14	2	76	18	0	0.90	0.90	0.10	0.10	A	1.55	4.80879E-16	Bronchopulmonary dysplasia	Pulmonology
rs111383589	C	T	77	16	1	76	18	0	0.90	0.90	0.10	0.10	C	0.087	4.80879E-16	Bulimia nervosa	Brain health and disorders
rs4990638	T	C	77	16	1	77	16	1	0.90	0.90	0.10	0.10	C	0.06	4.80879E-16	Personality dimensions	Brain health and disorders
rs10894147	C	T	77	16	1	77	16	1	0.90	0.90	0.10	0.10	A	0.03	4.80879E-16	Obesity-related traits	Obesity
rs359980	T	C	74	18	2	73	20	1	0.88	0.88	0.12	0.12	G	0.03	4.02927E-16	Obesity-related traits	Obesity
rs75565482	A	G	80	14	0	80	14	0	0.93	0.93	0.07	0.07	A	5.1	4.02707E-16	Emphysema imaging phenotypes	Pulmonology
rs77061563	C	T	92	2	0	92	2	0	0.99	0.99	0.01	0.01	C	1.1904762	3.29635E-16	Leprosy	Immune diseases and disorders
rs78177980	G	A	92	2	0	92	2	0	0.99	0.99	0.01	0.01	G	1.1235955	3.29635E-16	Schizophrenia	Brain health and disorders
rs61528732	T	C	92	2	0	92	2	0	0.99	0.99	0.01	0.01	T	0.4	3.29635E-16	Intraocular pressure	General health
rs11006464	T	C	92	2	0	92	2	0	0.99	0.99	0.01	0.01	T	0.3832	3.29635E-16	Oleic acid 18:1n-9 plasma levels	General health
rs34670419	G	T	92	2	0	93	0	1	0.99	0.99	0.01	0.01	T	0.346	3.29635E-16	Sex hormone levels	Reproductive health
rs10520189	G	A	92	2	0	92	2	0	0.99	0.99	0.01	0.01	A	0.29	3.29635E-16	Cannabis use age at onset	General health
rs142816172	C	T	92	2	0	92	2	0	0.99	0.99	0.01	0.01	C	0.273	3.29635E-16	Eating disorders purging via substances	Brain health and disorders
rs1408272	T	G	92	2	0	92	2	0	0.99	0.99	0.01	0.01	G	0.033	3.29635E-16	Red blood cell traits	Immune diseases and disorders
rs11930273	G	A	65	29	0	68	23	3	0.85	0.85	0.15	0.15	G	1	2.12751E-16	Visceral adipose tissue adjusted for BMI	Obesity
rs3811345	A	G	65	27	2	65	27	2	0.84	0.84	0.16	0.16	A	3.4	2.0156E-16	Emphysema imaging phenotypes	Pulmonology
rs4952632	T	G	62	31	1	66	23	5	0.82	0.82	0.18	0.18	C	2.325	1.91788E-16	Electrocardiographic traits	Heart health and disorders
rs12997023	T	C	62	31	1	66	23	5	0.82	0.82	0.18	0.18	C	1.69	1.91788E-16	QT interval	Heart health and disorders
rs17213965	C	T	64	27	3	64	27	3	0.82	0.82	0.18	0.18	T	0.12	1.91788E-16	Waist-hip ratio	General health
rs4734806	A	G	79	15	0	81	11	2	0.92	0.92	0.08	0.08	G	0.2075	1.89016E-16	Periodontitis DPAL	Misc
rs16942887	G	A	63	28	3	64	26	4	0.82	0.82	0.18	0.18	A	1.27	1.87355E-16	HDL cholesterol	General health
rs970843	G	C	62	30	2	60	34	0	0.82	0.82	0.18	0.18	C	1	1.87355E-16	Obesity extreme	Obesity
rs6782531	G	C	66	22	6	60	34	0	0.82	0.82	0.18	0.18	G	0.97	1.87355E-16	Blood pressure	Heart health and disorders
rs780092	A	G	60	34	0	61	32	1	0.82	0.82	0.18	0.18	G	0.05	1.87355E-16	Triglycerides	General health
rs7590720	G	A	6	24	64	4	28	62	0.19	0.19	0.81	0.81	G	1.35	1.79275E-16	Alcohol dependence	General health
rs6544366	G	T	60	31	3	60	31	3	0.80	0.80	0.20	0.20	T	0.04	1.75585E-16	Triglycerides	General health
rs84044	T	G	4	29	61	6	25	63	0.20	0.20	0.80	0.80	A	0.03	1.75585E-16	Obesity-related traits	Obesity
rs10486483	G	A	58	32	4	56	36	2	0.79	0.79	0.21	0.21	A	1.0987586	1.65708E-16	Crohn's disease	Digestive system and its disorders
rs2900	G	A	60	28	6	59	30	5	0.79	0.79	0.21	0.21	G	0.2021	1.65708E-16	IgG glycosylation	Immune diseases and disorders
rs2460504	G	C	57	33	4	55	37	2	0.78	0.78	0.22	0.22	C	24.57	1.62766E-16	Thiazide-induced adverse metabolic effects in hypertensive patients	General health
rs1158058	A	T	55	36	3	56	34	4	0.78	0.78	0.22	0.22	T	0.2918	1.59979E-16	Metabolite levels MHPG	General health
rs17651119	C	T	85	9	0	85	9	0	0.95	0.95	0.05	0.05	C	3.1807	1.52234E-16	Major depressive disorder	Brain health and disorders
rs17053082	C	T	85	9	0	85	9	0	0.95	0.95	0.05	0.05	T	1.49	1.52234E-16	Type 2 diabetes	Diabetes
rs118136136	T	A	87	5	2	86	7	1	0.95	0.95	0.05	0.05	T	0.3363	1.52234E-16	Cerebral amyloid deposition in APOEe4 non-carriers PET imaging	Brain health and disorders
rs1521	C	T	3	40	51	4	38	52	0.24	0.24	0.76	0.76	T	1.92	1.50183E-16	Graves' disease	Immune diseases and disorders
rs17042171	C	A	49	38	7	53	30	11	0.72	0.72	0.28	0.28	A	1.65	1.38715E-16	Atrial fibrillation	Heart health and disorders
rs6817105	T	C	49	38	7	53	30	11	0.72	0.72	0.28	0.28	C	1.64	1.38715E-16	Atrial fibrillation	Heart health and disorders
rs58880514	T	A	49	38	7	47	42	5	0.72	0.72	0.28	0.28	A	1.2987013	1.38715E-16	Schizophrenia	Brain health and disorders
rs2200733	C	T	49	38	7	53	30	11	0.72	0.72	0.28	0.28	T	1.26	1.38715E-16	Stroke ischemic	Brain health and disorders
rs17522122	G	T	47	40	7	45	44	5	0.71	0.71	0.29	0.29	T	0.019	1.35571E-16	Body mass index	Obesity
rs10088218	G	A	73	19	2	73	19	2	0.88	0.88	0.12	0.12	A	1.2987013	1.29248E-16	Epithelial ovarian cancer	Cancer
rs4321386	C	G	72	21	1	71	23	0	0.88	0.88	0.12	0.12	G	1	1.29248E-16	Hormone measurements	General health
rs2769264	T	G	44	40	10	48	32	14	0.68	0.68	0.32	0.32	G	0.313	1.27733E-16	Blood trace element Cu levels	Heart health and disorders
rs7815909	A	G	71	22	1	71	22	1	0.87	0.87	0.13	0.13	A	0.102	1.24618E-16	Height	General health
rs7952067	G	C	72	20	2	70	24	0	0.87	0.87	0.13	0.13	C	0.0052	1.24618E-16	Trans fatty acid levels	General health
rs12637471	G	A	35	51	8	41	39	14	0.64	0.64	0.36	0.36	G	1.1876	1.21006E-16	Parkinson's disease	Brain health and disorders
rs6480463	C	T	7	54	33	16	36	42	0.36	0.36	0.64	0.64	G	1.415	1.2022E-16	Suicide behavior	Brain health and disorders
rs6902771	C	T	39	42	13	37	46	11	0.64	0.64	0.36	0.36	C	1.24	1.2022E-16	Alcohol dependence	General health
rs7957470	A	G	40	38	16	39	40	15	0.63	0.63	0.37	0.37	G	0.02	1.18764E-16	Obesity-related traits	Obesity
rs27524	A	G	17	37	40	13	45	36	0.38	0.38	0.62	0.62	A	1.195	1.18092E-16	Psoriasis	Immune diseases and disorders
rs13160161	G	A	40	35	19	34	47	13	0.61	0.61	0.39	0.39	A	0.04	1.16854E-16	Obesity-related traits	Obesity
rs2187324	T	G	32	50	12	31	52	11	0.61	0.61	0.39	0.39	T	4.614	1.16287E-16	Very long-chain saturated fatty acid levels fatty acid 20:0	General health
rs838705	G	A	19	36	39	13	48	33	0.39	0.39	0.61	0.61	A	0.02	1.16287E-16	Calcium levels	General health
rs11924265	T	C	82	12	0	82	12	0	0.94	0.94	0.06	0.06	C	2.27	1.16121E-16	Crohn's disease-related phenotypes	Digestive system and its disorders
rs11241261	C	T	82	12	0	82	12	0	0.94	0.94	0.06	0.06	T	0.5443	1.16121E-16	Hippocampal sclerosis	Brain health and disorders
rs12084151	A	G	83	10	1	82	12	0	0.94	0.94	0.06	0.06	G	0.3896	1.16121E-16	Neurofibrillary tangles	Brain health and disorders
rs6479779	C	G	19	39	36	13	51	30	0.41	0.41	0.59	0.59	C	0.1943	1.14776E-16	IgG glycosylation	Immune diseases and disorders
rs694419	T	C	19	45	30	13	57	24	0.44	0.44	0.56	0.56	T	0.0095	1.12564E-16	Serum albumin level	General health
rs7733195	G	A	26	52	16	30	44	20	0.55	0.55	0.45	0.45	G	0.066	1.12293E-16	Sitting height ratio	Appearance
rs10244051	T	G	17	52	25	22	42	30	0.46	0.46	0.54	0.54	C	0.05	1.11832E-16	Metabolic traits	Misc
rs11577354	G	A	25	42	27	20	52	22	0.49	0.49	0.51	0.51	G	0.04	1.11073E-16	Obesity-related traits	Obesity
rs1877101	C	T	0	8	86	1	6	87	0.04	0.04	0.96	0.96	G	9.55	0	Diisocyanate-induced asthma	Pulmonology
rs4713858	A	G	1	23	70	3	19	72	0.13	0.13	0.87	0.87	G	6.8	0	Height	General health
rs9271366	G	A	1	17	76	2	15	77	0.10	0.10	0.90	0.90	C	4.44	0	Ulcerative colitis or Crohn's disease	Digestive system and its disorders
rs3129934	T	C	4	19	71	2	23	69	0.14	0.14	0.86	0.86	T	3.3	0	Multiple sclerosis	Brain health and disorders
rs2002675	A	G	56	30	8	53	36	5	0.76	0.76	0.24	0.24	G	2.2	0	Menarche age at onset	Reproductive health
rs194045	C	T	60	30	4	59	32	3	0.80	0.80	0.20	0.20	G	2.13	0	Yu-Zhi constitution type in type 2 diabetes	Diabetes
rs11856574	G	A	62	29	3	59	35	0	0.81	0.81	0.19	0.19	G	2.02	0	Life threatening arrhythmia	Heart health and disorders
rs7800418	C	T	34	41	19	31	47	16	0.58	0.58	0.42	0.42	T	1.9628	0	Cognitive function	Brain health and disorders
rs7689350	A	C	60	30	4	62	26	6	0.80	0.80	0.20	0.20	C	1.93	0	Classic bladder exstrophy	Misc
rs143536437	C	T	60	32	2	60	32	2	0.81	0.81	0.19	0.19	C	1.73	0	Epilepsy remission after treatment	Brain health and disorders
rs2903692	G	A	44	44	6	48	36	10	0.70	0.70	0.30	0.30	G	1.54	0	Type 1 diabetes	Diabetes
rs2724384	G	A	4	30	60	1	36	57	0.20	0.20	0.80	0.80	A	1.47	0	Febrile seizures	General health
rs10144042	G	A	45	39	10	41	47	6	0.69	0.69	0.31	0.31	A	1.4	0	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	General health
rs1337875	G	A	0	14	80	0	14	80	0.07	0.07	0.93	0.93	G	1.37	0	Sporadic pituitary adenoma	Cancer
rs10503733	G	T	49	35	10	45	43	6	0.71	0.71	0.29	0.29	T	1.29	0	Prostate cancer	Cancer
rs12408810	C	T	61	28	5	56	38	0	0.80	0.80	0.20	0.20	C	1.25	0	Obesity early onset extreme	Obesity
rs7216064	G	A	61	30	3	62	28	4	0.81	0.81	0.19	0.19	A	1.16	0	Lung cancer	Cancer
rs181900	A	C	0	1	93	0	1	93	0.01	0.01	0.99	0.99	C	1.1494253	0	Schizophrenia	Brain health and disorders
rs561722	C	T	39	48	7	42	42	10	0.67	0.67	0.33	0.33	G	1.1328671	0	Ulcerative colitis	Immune diseases and disorders
rs1894292	G	A	44	41	9	40	49	5	0.69	0.69	0.31	0.31	G	1.1	0	Prostate cancer	Cancer
rs7141529	T	C	23	42	29	20	48	26	0.47	0.47	0.53	0.53	G	1.09	0	Prostate cancer	Cancer
rs573521	A	G	9	44	41	13	36	45	0.33	0.33	0.67	0.67	A	1	0	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Brain health and disorders
rs7725052	C	T	24	50	20	26	46	22	0.52	0.52	0.48	0.48	C	1	0	Pediatric autoimmune diseases	Immune diseases and disorders
rs1633735	C	T	60	30	4	60	30	4	0.80	0.80	0.20	0.20	T	1	0	Verbal declarative memory	Brain health and disorders
rs3851050	T	C	48	36	10	44	44	6	0.70	0.70	0.30	0.30	C	1	0	Chronic obstructive pulmonary disease-related biomarkers	Immune diseases and disorders
rs7121800	T	C	45	39	10	44	41	9	0.69	0.69	0.31	0.31	T	0.7138	0	Pit-and-Fissure caries	Misc
rs10506525	T	C	10	36	48	11	34	49	0.30	0.30	0.70	0.70	C	0.46	0	Primary tooth development time to first tooth eruption	Misc
rs9349204	A	G	65	26	3	66	24	4	0.83	0.83	0.17	0.17	G	0.367	0	Red blood cell traits	Immune diseases and disorders
rs4866334	C	T	0	16	78	1	14	79	0.09	0.09	0.91	0.91	C	0.2533	0	IgG glycosylation	Immune diseases and disorders
rs7387468	G	T	26	45	23	27	43	24	0.52	0.52	0.48	0.48	T	0.22	0	Temperament	Mental aptitude and behavioural traits
rs12446940	A	G	17	53	24	13	61	20	0.46	0.46	0.54	0.54	A	0.1929	0	Neurofibrillary tangles	Brain health and disorders
rs2352908	T	G	10	33	51	7	39	48	0.28	0.28	0.72	0.72	G	0.12	0	Social communication problems	Brain health and disorders
rs4818184	A	G	0	8	86	0	8	86	0.04	0.04	0.96	0.96	A	0.1	0	Expressive vocabulary in infants	Mental aptitude and behavioural traits
rs4771122	G	A	5	33	56	4	35	55	0.23	0.23	0.77	0.77	G	0.09	0	Body mass index	Obesity
rs7577696	A	G	31	43	20	32	41	21	0.56	0.56	0.44	0.44	G	0.08	0	Inflammatory biomarkers	Immune diseases and disorders
rs11611647	T	C	54	34	6	52	38	4	0.76	0.76	0.24	0.24	C	0.071	0	Red blood cell count	Immune diseases and disorders
rs6900489	G	C	1	19	74	1	19	74	0.11	0.11	0.89	0.89	C	0.06	0	Metabolite levels  X-11787	General health
rs9733352	G	C	34	41	19	28	53	13	0.58	0.58	0.42	0.42	C	0.06	0	Apolipoprotein Levels	General health
rs9403521	T	C	64	28	2	64	28	2	0.83	0.83	0.17	0.17	G	0.03	0	Obesity-related traits	Obesity
rs979012	T	C	11	40	43	11	40	43	0.33	0.33	0.67	0.67	T	0.0284	0	Waist-to-hip ratio adjusted for body mass index	Obesity
rs1016287	T	C	9	40	45	11	36	47	0.31	0.31	0.69	0.69	T	0.025	0	Body mass index	Obesity
rs2227901	G	A	62	28	4	60	32	2	0.81	0.81	0.19	0.19	A	0.025	0	Height	General health
rs1815314	G	A	39	44	11	36	50	8	0.65	0.65	0.35	0.35	A	0.022	0	Height	General health
rs1441264	G	A	5	51	38	10	41	43	0.32	0.32	0.68	0.68	A	0.018	0	Body mass index	Obesity
rs2633727	A	G	1	7	86	1	7	86	0.05	0.05	0.95	0.95	A	0.0016	0	Trans fatty acid levels	General health
rs13016963	A	G	31	39	24	29	43	22	0.54	0.54	0.46	0.46	A	1.14	-1.11641E-16	Melanoma	Cancer
rs314253	T	C	32	46	16	34	42	18	0.59	0.59	0.41	0.41	C	2.1	-1.14335E-16	Liver enzyme levels alkaline phosphatase	General health
rs6732565	A	G	32	46	16	34	42	18	0.59	0.59	0.41	0.41	A	1.1	-1.14335E-16	Rheumatoid arthritis	Immune diseases and disorders
rs743793	T	C	32	46	16	33	44	17	0.59	0.59	0.41	0.41	T	1	-1.14335E-16	Visceral adipose tissue_subcutaneous adipose tissue ratio	Obesity
rs7814403	T	C	37	38	19	31	50	13	0.60	0.60	0.40	0.40	G	0.03	-1.15248E-16	Obesity-related traits	Obesity
rs2382817	A	C	14	45	35	19	35	40	0.39	0.39	0.61	0.61	A	1.0738211	-1.16854E-16	Crohn's disease	Digestive system and its disorders
rs445	C	T	71	21	2	71	21	2	0.87	0.87	0.13	0.13	C	0.024	-1.20367E-16	Neutrophil count	Immune diseases and disorders
rs1192201	G	A	1	9	84	0	11	83	0.06	0.06	0.94	0.94	G	0.08	-1.25962E-16	Age-related nuclear cataracts	Aging
rs11698685	G	A	46	35	13	41	45	8	0.68	0.68	0.32	0.32	G	1.27	-1.26629E-16	Type 1 diabetes nephropathy	Diabetes
rs6691170	G	T	45	37	12	44	39	11	0.68	0.68	0.32	0.32	T	1.06	-1.26629E-16	Colorectal cancer	Cancer
rs7193343	T	C	6	33	55	5	35	54	0.24	0.24	0.76	0.76	T	1.21	-1.52446E-16	Atrial fibrillation	Heart health and disorders
rs2806974	C	T	6	33	55	9	27	58	0.24	0.24	0.76	0.76	T	0.0025	-1.52446E-16	Trans fatty acid levels	General health
rs9816226	A	T	4	27	63	2	31	61	0.19	0.19	0.81	0.81	T	0.14	-1.83192E-16	Body mass index	Obesity
rs844917	T	C	1	27	66	2	25	67	0.15	0.15	0.85	0.85	A	0.111	-2.12751E-16	Liver enzyme levels alanine transaminase	General health
rs4862110	T	C	69	23	2	67	27	0	0.86	0.86	0.14	0.14	C	1.44	-2.25671E-16	Wegener's granulomatosis	General health
rs10947261	G	T	70	21	3	67	27	0	0.86	0.86	0.14	0.14	T	1.36	-2.25671E-16	Crohn's disease	Digestive system and its disorders
rs1031261	G	C	69	23	2	68	25	1	0.86	0.86	0.14	0.14	C	1	-2.25671E-16	Hippocampal atrophy	Brain health and disorders
rs1803274	C	T	70	21	3	68	25	1	0.86	0.86	0.14	0.14	T	0.365	-2.25671E-16	Cardiovascular disease risk factors	Heart health and disorders
rs11172134	T	A	72	17	5	70	21	3	0.86	0.86	0.14	0.14	T	0.095	-2.25671E-16	Urate levels in overweight individuals	Obesity
rs7524694	T	C	69	23	2	68	25	1	0.86	0.86	0.14	0.14	G	0.03	-2.25671E-16	Obesity-related traits	Obesity
rs11190604	A	G	71	19	4	70	21	3	0.86	0.86	0.14	0.14	A	0.0236	-2.25671E-16	Palmitoleic acid 16:1n-7 plasma levels	General health
rs1801085	A	G	47	43	4	53	31	10	0.73	0.73	0.27	0.27	G	1.45	-2.80805E-16	Hypospadias	Misc
rs7843479	C	A	50	37	7	48	41	5	0.73	0.73	0.27	0.27	A	0.072	-2.80805E-16	Mean corpuscular volume	Heart health and disorders
rs9392556	T	C	51	35	8	50	37	7	0.73	0.73	0.27	0.27	T	0.036	-2.80805E-16	Blood metabolite levels	Heart health and disorders
rs12902137	T	C	49	40	5	48	42	4	0.73	0.73	0.27	0.27	T	0.1809	-2.84346E-16	Periodontitis DPAL	Misc
rs7731703	C	T	50	38	6	50	38	6	0.73	0.73	0.27	0.27	T	0.03	-2.84346E-16	Height	General health
rs2381759	A	T	74	20	0	75	18	1	0.89	0.89	0.11	0.11	T	1.0869565	-2.91962E-16	Schizophrenia	Brain health and disorders
rs17673138	A	C	76	16	2	75	18	1	0.89	0.89	0.11	0.11	C	0.4143	-2.91962E-16	Pharmacokinetics of olanzapine in severe mental disorder concentration dose ratio	General health
rs73635312	G	A	53	37	4	53	37	4	0.76	0.76	0.24	0.24	G	1.35	-3.04893E-16	Basal cell carcinoma	Cancer
rs6679454	A	G	52	39	3	54	35	5	0.76	0.76	0.24	0.24	G	1	-3.04893E-16	Immune reponse to smallpox secreted IL-10	Immune diseases and disorders
rs4149639	T	C	71	20	3	68	26	0	0.86	0.86	0.14	0.14	C	2.763	-3.49357E-16	Adverse response to chemotherapy neutropenia_leucopenia all anthracycline-based drugs	Drug response
rs2423294	G	A	72	18	4	68	26	0	0.86	0.86	0.14	0.14	T	1.41	-3.49357E-16	Ossification of the posterior longitudinal ligament of the spine	Misc
rs11665307	T	C	71	20	3	68	26	0	0.86	0.86	0.14	0.14	C	0.2071	-3.49357E-16	IgG glycosylation	Immune diseases and disorders
rs11777116	C	T	80	12	2	79	14	1	0.91	0.91	0.09	0.09	T	1.27	-3.56466E-16	Migraine - clinic-based	Brain health and disorders
rs17106184	G	A	79	14	1	80	12	2	0.91	0.91	0.09	0.09	G	1.1	-3.56466E-16	Type 2 diabetes	Diabetes
rs79464052	G	C	74	19	1	74	19	1	0.89	0.89	0.11	0.11	C	1.34	-4.19586E-16	Diffuse large B cell lymphoma	Cancer
rs7188861	C	A	74	19	1	74	19	1	0.89	0.89	0.11	0.11	A	0.044	-4.19586E-16	HDL cholesterol	General health
rs12955983	A	G	74	19	1	74	19	1	0.89	0.89	0.11	0.11	A	0.036	-4.19586E-16	Urate levels	General health
rs10947262	C	T	70	20	4	66	28	0	0.85	0.85	0.15	0.15	T	1.31	-4.37943E-16	Knee osteoarthritis	Immune diseases and disorders
rs3797535	C	T	87	7	0	87	7	0	0.96	0.96	0.04	0.04	T	1	-5.80698E-16	Blood and toenail selenium levels	Heart health and disorders
rs6085820	G	T	87	7	0	87	7	0	0.96	0.96	0.04	0.04	A	1	-5.80698E-16	Alzheimer's disease late onset	Brain health and disorders
rs12214416	T	A	88	5	1	87	7	0	0.96	0.96	0.04	0.04	A	0.5	-5.80698E-16	Lp a levels	General health
rs11216230	G	A	87	7	0	87	7	0	0.96	0.96	0.04	0.04	A	0.22	-5.80698E-16	HDL cholesterol	General health
rs2135319	G	A	87	7	0	87	7	0	0.96	0.96	0.04	0.04	A	0.194	-5.80698E-16	Bilirubin levels	General health
rs6927090	G	T	87	7	0	87	7	0	0.96	0.96	0.04	0.04	A	0.015	-5.80698E-16	Hematology traits	Heart health and disorders
rs9300039	C	A	82	11	1	82	11	1	0.93	0.93	0.07	0.07	C	1.48	-6.46809E-16	Type 2 diabetes	Diabetes
rs6756629	G	A	81	13	0	81	13	0	0.93	0.93	0.07	0.07	G	0.15	-6.46809E-16	Cholesterol, total	General health
rs17505102	G	C	84	10	0	84	10	0	0.95	0.95	0.05	0.05	G	1.5873016	-6.889E-16	Acute lymphoblastic leukemia childhood	Cancer
rs16985493	G	A	84	10	0	84	10	0	0.95	0.95	0.05	0.05	A	1.37	-6.889E-16	Migraine - clinic-based	Brain health and disorders
rs17610181	G	A	84	10	0	84	10	0	0.95	0.95	0.05	0.05	A	1.12	-6.889E-16	Osteoarthritis hip	Immune diseases and disorders
rs4736655	C	T	90	3	1	89	5	0	0.97	0.97	0.03	0.03	A	34.08	-1.34015E-15	Diisocyanate-induced asthma	Pulmonology
rs17167021	A	G	89	5	0	89	5	0	0.97	0.97	0.03	0.03	G	1.81	-1.34015E-15	Large artery stroke	Heart health and disorders
rs2596500	A	C	89	5	0	89	5	0	0.97	0.97	0.03	0.03	A	1.18	-1.34015E-15	Schizophrenia	Brain health and disorders
rs12529514	T	C	89	5	0	89	5	0	0.97	0.97	0.03	0.03	C	1.14	-1.34015E-15	Rheumatoid arthritis	Immune diseases and disorders
rs140838333	C	T	89	5	0	89	5	0	0.97	0.97	0.03	0.03	C	0.3681	-1.34015E-15	Cerebral amyloid deposition in APOEe4 non-carriers PET imaging	Brain health and disorders
rs1530530	A	G	89	5	0	89	5	0	0.97	0.97	0.03	0.03	G	0.03	-1.34015E-15	Obesity-related traits	Obesity
rs75094680	G	A	91	3	0	91	3	0	0.98	0.98	0.02	0.02	A	3.5714285	-3.09322E-15	Schizophrenia	Brain health and disorders
rs185572712	A	G	91	3	0	91	3	0	0.98	0.98	0.02	0.02	G	1.1764705	-3.09322E-15	Schizophrenia	Brain health and disorders
rs2540277	C	T	91	3	0	91	3	0	0.98	0.98	0.02	0.02	C	1.098901	-3.09322E-15	Schizophrenia	Brain health and disorders
rs11134178	T	C	91	3	0	91	3	0	0.98	0.98	0.02	0.02	T	1	-3.09322E-15	Attention deficit hyperactivity disorder	Brain health and disorders
rs144442299	C	T	93	1	0	93	1	0	0.99	0.99	0.01	0.01	T	5.4	-1.04919E-14	Emphysema imaging phenotypes	Pulmonology
rs17025867	G	A	93	1	0	93	1	0	0.99	0.99	0.01	0.01	A	1.81	-1.04919E-14	Obesity early onset extreme	Obesity
rs76316943	G	A	93	1	0	93	1	0	0.99	0.99	0.01	0.01	A	1.58	-1.04919E-14	Colorectal cancer	Cancer
rs41266839	G	C	93	1	0	93	1	0	0.99	0.99	0.01	0.01	G	1.25	-1.04919E-14	Schizophrenia	Brain health and disorders
rs13217619	T	C	93	1	0	93	1	0	0.99	0.99	0.01	0.01	T	1.25	-1.04919E-14	Schizophrenia	Brain health and disorders
rs34706883	A	C	93	1	0	93	1	0	0.99	0.99	0.01	0.01	A	1.24	-1.04919E-14	Schizophrenia	Brain health and disorders
rs74804370	T	C	93	1	0	93	1	0	0.99	0.99	0.01	0.01	C	1.1494253	-1.04919E-14	Schizophrenia	Brain health and disorders
rs114846446	G	A	93	1	0	93	1	0	0.99	0.99	0.01	0.01	A	1	-1.04919E-14	Pediatric autoimmune diseases	Immune diseases and disorders
rs75638798	C	T	93	1	0	93	1	0	0.99	0.99	0.01	0.01	C	0.7185	-1.04919E-14	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs140564516	A	G	93	1	0	93	1	0	0.99	0.99	0.01	0.01	A	0.5032	-1.04919E-14	Cognitive decline rate in late mild cognitive impairment	Brain health and disorders
rs142981069	A	G	93	1	0	93	1	0	0.99	0.99	0.01	0.01	G	0.47	-1.04919E-14	Cannabis use age at onset	General health
rs140320399	G	A	93	1	0	93	1	0	0.99	0.99	0.01	0.01	G	0.4389	-1.04919E-14	Cerebral amyloid deposition in APOEe4 non-carriers PET imaging	Brain health and disorders
rs111854052	A	T	93	1	0	93	1	0	0.99	0.99	0.01	0.01	A	0.3228	-1.04919E-14	Periodontitis Mean PAL	Misc
rs140104968	C	T	93	1	0	93	1	0	0.99	0.99	0.01	0.01	C	0.224	-1.04919E-14	Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	General health
rs1028771	A	C	93	1	0	93	1	0	0.99	0.99	0.01	0.01	A	0.2188	-1.04919E-14	HDL cholesterol	General health
rs1883711	G	C	93	1	0	93	1	0	0.99	0.99	0.01	0.01	C	0.147	-1.04919E-14	Cholesterol, total	General health
rs2734331	A	G	93	1	0	93	1	0	0.99	0.99	0.01	0.01	A	0.073	-1.04919E-14	Blood metabolite levels	Heart health and disorders
rs12432260	C	T	93	1	0	93	1	0	0.99	0.99	0.01	0.01	A	0.03	-1.04919E-14	Obesity-related traits	Obesity
